PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Keller, T; Egenberger, B; Gorboulev, V; Bernhard, F; Uzelac, Z; Gorbunov, D; Wirth, C; Koppatz, S; Dotsch, V; Hunte, C; Sitte, HH; Koepsell, H				Keller, Thorsten; Egenberger, Brigitte; Gorboulev, Valentin; Bernhard, Frank; Uzelac, Zeljko; Gorbunov, Dmitry; Wirth, Christophe; Koppatz, Stefan; Doetsch, Volker; Hunte, Carola; Sitte, Harald H.; Koepsell, Hermann			The Large Extracellular Loop of Organic Cation Transporter 1 Influences Substrate Affinity and Is Pivotal for Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; D-GLUCOSE COTRANSPORTER; CELL-FREE EXPRESSION; AMINO-ACIDS; PLASMA-MEMBRANE; FUNCTIONAL RECONSTITUTION; ANION TRANSPORTER; BINDING REGION; ROCT1; PROTEIN	Polyspecific organic anion transporters (OATs) and organic cation transporters (OCTs) of the SLC22 transporter family play a pivotal role in absorption, distribution, and excretion of drugs. Polymorphisms in these transporters influence therapeutic effects. On the basis of functional characterizations, homology modeling, and mutagenesis, hypotheses for how OCTs bind and translocate structurally different cations were raised, assuming functionally competent monomers. However, homo-oligomerization has been described for OATs and OCTs. In the present study, evidence is provided that the large extracellular loops (EL) of rat Oct1 (rOct1) and rat Oat1 (rOat1) mediate homo-but not hetero-oligomerization. Replacement of the cysteine residues in the EL of rOct1 by serine residues (rOct1(6 Delta C-l)) or breaking disulfide bonds with dithiothreitol prevented oligomerization. rOct1 chimera containing the EL of rOat1 (rOct1(rOat1-l)) showed oligomerization but reduced transporter amount in the plasma membrane. For rOct1(6 Delta C-l) and rOct1(rOat1-l), similar K-m values for 1-methyl-4-phenylpyridinium(+) (MPP+) and tetraethylammonium(+) (TEA(+)) were obtained that were higher compared with rOct1 wild type. The increased K-m of rOct1(rOat1-l) indicates an allosteric effect of EL on the cation binding region. The similar substrate affinity of the oligomerizing and non-oligomerizing loop mutants suggests that oligomerization does not influence transport function. Independent transport function of rOct1 monomers was also demonstrated by showing that K-m values for MPP+ and TEA(+) were not changed after treatment with dithiothreitol and that a tandem protein with two rOct1 monomers showed about 50% activity with unchanged K-m values for MPP+ and TEA(+) when one monomer was blocked. The data help to understand how OCTs work and how mutations in patients may affect their functions.	[Keller, Thorsten; Egenberger, Brigitte; Gorboulev, Valentin; Gorbunov, Dmitry; Koppatz, Stefan; Koepsell, Hermann] Univ Wurzburg, Inst Anat & Cell Biol, D-97070 Wurzburg, Germany; [Bernhard, Frank; Doetsch, Volker] Goethe Univ Frankfurt, Dept Biophys Chem, D-60438 Frankfurt, Germany; [Uzelac, Zeljko; Sitte, Harald H.] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; [Wirth, Christophe; Hunte, Carola] Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Hunte, Carola] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany	University of Wurzburg; Goethe University Frankfurt; Medical University of Vienna; University of Freiburg; University of Freiburg	Koepsell, H (corresponding author), Univ Wurzburg, Inst Anat & Cell Biol, Koellikerstr 6, D-97070 Wurzburg, Germany.	Hermann@Koepsell.de	Sitte, Harald/N-2681-2013; Gorbunov, Dmitry/F-2295-2014; Sitte, Harald/O-7025-2019; Hunte, Carola/E-4071-2015	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Hunte, Carola/0000-0002-0826-3986; Wirth, Christophe/0000-0001-8864-6508; Dotsch, Volker/0000-0001-5720-212X; Bernhard, Frank/0000-0002-4860-1783; Keller, Thorsten/0000-0002-2897-5761	Deutsche Forschungsgemeinschaft [SFB 487/A4, SFB 746/P21]; Excellence Initiative of the German Federal and State Governments [EXC 294]; Austrian Science Fund/FWF [SFB3506]; Austrian Science Fund (FWF) [F 3506] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Austrian Science Fund/FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 487/A4 (to H. K.) and SFB 746/P21 (to C. H.), by the Excellence Initiative of the German Federal and State Governments (EXC 294) (to C. H.), and the Austrian Science Fund/FWF (SFB3506 to H. H. S.).	Arndt P, 2001, AM J PHYSIOL-RENAL, V281, pF454, DOI 10.1152/ajprenal.2001.281.3.F454; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Brosig B, 1998, PROTEIN SCI, V7, P1052; Busch AE, 1996, FEBS LETT, V395, P153, DOI 10.1016/0014-5793(96)01030-7; Ciarimboli G, 2005, PFLUG ARCH EUR J PHY, V449, P423, DOI 10.1007/s00424-004-1355-5; Duan P, 2011, MOL PHARMACOL, V79, P569, DOI 10.1124/mol.110.070185; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Gorboulev V, 1999, MOL PHARMACOL, V56, P1254, DOI 10.1124/mol.56.6.1254; Gorboulev V, 2005, MOL PHARMACOL, V67, P1612, DOI 10.1124/mol.104.008821; Gorbunov D, 2008, MOL PHARMACOL, V73, P50, DOI 10.1124/mol.107.040170; GRUNDEMANN D, 1994, NATURE, V372, P549, DOI 10.1038/372549a0; GRUNDEMANN D, 1994, ANAL BIOCHEM, V216, P459, DOI 10.1006/abio.1994.1069; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hong M, 2005, J BIOL CHEM, V280, P32285, DOI 10.1074/jbc.M501447200; Kamsteeg EJ, 2001, BIOCHEM BIOPH RES CO, V282, P683, DOI 10.1006/bbrc.2001.4629; Keller T, 2005, BIOCHEMISTRY-US, V44, P12253, DOI 10.1021/bi050676c; Keller T, 2008, BIOCHEMISTRY-US, V47, P4552, DOI 10.1021/bi800060w; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Koepsell H, 2011, BIOL CHEM, V392, P95, DOI 10.1515/BC.2011.009; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Perry JL, 2006, J BIOL CHEM, V281, P38071, DOI 10.1074/jbc.M608834200; Popp C, 2005, MOL PHARMACOL, V67, P1600, DOI 10.1124/mol.104.008839; Rizwan AN, 2007, PHARM RES-DORDR, V24, P450, DOI 10.1007/s11095-006-9181-4; Schmid JA, 2003, CURR OPIN ONCOL, V15, P55, DOI 10.1097/00001622-200301000-00008; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Sturm A, 2007, AM J PHYSIOL-RENAL, V293, pF767, DOI 10.1152/ajprenal.00106.2007; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; Valentin M, 2000, BBA-BIOMEMBRANES, V1468, P367, DOI 10.1016/S0005-2736(00)00277-7; VEYHL M, 1993, J BIOL CHEM, V268, P25041; Veyhl M, 2003, J MEMBRANE BIOL, V196, P71, DOI 10.1007/s00232-003-0626-y; Volk C, 2009, MOL PHARMACOL, V76, P275, DOI 10.1124/mol.109.054783; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9	37	52	52	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37874	37886		10.1074/jbc.M111.289330	http://dx.doi.org/10.1074/jbc.M111.289330			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896487	Green Published, hybrid			2022-12-27	WOS:000296542400082
J	Bansal, K; Trinath, J; Chakravortty, D; Patil, SA; Balaji, KN				Bansal, Kushagra; Trinath, Jamma; Chakravortty, Dipshikha; Patil, Shripad A.; Balaji, Kithiganahalli Narayanaswamy			RETRACTED: Pathogen-specific TLR2 Protein Activation Programs Macrophages to Induce Wnt-beta-Catenin Signaling (Retracted article. See vol. 294, pg. 19450, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							REGULATORY T-CELLS; KINASE-C; IMMUNE-RESPONSES; NOTCH; TUBERCULOSIS; PATHWAYS; TOLERANCE; TH1; INFLAMMATION; EXPRESSION	Innate immunity recognizes and resists various pathogens; however, the mechanisms regulating pathogen versus non-pathogen discrimination are still imprecisely understood. Here, we demonstrate that pathogen-specific activation of TLR2 upon infection with Mycobacterium bovis BCG, in comparison with other pathogenic microbes, including Salmonella typhimurium and Staphylococcus aureus, programs macrophages for robust up-regulation of signaling cohorts of Wnt-beta-catenin signaling. Signaling perturbations or genetic approaches suggest that infection-mediated stimulation of Wnt-beta-catenin is vital for activation of Notch1 signaling. Interestingly, inducible NOS (iNOS) activity is pivotal for TLR2-mediated activation of Wnt-beta-catenin signaling as iNOS(-/-) mice demonstrated compromised ability to trigger activation of Wnt-beta-catenin signaling as well as Notch1-mediated cellular responses. Intriguingly, TLR2-driven integration of iNOS/NO, Wnt-beta-catenin, and Notch1 signaling contributes to its capacity to regulate the battery of genes associated with T-Reg cell lineage commitment. These findings reveal a role for differential stimulation of TLR2 in deciding the strength of Wnt-beta-catenin signaling, which together with signals from Notch1 contributes toward the modulation of a defined set of effector functions in macrophages and thus establishes a conceptual framework for the development of novel therapeutics.	[Bansal, Kushagra; Trinath, Jamma; Chakravortty, Dipshikha; Balaji, Kithiganahalli Narayanaswamy] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Patil, Shripad A.] Natl Inst Mental Hlth & Neurosci, Dept Microbiol, Bangalore 560029, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India	Balaji, KN (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	balaji@mcbl.iisc.ernet.in	chakravortty, dipshikha/A-9492-2009; Chakravortty, Dipshikha/AAI-4448-2020	Chakravortty, Dipshikha/0000-0002-7838-5145	Indian Council of Medical Research Cooperation [INSERM-ICMR-AO 2009/2010]; Indian Institute of Science; Karolinska Institute from VINNOVA, Sweden; Department of Biotechnology, India; Department of Science and Technology; Council for Scientific and Industrial Research	Indian Council of Medical Research Cooperation; Indian Institute of Science; Karolinska Institute from VINNOVA, Sweden; Department of Biotechnology, India(Department of Biotechnology (DBT) India); Department of Science and Technology(Department of Science & Technology (India)); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Indian Council of Medical Research Cooperation Grant INSERM-ICMR-AO 2009/2010, Department of Biotechnology collaborative grant for Indian Institute of Science and Karolinska Institute from VINNOVA, Sweden, and Department of Biotechnology, India, and the Department of Science and Technology, Council for Scientific and Industrial Research (to K. N. B.).; Recipient of fellowship from Indian Institute of Science.	Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Albrecht V, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-69; Bansal K, 2009, J LEUKOCYTE BIOL, V85, P804, DOI 10.1189/jlb.0908561; Beck KF, 1999, J EXP BIOL, V202, P645; BETZ M, 1991, J IMMUNOL, V146, P108; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bournat JC, 2000, J NEUROSCI RES, V61, P21, DOI 10.1002/1097-4547(20000701)61:1<21::AID-JNR3>3.0.CO;2-7; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Collu GM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1671; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Desmedt M, 1998, J IMMUNOL, V160, P5300; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Garg A, 2008, EUR J IMMUNOL, V38, P459, DOI 10.1002/eji.200737268; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Howe LR, 1999, CANCER RES, V59, P1572; Jurynczyk M, 2008, J IMMUNOL, V180, P2634, DOI 10.4049/jimmunol.180.4.2634; Kapoor N, 2010, J IMMUNOL, V184, P3117, DOI 10.4049/jimmunol.0903174; Kircheis R, 2001, ADV DRUG DELIVER REV, V53, P341, DOI 10.1016/S0169-409X(01)00202-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maiese K, 2008, PHARMACOL THERAPEUT, V118, P58, DOI 10.1016/j.pharmthera.2008.01.004; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Mannick JB, 2002, ARCH BIOCHEM BIOPHYS, V408, P1, DOI 10.1016/S0003-9861(02)00490-3; Mellman I, 2010, SCIENCE, V329, P767, DOI 10.1126/science.1194185; Mikels A. J., 2006, PLOS BIOL, V4, pe115; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mun HS, 2005, INFECT IMMUN, V73, P4634, DOI 10.1128/IAI.73.8.4634-4642.2005; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pukrop T, 2008, J MOL MED, V86, P259, DOI 10.1007/s00109-007-0266-2; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Real E, 2007, J IMMUNOL, V179, P5649, DOI 10.4049/jimmunol.179.9.5649; Rock RB, 2008, CLIN MICROBIOL REV, V21, P243, DOI 10.1128/CMR.00042-07; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Shibata Y, 2005, J LEUKOCYTE BIOL, V78, P1281, DOI 10.1189/jlb.0605321; Sirard JC, 2006, EUR J IMMUNOL, V36, P260, DOI 10.1002/eji.200535777; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Tsukumo S, 2004, J IMMUNOL, V173, P7109, DOI 10.4049/jimmunol.173.12.7109; Urban-Klein B, 2005, GENE THER, V12, P461, DOI 10.1038/sj.gt.3302425; Valledor AF, 2000, J IMMUNOL, V164, P29, DOI 10.4049/jimmunol.164.1.29; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; Wang HY, 2009, J MOL MED, V87, P435, DOI 10.1007/s00109-009-0445-4; Yang CS, 2007, CELL MICROBIOL, V9, P382, DOI 10.1111/j.1462-5822.2006.00797.x; Yang HZ, 2009, J IMMUNOL, V182, P692, DOI 10.4049/jimmunol.182.1.692; Yoshimura A, 2004, J LEUKOCYTE BIOL, V75, P422, DOI 10.1189/jlb.0403194	52	40	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					37032	37044		10.1074/jbc.M111.260414	http://dx.doi.org/10.1074/jbc.M111.260414			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21862586	Green Published, hybrid			2022-12-27	WOS:000296538300081
J	Hibino, K; Shibata, T; Yanagida, T; Sako, Y				Hibino, Kayo; Shibata, Tatsuo; Yanagida, Toshio; Sako, Yasushi			Activation Kinetics of RAF Protein in the Ternary Complex of RAF, RAS-GTP, and Kinase on the Plasma Membrane of Living Cells SINGLE-MOLECULE IMAGING ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-RAF; PHOSPHORYLATION SITES; SIGNAL-TRANSDUCTION; H-RAS; DYNAMICS; FEEDBACK; IDENTIFICATION; RECRUITMENT; SURFACE; EGF	RAS is an important cell signaling molecule, regulating the activities of various effector proteins, including the kinase c-RAF (RAF). Despite the critical function of RAS signaling, the activation kinetics have not been analyzed experimentally in living cells for any of the RAS effectors. Here, we analyzed the kinetics of RAF activation on the plasma membrane in living HeLa cells after stimulation with EGF to activate RAS. RAF is recruited by the active form of RAS (RAS-GTP) from the cytoplasm to the plasma membrane through two RAS-binding sites (the RAS-binding domain and the cysteine-rich domain (CRD)) and is activated by its phosphorylation by still undetermined kinases on the plasma membrane. Using single-molecule imaging, we measured the dissociation time courses of GFP-tagged molecules of wild type RAF and fragments or mutants of RAF containing one or two of the three functional domains (the RAS-binding domain, the CRD, and the catalytic domain) to determine their interaction with membrane components. Each molecule showed a unique dissociation time course, indicating that both its interaction with RAS-GTP and its phosphorylation by the kinases are rate-limiting steps in RAF activation. Based on our experimental results, we propose a kinetic model for the activation of RAF. The model suggests the importance of the interaction between RAS-GTP and CRD for the effective activation of RAF, which is triggered by rapid RAS-GTP-induced conformational changes in RAF and the subsequent presentation of RAF to the kinase. The model also suggests necessary properties of the kinases that activate RAF.	[Hibino, Kayo; Sako, Yasushi] RIKEN, Adv Sci Inst, Cellular Informat Lab, Wako, Saitama 3510198, Japan; [Shibata, Tatsuo] RIKEN, Ctr Dev Biol, Phys Biol Lab, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Shibata, Tatsuo] JST, PRESTO, Chiyoda Ku, Tokyo 1020075, Japan; [Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Nano Biosci Labs, Suita, Osaka 5650871, Japan	RIKEN; RIKEN; Japan Science & Technology Agency (JST); Osaka University	Sako, Y (corresponding author), RIKEN, Adv Sci Inst, Cellular Informat Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	sako@riken.jp	Shibata, Tatsuo/A-8119-2012; Sako, Yasushi/B-3253-2015	Shibata, Tatsuo/0000-0002-9294-9998; Sako, Yasushi/0000-0002-5707-5455; Hibino, Kayo/0000-0002-4047-883X	Grants-in-Aid for Scientific Research [21570226] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; FORCE T, 1994, P NATL ACAD SCI USA, V91, P1270, DOI 10.1073/pnas.91.4.1270; HALLBERG B, 1994, J BIOL CHEM, V269, P3913; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hekman M, 2005, FEBS LETT, V579, P464, DOI 10.1016/j.febslet.2004.11.105; Hibino K, 2003, CHEMPHYSCHEM, V4, P748, DOI 10.1002/cphc.200300731; Hibino K, 2009, METHODS MOL BIOL, V544, P451, DOI 10.1007/978-1-59745-483-4_30; Hibino K, 2009, BIOPHYS J, V97, P1277, DOI 10.1016/j.bpj.2009.05.048; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Mayawala K, 2004, BIOPHYS J, V87, pL1, DOI 10.1529/biophysj.104.051888; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Mott HR, 1996, P NATL ACAD SCI USA, V93, P8312, DOI 10.1073/pnas.93.16.8312; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Sako Y, 2011, CELL SIGNALING REACTIONS: SINGLE-MOLECULAR KINETIC ANALYSIS, P1, DOI 10.1007/978-90-481-9864-1; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Terai K, 2005, EMBO REP, V6, P251, DOI 10.1038/sj.embor.7400349; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wittinghofer A, 1996, TRENDS BIOCHEM SCI, V21, P488, DOI 10.1016/S0968-0004(96)10064-5; Zang MW, 2008, J BIOL CHEM, V283, P31429, DOI 10.1074/jbc.M802855200; Zhang XL, 2006, J BIOL CHEM, V281, P13949, DOI 10.1074/jbc.M601384200; Zhu J, 2005, MOL BIOL CELL, V16, P4733, DOI 10.1091/mbc.E05-02-0090; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	44	28	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36460	36468		10.1074/jbc.M111.262675	http://dx.doi.org/10.1074/jbc.M111.262675			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21862573	hybrid, Green Published			2022-12-27	WOS:000296538300031
J	Xu, LS; Xiao, HL; Xu, MH; Zhou, C; Yi, L; Liang, H				Xu, Lunshan; Xiao, Hualiang; Xu, Minhui; Zhou, Chun; Yi, Liang; Liang, Hong			Glioma-derived T Cell Immunoglobulin- and Mucin Domain-containing Molecule-4 (TIM4) Contributes to Tumor Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-INITIATING CELLS; TGF-BETA; IMMUNE CELLS; PHOSPHATIDYLSERINE; MICROENVIRONMENT; PROLIFERATION; GLIOBLASTOMA; INFLAMMATION; PROGRESSION; RESPONSES	Tumor tolerance plays a critical role in tumor growth and escape from immune surveillance. The mechanism of tumor tolerance development is not fully understood. Regulatory T cells (Tregs) play a critical role in tumor tolerance. TIM4 (T cell immunoglobulin-and mucin domain-containing molecule-4) is involved in immune regulation. We investigated the role of TIM4 in the induction of Tregs in tumors. Surgically removed glioma tissue and peripheral blood samples were obtained from 25 glioma patients. Immune cells were isolated from the tissue and blood samples. Confocal microscopy was employed to detect macrophages phagocytosing apoptotic T cells. The generation of tumor-specific Tregs and the immune suppression function of Tregs were observed in cell culture models. High levels of TIM4 were detected in glioma-derived macrophages. Phosphatidylserine (PS) was detected in glioma-derived T cells; naive T cells expressed low levels of PS that could be up-regulated by hypoxia. Glioma-derived macrophages phagocytosed PS-expressing T cells, gaining the tolerogenic properties, which could induce tumor-specific Tregs; the latter could suppress tumor-specific CD8(+) T cells. We conclude that macrophage-derived TIM4 plays an important role in the induction of Tregs in gliomas, which may play an important role in tumor tolerance.	[Xu, Minhui] Third Mil Med Univ, PLA, Daping Hosp, Dept Neurosurg, Chongqing 400042, Peoples R China; [Xiao, Hualiang] Third Mil Med Univ, Dept Pathol, Daping Hosp, Chongqing 400042, Peoples R China	Army Medical University; Army Medical University	Xu, MH (corresponding author), Third Mil Med Univ, PLA, Daping Hosp, Dept Neurosurg, Chongqing 400042, Peoples R China.	xuminhui8@163.com			National Natural Science Foundation of China [30872649/C1608]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Foundation of China Grant 30872649/C1608.	Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dorfman DM, 2010, HUM PATHOL, V41, P1486, DOI 10.1016/j.humpath.2010.04.005; Douglass TG, 2008, INT IMMUNOPHARMACOL, V8, P1354, DOI 10.1016/j.intimp.2008.04.016; Fecci PE, 2006, CLIN CANCER RES, V12, P4294, DOI 10.1158/1078-0432.CCR-06-0053; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; He SH, 2011, GASTROENTEROLOGY, V141, P249, DOI 10.1053/j.gastro.2011.04.006; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Jokilehto T, 2010, J CELL MOL MED, V14, P758, DOI 10.1111/j.1582-4934.2010.01030.x; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kren L, 2010, J NEUROIMMUNOL, V220, P131, DOI 10.1016/j.jneuroim.2010.01.014; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Piersma SJ, 2008, HUM IMMUNOL, V69, P241, DOI 10.1016/j.humimm.2008.02.005; Rodriguez-Manzanet R, 2008, J IMMUNOL, V180, P4706, DOI 10.4049/jimmunol.180.7.4706; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sorensen AG, 2008, NAT CLIN PRACT ONCOL, V5, P634, DOI 10.1038/ncponc1204; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wei J, 2010, MOL CANCER THER, V9, P67, DOI 10.1158/1535-7163.MCT-09-0734; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yang PC, 2007, GASTROENTEROLOGY, V133, P1522, DOI 10.1053/j.gastro.2007.08.006; Yang SB, 2011, J LEUKOCYTE BIOL, V89, P85, DOI 10.1189/jlb.0910506; Zhao PQ, 2010, CELL MOL IMMUNOL, V7, P152, DOI 10.1038/cmi.2009.118	29	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36694	36699		10.1074/jbc.M111.292540	http://dx.doi.org/10.1074/jbc.M111.292540			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21896488	hybrid, Green Published			2022-12-27	WOS:000296538300052
J	Alegre, KO; Reverter, D				Alegre, Kamela O.; Reverter, David			Swapping Small Ubiquitin-like Modifier (SUMO) Isoform Specificity of SUMO Proteases SENP6 and SENP7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PML; SUMOYLATION; PRECURSORS; MATURATION; PROTEINS; DISTINCT; RNF4	SUMO proteases can regulate the amounts of SUMO-conjugated proteins in the cell by cleaving off the isopeptidic bond between SUMO and the target protein. Of the six members that constitute the human SENP/ULP protease family, SENP6 and SENP7 are the most divergent members in their conserved catalytic domain. The SENP6 and SENP7 subclass displays a clear proteolytic cleavage preference for SUMO2/3 isoforms. To investigate the structural determinants for such isoform specificity, we have identified a unique sequence insertion in the SENP6 and SENP7 subclass that is essential for their proteolytic activity and that forms a more extensive interface with SUMO during the proteolytic reaction. Furthermore, we have identified a region in the SUMO surface determinant for the SUMO2/3 isoform specificity of SENP6 and SENP7. Double point amino acid mutagenesis on the SUMO surface allows us to swap the specificity of SENP6 and SENP7 between the two SUMO isoforms. Structure-based comparisons combined with biochemical and mutagenesis analysis have revealed Loop 1 insertion in SENP6 and SENP7 as a platform to discriminate between SUMO1 and SUMO2/3 isoforms in this subclass of the SUMO protease family.	[Alegre, Kamela O.; Reverter, David] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	Autonomous University of Barcelona	Reverter, D (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain.	david.reverter@uab.cat	Reverter, David/H-5360-2015	Reverter, David/0000-0002-5347-0992; Alegre, Kamela/0000-0002-2666-4767	Ministerio de Educacion y Ciencia [BFU2008-0364]; European Community [MIRG-CT-2007-200346]	Ministerio de Educacion y Ciencia(Spanish Government); European Community(European Commission)	This work was supported by Ministerio de Educacion y Ciencia Grant BFU2008-0364 and European Community Grant MIRG-CT-2007-200346.	Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bekes M, 2011, J BIOL CHEM, V286, P10238, DOI 10.1074/jbc.M110.205153; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; Fu CH, 2005, ONCOGENE, V24, P5401, DOI 10.1038/sj.onc.1208714; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Itahana Y, 2006, MOL CELL BIOL, V26, P4675, DOI 10.1128/MCB.01830-05; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KNIPSCHEER P, 2003, CURR OPIN STRUC BIOL, V6, P665; Kolli N, 2010, BIOCHEM J, V430, P335, DOI 10.1042/BJ20100504; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lima CD, 2008, J BIOL CHEM, V283, P32045, DOI 10.1074/jbc.M805655200; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Reverter David, 2009, V497, P225, DOI 10.1007/978-1-59745-566-4_15; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Shen LN, 2009, BIOCHEM J, V421, P223, DOI 10.1042/BJ20090246; Shen LN, 2006, NAT STRUCT MOL BIOL, V13, P1069, DOI 10.1038/nsmb1172; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Xu Z, 2005, BIOCHEM J, V386, P325, DOI 10.1042/BJ20041210; Xu Z, 2006, BIOCHEM J, V398, P345, DOI 10.1042/BJ20060526; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002	36	20	21	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36142	36151		10.1074/jbc.M111.268847	http://dx.doi.org/10.1074/jbc.M111.268847			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21878624	hybrid, Green Published			2022-12-27	WOS:000295927100086
J	Jiang, YL; Zhang, JW; Yu, WL; Cheng, W; Zhang, CC; Frolet, C; Di Guilmi, AM; Vernet, T; Zhou, CZ; Chen, YX				Jiang, Yong-Liang; Zhang, Jun-Wei; Yu, Wei-Li; Cheng, Wang; Zhang, Chen-Chen; Frolet, Cecile; Di Guilmi, Anne-Marie; Vernet, Thierry; Zhou, Cong-Zhao; Chen, Yuxing			Structural and Enzymatic Characterization of the Streptococcal ATP/Diadenosine Polyphosphate and Phosphodiester Hydrolase Spr1479/SapH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIADENOSINE TETRAPHOSPHATE HYDROLASE; CLOSTRIDIUM-THERMOCELLUM; CRYSTAL-STRUCTURE; PROTEIN PHOSPHATASE; NUDIX HYDROLASES; ADP-RIBOSE; MECHANISM; GENOME; CATABOLISM; REVEALS	Spr1479 from Streptococcus pneumoniae R6 is a 33-kDa hypothetical protein of unknown function. Here, we determined the crystal structures of its apo-form at 1.90 angstrom and complex forms with inorganic phosphate and AMP at 2.30 and 2.20 angstrom, respectively. The core structure of Spr1479 adopts a four-layer alpha beta beta alpha-sandwich fold, with Fe3+ and Mn2+ coordinated at the binuclear center of the active site (similar to metallophosphoesterases). Enzymatic assays showed that, in addition to phosphodiesterase activity for bis(p-nitrophenyl) phosphate, Spr1479 has hydrolase activity for diadenosine polyphosphate (Ap(n)A) and ATP. Residues that coordinate with the two metals are indispensable for both activities. By contrast, the streptococcus-specific residue Trp-67, which binds to phosphate in the two complex structures, is indispensable for the ATP/Ap(n)A hydrolase activity only. Moreover, the AMP-binding pocket is conserved exclusively in all streptococci. Therefore, we named the protein SapH for streptococcal (A) under bar TP/Ap(n)A and phosphodiester hydrolase.	[Jiang, Yong-Liang; Zhang, Jun-Wei; Yu, Wei-Li; Cheng, Wang; Zhang, Chen-Chen; Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Jiang, Yong-Liang; Zhang, Jun-Wei; Yu, Wei-Li; Cheng, Wang; Zhang, Chen-Chen; Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Frolet, Cecile; Di Guilmi, Anne-Marie; Vernet, Thierry] Inst Biol Struct Jean Pierre Ebel, UMR 5075, Lab Ingn Macromol, F-38027 Grenoble, France	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	zcz@ustc.edu.cn; cyxing@ustc.edu.cn	Chen, Yuxing/P-4156-2014; Zhou, Cong-Zhao/E-9174-2011; Vernet, Thierry/G-1118-2012	Chen, Yuxing/0000-0002-7560-1922; Zhou, Cong-Zhao/0000-0002-6881-7151; Di Guilmi, Anne Marie/0000-0001-7335-3470; Jiang, YongLiang/0000-0001-5441-4936	Ministry of Science and Technology of China [2009CB918804]; National Natural Science Foundation of China [30870488]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2009CB918804 and National Natural Science Foundation of China Grant 30870488.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailey S, 2002, STRUCTURE, V10, P589, DOI 10.1016/S0969-2126(02)00746-3; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bellinzoni M, 2007, STRUCTURE, V15, P863, DOI 10.1016/j.str.2007.06.002; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Chen SF, 2004, J BIOL CHEM, V279, P31854, DOI 10.1074/jbc.M401059200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gabelli SB, 2001, NAT STRUCT BIOL, V8, P467, DOI 10.1038/87647; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guranowski A, 2000, PHARMACOL THERAPEUT, V87, P117, DOI 10.1016/S0163-7258(00)00046-2; GURANOWSKI A, 1983, J BIOL CHEM, V258, P4784; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Iwai T, 2004, J BIOL CHEM, V279, P21732, DOI 10.1074/jbc.M312018200; Iwanicki A, 2002, BIOCHEM J, V366, P929, DOI 10.1042/BJ20011591; Jeyakanthan J, 2010, ACTA CRYSTALLOGR D, V66, P116, DOI 10.1107/S0907444909047064; Keppetipola N, 2006, RNA, V12, P73, DOI 10.1261/rna.2196406; Keppetipola N, 2007, NUCLEIC ACIDS RES, V35, P7721, DOI 10.1093/nar/gkm868; Keppetipola N, 2006, J BIOL CHEM, V281, P19251, DOI 10.1074/jbc.M602549200; Keppetipola Niroshika, 2008, J Biol Chem, V283, P30942, DOI 10.1074/jbc.M805064200; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Klabunde T, 1996, J MOL BIOL, V259, P737, DOI 10.1006/jmbi.1996.0354; Knofel T, 2001, J MOL BIOL, V309, P239, DOI 10.1006/jmbi.2001.4656; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Martins A, 2005, RNA, V11, P1271, DOI 10.1261/rna.2690505; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Miller DJ, 2007, PROTEIN SCI, V16, P1338, DOI 10.1110/ps.072764907; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Handley SF, 1998, J BIOL CHEM, V273, P3192, DOI 10.1074/jbc.273.6.3192; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Podobnik M, 2009, J BIOL CHEM, V284, P32846, DOI 10.1074/jbc.M109.049635; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Schenk G, 2005, P NATL ACAD SCI USA, V102, P273, DOI 10.1073/pnas.0407239102; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; Swarbrick JD, 2000, J MOL BIOL, V302, P1165, DOI 10.1006/jmbi.2000.4085; Swarbrick JD, 2005, J BIOL CHEM, V280, P8471, DOI 10.1074/jbc.M412318200; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Voegtli WC, 2000, BIOCHEMISTRY-US, V39, P15365, DOI 10.1021/bi0021030; Wang DQ, 2005, J BIOL CHEM, V280, P22962, DOI 10.1074/jbc.M500464200; Wang QH, 2006, PROTEINS, V65, P1032, DOI 10.1002/prot.21106; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Xu WL, 2002, J BIOL CHEM, V277, P23181, DOI 10.1074/jbc.M203325200	49	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35906	35914		10.1074/jbc.M111.228585	http://dx.doi.org/10.1074/jbc.M111.228585			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865160	Green Published, hybrid			2022-12-27	WOS:000295927100064
J	Jung, YS; Qian, YJ; Chen, XB				Jung, Yong-Sam; Qian, Yingjuan; Chen, Xinbin			The p73 Tumor Suppressor Is Targeted by Pirh2 RING Finger E3 Ubiquitin Ligase for the Proteasome-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ETA; P53 FAMILY; PROTEIN LIGASE; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTIONAL ACTIVITY; SV40-TRANSFORMED CELLS; APOPTOTIC RESPONSE; GENE-EXPRESSION; REGULATES P73; HUMAN CANCER	The p73 gene, a homologue of the p53 tumor suppressor, is expressed as TA and Delta N isoforms. TAp73 has similar activity as p53 and functions as a tumor suppressor whereas Delta Np73 has both pro-and anti-survival functions. While p73 is rarely mutated in spontaneous tumors, the expression status of p73 is linked to the sensitivity of tumor cells to chemotherapy and prognosis for many types of human cancer. Thus, uncovering its regulators in tumors is of great interest. Here, we found that Pirh2, a RING finger E3 ubiquitin ligase, promotes the proteasome-dependent degradation of p73. Specifically, we showed that knockdown of Pirh2 up-regulates, whereas ectopic expression of Pirh2 down-regulates, expression of endogenous and exogenous p73. In addition, Pirh2 physically associates with and promotes TAp73 polyubiquitination both in vivo and in vitro. Moreover, we found that p73 can be degraded by both 20 S and 26 S proteasomes. Finally, we showed that Pirh2 knockdown leads to growth suppression in a TAp73-dependent manner. Taken together, our findings indicate that Pirh2 promotes the proteasomal turnover of TAp73, and thus targeting Pirh2 to restore TAp73-mediated growth suppression in p53-deficient tumors may be developed as a novel anti-cancer strategy.	[Jung, Yong-Sam; Qian, Yingjuan; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [CA123227, CA081237]; NATIONAL CANCER INSTITUTE [R01CA081237, P30CA093373, R01CA123227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA123227 and CA081237.	Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Corn PG, 1999, CANCER RES, V59, P3352; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Duan SS, 2007, EMBO J, V26, P3062, DOI 10.1038/sj.emboj.7601749; Duan WR, 2006, EXP CELL RES, V312, P3370, DOI 10.1016/j.yexcr.2006.07.005; Duan WR, 2004, JNCI-J NATL CANCER I, V96, P1718, DOI 10.1093/jnci/djh292; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gong JG, 1999, NATURE, V399, P806; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; Hosoda M, 2005, ONCOGENE, V24, P7156, DOI 10.1038/sj.onc.1208872; Huang XD, 2011, HUM PATHOL, V42, P507, DOI 10.1016/j.humpath.2010.04.021; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Jung YS, 2008, J BIOL CHEM, V283, P1018, DOI 10.1074/jbc.M707722200; Jung YS, 2010, MOL CELL BIOL, V30, P1041, DOI 10.1128/MCB.01198-09; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kawano S, 1999, BLOOD, V94, P1113; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862; Liu ML, 2001, LEUKEMIA RES, V25, P441, DOI 10.1016/S0145-2126(00)00148-X; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Maruyama S, 2008, MOL CELL BIOCHEM, V307, P73, DOI 10.1007/s11010-007-9586-3; Miyazaki K, 2003, BIOCHEM BIOPH RES CO, V308, P106, DOI 10.1016/S0006-291X(03)01347-0; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Muller M, 2005, CELL DEATH DIFFER, V12, P1564, DOI 10.1038/sj.cdd.4401774; Ohtsuka T, 2003, ONCOGENE, V22, P1678, DOI 10.1038/sj.onc.1206306; Peschiaroli A, 2009, ONCOGENE, V28, P3157, DOI 10.1038/onc.2009.177; Petrenko O, 2003, MOL CELL BIOL, V23, P5540, DOI 10.1128/MCB.23.16.5540-5555.2003; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Prives C, 2005, MOL CELL, V19, P719, DOI 10.1016/j.molcel.2005.08.024; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Shimada M, 2009, CANCER SCI, V100, P866, DOI 10.1111/j.1349-7006.2009.01122.x; Stiewe T, 2002, CANCER RES, V62, P3598; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Sun XF, 2002, CLIN CANCER RES, V8, P165; Tokuchi Y, 1999, BRIT J CANCER, V80, P1623, DOI 10.1038/sj.bjc.6690572; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Vilgelm A, 2008, DRUG RESIST UPDATE, V11, P152, DOI 10.1016/j.drup.2008.08.001; Wang ZH, 2011, CANCER SCI, V102, P909, DOI 10.1111/j.1349-7006.2011.01899.x; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Zaika AI, 1999, CANCER RES, V59, P3257; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhu JH, 2001, ONCOGENE, V20, P4050, DOI 10.1038/sj.onc.1204516	57	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35388	35395		10.1074/jbc.M111.261537	http://dx.doi.org/10.1074/jbc.M111.261537			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852228	Green Published, hybrid			2022-12-27	WOS:000295927100010
J	Kitanishi, K; Kobayashi, K; Uchida, T; Ishimori, K; Igarashi, J; Shimizu, T				Kitanishi, Kenichi; Kobayashi, Kazuo; Uchida, Takeshi; Ishimori, Koichiro; Igarashi, Jotaro; Shimizu, Toru			Identification and Functional and Spectral Characterization of a Globin-coupled Histidine Kinase from Anaeromyxobacter sp Fw109-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-DISTAL SIDE; COLI EC DOS; MYCOBACTERIUM-TUBERCULOSIS DOSS; RESONANCE RAMAN-SPECTRA; OXYGEN-SENSOR; ESCHERICHIA-COLI; LIGAND-BINDING; BACILLUS-SUBTILIS; PAS-DOMAIN; REGULATED PHOSPHODIESTERASE	Two-component signal transduction systems regulate numerous important physiological functions in bacteria. In this study we have identified, cloned, overexpressed, and characterized a dimeric full-length heme-bound (heme: protein, 1: 1 stoichiometry) globin-coupled histidine kinase (AfGcHK) from Anaeromyxobacter sp. strain Fw109-5 for the first time. The Fe(III), Fe(II)-O-2, and Fe(II)-CO complexes of the protein displayed autophosphorylation activity, whereas the Fe(II) complex had no significant activity. A H99A mutant lost heme binding ability, suggesting that this residue is the heme proximal ligand. Moreover, His-183 was proposed as the autophosphorylation site based on the finding that the H183A mutant protein was not phosphorylated. The phosphate group of autophosphorylated AfGcHK was transferred to Asp-52 and Asp-169 of a response regulator, as confirmed from site-directed mutagenesis experiments. Based on the amino acid sequences and crystal structures of other globin-coupled oxygen sensor enzymes, Tyr-45 was assumed to be the O-2 binding site at the heme distal side. The O-2 dissociation rate constant, 0.10 s(-1), was substantially increased up to 8.0 s(-1) upon Y45L mutation. The resonance Raman frequencies representing nu(Fe-O2) (559 cm(-1)) and nu(O-O) (1149 cm(-1)) of the Fe(II)-O-2 complex of Y45F mutant AfGcHK were distinct from those of the wildtype protein (nu(Fe-O2), 557 cm(-1); nu(O-O), 1141 cm(-1)), supporting the proposal that Tyr-45 is located at the distal side and forms hydrogen bonds with the oxygen molecule bound to the Fe(II) complex. Thus, we have successfully identified and characterized a novel heme-based globin-coupled oxygen sensor histidine kinase, AfGcHK, in this study.	[Kitanishi, Kenichi; Igarashi, Jotaro; Shimizu, Toru] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Kobayashi, Kazuo] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Uchida, Takeshi; Ishimori, Koichiro] Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan	Tohoku University; Osaka University; Hokkaido University	Shimizu, T (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	shimizu@tagen.tohoku.ac.jp	Igarashi, Jotaro/B-4550-2008; Kobayashi, Kazuo/H-9279-2012; Uchida, Takeshi/A-6455-2017; Ishimori, Koichiro/AAQ-4434-2021; Igarashi, Jotaro/ABC-9207-2021; Kitanishi, Kenichi/I-3323-2014; Ishimori, Koichiro/S-1247-2016	Igarashi, Jotaro/0000-0002-6165-3350; Kobayashi, Kazuo/0000-0002-5586-9112; Uchida, Takeshi/0000-0001-9270-8329; Ishimori, Koichiro/0000-0002-5868-0462; Igarashi, Jotaro/0000-0002-6165-3350; Kitanishi, Kenichi/0000-0002-2110-8104; Ishimori, Koichiro/0000-0002-5868-0462; Shimizu, Toru/0000-0002-3950-5554	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Management Expenses Grants for National Universities Corporations from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) (to T. S.) as well as a Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists (to K. Kitanishi).	Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; Boon EM, 2005, J INORG BIOCHEM, V99, P892, DOI 10.1016/j.jinorgbio.2004.12.016; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Das TK, 1999, BIOCHEMISTRY-US, V38, P15360, DOI 10.1021/bi991237e; Das TK, 2000, BIOCHEMISTRY-US, V39, P837, DOI 10.1021/bi9922087; Das TK, 2000, BIOCHEMISTRY-US, V39, P14330, DOI 10.1021/bi001681d; Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024; Freitas TAK, 2003, FEBS LETT, V552, P99, DOI 10.1016/S0014-5793(03)00923-2; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Gilles-Gonzalez MA, 2004, J APPL PHYSIOL, V96, P774, DOI 10.1152/japplphysiol.00941.2003; GILLESGONZALEZ MA, 1994, BIOCHEMISTRY-US, V33, P8067, DOI 10.1021/bi00192a011; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Igarashi J, 2011, HANDB PORPHYR SCI, V15, P399; Inouye M, 2003, HISTIDINE KINASES SI; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Ishitsuka Y, 2008, BIOCHEMISTRY-US, V47, P8874, DOI 10.1021/bi800248c; Ito Y, 2009, FEBS LETT, V583, P2244, DOI 10.1016/j.febslet.2009.06.001; Jenal U, 2009, CURR OPIN MICROBIOL, V12, P152, DOI 10.1016/j.mib.2009.01.010; KITAGAWA T, 1979, FEBS LETT, V104, P376, DOI 10.1016/0014-5793(79)80856-X; Kitagawa T, 1988, BIOL APPL RAMAN SPEC, V3, P97; Kitanishi K, 2010, BIOCHEMISTRY-US, V49, P10381, DOI 10.1021/bi100733q; Kobayashi K, 2001, J BIOL CHEM, V276, P39864, DOI 10.1074/jbc.M102537200; Kobayashi K, 2010, J BIOCHEM, V148, P693, DOI 10.1093/jb/mvq103; Kramer R, 2010, BACTERIAL SIGNALING; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Moskvin OV, 2007, J BIOL CHEM, V282, P28740, DOI 10.1074/jbc.M703261200; Mukai M, 2000, BIOCHEMISTRY-US, V39, P13810, DOI 10.1021/bi001184x; Nakajima H, 2001, J BIOL CHEM, V276, P37895; Nakamura H, 2004, P NATL ACAD SCI USA, V101, P2742, DOI 10.1073/pnas.0305795101; Ohta T, 2004, J AM CHEM SOC, V126, P15000, DOI 10.1021/ja046896f; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Pesce A, 2009, J MOL BIOL, V386, P246, DOI 10.1016/j.jmb.2008.12.023; RAMSDEN J, 1989, BIOCHEMISTRY-US, V28, P3125, DOI 10.1021/bi00434a001; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; Sasakura Y, 2006, ACCOUNTS CHEM RES, V39, P37, DOI 10.1021/ar0501525; Sato A, 2002, J BIOL CHEM, V277, P32650, DOI 10.1074/jbc.M204559200; Sawai H, 2010, BBA-PROTEINS PROTEOM, V1804, P166, DOI 10.1016/j.bbapap.2009.09.028; Shi XQ, 2008, J BACTERIOL, V190, P613, DOI 10.1128/JB.01502-07; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; Spiro TG, 1988, BIOL APPL RAMAN SPEC, V3, P1; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Taguchi S, 2004, J BIOL CHEM, V279, P3340, DOI 10.1074/jbc.M301013200; Tanaka A, 2007, J BIOL CHEM, V282, P21301, DOI 10.1074/jbc.M701920200; Tanaka A, 2008, BIOCHEMISTRY-US, V47, P13438, DOI 10.1021/bi8012017; Thijs L, 2007, J BIOL CHEM, V282, P37325, DOI 10.1074/jbc.M705541200; Tuckerman JR, 2009, BIOCHEMISTRY-US, V48, P9764, DOI 10.1021/bi901409g; Uchida T, 2005, ACCOUNTS CHEM RES, V38, P662, DOI 10.1021/ar030267d; Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6; Wan XH, 2009, J MOL BIOL, V388, P262, DOI 10.1016/j.jmb.2009.03.015; Yamada S, 2007, ANAL BIOCHEM, V360, P160, DOI 10.1016/j.ab.2006.10.005; Yeh SR, 2000, J BIOL CHEM, V275, P1679, DOI 10.1074/jbc.275.3.1679; Yoshioka S, 2005, BIOCHEMISTRY-US, V44, P15406, DOI 10.1021/bi0513352; Yukl ET, 2008, BIOCHEMISTRY-US, V47, P12532, DOI 10.1021/bi801234w; Zhang W, 2005, BIOPHYS J, V88, P2801, DOI 10.1529/biophysj.104.047936; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2; Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770	66	37	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35522	35534		10.1074/jbc.M111.274811	http://dx.doi.org/10.1074/jbc.M111.274811			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852234	Green Published, hybrid			2022-12-27	WOS:000295927100024
J	Peterson, FC; Chen, DW; Lytle, BL; Rossi, MN; Ahel, I; Denu, JM; Volkman, BF				Peterson, Francis C.; Chen, Dawei; Lytle, Betsy L.; Rossi, Marianna N.; Ahel, Ivan; Denu, John M.; Volkman, Brian F.			Orphan Macrodomain Protein (Human C6orf130) Is an O-Acyl-ADP-ribose Deacylase SOLUTION STRUCTURE AND CATALYTIC PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE/PROTEIN DEACETYLASES; LYSINE PROPIONYLATION; ARABIDOPSIS-THALIANA; HISTONE MACROH2A; DOMAIN; NMR; METABOLITE; BINDING; IDENTIFICATION; CHROMATIN	Background: Protein deacylation by sirtuins yields O-acyl-ADP-ribose molecules, which are implicated in cell signaling and metabolism. Results: Structural and functional analysis of a human orphan macrodomain protein reveals a common core structure and ability to hydrolyze O-acyl-ADP-ribose. Conclusion: Diverse macrodomains are capable of hydrolyzing O-acyl-ADP-ribose but utilize a different set of catalytic amino acids. Significance: Macrodomain-containing proteins provide a biochemical and biological link to sirtuin-dependent deacylation.	[Chen, Dawei; Denu, John M.] Univ Wisconsin Madison, Dept Biomol Chem, Madison, WI 53715 USA; [Chen, Dawei; Denu, John M.] Univ Wisconsin Madison, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Volkman, Brian F.] Med Coll Wisconsin, Ctr Eukaryot Struct Genom, Milwaukee, WI 53226 USA; [Rossi, Marianna N.; Ahel, Ivan] Univ Manchester, Paterson Inst Canc Res, DNA Damage Response Grp, Manchester M20 4BX, Lancs, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin; Medical College of Wisconsin; Paterson Institute for Cancer Research; University of Manchester	Denu, JM (corresponding author), 2178 Wisconsin Inst Discovery, 330 N Orchard Str, Madison, WI 53715 USA.	jmdenu@wisc.edu; bvolkman@mcw.edu	Rossi, Marianna Nicoletta/S-5083-2019; Volkman, Brian F./ABE-7306-2020; Volkman, Brian F./ABE-7312-2020	Rossi, Marianna Nicoletta/0000-0003-4485-7738; Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; Ahel, Ivan/0000-0002-9446-3756	National Institutes of Health from the NIGMS Protein Structure Initiative [U54 GM064598, P50 GM064598]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059785, P50GM064598] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS Protein Structure Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants U54 GM064598 and P50 GM064598 from the NIGMS Protein Structure Initiative.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Allen MD, 2003, J MOL BIOL, V330, P503, DOI 10.1016/S0022-2836(03)00473-X; Anantharaman V, 2002, GENOME BIOL, P3, DOI [DOI 10.1186/GB-2002-3-5-RESEARCH0023, 10.1186/gb-2002-3-11-research0061, 10.1186/gb-2002-3-5-research0023]; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; Chen D, 2011, J BIOL CHEM, V286, P13261, DOI 10.1074/jbc.M110.206771; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Comstock LR, 2007, ORG BIOMOL CHEM, V5, P3087, DOI 10.1039/b710231c; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Grubisha O, 2006, J BIOL CHEM, V281, P14057, DOI 10.1074/jbc.M513741200; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hallows WC, 2009, CELL, V137, P404, DOI 10.1016/j.cell.2009.04.036; Han WD, 2011, MUTAT RES-REV MUTAT, V727, P86, DOI 10.1016/j.mrrev.2011.03.001; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hoff KG, 2005, NAT STRUCT MOL BIOL, V12, P560, DOI 10.1038/nsmb0705-560; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Kraus WL, 2009, NAT STRUCT MOL BIOL, V16, P904, DOI 10.1038/nsmb0909-904; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Ladurner AG, 2003, MOL CELL, V12, P1, DOI 10.1016/S1097-2765(03)00284-3; Lee S, 2008, ANAL BIOCHEM, V383, P174, DOI 10.1016/j.ab.2008.08.033; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Lytle BL, 2004, J BIOMOL NMR, V28, P397, DOI 10.1023/B:JNMR.0000015385.54050.19; Marina O, 2010, CANCER RES, V70, P1344, DOI 10.1158/0008-5472.CAN-09-3143; Markley J, 2009, STRUCTURAL BIOINFORM, V2, P93; Mate SE, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-20; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Neuvonen M, 2009, J MOL BIOL, V385, P212, DOI 10.1016/j.jmb.2008.10.045; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Pehrson JR, 1998, NUCLEIC ACIDS RES, V26, P2837, DOI 10.1093/nar/26.12.2837; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; Smith BC, 2007, J BIOL CHEM, V282, P37256, DOI 10.1074/jbc.M707878200; Stuart AC, 1999, J AM CHEM SOC, V121, P5346, DOI 10.1021/ja984172w; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Till S, 2009, FRONT BIOSCI-LANDMRK, V14, P3246, DOI 10.2741/3448; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Tong L, 2010, BBA-PROTEINS PROTEOM, V1804, P1617, DOI 10.1016/j.bbapap.2010.02.007; Tong L, 2009, J BIOL CHEM, V284, P11256, DOI 10.1074/jbc.M809790200; Tyler RC, 2005, PROTEIN EXPRES PURIF, V40, P268, DOI 10.1016/j.pep.2004.12.024; Vinarov DA, 2004, NAT METHODS, V1, P149, DOI 10.1038/NMETH716; Waltner JK, 2005, PROTEIN SCI, V14, P2478, DOI 10.1110/ps.051606305; Wang LY, 2009, J BIOMOL NMR, V44, P95, DOI 10.1007/s10858-009-9324-0; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495; Ziarek JJ, 2011, METHOD ENZYMOL, V493, P241, DOI 10.1016/B978-0-12-381274-2.00010-8	51	65	67	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35955	35965		10.1074/jbc.M111.276238	http://dx.doi.org/10.1074/jbc.M111.276238			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21849506	hybrid, Green Published			2022-12-27	WOS:000295927100069
J	Sebastian, BM; Roychowdhury, S; Tang, H; Hillian, AD; Feldstein, AE; Stahl, GL; Takahashi, K; Nagy, LE				Sebastian, Becky M.; Roychowdhury, Sanjoy; Tang, Hui; Hillian, Antoinette D.; Feldstein, Ariel E.; Stahl, Gregory L.; Takahashi, Kazue; Nagy, Laura E.			Identification of a Cytochrome P4502E1/Bid/C1q-dependent Axis Mediating Inflammation in Adipose Tissue after Chronic Ethanol Feeding to Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED LIVER-INJURY; INDUCED FATTY LIVER; INSULIN-RESISTANCE; MACROPHAGE INFILTRATION; HEPATIC STEATOSIS; APOPTOTIC CELLS; DEFICIENT MICE; COMPLEMENT; OBESITY; ADIPONECTIN	Background: Chronic alcohol consumption leads to inflammation in adipose tissue, disrupting normal metabolic activity of adipocytes. Results: Expression of an alcohol metabolizing enzyme, cytochrome P4502E1, initiates inflammation in adipose. Bid-dependent apoptosis and activation of complement then exacerbate this initial response. Conclusion: Adipose inflammation during alcohol feeding develops in response to cytochrome P450 expression. Significance: Preventing adipose inflammation may prevent the pathphysiological effects of ethanol.	[Nagy, Laura E.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Liver Dis Res Ctr, Cleveland, OH 44195 USA; [Feldstein, Ariel E.] Cleveland Clin, Dept Cell Biol, Liver Dis Res Ctr, Cleveland, OH 44195 USA; [Feldstein, Ariel E.] Cleveland Clin, Dept Pediat Gastroenterol, Liver Dis Res Ctr, Cleveland, OH 44195 USA; [Nagy, Laura E.] Cleveland Clin, Dept Gastroenterol & Hepatol, Liver Dis Res Ctr, Cleveland, OH 44195 USA; [Feldstein, Ariel E.; Nagy, Laura E.] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Mol Med, Cleveland, OH 44190 USA; [Stahl, Gregory L.] Harvard Univ, Sch Med, Dept Anesthesiol Peroperat & Pain Med, Boston, MA 02115 USA; [Takahashi, Kazue] Harvard Univ, Sch Med, Lab Dev Immunol, Boston, MA 02115 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Nagy, LE (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Liver Dis Res Ctr, NE40,9500 Euclid Ave, Cleveland, OH 44195 USA.	nagyL3@ccf.org		Stahl, Gregory/0000-0002-4805-8119	National Institutes of Health [P20 AA017837, 5R01 AA016399, R37 AA011876, P20 AA17069 (6017), R01 DK076852, R56AI089781, RC1HL099130, R01HL056086, T32DK007319, U01 AI074503]; Case Western Reserve University [CTSA UL1RR024989]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099130, R01HL056086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074503, R56AI089781, R01AI089781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076852, T32DK007319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA011876, P20AA017837, R01AA016399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 AA017837, 5R01 AA016399, and R37 AA011876 (to L. E. N.), P20 AA17069 (#6017) and R01 DK076852 (to A. E. F.), R56AI089781, RC1HL099130, and R01HL056086 (to G. L. S.), Training grant T32DK007319 (to A. D. H.), and U01 AI074503 (to K. T.). This work was also supported by Case Western Reserve University/Cleveland Clinic Grant CTSA UL1RR024989.	Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Chen XC, 2009, HEPATOLOGY, V49, P1554, DOI 10.1002/hep.22811; Cohen JI, 2011, ANTIOXID REDOX SIGN, V15, P523, DOI 10.1089/ars.2010.3746; Cohen JI, 2010, GASTROENTEROLOGY, V139, P664, DOI 10.1053/j.gastro.2010.04.041; Fischer MB, 1996, J IMMUNOL, V157, P549; Fraser DA, 2009, J IMMUNOL, V183, P6175, DOI 10.4049/jimmunol.0902232; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Hillemacher T, 2009, DRUG ALCOHOL DEPEN, V99, P333, DOI 10.1016/j.drugalcdep.2008.07.019; Kang L, 2007, J BIOL CHEM, V282, P28465, DOI 10.1074/jbc.M705503200; Kang L, 2007, ALCOHOL CLIN EXP RES, V31, P1581, DOI 10.1111/j.1530-0277.2007.00452.x; KORTELAINEN ML, 1991, ALCOHOL, V8, P151, DOI 10.1016/0741-8329(91)91324-U; Kurosaka K, 2003, J IMMUNOL, V171, P4672, DOI 10.4049/jimmunol.171.9.4672; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004; Lu YK, 2010, FREE RADICAL BIO MED, V49, P1406, DOI 10.1016/j.freeradbiomed.2010.07.026; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Mevorach D, 2010, APOPTOSIS, V15, P1114, DOI 10.1007/s10495-010-0530-8; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pattrick M, 2009, MOL IMMUNOL, V46, P755, DOI 10.1016/j.molimm.2008.09.013; Pravdova E, 2009, Endocr Regul, V43, P117; Pravdova Eliska, 2006, Endocr Regul, V40, P91; Pritchard MT, 2007, GASTROENTEROLOGY, V132, P1117, DOI 10.1053/j.gastro.2007.01.053; Roychowdhury S, 2009, HEPATOLOGY, V49, P1326, DOI 10.1002/hep.22776; Sebastian Becky M., 2008, V447, P357, DOI 10.1007/978-1-59745-242-7_23; Shannon JG, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-26; Tenner AJ, 2006, ADV EXP MED BIOL, V586, P153; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wu Defeng, 2008, V447, P137, DOI 10.1007/978-1-59745-242-7_11; Wurst FM, 2007, ALCOHOL CLIN EXP RES, V31, P1963, DOI 10.1111/j.1530-0277.2007.00531.x; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Xu YY, 2001, P NATL ACAD SCI USA, V98, P14577, DOI 10.1073/pnas.261428398; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yoshinari K, 2004, J PHARMACOL EXP THER, V311, P147, DOI 10.1124/jpet.104.067066	43	68	68	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35989	35997		10.1074/jbc.M111.254201	http://dx.doi.org/10.1074/jbc.M111.254201			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21856753	Green Published, hybrid			2022-12-27	WOS:000295927100072
J	Velours, J; Stines-Chaumeil, C; Habersetzer, J; Chaignepain, S; Dautant, A; Brethes, D				Velours, Jean; Stines-Chaumeil, Claire; Habersetzer, Johan; Chaignepain, Stephane; Dautant, Alain; Brethes, Daniel			Evidence of the Proximity of ATP Synthase Subunits 6 (a) in the Inner Mitochondrial Membrane and in the Supramolecular Forms of Saccharomyces cerevisiae ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; F1F0-ATP SYNTHASE; CRYOELECTRON TOMOGRAPHY; YEAST MITOCHONDRIA; SPANNING SEGMENT; CROSS-LINKING; GXXXG MOTIF; IN-VIVO; COMPLEX; CRISTAE	The involvement of subunit 6 (a) in the interface between yeast ATP synthase monomers has been highlighted. Based on the formation of a disulfide bond and using the unique cysteine 23 as target, we show that two subunits 6 are close in the inner mitochondrial membrane and in the solubilized supramolecular forms of the yeast ATP synthase. In a null mutant devoid of supernumerary subunits e and g that are involved in the stabilization of ATP synthase dimers, ATP synthase monomers are close enough in the inner mitochondrial membrane to make a disulfide bridge between their subunits 6, and this proximity is maintained in detergent extract containing this enzyme. The cross-linking of cysteine 23 located in the N-terminal part of the first transmembrane helix of subunit 6 suggests that this membrane-spanning segment is in contact with its counterpart belonging to the ATP synthase monomer that faces it and participates in the monomer-monomer interface.	[Velours, Jean; Stines-Chaumeil, Claire; Habersetzer, Johan; Chaignepain, Stephane; Dautant, Alain; Brethes, Daniel] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33077 Bordeaux, France; [Velours, Jean; Stines-Chaumeil, Claire; Habersetzer, Johan; Chaignepain, Stephane; Dautant, Alain; Brethes, Daniel] Univ Bordeaux, UMR 5095, F-33077 Bordeaux, France; [Chaignepain, Stephane] CNRS, UMR 5248, F-33600 Pessac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux	Velours, J (corresponding author), CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	jean.velours@ibgc.cnrs.fr; daniel.brethes@ibgc.cnrs.fr			CNRS; Universite Victor Segalen, Bordeaux; Conseil Regional d'Aquitaine; Agence Nationale de la Recherche [ANR-06-PCV-0016]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Victor Segalen, Bordeaux; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the CNRS, the Universite Victor Segalen, Bordeaux, the Conseil Regional d'Aquitaine, and the Agence Nationale de la Recherche (ANR-06-PCV-0016).	ANSORGE W, 1983, ELECTROPHORESIS, V82, P235; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284; Belogrudov GI, 1996, J BIOL CHEM, V271, P20340, DOI 10.1074/jbc.271.34.20340; Bustos DM, 2005, J BIOL CHEM, V280, P29004, DOI 10.1074/jbc.M502140200; Buzhynskyy N, 2007, BIOPHYS J, V93, P2870, DOI 10.1529/biophysj.107.109728; Cano-Estrada A, 2010, BBA-BIOENERGETICS, V1797, P1439, DOI 10.1016/j.bbabio.2010.02.024; Chateaubodeau G A, 1976, Biochimie, V58, P601, DOI 10.1016/S0300-9084(76)80230-1; Couoh-Cardel SJ, 2010, J BIOL CHEM, V285, P36447, DOI 10.1074/jbc.M110.144907; COX GB, 1986, BIOCHIM BIOPHYS ACTA, V849, P62, DOI 10.1016/0005-2728(86)90096-4; Dautant A, 2010, J BIOL CHEM, V285, P29502, DOI 10.1074/jbc.M110.124529; Devenish RJ, 2008, INT REV CEL MOL BIO, V267, P1, DOI 10.1016/S1937-6448(08)00601-1; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P272, DOI 10.1016/j.bbabio.2009.11.004; Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; FEARNLEY IM, 1986, EMBO J, V5, P2003, DOI 10.1002/j.1460-2075.1986.tb04456.x; Fronzes R, 2006, BIOCHEMISTRY-US, V45, P6715, DOI 10.1021/bi0601407; Gavin PD, 2005, J BIOENERG BIOMEMBR, V37, P55, DOI 10.1007/s10863-005-4128-8; Gavin PD, 2004, J CELL SCI, V117, P2333, DOI 10.1242/jcs.01074; GrandierVazeille X, 1996, ANAL BIOCHEM, V242, P248, DOI 10.1006/abio.1996.0460; Guerin B, 1979, Methods Enzymol, V55, P149; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Krause F, 2005, BIOCHEM BIOPH RES CO, V329, P583, DOI 10.1016/j.bbrc.2005.02.010; Lau WCY, 2008, J MOL BIOL, V382, P1256, DOI 10.1016/j.jmb.2008.08.014; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MICHON T, 1988, EUR J BIOCHEM, V172, P621, DOI 10.1111/j.1432-1033.1988.tb13934.x; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Nicastro D, 2000, J STRUCT BIOL, V129, P48, DOI 10.1006/jsbi.1999.4204; PAUL MF, 1989, EUR J BIOCHEM, V185, P163, DOI 10.1111/j.1432-1033.1989.tb15098.x; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Paumard P, 2002, BIOCHEMISTRY-US, V41, P10390, DOI 10.1021/bi025923g; Paumard P, 2000, BIOCHEMISTRY-US, V39, P4199, DOI 10.1021/bi992438l; Rais I, 2004, PROTEOMICS, V4, P2567, DOI 10.1002/pmic.200400829; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Soubannier V, 2002, J BIOL CHEM, V277, P10739, DOI 10.1074/jbc.M111882200; Spannagel C, 1998, BIOCHEMISTRY-US, V37, P615, DOI 10.1021/bi9714971; Spannagel C, 1998, BBA-BIOMEMBRANES, V1414, P260, DOI 10.1016/S0005-2736(98)00174-6; Stephens AN, 2003, J BIOL CHEM, V278, P17867, DOI 10.1074/jbc.M300967200; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Thomas D, 2008, BIOL CELL, V100, P591, DOI 10.1042/BC20080022; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Velours J, 2001, J BIOL CHEM, V276, P8602, DOI 10.1074/jbc.M008123200; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Weimann T, 2008, BIOCHEMISTRY-US, V47, P3556, DOI 10.1021/bi702000g; Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027; Wittig I, 2008, MOL CELL PROTEOMICS, V7, P995, DOI 10.1074/mcp.M700465-MCP200; YOSHIDA M, 1975, J BIOL CHEM, V250, P7910	54	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35477	35484		10.1074/jbc.M111.275776	http://dx.doi.org/10.1074/jbc.M111.275776			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21868388	Green Published, hybrid			2022-12-27	WOS:000295927100019
J	Costello, DA; Lyons, A; Denieffe, S; Browne, TC; Cox, FF; Lynch, MA				Costello, Derek A.; Lyons, Anthony; Denieffe, Stephanie; Browne, Tara C.; Cox, F. Fionnuala; Lynch, Marina A.			Long Term Potentiation Is Impaired in Membrane Glycoprotein CD200-deficient Mice A ROLE FOR Toll-LIKE RECEPTOR ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-INDUCED ARTHRITIS; NITRIC-OXIDE SYNTHASE; MICROGLIAL CELLS; IN-VITRO; CD200; EXPRESSION; INHIBITION; INTERLEUKIN-1-BETA; INFLAMMATION; LIGAND	The membrane glycoprotein CD200 is expressed on several cell types, including neurons, whereas expression of its receptor, CD200R, is restricted principally to cells of the myeloid lineage, including microglia. The interaction between CD200 and CD200R maintains microglia and macrophages in a quiescent state; therefore, CD200-deficient mice express an inflammatory phenotype exhibiting increased macrophage or microglial activation in models of arthritis, encephalitis, and uveoretinitis. Here, we report that lipopolysaccharide (LPS) and Pam(3)CysSerLys(4) exerted more profound effects on release of the proinflammatory cytokines, interleukin (IL)-1 beta, IL-6, and tumor necrosis factor-alpha (TNF alpha), in glia prepared from CD200(-/-) mice compared with wild type mice. This effect is explained by the loss of CD200 on astrocytes, which modulates microglial activation. Expression of Toll-like receptors 4 and 2 (TLR4 and -2) was increased in glia prepared from CD200(-/-) mice, and the evidence indicates that microglial activation, assessed by the increased numbers of CD11b(+) cells that stained positively for both MHCII and CD40, was enhanced in CD200(-/-) mice compared with wild type mice. These neuroinflammatory changes were associated with impaired long term potentiation (LTP) in CA1 of hippocampal slices prepared from CD200(-/-) mice. One possible explanation for this is the increase in TNF alpha in hippocampal tissue prepared from CD200(-/-) mice because TNF alpha application inhibited LTP in CA1. Significantly, LPS and Pam(3)CysSerLys(4), at concentrations that did not affect LTP in wild type mice, inhibited LTP in slices prepared from CD200(-/-) mice, probably due to the accompanying increase in TLR2 and TLR4. Thus, the neuroinflammatory changes that result from CD200 deficiency have a negative impact on synaptic plasticity.	[Costello, Derek A.] Trinity Coll Dublin, Dept Physiol, Inst Neurosci, Dublin 2, Ireland	Trinity College Dublin	Costello, DA (corresponding author), Trinity Coll Dublin, Dept Physiol, Inst Neurosci, Dublin 2, Ireland.	derek.costello@tcd.ie		Costello, Derek/0000-0002-5449-6166; Lynch, Marina/0000-0002-4631-0499	Science Foundation Ireland; Health Research Board, Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board, Ireland	This work was supported by Science Foundation Ireland and the Health Research Board, Ireland.	BARCLAY AN, 1981, IMMUNOLOGY, V44, P727; Barclay AN, 2002, TRENDS IMMUNOL, V23, P285, DOI 10.1016/S1471-4906(02)02223-8; Broderick C, 2002, AM J PATHOL, V161, P1669, DOI 10.1016/S0002-9440(10)64444-6; Butler MP, 2004, NEUROSCIENCE, V124, P319, DOI 10.1016/j.neuroscience.2003.11.040; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; Chitnis T, 2007, AM J PATHOL, V170, P1695, DOI 10.2353/ajpath.2007.060677; Costello DA, 2011, J NEUROSCI, V31, P3871, DOI 10.1523/JNEUROSCI.6676-10.2011; Cowley T. R., 2010, NEUROBIOL A IN PRESS; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; Deckert M, 2006, ACTA NEUROPATHOL, V111, P548, DOI 10.1007/s00401-006-0062-z; Downer EJ, 2010, NEUROBIOL AGING, V31, P118, DOI 10.1016/j.neurobiolaging.2008.03.017; Gorczynski RM, 2000, J IMMUNOL, V165, P4854, DOI 10.4049/jimmunol.165.9.4854; Gorczynski RM, 2002, CLIN IMMUNOL, V104, P256, DOI 10.1006/clim.2002.5232; Gorczynski RM, 2001, CLIN IMMUNOL, V101, P328, DOI 10.1006/clim.2001.5117; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Hailer NP, 1998, BRAIN PATHOL, V8, P459; Hauss-Wegrzyniak B, 2002, EXP NEUROL, V176, P336, DOI 10.1006/exnr.2002.7966; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Koning N, 2009, J NEUROPATH EXP NEUR, V68, P159, DOI 10.1097/NEN.0b013e3181964113; Lehnardt S, 2006, J IMMUNOL, V177, P583, DOI 10.4049/jimmunol.177.1.583; Lin HY, 2011, J CELL PHYSIOL, V226, P1573, DOI 10.1002/jcp.22489; Lotz M, 2005, J NEUROCHEM, V94, P289, DOI 10.1111/j.1471-4159.2005.03188.x; Lynch AM, 2007, NEUROBIOL AGING, V28, P845, DOI 10.1016/j.neurobiolaging.2006.04.006; Lyons A, 2007, J NEUROSCI, V27, P8309, DOI 10.1523/JNEUROSCI.1781-07.2007; Lyons A, 2009, BRAIN BEHAV IMMUN, V23, P1020, DOI 10.1016/j.bbi.2009.05.060; Mihrshahi R, 2009, J IMMUNOL, V183, P4879, DOI 10.4049/jimmunol.0901531; Mishra BB, 2006, J NEUROIMMUNOL, V181, P46, DOI 10.1016/j.jneuroim.2006.07.019; Mukhopadhyay S, 2010, CELL HOST MICROBE, V8, P236, DOI 10.1016/j.chom.2010.08.005; Murray CA, 1998, J NEUROSCI, V18, P2974; Nolan Y, 2005, J BIOL CHEM, V280, P9354, DOI 10.1074/jbc.M412170200; Pallasch CP, 2009, LEUKEMIA RES, V33, P460, DOI 10.1016/j.leukres.2008.08.021; Rosenblum MD, 2004, BLOOD, V103, P2691, DOI 10.1182/blood-2003-09-3184; Rosi S, 2006, NEUROSCIENCE, V142, P1303, DOI 10.1016/j.neuroscience.2006.08.017; Siva A, 2008, CANCER IMMUNOL IMMUN, V57, P987, DOI 10.1007/s00262-007-0429-6; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Tancredi V, 2000, J NEUROCHEM, V75, P634, DOI 10.1046/j.1471-4159.2000.0750634.x; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Vincent VAM, 1997, GLIA, V19, P190, DOI 10.1002/(SICI)1098-1136(199703)19:3<190::AID-GLIA2>3.0.CO;2-3; Vincent VAM, 1996, GLIA, V17, P94	40	111	115	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34722	34732		10.1074/jbc.M111.280826	http://dx.doi.org/10.1074/jbc.M111.280826			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21835925	Green Published, hybrid			2022-12-27	WOS:000295406300026
J	Garcia-del Portillo, F; Calvo, E; D'Orazio, V; Graciela Pucciarelli, M				Garcia-del Portillo, Francisco; Calvo, Enrique; D'Orazio, Valentina; Graciela Pucciarelli, M.			Association of ActA to Peptidoglycan Revealed by Cell Wall Proteomics of Intracellular Listeria monocytogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; SORTASE-B; SALMONELLA-ENTERICA; SURFACE-PROTEINS; COMPARATIVE GENOMICS; CARBON METABOLISM; STATISTICAL-MODEL; MASS-SPECTROMETRY; EPITHELIAL-CELLS; VIRULENCE	Listeria monocytogenes is a Gram-positive intracellular bacterial pathogen that colonizes the cytosol of eukaryotic cells. Recent transcriptomic studies have revealed that intracellular L. monocytogenes alter expression of genes encoding envelope components. However, no comparative global analysis of this cell wall remodeling process is yet known at the protein level. Here, we used high resolution mass spectrometry to define the cell wall proteome of L. monocytogenes growing inside epithelial cells. When compared with extracellular bacteria growing in a nutrient-rich medium, a major difference found in the proteome was the presence of the actin assembly-inducing protein ActA in peptidoglycan purified from intracellular bacteria. ActA was also identified in the peptidoglycan of extracellular bacteria growing in a chemically defined minimal medium. In this condition, ActA maintains its membrane anchoring domain and promotes efficient bacterial entry into nonphagocytic host cells. Unexpectedly, Internalin-A, which mediates entry of extracellular L. monocytogenes into eukaryotic cells, was identified at late infection times (6 h) as an abundant protein in the cell wall of intracellular bacteria. Other surface proteins covalently bound to the peptidoglycan, as Lmo0514 and Lmo2085, were detected exclusively in intracellular and extracellular bacteria, respectively. Altogether, these data provide the first insights into the changes occurring at the protein level in the L. monocytogenes cell wall as the pathogen transits from the extracellular environment to an intracytosolic lifestyle inside eukaryotic cells. Some of these changes include alterations in the relative amount and the mode of association of certain surface proteins.	[Garcia-del Portillo, Francisco; D'Orazio, Valentina; Graciela Pucciarelli, M.] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid 28049, Spain; [Calvo, Enrique] Ctr Nacl Invest Cardiovasc, Unidad Proteo, Madrid 28029, Spain; [Graciela Pucciarelli, M.] Univ Autonoma Madrid, Dept Biol Mol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid	Graciela Pucciarelli, M (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid 28049, Spain.	mg.pucciarelli@uam.es	García-del Portillo, Francisco/D-2576-2009	Pucciarelli Morrone, Maria Graciela/0000-0002-4268-2316; Garcia-del Portillo, Francisco/0000-0002-4120-0530	ERA-NET Pathogenomics LISTRESS Consortium [PIM2010EPA-00714]; Spanish Ministry of Science and Innovation [BIO2010-18962]	ERA-NET Pathogenomics LISTRESS Consortium; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by Grants PIM2010EPA-00714 from the ERA-NET Pathogenomics LISTRESS Consortium (to F. G.-P.) and BIO2010-18962 (to M. G. P.) from the Spanish Ministry of Science and Innovation.	Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Bonazzi M, 2009, CELL MICROBIOL, V11, P693, DOI 10.1111/j.1462-5822.2009.01293.x; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Cabanes D, 2005, EMBO J, V24, P2827, DOI 10.1038/sj.emboj.7600750; Cabanes D, 2002, TRENDS MICROBIOL, V10, P238, DOI 10.1016/S0966-842X(02)02342-9; Calvo E, 2005, PROTEOMICS, V5, P433, DOI 10.1002/pmic.200400936; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; Chatterjee SS, 2006, INT J MED MICROBIOL, V296, P277, DOI 10.1016/j.ijmm.2005.10.001; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; Donaldson JR, 2011, J PROTEOMICS, V74, P1906, DOI 10.1016/j.jprot.2011.05.008; Doumith M, 2004, INFECT IMMUN, V72, P1072, DOI 10.1128/IAI.72.2.1072-1083.2004; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Fedtke I, 2004, INT J MED MICROBIOL, V294, P189, DOI 10.1016/j.ijmm.2004.06.016; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Glaser P, 2001, SCIENCE, V294, P849; GUZMAN CA, 1995, INFECT IMMUN, V63, P3665, DOI 10.1128/IAI.63.9.3665-3673.1995; Hain T, 2007, INT J MED MICROBIOL, V297, P541, DOI 10.1016/j.ijmm.2007.03.016; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Hecker M, 2008, PROTEOMICS, V8, P4958, DOI 10.1002/pmic.200800278; Hendrickx APA, 2009, TRENDS MICROBIOL, V17, P423, DOI 10.1016/j.tim.2009.06.004; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; Joseph B, 2006, J BACTERIOL, V188, P556, DOI 10.1128/JB.188.2.556-568.2006; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Lathrop AA, 2008, J APPL MICROBIOL, V104, P627, DOI 10.1111/j.1365-2672.2007.03574.x; Lebrun M, 1996, MOL MICROBIOL, V21, P579, DOI 10.1111/j.1365-2958.1996.tb02566.x; Luu PT, 1997, INT J FOOD MICROBIOL, V35, P91, DOI 10.1016/S0168-1605(96)01205-6; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Mariscotti JF, 2009, J BIOL CHEM, V284, P6140, DOI 10.1074/jbc.M807989200; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mostowy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004196; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NIEBUHR K, 1993, INFECT IMMUN, V61, P2793, DOI 10.1128/IAI.61.7.2793-2802.1993; Personnic N, 2010, INFECT IMMUN, V78, P1979, DOI 10.1128/IAI.01096-09; Poetsch A, 2008, PROTEOMICS, V8, P4100, DOI 10.1002/pmic.200800273; Pucciarelli M. G., 2007, LISTERIA MONOCYTOGEN, P81; Pucciarelli MG, 2005, PROTEOMICS, V5, P4808, DOI 10.1002/pmic.200402075; Pucciarelli MG, 2003, MOL MICROBIOL, V48, P573, DOI 10.1046/j.1365-2958.2003.03469.x; Pucciarelli MG, 2002, MICROBIOL-SGM, V148, P1171, DOI 10.1099/00221287-148-4-1171; Rafelski SM, 2006, MOL MICROBIOL, V59, P1262, DOI 10.1111/j.1365-2958.2006.05025.x; Reis O, 2010, J INFECT DIS, V202, P551, DOI 10.1086/654880; Ripio MT, 1997, J BACTERIOL, V179, P1533, DOI 10.1128/jb.179.5.1533-1540.1997; Schaumburg J, 2004, PROTEOMICS, V4, P2991, DOI 10.1002/pmic.200400928; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Stoll R, 2008, MICROBIOL-SGM, V154, P3856, DOI 10.1099/mic.0.2008/018283-0; Suarez M, 2001, CELL MICROBIOL, V3, P853, DOI 10.1046/j.1462-5822.2001.00160.x; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x	56	34	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34675	34689		10.1074/jbc.M111.230441	http://dx.doi.org/10.1074/jbc.M111.230441			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846725	Green Published, hybrid			2022-12-27	WOS:000295406300022
J	Wisskirchen, C; Ludersdorfer, TH; Muller, DA; Moritz, E; Pavlovic, J				Wisskirchen, Christian; Ludersdorfer, Thomas H.; Mueller, Dominik A.; Moritz, Eva; Pavlovic, Jovan			Interferon-induced Antiviral Protein MxA Interacts with the Cellular RNA Helicases UAP56 and URH49	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-A VIRUS; MESSENGER-RNA; THOGOTO-VIRUS; BOX PROTEIN; NUCLEAR-LOCALIZATION; GTPASE; OLIGOMERIZATION; EXPRESSION; OVEREXPRESSION; TRANSCRIPTION	Mx proteins are a family of large GTPases that are induced exclusively by interferon-alpha/beta and have a broad antiviral activity against several viruses, including influenza A virus (IAV). Although the antiviral activities of mouse Mx1 and human MxA have been studied extensively, the molecular mechanism of action remains largely unsolved. Because no direct interaction between Mx proteins and IAV proteins or RNA had been demonstrated so far, we addressed the question of whether Mx protein would interact with cellular proteins required for efficient replication of IAV. Immunoprecipitation of MxA revealed its association with two closely related RNA helicases, UAP56 and URH49. UAP56 and its paralog URH49 play an important role in IAV replication and are involved in nuclear export of IAV mRNAs and prevention of dsRNA accumulation in infected cells. In vitro binding assays with purified recombinant proteins revealed that MxA formed a direct complex with the RNA helicases. In addition, recombinant mouse Mx1 was also able to bind to UAP56 or URH49. Furthermore, the complex formation between cytoplasmic MxA and UAP56 or URH49 occurred in the perinuclear region, whereas nuclear Mx1 interacted with UAP56 or URH49 in distinct dots in the nucleus. Taken together, our data reveal that Mx proteins exerting antiviral activity can directly bind to the two cellular DExD/H box RNA helicases UAP56 and URH49. Moreover, the observed subcellular localization of the Mx-RNA helicase complexes coincides with the subcellular localization, where human MxA and mouse Mx1 proteins act antivirally. On the basis of these data, we propose that Mx proteins exert their antiviral activity against IAV by interfering with the function of the RNA helicases UAP56 and URH49.	[Wisskirchen, Christian; Ludersdorfer, Thomas H.; Mueller, Dominik A.; Moritz, Eva; Pavlovic, Jovan] Univ Zurich, Inst Med Virol, CH-8057 Zurich, Switzerland; [Wisskirchen, Christian; Ludersdorfer, Thomas H.] Univ Zurich, PhD Program Microbiol & Immunol, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich	Pavlovic, J (corresponding author), Univ Zurich, Inst Med Virol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	pavlovic.jovan@virology.uzh.ch	Pavlovic, Jovan/G-9669-2015	Pavlovic, Jovan/0000-0003-4428-2487	Swiss National Science Foundation; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich	This work was supported by a grant from the Swiss National Science Foundation and a Forschungskredit from the University of Zurich.	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; AEBI M, 1989, MOL CELL BIOL, V9, P5062, DOI 10.1128/MCB.9.11.5062; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Di Paolo C, 1999, J BIOL CHEM, V274, P32071, DOI 10.1074/jbc.274.45.32071; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Engelhardt OG, 2004, J GEN VIROL, V85, P2315, DOI 10.1099/vir.0.79795-0; Engelhardt OG, 2001, EXP CELL RES, V271, P286, DOI 10.1006/excr.2001.5380; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; FRESE M, 1995, J VIROL, V69, P3904, DOI 10.1128/JVI.69.6.3904-3909.1995; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Haller O, 2010, J BIOL CHEM, V285, P28419, DOI 10.1074/jbc.R110.145839; HORISBERGER MA, 1992, J VIROL, V66, P4705, DOI 10.1128/JVI.66.8.4705-4709.1992; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; HUANG T, 1992, J VIROL, V66, P4154, DOI 10.1128/JVI.66.7.4154-4160.1992; Janzen C, 2000, J VIROL, V74, P8202, DOI 10.1128/JVI.74.17.8202-8206.2000; Kapadia F, 2006, GENE, V384, P37, DOI 10.1016/j.gene.2006.07.010; Kawaguchi A, 2011, J VIROL, V85, P6197, DOI 10.1128/JVI.00277-11; Kochs G, 1999, J BIOL CHEM, V274, P4370, DOI 10.1074/jbc.274.7.4370; Kochs G, 2002, P NATL ACAD SCI USA, V99, P3153, DOI 10.1073/pnas.052430399; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; Kota KP, 2008, J CELL SCI, V121, P1526, DOI 10.1242/jcs.021055; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Meignin C, 2008, DEV BIOL, V315, P89, DOI 10.1016/j.ydbio.2007.12.004; Melen K, 1997, J BIOL CHEM, V272, P32353, DOI 10.1074/jbc.272.51.32353; Momose F, 2001, J VIROL, V75, P1899, DOI 10.1128/JVI.75.4.1899-1908.2001; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Pryor A, 2004, NUCLEIC ACIDS RES, V32, P1857, DOI 10.1093/nar/gkh347; Read EKC, 2010, J GEN VIROL, V91, P1290, DOI 10.1099/vir.0.018564-0; Sahni A, 2010, BIOCHEM BIOPH RES CO, V393, P106, DOI 10.1016/j.bbrc.2010.01.093; Schmidt U, 2009, RNA, V15, P862, DOI 10.1261/rna.1387009; Schumacher B, 1998, J BIOL CHEM, V273, P28365, DOI 10.1074/jbc.273.43.28365; SCHWEMMLE M, 1995, VIROLOGY, V206, P545, DOI 10.1016/S0042-6822(95)80071-9; Shen HH, 2008, GENE DEV, V22, P1796, DOI 10.1101/gad.1657308; Shen HH, 2009, BMB REP, V42, P185, DOI 10.5483/BMBRep.2009.42.4.185; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; STRANDEN AM, 1993, VIROLOGY, V197, P642, DOI 10.1006/viro.1993.1639; Thomas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022671; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; Wisskirchen C, 2011, J VIROL, V85, P8646, DOI 10.1128/JVI.02559-10; Zhao R, 2004, STRUCTURE, V12, P1373, DOI 10.1016/j.str.2004.06.006; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11; ZURCHER T, 1992, EMBO J, V11, P1657, DOI 10.1002/j.1460-2075.1992.tb05212.x; ZURCHER T, 1992, J VIROL, V66, P5059	49	31	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34743	34751		10.1074/jbc.M111.251843	http://dx.doi.org/10.1074/jbc.M111.251843			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21859714	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000295406300028
J	Zhu, XJ; Cha, BY; Zachos, NC; Sarker, R; Chakraborty, M; Chen, TE; Kovbasnjuk, O; Donowitz, M				Zhu, Xinjun; Cha, Boyoung; Zachos, Nicholas C.; Sarker, Rafiquel; Chakraborty, Molee; Chen, Tian-e; Kovbasnjuk, Olga; Donowitz, Mark			Elevated Calcium Acutely Regulates Dynamic Interactions of NHERF2 and NHE3 Proteins in Opossum Kidney (OK) Cell Microvilli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORDER NA+/H+ EXCHANGER; INTESTINAL EPITHELIAL NHE3; ILEAL BRUSH-BORDER; PROXIMAL TUBULE; CA2+-DEPENDENT INHIBITION; INTRACELLULAR CALCIUM; STIMULATES NHE3; APICAL SURFACE; BASAL ACTIVITY; PKC-ALPHA	The brush border (BB) Na+H+ exchanger NHE3 is rapidly activated or inhibited by changes in trafficking, which mimics renal and intestinal physiology. However, there is a paradox in that NHE3 has limited mobility in the BB due to its binding to the multi-PDZ domain containing the NHERF family. To allow increased endocytosis, as occurs with elevated intracellular Ca2+, we hypothesized that NHE3 had to be, at least transiently, released from the BB cytoskeleton. BecauseNHERF1 and -2 are localized at the BB, where they bind NHE3 as well as the cytoskeleton, we tested whether either or both might dynamically interact with NHE3 as part of Ca2+ signaling. We employed FRET to study close association of NHE3 and these NHERFs and fluorescence recovery after photobleaching to monitor NHE3 mobility in the apical domain in polarized opossum kidney cells. Under basal conditions, NHERF2 and NHE3 exhibited robust FRET signaling. Within 1 min of A23187 (0.5 mu M) exposure, the NHERF2-NHE3 FRET signal was abolished, and BB NHE3 mobility was transiently increased. The dynamics in FRET signal and NHE3 mobility correlated well with a change in co-precipitation of NHE3 and NHERF2 but not NHERF1. We conclude the following. 1) Under basal conditions, NHE3 closely associates with NHERF2 in opossum kidney cell microvilli. 2) Within 1 min of elevated Ca2+, the close association of NHE3-NHERF2 is abolished but is re-established in similar to 60 min. 3) The change in NHE3-NHERF2 association is accompanied by an increased BB mobile fraction of NHE3, which contributes to inhibition of NHE3 transport activity via increased endocytosis.	[Donowitz, Mark] Johns Hopkins Univ, Div Gastroenterol & Hepatol, Dept Med, Sch Med, Baltimore, MD 21205 USA; [Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Gastroenterol, Baltimore, MD 21205 USA; [Zhu, Xinjun] Albany Med Coll, Gastrointestinal Div, Albany, NY 12008 USA	Johns Hopkins University; Johns Hopkins University; Albany Medical College	Donowitz, M (corresponding author), Johns Hopkins Univ, Div Gastroenterol & Hepatol, Dept Med, Sch Med, 925 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Zachos, Nicholas/GWC-7914-2022		National Institutes of Health [R01DK26523, RO1DK61765, PO1 DK072084, R24DK64388]; NIDDK [KO8DK088950, T32DK2007632]; Johns Hopkins Center for Epithelial Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK091482, R24DK064388, P01DK072084, R01DK061765, K08DK088950, R01DK026523] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Johns Hopkins Center for Epithelial Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK26523, RO1DK61765, PO1 DK072084, and R24DK64388 (Johns Hopkins Basic Research Digestive Diseases Development Core Center) and KO8DK088950 and T32DK2007632 from NIDDK. This work was also supported by the Johns Hopkins Center for Epithelial Biology.	Akhter S, 2002, AM J PHYSIOL-CELL PH, V283, pC927, DOI 10.1152/ajpcell.00613.2001; Alexander RT, 2009, J EXP BIOL, V212, P1630, DOI 10.1242/jeb.027375; Alexander RT, 2005, P NATL ACAD SCI USA, V102, P12253, DOI 10.1073/pnas.0409197102; Banday AA, 2011, AM J PHYSIOL-RENAL, V301, pF364, DOI 10.1152/ajprenal.00121.2011; Biemesderfer D, 2001, J BIOL CHEM, V276, P10161, DOI 10.1074/jbc.M008098200; Bobulescu IA, 2006, SEMIN NEPHROL, V26, P334, DOI 10.1016/j.semnephrol.2006.07.001; Bobulescu IA, 2009, PFLUG ARCH EUR J PHY, V458, P5, DOI 10.1007/s00424-008-0595-1; Cha BY, 2010, J CELL SCI, V123, P2434, DOI 10.1242/jcs.056713; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Choi JW, 2004, BBA-MOL CELL BIOL L, V1683, P59, DOI 10.1016/j.bbalip.2004.04.005; Di Sole F, 2003, J AM SOC NEPHROL, V14, P1720, DOI 10.1097/01.ASN.0000072743.97583.DB; DONOWITZ M, 1989, J CLIN INVEST, V83, P1953, DOI 10.1172/JCI114104; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Gill RK, 2005, GASTROENTEROLOGY, V128, P962, DOI 10.1053/j.gastro.2005.02.011; Hayashi H, 2004, J GEN PHYSIOL, V123, P491, DOI 10.1085/jgp.200308979; Janecki AJ, 2000, J BIOL CHEM, V275, P8133, DOI 10.1074/jbc.275.11.8133; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; McDonough AA, 2003, CURR OPIN NEPHROL HY, V12, P533, DOI 10.1097/00041552-200309000-00009; Morris AP, 2001, AM J PHYSIOL-GASTR L, V281, pG303, DOI 10.1152/ajpgi.2001.281.2.G303; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Murtazina R, 2011, AM J PHYSIOL-CELL PH, V301, pC126, DOI 10.1152/ajpcell.00311.2010; Musch MW, 2007, AM J PHYSIOL-GASTR L, V292, pG1549, DOI 10.1152/ajpgi.00388.2006; Musch MW, 2010, AM J PHYSIOL-GASTR L, V298, pG203, DOI 10.1152/ajpgi.00379.2009; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Riquier ADM, 2009, AM J PHYSIOL-CELL PH, V296, pC900, DOI 10.1152/ajpcell.00526.2008; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Weinman EJ, 2001, AM J PHYSIOL-RENAL, V281, pF374, DOI 10.1152/ajprenal.2001.281.2.F374; Yang LE, 2005, J AM SOC NEPHROL, V16, P2890, DOI 10.1681/ASN.2005040366; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; Zachos NC, 2009, J BIOL CHEM, V284, P23708, DOI 10.1074/jbc.M109.012641; Zachos NC, 2009, ANN NY ACAD SCI, V1165, P240, DOI 10.1111/j.1749-6632.2009.04055.x; Zachos NC, 2008, CELL PHYSIOL BIOCHEM, V22, P693, DOI 10.1159/000185553	45	15	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34486	34496		10.1074/jbc.M111.230219	http://dx.doi.org/10.1074/jbc.M111.230219			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21799002	Green Published, hybrid			2022-12-27	WOS:000295406300002
J	Archuleta, TL; Du, YQ; English, CA; Lory, S; Lesser, C; Ohi, MD; Ohi, R; Spiller, BW				Archuleta, Tara L.; Du, Yaqing; English, Chauca A.; Lory, Stephen; Lesser, Cammie; Ohi, Melanie D.; Ohi, Ryoma; Spiller, Benjamin W.			The Chlamydia Effector Chlamydial Outer Protein N (CopN) Sequesters Tubulin and Prevents Microtubule Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION TRANSLOCATOR; STATHMIN-LIKE DOMAIN; HOST-CELLS; IN-VITRO; DYNAMIC INSTABILITY; BACTERIAL INVASION; TRACHOMATIS; POLYMERIZATION; CHAPERONES; SHIGELLA	Chlamydia species are obligate intracellular pathogens that utilize a type three secretion system to manipulate host cell processes. Genetic manipulations are currently not possible in Chlamydia, necessitating study of effector proteins in heterologous expression systems and severely complicating efforts to relate molecular strategies used by Chlamydia to the biochemical activities of effector proteins. CopN is a chlamydial type three secretion effector that is essential for virulence. Heterologous expression of CopN in cells results in loss of microtubule spindles and metaphase plate formation and causes mitotic arrest. CopN is a multidomain protein with similarity to type three secretion system "plug" proteins from other organisms but has functionally diverged such that it also functions as an effector protein. Weshow that CopN binds directly to alpha beta-tubulin but not to microtubules (MTs). Furthermore, CopN inhibits tubulin polymerization by sequestering free alpha beta-tubulin, similar to one of the mechanisms utilized by stathmin. Although CopN and stathmin share no detectable sequence identity, both influence MT formation by sequestration of alpha beta-tubulin. CopN displaces stathmin from preformed stathmin-tubulin complexes, indicating that the proteins bind overlapping sites on tubulin. CopN is the first bacterial effector shown to disrupt MT formation directly. This recognition affords a mechanistic understanding of a strategy Chlamydia species use to manipulate the host cell cycle.	[Archuleta, Tara L.; Spiller, Benjamin W.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; [Archuleta, Tara L.] Vanderbilt Univ, Div Chem & Phys Biol, Sch Med, Nashville, TN 37232 USA; [Du, Yaqing; English, Chauca A.; Ohi, Melanie D.; Ohi, Ryoma] Vanderbilt Univ, Dept Cell & Dev Biol, Sch Med, Nashville, TN 37232 USA; [Spiller, Benjamin W.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, Nashville, TN 37232 USA; [Lory, Stephen; Lesser, Cammie] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Lesser, Cammie] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Spiller, BW (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA.	benjamin.spiller@vanderbilt.edu			National Institutes of Health [5T90 DA022873]; National Center for Research Resources [UL1RR024975-01, DK058404]; NATIONAL CANCER INSTITUTE [T32CA119925] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant UL1RR024975-01 from the National Center for Research Resources and Grant DK058404 (to B. W. S.) and Grant NIH 5T90 DA022873 (to T. L. A.).	Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010; Balsara ZR, 2006, INFECT IMMUN, V74, P5602, DOI 10.1128/IAI.00266-06; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BULINSKI JC, 1980, ANAL BIOCHEM, V104, P432, DOI 10.1016/0003-2697(80)90095-0; Buttner CR, 2008, J MOL BIOL, V375, P997, DOI 10.1016/j.jmb.2007.11.009; Campbell L. A., 2009, CURR PROTOC MICROBIO, V11, p11B1; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; Deane JE, 2008, J MOL BIOL, V377, P985, DOI 10.1016/j.jmb.2008.01.072; Deng WY, 2005, INFECT IMMUN, V73, P2135, DOI 10.1128/IAI.73.4.2135-2146.2005; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Du YQ, 2010, CURR BIOL, V20, P374, DOI 10.1016/j.cub.2009.12.049; Engel J, 2004, P NATL ACAD SCI USA, V101, P9947, DOI 10.1073/pnas.0403633101; Fields KA, 2005, J BACTERIOL, V187, P6466, DOI 10.1128/JB.187.18.6466-6478.2005; Fields KA, 2000, MOL MICROBIOL, V38, P1048, DOI 10.1046/j.1365-2958.2000.02212.x; Germane KL, 2008, BIOCHEMISTRY-US, V47, P10241, DOI 10.1021/bi801533k; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Grieshaber SS, 2006, TRAFFIC, V7, P940, DOI 10.1111/j.1600-0854.2006.00439.x; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Ho TD, 2005, INFECT IMMUN, V73, P905, DOI 10.1128/IAI.73.2.905-911.2005; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; Hsia RC, 1997, MOL MICROBIOL, V25, P351, DOI 10.1046/j.1365-2958.1997.4701834.x; Huang J, 2008, NATURE, V456, P112, DOI 10.1038/nature07355; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Johnson S, 2005, CURR OPIN STRUC BIOL, V15, P700, DOI 10.1016/j.sbi.2005.10.007; Jourdain I, 2004, BIOCHEM J, V378, P877, DOI 10.1042/BJ20031413; Lachkar S, 2010, J BIOL CHEM, V285, P11667, DOI 10.1074/jbc.M109.096727; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Manna T, 2006, J BIOL CHEM, V281, P2071, DOI 10.1074/jbc.M510661200; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; MARGOLIS RL, 1978, CELL, V13, P1, DOI 10.1016/0092-8674(78)90132-0; Mital J, 2010, CELL MICROBIOL, V12, P1235, DOI 10.1111/j.1462-5822.2010.01465.x; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Mukhopadhyay S, 2004, J CLIN MICROBIOL, V42, P3288, DOI 10.1128/JCM.42.7.3288-3290.2004; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rodgers L, 2008, J BIOL CHEM, V283, P20857, DOI 10.1074/jbc.M802339200; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009; Slepenkin A, 2005, J BACTERIOL, V187, P473, DOI 10.1128/JB.187.2.473-479.2005; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; WEISENBERG RC, 1976, BIOCHEMISTRY-US, V15, P4248, DOI 10.1021/bi00664a018; Yoshida S, 2003, TRENDS MICROBIOL, V11, P139, DOI 10.1016/S0966-842X(03)00023-4	64	34	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33992	33998		10.1074/jbc.M111.258426	http://dx.doi.org/10.1074/jbc.M111.258426			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21841198	hybrid, Green Published			2022-12-27	WOS:000295159200031
J	Beaudoin, J; Ioannoni, R; Lopez-Maury, L; Bahler, J; Ait-Mohand, S; Guerin, B; Dodani, SC; Chang, CJ; Labbe, S				Beaudoin, Jude; Ioannoni, Raphael; Lopez-Maury, Luis; Baehler, Juerg; Ait-Mohand, Samia; Guerin, Brigitte; Dodani, Sheel C.; Chang, Christopher J.; Labbe, Simon			Mfc1 Is a Novel Forespore Membrane Copper Transporter in Meiotic and Sporulating Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING FACTOR PHP4; FISSION YEAST; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; MOLECULAR-MECHANISMS; IRON-DEFICIENCY; MEIOSIS; PROTEIN; CTR1; IDENTIFICATION	To gain insight in the molecular basis of copper homeostasis during meiosis, we have used DNA microarrays to analyze meiotic gene expression in the model yeast Schizosaccharomyces pombe. Profiling data identified a novel meiosis-specific gene, termed mfc1(+), that encodes a putative major facilitator super-family-type transporter. Although Mfc1 does not exhibit any significant sequence homology with the copper permease Ctr4, it contains four putative copper-binding motifs that are typically found in members of the copper transporter family of copper transporters. Similarly to the ctr4(+) gene, the transcription of mfc1(+) was induced by low concentrations of copper. However, its temporal expression profile during meiosis was distinct to ctr4(+). Whereas Ctr4 was observed at the plasma membrane shortly after induction of meiosis, Mfc1 appeared later in precursor vesicles and, subsequently, at the forespore membrane of ascospores. Using the fluorescent copper-binding tracker Coppersensor-1 (CS1), labile cellular copper was primarily detected in the forespores in an mfc1(+)/mfc1(+) strain, whereas an mfc1 Delta/mfc1 Delta mutant exhibited an intracellular dispersed punctate distribution of labile copper ions. In addition, the copper amine oxidase Cao1, which localized primarily in the forespores of asci, was fully active in mfc1(+)/mfc1(+) cells, but its activity was drastically reduced in an mfc1 Delta/mfc1 Delta strain. Furthermore, our data showed that meiotic cells that express the mfc1(+) gene have a distinct developmental advantage over mfc1 Delta/mfc1 Delta mutant cells when copper is limiting. Taken together, the data reveal that Mfc1 serves to transport copper for accurate and timely meiotic differentiation under copper-limiting conditions.	[Labbe, Simon] Univ Sherbrooke, Fac Med, Dept Biochim, Sherbrooke, PQ J1H 5N4, Canada; [Guerin, Brigitte] Univ Sherbrooke, Dept Med Nucl & Radiobiol, Fac Med & Sci Sante, Sherbrooke, PQ J1H 5N4, Canada; [Ait-Mohand, Samia; Guerin, Brigitte] Univ Sherbrooke, Ctr Imagerie Mol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada; [Lopez-Maury, Luis; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Dodani, Sheel C.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of London; University College London; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Labbe, S (corresponding author), Univ Sherbrooke, Fac Med, Dept Biochim, 3001,12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Simon.Labbe@USherbrooke.ca	Bahler, Jurg/B-4572-2009; Lopez-Maury, Luis/B-3715-2015	Bahler, Jurg/0000-0003-4036-1532; Lopez-Maury, Luis/0000-0002-3510-0621; Labbe, Simon/0000-0002-4947-523X	National Institutes of Health, NIGMS [GM-79465]; Canadian Institutes of Health Research [MOP-3645, MOP-114986]; Foundation of Stars for Children's Health Research; Cancer Research UK [CUK C9546/A6517]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Foundation of Stars for Children's Health Research; Cancer Research UK(Cancer Research UK); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-79465 from NIGMS (to C. J. C.). This work was also supported by Grants MOP-3645 and MOP-114986 from the Canadian Institutes of Health Research, by a grant from the Foundation of Stars for Children's Health Research (to S. L.), and by Cancer Research UK Grant CUK C9546/A6517 (to J. B.).; Recipient of a studentship from the Natural Sciences and Engineering Research Council of Canada.	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; BAHLER J, 1991, CURR GENET, V19, P445, DOI 10.1007/BF00312735; Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Beaudoin J, 2003, J BIOL CHEM, V278, P14565, DOI 10.1074/jbc.M300861200; Beaudoin J, 2001, J BIOL CHEM, V276, P15472, DOI 10.1074/jbc.M011256200; Beaudoin J, 2011, MICROBIOL-SGM, V157, P1021, DOI 10.1099/mic.0.046854-0; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bezanilla M, 1997, MOL BIOL CELL, V8, P2693, DOI 10.1091/mbc.8.12.2693; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; COTTAREL G, 1993, CURR GENET, V23, P547, DOI 10.1007/BF00312650; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Doll E, 2008, GENETICS, V180, P727, DOI 10.1534/genetics.108.092619; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Ioannoni R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011964; KEENEY JB, 1994, GENETICS, V136, P849; Kim AM, 2011, ACS CHEM BIOL, V6, P716, DOI 10.1021/cb200084y; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim J, 1998, GENETICS, V149, P795; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Kuo YM, 2006, J NUTR, V136, P21, DOI 10.1093/jn/136.1.21; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Laliberte J, 2004, J BIOL CHEM, V279, P28744, DOI 10.1074/jbc.M403426200; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Loidl J, 2009, METHODS MOL BIOL, V558, P15, DOI 10.1007/978-1-60761-103-5_2; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Maeda Y, 2009, BIOSCI BIOTECH BIOCH, V73, P339, DOI 10.1271/bbb.80575; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Matsuyama A, 2000, GENETICS, V155, P539; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Miller EW, 2006, NAT PROTOC, V1, P824, DOI 10.1038/nprot.2006.140; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakamura T, 2008, MOL BIOL CELL, V19, P3544, DOI 10.1091/mbc.E08-04-0414; Nevitt T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001322; Nose Y, 2006, TRENDS BIOCHEM SCI, V31, P604, DOI 10.1016/j.tibs.2006.09.003; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Peter C, 2008, EUKARYOT CELL, V7, P1781, DOI 10.1128/EC.00230-08; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Siam R, 2004, METHODS, V33, P189, DOI 10.1016/j.ymeth.2003.11.013; Steiger D, 2010, J BIOL CHEM, V285, P17089, DOI 10.1074/jbc.M109.090282; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; Yamamoto M, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P297; Zeng L, 2006, J AM CHEM SOC, V128, P10, DOI 10.1021/ja055064u; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	64	31	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34356	34372		10.1074/jbc.M111.280396	http://dx.doi.org/10.1074/jbc.M111.280396			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828039	Green Published, hybrid			2022-12-27	WOS:000295159200064
J	Delvaux, D; Murty, MRVS; Gabelica, V; Lakaye, B; Lunin, VV; Skarina, T; Onopriyenko, O; Kohn, G; Wins, P; De Pauw, E; Bettendorff, L				Delvaux, David; Murty, Mamidanna R. V. S.; Gabelica, Valerie; Lakaye, Bernard; Lunin, Vladimir V.; Skarina, Tatiana; Onopriyenko, Olena; Kohn, Gregory; Wins, Pierre; De Pauw, Edwin; Bettendorff, Lucien			A Specific Inorganic Triphosphatase from Nitrosomonas europaea STRUCTURE AND CATALYTIC MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST RNA TRIPHOSPHATASE; IV ADENYLYL-CYCLASE; TUNNEL METALLOENZYME SUPERFAMILY; THIAMINE TRIPHOSPHATASE; ESCHERICHIA-COLI; SOLUBLE EXOPOLYPHOSPHATASE; SACCHAROMYCES-CEREVISIAE; PHOSPHORYL TRANSFER; TRYPANOSOMA-BRUCEI; PYROPHOSPHATASE	The CYTH superfamily of proteins is named after its two founding members, the CyaB adenylyl cyclase from Aeromonas hydrophila and the human 25-kDa thiamine triphosphatase. Because these proteins often form a closed beta-barrel, they are also referred to as triphosphate tunnel metalloenzymes (TTM). Functionally, they are characterized by their ability to bind triphosphorylated substrates and divalent metal ions. These proteins exist in most organisms and catalyze different reactions depending on their origin. Here we investigate structural and catalytic properties of the recombinant TTM protein from Nitrosomonas europaea (NeuTTM), a 19-kDa protein. Crystallographic data show that it crystallizes as a dimer and that, in contrast to other TTM proteins, it has an open beta-barrel structure. We demonstrate that NeuTTM is a highly specific inorganic triphosphatase, hydrolyzing tripolyphosphate (PPPi) with high catalytic efficiency in the presence of Mg2+. These data are supported by native mass spectrometry analysis showing that the enzyme binds PPPi (and Mg-PPPi) with high affinity (K-d < 1.5 mu M), whereas it has a low affinity for ATP or thiamine triphosphate. In contrast to Aeromonas and Yersinia CyaB proteins, NeuTTM has no adenylyl cyclase activity, but it shares several properties with other enzymes of the CYTH superfamily, e. g. heat stability, alkaline pH optimum, and inhibition by Ca2+ and Zn2+ ions. We suggest a catalytic mechanism involving a catalytic dyad formed by Lys-52 and Tyr-28. The present data provide the first characterization of a new type of phosphohydrolase (unrelated to pyrophosphatases or exopolyphosphatases), able to hydrolyze inorganic triphosphate with high specificity.	[Bettendorff, Lucien] Univ Liege, Unit Bioenerget & Cerebral Excitabil, GIGA Neurosci, B-4000 Liege, Belgium; [Murty, Mamidanna R. V. S.; Gabelica, Valerie; De Pauw, Edwin] Univ Liege, GIGA Syst Biol & Chem Biol, B-4000 Liege, Belgium; [Lunin, Vladimir V.; Skarina, Tatiana; Onopriyenko, Olena] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	University of Liege; University of Liege; University of Toronto	Bettendorff, L (corresponding author), Univ Liege, Unit Bioenerget & Cerebral Excitabil, GIGA Neurosci, Ave Hop 1, B-4000 Liege, Belgium.	L.Bettendorff@ulg.ac.be	Gabelica, Valérie/E-9417-2011	Gabelica, Valérie/0000-0001-9496-0165; De Pauw, Edwin/0000-0003-3475-1315	National Institutes of Health Protein Structure Initiative (NIH) [GM074942, P50-GM62413-02]; Fonds de la Recherche Fondamentale Collective of the Fonds de la Recherche Scientifique [2.4558.04, 2.4508.10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062413, U54GM074942] Funding Source: NIH RePORTER	National Institutes of Health Protein Structure Initiative (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche Fondamentale Collective of the Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Nucleic acid sequencing was performed by Veronique Dhennin, Genotranscriptomics Platform, GIGA, University of Liege. We thank Dr. Eric Oldfield for the gift of tetrapolyphosphate and Dr. Ilca Margineanu for help with the manuscript and some experiments. We are grateful to Dr. Alexei Savchenko for the gift of the pET15b vector for the expression of NeuTTM and helpful discussion. The structure of NeuTTM was determined by the Midwest Centre for Structural Genomics as part of NIH Protein Structure Initiative Grant GM074942.; This work was supported, in whole or in part, by National Institutes of Health Protein Structure Initiative Grant P50-GM62413-02 (to Alexei Savchenko (Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario, M5G 1L6, Canada). This work was also supported by Grants 2.4558.04 and 2.4508.10 from the Fonds de la Recherche Fondamentale Collective of the Fonds de la Recherche Scientifique (to L. B., E. D. P., and B. L.).	Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Baykov AA, 2000, BIOCHEMISTRY-US, V39, P11939, DOI 10.1021/bi000627u; Bettendorff L, 2003, ANAL BIOCHEM, V322, P190, DOI 10.1016/j.ab.2003.08.013; Bisaillon M, 2001, J BIOL CHEM, V276, P17261, DOI 10.1074/jbc.M100980200; BRILEY PA, 1975, BIOCHEM J, V145, P501, DOI 10.1042/bj1450501; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; EGOROV S N, 1976, Biokhimiya, V41, P1958; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fabrichniy IP, 2007, J BIOL CHEM, V282, P1422, DOI 10.1074/jbc.M513161200; Fang JM, 2007, J BIOL CHEM, V282, P32501, DOI 10.1074/jbc.M704841200; Gallagher DT, 2006, J MOL BIOL, V362, P114, DOI 10.1016/j.jmb.2006.07.008; Gallagher DT, 2011, J MOL BIOL, V405, P787, DOI 10.1016/j.jmb.2010.11.026; Gangolf M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013616; Gong CL, 2006, RNA, V12, P1468, DOI 10.1261/rna.119806; Gong CL, 2003, J BIOL CHEM, V278, P50843, DOI 10.1074/jbc.M309188200; Gong CL, 2002, J BIOL CHEM, V277, P15317, DOI 10.1074/jbc.M200532200; GONZALEZ MA, 1984, BIOCHEMISTRY-US, V23, P797, DOI 10.1021/bi00300a002; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; Hausmann S, 2003, J BIOL CHEM, V278, P30487, DOI 10.1074/jbc.M303060200; Heikinheimo P, 2001, P NATL ACAD SCI USA, V98, P3121, DOI 10.1073/pnas.061612498; HILL M, 1987, METHOD ENZYMOL, V148, P132; Ho CK, 1998, J BIOL CHEM, V273, P34151, DOI 10.1074/jbc.273.51.34151; Issur M, 2009, NUCLEIC ACIDS RES, V37, P3714, DOI 10.1093/nar/gkp227; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33; Jain Ruchi, 2008, J Biol Chem, V283, P31047, DOI 10.1074/jbc.M805392200; Keppetipola N, 2007, J BIOL CHEM, V282, P11941, DOI 10.1074/jbc.M611328200; KORNBERG SR, 1958, J BIOL CHEM, V233, P159; Kuo CC, 2008, BIOCHEM J, V411, P467, DOI 10.1042/BJ20071278; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Lakaye B, 2004, INT J BIOCHEM CELL B, V36, P1348, DOI 10.1016/j.biocel.2003.11.013; Lakaye B, 2004, J BIOL CHEM, V279, P17142, DOI 10.1074/jbc.M313569200; Lakaye B, 2002, J BIOL CHEM, V277, P13771, DOI 10.1074/jbc.M111241200; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mato IP, 2001, J BIOL CHEM, V276, P13803, DOI 10.1074/jbc.M009017200; Moreno B, 2000, J BIOL CHEM, V275, P28356, DOI 10.1074/jbc.M003893200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nghiem HO, 2000, FASEB J, V14, P543, DOI 10.1096/fasebj.14.3.543; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Simonovic AD, 2004, ANAL BIOCHEM, V334, P312, DOI 10.1016/j.ab.2004.07.010; Sismeiro O, 1998, J BACTERIOL, V180, P3339, DOI 10.1128/JB.180.13.3339-3344.1998; Smith N, 2006, ACTA CRYSTALLOGR F, V62, P200, DOI 10.1107/S1744309106002855; Song JK, 2008, J BIOL CHEM, V283, P10939, DOI 10.1074/jbc.M709675200; SWITCHENKO AC, 1984, BIOCHEM BIOPH RES CO, V120, P754, DOI 10.1016/S0006-291X(84)80171-0; Tammenkoski M, 2008, BIOCHEMISTRY-US, V47, P9707, DOI 10.1021/bi8010847; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; TSUTSUI K, 1986, J BIOL CHEM, V261, P2645; Weeks CM, 2005, ACTA CRYSTALLOGR A, V61, pC152, DOI 10.1107/S0108767305093554; WURST H, 1994, J BIOL CHEM, V269, P10996; Zyryanov AB, 2001, J BIOL CHEM, V276, P17629, DOI 10.1074/jbc.M100343200	55	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34023	34035		10.1074/jbc.M111.233585	http://dx.doi.org/10.1074/jbc.M111.233585			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21840996	Green Published, hybrid			2022-12-27	WOS:000295159200035
J	Park, K; Elias, PM; Oda, Y; Mackenzie, D; Mauro, T; Holleran, WM; Uchida, Y				Park, Kyungho; Elias, Peter M.; Oda, Yuko; Mackenzie, Donald; Mauro, Theodora; Holleran, Walter M.; Uchida, Yoshikazu			Regulation of Cathelicidin Antimicrobial Peptide Expression by an Endoplasmic Reticulum (ER) Stress Signaling, Vitamin D Receptor-independent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; BINDING PROTEIN; C/EBP-ALPHA; 1,25-DIHYDROXYVITAMIN D-3; NEUTROPHIL DEVELOPMENT; INFLAMMATORY RESPONSE; INDUCED APOPTOSIS; GENE-EXPRESSION; IMMUNE DEFENSE; KERATINOCYTES	Vitamin D receptor (VDR)-dependent mechanisms regulate human cathelicidin antimicrobial peptide (CAMP)/LL-37 in various cell types, but CAMP expression also increases after external perturbations (such as infection, injuries, UV irradiation, and permeability barrier disruption) in parallel with induction of endoplasmic reticulum (ER) stress. We demonstrate that CAMP mRNA and protein expression increase in epithelial cells (human primary keratinocytes, HaCaT keratinocytes, and HeLa cells), but not in myeloid (U937 and HL-60) cells, following ER stress generated by two mechanistically different, pharmacological stressors, thapsigargin or tunicamycin. The mechanism for increased CAMP following exposure to ER stress involves NF-kappa B activation leading to CCAAT/enhancer-binding protein alpha (C/EBP alpha) activation via MAP kinase-mediated phosphorylation. Furthermore, both increased CAMP secretion and its proteolytic processing to LL-37 are required for antimicrobial activities occur following ER stress. In addition, topical thapsigargin also increases production of the murine homologue of CAMP in mouse epidermis. Finally and paradoxically, ER stress instead suppresses the 1,25(OH)(2) vitamin D-3-induced activation of VDR, but blockade of VDR activity does not alter ER stress-induced CAMP up-regulation. Hence, ER stress increases CAMP expression via NF-kappa B-C/EBP alpha activation, independent of VDR, illuminating a novel VDR-independent role for ER stress in stimulating innate immunity.	[Park, Kyungho; Elias, Peter M.; Mackenzie, Donald; Mauro, Theodora; Holleran, Walter M.; Uchida, Yoshikazu] Univ Calif San Francisco, Sch Med, Dept Dermatol, San Francisco, CA 94143 USA; [Oda, Yuko] Univ Calif San Francisco, Sch Med, Dept Med & Endocrinol, San Francisco, CA 94143 USA; [Park, Kyungho; Elias, Peter M.; Oda, Yuko; Mackenzie, Donald; Mauro, Theodora; Holleran, Walter M.; Uchida, Yoshikazu] Dept Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Park, Kyungho; Elias, Peter M.; Oda, Yuko; Mackenzie, Donald; Mauro, Theodora; Holleran, Walter M.; Uchida, Yoshikazu] No Calif Inst Res & Educ, San Francisco, CA 94121 USA; [Holleran, Walter M.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94131 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Northern California Institute for Research & Education; University of California System; University of California San Francisco	Uchida, Y (corresponding author), Vet Adm Med Ctr, Dermatol Serv 190, 4150 Clement St, San Francisco, CA 94121 USA.	uchiday@derm.ucsf.edu		Park, Kyungho/0000-0002-1552-9914; Uchida, Yoshikazu/0000-0002-4980-3416	Research Evaluation and Allocation Committee, University of California, San Francisco; National Institutes of Health [AR051077]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051077] Funding Source: NIH RePORTER	Research Evaluation and Allocation Committee, University of California, San Francisco(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	These studies were supported by a Research Evaluation and Allocation Committee award from the University of California, San Francisco and National Institutes of Health Grant AR051077 (to Y. U.).	Aberg KM, 2008, J INVEST DERMATOL, V128, P917, DOI 10.1038/sj.jid.5701099; Anand S, 2005, J INVEST DERMATOL, V125, P323, DOI 10.1111/j.0022-202X.2005.23784.x; Bergsson G, 2009, J IMMUNOL, V183, P543, DOI 10.4049/jimmunol.0803959; Braff MH, 2005, INFECT IMMUN, V73, P6771, DOI 10.1128/IAI.73.10.6771-6781.2005; Buchau AS, 2009, J INVEST DERMATOL, V129, P2148, DOI 10.1038/jid.2009.49; Celli A, 2011, BRIT J DERMATOL, V164, P16, DOI 10.1111/j.1365-2133.2010.10046.x; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; Elias PM, 2007, SEMIN IMMUNOPATHOL, V29, P3, DOI 10.1007/s00281-007-0060-9; Geest CR, 2009, STEM CELLS, V27, P2271, DOI 10.1002/stem.152; Gira AK, 2003, J INVEST DERMATOL, V121, P1191, DOI 10.1046/j.1523-1747.2003.12535.x; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; HOLLERAN WM, 1990, J LIPID RES, V31, P1655; Hong SP, 2008, J INVEST DERMATOL, V128, P2880, DOI 10.1038/jid.2008.169; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Houben E, 2006, J LIPID RES, V47, P1063, DOI 10.1194/jlr.M600001-JLR200; Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763; Inesi G, 1998, ANN NY ACAD SCI, V853, P195, DOI 10.1111/j.1749-6632.1998.tb08267.x; Jackson SM, 1998, J LIPID RES, V39, P767; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; LEE AS, 1986, J CELL PHYSIOL, V129, P277, DOI 10.1002/jcp.1041290302; Li GM, 2009, INT ARCH ALLERGY IMM, V150, P122, DOI 10.1159/000218115; Mendez-Samperio P, 2010, PEPTIDES, V31, P1791, DOI 10.1016/j.peptides.2010.06.016; Mera K, 2010, BIOCHEM BIOPH RES CO, V397, P350, DOI 10.1016/j.bbrc.2010.05.128; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Paschen W, 2003, CELL CALCIUM, V34, P365, DOI 10.1016/S0143-4160(03)00139-8; PITTELKOW MR, 1986, MAYO CLIN PROC, V61, P771, DOI 10.1016/S0025-6196(12)64815-0; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; Schauber J, 2008, J INVEST DERMATOL, V128, P816, DOI 10.1038/sj.jid.5701102; Schauber J, 2006, MOL NUTR FOOD RES, V50, P1006, DOI 10.1002/mnfr.200600084; Schauber J, 2009, J ALLERGY CLIN IMMUN, V124, pR13, DOI 10.1016/j.jaci.2009.07.014; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Schroder JM, 2010, CURR OPIN INFECT DIS, V23, P106, DOI 10.1097/QCO.0b013e328335b004; Sugiura K, 2009, J INVEST DERMATOL, V129, P2126, DOI 10.1038/jid.2009.51; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Uchida Y, 2002, J LIPID RES, V43, P1293, DOI 10.1194/jlr.M100442-JLR200; Uchida Y, 2010, J INVEST DERMATOL, V130, P2472, DOI 10.1038/jid.2010.153; Verbeek W, 1999, BLOOD, V94, P3141, DOI 10.1182/blood.V94.9.3141.421k41_3141_3150; Wang DH, 2009, J IMMUNOL, V182, P5757, DOI 10.4049/jimmunol.0803861; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xie ZJ, 2002, J INVEST DERMATOL, V118, P11, DOI 10.1046/j.1523-1747.2002.01644.x; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang KZ, 2008, METHOD ENZYMOL, V442, P395, DOI 10.1016/S0076-6879(08)01420-1; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang P, 1997, J BIOL CHEM, V272, P9609	51	99	106	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34121	34130		10.1074/jbc.M111.250431	http://dx.doi.org/10.1074/jbc.M111.250431			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832078	hybrid, Green Published			2022-12-27	WOS:000295159200043
J	Pinto, JR; Siegfried, JD; Parvatiyar, MS; Li, DX; Norton, N; Jones, MA; Liang, JS; Potter, JD; Hershberger, RE				Pinto, Jose Renato; Siegfried, Jill D.; Parvatiyar, Michelle S.; Li, Duanxiang; Norton, Nadine; Jones, Michelle A.; Liang, Jingsheng; Potter, James D.; Hershberger, Ray E.			Functional Characterization of TNNC1 Rare Variants Identified in Dilated Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC TROPONIN-C; HYPERTROPHIC CARDIOMYOPATHY; HEART-FAILURE; I PHOSPHORYLATION; CA2+ SENSITIVITY; TRANSGENIC MICE; G159D MUTATION; MOUSE MODEL; PHOSPHOLAMBAN; GENE	TNNC1, which encodes cardiac troponin C (cTnC), remains elusive as a dilated cardiomyopathy (DCM) gene. Here, we report the clinical, genetic, and functional characterization of four TNNC1 rare variants (Y5H, M103I, D145E, and I148V), all previously reported by us in association with DCM (Hershberger, R. E., Norton, N., Morales, A., Li, D., Siegfried, J. D., and Gonzalez-Quintana, J. (2010) Circ. Cardiovasc. Genet. 3, 155-161); in the previous study, two variants (Y5H and D145E) were identified in subjects who also carried MYH7 and MYBPC3 rare variants, respectively. Functional studies using the recombinant human mutant cTnC proteins reconstituted into porcine papillary skinned fibers showed decreased Ca2+ sensitivity of force development (Y5H and M103I). Furthermore, the cTnC mutants diminished (Y5H and I148V) or abolished (M103I) the effects of PKA phosphorylation on Ca2+ sensitivity. Only M103I decreased the troponin activation properties of the actomyosin ATPase when Ca2+ was present. CD spectroscopic studies of apo (absence of divalent cations)-, Mg2+-, and Ca2+/Mg2+-bound states indicated that all of the cTnC mutants (except I148V in the Ca2+/Mg2+ condition) decreased the alpha-helical content. These results suggest that each mutation alters the function/ability of the myofilament to bind Ca2+ as a result of modifications in cTnC structure. One variant (D145E) that was previously reported in association with hypertrophic cardiomyopathy and that produced results in vivo in this study consistent with prior hypertrophic cardiomyopathy functional studies was found associated with the MYBPC3 P910T rare variant, likely contributing to the observed DCM phenotype. We conclude that these rare variants alter the regulation of contraction in some way, and the combined clinical, molecular, genetic, and functional data reinforce the importance of TNNC1 rare variants in the pathogenesis of DCM.	[Pinto, Jose Renato] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, RMSB, Miami, FL 33136 USA; [Siegfried, Jill D.; Li, Duanxiang; Norton, Nadine; Hershberger, Ray E.] Univ Miami, Miller Sch Med, Div Cardiovasc, Dept Med, Miami, FL 33136 USA	University of Miami; University of Miami	Pinto, JR (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, RMSB, Rm 6104C,1600 NW 10th Ave, Miami, FL 33136 USA.	jpinto1@med.miami.edu; rhershberger@med.miami.edu	Pinto, Jose Renato/H-2631-2017; parvatiyar, michelle/ABH-7542-2020	Pinto, Jose Renato/0000-0001-9092-4976; Hershberger, Ray/0000-0001-5683-6526; Parvatiyar, Michelle/0000-0002-9416-0069	National Institutes of Health [R01-HL58626, R01-HL42325, 1K99HL103840-01]; NHLBI [N01-HV-48194]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL103840, R01HL058626, R00HL103840, R01HL042325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01-HL58626 (to R. E. H.), R01-HL42325 (to J. D. P.), and 1K99HL103840-01 (to J. R. P.). Resequencing services were provided by the University of Washington Department of Genome Sciences under United States Federal Government Contract N01-HV-48194 from NHLBI.	Baryshnikova OK, 2008, BIOCHEMISTRY-US, V47, P10950, DOI 10.1021/bi801165c; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066; Carballo S, 2009, CIRC RES, V105, P375, DOI 10.1161/CIRCRESAHA.109.196055; DeWitt MM, 2006, J AM COLL CARDIOL, V48, P1396, DOI 10.1016/j.jacc.2006.07.016; Dweck D, 2010, J BIOL CHEM, V285, P17371, DOI 10.1074/jbc.M109.064105; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; Dyer EC, 2009, CIRC-HEART FAIL, V2, P456, DOI 10.1161/CIRCHEARTFAILURE.108.818237; Endoh M, 2008, CIRC J, V72, P1915, DOI 10.1253/circj.CJ-08-0838; Fiske CH, 1925, J BIOL CHEM, V66, P375; Freeman K, 2001, AM J PHYSIOL-HEART C, V280, pH151, DOI 10.1152/ajpheart.2001.280.1.H151; Fujino N, 2001, CLIN CARDIOL, V24, P397, DOI 10.1002/clc.4960240510; Fujino N, 2002, AM J CARDIOL, V89, P29, DOI 10.1016/S0002-9149(01)02158-0; Girolami F, 2010, J AM COLL CARDIOL, V55, P1444, DOI 10.1016/j.jacc.2009.11.062; Gomes AV, 2005, J MOL CELL CARDIOL, V39, P754, DOI 10.1016/j.yjmcc.2005.05.013; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Hershberger RE, 2008, CTS-CLIN TRANSL SCI, V1, P21, DOI 10.1111/j.1752-8062.2008.00017.x; Hershberger RE, 2010, GENET MED, V12, P655, DOI 10.1097/GIM.0b013e3181f2481f; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; Ho YL, 2009, CIRC J, V73, P1691, DOI 10.1253/circj.CJ-09-0210; Kaski JP, 2007, CARDIOL YOUNG, V17, P675, DOI 10.1017/S1047951107001291; KRANIAS EG, 1982, NATURE, V298, P182, DOI 10.1038/298182a0; Kushner JD, 2006, J CARD FAIL, V12, P422, DOI 10.1016/j.cardfail.2006.03.009; Lakdawala NK, 2010, CIRCULATION, V122, P527, DOI 10.1161/CIRCULATIONAHA.109.892240; Landstrom AP, 2008, J MOL CELL CARDIOL, V45, P281, DOI 10.1016/j.yjmcc.2008.05.003; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Lim CC, 2008, BIOPHYS J, V94, P3577, DOI 10.1529/biophysj.107.112896; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Nanni L, 2003, BIOCHEM BIOPH RES CO, V309, P391, DOI 10.1016/j.bbrc.2003.08.014; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Parvatiyar MS, 2010, J BIOL CHEM, V285, P27785, DOI 10.1074/jbc.M110.112326; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Smith L, 1999, BIOPHYS J, V76, P400, DOI 10.1016/S0006-3495(99)77206-1; SMITH L, 1994, J BIOL CHEM, V269, P9857; Song WH, 2010, J MOL CELL CARDIOL, V49, P380, DOI 10.1016/j.yjmcc.2010.05.009; Tsoutsman T, 2008, CIRCULATION, V117, P1820, DOI 10.1161/CIRCULATIONAHA.107.755777; van Spaendonck-Zwarts KY, 2010, CIRCULATION, V121, P2169, DOI 10.1161/CIRCULATIONAHA.109.929646; Venkatraman G, 2003, J BIOL CHEM, V278, P41670, DOI 10.1074/jbc.M302148200; Wehrens XHT, 2005, ANN NY ACAD SCI, V1047, P366, DOI 10.1196/annals.1341.032; Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200; Wen YH, 2009, J MOL BIOL, V392, P1158, DOI 10.1016/j.jmb.2009.07.080; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028	49	39	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34404	34412		10.1074/jbc.M111.267211	http://dx.doi.org/10.1074/jbc.M111.267211			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832052	Green Published, hybrid			2022-12-27	WOS:000295159200068
J	Deb, DK; Wang, YL; Zhang, ZY; Nie, HG; Huang, XS; Yuan, ZW; Chen, YZ; Zhao, Q; Li, YC				Deb, Dilip K.; Wang, Youli; Zhang, Zhongyi; Nie, Hongguang; Huang, Xueshi; Yuan, Zhengwei; Chen, Yunzi; Zhao, Qun; Li, Yan Chun			Molecular Mechanism Underlying 1,25-Dihydroxyvitamin D Regulation of Nephrin Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; CHRONIC KIDNEY-DISEASE; DIABETIC-NEPHROPATHY; D ANALOG; ALBUMINURIA; ACTIVATION; PODOCYTES; D-3; IDENTIFICATION; TRANSCRIPTION	Nephrin plays a key role in maintaining the structure of the slit diaphragm in the glomerular filtration barrier. Our previous studies have demonstrated potent renoprotective activity for 1,25-dihydroxyvitamin D (1,25(OH)(2)D-3). Here we showed that in podocytes 1,25(OH)(2)D-3 markedly stimulated nephrin mRNA and protein expression. ChIP scan of the 6-kb 5' upstream region of the mouse nephrin gene identified several putative vitamin D response elements (VDREs), and EMSA confirmed that the VDRE at -312 (a DR4-type VDRE) could be bound by vitamin D receptor (VDR)/retinoid X receptor. Luciferase reporter assays of the proximal nephrin promoter fragment (-427 to +173) showed strong induction of luciferase activity upon 1,25(OH)(2)D-3 treatment, and the induction was abolished by mutations within -312VDRE. ChIP assays showed that, upon 1,25(OH)(2)D-3 activation, VDR bound to this VDRE leading to recruitment of DRIP205 and RNA polymerase II and histone 4 acetylation. Treatment of mice with a vitamin D analog induced nephrin mRNA and protein in the kidney, accompanied by increased VDR binding to the -312VDRE and histone 4 acetylation. 1,25(OH)(2)D-3 reversed high glucose-induced nephrin reduction in podocytes, and vitamin D analogs prevented nephrin decline in both type 1 and 2 diabetic mice. Together these data demonstrate that 1,25(OH)(2)D-3 stimulates nephrin expression in podocytes by acting on a VDRE in the proximal nephrin promoter. Nephrin up-regulation likely accounts for part of the renoprotective activity of vitamin D.	[Yuan, Zhengwei; Zhao, Qun] China Med Univ, Shengjing Hosp, Minist Hlth, Key Lab Congenital Malformat, Shenyang, Peoples R China; [Deb, Dilip K.; Wang, Youli; Zhang, Zhongyi; Chen, Yunzi; Li, Yan Chun] Univ Chicago, Dept Med, Div Biol Sci, Chicago, IL 60637 USA; [Nie, Hongguang; Huang, Xueshi; Li, Yan Chun] China Med Univ, Lab Metab Dis Res & Drug Dev, Shenyang, Peoples R China	China Medical University; University of Chicago; China Medical University	Zhao, Q (corresponding author), China Med Univ, Shengjing Hosp, Minist Hlth, Key Lab Congenital Malformat, 36 Sanhao St, Shenyang, Peoples R China.	rezh2001@yahoo.com; cyan@medicine.bsd.uchicago.edu	聂, 宏光/GYJ-8253-2022	聂, 宏光/0000-0002-9973-6354	National Institutes of Health [R01HL085793]; Genzyme renal research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme renal research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL085793. This work was also supported by a Genzyme renal research fellowship.	Alborzi P, 2008, HYPERTENSION, V52, P249, DOI 10.1161/HYPERTENSIONAHA.108.113159; CARLBERG C, 1993, NATURE, V361, P657, DOI 10.1038/361657a0; de Boer IH, 2007, AM J KIDNEY DIS, V50, P69, DOI 10.1053/j.ajkd.2007.04.015; de Zeeuw D, 2010, LANCET, V376, P1543, DOI 10.1016/S0140-6736(10)61032-X; Deb DK, 2010, KIDNEY INT, V77, P1000, DOI 10.1038/ki.2010.22; Deb DK, 2009, AM J PHYSIOL-RENAL, V296, pF1212, DOI 10.1152/ajprenal.00002.2009; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Li YC, 2011, CURR DIABETES REV, V7, P35, DOI 10.2174/157339911794273964; Li YC, 2010, KIDNEY INT, V78, P134, DOI 10.1038/ki.2009.175; Li YC, 2001, AM J PHYSIOL-ENDOC M, V281, pE558, DOI 10.1152/ajpendo.2001.281.3.E558; Meyer MB, 2007, J BIOL CHEM, V282, P22344, DOI 10.1074/jbc.M703475200; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Qi XM, 2002, J BIOL CHEM, V277, P25884, DOI 10.1074/jbc.M203039200; Quack M, 2000, J MOL BIOL, V296, P743, DOI 10.1006/jmbi.2000.3499; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; SCHRADER M, 1994, NATURE, V370, P382, DOI 10.1038/370382a0; Sutton ALM, 2003, MOL ENDOCRINOL, V17, P777, DOI 10.1210/me.2002-0363; Takano Y, 2007, AM J PHYSIOL-RENAL, V292, pF1573, DOI 10.1152/ajprenal.00423.2006; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; VIBERTI GC, 1982, LANCET, V1, P1430; Wang Y, 2006, KIDNEY INT, V70, P882, DOI 10.1038/sj.ki.5001624; Yamauchi K, 2006, KIDNEY INT, V70, P892, DOI 10.1038/sj.ki.5001625; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200; Zhang Y, 2009, AM J PHYSIOL-RENAL, V297, pF791, DOI 10.1152/ajprenal.00247.2009; Zhang Z, 2008, KIDNEY INT, V73, P163, DOI 10.1038/sj.ki.5002572; Zhang Z, 2008, P NATL ACAD SCI USA, V105, P15896, DOI 10.1073/pnas.0803751105	32	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32011	32017		10.1074/jbc.M111.269118	http://dx.doi.org/10.1074/jbc.M111.269118			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21803771	hybrid, Green Published			2022-12-27	WOS:000294726800010
J	Edrington, TC; Kintz, E; Goldberg, JB; Tamm, LK				Edrington, Thomas C.; Kintz, Erica; Goldberg, Joanna B.; Tamm, Lukas K.			Structural Basis for the Interaction of Lipopolysaccharide with Outer Membrane Protein H (OprH) from Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR-SPECTROSCOPY; POLYMYXIN-B; PHOP-PHOQ; TRANSMEMBRANE DOMAIN; REGULATED GENES; SOFTWARE SUITE; RESISTANCE; DYNAMICS; SYSTEM; H-1	Pseudomonas aeruginosa is a major nosocomial pathogen that infects cystic fibrosis and immunocompromised patients. The impermeability of the P. aeruginosa outer membrane contributes substantially to the notorious antibiotic resistance of this human pathogen. This impermeability is partially imparted by the outer membrane protein H (OprH). Here we have solved the structure of OprH in a lipid environment by solution NMR. The structure reveals an eight-stranded beta-barrel protein with four extracellular loops of unequal size. Fast time-scale dynamics measurements show that the extracellular loops are disordered and unstructured. It was previously suggested that the function of OprH is to provide increased stability to the outer membranes of P. aeruginosa by directly interacting with lipopolysaccharide (LPS) molecules. Using in vivo and in vitro biochemical assays, we show that OprH indeed interacts with LPS in P. aeruginosa outer membranes. Based upon NMR chemical shift perturbations observed upon the addition of LPS to OprH in lipid micelles, we conclude that the interaction is predominantly electrostatic and localized to charged regions near both rims of the barrel, but also through two conspicuous tyrosines in the middle of the bilayer. These results provide the first molecular structure of OprH and offer evidence for multiple interactions between OprH and LPS that likely contribute to the antibiotic resistance of P. aeruginosa.	[Edrington, Thomas C.; Kintz, Erica; Goldberg, Joanna B.; Tamm, Lukas K.] Univ Virginia, Ctr Membrane Biol, Charlottesville, VA 22908 USA; [Edrington, Thomas C.; Tamm, Lukas K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Kintz, Erica; Goldberg, Joanna B.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Tamm, LK (corresponding author), POB 800886, Charlottesville, VA 22908 USA.	lkt2e@virginia.edu			National Institutes of Health [RO1 GM51329]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051329] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM51329 (to L. K. T.).	Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214; BELL A, 1991, J BACTERIOL, V173, P6657, DOI 10.1128/jb.173.21.6657-6664.1991; BELL A, 1989, J BACTERIOL, V171, P3211, DOI 10.1128/jb.171.6.3211-3217.1989; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; BROWN MRW, 1969, J GEN MICROBIOL, V59, P263, DOI 10.1099/00221287-59-2-263; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Ferguson AD, 2000, STRUCTURE, V8, P585; Fernandez C, 2001, P NATL ACAD SCI USA, V98, P2358, DOI 10.1073/pnas.051629298; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HANCOCK REW, 1988, J CLIN MICROBIOL, V26, P2423, DOI 10.1128/JCM.26.11.2423-2424.1988; HANCOCK REW, 1979, J BACTERIOL, V140, P902, DOI 10.1128/JB.140.3.902-910.1979; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o; Hunter RC, 2005, J BACTERIOL, V187, P7619, DOI 10.1128/JB.187.22.7619-7630.2005; Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; Lee D, 2006, J MAGN RESON, V178, P72, DOI 10.1016/j.jmr.2005.08.014; Liang B, 2010, BBA-BIOMEMBRANES, V1798, P68, DOI 10.1016/j.bbamem.2009.07.022; Liu WM, 1998, J MOL BIOL, V275, P541, DOI 10.1006/jmbi.1997.1501; Macfarlane ELA, 2000, MICROBIOL-SGM, V146, P2543, DOI 10.1099/00221287-146-10-2543; Macfarlane ELA, 1999, MOL MICROBIOL, V34, P305, DOI 10.1046/j.1365-2958.1999.01600.x; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; METZLER WJ, 1993, BIOCHEMISTRY-US, V32, P13818, DOI 10.1021/bi00213a010; Moseley HNB, 2004, J BIOMOL NMR, V28, P341, DOI 10.1023/B:JNMR.0000015420.44364.06; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; NICAS TI, 1980, J BACTERIOL, V143, P872, DOI 10.1128/JB.143.2.872-878.1980; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Rajan Sujatha, 2002, Semin Respir Infect, V17, P47, DOI 10.1053/srin.2002.31690; Rehm BH, 1996, J BACTERIOL, V178, P3346, DOI 10.1128/jb.178.11.3346-3349.1996; Renault M, 2009, J MOL BIOL, V385, P117, DOI 10.1016/j.jmb.2008.10.021; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Soncini FC, 1996, J BACTERIOL, V178, P6796, DOI 10.1128/jb.178.23.6796-6801.1996; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716	49	47	48	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39211	39223		10.1074/jbc.M111.280933	http://dx.doi.org/10.1074/jbc.M111.280933			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21865172	Green Published, hybrid			2022-12-27	WOS:000296759800040
J	Bernardo, BC; Belluoccio, D; Rowley, L; Little, CB; Hansen, U; Bateman, JF				Bernardo, Bianca C.; Belluoccio, Daniele; Rowley, Lynn; Little, Christopher B.; Hansen, Uwe; Bateman, John F.			Cartilage Intermediate Layer Protein 2 (CILP-2) Is Expressed in Articular and Meniscal Cartilage and Down-regulated in Experimental Osteoarthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-PLATE CARTILAGE; AGE-RELATED-CHANGES; CELL-ADHESION; NUCLEOTIDE PYROPHOSPHOHYDROLASE; KNEE OSTEOARTHRITIS; SKELETAL-MUSCLES; CANDIDATE GENES; MICROARRAY DATA; TYPE-1 REPEATS; THROMBOSPONDIN	Using transcriptome profiling to determine differential gene expression between the permanent mouse articular cartilage and the transient growth plate cartilage, we identified a highly expressed gene, Cilp2, which is expressed differentially by articular chondrocytes. CILP-2 is highly homologous to CILP-1 (cartilage intermediate layer protein 1), which is expressed in the intermediate zone of articular cartilage and has been linked to cartilage degenerative diseases. We demonstrated that Cilp2 has a restricted mRNA distribution at the surface of the mouse articular cartilage during development, becoming localized to the intermediate zone of articular cartilage and meniscal cartilage with maturity. Although the extracellular CILP-2 protein localization is broadly similar to CILP-1, CILP-2 appears to be more localized in the deeper intermediate zone of the articular cartilage extracellular matrix at maturity. CILP-2 was shown to be proteolytically processed, N-glycosylated, and present in human articular cartilage. In surgically induced osteoarthritis in mice, Cilp1 and Cilp2 gene expression was dysregulated. However, whereas Cilp1 expression was increased, Cilp2 gene expression was down-regulated demonstrating a differential response to mechanically induced joint destabilization. CILP-2 protein was reduced in the mouse osteoarthritic cartilage. Ultrastructural analysis also suggested that CILP-2 may be associated with collagen VI microfibrils and thus may mediate interactions between matrix components in the territorial and inter-territorial articular cartilage matrix. mRNA expression analysis indicated that whereas Cilp1 and Cilp2 are expressed most abundantly in cartilaginous tissues, expression can be detected in muscle and heart.	[Bernardo, Bianca C.; Belluoccio, Daniele; Rowley, Lynn; Bateman, John F.] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Bernardo, Bianca C.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Bateman, John F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Little, Christopher B.] Royal N Shore Hosp, Univ Sydney, Raymond Purves Bone & Joint Res Labs, Kolling Inst Med Res, St Leonards, NSW 2065, Australia; [Hansen, Uwe] Univ Hosp Muenster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Melbourne; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Munster	Bateman, JF (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	john.bateman@mcri.edu.au	Little, Christopher B/A-9280-2015	Little, Christopher B/0000-0002-0353-7634; Bateman, John/0000-0001-8542-0730; Bernardo, Bianca Christine/0000-0002-4534-0549	National Health and Medical Research Council of Australia [607399]; Murdoch Childrens Research Institute; Victorian Government; Sonderforschungsbereich [SFB 492, TP A2]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Murdoch Childrens Research Institute; Victorian Government; Sonderforschungsbereich(German Research Foundation (DFG))	This work was supported in part by National Health and Medical Research Council of Australia Grant 607399), the Murdoch Childrens Research Institute, the Victorian Government's Operational Infrastructure Support Program, and Sonderforschungsbereich Grant SFB 492, TP A2.	Allen JM, 2006, J BIOL CHEM, V281, P7341, DOI 10.1074/jbc.M513746200; Alman BA, 2008, CLIN GENET, V73, P24, DOI 10.1111/j.1399-0004.2007.00933.x; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Belluoccio D, 2008, BBA-GENE REGUL MECH, V1779, P330, DOI 10.1016/j.bbagrm.2008.02.010; Belluoccio D, 2006, PROTEOMICS, V6, P6549, DOI 10.1002/pmic.200600191; Bock HC, 2001, OSTEOARTHR CARTILAGE, V9, P654, DOI 10.1053/joca.2001.0420; Cameron TL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-20; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Dehne T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2800; Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380; Gantt SM, 1997, J BIOL CHEM, V272, P19205, DOI 10.1074/jbc.272.31.19205; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; GUO NH, 1992, J BIOL CHEM, V267, P19349; Hauser N, 1996, J BIOL CHEM, V271, P32247, DOI 10.1074/jbc.271.50.32247; Johnson K, 2003, ARTHRITIS RHEUM-US, V48, P1302, DOI 10.1002/art.10927; Kassner A, 2003, MATRIX BIOL, V22, P131, DOI 10.1016/S0945-053X(03)00008-8; LIGHT N, 1984, BIOCHEM J, V219, P1017, DOI 10.1042/bj2191017; Listrat A, 1999, TISSUE CELL, V31, P17, DOI 10.1054/tice.1998.0015; Listrat A, 2000, HISTOCHEM J, V32, P349, DOI 10.1023/A:1004013613793; Lorenzo P, 1998, J BIOL CHEM, V273, P23463, DOI 10.1074/jbc.273.36.23463; Lorenzo P, 2004, MATRIX BIOL, V23, P381, DOI 10.1016/j.matbio.2004.07.007; Lorenzo P, 1998, J BIOL CHEM, V273, P23469, DOI 10.1074/jbc.273.36.23469; Magnetto S, 1998, CELL BIOCHEM FUNCT, V16, P211, DOI 10.1002/(SICI)1099-0844(199809)16:3<211::AID-CBF788>3.3.CO;2-Q; Masuda I, 2001, J BONE MINER RES, V16, P868, DOI 10.1359/jbmr.2001.16.5.868; Mori M, 2006, BIOCHEM BIOPH RES CO, V341, P121, DOI 10.1016/j.bbrc.2005.12.159; Mundlos S., 2002, CONNECTIVE TISSUE IT, P993; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Pacifici M, 1995, MATRIX BIOL, V14, P689, DOI 10.1016/S0945-053X(05)80011-3; Passerieux E, 2006, J STRUCT BIOL, V154, P206, DOI 10.1016/j.jsb.2006.01.002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Seki S, 2005, NAT GENET, V37, P607, DOI 10.1038/ng1557; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Tsuruha J, 2001, ARTHRITIS RHEUM, V44, P838, DOI 10.1002/1529-0131(200104)44:4<838::AID-ANR140>3.3.CO;2-3; Valdes AM, 2006, ARTHRITIS RHEUM-US, V54, P533, DOI 10.1002/art.21621; Valdes AM, 2004, ARTHRITIS RHEUM-US, V50, P2497, DOI 10.1002/art.20443; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200; Zhen EY, 2008, ARTHRITIS RHEUM-US, V58, P2420, DOI 10.1002/art.23654	43	47	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37758	37767		10.1074/jbc.M111.248039	http://dx.doi.org/10.1074/jbc.M111.248039			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880736	Green Published, hybrid			2022-12-27	WOS:000296542400071
J	Pfeiffer, M; Kayzer, EB; Yang, XM; Abramson, E; Kenaston, MA; Lago, CU; Lo, HH; Sedensky, MM; Lunceford, A; Clarke, CF; Wu, SJ; McLeod, C; Finkel, T; Morgan, PG; Mills, EM				Pfeiffer, Matthew; Kayzer, Ernst-Bernhard; Yang, Xianmei; Abramson, Ellen; Kenaston, M. Alexander; Lago, Cory U.; Lo, Herng-Hsiang; Sedensky, Margaret M.; Lunceford, Adam; Clarke, Catherine F.; Wu, Sarah J.; McLeod, Chris; Finkel, Toren; Morgan, Philip G.; Mills, Edward M.			Caenorhabditis elegans UCP4 Protein Controls Complex II-mediated Oxidative Phosphorylation through Succinate Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL UNCOUPLING-PROTEIN; BROWN-ADIPOSE-TISSUE; RECEPTOR GPR91; PROTON CONDUCTANCE; CLK-1 MUTANTS; FAT STORAGE; C-ELEGANS; RECONSTITUTION; SUPEROXIDE; METABOLISM	The novel uncoupling proteins (UCP2-5) are implicated in the mitochondrial control of oxidant production, insulin signaling, and aging. Attempts to understand their functions have been complicated by overlapping expression patterns in most organisms. Caenorhabditis elegans nematodes are unique because they express only one UCP ortholog, ceUCP4 (ucp4). Here, we performed detailed metabolic analyzes in genetically modified nematodes to define the function of the ceUCP4. The knock-out mutant ucp4 (ok195) exhibited sharply decreased mitochondrial succinate-driven (complex II) respiration. However, respiratory coupling and electron transport chain function were normal in ucp4 mitochondria. Surprisingly, isolated ucp4 mitochondria showed markedly decreased succinate uptake. Similarly, ceUCP4 inhibition blocked succinate respiration and import in wild type mitochondria. Genetic and pharmacologic inhibition of complex I function was selectively lethal to ucp4 worms, arguing that ceUCP4-regulated succinate transport is required for optimal complex II function in vivo. Additionally, ceUCP4 deficiency prolonged lifespan in the short-lived mev1 mutant that exhibits complex II-generated oxidant production. These results identify a novel function for ceUCP4 in the regulation of complex II-based metabolism through an unexpected mechanism involving succinate transport.	[Kayzer, Ernst-Bernhard; Sedensky, Margaret M.; Morgan, Philip G.] Seattle Childrens Res Inst, Ctr Dev Therapeut, Seattle, WA USA; [Pfeiffer, Matthew; Abramson, Ellen; Kenaston, M. Alexander; Lago, Cory U.; Lo, Herng-Hsiang; Wu, Sarah J.; Mills, Edward M.] Univ Texas Austin, Dept Pharmacol & Toxicol, Coll Pharm, Austin, TX 78712 USA; [Abramson, Ellen; Lago, Cory U.; Lo, Herng-Hsiang; Mills, Edward M.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Yang, Xianmei] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Lunceford, Adam; Clarke, Catherine F.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Lago, Cory U.; Finkel, Toren] NHLBI, NIH, Bethesda, MD 20892 USA; [McLeod, Chris] Mayo Clin, Rochester, MN 55905 USA	Seattle Children's Hospital; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Fudan University; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Mayo Clinic	Morgan, PG (corresponding author), Seattle Childrens Res Inst, Ctr Dev Therapeut, Seattle, WA USA.	philip.morgan@seattlechildrens.org; ted_mills@mail.utexas.edu		Wu, Sarah/0000-0003-1755-6454	National Institutes of Health [DK089224, GM58881, AG026073, GMS 45952, ES007247]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK089224 (to E. M. M.), GM58881 and AG026073 (to P. G. M., M. M. S., and E.-B. K.), and GMS 45952 (to C. F. C.), and Training Grant ES007247 (to M. E. P).	Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; CANNON B, 1982, FEBS LETT, V150, P129, DOI 10.1016/0014-5793(82)81319-7; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Falk MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006607; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Hakak Y, 2009, J LEUKOCYTE BIOL, V85, P837, DOI 10.1189/jlb.1008618; Hanak P, 2001, FEBS LETT, V495, P137, DOI 10.1016/S0014-5793(01)02338-9; Hartman PS, 2001, MECH AGEING DEV, V122, P1187, DOI 10.1016/S0047-6374(01)00259-7; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Ichimiya H, 2002, MITOCHONDRION, V2, P191, DOI 10.1016/S1567-7249(02)00069-7; Iser WB, 2005, MECH AGEING DEV, V126, P1090, DOI 10.1016/j.mad.2005.04.002; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Ishii N, 2006, EXP GERONTOL, V41, P952, DOI 10.1016/j.exger.2006.06.037; Ivanova MV, 2010, BIOCHEMISTRY-US, V49, P512, DOI 10.1021/bi901742g; Jaburek M, 2003, J BIOL CHEM, V278, P25825, DOI 10.1074/jbc.M302126200; Jezek P, 2010, FEBS LETT, V584, P2135, DOI 10.1016/j.febslet.2010.02.068; Jonassen T, 2002, J BIOL CHEM, V277, P45020, DOI 10.1074/jbc.M204758200; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; KAPLAN RS, 1985, J BIOL CHEM, V260, P293; Kayser EB, 2004, J BIOL CHEM, V279, P54479, DOI 10.1074/jbc.M403066200; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; Klingenberg M, 2001, BIOCHEM SOC T, V29, P806; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lee HJ, 2008, CLIN CHIM ACTA, V398, P27, DOI 10.1016/j.cca.2008.07.029; LIPPITT B, 1972, J BIOL CHEM, V247, P4688; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; Nakamichi N, 2009, PLANT SIGNAL BEHAV, V4, P660, DOI [10.4161/psb.4.7.9001, 10.1073/pnas.0900952106]; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri L, 2008, BIOCHEM J, V410, P621, DOI 10.1042/BJ20070867; Parker N, 2008, BIOSCIENCE REP, V28, P83, DOI 10.1042/BSR20080002; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; Sokolova IM, 2005, FEBS LETT, V579, P313, DOI 10.1016/j.febslet.2004.11.103; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Szolnoki Z, 2011, ACTA NEUROL SCAND, V123, P352, DOI 10.1111/j.1600-0404.2010.01391.x; Szolnoki Z, 2009, NEUROMOL MED, V11, P101, DOI 10.1007/s12017-009-8071-4; Talbot DA, 2004, FEBS LETT, V556, P111, DOI 10.1016/S0014-5793(03)01386-3; Tanaka Y, 2010, EMBO J, V29, P1510, DOI 10.1038/emboj.2010.56; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Urbankova E, 2003, INT J BIOCHEM CELL B, V35, P212, DOI 10.1016/S1357-2725(02)00131-0; Yasuno K, 2007, AM J MED GENET B, V144B, P250, DOI 10.1002/ajmg.b.30443	52	28	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37712	37720		10.1074/jbc.M111.271452	http://dx.doi.org/10.1074/jbc.M111.271452			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21862587	Green Published, hybrid			2022-12-27	WOS:000296542400067
J	Estela, A; Pla-Martin, D; Sanchez-Piris, M; Sesaki, H; Palau, F				Estela, Anna; Pla-Martin, David; Sanchez-Piris, Maribel; Sesaki, Hiromi; Palau, Francesc			Charcot-Marie-Tooth-related Gene GDAP1 Complements Cell Cycle Delay at G(2)/M Phase in Saccharomyces cerevisiae fis1 Gene-defective Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-ASSOCIATED PROTEIN-1; DOMINANT OPTIC ATROPHY; MITOCHONDRIAL FISSION; GLUTATHIONE TRANSFERASE; ORGANELLE INHERITANCE; 4A DISEASE; MUTATIONS; GTPASE; YEAST; SYSTEM	Mutations in the GDAP1 gene are responsible of the Charcot-Marie-Tooth CMT4A, ARCMT2K, and CMT2K variants. GDAP1 is a mitochondrial outer membrane protein that has been related to the fission pathway of the mitochondrial network dynamics. As mitochondrial dynamics is a conserved process, we reasoned that expressing GDAP1 in Saccharomyces cerevisiae strains defective for genes involved in mitochondrial fission or fusion could increase our knowledge of GDAP1 function. We discovered a consistent relation between Fis1p and the cell cycle because fis1 Delta cells showed G(2)/M delay during cell cycle progression. The fis1 Delta phenotype, which includes cell cycle delay, was fully rescued by GDAP1. By contrast, clinical missense mutations rescued the fis1 Delta phenotype except for the cell cycle delay. In addition, both Fis1p and human GDAP1 interacted with beta-tubulins Tub2p and TUBB, respectively. A defect in the fis1 gene may induce abnormal location of mitochondria during budding mitosis, causing the cell cycle delay at G(2)/M due to its anomalous interaction with microtubules from the mitotic spindle. In the case of neurons harboring defects in GDAP1, the interaction between mitochondria and the microtubule cytoskeleton would be altered, which might affect mitochondrial axonal transport and movement within the cell and may explain the pathophysiology of the GDAP1-related Charcot-Marie-Tooth disease.	[Estela, Anna; Pla-Martin, David; Sanchez-Piris, Maribel; Palau, Francesc] CSIC, Inst Biomed Valencia, Genet & Mol Med Unit, Valencia 46010, Spain; [Estela, Anna; Pla-Martin, David; Palau, Francesc] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Valencia 46010, Spain; [Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Johns Hopkins University	Palau, F (corresponding author), CSIC, Inst Biomed Valencia, Genet & Mol Med Unit, C Jaume Roig 11, Valencia 46010, Spain.	fpalau@ibv.csic.es	Pla Martin, David/GXV-8888-2022; Palau, Francesc/A-9391-2014	Palau, Francesc/0000-0002-8635-5421; Pla Martin, David/0000-0002-5189-0723	National Institutes of Health [GM089853]; Spanish Ministry of Science and Innovation [SAF2006-01147, SAF2009-07063]; Instituto de Salud Carlos III; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM089853. This work was also supported by Grants SAF2006-01147 and SAF2009-07063 and a predoctoral FPI fellowship (to D. P.-M.) from the Spanish Ministry of Science and Innovation, a "Sara Borrell" postdoctoral contract from the Instituto de Salud Carlos III (to A. E.), the Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), an initiative from the Instituto de Salud Carlos III, and the INGENIO 2010 Program.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Ashrafian H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001000; Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796; Burke D., 2000, METHODS YEAST GENETI; Cerveny KL, 2007, DEV CELL, V12, P363, DOI 10.1016/j.devcel.2007.01.017; Cheng WC, 2008, CELL DEATH DIFFER, V15, P1838, DOI 10.1038/cdd.2008.117; Claramunt R, 2005, J MED GENET, V42, P358, DOI 10.1136/jmg.2004.022178; Cuesta A, 2002, NAT GENET, V30, P22, DOI 10.1038/ng798; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Fagarasanu A, 2007, CURR OPIN MICROBIOL, V10, P528, DOI 10.1016/j.mib.2007.10.002; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Lawson VH, 2005, NEUROLOGY, V65, P197, DOI 10.1212/01.wnl.0000168898.76071.70; Lee Choogon, 2007, Methods Mol Biol, V362, P385; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; Marco A, 2004, MOL BIOL EVOL, V21, P176, DOI 10.1093/molbev/msh013; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011; Niu W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000120; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Pedrola L, 2005, HUM MOL GENET, V14, P1087, DOI 10.1093/hmg/ddi121; Pedrola L, 2008, J CELL MOL MED, V12, P679, DOI 10.1111/j.1582-4934.2007.00158.x; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; Shield AJ, 2006, BIOCHEM BIOPH RES CO, V347, P859, DOI 10.1016/j.bbrc.2006.06.189; Warren G, 1996, CELL, V84, P395, DOI 10.1016/S0092-8674(00)81284-2; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Wells RC, 2007, J BIOL CHEM, V282, P33769, DOI 10.1074/jbc.M700807200; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; YANG XO, 1992, SCIENCE, V257, P680, DOI 10.1126/science.1496382; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	38	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36777	36786		10.1074/jbc.M111.260042	http://dx.doi.org/10.1074/jbc.M111.260042			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21890626	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000296538300059
J	Park, S; Kim, W; Tian, G; Gygi, SP; Finley, D				Park, Soyeon; Kim, Woong; Tian, Geng; Gygi, Steven P.; Finley, Daniel			Structural Defects in the Regulatory Particle-Core Particle Interface of the Proteasome Induce a Novel Proteasome Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							26 S-PROTEASOME; UBIQUITIN LIGASE HUL5; REG-GAMMA-PROTEASOME; 20S PROTEASOME; TRANSCRIPTION FACTOR; ASSEMBLY PATHWAY; AAA SUBUNITS; PROTEIN; YEAST; COMPLEX	Proteasomes consist of a 19-subunit regulatory particle (RP) and 28-subunit core particle (CP), an alpha(7)alpha(7)alpha(7)alpha(7) structure. The RP recognizes substrates and translocates them into the CP for degradation. At the RP-CP interface, a heterohexameric Rpt ring joins to a heteroheptameric CP alpha ring. Rpt C termini insert individually into the alpha ring pockets to form a salt bridge with a pocket lysine residue. We report that substitutions of alpha pocket lysine residues produce an unexpected block to CP assembly, arising from a late stage defect in beta ring assembly. Substitutions alpha 5(K66A) and alpha 6(K62A) resulted in abundant incorporation of immature CP beta subunits, associated with a complete beta ring, into proteasome holoenzymes. Incorporation of immature CP into the proteasome depended on a proteasome-associated protein, Ecm29. Using ump1 mutants, we identified Ecm29 as a potent negative regulator of RP assembly and confirmed our previous findings that proper RP assembly requires the CP. Ecm29 was enriched on proteasomes of pocket lysine mutants, as well as those of rpt4-Delta 1 and rpt6-Delta 1 mutants, in which the C-terminal residue, thought to contact the pocket lysine, is deleted. In both rpt6-Delta 1 and Delta 6(K62A) proteasomes, Ecm29 suppressed opening of the CP substrate translocation channel, which is gated through interactions between Rpt C termini and the alpha pockets. The ubiquitin ligase Hul5 was recruited to these proteasomes together with Ecm29. Proteasome remodeling through the addition of Ecm29 and Hul5 suggests a new layer of the proteasome stress response and may be a common response to structurally aberrant proteasomes or deficient proteasome function.	[Park, Soyeon; Kim, Woong; Tian, Geng; Gygi, Steven P.; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	daniel_finley@hms.harvard.edu	Tian, Geng/G-7374-2011		National Institutes of Health [GM43601, GM67945]; Charles A. King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043601, R37GM043601, R01GM067945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM43601 (to D.F.) and GM67945 (to S.P.G.). This work was also supported by a fellowship from the Charles A. King Trust Postdoctoral Fellowship Program (to S.P.).	Aviram S, 2010, MOL CELL BIOL, V30, P985, DOI 10.1128/MCB.00909-09; Bader M, 2011, CELL, V145, P371, DOI 10.1016/j.cell.2011.03.021; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Dohmen R. Jurgen, 2005, V301, P243; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fehlker M, 2003, EMBO REP, V4, P959, DOI 10.1038/sj.embor.embor938; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Gorbea C, 2004, J BIOL CHEM, V279, P54849, DOI 10.1074/jbc.M410444200; Gorbea C, 2010, J BIOL CHEM, V285, P31616, DOI 10.1074/jbc.M110.154120; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; GUTHRIE C, 1991, GUIDE YEAST GENETICS, P3; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kohlmann S, 2008, J BIOL CHEM, V283, P16374, DOI 10.1074/jbc.M801702200; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee SYC, 2011, J BIOL CHEM, V286, P36641, DOI 10.1074/jbc.M111.280875; Leggett David S., 2005, V301, P57; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehmann A, 2010, MOL CELL, V38, P879, DOI 10.1016/j.molcel.2010.06.016; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Lopez AD, 2011, MOL BIOL CELL, V22, P528, DOI 10.1091/mbc.E10-04-0352; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Marques AJ, 2007, J BIOL CHEM, V282, P34869, DOI 10.1074/jbc.M705836200; Metzger MB, 2009, MOL BIOL CELL, V20, P1006, DOI 10.1091/mbc.E08-02-0140; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Panasenko OO, 2011, MOL CELL BIOL, V31, P1610, DOI 10.1128/MCB.01210-10; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Stitzel ML, 2001, GENE DEV, V15, P128, DOI 10.1101/gad.863801; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Tian G., 2011, NAT STRUCT IN PRESS; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; van Deventer S, 2010, CELL, V142, P517, DOI 10.1016/j.cell.2010.08.002; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yashiroda H, 2008, NAT STRUCT MOL BIOL, V15, P228, DOI 10.1038/nsmb.1386; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	69	49	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36652	36666		10.1074/jbc.M111.285924	http://dx.doi.org/10.1074/jbc.M111.285924			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878652	Green Published, hybrid			2022-12-27	WOS:000296538300048
J	Cottingham, C; Chen, YJ; Jiao, K; Wang, Q				Cottingham, Christopher; Chen, Yunjia; Jiao, Kai; Wang, Qin			The Antidepressant Desipramine Is an Arrestin-biased Ligand at the alpha(2A)-Adrenergic Receptor Driving Receptor Down-regulation in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; LONG-TERM TREATMENT; MICE LACKING; SOMATODENDRITIC ALPHA(2)-ADRENOCEPTORS; NORADRENERGIC TRANSMISSION; NORADRENALINE RELEASE; MEMBRANE TRAFFICKING; AGONIST BINDING; SUICIDE VICTIMS; LOCUS-COERULEUS	The neurobiological mechanisms of action underlying antidepressant drugs remain poorly understood. Desipramine (DMI) is an antidepressant classically characterized as an inhibitor of norepinephrine reuptake. Available evidence, however, suggests a mechanism more complex than simple reuptake inhibition. In the present study, we have characterized the direct interaction between DMI and the alpha(2A)-adrenergic receptor (alpha(2A)AR), a key regulator of noradrenergic neurotransmission with altered expression and function in depression. DMI alone was found to be sufficient to drive receptor internalization acutely and a robust down-regulation of alpha(2A)AR expression and signaling following prolonged stimulation in vitro. These effects are achieved through arrestin-biased regulation of the receptor, as DMI selectively induces recruitment of arrestin but not activation of heterotrimeric G proteins. Meanwhile, a physiologically relevant concentration of endogenous agonist (norepinephrine) was unable to sustain a down-regulation response. Prolonged in vivo administration of DMI resulted in significant down-regulation of synaptic alpha(2A)AR expression, a response that was lost in arrestin3-null animals. We contend that direct DMI-driven arrestin-mediated alpha(2A)AR down-regulation accounts for the therapeutically desirable but mechanistically unexplained adaptive alterations in receptor expression associated with this antidepressant. Our results provide novel insight into both the pharmacology of this antidepressant drug and the targeting of the alpha(2A)AR in depression.	[Cottingham, Christopher; Chen, Yunjia; Wang, Qin] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Jiao, Kai] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, Q (corresponding author), 986 MCLM,1918 Univ Blvd, Birmingham, AL 35294 USA.	qinwang@uab.edu		jiao, kai/0000-0002-1901-8329; Wang, Qin/0000-0002-1079-5914; Jiao, Kai/0000-0002-5415-9020	National Institutes of Health [T32 NS061788-03]; National Institute of Mental Health [MH081917]; University of Alabama at Birmingham; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of Alabama at Birmingham; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 NS061788-03 (to C. C.), Grant MH081917 from the National Institute of Mental Health (to Q. W.), and the University of Alabama at Birmingham Training Program in Neurobiology of Cognition and Cognitive Disorders.	Ahern TH, 2006, NEUROPSYCHOPHARMACOL, V31, P730, DOI 10.1038/sj.npp.1300847; ALEXANDER SP, 2001, TRENDS PHARM SCI N S, V12, P15; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Baldessarini R.J., 2001, GOODMAN GILMANS PHAR, P447; BALDESSARINI RJ, 1989, J CLIN PSYCHIAT, V50, P117; BARTUREN F, 1992, MOL PHARMACOL, V42, P846; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1038/nrdp.2016.65; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Brady AE, 2003, J BIOL CHEM, V278, P32405, DOI 10.1074/jbc.M304195200; Brady AE, 2005, MOL PHARMACOL, V67, P1690, DOI 10.1124/mol.104.005215; Callado LF, 1998, J NEUROCHEM, V70, P1114; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHERRY DK, 2008, NATL HLTH STAT REPOR, V6, P1; CHOU TC, 1974, MOL PHARMACOL, V10, P235; DePaermentier F, 1997, BRAIN RES, V757, P60, DOI 10.1016/S0006-8993(97)00138-8; Deupree JD, 2007, EUR J PHARMACOL, V576, P55, DOI 10.1016/j.ejphar.2007.08.017; DEVOS H, 1992, J NEUROCHEM, V58, P1555; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dziedzicka-Wasylewska M, 2006, NEUROPSYCHOPHARMACOL, V31, P2424, DOI 10.1038/sj.npp.1301064; Escriba PV, 2004, NEUROPSYCHOPHARMACOL, V29, P1512, DOI 10.1038/sj.npp.1300459; Esteban S, 1999, N-S ARCH PHARMACOL, V360, P135, DOI 10.1007/s002109900045; Garcia-Sevilla JA, 1999, J NEUROCHEM, V72, P282, DOI 10.1046/j.1471-4159.1999.0720282.x; Gilsbach R, 2006, J NEUROCHEM, V96, P1111, DOI 10.1111/j.1471-4159.2005.03598.x; Gilsbach R, 2009, MOL PHARMACOL, V75, P1160, DOI 10.1124/mol.109.054544; GIRALT MT, 1989, EUR J PHARMACOL, V164, P455; GLOTZBACH RK, 1982, PSYCHOPHARMACOLOGY, V78, P25, DOI 10.1007/BF00470582; Gonzalez-Maeso J, 2002, MOL PSYCHIATR, V7, P755, DOI 10.1038/sj.mp.4001067; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Knaus AE, 2007, NEUROCHEM INT, V51, P277, DOI 10.1016/j.neuint.2007.06.036; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2010, AM J PSYCHIAT, V167, P1305, DOI 10.1176/appi.ajp.2009.10030434; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Limbird LE, 2005, CELL SURFACE RECEPTO; Lu R, 2010, MOL PHARMACOL, V78, P279, DOI 10.1124/mol.110.065300; Lu RJ, 2009, J BIOL CHEM, V284, P13233, DOI 10.1074/jbc.M807535200; MacMillan LB, 1996, SCIENCE, V273, P801, DOI 10.1126/science.273.5276.801; Mateo Y, 1998, J NEUROCHEM, V71, P790; Mateo Y, 2001, BRIT J PHARMACOL, V133, P1362, DOI 10.1038/sj.bjp.0704196; MEANA JJ, 1992, BIOL PSYCHIAT, V31, P471; MONGEAU R, 1994, NEUROPSYCHOPHARMACOL, V10, P41, DOI 10.1038/npp.1994.6; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Ordway GA, 2003, BIOL PSYCHIAT, V53, P315, DOI 10.1016/S0006-3223(02)01728-6; Ouimet CC, 2004, J COMP NEUROL, V479, P374, DOI 10.1002/cne.20313; Parini S, 2005, NEUROPSYCHOPHARMACOL, V30, P1048, DOI 10.1038/sj.npp.1300661; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; RICHELSON E, 1984, J PHARMACOL EXP THER, V230, P94; Sacchetti G, 2001, N-S ARCH PHARMACOL, V363, P66, DOI 10.1007/s002100000334; SASTRE M, 1994, J NEUROCHEM, V63, P1077; Schramm NL, 1999, J BIOL CHEM, V274, P24935, DOI 10.1074/jbc.274.35.24935; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shields AD, 2009, NEUROSCIENCE, V163, P339, DOI 10.1016/j.neuroscience.2009.06.022; Subhash MN, 2003, NEUROCHEM INT, V43, P603, DOI 10.1016/S0197-0186(03)00097-4; Tan CM, 2002, P NATL ACAD SCI USA, V99, P12471, DOI 10.1073/pnas.122368499; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Wang Q, 2006, J BIOL CHEM, V281, P25948, DOI 10.1074/jbc.M605415200; Wang R, 1996, NEUROSCIENCE, V74, P199, DOI 10.1016/0306-4522(96)00116-9; WONG DT, 1982, J PHARMACOL EXP THER, V222, P61; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839; Xu JM, 2008, J BIOL CHEM, V283, P14516, DOI 10.1074/jbc.M710340200; Yanpallewar SU, 2010, J NEUROSCI, V30, P1096, DOI 10.1523/JNEUROSCI.2309-09.2010	69	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36063	36075		10.1074/jbc.M111.261578	http://dx.doi.org/10.1074/jbc.M111.261578			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21859713	hybrid, Green Published			2022-12-27	WOS:000295927100079
J	Dahl, JU; Urban, A; Bolte, A; Sriyabhaya, P; Donahue, JL; Nimtz, M; Larson, TJ; Leimkuhler, S				Dahl, Jan-Ulrik; Urban, Alexander; Bolte, Andrea; Sriyabhaya, Promjit; Donahue, Janet L.; Nimtz, Manfred; Larson, Timothy J.; Leimkuehler, Silke			The Identification of a Novel Protein Involved in Molybdenum Cofactor Biosynthesis in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO SYNTHESIS; FE-S CLUSTER; MOLYBDOPTERIN SYNTHASE; CYSTEINE DESULFURASE; CRYSTAL-STRUCTURE; CONVERTING FACTOR; PRECURSOR-Z; SULFUR; DOMAIN; GENE	Background: In Moco biosynthesis, sulfur is transferred from L-cysteine to MPT synthase, catalyzing the conversion of cPMP to MPT. Results: The rhodanese-like protein YnjE is a novel protein involved in Moco biosynthesis. Conclusion: YnjE enhances the rate of conversion of cPMP to MPT and interacts with MoeB and IscS. S ignificance: To understand the mechanism of sulfur transfer and the role of rhodaneses in the cell.	[Dahl, Jan-Ulrik; Urban, Alexander; Bolte, Andrea; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Sriyabhaya, Promjit; Donahue, Janet L.; Larson, Timothy J.] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Nimtz, Manfred] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	University of Potsdam; Virginia Polytechnic Institute & State University; Helmholtz Association; Helmholtz-Center for Infection Research	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	sleim@uni-potsdam.de	Dahl, Jan-Ulrik/J-4970-2017; Dahl, Jan-Ulrik/J-1893-2019	Dahl, Jan-Ulrik/0000-0002-4164-6129; Dahl, Jan-Ulrik/0000-0001-8597-7416; Leimkuhler, Silke/0000-0003-3238-2122	Deutsche Forschungsgemeinschaft [LE1171/5-3]; Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust	This work was supported by Deutsche Forschungsgemeinschaft Grant LE1171/5-3 (to S. L.), and by a grant from the Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust (to T. J. L.).	Begley TP, 1999, CURR OPIN CHEM BIOL, V3, P623, DOI 10.1016/S1367-5931(99)00018-6; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Cheng Hui, 2008, Open Microbiol J, V2, P18, DOI 10.2174/1874285800802010018; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Keyzer J, 2003, CELL MOL LIFE SCI, V60, P2034, DOI 10.1007/s00018-003-3006-y; GLASER JH, 1972, MOL GEN GENET, V116, P1, DOI 10.1007/BF00334254; Gully D, 2003, FEBS LETT, V548, P90, DOI 10.1016/S0014-5793(03)00746-4; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hanzelmann P, 2009, PROTEIN SCI, V18, P2480, DOI 10.1002/pro.260; Heidenreich T, 2005, J BIOL CHEM, V280, P4213, DOI 10.1074/jbc.M411195200; Hilton JC, 1996, ARCH BIOCHEM BIOPHYS, V325, P139, DOI 10.1006/abbi.1996.0017; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; JONES RW, 1977, BIOCHEM J, V164, P199, DOI 10.1042/bj1640199; Krepinsky K, 2007, FEBS J, V274, P2778, DOI 10.1111/j.1742-4658.2007.05811.x; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Leimkuhler S, 2001, J BIOL CHEM, V276, P22024, DOI 10.1074/jbc.M102072200; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Marquet A, 2001, CURR OPIN CHEM BIOL, V5, P541, DOI 10.1016/S1367-5931(00)00249-0; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Mueller EG, 1999, PROTEIN SCI, V8, P2424; Neumann M, 2009, J BIOL CHEM, V284, P21891, DOI 10.1074/jbc.M109.008565; Nichols BP, 1998, J BACTERIOL, V180, P6408; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; PITTERLE DM, 1989, J BACTERIOL, V171, P3373, DOI 10.1128/jb.171.6.3373-3378.1989; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; RAJAGOPALAN KV, 1996, ESCHERICHIA COLI SAL, P674; Regev-Rudzki N, 2007, BIOESSAYS, V29, P772, DOI 10.1002/bies.20609; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schmitz J, 2007, BIOCHEMISTRY-US, V46, P909, DOI 10.1021/bi062011w; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Silhavy T. J., 1984, EXPT GENE FUSIONS, P107; Spallarossa A, 2001, STRUCTURE, V9, P1117, DOI 10.1016/S0969-2126(01)00666-9; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Wang CY, 2001, NAT STRUCT BIOL, V8, P47; Wolfe MD, 2004, J BIOL CHEM, V279, P1801, DOI 10.1074/jbc.M310442200; Wuebbens MM, 2003, J BIOL CHEM, V278, P14523, DOI 10.1074/jbc.M300453200; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	49	37	39	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35801	35812		10.1074/jbc.M111.282368	http://dx.doi.org/10.1074/jbc.M111.282368			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21856748	Green Published, hybrid			2022-12-27	WOS:000295927100053
J	Chen, W; Hoo, RLC; Konishi, M; Itoh, N; Lee, PC; Ye, HY; Lam, KSL; Xu, AM				Chen, Wei; Hoo, Ruby Lai-chong; Konishi, Morichika; Itoh, Nobuyuki; Lee, Pui-chi; Ye, Hong-ying; Lam, Karen Siu-ling; Xu, Aimin			Growth Hormone Induces Hepatic Production of Fibroblast Growth Factor 21 through a Mechanism Dependent on Lipolysis in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACIDS; PPAR-ALPHA ACTIVATION; INSULIN SENSITIVITY; FGF21; INHIBITION; METABOLISM; EXPRESSION; RESISTANCE; SECRETION; GLUCOSE	Fibroblast growth factor (FGF) 21 and growth hormone (GH) are metabolic hormones that play important roles in regulating glucose and lipid metabolism. Both hormones are induced in response to fasting and exert their actions on adipocytes to regulate lipolysis. However, the molecular interaction between these two hormones remains unclear. Here we demonstrate the existence of a feedback loop between GH and FGF21 on the regulation of lipolysis in adipocytes. A single bolus injection of GH into C57 mice acutely increases both mRNA and protein expression of FGF21 in the liver, thereby leading to a marked elevation of serum FGF21 concentrations. Such a stimulatory effect of GH on hepatic FGF21 production is abrogated by pretreatment of mice with the lipolysis inhibitor niacin. Direct incubation of either liver explants or human HepG2 hepatocytes with GH has no effect on FGF21 expression. On the other hand, FGF21 production in HepG2 cells is significantly induced by incubation with the conditioned medium harvested from GH-treated adipose tissue explants, which contains high concentrations of free fatty acids (FFA). Further analysis shows that FFA released by GH-induced lipolysis stimulates hepatic FGF21 expression by activation of the transcription factor PPAR alpha. In FGF21-null mice, both the magnitude and duration of GH-induced lipolysis are significantly higher than those in their wild type littermates. Taken together, these findings suggest that GH-induced hepatic FGF21 production is mediated by FFA released from adipose tissues, and elevated FGF21 in turn acts as a negative feedback signal to terminate GH-stimulated lipolysis in adipocytes.	[Chen, Wei; Hoo, Ruby Lai-chong; Lee, Pui-chi; Lam, Karen Siu-ling; Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Chen, Wei] Fudan Univ, Dept Geriatr, Hua Shan Hosp, Shanghai 200040, Peoples R China; [Ye, Hong-ying] Fudan Univ, Dept Endocrinol, Hua Shan Hosp, Shanghai 200040, Peoples R China; [Hoo, Ruby Lai-chong; Lam, Karen Siu-ling; Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Ageing, Hong Kong, Hong Kong, Peoples R China; [Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Konishi, Morichika; Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Sakyo Ku, Kyoto 6068501, Japan	University of Hong Kong; Fudan University; Fudan University; University of Hong Kong; University of Hong Kong; Kyoto University	Lam, KSL (corresponding author), Univ Hong Kong, Dept Med, L8-40,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	ksllam@hku.hk; amxu@hkucc.hku.hk	Xu, Aimin/D-3291-2013	Xu, Aimin/0000-0002-0668-033X	Research Grant Council of Hong Kong [HKU3/CRF/09]; University of Hong Kong [2011CB504004]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong)	This work was supported by the Collaborative Research Fund (HKU3/CRF/09), from the Research Grant Council of Hong Kong, seeding fund for basic research and the matching fund for the National Basic Research Program of China (Project no: 2011CB504004) from the University of Hong Kong.	Adams AC, 2010, J BIOL CHEM, V285, P14078, DOI 10.1074/jbc.C110.107375; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Cuevas-Ramos D, 2009, CURR DIABETES REV, V5, P216, DOI 10.2174/157339909789804396; Fazeli PK, 2010, J CLIN ENDOCR METAB, V95, P369, DOI 10.1210/jc.2009-1730; Friend K, 1997, EUR J ENDOCRINOL, V137, P377, DOI 10.1530/eje.0.1370377; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gravholt CH, 1999, AM J PHYSIOL-ENDOC M, V277, pE848, DOI 10.1152/ajpendo.1999.277.5.E848; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2009, CURR OPIN INVEST DR, V10, P359; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; Mai K, 2010, AM J PHYSIOL-ENDOC M, V299, pE126, DOI 10.1152/ajpendo.00020.2010; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; MOLLER N, 1990, AM J PHYSIOL, V258, pE86, DOI 10.1152/ajpendo.1990.258.1.E86; Moller N, 2009, CLIN NUTR, V28, P597, DOI 10.1016/j.clnu.2009.08.015; Murata Y, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/981315; Nielsen S, 2001, DIABETES, V50, P2301, DOI 10.2337/diabetes.50.10.2301; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Norrelund H, 2003, J CLIN ENDOCR METAB, V88, P4371, DOI 10.1210/jc.2003-030267; Oishi K, 2008, FEBS LETT, V582, P3639, DOI 10.1016/j.febslet.2008.09.046; ROSENTHAL MJ, 1988, METABOLISM, V37, P645, DOI 10.1016/0026-0495(88)90083-2; Segerlantz M, 2001, J CLIN ENDOCR METAB, V86, P5813, DOI 10.1210/jc.86.12.5813; Segerlantz M, 2003, EUR J ENDOCRINOL, V149, P511, DOI 10.1530/eje.0.1490511; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; WEITZMAN ED, 1976, ANNU REV MED, V27, P225, DOI 10.1146/annurev.me.27.020176.001301; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Yu HY, 2011, CLIN CHEM, V57, P691, DOI 10.1373/clinchem.2010.155184; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	40	110	118	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34559	34566		10.1074/jbc.M111.285965	http://dx.doi.org/10.1074/jbc.M111.285965			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21849508	Green Published, hybrid			2022-12-27	WOS:000295406300010
J	Wu, K; Yan, H; Fang, L; Wang, XJ; Pfleger, C; Jiang, XJ; Huang, L; Pan, ZQ				Wu, Kenneth; Yan, Hua; Fang, Lei; Wang, Xinjiang; Pfleger, Cathie; Jiang, Xuejun; Huang, Lan; Pan, Zhen-Qiang			Mono-ubiquitination Drives Nuclear Export of the Human DCN1-like Protein hDCNL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL CONTROL; CULLIN NEDDYLATION; C-TERMINUS; LIGASE; NEDD8; SCF; CONJUGATION; COMPLEX; ACTIVATION; DOMAIN	Conjugation of Nedd8 to a cullin protein, termed neddylation, is an evolutionarily conserved process that functions to activate the cullin-RING family E3 ubiquitin ligases, leading to increased proteasomal degradation of a wide range of substrate proteins. Recent emerging evidence demonstrates that cellular neddylation requires the action of Dcn1, which, in humans, consists of five homologues designated as hDCNL1-5. Here we revealed a previously unknown mechanism that regulates hDCNL1. In cultured mammalian cells ectopically expressed hDCNL1 was mono-ubiquitinated predominantly at K143, K149, and K171. Using a classical chromatographic purification strategy, we identified Nedd4-1 as an E3 ligase that can catalyze mono-ubiquitination of hDCNL1 in a reconstituted ubiquitination system. In addition, the hDCNL1 N-terminal ubiquitin-binding domain is necessary and sufficient to mediate mono-ubiquitination. Finally, fluorescence microscopic and subcellular fractionation analyses revealed a role for mono-ubiquitination in driving nuclear export of hDCNL1. Taken together, these results suggest a mono-ubiquitination-mediated mechanism that governs nuclear-cytoplasmic trafficking of hDCNL1, thereby regulating hDCNL1-dependent activation of the cullin-RING E3 ubiquitin ligases in selected cellular compartments.	[Wu, Kenneth; Yan, Hua; Pfleger, Cathie; Pan, Zhen-Qiang] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Fang, Lei; Huang, Lan] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Fang, Lei; Huang, Lan] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Wang, Xinjiang; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California Irvine; University of California System; University of California Irvine; Memorial Sloan Kettering Cancer Center	Pan, ZQ (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA.	zhen-qiang.pan@mssm.edu	Yan, Hua/E-5305-2011; Huang, Lan/C-3618-2011	Fang, Lei/0000-0002-2582-4845	NIH-NCI [1 R24 CA095823-01]; NSF [DBI-9724504]; Public Health Service [CA140451, GM74830, GM61051, CA095634]; NCI, National Institutes of Health; American Cancer Society [ACS-RSG-07-081-01-MGO-01]; Geoffrey Beene Cancer Research fund; NATIONAL CANCER INSTITUTE [R01CA095634, R24CA095823, R01CA140451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074830, R01GM061051] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF)); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Geoffrey Beene Cancer Research fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Hurwitz for regents. Fluorescent microscopy was performed at the MSSM-Microscopy Shared Research Facility, supported with funding from NIH-NCI shared resources grant (1 R24 CA095823-01) and NSF major research instrumentation grant (DBI-9724504).; This study was supported by Public Health Service Grants CA140451 (to C. P.), GM74830 (to L. H.), as well as GM61051 and CA095634 (to Z.-Q. P.). This work was also supported by a post-doctoral training grant from NCI, National Institutes of Health (to K. W.) and by American Cancer Society Fund (ACS-RSG-07-081-01-MGO-01) and Geoffrey Beene Cancer Research fund (to X. J.).	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Boh BK, 2011, J MOL BIOL, V409, P136, DOI 10.1016/j.jmb.2011.03.023; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fang L, 2008, J PROTEOME RES, V7, P4914, DOI 10.1021/pr800574c; French ME, 2009, J BIOL CHEM, V284, P12071, DOI 10.1074/jbc.M901106200; Huang DT, 2004, ONCOGENE, V23, P1958, DOI 10.1038/sj.onc.1207393; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Ma T, 2008, CANCER SCI, V99, P2128, DOI 10.1111/j.1349-7006.2008.00929.x; Meyer-Schaller N, 2009, P NATL ACAD SCI USA, V106, P12365, DOI 10.1073/pnas.0812528106; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Ogunjimi AA, 2010, J BIOL CHEM, V285, P6308, DOI 10.1074/jbc.M109.044537; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Villa C, 2009, EUR J NEUROL, V16, P870, DOI 10.1111/j.1468-1331.2009.02611.x; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Wu K, 2003, J BIOL CHEM, V278, P28882, DOI 10.1074/jbc.M302888200; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Yang XY, 2007, J BIOL CHEM, V282, P24490, DOI 10.1074/jbc.C700038200	40	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34060	34070		10.1074/jbc.M111.273045	http://dx.doi.org/10.1074/jbc.M111.273045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21813641	Green Published, hybrid			2022-12-27	WOS:000295159200038
J	Barros, MH; Rak, M; Paulela, JA; Tzagoloff, A				Barros, Mario H.; Rak, Malgorzata; Paulela, Janaina A.; Tzagoloff, Alexander			Characterization of Gtf1p, the Connector Subunit of Yeast Mitochondrial tRNA-dependent Amidotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; ELONGATION-FACTOR TU; SACCHAROMYCES-CEREVISIAE; INNER MEMBRANE; ATP SYNTHASE; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; PROTEIN-SYNTHESIS; GENE; EXPRESSION	The bacterial GatCAB operon for tRNA-dependent amidotransferase (AdT) catalyzes the transamidation of mischarged glutamyl-tRNA(Gln) to glutaminyl-tRNA(Gln). Here we describe the phenotype of temperature-sensitive (ts) mutants of GTF1, a gene proposed to code for subunit F of mitochondrial AdT in Saccharomyces cerevisiae. The ts gtf1 mutants accumulate an electrophoretic variant of the mitochondrially encoded Cox2p subunit of cytochrome oxidase and an unstable form of the Atp8p subunit of the F-1-F-0 ATP synthase that is degraded, thereby preventing assembly of the F-0 sector. Allotopic expression of recoded ATP8 and COX2 did not significantly improve growth of gtf1 mutants on respiratory substrates. However, ts gft1 mutants are partially rescued by overexpression of PET112 and HER2 that code for the yeast homologues of the catalytic subunits of bacterial AdT. Additionally, B66, a her2 point mutant has a phenotype similar to that of gtf1 mutants. These results provide genetic support for the essentiality, in vivo, of the GatF subunit of the heterotrimeric AdT that catalyzes formation of glutaminyl-tRNA(Gln) (Frechin, M., Senger, B., Braye, M., Kern, D., Martin, R. P., and Becker, H. D. (2009) Genes Dev. 23, 1119-1130).	[Rak, Malgorzata; Tzagoloff, Alexander] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Barros, Mario H.; Paulela, Janaina A.] Univ Sao Paulo, Dept Microbiol, BR-05508900 Sao Paulo, Brazil	Columbia University; Universidade de Sao Paulo	Tzagoloff, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	spud@columbia.edu	Barros, Mario H/B-8118-2012; Barros, Mario/Q-6358-2019	Barros, Mario/0000-0003-2977-9815	National Institutes of Health [GM 50187]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL022174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 50187 (to A. T.). This work was also supported by a Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grant (to M. H. B.).	Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barros MH, 2006, J BIOL CHEM, V281, P3743, DOI 10.1074/jbc.M510778200; Barros MH, 2002, J BIOL CHEM, V277, P9997, DOI 10.1074/jbc.M112025200; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; BROACH JR, 1979, GENE, V8, P121, DOI 10.1016/0378-1119(79)90012-X; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; DIECKMANN CL, 1994, INT REV CYTOL, V152, P145, DOI 10.1016/S0074-7696(08)62556-5; FAYE G, 1974, J MOL BIOL, V88, P105, DOI 10.1016/0022-2836(74)90304-0; Feng L, 2005, J BIOL CHEM, V280, P8150, DOI 10.1074/jbc.M411098200; Frechin M, 2009, GENE DEV, V23, P1119, DOI 10.1101/gad.518109; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Green-Willms NS, 2001, J BIOL CHEM, V276, P6392, DOI 10.1074/jbc.M009856200; He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449; He SC, 1999, MOL CELL BIOL, V19, P6598; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; Hell K, 2000, J BIOL CHEM, V275, P4571, DOI 10.1074/jbc.275.7.4571; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; HERRMANN JM, 1995, J BIOL CHEM, V270, P27079, DOI 10.1074/jbc.270.45.27079; Jan PS, 2000, MOL GEN GENET, V263, P483, DOI 10.1007/s004380051192; Kim SI, 1997, J BACTERIOL, V179, P5625, DOI 10.1128/jb.179.17.5625-5627.1997; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPOINTE J, 1986, J BACTERIOL, V165, P88, DOI 10.1128/jb.165.1.88-93.1986; LAW RHP, 1988, FEBS LETT, V236, P501, DOI 10.1016/0014-5793(88)80086-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Min B, 2003, J BACTERIOL, V185, P3524, DOI 10.1128/JB.185.12.3524-3526.2003; MULERO JJ, 1994, CURR GENET, V25, P299, DOI 10.1007/BF00351481; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106; Nagao Asuteka, 2007, Nucleic Acids Symp Ser (Oxf), P41; NAKAGAWA K, 1991, J BIOL CHEM, V266, P1977; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Paul MF, 2000, J BIOL CHEM, V275, P29238, DOI 10.1074/jbc.M004546200; Pelchat M, 1998, CAN J MICROBIOL, V44, P378, DOI 10.1139/cjm-44-4-378; PELISSIER P, 1995, CURR GENET, V27, P409, DOI 10.1007/BF00311209; POUTRE CG, 1987, GENETICS, V115, P637; Pujol C, 2008, P NATL ACAD SCI USA, V105, P6481, DOI 10.1073/pnas.0712299105; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; Rinehart J, 2005, GENE DEV, V19, P583, DOI 10.1101/gad.1269305; Roy H, 2007, NUCLEIC ACIDS RES, V35, P3420, DOI 10.1093/nar/gkm211; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHNEIDER A, 1991, EMBO J, V10, P247, DOI 10.1002/j.1460-2075.1991.tb07944.x; SCHON A, 1988, BIOCHIMIE, V70, P391, DOI 10.1016/0300-9084(88)90212-X; SIMON M, 1984, MOL GEN GENET, V196, P266, DOI 10.1007/BF00328059; Soto IC, 2009, BBA-MOL CELL RES, V1793, P1776, DOI 10.1016/j.bbamcr.2009.09.002; STANZEL M, 1994, EUR J BIOCHEM, V219, P435, DOI 10.1111/j.1432-1033.1994.tb19956.x; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; Supekova L, 2010, P NATL ACAD SCI USA, V107, P5047, DOI 10.1073/pnas.1000735107; TERPSTRA P, 1979, J BIOL CHEM, V254, P2662; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TZAGOLOFF A, 1969, J BIOL CHEM, V244, P5020; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; WILCOX M, 1969, EUR J BIOCHEM, V11, P405, DOI 10.1111/j.1432-1033.1969.tb00788.x; WILCOX M, 1968, P NATL ACAD SCI USA, V61, P229, DOI 10.1073/pnas.61.1.229	59	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32937	32947		10.1074/jbc.M111.265371	http://dx.doi.org/10.1074/jbc.M111.265371			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799017	hybrid, Green Published			2022-12-27	WOS:000294968800012
J	Hsu, FN; Chen, MC; Chiang, MC; Lin, E; Lee, YT; Huang, PH; Lee, GS; Lin, H				Hsu, Fu-Ning; Chen, Mei-Chih; Chiang, Ming-Ching; Lin, Eugene; Lee, Yueh-Tsung; Huang, Pao-Hsuan; Lee, Guan-Shun; Lin, Ho			Regulation of Androgen Receptor and Prostate Cancer Growth by Cyclin-dependent Kinase 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-LOCALIZATION; TRANSCRIPTIONAL ACTIVITY; PHOSPHORYLATION SITES; SIGNAL TRANSDUCER; INDUCED APOPTOSIS; CDK5; CELLS; PROTEIN; ACTIVATION; NEURODEGENERATION	Prostate cancer is the most frequently diagnosed male malignancy. The normal prostate development and prostate cancer progression are mediated by androgen receptor (AR). Recently, the roles of cyclin-dependent kinase 5 (Cdk5) and its activator, p35, in cancer biology are explored one after another. We have previously demonstrated that Cdk5 may regulate proliferation of thyroid cancer cells. In addition, we also identify that Cdk5 overactivation can be triggered by drug treatments and leads to apoptosis of prostate cancer cells. The aim of this study is to investigate how Cdk5 regulates AR activation and growth of prostate cancer cells. At first, the data show that Cdk5 enables phosphorylation of AR at Ser-81 site through direct biochemical interaction and, therefore, results in the stabilization of AR proteins. The Cdk5-dependent AR stabilization causes accumulation of AR proteins and subsequent activation. Besides, the positive regulations of Cdk5-AR on cell growth are also determined in vitro and in vivo. S81A mutant of AR diminishes its interaction with Cdk5, reduces its nuclear localization, fails to stabilize its protein level, and therefore, decreases prostate cancer cell proliferation. Prostate carcinoma specimens collected from 177 AR-positive patients indicate the significant correlations between the protein levels of AR and Cdk5 or p35. These findings demonstrate that Cdk5 is an important modulator of AR and contributes to prostate cancer growth. Therefore, Cdk5-p35 may be suggested as diagnostic and therapeutic targets for prostate cancer in the near future.	[Hsu, Fu-Ning; Chen, Mei-Chih; Chiang, Ming-Ching; Lin, Eugene; Lee, Yueh-Tsung; Huang, Pao-Hsuan; Lee, Guan-Shun; Lin, Ho] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan; [Lin, Ho] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 402, Taiwan; [Lin, Ho] China Med Univ, Grad Inst Rehabil Sci, Taichung 404, Taiwan; [Lin, Eugene] Chang Bing Show Chwan Mem Hosp, Dept Urol, Changhua 505, Taiwan; [Lee, Yueh-Tsung] Chang Bing Show Chwan Mem Hosp, Dept Surg, Changhua 505, Taiwan; [Lin, Ho] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan	National Chung Hsing University; National Chung Hsing University; China Medical University Taiwan; Chang Bing Show Chwan Memorial Hospital; Chang Bing Show Chwan Memorial Hospital; National Cheng Kung University	Lin, H (corresponding author), 250 Kuokuang Rd, Taichung 402, Taiwan.	hlin@dragon.nchu.edu.tw		Lin, Ho/0000-0001-7849-9137	National Science Council [NSC97-2320-B-005-002-MY3, NSC96-2628-B-005-013-MY3]; Taiwan Ministry of Education	National Science Council(Ministry of Science and Technology, Taiwan); Taiwan Ministry of Education(Ministry of Education, Taiwan)	This work was supported by National Science Council Grants NSC97-2320-B-005-002-MY3 and NSC96-2628-B-005-013-MY3 and in part by the Taiwan Ministry of Education under the Aiming for the Top University plan.	Berger R, 2006, CANCER RES, V66, P5723, DOI 10.1158/0008-5472.CAN-05-3928; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chen MC, 2010, AM J PHYSIOL-CELL PH, V299, pC516, DOI 10.1152/ajpcell.00534.2009; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Chen SY, 2009, J BIOL CHEM, V284, P25576, DOI 10.1074/jbc.M109.043133; Choi HS, 2009, J HUM GENET, V54, P298, DOI 10.1038/jhg.2009.29; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Feldmann G, 2010, CANCER RES, V70, P4460, DOI 10.1158/0008-5472.CAN-09-1107; Fu AKY, 2004, P NATL ACAD SCI USA, V101, P6728, DOI 10.1073/pnas.0307606100; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Goodyear S, 2007, EXP MOL PATHOL, V82, P25, DOI 10.1016/j.yexmp.2006.09.002; Gordon V, 2010, MOL ENDOCRINOL, V24, P2267, DOI 10.1210/me.2010-0238; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; Hsu FN, 2011, AM J PHYSIOL-ENDOC M, V300, pE902, DOI 10.1152/ajpendo.00610.2010; Isaacs JT, 2004, NAT MED, V10, P26, DOI 10.1038/nm0104-26; Kesler CT, 2007, MOL ENDOCRINOL, V21, P2071, DOI 10.1210/me.2007-0240; Kim E, 2006, INT J ONCOL, V28, P191; Kino T, 2007, MOL ENDOCRINOL, V21, P1552, DOI 10.1210/me.2006-0345; Kuo HS, 2009, CHINESE J PHYSIOL, V52, P23, DOI 10.4077/CJP.2009.AMG067; Lilja L, 2001, J BIOL CHEM, V276, P34199, DOI 10.1074/jbc.M103776200; Lin H, 2007, CELL DEATH DIFFER, V14, P607, DOI 10.1038/sj.cdd.4402033; Lin H, 2004, J BIOL CHEM, V279, P29302, DOI 10.1074/jbc.M403664200; Lin H, 2009, ADAPT MED, V1, P22; Lin H, 2007, J BIOL CHEM, V282, P2776, DOI 10.1074/jbc.M607234200; Lin H, 2009, ENDOCRINOLOGY, V150, P396, DOI 10.1210/en.2008-0496; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Liu JL, 2011, MED ONCOL, V28, P673, DOI 10.1007/s12032-010-9510-7; Liu SC, 2010, BIOCHEM BIOPH RES CO, V394, P297, DOI 10.1016/j.bbrc.2010.02.164; Lockwood WW, 2008, ONCOGENE, V27, P4615, DOI 10.1038/onc.2008.98; Mellinghoff IK, 2004, CANCER CELL, V6, P517, DOI 10.1016/j.ccr.2004.09.031; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Rhim JS, 1997, CRIT REV ONCOGENESIS, V8, P305, DOI 10.1615/CritRevOncog.v8.i4.20; Selvendiran K, 2006, CANCER RES, V66, P4826, DOI 10.1158/0008-5472.CAN-05-4062; Sheflin L, 2000, BIOCHEM BIOPH RES CO, V276, P144, DOI 10.1006/bbrc.2000.3424; Shigemura K, 2009, PROSTATE, V69, P949, DOI 10.1002/pros.20944; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Upadhyay AK, 2008, CURR CANCER DRUG TAR, V8, P741, DOI 10.2174/156800908786733405	45	70	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33141	33149		10.1074/jbc.M111.252080	http://dx.doi.org/10.1074/jbc.M111.252080			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799006	Green Published, hybrid			2022-12-27	WOS:000294968800033
J	Nagase, L; Murata-Kamiya, N; Hatakeyama, M				Nagase, Lisa; Murata-Kamiya, Naoko; Hatakeyama, Masanori			Potentiation of Helicobacter pylori CagA Protein Virulence through Homodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHATASE; PHOSPHORYLATION SITES; BIOLOGICAL-ACTIVITY; ONCOGENIC DRIVER; KINASE; CELLS; DIVERSITY; ACTIVATION; POLARITY; CANCER	Chronic infection with Helicobacter pylori cagA-positive strains is associated with atrophic gastritis, peptic ulceration, and gastric carcinoma. The cagA gene product, CagA, is delivered into gastric epithelial cells via type IV secretion, where it undergoes tyrosine phosphorylation at the EPIYA motifs. Tyrosine-phosphorylated CagA binds and aberrantly activates the oncogenic tyrosine phosphatase SHP2, which mediates induction of elongated cell morphology (hummingbird phenotype) that reflects CagA virulence. CagA also binds and inhibits the polarity-regulating kinase partitioning-defective 1 (PAR1)/microtubule affinity-regulating kinase (MARK) via the CagA multimerization (CM) sequence independently of tyrosine phosphorylation. Because PAR1 exists as a homodimer, two CagA proteins appear to be passively dimerized through complex formation with a PAR1 dimer in cells. Interestingly, a CagA mutant that lacks the CM sequence displays a reduced SHP2 binding activity and exhibits an attenuated ability to induce the hummingbird phenotype, indicating that the CagA-PAR1 interaction also influences the morphological transformation. Here we investigated the role of CagA dimerization in induction of the hummingbird phenotype with the use of a chemical dimerizer, coumermycin. We found that CagA dimerization markedly stabilizes the CagA-SHP2 complex and thereby potentiates SHP2 deregulation, causing an increase in the number of hummingbird cells. Protrusions of hummingbird cells induced by chemical dimerization of CagA are further elongated by simultaneous inhibition of PAR1. This study revealed a role of the CM sequence in amplifying the magnitude of SHP2 deregulation by CagA, which, in conjunction with the CM sequence-mediated inhibition of PAR1, evokes morphological transformation that reflects in vivo CagA virulence.	[Nagase, Lisa; Murata-Kamiya, Naoko; Hatakeyama, Masanori] Univ Tokyo, Div Microbiol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Hatakeyama, M (corresponding author), Univ Tokyo, Div Microbiol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mhata@m.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [22240085, 22114001, 22114002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research on innovative areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Argent RH, 2004, GASTROENTEROLOGY, V127, P514, DOI 10.1053/j.gastro.2004.06.006; Argent RH, 2008, J MED MICROBIOL, V57, P1062, DOI 10.1099/jmm.0.2008/001818-0; Azuma T, 2004, J INFECT DIS, V189, P820, DOI 10.1086/381782; Backert S, 2005, TRENDS MICROBIOL, V13, P476, DOI 10.1016/j.tim.2005.08.002; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Batista SA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-61; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Farrar MA, 2000, J BIOL CHEM, V275, P31318, DOI 10.1074/jbc.M003399200; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; GILBERT EJ, 1994, MOL MICROBIOL, V12, P365, DOI 10.1111/j.1365-2958.1994.tb01026.x; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2008, ONCOGENE, V27, P7047, DOI 10.1038/onc.2008.353; Hatakeyama M, 2011, CANCER SCI, V102, P36, DOI 10.1111/j.1349-7006.2010.01743.x; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Higuchi M, 2004, CANCER SCI, V95, P442, DOI 10.1111/j.1349-7006.2004.tb03229.x; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; Lu HS, 2008, CANCER SCI, V99, P2004, DOI 10.1111/j.1349-7006.2008.00950.x; Lu HS, 2009, J BIOL CHEM, V284, P23024, DOI 10.1074/jbc.M109.001008; Miura M, 2009, INT J CANCER, V125, P2497, DOI 10.1002/ijc.24740; Mizuguchi R, 1998, J BIOL CHEM, V273, P32297, DOI 10.1074/jbc.273.48.32297; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Mohi MG, 1998, MOL BIOL CELL, V9, P3299, DOI 10.1091/mbc.9.12.3299; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Naito M, 2006, GASTROENTEROLOGY, V130, P1181, DOI 10.1053/j.gastro.2005.12.038; Nesic D, 2010, NAT STRUCT MOL BIOL, V17, P130, DOI 10.1038/nsmb.1705; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Saito Y, 2010, J EXP MED, V207, P2157, DOI 10.1084/jem.20100602; Schmidt HMA, 2009, HELICOBACTER, V14, P256, DOI 10.1111/j.1523-5378.2009.00684.x; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Takahashi A, 2011, MOL CELL, V43, P45, DOI 10.1016/j.molcel.2011.05.014; Tartaglia M, 2005, EUR J MED GENET, V48, P81, DOI 10.1016/j.ejmg.2005.03.001; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016	39	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33622	33631		10.1074/jbc.M111.258673	http://dx.doi.org/10.1074/jbc.M111.258673			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813645	Green Published, hybrid			2022-12-27	WOS:000294968800078
J	Sharma, NM; Kochenova, OV; Shcherbakova, PV				Sharma, Neeru M.; Kochenova, Olga V.; Shcherbakova, Polina V.			The Non-canonical Protein Binding Site at the Monomer-Monomer Interface of Yeast Proliferating Cell Nuclear Antigen (PCNA) Regulates the Rev1-PCNA Interaction and Pol zeta/Rev1-dependent Translesion DNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYCYTIDYL TRANSFERASE-ACTIVITY; DAMAGE-INDUCED MUTAGENESIS; REV1 PROTEIN; POLYMERASE-ETA; SACCHAROMYCES-CEREVISIAE; UBIQUITIN-BINDING; COMPLEX-FORMATION; DCMP TRANSFERASE; POL32 SUBUNIT; LESION-BYPASS	Rev1 and DNA polymerase zeta (Pol zeta) are involved in the tolerance of DNA damage by translesion synthesis (TLS). The proliferating cell nuclear antigen (PCNA), the auxiliary factor of nuclear DNA polymerases, plays an important role in regulating the access of TLS polymerases to the primer terminus. Both Rev1 and Pol zeta lack the conserved hydrophobic motif that is used by many proteins for the interaction with PCNA at its interdomain connector loop. We have previously reported that the interaction of yeast Pol zeta with PCNA occurs at an unusual site near the monomer-monomer interface of the trimeric PCNA. Using GST pull-down assays, PCNA-coupled affinity beads pull-down and gel filtration chromatography, we show that the same region is required for the physical interaction of PCNA with the polymerase-associated domain (PAD) of Rev1. The interaction is disrupted by the pol30-113 mutation that results in a double amino acid substitution at the monomer-monomer interface of PCNA. Genetic analysis of the epistatic relationship of the pol30-113 mutation with an array of DNA repair and damage tolerance mutations indicated that PCNA-113 is specifically defective in the Rev1/Pol zeta-dependent TLS pathway. Taken together, the data suggest that Pol zeta and Rev1 are unique among PCNA-interacting proteins in using the novel binding site near the intermolecular interface of PCNA. The new mode of Rev1-PCNA binding described here suggests a mechanism by which Rev1 adopts a catalytically inactive configuration at the replication fork.	[Sharma, Neeru M.; Kochenova, Olga V.; Shcherbakova, Polina V.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Shcherbakova, PV (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 986805 Nebraska Med Ctr, Omaha, NE 68198 USA.	pshcherb@unmc.edu		Sharma, Neeru/0000-0002-8477-7065	Nebraska DHHS [LB506]; National Institutes of Health [ES011644, ES015869]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015869, K22ES011644] Funding Source: NIH RePORTER	Nebraska DHHS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Nebraska DHHS Grant LB506, and National Institutes of Health Grants ES011644 and ES015869 (to P. V. S.).	Acharya N, 2005, MOL CELL BIOL, V25, P9734, DOI 10.1128/MCB.25.21.9734-9740.2005; Acharya N, 2009, P NATL ACAD SCI USA, V106, P9631, DOI 10.1073/pnas.0902175106; Acharya N, 2007, MOL CELL BIOL, V27, P8401, DOI 10.1128/MCB.01478-07; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Broyde S, 2008, TRENDS BIOCHEM SCI, V33, P209, DOI 10.1016/j.tibs.2008.02.004; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; D'Souza S, 2008, DNA REPAIR, V7, P1455, DOI 10.1016/j.dnarep.2008.05.009; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Freudenthal BD, 2009, ACTA CRYSTALLOGR D, V65, P560, DOI 10.1107/S0907444909011329; Freudenthal BD, 2008, BIOCHEMISTRY-US, V47, P13354, DOI 10.1021/bi8017762; Fukuda H, 2009, J BIOL CHEM, V284, P25585, DOI 10.1074/jbc.M109.037259; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Garg P, 2005, J BIOL CHEM, V280, P23446, DOI 10.1074/jbc.C500173200; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Haracska L, 2002, J BIOL CHEM, V277, P15546, DOI 10.1074/jbc.M112146200; Haracska L, 2002, MOL CELL BIOL, V22, P784, DOI 10.1128/MCB.22.3.784-791.2002; Haracska L, 2001, P NATL ACAD SCI USA, V98, P14256, DOI 10.1073/pnas.261560798; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Lin WS, 1999, NUCLEIC ACIDS RES, V27, P4468, DOI 10.1093/nar/27.22.4468; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Masuda Y, 2002, J BIOL CHEM, V277, P3040, DOI 10.1074/jbc.M110149200; Masuda Y, 2001, J BIOL CHEM, V276, P15051, DOI 10.1074/jbc.M008082200; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Northam MR, 2006, EMBO J, V25, P4316, DOI 10.1038/sj.emboj.7601320; Northam MR, 2010, GENETICS, V184, P27, DOI 10.1534/genetics.109.107482; Ogi T, 2005, J CELL SCI, V118, P129, DOI 10.1242/jcs.01603; Parker JL, 2007, NUCLEIC ACIDS RES, V35, P881, DOI 10.1093/nar/gkl1102; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Ross AL, 2005, NUCLEIC ACIDS RES, V33, P1280, DOI 10.1093/nar/gki279; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Vidal AE, 2004, J BIOL CHEM, V279, P48360, DOI 10.1074/jbc.M406511200; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wood A, 2007, J BIOL CHEM, V282, P20256, DOI 10.1074/jbc.M702366200; Yang W, 2005, FEBS LETT, V579, P868, DOI 10.1016/j.febslet.2004.11.047; Yang W, 2003, CURR OPIN STRUC BIOL, V13, P23, DOI 10.1016/S0959-440X(02)00003-9; Zhang HS, 2006, GENETICS, V173, P1983, DOI 10.1534/genetics.106.058545; Zhang YB, 2002, NUCLEIC ACIDS RES, V30, P1630, DOI 10.1093/nar/30.7.1630; Zhou Y, 2010, NUCLEIC ACIDS RES, V38, P5036, DOI 10.1093/nar/gkq225	51	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33557	33566		10.1074/jbc.M110.206680	http://dx.doi.org/10.1074/jbc.M110.206680			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799021	Green Published, hybrid			2022-12-27	WOS:000294968800072
J	Kobayashi, H; Ogura, Y; Sawada, M; Nakayama, R; Takano, K; Minato, Y; Takemoto, Y; Tashiro, E; Watanabe, H; Imoto, M				Kobayashi, Hiroki; Ogura, Yusuke; Sawada, Masato; Nakayama, Ryoji; Takano, Kei; Minato, Yusuke; Takemoto, Yasushi; Tashiro, Etsu; Watanabe, Hidenori; Imoto, Masaya			Involvement of 14-3-3 Proteins in the Second Epidermal Growth Factor-induced Wave of Rac1 Activation in the Process of Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN STRESS FIBERS; RHO; CDC42; COMPLEXES; MOTILITY; GTPASES; 14-3-3-PROTEINS; PHOSPHORYLATION; LAMELLIPODIA; ADHESION	Immense previous efforts have elucidated the core machinery in cell migration, actin remodeling regulated by Rho family small GTPases including RhoA, Cdc42, and Rac1; however, the spatiotemporal regulation of these molecules remains largely unknown. Here, we report that EGF induces biphasic Rac1 activation in the process of cell migration, and UTKO1, a cell migration inhibitor, inhibits the second EGF-induced wave of Rac1 activation but not the first wave. To address the regulation mechanism and role of the second wave of Rac1 activation, we identified 14-3-3 xi as a target protein of UTKO1 and also showed that UTKO1 abrogated the binding of 14-3-3 xi to Tiam1 that was responsible for the second wave of Rac1 activation, suggesting that the interaction of 14-3-3 xi with Tiam1 is involved in this event. To our knowledge, this is the first report to use a chemical genetic approach to demonstrate the mechanism of temporal activation of Rac1.	[Kobayashi, Hiroki; Sawada, Masato; Nakayama, Ryoji; Takano, Kei; Minato, Yusuke; Takemoto, Yasushi; Tashiro, Etsu; Imoto, Masaya] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Ogura, Yusuke; Watanabe, Hidenori] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Keio University; University of Tokyo	Imoto, M (corresponding author), Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	imoto@bio.keio.ac.jp	Tashiro, Etsu/C-4903-2014; Imoto, Masaya/F-7957-2014	Sawada, Masato/0000-0002-8694-8526; Tashiro, Etsu/0000-0003-4533-623X; Kobayashi, Hiroki/0000-0002-3785-2317; Takano, Kei/0000-0002-4219-6123	Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [23102010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology.	AITKEN A, 1995, BIOCHEM SOC T, V23, P605, DOI 10.1042/bst0230605; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Biyasheva A, 2004, J CELL SCI, V117, P837, DOI 10.1242/jcs.00921; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; CHINKERS M, 1979, J CELL BIOL, V83, P260, DOI 10.1083/jcb.83.1.260; Deakin NO, 2009, J CELL SCI, V122, P1654, DOI 10.1242/jcs.049130; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Jones GE, 1998, CELL ADHES COMMUN, V6, P237, DOI 10.3109/15419069809004479; Jones SM, 1999, CURR BIOL, V9, P512, DOI 10.1016/S0960-9822(99)80235-8; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee SH, 2007, CANCER RES, V67, P11045, DOI 10.1158/0008-5472.CAN-07-0986; Marcoux N, 2003, ONCOGENE, V22, P6100, DOI 10.1038/sj.onc.1206712; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; O'Toole TE, 2011, J CELL PHYSIOL, V226, P2965, DOI 10.1002/jcp.22644; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Sawada M, 2011, BIOORG MED CHEM LETT, V21, P1385, DOI 10.1016/j.bmcl.2011.01.028; Sini P, 2004, NAT CELL BIOL, V6, P268, DOI 10.1038/ncb1096; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takemoto Y, 2005, CHEM BIOL, V12, P1337, DOI 10.1016/j.chembiol.2005.09.017; Takenawa T, 2001, J CELL SCI, V114, P1801; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Veluthakal R, 2009, BIOCHEM PHARMACOL, V77, P101, DOI 10.1016/j.bcp.2008.09.021; Woodcock SA, 2009, J PROTEOME RES, V8, P5629, DOI 10.1021/pr900716e; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770	39	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39259	39268		10.1074/jbc.M111.255489	http://dx.doi.org/10.1074/jbc.M111.255489			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21868386	hybrid, Green Published			2022-12-27	WOS:000296759800044
J	Wang, L; Li, L; Zhang, HL; Luo, X; Dai, JQ; Zhou, SL; Gu, J; Zhu, JD; Atadja, P; Lu, C; Li, E; Zhao, KH				Wang, Li; Li, Ling; Zhang, Hailong; Luo, Xiao; Dai, Jingquan; Zhou, Shaolian; Gu, Justin; Zhu, Jidong; Atadja, Peter; Lu, Chris; Li, En; Zhao, Kehao			Structure of Human SMYD2 Protein Reveals the Basis of p53 Tumor Suppressor Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE; IDENTIFICATION; PROLIFERATION; SPECIFICITY; MECHANISM; DOMAINS; SET	SMYD2 belongs to a subfamily of histone lysine methyltransferase and was recently identified to methylate tumor suppressor p53 and Rb. Here we report that SMYD2 prefers to methylate p53 Lys-370 over histone substrates in vitro. Consistently, the level of endogenous p53 Lys-370 monomethylation is significantly elevated when SMYD2 is overexpressed in vivo. We have solved the high resolution crystal structures of the full-length SMYD2 protein in binary complex with its cofactor S-adenosylmethionine and in ternary complex with cofactor product S-adenosylhomocysteine and p53 substrate peptide (residues 368375), respectively. p53 peptide binds to a deep pocket of the interface between catalytic SET(1-282) and C-terminal domain (CTD) with an unprecedented U-shaped conformation. Subtle conformational change exists around the p53 binding site between the binary and ternary structures, in particular the tetratricopeptide repeat motif of the CTD. In addition, a unique EDEE motif between the loop of anti-parallel beta 7 and beta 8 sheets of the SET core not only interacts with p53 substrate but also forms a hydrogen bond network with residues from CTD. These observations suggest that the tetratricopeptide repeat and EDEE motif may play an important role in determining p53 substrate binding specificity. This is further verified by the findings that deletion of the CTD domain drastically reduces the methylation activity of SMYD2 to p53 protein. Meanwhile, mutation of EDEE residues impairs both the binding and the enzymatic activity of SMYD2 to p53 Lys-370. These data together reveal the molecular basis of SMYD2 in specifically recognizing and regulating functions of p53 tumor suppressor through Lys-370 monomethylation.	[Wang, Li; Li, Ling; Zhang, Hailong; Luo, Xiao; Dai, Jingquan; Zhou, Shaolian; Gu, Justin; Zhu, Jidong; Atadja, Peter; Lu, Chris; Li, En; Zhao, Kehao] Novartis Inst BioMed Res, Shanghai 201203, Peoples R China	Novartis	Zhao, KH (corresponding author), Novartis Inst BioMed Res, Bldg 8,Lane 898,Halei Rd, Shanghai 201203, Peoples R China.	Kehao.zhao@novartis.com		Zhao, Kehao/0000-0003-2485-058X	Novartis	Novartis(Novartis)	This work was supported by a Novartis postdoctoral fellowship.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Campagna-Slater V, 2011, J CHEM INF MODEL, V51, P612, DOI 10.1021/ci100479z; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Del Rizzo PA, 2010, J BIOL CHEM, V285, P31849, DOI 10.1074/jbc.M110.114587; Diehl F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009748; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hu LP, 2009, CANCER RES, V69, P4067, DOI 10.1158/0008-5472.CAN-08-4097; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Jiang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021640; Kawamura S, 2008, CYTOTECHNOLOGY, V57, P161, DOI 10.1007/s10616-008-9128-1; Komatsu S, 2009, CARCINOGENESIS, V30, P1139, DOI 10.1093/carcin/bgp116; Kunizaki M, 2007, CANCER RES, V67, P10759, DOI 10.1158/0008-5472.CAN-07-1132; Luger K, 1999, METHOD ENZYMOL, V304, P3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park CY, 2010, P NATL ACAD SCI USA, V107, P20750, DOI 10.1073/pnas.1013493107; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Scoumanne A, 2008, HISTOL HISTOPATHOL, V23, P1143, DOI 10.14670/HH-23.1143; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sirinupong N, 2011, J MOL BIOL, V406, P149, DOI 10.1016/j.jmb.2010.12.014; Sirinupong N, 2010, J BIOL CHEM, V285, P40635, DOI 10.1074/jbc.M110.168187; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Thompson EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003008; West LE, 2010, J BIOL CHEM, V285, P37725, DOI 10.1074/jbc.M110.139527; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xu S., 2011, J MOL CELL IN PRESS; Xu ST, 2011, NUCLEIC ACIDS RES, V39, P4438, DOI 10.1093/nar/gkr019	40	53	56	7	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38725	38737		10.1074/jbc.M111.262410	http://dx.doi.org/10.1074/jbc.M111.262410			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21880715	Green Published, hybrid			2022-12-27	WOS:000296594200084
J	Nemet, I; Monnier, VM				Nemet, Ina; Monnier, Vincent M.			Vitamin C Degradation Products and Pathways in the Human Lens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DICARBONYL COMPOUNDS; L-ASCORBIC-ACID; MAILLARD REACTION; PHYSIOLOGICAL CONDITIONS; ARGININE RESIDUES; CROSS-LINKS; EYE LENS; PROTEINS; LYSINE; CATARACTOGENESIS	Vitamin C and its degradation products participate in chemical modifications of proteins in vivo through non-enzymatic glycation (Maillard reaction) and formation of different products called advanced glycation end products. Vitamin C levels are particularly high in selected tissues, such as lens, brain and adrenal gland, and its degradation products can inflict substantial protein damage via formation of advanced glycation end products. However, the pathways of in vivo vitamin C degradation are poorly understood. Here we have determined the levels of vitamin C oxidation and degradation products dehydroascorbic acid, 2,3-dike-togulonic acid, 3-deoxythreosone, xylosone, and threosone in the human lens using o-phenylenediamine to trap both free and protein-bound adducts. In the protein-free fraction and water-soluble proteins (WSP), all five listed degradation products were identified. Dehydroascorbic acid, 2,3-diketogulonic acid, and 3-deoxythreosone were the major products in the protein-free fraction, whereas in the WSP, 3-deoxythreosone was the most abundant measured dicarbonyl. In addition, 3-deoxythreosone in WSP showed positive linear correlation with age (p < 0.05). In water-insoluble proteins, only 3-deoxythreosone and threosone were detected, whereby the level of 3-deoxythreosone was similar to 20 times higher than the level of threosone. The identification of 3-deoxythreosone as the major degradation product bound to human lens proteins provides in vivo evidence for the non-oxidative pathway of dehydroascorbate degradation in to erythrulose as a major pathway for vitamin C degradation in vivo.	[Nemet, Ina; Monnier, Vincent M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Monnier, Vincent M.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Nemet, Ina] Rudjer Boskovic Inst, Div Organ Chem & Biochem, Zagreb 10000, Croatia	Case Western Reserve University; Case Western Reserve University; Rudjer Boskovic Institute	Monnier, VM (corresponding author), 2103 Cornell Rd,WRB 5127, Cleveland, OH 44106 USA.	vmm3@cwru.edu	Nemet, Ina/ABG-2855-2021	Nemet, Ina/0000-0002-0657-7121	NEI, National Institutes of Health [EY07099]; Ministry of Science, Education, and Sports of Croatia [098-0982933-2936]; Juvenile Diabetes Research International; NATIONAL EYE INSTITUTE [R01EY007099] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Ministry of Science, Education, and Sports of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Juvenile Diabetes Research International; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by NEI, National Institutes of Health, Grant EY07099. This work was also supported by Ministry of Science, Education, and Sports of Croatia Grant 098-0982933-2936.; Recipient of a fellowship from the Juvenile Diabetes Research International.	Argirov OK, 2004, J BIOL CHEM, V279, P6487, DOI 10.1074/jbc.M309090200; Atalay A, 1998, BIOCHIMIE, V80, P283, DOI 10.1016/S0300-9084(98)80068-0; Cheng RZ, 2006, BBA-MOL BASIS DIS, V1762, P533, DOI 10.1016/j.bbadis.2006.01.009; DUNN JA, 1990, BIOCHEMISTRY-US, V29, P10964, DOI 10.1021/bi00501a014; Fan XJ, 2006, P NATL ACAD SCI USA, V103, P16912, DOI 10.1073/pnas.0605101103; Fan XJ, 2009, J BIOL CHEM, V284, P34618, DOI 10.1074/jbc.M109.032094; Glomb MA, 2001, J AGR FOOD CHEM, V49, P5543, DOI 10.1021/jf010148h; Glomb MA, 2001, J AGR FOOD CHEM, V49, P1493, DOI 10.1021/jf001082d; Gobert J, 2009, J AGR FOOD CHEM, V57, P8591, DOI 10.1021/jf9019085; LO TWC, 1994, J BIOL CHEM, V269, P32299; Mittelmaier S, 2010, J CHROMATOGR B, V878, P877, DOI 10.1016/j.jchromb.2010.02.004; NAGARAJ RH, 1991, P NATL ACAD SCI USA, V88, P10257, DOI 10.1073/pnas.88.22.10257; Nishikawa Y, 2001, BIOSCI BIOTECH BIOCH, V65, P1707, DOI 10.1271/bbb.65.1707; OTSUKA M, 1986, AGR BIOL CHEM TOKYO, V50, P531, DOI 10.1080/00021369.1986.10867421; PATTHY L, 1975, J BIOL CHEM, V250, P557; Reihl O, 2004, CARBOHYD RES, V339, P483, DOI 10.1016/j.carres.2003.12.004; Salomon L. L., 1952, J AM CHEM SOC, P5161; Sell DR, 2005, ANN NY ACAD SCI, V1043, P118, DOI 10.1196/annals.1333.015; SHIN DB, 1990, CARBOHYD RES, V208, P246; Simpson GLW, 2000, BBA-MOL BASIS DIS, V1501, P12, DOI 10.1016/S0925-4439(00)00009-0; TAKAHASHI K, 1968, J BIOL CHEM, V243, P6171; Tessier F, 1999, J BIOL CHEM, V274, P20796, DOI 10.1074/jbc.274.30.20796; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Usui T, 2007, BIOSCI BIOTECH BIOCH, V71, P2465, DOI 10.1271/bbb.70229; VARMA SD, 1988, OPHTHALMIC RES, V20, P164, DOI 10.1159/000266579; VUORINEN T, 1990, CARBOHYD RES, V207, P185, DOI 10.1016/0008-6215(90)84048-Y; WELLS WW, 1994, J BIOENERG BIOMEMBR, V26, P369, DOI 10.1007/BF00762777; Xing KY, 2010, INVEST OPHTH VIS SCI, V51, P6598, DOI 10.1167/iovs.10-5672; Xue MZ, 2011, SEMIN CELL DEV BIOL, V22, P293, DOI 10.1016/j.semcdb.2011.02.013	29	54	56	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37128	37136		10.1074/jbc.M111.245100	http://dx.doi.org/10.1074/jbc.M111.245100			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21885436	hybrid, Green Published			2022-12-27	WOS:000296542400013
J	Brammer, LA; Smith, JM; Wade, H; Meyers, CF				Brammer, Leighanne A.; Smith, Jessica M.; Wade, Herschel; Meyers, Caren Freel			1-Deoxy-D-xylulose 5-Phosphate Synthase Catalyzes a Novel Random Sequential Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; 2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE PATHWAY; ESCHERICHIA-COLI; ISOPRENOID BIOSYNTHESIS; ISOPENTENYL DIPHOSPHATE; THIAMIN DIPHOSPHATE; ENZYME; SUBSTRATE; CLONING; IDENTIFICATION	Emerging resistance of human pathogens to anti-infective agents make it necessary to develop new agents to treat infection. The methylerythritol phosphate pathway has been identified as an anti-infective target, as this essential isoprenoid biosynthetic pathway is widespread in human pathogens but absent in humans. The first enzyme of the pathway, 1-deoxy-D-xylulose 5-phosphate (DXP) synthase, catalyzes the formation of DXP via condensation of D-glyceraldehyde 3-phosphate (D-GAP) and pyruvate in a thiamine diphosphate-dependent manner. Structural analysis has revealed a unique domain arrangement suggesting opportunities for the selective targeting of DXP synthase; however, reports on the kinetic mechanism are conflicting. Here, we present the results of tryptophan fluorescence binding and kinetic analyses of DXP synthase and propose a new model for substrate binding and mechanism. Our results are consistent with a random sequential kinetic mechanism, which is unprecedented in this enzyme class.	[Brammer, Leighanne A.; Smith, Jessica M.; Meyers, Caren Freel] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Wade, Herschel] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Meyers, CF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	cmeyers@jhmi.edu		Basta, Leighanne/0000-0002-4121-5505; Freel Meyers, Caren/0000-0003-1458-0897	National Institutes of Health [GM084998, 5T32GM007445-34]; Johns Hopkins Malaria Research Institute Pilot; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084998, T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Malaria Research Institute Pilot; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM084998 (to L.A.B. and C.F.M.) and 5T32GM007445-34 (to J.M.S.). This work was also supported by a grant from The Johns Hopkins Malaria Research Institute Pilot (to L.A.B. and C.F.M.).	Altincicek B, 2000, FEMS MICROBIOL LETT, V190, P329, DOI 10.1111/j.1574-6968.2000.tb09307.x; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; Bailey AM, 2002, GLYCOBIOLOGY, V12, P813, DOI 10.1093/glycob/cwf100; Brammer LA, 2009, ORG LETT, V11, P4748, DOI 10.1021/ol901961q; Brandt GS, 2009, BIOCHEMISTRY-US, V48, P3247, DOI 10.1021/bi801950k; BUBB WA, 1995, BIOORG CHEM, V23, P119, DOI 10.1006/bioo.1995.1010; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Cane DE, 2001, BIOORGAN MED CHEM, V9, P1467, DOI 10.1016/S0968-0896(01)00050-5; Copeland R. A., 2005, EVALUATION ENZYME IN, P42; Eoh H, 2009, TUBERCULOSIS, V89, P1, DOI 10.1016/j.tube.2008.07.004; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; Fang MH, 2010, BIOCHEMISTRY-US, V49, P2672, DOI 10.1021/bi901432d; FLOURNOY DS, 1989, BIOCHEMISTRY-US, V28, P9594, DOI 10.1021/bi00451a007; Frank RAW, 2007, CELL MOL LIFE SCI, V64, P892, DOI 10.1007/s00018-007-6423-5; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; GISH G, 1988, J AM CHEM SOC, V110, P6230, DOI 10.1021/ja00226a044; Hahn FM, 2001, J BACTERIOL, V183, P1, DOI 10.1128/JB.183.1.1-11.2001; Hill RE, 1996, J BIOL CHEM, V271, P30426, DOI 10.1074/jbc.271.48.30426; Kale S, 2007, J BIOL CHEM, V282, P28106, DOI 10.1074/jbc.M704326200; KLUGER R, 1977, J AM CHEM SOC, V99, P4504, DOI 10.1021/ja00455a052; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuzuyama T, 2000, J BACTERIOL, V182, P891, DOI 10.1128/JB.182.4.891-897.2000; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Matsue Y, 2010, J ANTIBIOT, V63, P583, DOI 10.1038/ja.2010.100; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Nemeria NS, 2006, BIOORG CHEM, V34, P362, DOI 10.1016/j.bioorg.2006.09.001; OBRIEN TA, 1980, BIOCHIM BIOPHYS ACTA, V613, P10, DOI 10.1016/0005-2744(80)90186-2; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Querol J, 2001, BIOCHEM BIOPH RES CO, V289, P155, DOI 10.1006/bbrc.2001.5957; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Segel I. H., 1975, ENZYME KINETICS, P273; Sisquella X, 2010, FASEB J, V24, P4203, DOI 10.1096/fj.10-155507; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Steinmetz A, 2010, BIOCHEMISTRY-US, V49, P5188, DOI 10.1021/bi100555q; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Xiang S, 2007, J BIOL CHEM, V282, P2676, DOI 10.1074/jbc.M610235200	38	44	44	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36522	36531		10.1074/jbc.M111.259747	http://dx.doi.org/10.1074/jbc.M111.259747			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878632	Green Published, hybrid			2022-12-27	WOS:000296538300037
J	Bruck, I; Kanter, DM; Kaplan, DL				Bruck, Irina; Kanter, Diane M.; Kaplan, Daniel L.			Enabling Association of the GINS Protein Tetramer with the Mini Chromosome Maintenance (Mcm)2-7 Protein Complex by Phosphorylated Sld2 Protein and Single-stranded Origin DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTHMUND-THOMSON-SYNDROME; CYCLIN-DEPENDENT KINASE; BUDDING YEAST; MCM2-7 HELICASE; SACCHAROMYCES-CEREVISIAE; REPLICATION FORKS; S-PHASE; CDC45; INITIATION; PROGRESSION	The Cdc45-Mcm2-7-GINS (CMG) complex is the replication fork helicase in eukaryotes. Synthetic lethal with Dpb11-1 (Sld2) is required for the initiation of DNA replication, and the S phase cyclin-dependent kinase (S-CDK) phosphorylates Sld2 in vivo. We purified components of the replication initiation machinery and studied their interactions in vitro. We found that unphosphorylated or CDK-phosphorylated Sld2 binds to the mini chromosome maintenance (Mcm) 2-7 complex with similar efficiency. Sld2 interaction with Mcm2-7 blocks the interaction between GINS and Mcm2-7. The interaction between CDK-phosphorylated Sld2 and Mcm2-7 is substantially inhibited by origin single-stranded DNA (ssDNA). Furthermore, origin ssDNA allows GINS to bind to Mcm2-7 in the presence of CDK-phosphorylated Sld2. However, unphosphorylated Sld2 blocks the interaction between GINS and Mcm2-7 even in the presence of origin ssDNA. We identified a mutant of Sld2 that does not bind to DNA. When this mutant is expressed in yeast cells, cell growth is severely inhibited with very slow progression into S phase. We propose a model wherein Sld2 blocks the interaction between GINS and Mcm2-7 in vivo. Once origin ssDNA is extruded from the Mcm2-7 ring and CDK phosphorylates Sld2, the origin ssDNA binds to CDK-phosphorylated Sld2. This event may allow the interaction between GINS and Mcm2-7 in vivo. Thus, CDK phosphorylation of Sld2 may be important to release Sld2 from Mcm2-7, thereby allowing GINS to bind Mcm2-7. Furthermore, origin ssDNA may stimulate the formation of the CMG complex by alleviating inhibitory interactions between Sld2 with Mcm2-7.	[Kaplan, Daniel L.] Vanderbilt Univ, Stn B, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Kaplan, DL (corresponding author), Vanderbilt Univ, Stn B, Dept Biol Sci, Box 35-1634, Nashville, TN 37235 USA.	daniel.kaplan@vanderbilt.edu		Kaplan, Daniel/0000-0003-2760-7745	American Cancer Society [RSG-08-124-01-CCG]; National Science Foundation [1121534]; Vanderbilt University; Vanderbilt Ingram Cancer Center	American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); Vanderbilt University; Vanderbilt Ingram Cancer Center	This work was supported by American Cancer Society Research Scholar Grant RSG-08-124-01-CCG (to D.L.K. and I.B.), National Science Foundation Grant 1121534 (to D.L.K. and I.B.), a Vanderbilt University Discovery grant (to D.L.K.), and a Vanderbilt Ingram Cancer Center grant (to D.L.K.).	Araki H, 2010, CURR OPIN CELL BIOL, V22, P766, DOI 10.1016/j.ceb.2010.07.015; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Diffley JFX, 2010, COLD SH Q B, V75, P135, DOI 10.1101/sqb.2010.75.062; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kanter DM, 2011, NUCLEIC ACIDS RES, V39, P2580, DOI 10.1093/nar/gkq1222; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; MacNeill SA, 2010, BIOCHEM J, V425, P489, DOI 10.1042/BJ20091531; Masai H, 2011, J BIOCHEM, V149, P629, DOI 10.1093/jb/mvr031; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pospiech H, 2010, SUBCELL BIOCHEM, V50, P79, DOI 10.1007/978-90-481-3471-7_5; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sanchez-Pulido L, 2010, CURR BIOL, V20, pR509, DOI 10.1016/j.cub.2010.05.021; SANCHEZDIAZ A, 2004, SCI STKE, pPL8, DOI DOI 10.1126/STKE.2232004PL8; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Wu JH, 2008, DEV BIOL, V323, P130, DOI 10.1016/j.ydbio.2008.08.006; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	42	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36414	36426		10.1074/jbc.M111.282822	http://dx.doi.org/10.1074/jbc.M111.282822			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21868389	Green Published, hybrid			2022-12-27	WOS:000296538300027
J	Coppe, JP; Rodier, F; Patil, CK; Freund, A; Desprez, PY; Campisi, J				Coppe, Jean-Philippe; Rodier, Francis; Patil, Christopher K.; Freund, Adam; Desprez, Pierre-Yves; Campisi, Judith			Tumor Suppressor and Aging Biomarker p16(INK4a) Induces Cellular Senescence without the Associated Inflammatory Secretory Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; REPLICATIVE SENESCENCE; FIBROBLAST SENESCENCE; TRIGGERS SENESCENCE; DEPENDENT KINASES; HUMAN-CELLS; EXPRESSION; GROWTH; P53; INHIBITORS	Cellular senescence suppresses cancer by preventing the proliferation of cells that experience potentially oncogenic stimuli. Senescent cells often express p16(INK4a), a cyclin-dependent kinase inhibitor, tumor suppressor, and biomarker of aging, which renders the senescence growth arrest irreversible. Senescent cells also acquire a complex phenotype that includes the secretion of many cytokines, growth factors, and proteases, termed a senescence-associated secretory phenotype (SASP). The SASP is proposed to underlie age-related pathologies, including, ironically, late life cancer. Here, we show that ectopic expression of p16(INK4a) and another cyclin-dependent kinase inhibitor, p21(CIP1/WAF1), induces senescence without a SASP, even though they induced other features of senescence, including a stable growth arrest. Additionally, human fibroblasts induced to senesce by ionizing radiation or oncogenic RAS developed a SASP regardless of whether they expressed p16(INK4a). Cells induced to senesce by ectopic p16(INK4a) expression lacked paracrine activity on epithelial cells, consistent with the absence of a functional SASP. Nonetheless, expression of p16(INK4a) by cells undergoing replicative senescence limited the accumulation of DNA damage and premature cytokine secretion, suggesting an indirect role for p16(INK4a) in suppressing the SASP. These findings suggest that p16(INK4a)-positive cells may not always harbor a SASP in vivo and, furthermore, that the SASP is not a consequence of p16(INK4a) activation or senescence per se, but rather is a damage response that is separable from the growth arrest.	[Coppe, Jean-Philippe; Rodier, Francis; Patil, Christopher K.; Freund, Adam; Campisi, Judith] Buck Inst Res Aging, Novato, CA 94945 USA; [Coppe, Jean-Philippe; Rodier, Francis; Patil, Christopher K.; Freund, Adam; Desprez, Pierre-Yves; Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Rodier, Francis] Univ Montreal, Inst Canc Montreal, Dept Radiol Radiooncol & Nucl Med, CRCHUM, Montreal, PQ H2L 4M1, Canada; [Desprez, Pierre-Yves] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA	Buck Institute for Research on Aging; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Universite de Montreal; California Pacific Medical Center; California Pacific Medical Center Research Institute	Campisi, J (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	jcampisi@buckinstitute.org		Rodier, Francis/0000-0003-2523-309X	National Institutes of Health [AG09909, AG017242, CA126540]; NATIONAL CANCER INSTITUTE [U54CA126540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG009909, R01AG009909, R37AG009909, P01AG017242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants AG09909, AG017242, and CA126540 (to J. C.).	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Brooke S, 2004, EXP CELL RES, V298, P549, DOI 10.1016/j.yexcr.2004.04.035; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Castro P, 2003, PROSTATE, V55, P30, DOI 10.1002/pros.10204; Chang BD, 1999, CANCER RES, V59, P3761; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; DESPREZ PY, 1995, MOL CELL BIOL, V15, P3398; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Donehower LA, 1996, SEMIN CANCER BIOL, V7, P269, DOI 10.1006/scbi.1996.0035; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014; McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X; Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nielsen GP, 1999, LAB INVEST, V79, P1137; Novakova Z, 2010, ONCOGENE, V29, P273, DOI 10.1038/onc.2009.318; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stein GH, 1999, MOL CELL BIOL, V19, P2109; te Poele RH, 2002, CANCER RES, V62, P1876; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zindy F, 1997, CELL GROWTH DIFFER, V8, P1139	62	279	288	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36396	36403		10.1074/jbc.M111.257071	http://dx.doi.org/10.1074/jbc.M111.257071			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880712	Green Published, hybrid			2022-12-27	WOS:000296538300025
J	Cheng, J; Phong, B; Wilson, DC; Hirsch, R; Kane, LP				Cheng, Jing; Phong, Binh; Wilson, David C.; Hirsch, Raphael; Kane, Lawrence P.			Akt Fine-tunes NF-kappa B-dependent Gene Expression during T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLISTATIN-LIKE PROTEIN-1; TNF-ALPHA PRODUCTION; IN-VIVO; POSTTRANSCRIPTIONAL REGULATION; TEMPORAL CONTROL; UP-REGULATION; KINASE B/AKT; IFN-GAMMA; BONE LOSS; TRANSCRIPTION	Activation of the NF-kappa B signaling pathway is critical for leukocyte activation and development. Although previous studies suggested a role for the Akt kinase in coupling the T cell antigen receptor and CD28 to NF-kappa B activation in T cells, the nature of the role of Akt in this pathway is still unclear. Using a targeted gene profiling approach, we found that a subset of NF-kappa B-dependent genes required Akt for optimal up-regulation during T cell activation. The selective effects of Akt were manifest at the level of mRNA transcription and p65/RelA binding to upstream promoters and appear to be due to altered formation of the Carma1-Bcl10 complex. The proinflammatory cytokine TNF-alpha was found to be particularly sensitive to Akt inhibition or knockdown, including in primary human blood T cells and a murine model of rheumatoid arthritis. Our findings are consistent with a hierarchy in the expression of NF-kappa B-dependent genes, controlled by the strength and/or duration of NF-kappa B signaling. More broadly, our results suggest that defining the more graded effects of signaling, such as those demonstrated here for Akt and the NF-kappa B pathway, is important to understanding how cells can fine-tune signaling responses for optimal sensitivity and specificity.	[Cheng, Jing; Phong, Binh; Kane, Lawrence P.] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15261 USA; [Wilson, David C.; Hirsch, Raphael] Childrens Hosp Pittsburgh, Div Rheumatol, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kane, LP (corresponding author), Univ Pittsburgh, Dept Immunol, Sch Med, BST E-1056, Pittsburgh, PA 15261 USA.	lkane@pitt.edu	Cheng, Jing/AGR-7527-2022	Hirsch, Raphael/0000-0002-7273-8536; Kane, Lawrence/0000-0001-5198-516X	NIGMS National Institutes of Health [GM030398]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080398] Funding Source: NIH RePORTER	NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS National Institutes of Health Grant GM030398 (to L. P. K.).	Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brehm MA, 2007, BLOOD, V109, P819, DOI 10.1182/blood-2006-03-008219; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Changelian PS, 2008, BLOOD, V111, P2155, DOI 10.1182/blood-2007-09-115030; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Clark A, 2000, ARTHRITIS RES, V2, P172, DOI 10.1186/ar83; Clutter SD, 2009, J IMMUNOL, V182, P234, DOI 10.4049/jimmunol.182.1.234; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilot D, 2010, CHEM-BIOL INTERACT, V188, P546, DOI 10.1016/j.cbi.2010.08.011; Gold MR, 2003, TRENDS IMMUNOL, V24, P104, DOI 10.1016/S1471-4906(03)00022-X; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Jones RG, 2005, J IMMUNOL, V175, P3790, DOI 10.4049/jimmunol.175.6.3790; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Killestein J, 2001, NEUROLOGY, V57, P1129, DOI 10.1212/WNL.57.6.1129; Latham KA, 2005, J IMMUNOL, V174, P3978, DOI 10.4049/jimmunol.174.7.3978; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; LoPiccolo J, 2007, ANTI-CANCER DRUG, V18, P861; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Miyamae T, 2006, J IMMUNOL, V177, P4758, DOI 10.4049/jimmunol.177.7.4758; Narayan P, 2006, MOL CELL BIOL, V26, P2327, DOI 10.1128/MCB.26.6.2327-2336.2006; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shen Z, 2002, BIOTECHNIQUES, V32, P1168, DOI 10.2144/02325dd07; Shi N, 2009, MULT SCLER J, V15, P120, DOI 10.1177/1352458508096871; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Thome M, 2007, TRENDS IMMUNOL, V28, P281, DOI 10.1016/j.it.2007.04.004; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; TREDE NS, 1995, J IMMUNOL, V155, P902; Uddin S, 2004, BIOCHEM BIOPH RES CO, V320, P932, DOI 10.1016/j.bbrc.2004.06.038; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319	43	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36076	36085		10.1074/jbc.M111.259549	http://dx.doi.org/10.1074/jbc.M111.259549			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862580	Green Published, hybrid			2022-12-27	WOS:000295927100080
J	Maiti, A; Drohat, AC				Maiti, Atanu; Drohat, Alexander C.			Thymine DNA Glycosylase Can Rapidly Excise 5-Formylcytosine and 5-Carboxylcytosine POTENTIAL IMPLICATIONS FOR ACTIVE DEMETHYLATION OF CpG SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN DNA; TET PROTEINS; 5-METHYLCYTOSINE; REPAIR; DEAMINATION; PRODUCT; 5-FORMYL-2'-DEOXYCYTIDINE; 5-HYDROXYMETHYLCYTOSINE; HYDROXYLATION; CONVERSION	Thymine DNA glycosylase (TDG) excises T from G.T mispairs and is thought to initiate base excision repair (BER) of deaminated 5-methylcytosine (mC). Recent studies show that TDG, including its glycosylase activity, is essential for active DNA demethylation and embryonic development. These and other findings suggest that active demethylation could involve mC deamination by a deaminase, giving a G.T mispair followed by TDG-initiated BER. An alternative proposal is that demethylation could involve iterative oxidation of mC to 5-hydroxymethylcytosine (hmC) and then to 5-formylcytosine (fC) and 5-carboxylcytosine (caC), mediated by a Tet (ten eleven translocation) enzyme, with conversion of caC to C by a putative decarboxylase. Our previous studies suggest that TDG could excise fC and caC from DNA, which could provide another potential demethylation mechanism. We show here that TDG rapidly removes fC, with higher activity than for G.T mispairs, and has substantial caC excision activity, yet it cannot remove hmC. TDG excision of fC and caC, oxidation products of mC, is consistent with its strong specificity for excising bases from a CpG context. Our findings reveal a remarkable new aspect of specificity for TDG, inform its catalytic mechanism, and suggest that TDG could protect against fC-induced mutagenesis. The results also suggest a new potential mechanism for active DNA demethylation, involving TDG excision of Tet-produced fC (or caC) and subsequent BER. Such a mechanism obviates the need for a decarboxylase and is consistent with findings that TDG glycosylase activity is essential for active demethylation and embryonic development, as are mechanisms involving TDG excision of deaminated mC or hmC.	[Maiti, Atanu; Drohat, Alexander C.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Drohat, AC (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	adrohat@som.umaryland.edu	Maiti, Atanu/E-9968-2012	Maiti, Atanu/0000-0002-9080-1025; Drohat, Alex/0000-0002-7458-8770	National Institutes of Health [R01-GM72711]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM72711 (to A.C.D.).	Abu M, 2003, J BIOL CHEM, V278, P8739, DOI 10.1074/jbc.M211084200; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Darwanto A, 2009, J BIOL CHEM, V284, P15835, DOI 10.1074/jbc.M807846200; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fitzgerald ME, 2008, J BIOL CHEM, V283, P32680, DOI 10.1074/jbc.M805504200; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; HANSCH C, 1973, J MED CHEM, V16, P1207, DOI 10.1021/jm00269a003; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kamiya H, 2002, J BIOCHEM, V132, P551, DOI 10.1093/oxfordjournals.jbchem.a003256; Karino N, 2001, NUCLEIC ACIDS RES, V29, P2456, DOI 10.1093/nar/29.12.2456; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; La Francois CJ, 2000, CHEM RES TOXICOL, V13, P462, DOI 10.1021/tx990209u; Leatherbarrow R, 1998, GRAFIT 5 0; Loenarz C, 2009, CHEM BIOL, V16, P580, DOI 10.1016/j.chembiol.2009.06.002; Maiti A, 2008, P NATL ACAD SCI USA, V105, P8890, DOI 10.1073/pnas.0711061105; Maiti A, 2009, J BIOL CHEM, V284, P36680, DOI 10.1074/jbc.M109.062356; Masaoka A, 2003, BIOCHEMISTRY-US, V42, P5003, DOI 10.1021/bi0273213; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Morgan MT, 2007, J BIOL CHEM, V282, P27578, DOI 10.1074/jbc.M704253200; Morgan MT, 2011, NUCLEIC ACIDS RES, V39, P2319, DOI 10.1093/nar/gkq1164; Murata-Kamiya N, 1999, NUCLEIC ACIDS RES, V27, P4385, DOI 10.1093/nar/27.22.4385; Neidigh JW, 2009, CHEM RES TOXICOL, V22, P885, DOI 10.1021/tx8004482; O'Brien PJ, 2004, J BIOL CHEM, V279, P26876, DOI 10.1074/jbc.M403860200; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Privat E, 1996, CHEM RES TOXICOL, V9, P745, DOI 10.1021/tx950182o; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; SIBGHATULLAH GP, 1996, BIOCHEMISTRY-US, V35, P12926; Simmons JM, 2008, DALTON T, P5132, DOI 10.1039/b803512a; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Sumino M, 2008, BIOORG MED CHEM LETT, V18, P274, DOI 10.1016/j.bmcl.2007.10.081; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Wu PY, 2003, J BIOL CHEM, V278, P5285, DOI 10.1074/jbc.M210884200; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950	47	603	634	4	84	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35334	35338		10.1074/jbc.C111.284620	http://dx.doi.org/10.1074/jbc.C111.284620			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862836	hybrid, Green Published			2022-12-27	WOS:000295927100004
J	Guo, J; Wang, TZ; Yang, TH; Xu, JM; Li, WT; Fridman, MD; Fisher, JT; Zhang, ST				Guo, Jun; Wang, Tingzhong; Yang, Tonghua; Xu, Jianmin; Li, Wentao; Fridman, Michael D.; Fisher, John T.; Zhang, Shetuan			Interaction between the Cardiac Rapidly (I-Kr) and Slowly (I-Ks) Activating Delayed Rectifier Potassium Channels Revealed by Low K+-induced hERG Endocytic Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; EXTRACELLULAR K+; CELL-LINES; TRAFFICKING; COMPLEX; REPOLARIZATION; ARRHYTHMIA; CURRENTS; BLOCK; IDENTIFICATION	Cardiac repolarization is controlled by the rapidly (I-Kr) and slowly (I-Ks) activating delayed rectifier potassium channels. The human ether-a-go-go-related gene (hERG) encodes I-Kr, whereas KCNQ1 and KCNE1 together encode I-Ks. Decreases in I-Kr or I-Ks cause long QT syndrome (LQTS), a cardiac disorder with a high risk of sudden death. A reduction in extracellular K+ concentration ([K+](o)) induces LQTS and selectively causes endocytic degradation of mature hERG channels from the plasma membrane. In the present study, we investigated whether I-Ks compensates for the reduced I-Kr under low K+ conditions. Our data show that when hERG and KCNQ1 were expressed separately in human embryonic kidney (HEK) cells, exposure to 0 mM K+ for 6 h completely eliminated the mature hERG channel expression but had no effect on KCNQ1. When hERG and KCNQ1 were co-expressed, KCNQ1 significantly delayed 0 mM K+-induced hERG reduction. Also, hERG degradation led to a significant reduction in KCNQ1 in 0 mM K+ conditions. An interaction between hERG and KCNQ1 was identified in hERG + KCNQ1-expressing HEK cells. Furthermore, KCNQ1 preferentially co-immunoprecipitated with mature hERG channels that are localized in the plasma membrane. Biophysical and pharmacological analyses indicate that although hERG and KCNQ1 closely interact with each other, they form distinct hERG and KCNQ1 channels. These data extend our understanding of delayed rectifier potassium channel trafficking and regulation, as well as the pathology of LQTS.	[Guo, Jun; Wang, Tingzhong; Yang, Tonghua; Xu, Jianmin; Li, Wentao; Fridman, Michael D.; Fisher, John T.; Zhang, Shetuan] Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Physiol, 18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca	Fisher, John/E-2568-2012	Fisher, John/0000-0001-6185-5940; Wang, Tingzhong/0000-0002-6390-7967; Zhang, Shetuan/0000-0002-2297-0193	Heart and Stroke Foundation of Ontario [T 6612]; Canadian Institutes of Health Research [MOP 72911]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Heart and Stroke Foundation of Ontario Grant T 6612 and Canadian Institutes of Health Research Grant MOP 72911 (to S. Z.).	Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Biliczki P, 2002, BRIT J PHARMACOL, V137, P361, DOI 10.1038/sj.bjp.0704881; Biliczki P, 2009, HEART RHYTHM, V6, P1792, DOI 10.1016/j.hrthm.2009.08.009; Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Ehrlich JR, 2004, J BIOL CHEM, V279, P1233, DOI 10.1074/jbc.M309087200; Funck-Brentano C, 1993, AM J CARDIOL, V72, p17B; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hayashi K, 2010, HEART RHYTHM, V7, P973, DOI 10.1016/j.hrthm.2010.03.038; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Massaeli H, 2010, J BIOL CHEM, V285, P27259, DOI 10.1074/jbc.M110.124909; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; MATSUURA H, 1987, PFLUG ARCH EUR J PHY, V410, P596, DOI 10.1007/BF00581319; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; NOBLE D, 1969, J PHYSIOL-LONDON, V200, P205, DOI 10.1113/jphysiol.1969.sp008689; Odening KE, 2008, AM J PHYSIOL-HEART C, V295, pH2264, DOI 10.1152/ajpheart.00680.2008; Osteen JD, 2010, P NATL ACAD SCI USA, V107, P18751, DOI 10.1073/pnas.1014150107; Rajamani S, 2002, CIRCULATION, V105, P2830, DOI 10.1161/01.CIR.0000019513.50928.74; Ren XQ, 2010, AM J PHYSIOL-HEART C, V299, pH1525, DOI 10.1152/ajpheart.00479.2009; Rizzuto R, 2003, NAT GENET, V34, P135, DOI 10.1038/ng0603-135; RODEN DM, 1986, AM HEART J, V111, P1088, DOI 10.1016/0002-8703(86)90010-4; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Varro A, 2000, J PHYSIOL-LONDON, V523, P67, DOI 10.1111/j.1469-7793.2000.00067.x; Zhang ST, 2006, AM J PHYSIOL-HEART C, V290, pH1038, DOI 10.1152/ajpheart.00679.2005; Zhang ST, 1999, CIRC RES, V84, P989, DOI 10.1161/01.RES.84.9.989; Zhang ST, 2001, MOL PHARMACOL, V59, P1069, DOI 10.1124/mol.59.5.1069; Zhou ZF, 1999, J CARDIOVASC ELECTR, V10, P836, DOI 10.1111/j.1540-8167.1999.tb00264.x	36	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34664	34674		10.1074/jbc.M111.253351	http://dx.doi.org/10.1074/jbc.M111.253351			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844197	Green Published, hybrid			2022-12-27	WOS:000295406300021
J	Soshilov, A; Denison, MS				Soshilov, Anatoly; Denison, Michael S.			Ligand Displaces Heat Shock Protein 90 from Overlapping Binding Sites within the Aryl Hydrocarbon Receptor Ligand-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX-LOOP-HELIX; AH RECEPTOR; DIOXIN RECEPTOR; ALPHA-NAPHTHOFLAVONE; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; BREAST-CANCER; HSP90; KINASE; IDENTIFICATION	Hsp90 (heat shock protein of 90 kDa) is often found associated with functional domains of client proteins, including those for ligand binding, dimerization, DNA binding, and enzymatic activity. Although Hsp90 can maintain the conformation of functionally important domains prior to activation of the client protein, its specific binding site and the mechanism(s) of Hsp90 dissociation during activation are unknown. Here, we have identified and characterized residues involved in Hsp90 binding within the aryl hydrocarbon receptor (AhR) ligand-binding domain and demonstrate that they overlap with those involved in ligand binding. In agreement with this spatial model, ligand binding results in Hsp90 dissociation from the AhR Per-ARNT-Sim B fragment. Interestingly, whereas Hsp90-binding residues within the ligand-binding domain were not involved in Hsp90-dependent AhR protein stability, several of these residues are important for ligand-dependent AhR activation, and their mutation resulted in conversion of two AhR antagonists/partial agonists into full AhR agonists. These studies reveal co-localization of a tentative Hsp90-binding site with that for AhR ligand binding and provide the first molecular mechanism for Hsp90 dissociation in the activation of a client protein.	[Soshilov, Anatoly; Denison, Michael S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA	University of California System; University of California Davis	Denison, MS (corresponding author), Univ Calif Davis, Dept Environm Toxicol, Meyer Hall,1 Shields Ave, Davis, CA 95616 USA.	msdenison@ucdavis.edu			National Institutes of Health, NIEHS [R01 ES007685, R01 ES012498]; California Agricultural Experiment Station; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007685, R01ES012498] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); California Agricultural Experiment Station; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES007685 and R01 ES012498 from NIEHS. This work was also supported by the California Agricultural Experiment Station.	ANTONSSON C, 1995, MOL CELL BIOL, V15, P756; Bai ZL, 2009, ARCH PHARM, V342, P133, DOI 10.1002/ardp.200800174; BROWN DJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P217, DOI 10.1006/abbi.1995.1285; CARVER LA, 1994, J BIOL CHEM, V269, P30109; Chen HS, 1997, ARCH BIOCHEM BIOPHYS, V348, P190, DOI 10.1006/abbi.1997.0398; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Clark RD, 2008, CURR TOP MED CHEM, V8, P813, DOI 10.2174/156802608784535011; Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Fukunaga BN, 1996, J BIOL CHEM, V271, P3743; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Ibrahim NO, 2005, CANCER RES, V65, P11094, DOI 10.1158/0008-5472.CAN-05-1877; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Kaul S, 2002, J BIOL CHEM, V277, P36223, DOI 10.1074/jbc.M206748200; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Lees MJ, 1999, MOL CELL BIOL, V19, P5811; LU YF, 1995, ARCH BIOCHEM BIOPHYS, V316, P470, DOI 10.1006/abbi.1995.1062; MERCHANT M, 1990, ARCH BIOCHEM BIOPHYS, V281, P84, DOI 10.1016/0003-9861(90)90416-V; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Pandini A, 2007, BIOCHEMISTRY-US, V46, P696, DOI 10.1021/bi061460t; Pandini A, 2009, BIOCHEMISTRY-US, V48, P5972, DOI 10.1021/bi900259z; Papapetropoulos A, 2005, MOL PHARMACOL, V68, P1133, DOI 10.1124/mol.105.012682; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Perdew GH, 1996, BIOCHEM MOL BIOL INT, V39, P589; Phelan DM, 1998, ARCH BIOCHEM BIOPHYS, V353, P47, DOI 10.1006/abbi.1997.0614; POLAND A, 1994, MOL PHARMACOL, V46, P915; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; Prince T, 2005, BIOCHEMISTRY-US, V44, P15287, DOI 10.1021/bi051423m; PROBST MR, 1993, MOL PHARMACOL, V44, P511; Rushing SR, 2002, ARCH BIOCHEM BIOPHYS, V403, P189, DOI 10.1016/S0003-9861(02)00233-3; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Scroggins BT, 2003, BIOCHEMISTRY-US, V42, P12550, DOI 10.1021/bi035001t; Simizu S, 2000, NAT CELL BIOL, V2, P852, DOI 10.1038/35041102; Soshilov A, 2008, J BIOL CHEM, V283, P32995, DOI 10.1074/jbc.M802414200; WHITELAW ML, 1995, P NATL ACAD SCI USA, V92, P4437, DOI 10.1073/pnas.92.10.4437; WILHELMSSON A, 1994, J BIOL CHEM, V269, P19028; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Zhou JG, 2003, ARCH BIOCHEM BIOPHYS, V416, P68, DOI 10.1016/S0003-9861(03)00274-1	41	34	36	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35275	35282		10.1074/jbc.M111.246439	http://dx.doi.org/10.1074/jbc.M111.246439			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21856752	Green Published, hybrid			2022-12-27	WOS:000295406300080
J	Appleby-Tagoe, JH; Thiel, IV; Wang, Y; Wang, YF; Mootz, HD; Liu, XQ				Appleby-Tagoe, Julia H.; Thiel, Ilka V.; Wang, Yi; Wang, Yanfei; Mootz, Henning D.; Liu, Xiang-Qin			Highly Efficient and More General cis- and trans-Splicing Inteins through Sequential Directed Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEMISYNTHETIC SPLIT INTEIN; PROTEIN LIGATION; IN-VIVO; CRYSTAL-STRUCTURE; MINI-INTEIN; DNAE INTEIN; CYCLIZATION; MODULATION; SELECTION; ELEMENTS	Inteins are internal protein sequences that post-translationally self-excise and splice together the flanking sequences, the so-called exteins. Natural and engineered inteins have been used in many practical applications. However, inteins are often inefficient or inactive when placed in a non-native host protein and may require the presence of several amino acid residues of the native exteins, which will then remain as a potential scar in the spliced protein. Thus, more general inteins that overcome these limitations are highly desirable. Here we report sequential directed evolution as a new approach to produce inteins with such properties. Random mutants of the Ssp (Synechocystis sp. PCC6803) DnaB mini-intein were inserted into the protein conferring kanamycin resistance at a site where the parent intein was inactive for splicing. The mutants selected for splicing activity were further improved by iterating the procedure for two more cycles at different positions in the same protein. The resulting improved inteins showed high activity in the positions of the first rounds of selection, in multiple new insertion sites, and in different proteins. One of these inteins, the M86 mutant, which accumulated 8 amino acid substitutions, was also biochemically characterized in an artificially split form with a chemically synthesized N-terminal intein fragment consisting of 11 amino acids. When compared with the unevolved split intein, it exhibited an similar to 60-fold increased rate in the protein trans-splicing reaction and a K-d value for the interaction of the split intein fragments improved by an order of magnitude. Implications on the intein structure-function, practical application, and evolution are discussed.	[Thiel, Ilka V.; Mootz, Henning D.] Univ Munster, Inst Biochem, D-48149 Munster, Germany; [Appleby-Tagoe, Julia H.; Wang, Yi; Wang, Yanfei; Liu, Xiang-Qin] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada	University of Munster; Dalhousie University	Mootz, HD (corresponding author), Univ Munster, Inst Biochem, Wilhelm Klemm Str 2, D-48149 Munster, Germany.	henning.mootz@uni-muenster.de; Paul.Liu@Dal.Ca			National Science and Engineering Research Council (NSERC) of Canada; Canadian Institutes of Health Research (CIHR); Deutsche Forschungsgemeinschaft (DFG) [MO1073/3-1]; German National Merit Foundation	National Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German National Merit Foundation	This work was supported by grants from the National Science and Engineering Research Council (NSERC) of Canada, the Canadian Institutes of Health Research (CIHR), the Deutsche Forschungsgemeinschaft (DFG Grant MO1073/3-1), and a Ph.D. stipend from the German National Merit Foundation (to I. V. T.).	Adam E, 2002, J MOL MICROB BIOTECH, V4, P479; Amitai G, 2009, P NATL ACAD SCI USA, V106, P11005, DOI 10.1073/pnas.0904366106; Binschik J, 2011, ANGEW CHEM INT EDIT, V50, P3249, DOI 10.1002/anie.201007078; Busche AEL, 2009, ANGEW CHEM INT EDIT, V48, P6128, DOI 10.1002/anie.200901488; Buskirk AR, 2004, P NATL ACAD SCI USA, V101, P10505, DOI 10.1073/pnas.0402762101; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Garbe D, 2010, J PEPT SCI, V16, P575, DOI 10.1002/psc.1243; Hiraga K, 2005, J MOL BIOL, V354, P916, DOI 10.1016/j.jmb.2005.09.088; Hiraga K, 2009, J MOL BIOL, V393, P1106, DOI 10.1016/j.jmb.2009.08.074; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Iwai H, 1999, FEBS LETT, V459, P166, DOI 10.1016/S0014-5793(99)01220-X; Li J, 2008, HUM GENE THER, V19, P958, DOI 10.1089/hum.2008.009; Liu XQ, 2000, ANNU REV GENET, V34, P61, DOI 10.1146/annurev.genet.34.1.61; Lockless SW, 2009, P NATL ACAD SCI USA, V106, P10999, DOI 10.1073/pnas.0902964106; Ludwig C, 2008, J BIOL CHEM, V283, P25264, DOI 10.1074/jbc.M802972200; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Mathys S, 1999, GENE, V231, P1, DOI 10.1016/S0378-1119(99)00103-1; Mootz HD, 2003, J AM CHEM SOC, V125, P10561, DOI 10.1021/ja0362813; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Ozawa T, 2003, NAT BIOTECHNOL, V21, P287, DOI 10.1038/nbt791; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Peck SH, 2011, CHEM BIOL, V18, P619, DOI 10.1016/j.chembiol.2011.02.014; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; Saleh L, 2006, CHEM REC, V6, P183, DOI 10.1002/tcr.20082; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Sonntag T, 2011, MOL BIOSYST, V7, P2031, DOI 10.1039/c1mb05025g; Sun L, 2001, APPL ENVIRON MICROB, V67, P1025, DOI 10.1128/AEM.67.3.1025-1029.2001; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x; Yang JJ, 2003, P NATL ACAD SCI USA, V100, P3513, DOI 10.1073/pnas.0635899100; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979	42	74	79	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34440	34447		10.1074/jbc.M111.277350	http://dx.doi.org/10.1074/jbc.M111.277350			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832069	hybrid, Green Published			2022-12-27	WOS:000295159200071
J	Baskaran, S; Chikwana, VM; Contreras, CJ; Davis, KD; Wilson, WA; DePaoli-Roach, AA; Roach, PJ; Hurley, TD				Baskaran, Sulochanadevi; Chikwana, Vimbai M.; Contreras, Christopher J.; Davis, Keri D.; Wilson, Wayne A.; DePaoli-Roach, Anna A.; Roach, Peter J.; Hurley, Thomas D.			Multiple Glycogen-binding Sites in Eukaryotic Glycogen Synthase Are Required for High Catalytic Efficiency toward Glycogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; SUBCELLULAR-LOCALIZATION; LAFORA-DISEASE; DOMAIN; GLUCOSE-6-PHOSPHATE; IDENTIFICATION; ACCUMULATION; PHOSPHATASE	Glycogen synthase is a rate-limiting enzyme in the biosynthesis of glycogen and has an essential role in glucose homeostasis. The three-dimensional structures of yeast glycogen synthase (Gsy2p) complexed with maltooctaose identified four conserved maltodextrin-binding sites distributed across the surface of the enzyme. Site-1 is positioned on the N-terminal domain, site-2 and site-3 are present on the C-terminal domain, and site-4 is located in an interdomain cleft adjacent to the active site. Mutation of these surface sites decreased glycogen binding and catalytic efficiency toward glycogen. Mutations within site-1 and site-2 reduced the V-max/S-0.5 for glycogen by 40- and 70-fold, respectively. Combined mutation of site-1 and site-2 decreased the Vmax/S0.5 for glycogen by> 3000-fold. Consistent with the in vitro data, glycogen accumulation in glycogen synthase-deficient yeast cells (Delta gsy1-gsy2) transformed with the site-1, site-2, combined site-1/site-2, or site-4 mutant form of Gsy2p was decreased by up to 40-fold. In contrast to the glycogen results, the ability to utilize maltooctaose as an in vitro substrate was unaffected in the site-2 mutant, moderately affected in the site-1 mutant, and almost completely abolished in the site-4 mutant. These data show that the ability to utilize maltooctaose as a substrate can be independent of the ability to utilize glycogen. Our data support the hypothesis that site-1 and site-2 provide a "toehold mechanism," keeping glycogen synthase tightly associated with the glycogen particle, whereas site-4 is more closely associated with positioning of the nonreducing end during catalysis.	[Baskaran, Sulochanadevi; Chikwana, Vimbai M.; Contreras, Christopher J.; DePaoli-Roach, Anna A.; Roach, Peter J.; Hurley, Thomas D.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Davis, Keri D.; Wilson, Wayne A.] Des Moines Univ, Dept Biochem & Nutr, Des Moines, IA 50312 USA	Indiana University System; Indiana University Bloomington	Hurley, TD (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr,MS-4019, Indianapolis, IN 46202 USA.	thurley@iupui.edu		Wilson, Wayne/0000-0003-2417-5756; HURLEY, THOMAS/0000-0002-5942-1163	United States Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Institutes of Health [R37-DK027221, R01-NS056454, R01-DK079887, R15-GM081810]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079887, T32DK064466, R37DK027221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM081810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056454] Funding Source: NIH RePORTER	United States Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Martin Schmidt (Des Moines University) for providing the anti-yeast Hsp90 polyclonal antibody. We thank the staff of the General Medical Sciences Cancer Institute Collaborative Access Team at the Advanced Photon Source at the Argonne National Laboratory. The Argonne National Laboratory is operated by the UChicago Argonne, LLC, for the United States Department of Energy Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.; This work was supported, in whole or in part, by National Institutes of Health Grants R37-DK027221 and R01-NS056454 (to P. J. R.), R01-DK079887 (to T. D. H.), and R15-GM081810 (to W. A. W.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Baskaran S, 2010, P NATL ACAD SCI USA, V107, P17563, DOI 10.1073/pnas.1006340107; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Christiansen C, 2009, FEBS J, V276, P5006, DOI 10.1111/j.1742-4658.2009.07221.x; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; Diaz A, 2011, J BIOL CHEM, V286, P18505, DOI 10.1074/jbc.M111.236109; FARKAS I, 1991, J BIOL CHEM, V266, P15602; Hanashiro I, 2002, ARCH BIOCHEM BIOPHYS, V397, P286, DOI 10.1006/abbi.2001.2623; HARDY TA, 1994, J BIOL CHEM, V269, P27907; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Jiang SX, 2010, J BIOL CHEM, V285, P34960, DOI 10.1074/jbc.M110.150839; JOHNSON LN, 1990, J MOL BIOL, V211, P645, DOI 10.1016/0022-2836(90)90271-M; LARNER J, 1976, MOL CELL BIOCHEM, V12, P131, DOI 10.1007/BF01741711; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pederson BA, 2000, J BIOL CHEM, V275, P27753; PENG ZY, 1990, J BIOL CHEM, V265, P13871; Sheng F, 2009, BIOCHEMISTRY-US, V48, P10089, DOI 10.1021/bi900916t; SIKORSKI RS, 1989, GENETICS, V122, P19; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Weinstein DA, 2006, MOL GENET METAB, V87, P284, DOI 10.1016/j.ymgme.2005.10.006; Wilson WA, 2010, CAN J MICROBIOL, V56, P408, DOI [10.1139/W10-027, 10.1139/w10-027]	30	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33999	34006		10.1074/jbc.M111.264531	http://dx.doi.org/10.1074/jbc.M111.264531			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21835915	Green Published, hybrid			2022-12-27	WOS:000295159200032
J	Li, CH; Li, M; Chen, P; Narayan, S; Matschinsky, FM; Bennett, MJ; Stanley, CA; Smith, TJ				Li, Changhong; Li, Ming; Chen, Pan; Narayan, Srinivas; Matschinsky, Franz M.; Bennett, Michael J.; Stanley, Charles A.; Smith, Thomas J.			Green Tea Polyphenols Control Dysregulated Glutamate Dehydrogenase in Transgenic Mice by Hijacking the ADP Activation Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; REGULATORY MUTATIONS; ACTIVE-SITE; MECHANISM; (-)-EPIGALLOCATECHIN-3-GALLATE; HYPERINSULINISM; CRYSTALLOGRAPHY; CELLS; HYPERAMMONEMIA; METABOLISM	Glutamate dehydrogenase (GDH) catalyzes the oxidative deamination of L-glutamate and, in animals, is extensively regulated by a number of metabolites. Gain of function mutations in GDH that abrogate GTP inhibition cause the hyperinsulinism/hyperammonemia syndrome (HHS), resulting in increased pancreatic beta-cell responsiveness to leucine and susceptibility to hypoglycemia following high protein meals. We have previously shown that two of the polyphenols from green tea (epigallocatechin gallate (EGCG) and epicatechin gallate (ECG)) inhibit GDH in vitro and that EGCG blocks GDH-mediated insulin secretion in wild type rat islets. Using structural and site-directed mutagenesis studies, we demonstrate that ECG binds to the same site as the allosteric regulator, ADP. Perifusion assays using pancreatic islets from transgenic mice expressing a human HHS form of GDH demonstrate that the hyperresponse to glutamine caused by dysregulated GDH is blocked by the addition of EGCG. As observed in HHS patients, these transgenic mice are hypersensitive to amino acid feeding, and this is abrogated by oral administration of EGCG prior to challenge. Finally, the low basal blood glucose level in the HHS mouse model is improved upon chronic administration of EGCG. These results suggest that this common natural product or some derivative thereof may prove useful in controlling this genetic disorder. Of broader clinical implication is that other groups have shown that restriction of glutamine catabolism via these GDH inhibitors can be useful in treating various tumors. This HHS transgenic mouse model offers a highly useful means to test these agents in vivo.	[Li, Ming; Smith, Thomas J.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Li, Changhong; Chen, Pan; Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol, Philadelphia, PA 19104 USA; [Narayan, Srinivas; Bennett, Michael J.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Matschinsky, Franz M.] Univ Penn, Diabet Res Ctr, Philadelphia, PA 19104 USA; Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Donald Danforth Plant Science Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Smith, TJ (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	tsmith@danforthcenter.org	Smith, Thomas J/K-9086-2013	Smith, Thomas J/0000-0003-3528-6793; STANLEY, CHARLES/0000-0003-4881-9392	National Institutes of Health [DK072171, DK53012, DK19525]; American Diabetes Association [1-05-RA-128]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, R01DK072171, R01DK053012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK072171 (to T. J. S.), DK53012 (to C. A. S.), and DK19525 (for the islet biology and radioimmunoassay cores). This work was also supported by American Diabetes Association Research Award 1-05-RA-128 (to C. A. S.).	Allen A, 2004, BIOCHEMISTRY-US, V43, P14431, DOI 10.1021/bi048817i; Bahi-Buisson N, 2008, DEV MED CHILD NEUROL, V50, P945, DOI 10.1111/j.1469-8749.2008.03114.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER PJ, 1992, PROTEINS, V12, P75, DOI 10.1002/prot.340120109; Banerjee S, 2003, BIOCHEMISTRY-US, V42, P3446, DOI 10.1021/bi0206917; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; DEAN JLE, 1994, BIOCHEM J, V301, P13, DOI 10.1042/bj3010013; Di Gangi IM, 2010, ANAL CHIM ACTA, V677, P140, DOI 10.1016/j.aca.2010.08.011; EARHART RH, 1990, INVEST NEW DRUG, V8, P113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAHIEN LA, 1981, ARCH BIOCHEM BIOPHYS, V212, P247, DOI 10.1016/0003-9861(81)90364-7; Fang J, 2002, BIOCHEM J, V363, P81, DOI 10.1042/0264-6021:3630081; Feng WY, 2006, CURR DRUG METAB, V7, P755, DOI 10.2174/138920006778520552; FRIEDEN C, 1965, J BIOL CHEM, V240, P2028; FRIEDEN C, 1963, BIOCHEM BIOPH RES CO, V10, P410, DOI 10.1016/0006-291X(63)90547-3; GEORGE A, 1980, BIOCHEMISTRY-US, V19, P6057, DOI 10.1021/bi00567a017; Hong J, 2002, CANCER RES, V62, P7241; Hou Z, 2005, CANCER RES, V65, P8049, DOI 10.1158/0008-5472.CAN-05-0480; Hsu BYL, 2001, J PEDIATR-US, V138, P383, DOI 10.1067/mpd.2001.111818; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; IWATSUBO M, 1967, B SOC CHIM BIOL, V49, P1563; Katpally U, 2007, J VIROL, V81, P6307, DOI 10.1128/JVI.00441-07; KOBERSTEIN R, 1973, EUR J BIOCHEM, V36, P545, DOI 10.1111/j.1432-1033.1973.tb02942.x; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Li CH, 2004, J BIOL CHEM, V279, P13393, DOI 10.1074/jbc.M311502200; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; Li CH, 2006, J BIOL CHEM, V281, P15064, DOI 10.1074/jbc.M600994200; Li CH, 2010, J BIOL CHEM, V285, P31806, DOI 10.1074/jbc.M110.123638; Li M, 2007, BIOCHEMISTRY-US, V46, P15089, DOI 10.1021/bi7018783; Li M, 2009, J BIOL CHEM, V284, P22988, DOI 10.1074/jbc.M109.020222; Mochizuki M, 2002, BBA-GEN SUBJECTS, V1569, P35, DOI 10.1016/S0304-4165(01)00230-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peterson PE, 1999, STRUCTURE, V7, P769, DOI 10.1016/S0969-2126(99)80101-4; Sang SM, 2005, J AGR FOOD CHEM, V53, P9478, DOI 10.1021/jf0519055; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Smith CA, 1996, ACTA CRYSTALLOGR A, V52, pC226, DOI 10.1107/S0108767396090319; Smith TJ, 2011, EXPERT OPIN DRUG DIS, V6, P589, DOI 10.1517/17460441.2011.570750; Smith TJ, 2008, TRENDS BIOCHEM SCI, V33, P557, DOI 10.1016/j.tibs.2008.07.007; Smith TJ, 1999, ADV VIRUS RES, V52, P1, DOI 10.1016/S0065-3527(08)60297-3; Smith TJ, 2002, J MOL BIOL, V318, P765, DOI 10.1016/S0022-2836(02)00161-4; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; SMITH TJ, 1986, SCIENCE, V233, P1286, DOI 10.1126/science.3018924; Stanley C A, 1976, Adv Pediatr, V23, P315; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; YIELDING KL, 1961, P NATL ACAD SCI USA, V47, P983, DOI 10.1073/pnas.47.7.983	49	53	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34164	34174		10.1074/jbc.M111.268599	http://dx.doi.org/10.1074/jbc.M111.268599			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21813650	Green Published, hybrid			2022-12-27	WOS:000295159200047
J	Motani, K; Kushiyama, H; Imamura, R; Kinoshita, T; Nishiuchi, T; Suda, T				Motani, Kou; Kushiyama, Hiroko; Imamura, Ryu; Kinoshita, Takeshi; Nishiuchi, Takumi; Suda, Takashi			Caspase-1 Protein Induces Apoptosis-associated Speck-like Protein Containing a Caspase Recruitment Domain (ASC)mediated Necrosis Independently of Its Catalytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CELL-DEATH; LISTERIA-MONOCYTOGENES; MONOCYTIC CELLS; CATHEPSIN-B; ASC; INFLAMMASOME; ACTIVATION; ADAPTER; IDENTIFICATION; MACROPHAGES	The adaptor protein, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), connects pathogen/danger sensors such as NLRP3 and NLRC4 with caspases and is involved in inflammation and cell death. We have found that ASC activation induced caspase-8-dependent apoptosis or CA-074Me (cathepsin B inhibitor)-inhibitable necrosis depending on the cell type. Unlike necroptosis, another necrotic cell death, ASC-mediated necrosis, was neither RIP3-dependent nor necrostatin-1-inhibitable. Although acetyl-YVAD-chloromethylketone (Ac-YVAD-CMK) (caspase-1 inhibitor) did not inhibit ASC-mediated necrosis, comprehensive gene expression analyses indicated that caspase-1 expression coincided with the necrosis type. Furthermore, caspase-1 knockdown converted necrosis-type cells to apoptosis-type cells, whereas exogenous expression of either wild-type or catalytically inactive caspase-1 did the opposite. Knockdown of caspase-1, but not Ac-YVAD-CMK, suppressed the monocyte necrosis induced by Staphylococcus and Pseudomonas infection. Thus, the catalytic activity of caspase-1 is dispensable for necrosis induction. Intriguingly, a short period of caspase-1 knockdown inhibited IL-1 beta production but not necrosis, although longer knockdown suppressed both responses. Possible explanations of this phenomenon are discussed.	[Motani, Kou; Kushiyama, Hiroko; Imamura, Ryu; Kinoshita, Takeshi; Suda, Takashi] Kanazawa Univ, Div Immunol & Mol Biol, Canc Res Inst, Kanazawa, Ishikawa 9201192, Japan; [Nishiuchi, Takumi] Kanazawa Univ, Adv Sci Res Ctr, Div Funct Genom, Kanazawa, Ishikawa 9200934, Japan	Kanazawa University; Kanazawa University	Suda, T (corresponding author), Kanazawa Univ, Div Immunol & Mol Biol, Canc Res Inst, Kakumamachi, Kanazawa, Ishikawa 9201192, Japan.	sudat@kenroku.kanazawa-u.ac.jp	IMAMURA, Ryu/D-8433-2015; KINOSHITA, Takeshi/D-8436-2015; Nishiuchi, Takumi/F-1708-2013	Nishiuchi, Takumi/0000-0001-9429-5396	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research on priority areas (cancer) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Averette KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007913; Barlan AU, 2011, J VIROL, V85, P146, DOI 10.1128/JVI.01265-10; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Cervantes J, 2008, CELL MICROBIOL, V10, P41, DOI 10.1111/j.1462-5822.2007.01012.x; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Conway KE, 2000, CANCER RES, V60, P6236; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fujisawa A, 2007, BLOOD, V109, P2903, DOI 10.1182/blood-2006-07-033597; Fukui M, 2003, J IMMUNOL, V171, P1868, DOI 10.4049/jimmunol.171.4.1868; Hasegawa M, 2007, ONCOGENE, V26, P1748, DOI 10.1038/sj.onc.1209965; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; Hasegawa M, 2009, J IMMUNOL, V182, P7655, DOI 10.4049/jimmunol.0800448; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hoffman HM, 2010, CURR ALLERGY ASTHM R, V10, P229, DOI 10.1007/s11882-010-0109-z; Imamura R, 2010, J IMMUNOL, V184, P5874, DOI 10.4049/jimmunol.0900779; Kelk P, 2003, INFECT IMMUN, V71, P4448, DOI 10.1128/IAI.71.8.4448-4455.2003; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; McIlroy D, 1999, ONCOGENE, V18, P4401, DOI 10.1038/sj.onc.1202868; Motani K, 2010, CANCER SCI, V101, P1822, DOI 10.1111/j.1349-7006.2010.01610.x; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Wang YT, 2004, INT IMMUNOL, V16, P777, DOI 10.1093/intimm/dxh081; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	40	43	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33963	33972		10.1074/jbc.M111.286823	http://dx.doi.org/10.1074/jbc.M111.286823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832064	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000295159200028
J	Richter, D; Katz, B; Oberacker, T; Tzarfaty, V; Belusic, G; Minke, B; Huber, A				Richter, David; Katz, Ben; Oberacker, Tina; Tzarfaty, Vered; Belusic, Gregor; Minke, Baruch; Huber, Armin			Translocation of the Drosophila Transient Receptor Potential-like (TRPL) Channel Requires Both the N- and C-terminal Regions Together with Sustained Ca2+ Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR TRANSLOCATION; LIGHT RESPONSE; ACTIVATION; PHOTORECEPTORS; TRAFFICKING; ADAPTATION; CALCIUM; PATHWAY; INSULIN; PROTEIN	In Drosophila photoreceptors the transient receptor potential-like (TRPL), but not the TRP channels undergo light-dependent translocation between the rhabdomere and cell body. Here we studied which of the TRPL channel segments are essential for translocation and why the TRP channels are required for inducing TRPL translocation. We generated transgenic flies expressing chimeric TRP and TRPL proteins that formed functional light-activated channels. Translocation was induced only in chimera containing both the N- and C-terminal segments of TRPL. Using an inactive trp mutation and overexpressing the Na+/Ca2+ exchanger revealed that the essential function of the TRP channels in TRPL translocation is to enhance Ca2+-influx. These results indicate that motifs present at both the N and C termini as well as sustained Ca2+ entry are required for proper channel translocation.	[Richter, David; Oberacker, Tina; Huber, Armin] Univ Hohenheim, Dept Biosensor, Inst Physiol, D-70599 Stuttgart, Germany; [Katz, Ben; Tzarfaty, Vered; Minke, Baruch] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Med Neurobiol, IL-91120 Jerusalem, Israel; [Katz, Ben; Tzarfaty, Vered; Minke, Baruch] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuhne Minerva Ctr Studies Visual Transduct, IL-91120 Jerusalem, Israel; [Belusic, Gregor] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana 1000, Slovenia	University Hohenheim; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Ljubljana	Huber, A (corresponding author), Univ Hohenheim, Dept Biosensor, Inst Physiol, August von Hartmann Str 3, D-70599 Stuttgart, Germany.	Armin.Huber@uni-hohenheim.de	Huber, Armin/GYU-6322-2022	Belusic, Gregor/0000-0003-3571-1948; Huber, Armin/0000-0003-3977-089X	National Institutes of Health [EY 03529]; Deutsche Forschungsgemeinschaft [Hu 839/2-5]; German-Israeli Foundation for Scientific Research and Development [I-1001-96.13/2008]; Israel Science Foundation (ISF); NATIONAL EYE INSTITUTE [R01EY003529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation (ISF)(Israel Science Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by grants from the National Institutes of Health (EY 03529) (to B. M.), Deutsche Forschungsgemeinschaft (Hu 839/2-5) (to A. H.), the German-Israeli Foundation for Scientific Research and Development (I-1001-96.13/2008) (to B. M. and A. H.), and the Israel Science Foundation (ISF) (to B. M.).	Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; Becker D, 2008, MOL MEMBR BIOL, V25, P139, DOI 10.1080/09687680701635237; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Boels K, 2001, J CELL SCI, V114, P3599; Cerny AC, 2011, ADV EXP MED BIOL, V704, P545, DOI 10.1007/978-94-007-0265-3_30; Chorna-Ornan I, 2005, J CELL BIOL, V171, P143, DOI 10.1083/jcb.200503014; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cronin MA, 2006, J CELL SCI, V119, P2935, DOI 10.1242/jcs.03049; Deen PMT, 1997, J AM SOC NEPHROL, V8, P1493; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Huber A., 2004, INVERTEBRATE PHOTOTR; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Katsura T, 1997, AM J PHYSIOL-RENAL, V272, pF816; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Lambers TT, 2007, MOL CELL BIOL, V27, P1486, DOI 10.1128/MCB.01468-06; Meyer NE, 2008, FLY, V2, P36, DOI 10.4161/fly.5773; Meyer NE, 2006, J CELL SCI, V119, P2592, DOI 10.1242/jcs.02986; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Oberegelsbacher C, 2011, EUR J CELL BIOL, V90, P620, DOI 10.1016/j.ejcb.2011.02.003; OTOUSA JE, 1992, VISUAL NEUROSCI, V8, P385, DOI 10.1017/S0952523800004910; Pak W. L., 1979, NEUROGENETICS GENETI; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; PERETZ A, 1994, J GEN PHYSIOL, V104, P1057, DOI 10.1085/jgp.104.6.1057; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Toro CA, 2011, CURR PHARM BIOTECHNO, V12, P12; van Balkom BWM, 2004, AM J PHYSIOL-CELL PH, V286, pC372, DOI 10.1152/ajpcell.00271.2003; Van Buren JJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-17; Wang T, 2005, J CELL BIOL, V171, P685, DOI 10.1083/jcb.200508030; Wang T, 2005, NEURON, V45, P367, DOI 10.1016/j.neuron.2004.12.046; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	46	15	15	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34234	34243		10.1074/jbc.M111.278564	http://dx.doi.org/10.1074/jbc.M111.278564			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21816824	hybrid, Green Published			2022-12-27	WOS:000295159200053
J	Spratley, SJ; Bastea, LI; Doppler, H; Mizuno, K; Storz, P				Spratley, Samantha J.; Bastea, Ligia I.; Doeppler, Heike; Mizuno, Kensaku; Storz, Peter			Protein Kinase D Regulates Cofilin Activity through p21-activated Kinase 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELL-MIGRATION; LIM-KINASE; ACTIN REORGANIZATION; PHOSPHATASE SLINGSHOT; LEADING-EDGE; PHOSPHORYLATION; ACTIVATION; INVASION; MOTILITY; DYNAMICS	Dynamic reorganization of the actin cytoskeleton at the leading edge is required for directed cell migration. Cofilin, a small actin-binding protein with F-actin severing activities, is a key enzyme initiating such actin remodeling processes. Cofilin activity is tightly regulated by phosphorylation and dephosphorylation events that are mediated by LIM kinase (LIMK) and the phosphatase slingshot (SSH), respectively. Protein kinase D (PKD) is a serine/threonine kinase that inhibits actin-driven directed cell migration by phosphorylation and inactivation of SSH. Here, we show that PKD can also regulate LIMK through direct phosphorylation and activation of its upstream kinase p21-activated kinase 4 (PAK4). Therefore, active PKD increases the net amount of phosphorylated inactive cofilin in cells through both pathways. The regulation of cofilin activity at multiple levels may explain the inhibitory effects of PKD on barbed end formation as well as on directed cell migration.	[Spratley, Samantha J.; Bastea, Ligia I.; Doeppler, Heike; Storz, Peter] Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Jacksonville, FL 32224 USA; [Mizuno, Kensaku] Tohoku Univ, Dept Biomol Sci, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan	Mayo Clinic; Tohoku University	Storz, P (corresponding author), Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Griffin Rm 306,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu	Mizuno, Kensaku/G-8631-2015		National Institutes of Health [GM086438, CA140182]; Florida Department of Health [10BG11]; Ministry of Education, Culture, Science, Sports, and Technology of Japan [21370086, 22121501]; NATIONAL CANCER INSTITUTE [R01CA140182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants GM086438 and CA140182 (to P. S.). This work was also supported by Bankhead-Coley Grant 10BG11 from the Florida Department of Health (to P. S.) and by Ministry of Education, Culture, Science, Sports, and Technology of Japan Grants 21370086 and 22121501 (to K. M.).	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Callow MG, 2002, J BIOL CHEM, V277, P550, DOI 10.1074/jbc.M105732200; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Dan C, 2001, J BIOL CHEM, V276, P32115, DOI 10.1074/jbc.M100871200; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Eswaran J, 2009, CANCER METAST REV, V28, P209, DOI 10.1007/s10555-008-9181-4; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Ikebe C, 1997, GENOMICS, V46, P504, DOI 10.1006/geno.1997.5060; Jaggi M, 2005, CANCER RES, V65, P483; Janssens K, 2009, CELL SIGNAL, V21, P282, DOI 10.1016/j.cellsig.2008.10.012; Kim M, 2008, CARCINOGENESIS, V29, P629, DOI 10.1093/carcin/bgm291; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MIZUNO K, 1994, ONCOGENE, V9, P1605; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Riol-Blanco L, 2004, EUR J IMMUNOL, V34, P108, DOI 10.1002/eji.200324640; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Sinha P, 1999, ELECTROPHORESIS, V20, P2952, DOI 10.1002/(SICI)1522-2683(19991001)20:14<2952::AID-ELPS2952>3.0.CO;2-H; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Storz P, 2003, J BIOL CHEM, V278, P17969, DOI 10.1074/jbc.M213224200; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; von Blume J, 2007, EMBO J, V26, P4619, DOI 10.1038/sj.emboj.7601891; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Ziegler S, 2011, MOL BIOL CELL, V22, P570, DOI 10.1091/mbc.E10-05-0427	47	58	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34254	34261		10.1074/jbc.M111.259424	http://dx.doi.org/10.1074/jbc.M111.259424			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832093	hybrid, Green Published			2022-12-27	WOS:000295159200055
J	Sun, Z; Singh, N; Mullican, SE; Everett, LJ; Li, L; Yuan, LJ; Liu, X; Epstein, JA; Lazar, MA				Sun, Zheng; Singh, Nikhil; Mullican, Shannon E.; Everett, Logan J.; Li, Li; Yuan, Lijun; Liu, Xi; Epstein, Jonathan A.; Lazar, Mitchell A.			Diet-induced Lethality Due to Deletion of the Hdac3 Gene in Heart and Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; FATTY-ACID OXIDATION; ERR-ALPHA; OBESITY CARDIOMYOPATHY; COREPRESSOR COMPLEX; DIABETIC HEART; CARDIAC-MUSCLE; RECEPTOR; METABOLISM	Many human diseases result from the influence of the nutritional environment on gene expression. The environment interacts with the genome by altering the epigenome, including covalent modification of nucleosomal histones. Here, we report a novel and dramatic influence of diet on the phenotype and survival of mice in which histone deacetylase 3 (Hdac3) is deleted postnatally in heart and skeletal muscle. Although embryonic deletion of myocardial Hdac3 causes major cardiomyopathy that reduces survival, we found that excision of Hdac3 in heart and muscle later in development leads to a much milder phenotype and does not reduce survival when mice are fed normal chow. Remarkably, upon switching to a high fat diet, the mice begin to die within weeks and display signs of severe hypertrophic cardiomyopathy and heart failure. Down-regulation of myocardial mitochondrial bioenergetic genes, specifically those involved in lipid metabolism, precedes the full development of cardiomyopathy, suggesting that HDAC3 is important in maintaining proper mitochondrial function. These data suggest that loss of the epigenomic modifier HDAC3 causes dietary lethality by compromising the ability of cardiac mitochondria to respond to changes of nutritional environment. In addition, this study provides a mouse model for diet-inducible heart failure.	[Sun, Zheng; Mullican, Shannon E.; Everett, Logan J.; Lazar, Mitchell A.] Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Sun, Zheng; Mullican, Shannon E.; Everett, Logan J.; Lazar, Mitchell A.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Sun, Zheng; Mullican, Shannon E.; Everett, Logan J.; Lazar, Mitchell A.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Singh, Nikhil; Li, Li; Yuan, Lijun; Liu, Xi; Epstein, Jonathan A.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Singh, Nikhil; Li, Li; Yuan, Lijun; Liu, Xi; Epstein, Jonathan A.] Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Lazar, MA (corresponding author), 3400 Civ Ctr Blvd,12-102 TRC, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Everett, Logan/AAK-1523-2021; Lazar, Mitchell A/AAF-3738-2019; Sun, Zheng/C-1146-2012; singh, Nikhil/AAX-5380-2020	Sun, Zheng/0000-0002-6858-0633; Epstein, Jonathan/0000-0001-8637-4465; Singh, Nikhil/0000-0002-5269-8469	National Institutes of Health [DK43806, R01 HL071546]; Cox Institute for Medical Research; Medical Scientist Training Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043806, R37DK043806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cox Institute for Medical Research; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43806 (to M. A. L.) and R01 HL071546 (to J. A. E.). This work was also supported by the Cox Institute for Medical Research (to M. A. L.) and a Medical Scientist Training Program grant (to N. S.).	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Alpert MA, 2001, AM J MED SCI, V321, P225, DOI 10.1097/00000441-200104000-00003; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Carafa V, 2011, RECENT PAT ANTI-CANC, V6, P131, DOI 10.2174/157489211793980088; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Duncan JG, 2011, BBA-MOL CELL RES, V1813, P1351, DOI 10.1016/j.bbamcr.2011.01.014; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; He YJ, 2010, J BIOL CHEM, V285, P9516, DOI 10.1074/jbc.M109.092429; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Kolwicz SC, 2009, TRENDS CARDIOVAS MED, V19, P201, DOI 10.1016/j.tcm.2009.12.005; Larsen TS, 2008, CARDIOVASC DRUG THER, V22, P91, DOI 10.1007/s10557-008-6083-1; Lehman JJ, 2008, AM J PHYSIOL-HEART C, V295, pH185, DOI 10.1152/ajpheart.00081.2008; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tessari A, 2008, CIRC RES, V102, P813, DOI 10.1161/CIRCRESAHA.107.163188; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; WEYDERT A, 1987, CELL, V49, P121, DOI 10.1016/0092-8674(87)90762-8; Wong C, 2007, NAT CLIN PRACT CARD, V4, P436, DOI 10.1038/ncpcardio0943; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	58	72	74	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33301	33309		10.1074/jbc.M111.277707	http://dx.doi.org/10.1074/jbc.M111.277707			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808063	Green Published, hybrid			2022-12-27	WOS:000294968800049
J	Cohen, C				Cohen, Carolyn			Mrs. Professor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Brandeis Univ, Dept Biol, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA	Brandeis University	Cohen, C (corresponding author), Brandeis Univ, Dept Biol, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA.	ccohen@brandeis.edu						Cohen C, 2007, J BIOL CHEM, V282, P32529, DOI 10.1074/JBC.X700001200; Ozick C., 1983, ART ARDOR, P298; Ozick C., 1983, ART ARDOR, P304	3	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					31929	31931		10.1074/jbc.X111.287250	http://dx.doi.org/10.1074/jbc.X111.287250			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21799004	Green Published, hybrid			2022-12-27	WOS:000294726800001
J	Catty, P; Boutigny, S; Miras, R; Joyard, J; Rolland, N; Seigneurin-Berny, D				Catty, Patrice; Boutigny, Sylvain; Miras, Roger; Joyard, Jacques; Rolland, Norbert; Seigneurin-Berny, Daphne			Biochemical Characterization of AtHMA6/PAA1, a Chloroplast Envelope Cu(I)-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; METAL TRANSPORT; SACCHAROMYCES-CEREVISIAE; ARCHAEOGLOBUS-FULGIDUS; FUNCTIONAL EXPRESSION; COPPER HOMEOSTASIS; ENTEROCOCCUS-HIRAE; COFACTOR DELIVERY; P-1B-TYPE ATPASE; ARABIDOPSIS	Copper is an essential plant micronutrient playing key roles in cellular processes, among them photosynthesis. In Arabidopsis thaliana, copper delivery to chloroplasts, mainly studied by genetic approaches, is thought to involve two P-IB-type ATPases: AtHMA1 and AtHMA6/PAA1. The lack of biochemical characterization of AtHMA1 and PAA1, and more generally of plant P-IB-type ATPases, is due to the difficulty of getting high amounts of these membrane proteins in an active form, either from their native environment or after expression in heterologous systems. In this study, we report the first biochemical characterization of PAA1, a plant copper-transporting ATPase. PAA1 produced in Lactococcus lactis is active, forming an aspartyl phosphate intermediate in the presence of ATP and the adequate metal ion. PAA1 can also be phosphorylated using inorganic phosphate in the absence of transition metal. Both phosphorylation types allowed us to demonstrate that PAA1 is activated by monovalent copper ions (and to a lower extent by silver ions) with an apparent affinity in the micromolar range. In agreement with these biochemical data, we also demonstrate that when expressed in yeast, PAA1 induces increased sensitivities to copper and silver. These data provide the first enzymatic characterization of a P-IB-1-type plant ATPase and clearly identify PAA1 as a high affinity Cu(I) transporter of the chloroplast envelope.	[Catty, Patrice; Miras, Roger] CNRS, Lab Chim & Biol Metaux, UMR5249, F-38054 Grenoble, France; [Catty, Patrice; Miras, Roger] Commissariat Energie Atom & Energies Alternat CEA, Direct Sci Vivant, IRTSV, Lab Chim & Biol Metaux, F-38054 Grenoble, France; [Boutigny, Sylvain; Joyard, Jacques; Rolland, Norbert; Seigneurin-Berny, Daphne] Commissariat Energie Atom & Energies Alternat CEA, Direct Sci Vivant, IRTSV, Physiol Cellulaire Vegetale Lab, F-38054 Grenoble, France; [Catty, Patrice; Miras, Roger] Univ Grenoble 1, Lab Chim & Biol Metaux, F-38054 Grenoble, France; [Boutigny, Sylvain; Joyard, Jacques; Rolland, Norbert; Seigneurin-Berny, Daphne] INRA, Physiol Cellulaire Vegetale Lab, UMR1200, F-38054 Grenoble, France; [Boutigny, Sylvain; Joyard, Jacques; Rolland, Norbert; Seigneurin-Berny, Daphne] Univ Grenoble 1, Physiol Cellulaire Vegetale Lab, F-38054 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Seigneurin-Berny, D (corresponding author), CNRS UJF INRA CEA Grenoble, Physiol Cellulaire Vegetale Lab, IRTSV, UMR5168, 17 Rue Martyrs, F-38054 Grenoble, France.	daphne.berny@cea.fr	ROLLAND, Norbert/B-4405-2012; SEIGNEURIN-BERNY, Daphne/C-8412-2017	ROLLAND, Norbert/0000-0003-1959-6636; SEIGNEURIN-BERNY, Daphne/0000-0002-7436-9885	CEA; CEA-PM project; CNRS; INRA; University of Grenoble	CEA(French Atomic Energy Commission); CEA-PM project; CNRS(Centre National de la Recherche Scientifique (CNRS)); INRA; University of Grenoble	This work was supported by the CEA (funding of the CEA-PM project), a Ph. D. fellowship from the CNRS (to S. B.), the INRA, and the University of Grenoble.	Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Andres-Colas N, 2006, PLANT J, V45, P225, DOI 10.1111/j.1365-313X.2005.02601.x; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Barnes N, 2005, J BIOL CHEM, V280, P9640, DOI 10.1074/jbc.M413840200; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Binder BM, 2010, J BIOL CHEM, V285, P37263, DOI 10.1074/jbc.M110.170027; Bissig KD, 2001, FEBS LETT, V507, P367, DOI 10.1016/S0014-5793(01)03009-5; Blair D., 1961, TALANTA LONDON, V7, P163; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; Chua N. H, 1980, METHOD ENZYMOL, V69, P434; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Eren E, 2004, PLANT PHYSIOL, V136, P3712, DOI 10.1104/pp.104.046292; Fan B, 2002, J BIOL CHEM, V277, P46987, DOI 10.1074/jbc.M208490200; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Forbes JR, 1998, AM J HUM GENET, V63, P1663, DOI 10.1086/302163; Frelet-Barrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008746; Gardarin A, 2010, MOL MICROBIOL, V76, P1034, DOI 10.1111/j.1365-2958.2010.07166.x; Gravot A, 2004, FEBS LETT, V561, P22, DOI 10.1016/S0014-5793(04)00072-9; GUIMARAESMOTTA H, 1980, ARCH BIOCHEM BIOPHYS, V203, P395, DOI 10.1016/0003-9861(80)90192-7; Hirayama T, 1999, CELL, V97, P383, DOI 10.1016/S0092-8674(00)80747-3; Hung YH, 2007, BIOCHEM J, V401, P569, DOI 10.1042/BJ20060924; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Kim YY, 2009, PLANT J, V58, P737, DOI 10.1111/j.1365-313X.2009.03818.x; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; KUO CL, 1983, MOL CELL BIOL, V3, P1730, DOI 10.1128/MCB.3.10.1730; Lowe J, 2004, J BIOL CHEM, V279, P25986, DOI 10.1074/jbc.M308736200; Lutsenko S, 2008, ARCH BIOCHEM BIOPHYS, V476, P22, DOI 10.1016/j.abb.2008.05.005; Mana-Capelli S, 2003, J BIOL CHEM, V278, P40534, DOI 10.1074/jbc.M306907200; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Moreno I, 2008, J BIOL CHEM, V283, P9633, DOI 10.1074/jbc.M800736200; Morin I, 2009, FEBS J, V276, P4483, DOI 10.1111/j.1742-4658.2009.07155.x; ODERMATT A, 1993, J BIOL CHEM, V268, P12775; Palmer CM, 2009, NAT CHEM BIOL, V5, P333, DOI 10.1038/nchembio.166; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; PHUNG LT, 1994, P NATL ACAD SCI USA, V91, P9651, DOI 10.1073/pnas.91.20.9651; Pilon M, 2006, CURR OPIN PLANT BIOL, V9, P256, DOI 10.1016/j.pbi.2006.03.007; Rensing C, 1997, P NATL ACAD SCI USA, V94, P14326, DOI 10.1073/pnas.94.26.14326; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; SIKORSKI RS, 1989, GENETICS, V122, P19; Tottey S, 2001, J BIOL CHEM, V276, P19999, DOI 10.1074/jbc.M011243200; Verret F, 2004, FEBS LETT, V576, P306, DOI 10.1016/j.febslet.2004.09.023; Voskoboinik I, 2001, J BIOL CHEM, V276, P28620, DOI 10.1074/jbc.M103532200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Woeste KE, 2000, PLANT CELL, V12, P443, DOI 10.1105/tpc.12.3.443; Wu CC, 2004, BIOCHEM BIOPH RES CO, V324, P1034, DOI 10.1016/j.bbrc.2004.09.160; Wu CC, 2006, J BIOL CHEM, V281, P29533, DOI 10.1074/jbc.M604658200; Yoshimizu T, 1998, BIOSCI BIOTECH BIOCH, V62, P1258, DOI 10.1271/bbb.62.1258; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	55	40	44	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36188	36197		10.1074/jbc.M111.241034	http://dx.doi.org/10.1074/jbc.M111.241034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878617	Green Published, hybrid			2022-12-27	WOS:000296538300004
J	Jin, ZG; Mei, WY; Strack, S; Jia, JH; Yang, J				Jin, Zhigang; Mei, Wenyan; Strack, Stefan; Jia, Jianhang; Yang, Jing			The Antagonistic Action of B56-containing Protein Phosphatase 2As and Casein Kinase 2 Controls the Phosphorylation and Gli Turnover Function of Daz Interacting Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; ZINC-FINGER PROTEIN; DROSOPHILA-MELANOGASTER; TRANSCRIPTION FACTOR; CUBITUS-INTERRUPTUS; REPRESSOR FUNCTIONS; REGULATORY SUBUNIT; DEGRADATION; LOCALIZATION; ZEBRAFISH	The Hedgehog (Hh) pathway is evolutionarily conserved and plays critical roles during embryonic development and adult tissue homeostasis. Defective Hh signaling has been linked to a wide range of birth defects and cancers. Hh family proteins regulate the expression of their downstream target genes through the control of proteolytic processing and the transcriptional activation function of Gli transcription factors. Although Hh-dependent regulation of Gli has been studied extensively, other Gli regulatory mechanisms remain relatively unappreciated. Here we report our identification of a novel signaling cascade that controls the stability of Gli proteins. This cascade consists of Daz interacting protein 1 (Dzip1), casein kinase 2 (CK2), and B56 containing protein phosphatase 2As (PP2As). We provide evidence that Dzip1 is involved in a novel Gli turnover pathway. We show that CK2 directly phosphorylates Dzip1 at four serine residues, Ser-664/665/706/714. B56-containing PP2As, through binding to a domain located between amino acid residue 474 and 550 of Dzip1, dephosphorylate Dzip1 on these CK2 sites. Our mutagenesis analysis further demonstrates that the unphosphorylatable form of Dzip1 is more potent in promoting Gli turnover. Consistently, we found that the stability of Gli proteins was decreased upon CK2 inhibition and increased by inhibition of B56-containing PP2As. Thus, reversible phosphorylation of Dzip1, which is controlled by the antagonistic action of CK2 and B56-containing PP2As, has an important impact on the stability of Gli transcription factors and Hh signaling.	[Jin, Zhigang; Mei, Wenyan; Yang, Jing] Ohio State Univ, Res Inst, Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA; [Strack, Stefan] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA; [Jia, Jianhang] Univ Kentucky, Markey Canc Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Iowa; University of Kentucky	Yang, J (corresponding author), Ohio State Univ, Res Inst, Nationwide Childrens Hosp, Dept Pediat, 700 Childrens Dr, Columbus, OH 43205 USA.	Jing.Yang@nationwidechildrens.org	Jin, Zhigang/T-7125-2019	Jin, Zhigang/0000-0001-7557-2968; Jia, Jianhang/0000-0002-9313-3843; Strack, Stefan/0000-0002-6175-7280	National Institutes of Health [R01GM093217, 1R01GM079684]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093217, R01GM079684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM093217 (to J. Y.) and 1R01GM079684 (to J. J.).	AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Di Marcotullio L, 2011, ONCOGENE, V30, P65, DOI 10.1038/onc.2010.394; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Glazer AM, 2010, DEV BIOL, V337, P148, DOI 10.1016/j.ydbio.2009.10.025; Hannus M, 2002, DEVELOPMENT, V129, P3493; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia HG, 2010, J BIOL CHEM, V285, P37218, DOI 10.1074/jbc.M110.174565; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jin ZG, 2010, J BIOL CHEM, V285, P34493, DOI 10.1074/jbc.M110.169581; Jin Z, 2009, J BIOL CHEM, V284, P7190, DOI 10.1074/jbc.M807907200; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Kim HR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-65; Krauss S, 2008, CANCER RES, V68, P4658, DOI 10.1158/0008-5472.CAN-07-6174; Krauss S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007471; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Rorick AM, 2007, DEV BIOL, V302, P477, DOI 10.1016/j.ydbio.2006.10.011; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sekimizu K, 2004, DEVELOPMENT, V131, P2521, DOI 10.1242/dev.01059; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Sive H., 2000, EARLY DEV XENOPUS LA, P91; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Stubbs JL, 2006, DEVELOPMENT, V133, P2507, DOI 10.1242/dev.02417; Tay SY, 2010, DEV DYNAM, V239, P527, DOI 10.1002/dvdy.22199; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Vokes SA, 2004, CURR BIOL, V14, pR668, DOI 10.1016/j.cub.2004.08.015; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Yang J, 2003, DEVELOPMENT, V130, P5569, DOI 10.1242/dev.00762; Yang J, 2010, LIFE SCI, V87, P659, DOI 10.1016/j.lfs.2010.10.003; Yang J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000363; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106	46	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36171	36179		10.1074/jbc.M111.274761	http://dx.doi.org/10.1074/jbc.M111.274761			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878643	Green Published, hybrid			2022-12-27	WOS:000296538300002
J	Phillips, NB; Racca, J; Chen, YS; Singh, R; Jancso-Radek, A; Radek, JT; Wickramasinghe, NP; Haas, E; Weiss, MA				Phillips, Nelson B.; Racca, Joseph; Chen, Yen-Shan; Singh, Rupinder; Jancso-Radek, Agnes; Radek, James T.; Wickramasinghe, Nalinda P.; Haas, Elisha; Weiss, Michael A.			Mammalian Testis-determining Factor SRY and the Enigma of Inherited Human Sex Reversal FRUSTRATED INDUCED FIT IN A BENT PROTEIN-DNA COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOBILITY-GROUP BOX; HMG BOX; DETERMINING REGION; TRUE HERMAPHRODITISM; MOLECULAR-BASIS; Y-CHROMOSOME; CAMPOMELIC DYSPLASIA; NUCLEAR-LOCALIZATION; CHROMATIN-STRUCTURE; MISSENSE MUTATIONS	Mammalian testis-determining factor SRY contains a high mobility group box, a conserved eukaryotic motif of DNA bending. Mutations in SRY cause XY gonadal dysgenesis and somatic sex reversal. Although such mutations usually arise de novo in spermatogenesis, some are inherited and so specify male development in one genetic background (the father) but not another (the daughter). Here, we describe the biophysical properties of a representative inherited mutation, V60L, within the minor wing of the L-shaped domain (box position 5). Although the stability and DNA binding properties of the mutant domain are similar to those of wildtype, studies of SRY-induced DNA bending by subnanosecond time-resolved fluorescence resonance energy transfer (FRET) revealed enhanced conformational fluctuations leading to long range variation in bend angle. H-1 NMR studies of the variant protein-DNA complex demonstrated only local perturbations near the mutation site. Because the minor wing of SRY folds on DNA binding, the inherited mutation presumably hinders induced fit. Stopped-flow FRET studies indicated that such frustrated packing leads to accelerated dissociation of the bent complex. Studies of SRY-directed transcriptional regulation in an embryonic gonadal cell line demonstrated partial activation of downstream target Sox9. Our results have demonstrated a nonlocal coupling between DNA-directed protein folding and protein-directed DNA bending. Perturbation of this coupling is associated with a genetic switch poised at the threshold of activity.	[Wickramasinghe, Nalinda P.; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Haas, Elisha] Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel	Case Western Reserve University; Bar Ilan University	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu	Wickramasinghe, Nalinda P/F-9465-2010	Wickramasinghe, Nalinda P./0000-0002-8700-2775	National Institutes of Health [GM080505]; United States/Israel Binational Foundation [98-362]; Israel Science Foundation [ISF 1464/10]; NCI, National Institutes of Health [T32 CA059366]; NATIONAL CANCER INSTITUTE [T32CA059366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States/Israel Binational Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080505 (to M. A. W.). This work was also supported in its early stages by Grant 98-362 from the United States/Israel Binational Foundation (to E. H. and M. A. W.) and by Grant ISF 1464/10 from the Israel Science Foundation (to E. H.); Supported in part by National Institutes of Health T32 CA059366 Training Grant from NCI (to C. Distelhorst) to the Clinical Oncology Research Career Development Program at Case Western Reserve University School of Medicine.	Albrecht KH, 2003, GENETICS, V164, P277; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P1604, DOI 10.1093/nar/23.9.1604; BEECHEM JM, 1989, BIOPHYS J, V55, P1225, DOI 10.1016/S0006-3495(89)82918-2; Benevides JM, 2000, BIOCHEMISTRY-US, V39, P537, DOI 10.1021/bi9900525; Bergstrom DE, 2000, GENESIS, V28, P111, DOI 10.1002/1526-968X(200011/12)28:3/4<111::AID-GENE40>3.0.CO;2-5; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Bieri M, 2011, FEBS J, V278, P704, DOI 10.1111/j.1742-4658.2011.08005.x; Bouma GJ, 2005, DEVELOPMENT, V132, P3045, DOI 10.1242/dev.01890; BRAUN A, 1993, AM J HUM GENET, V52, P578; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bullejos M, 2005, DEV BIOL, V278, P473, DOI 10.1016/j.ydbio.2004.11.030; Cameron FJ, 1997, HUM MUTAT, V9, P388; Canto P, 2005, MOL HUM REPROD, V11, P833, DOI 10.1093/molehr/gah216; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Clore GM, 2002, CURR OPIN STRUC BIOL, V12, P146, DOI 10.1016/S0959-440X(02)00302-0; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; DAWSON WR, 1968, J PHYS CHEM-US, V72, P3251, DOI 10.1021/j100855a027; Desclozeaux M, 1998, J BIOL CHEM, V273, P7988, DOI 10.1074/jbc.273.14.7988; Dragan AI, 2004, J MOL BIOL, V343, P371, DOI 10.1016/j.jmb.2004.08.035; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; EICHER EM, 1982, SCIENCE, V217, P535, DOI 10.1126/science.7089579; Eicher EM, 2001, J EXP ZOOL, V290, P322, DOI 10.1002/jez.1072; FERRARI S, 1992, EMBO J, V11, P4497, DOI 10.1002/j.1460-2075.1992.tb05551.x; Forwood JK, 2001, J BIOL CHEM, V276, P46575, DOI 10.1074/jbc.M101668200; FOSTER JW, 1994, P NATL ACAD SCI USA, V91, P1927, DOI 10.1073/pnas.91.5.1927; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Haas E, 1996, IEEE J SEL TOP QUANT, V2, P1088, DOI 10.1109/2944.577340; HADJIATHANASIOU CG, 1994, J PEDIATR-US, V125, P738, DOI 10.1016/S0022-3476(06)80172-1; HAQQ CM, 1993, P NATL ACAD SCI USA, V90, P1097, DOI 10.1073/pnas.90.3.1097; Haqq CM, 1998, PHYSIOL REV, V78, P1; HAQQ CM, 1994, SCIENCE, V266, P1494, DOI 10.1126/science.7985018; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; Harley VR, 2002, NOVART FDN SYMP, V244, P57; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; Harley VR, 1996, FEBS LETT, V391, P24, DOI 10.1016/0014-5793(96)00694-1; HAWKINS JR, 1992, HUM GENET, V88, P471, DOI 10.1007/BF00215684; HIORT O, 1995, J PEDIATR-US, V126, P1022, DOI 10.1016/S0022-3476(95)70247-4; Isidor B, 2009, J CLIN ENDOCR METAB, V94, P3467, DOI 10.1210/jc.2009-0226; JONES DNM, 1994, STRUCTURE, V2, P609, DOI 10.1016/S0969-2126(00)00063-0; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; KING CY, 1993, P NATL ACAD SCI USA, V90, P11990, DOI 10.1073/pnas.90.24.11990; Knower KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017751; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koopman P, 2001, EXS, V91, P25; KORNBERG RD, 1995, CURR OPIN CELL BIOL, V7, P371, DOI 10.1016/0955-0674(95)80092-1; KWOK C, 1995, AM J HUM GENET, V57, P1028; LEE CH, 1994, DEV BIOL, V165, P442, DOI 10.1006/dbio.1994.1266; Lee CH, 2001, GENESIS, V30, P7, DOI 10.1002/gene.1026; Li B, 2006, J MOL BIOL, V360, P310, DOI 10.1016/j.jmb.2006.04.048; Li BR, 2001, J BIOL CHEM, V276, P46480, DOI 10.1074/jbc.C100388200; Love JJ, 2004, BIOCHEMISTRY-US, V43, P8725, DOI 10.1021/bi049591m; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Lovell-Badge R, 2002, NOVART FDN SYMP, V244, P4; Lovell-Badge R, 2010, INT J BIOCHEM CELL B, V42, P378, DOI 10.1016/j.biocel.2009.12.003; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Matsuzawa-Watanabe Y, 2003, ONCOGENE, V22, P7900, DOI 10.1038/sj.onc.1206717; MCELREAVY K, 1992, P NATL ACAD SCI USA, V89, P11016, DOI 10.1073/pnas.89.22.11016; Mitchell CL, 2002, MOL GENET METAB, V77, P217, DOI 10.1016/S1096-7192(02)00165-8; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; NAGAMINE CM, 1987, DIFFERENTIATION, V33, P214, DOI 10.1111/j.1432-0436.1987.tb01560.x; Nagamine CM, 1999, DEV BIOL, V216, P182, DOI 10.1006/dbio.1999.9436; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; NER S S, 1992, Current Biology, V2, P208, DOI 10.1016/0960-9822(92)90541-H; Oh H, 2005, BIOL REPROD, V72, P407, DOI 10.1095/biolreprod.104.034447; Ohe K, 2002, P NATL ACAD SCI USA, V99, P1146, DOI 10.1073/pnas.022645899; Palasingam P, 2009, J MOL BIOL, V388, P619, DOI 10.1016/j.jmb.2009.03.055; PALMER SJ, 1991, DEVELOPMENT, V113, P709; Parkhurst KM, 1996, BIOCHEMISTRY-US, V35, P7459, DOI 10.1021/bi9530301; PETERS R, 1995, BIOCHEMISTRY-US, V34, P4569, DOI 10.1021/bi00014a009; Phillips NB, 2006, J MOL BIOL, V358, P172, DOI 10.1016/j.jmb.2006.01.060; Phillips NB, 2004, BIOCHEMISTRY-US, V43, P7066, DOI 10.1021/bi049920a; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; PONTIGGIA A, 1995, GENE, V154, P277, DOI 10.1016/0378-1119(94)00853-K; Poulat F, 1997, J BIOL CHEM, V272, P7167, DOI 10.1074/jbc.272.11.7167; Ratner V, 2000, J MOL BIOL, V299, P1363, DOI 10.1006/jmbi.2000.3814; READ CM, 1993, NUCLEIC ACIDS RES, V21, P3427, DOI 10.1093/nar/21.15.3427; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Sanchez IE, 2010, P NATL ACAD SCI USA, V107, P7751, DOI 10.1073/pnas.0911734107; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Sim H, 2005, MOL ENDOCRINOL, V19, P1884, DOI 10.1210/me.2004-0334; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; TAKETO T, 1991, DEV BIOL, V146, P386, DOI 10.1016/0012-1606(91)90240-4; Thevenet L, 2005, J BIOL CHEM, V280, P38625, DOI 10.1074/jbc.M504127200; Ukiyama E, 2001, MOL ENDOCRINOL, V15, P363, DOI 10.1210/me.15.3.363; vanHoute LPA, 1995, J BIOL CHEM, V270, P30516, DOI 10.1074/jbc.270.51.30516; VILAIN E, 1993, DIFFERENTIATION, V52, P151, DOI 10.1111/j.1432-0436.1993.tb00625.x; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Washburn LL, 2001, GENETICS, V158, P1675; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; Weiss MA, 1997, J BIOMOL STRUCT DYN, V15, P177, DOI 10.1080/07391102.1997.10508185; WEISS MA, 1995, J BIOMOL STRUCT DYN, V13, P261, DOI 10.1080/07391102.1995.10508838; Weiss MA, 2005, MOL B INT U, P159; Weiss MA, 2001, MOL ENDOCRINOL, V15, P353, DOI 10.1210/me.15.3.353; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; WERNER MH, 1995, BIOCHEMISTRY-US, V34, P11998, DOI 10.1021/bi00037a042; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Zheng GH, 2010, PHYS CHEM CHEM PHYS, V12, P1399, DOI 10.1039/b916183j	107	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36787	36807		10.1074/jbc.M111.260091	http://dx.doi.org/10.1074/jbc.M111.260091			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21849498	Green Published, hybrid			2022-12-27	WOS:000296538300060
J	Pircher, H; Straganz, GD; Ehehalt, D; Morrow, G; Tanguay, RM; Jansen-Durr, P				Pircher, Haymo; Straganz, Grit D.; Ehehalt, Daniela; Morrow, Genevieve; Tanguay, Robert M.; Jansen-Duerr, Pidder			Identification of Human Fumarylacetoacetate Hydrolase Domain-containing Protein 1 (FAHD1) as a Novel Mitochondrial Acylpyruvase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY TYROSINEMIA; FUMARYLHYDROLASE; PURIFICATION; DEFICIENT; LIVER; ACID	The human fumarylacetoacetate hydrolase (FAH) domain-containing protein 1 (FAHD1) is part of the FAH protein superfamily, but its enzymatic function is unknown. In the quest for a putative enzymatic function of FAHD1, we found that FAHD1 exhibits acylpyruvase activity, demonstrated by the hydrolysis of acetylpyruvate and fumarylpyruvate in vitro, whereas several structurally related compounds were not hydrolyzed as efficiently. Conserved amino acids Asp-102 and Arg-106 of FAHD1 were found important for its catalytic activity, and Mg2+ was required for maximal enzyme activity. FAHD1 was found expressed in all tested murine tissues, with highest expression in liver and kidney. FAHD1 was also found in several human cell lines, where it localized to mitochondria. In summary, the current work identified mammalian FAHD1 as a novel mitochondrial enzyme with acylpyruvate hydrolase activity.	[Pircher, Haymo; Ehehalt, Daniela; Jansen-Duerr, Pidder] Austrian Acad Sci, Inst Biomed Aging Res, A-6020 Innsbruck, Austria; [Straganz, Grit D.] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Morrow, Genevieve; Tanguay, Robert M.] Univ Laval, Lab Cell & Dev Genet, Dept Mol Biol Med Biochem & Pathol, IBIS, Quebec City, PQ G1V 0A6, Canada; [Morrow, Genevieve; Tanguay, Robert M.] Univ Laval, PROTEO, Quebec City, PQ G1V 0A6, Canada	Austrian Academy of Sciences; Graz University of Technology; Laval University; Laval University	Jansen-Durr, P (corresponding author), Austrian Acad Sci, Inst Biomed Aging Res, Rennweg 10, A-6020 Innsbruck, Austria.	p.jansen-duerr@oeaw.ac.at	Jansen-Dürr, Pidder/ABG-2466-2020	Jansen-Dürr, Pidder/0000-0001-7771-3429	Austrian Science Fund (FWF) [NFN S93, P18828]; European Union; Canadian Institutes of Health Research [MOP-86566]; MiMage project	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Union(European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MiMage project	This work was supported by the Austrian Science Fund (FWF) through Grant NFN S93 and by the European Union through the MiMage project.; Supported by the Austrian Science Fund (FWF) through Grant P18828.; Supported by the Canadian Institutes of Health Research (Grant MOP-86566) and the MiMage project.	Brecker L, 1999, NEW J CHEM, V23, P437, DOI 10.1039/a807247g; Brouns SJJ, 2008, J MOL BIOL, V379, P357, DOI 10.1016/j.jmb.2008.03.064; DAVEY JF, 1975, J BIOL CHEM, V250, P3826; HSIANG HH, 1972, BIOCHEMISTRY-US, V11, P2098, DOI 10.1021/bi00761a016; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Krebs HA, 1937, BIOCHEM J, V31, P772, DOI 10.1042/bj0310772; KVITTINGEN EA, 1981, CLIN CHIM ACTA, V115, P311, DOI 10.1016/0009-8981(81)90244-8; LINDBLAD B, 1977, P NATL ACAD SCI USA, V74, P4641, DOI 10.1073/pnas.74.10.4641; MAHURAN DJ, 1977, CAN J BIOCHEM CELL B, V55, P1; Manjasetty BA, 2004, BIOL CHEM, V385, P935, DOI 10.1515/BC.2004.122; MEISTER A, 1948, J BIOL CHEM, V175, P573; MITCHELL GA, 2001, METABOLIC MOL BASES, P1777; Muck C, 2010, J GERONTOL A-BIOL, V65, P1165, DOI 10.1093/gerona/glq129; PHANEUF D, 1991, AM J HUM GENET, V48, P525; Pollard JR, 1998, EUR J BIOCHEM, V251, P98, DOI 10.1046/j.1432-1327.1998.2510098.x; Tame JRH, 2002, BIOCHEMISTRY-US, V41, P2982, DOI 10.1021/bi015717t; Unterluggauer H, 2003, EXP GERONTOL, V38, P1149, DOI 10.1016/j.exger.2003.08.007; Zhou NY, 2001, J BACTERIOL, V183, P700, DOI 10.1128/JB.183.2.700-708.2001	18	23	26	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36500	36508		10.1074/jbc.M111.264770	http://dx.doi.org/10.1074/jbc.M111.264770			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878618	Green Published, hybrid			2022-12-27	WOS:000296538300035
J	Teng, YW; Mehedint, MG; Garrow, TA; Zeisel, SH				Teng, Ya-Wen; Mehedint, Mihai G.; Garrow, Timothy A.; Zeisel, Steven H.			Deletion of Betaine-Homocysteine S-Methyltransferase in Mice Perturbs Choline and 1-Carbon Metabolism, Resulting in Fatty Liver and Hepatocellular Carcinomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; DIETARY REQUIREMENTS; RAT-LIVER; ADENOSYLMETHIONINE; DEFICIENT; ADENOSYLHOMOCYSTEINE; PURIFICATION; METHIONINE; TISSUES; CANCER	Betaine-homocysteine S-methyltransferase (BHMT) uses betaine to catalyze the conversion of homocysteine (Hcy) to methionine. There are common genetic polymorphisms in the BHMT gene in humans that can alter its enzymatic activity. We generated the first Bhmt(-/-) mouse to model the functional effects of mutations that result in reduced BHMT activity. Deletion of Bhmt resulted in a 6-fold increase (p < 0.01) in hepatic and an 8-fold increase (p < 0.01) in plasma total Hcy concentrations. Deletion of Bhmt resulted in a 43% reduction in hepatic S-adenosylmethionine (AdoMet) (p < 0.01) and a 3-fold increase in hepatic S-adenosylhomocysteine (AdoHcy) (p < 0.01) concentrations, resulting in a 75% reduction in methylation potential (AdoMet: AdoHcy) (p < 0.01). Bhmt(-/-) mice accumulated betaine in most tissues, including a 21-fold increase in the liver concentration compared with wild type (WT) (p < 0.01). These mice had lower concentrations of choline, phosphocholine, glycerophosphocholine, phosphatidylcholine, and sphingomyelin in several tissues. At 5 weeks of age, Bhmt(-/-) mice had 36% lower total hepatic phospholipid concentrations and a 6-fold increase in hepatic triacyglycerol concentrations compared with WT (p < 0.01), which was due to a decrease in the secretion of very low density lipoproteins. At 1 year of age, 64% of Bhmt(-/-) mice had visible hepatic tumors. Histopathological analysis revealed that Bhmt(-/-) mice developed hepatocellular carcinoma or carcinoma precursors. These results indicate that BHMT has an important role in Hcy, choline, and one-carbon homeostasis. A lack of Bhmt also affects susceptibility to fatty liver and hepatocellular carcinoma. We suggest that functional polymorphisms in BHMT that significantly reduce activity may have similar effects in humans.	[Teng, Ya-Wen; Zeisel, Steven H.] Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; [Mehedint, Mihai G.; Zeisel, Steven H.] Univ N Carolina, Inst Nutr Res, Kannapolis, NC 28081 USA; [Garrow, Timothy A.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of Illinois System; University of Illinois Urbana-Champaign	Zeisel, SH (corresponding author), 500 Laureate Way, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu			National Institutes of Health [DK55865, DK36530, DK52501]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052501, R29DK052501, R01DK055865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK55865 and DK36530 (to S. H. Z.) and DK52501 (to T. A. G.).	BARAK AJ, 1993, ALCOHOL CLIN EXP RES, V17, P552, DOI 10.1111/j.1530-0277.1993.tb00798.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLUMENSTEIN J, 1963, CAN J BIOCHEM PHYS, V41, P201, DOI 10.1139/y63-025; Boyles AL, 2006, ENVIRON HEALTH PERSP, V114, P1547, DOI 10.1289/ehp.9166; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Collinsova M, 2006, J NUTR, V136, P1493, DOI 10.1093/jn/136.6.1493; Costello JF, 2001, J MED GENET, V38, P285, DOI 10.1136/jmg.38.5.285; da Costa KA, 2004, AM J CLIN NUTR, V80, P163; da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06-5734com; DACOSTA KA, 1993, J BIOL CHEM, V268, P2100; Delgado-Reyes CV, 2001, ARCH BIOCHEM BIOPHYS, V393, P184, DOI 10.1006/abbi.2001.2474; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Feng QP, 2011, MOL GENET METAB, V102, P126, DOI 10.1016/j.ymgme.2010.10.010; Feo F, 2006, BBA-REV CANCER, V1765, P126, DOI 10.1016/j.bbcan.2005.08.007; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; GROSSMAN EB, 1989, AM J PHYSIOL, V256, pF107; HORNE DW, 1988, CLIN CHEM, V34, P2357; Johnson AR, 2010, FASEB J, V24, P2752, DOI 10.1096/fj.09-153718; Kharbanda KK, 2007, J HEPATOL, V46, P314, DOI 10.1016/j.jhep.2006.08.024; Kim SK, 2003, BIOCHEM PHARMACOL, V65, P1565, DOI 10.1016/S0006-2952(03)00115-1; Koc H, 2002, ANAL CHEM, V74, P4734, DOI 10.1021/ac025624x; Kwon DY, 2009, J NUTR, V139, P63, DOI 10.3945/jn.108.094771; Lillie RD, 1965, HISTOPATHOLOGIC TECH; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; MOLLOY AM, 1990, BIOMED CHROMATOGR, V4, P257, DOI 10.1002/bmc.1130040611; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; NEWBERNE PM, 1986, ANNU REV NUTR, V6, P407, DOI 10.1146/annurev.nu.06.070186.002203; Newell P, 2008, J HEPATOL, V48, P858, DOI 10.1016/j.jhep.2008.01.008; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Pajares MA, 2006, CELL MOL LIFE SCI, V63, P2792, DOI 10.1007/s00018-006-6249-6; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; RIDGWAY ND, 1988, J BIOL CHEM, V263, P16864; RIDGWAY ND, 1988, J BIOL CHEM, V263, P16856; RUSHMORE TH, 1984, CANCER LETT, V24, P251, DOI 10.1016/0304-3835(84)90020-X; Schwahn BC, 2003, FASEB J, V17, P512, DOI 10.1096/fj.02-0456fje; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; SHIVAPURKAR N, 1983, CARCINOGENESIS, V4, P1051, DOI 10.1093/carcin/4.8.1051; Stabler SP, 2009, FREE RADICAL BIO MED, V47, P1147, DOI 10.1016/j.freeradbiomed.2009.07.019; Strakova J, 2010, NUTR RES, V30, P492, DOI 10.1016/j.nutres.2010.06.017; SVANBORG A, 1961, ACTA MED SCAND, V169, P43; Szegedi SS, 2008, J BIOL CHEM, V283, P8939, DOI 10.1074/jbc.M710449200; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; WAGNER C, 1985, BIOCHEM BIOPH RES CO, V127, P746, DOI 10.1016/S0006-291X(85)80006-1; Watkins SM, 2001, LIPIDS, V36, P247, DOI 10.1007/s11745-001-0714-8; Weisberg IS, 2003, ATHEROSCLEROSIS, V167, P205, DOI 10.1016/S0021-9150(03)00010-8; Xu XR, 2009, FASEB J, V23, P4022, DOI 10.1096/fj.09-136507; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zhou L, 2006, WORLD J GASTROENTERO, V12, P1175, DOI 10.3748/wjg.v12.i8.1175	52	134	140	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36258	36267		10.1074/jbc.M111.265348	http://dx.doi.org/10.1074/jbc.M111.265348			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878621	hybrid, Green Published			2022-12-27	WOS:000296538300010
J	Hezroni, H; Sailaja, BS; Meshorer, E				Hezroni, Hadas; Sailaja, Badi Sri; Meshorer, Eran			Pluripotency-related, Valproic Acid (VPA)-induced Genome-wide Histone H3 Lysine 9 (H3K9) Acetylation Patterns in Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-STRUCTURE; CHIP-SEQ; DIFFERENTIATION; TRANSCRIPTION; INDUCTION; STATE; METHYLATION; NUCLEAR; MODEL; MAPS	Background: Embryonic stem cell (ESC) chromatin is characterized by a unique set of histone modifications, including enrichment for H3K9ac. Recent studies suggest that HDAC inhibitors (HDACi) promote pluripotency. Results: Using H3K9ac ChIP-seq analyses and gene expression in E14 mouse ESCs before and after treatment with a low level of the HDACi valproic acid (VPA), we show that H3K9ac is enriched at gene promoters and is highly correlated with gene expression and with various genomic features, including different active histone marks and pluripotency-related transcription factors. Conclusion: This study provides insights into the genomic response of ESCs to low level HDACi, which leads to increased pluripotency. The results suggest that a mild (averaging less than 40%) but global change in the chromatin state is involved in increased pluripotency and that specific mechanisms operate selectively in bivalent genes to maintain constant H3K9ac levels. Our data support the notion that H3K9ac has an important role in ESC biology. Significance: Understanding the mechanisms that improve and support pluripotency of ESCs, such as the use of the HDAC inhibitor VPA, will promote intelligent manipulation of ESCs and expedite their use in the clinic.	[Hezroni, Hadas; Sailaja, Badi Sri; Meshorer, Eran] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Meshorer, E (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	meshorer@huji.ac.il		Sailaja, Badi Sri/0000-0003-4488-738X; Meshorer, Eran/0000-0003-4777-986X	Edmond J. Safra Foundation; Israel Science Foundation [215/07, 943/09]; Israel Ministry of Health [6007]; European Union [IRG-206872, 238176]; Israel Cancer Research Foundation; Hebrew University	Edmond J. Safra Foundation; Israel Science Foundation(Israel Science Foundation); Israel Ministry of Health; European Union(European Commission); Israel Cancer Research Foundation; Hebrew University	This work was supported in part by the Edmond J. Safra Foundation.; A Joseph H. and Belle R. Braun Senior Lecturer in Life Sciences, supported by Israel Science Foundation Grants 215/07 and 943/09, Israel Ministry of Health Grant 6007, European Union Grants IRG-206872 and 238176, the Israel Cancer Research Foundation, and the Internal Applicative Medical Grants of the Hebrew University. To whom correspondence should be addressed. E-mail: meshorer@huji.ac.il.	Aoto T, 2006, DEV BIOL, V298, P354, DOI 10.1016/j.ydbio.2006.04.450; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bartova E, 2008, DEV DYNAM, V237, P3690, DOI 10.1002/dvdy.21773; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Conigliaro A, 2008, CELL DEATH DIFFER, V15, P123, DOI 10.1038/sj.cdd.4402236; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Efroni S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000425; Efroni S, 2009, CELL CYCLE, V8, P43, DOI 10.4161/cc.8.1.7216; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Glover CH, 2006, PLOS COMPUT BIOL, V2, P1463, DOI 10.1371/journal.pcbi.0020158; Hezroni H, 2011, NUCLEUS-PHILA, V2, P300, DOI 10.4161/nucl.2.4.16767; HU ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Karantzali E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r65; Kobayakawa S, 2007, GENES CELLS, V12, P447, DOI 10.1111/j.1365-2443.2007.01063.x; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Krejci J, 2009, J CELL PHYSIOL, V219, P677, DOI 10.1002/jcp.21714; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Mattout A, 2010, CURR OPIN CELL BIOL, V22, P334, DOI 10.1016/j.ceb.2010.02.001; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Xu H, 2010, BIOINFORMATICS, V26, P1199, DOI 10.1093/bioinformatics/btq128; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou QJ, 2007, J CELL BIOCHEM, V100, P29, DOI 10.1002/jcb.20970	45	60	60	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35977	35988		10.1074/jbc.M111.266254	http://dx.doi.org/10.1074/jbc.M111.266254			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21849501	Green Published, hybrid			2022-12-27	WOS:000295927100071
J	Kumaraswami, M; Avanigadda, L; Rai, R; Park, HW; Howe, MM				Kumaraswami, Muthiah; Avanigadda, Lakshmi; Rai, Rajendra; Park, Hee-Won; Howe, Martha M.			Genetic Analysis of Phage Mu Mor Protein Amino Acids Involved in DNA Minor Groove Binding and Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATOR COMPLEX REVEALS; BACTERIOPHAGE-MU; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GENOME SEQUENCE; TRANSCRIPTION ACTIVATION; POSITIVE REGULATOR; TERMINAL DOMAIN; RNA-POLYMERASE; P-M	Background: The phage Mu Mor activator protein structure led to predictions of key amino acids needed for DNA binding. Results: Mutational analysis identified specific Mor amino acids needed for DNA binding and transcription activation. Conclusion: The properties of the mutants support the predictions from the structure. Significance: The Mor protein family is unique among regulatory proteins.	[Kumaraswami, Muthiah; Avanigadda, Lakshmi; Rai, Rajendra; Howe, Martha M.] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada	University of Tennessee System; University of Tennessee Health Science Center; University of Toronto; Structural Genomics Consortium	Howe, MM (corresponding author), 858 Madison Ave, Memphis, TN 38163 USA.	mhowe@uthsc.edu			National Institutes of Health [GM-35642]; Harriett S. Van Vleet Chair of Excellence in Virology; Harriett S. Van Vleet Chair of Excellence in Microbiology and Immunology; College of Medicine at the University of Tennessee Health Science Center; National Science Foundation [MCB-0318108, MCB-0418108]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harriett S. Van Vleet Chair of Excellence in Virology; Harriett S. Van Vleet Chair of Excellence in Microbiology and Immunology; College of Medicine at the University of Tennessee Health Science Center; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35642, the Harriett S. Van Vleet Chair of Excellence in Virology, Harriett S. Van Vleet Chair of Excellence in Microbiology and Immunology, the College of Medicine at the University of Tennessee Health Science Center, and National Science Foundation Grants MCB-0318108 and MCB-0418108.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Artsimovitch I, 1996, J BIOL CHEM, V271, P32343, DOI 10.1074/jbc.271.50.32343; Artsimovitch I, 1996, P NATL ACAD SCI USA, V93, P9408, DOI 10.1073/pnas.93.18.9408; Artsimovitch I, 1996, NUCLEIC ACIDS RES, V24, P450, DOI 10.1093/nar/24.3.450; Bell CE, 2001, J MOL BIOL, V312, P921, DOI 10.1006/jmbi.2001.5024; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Braid MD, 2004, J BACTERIOL, V186, P6560, DOI 10.1128/JB.186.19.6560-6574.2004; BRENNAN RG, 1993, CELL, V74, P773, DOI 10.1016/0092-8674(93)90456-Z; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FOX KR, 1985, NUCLEIC ACIDS RES, V13, P8695, DOI 10.1093/nar/13.24.8695; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Fuhrmann J, 2009, SCIENCE, V324, P1323, DOI 10.1126/science.1170088; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Hamelberg D, 2005, J AM CHEM SOC, V127, P13778, DOI 10.1021/ja054338a; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Hou MH, 2004, NUCLEIC ACIDS RES, V32, P2214, DOI 10.1093/nar/gkh549; HOWE MM, 1979, VIROLOGY, V93, P303, DOI 10.1016/0042-6822(79)90235-6; Hsieh TJ, 2010, NUCLEIC ACIDS RES, V38, P4173, DOI 10.1093/nar/gkq153; Jones S, 1999, J MOL BIOL, V287, P877, DOI 10.1006/jmbi.1999.2659; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; KahmeyerGabbe M, 1996, J BACTERIOL, V178, P1585, DOI 10.1128/jb.178.6.1585-1592.1996; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KRAUSE HM, 1986, J BIOL CHEM, V261, P3744; Kumaraswami M, 2004, J BIOL CHEM, V279, P16581, DOI 10.1074/jbc.M313555200; Kurkcuoglu O, 2010, BIOPHYS J, V99, P1212, DOI 10.1016/j.bpj.2010.06.006; LAHM A, 1991, J MOL BIOL, V222, P645, DOI 10.1016/0022-2836(91)90502-W; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Luscombe NM, 2000, GENOME BIOL, V1; Ma J, 2004, J BACTERIOL, V186, P7858, DOI 10.1128/JB.186.23.7858-7864.2004; MARGOLIN W, 1986, NUCLEIC ACIDS RES, V14, P4881, DOI 10.1093/nar/14.12.4881; MARGOLIN W, 1990, J BACTERIOL, V172, P1424, DOI 10.1128/jb.172.3.1424-1429.1990; MARGOLIN W, 1989, J BACTERIOL, V171, P2003, DOI 10.1128/jb.171.4.2003-2018.1989; MARRS CF, 1990, VIROLOGY, V174, P192, DOI 10.1016/0042-6822(90)90068-3; MATHEE K, 1990, J BACTERIOL, V172, P6641, DOI 10.1128/jb.172.12.6641-6650.1990; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2002.5437; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; Paolozzi L, 2006, BACTERIOPHAGES, P469; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Ramesh V, 1996, J MOL BIOL, V260, P22, DOI 10.1006/jmbi.1996.0379; REIDHAAROLSON JF, 1991, METHOD ENZYMOL, V208, P564; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; ROBERTS MS, 1988, J VIROL, V62, P4307, DOI 10.1128/JVI.62.11.4307-4320.1988; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Schumacher MA, 1997, J BIOL CHEM, V272, P22648, DOI 10.1074/jbc.272.36.22648; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; STODDARD SF, 1989, J BACTERIOL, V171, P3440, DOI 10.1128/jb.171.6.3440-3448.1989; Suzuki M, 1996, J MOL BIOL, V255, P677, DOI 10.1006/jmbi.1996.0055; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Vila R, 2002, PROTEIN SCI, V11, P214, DOI 10.1110/ps.29602; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Waheed I, 1998, VIROLOGY, V252, P235, DOI 10.1006/viro.1998.9448; WELCH JJ, 1994, J BIOL CHEM, V269, P31051; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; Wyrwicz LS, 2007, ACTA BIOCHIM POL, V54, P551, DOI 10.18388/abp.2007_3228; Yan BX, 1997, J BIOL CHEM, V272, P3190, DOI 10.1074/jbc.272.6.3190; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhou YZ, 2008, J MOL BIOL, V381, P174, DOI 10.1016/j.jmb.2008.05.084	69	1	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35852	35862		10.1074/jbc.M111.269860	http://dx.doi.org/10.1074/jbc.M111.269860			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21859715	Green Published, hybrid			2022-12-27	WOS:000295927100058
J	Murayama, T; Kurebayashi, N; Oba, T; Oyamada, H; Oguchi, K; Sakurai, T; Ogawa, Y				Murayama, Takashi; Kurebayashi, Nagomi; Oba, Toshiharu; Oyamada, Hideto; Oguchi, Katsuji; Sakurai, Takashi; Ogawa, Yasuo			Role of Amino-terminal Half of the S4-S5 Linker in Type 1 Ryanodine Receptor (RyR1) Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; CONTINUUM SECONDARY STRUCTURE; CA2+-INDUCED CA2+ RELEASE; CENTRAL CORE DISEASE; SKELETAL-MUSCLE; MALIGNANT HYPERTHERMIA; CALCIUM-RELEASE; POSTULATED ROLE; VOLTAGE SENSOR; CONTRACTION	The type 1 ryanodine receptor (RyR1) is a Ca2+ release channel found in the sarcoplasmic reticulum of skeletal muscle and plays a pivotal role in excitation-contraction coupling. The RyR1 channel is activated by a conformational change of the dihydropyridine receptor upon depolarization of the transverse tubule, or by Ca2+ itself, i.e. Ca2+-induced Ca2+ release (CICR). The molecular events transmitting such signals to the ion gate of the channel are unknown. The S4-S5 linker, a cytosolic loop connecting the S4 and S5 transmembrane segments in six-transmembrane type channels, forms an alpha-helical structure and mediates signal transmission in a wide variety of channels. To address the role of the S4-S5 linker in RyR1 channel gating, we performed alanine substitution scan of N-terminal half of the putative S4-S5 linker (Thr(4825)-Ser(4829)) that exhibits high helix probability. The mutant RyR1 was expressed in HEK cells, and CICR activity was investigated by caffeine-induced Ca2(+) release, single-channel current recordings, and [H-3] ryanodine binding. Four mutants (T4825A, I4826A, S4828A, and S4829A) had reduced CICR activity without changing Ca2+ sensitivity, whereas the L4827A mutant formed a constitutive active channel. T4825I, a disease-associated mutation for malignant hyperthermia, exhibited enhanced CICR activity. An alpha-helical wheel representation of the N-terminal S4-S5 linker provides a rational explanation to the observed activities of the mutants. These results suggest that N-terminal half of the S4-S5 linker may form an alpha-helical structure and play an important role in RyR1 channel gating.	[Murayama, Takashi] Juntendo Univ, Dept Cellular & Mol Pharmacol, Grad Sch Med, Bunkyo Ku, Tokyo 1138421, Japan; [Oba, Toshiharu] Nagoya City Univ, Dept Cell Physiol, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan; [Oyamada, Hideto; Oguchi, Katsuji] Showa Univ, Sch Med, Dept Pharmacol, Tokyo 1428555, Japan	Juntendo University; Nagoya City University; Showa University	Murayama, T (corresponding author), Juntendo Univ, Dept Cellular & Mol Pharmacol, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	takashim@juntendo.ac.jp			Japan Society for the Promotion of Science; Japan Science and Technology Agency; Vehicle Racing Commemorative Foundation; Sportology Center, Juntendo University Graduate School of Medicine	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Vehicle Racing Commemorative Foundation; Sportology Center, Juntendo University Graduate School of Medicine	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, the Japan Science and Technology Agency (to T. M.), the Vehicle Racing Commemorative Foundation (to N. K.), and the Sportology Center, Juntendo University Graduate School of Medicine (to N. K. and T. S.).	Boden M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-68; Boden M, 2006, BIOINFORMATICS, V22, P1809, DOI 10.1093/bioinformatics/btl198; Boukalova S, 2010, J BIOL CHEM, V285, P41455, DOI 10.1074/jbc.M110.145466; Brown RL, 2000, HUM MOL GENET, V9, P1515, DOI 10.1093/hmg/9.10.1515; Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; Hamada T, 2007, BIOCHEMISTRY-US, V46, P4272, DOI 10.1021/bi061557f; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kusch J, 2010, BIOPHYS J, V99, P2488, DOI 10.1016/j.bpj.2010.07.041; Lee EH, 2007, EXP MOL MED, V39, P594, DOI 10.1038/emm.2007.65; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Murayama T, 2005, AM J PHYSIOL-CELL PH, V288, pC1222, DOI 10.1152/ajpcell.00415.2004; Murayama T, 2000, BIOPHYS J, V78, P1810, DOI 10.1016/S0006-3495(00)76731-2; Murayama T, 2007, BIOCHEM J, V402, P349, DOI 10.1042/BJ20061040; Murayama T, 2011, PROG BIOPHYS MOL BIO, V105, P134, DOI 10.1016/j.pbiomolbio.2010.10.003; Muschol M, 1999, BIOPHYS J, V77, P577, DOI 10.1016/S0006-3495(99)76914-6; Oba T, 2004, AM J PHYSIOL-CELL PH, V286, pC1188, DOI 10.1152/ajpcell.00388.2003; OGAWA Y, 1994, CRIT REV BIOCHEM MOL, V29, P229, DOI 10.3109/10409239409083482; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; SCHNEIDER MF, 1994, ANNU REV PHYSIOL, V56, P463, DOI 10.1146/annurev.ph.56.030194.002335; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Sei Y, 2004, ANESTHESIOLOGY, V101, P824, DOI 10.1097/00000542-200410000-00005; Shepherd S, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.014274; Song DW, 2011, PROG BIOPHYS MOL BIO, V105, P145, DOI 10.1016/j.pbiomolbio.2010.09.021; Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	36	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35571	35577		10.1074/jbc.M111.255240	http://dx.doi.org/10.1074/jbc.M111.255240			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862589	Green Published, hybrid			2022-12-27	WOS:000295927100029
J	Zhang, W; Peng, G; Lin, SY; Zhang, PM				Zhang, Wei; Peng, Guang; Lin, Shiaw-Yih; Zhang, Pumin			DNA Damage Response Is Suppressed by the High Cyclin-dependent Kinase 1 Activity in Mitotic Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; SPINDLE CHECKPOINT; END RESECTION; PROTEIN; PHOSPHORYLATION; EXIT; REPAIR; BRIT1/MCPH1; ACTIVATION; MECHANISM	DNA damage response (DDR) is vital for genomic stability, and its deficiency is linked to tumorigenesis. Extensive studies in interphase (G(1)-S-G(2)) mammalian cells have revealed the mechanisms of DDR in great detail; however, how mitotic cells respond to DNA damage remains less defined. We report here that a full DDR is suppressed in mitotic mammalian cells until telophase/cytokinesis. Although early DDR markers such as the phosphorylations of ataxia telangiectasia mutated (ATM) and histone H2A.x(H2AX) can be readily detected, the ionizing radiation-induced foci (IRIF) formation of late DDR markers such as breast cancer type 1 susceptibility protein (BRCA1) and p53-binding protein 1 (53BP1) are absent until the telophase/cytokinesis stage. We further showed that the IR-induced ubiquitination cascade around DNA damage sites did not occur in mitotic cells, which explains, at least in part, why BRCA1 and 53BP1 cannot be recruited to the damaged sites. These observations indicate that DDR is suppressed in mitotic cells after the step of gamma H2AX formation. Not surprisingly, we found that the absence of a full DDR in mitotic cells was associated with the high cyclin-dependent kinase 1 (CDK1) activities. More 53BP1 IRIF could be detected when the irradiated mitotic cells were treated with a CDK1 inhibitor. Further, the activation of CDK5 in interphase cells impedes the formation of 53BP1 IRIF. Together, these results suggest that the DDR is suppressed by the high CDK1 activity in mitotic mammalian cells.	[Zhang, Wei; Zhang, Pumin] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Peng, Guang; Lin, Shiaw-Yih] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77054 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Zhang, PM (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, 1 Baylor Plaza, Houston, TX 77030 USA.	pzhang@bcm.edu			National Institutes of Health [CA116097, CA122623]; NATIONAL CANCER INSTITUTE [R01CA116097, R01CA122623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA116097 and CA122623 (to P. Z.).	Anantha RW, 2008, P NATL ACAD SCI USA, V105, P12903, DOI 10.1073/pnas.0803001105; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bloecher A, 2000, NAT CELL BIOL, V2, P556, DOI 10.1038/35019601; Cerqueira A, 2009, J CELL BIOL, V187, P773, DOI 10.1083/jcb.200903033; Chang DC, 2003, J BIOL CHEM, V278, P37865, DOI 10.1074/jbc.M306376200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Deans AJ, 2006, CANCER RES, V66, P8219, DOI 10.1158/0008-5472.CAN-05-3945; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Duan Q, 2008, J BIOL CHEM, V283, P33585, DOI 10.1074/jbc.M803312200; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Furuya T, 2010, MOL CELL, V38, P500, DOI 10.1016/j.molcel.2010.05.009; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Huang XX, 2005, P NATL ACAD SCI USA, V102, P1065, DOI 10.1073/pnas.0409130102; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Johnson N, 2009, MOL CELL, V35, P327, DOI 10.1016/j.molcel.2009.06.036; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Krishnan R, 2000, GENETICS, V156, P489; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Myers JS, 2007, CANCER RES, V67, P6685, DOI 10.1158/0008-5472.CAN-07-0495; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Smith DS, 2002, TRENDS CELL BIOL, V12, P28, DOI 10.1016/S0962-8924(01)02181-X; Stephan H, 2009, NUCLEIC ACIDS RES, V37, P6028, DOI 10.1093/nar/gkp605; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; Wang YC, 2000, CURR BIOL, V10, P1379, DOI 10.1016/S0960-9822(00)00779-X; Wohlbold L, 2009, DNA REPAIR, V8, P1018, DOI 10.1016/j.dnarep.2009.04.009; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200	44	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35899	35905		10.1074/jbc.M111.267690	http://dx.doi.org/10.1074/jbc.M111.267690			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21878640	Green Published, hybrid			2022-12-27	WOS:000295927100063
J	Zheng, H; Qian, J; Baker, DP; Fuchs, SY				Zheng, Hui; Qian, Juan; Baker, Darren P.; Fuchs, Serge Y.			Tyrosine Phosphorylation of Protein Kinase D2 Mediates Ligand-inducible Elimination of the Type 1 Interferon Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION LOOP SER(744); PLECKSTRIN HOMOLOGY DOMAIN; DELTA PKC-DELTA; NF-KAPPA-B; ALPHA RECEPTOR; DEPENDENT ACTIVATION; SIGNAL-TRANSDUCTION; LEUKEMIA-CELLS; C-THETA; TYK2	Type 1 interferons (including IFN alpha/beta) activate their cell surface receptor to induce the intracellular signal transduction pathways that play an important role in host defenses against infectious agents and tumors. The extent of cellular responses to IFN alpha is limited by several important mechanisms including the ligand-stimulated and specific serine phosphorylation-dependent degradation of the IFNAR1 chain of Type 1 IFN receptor. Previous studies revealed that acceleration of IFNAR1 degradation upon IFN stimulation requires activities of tyrosine kinase TYK2 and serine/threonine protein kinase D2 (PKD2), whose recruitment to IFNAR1 is also induced by the ligand. Here we report that activation of PKD2 by IFN alpha (but not its recruitment to the receptor) depends on TYK2 catalytic activity. PKD2 undergoes IFN alpha-inducible tyrosine phosphorylation on specific phospho-acceptor site (Tyr-438) within the plekstrin homology domain. Activated TYK2 is capable of facilitating this phosphorylation in vitro. Tyrosine phosphorylation of PKD2 is required for IFN alpha-stimulated activation of this kinase as well as for efficient serine phosphorylation and degradation of IFNAR1 and ensuing restriction of the extent of cellular responses to IFN alpha.	[Zheng, Hui; Qian, Juan; Fuchs, Serge Y.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Zheng, Hui; Qian, Juan; Fuchs, Serge Y.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Baker, Darren P.] Biogen Idec Inc, Cambridge, MA 02142 USA	University of Pennsylvania; University of Pennsylvania; Biogen	Fuchs, SY (corresponding author), 380 S Univ Ave,Hill 316, Philadelphia, PA 19104 USA.	syfuchs@vet.upenn.edu	Zheng, Hui/ABD-6141-2021		National Institutes of Health [CA92900, CA142425]; NATIONAL CANCER INSTITUTE [R01CA142425, R01CA092900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA92900 and CA142425 (to S. Y. F.). All authors involved in this studies have no conflict of interest to declare except Dr. Darren P. Baker, who is a Biogen Idec employee and owns a company stock.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Agrawal M, 2011, CANCER-AM CANCER SOC, V117, P662, DOI 10.1002/cncr.25672; Arun SN, 2011, ONCOGENE, V30, P1586, DOI 10.1038/onc.2010.540; Bhattacharya S, 2010, J BIOL CHEM, V285, P2318, DOI 10.1074/jbc.M109.071498; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Coccia EM, 2006, CELL MOL BIOL, V52, P77, DOI 10.1170/T701; COLAMONICI OR, 1991, PHARMACOL THERAPEUT, V52, P227, DOI 10.1016/0163-7258(91)90010-J; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fuchs SY, 2005, CANCER METAST REV, V24, P329, DOI 10.1007/s10555-005-1581-0; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Goldman LA, 1999, J INTERF CYTOK RES, V19, P15, DOI 10.1089/107999099314379; Good LM, 2011, J AM ACAD DERMATOL, V64, P413, DOI 10.1016/j.jaad.2009.12.013; Huangfu Wei-Chun, 2010, Genes Cancer, V1, P725, DOI 10.1177/1947601910382901; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kaur S, 2005, EXP HEMATOL, V33, P550, DOI 10.1016/j.exphem.2005.01.014; KESSLER DS, 1991, J BIOL CHEM, V266, P23471; Kumar KGS, 2008, J BIOL CHEM, V283, P18566, DOI 10.1074/jbc.M800991200; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Kumar KGS, 2003, EMBO J, V22, P5480; Li Y, 2004, J BIOL CHEM, V279, P11074, DOI 10.1074/jbc.M312301200; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Lukashova V, 2001, J BIOL CHEM, V276, P24113, DOI 10.1074/jbc.M100720200; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Marijanovic Z, 2006, BIOCHEM J, V397, P31, DOI 10.1042/BJ20060272; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Parisien JP, 2002, J VIROL, V76, P4190, DOI 10.1128/JVI.76.9.4190-4198.2002; PFEFFER LM, 1991, PHARMACOL THERAPEUT, V52, P149, DOI 10.1016/0163-7258(91)90005-7; PFEFFER LM, 1991, P NATL ACAD SCI USA, V88, P7988, DOI 10.1073/pnas.88.18.7988; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Rani MRS, 1999, J BIOL CHEM, V274, P1891, DOI 10.1074/jbc.274.4.1891; REICH NC, 1990, P NATL ACAD SCI USA, V87, P8761, DOI 10.1073/pnas.87.22.8761; Rey O, 2004, J BIOL CHEM, V279, P34361, DOI 10.1074/jbc.M403265200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Soldatenkov VA, 1999, CANCER RES, V59, P5085; Srivastava KK, 2004, J BIOL CHEM, V279, P29911, DOI 10.1074/jbc.M401997200; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, J BIOL CHEM, V278, P17969, DOI 10.1074/jbc.M213224200; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Yan H, 1996, MOL CELL BIOL, V16, P2074; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Yuan JZ, 2002, BIOCHEM BIOPH RES CO, V291, P444, DOI 10.1006/bbrc.2002.6469; Yuen MF, 2011, J GASTROEN HEPATOL, V26, P138, DOI 10.1111/j.1440-1746.2010.06545.x; Zheng H, 2011, MOL CELL BIOL, V31, P710, DOI 10.1128/MCB.01154-10	58	29	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35733	35741		10.1074/jbc.M111.263608	http://dx.doi.org/10.1074/jbc.M111.263608			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865166	Green Published, hybrid			2022-12-27	WOS:000295927100046
J	Chen, JS; Song, J; Yuan, PX; Tian, QJ; Ji, YY; Ren-Patterson, R; Liu, GP; Sei, Y; Weinberger, DR				Chen, Jingshan; Song, Jian; Yuan, Peixiong; Tian, Qingjun; Ji, Yuanyuan; Ren-Patterson, Renee; Liu, Guangping; Sei, Yoshitasu; Weinberger, Daniel R.			Orientation and Cellular Distribution of Membrane-bound Catechol-O-methyltransferase in Cortical Neurons IMPLICATIONS FOR DRUG DEVELOPMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; PROTEIN EXPRESSION; DOPAMINE CLEARANCE; PREFRONTAL CORTEX; GENETIC-VARIATION; ENZYME-ACTIVITY; RAT-BRAIN; COMT; LIVER; INHIBITORS	Catechol-O-methyltransferase (COMT) is a key enzyme for inactivation and metabolism of catechols, including dopamine, norepinephrine, caffeine, and estrogens. It plays an important role in cognition, arousal, pain sensitivity, and stress reactivity in humans and in animal models. The human COMT gene is associated with a diverse spectrum of human behaviors and diseases from cognition and psychiatric disorders to chronic pain and cancer. There are two major forms of COMT proteins, membrane-bound (MB) COMT and soluble (S) COMT. MB-COMT is the main form in the brain. The cellular distribution of MB-COMT in cortical neurons remains unclear and the orientation of MB-COMT on the cellular membrane is controversial. In this study, we demonstrate that MB-COMT is located in the cell body and in axons and dendrites of rat cortical neurons. Analyses of MB-COMT orientation with computer simulation, flow cytometry and a cell surface enzyme assay reveal that the C-terminal catalytic domain of MB-COMT is in the extracellular space, which suggests that MB-COMT can inactivate synaptic and extrasynaptic dopamine on the surface of presynaptic and postsynaptic neurons. Finally, we show that the COMT inhibitor tolcapone induces cell death via the mechanism of apoptosis, and its cytotoxicity is dependent on dosage and correlated with COMT Val/Met genotypes in human lymphoblastoid cells. These results suggest that MB-COMT specific inhibitors can be developed and that tolcapone may be less hazardous at low doses and in specific genetic backgrounds.	[Chen, Jingshan; Song, Jian; Yuan, Peixiong; Tian, Qingjun; Ji, Yuanyuan; Ren-Patterson, Renee; Liu, Guangping; Sei, Yoshitasu; Weinberger, Daniel R.] NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Weinberger, DR (corresponding author), NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH, Room 3C-103A,10 Ctr Dr,MSC 1379, Bethesda, MD 20892 USA.	weinberd@mail.nih.gov			NIMH, National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002901] Funding Source: NIH RePORTER	NIMH, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIMH, National Institutes of Health Intramural Research Program.	Acuna Gonzalo, 2002, Pharmacogenomics Journal, V2, P327, DOI 10.1038/sj.tpj.6500123; Akil M, 2003, J NEUROSCI, V23, P2008; Apud JA, 2007, NEUROPSYCHOPHARMACOL, V32, P1011, DOI 10.1038/sj.npp.1301227; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Davies NM, 2004, J PHARM PHARM SCI, V7, P332; DINGEMANSE J, 1995, CLIN PHARMACOL THER, V57, P508, DOI 10.1016/0009-9236(95)90035-7; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Farmer John A, 2003, Curr Atheroscler Rep, V5, P96, DOI 10.1007/s11883-003-0079-x; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Goetz Christopher G., 1998, Neurology, V50, pS26; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; GROSSMAN MH, 1985, J NEUROCHEM, V44, P421, DOI 10.1111/j.1471-4159.1985.tb05432.x; Haasio K, 2002, EXP TOXICOL PATHOL, V54, P9, DOI 10.1078/0940-2993-00228; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Huotari M, 2002, EUR J NEUROSCI, V15, P246, DOI 10.1046/j.0953-816x.2001.01856.x; Kaenmaki M, 2010, J NEUROCHEM, V114, P1745, DOI 10.1111/j.1471-4159.2010.06889.x; KARHUNEN T, 1995, NEUROSCI LETT, V187, P57, DOI 10.1016/0304-3940(95)11337-V; Korlipara LVP, 2004, NEUROPHARMACOLOGY, V46, P562, DOI 10.1016/j.neuropharm.2003.10.015; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; LUNDSTROM K, 1991, DNA CELL BIOL, V10, P181, DOI 10.1089/dna.1991.10.181; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Myohanen TT, 2010, J NEUROCHEM, V113, P1632, DOI 10.1111/j.1471-4159.2010.06723.x; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nunes T, 2009, CLIN THER, V31, P2258, DOI 10.1016/j.clinthera.2009.10.019; Papaleo F, 2008, J NEUROSCI, V28, P8709, DOI 10.1523/JNEUROSCI.2077-08.2008; Parl FF, 2009, ANN NY ACAD SCI, V1155, P68, DOI 10.1111/j.1749-6632.2008.03676.x; Pasquier C, 1999, PROTEIN ENG, V12, P631, DOI 10.1093/protein/12.8.631; Scheen AJ, 2001, DIABETES METAB, V27, P305; Sei Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010789; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Slifstein M, 2008, MOL PSYCHIATR, V13, P821, DOI 10.1038/mp.2008.19; Soares-Da-Silva P, 2003, PHARMACOL TOXICOL, V92, P272, DOI 10.1034/j.1600-0773.2003.920604.x; Tammimaki A, 2011, BASIC CLIN PHARMACOL, V108, P2, DOI 10.1111/j.1742-7843.2010.00647.x; Tan HY, 2007, J NEUROSCI, V27, P13393, DOI 10.1523/JNEUROSCI.4041-07.2007; Tan Hao-Yang, 2009, Cogn Neuropsychiatry, V14, P277, DOI 10.1080/13546800903091665; Tunbridge EM, 2007, CEREB CORTEX, V17, P1206, DOI 10.1093/cercor/bhl032; Ulmanen I, 1997, EUR J BIOCHEM, V243, P452, DOI 10.1111/j.1432-1033.1997.0452a.x; ULMANEN I, 1991, EUR J BIOCHEM, V202, P1013, DOI 10.1111/j.1432-1033.1991.tb16464.x; Watkins P, 2000, NEUROLOGY, V55, pS51; Weinberger DR, 2005, CLIN THER, V27, pS8, DOI 10.1016/j.clinthera.2005.07.016; ZURCHER G, 1982, J NEUROCHEM, V38, P191, DOI 10.1111/j.1471-4159.1982.tb10871.x	44	52	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34752	34760		10.1074/jbc.M111.262790	http://dx.doi.org/10.1074/jbc.M111.262790			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846718	hybrid, Green Published			2022-12-27	WOS:000295406300029
J	Lake, RJ; Basheer, A; Fan, HY				Lake, Robert J.; Basheer, Asjad; Fan, Hua-Ying			Reciprocally Regulated Chromatin Association of Cockayne Syndrome Protein B and p53 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; DNA-DAMAGE; COUPLING FACTOR; CSB PROTEIN; IN-VIVO; TRANSCRIPTION; ELONGATION; BINDING; COMPLEXES	The Cockayne syndrome complementation group B (CSB) protein is an ATP-dependent chromatin remodeler with an essential function in transcription-coupled DNA repair, and mutations in the CSB gene are associated with Cockayne syndrome. The p53 tumor suppressor has been known to interact with CSB, and both proteins have been implicated in overlapping biological processes, such as DNA repair and aging. The significance of the interaction between CSB and p53 has remained unclear, however. Here, we show that the chromatin association of CSB and p53 is inversely related. Using in vitro binding and chromatin immunoprecipitation approaches, we demonstrate that CSB facilitates the sequence-independent association of p53 with chromatin when p53 concentrations are low and that this is achieved by the interaction of CSB with the C-terminal region of p53. Remarkably, p53 prevents CSB from binding to nucleosomes when p53 concentrations are elevated. Examining the enzymatic properties of CSB revealed that p53 excludes CSB from nucleosomes by occluding a nucleosome interaction surface on CSB. Together, our results suggest that the reciprocal regulation of chromatin access by CSB and p53 could be part of a mechanism by which these two proteins coordinate their activities to regulate DNA repair, cell survival, and aging.	[Lake, Robert J.; Basheer, Asjad; Fan, Hua-Ying] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Fan, HY (corresponding author), Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, 564 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	hfan@mail.med.upenn.edu			National Institutes of Health [GM 084983]; University of Pennsylvania; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 084983 (to H.-Y.F.). This work was also supported by the Academic Development Fund of the University of Pennsylvania.	Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Fan HY, 2005, MOL CELL, V17, P805, DOI 10.1016/j.molcel.2005.02.024; Fan HY, 2003, MOL CELL, V11, P1311, DOI 10.1016/S1097-2765(03)00192-8; Filippi S, 2008, EMBO J, V27, P2545, DOI 10.1038/emboj.2008.180; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; FORD JM, 1995, P NATL ACAD SCI USA, V92, P8876, DOI 10.1073/pnas.92.19.8876; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Fresht A., 1998, STRUCTURE MECH PROTE; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hogan C, 2007, MUTAT RES-FUND MOL M, V618, P41, DOI 10.1016/j.mrfmmm.2006.07.010; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; KERN SE, 1991, ONCOGENE, V6, P131; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lake RJ, 2010, MOL CELL, V37, P235, DOI 10.1016/j.molcel.2009.10.027; LEE S, 1995, CELL, V81, P1013, DOI 10.1016/S0092-8674(05)80006-6; Lee SK, 2001, MOL CELL BIOL, V21, P8651, DOI 10.1128/MCB.21.24.8651-8656.2001; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Licht CL, 2003, AM J HUM GENET, V73, P1217, DOI 10.1086/380399; Liu YG, 2001, CARCINOGENESIS, V22, P851, DOI 10.1093/carcin/22.6.851; Mattia M, 2007, MOL CELL BIOL, V27, P1309, DOI 10.1128/MCB.01520-06; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; Narlikar GJ, 2001, MOL CELL, V8, P1219, DOI 10.1016/S1097-2765(01)00412-9; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Newman JC, 2006, P NATL ACAD SCI USA, V103, P9613, DOI 10.1073/pnas.0510909103; Peterson CL, 2002, EMBO REP, V3, P319, DOI 10.1093/embo-reports/kvf075; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Selivanova G, 1996, NUCLEIC ACIDS RES, V24, P3560, DOI 10.1093/nar/24.18.3560; SHRADER TE, 1989, P NATL ACAD SCI USA, V86, P7418, DOI 10.1073/pnas.86.19.7418; Stevnsner T, 2008, MECH AGEING DEV, V129, P441, DOI 10.1016/j.mad.2008.04.009; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Tafvizi A, 2008, BIOPHYS J, V95, pL1, DOI 10.1529/biophysj.108.134122; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; Therrien JP, 1999, P NATL ACAD SCI USA, V96, P15038, DOI 10.1073/pnas.96.26.15038; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; Vigneron A, 2010, AGING-US, V2, P471, DOI 10.18632/aging.100189; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; Yu AD, 2000, MOL CELL, V5, P801, DOI 10.1016/S1097-2765(00)80320-2; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021	43	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34951	34958		10.1074/jbc.M111.252643	http://dx.doi.org/10.1074/jbc.M111.252643			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21852235	Green Published, hybrid			2022-12-27	WOS:000295406300049
J	Mukerjee, R; Chang, JR; Del Valle, L; Bagashev, A; Gayed, MM; Lyde, RB; Hawkins, BJ; Brailoiu, E; Cohen, E; Power, C; Azizi, SA; Gelman, BB; Sawaya, BE				Mukerjee, Ruma; Chang, J. Robert; Del Valle, Luis; Bagashev, Asen; Gayed, Monika M.; Lyde, Randolph B.; Hawkins, Brian J.; Brailoiu, Eugen; Cohen, Eric; Power, Chris; Azizi, S. Ausim; Gelman, Benjamin B.; Sawaya, Bassel E.			Deregulation of microRNAs by HIV-1 Vpr Protein Leads to the Development of Neurocognitive Disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEURONAL INJURY; RECEPTOR; BRAIN; EXPRESSION; APOPTOSIS; INVOLVEMENT; DEATH; STEM; P53	Studies have shown that HIV-infected patients develop neurocognitive disorders characterized by neuronal dysfunction. The lack of productive infection of neurons by HIV suggests that viral and cellular proteins, with neurotoxic activities, released from HIV-1-infected target cells can cause this neuronal deregulation. The viral protein R (Vpr), a protein encoded by HIV-1, has been shown to alter the expression of various important cytokines and inflammatory proteins in infected and uninfected cells; however the mechanisms involved remain unclear. Using a human neuronal cell line, we found that Vpr can be taken up by neurons causing: (i) deregulation of calcium homeostasis, (ii) endoplasmic reticulum-calcium release, (iii) activation of the oxidative stress pathway, (iv) mitochondrial dysfunction and v-synaptic retraction. In search for the cellular factors involved, we performed microRNAs and gene array assays using human neurons (primary cultures or cell line, SH-SY5Y) that we treated with recombinant Vpr proteins. Interestingly, Vpr deregulates the levels of several microRNAs (e. g. miR-34a) and their target genes (e. g. CREB), which could lead to neuronal dysfunctions. Therefore, we conclude that Vpr plays a major role in neuronal dysfunction through deregulating microRNAs and their target genes, a phenomenon that could lead to the development of neurocognitive disorders.	[Mukerjee, Ruma; Chang, J. Robert; Bagashev, Asen; Gayed, Monika M.; Lyde, Randolph B.; Azizi, S. Ausim; Sawaya, Bassel E.] Temple Univ, Sch Med, Mol Studies Neurodegenerat Dis Lab, Dept Neurol, 3420 N Broad St MRB 719, Philadelphia, PA 19140 USA; [Brailoiu, Eugen] Temple Univ, Sch Med, Mol Studies Neurodegenerat Dis Lab, Dept Pharmacol, Philadelphia, PA 19140 USA; [Del Valle, Luis] Louisiana State Univ, Sch Med, Stanley S Scott Canc Ctr, Dept Med,Sect Hematol Oncol, New Orleans, LA 70112 USA; [Del Valle, Luis] Louisiana State Univ, Sch Med, Stanley S Scott Canc Ctr, Dept Pathol, New Orleans, LA 70112 USA; [Hawkins, Brian J.] Univ Washington, Mitochondria & Metab Ctr, Seattle, WA 98109 USA; [Cohen, Eric] Univ Montreal, IRCM, Quebec City, PQ, Canada; [Cohen, Eric] Univ Montreal, Dept Microbiol & Immunol, Quebec City, PQ, Canada; [Power, Chris] Univ Alberta, Dept Med Neurol Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada; [Power, Chris] Univ Alberta, Dept Psychiat, Edmonton, AB T6G 2S2, Canada; [Gelman, Benjamin B.] Univ Texas, Med Branch, Texas NeuroAIDS Res Ctr, Dept Pathol & Neurosci, Galveston, TX 77555 USA; [Gelman, Benjamin B.] Univ Texas, Med Branch, Texas NeuroAIDS Res Ctr, Dept Cell Biol, Galveston, TX 77555 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Louisiana State University System; Louisiana State University System; University of Washington; University of Washington Seattle; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; University of Alberta; University of Alberta; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Sawaya, BE (corresponding author), Temple Univ, Sch Med, Mol Studies Neurodegenerat Dis Lab, Dept Neurol, 3420 N Broad St MRB 719, Philadelphia, PA 19140 USA.	sawaya@temple.edu	Power, Christopher/C-7181-2013; Bagashev, Asen/D-2913-2011; Del Valle, Luis/J-4085-2015	Bagashev, Asen/0000-0001-9900-8106; Del Valle, Luis/0000-0003-3894-9206; Azizi, Sayed/0000-0002-0888-5013; Power, Christopher/0000-0002-5131-9711	National Institutes of Health [R01-NS059327]; Harvard Catalyst; Harvard Clinical and Translational Science Center (National Institutes of Health, Harvard University and its affiliated academic health care centers) [UL1 RR 025758]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL094536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH083545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst; Harvard Clinical and Translational Science Center (National Institutes of Health, Harvard University and its affiliated academic health care centers)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NINDS, R01-NS059327 (to B. E. S.). This work was also conducted with support from Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Institutes of Health Award UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers).	Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Anthony IC, 2008, INT REV PSYCHIATR, V20, P15, DOI 10.1080/09540260701862037; Aquaro Stefano, 2008, Recent Pat CNS Drug Discov, V3, P23; Barbato C, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/871313; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Brailoiu GC, 2011, J BIOL CHEM, V286, P29166, DOI 10.1074/jbc.M110.217463; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Carter CC, 2011, CELL HOST MICROBE, V9, P223, DOI 10.1016/j.chom.2011.02.005; Cheng XD, 2007, DNA CELL BIOL, V26, P116, DOI 10.1089/dna.2006.0541; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; Dickie P, 2004, VIROLOGY, V322, P69, DOI 10.1016/j.virol.2004.01.026; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Everall I, 2009, J NEUROVIROL, V15, P360, DOI 10.3109/13550280903131915; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Han Y, 2007, NAT MED, V13, P1138, DOI 10.1038/nm1007-1138; Henklein P, 2000, J BIOL CHEM, V275, P32016, DOI 10.1074/jbc.M004044200; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Jacquot G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-84; Jones GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007; Kaul M, 2008, FRONT BIOSCI-LANDMRK, V13, P2484, DOI 10.2741/2860; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kitayama H, 2008, J VIROL, V82, P2528, DOI 10.1128/JVI.02094-07; Kriz J, 2000, BRAIN RES, V885, P32, DOI 10.1016/S0006-8993(00)02899-7; Lau P, 2010, SEMIN CELL DEV BIOL, V21, P768, DOI 10.1016/j.semcdb.2010.01.009; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Moser JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013445; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Pandey RC, 2009, CURR HIV RES, V7, P114, DOI 10.2174/157016209787581508; Poluektova L, 2005, GLIA, V52, P344, DOI 10.1002/glia.20253; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; Rom I, 2009, BRAIN RES, V1275, P81, DOI 10.1016/j.brainres.2009.03.024; Rossbach M, 2010, CURR MOL MED, V10, P361, DOI 10.2174/156652410791317048; Sabbah EN, 2005, J NEUROVIROL, V11, P489, DOI 10.1080/13550280500384941; Sawaya BE, 1998, J BIOL CHEM, V273, P20052, DOI 10.1074/jbc.273.32.20052; Schipper HM, 2007, GENE REGUL SYST BIO, V1, P263; Singh SK, 2007, PHARMACOGENOMICS, V8, P971, DOI 10.2217/14622416.8.8.971; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Sonntag KC, 2010, BRAIN RES, V1338, P48, DOI 10.1016/j.brainres.2010.03.106; Stallings RL, 2009, CURR PHARM DESIGN, V15, P456, DOI 10.2174/138161209787315837; Sun FN, 2010, MOL CELL PROTEOMICS, V9, P963, DOI 10.1074/mcp.R900003-MCP200; Vivithanaporn P, 2010, NEUROLOGY, V75, P1150, DOI 10.1212/WNL.0b013e3181f4d5bb; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wheeler EDA, 2006, J NEUROVIROL, V12, P200, DOI 10.1080/13550280600827377; Yamaguchi A, 1999, J CELL BIOL, V147, P1195, DOI 10.1083/jcb.147.6.1195; Yamakage M, 2002, CAN J ANAESTH, V49, P151, DOI 10.1007/BF03020488; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Zhao RY, 2007, ADV PHARMACOL, V55, P233, DOI 10.1016/S1054-3589(07)55007-6; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131; Zieg J, 2008, CELL, V134, DOI 10.1016/j.cell.2008.09.010	54	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34976	34985		10.1074/jbc.M111.241547	http://dx.doi.org/10.1074/jbc.M111.241547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21816823	Green Published, hybrid			2022-12-27	WOS:000295406300051
J	Takahata, S; Yu, YX; Stillman, DJ				Takahata, Shinya; Yu, Yaxin; Stillman, David J.			Repressive Chromatin Affects Factor Binding at Yeast HO (Homothallic Switching) Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; CELL-CYCLE; RNA-POLYMERASE; ASYMMETRIC ACCUMULATION; MEDIATOR COMPLEX; II ELONGATION; HISTONE H4; IN-VIVO; ACTIVATION	The yeast HO gene is tightly regulated, with multiple activators and coactivators needed to overcome repressive chromatin structures that form over this promoter. Coactivator binding is strongly interdependent, as loss of one factor sharply reduces recruitment of other factors. The Rpd3(L) histone deacetylase is recruited to HO at two distinct times during the cell cycle, first by Ash1 to the URS1 region of the promoter and then by SBF/Whi5/Stb1 to URS2. SBF itself is localized to only a subset of its potential binding sites in URS2, and this localization takes longer and is less robust than at other SBF target genes, suggesting that binding to the HO promoter is limited by chromatin structures that dynamically change as the cell cycle progresses. Ash1 only binds at the URS1 region of the promoter, but an ash1 mutation results in markedly increased binding of SBF and Rpd3(L) at URS2, some 450 bp distant from the site of Ash1 binding, suggesting these two regions of the promoter interact. An ash1 mutation also results in increased coactivator recruitment, Swi/Snf and Mediator localization in the absence of the normally required Gcn5 histone acetyltransferase, and HO expression even in the presence of a taf1 mutation affecting TFIID activity that otherwise blocks HO transcription. Ash1 therefore appears to play a central role in generating the strongly repressive environment at the HO promoter, which limits the binding of several coactivators at URS2 and TATA region.	[Takahata, Shinya; Yu, Yaxin; Stillman, David J.] Univ Utah, Dept Pathol, Hlth Sci Ctr, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Stillman, DJ (corresponding author), Univ Utah, Dept Pathol, Hlth Sci Ctr, 15 N Med Dr E, Salt Lake City, UT 84112 USA.	david.stillman@path.utah.edu		Stillman, David/0000-0002-5268-2416	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health grants.	Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bai L, 2011, MOL CELL, V42, P465, DOI 10.1016/j.molcel.2011.03.028; Bhoite LT, 2002, J BIOL CHEM, V277, P37612, DOI 10.1074/jbc.M206125200; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Biddick RK, 2008, J BIOL CHEM, V283, P33101, DOI 10.1074/jbc.M805258200; Biswas D, 2008, MOL CELL BIOL, V28, P4445, DOI 10.1128/MCB.00164-08; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Carrozza MJ, 2005, BBA-GENE STRUCT EXPR, V1731, P77, DOI 10.1016/j.bbaexp.2005.09.005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chandarlapaty S, 1998, MOL CELL BIOL, V18, P2884, DOI 10.1128/MCB.18.5.2884; Cosma MP, 2004, EMBO REP, V5, P953, DOI 10.1038/sj.embor.7400251; Cosma MP, 2001, MOL CELL, V7, P1213, DOI 10.1016/S1097-2765(01)00266-0; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Bruin RAM, 2008, MOL CELL BIOL, V28, P6919, DOI 10.1128/MCB.00211-08; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Di Talia S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000221; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Dorland S, 2000, GENETICS, V154, P573; Eriksson P, 2004, MOL CELL BIOL, V24, P6419, DOI 10.1128/MCB.24.14.6419-6429.2004; Formosa T, 2008, MOL BIOSYST, V4, P1085, DOI 10.1039/b812136b; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Hallberg M, 2006, MOL GENET GENOMICS, V276, P197, DOI 10.1007/s00438-006-0135-7; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Liu QQ, 2011, MOL CELL BIOL, V31, P584, DOI 10.1128/MCB.00845-10; Lorch Y, 2000, MOL CELL, V6, P197, DOI 10.1016/S1097-2765(00)00021-6; McBride HJ, 2001, MOL MICROBIOL, V42, P345, DOI 10.1046/j.1365-2958.2001.02601.x; Mitra D, 2006, MOL CELL BIOL, V26, P4095, DOI 10.1128/MCB.01849-05; NASMYTH K, 1985, CELL, V42, P213, DOI 10.1016/S0092-8674(85)80117-3; Ornaghi P, 1999, J MOL BIOL, V287, P1, DOI 10.1006/jmbi.1999.2577; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pan XW, 2000, MOL CELL BIOL, V20, P8364, DOI 10.1128/MCB.20.22.8364-8372.2000; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; Qiu HF, 2005, MOL CELL BIOL, V25, P3461, DOI 10.1128/MCB.25.9.3461-3474.2005; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sidorova J, 1999, GENETICS, V151, P45; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; STILLMAN DJ, 1994, GENETICS, V136, P781; TABA MRM, 1991, GENE DEV, V5, P2000, DOI 10.1101/gad.5.11.2000; Takahata S, 2009, EMBO J, V28, P3378, DOI 10.1038/emboj.2009.270; Takahata S, 2009, MOL CELL, V34, P405, DOI 10.1016/j.molcel.2009.04.010; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Verdone L, 2002, EMBO J, V21, P1101, DOI 10.1093/emboj/21.5.1101; Voth WP, 2007, EMBO J, V26, P4324, DOI 10.1038/sj.emboj.7601859; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606	57	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34809	34819		10.1074/jbc.M111.281626	http://dx.doi.org/10.1074/jbc.M111.281626			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21840992	Green Published, hybrid			2022-12-27	WOS:000295406300035
J	Low, LY; Yang, C; Perego, M; Osterman, A; Liddington, R				Low, Lieh Yoon; Yang, Chen; Perego, Marta; Osterman, Andrei; Liddington, Robert			Role of Net Charge on Catalytic Domain and Influence of Cell Wall Binding Domain on Bactericidal Activity, Specificity, and Host Range of Phage Lysins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEINS; LACTOCOCCUS-LACTIS PHAGES; MAJOR PHYSIOLOGICAL-ROLE; LYTIC ENZYME CPL-1; BACILLUS-ANTHRACIS; CRYSTAL-STRUCTURE; STREPTOCOCCUS-PNEUMONIAE; TEICHOIC-ACID; BACTERIOPHAGE ENDOLYSINS; ANTIBACTERIAL PROPERTIES	The recombinant lysins of lytic phages, when applied externally to Gram-positive bacteria, can be efficient bactericidal agents, typically retaining high specificity. Their development as novel antibacterial agents offers many potential advantages over conventional antibiotics. Protein engineering could exploit this potential further by generating novel lysins fit for distinct target populations and environments. However, access to the peptidoglycan layer is controlled by a variety of secondary cell wall polymers, chemical modifications, and (in some cases) S-layers and capsules. Classical lysins require a cell wall-binding domain (CBD) that targets the catalytic domain to the peptidoglycan layer via binding to a secondary cell wall polymer component. The cell walls of Gram-positive bacteria generally have a negative charge, and we noticed a correlation between (positive) charge on the catalytic domain and bacteriolytic activity in the absence of the CBD (nonclassical behavior). We investigated a physical basis for this correlation by comparing the structures and activities of pairs of lysins where the lytic activity of one of each pair was CBD-independent. We found that by engineering a reversal of sign of the net charge of the catalytic domain, we could either eliminate or create CBD dependence. We also provide evidence that the S-layer of Bacillus anthracis acts as a molecular sieve that is chiefly size-dependent, favoring catalytic domains over full-length lysins. Our work suggests a number of facile approaches for fine-tuning lysin activity, either to enhance or reduce specificity/host range and/or bactericidal potential, as required.	[Low, Lieh Yoon; Yang, Chen; Osterman, Andrei; Liddington, Robert] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Perego, Marta] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute	Liddington, R (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	liehyoon@gmail.com; rlidding@sanfordburnham.org			National Institutes of Health, NIAID [AI055789, AI055860]; United States Army Medical Research and Materiel Command [DAMD17-03-2-0038]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055789, R01AI055860] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI055789 and AI055860 from NIAID. This work was also supported by United States Army Medical Research and Materiel Command Grant DAMD17-03-2-0038.	Alcantara EH, 2007, J BIOCHEM MOL BIOL, V40, P539; Becker SC, 2009, GENE, V443, P32, DOI 10.1016/j.gene.2009.04.023; Beers SA, 2002, J BIOL CHEM, V277, P1788, DOI 10.1074/jbc.M109777200; Bernhardt TG, 2002, RES MICROBIOL, V153, P493, DOI 10.1016/S0923-2508(02)01330-X; Bhavsar AP, 2004, J BACTERIOL, V186, P7865, DOI 10.1128/JB.186.23.7865-7873.2004; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; BRAU B, 1991, APPL MICROBIOL BIOT, V34, P481; Briers Y, 2009, BIOCHEM BIOPH RES CO, V383, P187, DOI 10.1016/j.bbrc.2009.03.161; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buckland AG, 2000, BBA-MOL CELL BIOL L, V1488, P71, DOI 10.1016/S1388-1981(00)00111-6; Buckland AG, 2000, BBA-MOL CELL BIOL L, V1484, P195, DOI 10.1016/S1388-1981(00)00018-4; Claus H, 2005, CAN J MICROBIOL, V51, P731, DOI 10.1139/W05-093; DeLano W.L., 2005, PYMOL MOL GRAPHICS S; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; DIAZ E, 1990, P NATL ACAD SCI USA, V87, P8125, DOI 10.1073/pnas.87.20.8125; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Djurkovic S, 2005, ANTIMICROB AGENTS CH, V49, P1225, DOI 10.1128/AAC.49.3.1225-1228.2005; Donovan DM, 2006, FEMS MICROBIOL LETT, V265, P133, DOI 10.1111/j.1574-6968.2006.00483.x; Donovan DM, 2006, APPL ENVIRON MICROB, V72, P5108, DOI 10.1128/AEM.03065-05; Dziarski R, 2010, INNATE IMMUN-LONDON, V16, P168, DOI 10.1177/1753425910366059; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ETIENNETOUMELIN I, 1995, J BACTERIOL, V177, P614, DOI 10.1128/jb.177.3.614-620.1995; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Foreman-Wykert AK, 1999, J CLIN INVEST, V103, P715, DOI 10.1172/JCI5468; Fouet A, 2009, MOL ASPECTS MED, V30, P374, DOI 10.1016/j.mam.2009.07.001; GARCIA P, 1990, GENE, V86, P81, DOI 10.1016/0378-1119(90)90116-9; GROMAN NB, 1962, J BACTERIOL, V84, P596, DOI 10.1128/JB.84.3.596-597.1962; GROMAN NB, 1963, J BACTERIOL, V86, P187, DOI 10.1128/JB.86.2.187-194.1963; Guan RJ, 2006, PROTEIN SCI, V15, P1199, DOI 10.1110/ps.062077606; Guan RJ, 2007, TRENDS MICROBIOL, V15, P127, DOI 10.1016/j.tim.2007.01.006; Hermoso JA, 2003, STRUCTURE, V11, P1239, DOI 10.1016/j.str.2003.09.005; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; HUDSON IRB, 1994, J HOSP INFECT, V27, P81, DOI 10.1016/0195-6701(94)90001-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kerff F, 2010, J MOL BIOL, V397, P249, DOI 10.1016/j.jmb.2009.12.038; Kern J, 2010, J MOL BIOL, V401, P757, DOI 10.1016/j.jmb.2010.06.059; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Koch AL, 2003, TRENDS MICROBIOL, V11, P166, DOI 10.1016/S0966-842X(03)00063-5; Koprivnjak T, 2008, INFECT IMMUN, V76, P2169, DOI 10.1128/IAI.01705-07; Korndorfer IP, 2006, J MOL BIOL, V364, P678, DOI 10.1016/j.jmb.2006.08.069; KOZACK RE, 1995, BIOPHYS J, V68, P807, DOI 10.1016/S0006-3495(95)80257-2; Kumar S, 2005, J BIOL CHEM, V280, P37005, DOI 10.1074/jbc.M506385200; Lambert PA, 2002, J APPL MICROBIOL, V92, p46S, DOI 10.1046/j.1365-2672.92.5s1.7.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leoff C, 2008, J BIOL CHEM, V283, P29812, DOI 10.1074/jbc.M803234200; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loeffler JM, 2003, INFECT IMMUN, V71, P6199, DOI 10.1128/IAI.71.11.6199-6204.2003; Loessner MJ, 1997, J BACTERIOL, V179, P2845, DOI 10.1128/jb.179.9.2845-2851.1997; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; LONGCHAMP PF, 1994, MICROBIOL-UK, V140, P1855, DOI 10.1099/13500872-140-8-1855; Lopez R, 1997, MICROB DRUG RESIST, V3, P199, DOI 10.1089/mdr.1997.3.199; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyston PCF, 2009, J MED MICROBIOL, V58, P977, DOI 10.1099/jmm.0.011122-0; Pastagia M, 2011, ANTIMICROB AGENTS CH, V55, P738, DOI 10.1128/AAC.00890-10; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Perez-Dorado I, 2007, J BIOL CHEM, V282, P24990, DOI 10.1074/jbc.M704317200; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Porter CJ, 2007, J MOL BIOL, V366, P540, DOI 10.1016/j.jmb.2006.11.056; Rashel M, 2007, J INFECT DIS, V196, P1237, DOI 10.1086/521305; Roy H, 2009, IUBMB LIFE, V61, P940, DOI 10.1002/iub.240; Saha S, 2009, CELL HOST MICROBE, V5, P137, DOI 10.1016/j.chom.2008.12.010; SANZ JM, 1992, BIOCHEMISTRY-US, V31, P8495, DOI 10.1021/bi00151a016; SANZ JM, 1992, MOL MICROBIOL, V6, P921, DOI 10.1111/j.1365-2958.1992.tb01542.x; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Scott JR, 2006, ANNU REV MICROBIOL, V60, P397, DOI 10.1146/annurev.micro.60.080805.142256; Severin A, 2004, MICROB DRUG RESIST, V10, P77, DOI 10.1089/1076629041310082; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; Sugahara K, 2007, GENE, V404, P41, DOI 10.1016/j.gene.2007.08.023; Swaminathan CP, 2006, P NATL ACAD SCI USA, V103, P684, DOI 10.1073/pnas.0507656103; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Tremblay DM, 2006, J BACTERIOL, V188, P2400, DOI 10.1128/JB.188.7.2400-2410.2006; Turner MS, 2004, FEMS MICROBIOL LETT, V238, P9, DOI 10.1016/j.femsle.2004.07.008; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Witzenrath M, 2009, CRIT CARE MED, V37, P642, DOI 10.1097/CCM.0b013e31819586a6; Yoong P, 2004, J BACTERIOL, V186, P4808, DOI 10.1128/JB.186.14.4808-4812.2004; Young R, 2000, TRENDS MICROBIOL, V8, P120, DOI 10.1016/S0966-842X(00)01705-4; YOUNG R, 1995, FEMS MICROBIOL REV, V17, P191, DOI 10.1016/0168-6445(94)00079-4	93	97	101	1	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34391	34403		10.1074/jbc.M111.244160	http://dx.doi.org/10.1074/jbc.M111.244160			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21816821	hybrid, Green Published			2022-12-27	WOS:000295159200067
J	Qian, YF; Shi, L; Tien, M				Qian, Yufeng; Shi, Liang; Tien, Ming			SO2907, a Putative TonB-dependent Receptor, Is Involved in Dissimilatory Iron Reduction by Shewanella oneidensis Strain MR-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-CATALYZED OXIDATION; EXTRACELLULAR ELECTRON-TRANSFER; MEMBRANE CYTOCHROMES MTRC; AMINO-ACID-RESIDUES; ANAEROBIC RESPIRATION; TETRAHEME CYTOCHROME; ESCHERICHIA-COLI; PROTEINS; BINDING; OUTER	Shewanella oneidensis strain MR-1 utilizes soluble and insoluble ferric ions as terminal electron acceptors during anaerobic respiration. The components of respiratory metabolism are localized in the membrane fractions which include the outer membrane and cytoplasmic membrane. Many of the biological components that interact with the various iron forms are proposed to be localized in these membrane fractions. To identify the iron-binding proteins acting either as an iron transporter or as a terminal iron reductase, we used metal-catalyzed oxidation reactions. This system catalyzed the oxidation of amino acids in close proximity to the iron binding site. The carbonyl groups formed from this oxidation can then be labeled with fluoresceinamine (FLNH2). The peptide harboring the FLNH2 can then be proteolytically digested, purified by HPLC and then identified by MALDI-TOF tandem MS. A predominant peptide was identified to be part of SO2907 that encodes a putative TonB-dependent receptor. Compared with wild type (wt), the so2907 gene deletion (Delta SO2907) mutant has impaired ability to reduce soluble Fe(III), but retains the same ability to respire oxygen or fumarate as the wt. The Delta SO2907 mutant was also impacted in reduction of insoluble iron. Iron binding assays using isothermal titration calorimetry and fluorescence tryptophan quenching demonstrated that a truncated form of heterologous-expressed SO2907 that contains the Fe(III) binding site, is capable of binding soluble Fe(III) forms with K-d of approximate 50 mu M. To the best of our knowledge, this is the first report of the physiological role of SO2907 in Fe(III) reduction by MR-1.	[Qian, Yufeng; Tien, Ming] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Shi, Liang] Pacific NW Natl Lab, Richland, WA 99352 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Tien, M (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	mxt3@psu.edu	Qian, Yufeng/F-3699-2012	Qian, Yufeng/0000-0002-9901-6154	NSF Environmental Molecular Sciences Institute through the Penn State Center for environmental Kinetics Analysis [CHE-0431328]; DOE [ER64399 0013153]	NSF Environmental Molecular Sciences Institute through the Penn State Center for environmental Kinetics Analysis; DOE(United States Department of Energy (DOE))	This work was supported by the NSF Environmental Molecular Sciences Institute program (CHE-0431328) through the Penn State Center for environmental Kinetics Analysis and by DOE Grant ER64399 0013153.	Ali FE, 2004, J INORG BIOCHEM, V98, P173, DOI 10.1016/j.jinorgbio.2003.10.002; AMICI A, 1989, J BIOL CHEM, V264, P3341; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; CAMPBELL JA, 1994, ANAL CHEM, V66, pA1208, DOI 10.1021/ac00096a711; CLIMENT I, 1989, ANAL BIOCHEM, V182, P226, DOI 10.1016/0003-2697(89)90584-8; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Fredrickson JK, 2004, GEOCHIM COSMOCHIM AC, V68, P3171, DOI 10.1016/j.gca.2003.10.024; Fredrickson JK, 2000, GEOCHIM COSMOCHIM AC, V64, P3085, DOI 10.1016/S0016-7037(00)00397-5; Gescher JS, 2008, MOL MICROBIOL, V68, P706, DOI 10.1111/j.1365-2958.2008.06183.x; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Gralnick JA, 2007, MOL MICROBIOL, V65, P1, DOI 10.1111/j.1365-2958.2007.05778.x; Jones ME, 2010, ENVIRON MICROBIOL, V12, P938, DOI 10.1111/j.1462-2920.2009.02137.x; Lies DP, 2005, APPL ENVIRON MICROB, V71, P4414, DOI 10.1128/AEM.71.8.4414-4426.2005; Lower BH, 2007, J BACTERIOL, V189, P4944, DOI 10.1128/JB.01518-06; Madigan M. T., 2000, BROCK BIOL MICROORGA; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Nancharaiah YV, 2006, WATER RES, V40, P1539, DOI 10.1016/j.watres.2006.02.006; Nealson K. H., 1997, GEOMICROBIOLOGY INTE; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Newton SMC, 1999, MOL MICROBIOL, V32, P1153, DOI 10.1046/j.1365-2958.1999.01424.x; PEALING SL, 1995, BIOCHEMISTRY-US, V34, P6153, DOI 10.1021/bi00018a018; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; PERRY AJ, 1973, J MATER SCI, V8, P904, DOI 10.1007/BF02397923; Postle K, 1999, NAT STRUCT BIOL, V6, P3, DOI 10.1038/4869; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6; Qian YF, 2011, BIOCHEMISTRY-US, V50, P6217, DOI 10.1021/bi2005015; Ruebush SS, 2006, APPL ENVIRON MICROB, V72, P2925, DOI 10.1128/AEM.72.4.2925-2935.2006; Schwalb C, 2003, BIOCHEMISTRY-US, V42, P9491, DOI 10.1021/bi034456f; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; STADTMAN ER, 1991, J BIOL CHEM, V266, P2005; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Taillefert M, 2007, J INORG BIOCHEM, V101, P1760, DOI 10.1016/j.jinorgbio.2007.07.020; Temple A, 2006, J AM SOC MASS SPECTR, V17, P1172, DOI 10.1016/j.jasms.2006.04.030; Tiedje JM, 2002, NAT BIOTECHNOL, V20, P1093, DOI 10.1038/nbt1102-1093; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; Wade R, 2000, FEMS MICROBIOL LETT, V184, P143, DOI 10.1111/j.1574-6968.2000.tb09005.x; Wang ZM, 2008, APPL ENVIRON MICROB, V74, P6746, DOI 10.1128/AEM.01454-08; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; WINZOR DJ, 1995, QUANTITATIVE CHARACT; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	45	7	8	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33973	33980		10.1074/jbc.M111.262113	http://dx.doi.org/10.1074/jbc.M111.262113			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21813652	Green Published, hybrid			2022-12-27	WOS:000295159200029
J	Wong, KE; Kong, J; Zhang, WS; Szeto, FL; Ye, HG; Deb, DK; Brady, MJ; Li, YC				Wong, Kari E.; Kong, Juan; Zhang, Wenshuo; Szeto, Frances L.; Ye, Honggang; Deb, Dilip K.; Brady, Matthew J.; Li, Yan Chun			Targeted Expression of Human Vitamin D Receptor in Adipocytes Decreases Energy Expenditure and Induces Obesity in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; MITOCHONDRIAL UNCOUPLING PROTEIN; ADIPOSE TRIGLYCERIDE LIPASE; KNOCKOUT MICE; 3T3-L1 CELLS; GENE; TISSUE; THERMOGENESIS; METABOLISM; TRIACYLGLYCEROL	Our previous studies demonstrated a high fat diet-resistant lean phenotype of vitamin D receptor (VDR)-null mutant mice mainly due to increased energy expenditure, suggesting an involvement of the VDR in energy metabolism. Here, we took a transgenic approach to further define the role of VDR in adipocyte biology. We used the aP2 gene promoter to target the expression of the human (h) VDR in adipocytes in mice. In contrast to the VDR-null mice, the aP2-hVDR Tg mice developed obesity compared with the wild-type counterparts without changes in food intake. The increase in fat mass was mainly due to markedly reduced energy expenditure, which was correlated with decreased locomotive activity and reduced fatty acid beta-oxidation and lipolysis in the adipose tissue in the transgenic mice. Consistently, the expression of genes involved in the regulation of fatty acid transport, thermogenesis, and lipolysis were suppressed in the transgenic mice. Taken together, these data confirm an important role of the VDR in the regulation of energy metabolism.	[Kong, Juan; Ye, Honggang; Deb, Dilip K.; Brady, Matthew J.; Li, Yan Chun] Univ Chicago, Dept Med, Div Biol Sci, Chicago, IL 60637 USA; [Wong, Kari E.; Zhang, Wenshuo; Szeto, Frances L.; Brady, Matthew J.; Li, Yan Chun] Univ Chicago, Comm Mol Metab & Nutr, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Li, YC (corresponding author), Univ Chicago, Dept Med, Div Biol Sci, 900 E 57th St,KCBD 9-9110, Chicago, IL 60637 USA.	cyan@medicine.bsd.uchicago.edu		Zhang, Wenshuo/0000-0002-5124-799X	National Institutes of Health [T32DK07074, R01HL085793, 5P60DK020595-34, 5P30CA014599-36]; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007074, P60DK020595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants T32DK07074 and R01HL085793. The Diabetes Research and Training Center at the University of Chicago was supported by National Institutes of Health Grant 5P60DK020595-34. The University of Chicago Transgenic Mouse Facility was supported in part by National Institutes of Health Grant 5P30CA014599-36.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Arunabh S, 2003, J CLIN ENDOCR METAB, V88, P157, DOI 10.1210/jc.2002-020978; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Blumberg JM, 2006, J BIOL CHEM, V281, P11205, DOI 10.1074/jbc.M510343200; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Brasaemle DL, 2010, CELL METAB, V11, P173, DOI 10.1016/j.cmet.2010.02.008; Clifford GM, 2000, J BIOL CHEM, V275, P5011, DOI 10.1074/jbc.275.7.5011; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; HOGAN B, 1986, MANIPULATING MOUSE E; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Kong J, 2006, AM J PHYSIOL-ENDOC M, V290, pE916, DOI 10.1152/ajpendo.00410.2005; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Li YC, 2001, AM J PHYSIOL-ENDOC M, V281, pE558, DOI 10.1152/ajpendo.2001.281.3.E558; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; ROSS SR, 1993, GENE DEV, V7, P1318, DOI 10.1101/gad.7.7b.1318; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Snijder MB, 2005, J CLIN ENDOCR METAB, V90, P4119, DOI 10.1210/jc.2005-0216; Soloveva V, 1997, MOL ENDOCRINOL, V11, P27, DOI 10.1210/me.11.1.27; Vidal-Puig AJ, 2000, NAT GENET, V26, P387, DOI 10.1038/82489; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wong KE, 2009, AM J PHYSIOL-ENDOC M, V296, pE820, DOI 10.1152/ajpendo.90763.2008; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1	34	134	140	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33804	33810		10.1074/jbc.M111.257568	http://dx.doi.org/10.1074/jbc.M111.257568			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21840998	Green Published, hybrid			2022-12-27	WOS:000295159200011
J	Nguyen, TTA; Nishitani, M; Harada, S; Yamaguchi, M; Kamei, K				Nguyen Thi Tu Anh; Nishitani, Maiko; Harada, Shigeharu; Yamaguchi, Masamitsu; Kamei, Kaeko			Essential Role of Duox in Stabilization of Drosophila Wing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL OXIDASE; REACTIVE OXYGEN; GUT IMMUNITY; CELL-DEATH; MELANOGASTER; FAMILY; GENE; PATHOPHYSIOLOGY; PHYSIOLOGY; ENZYMES	NADPH oxidase produces reactive oxygen species (ROS). Drosophila melanogaster has two homologs of NADPH oxidase, dNox and dDuox, with functions that remain unclear in vivo. To clarify these functions, two independent transgenic fly lines expressing dsRNA targeted for different portions of dDuox mRNA were used. In both flies, en-GAL4> UAS-dDuoxIR(976-1145) and en-GAL4> UAS-dDuoxIR(370-518), in which dDuox was knocked down selectively in the posterior area of the wing disc, the posterior compartment of the adult wings became paler and more fragile with wing veins that were indistinct by comparison with the anterior one. Fluorescence staining of the en-GAL4> UAS-dDuoxIR(976-1145) adult wings revealed that the ROS concentration in the posterior compartment was significantly lower than that in the anterior compartment. Moreover, in these flies, the posterior compartment of the wing imaginal disc showed a greater number of apoptotic cells detected by immunostaining with anti-cleaved caspase-3 antibody than those in the anterior compartment. Respective knockdown of tyrosine hydroxylase or dopa-decarboxylase showed paler wing blades in the posterior compartment similar to the phenotype of dDuox-knockdown files. Along with this observation, analysis of the catecholic and dityrosine components in the wings of adult flies proved that dDuox plays important roles in the stabilization of the cuticle structure of the wings via tyrosine cross-linking, the sclerotization and melanization processes possibly through ROS production. These dDuox-knockdown fly lines would be useful tools for further studying dDuox functions during the development of Drosophila.	[Kamei, Kaeko] Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan; [Nguyen Thi Tu Anh; Nishitani, Maiko; Harada, Shigeharu; Yamaguchi, Masamitsu] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan	Kyoto Institute of Technology; Kyoto Institute of Technology	Kamei, K (corresponding author), Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan.	kame@kit.ac.jp		Yamaguchi, Masamitsu/0000-0002-6321-9750	Scientific Research [22570140]	Scientific Research	This work was supported by Grant-in-aid for Scientific Research (C) 22570140 and Grant-in-aid for Scientific Research (A) 22241052.	Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Jane SM, 2005, CURR OPIN GENET DEV, V15, P447, DOI 10.1016/j.gde.2005.05.005; Kato Y, 2000, BIOCHEM BIOPH RES CO, V275, P11, DOI 10.1006/bbrc.2000.3265; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Milan M, 1997, P NATL ACAD SCI USA, V94, P5691, DOI 10.1073/pnas.94.11.5691; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; RIOUX C, 1983, ANAL BIOCHEM, V133, P163, DOI 10.1016/0003-2697(83)90238-5; Ris-Stalpers C, 2006, ANTIOXID REDOX SIGN, V8, P1563, DOI 10.1089/ars.2006.8.1563; Ritsick DR, 2007, FREE RADICAL BIO MED, V43, P31, DOI 10.1016/j.freeradbiomed.2007.03.006; ROBERTSON HM, 1988, GENETICS, V118, P461; Wong JL, 2004, DEV CELL, V7, P801, DOI 10.1016/j.devcel.2004.10.014; Xie XJ, 2010, INT J BIOL SCI, V6, P252	27	40	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33244	33251		10.1074/jbc.M111.263178	http://dx.doi.org/10.1074/jbc.M111.263178			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808060	hybrid, Green Published			2022-12-27	WOS:000294968800043
J	Stanley, BA; Sivakumaran, V; Shi, S; McDonald, I; Lloyd, D; Watson, WH; Aon, MA; Paolocci, N				Stanley, Brian A.; Sivakumaran, Vidhya; Shi, Sa; McDonald, Iain; Lloyd, David; Watson, Walter H.; Aon, Miguel A.; Paolocci, Nazareno			Thioredoxin Reductase-2 Is Essential for Keeping Low Levels of H2O2 Emission from Isolated Heart Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-REDUCTASE; HYDROGEN-PEROXIDE; ANTICANCER THERAPEUTICS; REDOX ENVIRONMENT; APOPTOSIS; METABOLISM; CELL; RAT; SELENOCYSTEINE; PEROXIREDOXIN	Respiring mitochondria produce H2O2 continuously. When production exceeds scavenging, H2O2 emission occurs, endangering cell functions. The mitochondrial peroxidase peroxiredoxin-3 reduces H2O2 to water using reducing equivalents from NADPH supplied by thioredoxin-2 (Trx2) and, ultimately, thioredoxin reductase-2 (TrxR2). Here, the contribution of this mitochondrial thioredoxin system to the control of H2O2 emission was studied in isolated mitochondria and cardiomyocytes from mouse or guinea pig heart. Energization of mitochondria by the addition of glutamate/malate resulted in a 10-fold decrease in the ratio of oxidized to reduced Trx2. This shift in redox state was accompanied by an increase in NAD(P) H and was dependent on TrxR2 activity. Inhibition of TrxR2 in isolated mitochondria by auranofin resulted in increased H2O2 emission, an effect that was seen under both forward and reverse electron transport. This effect was independent of changes in NAD(P) H or membrane potential. The effects of auranofin were reproduced in cardiomyocytes; superoxide and H2O2 levels increased, but similarly, there was no effect on NAD(P) H or membrane potential. These data show that energization of mitochondria increases the antioxidant potential of the TrxR2/Trx2 system and that inhibition of TrxR2 results in increased H2O2 emission through a mechanism that is independent of changes in other redox couples.	[Stanley, Brian A.; Sivakumaran, Vidhya; Shi, Sa; Aon, Miguel A.; Paolocci, Nazareno] Johns Hopkins Univ, Johns Hopkins Sch Med, Div Cardiol, Baltimore, MD 21205 USA; [Shi, Sa] Harbin Med Univ, Dept Pathophysiol, Harbin 150081, Peoples R China; [McDonald, Iain; Lloyd, David] Cardiff Univ, Sch Earth Sci, Cardiff CF10 3AT, S Glam, Wales; [McDonald, Iain; Lloyd, David] Cardiff Univ, Sch Biosci, Cardiff CF10 3AT, S Glam, Wales; [Watson, Walter H.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Paolocci, Nazareno] Univ Perugia, Sect Gen Pathol, Dept Clin & Expt Med, I-06122 Perugia, Italy	Johns Hopkins University; Johns Hopkins Medicine; Harbin Medical University; Cardiff University; Cardiff University; University of Louisville; University of Perugia	Aon, MA (corresponding author), Johns Hopkins Univ, Johns Hopkins Sch Med, Div Cardiol, 720 Rutland Ave,Ross Bldg 1059, Baltimore, MD 21205 USA.	maon1@jhmi.edu	Aon, Miguel Antonio/A-6564-2008; paolocci, nazareno/A-7124-2009	Aon, Miguel Antonio/0000-0002-4355-5431; Lloyd, David/0000-0002-5656-0571; McDonald, Iain/0000-0001-9066-7244; Paolocci, Nazareno/0000-0001-7011-997X	National Institutes of Health [R01-HL091923-01]; American Heart Association [10POST414001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL091923-01 (to M. A. A. and N. P.). This work was also supported by American Heart Association Postdoctoral Fellowship 10POST414001 (to B. A. S.).	Akar FG, 2005, J CLIN INVEST, V115, P3527, DOI 10.1172/JCI25371; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; Aon MA, 2009, INT J BIOCHEM CELL B, V41, P1940, DOI 10.1016/j.biocel.2009.02.016; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Aon MA, 2007, J BIOL CHEM, V282, P21889, DOI 10.1074/jbc.M702841200; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P71, DOI 10.1016/j.bbabio.2009.08.002; Arner E. S. J., 2000, CURRENT PROTOCOL S24, V7.4, P1; ARNER ESJ, 1995, J BIOL CHEM, V270, P3479, DOI 10.1074/jbc.270.8.3479; AYERS FC, 1986, ANAL BIOCHEM, V154, P186, DOI 10.1016/0003-2697(86)90513-0; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Camara AKS, 2010, ANTIOXID REDOX SIGN, V13, P279, DOI 10.1089/ars.2009.2788; Chen Y, 2002, J BIOL CHEM, V277, P33242, DOI 10.1074/jbc.M202026200; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Cox AG, 2008, BIOCHEM PHARMACOL, V76, P1097, DOI 10.1016/j.bcp.2008.08.021; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Di Lisa F, 2007, HEART FAIL REV, V12, P249, DOI 10.1007/s10741-007-9028-z; Drechsel DA, 2010, J BIOL CHEM, V285, P27850, DOI 10.1074/jbc.M110.101196; Friederich M, 2009, CURR DIABETES REV, V5, P120, DOI 10.2174/157339909788166800; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; Go Y. M., 2009, CURR PROTOC TOXI S41, V17.12, P1; Go YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018918; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Halvey PJ, 2005, BIOCHEM J, V386, P215, DOI 10.1042/BJ20041829; Han D, 2003, MOL PHARMACOL, V64, P1136, DOI 10.1124/mol.64.5.1136; Hansen JM, 2006, FREE RADICAL BIO MED, V40, P138, DOI 10.1016/j.freeradbiomed.2005.09.023; Hirasaka K, 2011, ANTIOXID REDOX SIGN, V15, P2645, DOI 10.1089/ars.2011.3888; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Inarrea P, 2007, BIOCHEM J, V405, P173, DOI 10.1042/BJ20061809; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Nordberg J, 1998, J BIOL CHEM, V273, P10835, DOI 10.1074/jbc.273.18.10835; NOVOGRODSKY A, 1979, P NATL ACAD SCI USA, V76, P4932, DOI 10.1073/pnas.76.10.4932; ONDARZA RN, 1983, J MOL EVOL, V19, P371, DOI 10.1007/BF02101641; Rackham O, 2007, BIOCHEM PHARMACOL, V74, P992, DOI 10.1016/j.bcp.2007.07.022; RADI R, 1991, J BIOL CHEM, V266, P22028; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rigobello MP, 2009, FREE RADICAL BIO MED, V47, P710, DOI 10.1016/j.freeradbiomed.2009.05.027; Rigobello MP, 2005, ARCH BIOCHEM BIOPHYS, V441, P112, DOI 10.1016/j.abb.2005.07.007; Rigobello MP, 2005, FREE RADICAL RES, V39, P687, DOI 10.1080/10715760500135391; Rogers LK, 2004, TOXICOL SCI, V82, P367, DOI 10.1093/toxsci/kfh268; Salvi M, 2007, J BIOL CHEM, V282, P24407, DOI 10.1074/jbc.M701589200; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]; Tocchetti CG, 2007, CIRC RES, V100, P96, DOI 10.1161/01.RES.0000253904.53601.c9; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; Ueda S, 2002, ANTIOXID REDOX SIGN, V4, P405, DOI 10.1089/15230860260196209; Vergara E, 2010, CHEMMEDCHEM, V5, P96, DOI 10.1002/cmdc.200900370; Watson WH, 2004, TOXICOL SCI, V78, P3, DOI 10.1093/toxsci/kfh050; Zhang Min, 2007, Curr Heart Fail Rep, V4, P26, DOI 10.1007/s11897-007-0022-5; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581	58	147	151	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33669	33677		10.1074/jbc.M111.284612	http://dx.doi.org/10.1074/jbc.M111.284612			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21832082	Green Published, hybrid			2022-12-27	WOS:000294968800083
J	Verma, V; Testero, SA; Amini, K; Wei, W; Liu, J; Balachandran, N; Monoharan, T; Stynes, S; Kotra, LP; Golemi-Kotra, D				Verma, Vidhu; Testero, Sebastian A.; Amini, Kaveh; Wei, William; Liu, Jerome; Balachandran, Naresh; Monoharan, Tharseekan; Stynes, Siobhan; Kotra, Lakshmi P.; Golemi-Kotra, Dasantila			Hydrolytic Mechanism of OXA-58 Enzyme, a Carbapenem-hydrolyzing Class D beta-Lactamase from Acinetobacterbaumannii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; CLASS-A; RESISTANCE; BAUMANNII; INHIBITION; INSIGHTS; DESIGN; LYSINE; ACID	Carbapenem-hydrolyzing class D beta-lactamases (CHDLs) represent an emerging antibiotic resistance mechanism encountered among the most opportunistic Gram-negative bacterial pathogens. We report here the substrate kinetics and mechanistic characterization of a prominent CHDL, the OXA-58 enzyme, from Acinetobacter baumannii. OXA-58 uses a carbamylated lysine to activate the nucleophilic serine used for beta-lactam hydrolysis. The deacylating water molecule approaches the acyl-enzyme species, anchored at this serine (Ser-83), from the alpha-face. Our data show that OXA-58 retains the catalytic machinery found in class D beta-lactamases, of which OXA-10 is representative. Comparison of the homology model of OXA-58 and the recently solved crystal structures of OXA-24 and OXA-48 with the OXA-10 crystal structure suggests that these CHDLs have evolved the ability to hydrolyze imipenem, an important carbapenem in clinical use, by subtle structural changes in the active site. These changes may contribute to tighter binding of imipenem to the active site and removal of steric hindrances from the path of the deacylating water molecule.	[Verma, Vidhu; Amini, Kaveh; Liu, Jerome; Balachandran, Naresh; Monoharan, Tharseekan; Stynes, Siobhan; Golemi-Kotra, Dasantila] York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada; [Testero, Sebastian A.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Wei, William; Kotra, Lakshmi P.] Univ Hlth Network, Ctr Mol Design & Preformulat, Toronto Gen Res Inst, Toronto, ON M5G 1L7, Canada	York University - Canada; University of Notre Dame; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Golemi-Kotra, D (corresponding author), York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada.	dgkotra@yorku.ca	/N-6611-2013; Testero, Sebastian A./AAF-6532-2019	/0000-0003-1299-6987; Testero, Sebastian A./0000-0002-0185-5751; Amini, Kaveh/0000-0001-8587-2120; Kotra, Lakshmi P./0000-0002-7071-4637				Afzal-Shah M, 2001, ANTIMICROB AGENTS CH, V45, P583, DOI 10.1128/AAC.45.2.583-588.2001; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bonfiglio G, 2002, EXPERT OPIN INV DRUG, V11, P529; Bou G, 2010, J AM CHEM SOC, V132, P13320, DOI 10.1021/ja104092z; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Chen Y, 2009, PROTEIN SCI, V18, P662, DOI 10.1002/pro.60; Docquier JD, 2009, CHEM BIOL, V16, P540, DOI 10.1016/j.chembiol.2009.04.010; Dubus A, 1996, PROTEINS, V25, P473, DOI 10.1002/prot.7; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Golemi D, 2000, J ANTIBIOT, V53, P1022, DOI 10.7164/antibiotics.53.1022; Golemi D, 2000, J AM CHEM SOC, V122, P6132, DOI 10.1021/ja0013881; Golemi-Kotra D, 2004, J BIOL CHEM, V279, P34665, DOI 10.1074/jbc.M313143200; Heritier C, 2005, J ANTIMICROB CHEMOTH, V55, P115, DOI 10.1093/jac/dkh500; HERZBERG O, 1987, SCIENCE, V236, P694, DOI 10.1126/science.3107125; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; KITZ RJ, 1967, BIOCHEM PHARMACOL, V16, P2201, DOI 10.1016/0006-2952(67)90019-6; LAMOTTEBRASSEUR J, 1991, BIOCHEM J, V279, P213, DOI 10.1042/bj2790213; Li J, 2005, PROTEINS, V61, P246, DOI 10.1002/prot.20596; Livermore DM, 1998, J ANTIMICROB CHEMOTH, V41, P25, DOI 10.1093/jac/41.suppl_4.25; Marque S, 2005, J CLIN MICROBIOL, V43, P4885, DOI 10.1128/JCM.43.9.4885-4888.2005; Maveyraud L, 1996, J AM CHEM SOC, V118, P7435, DOI 10.1021/ja9609718; Maveyraud L, 2002, J AM CHEM SOC, V124, P2461, DOI 10.1021/ja016736t; Maveyraud L, 2000, STRUCTURE, V8, P1289, DOI 10.1016/S0969-2126(00)00534-7; MIYASHITA K, 1995, J AM CHEM SOC, V117, P11055, DOI 10.1021/ja00150a003; Mourey L, 1998, J AM CHEM SOC, V120, P9382, DOI 10.1021/ja9817996; Nagase T, 2001, BIOORG CHEM, V29, P140, DOI 10.1006/bioo.2001.1205; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; OEFNER C, 1990, NATURE, V343, P284, DOI 10.1038/343284a0; Paton R, 1993, Int J Antimicrob Agents, V2, P81, DOI 10.1016/0924-8579(93)90045-7; Pernot L, 2001, J MOL BIOL, V310, P859, DOI 10.1006/jmbi.2001.4805; Poduch E, 2006, J MED CHEM, V49, P4937, DOI 10.1021/jm060202r; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P202, DOI 10.1128/AAC.49.1.202-208.2005; Poirel L, 2007, FUTURE MICROBIOL, V2, P501, DOI 10.2217/17460913.2.5.501; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Santillana E, 2007, P NATL ACAD SCI USA, V104, P5354, DOI 10.1073/pnas.0607557104; Schneider KD, 2011, J MOL BIOL, V406, P583, DOI 10.1016/j.jmb.2010.12.042; Schneider KD, 2009, BIOCHEMISTRY-US, V48, P6136, DOI 10.1021/bi900448u; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Sun T, 2003, PROTEIN SCI, V12, P82, DOI 10.1110/ps.0224303; Swaren P, 1999, BIOCHEMISTRY-US, V38, P9570, DOI 10.1021/bi990758z; Testero A., 2010, BURGER MED CHEM DRUG, P259; Testero SA, 2009, ORG LETT, V11, P2515, DOI 10.1021/ol900668k; Vercheval L, 2010, BIOCHEM J, V432, P495, DOI 10.1042/BJ20101122; Walsh TR, 2008, CURR OPIN INFECT DIS, V21, P367, DOI 10.1097/QCO.0b013e328303670b; Walther-Rasmussen J, 2006, J ANTIMICROB CHEMOTH, V57, P373, DOI 10.1093/jac/dki482; Walther-Rasmussen J, 2007, J ANTIMICROB CHEMOTH, V60, P470, DOI 10.1093/jac/dkm226; Zarrilli Raffaele, 2009, J Infect Dev Ctries, V3, P335, DOI 10.3855/jidc.240	48	30	34	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37292	37303		10.1074/jbc.M111.280115	http://dx.doi.org/10.1074/jbc.M111.280115			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880707	Green Published, hybrid			2022-12-27	WOS:000296542400029
J	Hidalgo, AA; Deeb, KK; Pike, JW; Johnson, CS; Trump, DL				Hidalgo, Alejandro A.; Deeb, Kristin K.; Pike, J. Wesley; Johnson, Candace S.; Trump, Donald L.			Dexamethasone Enhances 1 alpha,25-Dihydroxyvitamin D-3 Effects by Increasing Vitamin D Receptor Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCORTICOID-RECEPTOR; ENDOTHELIAL-CELLS; BINDING-SITES; IN-VIVO; GENE; CALCITRIOL; DNA; PROMOTER; CALCIUM; SEQUENCES	Calcitriol, the active form of vitamin D, in combination with the glucocorticoid dexamethasone (Dex) has been shown to increase the antitumor effects of calcitriol in squamous cell carcinoma. In this study we found that pretreatment with Dex potentiates calcitriol effects by inhibiting cell growth and increasing vitamin D receptor (VDR) and VDR-mediated transcription. Treatment with actinomycin D inhibits Vdr mRNA synthesis, indicating that Dex regulates VDR expression at transcriptional level. Real time PCR shows that treatment with Dex increases Vdr transcripts in a time-and a dose-dependent manner, indicating that Dex directly regulates expression of Vdr. RU486, an inhibitor of glucocorticoids, inhibits Dex-induced Vdr expression. In addition, the silencing of glucocorticoid receptor (GR) abolishes the induction of Vdr by Dex, indicating that Dex increases Vdr transcripts in a GR-dependent manner. A fragment located 5.2 kb upstream of Vdr transcription start site containing two putative glucocorticoid response elements (GREs) was evaluated using a luciferase-based reporter assay. Treatment with 100 nM Dex induces transcription of luciferase driven by the fragment. Deletion of the GRE distal to transcription start site was sufficient to abolish Dex induction of luciferase. Also, chromatin immunoprecipitation reveals recruitment of GR to distal GRE with Dex treatment. We conclude that Dex increases VDR and vitamin D effects by increasing Vdr de novo transcription in a GR-dependent manner.	[Trump, Donald L.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Hidalgo, Alejandro A.; Johnson, Candace S.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Hidalgo, Alejandro A.; Deeb, Kristin K.; Johnson, Candace S.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; University of Wisconsin System; University of Wisconsin Madison	Trump, DL (corresponding author), Roswell Pk Canc Inst, Dept Med, Elm & Carlton Sts, Buffalo, NY 14263 USA.	donald.trump@roswellpark.org	Deeb, Kristin K/H-5619-2016		National Institutes of Health [CA67267, CA85142, CA95045]; Department of Defense [PCRP050202]; Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile; NATIONAL CANCER INSTITUTE [R01CA085142, R01CA095045, R01CA067267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA67267, CA85142, and CA95045.; Supported by predoctoral fellowships from Department of Defense (PCRP050202) and Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile.	Alheim K, 2003, J MOL ENDOCRINOL, V30, P359, DOI 10.1677/jme.0.0300359; Arriagada G, 2007, J STEROID BIOCHEM, V103, P425, DOI 10.1016/j.jsbmb.2006.12.021; Bagamasbad P, 2011, GEN COMP ENDOCR, V170, P3, DOI 10.1016/j.ygcen.2010.03.013; BEATO M, 1989, J STEROID BIOCHEM, V32, P737, DOI 10.1016/0022-4731(89)90521-9; Bernardi RJ, 2001, CLIN CANCER RES, V7, P4164; CHANDLER VL, 1983, CELL, V33, P489, DOI 10.1016/0092-8674(83)90430-0; Chung I, 2007, J STEROID BIOCHEM, V103, P768, DOI 10.1016/j.jsbmb.2006.12.042; Chung I, 2007, J BIOL CHEM, V282, P8704, DOI 10.1074/jbc.M608894200; Chung I, 2006, CANCER RES, V66, P8565, DOI 10.1158/0008-5472.CAN-06-0905; CUNNINGHAM D, 1985, BRIT MED J, V291, P1153, DOI 10.1136/bmj.291.6503.1153; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Dhawan P, 2010, J CELL BIOCHEM, V110, P1314, DOI 10.1002/jcb.22645; Feldman D, 2000, ENDOCRINOLOGY, V141, P5, DOI 10.1210/en.141.1.5; Flynn G, 2006, ONCOLOGY-BASEL, V70, P447, DOI 10.1159/000098872; Halsall JA, 2007, J STEROID BIOCHEM, V103, P352, DOI 10.1016/j.jsbmb.2006.12.046; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HARDIN J, 1994, BLOOD, V84, P3063; Hidalgo AA, 2007, J STEROID BIOCHEM, V103, P731, DOI 10.1016/j.jsbmb.2006.12.072; Hidalgo AA, 2010, J STEROID BIOCHEM, V121, P372, DOI 10.1016/j.jsbmb.2010.03.081; HSIEH JC, 1991, P NATL ACAD SCI USA, V88, P9315, DOI 10.1073/pnas.88.20.9315; Inaba H, 2010, CANCER, V117, P1313; Jakubowiak AJ, 2009, J CLIN ONCOL, V27, P5015, DOI 10.1200/JCO.2008.19.5370; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; Jehan F, 2000, ARCH BIOCHEM BIOPHYS, V377, P273, DOI 10.1006/abbi.2000.1788; Johnson CS, 2006, ANTICANCER RES, V26, P2543; JURUTKA PW, 1993, J BIOL CHEM, V268, P6791; Kallay E, 2001, CARCINOGENESIS, V22, P1429, DOI 10.1093/carcin/22.9.1429; Kim MH, 2009, LIFE SCI, V85, P146, DOI 10.1016/j.lfs.2009.05.013; Kim MH, 2009, EXP PHYSIOL, V94, P138, DOI 10.1113/expphysiol.2008.044339; KIMBERG DV, 1971, J CLIN INVEST, V50, P1309, DOI 10.1172/JCI106610; KOEFFLER HP, 1985, CANCER TREAT REP, V69, P1399; Krishnan AV, 2003, J CELL BIOCHEM, V88, P363, DOI 10.1002/jcb.10334; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Maruyama R, 2006, CANCER RES, V66, P4574, DOI 10.1158/0008-5472.CAN-05-2562; McGuire TF, 2001, J BIOL CHEM, V276, P26365, DOI 10.1074/jbc.M010101200; Merkulov VM, 2009, J STEROID BIOCHEM, V115, P1, DOI 10.1016/j.jsbmb.2009.02.003; MIKSICEK R, 1986, CELL, V46, P283, DOI 10.1016/0092-8674(86)90745-2; Morris KL, 2005, OBES RES, V13, P670, DOI 10.1038/oby.2005.75; Muzikar KA, 2009, P NATL ACAD SCI USA, V106, P16598, DOI 10.1073/pnas.0909192106; PAYVAR F, 1983, CELL, V35, P381, DOI 10.1016/0092-8674(83)90171-X; Peehl DM, 2004, J STEROID BIOCHEM, V92, P307, DOI 10.1016/j.jsbmb.2004.10.006; Pike JW, 2010, J STEROID BIOCHEM, V121, P130, DOI 10.1016/j.jsbmb.2010.02.036; Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269; RENKAWITZ R, 1984, CELL, V37, P503, DOI 10.1016/0092-8674(84)90380-5; ROLLA D, 1993, PERITON DIALYSIS INT, V13, P118; Saramaki A, 2006, NUCLEIC ACIDS RES, V34, P543, DOI 10.1093/nar/gkj460; SHULTZ TD, 1982, P NATL ACAD SCI-BIOL, V79, P3542, DOI 10.1073/pnas.79.11.3542; Slater E P, 1985, Trans Assoc Am Physicians, V98, P66; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; Sun X, 2008, INT J OBESITY, V32, P1305, DOI 10.1038/ijo.2008.59; Thorne JL, 2011, NUCLEIC ACIDS RES, V39, P2045, DOI 10.1093/nar/gkq875; Trump DL, 2006, CANCER-AM CANCER SOC, V106, P2136, DOI 10.1002/cncr.21890; Verlinden L, 1998, MOL CELL ENDOCRINOL, V142, P57, DOI 10.1016/S0303-7207(98)00117-8; Wallace AD, 2001, J BIOL CHEM, V276, P42714, DOI 10.1074/jbc.M106033200; Wallace AD, 2010, STEROIDS, V75, P1016, DOI 10.1016/j.steroids.2010.06.015; Yu WD, 1998, J NATL CANCER I, V90, P134, DOI 10.1093/jnci/90.2.134; Zella LA, 2007, J STEROID BIOCHEM, V103, P435, DOI 10.1016/j.jsbmb.2006.12.019; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zella LA, 2010, MOL ENDOCRINOL, V24, P128, DOI 10.1210/me.2009-0140	59	49	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36228	36237		10.1074/jbc.M111.244061	http://dx.doi.org/10.1074/jbc.M111.244061			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21868377	Green Published, hybrid			2022-12-27	WOS:000296538300007
J	Laine, V; Frokjaer-Jensen, C; Couchoux, H; Jospin, M				Laine, Viviane; Frokjaer-Jensen, Christian; Couchoux, Harold; Jospin, Maelle			The alpha 1 Subunit EGL-19, the alpha 2/delta Subunit UNC-36, and the beta Subunit CCB-1 Underlie Voltage-dependent Calcium Currents in Caenorhabditis elegans Striated Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; C-ELEGANS; CA2+ CURRENT; PHARYNGEAL MUSCLE; ACTION-POTENTIALS; CHANNEL; CONTRACTION; EXPRESSION; MUTATIONS; ABSENCE	Voltage-gated calcium channels, which play key roles in many physiological processes, are composed of a pore-forming alpha 1 subunit associated with up to three auxiliary subunits. In vertebrates, the role of auxiliary subunits has mostly been studied in heterologous systems, mainly because of the severe phenotypes of knock-out animals. The genetic model Caenorhabditis elegans has all main types of voltage-gated calcium channels and strong loss-of-function mutations in all pore-forming and auxiliary subunits; it is therefore a useful model to investigate the roles of auxiliary subunits in their native context. By recording calcium currents from channel and auxiliary subunit mutants, we molecularly dissected the voltage-dependent calcium currents in striated muscle of C. elegans. We show that EGL-19 is the only alpha 1 subunit that carries calcium currents in muscle cells. We then demonstrate that the alpha 2/delta subunit UNC-36 modulates the voltage dependence, the activation kinetics, and the conductance of calcium currents, whereas another alpha 2/delta subunit TAG-180 has no effect. Finally, we characterize mutants of the two beta subunits, CCB-1 and CCB-2. CCB-1 is necessary for viability, and voltage-dependent calcium currents are abolished in the absence of CCB-1 whereas CCB-2 does not affect currents. Altogether these results show that EGL-19, UNC-36, and CCB-1 underlie voltage-dependent calcium currents in C. elegans striated muscle.	[Laine, Viviane; Couchoux, Harold; Jospin, Maelle] Univ Lyon 1, CNRS, UMR 5534, F-69622 Villeurbanne, France; [Frokjaer-Jensen, Christian] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Frokjaer-Jensen, Christian] Univ Copenhagen, Dept Biomed Sci, DK-1165 Copenhagen, Denmark; [Frokjaer-Jensen, Christian] Univ Copenhagen, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, DK-1165 Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen	Jospin, M (corresponding author), Univ Lyon 1, CNRS, UMR 5534, Batiment Dubois,43 Bd 11 Novembre, F-69622 Villeurbanne, France.	jospin@univ-lyon1.fr	Jospin, Maelle/G-9063-2017; Frøkjær-Jensen, Christian/ABB-4637-2020; Tuluc, Petronel/C-2527-2011	Jospin, Maelle/0000-0002-1694-4394; Frokjaer-Jensen, Christian/0000-0002-3178-0906	Centre National de la Recherche Scientifique; Universite Lyon 1; Lundbeck Foundation	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Lyon 1; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Centre National de la Recherche Scientifique, the Universite Lyon 1, and a postdoctoral fellowship (to C. F. J.) from the Lundbeck Foundation.	Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bauer CS, 2010, CURR OPIN NEUROBIOL, V20, P563, DOI 10.1016/j.conb.2010.05.007; BRENNER S, 1974, GENETICS, V77, P71; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Dayal A, 2010, CELL CALCIUM, V47, P500, DOI 10.1016/j.ceca.2010.04.003; Dempster J, 1993, COOPERATIVE LEARNING, P133; Dickman DK, 2008, J NEUROSCI, V28, P31, DOI 10.1523/JNEUROSCI.4498-07.2008; Dolphin AC, 1999, J PHYSIOL-LONDON, V519, P35, DOI 10.1111/j.1469-7793.1999.0035o.x; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Frokjaer-Jensen C, 2006, J NEUROBIOL, V66, P1125, DOI 10.1002/neu.20261; Fuller-Bicer GA, 2009, AM J PHYSIOL-HEART C, V297, pH117, DOI 10.1152/ajpheart.00122.2009; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Huang SLB, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-24; Jospin M, 2002, J CELL BIOL, V159, P337, DOI 10.1083/jcb.200203055; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Kwok TCY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000067; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Liu P, 2011, J PHYSIOL-LONDON, V589, P101, DOI 10.1113/jphysiol.2010.200683; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Ly CV, 2008, J CELL BIOL, V181, P157, DOI 10.1083/jcb.200712152; Mathews EA, 2003, J NEUROSCI, V23, P6537; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Obermair GJ, 2005, J BIOL CHEM, V280, P2229, DOI 10.1074/jbc.M411501200; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Saheki Y, 2009, NAT NEUROSCI, V12, P1257, DOI 10.1038/nn.2383; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Schredelseker J, 2009, J BIOL CHEM, V284, P1242, DOI 10.1074/jbc.M807767200; Shtonda B, 2005, J EXP BIOL, V208, P2177, DOI 10.1242/jeb.01615; Steger KA, 2005, J EXP BIOL, V208, P2191, DOI 10.1242/jeb.01616; Strube C, 1996, BIOPHYS J, V71, P2531, DOI 10.1016/S0006-3495(96)79446-8; Strube C, 2008, PFLUG ARCH EUR J PHY, V455, P921, DOI 10.1007/s00424-007-0345-9; Tam T, 2000, DEV BIOL, V226, P104, DOI 10.1006/dbio.2000.9854; Tuluc P, 2007, P NATL ACAD SCI USA, V104, P11091, DOI 10.1073/pnas.0700577104; Vinogradova Irina, 2006, Invertebrate Neuroscience, V6, P57, DOI 10.1007/s10158-006-0018-y; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1; Xu XF, 2011, J BIOL CHEM, V286, P9677, DOI 10.1074/jbc.M110.187864; Zhang Y, 2010, J BIOL CHEM, V285, P2527, DOI 10.1074/jbc.M109.022236; Zhou WB, 2006, CELL CALCIUM, V39, P227, DOI 10.1016/j.ceca.2005.10.015	47	17	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36180	36187		10.1074/jbc.M111.256149	http://dx.doi.org/10.1074/jbc.M111.256149			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878625	Green Published, hybrid			2022-12-27	WOS:000296538300003
J	Xiao, L; Chen, YH; Ji, M; Volle, DJ; Lewis, RE; Tsai, MY; Dong, JX				Xiao, Ling; Chen, Yuanhong; Ji, Ming; Volle, Deanna J.; Lewis, Robert E.; Tsai, Ming-Ying; Dong, Jixin			KIBRA Protein Phosphorylation Is Regulated by Mitotic Kinase Aurora and Protein Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; DOMAIN-CONTAINING PROTEIN; ORGAN SIZE CONTROL; TUMOR-SUPPRESSOR; CELL-PROLIFERATION; HIPPO PATHWAY; GROWTH-CONTROL; HEPATOCELLULAR-CARCINOMA; CONTACT INHIBITION; NEGATIVE REGULATOR	Recent genetic studies in Drosophila identified Kibra as a novel regulator of the Hippo pathway, which controls tissue growth and tumorigenesis by inhibiting cell proliferation and promoting apoptosis. The cellular function and regulation of human KIBRA remain largely unclear. Here, we show that KIBRA is a phosphoprotein and that phosphorylation of KIBRA is regulated in a cell cycle-dependent manner with the highest level of phosphorylated KIBRA detected in mitosis. We further demonstrate that the mitotic kinases Aurora-A and -B phosphorylate KIBRA both in vitro and in vivo. We identified the highly conserved Ser(539) as the primary phosphorylation site for Aurora kinases. Moreover, we found that wild-type, but not catalytically inactive, protein phosphatase 1 (PP1) associates with KIBRA. PP1 dephosphorylated Aurora-phosphorylated KIBRA. KIBRA depletion impaired the interaction between Aurora-A and PP1. We also show that KIBRA associates with neurofibromatosis type 2/Merlin in a Ser(539) phosphorylation-dependent manner. Phosphorylation of KIBRA on Ser(539) plays a role in mitotic progression. Our results suggest that KIBRA is a physiological substrate of Aurora kinases and reveal a new avenue between KIBRA/Hippo signaling and the mitotic machinery.	[Xiao, Ling; Chen, Yuanhong; Ji, Ming; Volle, Deanna J.; Lewis, Robert E.; Tsai, Ming-Ying; Dong, Jixin] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Dong, JX (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	dongj@unmc.edu	Lewis, Robert E./H-3404-2019		National Institutes of Health [5P20-RR018759]; National Center for Research Resources; Nebraska Cancer and Smoking Disease Research Program; NATIONAL CANCER INSTITUTE [R01CA090400] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Nebraska Cancer and Smoking Disease Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 5P20-RR018759 from the National Center for Research Resources. This work was also supported by a grant from the Nebraska Cancer and Smoking Disease Research Program (to J. D.).	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Bates TC, 2009, NEUROSCI LETT, V458, P140, DOI 10.1016/j.neulet.2009.04.050; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Bothos J, 2005, CANCER RES, V65, P6568, DOI 10.1158/0008-5472.CAN-05-0862; Buther K, 2004, BIOCHEM BIOPH RES CO, V317, P703, DOI 10.1016/j.bbrc.2004.03.107; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Cheng AY, 2000, J BIOL CHEM, V275, P1846, DOI 10.1074/jbc.275.3.1846; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Cohen PTW, 2002, J CELL SCI, V115, P241; Corneveaux JJ, 2010, NEUROBIOL AGING, V31, P901, DOI 10.1016/j.neurobiolaging.2008.07.014; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; FERNANDEZ A, 1992, J CELL BIOL, V116, P1421, DOI 10.1083/jcb.116.6.1421; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hergovich A, 2009, CURR BIOL, V19, P1692, DOI 10.1016/j.cub.2009.09.020; Hill VK, 2011, EPIGENETICS-US, V6, P326, DOI 10.4161/epi.6.3.14404; Hilton HN, 2008, BBA-MOL CELL RES, V1783, P383, DOI 10.1016/j.bbamcr.2007.12.007; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kilili GK, 2010, J BIOL CHEM, V285, P15076, DOI 10.1074/jbc.M109.078915; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lachenmayer Anja, 2010, Gastroenterology, V139, P692, DOI 10.1053/j.gastro.2010.06.036; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Liu CY, 2011, J BIOL CHEM, V286, P5558, DOI 10.1074/jbc.M110.194019; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Morisaki T, 2002, FEBS LETT, V529, P319, DOI 10.1016/S0014-5793(02)03360-4; Murata-Hori M, 2002, J CELL BIOL, V159, P45, DOI 10.1083/jcb.200207014; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Oh HJ, 2010, CURR BIOL, V20, P416, DOI 10.1016/j.cub.2009.12.054; Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Rodriguez-Rodriguez E, 2009, NEUROBIOL AGING, V30, P322, DOI 10.1016/j.neurobiolaging.2007.07.003; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Schaper K, 2008, NEUROBIOL AGING, V29, P1123, DOI 10.1016/j.neurobiolaging.2007.02.001; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	84	45	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36304	36315		10.1074/jbc.M111.246850	http://dx.doi.org/10.1074/jbc.M111.246850			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878642	Green Published, hybrid			2022-12-27	WOS:000296538300015
J	Popoff, V; Langer, JD; Reckmann, I; Hellwig, A; Kahn, RA; Brugger, B; Wieland, FT				Popoff, Vincent; Langer, Julian D.; Reckmann, Ingeborg; Hellwig, Andrea; Kahn, Richard A.; Bruegger, Britta; Wieland, Felix T.			Several ADP-ribosylation Factor (Arf) Isoforms Support COPI Vesicle Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; COATED TRANSPORT VESICLES; EARLY SECRETORY PATHWAY; AP-3 ADAPTER COMPLEX; CLASS-II ARFS; GOLGI MEMBRANES; FUNCTIONAL-CHARACTERIZATION; BINDING-PROTEINS; APPENDAGE DOMAIN; MAMMALIAN-CELLS	Newly synthesized proteins and lipids are transported in vesicular carriers along the secretory pathway. Arfs (ADP-ribosylation factors), a family of highly conserved GTPases within the Ras superfamily, control recruitment of molecular coats to membranes, the initial step of coated vesicle biogenesis. Arf1 and coatomer constitute the minimal cytosolic machinery leading to COPI vesicle formation from Golgi membranes. Although some functional redundancies have been suggested, other Arf isoforms have been poorly analyzed in this context. In this study, we found that Arf1, Arf4, and Arf5, but not Arf3 and Arf6, associate with COPI vesicles generated in vitro from Golgi membranes and purified cytosol. Using recombinant myristoylated proteins, we show that Arf1, Arf4, and Arf5 each support COPI vesicle formation individually. Unexpectedly, we found that Arf3 could also mediate vesicle biogenesis. However, Arf3 was excluded from the vesicle fraction in the presence of the other isoforms, highlighting a functional competition between the different Arf members.	[Popoff, Vincent; Reckmann, Ingeborg; Bruegger, Britta; Wieland, Felix T.] Univ Heidelberg, Biochem Ctr BZH, D-69120 Heidelberg, Germany; [Hellwig, Andrea] Univ Heidelberg, Dept Neurobiol IZN, D-69120 Heidelberg, Germany; [Langer, Julian D.] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany; [Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Max Planck Society; Emory University	Popoff, V (corresponding author), Univ Heidelberg, Biochem Ctr BZH, INF 364, D-69120 Heidelberg, Germany.	vincent.popoff@bzh.uni-heidelberg.de	Kahn, Richard/ABD-2666-2020	Kahn, Richard/0000-0002-0259-0601; Langer, Julian David/0000-0002-5190-577X	German Research Council [SFB 638, A10]; European Union; Max Planck Gesellschaft; FEBS	German Research Council(German Research Foundation (DFG)); European Union(European Commission); Max Planck Gesellschaft(Max Planck Society); FEBS	This work was supported by the German Research Council, SFB 638, A10, the ESFRI-INSTRUCT program of the European Union, and the Max Planck Gesellschaft.; Supported by a FEBS long-term fellowship. To whom correspondence should be addressed. E-mail: vincent.popoff@bzh.uni-heidelberg.de.	AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Austin C, 2002, BIOCHEMISTRY-US, V41, P4669, DOI 10.1021/bi016064j; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Chavrier P, 2001, METHOD ENZYMOL, V329, P272; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Drake MT, 2000, MOL BIOL CELL, V11, P3723, DOI 10.1091/mbc.11.11.3723; Duijsings D, 2009, TRAFFIC, V10, P316, DOI 10.1111/j.1600-0854.2008.00868.x; Faulstich D, 1996, J CELL BIOL, V135, P53, DOI 10.1083/jcb.135.1.53; Franco M, 1996, J BIOL CHEM, V271, P1573, DOI 10.1074/jbc.271.3.1573; Gaschet J, 1999, J BIOL CHEM, V274, P20040, DOI 10.1074/jbc.274.28.20040; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gommel D, 1999, FEBS LETT, V447, P179, DOI 10.1016/S0014-5793(99)00246-X; Gommel DU, 2001, EMBO J, V20, P6751, DOI 10.1093/emboj/20.23.6751; HELMS JB, 1993, J CELL BIOL, V121, P751, DOI 10.1083/jcb.121.4.751; Hill K, 2003, J BIOL CHEM, V278, P36032, DOI 10.1074/jbc.M301632200; Hoffman GR, 2003, MOL CELL, V12, P615, DOI 10.1016/j.molcel.2003.08.002; Honda A, 2005, J CELL BIOL, V168, P1039, DOI 10.1083/jcb.200409138; Hsia KC, 2010, P NATL ACAD SCI USA, V107, P11271, DOI 10.1073/pnas.1006297107; Hui N, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P46; Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Lay D, 2005, J BIOL CHEM, V280, P34489, DOI 10.1074/jbc.M503497200; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; LENHARD JM, 1992, J BIOL CHEM, V267, P13047; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; Liang JO, 1997, J BIOL CHEM, V272, P4141, DOI 10.1074/jbc.272.7.4141; Liu XQ, 2001, FEBS LETT, V490, P79, DOI 10.1016/S0014-5793(01)02134-2; Liu YZ, 2010, NAT STRUCT MOL BIOL, V17, P876, DOI 10.1038/nsmb.1853; Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601; Manolea F, 2010, MOL BIOL CELL, V21, P1836, DOI 10.1091/mbc.E10-01-0016; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; Pavel J, 1998, P NATL ACAD SCI USA, V95, P2140, DOI 10.1073/pnas.95.5.2140; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Randazzo PA, 1997, BIOCHEM J, V324, P413, DOI 10.1042/bj3240413; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011; Sun Z, 2007, TRAFFIC, V8, P582, DOI 10.1111/j.1600-0854.2007.00554.x; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; TSAI SC, 1991, J BIOL CHEM, V266, P8213; TSUCHIYA M, 1989, BIOCHEMISTRY-US, V28, P9668, DOI 10.1021/bi00451a019; TSUCHIYA M, 1991, J BIOL CHEM, V266, P2772; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Watson PJ, 2004, TRAFFIC, V5, P79, DOI 10.1111/j.1600-0854.2004.00158.x; Wegmann D, 2004, MOL CELL BIOL, V24, P1070, DOI 10.1128/MCB.24.3.1070-1080.2004; Yu WY, 2009, J MOL BIOL, V386, P903, DOI 10.1016/j.jmb.2008.12.083; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420	62	33	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35634	35642		10.1074/jbc.M111.261800	http://dx.doi.org/10.1074/jbc.M111.261800			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21844198	Green Published, hybrid			2022-12-27	WOS:000295927100035
J	Yang, X; Guo, ZY; Sun, F; Li, W; Alfano, A; Shimelis, H; Chen, MY; Brodie, AMH; Chen, HG; Xiao, Z; Veenstra, TD; Qiu, Y				Yang, Xi; Guo, Zhiyong; Sun, Feng; Li, Wei; Alfano, Alan; Shimelis, Hermela; Chen, Mingyuan; Brodie, Angela M. H.; Chen, Hegang; Xiao, Zhen; Veenstra, Timothy D.; Qiu, Yun			Novel Membrane-associated Androgen Receptor Splice Variant Potentiates Proliferative and Survival Responses in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; RESISTANT GROWTH; PALMITOYLATION; PROGRESSION; THERAPY	Progression from the androgen-sensitive to androgen-insensitive (or castration-resistant) stage is the major obstacle for sustained effectiveness of hormonal therapy for prostate cancer. The androgen receptor (AR) and its splice variants play important roles in regulating the transcription program essential for castration resistance. Here, we report the identification of a novel AR splice variant, designated as AR8, which is up-regulated in castration-resistant prostate cancer cells. AR8 is structurally different from other known AR splice variants because it lacks a DNA binding domain and therefore, unlikely functions as a transcription factor on its own. Immunofluorescence staining revealed that AR8 was primarily localized on the plasma membrane, possibly through palmitoylation of two cysteine residues within its unique C-terminal sequence. Mutation of these putative palmitoylation sites in AR8 led to loss of its plasma membrane localization. In addition, we demonstrated that overexpression of AR8 in prostate cancer cells promoted association of Src and AR with the EGF receptor in response to EGF treatment and enhanced tyrosine phosphorylation of AR. Conversely, specific knockdown of AR8 expression in prostate cancer cells compromised EGF-induced Src activation and AR phosphorylation. This effect was accompanied with attenuation of proliferation and increased apoptosis in prostate cancer cells cultured in androgen-depleted medium. We also showed that AR8 was required for optimal transcriptional activity of AR in response to treatment of both androgen and EGF. Taken together, our results demonstrate that the membrane-associated AR8 isoform may contribute to castration resistance by potentiating AR-mediated proliferative and survival responses to hormones and growth factors.	[Yang, Xi; Guo, Zhiyong; Sun, Feng; Li, Wei; Alfano, Alan; Shimelis, Hermela; Chen, Mingyuan; Brodie, Angela M. H.; Qiu, Yun] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA; [Chen, Hegang] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Xiao, Zhen; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, SAIC Frederick, NIH, Frederick, MD 21702 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Qiu, Y (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, 655 W Baltimore St,BRB Rm 4-002, Baltimore, MD 21202 USA.	yqiu@som.umaryland.edu	Chen, Ming/GVU-8412-2022	Shimelis, Hermela/0000-0003-1284-8909	National Institutes of Health [CA106504]; NCI [HHSN261200800001E]; Department of Defense [W81XWH-08-1-0174]; NATIONAL CANCER INSTITUTE [R01CA106504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA106504 (to Y. Q.) and Grant HHSN261200800001E through the NCI. This work was also supported by Department of Defense Grant W81XWH-08-1-0174 (to Y. Q.).	Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Culig Z, 2002, ENDOCR-RELAT CANCER, V9, P155, DOI 10.1677/erc.0.0090155; Dai BJ, 2010, CANCER RES, V70, P5587, DOI 10.1158/0008-5472.CAN-09-4610; DaSilva J, 2009, CANCER RES, V69, P7402, DOI 10.1158/0008-5472.CAN-08-4687; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Guo ZY, 2011, INT J BIOL SCI, V7, P815, DOI 10.7150/ijbs.7.815; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Scher HI, 2004, ENDOCR-RELAT CANCER, V11, P459, DOI 10.1677/erc.1.00525; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021	22	76	79	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36152	36160		10.1074/jbc.M111.265124	http://dx.doi.org/10.1074/jbc.M111.265124			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21878636	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000295927100087
J	Chakraborty, DC; Mukherjee, G; Banerjee, P; Banerjee, KK; Biswas, T				Chakraborty, Deep Chandan; Mukherjee, Gayatri; Banerjee, Pallavi; Banerjee, Kalyan K.; Biswas, Tapas			Hemolysin Induces Toll-like Receptor (TLR)-independent Apoptosis and Multiple TLR-associated Parallel Activation of Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIBRIO-CHOLERAE HEMOLYSIN; DENDRITIC CELLS; RECOGNITION; EXPRESSION; DISTINCT; TOXIN; PORE; COOPERATION; PNEUMOLYSIN; INFECTION	Vibrio cholerae hemolysin (HlyA) displays bipartite property while supervising macrophages (M Phi). The pore-forming toxin causes profound apoptosis within 3h of exposure and in parallel supports activation of the defying M Phi. HlyA-induced apoptosis of M Phi remains steady for 24 h, is Toll-like receptor (TLR)-independent, and is driven by caspase-9 and caspase-7, thus involving the mitochondrial or intrinsic pathway. Cell activation is carried forward by time dependent up-regulation of varying TLRs. The promiscuous TLR association of HlyA prompted investigation, which revealed the beta-prism lectin domain of HlyA simulated TLR4 up-regulation by jacalin, a plant lectin homologue besides expressing CD86 and type I cytokines TNF-alpha and IL-12. However, HlyA cytolytic protein domain up-regulated TLR2, which controlled CD40 for continuity of cell activation. Expression of TOLLIP before TLR2 and TLR6 abrogated TLR4, CD40, and CD86. We show that the transient expression of TOLLIP leading to curbing of activation-associated capabilities is a plausible feedback mechanism of M Phi to deploy TLR2 and prolong activation involving CD40 to encounter the HlyA cytolysin domain.	[Chakraborty, Deep Chandan; Mukherjee, Gayatri; Banerjee, Pallavi; Biswas, Tapas] Natl Inst Cholera & Enter Dis, Div Immunol, Kolkata 700010, W Bengal, India; [Banerjee, Kalyan K.] Natl Inst Cholera & Enter Dis, Div Biochem, Kolkata 700010, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Biswas, T (corresponding author), Natl Inst Cholera & Enter Dis, Div Immunol, P-33,CIT Rd, Kolkata 700010, W Bengal, India.	shigellaporin@yahoo.com						Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Blaecke A, 2002, CYTOMETRY, V48, P71, DOI 10.1002/cyto.10115; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Carrero JA, 2004, J IMMUNOL, V172, P4866, DOI 10.4049/jimmunol.172.8.4866; Chattopadhyay K, 2002, EUR J BIOCHEM, V269, P4351, DOI 10.1046/j.1432-1033.2002.03137.x; CHEN YJ, 1994, MICROB PATHOGENESIS, V17, P203, DOI 10.1006/mpat.1994.1066; COELHO A, 1995, J CLIN MICROBIOL, V33, P114, DOI 10.1128/JCM.33.1.114-118.1995; Dutta S, 2010, J BACTERIOL, V192, P169, DOI 10.1128/JB.00930-09; Epelman S, 2004, J IMMUNOL, V173, P2031, DOI 10.4049/jimmunol.173.3.2031; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mukherjee G, 2008, MOL IMMUNOL, V45, P266, DOI 10.1016/j.molimm.2007.04.024; Nelson KL, 1999, CELL MICROBIOL, V1, P69, DOI 10.1046/j.1462-5822.1999.00009.x; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Ray A, 2005, IMMUNOLOGY, V114, P94, DOI 10.1111/j.1365-2567.2004.02002.x; Ray A, 2003, IMMUNOL LETT, V89, P143, DOI 10.1016/S0165-2478(03)00135-4; Saha N, 1997, J BIOL CHEM, V272, P162, DOI 10.1074/jbc.272.1.162; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; VanGool SW, 1996, IMMUNOL REV, V153, P47; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhang Y, 2003, INFECT IMMUN, V71, P1513, DOI 10.1128/IAI.71.3.1513-1519.2003	36	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34542	34551		10.1074/jbc.M111.241851	http://dx.doi.org/10.1074/jbc.M111.241851			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846723	hybrid, Green Published			2022-12-27	WOS:000295406300008
J	Gur, M; Kahn, R; Karbat, I; Regev, N; Wang, JT; Catterall, WA; Gordon, D; Gurevitz, M				Gur, Maya; Kahn, Roy; Karbat, Izhar; Regev, Noa; Wang, Jinti; Catterall, William A.; Gordon, Dalia; Gurevitz, Michael			Elucidation of the Molecular Basis of Selective Recognition Uncovers the Interaction Site for the Core Domain of Scorpion alpha-Toxins on Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEA-ANEMONE TOXIN; VOLTAGE SENSOR; RAT-BRAIN; MEMBRANE-PROTEIN; RECEPTOR SITE-3; INACTIVATION; MODULATION; BINDING; INSECT; SUBUNIT	Neurotoxin receptor site-3 at voltage-gated Na+ channels is recognized by various peptide toxin inhibitors of channel inactivation. Despite extensive studies of the effects of these toxins, their mode of interaction with the channel remained to be described at the molecular level. To identify channel constituents that interact with the toxins, we exploited the opposing preferences of Lqh alpha IT and Lqh2 scorpion alpha-toxins for insect and mammalian brain Na+ channels. Construction of the DIV/S1-S2, DIV/S3-S4, DI/S5-SS1, and DI/SS2-S6 external loops of the rat brain rNa(v)1.2a channel (highly sensitive to Lqh2) in the background of the Drosophila DmNa(v)1 channel (highly sensitive to Lqh alpha IT), and examination of toxin activity on the channel chimera expressed in Xenopus oocytes revealed a substantial decrease in Lqh alpha IT effect, whereas Lqh2 was as effective as at rNa(v)1.2a. Further substitutions of individual loops and specific residues followed by examination of gain or loss in Lqh2 and Lqh alpha IT activities highlighted the importance of DI/S5-S6 (pore module) and the C-terminal region of DIV/S3 (gating module) of rNa(v)1.2a for Lqh2 action and selectivity. In contrast, a single substitution of Glu-1613 to Asp at DIV/S3-S4 converted rNa(v)1.2a to high sensitivity toward Lqh alpha IT. Comparison of depolarization-driven dissociation of Lqh2 and mutant derivatives off their binding site at rNa(v)1.2a mutant channels has suggested that the toxin core domain interacts with the gating module of DIV. These results constitute the first step in better understanding of the way scorpion alpha-toxins interact with voltage-gated Na+-channels at the molecular level.	[Wang, Jinti; Catterall, William A.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Gur, Maya; Kahn, Roy; Karbat, Izhar; Regev, Noa; Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Mol Biol & Ecol, IL-69978 Tel Aviv, Israel	University of Washington; University of Washington Seattle; Tel Aviv University	Catterall, WA (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.			Regev, Noa/0000-0002-5865-4774	National Institutes of Health [1U01 NS058039-01]; United States-Israel Binational Agricultural Research and Development [IS-4313-10]; Israeli Science Foundation [107/08]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development; Israeli Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1U01 NS058039-01 (to W. A. C. and M. G.). This work was also supported by United States-Israel Binational Agricultural Research and Development Grant IS-4313-10 (to M. G. and D. G.) and by Israeli Science Foundation Grant 107/08 (to M. G. and D. G.).	Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Campos FV, 2008, J GEN PHYSIOL, V132, P251, DOI 10.1085/jgp.200809995; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1979, J GEN PHYSIOL, V74, P375, DOI 10.1085/jgp.74.3.375; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Chen H, 2001, J GEN PHYSIOL, V117, P505, DOI 10.1085/jgp.117.6.505; Chen HJ, 2000, PFLUG ARCH EUR J PHY, V439, P423, DOI 10.1007/s004240050959; Derst C, 2006, BIOCHEM BIOPH RES CO, V339, P939, DOI 10.1016/j.bbrc.2005.11.096; Featherstone DE, 1996, BIOPHYS J, V71, P3098, DOI 10.1016/S0006-3495(96)79504-8; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; Gilles N, 2002, EUR J BIOCHEM, V269, P1500, DOI 10.1046/j.1432-1033.2002.02799.x; Gilles N, 2001, BIOCHEMISTRY-US, V40, P14576, DOI 10.1021/bi010973r; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Gordon D., 2004, NEUROTOX 03 NEUROTOX, P59; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Kahn R, 2009, J BIOL CHEM, V284, P20684, DOI 10.1074/jbc.M109.021303; Karbat I, 2004, J BIOL CHEM, V279, P31679, DOI 10.1074/jbc.M402048200; Karbat I, 2007, FEBS J, V274, P1918, DOI 10.1111/j.1742-4658.2007.05737.x; Leipold E, 2005, FEBS LETT, V579, P3881, DOI 10.1016/j.febslet.2005.05.077; Leipold E, 2004, MOL PHARMACOL, V65, P685, DOI 10.1124/mol.65.3.685; Liu LH, 2005, FASEB J, V19, P594, DOI 10.1096/fj.04-2485fje; Moran Y, 2007, BIOCHEM J, V406, P41, DOI 10.1042/BJ20070233; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Qu YS, 1999, J BIOL CHEM, V274, P32647, DOI 10.1074/jbc.274.46.32647; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Schnur E, 2008, BIOCHEMISTRY-US, V47, P911, DOI 10.1021/bi701323k; Sheets MF, 1999, BIOPHYS J, V77, P747, DOI 10.1016/S0006-3495(99)76929-8; Shichor I, 2002, J NEUROSCI, V22, P4364, DOI 10.1523/JNEUROSCI.22-11-04364.2002; STRICHARTZ GR, 1986, J GEN PHYSIOL, V88, P413, DOI 10.1085/jgp.88.3.413; TEJEDOR FJ, 1990, CELL MOL NEUROBIOL, V10, P257, DOI 10.1007/BF00734578; THOMSEN WJ, 1989, P NATL ACAD SCI USA, V86, P10161, DOI 10.1073/pnas.86.24.10161; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; WALLNER M, 1993, FEBS LETT, V336, P535, DOI 10.1016/0014-5793(93)80871-Q; Wang JT, 2011, BIOPHYS J, V100, P422; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119; Weinberger H, 2010, MOL BIOL EVOL, V27, P1025, DOI 10.1093/molbev/msp310; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Yang YC, 2003, J NEUROSCI, V23, P4922; Yu FH, 2003, J NEUROSCI, V23, P7577; Zlotkin E, 1999, ANNU REV ENTOMOL, V44, P429, DOI 10.1146/annurev.ento.44.1.429	43	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35209	35217		10.1074/jbc.M111.259507	http://dx.doi.org/10.1074/jbc.M111.259507			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832067	Green Published, hybrid			2022-12-27	WOS:000295406300073
J	Golubkov, VS; Chernov, AV; Strongin, AY				Golubkov, Vladislav S.; Chernov, Andrei V.; Strongin, Alex Y.			Intradomain Cleavage of Inhibitory Prodomain Is Essential to Protumorigenic Function of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CARCINOMA CELLS; BASEMENT-MEMBRANE; TISSUE INHIBITOR; EPITHELIAL-CELLS; FURIN CLEAVAGE; CANCER; ACTIVATION; PROTEIN; TUMORIGENICITY; EMBRYOGENESIS	Invasive cancers use pericellular proteolysis to breach the extracellular matrix and basement membrane barriers and invade the surrounding tissue. Proinvasive membrane type-1 matrix metalloproteinase (MT1-MMP) is the primary mediator of proteolytic events on the cancer cell surface. MT1-MMP is synthesized as a zymogen. The latency of MT1-MMP is maintained by its N-terminal inhibitory prodomain. In the course of MT1-MMP activation, the (RRKR111)-R-108 down arrow Y-112 prodomain sequence is processed by furin. The intact prodomain released by furin alone, however, is a potent inhibitor of the emerging MT1-MMP enzyme. Evidence suggests that the prodomain undergoes intradomain cleavage at the PGD down arrow L-50 site followed by the release of the degraded prodomain by furin cleavage that finalizes the two-step activation event. These cleavages, only if combined, cause the activation of MT1-MMP. The significance of the intradomain cleavage in the protumorigenic program of MT1-MMP, however, remained unidentified. To identify this important parameter, in our current study, we used the cells that expressed the wild-type prodomain-based fluorescent biosensor and the mutant biosensor with the inactivated PGD down arrow L-50 cleavage site (L50D mutant) and also the cells with the enforced expression of the wild-type and L50D mutant MT1-MMP. Using cell-based tests, orthotopic breast cancer xenografts in mice, and genome-wide transcriptional profiling of cultured cells and tumor xenografts, we demonstrated that the intradomain cleavage of the PGD down arrow L-50 sequence of the prodomain is essential for the protumorigenic function of MT1-MMP. Our results emphasize the importance of the intradomain cleavages resulting in the inactivation of the respective inhibitory prodomains not only for MT1-MMP but also for other MMP family members.	[Golubkov, Vladislav S.; Chernov, Andrei V.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019; Chernov, Andrei/I-1623-2019; Golubkov, Vladislav/L-6828-2017	Strongin, Alex/0000-0003-3765-3016; Chernov, Andrei/0000-0002-3294-5418; 	National Institutes of Health [CA83017, CA77470]; NATIONAL CANCER INSTITUTE [R01CA077470, R01CA083017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83017 and CA77470 (to A. Y. S.).	Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chernov AV, 2010, J BIOL CHEM, V285, P19647, DOI 10.1074/jbc.M109.088153; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Golubkov VS, 2007, J BIOL CHEM, V282, P36283, DOI 10.1074/jbc.M706290200; Golubkov VS, 2006, CANCER RES, V66, P10460, DOI 10.1158/0008-5472.CAN-06-2997; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Golubkov VS, 2010, J BIOL CHEM, V285, P27726, DOI 10.1074/jbc.M110.135442; Grum-Schwensen B, 2010, CANCER RES, V70, P936, DOI 10.1158/0008-5472.CAN-09-3220; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Murphy G, 2011, FEBS J, V278, P2, DOI 10.1111/j.1742-4658.2010.07918.x; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Remacle AG, 2006, J BIOL CHEM, V281, P16897, DOI 10.1074/jbc.M600295200; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Soulie P, 2005, ONCOGENE, V24, P1689, DOI 10.1038/sj.onc.1208360; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Szabova L, 2008, ONCOGENE, V27, P3274, DOI 10.1038/sj.onc.1210982; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934	36	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34215	34223		10.1074/jbc.M111.264036	http://dx.doi.org/10.1074/jbc.M111.264036			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832072	hybrid, Green Published			2022-12-27	WOS:000295159200051
J	Satapathy, AK; Kulczyk, AW; Ghosh, S; van Oijen, AM; Richardson, CC				Satapathy, Ajit K.; Kulczyk, Arkadiusz W.; Ghosh, Sharmistha; van Oijen, Antoine M.; Richardson, Charles C.			Coupling dTTP Hydrolysis with DNA Unwinding by the DNA Helicase of Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 4 PROTEIN; DEOXYRIBONUCLEIC-ACID; REPLICATION-FORK; NUCLEOTIDE HYDROLYSIS; STERIC EXCLUSION; RING HELICASE; STRANDED-DNA; DUPLEX DNA; PRIMASE; MECHANISM	The DNA helicase encoded by gene 4 of bacteriophage T7 assembles on single-stranded DNA as a hexamer of six identical subunits with the DNA passing through the center of the toroid. The helicase couples the hydrolysis of dTTP to unidirectional translocation on single-stranded DNA and the unwinding of duplex DNA. Phe(523), positioned in a beta-hairpin loop at the subunit interface, plays a key role in coupling the hydrolysis of dTTP to DNA unwinding. Replacement of Phe(523) with alanine or valine abolishes the ability of the helicase to unwind DNA or allow T7 polymerase to mediate strand-displacement synthesis on duplex DNA. In vivo complementation studies reveal a requirement for a hydrophobic residue with long side chains at this position. In a crystal structure of T7 helicase, when a nucleotide is bound at a subunit interface, Phe(523) is buried within the interface. However, in the unbound state, it is more exposed on the outer surface of the helicase. This structural difference suggests that the beta-hairpin bearing the Phe(523) may undergo a conformational change during nucleotide hydrolysis. We postulate that upon hydrolysis of dTTP, Phe(523) moves from within the subunit interface to a more exposed position where it contacts the displaced complementary strand and facilitates unwinding.	[Satapathy, Ajit K.; Kulczyk, Arkadiusz W.; Ghosh, Sharmistha; van Oijen, Antoine M.; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu	van Oijen, Antoine/I-3167-2014	van Oijen, Antoine/0000-0002-1794-5161	National Institutes of Health [GM54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C. C. R.).	Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Donmez I, 2008, EMBO J, V27, P1718, DOI 10.1038/emboj.2008.100; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; KOLODNER R, 1977, P NATL ACAD SCI USA, V74, P1525, DOI 10.1073/pnas.74.4.1525; LECHNER RL, 1983, J BIOL CHEM, V258, P1174; LECHNER RL, 1983, J BIOL CHEM, V258, P1185; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; MENDELMAN LV, 1992, P NATL ACAD SCI USA, V89, P10638, DOI 10.1073/pnas.89.22.10638; MENDELMAN LV, 1993, J BIOL CHEM, V268, P27208; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Picha KM, 1998, J BIOL CHEM, V273, P27315, DOI 10.1074/jbc.273.42.27315; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; Rothenberg E, 2007, J BIOL CHEM, V282, P34229, DOI 10.1074/jbc.M706300200; Satapathy AK, 2011, J BIOL CHEM, V286, P23113, DOI 10.1074/jbc.M111.218651; Satapathy AK, 2010, P NATL ACAD SCI USA, V107, P6782, DOI 10.1073/pnas.1002734107; Satapathy AK, 2009, J BIOL CHEM, V284, P14286, DOI 10.1074/jbc.M900557200; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; Zhu B, 2009, J BIOL CHEM, V284, P23842, DOI 10.1074/jbc.M109.026104	41	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34468	34478		10.1074/jbc.M111.283796	http://dx.doi.org/10.1074/jbc.M111.283796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21840995	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000295159200074
J	Ding, L; Forsburg, SL				Ding, Lin; Forsburg, Susan L.			Schizosaccharomyces pombe Minichromosome Maintenance-binding Protein (MCM-BP) Antagonizes MCM Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; REPLICATION FACTOR MCM4; DNA-DAMAGE CHECKPOINT; XENOPUS EGG EXTRACTS; FISSION YEAST; S-PHASE; CELL-CYCLE; DORMANT ORIGINS; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION	The minichromosome maintenance (MCM) complex, a replicative helicase, is a heterohexamer essential for DNA duplication and genome stability. We identified Schizosaccharomyces pombe mcb1(+) (Mcm-binding protein 1), an apparent orthologue of the human MCM-binding protein that associates with a subset of MCM complex proteins. mcb1(+) is an essential gene. Deletion of mcb1(+) caused cell cycle arrest after several generations with a cdc phenotype and disrupted nuclear structure. Mcb1 is an abundant protein, constitutively present across the cell cycle. It is widely distributed in cytoplasm and nucleoplasm and bound to chromatin. Co-immunoprecipitation suggested that Mcb1 interacts robustly with Mcm3-7 but not Mcm2. Overproduction of Mcb1 disrupted the association of Mcm2 with other MCM proteins, resulting in inhibition of DNA replication, DNA damage, and activation of the checkpoint kinase Chk1. Thus, Mcb1 appears to antagonize the function of MCM helicase.	[Ding, Lin; Forsburg, Susan L.] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA	University of Southern California	Forsburg, SL (corresponding author), Univ So Calif, Mol & Computat Biol Program, 1050 Childs Way,RRI 201, Los Angeles, CA 90089 USA.	forsburg@usc.edu		Forsburg, Susan L/0000-0002-4895-8598	National Institutes of Health [R01 GM059321]; University of Southern California Keck School of Medicine; University of Southern California; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southern California Keck School of Medicine; University of Southern California; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM059321 (to S. L. F.) and the National Institutes of Health Cellular, Biochemical, and Molecular Sciences Training Program at the University of Southern California Keck School of Medicine (to L. D.).; Supported by a University of Southern California college doctoral fellowship.	Adachi Y, 1997, GENES CELLS, V2, P467, DOI 10.1046/j.1365-2443.1997.1350333.x; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bailis JM, 2008, MOL CELL BIOL, V28, P1724, DOI 10.1128/MCB.01717-07; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Blow JJ, 2009, EMBO REP, V10, P406, DOI 10.1038/embor.2009.5; Bochman ML, 2010, NUCLEIC ACIDS RES, V38, P6078, DOI 10.1093/nar/gkq422; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Braun KA, 2007, MOL BIOL CELL, V18, P1447, DOI 10.1091/mbc.E06-09-0792; Catlett MG, 2003, MOL BIOL CELL, V14, P4707, DOI 10.1091/mbc.E03-05-0288; Chuang CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001110; COXON A, 1992, NUCLEIC ACIDS RES, V20, P5571, DOI 10.1093/nar/20.21.5571; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; FORSBURG SL, 1994, J CELL SCI, V107, P2779; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Forsburg SL, 1997, GENETICS, V147, P1025; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gomez EB, 2002, GENETICS, V160, P1305; Gozuacik D, 2003, NUCLEIC ACIDS RES, V31, P570, DOI 10.1093/nar/gkg136; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; HARTWELL L, 1994, COLD SPRING HARB SYM, V59, P259, DOI 10.1101/SQB.1994.059.01.030; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hingorani MM, 1998, CURR BIOL, V8, pR83, DOI 10.1016/S0960-9822(98)70052-1; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; KEENEY JB, 1994, GENETICS, V136, P849; KELLY TJ, 1993, COLD SPRING HARB SYM, V58, P637, DOI 10.1101/SQB.1993.058.01.071; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Krude T, 1996, J CELL SCI, V109, P309; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lei M, 1996, MOL CELL BIOL, V16, P5081; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Liang DT, 1999, J CELL SCI, V112, P559; Liang DT, 2001, GENETICS, V159, P471; Lutzmann M, 2005, GENE, V362, P51, DOI 10.1016/j.gene.2005.07.031; MADINE MA, 1995, CURR BIOL, V5, P1270, DOI 10.1016/S0960-9822(95)00253-3; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Mason JA, 1997, NUCLEIC ACIDS RES, V25, P4700, DOI 10.1093/nar/25.22.4700; Matsuo Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1992, DOI 10.1271/bbb.60087; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MIYAKE S, 1993, MOL BIOL CELL, V4, P1003, DOI 10.1091/mbc.4.10.1003; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MuziFalconi M, 1995, P NATL ACAD SCI USA, V92, P12475, DOI 10.1073/pnas.92.26.12475; Namdar M, 2006, EXP CELL RES, V312, P3360, DOI 10.1016/j.yexcr.2006.07.001; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Pasion SG, 1999, MOL BIOL CELL, V10, P4043, DOI 10.1091/mbc.10.12.4043; Radcliffe P, 1998, MOL BIOL CELL, V9, P1757, DOI 10.1091/mbc.9.7.1757; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Sabatinos Sarah A., 2009, V521, P449, DOI [10.1007/978-1-60327-815-7_25, 10.1007/978-1-60327-817-5_25]; SAKA Y, 1993, CELL, V74, P383, DOI 10.1016/0092-8674(93)90428-S; Sakwe AM, 2007, MOL CELL BIOL, V27, P3044, DOI 10.1128/MCB.02384-06; SAZER S, 1990, J CELL SCI, V97, P509; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Sherman DA, 1998, NUCLEIC ACIDS RES, V26, P3955, DOI 10.1093/nar/26.17.3955; Sherman DA, 1998, MOL BIOL CELL, V9, P1833, DOI 10.1091/mbc.9.7.1833; Shultz RW, 2007, PLANT PHYSIOL, V144, P1697, DOI 10.1104/pp.107.101105; Sible JC, 1998, CURR BIOL, V8, P347, DOI 10.1016/S0960-9822(98)70136-8; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; Takahashi N, 2008, EMBO J, V27, P1840, DOI 10.1038/emboj.2008.107; Takahashi N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000817; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Yin L, 2008, MOL BIOL CELL, V19, P4374, DOI 10.1091/mbc.E08-01-0020; Yoshida K, 2005, BIOCHEM BIOPH RES CO, V331, P669, DOI 10.1016/j.bbrc.2005.03.222	77	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32918	32930		10.1074/jbc.M111.282541	http://dx.doi.org/10.1074/jbc.M111.282541			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813639	Green Published, hybrid			2022-12-27	WOS:000294968800010
J	Kigoshi, Y; Tsuruta, F; Chiba, T				Kigoshi, Yu; Tsuruta, Fuminori; Chiba, Tomoki			Ubiquitin Ligase Activity of Cul3-KLHL7 Protein Is Attenuated by Autosomal Dominant Retinitis Pigmentosa Causative Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUL3-BASED E3 LIGASE; MYOSIN-VIIA; DOMAIN PROTEINS; RETINAL FASCIN; SCF; INSIGHTS; KEAP1; DEGRADATION; ACTIVATION; COMPLEXES	Substrate-specific protein degradation mediated by the ubiquitin proteasome system (UPS) is crucial for the proper function of the cell. Proteins are specifically recognized and ubiquitinated by the ubiquitin ligases (E3s) and are then degraded by the proteasome. BTB proteins act as the substrate recognition subunit that recruits their cognate substrates to the Cullin 3-based multisubunit E3s. Recently, it was reported that missense mutations in KLHL7, a BTB-Kelch protein, are related to autosomal dominant retinitis pigmentosa (adRP). However, the involvement of KLHL7 in the UPS and the outcome of the adRP causative mutations were unknown. In this study, we show that KLHL7 forms a dimer, assembles with Cul3 through its BTB and BACK domains, and exerts E3 activity. Lys-48-linked but not Lys-63-linked polyubiquitin chain co-localized with KLHL7, which increased upon proteasome inhibition suggesting that KLHL7 mediates protein degradation via UPS. An adRP-causative missense mutation in the BACK domain of KLHL7 attenuated only the Cul3 interaction but not dimerization. Nevertheless, the incorporation of the mutant as a heterodimer in the Cul3-KLHL7 complex diminished the E3 ligase activity. Together, our results suggest that KLHL7 constitutes a Cul3-based E3 and that the disease-causing mutation inhibits ligase activity in a dominant negative manner, which may lead to the inappropriate accumulation of the substrates targeted for proteasomal degradation.	[Kigoshi, Yu; Tsuruta, Fuminori; Chiba, Tomoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan	University of Tsukuba	Chiba, T (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	tchiba@biol.tsukuba.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan; Grants-in-Aid for Scientific Research [23770218] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan (to T.C.).	Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cirak S, 2010, BRAIN, V133, P2123, DOI 10.1093/brain/awq108; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Friedman JS, 2009, AM J HUM GENET, V84, P792, DOI 10.1016/j.ajhg.2009.05.007; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hugosson T, 2010, ARCH OPHTHALMOL-CHIC, V128, P772, DOI 10.1001/archophthalmol.2010.98; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kubota H, 2009, J BIOCHEM, V146, P609, DOI 10.1093/jb/mvp139; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Saishin Y, 2000, INVEST OPHTH VIS SCI, V41, P2087; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Tubb BE, 2000, GENOMICS, V65, P146, DOI 10.1006/geno.2000.6156; Udovichenko IP, 2002, J CELL SCI, V115, P445; Weil D, 1996, P NATL ACAD SCI USA, V93, P3232, DOI 10.1073/pnas.93.8.3232; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Williams DS, 2002, VISION RES, V42, P455, DOI 10.1016/S0042-6989(01)00228-0; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	47	47	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33613	33621		10.1074/jbc.M111.245126	http://dx.doi.org/10.1074/jbc.M111.245126			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828050	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000294968800077
J	Lee, J; Di Jeso, B; Arvan, P				Lee, Jaemin; Di Jeso, Bruno; Arvan, Peter			Maturation of Thyroglobulin Protein Region I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINESTERASE-LIKE DOMAIN; HEREDITARY CONGENITAL GOITER; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; TRANSPORT; HYPOTHYROIDISM; AGGREGATION; MUTATIONS; EVOLUTION; SEQUENCE	In vertebrates, the thyroglobulin (Tg) gene product must be exported to the lumen of thyroid follicles for thyroid hormone synthesis. In toto, Tg is composed of multiple type-1 repeats connected by linker and hinge (altogether considered as "region I," nearly 1,200 residues); regions II-III (similar to 720 residues); and cholinesterase-like (ChEL) domain (similar to 570 residues). Regions II-III and ChEL rapidly acquire competence for secretion, yet regions I-II-III require 20 min to become a partially mature disulfide isomer; stabilization of a fully oxidized form requires ChEL. Transition from partially mature to mature Tg occurs as a discrete "jump" in mobility by nonreducing SDS-PAGE, suggesting formation of at most a few final pairings of Cys residues that may be separated by significant intervening primary sequence. Using two independent approaches, we have investigated which portion of Tg is engaged in this late stage of its maturation. First, we demonstrate that this event is linked to oxidation involving region I. Introduction of the Tg-C1245R mutation in the hinge (identical to that causing human goitrous hypothyroidism) inhibits this maturation, although the Cys-1245 partner remains unidentified. Second, we find that Tg truncated after its fourth type-1 repeat is a fully independent secretory protein. Together, the data indicate that final acquisition of secretory competence includes conformational maturation in the interval between linker and hinge segments of region I.	Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Di Jeso, Bruno] Univ Lecce, Dipartimento Sci & Tecnol Biol & Ambientali, Fac Sci MFN, I-73100 Lecce, Italy	University of Michigan System; University of Michigan; University of Salento	Arvan, P (corresponding author), Univ Michigan, Div Metab Endocrinol & Diabet, 1000 Wall St,Rm 5112, Ann Arbor, MI 48105 USA.	parvan@umich.edu	Lee, Jaemin/AAP-4875-2021	Lee, Jaemin/0000-0002-0224-7141; di jeso, bruno/0000-0001-8713-5984	National Institutes of Health [R01-DK40344, 5P60 DK20572];  [P30 CA46592]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040344, P30DK020572, P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK40344 (to P. A.).; We gratefully acknowledge the University of Michigan Diabetes Research and Training Center Cell and Molecular Biology Core (supported by Grant NIH5P60 DK20572) and the University of Michigan Cancer Center Core laboratories (supported by Grant P30 CA46592).	Arvan P, 1997, THYROID, V7, P89, DOI 10.1089/thy.1997.7.89; Aryan P, 2004, THYROID, P77; Baryshev M, 2004, J MOL ENDOCRINOL, V32, P903, DOI 10.1677/jme.0.0320903; CHRISTOPHE D, 1990, TRENDS ENDOCRIN MET, V1, P351, DOI 10.1016/1043-2760(90)90083-F; Citterio CE, 2011, CLIN ENDOCRINOL, V74, P534, DOI 10.1111/j.1365-2265.2010.03932.x; DEVIJLDER JJM, 1978, ENDOCRINOLOGY, V102, P1214, DOI 10.1210/endo-102-4-1214; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Di Jeso B, 2003, BIOCHEM J, V370, P449, DOI 10.1042/BJ20021257; Dunn AD, 1998, J BIOL CHEM, V273, P25223, DOI 10.1074/jbc.273.39.25223; Fujikawa T, 2010, CELL STRESS CHAPERON, V15, P193, DOI 10.1007/s12192-009-0133-x; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Hishinuma A, 1999, J CLIN ENDOCR METAB, V84, P1438, DOI 10.1210/jc.84.4.1438; Hishinuma A, 2006, J CLIN ENDOCR METAB, V91, P3100, DOI 10.1210/jc.2005-2702; Kim PS, 2008, MOL ENDOCRINOL, V22, P477, DOI 10.1210/me.2007-0183; KIM PS, 1991, J BIOL CHEM, V266, P12412; KIM PS, 1993, AM J PHYSIOL, V265, pC704, DOI 10.1152/ajpcell.1993.265.3.C704; Kim PS, 1996, J CELL BIOL, V133, P517, DOI 10.1083/jcb.133.3.517; KIM PS, 1995, J CELL BIOL, V128, P29, DOI 10.1083/jcb.128.1.29; KIM PS, 1992, J CELL BIOL, V118, P541, DOI 10.1083/jcb.118.3.541; LAMAS L, 1977, ENDOCRINOLOGY, V100, P1129; Lee J, 2008, J CLIN INVEST, V118, P2950, DOI 10.1172/JCI35164; Lee J, 2011, J BIOL CHEM, V286, P26327, DOI 10.1074/jbc.M111.242099; Lee J, 2009, J BIOL CHEM, V284, P12752, DOI 10.1074/jbc.M806898200; MARRIQ C, 1991, MOL CELL ENDOCRINOL, V81, P155, DOI 10.1016/0303-7207(91)90214-D; MERCKEN L, 1985, NATURE, V316, P647, DOI 10.1038/316647a0; Mihelic M, 2007, BIOL CHEM, V388, P1123, DOI 10.1515/BC.2007.155; Molina F, 1996, EUR J BIOCHEM, V240, P125, DOI 10.1111/j.1432-1033.1996.0125h.x; Muresan Z, 1997, J BIOL CHEM, V272, P26095, DOI 10.1074/jbc.272.42.26095; Muresan Z, 1998, MOL ENDOCRINOL, V12, P458, DOI 10.1210/me.12.3.458; Park YN, 2004, J BIOL CHEM, V279, P17085, DOI 10.1074/jbc.M314042200; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Targovnik HM, 2010, MOL CELL ENDOCRINOL, V322, P44, DOI 10.1016/j.mce.2010.01.009; Taurog A, 1999, BIOCHIMIE, V81, P557, DOI 10.1016/S0300-9084(99)80110-2; Turakulov Ia Kh, 1976, Biokhimiia, V41, P1004; van de Graaf SAR, 1999, J CLIN ENDOCR METAB, V84, P2537, DOI 10.1210/jc.84.7.2537; VANVOORTHUIZEN WF, 1978, ENDOCRINOLOGY, V103, P2105, DOI 10.1210/endo-103-6-2105; VEENBOER GJM, 1993, ENDOCRINOLOGY, V132, P377, DOI 10.1210/en.132.1.377; Vono J, 1996, THYROID, V6, P11, DOI 10.1089/thy.1996.6.11; Vono-Toniolo J, 2005, THYROID, V15, P1021, DOI 10.1089/thy.2005.15.1021; Wang XF, 2010, J BIOL CHEM, V285, P17564, DOI 10.1074/jbc.M110.111641; Xiao S, 1996, ARCH BIOCHEM BIOPHYS, V334, P284, DOI 10.1006/abbi.1996.0457	42	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33045	33052		10.1074/jbc.M111.281337	http://dx.doi.org/10.1074/jbc.M111.281337			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21816825	Green Published, hybrid			2022-12-27	WOS:000294968800023
J	Sohail, A; Marco, M; Zhao, HR; Shi, QC; Merriman, S; Mobashery, S; Fridman, R				Sohail, Anjum; Marco, Marta; Zhao, Huiren; Shi, Qicun; Merriman, Scott; Mobashery, Shahriar; Fridman, Rafael			Characterization of the Dimerization Interface of Membrane Type 4 (MT4)-Matrix Metalloproteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; RICH LIPID RAFTS; MATRIX-METALLOPROTEINASE; EXPRESSION ANALYSIS; MMP25; PROTEINS; MT4-MMP; IDENTIFICATION; METASTASIS; INHIBITOR	MT4-MMP (MMP17) belongs to a unique subset of membrane type-matrix metalloproteinases that are anchored to the cell surface via a glycosylphosphatidylinositol moiety. However, little is known about its biochemical properties. Here, we report that MT4-MMP is displayed on the cell surface as a mixed population of monomeric, dimeric, and oligomeric forms. Sucrose gradient fractionation demonstrated that these forms of MT4-MMP are all present in lipid rafts. Mutational and computational analyses revealed that Cys(564), which is present within the stem region, mediates MT4-MMP homodimerization by forming a disulfide bond. Substitution of Cys(564) results in a more rapid MT4-MMP turnover, when compared with the wild-type enzyme, consistent with a role for dimerization in protein stability. Expression of MT4-MMP in Madin-Darby canine kidney cells enhanced cell migration and invasion of Matrigel, a process that requires catalytic activity. However, a serine substitution at Cys(564) did not reduce MT4-MMP-stimulated cell invasion of Matrigel suggesting that homodimerization is not required for this process. Deglycosylation studies showed that MT4-MMP is modified by N-glycosylation. Moreover, inhibition of N-glycosylation by tunicamycin diminished the extent of MT4-MMP dimerization suggesting that N-glycans may confer stability to the dimeric form. Taken together, the data presented here provide a new insight into the characteristics of MT4-MMP and highlight the common and distinct properties of the glycosylphosphatidylinositol-anchored membrane type-matrix metalloproteinases.	[Fridman, Rafael] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Sohail, Anjum; Marco, Marta; Zhao, Huiren; Merriman, Scott; Fridman, Rafael] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Shi, Qicun; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Shi, Qicun; Mobashery, Shahriar] Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46556 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Notre Dame; University of Notre Dame; Walther Cancer Institute	Fridman, R (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, 540 E Canfield Ave, Detroit, MI 48201 USA.	rfridman@med.wayne.edu		Sohail, Anjum/0000-0001-5567-9645	National Institutes of Health [CA-61986-16, CA-122417]; NATIONAL CANCER INSTITUTE [R01CA122417, R01CA061986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-61986-16 (to R. F.) and CA-122417 (to S. M.).	Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Caiolfa VR, 2007, J CELL BIOL, V179, P1067, DOI 10.1083/jcb.200702151; Chabottaux V, 2006, CANCER RES, V66, P5165, DOI 10.1158/0008-5472.CAN-05-3012; Chabottaux V, 2009, J CELL MOL MED, V13, P4002, DOI 10.1111/j.1582-4934.2009.00764.x; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; Clements KM, 2011, ANN RHEUM DIS, V70, P683, DOI 10.1136/ard.2010.130757; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; English WR, 2000, J BIOL CHEM, V275, P14046, DOI 10.1074/jbc.275.19.14046; English WR, 2001, FEBS LETT, V491, P137, DOI 10.1016/S0014-5793(01)02150-0; Funatsu N, 2004, CEREB CORTEX, V14, P1031, DOI 10.1093/cercor/bhh063; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Gauthier MC, 2003, INT J BIOCHEM CELL B, V35, P1667, DOI 10.1016/S1357-2725(03)00136-5; Hegedus L, 2008, J CELL PHYSIOL, V216, P480, DOI 10.1002/jcp.21417; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Huang CH, 2009, NEOPLASIA, V11, P1371, DOI 10.1593/neo.91326; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kajita M, 1999, FEBS LETT, V457, P353, DOI 10.1016/S0014-5793(99)01065-0; Kim JY, 2004, ENDOCRINOLOGY, V145, P613, DOI 10.1210/en.2003-0772; Kinoh H, 1999, CYTOGENET CELL GENET, V87, P97, DOI 10.1159/000015402; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nie J, 2004, EXP CELL RES, V296, P145, DOI 10.1016/j.yexcr.2004.02.008; Nuttall RK, 2004, FEBS LETT, V563, P129, DOI 10.1016/S0014-5793(04)00281-9; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Paladino S, 2007, TRAFFIC, V8, P251, DOI 10.1111/j.1600-0854.2006.00522.x; Patwari P, 2005, OSTEOARTHR CARTILAGE, V13, P269, DOI 10.1016/j.joca.2004.10.023; Plaisier M, 2006, MOL HUM REPROD, V12, P11, DOI 10.1093/molehr/gah257; Puente XS, 1996, CANCER RES, V56, P944; Rikimaru A, 2007, GENES CELLS, V12, P1091, DOI 10.1111/j.1365-2443.2007.01110.x; Rizki A, 2008, CANCER RES, V68, P1378, DOI 10.1158/0008-5472.CAN-07-2225; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Srichai MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017099; Sun Q, 2007, J BIOL CHEM, V282, P21998, DOI 10.1074/jbc.M701737200; Wu YI, 2004, J BIOL CHEM, V279, P8278, DOI 10.1074/jbc.M311870200; Zhang WL, 2007, BIOCHEMISTRY-US, V46, P10113, DOI 10.1021/bi700777x; Zhao HR, 2008, J BIOL CHEM, V283, P35023, DOI 10.1074/jbc.M806553200; Zhuang LY, 2002, CANCER RES, V62, P2227; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2	40	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33178	33189		10.1074/jbc.M111.253369	http://dx.doi.org/10.1074/jbc.M111.253369			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828052	hybrid, Green Published			2022-12-27	WOS:000294968800037
J	Ohara-Nemoto, Y; Shimoyama, Y; Kimura, S; Kon, A; Haraga, H; Ono, T; Nemoto, TK				Ohara-Nemoto, Yuko; Shimoyama, Yu; Kimura, Shigenobu; Kon, Asako; Haraga, Hiroshi; Ono, Toshio; Nemoto, Takayuki K.			Asp- and Glu-specific Novel Dipeptidyl Peptidase 11 of Porphyromonas gingivalis Ensures Utilization of Proteinaceous Energy Sources	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPEPTIDYL AMINOPEPTIDASE; STAPHYLOCOCCUS-EPIDERMIDIS; GLUTAMYL ENDOPEPTIDASE; BACILLUS-SPHAERICUS; PERIODONTAL-DISEASE; GENOME SEQUENCE; ORAL BACTERIA; STRAIN W83; BACTEROIDES; PURIFICATION	Porphyromonas gingivalis and Porphyromonas endodontalis, asaccharolytic black-pigmented anaerobes, are predominant pathogens of human chronic and periapical periodontitis, respectively. They incorporate di- and tripeptides from the environment as carbon and energy sources. In the present study we cloned a novel dipeptidyl peptidase (DPP) gene of P. endodontalis ATCC 35406, designated as DPP11. The DPP11 gene encoded 717 amino acids with a molecular mass of 81,090 Da and was present as a 75-kDa form with an N terminus of Asp(22). A homology search revealed the presence of a P. gingivalis orthologue, PGN0607, that has been categorized as an isoform of authentic DPP7. P. gingivalis DPP11 was exclusively cell-associated as a truncated 60-kDa form, and the gene ablation retarded cell growth. DPP11 specifically removed dipeptides from oligopeptides with the penultimate N-terminal Asp and Glu and has a P2-position preference to hydrophobic residues. Optimum pH was 7.0, and the k(cat)/K-m value was higher for Asp than Glu. Those activities were lost by substitution of Ser(652) in P. endodontalis and Ser(655) in P. gingivalis DPP11 to Ala, and they were consistently decreased with increasing NaCl concentration. Arg(670) is a unique amino acid completely conserved in all DPP11 members distributed in the genera Porphyromonas, Bacteroides, and Parabacteroides, whereas this residue is converted to Gly in all authentic DPP7 members. Substitution analysis suggested that Arg(670) interacts with an acidic residue of the substrate. Considered to preferentially utilize acidic amino acids, DPP11 ensures efficient degradation of oligopeptide substrates in these Gram-negative anaerobic rods.	[Ohara-Nemoto, Yuko; Ono, Toshio; Nemoto, Takayuki K.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Mol Biol, Course Med & Dent Sci, Nagasaki 8528588, Japan; [Shimoyama, Yu; Kimura, Shigenobu; Kon, Asako; Haraga, Hiroshi] Iwate Med Univ, Div Mol Microbiol, Dept Microbiol, Yahaba, Iwate 0283691, Japan	Nagasaki University; Iwate Medical University	Ohara-Nemoto, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Mol Biol, Course Med & Dent Sci, Nagasaki 8528588, Japan.	ynemoto@nagasaki-u.ac.jp		Nemoto, Takayuki K./0000-0002-5007-6260	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan ( to Y. O.-N., T. K. N., and S. K.).	Abbott CA, 2000, EUR J BIOCHEM, V267, P6140, DOI 10.1046/j.1432-1327.2000.01617.x; Banbula A, 1999, J BIOL CHEM, V274, P9246, DOI 10.1074/jbc.274.14.9246; Banbula A, 2001, J BIOL CHEM, V276, P6299, DOI 10.1074/jbc.M008789200; Banbula A, 2000, INFECT IMMUN, V68, P1176, DOI 10.1128/IAI.68.3.1176-1182.2000; Beauvais A, 1997, J BIOL CHEM, V272, P6238, DOI 10.1074/jbc.272.10.6238; CARMONA C, 1987, NUCLEIC ACIDS RES, V15, P6757, DOI 10.1093/nar/15.16.6757; CHEN ZX, 1992, J BIOL CHEM, V267, P18896; Citron D. M., 2007, MANUAL CLIN MICROBIO, V1, P911; Conrads G, 2005, INT J SYST EVOL MICR, V55, P607, DOI 10.1099/ijs.0.63234-0; Curtis MA, 1999, J PERIODONTAL RES, V34, P464, DOI 10.1111/j.1600-0765.1999.tb02282.x; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Dubois V, 2010, BBA-PROTEINS PROTEOM, V1804, P781, DOI 10.1016/j.bbapap.2009.11.022; ELLIS S, 1967, J BIOL CHEM, V242, P4623; Finegold SM, 2004, J CLIN MICROBIOL, V42, P5298, DOI 10.1128/JCM.42.11.5298-5301.2004; FUJIMURA S, 1992, ORAL MICROBIOL IMMUN, V7, P212, DOI 10.1111/j.1399-302X.1992.tb00027.x; Grenier D, 2001, ORAL MICROBIOL IMMUN, V16, P212, DOI 10.1034/j.1399-302X.2001.160403.x; GUINAND M, 1979, J BACTERIOL, V138, P126, DOI 10.1128/JB.138.1.126-132.1979; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Ikeda Y, 2004, CAN J MICROBIOL, V50, P493, DOI [10.1139/w04-055, 10.1139/W04-055]; Ito K, 2006, J MOL BIOL, V362, P228, DOI 10.1016/j.jmb.2006.06.083; Iwai T, 2005, J VASC SURG, V42, P107, DOI 10.1016/j.jvs.2005.03.016; KADOWAKI T, 1994, J BIOL CHEM, V269, P21371; KASTELEIN P, 1981, A VAN LEEUW J MICROB, V47, P1, DOI 10.1007/BF00399062; Kiyama M, 1998, BBA-GENE STRUCT EXPR, V1396, P39, DOI 10.1016/S0167-4781(97)00225-X; Kon A, 2002, DENT J IWATE MED U, V27, P187; KRIEGER TJ, 1994, FEBS LETT, V352, P385, DOI 10.1016/0014-5793(94)00988-0; Kshirsagar AV, 2007, BLOOD PURIFICAT, V25, P125, DOI 10.1159/000096411; LOESCHE WJ, 1985, J PERIODONTOL, V56, P447, DOI 10.1902/jop.1985.56.8.447; Maes MB, 2005, BIOCHEM J, V386, P315, DOI 10.1042/BJ20041156; MAYRAND D, 1988, MICROBIOL REV, V52, P134, DOI 10.1128/MMBR.52.1.134-152.1988; Mazumdar V, 2009, J BACTERIOL, V191, P74, DOI 10.1128/JB.01123-08; McDonald J. K., 1971, PROTEASES MAMMALIAN, P311; MCDONALD JK, 1968, J BIOL CHEM, V243, P2028; McNicholas K, 2009, CLIN CHEM LAB MED, V47, P262, DOI 10.1515/CCLM.2009.061; MOORE WEC, 1982, INFECT IMMUN, V38, P1137, DOI 10.1128/IAI.38.3.1137-1148.1982; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619, DOI 10.1074/jbc.270.40.23619; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nemoto TK, 2008, FEBS J, V275, P573, DOI 10.1111/j.1742-4658.2007.06224.x; Oda H, 2009, J PERIODONTAL RES, V44, P362, DOI 10.1111/j.1600-0765.2008.01117.x; Ohara-Nemoto Y, 2008, BIOL CHEM, V389, P1209, DOI 10.1515/BC.2008.137; OYA H, 1974, ARCH ORAL BIOL, V19, P489, DOI 10.1016/0003-9969(74)90158-7; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; PIKE R, 1994, J BIOL CHEM, V269, P406; Qi SY, 2003, BIOCHEM J, V373, P179, DOI 10.1042/BJ20021914; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Shoji M, 2002, MICROBIOL-SGM, V148, P1183, DOI 10.1099/00221287-148-4-1183; SUIDO H, 1986, J DENT RES, V65, P1335, DOI 10.1177/00220345860650111101; SUNDQVIST G, 1989, J ENDODONT, V15, P13, DOI 10.1016/S0099-2399(89)80092-5; Takahashi N, 2002, ORAL MICROBIOL IMMUN, V17, P50, DOI 10.1046/j.0902-0055.2001.00089.x; Takahashi N, 2001, J DENT RES, V80, P1425, DOI 10.1177/00220345010800050801; Takahashi N, 2000, J BACTERIOL, V182, P4704, DOI 10.1128/JB.182.17.4704-4710.2000; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; VACHERON MJ, 1979, EUR J BIOCHEM, V100, P189, DOI 10.1111/j.1432-1033.1979.tb02048.x; VANSTEENBERGEN TJM, 1984, INT J SYST BACTERIOL, V34, P118, DOI 10.1099/00207713-34-2-118; VANSTEENBERGEN TJM, 1986, FEMS MICROBIOL LETT, V33, P219, DOI 10.1016/0378-1097(86)90241-7; VANWINKELHOFF AJ, 1987, J DENT RES, V66, P1663, DOI 10.1177/00220345870660111201; VIMR ER, 1983, J BACTERIOL, V153, P1259, DOI 10.1128/JB.153.3.1259-1265.1983; WADA K, 1992, P NATL ACAD SCI USA, V89, P197, DOI 10.1073/pnas.89.1.197; WHITE D, 1981, J PERIODONTAL RES, V16, P259, DOI 10.1111/j.1600-0765.1981.tb00974.x	60	32	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38115	38127		10.1074/jbc.M111.278572	http://dx.doi.org/10.1074/jbc.M111.278572			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21896480	Green Published, hybrid			2022-12-27	WOS:000296594200025
J	Nakata, M; Kimura, KR; Sumitomo, T; Wada, S; Sugauchi, A; Oiki, E; Higashino, M; Kreikemeyer, B; Podbielski, A; Okahashi, N; Hamada, S; Isoda, R; Terao, Y; Kawabata, S				Nakata, Masanobu; Kimura, Keiji Richard; Sumitomo, Tomoko; Wada, Satoshi; Sugauchi, Akinari; Oiki, Eiji; Higashino, Miharu; Kreikemeyer, Bernd; Podbielski, Andreas; Okahashi, Nobuo; Hamada, Shigeyuki; Isoda, Ryutaro; Terao, Yutaka; Kawabata, Shigetada			Assembly Mechanism of FCT Region Type 1 Pili in Serotype M6 Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; GROUP-A STREPTOCOCCI; CORYNEBACTERIUM-DIPHTHERIAE; ISOPEPTIDE BONDS; CELL-WALL; STABILIZING ISOPEPTIDE; ESCHERICHIA-COLI; SURFACE PROTEIN; GENE; EXPRESSION	The human pathogen Streptococcus pyogenes produces diverse pili depending on the serotype. We investigated the assembly mechanism of FCT type 1 pili in a serotype M6 strain. The pili were found to be assembled from two precursor proteins, the backbone protein T6 and ancillary protein FctX, and anchored to the cell wall in a manner that requires both a housekeeping sortase enzyme (SrtA) and pilus-associated sortase enzyme (SrtB). SrtB is primarily required for efficient formation of the T6 and FctX complex and subsequent polymerization of T6, whereas proper anchoring of the pili to the cell wall is mainly mediated by SrtA. Because motifs essential for polymerization of pilus backbone proteins in other Gram-positive bacteria are not present in T6, we sought to identify the functional residues involved in this process. Our results showed that T6 encompasses the novel VAKS pilin motif conserved in streptococcal T6 homologues and that the lysine residue (Lys-175) within the motif and cell wall sorting signal of T6 are prerequisites for isopeptide linkage of T6 molecules. Because Lys-175 and the cell wall sorting signal of FctX are indispensable for substantial incorporation of FctX into the T6 pilus shaft, FctX is suggested to be located at the pilus tip, which was also implied by immunogold electron microscopy findings. Thus, the elaborate assembly of FCT type 1 pili is potentially organized by sortase-mediated cross-linking between sorting signals and the amino group of Lys-175 positioned in the VAKS motif of T6, thereby displaying T6 and FctX in a temporospatial manner.	[Nakata, Masanobu; Kimura, Keiji Richard; Sumitomo, Tomoko; Wada, Satoshi; Sugauchi, Akinari; Higashino, Miharu; Isoda, Ryutaro; Terao, Yutaka; Kawabata, Shigetada] Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Oiki, Eiji] Osaka Univ, Grad Sch Med, Ctr Med Res & Educ, Suita, Osaka 5650871, Japan; [Kreikemeyer, Bernd; Podbielski, Andreas] Univ Rostock, Inst Med Microbiol Virol & Hyg, D-18057 Rostock, Germany; [Okahashi, Nobuo] Osaka Univ, Grad Sch Dent, Dept Oral Frontier Biol, Suita, Osaka 5650871, Japan; [Hamada, Shigeyuki] Minist Publ Hlth, Res Collaborat Ctr Emerging & Reemerging Infect R, Dept Med Sci, Muang Nonthaburi 11000, Thailand	Osaka University; Osaka University; University of Rostock; Osaka University; Ministry of Public Health - Thailand	Kawabata, S (corresponding author), Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kawabata@dent.osaka-u.ac.jp	okahashi, nobuo/A-4032-2010	okahashi, nobuo/0000-0002-8045-7021; Nakata, Masanobu/0000-0003-1686-5415; Kreikemeyer, Bernd/0000-0001-9527-5098; Terao, Yutaka/0000-0002-4450-5583	Japan Society for the Promotion of Science [20390465]; Ministry of Education, Culture, Sports, Science and Technology [18073011, 2189048, 19791343, 20791336, 21791786]; Deutsche Forschungsgemeinschaft (German Research Foundation) [Po391/12-1, Kr1765/2-1]; Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research); Grants-in-Aid for Scientific Research [23592700, 23593027] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research (B) 20390465 from the Japan Society for the Promotion of Science and Grant-in-aid for Scientific Research on Priority Areas 18073011; Grant-in-aid for Scientific Research for Young Scientists (A) 2189048; and Grants-in-aid for Scientific Research for Young Scientists (B) 19791343, 20791336, and 21791786 from the Ministry of Education, Culture, Sports, Science and Technology.; Supported by Deutsche Forschungsgemeinschaft (German Research Foundation) Grants Po391/12-1 and Kr1765/2-1 and the Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research) in the framework of ERANet PathoGenoMics I and II and SysMO Systems Biology of Microorganisms I and II.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Barnett TC, 2002, J BACTERIOL, V184, P2181, DOI 10.1128/JB.184.8.2181-2191.2002; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; Bessen DE, 2010, FUTURE MICROBIOL, V5, P623, DOI [10.2217/fmb.10.28, 10.2217/FMB.10.28]; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; Griffith F, 1934, J HYG-CAMBRIDGE, V34, P542, DOI 10.1017/S0022172400043308; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, BIOPOLYMERS, V91, P1126, DOI 10.1002/bip.21170; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Kreikemeyer B, 2005, J BIOL CHEM, V280, P33228, DOI 10.1074/jbc.M502896200; Kreikemeyer B, 2011, INT J MED MICROBIOL, V301, P240, DOI 10.1016/j.ijmm.2010.09.003; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Murakami J, 2002, EPIDEMIOL INFECT, V128, P397, DOI 10.1017/S0950268802006854; Nakata M, 2005, MOL MICROBIOL, V57, P786, DOI 10.1111/j.1365-2958.2005.04730.x; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Okahashi N, 2011, MICROB PATHOGENESIS, V50, P148, DOI 10.1016/j.micpath.2011.01.005; Okahashi N, 2010, BIOCHEM BIOPH RES CO, V391, P1192, DOI 10.1016/j.bbrc.2009.12.029; Okura M, 2011, J BACTERIOL, V193, P822, DOI 10.1128/JB.01555-09; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Podbielski A, 1999, MOL MICROBIOL, V31, P1051, DOI 10.1046/j.1365-2958.1999.01241.x; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Quigley BR, 2009, MOL MICROBIOL, V72, P1379, DOI 10.1111/j.1365-2958.2009.06727.x; SCHNEEWIND O, 1990, J BACTERIOL, V172, P3310, DOI 10.1128/jb.172.6.3310-3317.1990; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Sumitomo T, 2011, J BIOL CHEM, V286, P2750, DOI 10.1074/jbc.M110.171504; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; Zahner D, 2008, J BACTERIOL, V190, P527, DOI 10.1128/JB.01520-07	46	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37566	37577		10.1074/jbc.M111.239780	http://dx.doi.org/10.1074/jbc.M111.239780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880740	Green Published, hybrid			2022-12-27	WOS:000296542400055
J	Ueno, N; Taketomi, Y; Yamamoto, K; Hirabayashi, T; Kamei, D; Kita, Y; Shimizu, T; Shinzawa, K; Tsujimoto, Y; Ikeda, K; Taguchi, R; Murakamia, M				Ueno, Noriko; Taketomi, Yoshitaka; Yamamoto, Kei; Hirabayashi, Tetsuya; Kamei, Daisuke; Kita, Yoshihiro; Shimizu, Takao; Shinzawa, Koei; Tsujimoto, Yoshihide; Ikeda, Kazutaka; Taguchi, Ryo; Murakamia, Makoto			Analysis of Two Major Intracellular Phospholipases A(2) (PLA(2)) in Mast Cells Reveals Crucial Contribution of Cytosolic PLA(2)alpha, Not Ca2+-independent PLA(2)beta, to Lipid Mobilization in Proximal Mast Cells and Distal Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; SMOOTH-MUSCLE-CELLS; TRANSCELLULAR BIOSYNTHESIS; PROSTAGLANDIN D-2; CYSTEINYL LEUKOTRIENES; EICOSANOID GENERATION; ALLERGIC INFLAMMATION; BROMOENOL LACTONE; EXPRESS GROUP; MICE LACKING	Mast cells release a variety of mediators, including arachidonic acid (AA) metabolites, to regulate allergy, inflammation, and host defense, and their differentiation and maturation within extravascular microenvironments depend on the stromal cytokine stem cell factor. Mouse mast cells express two major intracellular phospholipases A(2) (PLA(2)s), namely group IVA cytosolic PLA(2) (cPLA(2)alpha) and group VIA Ca2+-independent PLA2 (iPLA(2)beta), and the role of cPLA(2)alpha in eicosanoid synthesis by mast cells has been well documented. Lipidomic analyses of mouse bone marrow-derived mast cells (BMMCs) lacking cPLA(2)alpha (Pla2g4a(-/-)) or iPLA(2)beta (Pla2g6(-/-)) revealed that phospholipids with AA were selectively hydrolyzed by cPLA(2)alpha, not by iPLA(2)beta, during Fc epsilon RI-mediated activation and even during fibroblast-dependent maturation. Neither Fc epsilon RI-dependent effector functions nor maturation-driven phospholipid remodeling was impaired in Pla2g6(-/-) BMMCs. Although BMMCs did not produce prostaglandin E-2 (PGE(2)), the AA released by cPLA(2)alpha from BMMCs during maturation was converted to PGE(2) by microsomal PGE synthase-1 (mPGES-1) in cocultured fibroblasts, and accordingly, Pla2g4a(-/-) BMMCs promoted microenvironmental PGE(2) synthesis less efficiently than wild-type BMMCs both in vitro and in vivo. Mice deficient in mPGES-1 (Ptges(-/-)) had an augmented local anaphylactic response. These results suggest that cPLA(2)alpha in mast cells is functionally coupled, through the AA transfer mechanism, with stromal mPGES-1 to provide anti-anaphylactic PGE(2). Although iPLA(2)beta is partially responsible for PGE(2) production by macrophages and dendritic cells, it is dispensable for mast cell maturation and function.	[Ueno, Noriko; Taketomi, Yoshitaka; Yamamoto, Kei; Hirabayashi, Tetsuya; Murakamia, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, Tokyo 1568506, Japan; [Taketomi, Yoshitaka; Kamei, Daisuke] Showa Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Shinagawa Ku, Tokyo 1428555, Japan; [Kita, Yoshihiro; Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; [Kita, Yoshihiro] Univ Tokyo, Grad Sch Med, Dept Lipid, Bunkyo Ku, Tokyo 1130033, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Dept Metabolome, Bunkyo Ku, Tokyo 1130033, Japan; [Shinzawa, Koei; Tsujimoto, Yoshihide] Osaka Univ, Sch Med, Lab Mol Genet, Dept Med Genet, Suita, Osaka 5650871, Japan; [Ikeda, Kazutaka; Taguchi, Ryo; Murakamia, Makoto] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Ikeda, Kazutaka] Keio Univ, Inst Adv Biosci, Yamagata 9970052, Japan; [Taguchi, Ryo] Chubu Univ, Coll Life & Hlth Sci, Aichi 4878501, Japan	Tokyo Metropolitan Institute of Medical Science; Showa University; University of Tokyo; University of Tokyo; University of Tokyo; Osaka University; Japan Science & Technology Agency (JST); Keio University; Chubu University	Murakamia, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	murakami-mk@igakuken.or.jp	Shimizu, Takao/AAV-7052-2021	Hirabayashi, Tetsuya/0000-0001-8099-5367	Ministry of Education, Science, Culture, Sports and Technology of Japan; Japan Science and Technology Agency; Precursory Research for Embryonic Science and Technology from the Japan Science and Technology Agency; Toray Foundation; Mitsubishi Science Foundation; Terumo Life Science Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [22116005] Funding Source: KAKEN	Ministry of Education, Science, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Precursory Research for Embryonic Science and Technology from the Japan Science and Technology Agency; Toray Foundation; Mitsubishi Science Foundation; Terumo Life Science Foundation(Terumo Life Science Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in aid for scientific research from the Ministry of Education, Science, Culture, Sports and Technology of Japan.; Supported by Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency.; Supported by Precursory Research for Embryonic Science and Technology from the Japan Science and Technology Agency, The Toray Foundation, The Mitsubishi Science Foundation, The Terumo Life Science Foundation, and The Uehara Memorial Foundation.	Abonia JP, 2005, BLOOD, V105, P4308, DOI 10.1182/blood-2004-09-3578; Akers IA, 2000, AM J PHYSIOL-LUNG C, V278, pL193, DOI 10.1152/ajplung.2000.278.1.L193; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Austen KF, 2008, NAT IMMUNOL, V9, P113, DOI 10.1038/ni0208-113; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chandak PG, 2010, J BIOL CHEM, V285, P20192, DOI 10.1074/jbc.M110.107854; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; DAYTON ET, 1988, P NATL ACAD SCI USA, V85, P569, DOI 10.1073/pnas.85.2.569; Diaz BL, 2002, J IMMUNOL, V168, P1397, DOI 10.4049/jimmunol.168.3.1397; Dietrich HH, 2010, AM J PHYSIOL-HEART C, V298, pH2208, DOI 10.1152/ajpheart.00839.2009; Fabre JE, 2002, J CLIN INVEST, V109, P1373, DOI 10.1172/JCI200214869; Fensome-Green A, 2007, CELL CALCIUM, V41, P145, DOI 10.1016/j.ceca.2006.06.002; Fernandez JP, 2005, J BIOL CHEM, V280, P8544, DOI 10.1074/jbc.M413999200; Franchi L, 2009, J INNATE IMMUN, V1, P607, DOI 10.1159/000227263; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Fujishima H, 1999, P NATL ACAD SCI USA, V96, P4803, DOI 10.1073/pnas.96.9.4803; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gomi K, 2000, J IMMUNOL, V165, P6545, DOI 10.4049/jimmunol.165.11.6545; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Hammad H, 2007, J EXP MED, V204, P357, DOI 10.1084/jem.20061196; Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836; HU ZQ, 1995, J IMMUNOL, V155, P2134; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kamei D, 2004, J BIOL CHEM, V279, P33684, DOI 10.1074/jbc.M400199200; Kendall JC, 1997, J ALLERGY CLIN IMMUN, V99, P113; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; LEVISCHAFFER F, 1995, J INVEST DERMATOL, V104, P999, DOI 10.1111/1523-1747.ep12606237; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Li H, 2010, FASEB J, V24, P4103, DOI 10.1096/fj.10-161356; Lundequist A, 2010, J IMMUNOL, V184, P433, DOI 10.4049/jimmunol.0902835; Manguikian AD, 2004, J BIOL CHEM, V279, P52881, DOI 10.1074/jbc.M410659200; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mishra RS, 2008, J EXP MED, V205, P347, DOI 10.1084/jem.20071243; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; MURAKAMI M, 1995, J EXP MED, V182, P197, DOI 10.1084/jem.182.1.197; MURAKAMI M, 1995, J BIOL CHEM, V270, P3239, DOI 10.1074/jbc.270.7.3239; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; MURRAY JJ, 1986, NEW ENGL J MED, V315, P800, DOI 10.1056/NEJM198609253151304; Nakatani N, 2000, BIOCHEM J, V352, P311, DOI 10.1042/0264-6021:3520311; Nguyen MT, 2002, J IMMUNOL, V169, P4586, DOI 10.4049/jimmunol.169.8.4586; Nikolic DM, 2007, J BIOL CHEM, V282, P33405, DOI 10.1074/jbc.M704133200; NOCKA K, 1990, EMBO J, V9, P3287, DOI 10.1002/j.1460-2075.1990.tb07528.x; Ogasawara T, 1997, J IMMUNOL, V158, P393; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Reddy ST, 1996, J BIOL CHEM, V271, P186, DOI 10.1074/jbc.271.1.186; RUOSS SJ, 1991, J CLIN INVEST, V88, P493, DOI 10.1172/JCI115330; Sala A, 2010, PHARMACOL REP, V62, P503, DOI 10.1016/S1734-1140(10)70306-6; Satoh T, 2006, J IMMUNOL, V177, P2621, DOI 10.4049/jimmunol.177.4.2621; Sharma J, 2010, BIOCHEMISTRY-US, V49, P5473, DOI 10.1021/bi100752u; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Shiraishi Y, 2008, J IMMUNOL, V180, P541, DOI 10.4049/jimmunol.180.1.541; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smith RS, 1997, AM J PATHOL, V151, P317; Smith TJ, 1999, ENDOCRINOLOGY, V140, P3518, DOI 10.1210/en.140.8.3518; Song HW, 2010, BBA-MOL CELL BIOL L, V1801, P547, DOI 10.1016/j.bbalip.2010.01.006; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Taguchi R, 2005, J CHROMATOGR B, V823, P26, DOI 10.1016/j.jchromb.2005.06.005; Takano H, 2008, FEBS LETT, V582, P1444, DOI 10.1016/j.febslet.2008.03.033; Taketomi Y, 2003, BIOCHEM BIOPH RES CO, V306, P339, DOI 10.1016/S0006-291X(03)00942-2; Taketomi Y, 2007, J IMMUNOL, V178, P7042, DOI 10.4049/jimmunol.178.11.7042; Trautmann A, 1998, J IMMUNOL, V160, P5053; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wijewickrama GT, 2006, J BIOL CHEM, V281, P10935, DOI 10.1074/jbc.M512657200; Wong G. W., 1999, SIGNAL TRANSDUCTION, P39; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711; Yamashita A, 2005, J BIOCHEM, V137, P557, DOI 10.1093/jb/mvi067; Zarini S, 2009, P NATL ACAD SCI USA, V106, P8296, DOI 10.1073/pnas.0903851106; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200	85	23	23	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37249	37263		10.1074/jbc.M111.290312	http://dx.doi.org/10.1074/jbc.M111.290312			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880721	hybrid, Green Published			2022-12-27	WOS:000296542400025
J	Chouabe, C; Eyraud, V; Da Silva, P; Rahioui, I; Royer, C; Soulage, C; Bonvallet, R; Huss, M; Gressent, F				Chouabe, Christophe; Eyraud, Vanessa; Da Silva, Pedro; Rahioui, Isabelle; Royer, Corinne; Soulage, Christophe; Bonvallet, Robert; Huss, Markus; Gressent, Frederic			New Mode of Action for a Knottin Protein Bioinsecticide PEA ALBUMIN 1 SUBUNIT b (PA1b) IS THE FIRST PEPTIDIC INHIBITOR OF V-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASES; BIOLOGICAL-ACTIVITY; WEEVIL SITOPHILUS; PLASMA-MEMBRANE; BINDING-SITE; PEA-SEEDS; CELLS; ENTOMOTOXIN; PURIFICATION; CYCLOTIDES	PA1b (for pea albumin 1 subunit b) is a plant bioinsecticide lethal to several pests that are important in agriculture or human health. PA1b belongs to the inhibitory cystine knot family or knottin family. Originating from a plant (the garden pea) commonly eaten by humans without any known toxic or allergic effects, PA1b is a candidate for transgenic applications and is one of the most promising biopesticides for pest control. Using whole-cell patch-clamp techniques on Sf9 PA1b-sensitive lepidopteran insect cells, we discovered that PA1b reversibly blocked ramp membrane currents in a dose-dependent manner (EC50 = 0.52 mu M). PA1b had the same effect as bafilomycin, a specific inhibitor of the vacuolar proton pump (V-type H+-ATPase), and the PA1b-sensitive current depended on the internal proton concentration. Biochemical assays on purified V-ATPase from the lepidopteran model Manduca sexta showed that PA1b inhibited the V1V0-type H+-ATPase holoenzyme activity (IC50 similar to 70 nM) by interacting with the membrane-bound V-0 part of the V-ATPase. V-ATPase is a complex protein that has been studied increasingly because of its numerous physiological roles. In the midgut of insects, V-ATPase activity is essential for energizing nutrient absorption, and the results reported in this work explain the entomotoxic properties of PA1b. Targeting V-ATPase is a promising means of combating insect pests, and PA1b represents the first peptidic V-ATPase inhibitor. The search for V-ATPase inhibitors is currently of great importance because it has been demonstrated that V-ATPase plays a role in so many physiological processes.	[Eyraud, Vanessa; Da Silva, Pedro; Rahioui, Isabelle; Royer, Corinne; Gressent, Frederic] Univ Lyon, INSA Lyon Inst Natl Sci Appl, INRA, BF2I,UMR203, F-69621 Villeurbanne, France; [Chouabe, Christophe; Bonvallet, Robert] Univ Lyon, UMR CNRS 5534, Ctr Genet & Physiol Mol & Cellulaires, F-69622 Villeurbanne, France; [Soulage, Christophe] Univ Lyon 1, INSA Lyon, CarMeN, INSERM U1060, F-69621 Villeurbanne, France; [Huss, Markus] Univ Osnabruck, Abt Tierphysiol, Fachbereich Biol Chem, D-49069 Osnabruck, Germany	INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University Osnabruck	Gressent, F (corresponding author), Univ Lyon, INSA Lyon Inst Natl Sci Appl, INRA, BF2I,UMR203, F-69621 Villeurbanne, France.	frederic.gressent@lyon.inra.fr	SOULAGE, Christophe O/J-2759-2014	SOULAGE, Christophe O/0000-0002-8800-2144; GRESSENT, Frederic/0000-0002-7029-8709	Region Centre	Region Centre(Region Centre-Val de Loire)	This work was supported by the IFR41 (Lyon) and the Region Centre.	Baker MA, 2004, J BIOL CHEM, V279, P4811, DOI 10.1074/jbc.M311020200; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Bathori G, 1999, J BIOL CHEM, V274, P29607, DOI 10.1074/jbc.274.42.29607; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Chouabe C, 1997, J MOL CELL CARDIOL, V29, P193, DOI 10.1006/jmcc.1996.0264; Craik DJ, 2007, CURR OPIN DRUG DISC, V10, P176; Da Silva P, 2010, J BIOL CHEM, V285, P32689, DOI 10.1074/jbc.M110.147199; Daly NL, 2011, CURR OPIN CHEM BIOL, V15, P362, DOI 10.1016/j.cbpa.2011.02.008; DAVIES JM, 1994, P NATL ACAD SCI USA, V91, P8547, DOI 10.1073/pnas.91.18.8547; Delobel B., 1998, French Patent, Patent No. [9805877, 98 05877]; Dun XP, 2008, PEPTIDES, V29, P891, DOI 10.1016/j.peptides.2008.01.013; Dun XP, 2007, FEBS J, V274, P751, DOI 10.1111/j.1742-4658.2006.05619.x; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Grenier AM, 1997, HEREDITY, V79, P15, DOI 10.1038/hdy.1997.118; Gressent F, 2003, EUR J BIOCHEM, V270, P2429, DOI 10.1046/j.1432-1033.2003.03611.x; Gressent F, 2007, J INSECT SCI, V7; Gu JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021329; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HIGGINS TJV, 1986, J BIOL CHEM, V261, P1124; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067; Jouvensal L, 2003, BIOCHEMISTRY-US, V42, P11915, DOI 10.1021/bi034803l; Ma BY, 2011, CELL SIGNAL, V23, P1244, DOI 10.1016/j.cellsig.2011.03.003; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Perez-Sayans M, 2009, CANCER TREAT REV, V35, P707, DOI 10.1016/j.ctrv.2009.08.003; Petit J., 2009, Bureau IP, Patent No. [WO/2009/056689, 2009056689]; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; Rahioui I, 2007, BIOCHIMIE, V89, P1539, DOI 10.1016/j.biochi.2007.07.021; Rosengren KJ, 2002, BIOCHEMISTRY-US, V41, P3294, DOI 10.1021/bi011932y; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Wieczorek H, 1999, BIOESSAYS, V21, P637, DOI 10.1002/(SICI)1521-1878(199908)21:8<637::AID-BIES3>3.3.CO;2-N; WIECZOREK H, 1990, METHOD ENZYMOL, V192, P608; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007	36	30	32	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36291	36296		10.1074/jbc.M111.281055	http://dx.doi.org/10.1074/jbc.M111.281055			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21890633	hybrid, Green Published			2022-12-27	WOS:000296538300013
J	Miloslavina, Y; de Bianchi, S; Dall'Osto, L; Bassi, R; Holzwarth, AR				Miloslavina, Yuliya; de Bianchi, Silvia; Dall'Osto, Luca; Bassi, Roberto; Holzwarth, Alfred R.			Quenching in Arabidopsis thaliana Mutants Lacking Monomeric Antenna Proteins of Photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; CHARGE SEPARATION KINETICS; TIME-RESOLVED FLUORESCENCE; EXCITATION-ENERGY TRANSFER; PICOSECOND FLUORESCENCE; FUNCTIONAL ARCHITECTURE; PLASTOQUINONE POOL; BINDING-PROTEINS; CATION FORMATION; REACTION CENTERS	The minor light-harvesting complexes CP24, CP26, and CP29 have been proposed to play a key role in the zeaxanthin (Zx)-dependent high light-induced regulation (NPQ) of excitation energy in higher plants. To characterize the detailed roles of these minor complexes in NPQ and to determine their specific quenching effects we have studied the ultrafast fluorescence kinetics in knockout (ko) mutants koCP26, koCP29, and the double mutant koCP24/CP26. The data provide detailed insight into the quenching processes and the reorganization of the Photosystem (PS) II supercomplex under quenching conditions. All genotypes showed two NPQ quenching sites. Quenching site Q1 is formed by a light-induced functional detachment of parts of the PSII supercomplex and a pronounced quenching of the detached antenna parts. The antenna remaining bound to the PSII core was also quenched substantially in all genotypes under NPQ conditions (quenching site Q2) as compared with the dark-adapted state. The latter quenching was about equally strong in koCP26 and the koCP24/CP26 mutants as in the WT. Q2 quenching was substantially reduced, however, in koCP29 mutants suggesting a key role for CP29 in the total NPQ. The observed quenching effects in the knockout mutants are complicated by the fact that other minor antenna complexes do compensate in part for the lack of the CP24 and/or CP29 complexes. Their lack also causes some LHCII dissociation already in the dark.	[Miloslavina, Yuliya; Holzwarth, Alfred R.] Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany; [Miloslavina, Yuliya] Hungarian Acad Sci, Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary; [de Bianchi, Silvia; Dall'Osto, Luca; Bassi, Roberto] Univ Verona, Dipartimento Biotecnol, I-37134 Verona, Italy; [Bassi, Roberto] Forschungszentrum Julich, Inst Pflanzenwissensch 2, D-52425 Julich, Germany	Max Planck Society; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Verona; Helmholtz Association; Research Center Julich	Holzwarth, AR (corresponding author), Max Planck Inst Bioanorgan Chem, Stiftstr 34-36, D-45470 Mulheim, Germany.	holzwarth@mpi-muelheim.mpg.de	Holzwarth, Alfred R/G-2704-2013; Miloslavina, Yuliya/AAX-5751-2020; Holzwarth, Alfred/ABE-7424-2020	Miloslavina, Yuliya/0000-0001-6372-2420; Holzwarth, Alfred/0000-0002-9562-4873; bassi, roberto/0000-0002-4140-8446; Dall'Osto, Luca/0000-0001-9497-5156	European Union [238017]; Sonderforschungsbereich [SFB 663]; Heinrich-Heine-Universitat Dusseldorf; Max-Planck-Institutes Mulheim a.d. Ruhr	European Union(European Commission); Sonderforschungsbereich(German Research Foundation (DFG)); Heinrich-Heine-Universitat Dusseldorf; Max-Planck-Institutes Mulheim a.d. Ruhr	This work was supported by the Marie Curie Initial Training Network "HARVEST" Grant 238017 within the FP7 program of the European Union, Sonderforschungsbereich Grant SFB 663, Heinrich-Heine-Universitat Dusseldorf, and the Max-Planck-Institutes Mulheim a.d. Ruhr.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Avenson TJ, 2009, J BIOL CHEM, V284, P2830, DOI 10.1074/jbc.M807192200; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Ballottari M, 2010, J BIOL CHEM, V285, P28309, DOI 10.1074/jbc.M110.124115; Ballottari M, 2009, J BIOL CHEM, V284, P8103, DOI 10.1074/jbc.M808326200; BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; BRIANTAIS JM, 1994, PHOTOSYNTH RES, V40, P287, DOI 10.1007/BF00034778; Broess K, 2008, BBA-BIOENERGETICS, V1777, P404, DOI 10.1016/j.bbabio.2008.02.003; Broess K, 2006, BIOPHYS J, V91, P3776, DOI 10.1529/biophysj.106.085068; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Cheng YC, 2008, J PHYS CHEM B, V112, P13418, DOI 10.1021/jp802730c; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Dainese P., 1992, RES PHOTOSYNTHESIS, VII, P13; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; de Bianchi S, 2011, PLANT CELL, V23, P2659, DOI 10.1105/tpc.111.087320; de Bianchi S, 2010, BIOCHEM SOC T, V38, P651, DOI 10.1042/BST0380651; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DEMMIGADAMS B, 1989, PLANT BIOLOGY, V8, P375; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holzwarth A. R., 2008, P141, DOI 10.1007/978-3-540-73566-3_7; Holzwarth AR, 2009, CHEM PHYS LETT, V483, P262, DOI 10.1016/j.cplett.2009.10.085; Holzwarth AR, 2005, J PHYS CHEM B, V109, P5903, DOI 10.1021/jp046299f; Holzwarth AR, 1996, BIOPHYSICAL TECHNIQU, P75, DOI DOI 10.1007/0-306-47960-5_; Horton P, 1996, NATO ADV SCI INST SE, V287, P99; Jackowski G, 1998, Z NATURFORSCH C, V53, P841; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; JOHNSON GN, 1994, PLANTA, V194, P550, DOI 10.1007/BF00714469; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Krause GH, 2003, LIGHT HARVESTING ANT, P373; Lambrev PH, 2010, PLANT PHYSIOL, V152, P1611, DOI 10.1104/pp.109.148213; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li ZR, 2009, PLANT CELL, V21, P1798, DOI 10.1105/tpc.109.066571; MALKIN S, 1981, PLANT PHYSIOL, V67, P570, DOI 10.1104/pp.67.3.570; Miloslavina Y, 2006, BIOCHEMISTRY-US, V45, P2436, DOI 10.1021/bi052248c; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Miloslavina Y, 2009, BBA-BIOENERGETICS, V1787, P1189, DOI 10.1016/j.bbabio.2009.05.012; Morosinotto T, 2006, FEBS J, V273, P4616, DOI 10.1111/j.1742-4658.2006.05465.x; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Muller MG, 2010, CHEMPHYSCHEM, V11, P1289, DOI 10.1002/cphc.200900852; MULLER MG, 1992, CHEM PHYS LETT, V199, P465, DOI 10.1016/0009-2614(92)87028-N; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2003, NATURE, V421, P648, DOI 10.1038/nature01344; Slavov C, 2008, BIOPHYS J, V94, P3601, DOI 10.1529/biophysj.107.117101; Szczepaniak M, 2009, BIOPHYS J, V96, P621, DOI 10.1016/j.bpj.2008.09.036; Szczepaniak M, 2008, BBA-BIOENERGETICS, V1777, P1510, DOI 10.1016/j.bbabio.2008.09.002; Toth SZ, 2005, BBA-BIOENERGETICS, V1708, P275, DOI 10.1016/j.bbabio.2005.03.012; van Oort B, 2010, BIOPHYS J, V98, P922, DOI 10.1016/j.bpj.2009.11.012; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; WALTERS RG, 1995, PLANTA, V197, P306, DOI 10.1007/BF00202652; Yakushevska AE, 2001, EUR J BIOCHEM, V268, P6020, DOI 10.1046/j.0014-2956.2001.02505.x; YAMAMOTO HY, 1972, BIOCHIM BIOPHYS ACTA, V267, P538, DOI 10.1016/0005-2728(72)90182-X; [No title captured]	63	45	46	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36830	36840		10.1074/jbc.M111.273227	http://dx.doi.org/10.1074/jbc.M111.273227			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21844190	Green Published, hybrid			2022-12-27	WOS:000296538300063
J	Visweswaraiah, J; Lageix, S; Castilho, BA; Izotova, L; Kinzy, TG; Hinnebusch, AG; Sattlegger, E				Visweswaraiah, Jyothsna; Lageix, Sebastien; Castilho, Beatriz A.; Izotova, Lara; Kinzy, Terri Goss; Hinnebusch, Alan G.; Sattlegger, Evelyn			Evidence That Eukaryotic Translation Elongation Factor 1A (eEF1A) Binds the Gcn2 Protein C Terminus and Inhibits Gcn2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID CONTROL; EIF-2-ALPHA KINASE GCN2; UNCHARGED TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; SUBSTRATE RECOGNITION; NUCLEOTIDE EXCHANGE; EIF2-ALPHA KINASE; STARVED CELLS; ACTIVATION; DOMAIN	The eukaryotic elongation factor 1A (eEF1A) delivers aminoacyl-tRNAs to the ribosomal A-site during protein synthesis. To ensure a continuous supply of amino acids, cells harbor the kinase Gcn2 and its effector protein Gcn1. The ultimate signal for amino acid shortage is uncharged tRNAs. We have proposed a model for sensing starvation, in which Gcn1 and Gcn2 are tethered to the ribosome, and Gcn1 is directly involved in delivering uncharged tRNAs from the A-site to Gcn2 for its subsequent activation. Gcn1 and Gcn2 are large proteins, and these proteins as well as eEF1A access the A-site, leading us to investigate whether there is a functional or physical link between these proteins. Using Saccharomyces cerevisiae cells expressing His(6)-eEF1A and affinity purification, we found that eEF1A co-eluted with Gcn2. Furthermore, Gcn2 co-immunoprecipitated with eEF1A, suggesting that they reside in the same complex. The purified GST-tagged Gcn2 C-terminal domain (CTD) was sufficient for precipitating eEF1A from whole cell extracts generated from gcn2 Delta cells, independently of ribosomes. Purified GST-Gcn2-CTD and purified His(6)-eEF1A interacted with each other, and this was largely independent of the Lys residues in Gcn2-CTD known to be required for tRNA binding and ribosome association. Interestingly, Gcn2-eEF1A interaction was diminished in amino acid-starved cells and by uncharged tRNAs in vitro, suggesting that eEF1A functions as a Gcn2 inhibitor. Consistent with this possibility, purified eEF1A reduced the ability of Gcn2 to phosphorylate its substrate, eIF2 alpha, but did not diminish Gcn2 autophosphorylation. These findings implicate eEF1A in the intricate regulation of Gcn2 and amino acid homeostasis.	[Sattlegger, Evelyn] Massey Univ, Inst Nat Sci, N Shore Mail Ctr, Albany 0745, New Zealand; [Lageix, Sebastien; Hinnebusch, Alan G.; Sattlegger, Evelyn] NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Castilho, Beatriz A.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, BR-04023062 Sao Paulo, Brazil; [Izotova, Lara; Kinzy, Terri Goss] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA	Massey University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Universidade Federal de Sao Paulo (UNIFESP); Rutgers State University New Brunswick; Rutgers State University Medical Center	Sattlegger, E (corresponding author), Massey Univ, Inst Nat Sci, N Shore Mail Ctr, POB 102 904, Albany 0745, New Zealand.	e.sattlegger@massey.ac.nz	Castilho, Beatriz A/C-2503-2012	Castilho, Beatriz A/0000-0003-4509-5237; Kinzy, Terri/0000-0003-1394-9226	National Institutes of Health; Fundacao de Apoio a Pesquisa no Estado de Sao Paulo; Marsden Fund Council; Massey University; Royal Society of New Zealand [MAU0607];  [RO1 GM57483]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Apoio a Pesquisa no Estado de Sao Paulo; Marsden Fund Council(Royal Society of New ZealandMarsden Fund (NZ)); Massey University; Royal Society of New Zealand(Royal Society of New Zealand); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program (to A.G.H.) and by Grant RO1 GM57483 (to T.G.K.). This work was also supported by a grant from Fundacao de Apoio a Pesquisa no Estado de Sao Paulo (to B.A.C.), The Marsden Fund Council from Government funding, administered by the Royal Society of New Zealand (MAU0607), and a Massey University Technician Award and Research Fund (to E.S.).	ANDERSON JT, 1993, MOL CELL BIOL, V13, P6102, DOI 10.1128/MCB.13.10.6102; Bittencourt S, 2008, J COMP NEUROL, V507, P1811, DOI 10.1002/cne.21652; Carr-Schmid A, 1999, J BIOL CHEM, V274, P30297, DOI 10.1074/jbc.274.42.30297; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; Garcia-Barrio M, 2000, EMBO J, V19, P1887, DOI 10.1093/emboj/19.8.1887; Garriz A, 2009, MOL CELL BIOL, V29, P1592, DOI 10.1128/MCB.01446-08; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grallert B, 2007, CELL CYCLE, V6, P2768, DOI 10.4161/cc.6.22.4933; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Lamberti A, 2004, AMINO ACIDS, V26, P443, DOI 10.1007/s00726-004-0088-2; LAROSSA RA, 1984, J BIOL CHEM, V259, P8753; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; MURCHIE MJ, 1978, BIOCHIM BIOPHYS ACTA, V520, P233, DOI 10.1016/0005-2787(78)90024-2; Padyana AK, 2005, J BIOL CHEM, V280, P29289, DOI 10.1074/jbc.M504096200; Petrushenko ZM, 1997, FEBS LETT, V407, P13, DOI 10.1016/S0014-5793(97)00242-1; Pittman YR, 2009, J BIOL CHEM, V284, P4739, DOI 10.1074/jbc.M807945200; Qiu H, 2001, EMBO J, V20, P1425, DOI 10.1093/emboj/20.6.1425; Qiu HF, 1998, MOL CELL BIOL, V18, P2697, DOI 10.1128/MCB.18.5.2697; RAMIREZ M, 1992, MOL CELL BIOL, V12, P5801, DOI 10.1128/MCB.12.12.5801; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; Sambrook J., 2002, MOL CLONING LAB MANU; Sasse C, 2008, FUNGAL GENET BIOL, V45, P693, DOI 10.1016/j.fgb.2007.12.008; Sattlegger E, 2000, EMBO J, V19, P6622, DOI 10.1093/emboj/19.23.6622; Sattlegger E, 2005, J BIOL CHEM, V280, P16514, DOI 10.1074/jbc.M414566200; Sattlegger E, 2004, J BIOL CHEM, V279, P29952, DOI 10.1074/jbc.M404009200; Sattlegger E, 1998, J BIOL CHEM, V273, P20404, DOI 10.1074/jbc.273.32.20404; Sattlegger E, 2011, J BIOL CHEM, V286, P10341, DOI 10.1074/jbc.M110.171587; Taylor D. R., 2007, MONOGRAPH SERIES, V48, P59; Van Goietsenoven G, 2010, FASEB J, V24, P4575, DOI 10.1096/fj.10-162263; Visweswaraiah J., 2011, NAT PROTOC EXCHANGE, DOI [10.1038/protex.2011.2112, DOI 10.1038/PROTEX.2011.2112]; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Zhu SH, 1998, J BIOL CHEM, V273, P1808, DOI 10.1074/jbc.273.3.1808; Zhu SH, 1996, J BIOL CHEM, V271, P24989, DOI 10.1074/jbc.271.40.24989	42	33	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36568	36579		10.1074/jbc.M111.248898	http://dx.doi.org/10.1074/jbc.M111.248898			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21849502	hybrid, Green Published			2022-12-27	WOS:000296538300041
J	Zhao, XY; Zhao, KW; Jiang, Y; Zhao, M; Chen, GQ				Zhao, Xu-Yun; Zhao, Ke-Wen; Jiang, Yi; Zhao, Meng; Chen, Guo-Qiang			Synergistic Induction of Galectin-1 by CCAAT/Enhancer Binding Protein alpha and Hypoxia-inducible Factor 1 alpha and Its Role in Differentiation of Acute Myeloid Leukemic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLON-CANCER; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; INDUCED ACTIVATION; OXYGEN-TENSION; DEATH-RECEPTOR; STROMAL CELLS; C/EBP-ALPHA; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; IDENTIFICATION	Galectin-1 is a member of the galectin family and has a high affinity for galactose and N-acetylglucosamine moieties of glycoproteins. It mediates multiple signal transduction pathways to modulate cellular proliferation, survival, differentiation, and migration. However, the mechanisms for the regulation of its expression remain greatly elusive. We reported previously that galectin-1 is a direct target of the hypoxia-inducible factor 1 (HIF-1), a key heterodimeric transcriptional factor for the cellular response to hypoxia. Here we show that CCAAT/enhancer binding protein alpha (C/EBP alpha), a critical transcriptional factor for hematopoietic cell differentiation, can directly activate galectin-1 through binding to the -48 to -42 bp region of its promoter. Based on the physical interaction of C/EBP alpha and HIF-1 1 alpha, the synergistic transcriptional activity of C/EBP alpha and HIF-1 alpha on the promoter of the galectin-1 gene is also found by chromatin immunoprecipitation (ChIP), ChIP followed by ChIP (ChIP-reChIP), and luciferase assay. Moreover, knockdown or chemical inhibition of galectin-1 partially blocks the differentiation induced by HIF-1 alpha or C/EBP alpha, which can be rescued by recombinant galectin-1. These discoveries would shed new insights on the mechanisms for galectin-1 expression regulation and HIF-1 alpha- and C/EBP alpha-induced leukemic cell differentiation.	[Zhao, Xu-Yun; Zhao, Ke-Wen; Jiang, Yi; Zhao, Meng; Chen, Guo-Qiang] SJTU SM, Minist Educ China, Key Lab Cell Differentiat & Apoptosis, Dept Pathophysiol, Shanghai 200025, Peoples R China; [Zhao, Xu-Yun; Zhao, Ke-Wen; Jiang, Yi; Zhao, Meng; Chen, Guo-Qiang] Shanghai Jiao Tong Univ, Sch Med, Chem Biol Div, Shanghai Univ E Inst, Shanghai 200025, Peoples R China; [Chen, Guo-Qiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China	Ministry of Education, China; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, GQ (corresponding author), SJTU SM, Minist Educ China, Key Lab Cell Differentiat & Apoptosis, Dept Pathophysiol, 280 Chong Qing S Rd, Shanghai 200025, Peoples R China.	chengq@shsmu.edu.cn			National Key Program (973) for Basic Research of China [NO2009CB918404]; National Natural Science Foundation [30971274, 81000214]; Shanghai Municipal Education Commission [11ZR1419800, 11ZZ106]; Science and Technology Committee of Shanghai	National Key Program (973) for Basic Research of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Science and Technology Committee of Shanghai(Shanghai Science & Technology Committee)	This work was supported in part by National Key Program (973) for Basic Research of China Grant NO2009CB918404 (to G.-Q. C.), by National Natural Science Foundation Grants 30971274 (to Y. J.) and 81000214 (to M. Z.), by Program for Innovative Research Team of Shanghai Municipal Education Commission Grant 11ZR1419800 (to K.-W. Z.) from Science and Technology Committee of Shanghai, and by Shanghai Municipal Education Commission Grant 11ZZ106 (to K.-W. Z.).	Brandt B, 2008, HISTOCHEM CELL BIOL, V129, P599, DOI 10.1007/s00418-008-0395-x; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Fulcher JA, 2009, J BIOL CHEM, V284, P26860, DOI 10.1074/jbc.M109.037507; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200; Hittelet A, 2003, INT J CANCER, V103, P370, DOI 10.1002/ijc.10843; Huang Y, 2003, LEUKEMIA, V17, P2065, DOI 10.1038/sj.leu.2403141; Janardhan HP, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.143jc2; Jiang Y, 2005, LEUKEMIA, V19, P1239, DOI 10.1038/sj.leu.2403734; Kim JS, 2006, TOXICOLOGY, V223, P36, DOI 10.1016/j.tox.2006.03.004; Kovacs-Solyom F, 2010, IMMUNOL LETT, V127, P108, DOI 10.1016/j.imlet.2009.10.003; Lange F, 2009, HISTOCHEM CELL BIOL, V132, P211, DOI 10.1007/s00418-009-0597-x; Leroy H, 2005, LEUKEMIA, V19, P329, DOI 10.1038/sj.leu.2403614; Lutomski D, 1997, GLYCOBIOLOGY, V7, P1193, DOI 10.1093/glycob/7.8.1193; Miller M, 2003, J BIOL CHEM, V278, P15178, DOI 10.1074/jbc.M300417200; Mourcin F, 2011, BLOOD, V117, P6552, DOI 10.1182/blood-2010-12-323113; Nagy N, 2002, GUT, V50, P392, DOI 10.1136/gut.50.3.392; Nguyen-Khac F, 2006, ONCOGENE, V25, P4840, DOI 10.1038/sj.onc.1209503; Pace KE, 2003, METHOD ENZYMOL, V363, P499; Panepucci RA, 2004, STEM CELLS, V22, P1263, DOI 10.1634/stemcells.2004-0024; Preudhomme C, 2002, BLOOD, V100, P2717, DOI 10.1182/blood-2002-03-0990; PUCHE AC, 1995, J COMP NEUROL, V357, P513, DOI 10.1002/cne.903570403; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ren HY, 2006, BIOCHEM BIOPH RES CO, V347, P12, DOI 10.1016/j.bbrc.2006.05.169; Rosania GR, 1999, P NATL ACAD SCI USA, V96, P4797, DOI 10.1073/pnas.96.9.4797; Sakaguchi M, 2006, P NATL ACAD SCI USA, V103, P7112, DOI 10.1073/pnas.0508793103; Satelli A, 2011, INT J CANCER, V129, P799, DOI 10.1002/ijc.25750; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Silva WA, 2003, STEM CELLS, V21, P661, DOI 10.1634/stemcells.21-6-661; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; Smitha T, 2011, J Oral Maxillofac Pathol, V15, P26, DOI 10.4103/0973-029X.80034; Song LP, 2008, ONCOGENE, V27, P519, DOI 10.1038/sj.onc.1210670; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Vas V, 2005, STEM CELLS, V23, P279, DOI 10.1634/stemcells.2004-0084; Yang L, 2008, CARCINOGENESIS, V29, P291, DOI 10.1093/carcin/bgm262; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zhang J, 2008, HAEMATOL-HEMATOL J, V93, P1480, DOI 10.3324/haematol.13096; Zhang Jing, 2009, Pathophysiology, V16, P297, DOI 10.1016/j.pathophys.2009.02.005; Zhao KW, 2004, BLOOD, V104, P3731, DOI 10.1182/blood-2004-04-1630; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006552; Zhao XY, 2010, CARCINOGENESIS, V31, P1367, DOI 10.1093/carcin/bgq116; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	43	35	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36808	36819		10.1074/jbc.M111.247262	http://dx.doi.org/10.1074/jbc.M111.247262			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880716	Green Published, hybrid			2022-12-27	WOS:000296538300061
J	Cai, LQ; Phong, BL; Fisher, AL; Wang, Z				Cai, Liquan; Phong, Binh L.; Fisher, Alfred L.; Wang, Zhou			Regulation of Fertility, Survival, and Cuticle Collagen Function by the Caenorhabditis elegans eaf-1 and ell-1 Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ELONGATION-FACTOR; TRANSCRIPTION FACTOR; MLL; EXPRESSION; IDENTIFICATION; U19/EAF2; SUPPRESSION; MUTATIONS; HOMOLOG	EAF2, an androgen-regulated protein, interacts with members of the ELL (eleven-nineteen lysine-rich leukemia) transcription factor family and also acts as a tumor suppressor. Although these proteins control transcriptional elongation and perhaps modulate the effects of other transcription factors, the mechanisms of their actions remain largely unknown. To gain new insights into the biology of the EAF2 and ELL family proteins, we used Caenorhabditis elegans as a model to explore the in vivo roles of their worm orthologs. Through the use of transgenic worms, RNAi, and an eaf-1 mutant, we found that both genes are expressed in multiple cell types throughout the worm life cycle and that they play important roles in fertility, survival, and body size regulation. ELL-1 and EAF-1 likely contribute to these activities in part through modulating cuticle synthesis, given that we observed a disrupted cuticle structure in ell-1 RNAi-treated or eaf-1 mutant worms. Consistent with disruption of cuticle structure, loss of either ELL-1 or EAF-1 suppressed the rol phenotype of specific collagen mutants, possibly through the control of dpy-3, dpy-13, and sqt-3 collagen gene expression. Furthermore, we also noted the regulation of collagen expression by ELL overexpression in PC3 human prostate cancer cells. Together, these results reveal important roles for the eaf-1 and ell-1 genes in the regulation of extracellular matrix components.	[Fisher, Alfred L.] Univ Pittsburgh, Dept Med, Div Geriatr Med, Pittsburgh, PA 15260 USA; [Cai, Liquan; Phong, Binh L.; Wang, Zhou] Univ Pittsburgh, Dept Urol, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fisher, AL (corresponding author), Univ Pittsburgh, Dept Med, Div Geriatr Med, 930 Scaife Hall, Pittsburgh, PA 15260 USA.	afisher@pitt.edu; wangz2@upmc.edu	Fisher, Alfred/H-3031-2012	Cai, Liquan/0000-0001-9192-2673; Fisher, Alfred/0000-0001-6451-2644	National Institutes of Health [T32 DK007774, R37 DK51193, R01 CA120386, P50 CA090386, K08 AG028977]; NATIONAL CANCER INSTITUTE [P50CA090386, R01CA120386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051193, T32DK007774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG028977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 DK007774 (to L. C.); Grants R37 DK51193, R01 CA120386, and P50 CA090386 (to Z. W.); and Grant K08 AG028977 (to A. L. F.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Balakrishnan SK, 2008, ONCOGENE, V27, P2661, DOI 10.1038/sj.onc.1210935; Banks CAS, 2007, J BIOL CHEM, V282, P5761, DOI 10.1074/jbc.M610393200; Dou YL, 2008, INT J HEMATOL, V87, P10, DOI 10.1007/s12185-007-0009-8; Eissenberg JC, 2002, P NATL ACAD SCI USA, V99, P9894, DOI 10.1073/pnas.152193699; Ferguson AA, 2009, PLASMID, V62, P140, DOI 10.1016/j.plasmid.2009.06.001; Gerber M, 2001, EMBO J, V20, P6104, DOI 10.1093/emboj/20.21.6104; Gorlov IP, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-48; Hahn J, 2007, PROSTATE, V67, P146, DOI 10.1002/pros.20481; Hochbaum Daniel, 2010, J Vis Exp, DOI 10.3791/2090; Johnstone IL, 2000, TRENDS GENET, V16, P21, DOI 10.1016/S0168-9525(99)01857-0; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; KRAMER JM, 1993, GENETICS, V135, P1035; KRAMER JM, 1994, ANNU REV GENET, V28, P95; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Liu LQ, 2010, PROSTATE, V70, P797, DOI 10.1002/pros.21113; Luo RT, 2001, MOL CELL BIOL, V21, P5678, DOI 10.1128/MCB.21.16.5678-5687.2001; Miller T, 2000, J BIOL CHEM, V275, P32052, DOI 10.1074/jbc.M005175200; Mitani K, 2000, BIOCHEM BIOPH RES CO, V279, P563, DOI 10.1006/bbrc.2000.3970; Nystrom J, 2002, GENETICS, V161, P83; O'Malley KJ, 2009, PROSTATE, V69, P1716, DOI 10.1002/pros.21034; PETERS K, 1991, GENETICS, V129, P95; Pilipiuk J, 2009, DEV BIOL, V327, P34, DOI 10.1016/j.ydbio.2008.11.025; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Shilatifard A, 1997, P NATL ACAD SCI USA, V94, P3639, DOI 10.1073/pnas.94.8.3639; Shilatifard A, 1998, J BIOL CHEM, V273, P11212, DOI 10.1074/jbc.273.18.11212; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Simone F, 2003, BLOOD, V101, P2355, DOI 10.1182/blood-2002-06-1664; Simone F, 2001, BLOOD, V98, P201, DOI 10.1182/blood.V98.1.201; Suzuki Y, 2002, GENETICS, V162, P1631; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Thein MC, 2003, DEV DYNAM, V226, P523, DOI 10.1002/dvdy.10259; Thirman MJ, 1997, P NATL ACAD SCI USA, V94, P1408, DOI 10.1073/pnas.94.4.1408; THIRMAN MJ, 1994, P NATL ACAD SCI USA, V91, P12110, DOI 10.1073/pnas.91.25.12110; Wiederschain D, 2003, MOL CELL BIOL, V23, P4230, DOI 10.1128/MCB.23.12.4230-4246.2003; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Xiao WH, 2003, CANCER RES, V63, P4698; Xiao WH, 2009, CANCER RES, V69, P2599, DOI 10.1158/0008-5472.CAN-08-2595; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhang Y, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-119; Zhou JG, 2009, J BIOL CHEM, V284, P19142, DOI 10.1074/jbc.M109.010439	42	22	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35915	35921		10.1074/jbc.M111.270454	http://dx.doi.org/10.1074/jbc.M111.270454			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21880729	Green Published, hybrid			2022-12-27	WOS:000295927100065
J	Riboldi, E; Daniele, R; Parola, C; Inforzato, A; Arnold, PL; Bosisio, D; Fremont, DH; Bastone, A; Colonna, M; Sozzani, S				Riboldi, Elena; Daniele, Roberta; Parola, Carmen; Inforzato, Antonio; Arnold, Phoebe L.; Bosisio, Daniela; Fremont, Daved H.; Bastone, Antonio; Colonna, Marco; Sozzani, Silvano			Human C-type Lectin Domain Family 4, Member C (CLEC4C/BDCA-2/CD303) Is a Receptor for Asialo-galactosyl-oligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMACYTOID DENDRITIC CELLS; INHIBITS TLR9-MEDIATED ACTIVATION; ANTIGEN; RECOGNITION; INTERFERON	Plasmacytoid dendritic cells are specialized in the production of type I interferon (type I IFN), which promotes antiviral and antitumor responses, as well as autoimmune disorders. Activation of type I IFN secretion depends on the pattern recognition receptors TLR7 and TLR9, which sense microbial RNA and DNA, respectively. Type I IFN production is modulated by several receptors, including the type II C-type lectin domain family 4, member C (CLEC4C). The natural ligand of CLEC4C is unknown. To identify it, here we probed a glycan array with a soluble form of the CLEC4C ectodomain. We found that CLEC4C recognizes complex type sugars with terminal galactose. Importantly, soluble CLEC4C bound peripheral blood leukocytes and tumor cells that express glycans with galactose residues at the non-reducing ends. The positive and negative modulation of galactose residues on cell membranes was paralleled by the regulation of type I IFN secretion by plasmacytoid dendritic cells in co-culture experiments in vitro. These results suggest that the modulation in the expression of non-sialylated oligosaccharides by invading pathogens or transformed cells may affect type I IFN response and immune surveillance.	[Inforzato, Antonio; Sozzani, Silvano] Ist Clin Humanitas IRCCS, I-20089 Rozzano, MI, Italy; [Riboldi, Elena; Daniele, Roberta; Parola, Carmen; Bosisio, Daniela] Univ Brescia, Dipartimento Sci Biomed & Biotecnol, I-25123 Brescia, Italy; [Arnold, Phoebe L.; Fremont, Daved H.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Bastone, Antonio] Ist Ric Farmacol Mario Negri, I-20156 Milan, Italy	IRCCS Humanitas Research Hospital; University of Brescia; Washington University (WUSTL); Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Sozzani, S (corresponding author), Ist Clin Humanitas IRCCS, Via Manzoni 113, I-20089 Rozzano, MI, Italy.	sozzani@med.unibs.it	Inforzato, Antonio/K-6954-2012; Inforzato, Antonio/ABG-4513-2020; Sozzani, Silvano/C-1447-2009	Inforzato, Antonio/0000-0001-8110-0027; Fremont, Daved/0000-0002-8544-2689; Colonna, Marco/0000-0001-5222-4987; Sozzani, Silvano/0000-0002-3144-8743; BOSISIO, Daniela/0000-0001-6276-5365	Associazione Italiana per la Ricerca sul Cancro; Consorzio Interuniversitario per le Biotecnologie; Consiglio Nazionale delle Ricerche; Fondazione Humanitas per la Ricerca	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Consorzio Interuniversitario per le Biotecnologie; Consiglio Nazionale delle Ricerche(Consiglio Nazionale delle Ricerche (CNR)); Fondazione Humanitas per la Ricerca	This work was supported by Associazione Italiana per la Ricerca sul Cancro.; Supported by Consorzio Interuniversitario per le Biotecnologie and Consiglio Nazionale delle Ricerche.; Supported by Fondazione Humanitas per la Ricerca.	Aarnoudse CA, 2006, CURR OPIN IMMUNOL, V18, P105, DOI 10.1016/j.coi.2005.11.001; Arce I, 2001, EUR J IMMUNOL, V31, P2733, DOI 10.1002/1521-4141(200109)31:9<2733::AID-IMMU2733>3.0.CO;2-X; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Bracarda S, 2010, EUR J CANCER, V46, P284, DOI 10.1016/j.ejca.2009.10.013; Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Drickamer K, 2002, BIOCHEM SOC SYMP, V69, P59; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hartmann E, 2003, CANCER RES, V63, P6478; Kogelberg H, 2001, CURR OPIN STRUC BIOL, V11, P635, DOI 10.1016/S0959-440X(00)00259-1; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lybarger L, 2003, J BIOL CHEM, V278, P27105, DOI 10.1074/jbc.M303716200; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Riboldi E, 2009, IMMUNOBIOLOGY, V214, P868, DOI 10.1016/j.imbio.2009.06.016; Sozzani S, 2010, TRENDS IMMUNOL, V31, P270, DOI 10.1016/j.it.2010.05.004; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; van Gisbergen KPJM, 2005, CANCER RES, V65, P5935, DOI 10.1158/0008-5472.CAN-04-4140; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; VERMI W, 2011, J LEUKOCYTE IN PRESS; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031	25	25	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35329	35333		10.1074/jbc.C111.290494	http://dx.doi.org/10.1074/jbc.C111.290494			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21880719	hybrid, Green Published			2022-12-27	WOS:000295927100003
J	Singh, N; Pydi, SP; Upadhyaya, J; Chelikani, P				Singh, Nisha; Pydi, Sai Prasad; Upadhyaya, Jasbir; Chelikani, Prashen			Structural Basis of Activation of Bitter Taste Receptor T2R1 and Comparison with Class A G-protein-coupled Receptors (GPCRs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; BINDING-SITE; PREDICTION; RHODOPSIN; INSIGHTS; FAMILY; GENES	The human bitter taste receptors (T2Rs) are non-Class A members of the G-protein-coupled receptor (GPCR) superfamily, with very limited structural information. Amino acid sequence analysis reveals that most of the important motifs present in the transmembrane helices (TM1-TM7) of the well studied Class A GPCRs are absent in T2Rs, raising fundamental questions regarding the mechanisms of activation and how T2Rs recognize bitter ligands with diverse chemical structures. In this study, the bitter receptor T2R1 was used to systematically investigate the role of 15 transmembrane amino acids in T2Rs, including 13 highly conserved residues, by amino acid replacements guided by molecular modeling. Functional analysis of the mutants by calcium imaging analysis revealed that replacement of Asn-66(2.65) and the highly conserved Asn-24(1.50) resulted in greater than 90% loss of agonist-induced signaling. Our results show that Asn-24(1.50) plays a crucial role in receptor activation by mediating an hydrogen bond network connecting TM1-TM2-TM7, whereas Asn-66(2.65) is essential for binding to the agonist dextromethorphan. The interhelical hydrogen bond between Asn-24(1.50) and Arg-55(2.54) restrains T2R receptor activity because loss of this bond in I27A and R55A mutants results in hyperactive receptor. The conserved amino acids Leu-197(5.50), Ser-200(5.53), and Leu-201(5.54) form a putative LXXSL motif which performs predominantly a structural role by stabilizing the helical conformation of TM5 at the cytoplasmic end. This study provides for the first time mechanistic insights into the roles of the conserved transmembrane residues in T2Rs and allows comparison of the activation mechanisms of T2Rs with the Class A GPCRs.	[Singh, Nisha; Pydi, Sai Prasad; Upadhyaya, Jasbir; Chelikani, Prashen] Univ Manitoba, Dept Oral Biol, Winnipeg, MB R3E 0W2, Canada	University of Manitoba	Chelikani, P (corresponding author), Univ Manitoba, Dept Oral Biol, D319,780 Bannatyne Ave, Winnipeg, MB R3E 0W2, Canada.	chelikan@cc.umanitoba.ca	Upadhyaya, Jasbir/L-4724-2019; Pydi, sai Prasad/M-9017-2016	Upadhyaya, Jasbir/0000-0003-0815-2108; Singh, Nisha/0000-0003-0330-6411; Chelikani, Prashen/0000-0003-1129-7957; Pydi, sai Prasad/0000-0001-7170-6519	Natural Sciences and Engineering Research Council of Canada [RGPIN 356285]; Manitoba Health Research Council; Heart and Stroke Foundation of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Manitoba Health Research Council; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by Discovery Grant RGPIN 356285 from the Natural Sciences and Engineering Research Council of Canada, an Establishment Grant from Manitoba Health Research Council, and a New Investigator Award from the Heart and Stroke Foundation of Canada (to P.C.).	Anderson RJ, 2005, PROTEINS, V60, P679, DOI 10.1002/prot.20530; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Arakawa M, 2011, BBA-BIOMEMBRANES, V1808, P1170, DOI 10.1016/j.bbamem.2011.01.012; Arakawa M, 2010, PROTEIN SCI, V19, P85, DOI 10.1002/pro.285; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Chee MJS, 2008, J BIOL CHEM, V283, P33337, DOI 10.1074/jbc.M804671200; Chelikani P, 2007, P NATL ACAD SCI USA, V104, P7027, DOI 10.1073/pnas.0702024104; Conte C, 2002, CYTOGENET GENOME RES, V98, P45, DOI 10.1159/000068546; Fianagan CA, 1999, J BIOL CHEM, V274, P28880, DOI 10.1074/jbc.274.41.28880; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Friedrichs MS, 2009, J COMPUT CHEM, V30, P864, DOI 10.1002/jcc.21209; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Horn F, 2003, NUCLEIC ACIDS RES, V31, P294, DOI 10.1093/nar/gkg103; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Nygaard R, 2010, J BIOL CHEM, V285, P19625, DOI 10.1074/jbc.M110.106021; Proulx CD, 2008, MOL PHARMACOL, V74, P552, DOI 10.1124/mol.108.045054; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; Sakurai T, 2010, J BIOL CHEM, V285, P28373, DOI 10.1074/jbc.M110.144444; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Upadhyaya J, 2010, BIOCHEM BIOPH RES CO, V398, P331, DOI 10.1016/j.bbrc.2010.06.097; Wang MH, 2006, J BIOL CHEM, V281, P8864, DOI 10.1074/jbc.M512865200	34	57	58	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36032	36041		10.1074/jbc.M111.246983	http://dx.doi.org/10.1074/jbc.M111.246983			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852241	Green Published, hybrid			2022-12-27	WOS:000295927100076
J	Bidwell, P; Blackwell, DJ; Hou, ZJ; Zima, AV; Robia, SL				Bidwell, Philip; Blackwell, Daniel J.; Hou, Zhanjia; Zima, Aleksey V.; Robia, Seth L.			Phospholamban Binds with Differential Affinity to Calcium Pump Conformers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; SODIUM-POTASSIUM PUMP; RESONANCE ENERGY-TRANSFER; PROTEIN-KINASE-A; CA2+ PUMP; CRYSTAL-STRUCTURE; CROSS-LINKING; FUNCTIONAL INTERACTIONS; DILATED CARDIOMYOPATHY; PHYSICAL INTERACTIONS	To investigate the mechanism of regulation of sarco-endo-plasmic reticulum Ca2+-ATPase (SERCA) by phospholamban (PLB), we expressed Cerulean-SERCA and yellow fluorescent protein (YFP)-PLB in adult rabbit ventricular myocytes using adenovirus vectors. SERCA and PLB were localized in the sarcoplasmic reticulum and were mobile over multiple sarcomeres on a timescale of tens of seconds. We also observed robust fluorescence resonance energy transfer (FRET) from Cerulean-SERCA to YFP-PLB. Electrical pacing of cardiac myocytes elicited cytoplasmic Ca2+ elevations, but these increases in Ca2+ produced only modest changes in SERCA-PLB FRET. The data suggest that the regulatory complex is not disrupted by elevations of cytosolic calcium during cardiac contraction (systole). This conclusion was also supported by parallel experiments in heterologous cells, which showed that FRET was reduced but not abolished by calcium. Thapsigargin also elicited a small decrease in PLB-SERCA binding affinity. We propose that PLB is not displaced from SERCA by high calcium during systole, and relief of functional inhibition does not require dissociation of the regulatory complex. The observed modest reduction in the affinity of the PLB-SERCA complex with Ca2+ or thapsigargin suggests that the binding interface is altered by SERCA conformational changes. The results are consistent with multiple modes of PLB binding or alternative binding sites.	[Bidwell, Philip; Blackwell, Daniel J.; Hou, Zhanjia; Zima, Aleksey V.; Robia, Seth L.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	Loyola University Chicago	Robia, SL (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, 102-5689,2160 S 1st Ave, Maywood, IL 60153 USA.	srobia@lumc.edu		Bidwell, Philip/0000-0001-5045-4535	National Institutes of Health [HL092321, EB006061]; McCormick Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K01EB006061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McCormick Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants HL092321 and EB006061 (to S. L. R.). This work was also supported by the McCormick Foundation.	Akin BL, 2010, J BIOL CHEM, V285, P28540, DOI 10.1074/jbc.M110.151779; Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Autry J. M., 2011, J BIOL CHEM IN PRESS; BIGELOW DJ, 1992, BIOCHIM BIOPHYS ACTA, V1113, P323, DOI 10.1016/0304-4157(92)90005-U; Chen B, 2008, BIOCHEMISTRY-US, V47, P12448, DOI 10.1021/bi8014289; Chen Z., 2011, BIOCH J IN PRESS; Chen ZH, 2005, J BIOL CHEM, V280, P10530, DOI 10.1074/jbc.M414007200; Chen ZH, 2003, J BIOL CHEM, V278, P48348, DOI 10.1074/jbc.M309545200; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Domeier TL, 2009, J PHYSIOL-LONDON, V587, P5197, DOI 10.1113/jphysiol.2009.177576; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; HENDERSON IMJ, 1994, BIOCHEM J, V297, P615, DOI 10.1042/bj2970615; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; INESI G, 1988, METHOD ENZYMOL, V157, P154; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Lalli MJ, 2001, CIRC RES, V89, P160; Li JH, 2004, BIOCHEMISTRY-US, V43, P3870, DOI 10.1021/bi036183u; Lockamy EL, 2011, BIOCHEM BIOPH RES CO, V408, P388, DOI 10.1016/j.bbrc.2011.04.023; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; Negash S, 2000, BIOCHEM J, V351, P195, DOI 10.1042/0264-6021:3510195; O'Donnell JM, 2009, J MOL CELL CARDIOL, V47, P614, DOI 10.1016/j.yjmcc.2009.08.031; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Satoh K, 2011, J BIOL CHEM, V286, P20591, DOI 10.1074/jbc.M110.204685; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Sharma P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011496; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Song QJ, 2011, J BIOL CHEM, V286, P9120, DOI 10.1074/jbc.M110.198036; Stenoien DL, 2007, AM J PHYSIOL-CELL PH, V292, pC2084, DOI 10.1152/ajpcell.00523.2006; Teriete P, 2009, BBA-BIOMEMBRANES, V1788, P2462, DOI 10.1016/j.bbamem.2009.09.001; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	49	50	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35044	35050		10.1074/jbc.M111.266759	http://dx.doi.org/10.1074/jbc.M111.266759			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832088	Green Published, hybrid			2022-12-27	WOS:000295406300057
J	Toei, M; Toei, S; Forgac, M				Toei, Masashi; Toei, Satoko; Forgac, Michael			Definition of Membrane Topology and Identification of Residues Important for Transport in Subunit a of the Vacuolar ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST V-ATPASE; MEDIATED CROSS-LINKING; AQUEOUS ACCESS CHANNELS; BREAST-CANCER CELLS; H+-ATPASE; ESCHERICHIA-COLI; PROTON TRANSLOCATION; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE SEGMENTS; 100-KDA SUBUNIT	Subunit a of the vacuolar H+-ATPases plays an important role in proton transport. This membrane-integral 100-kDa subunit is thought to form or contribute to proton-conducting hemi-channels that allow protons to gain access to and leave buried carboxyl groups on the proteolipid subunits (c, c', and c") during proton translocation. We previously demonstrated that subunit a contains a large N-terminal cytoplasmic domain followed by a C-terminal domain containing eight transmembrane (TM) helices. TM7 contains a buried arginine residue (Arg-735) that is essential for proton transport and is located on a helical face that interacts with the proteolipid ring. To further define the topology of the C-terminal domain, the accessibility of 30 unique cysteine residues to the membrane-permeant reagent N-ethylmaleimide and the membrane-impermeant reagent polyethyleneglycol maleimide was determined. The results further define the borders of transmembrane segments in subunit a. To identify additional buried polar and charged residues important in proton transport, 25 sites were individually mutated to hydrophobic amino acids, and the effect on proton transport was determined. These and previous results identify a set of residues important for proton transport located on the cytoplasmic half of TM7 and TM8 and the lumenal half of TM3, TM4, and TM7. Based upon these data, we propose a tentative model in which the cytoplasmic hemi-channel is located at the interface of TM7 and TM8 of subunit a and the proteolipid ring, whereas the lumenal hemi-channel is located within subunit a at the interface of TM3, TM4, and TM7.	[Forgac, Michael] Tufts Univ, Sch Med, Dept Mol Physiol & Phamacol, Boston, MA 02111 USA; Tufts Univ, Grad Program Cell & Mol Physiol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA	Tufts University; Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Mol Physiol & Phamacol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			National Institutes of Health [GM34478]; Northeast Affiliate of the American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Affiliate of the American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34478 (to M. F.). This work was also supported by a Postdoctoral Fellowship from the Northeast Affiliate of the American Heart Association (to M. T.).	Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kawasaki-Nishi S, 2003, J BIOL CHEM, V278, P41908, DOI 10.1074/jbc.M308026200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; Leng XH, 1999, J BIOL CHEM, V274, P14655, DOI 10.1074/jbc.274.21.14655; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Shum WWC, 2009, J EXP BIOL, V212, P1753, DOI 10.1242/jeb.027284; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; Vasilyeva E, 2000, J BIOL CHEM, V275, P255, DOI 10.1074/jbc.275.1.255; VIK SB, 1994, J BIOL CHEM, V269, P30364; Wang Y, 2008, J BIOL CHEM, V283, P20696, DOI 10.1074/jbc.M803258200; Wang YR, 2005, J BIOL CHEM, V280, P40481, DOI 10.1074/jbc.M509106200; Wang YR, 2004, J BIOL CHEM, V279, P44628, DOI 10.1074/jbc.M407345200; ZHANG JM, 1992, J BIOL CHEM, V267, P9773	43	53	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35176	35186		10.1074/jbc.M111.273409	http://dx.doi.org/10.1074/jbc.M111.273409			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832060	Green Published, hybrid			2022-12-27	WOS:000295406300070
J	Dai, Y; Chen, S; Wang, L; Pei, XY; Funk, VL; Kramer, LB; Dent, P; Grant, S				Dai, Yun; Chen, Shuang; Wang, Li; Pei, Xin-Yan; Funk, Vanessa L.; Kramer, Lora B.; Dent, Paul; Grant, Steven			Disruption of I kappa B Kinase (IKK)-mediated RelA Serine 536 Phosphorylation Sensitizes Human Multiple Myeloma Cells to Histone Deacetylase (HDAC) Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; IKK-BETA; TRANSCRIPTIONAL ACTIVITY; DEPENDENT TRANSCRIPTION; SIGNALING PATHWAY; DOWN-REGULATION; LEUKEMIA-CELLS; ACTIVATION; P65; ACETYLATION	Post-translational modifications of RelA play an important role in regulation of NF-kappa B activation. We previously demonstrated that in malignant hematopoietic cells, histone deacetylase inhibitors (HDACIs) induced RelA hyperacetylation and NF-kappa B activation, attenuating lethality. We now present evidence that I kappa B kinase(IKK) beta-mediatedRelASer-536phosphorylation plays a significant functional role in promoting RelA acetylation, inducing NF-kappa B activation, and limiting HDACI lethality in human multiple myeloma (MM) cells. Immunoblot profiling revealed that although basal RelA phosphorylation varied in MM cells, Ser-536 phosphorylation correlated with IKK activity. Exposure to the pan-HDACIs vorinostat or LBH-589 induced phosphorylation of IKK alpha/beta(Ser-180/Ser-181) and RelA (Ser-536) in MM cells, including cells expressing an I kappa B alpha "super-repressor," accompanied by increased RelA nuclear translocation, acetylation, DNA binding, and transactivation activity. These events were substantially blocked by either pan-IKK or IKK beta-selective inhibitors, resulting in marked apoptosis. Consistent with these events, inhibitory peptides targeting either the NF-kappa B essential modulator (NEMO) binding domain for IKK complex formation or RelA phosphorylation sites also significantly increased HDACI lethality. Moreover, IKK beta knockdown by shRNA prevented Ser-536 phosphorylation and significantly enhanced HDACI susceptibility. Finally, introduction of a nonphosphorylatable RelA mutant S536A, which failed to undergo acetylation in response to HDACIs, impaired NF-kappa B activation and increased cell death. These findings indicate that HDACIs induce Ser-536 phosphorylation of the NF-kappa B subunit RelA through an IKK beta-dependent mechanism, an action that is functionally involved in activation of the cytoprotective NF-kappa B signaling cascade primarily through facilitation of RelA acetylation rather than nuclear translocation.	[Dai, Yun; Chen, Shuang; Wang, Li; Pei, Xin-Yan; Funk, Vanessa L.; Kramer, Lora B.; Grant, Steven] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Med, Richmond, VA 23298 USA; [Dent, Paul; Grant, Steven] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Biochem, Richmond, VA 23298 USA; [Grant, Steven] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Pharmacol, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Grant, S (corresponding author), 234 Goodwin,401 Coll St, Richmond, VA 23298 USA.	stgrant@vcu.edu	Dai, Yun/AAG-4040-2019	Dai, Yun/0000-0003-2285-0818	National Institutes of Health, NCI [CA 93738, CA100866, 1 P50 CA130805-01, 1 P50 CA142509-01]; Leukemia and Lymphoma Society of America [6181-10]; V Foundation; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [P50CA130805, P50CA142509, R01CA150214, R01CA100866, R01CA093738, R01CA141703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052825] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); V Foundation; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 93738, CA100866, 1 P50 CA130805-01, and 1 P50 CA142509-01 from NCI. This work was also supported by Grant 6181-10 from the Leukemia and Lymphoma Society of America and grants from the V Foundation and the Multiple Myeloma Research Foundation.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bednarski BK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006992; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Chavey C, 2008, MOL PHARMACOL, V74, P1359, DOI 10.1124/mol.108.047332; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Dai Y, 2002, BLOOD, V100, P3333, DOI 10.1182/blood-2002-03-0940; Demchenko YN, 2010, ONCOTARGET, V1, P59, DOI 10.18632/oncotarget.109; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Dickinson M, 2010, INVEST NEW DRUG, V28, pS3, DOI 10.1007/s10637-010-9596-y; Dimopoulos MA, 2011, EUR J HAEMATOL, V86, P1, DOI 10.1111/j.1600-0609.2010.01542.x; Gilmore TD, 2007, CANCER CELL, V12, P95, DOI 10.1016/j.ccr.2007.07.010; Grant S, 2007, NAT REV DRUG DISCOV, V6, P21, DOI 10.1038/nrd2227; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Haller D, 2002, J BIOL CHEM, V277, P38168, DOI 10.1074/jbc.M205737200; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hideshima T, 2006, CLIN CANCER RES, V12, P5887, DOI 10.1158/1078-0432.CCR-05-2501; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jeong SJ, 2005, J BIOL CHEM, V280, P10326, DOI 10.1074/jbc.M412643200; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim YK, 2006, CELL DEATH DIFFER, V13, P2033, DOI 10.1038/sj.cdd.4401915; Klein B, 2010, BLOOD, V115, P3422, DOI 10.1182/blood-2010-01-264796; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mayo MW, 2003, J BIOL CHEM, V278, P18980, DOI 10.1074/jbc.M211695200; Mitsiades CS, 2009, SEMIN HEMATOL, V46, P166, DOI 10.1053/j.seminhematol.2009.02.003; Moreno R, 2010, NUCLEIC ACIDS RES, V38, P6029, DOI 10.1093/nar/gkq439; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Oakley F, 2009, GASTROENTEROLOGY, V136, P2334, DOI 10.1053/j.gastro.2009.02.081; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Orian A, 2000, EMBO J, V19, P2580, DOI 10.1093/emboj/19.11.2580; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Rosato RR, 2010, J BIOL CHEM, V285, P10064, DOI 10.1074/jbc.M109.095208; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Takada Y, 2004, J BIOL CHEM, V279, P15096, DOI 10.1074/jbc.M311192200; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	68	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34036	34050		10.1074/jbc.M111.284216	http://dx.doi.org/10.1074/jbc.M111.284216			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21816815	Green Published, hybrid			2022-12-27	WOS:000295159200036
J	Mukherjee, AB; Zhang, ZJ				Mukherjee, Anil B.; Zhang, Zhongjian			Allergic Asthma: Influence of Genetic and Environmental Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DUST-MITE EXPOSURE; DENDRITIC CELLS; SUSCEPTIBILITY GENES; IMMUNE-RESPONSES; TH2 RESPONSES; SERUM IGE; MAST-CELL; EXPRESSION; UTEROGLOBIN; FILAGGRIN	Allergic asthma is a chronic airway inflammatory disease in which exposure to allergens causes intermittent attacks of breathlessness, airway hyper-reactivity, wheezing, and coughing. Allergic asthma has been called a "syndrome" resulting from a complex interplay between genetic and environmental factors. Worldwide, > 300 million individuals are affected by this disease, and in the United States alone, it is estimated that > 35 million people, mostly children, suffer from asthma. Although animal models, linkage analyses, and genome-wide association studies have identified numerous candidate genes, a solid definition of allergic asthma has not yet emerged; however, such studies have contributed to our understanding of the multiple pathways to this syndrome. In contrast with animal models, in which T-helper 2 (T(H)2) cell response is the dominant feature, in human asthma, an initial exposure to allergen results in T(H)2 cell-dependent stimulation of the immune response that mediates the production of IgE and cytokines. Re-exposure to allergen then activates mast cells, which release mediators such as histamines and leukotrienes that recruit other cells, including T(H)2 cells, which mediate the inflammatory response in the lungs. In this minireview, we discuss the current understanding of how associated genetic and environmental factors increase the complexity of allergic asthma and the challenges allergic asthma poses for the development of novel approaches to effective treatment and prevention.	[Mukherjee, Anil B.; Zhang, Zhongjian] Eunice Kennedy Shriver NICHD, Sect Dev Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Mukherjee, AB (corresponding author), Eunice Kennedy Shriver NICHD, Sect Dev Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA.	mukherja@exchange.nih.gov			National Institutes of Health Intramural Research Program of Eunice Kennedy Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000910] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of Eunice Kennedy Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health Intramural Research Program of Eunice Kennedy Shriver NICHD. This is the second article in the Thematic Minireview Series on Molecular Bases of Disease: Asthma. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Agrawal DK, 2010, CURR ALLERGY ASTHM R, V10, P39, DOI 10.1007/s11882-009-0081-7; Akinbami, 2006, STATE CHILDHOOD ASTH, V381; Amsen D, 2009, CURR OPIN IMMUNOL, V21, P153, DOI 10.1016/j.coi.2009.03.010; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barrett NA, 2009, IMMUNITY, V31, P425, DOI 10.1016/j.immuni.2009.08.014; Baurecht H, 2007, J ALLERGY CLIN IMMUN, V120, P1406, DOI 10.1016/j.jaci.2007.08.067; BEIER HM, 1968, BIOCHIM BIOPHYS ACTA, V160, P289, DOI 10.1016/0005-2795(68)90108-6; Bosse Y, 2007, ANNU REV MED, V58, P171, DOI 10.1146/annurev.med.58.071105.111738; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Brenner V, 2001, J IMMUNOL METHODS, V250, P15, DOI 10.1016/S0022-1759(01)00303-9; Chtanova T, 2001, J IMMUNOL, V167, P3057, DOI 10.4049/jimmunol.167.6.3057; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; D Sizing I, 2007, J IMMUNOL, V178, P2249, DOI 10.4049/jimmunol.178.4.2249; Encinas JA, 2005, J ALLERGY CLIN IMMUN, V116, P1343, DOI 10.1016/j.jaci.2005.08.031; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Feng BS, 2008, J ALLERGY CLIN IMMUN, V122, P55, DOI 10.1016/j.jaci.2008.04.036; Finkelman F., 2001, SAMTERS IMMUNOLOGIC, P111; Finkelman FD, 2008, J ALLERGY CLIN IMMUN, V121, P603, DOI 10.1016/j.jaci.2008.01.008; Finkelman FD, 2010, J ALLERGY CLIN IMMUN, V125, P312, DOI 10.1016/j.jaci.2009.12.936; Fukushima A, 2007, BIOCHEM BIOPH RES CO, V353, P211, DOI 10.1016/j.bbrc.2006.12.023; Garantziotis S, 2010, ANNU REV PUBL HEALTH, V31, P37, DOI 10.1146/annurev.publhealth.012809.103633; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; Guerra S, 2008, ANNU REV MED, V59, P327, DOI 10.1146/annurev.med.59.060406.213232; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Holloway JW, 2010, J ALLERGY CLIN IMMUN, V125, pS81, DOI 10.1016/j.jaci.2009.10.071; Hung CH, 2004, J ALLERGY CLIN IMMUN, V114, P664, DOI 10.1016/j.jaci.2004.05.042; Hunninghake GM, 2008, J ALLERGY CLIN IMMUN, V122, P93, DOI 10.1016/j.jaci.2008.03.015; Johansson S, 2007, J ALLERGY CLIN IMMUN, V120, P308, DOI 10.1016/j.jaci.2007.03.021; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim Y, 2007, GENES IMMUN, V8, P369, DOI 10.1038/sj.gene.6364394; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; LANE PW, 1972, J HERED, V63, P135, DOI 10.1093/oxfordjournals.jhered.a108252; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mapp CE, 2005, CURR OPIN ALLERGY CL, V5, P113, DOI 10.1097/01.all.0000162301.74610.21; Marks GB, 2006, CLIN EXP PHARMACOL P, V33, P285, DOI 10.1111/j.1440-1681.2006.04360.x; Mathias RA, 2010, J ALLERGY CLIN IMMUN, V125, P336, DOI 10.1016/j.jaci.2009.08.031; McIntire JJ, 2004, SPRINGER SEMIN IMMUN, V25, P335, DOI 10.1007/s00281-003-0141-3; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Miller RL, 2008, AM J RESP CRIT CARE, V177, P567, DOI 10.1164/rccm.200710-1511PP; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; O'Regan GM, 2008, J ALLERGY CLIN IMMUN, V122, P689, DOI 10.1016/j.jaci.2008.08.002; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Oettgen HC, 2001, J ALLERGY CLIN IMMUN, V107, P429, DOI 10.1067/mai.2001.113759; Ono SJ, 2000, ANNU REV IMMUNOL, V18, P347, DOI 10.1146/annurev.immunol.18.1.347; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; Prussin C, 2006, J ALLERGY CLIN IMMUN, V117, pS450, DOI 10.1016/j.jaci.2005.11.016; Ray R, 2005, J BIOL CHEM, V280, P9761, DOI 10.1074/jbc.C400581200; Ray R, 2006, FEBS LETT, V580, P6022, DOI 10.1016/j.febslet.2006.09.059; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rogge L, 2000, NAT GENET, V25, P96, DOI 10.1038/75671; Rothman Paul B, 2010, Trans Am Clin Climatol Assoc, V121, P156; Ryan CA, 2004, TOXICOL LETT, V150, P301, DOI 10.1016/j.toxlet.2004.02.002; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Saito H, 2001, INT ARCH ALLERGY IMM, V125, P1, DOI 10.1159/000053790; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Schmidt-Weber CB, 2006, CHEM IMMUNOL ALLERGY, V91, P188; Schwartz David A, 2010, Proc Am Thorac Soc, V7, P123, DOI 10.1513/pats.200908-084RM; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Sharma S, 2009, AM J RESP CRIT CARE, V179, P356, DOI 10.1164/rccm.200808-1268OC; SIBBALD B, 1980, THORAX, V35, P671, DOI 10.1136/thx.35.9.671; Silver MR, 2010, INFLAMM RES, V59, P207, DOI 10.1007/s00011-009-0088-5; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Singh G, 2000, ANN NY ACAD SCI, V923, P43; Smit LAM, 2009, AM J RESP CRIT CARE, V179, P363, DOI 10.1164/rccm.200810-1533OC; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Sokol CL, 2010, CURR OPIN IMMUNOL, V22, P73, DOI 10.1016/j.coi.2010.01.012; Sonar SS, 2010, J CLIN INVEST, V120, P2767, DOI 10.1172/JCI39543; TAYLOR B, 1981, ANN ALLERGY, V47, P197; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Vercelli D, 2010, J ALLERGY CLIN IMMUN, V125, P347, DOI 10.1016/j.jaci.2009.12.976; Vercelli D, 2009, NAT GENET, V41, P512, DOI 10.1038/ng0509-512; Wills-Karp M, 2004, NAT REV GENET, V5, P376, DOI 10.1038/nrg1326; Wohlfahrt JG, 2003, INT ARCH ALLERGY IMM, V131, P272, DOI 10.1159/000072139; Wohlfahrt JG, 2004, J IMMUNOL, V172, P843, DOI 10.4049/jimmunol.172.2.843; Wu H, 2007, ENVIRON HEALTH PERSP, V115, P616, DOI 10.1289/ehp.9740; Wu H, 2010, J ALLERGY CLIN IMMUN, V125, P321, DOI 10.1016/j.jaci.2009.09.007; Yang IA, 2008, THORAX, V63, P555, DOI 10.1136/thx.2007.079426; Yang IA, 2007, CLIN EXP ALLERGY, V37, P1264, DOI 10.1111/j.1365-2222.2007.02798.x; Zhang ZJ, 1997, SCIENCE, V276, P1408, DOI 10.1126/science.276.5317.1408; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zou J., 2002, GENOME BIOL, P3	94	103	139	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32883	32889		10.1074/jbc.R110.197046	http://dx.doi.org/10.1074/jbc.R110.197046			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799018	hybrid, Green Published			2022-12-27	WOS:000294968800006
J	Oh, JE; Kim, RH; Shin, KH; Park, NH; Kang, MK				Oh, Ju-Eun; Kim, Reuben H.; Shin, Ki-Hyuk; Park, No-Hee; Kang, Mo K.			Delta Np63 alpha Protein Triggers Epithelial-Mesenchymal Transition and Confers Stem Cell Properties in Normal Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ORAL KERATINOCYTES; IN-VITRO; P53 HOMOLOG; P63; DIFFERENTIATION; PROLIFERATION; SENESCENCE; INDUCTION; SKIN; OVEREXPRESSION	p63 is a p53 family protein required for morphogenesis and postnatal regeneration of epithelial tissues. Here we demonstrate that Delta Np63 alpha, a p63 isoform lacking the N-terminal trans-activation domain, induces epithelial-mesenchymal transition (EMT) in primary human keratinocytes in a TGF-beta-dependent manner. Rapidly proliferating normal human epidermal keratinocytes (NHEK) were infected with retroviral vector expressing Delta Np63 alpha or empty vector and serially subcultured until replicative senescence. No phenotypic changes were observed until the culture reached senescence. Then the Delta Np63 alpha-transduced cells underwent morphological changes resembling mesenchymal cells and acquired the EMT phenotype. Treatment with exogenous TGF-beta accelerated EMT in presenescent Delta Np63 alpha-transduced cells, whereas the inhibition of TGF-beta signaling reversed the EMT phenotype. TGF-beta treatment alone led to growth arrest in control NHEK with no evidence of EMT, indicating that Delta Np63 alpha altered the cellular response to TGF-beta treatment. Delta Np63 alpha-transduced cells acquiring EMT gained the ability to be differentiated to osteo-/odontogenic and adipogenic pathways, resembling mesenchymal stem cells. Furthermore, these cells expressed enhanced levels of Nanog and Lin28, which are transcription factors associated with pluripotency. These data indicate that EMT required Delta Np63 alpha transduction and intact TGF-beta signaling in NHEK.	[Kang, Mo K.] Univ Calif Los Angeles, Sch Dent, Ctr Hlth Sci, Los Angeles, CA 90095 USA; [Kim, Reuben H.; Shin, Ki-Hyuk; Park, No-Hee; Kang, Mo K.] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90095 USA; [Kim, Reuben H.; Shin, Ki-Hyuk; Park, No-Hee; Kang, Mo K.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Park, No-Hee] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kang, MK (corresponding author), Univ Calif Los Angeles, Sch Dent, Ctr Hlth Sci, Rm 43-009,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	mkang@dentistry.ucla.edu			National Institutes of Health, NIDCR [R01DE18295, K02DE18959]; Jack A. Weichman Endowed Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K02DE018959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018295] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Jack A. Weichman Endowed Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health, NIDCR, Grants R01DE18295 and K02DE18959. This work was also supported by the Jack A. Weichman Endowed Fund.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arpitha P, 2005, INVEST OPHTH VIS SCI, V46, P3631, DOI 10.1167/iovs.05-0343; Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Hudson LG, 2009, J DERMATOL SCI, V56, P19, DOI 10.1016/j.jdermsci.2009.06.009; Jamora C, 2005, PLOS BIOL, V3, P131, DOI 10.1371/journal.pbio.0030011; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang MK, 2000, EXP CELL RES, V258, P288, DOI 10.1006/excr.2000.4943; Kang MK, 2004, J CELL PHYSIOL, V199, P364, DOI 10.1002/jcp.10410; Kang MK, 1998, CELL GROWTH DIFFER, V9, P85; Kang MK, 2002, MECH AGEING DEV, V123, P585, DOI 10.1016/S0047-6374(01)00407-9; Kang Mo K, 2007, Methods Mol Biol, V371, P151; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kim RH, 2007, EXP CELL RES, V313, P462, DOI 10.1016/j.yexcr.2006.10.025; Kim RH, 2010, EXP CELL RES, V316, P2600, DOI 10.1016/j.yexcr.2010.04.013; Koster MI, 2007, P NATL ACAD SCI USA, V104, P3255, DOI 10.1073/pnas.0611376104; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lindley LE, 2010, BIOCHEM BIOPH RES CO, V399, P659, DOI 10.1016/j.bbrc.2010.07.138; Lindsay J, 2011, J BIOL CHEM, V286, P3915, DOI 10.1074/jbc.M110.162511; Liu LF, 2009, J BIOL CHEM, V284, P5165, DOI 10.1074/jbc.M807098200; Lo Muzio L, 2005, HUM PATHOL, V36, P187, DOI 10.1016/j.humpath.2004.12.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massion PP, 2003, CANCER RES, V63, P7113; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nakamura M, 2011, J DERMATOL SCI, V61, P7, DOI 10.1016/j.jdermsci.2010.11.015; Noszczyk BH, 2001, PLAST RECONSTR SURG, V108, P1242, DOI 10.1097/00006534-200110000-00022; PARK NH, 1991, CARCINOGENESIS, V12, P1627, DOI 10.1093/carcin/12.9.1627; Paula-Silva FWG, 2009, J DENT RES, V88, P339, DOI 10.1177/0022034509334070; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Thiboutot D, 2003, J INVEST DERMATOL, V120, P905, DOI 10.1046/j.1523-1747.2003.12244.x; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wang JM, 2010, BIOCHEM BIOPH RES CO, V400, P334, DOI 10.1016/j.bbrc.2010.08.058; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu YH, 2010, ENDOCRINOLOGY, V151, P5497, DOI 10.1210/en.2010-0486	54	49	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38757	38767		10.1074/jbc.M111.244939	http://dx.doi.org/10.1074/jbc.M111.244939			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21880709	Green Published, hybrid			2022-12-27	WOS:000296594200087
J	Holley, RJ; Deligny, A; Wei, W; Watson, HA; Ninonuevo, MR; Dagalv, A; Leary, JA; Bigger, BW; Kjellen, L; Merry, CLR				Holley, Rebecca J.; Deligny, Audrey; Wei, Wei; Watson, H. Angharad; Ninonuevo, Milady R.; Dagalv, Anders; Leary, Julie A.; Bigger, Brian W.; Kjellen, Lena; Merry, Catherine L. R.			Mucopolysaccharidosis Type I, Unique Structure of Accumulated Heparan Sulfate and Increased N-Sulfotransferase Activity in Mice Lacking alpha-L-iduronidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; PROGENITOR CELLS; BINDING-SITES; BIOSYNTHESIS; EXPRESSION; QUANTIFICATION; PROTEOGLYCANS; DOMAINS; NDST1; FGF	Mucopolysaccharide (MPS) diseases are characterized by accumulation of glycosaminoglycans (GAGs) due to deficiencies in lysosomal enzymes responsible for GAG breakdown. Using a murine model of MPSI Hurler (MPSIH), we have quantified the heparan sulfate (HS) accumulation resulting from alpha-L-iduronidase (Idua) deficiency. HS levels were significantly increased in liver and brain tissue from 12-week-old Idua(-/-) mice by 87- and 20-fold, respectively. In addition, HS chains were shown to contain significantly increased N-, 2-O-, and 6-O-sulfation. Disaccharide compositional analyses also uncovered an HS disaccharide uniquely enriched in MPSIH, representing the terminal iduronic acid residue capping the non-reducing end of the HS chain, where no further degradation can occur in the absence of Idua. Critically, we identified that excess HS, some of which is colocalized to the Golgi secretory pathway, acts as a positive regulator of HS-sulfation, increasing the N-sulfotransferase activity of HS-modifying N-deacetylase/N-sulfotransferase enzymes. This mechanism may have severe implications during disease progression but, now identified, could help direct improved therapeutic strategies.	[Holley, Rebecca J.; Merry, Catherine L. R.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England; [Deligny, Audrey; Dagalv, Anders; Kjellen, Lena] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Wei, Wei; Ninonuevo, Milady R.; Leary, Julie A.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Wei, Wei; Ninonuevo, Milady R.; Leary, Julie A.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Watson, H. Angharad; Bigger, Brian W.] Univ Manchester, Sch Biomed, Manchester M13 9PT, Lancs, England	University of Manchester; Uppsala University; University of California System; University of California Davis; University of California System; University of California Davis; University of Manchester	Merry, CLR (corresponding author), Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England.	Catherine.merry@manchester.ac.uk	Merry, Catherine/B-5713-2013; Bigger, Brian/I-3553-2012	Bigger, Brian/0000-0002-9708-1112; Watson, Angharad/0000-0003-4356-6891; merry, catherine/0000-0002-3490-2809	Human Frontier Science Program; Medical Research Council; Swedish Research Council; Swedish Cancer Society; Polysackaridforskning AB; National Institutes of Health [NIH GM47356]; UK Society for Mucopolysaccharide Diseases; National MPS Society; Biotechnology and Biological Sciences Research Council; Wellcome Trust; University of Manchester; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047356] Funding Source: NIH RePORTER; Medical Research Council [G0701165] Funding Source: researchfish; MRC [G0701165] Funding Source: UKRI	Human Frontier Science Program(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Polysackaridforskning AB(HOGANAS ABStatisticon AB); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Society for Mucopolysaccharide Diseases; National MPS Society; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); University of Manchester; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by funding from The Human Frontier Science Program (to R. J. H. and C. L. R. M.), The Medical Research Council (to C. L. R. M.), The Swedish Research Council (to A. Deligny, A. Dagalv, and L. K.), The Swedish Cancer Society (to A. Deligny, A. Dagalv, and L. K.), Polysackaridforskning AB (to A. Deligny, A. Dagalv, and L. K.), National Institutes of Health Grant NIH GM47356 (to W. W., M. R. N., and J. A. L.), The UK Society for Mucopolysaccharide Diseases (to H. A. W. and B. W. B.), and The National MPS Society (to H. A. W. and B. W. B.).; The Bioimaging Facility microscopes used in this study were purchased with grants from the Biotechnology and Biological Sciences Research Council, the Wellcome Trust, and the University of Manchester Strategic Fund.	Allen BL, 2001, J CELL BIOL, V155, P845, DOI 10.1083/jcb.200106075; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blackhall FH, 2001, BRIT J CANCER, V85, P1094, DOI 10.1054/bjoc.2001.2054; Braunlin E, 2006, PEDIATR RES, V59, P27, DOI 10.1203/01.pdr.0000190579.24054.39; Byers S, 1998, MOL GENET METAB, V65, P282, DOI 10.1006/mgme.1998.2761; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Clarke LA, 1997, HUM MOL GENET, V6, P503, DOI 10.1093/hmg/6.4.503; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dusing Stacey C, 2005, Pediatr Phys Ther, V17, P264, DOI 10.1097/01.pep.0000186510.37581.19; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; Fuller M, 2005, MOL GENET METAB, V84, P18, DOI 10.1016/j.ymgme.2004.09.004; Fuller M, 2004, PEDIATR RES, V56, P733, DOI 10.1203/01.PDR.0000141987.69757.DD; Fuller M, 2004, GLYCOBIOLOGY, V14, P443, DOI 10.1093/glycob/cwh049; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Kjellen L, 2003, BIOCHEM SOC T, V31, P340, DOI 10.1042/BST0310340; Kreuger J, 2005, BIOCHEM J, V389, P145, DOI 10.1042/BJ20042129; KRIVIT W, 1995, CELL TRANSPLANT, V4, P385, DOI 10.1016/0963-6897(95)00021-O; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Langford-Smith K, 2010, MOL GENET METAB, V99, P269, DOI 10.1016/j.ymgme.2009.10.175; Langford-Smith KJ, 2011, J INHERIT METAB DIS, V34, P499, DOI 10.1007/s10545-010-9254-8; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; LINHARDT RJ, 1988, BIOCHEM J, V254, P781, DOI 10.1042/bj2540781; LINKER A, 1972, BIOCHEMISTRY-US, V11, P563, DOI 10.1021/bi00754a013; LYON M, 1994, J BIOL CHEM, V269, P11208; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Muenzer J, 2009, PEDIATRICS, V123, P19, DOI 10.1542/peds.2008-0416; Pan CD, 2005, BLOOD, V106, P1956, DOI 10.1182/blood-2005-02-0657; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Saad OM, 2004, J AM SOC MASS SPECTR, V15, P1274, DOI 10.1016/j.jasms.2004.05.008; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; Wynn RF, 2009, J PEDIATR-US, V154, P609, DOI 10.1016/j.jpeds.2008.11.005	42	48	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37515	37524		10.1074/jbc.M111.287474	http://dx.doi.org/10.1074/jbc.M111.287474			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21873421	hybrid, Green Published			2022-12-27	WOS:000296542400050
J	Lehman, JA; Waning, DL; Batuello, CN; Cipriano, R; Kadakia, MP; Mayo, LD				Lehman, Jason A.; Waning, David L.; Batuello, Christopher N.; Cipriano, Rocky; Kadakia, Madhavi P.; Mayo, Lindsey D.			Induction of Apoptotic Genes by a p73-Phosphatase and Tensin Homolog (p73-PTEN) Protein Complex in Response to Genotoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; CELL-SURVIVAL; PTEN; P73; P53; MDM2; EXPRESSION; CANCER; P63; MICE	The p53 family member, p73, has been characterized as a tumor suppressor and functions in a similar manner as p53 to induce cellular death. The phosphatase and tensin homolog (PTEN) can function as a dual specificity lipid/protein phosphatase. However, recent data have described multiple roles for nuclear PTEN independent of its lipid phosphatase activity. PTEN can directly or indirectly activate p53 to promote apoptosis. We examined whether PTEN would interact and regulate p73 independent of p53. Co-localization in the nucleus and complex formation of p73/PTEN were observed after DNA damage. Furthermore, we also demonstrate that p73 alpha/PTEN proteins directly bind one another. Both overexpressed and endogenous p73-PTEN interactions were determined to be the strongest in the nuclear fraction after DNA damage, which suggested formation of a transcriptional complex. We employed chromatin immunoprecipitation (ChIP) and found that p73 and PTEN were associated with the PUMA promoter after genotoxic stress in TP53-null cells. We found that another p73 target, BAX, had an increased expression in the presence of p73 and PTEN. In addition, in virus-transduced cell lines stably expressing p73, PTEN, or both p73/PTEN, we found that the p73/PTEN cells were more sensitive to genotoxic stress and cellular death as measured by increased poly(ADP-ribose) polymerase cleavage and PUMA/Bax induction. Conversely, knockdown of PTEN dramatically reduced Bax and PUMA levels. Thus, a p73-PTEN protein complex is engaged to induce apoptosis independent of p53 in response to DNA damage.	[Lehman, Jason A.; Waning, David L.; Batuello, Christopher N.; Mayo, Lindsey D.] Case Western Reserve Univ, Herman B Wells Ctr Pediat Res, Dept Pediat, Cleveland, OH 44106 USA; [Batuello, Christopher N.; Mayo, Lindsey D.] Case Western Reserve Univ, Dept Biochem & Mol Biol, Cleveland, OH 44106 USA; [Cipriano, Rocky] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Kadakia, Madhavi P.] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Mayo, Lindsey D.] Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr, Indianapolis, IN 46202 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University System of Ohio; Wright State University Dayton; Indiana University System; Indiana University Bloomington	Mayo, LD (corresponding author), 980 W Walnut St,R3-C518, Indianapolis, IN 46202 USA.	ldmayo@iupui.edu			National Institutes of Health, NCI [CA109262]; NRSA [T32 CA 111198]; NATIONAL CANCER INSTITUTE [R01CA109262, T32CA111198, R21CA205437] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA109262 from NCI ( to L.D.M.) and NRSA T32 CA 111198 ( to J.A.L.).	Araki S, 2010, J CLIN INVEST, V120, P290, DOI 10.1172/JCI39194; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chang CJ, 2004, J BIOL CHEM, V279, P29841, DOI 10.1074/jbc.M401488200; Cipriano R, 2010, CELL CYCLE, V9, P1373, DOI 10.4161/cc.9.7.11193; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Jackson MW, 2006, J BIOL CHEM, V281, P16814, DOI 10.1074/jbc.M511617200; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Leslie NR, 2009, ADV ENZYME REGUL, V49, P190, DOI 10.1016/j.advenzreg.2008.12.002; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Minaguchi T, 2006, CANCER RES, V66, P11677, DOI 10.1158/0008-5472.CAN-06-2240; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Orloff MS, 2008, ONCOGENE, V27, P5387, DOI 10.1038/onc.2008.237; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Rosenbluth JM, 2008, GENE DEV, V22, P2591, DOI 10.1101/gad.1727408; Rosenbluth JM, 2008, MOL CELL BIOL, V28, P5951, DOI 10.1128/MCB.00305-08; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Sayan BS, 2010, P NATL ACAD SCI USA, V107, P12877, DOI 10.1073/pnas.0911828107; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tang YF, 2006, CANCER RES, V66, P736, DOI 10.1158/0008-5472.CAN-05-1557; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Tomasini R, 2008, TRENDS CELL BIOL, V18, P244, DOI 10.1016/j.tcb.2008.03.003; Vella V, 2009, INT J CANCER, V124, P2539, DOI 10.1002/ijc.24221; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Waning DL, 2010, PHARMACEUTICALS, V3, P1576, DOI 10.3390/ph3051576; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241	53	19	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36631	36640		10.1074/jbc.M110.217620	http://dx.doi.org/10.1074/jbc.M110.217620			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21873427	hybrid, Green Published			2022-12-27	WOS:000296538300046
J	Li, D; Liu, XG; Lin, L; Hou, J; Li, N; Wang, CM; Wang, P; Zhang, Q; Zhang, P; Zhou, WP; Wang, ZX; Ding, GS; Zhuang, SM; Zheng, LM; Tao, WZ; Cao, XT				Li, Dong; Liu, Xingguang; Lin, Li; Hou, Jin; Li, Nan; Wang, Chunmei; Wang, Pin; Zhang, Qian; Zhang, Peng; Zhou, Weiping; Wang, Zhengxin; Ding, Guoshan; Zhuang, Shi-Mei; Zheng, Limin; Tao, Wenzhao; Cao, Xuetao			MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSES TUMORIGENICITY; CANCER CELLS; LIVER-CANCER; EXPRESSION; IDENTIFICATION; APOPTOSIS; TARGET; DELIVERY; MTOR; PROGRESSION	In our in-depth analysis carried out by the Illumina Solexa massive parallel signature sequencing, microRNA-99a (miR-99a) was found to be the sixth abundant microRNA in the miR-Nome of normal human liver but was markedly down-regulated in hepatocellular carcinoma (HCC). Compelling evidence has suggested the important roles of microRNAs in HCC development. However, the biological function of miR-99a deregulation in HCC remains unknown. In this study, we found that miR-99a was remarkably decreased in HCC tissues and cell lines. Importantly, lower miR-99a expression in HCC tissues significantly correlated with shorter survival of HCC patients, and miR-99a was identified to be an independent predictor for the prognosis of HCC patients. Furthermore, restoration of miR-99a dramatically suppressed HCC cell growth in vitro by inducing the G(1) phase cell cycle arrest. Intratumoral injection of cholesterol-conjugated miR-99a mimics significantly inhibited tumor growth and reduced the alpha-fetoprotein level in HCC-bearing nude mice. Insulin-like growth factor 1 receptor (IGF-1R) and mammalian target of rapamycin (mTOR) were further characterized as the direct targets of miR-99a. Furthermore, protein levels of IGF-1R and mTOR were found to be inversely correlated with miR-99a expression in HCC tissues. miR-99a mimics inhibited IGF-1R and mTOR pathways and subsequently sup-pressed expression of cell cycle-related proteins, including cyclin D1 in HCC cells. Conclusively, miR-99a expression was frequently down-regulated in HCC tissues and correlates with the prognosis of HCC patients, thus proposing miR-99a as a prospective prognosis predictor of HCC. miR-99a suppresses HCC growth by inducing cell cycle arrest, suggesting miR-99a as potential tumor suppressor for HCC therapeutics.	[Li, Dong; Lin, Li; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Dong; Liu, Xingguang; Hou, Jin; Li, Nan; Wang, Chunmei; Wang, Pin; Zhang, Qian; Zhang, Peng; Tao, Wenzhao; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Li, Dong; Liu, Xingguang; Hou, Jin; Li, Nan; Wang, Chunmei; Wang, Pin; Zhang, Qian; Zhang, Peng; Tao, Wenzhao; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Zhou, Weiping] Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 3, Shanghai 200433, Peoples R China; [Wang, Zhengxin; Ding, Guoshan] Shanghai Changzheng Hosp, Dept Organ Transplantat, Shanghai 200433, Peoples R China; [Zhuang, Shi-Mei; Zheng, Limin] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Zhejiang University; Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University; Sun Yat Sen University	Cao, XT (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China.	caoxt@immunol.org	Hou, Jin/GRY-4960-2022; Zhou, Weiping/AGI-5344-2022; zheng, limin/HGB-2510-2022	Zheng, Limin/0000-0002-8281-1450; Zhuang, Shi-Mei/0000-0002-2512-3942	National 125 Key Project [2012ZX10002-014]; National Key Basic Research Program of China [2012CB518903]; National High Biotechnology Development Program of China [2009ZX09503-003]; National Natural Science Foundation of China [31170826]; Shanghai Committee of Science and Technology [10DZ1910300]	National 125 Key Project; National Key Basic Research Program of China(National Basic Research Program of China); National High Biotechnology Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by National 125 Key Project Grant 2012ZX10002-014, National Key Basic Research Program of China Grant 2012CB518903, National High Biotechnology Development Program of China Grant 2009ZX09503-003, National Natural Science Foundation of China Grant 31170826, and Shanghai Committee of Science and Technology Grant 10DZ1910300.	Alexander IE, 2008, GENE THER, V15, P831, DOI 10.1038/gt.2008.64; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arbuthnot P, 2009, CURR GENE THER, V9, P91, DOI 10.2174/156652309787909517; Braconi C, 2008, HEPATOLOGY, V47, P1807, DOI 10.1002/hep.22326; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Dufourny B, 1997, J BIOL CHEM, V272, P31163, DOI 10.1074/jbc.272.49.31163; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gramantieri L, 2008, J CELL MOL MED, V12, P2189, DOI 10.1111/j.1582-4934.2008.00533.x; Grewe M, 1999, CANCER RES, V59, P3581; Grimberg A, 2003, CANCER BIOL THER, V2, P630; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hua YJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-214; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kim SI, 2007, MOL THER, V15, P1145, DOI 10.1038/sj.mt.6300168; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nishina K, 2008, MOL THER, V16, P734, DOI 10.1038/mt.2008.14; Permuth-Wey J, 2011, J NEURO-ONCOL, V105, P639, DOI 10.1007/s11060-011-0634-1; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yamada H, 2008, GENE CHROMOSOME CANC, V47, P810, DOI 10.1002/gcc.20582; Yue C, 2011, GYNECOL ONCOL, V122, P33, DOI 10.1016/j.ygyno.2011.03.032; Zhou LD, 2010, MED ONCOL, V27, P255, DOI 10.1007/s12032-009-9201-4	53	192	204	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36677	36685		10.1074/jbc.M111.270561	http://dx.doi.org/10.1074/jbc.M111.270561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878637	Green Published, hybrid			2022-12-27	WOS:000296538300050
J	Li, SC; Kanno, S; Watanabe, R; Ogiwara, H; Kohno, T; WatanabeO, G; Yasui, A; Lieber, MR				Li, Sicong; Kanno, Shin-ichiro; Watanabe, Reiko; Ogiwara, Hideaki; Kohno, Takashi; WatanabeO, Go; Yasui, Akira; Lieber, Michael R.			Polynucleotide Kinase and Aprataxin-like Forkhead-associated Protein (PALF) Acts as Both a Single-stranded DNA Endonuclease and a Single-Stranded DNA 3 ' Exonuclease and Can Participate in DNA End Joining in a Biochemical System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZING-RADIATION; APLF C2ORF13; ARTEMIS; BREAKS; RESPONSES; SITES; PK	Polynucleotide kinase and aprataxin-like forkhead-associated protein (PALF, also called aprataxin- and PNK-like factor (APLF)) has been shown to have nuclease activity and to use its forkhead-associated domain to bind to x-ray repair complementing defective repair in Chinese hamster cells 4 (XRCC4). Because XRCC4 is a key component of the ligase IV complex that is central to the nonhomologous DNA end joining (NHEJ) pathway, this raises the possibility that PALF might play a role in NHEJ. For this reason, we further studied the nucleolytic properties of PALF, and we searched for any modulation of PALF by NHEJ components. We verified that PALF has 3' exonuclease activity. However, PALF also possesses single-stranded DNA endonuclease activity. This single-stranded DNA endonuclease activity can act at all single-stranded sites except those within four nucleotides 3' of a double-stranded DNA junction, suggesting that PALF minimally requires approximately four nucleotides of single-strandedness. Ku, DNA-dependent protein kinase catalytic subunit, and XRCC4-DNA ligase IV do not modulate PALF nuclease activity on single-stranded DNA or overhangs of duplex substrates. PALF does not open DNA hair-pins. However, in a reconstituted end joining assay that includes Ku, XRCC4-DNA ligase IV, and PALF, PALF is able to resect 3' overhanging nucleotides and permit XRCC4-DNA ligase IV to complete the joining process in a manner that is as efficient as Artemis. Reduction of PALF in vivo reduces the joining of incompatible DNA ends. Hence, PALF can function in concert with other NHEJ proteins.	[Li, Sicong; WatanabeO, Go; Lieber, Michael R.] Norris Comprehens Canc Ctr, Dept Pathol Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Li, Sicong; WatanabeO, Go; Lieber, Michael R.] Norris Comprehens Canc Ctr, Dept Biol Sci, Los Angeles, CA 90089 USA; [Li, Sicong; WatanabeO, Go; Lieber, Michael R.] Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA; [Kanno, Shin-ichiro; Watanabe, Reiko; Yasui, Akira] Tohoku Univ, Div Dynam Proteome, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Ogiwara, Hideaki; Kohno, Takashi] Natl Canc Ctr, Res Inst 1 1, Div Genome Biol, Tokyo 1040045, Japan	Tohoku University; National Cancer Center - Japan	Lieber, MR (corresponding author), Norris Comprehens Canc Ctr, Dept Pathol Biochem & Mol Biol, Los Angeles, CA 90089 USA.	lieber@usc.edu	Kanno, Shin-ichiro/AAE-4549-2019	Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345; Ogiwara, Hideaki/0000-0003-0860-1807	National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA100504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health grant (to M. R. L.).	Bekker-Jensen S, 2007, J BIOL CHEM, V282, P19638, DOI 10.1074/jbc.C700060200; Budman J, 2007, J BIOL CHEM, V282, P11950, DOI 10.1074/jbc.M610058200; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Gu JF, 2010, DNA REPAIR, V9, P429, DOI 10.1016/j.dnarep.2010.01.001; Huang Y, 2009, J EXP MED, V206, P893, DOI 10.1084/jem.20082396; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Koch CA, 2004, EMBO J, V23, P3874, DOI 10.1038/sj.emboj.7600375; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Ma YM, 2005, DNA REPAIR, V4, P845, DOI 10.1016/j.dnarep.2005.04.013; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Macrae CJ, 2008, DNA REPAIR, V7, P292, DOI 10.1016/j.dnarep.2007.10.008; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; Pawelczak KS, 2010, DNA REPAIR, V9, P670, DOI 10.1016/j.dnarep.2010.03.002; Rulten SL, 2011, MOL CELL, V41, P33, DOI 10.1016/j.molcel.2010.12.006; Tsai AG, 2009, J BIOL CHEM, V284, P7157, DOI 10.1074/jbc.M806866200	20	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36368	36377		10.1074/jbc.M111.287797	http://dx.doi.org/10.1074/jbc.M111.287797			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21885877	Green Published, hybrid			2022-12-27	WOS:000296538300022
J	Kersse, K; Lamkanfi, M; Bertrand, MJM; Vanden Berghe, T; Vandenabeele, P				Kersse, Kristof; Lamkanfi, Mohamed; Bertrand, Mathieu J. M.; Vanden Berghe, Tom; Vandenabeele, Peter			Interaction Patches of Procaspase-1 Caspase Recruitment Domains (CARDs) Are Differently Involved in Procaspase-1 Activation and Receptor-interacting Protein 2 (RIP2)-dependent Nuclear Factor kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; DEATH DOMAIN; NMR STRUCTURE; CELL-DEATH; CRYSTAL-STRUCTURE; MICE DEFICIENT; FORCE-FIELD; INFLAMMATION; GENERATION; APOPTOSIS	Background: The CARD of procaspase-1 regulates activation of procaspase-1 and NF-kappa B. Results: We show that the CARD procaspase-1 interacts with ASC through a type I interaction, whereas RIP2-mediated NF-kappa B activation involves a type III interaction. Conclusion: These findings indicate that the CARD of procaspase-1 is differently involved in inflammasome formation and NF-kappa B activation. Significance: These findings may allow development of therapeutics that specifically target a procaspase-1 function.	[Kersse, Kristof; Bertrand, Mathieu J. M.; Vanden Berghe, Tom; Vandenabeele, Peter] VIB, Dept Mol Biomed Res, B-9052 Ghent, Zwijnaarde, Belgium; [Kersse, Kristof; Bertrand, Mathieu J. M.; Vanden Berghe, Tom; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Zwijnaarde, Belgium; [Lamkanfi, Mohamed] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Vandenabeele, P (corresponding author), Technol Pk 927, B-9052 Zwijnaarde, Belgium.	peter.vandenabeele@dmbr.vib-ugent.be	Vanden Berghe, Tom/C-4916-2009; Bertrand, Mathieu JM/AAD-2653-2019; Bertrand, Mathieu J/P-6465-2016; Berghe, Tom Vanden/N-2902-2019; Vandenabeele, Peter/AAD-5793-2022; Vandenabeele, Peter/C-8597-2009	Vanden Berghe, Tom/0000-0002-1633-0974; Bertrand, Mathieu JM/0000-0001-9000-0626; Bertrand, Mathieu J/0000-0001-9000-0626; Berghe, Tom Vanden/0000-0002-1633-0974; Vandenabeele, Peter/0000-0002-6669-8822; 	EC [MRTN-CT-035624, FP7-200767]; Euregional PACT II; Belgian Grants Interuniversity Attraction Poles; IAP [6/18]; Flemish Grants Fonds Wetenschappelijk Onderzoek Vlaanderen [FWO G.0875.11, FWO G.0973.11]; Ghent University [BOF-GOA 12.0505.02, BOF-GOA 01.GC02.05]; Flanders Institute for Biotechnology; Stichting tegen Kanker; Fonds voor Wetenschappelijk Onderzoek; Flemish Government [BOF09/01M00709]	EC(European CommissionEuropean Commission Joint Research Centre); Euregional PACT II; Belgian Grants Interuniversity Attraction Poles(Belgian Federal Science Policy Office); IAP; Flemish Grants Fonds Wetenschappelijk Onderzoek Vlaanderen; Ghent University(Ghent University); Flanders Institute for Biotechnology; Stichting tegen Kanker; Fonds voor Wetenschappelijk Onderzoek(FWO); Flemish Government(European Commission)	This work was supported by European Grants FP6 ApopTrain MRTN-CT-035624 and FP7 EC RTD Integrated Project, Apo-Sys, FP7-200767, Euregional PACT II, Belgian Grants Interuniversity Attraction Poles, IAP 6/18, Flemish Grants Fonds Wetenschappelijk Onderzoek Vlaanderen, FWO G.0875.11 and FWO G.0973.11, Ghent University grants MRP, GROUP-ID, and grants from Flanders Institute for Biotechnology (to VIB).; Supported by Ghent University Grants BOF-GOA 12.0505.02 and BOF-GOA 01.GC02.05, "Stichting Emmanuel van der Schueren" and the "Stichting tegen Kanker."; Supported by a grant from the "Fonds voor Wetenschappelijk Onderzoek."; Supported by Methusalem Grant BOF09/01M00709 from the Flemish Government. To whom correspondence should be addressed: Technologiepark 927, B-9052 Zwijnaarde, Belgium. Tel.: 32-9-3313763; Fax: 32-9-3313609; E-mail: peter.vandenabeele@dmbr.vib-ugent.be.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; da Cunha JPC, 2008, J MOL EVOL, V66, P591, DOI 10.1007/s00239-008-9110-8; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Druilhe A, 2001, CELL DEATH DIFFER, V8, P649, DOI 10.1038/sj.cdd.4400881; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Inohara N, 2000, J BIOL CHEM, V275, P27823; Kersse K, 2007, BIOCHEM SOC T, V35, P1508, DOI 10.1042/BST0351508; Kersse K., 2011, TRENDS BIOC IN PRESS; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2004, J BIOL CHEM, V279, P51729, DOI 10.1074/jbc.M407891200; Lamkanfi M, 2004, J BIOL CHEM, V279, P24785, DOI 10.1074/jbc.M400985200; Lee SH, 2001, J BIOL CHEM, V276, P34495, DOI 10.1074/jbc.M101415200; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Mace PD, 2010, CURR OPIN CELL BIOL, V22, P828, DOI 10.1016/j.ceb.2010.08.004; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Naik E, 2010, J CLIN IMMUNOL, V30, P485, DOI 10.1007/s10875-010-9383-8; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Sarkar A, 2006, J IMMUNOL, V176, P4979, DOI 10.4049/jimmunol.176.8.4979; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shaw PJ, 2011, TRENDS MOL MED, V17, P57, DOI 10.1016/j.molmed.2010.11.001; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Van de Craen M, 1997, FEBS LETT, V403, P61, DOI 10.1016/S0014-5793(97)00026-4; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Yu JR, 2011, CURR ALLERGY ASTHM R, V11, P12, DOI 10.1007/s11882-010-0160-9	50	32	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35874	35882		10.1074/jbc.M111.242321	http://dx.doi.org/10.1074/jbc.M111.242321			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862576	Green Published, hybrid			2022-12-27	WOS:000295927100060
J	Lubos, E; Kelly, NJ; Oldebeken, SR; Leopold, JA; Zhang, YY; Loscalzo, J; Handy, DE				Lubos, Edith; Kelly, Neil J.; Oldebeken, Scott R.; Leopold, Jane A.; Zhang, Ying-Yi; Loscalzo, Joseph; Handy, Diane E.			Glutathione Peroxidase-1 Deficiency Augments Proinflammatory Cytokine-induced Redox Signaling and Human Endothelial Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ISCHEMIA-REPERFUSION INJURY; TUMOR-NECROSIS-FACTOR; DUAL-SPECIFICITY PHOSPHATASES; OXIDATIVE STRESS MEASUREMENTS; ADHESION MOLECULE-1 GENE; FREE-RADICAL FORMATION; TNF-ALPHA; HYDROGEN-PEROXIDE; TRANSCRIPTIONAL REGULATION	Glutathione peroxidase-1 (GPx-1) is a crucial antioxidant enzyme, the deficiency of which promotes atherogenesis. Accordingly, we examined the mechanisms by which GPx-1 deficiency enhances endothelial cell activation and inflammation. In human microvascular endothelial cells, we found that GPx-1 deficiency augments intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression by redox-dependent mechanisms that involve NF kappa B. Suppression of GPx-1 enhanced TNF-alpha-induced ROS production and ICAM-1 expression, whereas overexpression of GPx-1 attenuated these TNF-alpha-mediated responses. GPx-1 deficiency prolonged TNF-alpha-induced I kappa B alpha degradation and activation of ERK1/2 and JNK. JNK or NF kappa B inhibition attenuated TNF-alpha induction of ICAM-1 and VCAM-1 expression in GPx-1-deficient and control cells, whereas ERK1/2 inhibition attenuated only VCAM-1 expression. To analyze further signaling pathways involved in GPx-1-mediated protection from TNF-alpha-induced ROS, we performed microarray analysis of human microvascular endothelial cells treated with TNF-alpha in the presence and absence of GPx-1. Among the genes whose expression changed significantly, dual specificity phosphatase 4 (DUSP4), encoding an antagonist of MAPK signaling, was down-regulated by GPx-1 suppression. Targeted DUSP4 knockdown enhanced TNF-alpha-mediated ERK1/2 pathway activation and resulted in increased adhesion molecule expression, indicating that GPx-1 deficiency may augment TNF-alpha-mediated events, in part, by regulating DUSP4.	[Lubos, Edith; Kelly, Neil J.; Oldebeken, Scott R.; Leopold, Jane A.; Zhang, Ying-Yi; Loscalzo, Joseph; Handy, Diane E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Div, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Handy, DE (corresponding author), HMS NRB 0630,77 Ave Louis Pasteur, Boston, MA 02115 USA.	dhandy@rics.bwh.harvard.edu	Loscalzo, Joseph/ABD-8980-2021	Handy, Diane/0000-0002-4310-8527	National Institutes of Health [HL 58976, HL 61795, HV 28178, HL 81587, HL 48743]; NHLBI; Deutsche Forschungsgemeinschaft [LU 1452/1-1, LU 1452/2-1]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081587, P01HL048743, R01HL028178, R01HL061795, R37HL061795, R01HL105301, R01HL058976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 58976, HL 61795, HV 28178, HL 81587, and HL 48743 from the NHLBI and Deutsche Forschungsgemeinschaft Grants LU 1452/1-1 and LU 1452/2-1.	Ahmad M, 1998, J BIOL CHEM, V273, P4616, DOI 10.1074/jbc.273.8.4616; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Cao C, 2003, J BIOL CHEM, V278, P39609, DOI 10.1074/jbc.M305770200; Chrissobolis S, 2008, HYPERTENSION, V51, P872, DOI 10.1161/HYPERTENSIONAHA.107.103572; Crack PJ, 2006, STROKE, V37, P1533, DOI 10.1161/01.STR.0000221708.17159.64; D'Alessio P, 1998, FREE RADICAL BIO MED, V24, P979, DOI 10.1016/S0891-5849(97)00396-1; de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Espinola-Klein C, 2007, AM J CARDIOL, V99, P808, DOI 10.1016/j.amjcard.2006.10.041; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Forgione MA, 2002, CIRCULATION, V106, P1154, DOI 10.1161/01.CIR.0000026820.87824.6A; Forgione MA, 2002, AM J PHYSIOL-HEART C, V282, pH1255, DOI 10.1152/ajpheart.00598.2001; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; KretzRemy C, 1996, J CELL BIOL, V133, P1083, DOI 10.1083/jcb.133.5.1083; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Lee CW, 2006, J CELL PHYSIOL, V207, P174, DOI 10.1002/jcp.20549; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li Q, 2001, ANTIOXID REDOX SIGN, V3, P415, DOI 10.1089/15230860152409068; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Montes-Sanchez Delina, 2009, BMC Chemical Biology, V9, P7, DOI 10.1186/1472-6769-9-7; Murakami T, 2000, J Atheroscler Thromb, V7, P39; Murias Marek, 2005, Journal of Pharmacological and Toxicological Methods, V52, P302, DOI 10.1016/j.vascn.2005.03.002; NEISH AS, 1995, J BIOL CHEM, V270, P28903, DOI 10.1074/jbc.270.48.28903; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; RAES M, 1987, FREE RADICAL BIO MED, V3, P3, DOI 10.1016/0891-5849(87)90032-3; Rhee SG, 2010, MOL CELLS, V29, P539, DOI 10.1007/s10059-010-0082-3; Rota C, 1999, J BIOL CHEM, V274, P28161, DOI 10.1074/jbc.274.40.28161; Rota C, 1999, FREE RADICAL BIO MED, V27, P873, DOI 10.1016/S0891-5849(99)00137-9; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Shen WH, 2006, CANCER RES, V66, P6033, DOI 10.1158/0008-5472.CAN-05-3878; Sieben NLG, 2005, J CLIN ONCOL, V23, P7257, DOI 10.1200/JCO.2005.02.2541; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; Torzewski M, 2007, ARTERIOSCL THROM VAS, V27, P850, DOI 10.1161/01.ATV.0000258809.47285.07; URSINI F, 1995, METHOD ENZYMOL, V252, P38; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Wagner AH, 2009, ARTERIOSCL THROM VAS, V29, P1894, DOI 10.1161/ATVBAHA.109.194738; Weisbrot-Lefkowitz M, 1998, MOL BRAIN RES, V53, P333, DOI 10.1016/S0169-328X(97)00313-6; Wong CHY, 2008, J NEUROCHEM, V107, P241, DOI 10.1111/j.1471-4159.2008.05605.x; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Yoshida T, 1997, CIRCULATION, V96, P216; Zhang YF, 2005, CIRC RES, V96, P831, DOI 10.1161/01.RES.0000164401.21929.CF; Zhou J, 2002, INFLAMM RES, V51, P332, DOI 10.1007/PL00000312; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	57	50	52	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35407	35417		10.1074/jbc.M110.205708	http://dx.doi.org/10.1074/jbc.M110.205708			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852236	Green Published, hybrid			2022-12-27	WOS:000295927100012
J	Shakor, ABA; Taniguchi, M; Kitatani, K; Hashimoto, M; Asano, S; Hayashi, A; Nomura, K; Bielawski, J; Bielawska, A; Watanabe, K; Kobayashi, T; Igarashi, Y; Umehara, H; Takeya, H; Okazaki, T				Shakor, Abo Bakr Abdel; Taniguchi, Makoto; Kitatani, Kazuyuki; Hashimoto, Mayumi; Asano, Satoshi; Hayashi, Akira; Nomura, Kenichi; Bielawski, Jacek; Bielawska, Alicja; Watanabe, Ken; Kobayashi, Toshihide; Igarashi, Yasuyuki; Umehara, Hisanori; Takeya, Hiroyuki; Okazaki, Toshiro			Sphingomyelin Synthase 1-generated Sphingomyelin Plays an Important Role in Transferrin Trafficking and Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; GLUCOSYLCERAMIDE SYNTHASE; RAB11-POSITIVE ENDOSOMES; INDEPENDENT ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; RECEPTOR; CERAMIDE; SPHINGOLIPIDS; GROWTH; MECHANISMS	Transferrin (Tf) endocytosis and recycling are essential for iron uptake and the regulation of cell proliferation. Tf and Tf receptor (TfR) complexes are internalized via clathrin-coated pits composed of a variety of proteins and lipids and pass through early endosomes to recycling endosomes. We investigated the role of sphingomyelin (SM) synthases (SMS1 and SMS2) in clathrin-dependent trafficking of Tf and cell proliferation. We employed SM-deficient lymphoma cells that lacked SMSs and that failed to proliferate in response to Tf. Transfection of SMS1, but not SMS2, enabled these cells to incorporate SM into the plasma membrane, restoring Tf-mediated proliferation. SM-deficient cells showed a significant reduction in clathrin-dependent Tf uptake compared with the parental SM-producing cells. Both SMS1 gene transfection and exogenous short-chain SM treatment increased clathrin-dependent Tf uptake in SM-deficient cells, with the Tf being subsequently sorted to Rab11-positive recycling endosomes. We observed trafficking of the internalized Tf to late/endolysosomal compartments, and this was not dependent on the clathrin pathway in SM-deficient cells. Thus, SMS1-mediated SM synthesis directs Tf-TfR to undergo clathrin-dependent endocytosis and recycling, promoting the proliferation of lymphoma cells.	[Umehara, Hisanori; Okazaki, Toshiro] Kanazawa Med Univ, Dept Hematol & Immunol, Kanazawa, Ishikawa 9020293, Japan; [Shakor, Abo Bakr Abdel; Taniguchi, Makoto; Kitatani, Kazuyuki; Hashimoto, Mayumi; Asano, Satoshi; Hayashi, Akira; Nomura, Kenichi; Okazaki, Toshiro] Tottori Univ, Fac Med, Div Clin Lab Med & Hematol Oncol, Yonago, Tottori 6838503, Japan; [Takeya, Hiroyuki] Tottori Univ, Fac Med, Dept Biomed Sci, Div Pathol Biochem, Yonago, Tottori 6838503, Japan; [Bielawski, Jacek; Bielawska, Alicja] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Watanabe, Ken] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Aichi 4748511, Japan; [Kobayashi, Toshihide] RIKEN Adv Sci Inst, Wako, Saitama 3510198, Japan; [Igarashi, Yasuyuki] Hokkaido Univ, Fac Adv Life Sci, Lab Biomembrane & Biofunct Chem, Kita Ku, Sapporo, Hokkaido 0010021, Japan	Kanazawa Medical University; Tottori University; Tottori University; Medical University of South Carolina; National Center for Geriatrics & Gerontology; RIKEN; Hokkaido University	Okazaki, T (corresponding author), Kanazawa Med Univ, Dept Hematol & Immunol, 1-1 Daigaku Uchinada, Kanazawa, Ishikawa 9020293, Japan.	toshiroo@kanazawa-med.ac.jp	Asano, Satoshi/AAQ-3817-2020; Abdel shakor, Abo bakr/R-7133-2016; Kobayashi, Toshihide/B-6298-2015; Watanabe, Ken/I-3960-2013; Kitatani, Kazuyuki/H-7100-2019; KOBAYASHI, TOSHIHIDE/S-8313-2019; Taniguchi, Makoto/L-5757-2019	Abdel shakor, Abo bakr/0000-0003-2792-9066; Kobayashi, Toshihide/0000-0002-4811-7270; Watanabe, Ken/0000-0003-0664-3915; Kitatani, Kazuyuki/0000-0002-8516-6135; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Taniguchi, Makoto/0000-0001-5920-8285; Asano, Satoshi/0000-0003-1537-4307	Sapporo Biocluster "Bio-S"; Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science, and Technology (Japan); Japan Society for the Promotion of Science [21890144, 23790366]; Sumitomo Foundation; Japanese Ministry of Education, Culture, Sports, Science, and Technology [22249041, 21113530, 22390018]; RIKEN; Uehara Memorial Foundation; Vehicle Racing Commemorative Foundation; Kanazawa Medical University Research Foundation	Sapporo Biocluster "Bio-S"; Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science, and Technology (Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation; Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; Uehara Memorial Foundation(Uehara Memorial Foundation); Vehicle Racing Commemorative Foundation; Kanazawa Medical University Research Foundation	This study was supported in part by the Sapporo Biocluster "Bio-S," the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science, and Technology (Japan), Japan Society for the Promotion of Science Grants-in-aid for Young Scientists 21890144 and 23790366 (to K. K.), the Sumitomo Foundation (to K. K.), Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants 22249041 (to H. U.) and 21113530 and 22390018 (to T. K.), Lipid Dynamics Program of RIKEN (to T. K.), the Uehara Memorial Foundation (to H. U.), the Vehicle Racing Commemorative Foundation (to H. U.), and the Kanazawa Medical University Research Foundation (to H. U.).	Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bourteele S, 1998, J BIOL CHEM, V273, P31245, DOI 10.1074/jbc.273.47.31245; CANO E, 1990, EUR J IMMUNOL, V20, P765, DOI 10.1002/eji.1830200409; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Demmel L, 2008, MOL BIOL CELL, V19, P1991, DOI 10.1091/mbc.E06-10-0937; Ding T, 2008, J LIPID RES, V49, P376, DOI 10.1194/jlr.M700401-JLR200; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Gomme PT, 2005, DRUG DISCOV TODAY, V10, P267, DOI 10.1016/S1359-6446(04)03333-1; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; HANADA K, 1992, J BIOL CHEM, V267, P23527; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hernaez B, 2010, J VIROL, V84, P2100, DOI 10.1128/JVI.01557-09; Higgins MK, 2002, TRENDS BIOCHEM SCI, V27, P257, DOI 10.1016/S0968-0004(02)02089-3; Hughes WE, 2001, BIOCHEM J, V356, P727, DOI 10.1042/0264-6021:3560727; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Itoh M, 2003, CLIN CANCER RES, V9, P415; JEFFERIES WA, 1985, IMMUNOLOGY, V54, P333; Kaksonen M, 2008, J CELL BIOL, V180, P1059, DOI 10.1083/jcb.200802174; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Kitatani K, 2007, J BIOL CHEM, V282, P20647, DOI 10.1074/jbc.M609162200; KOVAL M, 1990, J CELL BIOL, V111, P429, DOI 10.1083/jcb.111.2.429; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Liebl D, 2006, J VIROL, V80, P4610, DOI 10.1128/JVI.80.9.4610-4622.2006; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MANGER B, 1986, J IMMUNOL, V136, P532; MATSUI T, 2011, TRAFFIC IN PRESS; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MIROOBRADORS MJ, 1993, CARCINOGENESIS, V14, P941, DOI 10.1093/carcin/14.5.941; Miyaji M, 2005, J EXP MED, V202, P249, DOI 10.1084/jem.20041685; Moura IC, 2001, J EXP MED, V194, P417, DOI 10.1084/jem.194.4.417; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; Padron D, 2006, MOL BIOL CELL, V17, P598, DOI 10.1091/mbc.E05-05-0389; PANACCIO M, 1987, IMMUNOL CELL BIOL, V65, P461, DOI 10.1038/icb.1987.55; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Riboni L, 2001, J BIOL CHEM, V276, P12797, DOI 10.1074/jbc.M011570200; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Roth MG, 1999, TRENDS CELL BIOL, V9, P174, DOI 10.1016/S0962-8924(99)01535-4; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; SUBTIL A, 1994, J CELL SCI, V107, P3461; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Taguchi Y, 2004, BLOOD, V104, P3285, DOI 10.1182/blood-2004-03-0900; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Trischler M, 1999, J CELL SCI, V112, P4773; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; VOELKER DR, 1982, BIOCHEMISTRY-US, V21, P2753, DOI 10.1021/bi00540a027; Watanabe M, 2004, CANCER RES, V64, P1000, DOI 10.1158/0008-5472.CAN-03-1383; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39	59	53	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36053	36062		10.1074/jbc.M111.228593	http://dx.doi.org/10.1074/jbc.M111.228593			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21856749	hybrid, Green Published			2022-12-27	WOS:000295927100078
J	Bielnicki, JA; Shkumatov, AV; Derewenda, U; Somlyo, AV; Svergun, DI; Derewenda, ZS				Bielnicki, Jakub A.; Shkumatov, Alexander V.; Derewenda, Urszula; Somlyo, Avril V.; Svergun, Dmitri I.; Derewenda, Zygmunt S.			Insights into the Molecular Activation Mechanism of the RhoA-specific Guanine Nucleotide Exchange Factor, PDZRhoGEF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; LEUKEMIA-ASSOCIATED RHO; PDZ-RHOGEF; SOLUTION SCATTERING; STRUCTURAL-CHARACTERIZATION; TRANSCRIPTIONAL REPRESSION; BIOLOGICAL MACROMOLECULES; CA2+ SENSITIZATION; CRYSTAL-STRUCTURE; DOMAIN	PDZRhoGEF (PRG) belongs to a small family of RhoA-specific nucleotide exchange factors that mediates signaling through select G-protein-coupled receptors via G alpha(12/13) and activates RhoA by catalyzing the exchange of GDP to GTP. PRG is a multidomain protein composed of PDZ, regulators of G-protein signaling-like (RGSL), Dbl-homology (DH), and pleckstrin-homology (PH) domains. It is autoinhibited in cytosol and is believed to undergo a conformational rearrangement and translocation to the membrane for full activation, although the molecular details of the regulation mechanism are not clear. It has been shown recently that the main autoregulatory elements of PDZRhoGEF, the autoinhibitory "activation box" and the "GEF switch," which is required for full activation, are located directly upstream of the catalytic DH domain and its RhoA binding surface, emphasizing the functional role of the RGSL-DH linker. Here, using a combination of biophysical and biochemical methods, we show that the mechanism of PRG regulation is yet more complex and may involve an additional autoinhibitory element in the form of a molten globule region within the linker between RGSL and DH domains. We propose a novel, two-tier model of autoinhibition where the activation box and the molten globule region act synergistically to impair the ability of RhoA to bind to the catalytic DH-PH tandem. The molten globule region and the activation box become less ordered in the PRG-RhoA complex and dissociate from the RhoA-binding site, which may constitute a critical step leading to PRG activation.	[Shkumatov, Alexander V.; Svergun, Dmitri I.] DESY, European Mol Biol Lab, EMBL, Hamburg Outstn, D-22603 Hamburg, Germany; [Bielnicki, Jakub A.; Derewenda, Urszula; Somlyo, Avril V.; Derewenda, Zygmunt S.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Virginia	Svergun, DI (corresponding author), DESY, European Mol Biol Lab, EMBL, Hamburg Outstn, Notkestr 85, D-22603 Hamburg, Germany.	svergun@embl-hamburg.de; zsd4n@virginia.edu		Svergun, Dmitri/0000-0003-0830-5696	National Institutes of Health [R01 GM086457]; Human Frontier Science Program Research [RGP 55/2006]; BMBF (Bundesministerium fur Bildung und Forschung) [05K10YEA]; EU [261572]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Research(Human Frontier Science Program); BMBF (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM086457. This work was also supported by Human Frontier Science Program Research Grant RGP 55/2006.; Supported by BMBF (Bundesministerium fur Bildung und Forschung) Research Grant SYNC-LIFE (Contract 05K10YEA) and EU FP7 e-Infrastructure grant WeNMR (Contract 261572). To whom correspondence may be addressed. Tel.: 49-40-89902-125; Fax: 49-40-89902-149; E-mail: svergun@embl-hamburg.de.; Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Bhattacharya M, 2004, BIOCHEM SOC T, V32, P1040, DOI 10.1042/BST0321040; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chen Z, 2001, NAT STRUCT BIOL, V8, P805, DOI 10.1038/nsb0901-805; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; Cierpicki T, 2009, PROTEIN SCI, V18, P2067, DOI 10.1002/pro.219; Colby R.H., 2003, POLYM PHYS; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Gong MC, 1996, P NATL ACAD SCI USA, V93, P1340, DOI 10.1073/pnas.93.3.1340; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; HARDING SE, 1995, BIOPHYS CHEM, V55, P69, DOI 10.1016/0301-4622(94)00143-8; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jachimska B, 2008, LANGMUIR, V24, P6866, DOI 10.1021/la800548p; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Longenecker K, 1999, ACTA CRYSTALLOGR D, V55, P1503, DOI 10.1107/S090744499900801X; Longenecker KL, 2001, STRUCTURE, V9, P559, DOI 10.1016/S0969-2126(01)00620-7; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; Mylonas E, 2008, BIOCHEMISTRY-US, V47, P10345, DOI 10.1021/bi800900d; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P490, DOI 10.1107/S0907444905002726; Oleksy A, 2004, ACTA CRYSTALLOGR D, V60, P740, DOI 10.1107/S0907444904002318; Papoian GA, 2008, P NATL ACAD SCI USA, V105, P14237, DOI 10.1073/pnas.0807977105; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Porod G, 1982, GEN THEORY SMALL ANG, P17; PTITSYN OB, 1994, FEBS LETT, V341, P15, DOI 10.1016/0014-5793(94)80231-9; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Romero P, 1997, 1997 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-4, P90, DOI 10.1109/ICNN.1997.611643; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; Shankaranarayanan A, 2010, CELL SIGNAL, V22, P1114, DOI 10.1016/j.cellsig.2010.03.006; Shkumatov AV, 2011, PROTEINS, V79, P2122, DOI 10.1002/prot.23033; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Unneberg P, 2001, PROTEINS, V42, P460, DOI 10.1002/1097-0134(20010301)42:4<460::AID-PROT50>3.0.CO;2-U; Verstraete K, 2011, BLOOD, V118, P60, DOI 10.1182/blood-2011-01-329532; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Woods VL, 2001, J CELL BIOCHEM, V84, P89, DOI 10.1002/jcb.10069; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zheng MY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-36; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zurdo J, 1997, BIOCHEMISTRY-US, V36, P9625, DOI 10.1021/bi9702400; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	72	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35163	35175		10.1074/jbc.M111.270918	http://dx.doi.org/10.1074/jbc.M111.270918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21816819	hybrid, Green Published			2022-12-27	WOS:000295406300069
J	Kulkarni, SS; Karlsson, HKR; Szekeres, F; Chibalin, AV; Krook, A; Zierath, JR				Kulkarni, Sameer S.; Karlsson, Hakan K. R.; Szekeres, Ferenc; Chibalin, Alexander V.; Krook, Anna; Zierath, Juleen R.			Suppression of 5 '-Nucleotidase Enzymes Promotes AMP-activated Protein Kinase (AMPK) Phosphorylation and Metabolism in Human and Mouse Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; GLUCOSE-UPTAKE; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; LIPID-METABOLISM; IN-VIVO; INSULIN; CELL; DEAMINASE; GENE; DIFFERENTIATION	The 5'-nucleotidase (NT5) family of enzyme dephosphorylates non-cyclic nucleoside monophosphates to produce nucleosides and inorganic phosphates. We hypothesized that gene silencing of NT5 enzymes to increase the intracellular availability of AMP would increase AMP-activated protein kinase (AMPK) activity and metabolism. We determined the role of cytosolic NT5 in metabolic responses linked to the development of insulin resistance in obesity and type 2 diabetes. Using siRNA to silence NT5C2 expression in cultured human myotubes, we observed a 2-fold increase in the AMP/ATP ratio, a 2.4-fold increase in AMPK phosphorylation (Thr(172)), and a 2.8-fold increase in acetyl-CoA carboxylase phosphorylation (Ser(79)) (p<0.05). siRNA silencing of NT5C2 expression increased palmitate oxidation by 2-fold in the absence and by 8-fold in the presence of 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside. This was paralleled by an increase in glucose transport and a decrease in glucose oxidation, incorporation into glycogen, and lactate release from NT5C2-depleted myotubes. Gene silencing of NT5C1A by shRNA injection and electroporation in mouse tibialis anterior muscle reduced protein content (60%; p<0.05) and increased phosphorylation of AMPK (60%; p<0.05) and acetyl-CoA carboxylase (50%; p<0.05) and glucose uptake (20%; p<0.05). Endogenous expression of NT5C enzymes inhibited basal lipid oxidation and glucose transport in skeletal muscle. Reduction of 5'-nucleotidase expression or activity may promote metabolic flexibility in type 2 diabetes.	[Zierath, Juleen R.] Karolinska Inst, Sect Integrat Physiol, Dept Mol Med & Surg, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Zierath, JR (corresponding author), Karolinska Inst, Sect Integrat Physiol, Dept Mol Med & Surg, Von Eulers Vag 4,4th Floor, S-17177 Stockholm, Sweden.	juleen.zierath@ki.se	Krook, Anna/K-1192-2015; Szekeres, Ferenc L M/E-4586-2018	Krook, Anna/0000-0002-0891-0258; Karlsson, Hakan/0000-0003-0818-5460; Chibalin, Alexander/0000-0002-6339-6271; Zierath, Juleen/0000-0001-6891-7497	European Research Council [ERC-2008-AdG23285]; Swedish Research Council; Swedish Diabetes Association; Strategic Research Foundation; Knut and Alice Wallenberg Foundation; Stockholm County Council; Novo Nordisk Research Foundation; Commission of the European Communities [LSHM-CT-2004-005272 EXGENESIS]; Karolinska Institutet	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Strategic Research Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Stockholm County Council(Stockholm County Council); Novo Nordisk Research Foundation(Novo Nordisk Foundation); Commission of the European Communities(European Commission); Karolinska Institutet(Karolinska Institutet)	This work was supported by the European Research Council Ideas Program (ICEBERG, ERC-2008-AdG23285), the Swedish Research Council, the Swedish Diabetes Association, the Strategic Research Foundation, the Knut and Alice Wallenberg Foundation, the Stockholm County Council, the Novo Nordisk Research Foundation, the Commission of the European Communities (Contract LSHM-CT-2004-005272 EXGENESIS), and the Strategic Research Programme in Diabetes at Karolinska Institutet.	Al-Khalili L, 2004, ACTA PHYSIOL SCAND, V180, P395, DOI 10.1111/j.1365-201X.2004.01259.x; Al-Khalili L, 2003, CELL MOL LIFE SCI, V60, P991, DOI 10.1007/s00018-003-3001-3; Allegrini S, 1997, BIOCHEM J, V328, P483, DOI 10.1042/bj3280483; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; BELSHAM GJ, 1980, BIOCHEM J, V192, P457, DOI 10.1042/bj1920457; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Bouzakri K, 2008, DIABETES, V57, P1508, DOI 10.2337/db07-0583; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Careddu MG, 2008, BBA-MOL CELL RES, V1783, P1529, DOI 10.1016/j.bbamcr.2008.03.018; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Fiedler M, 2001, DIABETOLOGIA, V44, P2180, DOI 10.1007/s001250100027; Goodarzi MO, 2005, DIABETES, V54, P1222, DOI 10.2337/diabetes.54.4.1222; Halseth AE, 2002, BIOCHEM BIOPH RES CO, V294, P798, DOI 10.1016/S0006-291X(02)00557-0; Hancock CR, 2006, J APPL PHYSIOL, V100, P406, DOI 10.1152/japplphysiol.00885.2005; Hanisch F, 2006, BIOL CHEM, V387, P53, DOI 10.1515/BC.2006.008; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; HARDIE DG, 1989, PROG LIPID RES, V28, P117, DOI 10.1016/0163-7827(89)90010-6; Henin N, 1996, BBA-GEN SUBJECTS, V1290, P197, DOI 10.1016/0304-4165(96)00021-9; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Hunsucker SA, 2001, J BIOL CHEM, V276, P10498, DOI 10.1074/jbc.M011218200; Janssen E, 2000, EMBO J, V19, P6371, DOI 10.1093/emboj/19.23.6371; Jaswal JS, 2010, AM J PHYSIOL-HEART C, V299, pH1135, DOI 10.1152/ajpheart.00186.2010; Kappock TJ, 2000, CURR OPIN CHEM BIOL, V4, P567, DOI 10.1016/S1367-5931(00)00133-2; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kelley DE, 2005, J CLIN INVEST, V115, P1699, DOI 10.1172/JCI25758; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Miyamoto L, 2007, J APPL PHYSIOL, V102, P1007, DOI 10.1152/japplphysiol.01034.2006; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Rampazzo C, 1999, EUR J BIOCHEM, V261, P689, DOI 10.1046/j.1432-1327.1999.00320.x; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Rune A, 2009, DIABETOLOGIA, V52, P2182, DOI 10.1007/s00125-009-1465-x; Sabina RL, 2000, PHARMACOL THERAPEUT, V87, P279, DOI 10.1016/S0163-7258(00)00040-1; Safranow K, 2009, SCAND J CLIN LAB INV, V69, P102, DOI 10.1080/00365510802430964; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995; Treebak JT, 2010, AM J PHYSIOL-CELL PH, V298, pC377, DOI 10.1152/ajpcell.00297.2009; Viana R, 2007, J BIOL CHEM, V282, P16117, DOI 10.1074/jbc.M611804200; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Witczak CA, 2010, AM J PHYSIOL-ENDOC M, V298, pE1150, DOI 10.1152/ajpendo.00659.2009; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	47	55	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34567	34574		10.1074/jbc.M111.268292	http://dx.doi.org/10.1074/jbc.M111.268292			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21873433	Green Published, hybrid			2022-12-27	WOS:000295406300011
J	Wu, R; Wu, H				Wu, Ren; Wu, Hui			A Molecular Chaperone Mediates a Two-protein Enzyme Complex and Glycosylation of Serine-rich Streptococcal Adhesins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIMBRIAE-ASSOCIATED ADHESIN; GROUP-B STREPTOCOCCUS; BIOFILM FORMATION; PROTEIN GLYCOSYLATION; PILIN GLYCOSYLATION; PARASANGUIS FW213; ESCHERICHIA-COLI; SURFACE PROTEIN; FAP1; GLYCOPROTEIN	Serine-rich repeat glycoproteins identified from streptococci and staphylococci are important for bacterial adhesion and biofilm formation. Two putative glycosyltransferases, Gtf1 and Gtf2, from Streptococcus parasanguinis form a two-protein enzyme complex that is required for glycosylation of a serinerich repeat adhesin, Fap1. Gtf1 is a glycosyltransferase; however, the function of Gtf2 is unknown. Here, we demonstrate that Gtf2 enhances the enzymatic activity of Gtf1 by its chaperone-like property. Gtf2 interacted with Gtf1, mediated the subcellular localization of Gtf1, and stabilized Gtf1. Deletion of invariable amino acid residues in a conserved domain of unknown function (DUF1975) at the N terminus of Gtf2 had a greater impact on Fap1 glycosylation than deletion of the C-terminal non-DUF1975 residues. The DUF1975 deletions concurrently reduced the interaction between Gtf1 and Gtf2, altered the subcellular localization of Gtf1, and destabilized Gtf1, suggesting that DUF1975 is crucial for the chaperone activity of Gtf2. Homologous GtfA and GtfB from Streptococcus agalactiae rescued the glycosylation defect in the gtf1gtf2 mutant; like Gtf2, GtfB also possesses chaperone-like activity. Taken together, our studies suggest that Gtf2 and its homologs possess the conserved molecular chaperone activity that mediates protein glycosylation of bacterial adhesins.	[Wu, Hui] Univ Alabama, Sch Dent, Dept Pediat Dent, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Sch Dent, Birmingham, AL 35294 USA; Univ Alabama, Sch Med, Birmingham, AL 35294 USA; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Wu, H (corresponding author), Univ Alabama, Sch Dent, Dept Pediat Dent, SDB 802, Birmingham, AL 35294 USA.	hwu@uab.edu			National Institutes of Health from NIDCR [R01DE017954]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017954] Funding Source: NIH RePORTER	National Institutes of Health from NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DE017954 from NIDCR (to H. W.).	Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; Arora SK, 2005, INFECT IMMUN, V73, P4395, DOI 10.1128/IAI.73.7.4395-4398.2005; Brockhausen I, 2008, J BACTERIOL, V190, P4922, DOI 10.1128/JB.00160-08; Bu S, 2008, J BACTERIOL, V190, P1256, DOI 10.1128/JB.01078-07; Chamot-Rooke J, 2007, P NATL ACAD SCI USA, V104, P14783, DOI 10.1073/pnas.0705335104; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; Chen Q, 2007, J BACTERIOL, V189, P7610, DOI 10.1128/JB.00748-07; COLE RM, 1976, J DENT RES, V55, pA142, DOI 10.1177/002203457605500106011; Deng LYL, 2010, BIOCHEM RES INT, V2010, DOI 10.1155/2010/395758; FRITHZLINDSTEN E, 1995, MOL MICROBIOL, V16, P635, DOI 10.1111/j.1365-2958.1995.tb02426.x; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Joliot A, 1998, CURR BIOL, V8, P856, DOI 10.1016/S0960-9822(07)00346-6; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kos V, 2010, J BIOL CHEM, V285, P19668, DOI 10.1074/jbc.M110.122598; Levesque C, 2001, J BACTERIOL, V183, P2724, DOI 10.1128/JB.183.9.2724-2732.2001; Li J, 1997, P NATL ACAD SCI USA, V94, P13251, DOI 10.1073/pnas.94.24.13251; Li YR, 2008, MOL MICROBIOL, V70, P1094, DOI 10.1111/j.1365-2958.2008.06456.x; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; McNab Roderick, 1998, Methods in Cell Science, V20, P209, DOI 10.1023/A:1009763626485; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Mohammadi T, 2007, MOL MICROBIOL, V65, P1106, DOI 10.1111/j.1365-2958.2007.05851.x; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Peng Z, 2008, ORAL MICROBIOL IMMUN, V23, P70, DOI 10.1111/j.1399-302X.2007.00401.x; Ramboarina S, 2010, J BIOL CHEM, V285, P32446, DOI 10.1074/jbc.M110.128165; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; Seepersaud R, 2010, MOL MICROBIOL, V78, P490, DOI 10.1111/j.1365-2958.2010.07346.x; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Stephenson AE, 2002, MOL MICROBIOL, V43, P147, DOI 10.1046/j.1365-2958.2002.02725.x; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wu H, 1999, MOL MICROBIOL, V34, P1070, DOI 10.1046/j.1365-2958.1999.01670.x; Wu H, 1998, MOL MICROBIOL, V28, P487, DOI 10.1046/j.1365-2958.1998.00805.x; Wu H, 2007, INFECT IMMUN, V75, P2181, DOI 10.1128/IAI.01544-06; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Wu R, 2010, APPL ENVIRON MICROB, V76, P7966, DOI 10.1128/AEM.01434-10; Yajima A, 2008, MICROBIOL IMMUNOL, V52, P69, DOI 10.1111/j.1348-0421.2008.00015.x; Zhou MX, 2008, INFECT IMMUN, V76, P5624, DOI 10.1128/IAI.00534-08; Zhou M, 2008, J MICROBIOL METH, V72, P249, DOI 10.1016/j.mimet.2007.12.002; Zhou MX, 2010, J BIOL CHEM, V285, P12140, DOI 10.1074/jbc.M109.066928; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0; Zurawski DV, 2004, MICROBIOL-SGM, V150, P2055, DOI 10.1099/mic.0.26997-0	49	34	41	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34923	34931		10.1074/jbc.M111.239350	http://dx.doi.org/10.1074/jbc.M111.239350			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21862581	Green Published, hybrid			2022-12-27	WOS:000295406300046
J	Yasui, N; Kitago, Y; Beppu, A; Kohno, T; Morishita, S; Gomi, H; Nagae, M; Hattori, M; Takagi, J				Yasui, Norihisa; Kitago, Yu; Beppu, Ayako; Kohno, Takao; Morishita, Shunsuke; Gomi, Hiroki; Nagae, Masamichi; Hattori, Mitsuharu; Takagi, Junichi			Functional Importance of Covalent Homodimer of Reelin Protein Linked via Its Central Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL REGION; VLDL RECEPTOR; IN-VIVO; BINDING; FRAGMENT; NEURONS; RECOGNITION; DISRUPTION; DOMAIN; BRAIN	Reelin is a 3461-residue secreted glycoprotein that plays a critical role in brain development through its action on target neurons. Although it is known that functional reelin protein exists as multimer formed by interchain disulfide bond(s) as well as through non-covalent interactions, the chemical nature of the multimer assembly has been elusive. In the present study, we identified, among 122 cysteines present in full-length reelin, the single critical cysteine residue (Cys(2101)) responsible for the covalent multimerization. C2101A mutant reelin failed to assemble into disulfide-bonded multimers, whereas it still exhibited non-covalently associated high molecular weight oligomeric states in solution. Detailed analysis of tryptic fragments produced from the purified reelin proteins revealed that the minimum unit of the multimer is a homodimeric reelin linked via Cys(2101) present in the central region and that this cysteine does not connect to the N-terminal region of reelin, which had been postulated as the primary oligomerization domain. A surface plasmon resonance binding assay confirmed that C2101A mutant reelin retained binding capability toward two neuronal receptors apolipoprotein E receptor 2 and very low density lipoprotein receptor. However, it failed to show signaling activity in the assay using the cultured neurons. These results indicate that an intact higher order architecture of reelin multimer maintained by both Cys(2101)-mediated homodimerization and other non-covalent association present elsewhere in the reelin primary structure are essential for exerting its full biological activity.	[Yasui, Norihisa; Kitago, Yu; Beppu, Ayako; Nagae, Masamichi; Takagi, Junichi] Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Suita, Osaka 5650871, Japan; [Kohno, Takao; Morishita, Shunsuke; Gomi, Hiroki; Hattori, Mitsuharu] Nagoya City Univ, Dept Biomed Sci, Grad Sch Pharmaceut Sci, Mizuho Ku, Aichi 4678603, Japan	Osaka University; Nagoya City University	Takagi, J (corresponding author), Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takagi@protein.osaka-u.ac.jp	Yasui, Norihisa/V-8252-2019; Hattori, Mitsuharu/F-3859-2010	Yasui, Norihisa/0000-0001-7117-3070; Hattori, Mitsuharu/0000-0002-0503-4969; Nagae, Masamichi/0000-0002-5470-3807; Kohno, Takao/0000-0003-2557-4281; Kitago, Yu/0000-0003-2325-6917	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [20770084]	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research (A) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), a grant-in-aid for scientific research on innovative areas from MEXT, a Protein 3000 Project grant from MEXT, and Grant-in-aid for Young Scientists (B) 20770084 (to N. Y.) from MEXT.	Andersen OM, 2003, BIOCHEMISTRY-US, V42, P9355, DOI 10.1021/bi034475p; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; de Rouvroit CL, 1999, EXP NEUROL, V156, P214, DOI 10.1006/exnr.1998.7007; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Ichihara H, 2001, MOL BRAIN RES, V97, P190, DOI 10.1016/S0169-328X(01)00307-2; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Jossin Y, 2003, CEREB CORTEX, V13, P627, DOI 10.1093/cercor/13.6.627; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Kohno S, 2009, BIOCHEM BIOPH RES CO, V380, P93, DOI 10.1016/j.bbrc.2009.01.039; Kohno T, 2009, J NEUROSCI RES, V87, P3043, DOI 10.1002/jnr.22143; Kubo K, 2002, NEUROSCI RES, V43, P381, DOI 10.1016/S0168-0102(02)00068-8; Lugli Giovanni, 2003, BMC Biochem, V4, P9, DOI 10.1186/1471-2091-4-9; Miyata T, 1997, J NEUROSCI, V17, P3599; Mize GJ, 2008, PROTEIN EXPRES PURIF, V57, P280, DOI 10.1016/j.pep.2007.09.018; Morimura T, 2005, J BIOL CHEM, V280, P16901, DOI 10.1074/jbc.M409048200; Nagae M, 2008, ACTA CRYSTALLOGR D, V64, P1138, DOI 10.1107/S0907444908028308; Nakajima K, 1997, P NATL ACAD SCI USA, V94, P8196, DOI 10.1073/pnas.94.15.8196; Nakano Y, 2007, J BIOL CHEM, V282, P20544, DOI 10.1074/jbc.M702300200; Nogi T, 2006, EMBO J, V25, P3675, DOI 10.1038/sj.emboj.7601240; Nogi T, 2008, PROTEIN SCI, V17, P2120, DOI 10.1110/ps.038299.108; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Sadler JE, 2009, J THROMB HAEMOST, V7, P24, DOI 10.1111/j.1538-7836.2009.03375.x; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Tabata S, 2010, J PROTEOMICS, V73, P1777, DOI 10.1016/j.jprot.2010.05.012; Takagi Junichi, 2008, P57, DOI 10.1007/978-0-387-76761-1_5; Tan KM, 2008, J MOL BIOL, V381, P1213, DOI 10.1016/j.jmb.2008.06.045; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Uchida T, 2009, J NEUROSCI, V29, P10653, DOI 10.1523/JNEUROSCI.0345-09.2009; Utsunomiya-Tate N, 2000, P NATL ACAD SCI USA, V97, P9729, DOI 10.1073/pnas.160272497; Yasui N, 2007, P NATL ACAD SCI USA, V104, P9988, DOI 10.1073/pnas.0700438104; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010	39	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35247	35256		10.1074/jbc.M111.242719	http://dx.doi.org/10.1074/jbc.M111.242719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844191	Green Published, hybrid			2022-12-27	WOS:000295406300077
J	Benson, MA; Fu, ZJ; Kim, JJP; Baldwin, MR				Benson, Marc A.; Fu, Zhuji; Kim, Jung-Ja P.; Baldwin, Michael R.			Unique Ganglioside Recognition Strategies for Clostridial Neurotoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-CC-DOMAIN; BOTULINUM NEUROTOXIN; TETANUS TOXIN; CRYSTAL-STRUCTURE; MEMBRANE-FUSION; SEROTYPE-F; BINDING; RECEPTOR; CRYSTALLOGRAPHY; SV2	Botulinum neurotoxins (BoNTs) and tetanus neurotoxin are the causative agents of the paralytic diseases botulism and tetanus, respectively. The potency of the clostridial neurotoxins (CNTs) relies primarily on their highly specific binding to nerve terminals and cleavage of SNARE proteins. Although individual CNTs utilize distinct proteins for entry, they share common ganglioside co-receptors. Here, we report the crystal structure of the BoNT/F receptor-binding domain in complex with the sugar moiety of ganglioside GD1a. GD1a binds in a shallow groove formed by the conserved peptide motif E ... H ... SXWY ... G, with additional stabilizing interactions provided by two arginine residues. Comparative analysis of BoNT/F with other CNTs revealed several differences in the interactions of each toxin with ganglioside. Notably, exchange of BoNT/F His-1241 with the corresponding lysine residue of BoNT/E resulted in increased affinity for GD1a and conferred the ability to bind ganglioside GM1a. Conversely, BoNT/E was not able to bind GM1a, demonstrating a discrete mechanism of ganglioside recognition. These findings provide a structural basis for ganglioside binding among the CNTs and show that individual toxins utilize unique ganglioside recognition strategies.	[Benson, Marc A.; Baldwin, Michael R.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA; [Fu, Zhuji; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	University of Missouri System; University of Missouri Columbia; Medical College of Wisconsin	Baldwin, MR (corresponding author), Univ Missouri, Dept Mol Microbiol & Immunol, M618 Med Sci Bldg, Columbia, MO 65212 USA.	baldwinmr@missouri.edu		Benson, Marc/0000-0002-7189-1133	Consortium for Functional Glycomics [GM62116]; National Institutes of Health, NIAID [U54 AI057153]; NINDS [R00 NS061763]; Great Lakes Regional Center of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS061763] Funding Source: NIH RePORTER	Consortium for Functional Glycomics; National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Great Lakes Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The GD1a analog (compound Te303) utilized in this study was provided by Consortium for Functional Glycomics Grant GM62116. We thank the staff at Advanced Photon Source beamline SBC 19ID for excellent assistance in data collection and Dr. Joseph T. Barbieri for helpful suggestions during the preparation of this manuscript.; This work was supported, in whole or in part, by National Institutes of Health Grant U54 AI057153 from NIAID (to J.-J. P. K.) and Grant R00 NS061763 from NINDS (to M. R. B.). This work was also supported by grants from the Great Lakes Regional Center of Excellence.	Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baldwin MR, 2007, NAT STRUCT MOL BIOL, V14, P9, DOI 10.1038/nsmb0107-9; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen C, 2008, BIOCHEMISTRY-US, V47, P7179, DOI 10.1021/bi800640y; Chen C, 2009, J BIOL CHEM, V284, P26569, DOI 10.1074/jbc.M109.027391; Davletov B, 2005, TRENDS NEUROSCI, V28, P446, DOI 10.1016/j.tins.2005.06.001; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; Fotinou C, 2001, J BIOL CHEM, V276, P32274, DOI 10.1074/jbc.M103285200; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; Hatheway CL, 1995, CURR TOP MICROBIOL, V195, P55; Jahn R, 2002, CURR OPIN CELL BIOL, V14, P488, DOI 10.1016/S0955-0674(02)00356-3; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johnson EA, 1999, ANNU REV MICROBIOL, V53, P551, DOI 10.1146/annurev.micro.53.1.551; Johnson EA, 2001, TOXICON, V39, P1703, DOI 10.1016/S0041-0101(01)00157-X; KITAMURA M, 1980, BIOCHIM BIOPHYS ACTA, V628, P328, DOI 10.1016/0304-4165(80)90382-7; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Montecucco C, 2004, TRENDS MICROBIOL, V12, P442, DOI 10.1016/j.tim.2004.08.002; MONTECUCCO C, 1989, BIOCHEM J, V259, P47, DOI 10.1042/bj2590047; Nishiki T, 1996, FEBS LETT, V378, P253, DOI 10.1016/0014-5793(95)01471-3; OCHANDA JO, 1986, J BIOCHEM-TOKYO, V100, P27, DOI 10.1093/oxfordjournals.jbchem.a121702; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; Rummel A, 2009, J NEUROCHEM, V110, P1942, DOI 10.1111/j.1471-4159.2009.06298.x; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; SIMPSON LI, 1989, J PHARMACOL EXP THER, V251, P1223; SIMPSON LL, 1971, J NEUROCHEM, V18, P1341, DOI 10.1111/j.1471-4159.1971.tb00235.x; SIMPSON LL, 1971, J NEUROCHEM, V18, P1761, DOI 10.1111/j.1471-4159.1971.tb03751.x; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; VANHEYNINGEN W, 1961, J GEN MICROBIOL, V24, P107, DOI 10.1099/00221287-24-1-107; VANHEYNINGEN W, 1961, BRIT J EXP PATHOL, V42, P397; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yeh FL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001207	41	43	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34015	34022		10.1074/jbc.M111.272054	http://dx.doi.org/10.1074/jbc.M111.272054			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21849494	Green Published, hybrid			2022-12-27	WOS:000295159200034
J	Geng, YF; Hsu, JJ; Lu, JX; Ting, TC; Miyazaki, M; Demer, LL; Tintut, Y				Geng, Yifan; Hsu, Jeffrey J.; Lu, Jinxiu; Ting, Tabitha C.; Miyazaki, Makoto; Demer, Linda L.; Tintut, Yin			Role of Cellular Cholesterol Metabolism in Vascular Cell Calcification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CHRONIC KIDNEY-DISEASE; IN-VITRO; MATRIX VESICLES; DEFICIENT MICE; RENAL-FAILURE; LDL RECEPTOR; MECHANISMS; ATHEROSCLEROSIS; PHOSPHATE	Vascular calcification impairs vessel compliance and increases the risk of cardiovascular events. We found previously that liver X receptor agonists, which regulate intracellular cholesterol homeostasis, augment PKA agonist-or high phosphate-induced osteogenic differentiation of vascular smooth muscle cells. Because cholesterol is an integral component of the matrix vesicles that nucleate calcium mineral, we examined the role of cellular cholesterol metabolism in vascular cell mineralization. The results showed that vascular smooth muscle cells isolated from LDL receptor null (Ldlr(-/-))mice, which have impaired cholesterol uptake, had lower levels of intracellular cholesterol and less osteogenic differentiation, as indicated by alkaline phosphatase activity and matrix mineralization, compared with WT cells. PKA activation with forskolin acutely induced genes that promote cholesterol uptake (LDL receptor) and biosynthesis (HMG-CoA reductase). In WT cells, inhibition of cholesterol uptake by lipoprotein-deficient serum attenuated forskolin-induced matrix mineralization, which was partially reversed by the addition of cell-permeable cholesterol. Prolonged activation of both uptake and biosynthesis pathways by cotreatment with a liver X receptor agonist further augmented forskolin-induced matrix mineralization. Inhibition of either cholesterol uptake, using Ldlr(-/-) cells, or of cholesterol biosynthesis, using mevastatin-treated WT cells, failed to inhibit matrix mineralization due to up-regulation of the respective compensatory pathway. Inhibition of both pathways simultaneously using mevastatintreated Ldlr(-/-) cells did inhibit forskolin-induced matrix mineralization. Altogether, the results suggest that up-regulation of cholesterol metabolism is essential for matrix mineralization by vascular cells.	[Tintut, Yin] Univ Calif Los Angeles, Ctr Hlth Sci, Dept Med, Los Angeles, CA 90095 USA; [Lu, Jinxiu; Demer, Linda L.] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Demer, Linda L.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Ting, Tabitha C.; Miyazaki, Makoto] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Tintut, Y (corresponding author), Univ Calif Los Angeles, Ctr Hlth Sci, Dept Med, A2-237,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	ytintut@mednet.ucla.edu	Hsu, Jeff/AAW-3115-2020; Demer, Linda L/I-5770-2013	Hsu, Jeff/0000-0002-9971-5916; Demer, Linda L/0000-0002-9618-6895; Ting, Tabitha/0000-0001-5206-9243	National Institutes of Health [DK081346, DK081346-S1, HL081202]; NIGMS Initiative for Maximizing Student Development [R25GM083333]; American Heart Association [10BGIA458005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081202, R21HL109628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK076009, R01DK081346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM083333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS Initiative for Maximizing Student Development; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK081346 and DK081346-S1 (to Y. T.) and HL081202 (to L. L. D.) and NIGMS Initiative for Maximizing Student Development Grant R25GM083333 (to T. C. T.). This work was also supported by American Heart Association Grant 10BGIA458005 (to M. M.).	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; BROWN MS, 1984, SCI AM, V251, P58, DOI 10.1038/scientificamerican1184-58; Chen NX, 2008, J BONE MINER RES, V23, P1798, DOI 10.1359/JBMR.080604; Giachelli CM, 2009, KIDNEY INT, V75, P890, DOI 10.1038/ki.2008.644; Hsu JJ, 2008, CURR DRUG TARGETS, V9, P224; Hsu JJ, 2009, FEBS LETT, V583, P1344, DOI 10.1016/j.febslet.2009.03.039; Huang MS, 2008, BIOCHEM BIOPH RES CO, V374, P553, DOI 10.1016/j.bbrc.2008.07.062; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kizu A, 2004, J CELL BIOCHEM, V93, P1011, DOI 10.1002/jcb.20207; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Neven E, 2011, CIRC RES, V108, P249, DOI 10.1161/CIRCRESAHA.110.225904; Neves KR, 2007, KIDNEY INT, V71, P1262, DOI 10.1038/sj.ki.5002241; PERESS NS, 1974, CALC TISS RES, V14, P275, DOI 10.1007/BF02060301; Rattazzi M, 2005, ARTERIOSCL THROM VAS, V25, P1420, DOI 10.1161/01.ATV.0000166600.58468.1b; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Sage AP, 2011, KIDNEY INT, V79, P414, DOI 10.1038/ki.2010.390; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Sawada N, 2007, BONE, V41, P52, DOI 10.1016/j.bone.2007.02.030; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Ting TC, 2011, J BIOL CHEM, V286, P23938, DOI 10.1074/jbc.M111.237065; Tintut Y, 1998, J BIOL CHEM, V273, P7547, DOI 10.1074/jbc.273.13.7547; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yin TT, 2000, CIRCULATION, V102, P2636, DOI 10.1161/01.cir.102.21.2636; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	28	26	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33701	33706		10.1074/jbc.M111.269639	http://dx.doi.org/10.1074/jbc.M111.269639			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21835914	Green Published, hybrid			2022-12-27	WOS:000294968800086
J	Sagi, SA; Lessard, CB; Winden, KD; Maruyama, H; Koo, JC; Weggen, S; Kukar, TL; Golde, TE; Koo, EH				Sagi, Sarah A.; Lessard, Christian B.; Winden, Kellen D.; Maruyama, Hiroko; Koo, Jeremy C.; Weggen, Sascha; Kukar, Thomas L.; Golde, Todd E.; Koo, Edward H.			Substrate Sequence Influences gamma-Secretase Modulator Activity, Role of the Transmembrane Domain of the Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BETA-LIKE PEPTIDE; ALZHEIMERS-DISEASE; A-BETA; INTRAMEMBRANE PROTEOLYSIS; INTRACELLULAR DOMAIN; TRANSGENIC MICE; MOUSE MODEL; A-BETA-42; GENERATION	A subset of non-steroidal anti-inflammatory drugs modulates the gamma cleavage site in the amyloid precursor protein (APP) to selectively reduce production of A beta 42. It is unclear precisely how these gamma-secretase modulators (GSMs) act to preferentially spare A beta 40 production as well as Notch processing and signaling. In an effort to determine the substrate requirements in NSAID/GSM activity, we determined the effects of sulindac sulfide and flurbiprofen on gamma-cleavage of artificial constructs containing several gamma-secretase substrates. Using FLAG-tagged constructs that expressed extracellularly truncated APP, Notch-1, or CD44, we found that these substrates have different sensitivities to sulindac sulfide. gamma-Secretase cleavage of APP was altered by sulindac sulfide, but CD44 and Notch-1 were either insensitive or only minimally altered by this compound. Using chimeric APP constructs, we observed that the transmembrane domain (TMD) of APP played a pivotal role in determining drug sensitivity. Substituting the APP TMD with that of APLP2 retained the sensitivity to gamma-cleavage modulation, but replacing TMDs from Notch-1 or ErbB4 rendered the resultant molecules insensitive to drug treatment. Specifically, the GXXXG motif within APP appeared to be critical to GSM activity. Consequently, the modulatory effects on gamma-cleavage appears to be substrate-dependent. We hypothesize that the substrate present in the gamma-secretase complex influences the conformation of the complex so that the binding site of GSMs is either stabilized or less favorable to influence the cleavage of the respective substrates.	[Sagi, Sarah A.; Lessard, Christian B.; Winden, Kellen D.; Maruyama, Hiroko; Koo, Jeremy C.; Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Weggen, Sascha] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Kukar, Thomas L.] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Golde, Todd E.] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Coll Med, Gainesville, FL 32610 USA; [Golde, Todd E.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA	University of California System; University of California San Diego; Heinrich Heine University Dusseldorf; Emory University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Koo, EH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	edkoo@ucsd.edu	Kukar, Thomas/AAW-2612-2021	Kukar, Thomas/0000-0002-3750-6262	National Institutes of Health [AG 20206, AG005131-22]; American Federation for Aging Research/Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [R00AG032362, P50AG005131, P01AG020206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research/Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG 20206 (to T. E. G. and E. H. K.) and AG005131-22 (to S. A. S.). This work was also supported by an American Federation for Aging Research/Ellison Medical Foundation fellowship (to S. A. S.).	Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Beher D, 2008, CURR TOP MED CHEM, V8, P34, DOI 10.2174/156802608783334051; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hahn S, 2011, J NEUROCHEM, V116, P385, DOI 10.1111/j.1471-4159.2010.07118.x; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Jantzen PT, 2002, J NEUROSCI, V22, P2246, DOI 10.1523/JNEUROSCI.22-06-02246.2002; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kukar TL, 2011, J BIOL CHEM, V286, P39804, DOI 10.1074/jbc.M111.274696; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Lichtenthaler SF, 1997, BIOCHEMISTRY-US, V36, P15396, DOI 10.1021/bi971071m; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Lim GP, 2001, NEUROBIOL AGING, V22, P983, DOI 10.1016/S0197-4580(01)00299-8; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; May P, 2002, J BIOL CHEM, V277, P18736, DOI 10.1074/jbc.M201979200; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Murakami D, 2003, ONCOGENE, V22, P1511, DOI 10.1038/sj.onc.1206298; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Oehlrich D, 2011, J MED CHEM, V54, P669, DOI 10.1021/jm101168r; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Sagi SA, 2003, J BIOL CHEM, V278, P31825, DOI 10.1074/jbc.M303588200; Szekely CA, 2004, NEUROEPIDEMIOLOGY, V23, P159, DOI 10.1159/000078501; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Tesco G, 2005, J NEUROCHEM, V95, P446, DOI 10.1111/j.1471-4159.2005.03381.x; Tomita T., 2010, 40 ANN M SOC NEUR SA; Townsend KP, 2005, FASEB J, V19, P1592, DOI 10.1096/fj.04-3620rev; Uemura K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1129; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Uljon SN, 2000, METH MOL B, V146, P439, DOI 10.1385/1-59259-045-4:439; van Groen T, 2005, BRAIN RES REV, V48, P370, DOI 10.1016/j.brainresrev.2004.12.026; Vidal GA, 2005, J BIOL CHEM, V280, P19777, DOI 10.1074/jbc.M412457200; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Zettl H, 2010, TRENDS PHARMACOL SCI, V31, P402, DOI 10.1016/j.tips.2010.05.007; Zhang JM, 2002, J BIOL CHEM, V277, P15069, DOI 10.1074/jbc.M105375200	47	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39794	39803		10.1074/jbc.M111.277228	http://dx.doi.org/10.1074/jbc.M111.277228			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21868380	Green Published, hybrid			2022-12-27	WOS:000296925700013
J	Battchikova, N; Wei, LZ; Du, LY; Bersanini, L; Aro, EM; Ma, WM				Battchikova, Natalia; Wei, Lanzhen; Du, Lingyu; Bersanini, Luca; Aro, Eva-Mari; Ma, Weimin			Identification of Novel Ssl0352 Protein (NdhS), Essential for Efficient Operation of Cyclic Electron Transport around Photosystem I, in NADPH:plastoquinone Oxidoreductase (NDH-1) Complexes of Synechocystis sp. PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDINE-NUCLEOTIDE DEHYDROGENASE; DISTINCT NAD(P)H DEHYDROGENASES; RESPIRATORY COMPLEX; NADPH DEHYDROGENASE; INTERSYSTEM CHAIN; THERMOSYNECHOCOCCUS-ELONGATUS; SUBUNIT COMPOSITION; SP PCC-6803; CYANOBACTERIUM; LOCALIZATION	Cyanobacterial NADPH:plastoquinone oxidoreductase, or type I NAD(P)H dehydrogenase, or the NDH-1 complex is involved in plastoquinone reduction and cyclic electron transfer (CET) around photosystem I. CET, in turn, produces extra ATP for cell metabolism particularly under stressful conditions. Despite significant achievements in the study of cyanobacterial NDH-1 complexes during the past few years, the entire subunit composition still remains elusive. To identify missing subunits, we screened a transposon-tagged library of Synechocystis 6803 cells grown under high light. Two NDH-1-mediated CET (NDH-CET)-defective mutants were tagged in the same ssl0352 gene encoding a short unknown protein. To clarify the function of Ssl0352, the ssl0352 deletion mutant and another mutant with Ssl0352 fused to yellow fluorescent protein (YFP) and the His(6) tag were constructed. Immunoblotting, mass spectrometry, and confocal microscopy analyses revealed that the Ssl0352 protein resides in the thylakoid membrane and associates with the NDH-1L and NDH-1M complexes. We conclude that Ssl0352 is a novel subunit of cyanobacterial NDH-1 complexes and designate it NdhS. Deletion of the ssl0352 gene considerably impaired the NDH-CET activity and also retarded cell growth under high light conditions, indicating that NdhS is essential for efficient operation of NDH-CET. However, the assembly of the NDH-1L and NDH-1M complexes and their content in the cells were not affected in the mutant. NdhS contains a Src homology 3-like domain and might be involved in interaction of the NDH-1 complex with an electron donor.	[Battchikova, Natalia; Bersanini, Luca; Aro, Eva-Mari] Univ Turku, Dept Biochem & Food Chem, FI-20520 Turku, Finland; [Wei, Lanzhen; Du, Lingyu; Ma, Weimin] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China	University of Turku; Shanghai Normal University	Aro, EM (corresponding author), Univ Turku, Dept Biochem & Food Chem, Tykistokatu 6A,Biocity 6th Floor, FI-20520 Turku, Finland.	evaaro@utu.fi; wma@shnu.edu.cn	Aro, Eva-Mari/Q-8664-2017; Ma, Weimin/A-8158-2015	Aro, Eva-Mari/0000-0002-2922-1435; Ma, Weimin/0000-0003-4964-415X	Academy of Finland [118637]; European Union [212508]; HARVEST Marie Curie Research Training Network [PITN-GA-2009-238017]; National Basic Research Program of China [2009CB118500]; National Natural Science Foundation of China [30770175]; Chinese Ministry of Education [209045]	Academy of Finland(Academy of Finland); European Union(European Commission); HARVEST Marie Curie Research Training Network; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China)	This work was supported in part by Academy of Finland Project 118637, European Union Project Solar-H2 (FP7 Contract 212508), HARVEST Marie Curie Research Training Network Grant PITN-GA-2009-238017, National Basic Research Program of China Grant 2009CB118500, National Natural Science Foundation of China Grant 30770175, and Key Project of Chinese Ministry of Education Grant 209045.	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Arteni AA, 2006, BBA-BIOENERGETICS, V1757, P1469, DOI 10.1016/j.bbabio.2006.05.042; ASADA K, 1993, PLANT CELL PHYSIOL, V34, P39; Battchikova N, 2005, J BIOL CHEM, V280, P2587, DOI 10.1074/jbc.M410914200; Battchikova N, 2007, PHYSIOL PLANTARUM, V131, P22, DOI 10.1111/j.1399-3054.2007.00929.x; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Battchikova N, 2010, J PROTEOME RES, V9, P5896, DOI 10.1021/pr100651w; Bernat G, 2011, J BACTERIOL, V193, P292, DOI 10.1128/JB.00984-10; Birungi M, 2010, BBA-BIOENERGETICS, V1797, P1681, DOI 10.1016/j.bbabio.2010.06.004; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; DEMENDEZ I, 1994, J BIOL CHEM, V269, P16326; Endo T, 1999, FEBS LETT, V457, P5, DOI 10.1016/S0014-5793(99)00989-8; FRIEDRICH T, 1995, FEBS LETT, V367, P107, DOI 10.1016/0014-5793(95)00548-N; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; GOMBOS Z, 1994, P NATL ACAD SCI USA, V91, P8787, DOI 10.1073/pnas.91.19.8787; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Ifuku K, 2011, PLANT CELL PHYSIOL, V52, P1560, DOI 10.1093/pcp/pcr098; Jansen T, 2002, J PLANT PHYSIOL, V159, P1205, DOI 10.1078/0176-1617-00829; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Kishan KVR, 2005, CURR PROTEIN PEPT SC, V6, P143, DOI 10.2174/1389203053545444; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kugler M, 1997, PHOTOSYNTH RES, V53, P35, DOI 10.1023/A:1005882406718; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ma W., 2009, FRONT BIOL CHINA, V4, P137, DOI [10.1007/s11515-009-0005-x, DOI 10.1007/S11515-009-0005-X]; Ma WM, 2008, PLANT PHYSIOL BIOCH, V46, P775, DOI 10.1016/j.plaphy.2008.04.019; Ma WM, 2006, PLANT CELL PHYSIOL, V47, P1432, DOI 10.1093/pcp/pcl008; Ma WM, 2005, PHYSIOL PLANTARUM, V125, P135, DOI 10.1111/j.1399-3054.2005.00555.x; Mallick P, 2010, NAT BIOTECHNOL, V28, P695, DOI 10.1038/nbt.1658; Mano J, 1995, PLANT CELL PHYSIOL, V36, P1589; Matsuo M, 1998, PLANT CELL PHYSIOL, V39, P263, DOI 10.1093/oxfordjournals.pcp.a029366; Maul JE, 2002, PLANT CELL, V14, P2659, DOI 10.1105/tpc.006155; MI HL, 1992, PLANT CELL PHYSIOL, V33, P1233; MI HL, 1995, PLANT CELL PHYSIOL, V36, P661; Mi HL, 2001, PHOTOSYNTH RES, V70, P167, DOI 10.1023/A:1017946524199; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Nowaczyk MM, 2011, BIOCHEMISTRY-US, V50, P1121, DOI 10.1021/bi102044b; OGAWA T, 1991, P NATL ACAD SCI USA, V88, P4275, DOI 10.1073/pnas.88.10.4275; Ogawa T, 2007, PHOTOSYNTH RES, V93, P69, DOI 10.1007/s11120-006-9128-y; Ohkawa H, 2000, J BIOL CHEM, V275, P31630, DOI 10.1074/jbc.M003706200; Ohkawa H, 2002, FUNCT PLANT BIOL, V29, P195, DOI 10.1071/PP01180; Ohkawa H, 2001, J BACTERIOL, V183, P4938, DOI 10.1128/JB.183.16.4938-4939.2001; Ozaki H, 2007, PLANT CELL PHYSIOL, V48, P451, DOI 10.1093/pcp/pcm015; Peng LW, 2011, BBA-BIOENERGETICS, V1807, P945, DOI 10.1016/j.bbabio.2010.10.015; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Prommeenate P, 2004, J BIOL CHEM, V279, P28165, DOI 10.1074/jbc.M401107200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Sirpio S, 2009, J BIOL CHEM, V284, P905, DOI 10.1074/jbc.M805404200; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WILLIAMS JGK, 1983, GENE, V24, P37, DOI 10.1016/0378-1119(83)90129-4; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Xu M, 2008, PLANT CELL PHYSIOL, V49, P994, DOI 10.1093/pcp/pcn074; Yamamoto H, 2011, PLANT CELL, V23, P1480, DOI 10.1105/tpc.110.080291; Zhang PP, 2005, BIOCHEM J, V390, P513, DOI 10.1042/BJ20050390; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526	60	66	70	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36992	37001		10.1074/jbc.M111.263780	http://dx.doi.org/10.1074/jbc.M111.263780			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880717	Green Published, hybrid			2022-12-27	WOS:000296538300077
J	Drosatos, K; Drosatos-Tampakaki, Z; Khan, R; Homma, S; Schulze, PC; Zannis, VI; Goldberg, IJ				Drosatos, Konstantinos; Drosatos-Tampakaki, Zoi; Khan, Raffay; Homma, Shunichi; Schulze, P. Christian; Zannis, Vassilis I.; Goldberg, Ira J.			Inhibition of c-Jun-N-terminal Kinase Increases Cardiac Peroxisome Proliferator-activated Receptor alpha Expression and Fatty Acid Oxidation and Prevents Lipopolysaccharide-induced Heart Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR HORMONE-RECEPTORS; HIGH-DOSE METHYLPREDNISOLONE; LIPOPROTEIN-LIPASE ACTIVITY; TUMOR-NECROSIS-FACTOR; SEVERE SEPSIS; GENE-EXPRESSION; MESSENGER-RNA; RAT-HEART; BACTERIAL LIPOPOLYSACCHARIDE; MITOCHONDRIAL DYSFUNCTION	Septic shock results from bacterial infection and is associated with multi-organ failure, high mortality, and cardiac dysfunction. Sepsis causes both myocardial inflammation and energy depletion. We hypothesized that reduced cardiac energy production is a primary cause of ventricular dysfunction in sepsis. The JNK pathway is activated in sepsis and has also been implicated in impaired fatty acid oxidation in several tissues. Therefore, we tested whether JNK activation inhibits cardiac fatty acid oxidation and whether blocking JNK would restore fatty acid oxidation during LPS treatment. LPS treatment of C57BL/6 mice and adenovirus-mediated activation of the JNK pathway in cardiomyocytes inhibited peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation. Surprisingly, none of the adaptive responses that have been described in other types of heart failure, such as increased glucose utilization, reduced alpha MHC:beta MHC ratio or induction of certain microRNAs, occurred in LPS-treated mice. Treatment of C57BL/6 mice with a general JNK inhibitor (SP600125) increased fatty acid oxidation in mice and a cardiomyocyte-derived cell line. JNK inhibition also prevented LPS-mediated reduction in fatty acid oxidation and cardiac dysfunction. Inflammation was not alleviated in LPS-treated mice that received the JNK inhibitor. We conclude that activation of JNK signaling reduces fatty acid oxidation and prevents the peroxisome proliferator-activated receptor alpha down-regulation that occurs with LPS.	[Goldberg, Ira J.] Columbia Univ, Dept Med, Coll Phys & Surg, Div Prevent Med & Nutr, New York, NY 10032 USA; [Homma, Shunichi; Schulze, P. Christian] Columbia Univ, Div Cardiol, Coll Phys & Surg, New York, NY 10032 USA; [Zannis, Vassilis I.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med, Boston, MA 02118 USA; [Zannis, Vassilis I.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Biochem, Boston, MA 02118 USA	Columbia University; Columbia University; Boston University; Boston University	Goldberg, IJ (corresponding author), Columbia Univ, Dept Med, Coll Phys & Surg, Div Prevent Med & Nutr, 630 W 168th St, New York, NY 10032 USA.	ijg3@columbia.edu	Schulze, Christian/AGJ-7744-2022; Drosatos, Konstantinos/H-9153-2013	Schulze, Christian/0000-0001-9442-7141; Drosatos, Konstantinos/0000-0003-0903-834X; Zannis, Vassilis/0000-0002-1295-7155	National Heart, Lung, and Blood Institute [HL45095, 73029, HL48739, T32 HL007343]; American Heart Association [10POST4440032]; American Diabetes Association [ADA 07-07-MN-22]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL007343, R01HL048739, R37HL045095, R01HL045095, T32HL007343, R01HL073029] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Heart, Lung, and Blood Institute Grants HL45095 and 73029 (to I. J. G.), HL48739 (V. I. Z.), and T32 HL007343 (to R. K.). This work was also supported by American Heart Association Postdoctoral Grant 10POST4440032 (to K. D.), by an American Diabetes Association mentored postdoctoral grant ADA 07-07-MN-22 (to I. J. G. and K. D.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7; ASTIZ M, 1988, CIRC SHOCK, V26, P311; BAGBY GJ, 1980, AM J PHYSIOL, V238, pH325, DOI 10.1152/ajpheart.1980.238.3.H325; BALLARD FB, 1960, J CLIN INVEST, V39, P717, DOI 10.1172/JCI104088; BISHOP SP, 1970, AM J PHYSIOL, V218, P153, DOI 10.1152/ajplegacy.1970.218.1.153; BOLUYT MO, 1994, CIRC RES, V75, P23, DOI 10.1161/01.RES.75.1.23; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; BRONSVELD W, 1985, CARDIOVASC RES, V19, P455, DOI 10.1093/cvr/19.8.455; Carlson DL, 2005, CRIT CARE MED, V33, P1021, DOI 10.1097/01.CCM.0000163398.79679.66; Ceylan-Isik AF, 2010, J MOL CELL CARDIOL, V48, P367, DOI 10.1016/j.yjmcc.2009.11.003; Chang L, 2003, EUR J PHARMACOL, V473, P171, DOI 10.1016/S0014-2999(03)01972-1; Chen HW, 2003, SHOCK, V20, P274, DOI 10.1097/00024382-200309000-00013; CHRISTE ME, 1994, J MOL CELL CARDIOL, V26, P1371, DOI 10.1006/jmcc.1994.1155; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DREYER C, 1993, BIOL CELL, V77, P67, DOI 10.1016/S0248-4900(05)80176-5; Drosatos K, 2007, J BIOL CHEM, V282, P19556, DOI 10.1074/jbc.M700986200; Duncan DJ, 2010, CELL CALCIUM, V47, P378, DOI 10.1016/j.ceca.2010.02.002; Escames G, 2007, FEBS J, V274, P2135, DOI 10.1111/j.1742-4658.2007.05755.x; Fairchild KD, 2011, AM J PHYSIOL-REG I, V300, pR330, DOI 10.1152/ajpregu.00487.2010; Fallach R, 2010, J MOL CELL CARDIOL, V48, P1236, DOI 10.1016/j.yjmcc.2010.02.020; Feingold K, 2004, AM J PHYSIOL-ENDOC M, V286, pE201, DOI 10.1152/ajpendo.00205.2003; Feingold KR, 2008, J LIPID RES, V49, P2179, DOI 10.1194/jlr.M800233-JLR200; Feingold KR, 2009, J LIPID RES, V50, P2055, DOI 10.1194/jlr.M800655-JLR200; FEINGOLD KR, 1994, ARTERIOSCLER THROMB, V14, P1866, DOI 10.1161/01.ATV.14.11.1866; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Fruchart JC, 2009, ATHEROSCLEROSIS, V205, P1, DOI 10.1016/j.atherosclerosis.2009.03.008; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; HEARSE DJ, 1979, AM J CARDIOL, V44, P1115, DOI 10.1016/0002-9149(79)90177-2; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOTCHKISS RS, 1991, AM J PHYSIOL, V260, pC50, DOI 10.1152/ajpcell.1991.260.1.C50; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Kapelko VI, 1996, MOL CELL BIOCHEM, V164, P131; Karbowska J, 2003, CELL MOL BIOL LETT, V8, P49; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kim YM, 2005, CIRC RES, V97, P629, DOI 10.1161/01.RES.0000183735.09871.61; Knuefermann P, 2002, CIRCULATION, V106, P2608, DOI 10.1161/01.CIR.0000038110.69369.4C; Levy B, 2003, INTENS CARE MED, V29, P292, DOI 10.1007/s00134-002-1611-0; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; LING PR, 1994, METABOLISM, V43, P279, DOI 10.1016/0026-0495(94)90093-0; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Lu B, 2010, BIOCHEM BIOPH RES CO, V391, P1737, DOI 10.1016/j.bbrc.2009.12.145; LUCE JM, 1988, AM REV RESPIR DIS, V138, P62, DOI 10.1164/ajrccm/138.1.62; Maitra U, 2009, MOL IMMUNOL, V47, P420, DOI 10.1016/j.molimm.2009.08.023; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Memon RA, 1999, BBA-MOL CELL BIOL L, V1440, P118, DOI 10.1016/S1388-1981(99)00120-1; Memon RA, 1998, AM J PHYSIOL-ENDOC M, V275, pE64, DOI 10.1152/ajpendo.1998.275.1.E64; MERCADIER JJ, 1981, CIRC RES, V49, P525, DOI 10.1161/01.RES.49.2.525; Neglia D, 2007, AM J PHYSIOL-HEART C, V293, pH3270, DOI 10.1152/ajpheart.00887.2007; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; NG WA, 1991, CIRC RES, V68, P1742, DOI 10.1161/01.RES.68.6.1742; OHLSSON K, 1990, NATURE, V348, P550, DOI 10.1038/348550a0; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; PASQUE MK, 1983, ARCH SURG-CHICAGO, V118, P1437; Patel D, 2000, J CRIT CARE, V15, P64, DOI 10.1053/jcrc.2000.7902; Peng TQ, 2009, CARDIOVASC RES, V81, P733, DOI 10.1093/cvr/cvn336; Ramana KV, 2006, CIRCULATION, V114, P1838, DOI 10.1161/CIRCULATIONAHA.106.630830; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Reinhart K, 2001, CRIT CARE MED, V29, pS121, DOI 10.1097/00003246-200107001-00037; Rozo AV, 2008, DIABETOLOGIA, V51, P1493, DOI 10.1007/s00125-008-1036-6; Ruiz-Lozano P, 1998, DEVELOPMENT, V125, P533; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Sanghera JS, 1996, J IMMUNOL, V156, P4457; Schilling J, 2011, CIRC-HEART FAIL, V4, P474, DOI 10.1161/CIRCHEARTFAILURE.110.959833; Schwartz Andrei, 2002, Eur J Intern Med, V13, P434, DOI 10.1016/S0953-6205(02)00130-9; Sihag S, 2009, J MOL CELL CARDIOL, V46, P201, DOI 10.1016/j.yjmcc.2008.10.025; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Supinski GS, 2009, AM J PHYSIOL-REG I, V297, pR1095, DOI 10.1152/ajpregu.90902.2008; Supinski GS, 2006, AM J RESP CRIT CARE, V173, P1240, DOI 10.1164/rccm.200410-1346OC; TAEGTMEYER H, 1988, HYPERTENSION, V11, P416, DOI 10.1161/01.HYP.11.5.416; TAKEYAMA D, 1995, CARDIOVASC RES, V29, P763, DOI 10.1016/S0008-6363(96)88610-X; Takuma S, 2001, AM J PHYSIOL-HEART C, V280, pH2364, DOI 10.1152/ajpheart.2001.280.5.H2364; Tang CS, 1996, AM J PHYSIOL-REG I, V270, pR254, DOI 10.1152/ajpregu.1996.270.1.R254; Tessier JP, 2003, CARDIOVASC RES, V60, P119, DOI 10.1016/S0008-6363(03)00320-1; Tsuiki H, 2003, CANCER RES, V63, P250; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Tuunanen H, 2006, CIRCULATION, V114, P2130, DOI 10.1161/CIRCULATIONAHA.106.645184; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wang CY, 2002, CIRCULATION, V105, P1609, DOI 10.1161/01.CIR.0000013022.11250.30; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Yang R, 2007, J BIOL CHEM, V282, P22765, DOI 10.1074/jbc.M700790200; Yu XX, 2008, AM J PHYSIOL-ENDOC M, V295, pE436, DOI 10.1152/ajpendo.00629.2007	90	74	75	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36331	36339		10.1074/jbc.M111.272146	http://dx.doi.org/10.1074/jbc.M111.272146			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21873422	hybrid, Green Published			2022-12-27	WOS:000296538300018
J	Gao, LL; Coope, H; Grant, S; Ma, A; Ley, SC; Harhaj, EW				Gao, Linlin; Coope, Helen; Grant, Susan; Ma, Averil; Ley, Steven C.; Harhaj, Edward W.			ABIN1 Protein Cooperates with TAX1BP1 and A20 Proteins to Inhibit Antiviral Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR CYLD; TOLL-LIKE RECEPTOR; RIG-I; INNATE IMMUNITY; REGULATORY FACTOR-3; NEGATIVE REGULATOR; INTERFERON; RNA; ACTIVATION	Upon virus infection, the innate immune response provides the first line of protection and rapidly induces type I interferons (IFN alpha/beta), which mediate potent antiviral effects. To maintain homeostasis and prevent autoimmunity, IFN production is tightly regulated; however, the mechanisms of negative regulation are poorly understood. Herein, we demonstrate that the A20 binding inhibitor of NF-kappa B 1 (ABIN1) is a novel negative regulator of antiviral signaling. Overexpression of ABIN1 inhibited IFN-beta promoter activation in response to virus infection or poly(I:C) transfection, whereas siRNA-mediated knockdown of ABIN1 enhanced IFN-beta production upon virus infection. ABIN1 interacted with the A20 regulatory molecule TAX1BP1 and was essential for the recruitment of TAX1BP1 and A20 to the noncanonical I kappa B kinases TBK1 and IKKi in response to poly(I:C) transfection. ABIN1 and TAX1BP1 together disrupted the interactions between the E3 ubiquitin ligase TRAF3 and TBK1/IKKi to attenuate lysine 63-linked polyubiquitination of TBK1/IKKi. Finally, an intact ubiquitin binding domain of ABIN1 was essential for ABIN1 to interact with TBK1/IKKi and inhibit IFN-beta production upon poly(I:C) transfection or virus infection. Together, these results suggest that ABIN1 requires its ubiquitin binding domain and cooperates with TAX1BP1 and A20 to restrict antiviral signaling.	[Gao, Linlin; Harhaj, Edward W.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Microbiol & Immunol,Grad Program Canc Biol, Miami, FL 33136 USA; [Coope, Helen; Grant, Susan; Ley, Steven C.] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England; [Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of Miami; MRC National Institute for Medical Research; University of California System; University of California San Francisco	Harhaj, EW (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Microbiol & Immunol,Grad Program Canc Biol, 1550 NW 10 Ave, Miami, FL 33136 USA.	eharhaj@med.miami.edu	Gao, Linlin/S-8070-2019	Gao, Linlin/0000-0001-7332-3538	National Institutes of Health [PO1CA128115, RO1GM083143]; United Kingdom Medical Research Council; Association for International Cancer Research [AICR 03-297]; NATIONAL CANCER INSTITUTE [P01CA128115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083143] Funding Source: NIH RePORTER; Medical Research Council [MC_U117584209, U117532003] Funding Source: researchfish; MRC [MC_U117584209] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Association for International Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1CA128115 and RO1GM083143 (to E.W.H.).; Supported by the United Kingdom Medical Research Council.; Supported by Association for International Cancer Research Grant AICR 03-297.	Balachandran S, 2007, J IMMUNOL, V178, P2429, DOI 10.4049/jimmunol.178.4.2429; Barral PM, 2009, PHARMACOL THERAPEUT, V124, P219, DOI 10.1016/j.pharmthera.2009.06.012; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Kaisho T, 2009, INT IMMUNOL, V21, P313, DOI 10.1093/intimm/dxp016; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Nanda SK, 2011, J EXP MED, V208, P1215, DOI 10.1084/jem.20102177; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Parvatiyar K, 2011, MICROBES INFECT, V13, P209, DOI 10.1016/j.micinf.2010.11.003; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shembade N, 2007, J VIROL, V81, P13735, DOI 10.1128/JVI.01790-07; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2011, NAT IMMUNOL, V12, P834, DOI 10.1038/ni.2066; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Yanai H, 2009, CURR OPIN IMMUNOL, V21, P17, DOI 10.1016/j.coi.2009.01.005; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200	44	58	59	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36592	36602		10.1074/jbc.M111.283762	http://dx.doi.org/10.1074/jbc.M111.283762			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21885437	Green Published, hybrid			2022-12-27	WOS:000296538300043
J	Kurita, S; Ogita, H; Takai, Y				Kurita, Souichi; Ogita, Hisakazu; Takai, Yoshimi			Cooperative Role of Nectin-Nectin and Nectin-Afadin Interactions in Formation of Nectin-based Cell-Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; SMALL G-PROTEINS; ADHERENS JUNCTIONS; GROWTH-FACTOR; E-CADHERIN; CONTACT INHIBITION; TRANS-INTERACTIONS; LEADING EDGES; NIH3T3 CELLS; ACTIVATION	The nectin cell adhesion molecules interact in trans with each other through their extracellular regions and with afadin through their cytoplasmic tails, forming adherens junctions in cooperation with cadherins. In a single cell, Necl-5 (nectin-like molecule-5) localizes at the leading edge and regulates directional cell movement in response to a chemoattractant. In such a single cell, afadin also localizes at the leading edge without interacting with nectins or Necl-5. It remains unknown how the nectin-nectin and nectin-afadin interactions are initiated when moving cells contact each other to initiate the formation of adherens junctions. We show here that the Necl-5-nectin interaction induced by cell-cell contact enhances the nectin-afadin interaction. This interaction then enhances the nectin-nectin interaction, which further enhances the nectin-afadin interaction in a positive feedback manner. Thus, the Necl-5-nectin, nectin-nectin, and nectin-afadin interactions cooperatively increase the clustering of the nectin-afadin complex at the cell-cell contact sites, promoting the formation of the nectin-based cell-cell adhesion.	[Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan	Kobe University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Ogita, Hisakazu/AAE-4416-2020	Ogita, Hisakazu/0000-0001-6750-1668	Global COE Program "Global Center for Education and Research in Integrative Membrane Biology"; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Core Research for Evolutional Science and Technology of the Japanese Science and Technology Agency; Grants-in-Aid for Scientific Research [23590335] Funding Source: KAKEN	Global COE Program "Global Center for Education and Research in Integrative Membrane Biology"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology of the Japanese Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Global COE Program "Global Center for Education and Research in Integrative Membrane Biology" and the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan, by grants-in-aid from the Japan Society for the Promotion of Science, and by the Core Research for Evolutional Science and Technology of the Japanese Science and Technology Agency.	ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; Amano H, 2008, GENES CELLS, V13, P269, DOI 10.1111/j.1365-2443.2008.01167.x; FISHER HW, 1967, SCIENCE, V155, P581, DOI 10.1126/science.155.3762.581; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; Fukuhara T, 2004, J CELL BIOL, V166, P393, DOI 10.1083/jcb.200401093; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Kakunaga S, 2004, J BIOL CHEM, V279, P36419, DOI 10.1074/jbc.M406340200; Kawakatsu T, 2002, J BIOL CHEM, V277, P50749, DOI 10.1074/jbc.M209846200; KOIKE S, 1990, EMBO J, V9, P3217, DOI 10.1002/j.1460-2075.1990.tb07520.x; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; Lorger M, 2006, J CELL SCI, V119, P3385, DOI 10.1242/jcs.03027; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; Miyahara M, 2000, J BIOL CHEM, V275, P613, DOI 10.1074/jbc.275.1.613; Miyata M, 2009, J CELL SCI, V122, P4319, DOI 10.1242/jcs.048439; Nakata S, 2007, J BIOL CHEM, V282, P37815, DOI 10.1074/jbc.M707461200; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Sakisaka T, 2001, J VIROL, V75, P4734, DOI 10.1128/JVI.75.10.4734-4743.2001; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takahashi M, 2008, GENES CELLS, V13, P549, DOI 10.1111/j.1365-2443.2008.01187.x; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tawa H, 2010, CIRC RES, V106, P1731, DOI 10.1161/CIRCRESAHA.110.216747; Woodard AS, 1998, J CELL SCI, V111, P469; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3	33	31	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36297	36303		10.1074/jbc.M111.261768	http://dx.doi.org/10.1074/jbc.M111.261768			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880730	hybrid, Green Published			2022-12-27	WOS:000296538300014
J	Marrero, E; Rossi, SG; Darr, A; Tsoulfas, P; Rotundo, RL				Marrero, Emilio; Rossi, Susana G.; Darr, Andrew; Tsoulfas, Pantelis; Rotundo, Richard L.			Translational Regulation of Acetylcholinesterase by the RNA-binding Protein Pumilio-2 at the Neuromuscular Synapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B1 MESSENGER-RNA; GERMLINE DEVELOPMENT; MOLECULAR-CLONING; XENOPUS PUMILIO; HOMOLOGY DOMAIN; PUM2 GENES; EXPRESSION; MUSCLE; NANOS; JUNCTION	Acetylcholinesterase (AChE) is highly expressed at sites of nerve-muscle contact where it is regulated at both the transcriptional and post-transcriptional levels. Our understanding of the molecular mechanisms underlying its regulation is incomplete, but they appear to involve both translational and post-translational events as well. Here, we show that Pumilio-2 (PUM2), an RNA binding translational repressor, is highly localized at the neuromuscular junction where AChE mRNA concentrates. Immunoprecipitation of muscle cell extracts with a PUM2 specific antibody precipitated AChE mRNA, suggesting that PUM2 binds to the AChE transcripts in a complex. Gel shift assays using a bacterially expressed PUM2 RNA binding domain showed specific binding using wild type AChE 3'-UTR RNA segment that was abrogated by mutation of the consensus recognition site. Transfecting skeletal muscle cells with shRNAs specific for PUM2 up-regulated AChE expression, whereas overexpression of PUM2 decreased AChE activity. We conclude that PUM2 binds to AChE mRNA and regulates AChE expression translationally at the neuromuscular synapse. Finally, we found that PUM2 is regulated by the motor nerve suggesting a trans-synaptic mechanism for locally regulating translation of specific proteins involved in modulating synaptic transmission, analogous to CNS synapses.	[Marrero, Emilio; Rossi, Susana G.; Tsoulfas, Pantelis; Rotundo, Richard L.] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; [Darr, Andrew; Tsoulfas, Pantelis; Rotundo, Richard L.] Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA; [Tsoulfas, Pantelis] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Tsoulfas, Pantelis] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Rotundo, RL (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, 1600 NW 10th Ave, Miami, FL 33136 USA.	rrotundo@miami.edu	Tsoulfas, Pantelis/GNH-1922-2022	Tsoulfas, Pantelis/0000-0003-1974-6366	National Institutes of Health [AG005917, T32 NS07044]; U.S. Army Research Office [ARO 49497-LS-HIS]; Miami Project; Buoniconti fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Research Office; Miami Project; Buoniconti fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grant AG005917 (to R.L.R.).; Supported in part by U.S. Army Research Office Training Grant ARO 49497-LS-HIS (to R.L.R.) and National Institutes of Health Training Grant T32 NS07044.; Supported by the Miami Project and the Buoniconti fund.	Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; BALDWIN TJ, 1988, DEVELOPMENT, V104, P557; BARKER DD, 1992, GENE DEV, V6, P2312, DOI 10.1101/gad.6.12a.2312; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Belanger G, 2003, J NEUROCHEM, V86, P669, DOI 10.1046/j.1471-4159.2003.01883.x; BURDEN S, 1977, DEV BIOL, V57, P317, DOI 10.1016/0012-1606(77)90218-4; BURDEN SJ, 1979, J CELL BIOL, V82, P412, DOI 10.1083/jcb.82.2.412; Cao QP, 2010, RNA, V16, P221, DOI 10.1261/rna.1884610; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Couteaux R, 1938, NATURE, V142, P481, DOI 10.1038/142481a0; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; JASMIN BJ, 1995, FEBS LETT, V374, P393, DOI 10.1016/0014-5793(95)01131-W; JASMIN BJ, 1993, NEURON, V11, P467, DOI 10.1016/0896-6273(93)90151-G; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; LEGAY C, 1993, FEBS LETT, V315, P163, DOI 10.1016/0014-5793(93)81155-S; Legay C, 2000, MICROSC RES TECHNIQ, V49, P56, DOI 10.1002/(SICI)1097-0029(20000401)49:1<56::AID-JEMT7>3.0.CO;2-R; LEGAY C, 1995, EUR J NEUROSCI, V7, P1803, DOI 10.1111/j.1460-9568.1995.tb00699.x; LI Y, 1991, J BIOL CHEM, V266, P23083; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Menon KP, 2009, J NEUROSCI, V29, P5558, DOI 10.1523/JNEUROSCI.0520-09.2009; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Padmanabhan K, 2006, GENE DEV, V20, P199, DOI 10.1101/gad.1383106; Parisi M, 1999, GENETICS, V153, P235; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; Richter JD, 2010, BIOCHEM SOC T, V38, P1527, DOI 10.1042/BST0381527; ROSSI SG, 1992, J CELL BIOL, V119, P1657, DOI 10.1083/jcb.119.6.1657; Rossi SG, 2000, J NEUROSCI, V20, P919, DOI 10.1523/JNEUROSCI.20-03-00919.2000; Rotundo RL, 2003, J NEUROCYTOL, V32, P743, DOI 10.1023/B:NEUR.0000020621.58197.d4; ROTUNDO RL, 1990, J CELL BIOL, V110, P715, DOI 10.1083/jcb.110.3.715; ROTUNDO RL, 1984, J BIOL CHEM, V259, P3186; Savas JN, 2010, J BIOL CHEM, V285, P13142, DOI 10.1074/jbc.M110.114561; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; Spassov DS, 2003, BLOOD CELL MOL DIS, V30, P55, DOI 10.1016/S1079-9796(03)00003-2; Spassov DS, 2002, GENE, V299, P195, DOI 10.1016/S0378-1119(02)01060-0; Tubing F, 2010, J NEUROSCI, V30, P4160, DOI 10.1523/JNEUROSCI.3537-09.2010; Vessey J. P., 2010, P NATL ACAD SCI US; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Wang YM, 2009, P NATL ACAD SCI USA, V106, P20186, DOI 10.1073/pnas.0812076106; White EK, 2001, RNA, V7, P1855; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	46	13	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36492	36499		10.1074/jbc.M111.285510	http://dx.doi.org/10.1074/jbc.M111.285510			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21865157	hybrid, Green Published			2022-12-27	WOS:000296538300034
J	Wissing, S; Montano, M; Garcia-Perez, JL; Moran, JV; Greene, WC				Wissing, Silke; Montano, Mauricio; Luis Garcia-Perez, Jose; Moran, John V.; Greene, Warner C.			Endogenous APOBEC3B Restricts LINE-1 Retrotransposition in Transformed Cells and Human Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN L1 RETROTRANSPOSITION; REVERSE TRANSCRIPTION; POTENT INHIBITOR; MOUSE; RNA; DNA; PROTEINS; TRANSLATION; EXPRESSION; ELEMENT	Members of the APOBEC3 (A3) family of cytidine deaminase enzymes act as host defense mechanisms limiting both infections by exogenous retroviruses and mobilization of endogenous retrotransposons. Previous studies revealed that the overexpression of some A3 proteins could restrict engineered human Long INterspersed Element-1 (LINE-1 or L1) retrotransposition in HeLa cells. However, whether endogenous A3 proteins play a role in restricting L1 retrotransposition remains largely unexplored. Here, we show that HeLa cells express endogenous A3B and A3C, whereas human embryonic stem cells (hESCs) express A3B, A3C, A3DE, A3F, and A3G. To study the relative contribution of endogenous A3 proteins in restricting L1 retrotransposition, we first generated small hairpin RNAs (shRNAs) to suppress endogenous A3 mRNA expression, and then assessed L1 mobility using a cell-based L1 retrotransposition assay. We demonstrate that in both HeLa and hESCs, shRNA-based knockdown of A3B promotes a similar to 2-3.7-fold increase in the retrotransposition efficiency of an engineered human L1. Knockdown of the other A3s produced no significant increase in L1 activity. Thus, A3B appears to restrict engineered L1 retrotransposition in a broad range of cell types, including pluripotent cells.	[Wissing, Silke; Montano, Mauricio; Greene, Warner C.] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Luis Garcia-Perez, Jose] Univ Granada, Ctr Biomed Res, Andalusian Stem Cell Bank, Granada 18100, Spain; [Luis Garcia-Perez, Jose; Moran, John V.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Moran, John V.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Moran, John V.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Luis Garcia-Perez, Jose] Univ Granada, GENYO Pfizer, Dept Human DNA Variabil, Granada 18007, Spain; [Luis Garcia-Perez, Jose] Andalusian Govt Ctr Genom & Oncol, Granada 18007, Spain	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Granada; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Pfizer; University of Granada	Greene, WC (corresponding author), 1650 Owens St, San Francisco, CA 94158 USA.	wgreene@gladstone.ucsf.edu		Garcia-Perez, Jose Luis/0000-0002-8132-9849	National Institutes of Health [GM082970, GM060518]; California Institute for Regenerative Medicine (CIRM) [RS1-00210-1, TRI-01227, TG2/01160]; German Academy of Sciences [BMBF-LPD 9901/8-144]; Instituto de Salud Carlos III-Consejeria de Salud Junta de Andalucia [FEDER/EMER07/056]; Marie Curie IRG action [FP7-PEOPLE-2007-4-3-IRG]; Miguel Servet [FEDER/CP07/00065]; ISCIII; Innovacion y Ciencia [P09-CTS-4980]; Junta de Andalucia (Spain) [PI-002]; Spanish Ministry of Health [PI08171]; Consejeria de Economia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082970, R01GM060518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); German Academy of Sciences; Instituto de Salud Carlos III-Consejeria de Salud Junta de Andalucia; Marie Curie IRG action(European Commission); Miguel Servet; ISCIII(Instituto de Salud Carlos III); Innovacion y Ciencia; Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Consejeria de Economia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM082970 and GM060518 (to J.V.M.), California Institute for Regenerative Medicine (CIRM) Grants RS1-00210-1 and TRI-01227 (to W.C.G.), and CIRM scholarship TG2/01160 and a German Academy of Sciences Leopoldina Fellowship BMBF-LPD 9901/8-144 (to S.W.). J.V.M. is an inventor on a patent entitled, "Compositions and Methods of Use of Human Retrotransposons," application number 60/006,831, issued November, 2000. J.V.M. has not received money from the patent and the issuance of the patent does not influence the results or interpretations in the paper.; Supported by Instituto de Salud Carlos III-Consejeria de Salud Junta de Andalucia (FEDER/EMER07/056), Marie Curie IRG action FP7-PEOPLE-2007-4-3-IRG, Miguel Servet Contract FEDER/CP07/00065, ISCIII, Consejeria de Economia, Innovacion y Ciencia P09-CTS-4980, Proyectos en Salud PI-002 from Junta de Andalucia (Spain), and Spanish Ministry of Health Grant Fondo Europeo Desarrollo Regional/Fondo de Investigacion Sanitaria PI08171.	Alisch RS, 2006, GENE DEV, V20, P210, DOI 10.1101/gad.1380406; An WF, 2006, P NATL ACAD SCI USA, V103, P18662, DOI 10.1073/pnas.0605300103; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2007, VIROLOGY, V364, P486, DOI 10.1016/j.virol.2007.03.019; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Brouha B, 2002, AM J HUM GENET, V71, P327, DOI 10.1086/341722; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Cordaux R, 2006, GENE, V373, P134, DOI 10.1016/j.gene.2006.01.019; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Dmitriev SE, 2007, MOL CELL BIOL, V27, P4685, DOI 10.1128/MCB.02138-06; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Doucet AJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001150; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; GRIMALDI G, 1983, NUCLEIC ACIDS RES, V11, P321, DOI 10.1093/nar/11.2.321; Hakata Y, 2006, J BIOL CHEM, V281, P36624, DOI 10.1074/jbc.M604980200; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Hulme AE, 2007, GENE, V390, P199, DOI 10.1016/j.gene.2006.08.032; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jones RB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001547; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kazazian HH, 1999, NAT GENET, V22, P130, DOI 10.1038/9638; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Komatsu A, 2008, INT J ONCOL, V33, P261, DOI 10.3892/ijo_00000005; Kubo S, 2006, P NATL ACAD SCI USA, V103, P8036, DOI 10.1073/pnas.0601954103; Kulpa DA, 2005, HUM MOL GENET, V14, P3237, DOI 10.1093/hmg/ddi354; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Macia A, 2011, MOL CELL BIOL, V31, P300, DOI 10.1128/MCB.00561-10; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; MARTIN SL, 1993, MOL CELL BIOL, V13, P5383, DOI 10.1128/MCB.13.9.5383; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MCMILLAN JP, 1993, P NATL ACAD SCI USA, V90, P11533, DOI 10.1073/pnas.90.24.11533; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Pak V, 2011, J VIROL, V85, P8538, DOI 10.1128/JVI.02645-10; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schumann GG, 2007, BIOCHEM SOC T, V35, P637, DOI 10.1042/BST0350637; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; Turelli P, 2004, J BIOL CHEM, V279, P43371, DOI 10.1074/jbc.C400334200; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	78	72	72	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36427	36437		10.1074/jbc.M111.251058	http://dx.doi.org/10.1074/jbc.M111.251058			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878639	hybrid, Green Published			2022-12-27	WOS:000296538300028
J	Yamaguchi, H; Yu, T; Noshita, T; Kidachi, Y; Kamiie, K; Yoshida, K; Akitaya, T; Umetsu, H; Ryoyama, K				Yamaguchi, Hideaki; Yu, Tao; Noshita, Toshiro; Kidachi, Yumi; Kamiie, Katsuyoshi; Yoshida, Kenji; Akitaya, Tatsuo; Umetsu, Hironori; Ryoyama, Kazuo			Ligand-receptor Interaction between Triterpenoids and the 11 beta-Hydroxysteroid dehydrogenase type 2 (11 beta HSD2) Enzyme Predicts Their Toxic Effects against Tumorigenic r/m HM-SFME-1 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE EMBRYO CELLS; GLYCYRRHETINIC ACID; SELECTIVE TOXICITY; DOWN-REGULATION; INHIBITION; CANCER; EXPRESSION; SERUM; GROWTH; RAS	The present study deals with in silico prediction and in vitro evaluation of the selective cytotoxic effects of triterpenoids on tumorigenic human c-Ha-ras and mouse c-myc cotransfected highly metastatic serum-free mouse embryo-1 (r/mHM-SFME-1) cells. Ligand fitting of five different triterpenoids to 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta HSD2) was analyzed with a molecular modeling method, and glycyrrhetinic acid (GA) was the best-fitted triterpenoid to the ligand binding site in 11 beta HSD2. Analysis of antiproliferative effects revealed that GA, oleanolic acid, and ursolic acid had selective toxicity against the tumor cells and that GA was the most potent triterpenoid in its selectivity. The toxic activity of the tested triterpenoids against the tumor cells showed good correlations with the partition coefficient (logP) and polar surface area values. Time-lapse microscopy, fluorescence staining, and confocal laser scanning microscopic observation revealed that GA induced morphologic changes typical of apoptosis such as cell shrinkage and blebbing and also disrupted the cytoskeletal proteins. Furthermore, GA exhibited a strong inhibitory effect on 11 beta HSD2 activity in the tumor cells. Our current results suggest that analysis of the ligand-receptor interaction between triterpenoids and 11 beta HSD2 can be utilized to predict their antitumor effects and that GA can be used as a possible chemopreventive and therapeutic antitumor agent. To the best of our knowledge, this is the first report on in silico prediction of the toxic effects of triterpenoids on tumor cells by 11 beta HSD2 inhibition.	[Yamaguchi, Hideaki; Yoshida, Kenji; Akitaya, Tatsuo] Meijo Univ, Fac Pharm, Dept Pharm, Nagoya, Aichi 4688503, Japan; [Yu, Tao] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Suita, Osaka 5650871, Japan; [Noshita, Toshiro] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Dept Life Sci, Shobara 7270023, Japan; [Kidachi, Yumi; Kamiie, Katsuyoshi; Ryoyama, Kazuo] Aomori Univ, Dept Pharm, Fac Pharm, Aomori 0300943, Japan; [Umetsu, Hironori] Gifu Shotoku Gakuen Univ, Jr Coll, Dept Life Sci, Food Chem Lab, Gifu 0558288, Japan	Meijo University; Osaka University	Yamaguchi, H (corresponding author), Meijo Univ, Fac Pharm, Dept Pharm, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.	hyamagu@meijo-u.ac.jp	Noshita, Toshiro/I-5180-2018	Noshita, Toshiro/0000-0001-7066-9314	Promotion and Mutual Aid Corporation for Private Schools of Japan	Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This work was supported in part by a grant-in-aid from the Promotion and Mutual Aid Corporation for Private Schools of Japan.	AGARWAL AK, 1995, ENDOCR RES, V21, P389, DOI 10.3109/07435809509030455; ALBISTON AL, 1994, MOL CELL ENDOCRINOL, V105, pR11, DOI 10.1016/0303-7207(94)90176-7; Bijman MNA, 2008, BIOCHEM PHARMACOL, V76, P707, DOI 10.1016/j.bcp.2008.06.014; Brown RW, 1996, BIOCHEM J, V313, P997, DOI 10.1042/bj3130997; CARMICHAEL J, 1987, CANCER RES, V47, P943; Chapman KE, 2006, MOL CELL ENDOCRINOL, V248, P3, DOI 10.1016/j.mce.2005.11.036; Cohen PG, 2005, MED HYPOTHESES, V64, P989, DOI 10.1016/j.mehy.2004.11.004; Couzin J, 2002, SCIENCE, V298, P522, DOI 10.1126/science.298.5593.522; Edwards CRW, 1996, STEROIDS, V61, P263, DOI 10.1016/0039-128X(96)00033-5; Ekins S, 2004, DRUG DISCOV TODAY, V9, P276, DOI 10.1016/S1359-6446(03)03008-3; FECHTELER T, 1995, J MOL BIOL, V253, P114, DOI 10.1006/jmbi.1995.0540; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Goto J, 2008, J CHEM INF MODEL, V48, P583, DOI 10.1021/ci700352q; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Ham R G, 1979, Methods Enzymol, V58, P44; Hirakawa H, 2009, PROTEIN ENG DES SEL, V22, P385, DOI 10.1093/protein/gzp014; Horigome H, 1999, AM J PHYSIOL-ENDOC M, V277, pE624, DOI 10.1152/ajpendo.1999.277.4.E624; JIAO D, 1994, CANCER RES, V54, P4327; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Koyama K, 2001, J STEROID BIOCHEM, V76, P153, DOI 10.1016/S0960-0760(00)00157-6; Kurogi Y, 2001, CURR MED CHEM, V8, P1035, DOI 10.2174/0929867013372481; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; LOO D, 1989, J CELL PHYSIOL, V139, P484, DOI 10.1002/jcp.1041390306; LOO DT, 1987, SCIENCE, V236, P200, DOI 10.1126/science.3494308; Mark PJ, 2009, BIOL REPROD, V80, P1209, DOI 10.1095/biolreprod.108.073650; Martin R, 2007, CANCER RES, V67, P3741, DOI 10.1158/0008-5472.CAN-06-4759; MATHER JP, 1979, EXP CELL RES, V124, P215, DOI 10.1016/0014-4827(79)90271-4; Mazzocchi G, 1998, FASEB J, V12, P1533, DOI 10.1096/fasebj.12.14.1533; Nigawara T, 2006, ENDOCRINOLOGY, V147, P769, DOI 10.1210/en.2005-0544; NOMURA T, 1993, IN VITRO CELL DEV-AN, V29A, P614; Noshita T, 2009, EUR J MED CHEM, V44, P4931, DOI 10.1016/j.ejmech.2009.08.005; Rabbitt E, 2003, ONCOGENE, V22, P1663, DOI 10.1038/sj.onc.1206293; Rabbitt EH, 2002, FASEB J, V16, P36, DOI 10.1096/fj.01-0582com; RAWSON C, 1990, EXP CELL RES, V186, P177, DOI 10.1016/0014-4827(90)90224-X; RAWSON C, 1991, ONCOGENE, V6, P487; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Stewart PM, 2009, J CLIN INVEST, V119, P760, DOI 10.1172/JCI38936; Tommasi S, 2007, INT J CANCER, V120, P2078, DOI 10.1002/ijc.22557; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; WALKER BR, 1992, ENDOCRINOLOGY, V131, P970, DOI 10.1210/en.131.2.970; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Yamaguchi H, 2011, BIOCHIMIE, V93, P1172, DOI 10.1016/j.biochi.2011.04.011; Yamaguchi H, 2008, J HEALTH SCI, V54, P654, DOI 10.1248/jhs.54.654; Yamaguchi H, 2010, EUR J MED CHEM, V45, P2943, DOI 10.1016/j.ejmech.2010.03.021; Yamaguchi H, 2010, BIOL PHARM BULL, V33, P321, DOI 10.1248/bpb.33.321; Yu T, 2010, TOXICOL LETT, V192, P425, DOI 10.1016/j.toxlet.2009.11.021; Zafir A, 2009, STRESS, V12, P167, DOI 10.1080/10253890802234168; Zbankova S, 2004, CANCER LETT, V210, P95, DOI 10.1016/j.canlet.2003.12.019; Zhang MZ, 2009, J CLIN INVEST, V119, P876, DOI 10.1172/JCI37398	49	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36888	36897		10.1074/jbc.M111.265900	http://dx.doi.org/10.1074/jbc.M111.265900			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880714	hybrid, Green Published			2022-12-27	WOS:000296538300068
J	Andres, E; Martinez, N; Planas, A				Andres, Eduardo; Martinez, Nuria; Planas, Antoni			Expression and Characterization of a Mycoplasma genitalium Glycosyltransferase in Membrane Glycolipid Biosynthesis POTENTIAL TARGET AGAINST MYCOPLASMA INFECTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACHOLEPLASMA-LAIDLAWII; 1,2-DIACYLGLYCEROL 3-GLUCOSYLTRANSFERASE; MONOGALACTOSYLDIACYLGLYCEROL SYNTHASE; STAPHYLOCOCCUS-AUREUS; DIGLUCOSYLDIACYLGLYCEROL SYNTHASE; LIPID GLYCOSYLTRANSFERASE; ARABIDOPSIS-THALIANA; LIPOTEICHOIC ACID; ESCHERICHIA-COLI; PHASE-EQUILIBRIA	Mycoplasmas contain glycoglycerolipids in their plasma membrane as key structural components involved in bilayer properties and stability. A membrane-associated glycosyltransferase (GT), GT MG517, has been identified in Mycoplasma genitalium, which sequentially produces monoglycosyl- and diglycosyldiacylglycerols. When recombinantly expressed in Escherichia coli, the enzyme was functional in vivo and yielded membrane glycolipids from which Glc beta 1,6Glc beta DAG was identified as the main product. A chaperone co-expression system and extraction with CHAPS detergent afforded soluble protein that was purified by affinity chromatography. GT MG517 transfers glucosyl and galactosyl residues from UDP-Glc and UDPGal to dioleoylglycerol (DOG) acceptor to form the corresponding beta-glycosyl-DOG, which then acts as acceptor to give beta-diglycosyl-DOG products. The enzyme (GT2 family) follows Michaelis-Menten kinetics. k(cat) is about 5-fold higher for UDP-Gal with either DOG or monoglucosyldioleoylglycerol acceptors, but it shows better binding for UDP-Glc than UDP-Gal, as reflected by the lower Km, which results in similar k(cat)/K-m values for both donors. Although sequentially adding glycosyl residues with beta-1,6 connectivity, the first glycosyltransferase activity (to DOG) is about 1 order of magnitude higher than the second (to monoglucosyldioleoylglycerol). Because the ratio between the non-bilayer-forming monoglycosyldiacylglycerols and the bilayer-prone diglycosyldiacylglycerols contributes to regulate the properties of the plasma membrane, both synthase activities are probably regulated. Dioleoylphosphatidylglycerol (anionic phospholipid) activates the enzyme, k(cat) linearly increasing with dioleoylphosphatidylglycerol concentration. GT MG517 is shown to be encoded by an essential gene, and the addition of GT inhibitors results in cell growth inhibition. It is proposed that glycolipid synthases are potential targets for drug discovery against infections by mycoplasmas.	[Andres, Eduardo; Martinez, Nuria; Planas, Antoni] Univ Ramon Llull, Inst Quim Sarria, Dept Bioengn, Biochem Lab, Barcelona 08017, Spain	Universitat Ramon Llull; Institut Quimic de Sarria	Planas, A (corresponding author), Via Augusta 390, Barcelona 08017, Spain.	antoni.planas@iqs.edu	PLANAS, ANTONI/I-4803-2015	PLANAS, ANTONI/0000-0001-7073-3320	Ministerio de Ciencia e Innovacion (MICINN), Spain [BIO2007-67904-C02-02, BFU2010-22209-C02-02]; Institut Quimic de Sarria; MICINN	Ministerio de Ciencia e Innovacion (MICINN), Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Institut Quimic de Sarria; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was supported by Ministerio de Ciencia e Innovacion (MICINN), Spain, Grants BIO2007-67904-C02-02 and BFU2010-22209-C02-02.; Recipient of a predoctoral fellowship from the Institut Quimic de Sarria.; Recipient of a predoctoral fellowship from MICINN.	ABE A, 1992, J BIOCHEM-TOKYO, V111, P191, DOI 10.1093/oxfordjournals.jbchem.a123736; Andersson AS, 1996, BIOCHEMISTRY-US, V35, P11119, DOI 10.1021/bi960561w; Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Awai K, 2006, PLANT PHYSIOL, V141, P1120, DOI 10.1104/pp.106.082859; Benning C, 2008, PROG LIPID RES, V47, P381, DOI 10.1016/j.plipres.2008.04.001; Berg S, 2001, J BIOL CHEM, V276, P22056, DOI 10.1074/jbc.M102576200; Botte C, 2005, J BIOL CHEM, V280, P34691, DOI 10.1074/jbc.M505622200; Burgos R, 2007, J BACTERIOL, V189, P7014, DOI 10.1128/JB.00975-07; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DAHLQVIST A, 1992, BIOCHIM BIOPHYS ACTA, V1105, P131, DOI 10.1016/0005-2736(92)90171-H; DAHLQVIST A, 1995, BIOCHEMISTRY-US, V34, P13381, DOI 10.1021/bi00041a015; Dormann P, 1999, SCIENCE, V284, P2181, DOI 10.1126/science.284.5423.2181; Dubots E, 2010, J BIOL CHEM, V285, P6003, DOI 10.1074/jbc.M109.071928; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Falk L, 2005, SEX TRANSM INFECT, V81, P73, DOI 10.1136/sti.2004.010439; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Hoelzl G, 2007, PROG LIPID RES, V46, P225, DOI 10.1016/j.plipres.2007.05.001; Holzl G, 2005, PLANT CELL PHYSIOL, V46, P1766, DOI 10.1093/pcp/pci189; Holzl G, 2005, GLYCOBIOLOGY, V15, P874, DOI 10.1093/glycob/cwi066; HORNER PJ, 1993, LANCET, V342, P582, DOI 10.1016/0140-6736(93)91411-E; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Jorasch P, 1998, MOL MICROBIOL, V29, P419, DOI 10.1046/j.1365-2958.1998.00930.x; Jorasch P, 2000, EUR J BIOCHEM, V267, P3770, DOI 10.1046/j.1432-1327.2000.01414.x; Karlsson OP, 1997, J BIOL CHEM, V272, P929, DOI 10.1074/jbc.272.2.929; KARLSSON OP, 1994, J BIOL CHEM, V269, P23484; Kiriukhin MY, 2001, J BACTERIOL, V183, P3506, DOI 10.1128/JB.183.11.3506-3514.2001; Klement MLR, 2007, MOL MICROBIOL, V65, P1444, DOI 10.1111/j.1365-2958.2007.05865.x; Kobayashi K, 2009, PLANT PHYSIOL BIOCH, V47, P518, DOI 10.1016/j.plaphy.2008.12.012; Li L, 2003, BIOCHEMISTRY-US, V42, P9677, DOI 10.1021/bi034360l; Lind J, 2007, BIOCHEMISTRY-US, V46, P5664, DOI 10.1021/bi700042x; LINDBLOM G, 1986, BIOCHEMISTRY-US, V25, P7502, DOI 10.1021/bi00371a037; LINDBLOM G, 1993, J BIOL CHEM, V268, P16198; Marechal E, 2000, BIOCHEM SOC T, V28, P732, DOI 10.1042/BST0280732; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; OSTERBERG F, 1995, BBA-LIPID LIPID MET, V1257, P18, DOI 10.1016/0005-2760(95)00042-B; Pich OQ, 2006, MICROBIOL-SGM, V152, P519, DOI 10.1099/mic.0.28287-0; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Razin S, 2010, BIOLOGICALS, V38, P183, DOI 10.1016/j.biologicals.2009.11.008; Sakurai I, 2007, PLANT PHYSIOL, V145, P1361, DOI 10.1104/pp.107.106781; Shimojima M, 1997, P NATL ACAD SCI USA, V94, P333, DOI 10.1073/pnas.94.1.333; TRULLY JG, 1975, MOL DIAGNOSTIC PROCE, V1, P33; Vikstrom S, 1999, BIOCHEMISTRY-US, V38, P5511, DOI 10.1021/bi982532m; Vikstrom S, 2000, J BIOL CHEM, V275, P9296, DOI 10.1074/jbc.275.13.9296; WIESLANDER A, 1977, BIOCHIM BIOPHYS ACTA, V466, P336, DOI 10.1016/0005-2736(77)90229-2; WIESLANDER A, 1980, BIOCHEMISTRY-US, V19, P3650, DOI 10.1021/bi00557a002; Yamaryo Y, 2006, FEBS LETT, V580, P4086, DOI 10.1016/j.febslet.2006.06.050; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263; ZWEIG C, 1972, HDB CHROMATOGRAPHY, V2, P107	53	25	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35367	35379		10.1074/jbc.M110.214148	http://dx.doi.org/10.1074/jbc.M110.214148			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21835921	Green Published, hybrid			2022-12-27	WOS:000295927100008
J	Maheswaranathan, M; Gole, HKA; Fernandez, I; Lassegue, B; Griendling, KK; San Martin, A				Maheswaranathan, Mithunan; Gole, Hope K. A.; Fernandez, Isabel; Lassegue, Bernard; Griendling, Kathy K.; San Martin, Alejandra			Platelet-derived Growth Factor (PDGF) Regulates Slingshot Phosphatase Activity via Nox1-dependent Auto-dephosphorylation of Serine 834 in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE PHOSPHATASES; 14-3-3 PROTEINS; NADPH OXIDASE; LIM KINASE; COFILIN; PHOSPHORYLATION; ACTIVATION; MIGRATION; EXPRESSION; MOTILITY	Migration of vascular smooth muscle cells (VSMCs) contributes to vascular pathology. PDGF induces VSMC migration by a Nox1-based NADPH oxidase mediated mechanism. We have previously shown that PDGF-induced migration in VSMCs requires Slingshot-1L (SSH1L) phosphatase activity. In the present work, the mechanism of SSH1L activation by PDGF is further investigated. We identified a 14-3-3 consensus binding motif encompassing Ser-834 in SSH1L that is constitutively phosphorylated. PDGF induces SSH1L auto-dephosphorylation at Ser-834 in wild type (wt), but not in Nox1(-/y) cells. A SSH1L-S834A phospho-deficient mutant has significantly lower binding capacity for 14-3-3 when compared with the phospho-mimetic SSH1L-S834D mutant, and acts as a constitutively active phosphatase, lacking of PDGF-mediated regulation. Given that Nox1 produces reactive oxygen species, we evaluated their participation in this SSH1L activation mechanism. We found that H2O2 activates SSH1L and this is accompanied by SSH1L/14-3-3 complex disruption and 14-3-3 oxidation in wt, but not in Nox1(-/y) cells. Together, these data demonstrate that PDGF activates SSH1L in VSMC by a mechanism that involves Nox1-mediated oxidation of 14-3-3 and Ser-834 SSH1L auto-dephosphorylation.	[Maheswaranathan, Mithunan; Gole, Hope K. A.; Fernandez, Isabel; Lassegue, Bernard; Griendling, Kathy K.; San Martin, Alejandra] Emory Univ, Div Cardiol, Dept Med, Atlanta, GA 30322 USA	Emory University	San Martin, A (corresponding author), Emory Univ, Div Cardiol, Dept Med, 319 WMB,1639 Pierce Dr, Atlanta, GA 30322 USA.	asanmartin@emory.edu	Gole, Hope/B-9196-2015; San Martin, Alejandra/HDN-0012-2022	Gole, Hope/0000-0001-8550-0853; Lassegue, Bernard/0000-0003-4924-6506; San Martin, Alejandra/0000-0002-4620-1591; Maheswaranathan, Mithu/0000-0003-0866-0022; Griendling, Kathy/0000-0002-9456-8582	National Institutes of Health Heart, Lung, and Blood Institute [HL93115, HL058863, HL007745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL093115, R00HL093115, R01HL058863, T32HL007745] Funding Source: NIH RePORTER	National Institutes of Health Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Heart, Lung, and Blood Institute Grants HL93115, HL058863, and HL007745.	Autieri MV, 1999, DNA CELL BIOL, V18, P555, DOI 10.1089/104454999315105; Autieri MV, 1996, CELL GROWTH DIFFER, V7, P1453; Brandes RP, 2001, THROMB HAEMOSTASIS, V85, P1104; Clark KL, 2004, J BIOL CHEM, V279, P19401, DOI 10.1074/jbc.M312626200; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Deshpande NN, 2002, ANTIOXID REDOX SIGN, V4, P845, DOI 10.1089/152308602760599007; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Ellis JJ, 2003, MOL CELL BIOCHEM, V242, P153, DOI 10.1023/A:1021158216582; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; GRUPPUSO PA, 1992, BIOCHEM BIOPH RES CO, V189, P1457, DOI 10.1016/0006-291X(92)90238-G; Henriksson ML, 2002, EUR J BIOCHEM, V269, P4921, DOI 10.1046/j.1432-1033.2002.03191.x; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kligys K, 2007, J BIOL CHEM, V282, P32520, DOI 10.1074/jbc.M707041200; Kligys K, 2009, BIOCHEM BIOPH RES CO, V383, P450, DOI 10.1016/j.bbrc.2009.04.031; Lee CK, 2006, PROTEOMICS, V6, P6455, DOI 10.1002/pmic.200600124; Lee MY, 2009, ARTERIOSCL THROM VAS, V29, P480, DOI 10.1161/ATVBAHA.108.181925; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Ohmi K, 1997, BIOCHEM BIOPH RES CO, V238, P154, DOI 10.1006/bbrc.1997.7218; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; San Martin A, 2008, CIRC RES, V102, P432, DOI 10.1161/CIRCRESAHA.107.158923; Schwartz SM, 1997, J CLIN INVEST, V99, P2814, DOI 10.1172/JCI119472; Sommer D, 2002, ARCH BIOCHEM BIOPHYS, V404, P271, DOI 10.1016/S0003-9861(02)00242-4; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Wu YL, 1998, FEBS LETT, V440, P111, DOI 10.1016/S0014-5793(98)01415-X; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4	34	30	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35430	35437		10.1074/jbc.M111.268284	http://dx.doi.org/10.1074/jbc.M111.268284			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21857021	Green Published, hybrid			2022-12-27	WOS:000295927100014
J	Yang, JH; Nahm, MH; Bush, CA; Cisar, JO				Yang, Jinghua; Nahm, Moon H.; Bush, C. Allen; Cisar, John O.			Comparative Structural and Molecular Characterization of Streptococcus pneumoniae Capsular Polysaccharide Serogroup 10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMOCOCCUS-GROUP; BIOSYNTHETIC LOCI; COMPETENCE; VARIANTS; SEROLOGY; ORALIS	Streptococcus pneumoniae serogroup 10 includes four cross-reactive capsular polysaccharide (CPS) serotypes (10F, 10A, 10B, and 10C). In the present study, the structures of CPS10B and CPS10C were determined by chemical and high resolution NMR methods to define the features of each serotype. Both CPS10C and CPS10F had beta 1-6-linked Galf branches formed from the termini of linear repeating units by wzy-dependent polymerization through the 4-OH of subterminal GalNAc. The only difference between these polysaccharides was the wcrC-dependent alpha 1-2 or wcrF-dependent alpha 1-4 linkages between Gal and ribitol-5-phosphate. The presence of one linkage or the other also distinguished the repeating units of CPS10B and CPS10A. However, whereas these polysaccharides both had beta 1-3-linked Galf branches linked to GalNAc, only CPS10A had additional beta 1-6-linked Galp branches. These Galp branches and the reaction of a CPS10A-specific monoclonal antibody were eliminated by deletion of wcrG from the cps10A locus. In contrast, deletion of this gene from the cps10B locus had no effect on the structure of CPS10B, thereby identifying wcrG as a pseudogene in this serotype. The beta 1-3-linked Galf branches of CPS10A and CPS10B were eliminated by deletion of wcrD from each corresponding cps locus. Deletion of this gene also eliminated wcrG-dependent beta 1-6-linked Galp branches from CPS10A, thereby identifying WcrG as a branching enzyme that acts on the product of WcrD. These findings provide a complete view of the molecular, structural, and antigenic features of CPS serogroup 10, as well as insight into the possible emergence of new serotypes.	[Yang, Jinghua; Cisar, John O.] NIDCR, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; [Nahm, Moon H.] Univ Alabama, Dept Pathol, Birmingham, AL 35249 USA; [Bush, C. Allen] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Alabama System; University of Alabama Birmingham; University System of Maryland; University of Maryland Baltimore County	Cisar, JO (corresponding author), NIDCR, Oral Infect & Immun Branch, NIH, Bldg 30,Rm 3A-301,30 Convent Dr, Bethesda, MD 20892 USA.	john.cisar@nih.gov		Nahm, Moon/0000-0002-6922-1042; Yang, Jinghua/0000-0001-7140-5548	National Institutes of Health [AI-31473]; NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-31473 (to M. H. N.). This work was also supported by the Intramural Research Program of the NIDCR.	Aanensen DM, 2007, J BACTERIOL, V189, P7856, DOI 10.1128/JB.00837-07; Abeygunawardana C, 1993, ADV BIOPHYSICAL CHEM, V3, P199; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; JONES C, 1995, CARBOHYD RES, V269, P175, DOI 10.1016/0008-6215(94)00340-L; Kamerling JP., 2000, STREPTOCOCCUS PNEUMO, P81; Kauffmann F, 1940, J IMMUNOL, V39, P397; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; Morch E, 1942, J IMMUNOL, V43, P177; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; ROBBINS JB, 1983, J INFECT DIS, V148, P1136, DOI 10.1093/infdis/148.6.1136; Vammen B, 1939, J IMMUNOL, V37, P359; van Selm S, 2003, INFECT IMMUN, V71, P6192, DOI 10.1128/IAI.71.11.6192-6198.2003; Whatmore AM, 1999, J BACTERIOL, V181, P3144, DOI 10.1128/JB.181.10.3144-3154.1999; Williamson RT, 2000, MAGN RESON CHEM, V38, P265, DOI 10.1002/(SICI)1097-458X(200004)38:4<265::AID-MRC637>3.0.CO;2-#; Yang JH, 2010, J BIOL CHEM, V285, P24217, DOI 10.1074/jbc.M110.123562; Yang JH, 2009, J BACTERIOL, V191, P1891, DOI 10.1128/JB.01532-08; Yu J, 2008, J MED MICROBIOL, V57, P171, DOI 10.1099/jmm.0.47549-0	19	9	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35813	35822		10.1074/jbc.M111.255422	http://dx.doi.org/10.1074/jbc.M111.255422			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21859716	Green Published, hybrid			2022-12-27	WOS:000295927100054
J	Bromley, KM; Kiss, AS; Lokappa, SB; Lakshminarayanan, R; Fan, DM; Ndao, M; Evans, JS; Moradian-Oldak, J				Bromley, Keith M.; Kiss, Andrew S.; Lokappa, Sowmya Bekshe; Lakshminarayanan, Rajamani; Fan, Daming; Ndao, Moise; Evans, John Spencer; Moradian-Oldak, Janet			Dissecting Amelogenin Protein Nanospheres CHARACTERIZATION OF METASTABLE OLIGOMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIC LIGHT-SCATTERING; INTRINSICALLY DISORDERED PROTEIN; BOVINE SERUM-ALBUMIN; RECOMBINANT AMELOGENIN; PORCINE AMELOGENIN; ENAMEL PROTEIN; PRION PROTEIN; CROSS-LINKING; IN-VITRO; DIFFUSION	Amelogenin self-assembles to form an extracellular protein matrix, which serves as a template for the continuously growing enamel apatite crystals. To gain further insight into the molecular mechanism of amelogenin nanosphere formation, we manipulated the interactions between amelogenin monomers by altering pH, temperature, and protein concentration to create isolated metastable amelogenin oligomers. Recombinant porcine amelogenins (rP172 and rP148) and three different mutants containing only a single tryptophan (Trp(161), Trp(45), and Trp(25)) were used. Dynamic light scattering and fluorescence studies demonstrated that oligomers were metastable and in constant equilibrium with monomers. Stable oligomers with an average hydrodynamic radius (R-H) of 7.5 nm were observed at pH 5.5 between 4 and 10 mg.ml(-1). We did not find any evidence of a significant increase in folding upon self-association of the monomers into oligomers, indicating that they are disordered. Fluorescence experiments with single tryptophan amelogenins revealed that upon oligomerization the C terminus of amelogenin (around residue Trp161) is exposed at the surface of the oligomers, whereas the N-terminal region around Trp25 and Trp45 is involved in protein-protein interaction. The truncated rP148 formed similar but smaller oligomers, suggesting that the C terminus is not critical for amelogenin oligomerization. We propose a model for nanosphere formation via oligomers, and we predict that nanospheres will break up to form oligomers in mildly acidic environments via histidine protonation. We further suggest that oligomeric structures might be functional components during maturation of enamel apatite.	[Bromley, Keith M.; Kiss, Andrew S.; Lokappa, Sowmya Bekshe; Lakshminarayanan, Rajamani; Fan, Daming; Moradian-Oldak, Janet] Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, Los Angeles, CA 90033 USA; [Ndao, Moise; Evans, John Spencer] NYU, Chem Phys Lab, New York, NY 10010 USA	University of Southern California; New York University	Moradian-Oldak, J (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.	joldak@usc.edu	Evans, John Spencer/AAD-2396-2019; Rajamani, Lakshminarayanan/AAG-5541-2019	Rajamani, Lakshminarayanan/0000-0001-8214-5315; Bromley, Keith/0000-0002-8001-3818	National Institutes of Health from the NIDCR [DE-13414, DE-020099, DE-015644]; United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-FG02-03ER46099]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013414, R01DE020099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015644] Funding Source: NIH RePORTER	National Institutes of Health from the NIDCR; United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE-13414, DE-020099, and DE-015644 from the NIDCR (to J. M.-O.). This work was also supported by the United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Award DE-FG02-03ER46099 (to J. S. E.). Portions of this work represent contribution number 61 from the Laboratory for Chemical Physics, New York University.	Aichmayer B, 2005, J STRUCT BIOL, V151, P239, DOI 10.1016/j.jsb.2005.06.007; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bouropoulos N, 2003, CALCIFIED TISSUE INT, V72, P599, DOI 10.1007/s00223-002-1099-1; BROIDE ML, 1991, P NATL ACAD SCI USA, V88, P5660, DOI 10.1073/pnas.88.13.5660; Brookes SJ, 2006, EUR J ORAL SCI, V114, P280, DOI 10.1111/j.1600-0722.2006.00311.x; Buchko GW, 2008, BIOCHEMISTRY-US, V47, P13215, DOI 10.1021/bi8018288; Cho KR, 2011, J AM CHEM SOC, V133, P8586, DOI 10.1021/ja1117446; Delak K, 2009, BIOCHEMISTRY-US, V48, P2272, DOI 10.1021/bi802175a; DOHERTY P, 1974, J CHEM PHYS, V61, P5426, DOI 10.1063/1.1681898; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; EASTOE JE, 1979, J DENT RES, V58, P753, DOI 10.1177/00220345790580022701; Edgcomb SP, 2002, PROTEINS, V49, P1, DOI 10.1002/prot.10177; Everett D.H., 1988, BASIC PRINCIPLES COL, DOI [10.1039/9781847550200, DOI 10.1039/9781847550200]; Fan DM, 2009, J STRUCT BIOL, V166, P88, DOI 10.1016/j.jsb.2009.01.003; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FINCHAM AG, 1995, J STRUCT BIOL, V115, P50, DOI 10.1006/jsbi.1995.1029; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; Fincham AG, 2000, DEV FUNCTION EVOLUTI, P37, DOI DOI 10.1017/CBO9780511542626.004; Gokarn YR, 2009, PROTEIN SCI, V18, P169, DOI 10.1002/pro.20; Hu CC, 1996, J DENT RES, V75, P1735, DOI 10.1177/00220345960750100501; Iijima M, 2010, CRYST GROWTH DES, V10, P4815, DOI 10.1021/cg100696r; Klug A, 1999, PHILOS T ROY SOC B, V354, P531, DOI 10.1098/rstb.1999.0404; Konev S. V., 1978, Journal of Applied Spectroscopy, V29, P785, DOI 10.1007/BF00618625; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Lakshminarayanan R, 2007, BIOPHYS J, V93, P3664, DOI 10.1529/biophysj.107.113936; Lee AC, 2009, J CHEM INF MODEL, V49, P2013, DOI 10.1021/ci900209w; LIMEBACK H, 1990, ARCH ORAL BIOL, V35, P459, DOI 10.1016/0003-9969(90)90209-S; Lowenstam H. A., 1989, BIOMINERALISATION, P182; Mechanic G., 1971, TOOTH ENAMEL, P88; Moradian-Oldak J., 2010, AMELOGENINS MULTIFAC, P106; Moradian-Oldak J, 2006, EUR J ORAL SCI, V114, P289, DOI 10.1111/j.1600-0722.2006.00285.x; MORADIANOLDAK J, 1994, BIOPOLYMERS, V34, P1339, DOI 10.1002/bip.360341006; NEAL DG, 1984, J CHEM PHYS, V80, P3469, DOI 10.1063/1.447103; Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6; Paine ML, 1997, J BONE MINER RES, V12, P221, DOI 10.1359/jbmr.1997.12.2.221; Pecora R., 1985, DYNAMIC LIGHT SCATTE, P363; PIAZZA R, 1993, J PHYS-CONDENS MAT, V5, pB173, DOI 10.1088/0953-8984/5/34B/021; Pusey P.N., 1972, J PHYS PARIS     SC1, V33, P1, DOI 10.1051/jphyscol:1972129; RAJ T, 1974, BIOCHEMISTRY-US, V13, P3336, DOI 10.1021/bi00713a024; Ravindranath HH, 2004, BIOCHEM BIOPH RES CO, V323, P1075, DOI 10.1016/j.bbrc.2004.08.207; SASAKI S, 1991, ARCH ORAL BIOL, V36, P227, DOI 10.1016/0003-9969(91)90090-H; SCHURR JM, 1986, ANNU REV PHYS CHEM, V37, P271; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Smith C E, 1996, Adv Dent Res, V10, P159; Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200; Sun Z, 2006, EUR J ORAL SCI, V114, P59, DOI 10.1111/j.1600-0722.2006.00296.x; Tarasevich BJ, 2009, J PHYS CHEM B, V113, P1833, DOI 10.1021/jp804548x; THOMAS JC, 1984, BIOCHEMISTRY-US, V23, P5407, DOI 10.1021/bi00318a005; Uskokovic V, 2010, J DENT RES, V89, P149, DOI 10.1177/0022034509354455; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2002, J PROTEOME RES, V1, P149, DOI 10.1021/pr0155127; Wang XQ, 2004, PROTEIN SCI, V13, P810, DOI 10.1110/ps.03367304; Wiedemann-Bidlack FB, 2007, J STRUCT BIOL, V160, P57, DOI 10.1016/j.jsb.2007.06.007; Zhang H, 2010, ARCH ORAL BIOL, V55, P417, DOI 10.1016/j.archoralbio.2010.03.009	56	48	48	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34643	34653		10.1074/jbc.M111.250928	http://dx.doi.org/10.1074/jbc.M111.250928			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21840988	Green Published, hybrid			2022-12-27	WOS:000295406300019
J	Korge, P; Yang, L; Yang, JH; Wang, YB; Qu, ZL; Weiss, JN				Korge, Paavo; Yang, Ling; Yang, Jun-Hai; Wang, Yibin; Qu, Zhilin; Weiss, James N.			Protective Role of Transient Pore Openings in Calcium Handling by Cardiac Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; CELL-DEATH; MEMBRANE; CA2+; ISCHEMIA; CHANNELS; RELEASE	Long-lasting mitochondrial permeability transition pore (mPTP) openings damage mitochondria, but transient mPTP openings protect against chronic cardiac stress. To probe the mechanism, we subjected isolated cardiac mitochondria to gradual Ca2+ loading, which, in the absence of BSA, induced long-lasting mPTP opening, causing matrix depolarization. However, with BSA present to mimic cytoplasmic fatty acid-binding proteins, the mitochondrial population remained polarized and functional, even after matrix Ca2+ release caused an extramitochondrial free [Ca2+] increase to >10 mu M, unless mPTP openings were inhibited. These findings could be explained by asynchronous transient mPTP openings allowing individual mitochondria to depolarize long enough to flush accumulated matrix Ca2+ and then to repolarize rapidly after pore closure. Because subsequent matrix Ca2+ reuptake via the Ca2+ uniporter is estimated to be > 100-fold slower than matrix Ca2+ release via mPTP, only a tiny fraction of mitochondria (<1%) are depolarized at any given time. Our results show that transient mPTP openings allow cardiac mitochondria to defend themselves collectively against elevated cytoplasmic Ca2+ levels as long as respiratory chain activity is able to balance proton influx with proton pumping. We found that transient mPTP openings also stimulated reactive oxygen species production, which may engage reactive oxygen species-dependent cardioprotective signaling.	[Weiss, James N.] Univ Calif Los Angeles, Div Cardiol, David Geffen Sch Med, Cardiovasc Res Lab,Dept Med Cardiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Weiss, JN (corresponding author), Univ Calif Los Angeles, Div Cardiol, David Geffen Sch Med, Cardiovasc Res Lab,Dept Med Cardiol, 3641 MRL Bldg, Los Angeles, CA 90095 USA.	jweiss@mednet.ucla.edu	Yang, Ling/D-2368-2011	Wang, Yibin/0000-0003-0852-0767	National Institutes of Health from NHLBI [P01 HL080111, R01 HL071870, R01 HL095663]; Laubisch Endowment; Kawata Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071870, P01HL080111, R01HL095663] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Laubisch Endowment; Kawata Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL080111, R01 HL071870, and R01 HL095663 from NHLBI. This work was also supported by the Laubisch and Kawata Endowments.	Andrienko TN, 2009, J MOL CELL CARDIOL, V46, P1027, DOI 10.1016/j.yjmcc.2009.03.015; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; DATORRE SD, 1991, J MOL CELL CARDIOL, V23, P11, DOI 10.1016/0022-2828(91)90019-I; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; Hausenloy DJ, 2009, BASIC RES CARDIOL, V104, P189, DOI 10.1007/s00395-009-0010-x; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Jacobson J, 2002, J CELL SCI, V115, P1175; Juhaszova M, 2008, ANN NY ACAD SCI, V1123, P197, DOI 10.1196/annals.1420.023; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Korge P, 2001, AM J PHYSIOL-CELL PH, V280, pC517, DOI 10.1152/ajpcell.2001.280.3.C517; Korge P, 2008, CIRC RES, V103, P873, DOI 10.1161/CIRCRESAHA.108.180869; Liobikas J, 2001, BBA-BIOENERGETICS, V1505, P220, DOI 10.1016/S0005-2728(01)00170-0; Murphy E, 2007, ANNU REV PHYSIOL, V69, P51, DOI 10.1146/annurev.physiol.69.031905.163645; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Novgorodov SA, 1996, J BIOENERG BIOMEMBR, V28, P139, DOI 10.1007/BF02110644; Penna C, 2009, BBA-BIOENERGETICS, V1787, P781, DOI 10.1016/j.bbabio.2009.02.008; PETRONILLI V, 1989, FEBS LETT, V259, P137, DOI 10.1016/0014-5793(89)81513-3; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Saotome M, 2009, AM J PHYSIOL-HEART C, V296, pH1125, DOI 10.1152/ajpheart.00436.2008; Skulachev VP, 1999, J BIOENERG BIOMEMBR, V31, P431, DOI 10.1023/A:1005492205984; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	34	58	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34851	34857		10.1074/jbc.M111.239921	http://dx.doi.org/10.1074/jbc.M111.239921			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21859717	hybrid, Green Published			2022-12-27	WOS:000295406300039
J	Carayon, K; Chaoui, K; Ronzier, E; Lazar, I; Bertrand-Michel, J; Roques, V; Balor, S; Terce, F; Lopez, A; Salome, L; Joly, E				Carayon, Kevin; Chaoui, Karima; Ronzier, Elsa; Lazar, Ikrame; Bertrand-Michel, Justine; Roques, Veronique; Balor, Stephanie; Terce, Francois; Lopez, Andre; Salome, Laurence; Joly, Etienne			Proteolipidic Composition of Exosomes Changes during Reticulocyte Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DERIVED EXOSOMES; IN-VITRO; MEMBRANE MICRODOMAINS; TRANSFERRIN RECEPTOR; LIPIDS; VESICLES; PHOSPHOLIPIDS; BIOGENESIS; PROTEOMICS; PROTEINS	During the orchestrated process leading to mature erythrocytes, reticulocytes must synthesize large amounts of hemoglobin, while eliminating numerous cellular components. Exosomes are small secreted vesicles that play an important role in this process of specific elimination. To understand the mechanisms of proteolipidic sorting leading to their biogenesis, we have explored changes in the composition of exosomes released by reticulocytes during their differentiation, in parallel to their physical properties. By combining proteomic and lipidomic approaches, we found dramatic alterations in the composition of the exosomes retrieved over the course of a 7-day in vitro differentiation protocol. Our data support a previously proposed model, whereby in reticulocytes the biogenesis of exosomes involves several distinct mechanisms for the preferential recruitment of particular proteins and lipids and suggest that the respective prominence of those pathways changes over the course of the differentiation process.	[Carayon, Kevin; Chaoui, Karima; Ronzier, Elsa; Lazar, Ikrame; Lopez, Andre; Salome, Laurence] CNRS, Inst Pharmacol & Struct Biol, F-31077 Toulouse, France; [Carayon, Kevin; Chaoui, Karima; Ronzier, Elsa; Lazar, Ikrame; Lopez, Andre; Salome, Laurence; Joly, Etienne] Univ Toulouse 3, Univ Toulouse, F-31077 Toulouse, France; [Bertrand-Michel, Justine; Roques, Veronique; Terce, Francois] CHU Purpan, INSERM CPTP U563, F-31024 Toulouse 3, France; [Balor, Stephanie] CNRS, Inst Explorat Fonct Genomes, IFR109, Batiment Inst Biol Cellulaire & Genet, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Carayon, K (corresponding author), CNRS, Inst Pharmacol & Struct Biol, 205 Route Narbonne, F-31077 Toulouse, France.	kevin.carayon@ipbs.fr; atnjoly@mac.com	Joly, Etienne/A-5644-2009; Tercé, François/M-5863-2018	Joly, Etienne/0000-0002-7264-2681; Tercé, François/0000-0003-4488-2167; Lazar, Ikrame/0000-0003-4062-3627; SALOME, Laurence/0000-0001-9667-4154	CNRS; Agence Nationale de la Recherche (Agence Nationale de la Recherche/INCa Programme Plates-Formes Technologiques du Vivant); Fondation pour la Recherche Medicale; Region Midi-Pyrenees	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (Agence Nationale de la Recherche/INCa Programme Plates-Formes Technologiques du Vivant)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie)	This work was supported in part by the CNRS (PEPS 2009 Program).; Supported by a postdoctoral grant from CNRS. To whom correspondence may be addressed: Institute of Pharmacology and Structural Biology; 205 Route de Narbonne, F-31077 Toulouse, France. Tel.: 33-561-17-58-70; Fax: 33-561-17-59-94; E-mail: kevin.carayon@ipbs.fr.; We are thankful to S. Powis, A. Saoudi, and I. Bernard-Cadenat for the gifts of antibody reagents and to members of the O. Cuvillier and M-L. Maddelein teams for providing us with materials and reagents for the Western blot analyses. We gratefully acknowledge L. Kaddoum, B. Monsarrat, M. Record, C. Thery, and M. Vidal for helpful discussions and technical advice, as well as the anonymous referees for their helpful suggestions. This work benefited from the assistance of the electron microscopy facility of the IFR 109 and of the TRI Imaging platform of Toulouse. The IPBS proteomic platform was supported by grants from the Agence Nationale de la Recherche (Agence Nationale de la Recherche/INCa Programme Plates-Formes Technologiques du Vivant), the Fondation pour la Recherche Medicale (Programme Grands Equipements), and the Region Midi-Pyrenees. Institut de Pharmacologie et de Biologie Structurale belongs to the CNRS Consortium CellTiss.	Amigorena S, 2000, MEDICINA-BUENOS AIRE, V60, P51; APOVO M, 1994, BBA-MOL BASIS DIS, V1225, P255, DOI 10.1016/0925-4439(94)90003-5; Bagatolli LA, 2010, PROG LIPID RES, V49, P378, DOI 10.1016/j.plipres.2010.05.001; BARRANS A, 1994, J BIOL CHEM, V269, P11572; Barres C, 2010, BLOOD, V115, P696, DOI 10.1182/blood-2009-07-231449; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Blanc L, 2010, CURR OPIN HEMATOL, V17, P177, DOI 10.1097/MOH.0b013e328337b4e3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bouyssie D, 2007, MOL CELL PROTEOMICS, V6, P1621, DOI 10.1074/mcp.T600069-MCP200; Brittain JE, 2008, TRANSFUS CLIN BIOL, V15, P19, DOI 10.1016/j.tracli.2008.03.013; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Criswell KA, 2000, J APPL TOXICOL, V20, P25, DOI 10.1002/(SICI)1099-1263(200001/02)20:1<25::AID-JAT624>3.0.CO;2-7; De Franceschi L, 2009, MEDITERR J HEMATOL I, V1, DOI [10.4084/MJHID.2009.024, 10.4084/MMID.2009.024]; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Destainville Nicolas, 2008, J Chem Biol, V1, P37, DOI 10.1007/s12154-008-0005-3; FLANAGAN J P, 1970, Ohio Journal of Science, V70, P300; FOLCH J, 1951, J BIOL CHEM, V191, P833; Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.0167.x; GRONOWICZ G, 1984, J CELL SCI, V71, P177; Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Joly E, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-3; Kakhniashvili DG, 2005, EXP BIOL MED, V230, P787, DOI 10.1177/153537020523001102; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Koury MJ, 2005, BLOOD, V105, P2168, DOI 10.1182/blood-2004-02-0616; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Laulagnier K, 2005, BLOOD CELL MOL DIS, V35, P116, DOI 10.1016/j.bcmd.2005.05.010; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; LEBORGNE N, 1992, PLANT PHYSIOL, V100, P246, DOI 10.1104/pp.100.1.246; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lynch S, 2009, J IMMUNOL, V183, P1884, DOI 10.4049/jimmunol.0900798; Mairhofer M, 2002, BLOOD, V100, P897, DOI 10.1182/blood.V100.3.897; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; MEL HC, 1977, BLOOD, V49, P1001; Mouton-Barbosa E, 2010, MOL CELL PROTEOMICS, V9, P1006, DOI 10.1074/mcp.M900513-MCP200; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Schroeder F, 2001, EXP BIOL MED, V226, P873, DOI 10.1177/153537020122601002; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; van Meer G, 2010, EMBO REP, V11, P331, DOI 10.1038/embor.2010.60; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; VIDAL M, 1989, J CELL PHYSIOL, V140, P455, DOI 10.1002/jcp.1041400308; Vidal M, 2010, TRANSFUS CLIN BIOL, V17, P131, DOI 10.1016/j.tracli.2010.05.004; Vieu C, 2002, J LIPID RES, V43, P510; Woodman PG, 2008, CURR OPIN CELL BIOL, V20, P408, DOI 10.1016/j.ceb.2008.04.001; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; YAO JK, 1985, ANAL BIOCHEM, V150, P111, DOI 10.1016/0003-2697(85)90447-6; ZAK B, 1954, AM J CLIN PATHOL, V24, P1307, DOI 10.1093/ajcp/24.11_ts.1307; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	60	130	136	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34426	34439		10.1074/jbc.M111.257444	http://dx.doi.org/10.1074/jbc.M111.257444			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828046	hybrid, Green Published			2022-12-27	WOS:000295159200070
J	Chartron, JW; Gonzalez, GM; Clemons, WM				Chartron, Justin W.; Gonzalez, Grecia M.; Clemons, William M., Jr.			A Structural Model of the Sgt2 Protein and Its Interactions with Chaperones and the Get4/Get5 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH TETRATRICOPEPTIDE REPEAT; TAIL-ANCHORED PROTEINS; MEMBRANE-PROTEINS; BINDING; IDENTIFICATION; HSC70; COCHAPERONE; RECOGNITION; LANDSCAPE; INSERTION	The insertion of tail-anchored transmembrane (TA) proteins into the appropriate membrane is a post-translational event that requires stabilization of the transmembrane domain and targeting to the proper destination. Sgt2 is a heat-shock protein cognate (HSC) co-chaperone that preferentially binds endoplasmic reticulum-destined TA proteins and directs them to the GET pathway via Get4 and Get5. Here, we present the crystal structure from a fungal Sgt2 homolog of the tetratrico-repeat (TPR) domain and part of the linker that connects to the C-terminal domain. The linker extends into the two-carboxylate clamp of the TPR domain from a symmetry-related molecule mimicking the binding to HSCs. Based on this structure, we provide biochemical evidence that the Sgt2 TPR domain has the ability to directly bind multiple HSC family members. The structure allows us to propose features involved in this lower specificity relative to other TPR containing co-chaperones. We further show that a dimer of Sgt2 binds a single Get5 and use small angle x-ray scattering to characterize the domain arrangement of Sgt2 in solution. These results allow us to present a structural model of the Sgt2-Get4/Get5-HSC complex.	[Chartron, Justin W.; Gonzalez, Grecia M.; Clemons, William M., Jr.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Clemons, WM (corresponding author), M-C 114-96,1200 E Calif Blvd, Pasadena, CA 91104 USA.	clemons@caltech.edu	Chartron, Justin/L-9096-2019; Clemons, William M/D-1026-2009	Chartron, Justin/0000-0003-1734-3424; Clemons, William M/0000-0002-0021-889X	National Institutes of Health [R01GM097572]; Searle Scholar program; Burroughs-Wellcome Fund Career Award for the Biological Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar program; Burroughs-Wellcome Fund Career Award for the Biological Sciences(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM097572 (to W. M. C.).; Supported by the Searle Scholar program and a Burroughs-Wellcome Fund Career Award for the Biological Sciences. To whom correspondence should be addressed: M/C 114-96, 1200 E. California Blvd., Pasadena, CA 91104. Tel.: 626-395-1796; E-mail: clemons@caltech.edu.	Abbas-Terki T, 2001, MOL CELL BIOL, V21, P7569, DOI 10.1128/MCB.21.22.7569-7575.2001; Abell BM, 2011, PLANT CELL REP, V30, P137, DOI 10.1007/s00299-010-0925-6; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angeletti PC, 2002, CELL STRESS CHAPERON, V7, P258, DOI 10.1379/1466-1268(2002)007<0258:SGRPVP>2.0.CO;2; Battle A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.27; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Bozkurt G, 2010, FEBS LETT, V584, P1509, DOI 10.1016/j.febslet.2010.02.070; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Buchanan G, 2007, CANCER RES, V67, P10087, DOI 10.1158/0008-5472.CAN-07-1646; Callahan MA, 1998, J VIROL, V72, P5189, DOI 10.1128/JVI.72.6.5189-5197.1998; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cziepluch C, 1998, J VIROL, V72, P4149, DOI 10.1128/JVI.72.5.4149-4156.1998; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; Dutta S, 2008, BIOCHEMISTRY-US, V47, P10123, DOI 10.1021/bi800758a; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fielding BC, 2006, BIOCHEM BIOPH RES CO, V343, P1201, DOI 10.1016/j.bbrc.2006.03.091; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Kajander T, 2009, J BIOL CHEM, V284, P25364, DOI 10.1074/jbc.M109.033894; Kohl C, 2011, BIOL CHEM, V392, P601, DOI 10.1515/BC.2011.066; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kordes E, 1998, GENOMICS, V52, P90, DOI 10.1006/geno.1998.5385; KRIECHBAUMER V, 2011, PROTOPLASMA IN PRESS; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Liou ST, 2007, CELL STRESS CHAPERON, V12, P59, DOI 10.1379/CSC-220R.1; Liou ST, 2005, ARCH BIOCHEM BIOPHYS, V435, P253, DOI 10.1016/j.abb.2004.12.020; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rabu C, 2008, J BIOL CHEM, V283, P27504, DOI 10.1074/jbc.M804591200; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schlegel T, 2007, MOL BIOL EVOL, V24, P2763, DOI 10.1093/molbev/msm211; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tobaben S, 2003, J BIOL CHEM, V278, P38376, DOI 10.1074/jbc.M301558200; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wang HX, 2003, BIOCHEM BIOPH RES CO, V311, P877, DOI 10.1016/j.bbrc.2003.10.080; Wang L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201814; Worrall LJ, 2008, BBA-PROTEINS PROTEOM, V1784, P496, DOI 10.1016/j.bbapap.2007.12.003; Wu SJ, 2001, BIOCHEM J, V359, P419, DOI 10.1042/0264-6021:3590419; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	62	50	51	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34325	34334		10.1074/jbc.M111.277798	http://dx.doi.org/10.1074/jbc.M111.277798			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832041	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-27	WOS:000295159200061
J	Della-Maria, J; Zhou, Y; Tsai, MS; Kuhnlein, J; Carney, JP; Paull, TT; Tomkinson, AE				Della-Maria, Julie; Zhou, Yi; Tsai, Miaw-Sheue; Kuhnlein, Jeff; Carney, James P.; Paull, Tanya T.; Tomkinson, Alan E.			Human Mre11/Human Rad50/Nbs1 and DNA Ligase III alpha/XRCC1 Protein Complexes Act Together in an Alternative Nonhomologous End Joining Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; V(D)J RECOMBINATION; POLY(ADP-RIBOSE) POLYMERASE; CHROMOSOMAL TRANSLOCATIONS; BACKUP PATHWAYS; HUMAN-CELLS; III-ALPHA; REPAIR; MRE11; ATM	Recent studies have implicated a poorly defined alternative pathway of nonhomologous end joining (alt-NHEJ) in the generation of large deletions and chromosomal translocations that are frequently observed in cancer cells. Here, we describe an interaction between two factors, hMre11/hRad50/Nbs1 (MRN) and DNA ligase III alpha/XRCC1, that have been linked with alt-NHEJ. Expression of DNA ligase III alpha and the association between MRN and DNA ligase III alpha/XRCC1 are altered in cell lines defective in the major NHEJ pathway. Most notably, DNA damage induced the association of these factors in DNA ligase IV-deficient cells. MRN interacts with DNA ligase III alpha/XRCC1, stimulating intermolecular ligation, and together these proteins join incompatible DNA ends in a reaction that mimics alt-NHEJ. Thus, our results provide novel mechanistic insights into the alt-NHEJ pathway that not only contributes to genome instability in cancer cells but may also be a therapeutic target.	[Della-Maria, Julie; Carney, James P.; Tomkinson, Alan E.] Univ Maryland, Sch Med, Dept Radiat Oncol, Radiat Oncol Res Lab, Baltimore, MD 21201 USA; [Della-Maria, Julie; Carney, James P.; Tomkinson, Alan E.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Tsai, Miaw-Sheue] Univ Calif Berkeley, Ernest Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Zhou, Yi; Kuhnlein, Jeff; Paull, Tanya T.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA; [Zhou, Yi; Kuhnlein, Jeff; Paull, Tanya T.] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Tomkinson, Alan E.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Tomkinson, Alan E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of New Mexico; University of New Mexico	Tomkinson, AE (corresponding author), 1 Univ New Mexico, Canc Res Facil, 915 Camino Salud, Albuquerque, NM 87131 USA.	atomkinson@salud.unm.edu	Classen, Scott/AAY-8176-2020; Zhou, Yi/P-1039-2015	Zhou, Yi/0000-0002-1650-4591; Paull, Tanya/0000-0002-2991-651X	National Institutes of Health (NIH) from the NIEHS [ES012512]; NIH from the NCI [CA92584]; NIH [CA094008]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA094008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012512] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH from the NCI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant ES012512 from the NIEHS (to A. E. T.), NIH Program Project Grant CA92584 from the NCI (to A. E. T. and T. T. P.), and NIH Grant CA094008 (to T. T. P.).	Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bentley DJ, 2002, J CELL SCI, V115, P1551; Boboila C, 2010, P NATL ACAD SCI USA, V107, P3034, DOI 10.1073/pnas.0915067107; Bressan DA, 1998, GENETICS, V150, P591; Brown ML, 2002, P NATL ACAD SCI USA, V99, P4532, DOI 10.1073/pnas.072495299; Cahill D, 2007, MUTAGENESIS, V22, P269, DOI 10.1093/mutage/gem011; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Chen X, 2008, CANCER RES, V68, P3169, DOI 10.1158/0008-5472.CAN-07-6636; Cheng WH, 2004, J BIOL CHEM, V279, P21169, DOI 10.1074/jbc.M312770200; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Deriano L, 2009, MOL CELL, V34, P13, DOI 10.1016/j.molcel.2009.03.009; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Guirouilh-Barbat J, 2007, P NATL ACAD SCI USA, V104, P20902, DOI 10.1073/pnas.0708541104; Haber JE, 2008, P NATL ACAD SCI USA, V105, P405, DOI 10.1073/pnas.0711334105; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; HUSAIN I, 1995, J BIOL CHEM, V270, P9683, DOI 10.1074/jbc.270.16.9683; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2010, EMBO J, V29, P574, DOI 10.1038/emboj.2009.372; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Liang L, 2008, NUCLEIC ACIDS RES, V36, P3297, DOI 10.1093/nar/gkn184; Lieber MR, 2010, NAT STRUCT MOL BIOL, V17, P393, DOI 10.1038/nsmb0410-393; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Mackey ZB, 1997, MOL CELL BIOL, V17, P989, DOI 10.1128/MCB.17.2.989; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nussenzweig A, 2007, CELL, V131, P223, DOI 10.1016/j.cell.2007.10.005; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Okano S, 2005, NUCLEIC ACIDS RES, V33, P422, DOI 10.1093/nar/gki190; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2000, P NATL ACAD SCI USA, V97, P6409, DOI 10.1073/pnas.110144297; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sharpless NE, 2001, MOL CELL, V8, P1187, DOI 10.1016/S1097-2765(01)00425-7; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Soulas-Sprauel P, 2007, J EXP MED, V204, P1717, DOI 10.1084/jem.20070255; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Tsuchida R, 2002, RADIAT RES, V158, P195, DOI 10.1667/0033-7587(2002)158[0195:DOAGMI]2.0.CO;2; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Vijayakumar S, 2009, MOL CELL BIOL, V29, P2042, DOI 10.1128/MCB.01732-08; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Wang JH, 2008, J EXP MED, V205, P3079, DOI 10.1084/jem.20082271; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	65	93	94	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33845	33853		10.1074/jbc.M111.274159	http://dx.doi.org/10.1074/jbc.M111.274159			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21816818	hybrid, Green Published			2022-12-27	WOS:000295159200016
J	Domes, K; Ding, J; Lemke, T; Blaich, A; Wegener, JW; Brandmayr, J; Moosmang, S; Hofmann, F				Domes, Katrin; Ding, Jie; Lemke, Toni; Blaich, Anne; Wegener, Joerg W.; Brandmayr, Julia; Moosmang, Sven; Hofmann, Franz			Truncation of Murine Ca(v)1.2 at Asp-1904 Results in Heart Failure after Birth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL CA(V)1.2; CALMODULIN KINASE-II; CA2+ CHANNEL; CA2+-DEPENDENT INACTIVATION; DEPENDENT FACILITATION; CARBOXYL-TERMINUS; C-TERMINUS; ALPHA(1C); PHOSPHORYLATION; SUBUNIT	The carboxyl-terminal intracellular tail of the L-type Ca2+ channel Ca(V)1.2 modulates various aspects of channel activity. For example, deletion of the carboxyl-terminal sequence at Ser-1905 increased Ca(V)1.2 currents in an expression model. To verify this finding in an animal model, we inserted three stop codons at the corresponding Asp-1904 in the murine Ca(V)1.2 gene. Mice homozygous for the Stop mutation (Stop/Stop mice) were born at a Mendelian ratio but died after birth. Stop/Stop hearts showed reduced beating frequencies and contractions. Surprisingly, Stop/Stop cardiomyocytes displayed reduced I-Ba and a minor expression of the Ca(V)1.2(Stop) protein. In contrast, expression of the Ca(V)1.2(Stop) protein was normal in pooled smooth muscle samples from Stop/Stop embryos. As the Ca(V)1.2 channel exists in a cardiac and smooth muscle splice variant, HK1 and LK1, respectively, we analyzed the consequences of the deletion of the carboxyl terminus in the respective splice variant using the rabbit Ca(V)1.2 clone expressed in HEK293 cells. HEK293 cells transfected with the HK1(Stop) channel showed a reduced I-Ba and Ca(V)1.2 expression. Treatment with proteasome inhibitors increased the expression of HK1(Stop) protein and I-Ba in HEK293 cells and in Stop/Stop cardiomyocytes indicating that truncation of Ca(V)1.2 containing the cardiac exon 1a amino terminus results in proteasomal degradation of the translated protein. In contrast, HEK293 cells transfected with the LK1(Stop) channel had normal I-Ba and Ca(V)1.2 expression. These findings indicate that absence of the carboxyl-terminal tail differentially determines the fate of the cardiac and smooth muscle splice variant of the Ca(V)1.2 channel in the mouse.	[Hofmann, Franz] Tech Univ Munich, FOR 923, Inst Pharmakol & Toxikol, Forschergrp 923, D-80802 Munich, Germany	Technical University of Munich	Hofmann, F (corresponding author), Tech Univ Munich, FOR 923, Inst Pharmakol & Toxikol, Forschergrp 923, Biedersteiner Str 29, D-80802 Munich, Germany.	Franz.Hofmann@mytum.de		Wegener, Jorg/0000-0002-8129-1537	Deutsche Forschungsgemeinschaft; Fond der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fond der Chemischen Industrie(Fonds der Chemischen Industrie)	This work was supported by grants from Deutsche Forschungsgemeinschaft and Fond der Chemischen Industrie.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; BIEL M, 1991, EUR J BIOCHEM, V200, P81, DOI 10.1111/j.1432-1033.1991.tb21051.x; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; Blaich A, 2010, P NATL ACAD SCI USA, V107, P10285, DOI 10.1073/pnas.0914287107; Bunemann M, 1999, J BIOL CHEM, V274, P33851, DOI 10.1074/jbc.274.48.33851; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Corrigan N, 2010, REPROD SCI, V17, P147, DOI 10.1177/1933719109348923; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Fu Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.175307; Fuller MD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001152; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Hamilton S. L., 2005, SCI STKE; Hu H, 1998, MOL PHARMACOL, V53, P902; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Kobrinsky E, 2005, J BIOL CHEM, V280, P12474, DOI 10.1074/jbc.M412140200; Kobrinsky E, 2004, BIOPHYS J, V87, P844, DOI 10.1529/biophysj.104.041152; Langwieser N, 2010, J NEUROSCI, V30, P8367, DOI 10.1523/JNEUROSCI.4164-08.2010; Lee TS, 2006, J BIOL CHEM, V281, P25560, DOI 10.1074/jbc.M508661200; Link S, 2009, J BIOL CHEM, V284, P30129, DOI 10.1074/jbc.M109.045583; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Poomvanicha M, 2011, J BIOL CHEM, V286, P26702, DOI 10.1074/jbc.M111.247841; Rougier JS, 2011, J BIOL CHEM, V286, P8829, DOI 10.1074/jbc.M110.166520; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Shistik E, 1998, J BIOL CHEM, V273, P17901, DOI 10.1074/jbc.273.28.17901; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; Wegener JW, 2006, FASEB J, V20, P1260, DOI 10.1096/fj.05-5292fje; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; WEI XY, 1994, J BIOL CHEM, V269, P1635; Welling A, 1997, CIRC RES, V81, P526, DOI 10.1161/01.RES.81.4.526; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	41	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33863	33871		10.1074/jbc.M111.252312	http://dx.doi.org/10.1074/jbc.M111.252312			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832054	hybrid, Green Published			2022-12-27	WOS:000295159200018
J	Imai, A; Yoshie, S; Ishibashi, K; Haga-Tsujimura, M; Nashida, T; Shimomura, H; Fukuda, M				Imai, Akane; Yoshie, Sumio; Ishibashi, Koutaro; Haga-Tsujimura, Maiko; Nashida, Tomoko; Shimomura, Hiromi; Fukuda, Mitsunori			EPI64 Protein Functions as a Physiological GTPase-activating Protein for Rab27 Protein and Regulates Amylase Release in Rat Parotid Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APICAL PLASMA-MEMBRANE; BINDING PROTEINS; PC12 CELLS; RAB35; DOMAIN; SECRETION; EFFECTOR; IDENTIFICATION; STIMULATION; SALIVARY	Rab27, a small GTPase, is generally recognized as an important regulator of secretion that interacts with Rab27-specific effectors to regulate events in a wide variety of cells, including endocrine and exocrine cells. However, the mechanisms governing the spatio-temporal regulation of GTPase activity of Rab27 are not firmly established, and no GTPase-activating protein (GAP) specific for Rab27 has been identified in secretory cells. We previously showed that expression of EPI64, a Tre-2/Bub2/Cdc16 (TBC)-domain-containing protein, in melanocytes inactivates endogenous Rab27A on melanosomes (Itoh, T., and Fukuda, M. (2006) J. Biol. Chem. 281, 31823-31831), but the EPI64 role in secretory cells has never been investigated. In this study, we investigated the effect of EPI64 on Rab27 in isoproterenol (IPR)-stimulated amylase release from rat parotid acinar cells. Subcellular fractionation and immunohistochemical analyses indicated that EPI64 was enriched on the apical plasma membrane of parotid acinar cells. We found that an antibody against the TBC/Rab-GAP domain of EPI64 inhibited the reduction in levels of the endogenous GTP-Rab27 in streptolysin-O-permeabilized parotid acinar cells and suppressed amylase release in a dose-dependent manner. We also found that the levels of EPI64 mRNA and EPI64 protein increased after IPR stimulation, and that treatment with actinomycin D or anti-sense-EPI64 oligonucleotides suppressed the increase of EPI64 mRNA/EPI64 protein and the amount of amylase released. Our findings indicated that EPI64 acted as a physiological Rab27-GAP that enhanced GTPase activity of Rab27 in response to IPR stimulation, and that this activity is required for IPR-induced amylase release.	[Imai, Akane; Nashida, Tomoko; Shimomura, Hiromi] Nippon Dent Univ, Dept Biochem, Sch Life Dent Niigata, Chuo Ku, Niigata 9518580, Japan; [Yoshie, Sumio; Haga-Tsujimura, Maiko] Nippon Dent Univ, Dept Histol, Sch Life Dent Niigata, Chuo Ku, Niigata 9518580, Japan; [Ishibashi, Koutaro; Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Nippon Dental University; Nippon Dental University; Tohoku University	Imai, A (corresponding author), Nippon Dent Univ, Dept Biochem, Sch Life Dent Niigata, Chuo Ku, 1-8 Hamaura Cho, Niigata 9518580, Japan.	imaiak@ngt.ndu.ac.jp; nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Nippon Dental University [NDUF-10-03, 11-10]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [20113006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nippon Dental University(Nippon Dental University); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (to A. I. and M. F.), by a Research Promotion Grant (NDUF-10-03 and 11-10; to A. I.) from The Nippon Dental University, and by a grant from the Global Center of Excellence (GCOE) Program (Basic & Translational Research Center for Global Brain Science) from MEXT of Japan (to M. F.). Supported was also provided by the Japan Society for the Promotion of Science (to K. I.).	Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BUTCHER FR, 1975, BIOCHIM BIOPHYS ACTA, V392, P82, DOI 10.1016/0304-4165(75)90168-3; Castle D, 1998, CRIT REV ORAL BIOL M, V9, P4, DOI 10.1177/10454411980090010301; Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012; Fluiter K, 2003, NUCLEIC ACIDS RES, V31, P953, DOI 10.1093/nar/gkg185; Fujita-Yoshigaki J, 1998, CELL SIGNAL, V10, P371, DOI 10.1016/S0898-6568(97)00178-2; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2004, J BIOL CHEM, V279, P13065, DOI 10.1074/jbc.M306812200; Fukuda M, 2005, J BIOL CHEM, V280, P39175, DOI 10.1074/jbc.M505759200; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Gao YJ, 2010, J BIOL CHEM, V285, P17938, DOI 10.1074/jbc.M109.086553; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hanono A, 2006, J CELL BIOL, V175, P803, DOI 10.1083/jcb.200604046; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Imai A, 2004, ARCH BIOCHEM BIOPHYS, V422, P175, DOI 10.1016/j.abb.2003.12.021; Imai A, 2003, ARCH ORAL BIOL, V48, P597, DOI 10.1016/S0003-9969(03)00116-X; Imai A, 2006, ARCH BIOCHEM BIOPHYS, V455, P127, DOI 10.1016/j.abb.2006.09.021; Imai A, 2009, EUR J ORAL SCI, V117, P224, DOI 10.1111/j.1600-0722.2009.00618.x; Imai A, 2009, ARCH ORAL BIOL, V54, P361, DOI 10.1016/j.archoralbio.2008.12.007; Ishibashi K, 2009, GENES CELLS, V14, P41, DOI 10.1111/j.1365-2443.2008.01251.x; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kondo H, 2006, J BIOL CHEM, V281, P28657, DOI 10.1074/jbc.M603227200; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Matsuzaki T, 1999, CELL TISSUE RES, V295, P513, DOI 10.1007/s004410051257; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; PAUL E, 1992, J MEMBRANE BIOL, V127, P129; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Reczek D, 2001, J CELL BIOL, V153, P191, DOI 10.1083/jcb.153.1.191; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Shim J, 2010, MOL CELL BIOL, V30, P1421, DOI 10.1128/MCB.01463-09; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; TAKUMA T, 1988, J BIOCHEM-TOKYO, V103, P95, DOI 10.1093/oxfordjournals.jbchem.a122247; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; Yu E, 2008, P NATL ACAD SCI USA, V105, P16003, DOI 10.1073/pnas.0804825105; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921	51	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33854	33862		10.1074/jbc.M111.281394	http://dx.doi.org/10.1074/jbc.M111.281394			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832089	Green Published, hybrid			2022-12-27	WOS:000295159200017
J	Lin, AP; Anderson, SL; Minard, KI; McAlister-Henn, L				Lin, An-Ping; Anderson, Sondra L.; Minard, Karyl I.; McAlister-Henn, Lee			Effects of Excess Succinate and Retrograde Control of Metabolite Accumulation in Yeast Tricarboxylic Cycle Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ISOCITRATE DEHYDROGENASE; MALATE-DEHYDROGENASE; FUMARATE HYDRATASE; GENE-EXPRESSION; RENAL-CANCER; KREBS CYCLE; MITOCHONDRIAL; MUTATIONS; IDENTIFICATION	Cellular and mitochondrial metabolite levels were measured in yeast TCA cycle mutants (sdh2 Delta or fum1 Delta) lacking succinate dehydrogenase or fumarase activities. Cellular levels of succinate relative to parental strain levels were found to be elevated similar to 8-fold in the sdh2 Delta mutant and similar to 4-fold in the fum1 Delta mutant, and there was a preferential increase in mitochondrial levels in these mutant strains. The sdh2 Delta and fum1 Delta strains also exhibited 3-4-fold increases in expression of Cit2, the cytosolic form of citrate synthase that functions in the glyoxylate pathway. Co-disruption of the SFC1 gene encoding the mitochondrial succinate/fumarate transporter resulted in higher relative mitochondrial levels of succinate and in substantial reductions of Cit2 expression in sdh2 Delta sfc1 Delta and fum1 Delta sfc1 Delta strains as compared with sdh2 Delta and fum1 Delta strains, suggesting that aberrant transport of succinate out of mitochondria mediated by Sfc1 is related to the increased expression of Cit2 in sdh2 Delta and fum1 Delta strains. A defect (rtg1 Delta) in the yeast retrograde response pathway, which controls expression of several mitochondrial proteins and Cit2, eliminated expression of Cit2 and reduced expression of NAD-specific isocitrate dehydrogenase (Idh) and aconitase (Aco1) in parental, sdh2 Delta, and fum1 Delta strains. Concomitantly, co-disruption of the RTG1 gene reduced the cellular levels of succinate in the sdh2 Delta and fum1 Delta strains, of fumarate in the fum1 Delta strain, and citrate in an idh Delta strain. Thus, the retrograde response is necessary for maintenance of normal flux through the TCA and glyoxylate cycles in the parental strain and for metabolite accumulation in TCA cycle mutants.	[Lin, An-Ping; Anderson, Sondra L.; Minard, Karyl I.; McAlister-Henn, Lee] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	McAlister-Henn, L (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	henn@uthscsa.edu			National Institutes of Health [GM051265]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM051265.	Alam NA, 2003, HUM MOL GENET, V12, P1241, DOI 10.1093/hmg/ddg148; Arikawa Y, 1999, J BIOSCI BIOENG, V87, P333, DOI 10.1016/S1389-1723(99)80041-3; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BIGL M, 1994, BIOL CHEM H-S, V375, P153, DOI 10.1515/bchm3.1994.375.3.153; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Castegna A, 2010, J BIOL CHEM, V285, P17359, DOI 10.1074/jbc.M109.097188; DAUM G, 1982, J BIOL CHEM, V257, P3028; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; FOX TD, 1991, METHOD ENZYMOL, V194, P149; GOTHAM SM, 1988, ANAL BIOCHEM, V173, P353, DOI 10.1016/0003-2697(88)90199-6; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; HASELBECK RJ, 1993, J BIOL CHEM, V268, P12116; Hu G, 2006, J BIOL CHEM, V281, P16935, DOI 10.1074/jbc.M512281200; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; KEYS DA, 1990, J BACTERIOL, V172, P4280, DOI 10.1128/jb.172.8.4280-4287.1990; Kirchman PA, 1999, GENETICS, V152, P179; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lin AP, 2008, ARCH BIOCHEM BIOPHYS, V474, P205, DOI 10.1016/j.abb.2008.03.005; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Maniatis T., 1982, MOL CLONING; McCammon MT, 2003, MOL BIOL CELL, V14, P958, DOI 10.1091/mbc.E02-07-0422; McCammon MT, 1996, GENETICS, V144, P57; MCCAMMON MT, 1990, J BACTERIOL, V172, P5816, DOI 10.1128/jb.172.10.5816-5827.1990; McKnight SL, 2010, SCIENCE, V330, P1338, DOI 10.1126/science.1199908; MINARD KI, 1991, MOL CELL BIOL, V11, P370, DOI 10.1128/MCB.11.1.370; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Palmieri L, 2000, J BIOENERG BIOMEMBR, V32, P67, DOI 10.1023/A:1005564429242; Palmieri L, 1997, FEBS LETT, V417, P114, DOI 10.1016/S0014-5793(97)01269-6; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Raab AM, 2010, METAB ENG, V12, P518, DOI 10.1016/j.ymben.2010.08.005; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Sass E, 2001, J BIOL CHEM, V276, P46111, DOI 10.1074/jbc.M106061200; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Srinivasan V, 2010, AGING CELL, V9, P933, DOI 10.1111/j.1474-9726.2010.00622.x; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Szeto SSW, 2010, J PROTEOME RES, V9, P6729, DOI 10.1021/pr100880y; THOMPSON LM, 1988, BIOCHEMISTRY-US, V27, P8393, DOI 10.1021/bi00422a015; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yogev O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000328	47	14	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33737	33746		10.1074/jbc.M111.266890	http://dx.doi.org/10.1074/jbc.M111.266890			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21841001	Green Published, hybrid			2022-12-27	WOS:000295159200004
J	Head, BP; Hu, Y; Finley, JC; Saldana, MD; Bonds, JA; Miyanohara, A; Niesman, IR; Ali, SS; Murray, F; Insel, PA; Roth, DM; Patel, HH; Patel, PM				Head, Brian P.; Hu, Yue; Finley, J. Cameron; Saldana, Michelle D.; Bonds, Jacqueline A.; Miyanohara, Atsushi; Niesman, Ingrid R.; Ali, Sameh S.; Murray, Fiona; Insel, Paul A.; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.			Neuron-targeted Caveolin-1 Protein Enhances Signaling and Promotes Arborization of Primary Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; NEUROTROPHIC FACTOR; DENDRITIC SPINES; NERVOUS-SYSTEM; GROWTH CONE; ACTIVATION; GANGLIOSIDES; KINASE; LOCALIZATION; REGENERATION	Decreased expression of prosurvival and progrowth-stimulatory pathways, in addition to an environment that inhibits neuronal growth, contribute to the limited regenerative capacity in the central nervous system following injury or neurodegeneration. Membrane/lipid rafts, plasmalemmal microdomains enriched in cholesterol, sphingolipids, and the protein caveolin (Cav) are essential for synaptic development/stabilization and neuronal signaling. Cav-1 concentrates glutamate and neurotrophin receptors and prosurvival kinases and regulates cAMP formation. Here, we show that primary neurons that express a synapsin-driven Cav-1 vector (SynCav1) have increased raft formation, neurotransmitter and neurotrophin receptor expression, NMDA- and BDNF-mediated prosurvival kinase activation, agonist-stimulated cAMP formation, and dendritic growth. Moreover, expression of SynCav1 in Cav-1 KO neurons restores NMDA- and BDNF-mediated signaling and enhances dendritic growth. The enhanced dendritic growth occurred even in the presence of inhibitory cytokines (TNF alpha, IL-1 beta) and myelin-associated glycoproteins (MAG, Nogo). Targeting of Cav-1 to neurons thus enhances prosurvival and progrowth signaling and may be a novel means to repair the injured and neurodegenerative brain.	[Head, Brian P.; Hu, Yue; Finley, J. Cameron; Saldana, Michelle D.; Bonds, Jacqueline A.; Niesman, Ingrid R.; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Ali, Sameh S.; Murray, Fiona; Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Miyanohara, Atsushi] Univ Calif San Diego, Gene Therapy Program, La Jolla, CA 92093 USA; [Head, Brian P.; Hu, Yue; Finley, J. Cameron; Saldana, Michelle D.; Bonds, Jacqueline A.; Niesman, Ingrid R.; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Head, BP (corresponding author), Vet Affairs Med Ctr 125, Dept Anesthesiol, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	bhead@ucsd.edu		Murray, Fiona/0000-0002-5572-4810; Niesman, Ingrid/0000-0001-9767-6629; Ali, Sameh Saad/0000-0002-0339-6106	National Institutes of Health [RO1 HL091071, RO1 GM085179]; Veterans Affairs Career Development Award; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL091061, R01HL091071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM085179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Career Development Award; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL091071 (to H. H. P.) and RO1 GM085179 (to P. M. P.). This work was also supported by Veterans Affairs Career Development Award 2 (to B. P. H.) and a Merit Award from the Department of Veterans Affairs (to D. M. R.).	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Assaife-Lopes N, 2010, J NEUROSCI, V30, P8468, DOI 10.1523/JNEUROSCI.5695-09.2010; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Besshoh S, 2005, J NEUROCHEM, V93, P186, DOI 10.1111/j.1471-4159.2004.03009.x; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bilderback TR, 1999, J BIOL CHEM, V274, P257, DOI 10.1074/jbc.274.1.257; Bist A, 2000, BIOCHEMISTRY-US, V39, P1966, DOI 10.1021/bi991721h; Bjork K, 2010, EXP CELL RES, V316, P1351, DOI 10.1016/j.yexcr.2010.02.034; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Carmichael ST, 2008, STROKE, V39, P1380, DOI 10.1161/STROKEAHA.107.499962; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V284, pC457, DOI 10.1152/ajpcell.00380.2002; DERRY DM, 1967, SCIENCE, V158, P1450, DOI 10.1126/science.158.3807.1450; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Gioiosa L, 2008, BEHAV BRAIN RES, V188, P255, DOI 10.1016/j.bbr.2007.11.002; Grider MH, 2009, J NEUROSCI RES, V87, P3033, DOI 10.1002/jnr.22140; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hassan GS, 2004, BIOCHEMISTRY-US, V43, P8312, DOI 10.1021/bi049609t; Hattiangady B, 2005, EXP NEUROL, V195, P353, DOI 10.1016/j.expneurol.2005.05.014; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Head BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015697; Hering H, 2003, J NEUROSCI, V23, P3262; Hibbert AP, 2006, MOL CELL NEUROSCI, V32, P387, DOI 10.1016/j.mcn.2006.06.001; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jasmin JF, 2007, CIRC RES, V100, P721, DOI 10.1161/01.RES.0000260180.42709.29; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Lemkuil BP, 2011, ANESTHESIOLOGY, V114, P49, DOI 10.1097/ALN.0b013e318201dcb3; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Lim ST, 2011, NEUROPHARMACOLOGY, V60, P1160, DOI 10.1016/j.neuropharm.2010.10.012; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; MacDonald E, 2007, NEUROREHAB NEURAL RE, V21, P486, DOI 10.1177/1545968307305521; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mermelstein PG, 2009, J NEUROENDOCRINOL, V21, P257, DOI 10.1111/j.1365-2826.2009.01838.x; Murray AJ, 2009, J NEUROSCI, V29, P15434, DOI 10.1523/JNEUROSCI.3071-09.2009; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Oshikawa J, 2003, AM J PHYSIOL-CELL PH, V285, pC567, DOI 10.1152/ajpcell.00422.2002; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Sotgia F, 2006, AM J PATHOL, V168, P292, DOI 10.2353/ajpath.2006.050429; SPARROW JR, 1984, J NEUROSCI RES, V12, P233, DOI 10.1002/jnr.490120211; Stern CM, 2010, CELL MOL LIFE SCI, V67, P3785, DOI 10.1007/s00018-010-0447-y; SUZUKI K, 1965, J NEUROCHEM, V12, P629, DOI 10.1111/j.1471-4159.1965.tb04256.x; Suzuki S, 2007, J NEUROSCI, V27, P6417, DOI 10.1523/JNEUROSCI.0690-07.2007; Suzumura A, 2006, ANN NY ACAD SCI, V1088, P219, DOI 10.1196/annals.1366.012; SVENNERHOLM L, 1956, NATURE, V177, P524, DOI 10.1038/177524b0; Takayasu Y, 2010, P NATL ACAD SCI USA, V107, P21778, DOI 10.1073/pnas.1015553107; Toescu EC, 2004, TRENDS NEUROSCI, V27, P614, DOI 10.1016/j.tins.2004.07.010; Trushina E, 2006, BEHAV BRAIN RES, V172, P24, DOI 10.1016/j.bbr.2006.04.024; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; YEE JK, 1994, METHOD CELL BIOL, V43, P99	62	66	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33310	33321		10.1074/jbc.M111.255976	http://dx.doi.org/10.1074/jbc.M111.255976			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799010	Green Published, hybrid			2022-12-27	WOS:000294968800050
J	Rombouts, Y; Alibaud, L; Carrere-Kremer, S; Maes, E; Tokarski, C; Elass, E; Kremer, L; Guerardel, Y				Rombouts, Yoann; Alibaud, Laeticia; Carrere-Kremer, Severine; Maes, Emmanuel; Tokarski, Caroline; Elass, Elisabeth; Kremer, Laurent; Guerardel, Yann			Fatty Acyl Chains of Mycobacterium marinum Lipooligosaccharides STRUCTURE, LOCALIZATION AND ACYLATION BY PapA4 (MMAR_2343) PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TREHALOSE-CONTAINING LIPOOLIGOSACCHARIDES; MODULAR POLYKETIDE SYNTHASES; TUBERCULOSIS; BIOSYNTHESIS; ACYLTRANSFERASES; IDENTIFICATION; VIRULENCE; ENVELOPE; COMPLEX; DOMAIN	We have recently established the fine structure of the glycan backbone of lipooligosaccharides (LOS-I to LOS-IV) isolated from Mycobacterium marinum, a close relative of Mycobacterium tuberculosis. These studies culminated with the description of an unusual terminal N-acylated monosaccharide that confers important biological functions to LOS-IV, such as macrophage activation, that may be relevant to granuloma formation. It was, however, also suggested that the lipid moiety was required for LOSs to exert their immunomodulatory activity. Herein, using highly purified LOSs from M. marinum, we have determined through a combination of mass spectrometric and NMR techniques, the structure and localization of the fatty acids composing the lipid moiety. The occurrence of two distinct polymethyl-branched fatty acids presenting specific localizations is consistent with the presence of two highly related polyketide synthases (Pks5 and Pks5.1) in M. marinum and presumably involved in the synthesis of these fatty acyl chains. In addition, a bioinformatic search permitted us to identify a set of enzymes potentially involved in the biosynthesis or transfer of these lipids to the LOS trehalose unit. These include MMAR_2343, a member of the Pap (polyketide-associated protein) family, that acylates trehalose-based glycolipids in M. marinum. The participation of MMAR_2343 to LOS assembly was demonstrated using a M. marinum mutant carrying a transposon insertion in the MMAR_2343 gene. Disruption of MMAR_2343 resulted in a severe LOS breakdown, indicating that MMAR_2343, here-after designated PapA4, fulfills the requirements for LOS acylation and assembly.	[Alibaud, Laeticia; Carrere-Kremer, Severine; Kremer, Laurent] Univ Montpellier 2 & 1, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Elass, Elisabeth; Guerardel, Yann] Univ Lille 1, Unite Glycobiol Struct & Fonct, F-59650 Villeneuve Dascq, France; [Rombouts, Yoann; Maes, Emmanuel; Elass, Elisabeth; Guerardel, Yann] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France; [Kremer, Laurent] DIMNP, INSERM, F-34095 Montpellier 05, France; [Tokarski, Caroline] Univ Lille 1 Sci & Technol, USR CNRS 3290, IFR 147, F-59655 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Lille - ISITE; Universite de Lille	Kremer, L (corresponding author), Univ Montpellier 2 & 1, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, Case 107,Pl Eugene Bataillon, F-34095 Montpellier 05, France.	laurent.kremer@univ-montp2.fr; yann.guerardel@univ-lille1.fr	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Rombouts, Yoann/0000-0003-4482-2199; Guerardel, Yann/0000-0003-4967-9512; elass, elisabeth/0000-0002-2573-2959	French National Research Agency [ANR-05-MIIM-025, ANR-10-MIDI010]; Ministere de l'Enseignement Superieur; Centre Commun de Mesure RMN (Resonance Magnetique Nucleaire) de l'Universite de Lille 1; European Union; Region Nord-Pas de Calais; CNRS; Institut Pasteur de Lille; European community; Region Nord-Pas de Calais (France); Infrastructures en Biologie Sante et Agronomie network; Universite Lille 1 Sciences et Technologies; TGE FT-ICR (Tres Grand Equipement Fourier Transform Ion Cyclotron Resonance)	French National Research Agency(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur; Centre Commun de Mesure RMN (Resonance Magnetique Nucleaire) de l'Universite de Lille 1; European Union(European Commission); Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur de Lille; European community(European Commission); Region Nord-Pas de Calais (France)(Region Hauts-de-France); Infrastructures en Biologie Sante et Agronomie network; Universite Lille 1 Sciences et Technologies; TGE FT-ICR (Tres Grand Equipement Fourier Transform Ion Cyclotron Resonance)	This work was supported by French National Research Agency Grant ANR-05-MIIM-025 (to Y. G. and L. K.), ZebraFlam Grant ANR-10-MIDI010 (to L. K.), and a grant from the Ministere de l'Enseignement Superieur (to Y. R.). The 400-MHz facility was funded by the Centre Commun de Mesure RMN (Resonance Magnetique Nucleaire) de l'Universite de Lille 1. The 600-MHz facility used in this study was funded by the European Union, Region Nord-Pas de Calais, CNRS, and Institut Pasteur de Lille. The mass spectrometry facilities used for this study are funded by the European community (Fonds Europeen de Developpement Regional), the Region Nord-Pas de Calais (France), the Infrastructures en Biologie Sante et Agronomie network, the CNRS, the Universite Lille 1 Sciences et Technologies, and the TGE FT-ICR (Tres Grand Equipement Fourier Transform Ion Cyclotron Resonance).	Alibaud L, 2011, MOL MICROBIOL, V80, P919, DOI 10.1111/j.1365-2958.2011.07618.x; Anand S, 2010, NUCLEIC ACIDS RES, V38, pW487, DOI 10.1093/nar/gkq340; BELISLE JT, 1989, J BACTERIOL, V171, P3465, DOI 10.1128/jb.171.6.3465-3470.1989; Bergendahl V, 2002, EUR J BIOCHEM, V269, P620, DOI 10.1046/j.0014-2956.2001.02691.x; BESRA GS, 1993, BIOCHEMISTRY-US, V32, P12705, DOI 10.1021/bi00210a020; BESRA GS, 1994, CARBOHYD RES, V251, P99, DOI 10.1016/0008-6215(94)84279-5; Bhatt K, 2007, MICROBIOL-SGM, V153, P513, DOI 10.1099/mic.0.2006/003103-0; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Buglino J, 2004, J BIOL CHEM, V279, P30634, DOI 10.1074/jbc.M404011200; Burguiere A, 2005, J BIOL CHEM, V280, P42124, DOI 10.1074/jbc.M507500200; CAMPHAUSEN RT, 1987, J BACTERIOL, V169, P5473, DOI 10.1128/jb.169.12.5473-5480.1987; Chopra T, 2009, METHOD ENZYMOL, V459, P259, DOI 10.1016/S0076-6879(09)04612-6; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; COLLINS FM, 1981, INFECT IMMUN, V32, P614, DOI 10.1128/IAI.32.2.614-624.1981; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; DAFFE M, 1991, RES MICROBIOL, V142, P405, DOI 10.1016/0923-2508(91)90110-V; DAFFE M, 1991, BIOCHEMISTRY-US, V30, P378, DOI 10.1021/bi00216a011; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Etienne G, 2009, J BACTERIOL, V191, P2613, DOI 10.1128/JB.01235-08; GILLERON M, 1993, J BIOL CHEM, V268, P3168; GOREN MB, 1970, BIOCHIM BIOPHYS ACTA, V210, P127, DOI 10.1016/0005-2760(70)90068-8; Hatzios SK, 2009, J BIOL CHEM, V284, P12745, DOI 10.1074/jbc.M809088200; HUNTER SW, 1984, J BIOL CHEM, V259, P9729; HUNTER SW, 1983, J BIOL CHEM, V258, P481; JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; Kwan DH, 2010, ACS CHEM BIOL, V5, P829, DOI 10.1021/cb100175a; Kwan DH, 2008, CHEM BIOL, V15, P1231, DOI 10.1016/j.chembiol.2008.09.012; Larsen Michelle H, 2007, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10a02s6; LEMASSU A, 1992, J GEN MICROBIOL, V138, P1535, DOI 10.1099/00221287-138-7-1535; LEWENDON A, 1988, BIOCHEMISTRY-US, V27, P7385, DOI 10.1021/bi00419a032; McAdam RA, 2002, MICROBIOL-SGM, V148, P2975, DOI 10.1099/00221287-148-10-2975; MCNEIL M, 1989, METHOD ENZYMOL, V179, P215; Munoz M, 1998, MICROBIOL-SGM, V144, P137, DOI 10.1099/00221287-144-1-137; Neyrolles O, 2011, TUBERCULOSIS, V91, P187, DOI 10.1016/j.tube.2011.01.002; Onwueme KC, 2004, P NATL ACAD SCI USA, V101, P4608, DOI 10.1073/pnas.0306928101; Ren HP, 2007, MOL MICROBIOL, V63, P1345, DOI 10.1111/j.1365-2958.2007.05603.x; Rombouts Y, 2010, J AM CHEM SOC, V132, P16073, DOI 10.1021/ja105807s; Rombouts Y, 2009, J BIOL CHEM, V284, P20975, DOI 10.1074/jbc.M109.011429; RYHAGE RAGNAR, 1960, JOUR LIPID RES, V1, P361; Sarkar D, 2011, J BACTERIOL, V193, P2336, DOI 10.1128/JB.00065-11; Schmidt Y, 2010, ORG LETT, V12, P2218, DOI 10.1021/ol1005399; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; van der Sar AM, 2004, INFECT IMMUN, V72, P6306, DOI 10.1128/IAI.72.11.6306-6312.2004; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8	49	25	25	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33678	33688		10.1074/jbc.M111.273920	http://dx.doi.org/10.1074/jbc.M111.273920			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21803773	Green Published, hybrid			2022-12-27	WOS:000294968800084
J	Fujikawa, A; Fukada, M; Makioka, Y; Suzuki, R; Chow, JPH; Matsumoto, M; Noda, M				Fujikawa, Akihiro; Fukada, Masahide; Makioka, Yoshikazu; Suzuki, Ryoko; Chow, Jeremy Pak Hong; Matsumoto, Masahito; Noda, Masaharu			Consensus Substrate Sequence for Protein-tyrosine Phosphatase Receptor Type Z	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZETA RPTP-BETA; PHOSPHORYLATION SITES; TRAPPING SYSTEM; CELL-ADHESION; GROWTH-FACTOR; PAXILLIN; GIT1; MICE; ACTIVATION; IDENTIFICATION	Protein-tyrosine phosphatase receptor type Z (Ptprz) has multiple substrate proteins, including G protein-coupled receptor kinase-interactor 1 (Git1), membrane-associated guanylate kinase, WW and PDZ domain-containing 1 (Magi1), and GTPase-activating protein for Rho GTPase (p190RhoGAP). We have identified a dephosphorylation site at Tyr-1105 of p190RhoGAP; however, the structural determinants employed for substrate recognition of Ptprz have not been fully defined. In the present study, we revealed that Ptprz selectively dephosphorylates Git1 at Tyr-554, and Magi1 at Tyr-373 and Tyr-858 by in vitro and cell-based assays. Of note, the dephosphorylation of the Magi1 Tyr-858 site required PDZ domain-mediated interaction between Magi1 and Ptprz in the cellular context. Alignment of the primary sequences surrounding the target phosphotyrosine residue in these three substrates showed considerable similarity, suggesting a consensus motif for recognition by Ptprz. We then estimated the contribution of surrounding individual amino acid side chains to the catalytic efficiency by using fluorescent peptides based on the Git1 Tyr-554 sequence in vitro. The typical substrate motif for the catalytic domain of Ptprz was deduced to be Glu/Asp-Glu/Asp-Glu/Asp-Xaa-Ile/Val-Tyr(P)-Xaa (Xaa is not an acidic residue). Intriguingly, a G854D substitution of the Magi1 Tyr-858 site matching better to the motif sequence turned this site to be susceptible to dephosphorylation by Ptprz independent of the PDZ domain-mediated interaction in cells. Furthermore, we found by database screening that the substrate motif is present in several proteins, including paxillin at Tyr-118, its major phosphorylation site. Expectedly, we verified that Ptprz efficiently dephosphorylates paxillin at this site in cells. Our study thus provides key insights into the molecular basis for the substrate recognition of Ptprz.	[Fujikawa, Akihiro; Fukada, Masahide; Suzuki, Ryoko; Chow, Jeremy Pak Hong; Matsumoto, Masahito; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Chow, Jeremy Pak Hong; Noda, Masaharu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448787, Japan; [Makioka, Yoshikazu] Tokyo Inst Technol, Chem Resources Lab, Synthet Organ Div, Midori Ku, Kanagawa 2268503, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Tokyo Institute of Technology	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan.	madon@nibb.ac.jp	Fujikawa, Akihiro/K-9805-2015; Noda, Masaharu/D-7146-2016; Matsumoto, Masahito/ABB-3002-2021	Fujikawa, Akihiro/0000-0002-3950-0550; Noda, Masaharu/0000-0002-3796-524X; 	Ministry of Education, Science, Sports, and Culture of Japan (MEXT)	Ministry of Education, Science, Sports, and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan (MEXT).	Amerongen GPV, 2004, CIRC RES, V94, P1041, DOI 10.1161/01.RES.0000125627.77235.0C; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Fujikawa A, 2007, J BIOCHEM, V142, P343, DOI 10.1093/jb/mvm140; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Fukada M, 2006, FEBS LETT, V580, P4051, DOI 10.1016/j.febslet.2006.06.041; Gee SH, 1998, J NEUROSCI, V18, P128; Iida J, 2007, MOL CELL BIOL, V27, P4388, DOI 10.1128/MCB.01901-06; Kawachi H, 1999, MOL BRAIN RES, V72, P47, DOI 10.1016/S0169-328X(99)00204-1; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Menon P, 2010, BRAIN RES, V1317, P218, DOI 10.1016/j.brainres.2009.11.084; Mitra S, 2005, BIOORG MED CHEM LETT, V15, P5142, DOI 10.1016/j.bmcl.2005.08.054; Muramatsu H, 2004, J CELL SCI, V117, P5405, DOI 10.1242/jcs.01423; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nakamura K, 2000, J BIOL CHEM, V275, P27155; Niisato K, 2005, J NEUROSCI, V25, P1081, DOI 10.1523/JNEUROSCI.2565.04.2005; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; Ratcliffe CF, 2000, NAT NEUROSCI, V3, P437, DOI 10.1038/74805; SABE H, 1992, MOL CELL BIOL, V12, P4706, DOI 10.1128/MCB.12.10.4706; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Schmalzigaug R, 2009, NEUROSCI LETT, V458, P79, DOI 10.1016/j.neulet.2009.04.037; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; Shintani T, 2008, J BIOCHEM, V144, P259, DOI 10.1093/jb/mvn064; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tsubouchi A, 2002, J CELL BIOL, V159, P673, DOI 10.1083/jcb.200202117; Webb DJ, 2005, J CELL SCI, V118, P4925, DOI 10.1242/jcs.02563; Webb DJ, 2006, J CELL SCI, V119, P2847, DOI 10.1242/jcs03044; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005	35	27	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37137	37146		10.1074/jbc.M111.270140	http://dx.doi.org/10.1074/jbc.M111.270140			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21890632	Green Published, hybrid			2022-12-27	WOS:000296542400014
J	Kim, SS; Seo, SR				Kim, Seon Sook; Seo, Su Ryeon			The Regulator of Calcineurin 1 (RCAN1/DSCR1) Activates the cAMP Response Element-binding Protein (CREB) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME CRITICAL REGION; DOWN-SYNDROME; TRANSCRIPTION FACTORS; GENE-TRANSCRIPTION; NERVOUS-SYSTEM; C-FOS; BRAIN; MEMORY; DSCR1; OVEREXPRESSION	cAMP response element-binding protein (CREB) is one of the best known transcription factors in the development and function of the nervous system. In this report, we found that the regulator of calcineurin 1 (RCAN1), which is overexpressed in the brain of patients with Down syndrome, increased the phosphorylation of CREB and cAMP response element-mediated gene transcription in response to the activation of the intracellular cAMP pathway. Furthermore, we found that the increased activation of CREB signaling by RCAN1 depended on the ability of RCAN1 to inhibit calcineurin activity. Our data provide the first evidence that RCAN1 acts as an important regulatory component in the control of CREB signaling.	[Kim, Seon Sook; Seo, Su Ryeon] Kangwon Natl Univ, Dept Mol Biosci, Coll Biomed Sci, Chunchon 200701, South Korea	Kangwon National University	Seo, SR (corresponding author), Kangwon Natl Univ, Dept Mol Biosci, Coll Biomed Sci, Chunchon 200701, South Korea.	suryeonseo@kangwon.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2009-0065231, 2010-0023815]; Brain Korea 21 program	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by Ministry of Education, Science, and Technology Grants 2009-0065231 and 2010-0023815 and by the Brain Korea 21 program.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Chang KT, 2003, P NATL ACAD SCI USA, V100, P15794, DOI 10.1073/pnas.2536696100; Cho KO, 2008, EXP NEUROL, V212, P85, DOI 10.1016/j.expneurol.2008.03.017; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Dodge KL, 2003, BIOCHEM BIOPH RES CO, V311, P1111, DOI 10.1016/j.bbrc.2003.09.040; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; EPSTEIN CJ, 1991, AM J HUM GENET, V49, P207; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Hahm SH, 2003, MOL PHARMACOL, V64, P1503, DOI 10.1124/mol.64.6.1503; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-005-5085-4; Hoeffer CA, 2007, J NEUROSCI, V27, P13161, DOI 10.1523/JNEUROSCI.3974-07.2007; Ji L, 1996, J BIOL CHEM, V271, P22687, DOI 10.1074/jbc.271.37.22687; KING MM, 1984, J BIOL CHEM, V259, P8080; Kingsbury TJ, 2007, J NEUROCHEM, V103, P761, DOI 10.1111/j.1471-4159.2007.04801.x; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; Lee EJ, 2007, MOL CELL NEUROSCI, V35, P585, DOI 10.1016/j.mcn.2007.05.003; Lee M, 2006, MOL CELLS, V22, P1; Liu F, 2005, J BIOL CHEM, V280, P37755, DOI 10.1074/jbc.M507475200; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Ravni A, 2006, J NEUROCHEM, V98, P321, DOI 10.1111/J.1471-4159.2006.03884.X; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shioda N, 2006, J NEUROCHEM, V98, P310, DOI 10.1111/j.1471-4159.2006.03874.x; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Yuan Q, 2003, J NEUROSCI, V23, P4760	42	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37841	37848		10.1074/jbc.M111.232165	http://dx.doi.org/10.1074/jbc.M111.232165			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21890628	Green Published, hybrid			2022-12-27	WOS:000296542400078
J	Tretter, V; Kerschner, B; Milenkovic, I; Ramsden, SL; Ramerstorfer, J; Saiepour, L; Maric, HM; Moss, SJ; Schindelin, H; Harvey, RJ; Sieghart, W; Harvey, K				Tretter, Verena; Kerschner, Bernd; Milenkovic, Ivan; Ramsden, Sarah L.; Ramerstorfer, Joachim; Saiepour, Leila; Maric, Hans-Michael; Moss, Stephen J.; Schindelin, Hermann; Harvey, Robert J.; Sieghart, Werner; Harvey, Kirsten			Molecular Basis of the gamma-Aminobutyric Acid A Receptor alpha 3 Subunit Interaction with the Clustering Protein Gephyrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE RECEPTOR; GABA(A) RECEPTORS; GABAERGIC SYNAPSES; KNOCKOUT MICE; A RECEPTORS; RAT-BRAIN; COLLYBISTIN; SUBTYPES; BINDING; LOCALIZATION	The multifunctional scaffolding protein gephyrin is a key player in the formation of the postsynaptic scaffold at inhibitory synapses, clustering both inhibitory glycine receptors (GlyRs) and selected GABA(A) receptor (GABA(A)R) subtypes. We report a direct interaction between the GABA(A)R alpha 3 subunit and gephyrin, mapping reciprocal binding sites using mutagenesis, overlay, and yeast two-hybrid assays. This analysis reveals that critical determinants of this interaction are located in the motif FNIVGTTYPI in the GABA(A)R alpha 3 M3-M4 domain and the motif SMDKAFITVL at the N terminus of the gephyrin E domain. GABA(A)R alpha 3 gephyrin binding-site mutants were unable to co-localize with endogenous gephyrin in transfected hippocampal neurons, despite being able to traffic to the cell membrane and form functional benzodiazepine-responsive GABA(A)Rs in recombinant systems. Interestingly, motifs responsible for interactions with GABA(A)R alpha 2, GABA(A)R alpha 3, and collybistin on gephyrin overlap. Curiously, two key residues (Asp-327 and Phe-330) in the GABA(A)R alpha 2 and alpha 3 binding sites on gephyrin also contribute to GlyR beta subunit-E domain interactions. However, isothermal titration calorimetry reveals a 27-fold difference in the interaction strength between GABA(A)R alpha 3 and GlyR beta subunits with gephyrin with dissociation constants of 5.3 mu M and 0.2 mu M, respectively. Taken together, these observations suggest that clustering of GABA(A)R alpha 2, alpha 3, and GlyRs by gephyrin is mediated by distinct mechanisms at mixed glycinergic/GABAergic synapses.	[Tretter, Verena; Kerschner, Bernd; Milenkovic, Ivan; Ramerstorfer, Joachim; Sieghart, Werner] Med Univ Vienna, Dept Biochem & Mol Biol, Ctr Brain Res, A-1090 Vienna, Austria; [Ramsden, Sarah L.; Saiepour, Leila; Harvey, Robert J.; Harvey, Kirsten] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Maric, Hans-Michael; Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr, D-97080 Wurzburg, Germany; [Moss, Stephen J.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	Medical University of Vienna; University of London; University College London; University of London School of Pharmacy; University of Wurzburg; Tufts University; University of London; University College London	Tretter, V (corresponding author), Med Univ Vienna, Dept Biochem & Mol Biol, Ctr Brain Res, Spitalgasse 4, A-1090 Vienna, Austria.	eva.tretter@meduniwien.ac.at; kirsten.harvey@pharmacy.ac.uk	Schindelin, Hermann/Q-2697-2019; Maric, Hans Michael/AAQ-8205-2020; Sieghart, Werner/A-4877-2013; Harvey, Robert/D-3994-2016	Maric, Hans Michael/0000-0002-2719-4752; Sieghart, Werner/0000-0002-0443-0302; Harvey, Robert/0000-0001-5956-6664; Milenkovic, Ivan/0000-0002-2990-0243	Medical Research Council [G0501258]; EC [HEALTH-F4-2008-202088]; Institute of Neurological Disorders and Stroke [NS047478, NS48045, NS051195, NS054900, NS056359, NS065725]; Deutsche Forschungsgemeinschaft Rudolf Virchow Center for Experimental Biomedicine [FZ 82, SFB487 C7]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS054900, R01NS081986, R01NS056359, R01NS051195, R01NS047478, R03NS065725, R01NS048045] Funding Source: NIH RePORTER; MRC [G0501258, G0800498] Funding Source: UKRI; Medical Research Council [G0800498] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EC(European CommissionEuropean Commission Joint Research Centre); Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Deutsche Forschungsgemeinschaft Rudolf Virchow Center for Experimental Biomedicine(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council New Investigator Award G0501258 (to K. H.), the EC-FP7 integrated project "Neurocypres," grant agreement (to W. S.), HEALTH-F4-2008-202088 grant, the Institute of Neurological Disorders and Stroke grants (NS047478, NS48045, NS051195, NS054900, NS056359, and NS065725, to S. J. M.), and the Deutsche Forschungsgemeinschaft Rudolf Virchow Center for Experimental Biomedicine Grants FZ 82 and SFB487 C7 (to H. S.).	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Corteen NL, 2011, EUR J NEUROSCI, V34, P250, DOI 10.1111/j.1460-9568.2011.07740.x; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fiorelli R, 2008, BEHAV PHARMACOL, V19, P582, DOI 10.1097/FBP.0b013e32830dc0c7; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Fuller KJ, 1998, BIOTECHNIQUES, V25, P85, DOI 10.2144/98251st04; Gross A, 2011, EUR J NEUROSCI, V33, P868, DOI 10.1111/j.1460-9568.2010.07552.x; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Li XY, 2003, J MED CHEM, V46, P5567, DOI 10.1021/jm034164c; Loebrich S, 2006, EMBO J, V25, P987, DOI 10.1038/sj.emboj.7600995; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; Schrader N, 2004, J BIOL CHEM, V279, P18733, DOI 10.1074/jbc.M311245200; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Studer R, 2006, EUR J NEUROSCI, V24, P1307, DOI 10.1111/j.1460-9568.2006.05006.x; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Winsky-Sommerer R, 2008, NEUROSCIENCE, V154, P595, DOI 10.1016/j.neuroscience.2008.03.081; Yee BK, 2005, P NATL ACAD SCI USA, V102, P17154, DOI 10.1073/pnas.0508752102; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008	35	75	75	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37702	37711		10.1074/jbc.M111.291336	http://dx.doi.org/10.1074/jbc.M111.291336			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880742	Green Published, hybrid			2022-12-27	WOS:000296542400066
J	Liao, WL; Wang, WC; Chang, WC; Tseng, JT				Liao, Wan-Lin; Wang, Wei-Chiao; Chang, Wen-Chang; Tseng, Joseph T.			The RNA-binding Protein HuR Stabilizes Cytosolic Phospholipase A(2)alpha mRNA under Interleukin-1 beta Treatment in Non-small Cell Lung Cancer A549 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENTS; GENE-EXPRESSION; POSTTRANSCRIPTIONAL REGULATION; ARACHIDONIC-ACID; A(2); INFLAMMATION; PHOSPHORYLATION; CYCLOOXYGENASE-2; TRISTETRAPROLIN; TRANSLATION	The activation of cytosolic phospholipase A(2)alpha (cPLA(2)alpha) plays an important role in initiating the inflammatory response. The regulation of cPLA(2)alpha mRNA turnover has been proposed to control cPLA(2)alpha gene expression under cytokine and growth factor stimulation. However, the detailed mechanism is still unknown. In this report, we have demonstrated that the cPLA(2)alpha mRNA stability was increased under IL-1 beta treatment in A549 cells. By using EMSAs, HuR was identified as binding with the cPLA(2)alpha mRNA 3'-UTR, and the binding region was located at nucleotides 2716-2807, a fragment containing AUUUA flanked by U-rich sequences. IL-1 beta treatment enhanced the association of cPLA(2)alpha mRNA with cytosolic HuR. The reduction of HuR expression by RNA interference technology inhibited IL-1 beta-induced cPLA2 alpha mRNA and protein expression. Furthermore, blocking the p38 MAPK signaling pathway with SB203580 abolished the effect of IL-1 beta-induced cPLA(2)alpha gene expression. Phosphorylation at residue Thr-118 of HuR is crucial in regulating the interaction between HuR and its target mRNAs. Mutation of HuR Thr-118 reduced the association between HuR and cPLA(2)alpha mRNA under IL-1 beta treatment. This inhibitory effect was also observed in binding with COX-2 mRNA. This result indicated that p38 MAPK-mediated Thr-118 phosphorylation may play a key role in regulating the interaction of HuR with its target mRNAs in inflammation.	[Liao, Wan-Lin; Tseng, Joseph T.] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan; [Wang, Wei-Chiao; Chang, Wen-Chang] Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, Tainan 701, Taiwan; [Chang, Wen-Chang; Tseng, Joseph T.] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan; [Chang, Wen-Chang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Taipei Medical University	Tseng, JT (corresponding author), Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan.	tctseng@mail.ncku.edu.tw	Tseng, Joseph Ta-Chien/I-2850-2018	Tseng, Joseph Ta-Chien/0000-0002-3304-6086	National Science Council (Taiwan) [NSC 97-2320-B-006-026-MY3, NSC 99-2923-B-006-002-MY3]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council (Taiwan) Grants NSC 97-2320-B-006-026-MY3 and NSC 99-2923-B-006-002-MY3.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Audic Y, 2004, BIOL CELL, V96, P479, DOI 10.1016/j.biolcel.2004.05.002; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Blaine SA, 2001, J BIOL CHEM, V276, P42737, DOI 10.1074/jbc.M107773200; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; BREWER G, 1991, MOL CELL BIOL, V11, P2460, DOI 10.1128/MCB.11.5.2460; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cowan MJ, 2004, BBA-GENE STRUCT EXPR, V1680, P145, DOI 10.1016/j.bbaexp.2004.09.006; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Dronadula N, 2005, J BIOL CHEM, V280, P3112, DOI 10.1074/jbc.M409739200; Fernau NS, 2010, J BIOL CHEM, V285, P3896, DOI 10.1074/jbc.M109.081430; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hegen M, 2003, J EXP MED, V197, P1297, DOI 10.1084/jem.20030016; Hirabayashi T, 2004, BIOL PHARM BULL, V27, P1168, DOI 10.1248/bpb.27.1168; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Hong KH, 2001, P NATL ACAD SCI USA, V98, P3935, DOI 10.1073/pnas.051635898; Huang WL, 2009, J NEUROTRAUM, V26, P1429, DOI [10.1089/neu.2008.0835, 10.1089/neu.2008-0835]; Ing NH, 2005, BIOL REPROD, V72, P1290, DOI 10.1095/biolreprod.105.040014; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; Krishnamurthy P, 2010, FASEB J, V24, P2484, DOI 10.1096/fj.09-149815; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Leslie CC, 2004, PROSTAG LEUKOTR ESS, V70, P373, DOI 10.1016/j.plefa.2003.12.012; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2622, DOI 10.1161/01.ATV.0000246779.78003.cf; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Linkous A, 2010, CELL MICROBIOL, V12, P1369, DOI 10.1111/j.1462-5822.2010.01505.x; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Morris AR, 2010, WIRES SYST BIOL MED, V2, P162, DOI 10.1002/wsbm.54; Myou S, 2001, NAT IMMUNOL, V2, P145, DOI 10.1038/84244; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Nakanishi M, 2006, BBA-MOL CELL BIOL L, V1761, P1335, DOI 10.1016/j.bbalip.2006.09.005; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Ronkina N, 2010, BIOCHEM PHARMACOL, V80, P1915, DOI 10.1016/j.bcp.2010.06.021; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; TAY A, 1994, BIOCHEM J, V304, P417, DOI 10.1042/bj3040417; van Hoof A, 2002, CURR BIOL, V12, pR285, DOI 10.1016/S0960-9822(02)00802-3; Weiser-Evans MCM, 2009, CANCER RES, V69, P1733, DOI 10.1158/0008-5472.CAN-08-3766; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011; Yeh CH, 2008, MOL BIOL CELL, V19, P3812, DOI 10.1091/mbc.E07-09-0962	49	27	29	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35499	35508		10.1074/jbc.M111.263582	http://dx.doi.org/10.1074/jbc.M111.263582			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862584	Green Published, hybrid			2022-12-27	WOS:000295927100022
J	Ge, X; Chen, C; Hui, XY; Wang, Y; Lam, KSL; Xu, AM				Ge, Xuan; Chen, Cheng; Hui, Xiaoyan; Wang, Yu; Lam, Karen S. L.; Xu, Aimin			Fibroblast Growth Factor 21 Induces Glucose Transporter-1 Expression through Activation of the Serum Response Factor/Ets-Like Protein-1 in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASES ENERGY-EXPENDITURE; BETA-KLOTHO; INSULIN SENSITIVITY; METABOLIC-ACTIVITY; GENE-EXPRESSION; PPAR-ALPHA; KINASE; OBESITY; FGF-21; PHOSPHORYLATION	Fibroblast growth factor 21 (FGF21) is a liver-secreted endocrine factor with multiple beneficial effects on obesity-related disorders. It enhances glucose uptake by inducing the expression of glucose transporter-1 (GLUT1) in adipocytes. Here we investigated the signaling pathways that mediate FGF21-induced GLUT1 expression and glucose uptake in vitro and in animals. Quantitative real-time PCR and a luciferase reporter assay showed that FGF21 induced GLUT1 expression through transcriptional activation. The truncation of the GLUT1 promoter from -3145 to -3105 bp, which contains two highly conserved serum response element (SRE) and E-Twenty Six (ETS) binding motif, dramatically decreased FGF21-induced promoter activity of the GLUT1 gene. A chromatin immunoprecipitation assay demonstrated that the transcription factors serum response factor (SRF) and Ets-like protein-1 (Elk-1) were recruited to the GLUT1 promoter upon FGF21 stimulation. The siRNA-mediated knockdown of either SRF or Elk-1 resulted in a marked attenuation in FGF21-induced GLUT1 expression and glucose uptake in adipocytes. In C57 lean mice, a single intravenous injection of FGF21 induced phosphorylation of Elk-1 at Ser(383) and SRF at Ser(103) and also led to the recruitment of Elk-1 and SRF to the GLUT1 promoter in epididymal fats. By contrast, such effects of in vivo FGF21 administration were blunted in high fat diet-induced obese mice. In conclusion, FGF21 induces GLUT1 expression and glucose uptake through sequential activation of ERK1/2 and SRF/Elk-1, which in turn triggers the transcriptional activation of GLUT1 in adipocytes. The impairment in this signaling pathway may contribute to FGF21 resistance in obese mice.	[Ge, Xuan; Chen, Cheng; Hui, Xiaoyan; Lam, Karen S. L.; Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Wang, Yu; Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Ge, Xuan; Chen, Cheng; Hui, Xiaoyan; Wang, Yu; Lam, Karen S. L.; Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Xu, AM (corresponding author), L8-40,New Lab Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	amxu@hkucc.hku.hk	Xu, Aimin/D-3291-2013; HUI, Xiaoyan Hannah/M-5175-2019	Xu, Aimin/0000-0002-0668-033X; HUI, Xiaoyan Hannah/0000-0002-7525-5812; wang, yu/0000-0001-8697-2940	Research Grant Council of Hong Kong [HKU3/09C]; University of Hong Kong	Research Grant Council of Hong Kong(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong)	This work was supported by Collaborative Research Fund (HKU3/09C) from the Research Grant Council of Hong Kong, Seeding fund for basic research, and matching funding for national 973 projects from the University of Hong Kong (to A. X.).	Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; CHEN RH, 1991, MOL CELL BIOL, V11, P1861, DOI 10.1128/MCB.11.4.1861; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Itoh N, 2010, CELL TISSUE RES, V342, P1, DOI 10.1007/s00441-010-1024-2; Jones S, 2008, MOL PHARMACEUT, V5, P42, DOI 10.1021/mp700105z; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Latinkic BV, 1996, NUCLEIC ACIDS RES, V24, P1345, DOI 10.1093/nar/24.7.1345; Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Olefsky JM, 1999, J BIOL CHEM, V274, P1863, DOI 10.1074/jbc.274.4.1863; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; TODAKA M, 1994, J BIOL CHEM, V269, P29265; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; Uonaga T, 2010, ISLETS, V2, P247, DOI 10.4161/isl.2.4.12402; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wang QF, 2000, MOL CELL BIOL, V20, P9203, DOI 10.1128/MCB.20.24.9203-9211.2000; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Wu XL, 2010, P NATL ACAD SCI USA, V107, P14158, DOI 10.1073/pnas.1009427107; Wu XL, 2010, J BIOL CHEM, V285, P5165, DOI 10.1074/jbc.M109.068783; Xu AM, 2004, FEBS LETT, V572, P129, DOI 10.1016/j.febslet.2004.07.020; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	45	111	122	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34533	34541		10.1074/jbc.M111.248591	http://dx.doi.org/10.1074/jbc.M111.248591			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846717	Green Published, hybrid			2022-12-27	WOS:000295406300007
J	Dennis, AT; Nassal, D; Deschenes, I; Thomas, D; Ficker, E				Dennis, Adrienne T.; Nassal, Drew; Deschenes, Isabelle; Thomas, Dierk; Ficker, Eckhard			Antidepressant-induced Ubiquitination and Degradation of the Cardiac Potassium Channel hERG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; K+ CHANNEL; PROTEIN TRAFFICKING; I-KR; DESIPRAMINE; MECHANISMS; INHIBITION; KV1.5; BLOCK; DISRUPTION	The most common cause for adverse cardiac events by antidepressants is acquired long QT syndrome (acLQTS), which produces electrocardiographic abnormalities that have been associated with syncope, torsade de pointes arrhythmias, and sudden cardiac death. acLQTS is often caused by direct block of the cardiac potassium current IKr/hERG, which is crucial for terminal repolarization in human heart. Importantly, desipramine belongs to a group of tricyclic antidepressant compounds that can simultaneously block hERG and inhibit its surface expression. Although up to 40% of all hERG blockers exert combined hERG block and trafficking inhibition, few of these compounds have been fully characterized at the cellular level. Here, we have studied in detail how desipramine inhibits hERG surface expression. We find a previously unrecognized combination of two entirely different mechanisms; desipramine increases hERG endocytosis and degradation as a consequence of drug-induced channel ubiquitination and simultaneously inhibits hERG forward trafficking from the endoplasmic reticulum. This unique combination of cellular effects in conjunction with acute channel block may explain why tricyclic antidepressants as a compound class are notorious for their association with arrhythmias and sudden cardiac death. Taken together, we describe the first example of drug-induced channel ubiquitination and degradation. Our data are directly relevant to the cardiac safety of not only tricyclic antidepressants but also other therapeutic compounds that exert multiple effects on hERG, as hERG trafficking and degradation phenotypes may go undetected in most preclinical safety assays designed to screen for acLQTS.	[Dennis, Adrienne T.; Nassal, Drew; Deschenes, Isabelle; Ficker, Eckhard] Case Western Reserve Univ, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA; [Nassal, Drew; Deschenes, Isabelle] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Thomas, Dierk] Med Univ Hosp Heidelberg, Dept Cardiol, D-69120 Heidelberg, Germany	Case Western Reserve University; MetroHealth System; Case Western Reserve University; Ruprecht Karls University Heidelberg	Ficker, E (corresponding author), MetroHlth Med Ctr, Rammelkamp Ctr, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	eficker@metrohealth.org	Thomas, Dierk/V-3940-2017; Thomas, Dierk/ABA-4706-2021	Thomas, Dierk/0000-0002-5687-7843	National Institutes of Health [T32HL105338, 1R01HL096962]; Deutsche Forschungsgemeinschaft; ADUMED foundation; German Heart Foundation/German Foundation of Heart Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096962, T32HL105338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ADUMED foundation; German Heart Foundation/German Foundation of Heart Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants T32HL105338 (to D. N.) and 1R01HL096962 (to I. D.). This work was also supported in part by research grants from the Deutsche Forschungsgemeinschaft (FRONTIERS program, the ADUMED foundation, and the German Heart Foundation/German Foundation of Heart Research (all to D. T.).	ALDERTON HR, 1995, CAN J PSYCHIAT, V40, P325; APODACA G, 1994, J BIOL CHEM, V269, P19005; Arancibia-Carcamo IL, 2009, P NATL ACAD SCI USA, V106, P17552, DOI 10.1073/pnas.0905502106; Balijepalli RC, 2007, CHANNELS, V1, P263, DOI 10.4161/chan.4946; Carter WP, 2003, INT J EAT DISORDER, V34, pS74, DOI 10.1002/eat.10207; CASAZZA F, 1986, Giornale Italiano di Cardiologia, V16, P1058; Choi WS, 2005, CIRC RES, V97, P363, DOI 10.1161/01.RES.0000179535.06458.f8; Christian AE, 1997, J LIPID RES, V38, P2264; Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707; Cordes JS, 2005, BRIT J PHARMACOL, V145, P15, DOI 10.1038/sj.bjp.0706140; Dennis A, 2007, BIOCHEM SOC T, V35, P1060, DOI 10.1042/BST0351060; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; Guo J, 2011, MOL PHARMACOL, V79, P806, DOI 10.1124/mol.110.069419; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; HONEGGER UE, 1983, J PHARMACOL EXP THER, V225, P436; Hong HK, 2010, BIOCHEM BIOPH RES CO, V394, P536, DOI 10.1016/j.bbrc.2010.03.010; HURSTING MJ, 1992, CLIN CHEM, V38, P2468; Jackson JL, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5222; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Kiesecker C, 2006, N-S ARCH PHARMACOL, V373, P212, DOI 10.1007/s00210-006-0068-z; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kuryshev YA, 2005, J PHARMACOL EXP THER, V312, P316, DOI 10.1124/jpet.104.073692; LEONARD HL, 1995, J AM ACAD CHILD PSY, V34, P1460, DOI 10.1097/00004583-199511000-00012; Liu AP, 2010, J CELL BIOL, V191, P1381, DOI 10.1083/jcb.201008117; Massaeli H, 2010, J BIOL CHEM, V285, P27259, DOI 10.1074/jbc.M110.124909; McEwen DP, 2007, J BIOL CHEM, V282, P29612, DOI 10.1074/jbc.M704402200; Obers S, 2010, N-S ARCH PHARMACOL, V381, P385, DOI 10.1007/s00210-010-0496-7; Pakkanen K, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046004; Pollard CE, 2010, BRIT J PHARMACOL, V159, P12, DOI 10.1111/j.1476-5381.2009.00207.x; PROZIALECK WC, 1982, J PHARMACOL EXP THER, V222, P509; Pull Charles B, 2008, Neuropsychiatr Dis Treat, V4, P779; Rajamani S, 2006, BRIT J PHARMACOL, V149, P481, DOI 10.1038/sj.bjp.0706892; Ray WA, 2004, CLIN PHARMACOL THER, V75, P234, DOI 10.1016/j.clpt.2003.09.019; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schumacher SM, 2009, CIRC RES, V104, P1390, DOI 10.1161/CIRCRESAHA.108.192773; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Shenoy SK, 2011, CURR TOP MEMBR, V67, P51, DOI 10.1016/B978-0-12-384921-2.00003-3; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Staudacher I, 2011, N-S ARCH PHARMACOL, V383, P119, DOI 10.1007/s00210-010-0583-9; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; Swanson JR, 1997, J FORENSIC SCI, V42, P335; Takemasa H, 2008, BRIT J PHARMACOL, V153, P439, DOI 10.1038/sj.bjp.0707537; Teschemacher AG, 1999, BRIT J PHARMACOL, V128, P479, DOI 10.1038/sj.bjp.0702800; Varley C K, 2001, Paediatr Drugs, V3, P613, DOI 10.2165/00128072-200103080-00006; Waslick BD, 1999, J AM ACAD CHILD PSY, V38, P179, DOI 10.1097/00004583-199902000-00017; Wible Barbara A., 2005, Journal of Pharmacological and Toxicological Methods, V52, P136, DOI 10.1016/j.vascn.2005.03.008; Witchel HJ, 2003, J CLIN PSYCHOPHARM, V23, P58, DOI 10.1097/00004714-200302000-00010; Zadeh AD, 2008, J PHYSIOL-LONDON, V586, P4793, DOI 10.1113/jphysiol.2008.161570; Zhang ST, 2006, AM J PHYSIOL-HEART C, V290, pH1038, DOI 10.1152/ajpheart.00679.2005	54	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34413	34425		10.1074/jbc.M111.254367	http://dx.doi.org/10.1074/jbc.M111.254367			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832094	Green Published, hybrid			2022-12-27	WOS:000295159200069
J	Silkov, A; Yoon, Y; Lee, H; Gokhale, N; Adu-Gyamfi, E; Stahelin, RV; Cho, W; Murray, D				Silkov, Antonina; Yoon, Youngdae; Lee, Hunjoong; Gokhale, Nikhil; Adu-Gyamfi, Emmanuel; Stahelin, Robert V.; Cho, Wonhwa; Murray, Diana			Genome-wide Structural Analysis Reveals Novel Membrane Binding Properties of AP180 N-terminal Homology (ANTH) Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN ASSEMBLY PROTEIN; ALZHEIMERS-DISEASE; DIFFERENTIAL ROLES; PREDICTION; ELECTROSTATICS; RECOGNITION; DATABASE; PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE; PTDINS(4,5)P-2; ENDOCYTOSIS	An increasing number of cytosolic proteins are shown to interact with membrane lipids during diverse cellular processes, but computational prediction of these proteins and their membrane binding behaviors remains challenging. Here, we introduce a new combinatorial computation protocol for systematic and robust functional prediction of membrane-binding proteins through high throughput homology modeling and in-depth calculation of biophysical properties. The approach was applied to the genomic scale identification of the AP180 N-terminal homology (ANTH) domain, one of the modular lipid binding domains, and prediction of their membrane binding properties. Our analysis yielded comprehensive coverage of the ANTH domain family and allowed classification and functional annotation of proteins based on the differences in local structural and biophysical features. Our analysis also identified a group of plant ANTH domains with unique structural features that may confer novel functionalities. Experimental characterization of a representative member of this subfamily confirmed its unique membrane binding mechanism and unprecedented membrane deforming activity. Collectively, these studies suggest that our new computational approach can be applied to genome-wide functional prediction of other lipid binding domains.	[Yoon, Youngdae; Gokhale, Nikhil; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Silkov, Antonina; Lee, Hunjoong; Murray, Diana] Columbia Univ, Dept Pharmacol, New York, NY 11032 USA; [Adu-Gyamfi, Emmanuel; Stahelin, Robert V.] Univ Notre Dame, Dept Biochem, South Bend, IN 46617 USA; [Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Cho, Wonhwa] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Columbia University; University of Notre Dame; Indiana University System; Indiana University South Bend; Pohang University of Science & Technology (POSTECH)	Cho, W (corresponding author), Univ Illinois, Dept Chem, Chicago, IL 60607 USA.	wcho@uic.edu; dm527@columbia.edu	Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863	National Institutes of Health [GM68849]; National Science Foundation [0618323]; National Research Foundation of Korea [R31-2008-000-10105-0]; Ministry of Education, Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68849 (to W. C.). This work was also supported by National Science Foundation Grant 0618323 (to D. M.) and by the World Class University Program Grant R31-2008-000-10105-0 (to W. C.) from the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology.	AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Bhardwaj N, 2006, J MOL BIOL, V359, P486, DOI 10.1016/j.jmb.2006.03.039; Bhardwaj N, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S6; BRUNE D, 1994, P NATL ACAD SCI USA, V91, P2930, DOI 10.1073/pnas.91.8.2930; CHO W, 2006, SCI STKE, pPE7, DOI DOI 10.1126/STKE.3212006PE7; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lee Hunjoong, 2010, Journal of Structural and Functional Genomics, V11, P51, DOI 10.1007/s10969-010-9086-7; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lin HH, 2006, J LIPID RES, V47, P824, DOI 10.1194/jlr.M500530-JLR200; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Mirkovic N, 2007, PROTEINS, V66, P766, DOI 10.1002/prot.21191; Mishra SK, 2001, J BIOL CHEM, V276, P46230, DOI 10.1074/jbc.M108177200; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Rao DS, 2002, J CLIN INVEST, V110, P351, DOI 10.1172/JCI200215529; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Sun Y, 2005, MOL BIOL CELL, V16, P717, DOI 10.1091/mbc.E04-08-0740; Xiong WJ, 2010, PROTEIN J, V29, P427, DOI 10.1007/s10930-010-9269-x; Yao PJ, 1998, J NEUROSCI, V18, P2399; Yao PJ, 1998, NEUROSCI LETT, V252, P33, DOI 10.1016/S0304-3940(98)00547-3; Yao PJ, 1999, NEUROSCIENCE, V94, P389, DOI 10.1016/S0306-4522(99)00360-7; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhang C, 1997, J MOL BIOL, V267, P707, DOI 10.1006/jmbi.1996.0859	45	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34155	34163		10.1074/jbc.M111.265611	http://dx.doi.org/10.1074/jbc.M111.265611			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828048	Green Published, hybrid			2022-12-27	WOS:000295159200046
J	Banerjee, P; Basu, A; Datta, D; Gasser, M; Waaga-Gasser, AM; Pal, S				Banerjee, Pallavi; Basu, Aninda; Datta, Dipak; Gasser, Martin; Waaga-Gasser, Ana Maria; Pal, Soumitro			The Heme Oxygenase-1 Protein Is Overexpressed in Human Renal Cancer Cells following Activation of the Ras-Raf-ERK Pathway and Mediates Anti-Apoptotic Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; GENE-EXPRESSION; EPITHELIAL-CELLS; KINASE PATHWAYS; MOLECULAR-MECHANISMS; ANTICANCER TREATMENT; ONCOGENIC RAS; RHO KINASE; NRF2; INHIBITION	The stress-inducible cytoprotective enzyme heme oxygenase-1 (HO-1) may play a critical role in the growth and metastasis of tumors. We demonstrated that overexpressed HO-1 promotes the survival of renal cancer cells by inhibiting cellular apoptosis; we also showed that the proto-oncogene H-Ras becomes activated in these cells under stress following treatment with immunosuppressive agents. However, it is not known if there is an association between Ras activation and HO-1 overexpression. Here, we examined if the activation of H-Ras pathway could induce HO-1, and promote the survival of renal cancer cells (786-0 and Caki-1). In co-transfection assays, using HO-1 promoter-luciferase construct, we found that the activated H-Ras, H-Ras(12V), promoted HO-1 transcriptional activation. The inhibition of endogenous H-Ras by specific dominant-negative mutant/siRNA markedly ablated the HO-1 promoter activity. Active H-Ras increased HO-1 mRNA and protein expression. Moreover, transfection with effector domain mutant constructs of active H-Ras showed that H-Ras-induced HO-1 overexpression was primarily mediated through the Raf signaling pathway. Using pharmacological inhibitor, we observed that ERK is a critical intermediary molecule for Ras-Raf-induced HO-1 expression. Activation of H-Ras and ERK promoted nuclear translocation of the transcription factor Nrf2 for its binding to the specific sequence of HO-1 promoter. The knockdown of Nrf2 significantly inhibited H-Ras-induced HO-1 transcription. Finally, by FACS analysis using Annexin-V staining, we demonstrated that the H-Ras-ERK-induced and HO-1-mediated pathway could protect renal cancer cells from apoptosis. Thus, targeting the Ras-Raf-ERK pathway for HO-1 overexpression may serve as novel therapeutics for the treatment of renal cancer.	[Banerjee, Pallavi; Basu, Aninda; Datta, Dipak; Pal, Soumitro] Harvard Univ, Div Nephrol, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA; [Banerjee, Pallavi; Basu, Aninda; Datta, Dipak; Pal, Soumitro] Harvard Univ, Dept Pediat, Sch Med, Boston, MA 02115 USA; [Gasser, Martin; Waaga-Gasser, Ana Maria] Univ Wurzburg, Dept Surg Mol Oncol & Immunol 1, D-97080 Wurzburg, Germany	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Wurzburg	Pal, S (corresponding author), Childrens Hosp, Div Nephrol, 300 Longwood Ave, Boston, MA 02115 USA.	soumitro.pal@childrens.harvard.edu			National Institutes of Health [R01 CA131145]; NATIONAL CANCER INSTITUTE [R01CA131145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA131145 (to S. P.).	Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; Akagi R, 2005, CONTRIB NEPHROL, V148, P70, DOI 10.1159/000086044; Alam J, 2000, J BIOL CHEM, V275, P27694; Alaoui-Jamali MA, 2009, CANCER RES, V69, P8017, DOI 10.1158/0008-5472.CAN-09-0419; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Datta D, 2006, CANCER RES, V66, P9509, DOI 10.1158/0008-5472.CAN-05-4345; Datta D, 2010, J BIOL CHEM, V285, P36842, DOI 10.1074/jbc.M110.170324; Datta D, 2009, CANCER RES, V69, P8902, DOI 10.1158/0008-5472.CAN-09-1404; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Durante W, 1999, ARTERIOSCL THROM VAS, V19, P2666, DOI 10.1161/01.ATV.19.11.2666; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Ekman S, 1999, ONCOGENE, V18, P2481, DOI 10.1038/sj.onc.1202606; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Ferrandiz ML, 2008, CURR PHARM DESIGN, V14, P473, DOI 10.2174/138161208783597399; Goodman AI, 1997, P SOC EXP BIOL MED, V214, P54; Hock TD, 2007, J BIOL CHEM, V282, P6875, DOI 10.1074/jbc.M608456200; Jo M, 2002, J BIOL CHEM, V277, P12479, DOI 10.1074/jbc.M111147200; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; KHOSRAVIFAR R, 1994, MOL CELL BIOL, V14, P6848, DOI 10.1128/MCB.14.10.6848; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kim T. H., 2011, CANC RES, V71; Kivela AM, 2008, J NUTR, V138, P1263, DOI 10.1093/jn/138.7.1263; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Miyake M, 2011, ONCOL REP, V25, P653, DOI 10.3892/or.2010.1125; Mo L, 2007, J CLIN INVEST, V117, P314, DOI 10.1172/JCI30062; Naidu S, 2009, J IMMUNOL, V182, P7048, DOI 10.4049/jimmunol.0900006; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Roberts RE, 2004, J PHARMACOL EXP THER, V311, P742, DOI 10.1124/jpet.104.071100; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rojo AI, 2006, FREE RADICAL BIO MED, V41, P247, DOI 10.1016/j.freeradbiomed.2006.04.002; Rushworth SA, 2008, BLOOD, V111, P3793, DOI 10.1182/blood-2007-07-104042; Rushworth SA, 2010, CANCER RES, V70, P2973, DOI 10.1158/0008-5472.CAN-09-3407; Ryter SW, 2005, ANTIOXID REDOX SIGN, V7, P80, DOI 10.1089/ars.2005.7.80; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; Sass G, 2008, INT J CANCER, V123, P1269, DOI 10.1002/ijc.23695; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; SCHLESSINGER J, 1993, TRENDS BIOCHEM SCI, V18, P273, DOI 10.1016/0968-0004(93)90031-H; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Srisook K, 2005, ANTIOXID REDOX SIGN, V7, P1674, DOI 10.1089/ars.2005.7.1674; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Xu L, 2005, CANCER RES, V65, P5711, DOI 10.1158/0008-5472.CAN-04-4313; Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200; Zipper LM, 2000, BIOCHEM BIOPH RES CO, V278, P484, DOI 10.1006/bbrc.2000.3830	54	53	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33580	33590		10.1074/jbc.M111.248401	http://dx.doi.org/10.1074/jbc.M111.248401			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808062	Green Published, hybrid			2022-12-27	WOS:000294968800074
J	Jin, XG; Chen, SR; Cao, XH; Li, L; Pan, HL				Jin, Xiao-Gao; Chen, Shao-Rui; Cao, Xue-Hong; Li, Li; Pan, Hui-Lin			Nitric Oxide Inhibits Nociceptive Transmission by Differentially Regulating Glutamate and Glycine Release to Spinal Dorsal Horn Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; SUBSTANTIA-GELATINOSA NEURONS; AMINO-ACID ANTAGONISTS; REDOX MODULATORY SITE; CALCIUM-CHANNELS; NMDA RECEPTOR; LAMINA-II; PHARMACOLOGICAL INHIBITION; NEUROTRANSMITTER RELEASE; BACKGROUND ACTIVITY	Nitric oxide (NO) is involved in many physiological functions, but its role in pain signaling remains uncertain. Surprisingly, little is known about how endogenous NO affects excitatory and inhibitory synaptic transmission at the spinal level. Here we determined how NO affects excitatory and inhibitory synaptic inputs to dorsal horn neurons using whole-cell recordings in rat spinal cord slices. The NO precursor L-arginine or the NO donor SNAP significantly increased the frequency of glycinergic spontaneous and miniature inhibitory postsynaptic currents (IPSCs) of lamina II neurons. However, neither L-arginine nor SNAP had any effect on GABAergic IPSCs. L-arginine and SNAP significantly reduced the amplitude of monosynaptic excitatory postsynaptic currents (EPSCs) evoked from the dorsal root with an increase in paired-pulse ratio. Inhibition of the soluble guanylyl cyclase abolished the effect of L-arginine on glycinergic IPSCs but not on evoked monosynaptic EPSCs. Also, inhibition of protein kinase G blocked the increase in glycinergic sIPSCs by the cGMP analog 8-bromo-cGMP. The inhibitory effects of L-arginine on evoked EPSCs and high voltage-activated Ca2+ channels expressed in HEK293 cells and dorsal root ganglion neurons were abolished by blocking the S-nitrosylation reaction with N-ethylmaleimide. Intrathecal injection of L-arginine and SNAP significantly increased mechanical nociceptive thresholds. Our findings suggest that spinal endogenous NO enhances inhibitory glycinergic input to dorsal horn neurons through sGC-cGMP-protein kinase G. Furthermore, NO reduces glutamate release from primary afferent terminals through S-nitrosylation of voltage-activated Ca2+ channels. Both of these actions probably contribute to inhibition of nociceptive transmission by NO at the spinal level.	[Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, Houston, TX 77030 USA; [Pan, Hui-Lin] Univ Texas Houston, Grad Sch Biomed Sci, Program Neurosci, Houston, TX 77225 USA; [Pan, Hui-Lin] Univ Texas Houston, Grad Sch Biomed Sci, Program Expt Therapeut, Houston, TX 77225 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	Li, Li/K-9630-2013	Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [GM064830, NS073935]; N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM064830 and NS073935 and the N. G. and Helen T. Hawkins Endowment (to H.-L. P.).	Aizenman E, 1999, BRIT J PHARMACOL, V126, P296, DOI 10.1038/sj.bjp.0702295; AKAIKE T, 1993, BIOCHEMISTRY-US, V32, P827, DOI 10.1021/bi00054a013; BERNARDI PS, 1995, J NEUROSCI, V15, P1363; Boettger MK, 2007, EUR J PAIN, V11, P810, DOI 10.1016/j.ejpain.2006.12.008; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Broillet MC, 1996, NEURON, V16, P377, DOI 10.1016/S0896-6273(00)80055-0; Butt E, 1995, BRIT J PHARMACOL, V116, P3110, DOI 10.1111/j.1476-5381.1995.tb15112.x; Chen SR, 2003, ANESTHESIOLOGY, V98, P217, DOI 10.1097/00000542-200301000-00033; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Chu YC, 2005, PAIN, V119, P113, DOI 10.1016/j.pain.2005.09.024; Ding JD, 2006, J COMP NEUROL, V495, P668, DOI 10.1002/cne.20901; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Gow AJ, 2004, AM J PHYSIOL-LUNG C, V287, pL262, DOI 10.1152/ajplung.00295.2003; Guan Y, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-29; Handy RLC, 1996, BRIT J PHARMACOL, V119, P423, DOI 10.1111/j.1476-5381.1996.tb16003.x; Head CA, 2010, AM J HEMATOL, V85, P800, DOI 10.1002/ajh.21832; Heinke B, 2004, J PHYSIOL-LONDON, V560, P249, DOI 10.1113/jphysiol.2004.070540; Hoheisel U, 2000, PAIN, V88, P249, DOI 10.1016/S0304-3959(00)00336-5; HOHEISEL U, 1995, NEUROSCI LETT, V188, P143, DOI 10.1016/0304-3940(95)11411-O; Hoheisel U, 2005, PAIN, V117, P358, DOI 10.1016/j.pain.2005.06.023; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jeong HJ, 2003, J PHYSIOL-LONDON, V550, P373, DOI 10.1113/jphysiol.2003.041053; Jeong SW, 1998, NEURON, V21, P1201, DOI 10.1016/S0896-6273(00)80636-4; Lee EA, 2009, J NEUROCHEM, V109, P275, DOI 10.1111/j.1471-4159.2009.05960.x; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; Li DP, 2002, J NEUROPHYSIOL, V88, P2664, DOI 10.1152/jn.00540.2002; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; Li K, 2010, NEUROSCI BULL, V26, P211, DOI 10.1007/s12264-010-0127-9; LIPTON SA, 1994, PROG BRAIN RES, V103, P359; Lu Y, 2003, J NEUROSCI, V23, P8752; MANZONI O, 1992, NEURON, V8, P653, DOI 10.1016/0896-6273(92)90087-T; McDavid S, 2006, J NEUROSCI, V26, P13373, DOI 10.1523/JNEUROSCI.3332-06.2006; Miyamoto T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007596; Nicholson R, 2004, NEUROSCI LETT, V359, P180, DOI 10.1016/j.neulet.2004.01.057; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; Pehl U, 1997, NEUROSCIENCE, V77, P563, DOI 10.1016/S0306-4522(96)00495-2; Rudkouskaya A, 2010, FREE RADICAL BIO MED, V49, P757, DOI 10.1016/j.freeradbiomed.2010.05.032; Santos SFA, 2007, J PHYSIOL-LONDON, V581, P241, DOI 10.1113/jphysiol.2006.126912; Schmidtko A, 2008, J NEUROSCI, V28, P8568, DOI 10.1523/JNEUROSCI.2128-08.2008; SEKHAR KR, 1992, MOL PHARMACOL, V42, P103; Sorkin LS, 1998, PAIN, V77, P181, DOI 10.1016/S0304-3959(98)00094-3; Sousa AM, 2001, BRAIN RES, V897, P9, DOI 10.1016/S0006-8993(01)01995-3; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Tanabe M, 2009, NEUROPHARMACOLOGY, V56, P702, DOI 10.1016/j.neuropharm.2008.12.003; Tao F, 2003, NEUROSCIENCE, V120, P847, DOI 10.1016/S0306-4522(03)00362-2; TERENGHI G, 1993, J NEUROL SCI, V118, P34, DOI 10.1016/0022-510X(93)90242-Q; Todd AJ, 1996, EUR J NEUROSCI, V8, P2492, DOI 10.1111/j.1460-9568.1996.tb01543.x; TODD AJ, 1990, J COMP NEUROL, V296, P496, DOI 10.1002/cne.902960312; UEDA H, 1990, J NEUROCHEM, V54, P841, DOI 10.1111/j.1471-4159.1990.tb02328.x; VALTSCHANOFF JG, 1992, NEUROSCI LETT, V148, P6, DOI 10.1016/0304-3940(92)90791-5; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Wang XL, 2006, J PHYSIOL-LONDON, V571, P403, DOI 10.1113/jphysiol.2005.102905; WINSLOW JW, 1987, J BIOL CHEM, V262, P4501; Wu SY, 1996, J PHYSIOL-LONDON, V495, P479, DOI 10.1113/jphysiol.1996.sp021608; Wu ZZ, 2005, J BIOL CHEM, V280, P18142, DOI 10.1074/jbc.M501229200; Wu ZZ, 2004, NEUROSCI LETT, V368, P96, DOI 10.1016/j.neulet.2004.06.067; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yuen KCJ, 2002, DIABETES CARE, V25, P1699, DOI 10.2337/diacare.25.10.1699; Zhang HM, 2005, J PHARMACOL EXP THER, V313, P697, DOI 10.1124/jpet.104.079939; Zhao YD, 2000, BIOCHEMISTRY-US, V39, P10848, DOI 10.1021/bi9929296; Zhou HY, 2008, J PHARMACOL EXP THER, V327, P375, DOI 10.1124/jpet.108.141226; Zhou HY, 2007, J NEUROPHYSIOL, V97, P871, DOI 10.1152/jn.00964.2006; Zhou HY, 2011, J PHARMACOL EXP THER, V336, P254, DOI 10.1124/jpet.110.173112; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010; ZHUO M, 1993, PAIN, V54, P71, DOI 10.1016/0304-3959(93)90101-T	66	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33190	33202		10.1074/jbc.M111.270967	http://dx.doi.org/10.1074/jbc.M111.270967			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813646	Green Published, hybrid			2022-12-27	WOS:000294968800038
J	Lin, RK; Zhou, N; Lyu, YL; Tsai, YC; Lu, CH; Kerrigan, J; Chen, YT; Guan, Z; Hsieh, TS; Liu, LF				Lin, Ren-Kuo; Zhou, Nai; Lyu, Yi Lisa; Tsai, Yuan-Chin; Lu, Chang-Hsien; Kerrigan, John; Chen, Yu-tsung; Guan, Ziqiang; Hsieh, Tao-Shih; Liu, Leroy F.			Dietary Isothiocyanate-induced Apoptosis via Thiol Modification of DNA Topoisomerase II alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; GREEN TEA; KAPPA-B; MEDIATED APOPTOSIS; BETA-LAPACHONE; ATPASE DOMAIN; PREVENTION; SELENIUM; SULFORAPHANE; EXPRESSION	Studies in animal models have indicated that dietary isothiocyanates (ITCs) exhibit cancer preventive activities through carcinogen detoxification-dependent and -independent mechanisms. The carcinogen detoxification-independent mechanism of cancer prevention by ITCs has been attributed at least in part to their ability to induce apoptosis of transformed (initiated) cells (e. g. through suppression of I kappa B kinase and nuclear factor kappa B as well as other proposed mechanisms). In the current studies we show that ITC-induced apoptosis of oncogene-transformed cells involves thiol modification of DNA topoisomerase II (Top2) based on the following observations. 1) siRNA-mediated knockdown of Top2 alpha in both SV40-transformed MEFs and Ras-transformed human mammary epithelial MCF10A cells resulted in reduced ITC sensitivity. 2) ITCs, like some anticancer drugs and cancer-preventive dietary components, were shown to induce reversible Top2 alpha cleavage complexes in vitro. 3) ITC-induced Top2 alpha cleavage complexes were abolished by co-incubation with excess glutathione. In addition, proteomic analysis revealed that several cysteine residues on human Top2 alpha were covalently modified by benzyl-ITC, suggesting that ITC-induced Top2 alpha cleavage complexes may involve cysteine modification. Interestingly, consistent with the thiol modification mechanism for Top2 alpha cleavage complex induction, the thiol-reactive selenocysteine, but not the non-thiol-reactive selenomethionine, was shown to induce Top2 alpha cleavage complexes. In the aggregate, our results suggest that thiol modification of Top2 alpha may contribute to apoptosis induction in transformed cells by ITCs.	[Lin, Ren-Kuo; Zhou, Nai; Lyu, Yi Lisa; Tsai, Yuan-Chin; Kerrigan, John; Liu, Leroy F.] Univ Med & Dent New Jersey, Dept Pharmacol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Lin, Ren-Kuo; Zhou, Nai; Lyu, Yi Lisa; Tsai, Yuan-Chin; Kerrigan, John; Liu, Leroy F.] Univ Med & Dent New Jersey, Canc Inst New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Lu, Chang-Hsien] Chang Gung Mem Hosp, Dept Hematol & Oncol, Chia Yi Branch, Chiayi 61363, Taiwan; [Chen, Yu-tsung; Guan, Ziqiang; Hsieh, Tao-Shih] Duke Univ, Dept Biochem, Med Ctr, Durham, NC 27710 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Chang Gung Memorial Hospital; Duke University	Liu, LF (corresponding author), 675 Hoes Lane, Piscataway, NJ 08854 USA.	lliu@umdnj.edu	Wu, Wan-lin/G-8937-2012; Hsieh, Tao-shih/G-9305-2012	Liu, Leroy/0000-0001-9396-763X	National Institutes of Health [CA39662, CA102463]; NATIONAL CANCER INSTITUTE [R01CA102463, R01CA039662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA39662 and CA102463.	Asano T, 1996, ONCOL RES, V8, P101; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Bandele OJ, 2008, CHEM RES TOXICOL, V21, P936, DOI 10.1021/tx700434v; Bandele OJ, 2007, BIOCHEMISTRY-US, V46, P6097, DOI 10.1021/bi7000664; Bender RP, 2007, BIOCHEMISTRY-US, V46, P2856, DOI 10.1021/bi062017l; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen G, 1999, ONCOGENE, V18, P7149, DOI 10.1038/sj.onc.1203149; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Chung FL, 2000, CARCINOGENESIS, V21, P2287, DOI 10.1093/carcin/21.12.2287; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Combs GF, 2001, NUTR CANCER, V40, P6, DOI 10.1207/S15327914NC401_4; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Frydman B, 1997, CANCER RES, V57, P620; Gasparian AV, 2002, MOL CANCER THER, V1, P1079; Genchi G, 2001, BBA-MOL CELL BIOL L, V1530, P146, DOI 10.1016/S1388-1981(00)00175-X; Giaccone G, 1995, BBA-GENE STRUCT EXPR, V1264, P337, DOI 10.1016/0167-4781(95)00171-9; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Herr I, 2010, CANCER TREAT REV, V36, P377, DOI 10.1016/j.ctrv.2010.01.002; Hu T, 2002, J BIOL CHEM, V277, P5944, DOI 10.1074/jbc.M111394200; Ip C, 1998, J NUTR, V128, P1845, DOI 10.1093/jn/128.11.1845; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; LIU LF, 1983, J BIOL CHEM, V258, P5365; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mi LX, 2011, CARCINOGENESIS, V32, P216, DOI 10.1093/carcin/bgq242; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; Na HK, 2008, FOOD CHEM TOXICOL, V46, P1271, DOI 10.1016/j.fct.2007.10.006; Na HK, 2006, MOL CARCINOGEN, V45, P368, DOI 10.1002/mc.20225; Nakamura Y, 2010, BIOSCI BIOTECH BIOCH, V74, P242, DOI 10.1271/bbb.90731; Neder K, 1998, CELL MOL BIOL, V44, P465; Ogawa K, 1998, INT J CANCER, V76, P851; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Sahu RP, 2009, JNCI-J NATL CANCER I, V101, P176, DOI 10.1093/jnci/djn470; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Shishodia S, 2005, CANCER RES, V65, P9555, DOI 10.1158/0008-5472.CAN-05-1585; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; SMITH K, 1993, ONCOGENE, V8, P933; SOULE HD, 1990, CANCER RES, V50, P6075; Stan SD, 2008, J CELL BIOCHEM, V104, P339, DOI 10.1002/jcb.21623; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Tsai Y.-C., 2011, PLOS ONE IN PRESS; Varis A, 2004, INT J CANCER, V109, P548, DOI 10.1002/ijc.20001; Wang HM, 2001, BIOCHEMISTRY-US, V40, P3316, DOI 10.1021/bi002786j; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang QJ, 1997, MOL CELL BIOL, V17, P389, DOI 10.1128/MCB.17.1.389; Warin R, 2009, CANCER RES, V69, P9473, DOI 10.1158/0008-5472.CAN-09-2960; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wei H, 2005, J BIOL CHEM, V280, P37041, DOI 10.1074/jbc.M506520200; WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209; Xu CJ, 2006, CARCINOGENESIS, V27, P437, DOI 10.1093/carcin/bgi251; Yang FJ, 2001, MOL PHARMACOL, V60, P528; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhou N, 2003, J BIOL CHEM, V278, P29532, DOI 10.1074/jbc.M301877200	63	38	38	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33591	33600		10.1074/jbc.M111.258137	http://dx.doi.org/10.1074/jbc.M111.258137			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828038	Green Published, hybrid			2022-12-27	WOS:000294968800075
J	Hossain, MA; Rosengren, KJ; Samuel, CS; Shabanpoor, F; Chan, LJ; Bathgate, RAD; Wade, JD				Hossain, Mohammed Akhter; Rosengren, K. Johan; Samuel, Chrishan S.; Shabanpoor, Fazel; Chan, Linda J.; Bathgate, Ross A. D.; Wade, John D.			The Minimal Active Structure of Human Relaxin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING SITE; SOLID-PHASE SYNTHESIS; IN-VIVO; A-CHAIN; CHIMERIC PEPTIDE; HORMONE RELAXIN; ACTIVATION; COLLAGEN; INSULIN; FIBROBLASTS	H2 relaxin is a peptide hormone associated with a number of therapeutically relevant physiological effects, including regulation of collagen metabolism and multiple vascular control pathways. It is currently in phase III clinical trials for the treatment of acute heart failure due to its ability to induce vasodilation and influence renal function. It comprises 53 amino acids and is characterized by two separate polypeptide chains (A-B) that are cross-linked by three disulfide bonds. This size and complex structure represents a considerable challenge for the chemical synthesis of H2 relaxin, a major limiting factor for the exploration of modifications and derivatizations of this peptide, to optimize effect and drug-like characteristics. To address this issue, we describe the solid phase peptide synthesis and structural and functional evaluation of 24 analogues of H2 relaxin with truncations at the termini of its peptide chains. We show that it is possible to significantly truncate both the N and C termini of the B-chain while still retaining potent biological activity. This suggests that these regions are not critical for interactions with the H2 relaxin receptor, RXFP1. In contrast, truncations do reduce the activity of H2 relaxin for the related receptor RXFP2 by improving RXFP1 selectivity. In addition to new mechanistic insights into the function of H2 relaxin, this study identifies a critical active core with 38 amino acids. This minimized core shows similar antifibrotic activity as native H2 relaxin when tested in human BJ3 cells and thus represents an attractive receptor-selective lead for the development of novel relaxin therapeutics.	[Hossain, Mohammed Akhter; Samuel, Chrishan S.; Shabanpoor, Fazel; Chan, Linda J.; Bathgate, Ross A. D.; Wade, John D.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia; [Chan, Linda J.; Wade, John D.] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Samuel, Chrishan S.; Bathgate, Ross A. D.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; University of Queensland	Hossain, MA (corresponding author), Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia.	akhter.hossain@florey.edu.au; john.wade@florey.edu.au	Rosengren, K. Johan/P-4450-2016; Bathgate, Ross/ABE-6471-2020	Rosengren, K. Johan/0000-0002-5007-8434; Bathgate, Ross/0000-0001-6301-861X; Hossain, Mohammed/0000-0002-9961-0006; Wade, John/0000-0002-1352-6568	National Health and Medical Research Council (NHMRC, Australia) [350284, 508995]; Victorian Government	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This work was supported by National Health and Medical Research Council (NHMRC, Australia) Project Grants 350284 and 508995 (to J. D. W. and R. A. D. B.). Studies at the FNI were supported by the Victorian Government's Operational Infrastructure support program.	Atherton E., 1998, SOLID PHASE PEPTIDE; Baccari MC, 2004, CURR PROTEIN PEPT SC, V5, P9, DOI 10.2174/1389203043486928; BULLESBACH EE, 1992, J BIOL CHEM, V267, P22957; Bullesbach EE, 2000, J BIOL CHEM, V275, P35276, DOI 10.1074/jbc.M005728200; BULLESBACH EE, 1987, J BIOL CHEM, V262, P12496; Bullesbach EE, 2005, J BIOL CHEM, V280, P14051, DOI 10.1074/jbc.M500030200; Bullesbach EE, 2005, J BIOL CHEM, V280, P14586, DOI 10.1074/jbc.M414443200; BULLESBACH EE, 1986, BIOCHEMISTRY-US, V25, P5998; Bullesbach EE, 1999, BIOCHEMISTRY-US, V38, P3073, DOI 10.1021/bi982687u; Bullesbach EE, 2001, J PEPT RES, V57, P77, DOI 10.1034/j.1399-3011.2001.00832.x; BULLESBACH EE, 1988, INT J PEPT PROT RES, V32, P361; Chan LJ, 2011, PROTEIN PEPTIDE LETT, V18, P220; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; Du XJ, 2010, NAT REV CARDIOL, V7, P48, DOI 10.1038/nrcardio.2009.198; GALLOP PM, 1975, PHYSIOL REV, V55, P418, DOI 10.1152/physrev.1975.55.3.418; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hartley BJ, 2009, ANN NY ACAD SCI, V1160, P67, DOI 10.1111/j.1749-6632.2009.03949.x; Haugaard-Jonsson LM, 2008, J BIOL CHEM, V283, P23811, DOI 10.1074/jbc.M800489200; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Hewitson TD, 2010, ENDOCRINOLOGY, V151, P4938, DOI 10.1210/en.2010-0286; Hossain MA, 2008, J BIOL CHEM, V283, P17287, DOI 10.1074/jbc.M801911200; Hossain MA, 2010, CURR PROTEIN PEPT SC, V11, P719; Hossain MA, 2009, ORG BIOMOL CHEM, V7, P1547, DOI 10.1039/b821882j; Hossain MA, 2009, BIOCONJUGATE CHEM, V20, P1390, DOI 10.1021/bc900181a; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Keller R., 2004, COMPUTER AIDED RESON, V1; Kuei C, 2007, J BIOL CHEM, V282, P25425, DOI 10.1074/jbc.M701416200; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; Liu CL, 2005, MOL PHARMACOL, V67, P231, DOI 10.1124/mol.104.006700; Masterson R, 2004, NEPHROL DIAL TRANSPL, V19, P544, DOI 10.1093/ndt/gfg598; Park JI, 2008, J BIOL CHEM, V283, P32099, DOI 10.1074/jbc.M806817200; Rosengren KJ, 2006, J BIOL CHEM, V281, P28287, DOI 10.1074/jbc.M603829200; Rosengren KJ, 2009, ANN NY ACAD SCI, V1160, P20, DOI 10.1111/j.1749-6632.2009.03833.x; Samuel CS, 2005, CLIN MED RES, V3, P241, DOI 10.3121/cmr.3.4.241; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Samuel CS, 1996, ENDOCRINOLOGY, V137, P3884, DOI 10.1210/en.137.9.3884; SCHWABE C, 1977, SCIENCE, V197, P914, DOI 10.1126/science.887933; Scott DJ, 2009, ANN NY ACAD SCI, V1160, P74, DOI 10.1111/j.1749-6632.2009.03950.x; Scott DJ, 2006, J BIOL CHEM, V281, P34942, DOI 10.1074/jbc.M602728200; Shabanpoor F, 2008, BIOCONJUGATE CHEM, V19, P1456, DOI 10.1021/bc800127p; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Svendsen AM, 2008, ENDOCRINOLOGY, V149, P1113, DOI 10.1210/en.2007-0412; Svendsen AM, 2008, MOL CELL ENDOCRINOL, V296, P10, DOI 10.1016/j.mce.2008.07.014; Teerlink JR, 2009, LANCET, V373, P1429, DOI 10.1016/S0140-6736(09)60622-X; Teichman Sam L, 2010, Curr Heart Fail Rep, V7, P75, DOI 10.1007/s11897-010-0010-z; Tozzi CA, 2005, PULM PHARMACOL THER, V18, P346, DOI 10.1016/j.pupt.2005.01.003; UNEMORI EN, 1990, J BIOL CHEM, V265, P10681; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K, 1986, NMR PROTEINS NUCL AC	51	41	49	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37555	37565		10.1074/jbc.M111.282194	http://dx.doi.org/10.1074/jbc.M111.282194			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878627	Green Published, hybrid			2022-12-27	WOS:000296542400054
J	Nagare, T; Sakaue, H; Matsumoto, M; Cao, YH; Inagaki, K; Sakai, M; Takashima, Y; Nakamura, K; Mori, T; Okada, Y; Matsuki, Y; Watanabe, E; Ikeda, K; Taguchi, R; Kamimura, N; Ohta, S; Hiramatsu, R; Kasuga, M				Nagare, Tomoki; Sakaue, Hiroshi; Matsumoto, Michihiro; Cao, Yongheng; Inagaki, Kenjiro; Sakai, Mashito; Takashima, Yasuhiro; Nakamura, Kyoko; Mori, Toshiyuki; Okada, Yuko; Matsuki, Yasushi; Watanabe, Eijiro; Ikeda, Kazutaka; Taguchi, Ryo; Kamimura, Naomi; Ohta, Shigeo; Hiramatsu, Ryuji; Kasuga, Masato			Overexpression of KLF15 Transcription Factor in Adipocytes of Mice Results in Down-regulation of SCD1 Protein Expression in Adipocytes and Consequent Enhancement of Glucose-induced Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE-1; KRUPPEL-LIKE FACTOR; PANCREATIC BETA-CELLS; GENE-EXPRESSION; OXIDATIVE STRESS; ENERGY-BALANCE; OBESITY; CONTRIBUTES; GLUCONEOGENESIS; ANTIOXIDANTS	Kruppel-like factor 15 (KLF15), a member of the Kruppel-like factor family of transcription factors, has been found to play diverse roles in adipocytes in vitro. However, little is known of the function of KLF15 in adipocytes in vivo. We have now found that the expression of KLF15 in adipose tissue is down-regulated in obese mice, and we therefore generated adipose tissue-specific KLF15 transgenic (aP2-KLF15Tg) mice to investigate the possible contribution of KLF15 to various pathological conditions associated with obesity in vivo. The aP2-KLF15 Tg mice manifest insulin resistance and are resistant to the development of obesity induced by maintenance on a high fat diet. However, they also exhibit improved glucose tolerance as a result of enhanced insulin secretion. Furthermore, this enhancement of insulin secretion was shown to result from down-regulation of the expression of stearoyl-CoA desaturase 1 (SCD1) in white adipose tissue and a consequent reduced level of oxidative stress. This is supported by the findings that restoration of SCD1 expression in white adipose tissue of aP2-KLF15 Tg mice exhibited increased oxidative stress in white adipose tissue and reduced insulin secretion with hyperglycemia. Our data thus provide an example of cross-talk between white adipose tissue and pancreatic beta cells mediated through modulation of oxidative stress.	[Kasuga, Masato] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Res Inst, Shinjuku Ku, Tokyo 1628655, Japan; [Nagare, Tomoki; Matsumoto, Michihiro; Cao, Yongheng; Inagaki, Kenjiro; Sakai, Mashito] Natl Ctr Global Hlth & Med, Dept Mol Metab Regulat, Tokyo 1628655, Japan; [Nagare, Tomoki; Sakaue, Hiroshi; Takashima, Yasuhiro; Nakamura, Kyoko; Mori, Toshiyuki; Okada, Yuko; Kasuga, Masato] Kobe Univ, Grad Sch Med, Div Diabet Metab & Endocrinol, Dept Internal Med, Kobe, Hyogo 6500017, Japan; [Sakaue, Hiroshi] Univ Tokushima, Grad Sch, Dept Nutr & Metab, Inst Hlth Biosci, Tokushima 7708503, Japan; [Matsuki, Yasushi; Watanabe, Eijiro; Hiramatsu, Ryuji] Dainippon Sumitomo Pharma Co Ltd, Pharmacol Res Labs, Takarazuka, Hyogo 6650051, Japan; [Ikeda, Kazutaka] Keio Univ, Inst Adv Biosci, Yamagata 9970052, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Dept Metabolome, Grad Sch Med, Tokyo 1130033, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol Program, Kawaguchi, Saitama 3320012, Japan; [Taguchi, Ryo] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Aichi 4878501, Japan; [Kamimura, Naomi; Ohta, Shigeo] Nippon Med Sch, Dept Biochem & Cell Biol, Inst Dev & Aging Sci, Grad Sch Med, Kawasaki, Kanagawa 2118533, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Kobe University; Tokushima University; Dainippon Sumitomo Pharmaceutical Company; Keio University; University of Tokyo; Japan Science & Technology Agency (JST); Chubu University; Nippon Medical School	Kasuga, M (corresponding author), Natl Ctr Global Hlth & Med, Diabet Res Ctr, Res Inst, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	kasuga@ri.ncgm.go.jp	Sakaue, Hiroshi/ABE-2337-2021	Sakaue, Hiroshi/0000-0002-2468-2363; Takashima, Yasuhiro/0000-0003-0126-7260; Sakai, Mashito/0000-0002-4908-2727	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Center for Global Health and Medicine [21S116]; Takeda Science Foundation; Takeda Medical Science Foundation; Grants-in-Aid for Scientific Research [21591151] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Takeda Medical Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for creative scientific research (to M. K. and M. M.), a grant-in-aid for scientific research (c) (to H. S. and M. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant from the National Center for Global Health and Medicine 21S116 (to M. M.), a grant from Takeda Science Foundation (to H. S. and M. M.), and a grant from Takeda Medical Science Foundation (to H. S.).	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Diehl AM, 1999, J BIOENERG BIOMEMBR, V31, P493, DOI 10.1023/A:1005452624640; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Hashimoto N, 2005, J CLIN INVEST, V115, P138, DOI 10.1172/JCI200522232; Hyun CK, 2010, BIOCHEM BIOPH RES CO, V399, P480, DOI 10.1016/j.bbrc.2010.07.072; Ikeda K, 2011, CANCER SCI, V102, P79, DOI 10.1111/j.1349-7006.2010.01754.x; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Laurent G, 2008, CELL METAB, V7, P113, DOI 10.1016/j.cmet.2007.12.010; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Liu XQ, 2010, ARTERIOSCL THROM VAS, V30, P31, DOI 10.1161/ATVBAHA.109.195636; Matsushita N, 2004, J NEUROSCI RES, V78, P7, DOI 10.1002/jnr.20229; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Nagare T, 2009, BIOCHEM BIOPH RES CO, V379, P98, DOI 10.1016/j.bbrc.2008.12.020; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Ntambi JM, 1999, J LIPID RES, V40, P1549; Oliveira HR, 2003, DIABETES, V52, P1457, DOI 10.2337/diabetes.52.6.1457; Oprescu AI, 2007, DIABETES, V56, P2927, DOI 10.2337/db07-0075; Pagel-Langenickel I, 2007, AM J PHYSIOL-HEART C, V293, pH2659, DOI 10.1152/ajpheart.00782.2007; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sakai T, 2007, J BIOL CHEM, V282, P2038, DOI 10.1074/jbc.M608144200; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Takashima M, 2010, DIABETES, V59, P1608, DOI 10.2337/db09-1679; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Teshigawara K, 2005, BIOCHEM BIOPH RES CO, V327, P920, DOI 10.1016/j.bbrc.2004.12.096; Uchida S, 2000, MOL CELL BIOL, V20, P7319, DOI 10.1128/MCB.20.19.7319-7331.2000; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200	37	24	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37458	37469		10.1074/jbc.M111.242651	http://dx.doi.org/10.1074/jbc.M111.242651			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21862590	Green Published, hybrid			2022-12-27	WOS:000296542400045
J	Stempin, CC; Chi, LY; Giraldo-Vela, JP; High, AA; Hacker, H; Redecke, V				Stempin, Cinthia C.; Chi, Liying; Giraldo-Vela, Juan P.; High, Anthony A.; Haecker, Hans; Redecke, Vanessa			The E3 Ubiquitin Ligase Mind Bomb-2 (MIB2) Protein Controls B-cell CLL/Lymphoma 10 (BCL10)-dependent NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE PRODUCTION; SIGNALING PATHWAY; MALT LYMPHOMA; BCL10 PLAYS; KINASE; TRAF6; TAK1; RECEPTORS; COMPLEX; ANTIGEN	B-cell CLL/lymphoma 10 (BCL10) is crucial for the activation of NF-kappa B in numerous immune receptor signaling pathways, including the T-cell receptor (TCR) and B-cell receptor signaling pathways. However, the molecular mechanisms that lead to signal transduction from BCL10 to downstream NF-kappa B effector kinases, such as TAK1 and components of the IKK complex, are not entirely understood. Here we used a proteomic approach and identified the E3 ligase MIB2 as a novel component of the activated BCL10 complex. In vitro translation and pulldown assays suggest direct interaction between BCL10 and MIB2. Overexpression experiments show that MIB2 controls BCL10-mediated activation of NF-kappa B by promoting autoubiquitination and ubiquitination of IKK gamma/NEMO, as well as recruitment and activation of TAK1. Knockdown of MIB2 inhibited BCL10-dependent NF-kappa B activation. Together, our results identify MIB2 as a novel component of the activated BCL10 signaling complex and a missing link in the BCL10-dependent NF-kappa B signaling pathway.	[Stempin, Cinthia C.; Chi, Liying; Giraldo-Vela, Juan P.; Haecker, Hans; Redecke, Vanessa] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [High, Anthony A.] St Jude Childrens Res Hosp, Hartwell Ctr, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Redecke, V (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	vanessa.redecke@stjude.org	Haecker, Hans/F-6826-2013	Haecker, Hans/0000-0001-5971-0451	National Institutes of Health [AI083443]; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI083443 (to H. H.). This work was also supported by the American Lebanese Syrian Associated Charities.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Blonska M, 2007, IMMUNITY, V26, P55, DOI 10.1016/j.immuni.2006.11.008; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Carrasco-Rando M, 2008, DEVELOPMENT, V135, P849, DOI 10.1242/dev.015529; Chen YH, 2007, J IMMUNOL, V178, P49, DOI 10.4049/jimmunol.178.1.49; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gross O, 2008, BLOOD, V112, P2421, DOI 10.1182/blood-2007-11-123513; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; HOYOS B, 1989, SCIENCE, V244, P457, DOI 10.1126/science.2497518; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jurd R, 2008, J BIOL CHEM, V283, P301, DOI 10.1074/jbc.M705580200; Kanarek N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000166; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Langel FD, 2008, J BIOL CHEM, V283, P32419, DOI 10.1074/jbc.M800670200; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Malarkannan S, 2007, J IMMUNOL, V179, P3752, DOI 10.4049/jimmunol.179.6.3752; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Nguyen HT, 2007, J CELL BIOL, V179, P219, DOI 10.1083/jcb.200708135; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Thome M, 2008, NAT REV IMMUNOL, V8, P495, DOI 10.1038/nri2338; Thome M, 2007, TRENDS IMMUNOL, V28, P281, DOI 10.1016/j.it.2007.04.004; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yamamoto M, 2006, J IMMUNOL, V177, P7520, DOI 10.4049/jimmunol.177.11.7520; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	47	33	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37147	37157		10.1074/jbc.M111.263384	http://dx.doi.org/10.1074/jbc.M111.263384			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896478	hybrid, Green Published			2022-12-27	WOS:000296542400015
J	Cascales, L; Henriques, ST; Kerr, MC; Huang, YH; Sweet, MJ; Daly, NL; Craik, DJ				Cascales, Laura; Henriques, Sonia T.; Kerr, Markus C.; Huang, Yen-Hua; Sweet, Matthew J.; Daly, Norelle L.; Craik, David J.			Identification and Characterization of a New Family of Cell-penetrating Peptides CYCLIC CELL-PENETRATING PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOTIDE KALATA B1; CYSTINE-KNOT MINIPROTEINS; PLASMA-MEMBRANE; PHOSPHATIDIC-ACID; HEPARAN-SULFATE; DRUG DESIGN; HIV-1 TAT; MOMORDICA-COCHINCHINENSIS; MACROCYCLIC PEPTIDES; BIOLOGICAL-ACTIVITY	Cell-penetrating peptides can translocate across the plasma membrane of living cells and thus are potentially useful agents in drug delivery applications. Disulfide-rich cyclic peptides also have promise in drug design because of their exceptional stability, but to date only one cyclic peptide has been reported to penetrate cells, the Momordica cochinchinensis trypsin inhibitor II (MCoTI-II). MCoTI-II belongs to the cyclotide family of plant-derived cyclic peptides that are characterized by a cyclic cystine knot motif. Previous studies in fixed cells showed that MCoTI-II could penetrate cells but kalata B1, a prototypic cyclotide from a separate subfamily of cyclotides, was bound to the plasma membrane and did not translocate into cells. Here, we show by live cell imaging that both MCoTI-II and kalata B1 can enter cells. Kalata B1 has the same cyclic cystine knot structural motif as MCoTI-II but differs significantly in sequence, and the mechanism by which these two peptides enter cells also differs. MCoTI-II appears to enter via macropinocytosis, presumably mediated by interaction of positively charged residues with phosphoinositides in the cell membrane, whereas kalata B1 interacts directly with the membrane by targeting phosphatidylethanolamine phospholipids, probably leading to membrane bending and vesicle formation. We also show that another plant-derived cyclic peptide, SFTI-1, can penetrate cells. SFTI-1 includes just 14 amino acids and, with the exception of its cyclic backbone, is structurally very different from the cyclotides, which are twice the size. Intriguingly, SFTI-1 does not interact with any of the phospholipids tested, and its mechanism of penetration appears to be distinct from MCoTI-II and kalata B1. The ability of diverse disulfide-rich cyclic peptides to penetrate cells enhances their potential in drug design, and we propose a new classification for them, i.e. cyclic cell-penetrating peptides.	[Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Henriques, Sonia T.] Univ Lisbon, Sch Med, Inst Mol Med, P-1649028 Lisbon, Portugal	University of Queensland; Universidade de Lisboa	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Sweet, Matthew J/F-2229-2011; Huang, Yen-Hua/J-9056-2014; Henriques, Sonia Troeira/J-3500-2016; Kerr, Markus C/A-9864-2014; Craik, David/B-1695-2010; Daly, Norelle L/D-4302-2013	Sweet, Matthew J/0000-0002-0406-8139; Huang, Yen-Hua/0000-0001-6937-2660; Henriques, Sonia Troeira/0000-0001-9564-9651; Craik, David/0000-0003-0007-6796; Daly, Norelle L/0000-0002-4697-6602	Australian Research Council [DP880105];  [PIOF-GA-2008-220318];  [FT100100657];  [APP1003470.]	Australian Research Council(Australian Research Council); ; ; 	This work was supported in part by Australian Research Council Grant DP880105.; Marie Curie International Outgoing Fellow supported by Grant PIOF-GA-2008-220318.; Australian Research Council Future Fellow supported by Grant FT100100657 and an honorary National Health and Medical Research Council Senior Research Fellow supported by Grant APP1003470.	Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Austin J, 2009, CHEMBIOCHEM, V10, P2663, DOI 10.1002/cbic.200900534; Avrutina O, 2008, CHEMBIOCHEM, V9, P33, DOI 10.1002/cbic.200700452; Balla T, 2009, PHYSIOLOGY, V24, P231, DOI 10.1152/physiol.00014.2009; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Cadmel B, 2008, J PROTEOME RES, V7, P5295, DOI 10.1021/pr800540h; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Chen B, 2006, J NAT PROD, V69, P23, DOI 10.1021/np050317i; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2010, CELL MOL LIFE SCI, V67, P9, DOI 10.1007/s00018-009-0159-3; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Craik DJ, 2004, CURR PROTEIN PEPT SC, V5, P297, DOI 10.2174/1389203043379512; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Daleke DL, 2008, CURR OPIN HEMATOL, V15, P191, DOI 10.1097/MOH.0b013e3282f97af7; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2006, J BIOL CHEM, V281, P23668, DOI 10.1074/jbc.M601426200; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Devaux PF, 2000, BIOCHIMIE, V82, P497, DOI 10.1016/S0300-9084(00)00209-1; Devaux PF, 2008, BBA-BIOMEMBRANES, V1778, P1591, DOI 10.1016/j.bbamem.2008.03.007; Farge E, 1999, AM J PHYSIOL-CELL PH, V276, pC725, DOI 10.1152/ajpcell.1999.276.3.C725; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Greenwood KP, 2007, INT J BIOCHEM CELL B, V39, P2252, DOI 10.1016/j.biocel.2007.06.016; Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; Heitz A, 2001, BIOCHEMISTRY-US, V40, P7973, DOI 10.1021/bi0106639; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Henriques ST, 2005, FEBS LETT, V579, P4498, DOI 10.1016/j.febslet.2005.06.085; Henriques ST, 2005, BIOCHEMISTRY-US, V44, P10189, DOI 10.1021/bi0502644; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Iwamoto K, 2007, BIOPHYS J, V93, P1608, DOI 10.1529/biophysj.106.101584; Jagadish K, 2010, BIOPOLYMERS, V94, P611, DOI 10.1002/bip.21433; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kolmar H, 2008, FEBS J, V275, P2684, DOI 10.1111/j.1742-4658.2008.06440.x; Kozlov MM, 2010, NATURE, V463, P439, DOI 10.1038/463439a; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lookene A, 1996, BIOCHEMISTRY-US, V35, P12155, DOI 10.1021/bi960008e; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Mabrouk K, 2007, BBA-BIOMEMBRANES, V1768, P2528, DOI 10.1016/j.bbamem.2007.06.030; Makino A, 2003, J BIOL CHEM, V278, P3204, DOI 10.1074/jbc.M210347200; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Plan MRR, 2007, CHEMBIOCHEM, V8, P1001, DOI 10.1002/cbic.200700097; Ram N, 2008, J BIOL CHEM, V283, P24274, DOI 10.1074/jbc.M709971200; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Satoh A, 2000, FEBS LETT, V477, P249, DOI 10.1016/S0014-5793(00)01746-4; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Sommerhoff CP, 2010, J MOL BIOL, V395, P167, DOI 10.1016/j.jmb.2009.10.028; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Thongyoo P, 2007, CHEMBIOCHEM, V8, P1107, DOI 10.1002/cbic.200700187; Thongyoo P, 2009, J MED CHEM, V52, P6197, DOI 10.1021/jm901233u; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; WRIGHT CS, 1984, J MOL BIOL, V178, P91, DOI 10.1016/0022-2836(84)90232-8; Yu Y, 2010, J AM CHEM SOC, V132, P195, DOI 10.1021/ja9059014; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zaro JL, 2005, EXP CELL RES, V307, P164, DOI 10.1016/j.yexcr.2005.02.024; Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	75	133	142	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36932	36943		10.1074/jbc.M111.264424	http://dx.doi.org/10.1074/jbc.M111.264424			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21873420	Green Published, hybrid			2022-12-27	WOS:000296538300072
J	Hradsky, J; Raghuram, V; Reddy, PP; Navarro, G; Hupe, M; Casado, V; McCormick, PJ; Sharma, Y; Kreutz, MR; Mikhaylova, M				Hradsky, Johannes; Raghuram, Vijeta; Reddy, Parameshwar Pasham; Navarro, Gemma; Hupe, Mike; Casado, Vicent; McCormick, Peter J.; Sharma, Yogendra; Kreutz, Michael R.; Mikhaylova, Marina			Post-translational Membrane Insertion of Tail-anchored Transmembrane EF-hand Ca2+ Sensor Calneurons Requires the TRC40/Asna1 Protein Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; CALCIUM; OLIGOMERIZATION; RECOGNITION; CURVATURE; DYNAMICS; SIGNAL; SPHINGOLIPIDS; HIPPOCALCIN; INTEGRATION	Calneuron-1 and -2 are neuronal EF-hand-type calcium sensor proteins that are prominently targeted to trans-Golgi network membranes and impose a calcium threshold at the Golgi for phosphatidylinositol 4-OH kinase III beta activation and the regulated local synthesis of phospholipids that are crucial for TGN-to-plasma membrane trafficking. /In this study, we show that calneurons are nonclassical type II tail-anchored proteins that are post-translationally inserted into the endoplasmic reticulum membrane via an association of a 23-amino acid-long transmembrane domain (TMD) with the TRC40/Asna1 chaperone complex. Following trafficking to the Golgi, calneurons are probably retained in the TGN because of the length of the TMD and phosphatidylinositol 4-phosphate lipid binding. Both calneurons rapidly self-associate in vitro and in vivo via their TMD and EF-hand containing theNterminus. Although dimerization and potentially multimerization precludes TRC40/Asna1 binding and thereby membrane insertion, we found no evidence for a cytosolic pool of calneurons and could demonstrate that self-association of calneurons is restricted to membrane-inserted protein. The dimerization properties and the fact that they, unlike every other EF-hand calmodulin-like Ca2+ sensor, are always associated with membranes of the secretory pathway, including vesicles and plasma membrane, suggests a high degree of spatial segregation for physiological target interactions.	[Hradsky, Johannes; Raghuram, Vijeta; Reddy, Parameshwar Pasham; Hupe, Mike; Kreutz, Michael R.; Mikhaylova, Marina] Leibniz Inst Neurobiol, Res Grp Neuroplast, D-39118 Magdeburg, Germany; [Hradsky, Johannes; Kreutz, Michael R.] German Ctr Neurodegenerat Dis, D-39118 Magdeburg, Germany; [Raghuram, Vijeta; Sharma, Yogendra] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Navarro, Gemma; Casado, Vicent; McCormick, Peter J.] Univ Barcelona, Fac Biol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-08028 Barcelona, Spain; [Navarro, Gemma; Casado, Vicent; McCormick, Peter J.] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain	Leibniz Institut fur Neurobiologie (LIN); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); CIBERNED; University of Barcelona; University of Barcelona	Kreutz, MR (corresponding author), Leibniz Inst Neurobiol, Res Grp Neuroplast, D-39118 Magdeburg, Germany.	kreutz@lin-magdeburg.de; mikhaylova@lin-magdeburg.de	Navarro, Gemma/AAO-7866-2021; Casadó, Vicent/K-1660-2014; McCormick, Peter/E-7387-2012; Mikhaylova, Marina/AAM-4368-2020	Navarro, Gemma/0000-0003-4654-0873; Casadó, Vicent/0000-0002-1764-3825; McCormick, Peter/0000-0002-2225-5181; Mikhaylova, Marina/0000-0001-7646-1346; Raghuram, Vijeta/0000-0002-9081-001X; Hupe, Mike/0000-0002-7735-2958	Deutsche Forschungsgemeinschaft; DZNE Magdeburg; Schram Foundation; Deutscher Akademischer Austauschdienst-Department of Science and Technology; Bundesministerium fur Bildung und Forschung, Department of Biotechnology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DZNE Magdeburg; Schram Foundation; Deutscher Akademischer Austauschdienst-Department of Science and Technology(Deutscher Akademischer Austausch Dienst (DAAD)); Bundesministerium fur Bildung und Forschung, Department of Biotechnology(Federal Ministry of Education & Research (BMBF))	This work was supported by research grants from the Deutsche Forschungsgemeinschaft, DZNE Magdeburg, and the Schram Foundation (to M. R. K.), a Deutscher Akademischer Austauschdienst-Department of Science and Technology scholar exchange grant, and a Bundesministerium fur Bildung und Forschung, Department of Biotechnology international cooperation grant (to Y. S. and M. R. K.).	Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Ceppi P, 2005, P NATL ACAD SCI USA, V102, P16269, DOI 10.1073/pnas.0508157102; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Dolman NJ, 2006, CELL CALCIUM, V40, P505, DOI 10.1016/j.ceca.2006.08.012; Favaloro V, 2010, J CELL SCI, V123, P1522, DOI 10.1242/jcs.055970; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Lundbaek JA, 2003, BIOPHYS J, V84, P2080, DOI 10.1016/S0006-3495(03)75015-2; Lusin JD, 2008, BIOCHEMISTRY-US, V47, P2252, DOI 10.1021/bi7017267; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Mccue HV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017853; McCue Hannah V, 2010, BMC Res Notes, V3, P118, DOI 10.1186/1756-0500-3-118; Mccue HV, 2009, BIOCHEM BIOPH RES CO, V380, P825, DOI 10.1016/j.bbrc.2009.01.177; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Micaroni M, 2010, CURR MOL MED, V10, P763, DOI 10.2174/156652410793384204; Mikhaylova M, 2006, BBA-MOL CELL RES, V1763, P1229, DOI 10.1016/j.bbamcr.2006.08.047; Mikhaylova M, 2011, J NEUROCHEM, V118, P695, DOI 10.1111/j.1471-4159.2011.07372.x; Mikhaylova M, 2010, BIOCHEM SOC T, V38, P177, DOI 10.1042/BST0380177; Mikhaylova M, 2009, P NATL ACAD SCI USA, V106, P9093, DOI 10.1073/pnas.0903001106; Navarro G, 2009, J BIOL CHEM, V284, P28058, DOI 10.1074/jbc.M109.034231; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; O'Callaghan DW, 2005, BIOCHEM J, V391, P231, DOI 10.1042/BJ20051001; O'Callaghan DW, 2003, J CELL BIOL, V163, P715, DOI 10.1083/jcb.200306042; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Osawa M, 2001, J BIOL CHEM, V276, P41005, DOI 10.1074/jbc.M105842200; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rabu C, 2008, J BIOL CHEM, V283, P27504, DOI 10.1074/jbc.M804591200; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Renthal R, 2010, CELL MOL LIFE SCI, V67, P1077, DOI 10.1007/s00018-009-0234-9; Robida AM, 2009, J MOL BIOL, V394, P391, DOI 10.1016/j.jmb.2009.08.069; Sasai K, 2001, J BIOL CHEM, V276, P759, DOI 10.1074/jbc.M004972200; Shih PY, 2009, BIOCHEM BIOPH RES CO, V388, P549, DOI 10.1016/j.bbrc.2009.08.046; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Stachowiak JC, 2010, P NATL ACAD SCI USA, V107, P7781, DOI 10.1073/pnas.0913306107; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511	54	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36762	36776		10.1074/jbc.M111.280339	http://dx.doi.org/10.1074/jbc.M111.280339			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878631	Green Published, hybrid			2022-12-27	WOS:000296538300058
J	Sen, S; Bunda, S; Shi, JY; Wang, A; Mitts, TF; Hinek, A				Sen, Sanjana; Bunda, Severa; Shi, Junyan; Wang, Andrew; Mitts, Thomas F.; Hinek, Aleksander			Retinoblastoma Protein Modulates the Inverse Relationship between Cellular Proliferation and Elastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; CYCLIN-DEPENDENT KINASES; WILLIAMS-BEUREN-SYNDROME; ELASTIN-BINDING PROTEIN; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-I; COSTELLO-SYNDROME; SP1-MEDIATED TRANSCRIPTION; IMPAIRED ELASTOGENESIS; PHOSPHORYLATION SITES	The mechanism that leads to the inverse relationship between heightened cellular proliferation and the cessation of elastic fibers production, observed during formation of the arterial occlusions and dermal scars, is not fully understood. Because the retinoblastoma protein (Rb), responsible for cell cycle initiation, has also been implicated in insulin-like growth factor-I-mediated signaling stimulating elastin gene activation, we explored whether differential phosphorylation of Rb by various cyclin.cyclin-dependent kinase complexes would be responsible for promoting either elastogenic or pro-proliferative signals. We first tested cultures of dermal fibroblasts derived from Costello syndrome patients, in which heightened proliferation driven by mutated oncogenic H-Ras coincides with inhibition of elastogenesis. We found that Costello syndrome fibroblasts display elevated level of Rb phosphorylation on serine 780 (Ser(P)-780-Rb) and that pharmacological inhibition of Ras with radicicol, Mek/Erk with PD98059, or cyclin-dependent kinase 4 with PD0332991 not only leads to down-regulation of Ser(P)-780-Rb levels but also enhances Rb phosphorylation on threonine-821 (Thr(P)-821-Rb), which coincides with the recovery of elastin production. Then we demonstrated that treatment of normal skin fibroblasts with the pro-proliferativePDGFBB also up-regulates Ser(P)-780-Rb levels, but treatment with the pro-elastogenic insulin-like growth factor-I activates cyclinE-cdk2 complex to phosphorylate Rb on Thr-821. Importantly, we have established that elevation of Thr(P)-821-Rb promotes Rb binding to the Sp1 transcription factor and that successive binding of the Rb-Sp1 complex to the retinoblastoma control element within the elastin gene promoter stimulates tropoelastin transcription. In summary, we provide novel insight into the role of Rb in mediating the inverse relationship between elastogenesis and cellular proliferation.	[Sen, Sanjana; Bunda, Severa; Shi, Junyan; Wang, Andrew; Hinek, Aleksander] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Sen, Sanjana; Bunda, Severa; Hinek, Aleksander] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada; [Mitts, Thomas F.] Human Matrix Sci LLC, Visalia, CA 93291 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Hinek, A (corresponding author), Univ Toronto, Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	alek.hinek@sickkids.on.ca	Hinek, Aleksander/V-8790-2019		Canadian Institute of Health Research [PG 13920]; Heart and Stroke Foundation [NA 4381]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported by Canadian Institute of Health Research Grant PG 13920 and by Heart and Stroke Foundation of Ontario Grant NA 4381 (to A.H.).	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Amadeu TP, 2004, WOUND REPAIR REGEN, V12, P169, DOI 10.1111/j.1067-1927.2004.012209.x; Banchio C, 2007, J BIOL CHEM, V282, P14827, DOI 10.1074/jbc.M700527200; Barnett CP, 2011, EUR J HUM GENET, V19, P624, DOI 10.1038/ejhg.2010.259; Barrientes S, 2000, ONCOGENE, V19, P562, DOI 10.1038/sj.onc.1203332; Bayat A, 2005, BRIT J PLAST SURG, V58, P28, DOI 10.1016/j.bjps.2004.04.024; Brooks EE, 1997, J BIOL CHEM, V272, P29207, DOI 10.1074/jbc.272.46.29207; Burke JR, 2010, J BIOL CHEM, V285, P16286, DOI 10.1074/jbc.M110.108167; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Chatterjee A, 2007, AM J RESP CRIT CARE, V176, P667, DOI 10.1164/rccm.200702-291OC; CHEN LI, 1994, MOL CELL BIOL, V14, P4380, DOI 10.1128/MCB.14.7.4380; Conn KJ, 1996, J BIOL CHEM, V271, P28853, DOI 10.1074/jbc.271.46.28853; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; De Falco G, 2006, ONCOGENE, V25, P5244, DOI 10.1038/sj.onc.1209623; Delston RB, 2011, ONCOGENE, V30, P588, DOI 10.1038/onc.2010.442; Dridi SM, 2005, J VASC RES, V42, P190, DOI 10.1159/000085141; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Fry DW, 2004, MOL CANCER THER, V3, P1427; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hennekam RCM, 2003, AM J MED GENET C, V117C, P42, DOI 10.1002/ajmg.c.10019; Hinek A, 1999, ACTA NEUROPATHOL, V97, P399, DOI 10.1007/s004010051004; Hinek A, 2000, AM J HUM GENET, V66, P859, DOI 10.1086/302829; Hinek A, 2000, AM J PATHOL, V156, P925, DOI 10.1016/S0002-9440(10)64961-9; Hinek A, 2005, AM J MED GENET A, V133A, P1, DOI 10.1002/ajmg.a.30495; Hinek A, 2004, AM J PATHOL, V164, P119, DOI 10.1016/S0002-9440(10)63103-3; Hwang M, 2009, CURR MED CHEM, V16, P3081, DOI 10.2174/092986709788802999; Iavarone A, 2004, NATURE, V432, P1040, DOI 10.1038/nature03068; Ikeda M, 2009, BIOCHEM BIOPH RES CO, V390, P1221, DOI 10.1016/j.bbrc.2009.10.125; JENSEN DE, 1995, J BIOL CHEM, V270, P6555, DOI 10.1074/jbc.270.12.6555; Jung S, 1999, GLIA, V25, P179, DOI 10.1002/(SICI)1098-1136(19990115)25:2<179::AID-GLIA8>3.0.CO;2-B; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; Kerr B., 2009, V17, P83; Ki SW, 1998, J ANTIBIOT, V51, P936, DOI 10.7164/antibiotics.51.936; Kielty CM, 2002, J CELL SCI, V115, P2817; KIM SJ, 1992, MOL CELL BIOL, V12, P2455, DOI 10.1128/MCB.12.6.2455; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Liu Q, 1999, MOL CELL BIOL, V19, P6229; Madrigal-Matute J, 2010, CARDIOVASC RES, V86, P330, DOI 10.1093/cvr/cvq046; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Merrilees MJ, 2011, ARTERIOSCL THROM VAS, V31, P1309, DOI 10.1161/ATVBAHA.111.225573; Mitts TF, 2010, J INVEST DERMATOL, V130, P2396, DOI 10.1038/jid.2010.155; MIYAJIMA M, 1995, NEUROREPORT, V6, P1130, DOI 10.1097/00001756-199505300-00014; Morris CA, 2000, ANNU REV GENOM HUM G, V1, P461; Ohnishi K, 1998, LAB INVEST, V78, P1077; OIKAWA T, 1993, EUR J PHARMACOL, V241, P221, DOI 10.1016/0014-2999(93)90206-W; Poznic M, 2009, J BIOSCIENCES, V34, P305, DOI 10.1007/s12038-009-0034-2; Rauen KA, 2007, CLIN GENET, V71, P101, DOI 10.1111/j.1399-0004.2007.00743.x; Ritz-Timme S, 2003, BRIT J DERMATOL, V149, P951, DOI 10.1111/j.1365-2133.2003.05618.x; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Schmitz NMR, 2006, AM J PATHOL, V169, P1074, DOI 10.2353/ajpath.2006.051137; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Sharma SV, 1998, ONCOGENE, V16, P2639, DOI 10.1038/sj.onc.1201790; Slemp AE, 2006, CURR OPIN PEDIATR, V18, P396, DOI 10.1097/01.mop.0000236389.41462.ef; Smith E, 1997, J CELL BIOCHEM, V66, P141, DOI 10.1002/(SICI)1097-4644(19970801)66:2<141::AID-JCB2>3.0.CO;2-Q; SMITH E, 1995, CANCER RES, V55, P5019; Soga S, 1998, J BIOL CHEM, V273, P822, DOI 10.1074/jbc.273.2.822; Takaki T, 2004, BIOCHEM BIOPH RES CO, V316, P252, DOI 10.1016/j.bbrc.2004.02.044; Tamrakar S, 2000, FRONT BIOSCI-LANDMRK, V5, pD121, DOI 10.2741/Tamrakar; THOMPSON RW, 1995, J CLIN INVEST, V96, P318, DOI 10.1172/JCI118037; TSAI LH, 1993, ONCOGENE, V8, P1593; UDVADIA AJ, 1993, P NATL ACAD SCI USA, V90, P3265, DOI 10.1073/pnas.90.8.3265; Urban Z, 2002, AM J HUM GENET, V71, P30, DOI 10.1086/341035; Villerbu N, 2002, INT J CANCER, V97, P761, DOI 10.1002/ijc.10125; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Waldburg N, 2004, EUR RESPIR J, V23, P783, DOI 10.1183/09031936.04.00073704; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Xiao L, 2006, MINI-REV MED CHEM, V6, P1137, DOI 10.2174/138955706778560166; Yoon JH, 2005, INT J ARTIF ORGANS, V28, P44, DOI 10.1177/039139880502800108; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	77	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36580	36591		10.1074/jbc.M111.269944	http://dx.doi.org/10.1074/jbc.M111.269944			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880723	Green Published, hybrid			2022-12-27	WOS:000296538300042
J	Ge, YJ; Yoon, MS; Chen, J				Ge, Yejing; Yoon, Mee-Sup; Chen, Jie			Raptor and Rheb Negatively Regulate Skeletal Myogenesis through Suppression of Insulin Receptor Substrate 1 (IRS1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS; MAMMALIAN TARGET; MYOBLAST DIFFERENTIATION; SIGNALING PATHWAYS; C2C12 MYOGENESIS; MUSCLE-CELLS; IGF-II; MTOR; GROWTH; PHOSPHORYLATION	The mammalian target of rapamycin (mTOR) is essential for skeletal myogenesis through controlling distinct cellular pathways. The importance of the canonical mTOR complex 1 signaling components, including raptor, S6K1, and Rheb, had been suggested in muscle maintenance, growth, and metabolism. However, the role of those components in myogenic differentiation is not entirely clear. In this study we have investigated the functions of raptor, S6K1, and Rheb in the differentiation of C2C12 mouse myoblasts. We find that although mTOR knockdown severely impairs myogenic differentiation as expected, the knockdown of raptor, as well as Rheb, enhances differentiation. Consistent with a negative role for these proteins in myogenesis, overexpression of raptor or Rheb inhibits C2C12 differentiation. On the other hand, neither knockdown nor overexpression of S6K1 has any effect. Moreover, the enhanced differentiation elicited by raptor or Rheb knockdown is accompanied by increased Akt activation, elevated IRS1 protein levels, and decreased Ser-307 (human Ser-312) phosphorylation on IRS1. Finally, IRS1 knockdown eliminated the enhancement in differentiation elicited by raptor or Rheb knockdown, suggesting that IRS1 is a critical mediator of the myogenic functions of raptor and Rheb. In conclusion, the Rheb-mTOR/raptor pathway negatively regulates myogenic differentiation by suppressing IRS1-PI3K-Akt signaling. These findings underscore the versatility of mTOR signaling in biological regulations and implicate the existence of novel mTOR complexes and/or signaling mechanism in skeletal myogenesis.	[Ge, Yejing; Yoon, Mee-Sup; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Chen, J (corresponding author), 601 S Goodwin Ave B107, Urbana, IL 61801 USA.	jiechen@illinois.edu		Chen, Jie/0000-0002-7887-3747	National Institutes of Health [AR048914]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant AR048914 (to J. C.) from the National Institutes of Health.	Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Conejo R, 2001, J CELL PHYSIOL, V186, P82, DOI 10.1002/1097-4652(200101)186:1<82::AID-JCP1001>3.0.CO;2-R; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; FLORINI JR, 1991, J BIOL CHEM, V266, P15917; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Jaafar R, 2011, J BIOL CHEM, V286, P22609, DOI 10.1074/jbc.M110.203885; Kaliman P, 1998, MOL ENDOCRINOL, V12, P66, DOI 10.1210/mend.12.1.0047; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; LASSAR A, 1994, CURR OPIN CELL BIOL, V6, P432, DOI 10.1016/0955-0674(94)90037-X; Lee CS, 2010, CELL DEATH DIFFER, V17, P1254, DOI 10.1038/cdd.2010.1; Long YC, 2011, MOL CELL BIOL, V31, P430, DOI 10.1128/MCB.00983-10; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Nicole S, 2003, J CELL BIOL, V161, P571, DOI 10.1083/jcb.200210117; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Park IH, 2005, J BIOL CHEM, V280, P32009, DOI 10.1074/jbc.M506120200; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2005, CELL CYCLE, V4, P46, DOI 10.4161/cc.4.1.1343; Shu LL, 2009, MOL CELL BIOL, V29, P4691, DOI 10.1128/MCB.00764-09; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	40	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35675	35682		10.1074/jbc.M111.262881	http://dx.doi.org/10.1074/jbc.M111.262881			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852229	hybrid, Green Published			2022-12-27	WOS:000295927100039
J	Henderson, JN; Kuriata, AM; Fromme, R; Salvucci, ME; Wachter, RM				Henderson, J. Nathan; Kuriata, Agnieszka M.; Fromme, Raimund; Salvucci, Michael E.; Wachter, Rebekka M.			Atomic Resolution X-ray Structure of the Substrate Recognition Domain of Higher Plant Ribulose-bisphosphate Carboxylase/Oxygenase (Rubisco) Activase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; INTRINSIC FLUORESCENCE; ARGININE RESIDUES; AAA+ PROTEINS; LARGE SUBUNIT; PHOTOSYNTHESIS; ATP; ARABIDOPSIS; SUBSTITUTION; ENHANCEMENT	The rapid release of tight-binding inhibitors from dead-end ribulose-bisphosphate carboxylase/oxygenase (Rubisco) complexes requires the activity of Rubisco activase, an AAA + ATPase that utilizes chemo-mechanical energy to catalyze the reactivation of Rubisco. Activase is thought to play a central role in coordinating the rate of CO2 fixation with the light reactions of photosynthesis. Here, we present a 1.9 angstrom crystal structure of the C-domain core of creosote activase. The fold consists of a canonical four-helix bundle, from which a paddle-like extension protrudes that entails a nine-turn helix lined by an irregularly structured peptide strand. The residues Lys-313 and Val-316 involved in the species-specific recognition of Rubisco are located near the tip of the paddle. An ionic bond between Lys-313 and Glu-309 appears to stabilize the glycine-rich end of the helix. Structural superpositions onto the distant homolog FtsH imply that the paddles extend away from the hexameric toroid in a fan-like fashion, such that the hydrophobic sides of each blade bearing Trp-302 are facing inward and the polar sides bearing Lys-313 and Val-316 are facing outward. Therefore, we speculate that upon binding, the activase paddles embrace the Rubisco cylinder by placing their hydrophobic patches near the partner protein. This model suggests that conformational adjustments at the remote end of the paddle may relate to selectivity in recognition, rather than specific ionic contacts involving Lys-313. Additionally, the superpositions predict that the catalytically critical Arg-293 does not interact with the bound nucleotide. Hypothetical ring-ring stacking and peptide threading models for Rubisco reactivation are briefly discussed.	[Henderson, J. Nathan; Kuriata, Agnieszka M.; Fromme, Raimund; Wachter, Rebekka M.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Salvucci, Michael E.] ARS, Arid Land Agr Res Ctr, USDA, Maricopa, AZ 85139 USA	Arizona State University; Arizona State University-Tempe; United States Department of Agriculture (USDA)	Wachter, RM (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.	rwachter@asu.edu	Fromme, Raimund/AAG-6578-2019; Fromme, Raimund/W-5838-2019	Fromme, Raimund/0000-0003-4835-1080	United States Department of Energy Office of Basic Energy Sciences [DE-FG02-09-ER16123, DE-FG02-08ER-20268]	United States Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy Office of Basic Energy Sciences Photosynthetic Systems Grants DE-FG02-09-ER16123 (to R. M. W.) and DE-FG02-08ER-20268 (to M. E. S.).	Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Barta C, 2010, ARCH BIOCHEM BIOPHYS, V499, P17, DOI 10.1016/j.abb.2010.04.022; Crafts-Brandner SJ, 2000, P NATL ACAD SCI USA, V97, P13430, DOI 10.1073/pnas.230451497; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Esau BD, 1996, ARCH BIOCHEM BIOPHYS, V326, P100, DOI 10.1006/abbi.1996.0052; Feller U, 1998, PLANT PHYSIOL, V116, P539, DOI 10.1104/pp.116.2.539; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kurek I, 2007, PLANT CELL, V19, P3230, DOI 10.1105/tpc.107.054171; Larson EM, 1997, J BIOL CHEM, V272, P17033, DOI 10.1074/jbc.272.27.17033; Li CH, 2005, J BIOL CHEM, V280, P24864, DOI 10.1074/jbc.M503547200; Li CS, 2006, ARCH BIOCHEM BIOPHYS, V450, P176, DOI 10.1016/j.abb.2006.04.002; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Mueller-Cajar O, 2008, PHOTOSYNTH RES, V98, P667, DOI 10.1007/s11120-008-9324-z; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuwald AF, 1999, GENOME RES, V9, P27; Niwa H, 2002, STRUCTURE, V10, P1415, DOI 10.1016/S0969-2126(02)00855-9; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Ott CM, 2000, J BIOL CHEM, V275, P26241, DOI 10.1074/jbc.M004580200; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; Salvucci ME, 2004, PLANT PHYSIOL, V134, P1460, DOI 10.1104/pp.103.038323; Salvucci ME, 2006, J EXP BOT, V57, P3793, DOI 10.1093/jxb/erl140; Sharkey TD, 2001, PHOTOSYNTH RES, V67, P147, DOI 10.1023/A:1010633823747; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Taylor TC, 1996, NAT STRUCT BIOL, V3, P95, DOI 10.1038/nsb0196-95; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; vandeLoo FJ, 1996, BIOCHEMISTRY-US, V35, P8143, DOI 10.1021/bi9604901; Wang DF, 2006, PHOTOSYNTH RES, V88, P185, DOI 10.1007/s11120-006-9051-2; WANG ZY, 1992, PLANT PHYSIOL, V99, P1348, DOI 10.1104/pp.99.4.1348; WANG ZY, 1992, PLANT PHYSIOL, V100, P1858, DOI 10.1104/pp.100.4.1858; WANG ZY, 1993, BIOCHIM BIOPHYS ACTA, V1202, P47, DOI 10.1016/0167-4838(93)90061-U; Zhang N, 2002, P NATL ACAD SCI USA, V99, P3330, DOI 10.1073/pnas.042529999	39	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35683	35688		10.1074/jbc.C111.289595	http://dx.doi.org/10.1074/jbc.C111.289595			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21880724	hybrid, Green Published			2022-12-27	WOS:000295927100040
J	Meng, XW; Peterson, KL; Dai, HM; Schneider, P; Lee, SH; Zhang, JS; Koenig, A; Bronk, S; Billadeau, DD; Gores, GJ; Kaufmann, SH				Meng, Xue Wei; Peterson, Kevin L.; Dai, Haiming; Schneider, Paula; Lee, Sun-Hee; Zhang, Jin-San; Koenig, Alexander; Bronk, Steve; Billadeau, Daniel D.; Gores, Gregory J.; Kaufmann, Scott H.			High Cell Surface Death Receptor Expression Determines Type I Versus Type II Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING LIGAND; TRAIL-INDUCED APOPTOSIS; WILD-TYPE; FAS EXPRESSION; CANCER-CELLS; DNA-DAMAGE; C-JUN; INHIBITOR; ACTIVATION; PROTEIN	Previous studies have suggested that there are two signaling pathways leading from ligation of the Fas receptor to induction of apoptosis. Type I signaling involves Fas ligand-induced recruitment of large amounts of FADD (FAS-associated death domain protein) and procaspase 8, leading to direct activation of caspase 3, whereas type II signaling involves Bid-mediated mitochondrial perturbation to amplify a more modest death receptor-initiated signal. The biochemical basis for this dichotomy has previously been unclear. Here we show that type I cells have a longer half-life for Fas message and express higher amounts of cell surface Fas, explaining the increased recruitment of FADD and subsequent signaling. Moreover, we demonstrate that cells with type II Fas signaling (Jurkat or HCT-15) can signal through a type I pathway upon forced receptor overexpression and that shRNA-mediated Fas down-regulation converts cells with type I signaling (A498) to type II signaling. Importantly, the same cells can exhibit type I signaling for Fas and type II signaling for TRAIL (TNF-alpha-related apoptosis-inducing ligand), indicating that the choice of signaling pathway is related to the specific receptor, not some other cellular feature. Additional experiments revealed that up-regulation of cell surface death receptor 5 levels by treatment with 7-ethyl-10-hydroxy-camptothecin converted TRAIL signaling in HCT116 cells from type II to type I. Collectively, these results suggest that the type I/type II dichotomy reflects differences in cell surface death receptor expression.	[Meng, Xue Wei; Peterson, Kevin L.; Dai, Haiming; Schneider, Paula; Lee, Sun-Hee; Zhang, Jin-San; Koenig, Alexander; Billadeau, Daniel D.; Kaufmann, Scott H.] Mayo Clin, Div Oncol Res, Dept Oncol, Rochester, MN 55905 USA; [Meng, Xue Wei; Kaufmann, Scott H.] Mayo Clin, Dept Mol Pharmacol, Rochester, MN 55905 USA; [Bronk, Steve; Gores, Gregory J.] Mayo Clin, Div Gastroenterol, Dept Med, Rochester, MN 55905 USA; [Billadeau, Daniel D.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Meng, XW (corresponding author), Mayo Clin, Div Oncol Res, Dept Oncol, 200 1st St SW, Rochester, MN 55905 USA.	Meng.Xue@Mayo.edu; Kaufmann.Scott@Mayo.edu		Kaufmann, Scott/0000-0002-4900-7145; Dai, Haiming/0000-0002-0484-7407	National Institutes of Health [R01 CA69008, P50 CA102701, R01 DK63947]; German Cancer Society; NATIONAL CANCER INSTITUTE [R01CA069008, P50CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Cancer Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA69008 (to S. H. K.), P50 CA102701 (to D. D. B.), and R01 DK63947 (to G. J. G.).; Supported by a Mildred Scheel Fellowship of the German Cancer Society.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Algeciras-Schimnich A, 2003, P NATL ACAD SCI USA, V100, P11445, DOI 10.1073/pnas.2034995100; Algeciras-Schimnich A, 2003, FEBS LETT, V546, P185, DOI 10.1016/S0014-5793(03)00558-1; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Chan H, 1999, MOL CELL BIOL, V19, P2098, DOI 10.1128/mcb.19.3.2098; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Conticello C, 2007, J CLIN ENDOCR METAB, V92, P1938, DOI 10.1210/jc.2006-2157; Crescenzi E, 2011, ONCOGENE, V30, P2707, DOI 10.1038/onc.2011.1; Dai HM, 2009, J BIOL CHEM, V284, P18311, DOI 10.1074/jbc.M109.004770; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Eischen CM, 1997, BLOOD, V90, P935, DOI 10.1182/blood.V90.3.935.935_935_943; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Guo F, 2004, CANCER RES, V64, P2580, DOI 10.1158/0008-5472.CAN-03-2629; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hallett WHD, 2008, J IMMUNOL, V180, P163, DOI 10.4049/jimmunol.180.1.163; Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Ivanov VN, 2002, J BIOL CHEM, V277, P4932, DOI 10.1074/jbc.M108233200; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Karp JE, 2009, BLOOD, V113, P4841, DOI 10.1182/blood-2008-08-172726; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kaufmann SH, 2003, ONCOGENE, V22, P7414, DOI 10.1038/sj.onc.1206945; Kaufmann SH, 2001, ANAL BIOCHEM, V296, P283, DOI 10.1006/abio.2001.5313; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Knight MJ, 2001, ONCOGENE, V20, P5789, DOI 10.1038/sj.onc.1204810; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lundqvist A, 2006, CANCER RES, V66, P7317, DOI 10.1158/0008-5472.CAN-06-0680; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Masuoka HC, 2009, J BIOL CHEM, V284, P30039, DOI 10.1074/jbc.M109.039545; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Meng XW, 2010, J BIOL CHEM, V285, P888, DOI 10.1074/jbc.M109.057638; Meng XW, 2003, J BIOL CHEM, V278, P47326, DOI 10.1074/jbc.M304793200; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Naka T, 2002, CANCER RES, V62, P5800; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nimmanapalli R, 2001, CANCER RES, V61, P759; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Peacock JW, 2009, MOL CELL BIOL, V29, P1222, DOI 10.1128/MCB.01660-08; Qiu YZ, 2007, CANCER RES, V67, P4973, DOI 10.1158/0008-5472.CAN-06-4044; Ravi R, 2002, CANCER RES, V62, P1583; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Smith AJ, 2011, J BIOL CHEM, V286, P17682, DOI 10.1074/jbc.M110.189092; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Sun XM, 2002, J BIOL CHEM, V277, P11345, DOI 10.1074/jbc.M109893200; Thorburn A, 2007, J THORAC ONCOL, V2, P461, DOI 10.1097/JTO.0b013e31805fea64; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wajant H, 2006, CANC TREAT, V130, P141; Wang SL, 2003, P NATL ACAD SCI USA, V100, P15095, DOI 10.1073/pnas.2435285100; Wen JH, 2000, BLOOD, V96, P3900, DOI 10.1182/blood.V96.12.3900.h8003900_3900_3906; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zhang JS, 2011, ONCOGENE, V30, P3705, DOI 10.1038/onc.2011.90; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792	75	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35823	35833		10.1074/jbc.M111.240432	http://dx.doi.org/10.1074/jbc.M111.240432			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865165	Green Published, hybrid			2022-12-27	WOS:000295927100055
J	Westendorf, C; Schmidt, A; Coin, I; Furkert, J; Ridelis, I; Zampatis, D; Rutz, C; Wiesner, B; Rosenthal, W; Beyermann, M; Schulein, R				Westendorf, Carolin; Schmidt, Antje; Coin, Irene; Furkert, Jens; Ridelis, Ingrid; Zampatis, Dimitris; Rutz, Claudia; Wiesner, Burkhard; Rosenthal, Walter; Beyermann, Michael; Schuelein, Ralf			Inhibition of Biosynthesis of Human Endothelin B Receptor by the Cyclodepsipeptide Cotransin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-PEPTIDE; COTRANSLATIONAL TRANSLOCATION; PROTEINS; PREDICTION; SEQUENCES; CLEAVAGE	The specific inhibition of the biosynthesis of target proteins is a relatively novel strategy in pharmacology and is based mainly on antisense approaches (e.g. antisense oligonucleotides or RNA interference). Recently, a novel class of substances was described acting at a later step of protein biosynthesis. The cyclic heptadepsipeptides CAM741 and cotransin were shown to inhibit selectively the biosynthesis of a small subset of secretory proteins by preventing stable insertion of the nascent chains into the Sec61 translocon complex at the endoplasmic reticulum membrane (Besemer, J., Harant, H., Wang, S., Oberhauser, B., Marquardt, K., Foster, C. A., Schreiner, E. P., de Vries, J. E., Dascher-Nadel, C., and Lindley, I. J. (2005) Nature 436, 290-293; Garrison, J. L., Kunkel, E. J., Hegde, R. S., and Taunton, J. (2005) Nature 436, 285-289). These peptides act in a signal sequence-discriminatory manner, which explains their selectivity. Here, we have analyzed the cotransin sensitivity of various G protein-coupled receptors in transfected HEK 293 cells. We show that the biosynthesis of the human endothelin B receptor (ETBR) is highly sensitive to cotransin, in contrast to that of the other G protein-coupled receptors analyzed. Using a novel biosynthesis assay based on fusions with the photoconvertible Kaede protein, we show that the IC50 value of cotransin action on ETBR biosynthesis is 5.4 mu M and that ETBR signaling could be completely blocked by treating cells with 30 mu M cotransin. Taken together, our data add an integral membrane protein, namely the ETBR, to the small group of cotransin-sensitive proteins.	[Westendorf, Carolin; Furkert, Jens; Ridelis, Ingrid; Zampatis, Dimitris; Rutz, Claudia; Wiesner, Burkhard; Beyermann, Michael; Schuelein, Ralf] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Schmidt, Antje; Rosenthal, Walter] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Coin, Irene] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Ridelis, Ingrid; Rosenthal, Walter] Charite, Bereich Mol Pharmakol & Zellbiol, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Salk Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schulein, R (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	schuelein@fmp-berlin.de			Deutsche Forschungsgemeinschaft [SFB 449, SCHU 1116/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft Grant SFB 449 and Grant SCHU 1116/2-1.	Alken M, 2005, BIOCHEM J, V390, P455, DOI 10.1042/BJ20050113; Alken M, 2009, MOL PHARMACOL, V75, P801, DOI 10.1124/mol.108.051581; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; AUDIGIER Y, 1987, P NATL ACAD SCI USA, V84, P5783, DOI 10.1073/pnas.84.16.5783; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; Boger DL, 1999, J AM CHEM SOC, V121, P6197, DOI 10.1021/ja990918u; Coin I, 2008, ORG LETT, V10, P3857, DOI 10.1021/ol800855p; Coin I, 2007, NAT PROTOC, V2, P3247, DOI 10.1038/nprot.2007.454; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; Grantcharova E, 2002, J BIOL CHEM, V277, P43933, DOI 10.1074/jbc.M208407200; Harant H, 2007, MOL PHARMACOL, V71, P1657, DOI 10.1124/mol.107.034249; Harant H, 2006, J BIOL CHEM, V281, P30492, DOI 10.1074/jbc.M607243200; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Kochl R, 2002, J BIOL CHEM, V277, P16131, DOI 10.1074/jbc.M111674200; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; MacKinnon AL, 2007, J AM CHEM SOC, V129, P14560, DOI 10.1021/ja076250y; Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; Moller T, 1997, NEUROREPORT, V8, P2127; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; Sambrook J., 2001, MOL CLONING LAB MANU; Schmidt A, 2009, TRAFFIC, V10, P2, DOI 10.1111/j.1600-0854.2008.00843.x; Schreiner EP, 2004, BIOORG MED CHEM LETT, V14, P5003, DOI 10.1016/j.bmcl.2004.07.012; von Heijne G, 1990, CURR OPIN CELL BIOL, V2, P604, DOI 10.1016/0955-0674(90)90100-S; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WATAKABE T, 1992, BIOCHEM BIOPH RES CO, V185, P867, DOI 10.1016/0006-291X(92)91707-W; Wietfeld D, 2004, J BIOL CHEM, V279, P38386, DOI 10.1074/jbc.M405335200	29	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35588	35600		10.1074/jbc.M111.239244	http://dx.doi.org/10.1074/jbc.M111.239244			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21808059	Green Published, hybrid			2022-12-27	WOS:000295927100031
J	Enomoto, T; Ohashi, K; Shibata, R; Higuchi, A; Maruyama, S; Izumiya, Y; Walsh, K; Murohara, T; Ouchi, N				Enomoto, Takashi; Ohashi, Koji; Shibata, Rei; Higuchi, Akiko; Maruyama, Sonomi; Izumiya, Yasuhiro; Walsh, Kenneth; Murohara, Toyoaki; Ouchi, Noriyuki			Adipolin/C1qdc2/CTRP12 Protein Functions as an Adipokine That Improves Glucose Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPONECTIN STIMULATES ANGIOGENESIS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; OBESE MICE; EXPRESSION; INFLAMMATION; DISEASE; KINASE; MUSCLE; ACRP30/ADIPONECTIN	Obesity is a major risk factor for the development of insulin resistance and type 2 diabetes. Adipose tissue secretes various bioactive molecules, referred to as adipokines, whose dysregulation can mediate changes in glucose homeostasis and inflammatory responses. Here, we identify C1qdc2/CTRP12 as an insulin-sensitizing adipokine that is abundantly expressed by fat tissues and designate this adipokine as adipolin (adipose-derived insulin-sensitizing factor). Adipolin expression in adipose tissue and plasma was reduced in rodent models of obesity. Adipolin expression was also decreased in cultured 3T3-L1 adipocytes by treatment with inducers of endoplasmic reticulum stress and inflammation. Systemic administration of adipolin ameliorated glucose intolerance and insulin resistance in diet-induced obese mice. Adipolin administration also reduced macrophage accumulation and proinflammatory gene expression in the adipose tissue of obese mice. Conditioned medium from adipolin-expressing cells diminished the expression of proinflammatory cytokines in response to stimulation with LPS or TNF alpha in cultured macrophages. These data suggest that adipolin functions as an anti-inflammatory adipokine that exerts beneficial actions on glucose metabolism. Therefore, adipolin represents a new target molecule for the treatment of insulin resistance and diabetes.	[Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Enomoto, Takashi; Shibata, Rei; Maruyama, Sonomi; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Higuchi, Akiko; Izumiya, Yasuhiro; Walsh, Kenneth] Boston Univ, Sch Med, Mol Cardiol Unit, Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Nagoya University; Nagoya University; Boston University	Ouchi, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	nouchi@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; OUCHI, Noriyuki/I-7306-2014; OHASHI, Koji/I-7307-2014	Enomoto, Takashi/0000-0002-7370-8013	National Institutes of Health [P01HL081587]; ministry of Education; Suzuken Memorial Foundation; Japan Research Foundation for Clinical Pharmacology; Uehara Memorial Foundation; Japan Heart Foundation/Novartis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ministry of Education; Suzuken Memorial Foundation; Japan Research Foundation for Clinical Pharmacology; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Heart Foundation/Novartis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01HL081587 (to K. W.). This work was also supported by a grant-in-aid for scientific research from the ministry of Education and grants from the Suzuken Memorial Foundation, the Japan Research Foundation for Clinical Pharmacology, and the Uehara Memorial Foundation (to N. O.) and by a grant-in-aid for young scientists (B) from the ministry of Education, the Uehara Memorial Foundation, and the Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology 2011 (to R. S.).	Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Masaki T, 2003, DIABETES, V52, P2266, DOI 10.2337/diabetes.52.9.2266; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Siegrist-Kaiser CA, 1997, J CLIN INVEST, V100, P2858, DOI 10.1172/JCI119834; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zhang Y, 2002, BBA-MOL CELL BIOL L, V1584, P115, DOI 10.1016/S1388-1981(02)00298-6	33	99	108	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34552	34558		10.1074/jbc.M111.277319	http://dx.doi.org/10.1074/jbc.M111.277319			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21849507	Green Published, hybrid			2022-12-27	WOS:000295406300009
J	Gardsvoll, H; Jacobsen, B; Kriegbaum, MC; Behrendt, N; Engelholm, L; Ostergaard, S; Ploug, M				Gardsvoll, Henrik; Jacobsen, Benedikte; Kriegbaum, Mette C.; Behrendt, Niels; Engelholm, Lars; Ostergaard, Soren; Ploug, Michael			Conformational Regulation of Urokinase Receptor Function IMPACT OF RECEPTOR OCCUPANCY AND EPITOPE-MAPPED MONOCLONAL ANTIBODIES ON LAMELLIPODIA INDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN ACTIVATION SYSTEM; VITRONECTIN-BINDING; CELL-MIGRATION; ENDOTHELIAL-CELLS; LIGAND-BINDING; UPA RECEPTOR; DOMAIN; ADHESION; CANCER; EXPRESSION	The urokinase-type plasminogen activator receptor ( uPAR) is a glycolipid-anchored membrane protein with an established role in focalizing uPA-mediated plasminogen activation on cell surfaces. Distinct from this function, uPAR also modulates cell adhesion and migration on vitronectin-rich matrices. Although uPA and vitronectin engage structurally distinct binding sites on uPAR, they nonetheless cooperate functionally, as uPA binding potentiates uPAR-dependent induction of lamellipodia on vitronectin matrices. We now present data advancing the possibility that it is the burial of the beta-hairpin in uPA per se into the hydrophobic ligand binding cavity of uPAR that modulates the function of this receptor. Based on these data, we now propose a model in which the inherent interdomain mobility in uPAR plays a major role in modulating its function. Particularly one uPAR conformation, which is stabilized by engagement of the beta-hairpin in uPA, favors the proper assembly of an active, compact receptor structure that stimulates lamellipodia induction on vitronectin. This molecular model has wide implications for drug development targeting uPAR function.	[Gardsvoll, Henrik; Jacobsen, Benedikte; Kriegbaum, Mette C.; Behrendt, Niels; Engelholm, Lars; Ploug, Michael] Rigshosp, Finsen Lab, Sect 3735, Copenhagen Bioctr, DK-2200 Copenhagen, Denmark; [Ostergaard, Soren] Novo Nordisk AS, DK-2760 Malov, Denmark; [Gardsvoll, Henrik; Jacobsen, Benedikte; Behrendt, Niels; Ploug, Michael] Danish Chinese Ctr Proteases & Canc, Aarhus, Denmark	Rigshospitalet; University of Copenhagen; Novo Nordisk	Ploug, M (corresponding author), Rigshosp, Finsen Lab, Sect 3735, Copenhagen Bioctr, Rm 3-3-31,Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	m-ploug@finsenlab.dk	Ostergaard, Soren/B-8123-2019	Ostergaard, Soren/0000-0002-9415-3352; Behrendt, Niels/0000-0003-1833-3922; Engelholm, Lars/0000-0002-6616-1232; Ploug, Michael/0000-0003-2215-4265	Danish National Research Foundation (Centre for Proteases and Cancer); Lundbeck Foundation	Danish National Research Foundation (Centre for Proteases and Cancer)(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from The Danish National Research Foundation (Centre for Proteases and Cancer) and The Lundbeck Foundation.	Chang AW, 1998, ARTERIOSCL THROM VAS, V18, P1855, DOI 10.1161/01.ATV.18.12.1855; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; ELLIS V, 1989, J BIOL CHEM, V264, P2185; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Galat A, 2008, CELL MOL LIFE SCI, V65, P3481, DOI 10.1007/s00018-008-8473-8; Gardsvoll H, 1999, J BIOL CHEM, V274, P37995, DOI 10.1074/jbc.274.53.37995; Gardsvoll H, 2004, PROTEIN EXPRES PURIF, V34, P284, DOI 10.1016/j.pep.2003.12.002; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Hillig T, 2008, J BIOL CHEM, V283, P15217, DOI 10.1074/jbc.C700214200; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; Jacobsen B, 2008, CURR MED CHEM, V15, P2559, DOI 10.2174/092986708785909012; Jorgensen TJD, 2004, BIOCHEMISTRY-US, V43, P15044, DOI 10.1021/bi048706j; Kanse SM, 1996, EXP CELL RES, V224, P344, DOI 10.1006/excr.1996.0144; Kjaergaard M, 2008, FRONT BIOSCI-LANDMRK, V13, P5441, DOI 10.2741/3092; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Kriegbaum M., 2011, CURRENT DRU IN PRESS, V12; Lin L, 2010, J BIOL CHEM, V285, P10982, DOI 10.1074/jbc.M109.093492; List K, 1999, J IMMUNOL METHODS, V222, P125, DOI 10.1016/S0022-1759(98)00189-6; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Magdolen V, 2001, BIOL CHEM, V382, P1197, DOI 10.1515/BC.2001.150; NUSRAT AR, 1991, J CLIN INVEST, V87, P1091, DOI 10.1172/JCI115070; Pass J, 2007, THROMB HAEMOSTASIS, V97, P1013, DOI 10.1160/TH06-11-0644; PLOUG M, 1995, BIOCHEMISTRY-US, V34, P12524, DOI 10.1021/bi00039a006; Ploug M, 2001, BIOCHEMISTRY-US, V40, P12157, DOI 10.1021/bi010662g; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Pluskota E, 2003, BLOOD, V101, P1582, DOI 10.1182/blood-2002-06-1842; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; RONNE E, 1991, FEBS LETT, V288, P233, DOI 10.1016/0014-5793(91)81042-7; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Salasznyk RM, 2007, MATRIX BIOL, V26, P359, DOI 10.1016/j.matbio.2007.01.009; Sato S, 2002, FEBS LETT, V528, P212, DOI 10.1016/S0014-5793(02)03311-2; Schmiedeberg N, 2002, J MED CHEM, V45, P4984, DOI 10.1021/jm020254q; Sidenius N, 2000, FEBS LETT, V470, P40, DOI 10.1016/S0014-5793(00)01282-5; Sidenius N, 2002, J BIOL CHEM, V277, P27982, DOI 10.1074/jbc.M111736200; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Stahl A, 1997, INT J CANCER, V71, P116, DOI 10.1002/(SICI)1097-0215(19970328)71:1<116::AID-IJC19>3.3.CO;2-Z; STRATTONTHOMAS JR, 1995, PROTEIN ENG, V8, P463, DOI 10.1093/protein/8.5.463; WALTZ DA, 1994, J BIOL CHEM, V269, P14746; WALTZ DA, 1993, J CLIN INVEST, V91, P1541, DOI 10.1172/JCI116360; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; WEI Y, 1994, J BIOL CHEM, V269, P32380; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551	48	49	50	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33544	33556		10.1074/jbc.M111.220087	http://dx.doi.org/10.1074/jbc.M111.220087			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799009	Green Published, hybrid			2022-12-27	WOS:000294968800071
J	Hashiguchi, T; Mizumoto, S; Nishimura, Y; Tamura, J; Yamada, S; Sugahara, K				Hashiguchi, Taishi; Mizumoto, Shuji; Nishimura, Yuko; Tamura, Jun-ichi; Yamada, Shuhei; Sugahara, Kazuyuki			Involvement of Human Natural Killer-1 (HNK-1) Sulfotransferase in the Biosynthesis of the GlcUA(3-O-sulfate)-Gal-Gal-Xyl Tetrasaccharide Found in alpha-Thrombomodulin from Human Urine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE-K; 3-O-SULFATED GLUCURONIC-ACID; MONOCLONAL-ANTIBODY; SOLUBLE THROMBOMODULIN; CARBOHYDRATE EPITOPE; EXPRESSION CLONING; IGM PARAPROTEINS; DERMATAN SULFATE; NERVOUS-SYSTEM; OLIGOSACCHARIDES	Thrombomodulin (TM) is an integral membrane glycoprotein, which occurs as both a chondroitin sulfate (CS) proteoglycan (PG) form (beta-TM) and a non-PG form without a CS chain (alpha-TM) and hence is a part-time PG. An alpha-TM preparation isolated from human urine contained the glycosaminoglycan linkage region tetrasaccharide GlcUA beta 1-3Gal beta 1-3Gal beta 1-4xylose, and the nonreducing terminal GlcUA residue is 3-O-sulfated. Because the human natural killer-1 sulfotransferase (HNK-1ST) transfers a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate to the C-3 position of the nonreducing terminal GlcUA residue in the HNK-1 antigen precursor trisaccharide, GlcUA beta 1-3Gal beta 1-4GlcNAc, the sulfotransferase activity toward the linkage region was investigated. In fact, the activity of HNK-1ST toward the linkage region was much higher than that toward the glucuronylneolactotetraosylceramide, the precursor of the HNK-1 epitope. HNK-1ST may be responsible for regulating the sorting of alpha- and beta-TM. Furthermore, HNK-1ST also transferred a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate to the C-3 position of the nonreducing terminal GlcUA residue of a chondroitin chain. Intriguingly, the HNK-1 antibody recognized CS chains and the linkage region if they contained GlcUA(3-O-sulfate), suggesting that HNK-1ST not only synthesizes the HNK-1 epitope but may also be involved in the generation of part-time PGs.	[Hashiguchi, Taishi; Mizumoto, Shuji; Yamada, Shuhei; Sugahara, Kazuyuki] Hokkaido Univ, Lab Proteoglycan Signaling & Therapeut, Frontier Res Ctr Postgenom Sci & Technol, Grad Sch Life Sci,Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Nishimura, Yuko; Tamura, Jun-ichi] Tottori Univ, Dept Reg Environm, Fac Reg Sci, Tottori 6808551, Japan	Hokkaido University; Tottori University	Yamada, S (corresponding author), Hokkaido Univ, Lab Proteoglycan Signaling & Therapeut, Frontier Res Ctr Postgenom Sci & Technol, Grad Sch Life Sci,Kita Ku, West 11,North 21, Sapporo, Hokkaido 0010021, Japan.	tjohej@sci.hokudai.ac.jp; k-sugar@sci.hokudai.ac.jp	Mizumoto, Shuji/F-8313-2018	Mizumoto, Shuji/0000-0002-4641-1505	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23390016, 23790066, 12660098]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research (B) 23390016 (to K. S.), Young Scientists (B) 23790066 (to S. M.), and Scientific Research (C) 12660098 (to J. T.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	ABO T, 1981, J IMMUNOL, V127, P1024; ARIGA T, 1987, J BIOL CHEM, V262, P848; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; Deepa SS, 2007, BIOCHEMISTRY-US, V46, P2453, DOI 10.1021/bi602374m; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dudek AZ, 1997, J BIOL CHEM, V272, P31785, DOI 10.1074/jbc.272.50.31785; Fongmoon D, 2007, J BIOL CHEM, V282, P36895, DOI 10.1074/jbc.M707082200; FRANSSON LA, 1987, TRENDS BIOCHEM SCI, V12, P406, DOI 10.1016/0968-0004(87)90197-6; Hashiguchi T, 2010, GLYCOCONJUGATE J, V27, P49, DOI 10.1007/s10719-009-9253-x; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; ILYAS AA, 1986, BRAIN RES, V385, P1, DOI 10.1016/0006-8993(86)91540-4; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P531, DOI 10.1093/glycob/7.4.531; KITAGAWA H, 1995, J BIOCHEM-TOKYO, V117, P1083, DOI 10.1093/oxfordjournals.jbchem.a124810; Kitagawa H, 1997, BIOCHEMISTRY-US, V36, P3998, DOI 10.1021/bi962740j; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Marcos I, 2002, J HUM GENET, V47, P677, DOI 10.1007/s100380200103; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Mitsumoto Y, 2000, GENOMICS, V65, P166, DOI 10.1006/geno.2000.6152; Morita I, 2008, J BIOCHEM, V143, P719, DOI 10.1093/jb/mvm221; Nadanaka S, 1998, J BIOL CHEM, V273, P33728, DOI 10.1074/jbc.273.50.33728; Nandini CD, 2006, ADV PHARMACOL, V53, P253, DOI 10.1016/S1054-3589(05)53012-6; NAWA K, 1990, BIOCHEM BIOPH RES CO, V171, P729, DOI 10.1016/0006-291X(90)91207-9; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; Plaas AHK, 1997, J BIOL CHEM, V272, P20603, DOI 10.1074/jbc.272.33.20603; SENO N, 1982, CARBOHYD RES, V103, P190; SHIODA Y, 1984, HISTOCHEM J, V16, P843, DOI 10.1007/BF01002790; Sugahara K, 1996, J BIOL CHEM, V271, P26745, DOI 10.1074/jbc.271.43.26745; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 1996, GLYCOCONJUGATE J, V13, P609, DOI 10.1007/BF00731449; Sugahara K, 1996, EUR J BIOCHEM, V239, P865, DOI 10.1111/j.1432-1033.1996.0865u.x; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; SVENNERHOLM L, 1980, BIOCHIM BIOPHYS ACTA, V617, P97, DOI 10.1016/0005-2760(80)90227-1; Tagawa H, 2005, J BIOL CHEM, V280, P23876, DOI 10.1074/jbc.M501728200; Tamura J, 2010, CARBOHYD RES, V345, P2115, DOI 10.1016/j.carres.2010.06.019; VIEIRA RP, 1991, J BIOL CHEM, V266, P13530; Wakabayashi H, 1999, J BIOL CHEM, V274, P5436, DOI 10.1074/jbc.274.9.5436	41	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33003	33011		10.1074/jbc.M111.279174	http://dx.doi.org/10.1074/jbc.M111.279174			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828042	Green Published, hybrid			2022-12-27	WOS:000294968800018
J	Valverde, MA; Cantero-Recasens, G; Garcia-Elias, A; Jung, C; Carreras-Sureda, A; Vicente, R				Valverde, Miguel A.; Cantero-Recasens, Gerard; Garcia-Elias, Anna; Jung, Carole; Carreras-Sureda, Amado; Vicente, Ruben			Ion Channels in Asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AIRWAY SMOOTH-MUSCLE; OBSTRUCTIVE PULMONARY-DISEASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; CA2+-ACTIVATED K+ CHANNEL; CYSTIC-FIBROSIS AIRWAY; MAST-CELL ACTIVATION; OPERATED CA2+ ENTRY; EPITHELIAL-CELLS; POTASSIUM CHANNEL; CALCIUM-CHANNELS	Ion channels are specialized transmembrane proteins that permit the passive flow of ions following their electrochemical gradients. In the airways, ion channels participate in the production of epithelium-based hydroelectrolytic secretions and in the control of intracellular Ca2+ levels that will ultimately activate almost all lung cells, either resident or circulating. Thus, ion channels have been the center of many studies aiming to understand asthma pathophysiological mechanisms or to identify therapeutic targets for better control of the disease. In this mini-review, we focus on molecular, genetic, and animal model studies associating ion channels with asthma.	[Valverde, Miguel A.; Cantero-Recasens, Gerard; Garcia-Elias, Anna; Jung, Carole; Carreras-Sureda, Amado; Vicente, Ruben] Univ Pompeu Fabra, Lab Mol Physiol & Channelopathies, Dept Expt & Hlth Sci, Barcelona 08003, Spain	Pompeu Fabra University	Valverde, MA (corresponding author), Univ Pompeu Fabra, Lab Mol Physiol & Channelopathies, Dept Expt & Hlth Sci, Barcelona 08003, Spain.	miguel.valverde@upf.edu	Garcia-Elias Heras, Anna/K-4367-2014; Cantero-Recasens, Gerard/AAH-1697-2019; García, Rubén Vicente/L-1097-2014; Jung, Carole/M-3590-2014; Cantero-Recasens, Gerard/AAE-9003-2022	Garcia-Elias Heras, Anna/0000-0002-6609-6119; Cantero-Recasens, Gerard/0000-0001-6452-782X; García, Rubén Vicente/0000-0003-0401-4808; Jung, Carole/0000-0002-0239-0343; Carreras Sureda, Amado/0000-0002-9032-5639; Valverde, Miguel A./0000-0002-6961-3361	Spanish Ministry of Science and Innovation/Fondos Europeos de Desarrollo Regional (FEDER) [SAF2009-09848, Red HERACLES RD06/0009]; Generalitat de Catalunya [2009SGR-1369]; Fundacio la Marato de TV3 [080430, SAF2010-16725]	Spanish Ministry of Science and Innovation/Fondos Europeos de Desarrollo Regional (FEDER)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacio la Marato de TV3	This work was supported in part by Grants SAF2009-09848 and Red HERACLES RD06/0009 from Spanish Ministry of Science and Innovation/Fondos Europeos de Desarrollo Regional (FEDER) Plan E, Grant 2009SGR-1369 from the Generalitat de Catalunya, and Grants 080430 (to M. A. V.) and SAF2010-16725 (to R. V.) from the Fundacio la Marato de TV3. This is the first article in the Thematic Minireview Series on Molecular Bases of Disease: Asthma. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Agopyan N, 2003, TOXICOL APPL PHARM, V192, P21, DOI 10.1016/S0041-008X(03)00259-X; ANDERSON MP, 1992, AM J PHYSIOL, V263, pL1, DOI 10.1152/ajplung.1992.263.1.L1; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Bardou O, 2009, AM J PHYSIOL-LUNG C, V296, pL145, DOI 10.1152/ajplung.90525.2008; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Becchetti A, 2010, ADV EXP MED BIOL, V674, P107; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Birrell MA, 2009, AM J RESP CRIT CARE, V180, P1042, DOI 10.1164/rccm.200905-0665OC; BLACK JL, 1990, AM REV RESPIR DIS, V142, P1384, DOI 10.1164/ajrccm/142.6_Pt_1.1384; BOUSQUET J, 1995, CLIN EXP ALLERGY, V25, P39, DOI 10.1111/j.1365-2222.1995.tb00419.x; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Cabral MD, 2010, AM J RESP CRIT CARE, V181, P1310, DOI [10.1164/rccm.200907-1166oc, 10.1164/rccm.200907-1166OC]; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Cantero-Recasens G, 2010, J BIOL CHEM, V285, P27532, DOI 10.1074/jbc.C110.159491; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Cheng G, 2008, CURR MOL MED, V8, P401, DOI 10.2174/156652408785160934; COLERIDGE HM, 1994, ANNU REV PHYSIOL, V56, P69, DOI 10.1146/annurev.ph.56.030194.000441; Colsoul B, 2009, CLIN EXP ALLERGY, V39, P1456, DOI 10.1111/j.1365-2222.2009.03315.x; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; de Cid R, 2001, EUR J HUM GENET, V9, P67; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Donaldson SH, 2003, CURR OPIN PULM MED, V9, P486, DOI 10.1097/00063198-200311000-00007; Eilers H, 2010, ANESTHESIOLOGY, V112, P1452, DOI 10.1097/ALN.0b013e3181d94e00; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; FLECKENSTEIN A, 1977, ANNU REV PHARMACOL, V17, P149, DOI 10.1146/annurev.pa.17.040177.001053; Galietta Luis J V, 2004, Proc Am Thorac Soc, V1, P62, DOI 10.1513/pats.2306017; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Groneberg DA, 2004, AM J RESP CRIT CARE, V170, P1276, DOI 10.1164/rccm.200402-174OC; Gu QH, 2010, J APPL PHYSIOL, V108, P891, DOI 10.1152/japplphysiol.01371.2009; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hao K, 2005, HUM GENET, V116, P378, DOI 10.1007/s00439-005-1256-5; Helve O, 2004, PEDIATRICS, V113, P1267, DOI 10.1542/peds.113.5.1267; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Houtmeyers E, 1999, EUR RESPIR J, V13, P1177, DOI 10.1034/j.1399-3003.1999.13e39.x; Howarth PH, 2005, THORAX, V60, P1012, DOI 10.1136/thx.2005.045260; Janssen LJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1757, DOI 10.1152/ajpcell.1997.272.6.C1757; Janssen LJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1161, DOI 10.1152/ajplung.00452.2001; Janssen LJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-123; Koskela HO, 2007, INT J CIRCUMPOL HEAL, V66, P91, DOI 10.3402/ijch.v66i2.18237; KOTLIKOFF MI, 1993, PHARMACOL THERAPEUT, V58, P1, DOI 10.1016/0163-7258(93)90064-K; Kotlikoff MI, 1998, AM J RESP CRIT CARE, V158, pS109, DOI 10.1164/ajrccm.158.supplement_2.13tac600; LAITINEN LA, 1985, AM REV RESPIR DIS, V131, P599, DOI 10.1164/arrd.1985.131.4.599; Lazaar AL, 2005, J ALLERGY CLIN IMMUN, V116, P488, DOI 10.1016/j.jaci.2005.06.030; Lee JS, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-138; Lee LY, 2009, CURR OPIN PHARMACOL, V9, P243, DOI 10.1016/j.coph.2009.02.002; LeSimple P, 2010, J PHYSIOL-LONDON, V588, P1195, DOI 10.1113/jphysiol.2009.182246; Li S, 2003, CELL CALCIUM, V33, P551, DOI 10.1016/S0143-4160(03)00060-5; LIN CS, 1993, J EXP MED, V177, P637, DOI 10.1084/jem.177.3.637; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Maddox L, 2002, ANNU REV MED, V53, P477, DOI 10.1146/annurev.med.53.082901.103921; Malerba M, 2010, J BIOL REG HOMEOS AG, V24, P123; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall MA, 2008, J AEROSOL MED PULM D, V21, P13, DOI 10.1089/jamp.2007.0659; MCCANN JD, 1986, J PHYSIOL-LONDON, V372, P113, DOI 10.1113/jphysiol.1986.sp016000; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nighot PK, 2010, AM J PHYSIOL-GASTR L, V299, pG449, DOI 10.1152/ajpgi.00520.2009; PATEL KR, 1981, BRIT MED J, V282, P932, DOI 10.1136/bmj.282.6268.932; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pelaia G, 2002, LIFE SCI, V70, P977, DOI 10.1016/S0024-3205(01)01487-4; Perez-Zoghbi JF, 2009, PULM PHARMACOL THER, V22, P388, DOI 10.1016/j.pupt.2008.09.006; Rajasekaran SA, 2008, BBA-BIOMEMBRANES, V1778, P757, DOI 10.1016/j.bbamem.2007.11.007; Rao JN, 2010, AM J PHYSIOL-CELL PH, V299, pC579, DOI 10.1152/ajpcell.00066.2010; Rate A, 2009, J IMMUNOL, V182, P72, DOI 10.4049/jimmunol.182.1.72; Reiter B, 2006, FASEB J, V20, P1802, DOI 10.1096/fj.06-5772com; Sabnis AS, 2008, AM J PHYSIOL-LUNG C, V295, pL194, DOI 10.1152/ajplung.00072.2008; SATIR P, 1990, ANNU REV PHYSIOL, V52, P137, DOI 10.1146/annurev.ph.52.030190.001033; Sausbier M, 2007, FASEB J, V21, P812, DOI 10.1096/fj.06-7167com; Schiller KR, 2010, AM J PHYSIOL-CELL PH, V299, pC912, DOI 10.1152/ajpcell.00215.2010; Seibold MA, 2008, HUM MOL GENET, V17, P2681, DOI 10.1093/hmg/ddn168; Sel S, 2008, CLIN EXP ALLERGY, V38, P1548, DOI 10.1111/j.1365-2222.2008.03043.x; Shepherd MC, 2007, AM J RESP CELL MOL, V37, P525, DOI 10.1165/rcmb.2006-0358OC; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Sweeney M, 2002, J APPL PHYSIOL, V92, P1594, DOI 10.1152/japplphysiol.00722.2001; Talavera K, 2009, NAT NEUROSCI, V12, P1293, DOI 10.1038/nn.2379; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tian W, 2009, P NATL ACAD SCI USA, V106, P14034, DOI 10.1073/pnas.0904084106; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; TOWNLEY RG, 1988, ANN NY ACAD SCI, V522, P732; Trinh NTN, 2008, AM J PHYSIOL-LUNG C, V295, pL866, DOI 10.1152/ajplung.90224.2008; Twiss MA, 2002, BRIT J CLIN PHARMACO, V53, P243, DOI 10.1046/j.0306-5251.2001.01560.x; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Veres TZ, 2009, PHARMACOL THERAPEUT, V122, P203, DOI 10.1016/j.pharmthera.2009.02.007; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; White TA, 2006, AM J RESP CELL MOL, V35, P243, DOI 10.1165/rcmb.2006-0003OC; Wilson JW, 2003, CURR ALLERGY ASTHM R, V3, P153, DOI 10.1007/s11882-003-0028-3; Xiao JH, 2010, AM J RESP CELL MOL, V43, P17, DOI 10.1165/rcmb.2009-0091OC; Yoshino T, 2007, EUR J PHARMACOL, V560, P225, DOI 10.1016/j.ejphar.2007.01.012; Zhang GF, 2008, J PHYSIOL-LONDON, V586, P5771, DOI 10.1113/jphysiol.2008.161042; Zhang MIN, 1999, ADV PHARMACOL, V46, P43, DOI 10.1016/S1054-3589(08)60469-X; Zhu GH, 2009, HUM MOL GENET, V18, P2053, DOI 10.1093/hmg/ddp111	102	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32877	32882		10.1074/jbc.R110.215491	http://dx.doi.org/10.1074/jbc.R110.215491			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799020	Green Published, hybrid			2022-12-27	WOS:000294968800005
J	Wu, LC				Wu, Lawren C.			Immunoglobulin E Receptor Signaling and Asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FC-EPSILON-RI; MAST-CELL ACTIVATION; AFFINITY IGE RECEPTOR; TYROSINE KINASE SYK; NEGATIVE REGULATION; ALLERGIC RESPONSES; IN-VIVO; PHOSPHOINOSITIDE 3-KINASE; CRAC CHANNEL; LYN KINASE	Elevated IgE levels and increased IgE sensitization to allergens are central features of allergic asthma. IgE binds to the high-affinity Fc epsilon receptor I (Fc epsilon RI) on mast cells, basophils, and dendritic cells and mediates the activation of these cells upon antigen-induced cross-linking of IgE-bound Fc epsilon RI. Fc epsilon RI activation proceeds through a network of signaling molecules and adaptor proteins and is negatively regulated by a number of cell surface and intracellular proteins. Therapeutic neutralization of serum IgE in moderate-to-severe allergic asthmatics reduces the frequency of asthma exacerbations through a reduction in cell surface Fc epsilon RI expression that results in decreased Fc epsilon RI activation, leading to improved asthma control. Our increasing understanding of IgE receptor signaling may lead to the development of novel therapeutics for the treatment of asthma.	Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Wu, LC (corresponding author), Genentech Inc, Dept Immunol, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	lawren@gene.com						Abramson J, 2002, MOL IMMUNOL, V38, P1307, DOI 10.1016/S0161-5890(02)00080-9; Acharya M, 2010, CLIN EXP IMMUNOL, V162, P12, DOI 10.1111/j.1365-2249.2010.04210.x; Akimoto M, 2009, SCAND J IMMUNOL, V69, P401, DOI 10.1111/j.1365-3083.2009.02235.x; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Ali K, 2008, J IMMUNOL, V180, P2538, DOI 10.4049/jimmunol.180.4.2538; Alvarez-Errico D, 2009, IMMUNOL REV, V232, P195, DOI 10.1111/j.1600-065X.2009.00834.x; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Bansal G, 2008, NAT IMMUNOL, V9, P73, DOI 10.1038/ni1533; Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; Cauvi DM, 2006, J BIOL CHEM, V281, P10448, DOI 10.1074/jbc.M510751200; Chang TW, 2007, ADV IMMUNOL, V93, P63, DOI 10.1016/S0065-2776(06)93002-8; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; Chung KF, 1999, EUR RESPIR J, V13, P1198; CONRAD DH, 1990, ANNU REV IMMUNOL, V8, P623, DOI 10.1146/annurev.immunol.8.1.623; Costello PS, 1996, ONCOGENE, V13, P2595; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Davey AM, 2008, J BIOL CHEM, V283, P7117, DOI 10.1074/jbc.M708879200; Davey AM, 2007, BIOPHYS J, V92, P343, DOI 10.1529/biophysj.106.088815; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Donnadieu E, 2000, IMMUNITY, V12, P515, DOI 10.1016/S1074-7613(00)80203-4; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fiebiger E, 2005, J EXP MED, V201, P267, DOI 10.1084/jem.20041384; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Furumoto Y, 2006, J IMMUNOL, V176, P5167, DOI 10.4049/jimmunol.176.9.5167; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Gomez G, 2005, J IMMUNOL, V175, P7602, DOI 10.4049/jimmunol.175.11.7602; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hartman ML, 2008, MOL IMMUNOL, V45, P2307, DOI 10.1016/j.molimm.2007.11.017; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Hernandez-Hansen V, 2004, J IMMUNOL, V173, P100, DOI 10.4049/jimmunol.173.1.100; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hitomi K, 2010, NAT IMMUNOL, V11, P601, DOI 10.1038/ni.1886; Holgate S, 2005, J ALLERGY CLIN IMMUN, V115, P459, DOI 10.1016/j.jaci.2004.11.053; Holgate ST, 2005, CLIN EXP ALLERGY, V35, P408, DOI 10.1111/j.1365-2222.2005.02191.x; Hong H, 2007, BLOOD, V110, P2511, DOI 10.1182/blood-2007-01-066092; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Iwaki S, 2005, J BIOL CHEM, V280, P40261, DOI 10.1074/jbc.M506063200; Iwaki S, 2008, CELL SIGNAL, V20, P195, DOI 10.1016/j.cellsig.2007.10.013; Jackman J, 2010, J BIOL CHEM, V285, P20850, DOI 10.1074/jbc.M110.113910; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; Kalesnikoff J, 2007, BLOOD, V109, P5308, DOI 10.1182/blood-2007-01-067363; Kambayashi T, 2010, MOL CELL BIOL, V30, P4188, DOI 10.1128/MCB.00305-10; Katz HR, 1996, P NATL ACAD SCI USA, V93, P10809, DOI 10.1073/pnas.93.20.10809; Katz HR, 2002, CURR OPIN IMMUNOL, V14, P698, DOI 10.1016/S0952-7915(02)00400-4; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; Kim MS, 2008, TRENDS IMMUNOL, V29, P493, DOI 10.1016/j.it.2008.07.004; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Kovarova M, 2006, J EXP MED, V203, P1161, DOI 10.1084/jem.20051701; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Lienard H, 1999, J BIOL CHEM, V274, P32493, DOI 10.1074/jbc.274.45.32493; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu Y, 2007, J EXP MED, V204, P93, DOI 10.1084/jem.20061598; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; Malbec O, 2004, J IMMUNOL, V173, P5086, DOI 10.4049/jimmunol.173.8.5086; McPherson VA, 2009, J IMMUNOL, V183, P4940, DOI 10.4049/jimmunol.0900702; Melendez AJ, 2007, NAT MED, V13, P1375, DOI 10.1038/nm1654; Nakata K, 2008, J IMMUNOL, V181, P5414, DOI 10.4049/jimmunol.181.8.5414; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Nishizumi H, 1997, J IMMUNOL, V158, P2350; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Olivera A, 2007, IMMUNITY, V26, P287, DOI 10.1016/j.immuni.2007.02.008; Oskeritzian CA, 2008, BLOOD, V111, P4193, DOI 10.1182/blood-2007-09-115451; Oskeritzian CA, 2010, J EXP MED, V207, P465, DOI 10.1084/jem.20091513; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Platzer B, 2010, J BIOL CHEM, V285, P15314, DOI 10.1074/jbc.M110.104281; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prussin C, 2003, J ALLERGY CLIN IMMUN, V112, P1147, DOI 10.1016/j.jaci.2003.10.003; Pushparaj PN, 2009, J IMMUNOL, V183, P221, DOI 10.4049/jimmunol.0803430; Rios EJ, 2008, BLOOD, V112, P4148, DOI 10.1182/blood-2008-04-152660; Rivera J, 2007, IMMUNOL REV, V217, P255, DOI 10.1111/j.1600-065X.2007.00505.x; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Saxon A, 2008, J ALLERGY CLIN IMMUN, V121, P320, DOI 10.1016/j.jaci.2007.10.017; Sheets ED, 1999, CURR OPIN CHEM BIOL, V3, P95, DOI 10.1016/S1367-5931(99)80017-9; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Siraganian RP, 2002, MOL IMMUNOL, V38, P1229, DOI 10.1016/S0161-5890(02)00068-8; Tam SW, 2004, ALLERGY, V59, P772, DOI 10.1111/j.1398-9995.2004.00332.x; Tkaczyk C, 2004, BLOOD, V104, P207, DOI 10.1182/blood-2003-08-2769; Uehara T, 2001, J CLIN INVEST, V108, P1041, DOI 10.1172/JCI200112195; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Vonakis BM, 2001, J BIOL CHEM, V276, P1041, DOI 10.1074/jbc.M003397200; Wines BD, 2006, J BIOL CHEM, V281, P17108, DOI 10.1074/jbc.M601640200; Xiao WB, 2005, J IMMUNOL, V175, P6885, DOI 10.4049/jimmunol.175.10.6885; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yamashita Y, 2007, J IMMUNOL, V179, P740, DOI 10.4049/jimmunol.179.2.740; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219; Zhu DC, 2002, NAT MED, V8, P518, DOI 10.1038/nm0502-518; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223; Zhu MH, 2006, J BIOL CHEM, V281, P18408, DOI 10.1074/jbc.M601535200	100	43	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32891	32897		10.1074/jbc.R110.205104	http://dx.doi.org/10.1074/jbc.R110.205104			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799019	hybrid, Green Published			2022-12-27	WOS:000294968800007
J	Shi, Y; Solomon, LR; Pereda-Lopez, A; Giranda, VL; Luo, Y; Johnson, EF; Shoemaker, AR; Leverson, J; Liu, XS				Shi, Yan; Solomon, Larry R.; Pereda-Lopez, Ana; Giranda, Vincent L.; Luo, Yan; Johnson, Eric F.; Shoemaker, Alexander R.; Leverson, Joel; Liu, Xuesong			Ubiquitin-specific Cysteine Protease 2a (USP2a) Regulates the Stability of Aurora-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; DEUBIQUITINATING ENZYME USP2A; PROSTATE-CANCER; P53 PATHWAY; B KINASE; CELLS; AMPLIFICATION; EXPRESSION	The ubiquitin/proteasome pathway plays critical roles in virtually all aspects of cell biology. Enzymes of the ubiquitin pathway add (ligases) or remove (deubiquitinases) ubiquitin tags to or from their target proteins in a selective fashion. USP2a is a member of a subfamily of deubiquitinases, called ubiquitin-specific cysteine proteases (USPs). Although USP2a has been reported to be a bona fide oncogene that regulates the stability of MDM2, MDMX, and FAS, it is likely that there are other unidentified substrates for USP2a. In this study, we show that USP2a mediates mitotic progression by regulating the stability of Aurora-A. Through cell-based screening of a USP siRNA library, we discovered that knockdown of USP2a reduced the protein levels of Aurora-A. USP2a interacts with Aurora-A directly in vitro and in vivo. In addition, Aurora-A is a substrate for USP2a in vitro and in vivo. Our study provides a novel mechanism for the role of USP2a in mediating the stability of Aurora-A.	[Shi, Yan; Solomon, Larry R.; Pereda-Lopez, Ana; Giranda, Vincent L.; Luo, Yan; Johnson, Eric F.; Shoemaker, Alexander R.; Leverson, Joel; Liu, Xuesong] Abbott Labs, Dept Canc Res, Abbott Pk, IL 60064 USA	Abbott Laboratories	Liu, XS (corresponding author), Abbott Labs, Dept Canc Res, 100 Abbott Pk Rd, Abbott Pk, IL 60064 USA.	xuesong.liu@abbott.com						Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Andrews PD, 2005, ONCOGENE, V24, P5005, DOI 10.1038/sj.onc.1208752; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; da Silva SD, 2009, ORAL ONCOL, V45, pE134, DOI 10.1016/j.oraloncology.2009.02.004; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Lin HJ, 2000, MOL CELL BIOL, V20, P6568, DOI 10.1128/MCB.20.17.6568-6578.2000; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Liu Q, 2006, P NATL ACAD SCI USA, V103, P5811, DOI 10.1073/pnas.0601425103; Liu XS, 2008, NEOPLASIA, V10, P828, DOI 10.1593/neo.08408; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Taguchi S, 2002, FEBS LETT, V519, P59, DOI 10.1016/S0014-5793(02)02711-4; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Wong BR, 2003, DRUG DISCOV TODAY, V8, P746, DOI 10.1016/S1359-6446(03)02780-6; Yang H, 2005, FEBS LETT, V579, P3385, DOI 10.1016/j.febslet.2005.04.080	28	48	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38960	38968		10.1074/jbc.M111.231498	http://dx.doi.org/10.1074/jbc.M111.231498			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21890637	Green Published, hybrid			2022-12-27	WOS:000296759800015
J	Biedzka-Sarek, M; Metso, J; Kateifides, A; Meri, T; Jokiranta, TS; Muszynski, A; Radziejewska-Lebrecht, J; Zannis, V; Skurnik, M; Jauhiainen, M				Biedzka-Sarek, Marta; Metso, Jari; Kateifides, Andreas; Meri, Taru; Jokiranta, T. Sakari; Muszynski, Artur; Radziejewska-Lebrecht, Joanna; Zannis, Vassilis; Skurnik, Mikael; Jauhiainen, Matti			Apolipoprotein A-I Exerts Bactericidal Activity against Yersinia enterocolitica Serotype O:3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; HUMAN-SERUM; APOA-I; FACTOR-H; COMPLEMENT; BINDING; HDL; LIPOPOLYSACCHARIDE; PSEUDOTUBERCULOSIS; INHIBITION	Apolipoprotein A-I (apoA-I), the main protein component of high density lipoprotein (HDL), is well recognized for its anti-atherogenic, antioxidant, and antiinflammatory properties. Here, we report a novel role for apoA-I as a host defense molecule that contributes to the complement-mediated killing of an important gastrointestinal pathogen, Gram-negative bacterium Yersinia enterocolitica. We specifically show that the C-terminal domain of apoA-I is the effector site providing the bactericidal activity. Although the presence of the lipopolysaccharide O-antigen on the bacterial surface is absolutely required for apoA-I to kill the bacteria, apoA-I does not interact with the bacteria directly. To the contrary, exposure of the bacteria by serum proteins triggers apoA-I deposition on the bacterial surface. As our data show that both purified lipid-free and HDL-associated apoA-I displays anti-bacterial potential, apoA-I mimetic peptides may be a promising therapeutic agent for the treatment of certain Gram-negative infections.	[Biedzka-Sarek, Marta; Metso, Jari; Jauhiainen, Matti] Natl Inst Hlth & Welf, Publ Hlth Genom Res Unit, Dept Chron Dis Prevent, Helsinki 00290, Finland; [Biedzka-Sarek, Marta; Metso, Jari; Jauhiainen, Matti] Inst Mol Med Finland FIMM, Helsinki 00290, Finland; [Kateifides, Andreas; Zannis, Vassilis] Boston Univ, Med Ctr, Dept Mol Genet, Boston, MA 02118 USA; [Meri, Taru; Jokiranta, T. Sakari; Skurnik, Mikael] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki 00014, Finland; [Meri, Taru; Skurnik, Mikael] Univ Helsinki, Cent Hosp, Dept Lab Diagnost, FIN-00290 Helsinki, Finland; [Muszynski, Artur] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Radziejewska-Lebrecht, Joanna] Univ Silesia, Inst Microbiol, PL-40032 Katowice, Poland	Finland National Institute for Health & Welfare; Boston University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University System of Georgia; University of Georgia; University of Silesia in Katowice	Biedzka-Sarek, M (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Publ Hlth Genom Res Unit, POB 104, FIN-00251 Helsinki, Finland.	marta.biedzka-sarek@thl.fi	Skurnik, Mikael/I-8477-2019	Skurnik, Mikael/0000-0001-8791-9260; Muszynski, Artur/0000-0003-3497-9977; Zannis, Vassilis/0000-0002-1295-7155	National Institutes of Health [HL48739]; Finnish Cultural Foundation; Paulo Foundation; Aarne Koskelon Foundation; Orion Farmos; Alfred Kordelin Foundation; Research Council for Biosciences and Environment, Academy of Finland [114075]; Finnish Foundation for Cardiovascular Research; Research Council for Health, Academy of Finland [132629]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Paulo Foundation; Aarne Koskelon Foundation; Orion Farmos; Alfred Kordelin Foundation; Research Council for Biosciences and Environment, Academy of Finland(Academy of FinlandFinnish Funding Agency for Technology & Innovation (TEKES)); Finnish Foundation for Cardiovascular Research; Research Council for Health, Academy of Finland(Academy of Finland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL48739 (to V. Z.). This work was also supported by the Finnish Cultural Foundation (to M. B.-S.), the Paulo Foundation (to M. B.-S.), the Aarne Koskelon Foundation (to M. B.-S.), Orion Farmos (to M. B.-S.), the Alfred Kordelin Foundation (to M. B.-S.), the Research Council for Biosciences and Environment, Academy of Finland Grant 114075 (to M. S.), the Finnish Foundation for Cardiovascular Research (to M. J.), and the Research Council for Health, Academy of Finland, Grant 132629 (to M. J.).	Autenrieth IB, 1996, J MED MICROBIOL, V44, P285, DOI 10.1099/00222615-44-4-285; Barlage S, 2001, J LIPID RES, V42, P281; Biedzka-Sarek M, 2005, INFECT IMMUN, V73, P2232, DOI 10.1128/IAI.73.4.2232-2244.2005; Biedzka-Sarek M, 2008, INFECT IMMUN, V76, P5016, DOI 10.1128/IAI.00314-08; Biedzka-Sarek M, 2008, INFECT IMMUN, V76, P4100, DOI 10.1128/IAI.00313-08; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Bresnihan B, 2004, ARTHRITIS RES THER, V6, pR563, DOI 10.1186/ar1443; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; CAROFF M, 1984, EUR J BIOCHEM, V139, P195, DOI 10.1111/j.1432-1033.1984.tb07994.x; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; CHINA B, 1994, INFECT IMMUN, V62, P1275, DOI 10.1128/IAI.62.4.1275-1281.1994; Chroni A, 2003, J BIOL CHEM, V278, P6719, DOI 10.1074/jbc.M205232200; Chroni A, 2007, BIOCHEMISTRY-US, V46, P5697, DOI 10.1021/bi602354t; Collins LA, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-42; HAMILTON KK, 1991, J CLIN INVEST, V88, P1833, DOI 10.1172/JCI115504; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Henning MF, 2011, INNATE IMMUN-LONDON, V17, P327, DOI 10.1177/1753425910370709; HOFFMAN J, 1980, CARBOHYD RES, V78, P212, DOI 10.1016/S0008-6215(00)83675-7; HUBSCH AP, 1995, J LAB CLIN MED, V126, P548; Kirjavainen V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000140; Koukos G, 2007, BIOCHEM J, V406, P167, DOI 10.1042/BJ20070296; Laccotripe M, 1997, J BIOL CHEM, V272, P17511, DOI 10.1074/jbc.272.28.17511; Lahtinen P, 2003, GENUS YERSINIA ENTER, P289; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; LINT TF, 1977, J IMMUNOL, V119, P883; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUDERITZ O, 1981, PHARMACOL THERAPEUT, V15, P383, DOI 10.1016/0163-7258(81)90051-6; Marra A, 1997, INFECT IMMUN, V65, P3412, DOI 10.1128/IAI.65.8.3412-3421.1997; MENDALL MA, 1994, BRIT HEART J, V71, P437; Muszynski A., 2004, THESIS U SILESIA KAT; Naktin J, 1999, CLIN LAB MED, V19, P523; NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3; PACKMAN CH, 1985, BIOCHIM BIOPHYS ACTA, V812, P107, DOI 10.1016/0005-2736(85)90527-9; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; PODACK ER, 1978, J IMMUNOL, V120, P1841; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; RIETSCHEL ET, 1992, SCI AM, V267, P54, DOI 10.1038/scientificamerican0892-54; ROSENFELD SI, 1983, J CLIN INVEST, V71, P795, DOI 10.1172/JCI110833; SAMMALKORPI K, 1988, METABOLISM, V37, P859, DOI 10.1016/0026-0495(88)90120-5; SIMONET M, 1990, INFECT IMMUN, V58, P841, DOI 10.1128/IAI.58.3.841-845.1990; Singh IP, 1999, ANTIVIR RES, V42, P211, DOI 10.1016/S0166-3542(99)00032-7; TOMSHICH SV, 1987, KHIM PRIR SOEDIN+, P657; ULEVITCH RJ, 1978, J CLIN INVEST, V62, P1313, DOI 10.1172/JCI109252; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206	47	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38211	38219		10.1074/jbc.M111.249482	http://dx.doi.org/10.1074/jbc.M111.249482			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21896489	hybrid, Green Published			2022-12-27	WOS:000296594200035
J	Zhang, SS; Roche, K; Nasheuer, HP; Lowndes, NF				Zhang, Suisheng; Roche, Kevin; Nasheuer, Heinz-Peter; Lowndes, Noel Francis			Modification of Histones by Sugar beta-N-Acetylglucosamine (GlcNAc) Occurs on Multiple Residues, Including Histone H3 Serine 10, and Is Cell Cycle-regulated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; O-GLCNAC; TRANSCRIPTIONAL ACTIVATION; NUCLEOCYTOPLASMIC PROTEINS; CHROMOSOME CONDENSATION; CHROMATIN-STRUCTURE; INSULIN-RESISTANCE; GENE-REGULATION; PHOSPHORYLATION; GLCNACYLATION	The monosaccharide, beta-N-acetylglucosamine (GlcNAc), can be added to the hydroxyl group of either serines or threonines to generate an O-linked beta-N-acetylglucosamine (O-GlcNAc) residue (Love, D. C., and Hanover, J. A. (2005) Sci. STKE 2005 312, 1-14; Hart, G. W., Housley, M. P., and Slawson, C. (2007) Nature 446, 1017-1022). This post-translational protein modification, termed O-GlcNAcylation, is reversible, analogous to phosphorylation, and has been implicated in many cellular processes. Here, we present evidence that in human cells all four core histones of the nucleosome are substrates for this glycosylation in the relative abundance H3, H4/H2B, and H2A. Increasing the intracellular level of UDP-GlcNAc, the nucleotide sugar donor substrate for O-GlcNAcylation enhanced histone O-GlcNAcylation and partially suppressed phosphorylation of histone H3 at serine 10 (H3S10ph). Expression of recombinant H3.3 harboring an S10A mutation abrogated histone H3 O-GlcNAcylation relative to its wild-type version, consistent with H3S10 being a site of histone O-GlcNAcylation (H3S10glc). Moreover, O-GlcNAcylated histones were lost from H3S10ph immunoprecipitates, whereas immunoprecipitation of either H3K4me3 or H3K9me3 (active or inactive histone marks, respectively) resulted in co-immunoprecipitation of O-GlcNAcylated histones. We also examined histone O-GlcNAcylation during cell cycle progression. Histone O-GlcNAcylation is high in G(1) cells, declines throughout the S phase, increases again during late S/early G(2), and persists through late G(2) and mitosis. Thus, O-GlcNAcylation is a novel histone post-translational modification regulating chromatin conformation during transcription and cell cycle progression.	[Zhang, Suisheng; Roche, Kevin; Lowndes, Noel Francis] Natl Univ Ireland Galway, Genome Stabil Lab, Ctr Chromosome Biol, Sch Nat Sci, Galway, Ireland; [Nasheuer, Heinz-Peter] Natl Univ Ireland Galway, Cell Cycle Control Lab, Ctr Chromosome Biol, Sch Nat Sci, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Lowndes, NF (corresponding author), Natl Univ Ireland Galway, Genome Stabil Lab, Ctr Chromosome Biol, Sch Nat Sci, Univ Rd, Galway, Ireland.	noel.lowndes@nuigalway.ie	Lowndes, Noel F/B-9084-2008; Nasheuer, Heinz P./B-9025-2008	Lowndes, Noel F/0000-0002-3216-4427; Nasheuer, Heinz Peter/0000-0002-9218-9079	Science Foundation Ireland (SFI) [07/IN1/B958]; Health Research Board (HRB) [RP/2005/265]; EMBARK Initiative; SFI CSET Systems Biology Ireland	Science Foundation Ireland (SFI)(Science Foundation Ireland); Health Research Board (HRB); EMBARK Initiative; SFI CSET Systems Biology Ireland(Science Foundation Ireland)	This work was supported by a Science Foundation Ireland (SFI) Principal Investigator award (07/IN1/B958) and a Health Research Board (HRB) Project Grant (RP/2005/265) (to N. F. L.).; Recipient of an EMBARK Initiative Postdoctoral Fellowship.; Supported by SFI CSET Systems Biology Ireland.	Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; BODE AM, 2005, SCI STKE, pRE4; BOOTSMA D, 1964, EXP CELL RES, V33, P301, DOI 10.1016/S0014-4827(64)81035-1; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; CHOU TY, 1995, P NATL ACAD SCI USA, V92, P4417, DOI 10.1073/pnas.92.10.4417; Clements A, 2003, MOL CELL, V12, P461, DOI 10.1016/S1097-2765(03)00288-0; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Dehde S, 2001, MOL CELL BIOL, V21, P2581, DOI 10.1128/MCB.21.7.2581-2593.2001; Duan Q, 2008, J BIOL CHEM, V283, P33585, DOI 10.1074/jbc.M803312200; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hartzog GA, 2007, GENE DEV, V21, P3209, DOI 10.1101/gad.1628707; He ZW, 2003, J BIOL CHEM, V278, P10588, DOI 10.1074/jbc.M208581200; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Hurtado-Guerrero R, 2008, CURR OPIN STRUC BIOL, V18, P551, DOI 10.1016/j.sbi.2008.09.005; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Johansen KM, 2006, CHROMOSOME RES, V14, P393, DOI 10.1007/s10577-006-1063-4; Kabra Dhiraj G, 2009, Biochim Biophys Acta, V1792, P574, DOI 10.1016/j.bbadis.2009.03.003; Kaleem A, 2008, J CELL BIOCHEM, V103, P835, DOI 10.1002/jcb.21454; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Markaki Y, 2009, J CELL SCI, V122, P2809, DOI 10.1242/jcs.043810; Mellor J, 2008, CURR OPIN GENET DEV, V18, P116, DOI 10.1016/j.gde.2007.12.005; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Perez-Cadahia B, 2009, BIOCHEM CELL BIOL, V87, P695, DOI 10.1139/O09-053; Pretlow T G 2nd, 1979, Cell Biophys, V1, P195, DOI 10.1007/BF02781351; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Teng HJ, 2009, J BIOL CHEM, V284, P26368, DOI 10.1074/jbc.M109.021360; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Zachara N. E., 2002, CURR PROTOCOLS MOL S, V57, P1761; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	63	94	98	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37483	37495		10.1074/jbc.M111.284885	http://dx.doi.org/10.1074/jbc.M111.284885			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896475	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000296542400047
J	Furuya, Y; Mori, K; Ninomiya, T; Tomimori, Y; Tanaka, S; Takahashi, N; Udagawa, N; Uchida, K; Yasuda, H				Furuya, Yuriko; Mori, Kaoru; Ninomiya, Tadashi; Tomimori, Yoshiya; Tanaka, Sakae; Takahashi, Naoyuki; Udagawa, Nobuyuki; Uchida, Kohji; Yasuda, Hisataka			Increased Bone Mass in Mice after Single Injection of Anti-receptor Activator of Nuclear Factor-kappa B Ligand-neutralizing Antibody EVIDENCE FOR BONE ANABOLIC EFFECT OF PARATHYROID HORMONE IN MICE WITH FEW OSTEOCLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCLASTOGENESIS-INHIBITORY FACTOR; HUMAN MONOCLONAL-ANTIBODY; DIFFERENTIATION FACTOR; POSTMENOPAUSAL WOMEN; OSTEOPROTEGERIN OPG; CELL FUNCTION; RANK LIGAND; RECEPTOR; RESORPTION; DENOSUMAB	Receptor activator of nuclear factor-kappa B ligand (RANKL) is a pivotal osteoclast differentiation factor. To investigate the effect of RANKL inhibition in normal mice, we prepared an anti-mouse RANKL-neutralizing monoclonal antibody (Mab, clone OYC1) and established a new mouse model with high bone mass induced by administration of OYC1. A single subcutaneous injection of 5 mg/kg OYC1 in normal mice significantly augmented the bone mineral density in the distal femoral metaphysis from day 2 to day 28. The OYC1 treatment markedly reduced the serum level of tartrate-resistant acid phosphatase-5b (TRAP-5b, a marker for osteoclasts) on day 1, and this level was undetectable from day 3 to day 28. The serum level of alkaline phosphatase (a marker for osteoblasts) declined significantly following the reduction of TRAP-5b. Histological analysis revealed few osteoclasts in femurs of the treated mice on day 4, and both osteoclasts and osteoblasts were markedly diminished on day 14. Daily injection of parathyroid hormone for 2 weeks increased the bone mineral density in trabecular and cortical bone by stimulating bone formation in the OYC1-treated mice. These results suggest that parathyroid hormone exerted its bone anabolic activity in mice with few osteoclasts. The mouse anti-RANKL neutralizing antibody OYC1 may be a useful tool to investigate unknown functions of RANKL in vivo.	[Yasuda, Hisataka] Oriental Yeast Co Ltd, Bioind Div, Itabashi Ku, Tokyo 1748505, Japan; [Furuya, Yuriko; Mori, Kaoru; Tomimori, Yoshiya; Uchida, Kohji] Oriental Yeast Co Ltd, Nagahama Branch, Nagahama Inst Biochem Sci, Shiga 5260804, Japan; [Ninomiya, Tadashi; Takahashi, Naoyuki; Udagawa, Nobuyuki] Matsumoto Dent Univ, Inst Oral Sci, Nagano 3990781, Japan; [Udagawa, Nobuyuki] Matsumoto Dent Univ, Dept Biochem, Nagano 3990781, Japan; [Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1130033, Japan	Oriental Yeast Co., Ltd.; Oriental Yeast Co., Ltd.; Matsumoto Dental University; Matsumoto Dental University; University of Tokyo	Yasuda, H (corresponding author), Oriental Yeast Co Ltd, Bioind Div, Itabashi Ku, 3-610 Azusawa, Tokyo 1748505, Japan.	hyasuda@oyc.co.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414				Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Bekker PJ, 2004, J BONE MINER RES, V19, P1059, DOI 10.1359/JBMR.040305; Capparelli C, 2003, J BONE MINER RES, V18, P852, DOI 10.1359/jbmr.2003.18.5.852; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Gerstenfeld LC, 2009, J BONE MINER RES, V24, P196, DOI 10.1359/JBMR.081113; Hofbauer LC, 2009, ARTHRITIS RHEUM, V60, P1427, DOI 10.1002/art.24445; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kamijo S, 2006, BIOCHEM BIOPH RES CO, V347, P124, DOI 10.1016/j.bbrc.2006.06.098; Koh AJ, 2005, ENDOCRINOLOGY, V146, P4584, DOI 10.1210/en.2005-0333; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Kostenuik PJ, 2001, ENDOCRINOLOGY, V142, P4295, DOI 10.1210/en.142.10.4295; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; Ominsky MS, 2007, OSTEOPOROSIS INT, V18, P1073, DOI 10.1007/s00198-007-0363-7; Oyajobi BO, 2001, CANCER RES, V61, P2572; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pierroz DD, 2010, J BIOL CHEM, V285, P28164, DOI 10.1074/jbc.M110.101964; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Truneh A, 2000, J BIOL CHEM, V275, P23319, DOI 10.1074/jbc.M910438199; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1999, BONE, V25, P109, DOI 10.1016/S8756-3282(99)00121-0; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	32	47	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					37023	37031		10.1074/jbc.M111.246280	http://dx.doi.org/10.1074/jbc.M111.246280			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21862583	hybrid, Green Published			2022-12-27	WOS:000296538300080
J	Sun, JL; Pan, HH; Lei, CW; Yuan, B; Nair, SJ; April, C; Parameswaran, B; Klotzle, B; Fan, JB; Ruan, JH; Li, R				Sun, Jianlong; Pan, Haihui; Lei, Chengwei; Yuan, Bin; Nair, Sreejith J.; April, Craig; Parameswaran, Balaji; Klotzle, Brandy; Fan, Jian-Bing; Ruan, Jianhua; Li, Rong			Genetic and Genomic Analyses of RNA Polymerase II-pausing Factor in Regulation of Mammalian Transcription and Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE ELONGATION-FACTOR; IMMUNODEFICIENCY-VIRUS TRANSCRIPTION; P-TEFB; POL-II; ACTIVE PROMOTERS; FACTOR NELF; DROSOPHILA; COMPLEX; DSIF; EXPRESSION	Many mammalian genes are occupied by paused RNA polymerase II (pol II) in the promoter-proximal region on both sides of the transcription start site. However, the impact of pol II pausing on gene expression and cell biology is not fully understood. In this study, we used a Cre-Lox system to conditionally knock out the b subunit of mouse negative elongation factor (Nelf-b), a key pol II-pausing factor, in mouse embryonic fibroblasts. We found that Nelf-b was associated with the promoter-proximal region of the majority of expressed genes, yet genetic ablation of Nelf-b only affected the steady-state mRNA levels of a small percentage of the Nelf-b-associated genes. Interestingly, Nelf-b deletion also increased levels of transcription start site upstream transcripts at multiple negative elongation factor-associated genes. The direct target genes of Nelf-b were highly enriched with those involved in the control of cell growth and cell death. Correspondingly, Nelf-b knock-out mouse embryonic fibroblasts exhibited slower progression from quiescence to proliferation, as well as in a cycling cell population. Furthermore, Nelf-b deletion also resulted in increased apoptosis. Thus, the genetic and genomic studies provide new physiological and molecular insight into Nelf-mediated pol II pausing.	[Lei, Chengwei; Ruan, Jianhua] Univ Texas San Antonio, Dept Comp Sci, San Antonio, TX 78249 USA; [Sun, Jianlong; Pan, Haihui; Yuan, Bin; Nair, Sreejith J.; Parameswaran, Balaji; Li, Rong] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Inst Biotechnol, San Antonio, TX 78245 USA; [April, Craig; Klotzle, Brandy; Fan, Jian-Bing] Illumina Inc, San Diego, CA 92121 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio; Illumina	Ruan, JH (corresponding author), Univ Texas San Antonio, Dept Comp Sci, San Antonio, TX 78249 USA.	jruan@cs.utsa.edu; lir3@uthscsa.edu	Yuan, Bin/AAT-1286-2021; Ruan, Jianhua/I-2529-2012	Parameswaran, Balaji/0000-0002-1665-4872; Nair, Sreejith Janardhanan/0000-0001-6295-1133; Ruan, Jianhua/0000-0002-5622-3137	Cancer Therapy and Research Center, University of Texas Health Science Center San Antonio, a National Institutes of Health NCI-designated Cancer Center; National Institutes of Health [SC3GM086305]; Voelcker scholar award; Department of Defense [W81XWH-09-1-0014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM086305] Funding Source: NIH RePORTER	Cancer Therapy and Research Center, University of Texas Health Science Center San Antonio, a National Institutes of Health NCI-designated Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Voelcker scholar award; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Kay-Uwe Wagner for plasmids and Drs. Paul Labhart, Vassili Alexiadis, and Wei Li for technical support and advice. We gratefully acknowledge the support of the Cancer Therapy and Research Center, University of Texas Health Science Center San Antonio, a National Institutes of Health NCI-designated Cancer Center.; This work was supported, in whole or in part, by National Institutes of Health Grant SC3GM086305 (to J. R.). This work was also supported by a Voelcker scholar award (to R. L.) and Department of Defense Breast Cancer Predoctoral Fellowship W81XWH-09-1-0014 (to S. J. N.).	Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Amleh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005034; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Fujita T, 2008, MOL CELL BIOL, V28, P1630, DOI 10.1128/MCB.01767-07; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Sun JL, 2010, J BIOL CHEM, V285, P6443, DOI 10.1074/jbc.M109.084285; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Wada T, 2000, MOL CELL, V5, P1067, DOI 10.1016/S1097-2765(00)80272-5; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang XL, 2007, GENE DEV, V21, P1031, DOI 10.1101/gad.1521207; Wu CH, 2005, NUCLEIC ACIDS RES, V33, P1269, DOI 10.1093/nar/gki274; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200	50	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36248	36257		10.1074/jbc.M111.269167	http://dx.doi.org/10.1074/jbc.M111.269167			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21865163	Green Published, hybrid			2022-12-27	WOS:000296538300009
J	Eliyahu, E; Shtraizent, N; He, XX; Chen, DN; Shalgi, R; Schuchman, EH				Eliyahu, Efrat; Shtraizent, Nataly; He, Xingxuan; Chen, Dafna; Shalgi, Ruth; Schuchman, Edward H.			Identification of Cystatin SA as a Novel Inhibitor of Acid Ceramidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; BREAST-CANCER; DISEASE; ASSAY; MICE	Autoproteolytic cleavage of the inactive acid ceramidase (AC) precursor into the active heterodimer exposes a free cysteine residue, leading us to study whether AC could be regulated by one or more members of the cystatin family. Co-expression of the full-length AC and cystatin SA (cysSA) cDNAs led to significant reduction of AC activity in the transfected cells. Expression of cysSA also inhibited endogenous AC activity in cells and increased ceramide. Conversely, cysSA siRNA expression led to elevated AC activity and reduction in ceramide. The effects of cysSA siRNA expression could be reversed by the addition of recombinant cysSA into the culture media. These results were consistent with detection of a physical interaction between AC and cysSA, assessed by co-immunoprecipitation and nickel-nitrilotriacetic acid affinity chromatography, and further supported by co-localization of the endogenous proteins using confocal microscopy. In vitro kinetic analysis of purified, recombinant AC and cysSA confirmed the transfection results and suggested a non-competitive type of inhibition with a K-i in the low micromolar range. Processing of the AC precursor into the active form was not affected by cysSA expression, suggesting that it likely inhibits AC by allosteric interference. Computer modeling and expression studies identified several potential inhibitory domains in cysSA, including a small "AC-like" domain (identical to the AC cleavage site, TICT). Small peptides, synthesized with combinations of this and a "cystatin-like" domain (QXVXG), exhibited significant AC inhibition as well. Such peptide-based AC inhibitors could potentially be used to regulate AC activity in cancer cells that are known to overexpress this enzyme alone and in combination with conventional anti-cancer drugs.	[Eliyahu, Efrat; Shtraizent, Nataly; He, Xingxuan; Chen, Dafna; Schuchman, Edward H.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Shtraizent, Nataly; Shalgi, Ruth] Tel Aviv Univ, Dept Dev & Cell Biol, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Icahn School of Medicine at Mount Sinai; Tel Aviv University; Sackler Faculty of Medicine	Schuchman, EH (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, Room 14-20A, New York, NY 10029 USA.	Edward.Schuchman@mssm.edu			National Institutes of Health [2 R01 DK54830]; Binational Science Foundation [2009212]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 R01 DK54830. This work was also supported by Binational Science Foundation Grant 2009212. N. S., E. E., X. H., and E. H. S. are inventors on AC-related patent applications, which if licensed could generate royalties for them and the Mount Sinai School of Medicine.	AZUMA N, 1994, ARCH BIOCHEM BIOPHYS, V311, P354, DOI 10.1006/abbi.1994.1248; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bielawska A, 2001, ANAL BIOCHEM, V298, P141, DOI 10.1006/abio.2001.5342; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Choi EH, 2009, CLIN CHIM ACTA, V406, P45, DOI 10.1016/j.cca.2009.05.008; Eliyahu E, 2007, FASEB J, V21, P1403, DOI 10.1096/fj.06-7016com; Feldman AS, 2009, CLIN CANCER RES, V15, P1024, DOI 10.1158/1078-0432.CCR-08-1143; HALL A, 1993, BIOCHEM J, V291, P123, DOI 10.1042/bj2910123; He XX, 2003, J BIOL CHEM, V278, P32978, DOI 10.1074/jbc.M301936200; He XX, 2001, ANAL BIOCHEM, V293, P204, DOI 10.1006/abio.2001.5108; Parker BS, 2008, J PATHOL, V214, P337, DOI 10.1002/path.2265; Rivenbark AG, 2009, FRONT BIOSCI-LANDMRK, V14, P453, DOI 10.2741/3254; Rzychon M, 2004, ACTA BIOCHIM POL, V51, P861; Saitoh E, 1998, ARCH BIOCHEM BIOPHYS, V352, P199, DOI 10.1006/abbi.1997.0609; Shtraizent N, 2008, J BIOL CHEM, V283, P11253, DOI 10.1074/jbc.M709166200; SUGITA M, 1972, SCIENCE, V178, P1100, DOI 10.1126/science.178.4065.1100; Tani M, 1999, J BIOCHEM-TOKYO, V125, P746; Usova TA, 2003, B EXP BIOL MED+, V135, P81, DOI 10.1023/A:1023462316317; van Lijnschoten G, 2000, PEDIATR DEVEL PATHOL, V3, P597, DOI 10.1007/s100240010107; Veena MS, 2008, GENE CHROMOSOME CANC, V47, P740, DOI 10.1002/gcc.20576; Vray B, 2002, CELL MOL LIFE SCI, V59, P1503, DOI 10.1007/s00018-002-8525-4; Zhang J, 2004, CANCER RES, V64, P6957, DOI 10.1158/0008-5472.CAN-04-0819; Zhang Y, 2009, BBA-BIOMEMBRANES, V1788, P178, DOI 10.1016/j.bbamem.2008.07.030	23	13	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35624	35633		10.1074/jbc.M111.260372	http://dx.doi.org/10.1074/jbc.M111.260372			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21846728	hybrid, Green Published			2022-12-27	WOS:000295927100034
J	Kopil, CM; Vais, H; Cheung, KH; Siebert, AP; Mak, DOD; Foskett, JK; Neumar, RW				Kopil, Catherine M.; Vais, Horia; Cheung, King-Ho; Siebert, Adam P.; Mak, Don-On Daniel; Foskett, J. Kevin; Neumar, Robert W.			Calpain-cleaved Type 1 Inositol 1,4,5-Trisphosphate Receptor (InsP(3)R1) Has InsP(3)-independent Gating and Disrupts Intracellular Ca2+ Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT GLOBAL-ISCHEMIA; ASPHYXIAL CARDIAC-ARREST; TRISPHOSPHATE RECEPTOR; RAT-BRAIN; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE; CA1 REGION; CELL-DEATH; SHORT-TERM; APOPTOSIS	The type 1 inositol 1,4,5-trisphosphate receptor (InsP(3)R1) is a ubiquitous intracellular Ca2+ release channel that is vital to intracellular Ca2+ signaling. InsP(3)R1 is a proteolytic target of calpain, which cleaves the channel to form a 95-kDa carboxyl-terminal fragment that includes the transmembrane domains, which contain the ion pore. However, the functional consequences of calpain proteolysis on channel behavior and Ca2+ homeostasis are unknown. In the present study we have identified a unique calpain cleavage site in InsP(3)R1 and utilized a recombinant truncated form of the channel (capn-InsP(3)R1) corresponding to the stable, carboxyl-terminal fragment to examine the functional consequences of channel proteolysis. Single-channel recordings of capn-InsP3R1 revealed InsP(3)-independent gating and high open probability (P-o) under optimal cytoplasmic Ca2+ concentration ([Ca2+](i)) conditions. However, some [Ca2+](i) regulation of the cleaved channel remained, with a lower P-o in suboptimal and inhibitory [Ca2+](i). Expression of capn-InsP(3)R1 in N2a cells reduced the Ca2+ content of ionomycin-releasable intracellular stores and decreased endoplasmic reticulum Ca2+ loading compared with control cells expressing full-length InsP(3)R1. Using a cleavage-specific antibody, we identified calpain-cleaved InsP(3)R1 in selectively vulnerable cerebellar Purkinje neurons after in vivo cardiac arrest. These findings indicate that calpain proteolysis of InsP(3)R1 generates a dys-regulated channel that disrupts cellular Ca2+ homeostasis. Furthermore, our results demonstrate that calpain cleaves InsP(3)R1 in a clinically relevant injury model, suggesting that Ca2+ leak through the proteolyzed channel may act as a feed-forward mechanism to enhance cell death.	[Kopil, Catherine M.; Neumar, Robert W.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; [Vais, Horia; Cheung, King-Ho; Siebert, Adam P.; Mak, Don-On Daniel; Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Cheung, King-Ho] Univ Hong Kong, Dept Physiol, Pok Fu Lam, Hong Kong, Peoples R China	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Hong Kong	Neumar, RW (corresponding author), 3400 Spruce St,Ground Floor Ravdin Bldg, Philadelphia, PA 19104 USA.	neumarr@uphs.upenn.edu	Foskett, Kevin/R-2549-2019; /B-3424-2011	/0000-0001-8683-1654; Foskett, J. Kevin/0000-0002-8854-0268	National Institutes of Health [NS039481, NS069951, NS071828, MH059937, GM065830]; American Heart Association [0815440D]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056328, R01GM065830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS071828, R21NS069951, R01NS039481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant Grants NS039481 (to R. W. N.), NS069951 (to R. W. N.), NS071828 (to C. M. K.), MH059937 (to J. K. F.), and GM065830 (D.-O. D. M. and J. K. F.). This work was also supported by American Heart Association Grant 0815440D (to C. M. K.).	Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; Beresewicz M, 2006, NEUROCHEM INT, V48, P568, DOI 10.1016/j.neuint.2005.11.020; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Che DF, 2011, CRIT CARE MED, V39, P1423, DOI 10.1097/CCM.0b013e318212020a; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; Colbourne F, 1996, J NEUROSCI METH, V67, P185, DOI 10.1016/0165-0270(96)00047-7; Dahl C, 2000, NEUROCHEM INT, V36, P379, DOI 10.1016/S0197-0186(99)00129-1; Davis RJ, 1999, BIOCHEM J, V341, P813, DOI 10.1042/0264-6021:3410813; Diaz F, 2000, CELL CALCIUM, V27, P315, DOI 10.1054/ceca.2000.0126; ERECINSKA M, 1992, CAN J PHYSIOL PHARM, V70, pS190, DOI 10.1139/y92-262; FISCHER GA, 1994, J BIOL CHEM, V269, P19216; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Foskett JK, 2010, CURR TOP MEMBR, V66, P235, DOI 10.1016/S1063-5823(10)66011-5; Galvan DL, 1999, J BIOL CHEM, V274, P29483, DOI 10.1074/jbc.274.41.29483; Hang LS, 2000, J NEUROCHEM, V75, P1852; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; Igwe OJ, 1997, MOL BRAIN RES, V46, P39, DOI 10.1016/S0169-328X(96)00269-0; Ionescu L, 2006, J PHYSIOL-LONDON, V573, P645, DOI 10.1113/jphysiol.2006.109504; Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005; JOSEPH SK, 1995, BIOCHEM J, V307, P859, DOI 10.1042/bj3070859; JOSEPH SK, 1993, J BIOL CHEM, V268, P6477; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Kohno K, 1997, NEUROSCI LETT, V224, P17, DOI 10.1016/S0304-3940(97)13459-0; Leissring MA, 1999, J NEUROCHEM, V72, P1061, DOI 10.1046/j.1471-4159.1999.0721061.x; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Mackrill JJ, 1996, BIOCHEM J, V318, P871, DOI 10.1042/bj3180871; MAGNUSSON A, 1993, FEBS LETT, V323, P229, DOI 10.1016/0014-5793(93)81345-Z; NAGASAWA H, 1991, NEUROSCI LETT, V133, P129, DOI 10.1016/0304-3940(91)90074-4; Nagata E, 1999, NEUROSCIENCE, V93, P995, DOI 10.1016/S0306-4522(99)00198-0; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; NEUMAR RW, 1995, RESUSCITATION, V29, P249, DOI 10.1016/0300-9572(94)00827-3; Neumar RW, 2000, ANN EMERG MED, V36, P483, DOI 10.1067/mem.2000.110995; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Sayers LG, 1997, BIOCHEM J, V323, P273, DOI 10.1042/bj3230273; SILVER IA, 1992, J CEREBR BLOOD F MET, V12, P759, DOI 10.1038/jcbfm.1992.107; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Verbert L, 2008, BIOL CELL, V100, P39, DOI 10.1042/BC20070086; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Wojcikiewicz RJH, 1996, J BIOL CHEM, V271, P16652, DOI 10.1074/jbc.271.28.16652; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; ZAIDAN E, 1994, J NEUROCHEM, V63, P1812	47	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35998	36010		10.1074/jbc.M111.254177	http://dx.doi.org/10.1074/jbc.M111.254177			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21859719	Green Published, hybrid			2022-12-27	WOS:000295927100073
J	Astudillo, AM; Perez-Chacon, G; Meana, C; Balgoma, D; Pol, A; del Pozo, MA; Balboa, MA; Balsinde, J				Astudillo, Alma M.; Perez-Chacon, Gema; Meana, Clara; Balgoma, David; Pol, Albert; del Pozo, Miguel A.; Balboa, Maria A.; Balsinde, Jesus			Altered Arachidonate Distribution in Macrophages from Caveolin-1 Null Mice Leading to Reduced Eicosanoid Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PHOSPHOLIPASE A(2); MOUSE PERITONEAL-MACROPHAGES; PLATELET-ACTIVATING-FACTOR; FATTY-ACID INCORPORATION; DIET-INDUCED OBESITY; PROTEIN-KINASE-C; P388D(1) MACROPHAGES; U937 CELLS; PLASMA-MEMBRANE; STIMULATED MACROPHAGES	In this work we have studied the effect of caveolin-1 deficiency on the mechanisms that regulate free arachidonic acid (AA) availability. The results presented here demonstrate that macrophages from caveolin-1-deficient mice exhibit elevated fatty acid incorporation and remodeling and a constitutively increased CoA-independent transacylase activity. Mass spectrometry-based lipidomic analyses reveal stable alterations in the profile of AA distribution among phospholipids, manifested by reduced levels of AA in choline glycerophospholipids but elevated levels in ethanolamine glycerophospholipids and phosphatidylinositol. Furthermore, macrophages from caveolin-1 null mice show decreased AA mobilization and prostaglandin E-2 and LTB4 production upon cell stimulation. Collectively, these results provide insight into the role of caveolin-1 in AA homeostasis and suggest an important role for this protein in the eicosanoid biosynthetic response.	[Astudillo, Alma M.; Perez-Chacon, Gema; Meana, Clara; Balgoma, David; Balboa, Maria A.; Balsinde, Jesus] Consejo Super Invest Cient, Inst Biol & Genet Mol, Valladolid 47003, Spain; [Astudillo, Alma M.; Meana, Clara; Balboa, Maria A.; Balsinde, Jesus] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona 08017, Spain; [Pol, Albert] Inst Invest Biomed August Pi & Sunyer, Barcelona 08036, Spain; [del Pozo, Miguel A.] Ctr Nacl Invest Cardiovasc, Dept Biol Vasc & Inflamac, Madrid 28029, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Balsinde, J (corresponding author), Univ Valladolid, Sch Med, Calle Sanz & Fores 3, Valladolid 47003, Spain.	jbalsinde@ibgm.uva.es	del Pozo, Miguel Angel/L-2861-2014; Perez-Chacon, Gema/H-5954-2015; Meana, Clara/AAN-4887-2020; Balboa, María A./V-9493-2018; Balgoma, David/ABG-9548-2020; Pol, Albert/M-1865-2014; Balsinde, Jesús/C-7833-2018	del Pozo, Miguel Angel/0000-0001-9077-391X; Perez-Chacon, Gema/0000-0002-2081-0882; Balboa, María A./0000-0002-2130-5298; Pol, Albert/0000-0002-1750-1085; Balsinde, Jesús/0000-0002-4157-6714; Balgoma Hernando, David/0000-0001-6463-4502; ASTUDILLO DEL VALLE, ALMA MARIA/0000-0002-9966-7950; Meana, Clara/0000-0003-3580-6058	Spanish Ministry of Science and Innovation [BFU2010-18826, SAF2010-18831]; Regional Government of Castile and Leon, Spain	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Castile and Leon, Spain	This work was supported by the Spanish Ministry of Science and Innovation Grants BFU2010-18826 and SAF2010-18831.; Supported by a predoctoral fellowship from the Regional Government of Castile and Leon, Spain.	Astudillo AM, 2011, BBA-MOL CELL BIOL L, V1811, P97, DOI 10.1016/j.bbalip.2010.11.009; Balboa MA, 2003, J BIOL CHEM, V278, P48059, DOI 10.1074/jbc.M305904200; Balboa MA, 2003, J IMMUNOL, V170, P5276, DOI 10.4049/jimmunol.170.10.5276; Balboa MA, 2008, FEBS J, V275, P1915, DOI 10.1111/j.1742-4658.2008.06350.x; Balboa MA, 2006, BBA-MOL CELL BIOL L, V1761, P385, DOI 10.1016/j.bbalip.2006.03.014; Balgoma D, 2010, BIOCHIMIE, V92, P645, DOI 10.1016/j.biochi.2009.11.010; Balgoma D, 2010, J IMMUNOL, V184, P3857, DOI 10.4049/jimmunol.0902883; Balgoma D, 2008, FEBS J, V275, P6180, DOI 10.1111/j.1742-4658.2008.06742.x; Balsinde J, 1996, EUR J BIOCHEM, V235, P480, DOI 10.1111/j.1432-1033.1996.00480.x; Balsinde J, 2000, J BIOL CHEM, V275, P22544, DOI 10.1074/jbc.M910163199; BALSINDE J, 1994, BBA-LIPID LIPID MET, V1210, P195, DOI 10.1016/0005-2760(94)90121-X; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; BALSINDE J, 1992, BIOCHIM BIOPHYS ACTA, V1136, P75, DOI 10.1016/0167-4889(92)90087-R; Balsinde J, 2002, BIOCHEM J, V364, P695, DOI 10.1042/BJ20020142; BALSINDE J, 1990, J IMMUNOL, V144, P4298; Balsinde J, 1997, BIOCHEM J, V321, P805, DOI 10.1042/bj3210805; BALSINDE J, 1994, P NATL ACAD SCI USA, V91, P11060, DOI 10.1073/pnas.91.23.11060; BALSINDE J, 1994, EUR J BIOCHEM, V221, P1013, DOI 10.1111/j.1432-1033.1994.tb18818.x; BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; Balsinde J, 2006, BBA-MOL CELL BIOL L, V1761, P1344, DOI 10.1016/j.bbalip.2006.07.013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boilard E, 2001, J BIOL CHEM, V276, P17568, DOI 10.1074/jbc.M006152200; Bosch M, 2011, CURR BIOL, V21, P681, DOI 10.1016/j.cub.2011.03.030; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Chilton FH, 1996, BBA-LIPID LIPID MET, V1299, P1, DOI 10.1016/0005-2760(95)00169-7; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; DIEZ E, 1987, BIOCHIM BIOPHYS ACTA, V921, P82, DOI 10.1016/0005-2760(87)90173-1; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Ehehalt R, 2006, MOL CELL BIOCHEM, V284, P135, DOI 10.1007/s11010-005-9034-1; FONTEH AN, 1992, J IMMUNOL, V148, P1784; FONTEH AN, 1993, J IMMUNOL, V150, P563; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gargalovic P, 2003, J LIPID RES, V44, P11, DOI 10.1194/jlr.R200005-JLR200; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; Heimer S, 2008, BIOCHEM BIOPH RES CO, V367, P826, DOI 10.1016/j.bbrc.2008.01.010; Hnasko Robert, 2003, Mol Interv, V3, P445, DOI 10.1124/mi.3.8.445; KAEVER V, 1988, PROSTAGLANDINS, V35, P885, DOI 10.1016/0090-6980(88)90114-1; KAYGANICH KA, 1992, ANAL CHEM, V64, P2965, DOI 10.1021/ac00047a015; KISS AL, 1995, CELL BIOL INT, V19, P527, DOI 10.1006/cbir.1995.1097; Kiss AL, 1997, EUR J CELL BIOL, V73, P19; Le Lay S, 2005, BBA-MOL CELL RES, V1746, P322, DOI 10.1016/j.bbamcr.2005.06.001; Leslie CC, 2004, BIOCHEM CELL BIOL, V82, P1, DOI 10.1139/o03-080; Morimoto R, 2010, J BIOL CHEM, V285, P29857, DOI 10.1074/jbc.M110.147025; Murphy R. C, 2002, MASS SPECTROMETRY PH; NIETO ML, 1991, J BIOL CHEM, V266, P18699; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Perez R, 2006, J LIPID RES, V47, P484, DOI 10.1194/jlr.M500397-JLR200; Perez R, 2006, J IMMUNOL, V176, P2555, DOI 10.4049/jimmunol.176.4.2555; Perez R, 2004, J BIOL CHEM, V279, P40385, DOI 10.1074/jbc.M402562200; Perez-Chacon G, 2010, J IMMUNOL, V184, P1071, DOI 10.4049/jimmunol.0902257; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Pohl J, 2004, BIOCHEMISTRY-US, V43, P4179, DOI 10.1021/bi035743m; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Razani B, 2001, J BIOL CHEM, V276, P38121; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Rouzer CA, 2007, BIOCHEMISTRY-US, V46, P6026, DOI 10.1021/bi0621617; SCOTT WA, 1982, J EXP MED, V155, P1148, DOI 10.1084/jem.155.4.1148; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Surette ME, 1999, CARCINOGENESIS, V20, P757, DOI 10.1093/carcin/20.5.757; Trigatti BL, 1999, BIOCHEM BIOPH RES CO, V255, P34, DOI 10.1006/bbrc.1998.0123; Trimboli AJ, 1999, CANCER RES, V59, P6171; VENABLE ME, 1991, J BIOL CHEM, V266, P18691; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Yan SR, 1996, FEBS LETT, V380, P198	71	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35299	35307		10.1074/jbc.M111.277137	http://dx.doi.org/10.1074/jbc.M111.277137			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21852231	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000295406300083
J	Win, S; Than, TA; Han, D; Petrovic, LM; Kaplowitz, N				Win, Sanda; Tin Aung Than; Han, Derick; Petrovic, Lydia M.; Kaplowitz, Neil			c-Jun N-terminal Kinase (JNK)-dependent Acute Liver Injury from Acetaminophen or Tumor Necrosis Factor (TNF) Requires Mitochondrial Sab Protein Expression in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED HEPATOCYTE APOPTOSIS; SIGNAL-TRANSDUCTION PATHWAY; REACTIVE OXYGEN; JNK ACTIVATION; MOUSE HEPATOCYTES; DNA-DAMAGE; CELL-DEATH; HEPATOTOXICITY; RELEASE; PHOSPHORYLATION	Sustained JNK activation plays a critical role in hepatotoxicity by acetaminophen or GalN/TNF-alpha. To address the importance of JNK translocation to mitochondria that accompanies sustained activation in these models, we assessed the importance of the expression of a potential initial target of JNK in the outer membrane of mitochondria, namely Sab (SH3 domain-binding protein that preferentially associates with Btk), also known as Sh3bp5 (SH3 domain-binding protein 5). Silencing the expression of Sab in the liver using adenoviral shRNA inhibited sustained JNK activation and mitochondrial targeting of JNK and the upstream MKK4 (MAPK kinase 4), accompanied by striking protection against liver injury in vivo and in cultured hepatocytes in both toxicity models. We conclude that mitochondrial Sab may serve as a platform for the MAPK pathway enzymes and that the interaction of stress-activated JNK with Sab is required for sustained JNK activation and toxicity.	[Win, Sanda; Tin Aung Than; Han, Derick; Kaplowitz, Neil] Univ So Calif, Keck Sch Med, USC Res Ctr Liver Dis, Div Gastrointestinal & Liver Dis, Los Angeles, CA 90089 USA; [Petrovic, Lydia M.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Kaplowitz, N (corresponding author), Univ So Calif, Keck Sch Med, USC Res Ctr Liver Dis, Div Gastrointestinal & Liver Dis, 2011 Zonal Ave,HMR 101, Los Angeles, CA 90089 USA.	kaplowit@usc.edu			National Institutes of Health [R01 DK067215];  [DK067215];  [AA016911]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067215, P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA016911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK067215 (to N. K.), a training supplement to Grant DK067215 to promote reentry into research careers (to S. W.), and K01 Award AA016911 (to D. H.).	Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Bradham CA, 1997, HEPATOLOGY, V25, P1128, DOI 10.1002/hep.510250514; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chauhan D, 2003, J BIOL CHEM, V278, P17593, DOI 10.1074/jbc.C300076200; Court NW, 2004, BIOCHEM BIOPH RES CO, V319, P130, DOI 10.1016/j.bbrc.2004.04.148; Cover C, 2005, J PHARMACOL EXP THER, V315, P879, DOI 10.1124/jpet.105.088898; Czaja MJ, 2007, SEMIN LIVER DIS, V27, P378, DOI 10.1055/s-2007-991514; DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Feng GP, 2002, AM J PHYSIOL-GASTR L, V282, pG825, DOI 10.1152/ajpgi.00467.2001; Getachew Y, 2010, BIOCHEM PHARMACOL, V79, P1363, DOI 10.1016/j.bcp.2009.12.019; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Han D., 2010, HDB EXP PHARM, V196, P267, DOI DOI 10.1007/978-3-642-00663-0_10; Han D, 2006, FREE RADICAL BIO MED, V41, P627, DOI 10.1016/j.freeradbiomed.2006.05.002; Han D, 2009, ANTIOXID REDOX SIGN, V11, P2245, DOI [10.1089/ars.2009.2611, 10.1089/ARS.2009.2611]; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kodama Y, 2009, GASTROENTEROLOGY, V136, P1423, DOI 10.1053/j.gastro.2008.12.064; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Liu HL, 2002, HEPATOLOGY, V35, P772, DOI 10.1053/jhep.2002.32534; Nagai H, 2002, HEPATOLOGY, V36, P55, DOI 10.1053/jhep.2002.33995; Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006; Osawa Y, 2001, J CELL PHYSIOL, V187, P374, DOI 10.1002/jcp.1088; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Shinohara M, 2010, J BIOL CHEM, V285, P8244, DOI 10.1074/jbc.M109.054999; Than TA, 2011, J BIOL CHEM, V286, P22047, DOI 10.1074/jbc.M111.240481; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wiltshire C, 2004, BIOCHEM SOC T, V32, P1075, DOI 10.1042/BST0321075; Wiltshire C, 2002, BIOCHEM J, V367, P577, DOI 10.1042/BJ20020553; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x	39	129	135	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35071	35078		10.1074/jbc.M111.276089	http://dx.doi.org/10.1074/jbc.M111.276089			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844199	hybrid, Green Published			2022-12-27	WOS:000295406300060
J	Gates, DP; Coonrod, LA; Berglund, JA				Gates, Devika P.; Coonrod, Leslie A.; Berglund, J. Andrew			Autoregulated Splicing of muscleblind-like 1 (MBNL1) Pre-mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE 2'-HYDROXYL ACYLATION; SECONDARY STRUCTURE PREDICTION; SINGLE NUCLEOTIDE RESOLUTION; EXPANDED-REPEAT TRANSCRIPTS; PRIMER EXTENSION SHAPE; TRACT BINDING-PROTEIN; DISTANT BRANCH-POINTS; MYOTONIC-DYSTROPHY; MAMMALIAN INTRONS; CHLORIDE CHANNEL	Muscleblind-like 1 (MBNL1) is a splicing factor whose improper cellular localization is a central component of myotonic dystrophy. In myotonic dystrophy, the lack of properly localized MBNL1 leads to missplicing of many pre-mRNAs. One of these events is the aberrant inclusion of exon 5 within the MBNL1 pre-mRNA. The region of the MBNL1 gene that includes exon 5 and flanking intronic sequence is highly conserved in vertebrate genomes. The 3'-end of intron 4 is non-canonical in that it contains a predicted branch point that is 141 nucleotides from the 3'-splice site and an AAG 3'-splice site. Using a minigene that includes exon 4, intron 4, exon 5, intron 5, and exon 6 of MBNL1, we showed that MBNL1 regulates inclusion of exon 5. Mapping of the intron 4 branch point confirmed that branching occurs primarily at the predicted distant branch point. Structure probing and footprinting revealed that the highly conserved region between the branch point and 3'-splice site is primarily unstructured and that MBNL1 binds within this region of the pre-mRNA. Deletion of the MBNL1 response element eliminated MBNL1 splicing regulation and led to complete inclusion of exon 5, which is consistent with the suppressive effect of MBNL1 on splicing.	[Berglund, J. Andrew] Univ Oregon, Inst Mol Biol 1229, Dept Chem, Eugene, OR 97403 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Berglund, JA (corresponding author), Univ Oregon, Inst Mol Biol 1229, Dept Chem, Eugene, OR 97403 USA.	aberglund@molbio.uoregon.edu	Berglund, Andrew/AAS-1065-2021		National Institutes of Health [AR053903, GM-07759]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR053903 (to J. A. B.) and Training Grant GM-07759 (to D. P. G.).	Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; Begemann G, 1997, DEVELOPMENT, V124, P4321; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Chen SY, 2000, P NATL ACAD SCI USA, V97, P593, DOI 10.1073/pnas.97.2.593; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Goers ES, 2010, NUCLEIC ACIDS RES, V38, P2467, DOI 10.1093/nar/gkp1209; Gooding C, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r1; Grossman JS, 1998, RNA, V4, P613, DOI 10.1017/S1355838298971448; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Kino Y, 2009, NUCLEIC ACIDS RES, V37, P6477, DOI 10.1093/nar/gkp681; Ladd AN, 2005, MOL CELL BIOL, V25, P6267, DOI 10.1128/MCB.25.14.6267-6278.2005; Lee JE, 2009, BIOCHEM SOC T, V37, P1281, DOI 10.1042/BST0371281; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Llorian M, 2010, NAT STRUCT MOL BIOL, V17, P1114, DOI 10.1038/nsmb.1881; Low JT, 2010, METHODS, V52, P150, DOI 10.1016/j.ymeth.2010.06.007; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Murray JI, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r97; Osborne RJ, 2006, HUM MOL GENET, V15, pR162, DOI 10.1093/hmg/ddl181; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Sathirapongsasuti JF, 2011, NUCLEIC ACIDS RES, V39, P1967, DOI 10.1093/nar/gkq949; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Terenzi F, 2010, RNA BIOL, V7, P43, DOI 10.4161/rna.7.1.10401; Tran H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194928; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Warf MB, 2009, P NATL ACAD SCI USA, V106, P9203, DOI 10.1073/pnas.0900342106; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	44	45	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34224	34233		10.1074/jbc.M111.236547	http://dx.doi.org/10.1074/jbc.M111.236547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832083	Green Published, hybrid			2022-12-27	WOS:000295159200052
J	Rishavy, MA; Hallgren, KW; Berkner, KL				Rishavy, Mark A.; Hallgren, Kevin W.; Berkner, Kathleen L.			The Vitamin K-dependent Carboxylase Generates gamma-Carboxylated Glutamates by Using CO2 to Facilitate Glutamate Deprotonation in a Concerted Mechanism That Drives Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-COAGULATION FACTORS; CARBON-HYDROGEN BOND; FACTOR-IX; COMBINED DEFICIENCY; POSTTRANSLATIONAL MODIFICATION; PROTEIN CARBOXYLATION; CARBOXYGLUTAMIC ACID; MAMMALIAN-CELLS; MUTATION; BASE	The gamma-glutamyl carboxylase converts Glu to carboxylated Glu (Gla) to activate a large number of vitamin K-dependent proteins with diverse functions, and this broad physiological impact makes it critical to understand the mechanism of carboxylation. Gla formation is thought to occur in two independent steps (i.e. Glu deprotonation to form a carbanion that then reacts with CO2), based on previous studies showing unresponsiveness of Glu deprotonation to CO2. However, our recent studies on the kinetic properties of a variant enzyme (H160A) showing impaired Glu deprotonation prompted a reevaluation of this model. Glu deprotonation monitored by tritium release from the glutamyl gamma-carbon was dependent upon CO2, and a proportional increase in both tritium release and Gla formation occurred over a range of CO2 concentrations. This discrepancy with the earlier studies using microsomes is probably due to the known accessibility of microsomal carboxylase to water, which reprotonates the carbanion. In contrast, tritium incorporation experiments with purified carboxylase showed very little carbanion reprotonation and consequently revealed the dependence of Glu deprotonation on CO2. Cyanide stimulated Glu deprotonation and carbanion reprotonation to the same extent in wild type enzyme but not in the H160A variant. Glu deprotonation that depends upon CO2 but that also occurs when water or cyanide are present strongly suggests a concerted mechanism facilitated by His-160 in which an electrophile accepts the negative charge on the developing carbanion. This revised mechanism provides important insight into how the carboxylase catalyzes the reaction by avoiding the formation of a high energy discrete carbanion.	[Rishavy, Mark A.; Hallgren, Kevin W.; Berkner, Kathleen L.] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Berkner, KL (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave,NB50, Cleveland, OH 44195 USA.	berknek@ccf.org		Berkner, Kathleen/0000-0001-8054-8081	National Institutes of Health [RO1 HL055666]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL055666 (to K. L. B.).	ANTON DL, 1983, J BIOL CHEM, V258, P4084; Bandyopadhyay PK, 2002, P NATL ACAD SCI USA, V99, P1264, DOI 10.1073/pnas.022637099; Berkner KL, 2008, VITAM HORM, V78, P131, DOI 10.1016/S0083-6729(07)00007-6; Berkner KL, 1997, METHOD ENZYMOL, V282, P313; Berkner KL, 2005, ANNU REV NUTR, V25, P127, DOI 10.1146/annurev.nutr.25.050304.092713; BERKNER KL, 1993, METHOD ENZYMOL, V222, P450; Brenner B, 1998, BLOOD, V92, P4554, DOI 10.1182/blood.V92.12.4554.424k42_4554_4559; Czerwiec E, 2002, EUR J BIOCHEM, V269, P6162, DOI 10.1046/j.1432-1033.2002.03335.x; Darghouth D, 2006, BLOOD, V108, P1925, DOI 10.1182/blood-2005-12-010660; DECOTTIGNIESLEMARECHAL P, 1984, J BIOL CHEM, V259, P5010; DECOTTIGNIESLEMARECHAL P, 1979, BIOCHEM BIOPH RES CO, V90, P700; DEMETZ M, 1982, FEBS LETT, V137, P253, DOI 10.1016/0014-5793(82)80361-X; DEMETZ M, 1981, FEBS LETT, V123, P215, DOI 10.1016/0014-5793(81)80290-6; DOWD P, 1995, SCIENCE, V269, P1684, DOI 10.1126/science.7569894; DOWD P, 1991, P NATL ACAD SCI USA, V88, P10583, DOI 10.1073/pnas.88.23.10583; DUBOIS J, 1983, J BIOL CHEM, V258, P7897; Finnan J. L., 1980, VITAMIN K METABOLISM, P509; FRIEDMAN PA, 1979, P NATL ACAD SCI USA, V76, P3126, DOI 10.1073/pnas.76.7.3126; Hallgren KW, 2002, BIOCHEMISTRY-US, V41, P15045, DOI 10.1021/bi026016e; HAUSCHKA PV, 1979, BIOCHEMISTRY-US, V18, P4992, DOI 10.1021/bi00589a029; Jiang Y, 2003, P NATL ACAD SCI USA, V100, P7527, DOI 10.1073/pnas.0932632100; Kulman JD, 2006, P NATL ACAD SCI USA, V103, P15794, DOI 10.1073/pnas.0607543103; LARSON AE, 1981, J BIOL CHEM, V256, P1032; Li QL, 2009, J INVEST DERMATOL, V129, P553, DOI 10.1038/jid.2008.271; Li T, 2000, J BIOL CHEM, V275, P18291, DOI 10.1074/jbc.M001790200; Lingenfelter SE, 1996, BIOCHEMISTRY-US, V35, P8234, DOI 10.1021/bi9523318; MCTIGUE JJ, 1983, J BIOL CHEM, V258, P2129; Morris DP, 1995, J BIOL CHEM, V270, P30491, DOI 10.1074/jbc.270.51.30491; Mutucumarana VP, 2003, J BIOL CHEM, V278, P46488, DOI 10.1074/jbc.M307707200; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Rishavy MA, 2005, J BIOL CHEM, V280, P34870, DOI 10.1074/jbc.M504345200; Rishavy MA, 2004, P NATL ACAD SCI USA, V101, P13732, DOI 10.1073/pnas.0404989101; Rishavy MA, 2008, BIOCHEMISTRY-US, V47, P9836, DOI 10.1021/bi800296r; Rishavy MA, 2006, BIOCHEMISTRY-US, V45, P13239, DOI 10.1021/bi0609523; Rost S, 2004, BRIT J HAEMATOL, V126, P546, DOI 10.1111/j.1365-2141.2004.05071.x; Schultz J, 2004, TRENDS BIOCHEM SCI, V29, P4, DOI 10.1016/j.tibs.2003.11.002; Spronk HMH, 2000, BLOOD, V96, P3650; Stenina O, 2001, BIOCHEMISTRY-US, V40, P10301, DOI 10.1021/bi0107039; Tie JK, 2008, VITAM HORM, V78, P103, DOI 10.1016/S0083-6729(07)00006-4; UOTILA L, 1988, ARCH BIOCHEM BIOPHYS, V264, P135, DOI 10.1016/0003-9861(88)90578-4; Vanakker OM, 2007, J INVEST DERMATOL, V127, P581, DOI 10.1038/sj.jid.5700610; Walker CS, 2001, J BIOL CHEM, V276, P7769, DOI 10.1074/jbc.M009576200; Wang CP, 2003, J THROMB HAEMOST, V1, P118, DOI 10.1046/j.1538-7836.2003.00069.x; Zhu AH, 2007, BLOOD, V109, P5270, DOI 10.1182/blood-2006-12-064188	45	5	5	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44821	44832		10.1074/jbc.M111.249177	http://dx.doi.org/10.1074/jbc.M111.249177			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	21896484	hybrid, Green Published			2022-12-27	WOS:000298645500051
J	Zawacka-Pankau, J; Grinkevich, VV; Huenten, S; Nikulenkov, F; Gluch, A; Li, H; Enge, M; Kel, A; Selivanova, G				Zawacka-Pankau, Joanna; Grinkevich, Vera V.; Huenten, Sabine; Nikulenkov, Fedor; Gluch, Angela; Li, Hai; Enge, Martin; Kel, Alexander; Selivanova, Galina			Inhibition of Glycolytic Enzymes Mediated by Pharmacologically Activated p53 TARGETING WARBURG EFFECT TO FIGHT CANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; ENDOTHELIAL GROWTH-FACTOR; SMALL-MOLECULE RITA; CELLULAR LIFE-SPAN; C-MYC; GENE-EXPRESSION; FACTOR 1-ALPHA; FACTOR-I; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION	Unique sensitivity of tumor cells to the inhibition of glycolysis is a good target for anticancer therapy. Here, we demonstrate that the pharmacologically activated tumor suppressor p53 mediates the inhibition of glycolytic enzymes in cancer cells in vitro and in vivo. We showed that p53 binds to the promoters of metabolic genes and represses their expression, including glucose transporters SLC2A12 (GLUT12) and SLC2A1 (GLUT 1). Furthermore, p53-mediated repression of transcription factors c-Myc and HIF1 alpha, key drivers of ATP-generating pathways in tumors, contributed to ATP production block. Inhibition of c-Myc by p53 mediated the ablation of several glycolytic genes in normoxia, whereas in hypoxia down-regulation of HIFla contributed to this effect. We identified Spl as a transcription cofactor cooperating with p53 in the ablation of metabolic genes. Using different approaches, we demonstrated that glycolysis block contributes to the robust induction of apoptosis by p53 in cancer cells. Taken together, our data suggest that tumor-specific reinstatement of p53 function targets the "Achilles heel" of cancer cells (i.e. their dependence on glycolysis), which could contribute to the tumor-selective killing of cancer cells by pharmacologically activated p53.	[Zawacka-Pankau, Joanna] Univ Gdansk, Intercollegiate Fac Biotechnol, Div Mol Diagnost, Dept Biotechnol, PL-80822 Gdansk, Poland; [Zawacka-Pankau, Joanna] Med Univ Gdansk, PL-80822 Gdansk, Poland; [Enge, Martin; Selivanova, Galina] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Gluch, Angela] Biobase GmbH, D-38304 Wolfenbuettel, Germany; [Kel, Alexander] GeneXplain GmbH, D-38302 Wolfenbuettel, Germany	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Karolinska Institutet	Zawacka-Pankau, J (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Div Mol Diagnost, Dept Biotechnol, Kladki 24, PL-80822 Gdansk, Poland.	jzawacka@biotech.ug.gda.pl; Galina.Selivanova@ki.se	Nikulenkov, Fedor/AAJ-2304-2021; Kel, Alexander E/I-7284-2013; Enge, Martin/GYQ-5073-2022; Zawacka-Pankau, Joanna/AAE-4600-2019	Zawacka-Pankau, Joanna/0000-0002-7415-2942; Enge, Martin/0000-0001-8748-8931; Selivanova, Galina/0000-0002-8698-4332	Swedish Cancer Society; Swedish Research Council; Torsten and Ragnar Soderberg Foundation; EC FP6 project "Mutant p53"; EC FP6 project "Active p53"; EC FP6 project "Net2Drug"	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderberg Foundation; EC FP6 project "Mutant p53"; EC FP6 project "Active p53"; EC FP6 project "Net2Drug"	This study was supported by grants from the Swedish Cancer Society, the Swedish Research Council, and the Torsten and Ragnar Soderberg Foundation (to G. S.). This work was also supported by EC FP6 projects "Mutant p53," "Active p53," and "Net2Drug."	Ahmed A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.42; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Ardyanto TD, 2006, INT J ONCOL, V29, P549; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Ceriotti L, 2007, ANAL BIOCHEM, V371, P92, DOI 10.1016/j.ab.2007.07.014; Choi C, 2004, COMP FUNCT GENOM, V5, P163, DOI 10.1002/cfg.386; Choi J, 2010, BIOCHEM BIOPH RES CO, V401, P327, DOI 10.1016/j.bbrc.2010.09.014; Czernin J, 2002, ANNU REV MED, V53, P89, DOI 10.1146/annurev.med.53.082901.104028; Dalvai M, 2011, ONCOGENE, V30, P2282, DOI 10.1038/onc.2010.588; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Grinkevich VV, 2009, CANCER CELL, V15, P441, DOI 10.1016/j.ccr.2009.03.021; Hainaut P, 2000, ADV CANCER RES, V77, P81; HAWKINS RA, 1988, CANCER METAST REV, V7, P119, DOI 10.1007/BF00046482; Hedstrom E, 2009, CELL CYCLE, V8, P3584, DOI 10.4161/cc.8.21.9977; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jackson P, 1998, ONCOGENE, V16, P283, DOI 10.1038/sj.onc.1201491; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kel A, 2008, SAR QSAR ENVIRON RES, V19, P481, DOI 10.1080/10629360802083806; Kel A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S13; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kondoh H, 2005, CANCER RES, V65, P177; Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Lou JJW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010522; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Ortega AD, 2009, CANCER LETT, V276, P125, DOI 10.1016/j.canlet.2008.08.007; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Ravi R, 2000, GENE DEV, V14, P34; REMPEL A, 1994, BBA-GENE STRUCT EXPR, V1219, P660, DOI 10.1016/0167-4781(94)90225-9; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinaldo C, 2009, CANCER RES, V69, P6241, DOI 10.1158/0008-5472.CAN-09-0337; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Scatena R, 2008, EXPERT OPIN INV DRUG, V17, P1533, DOI 10.1517/13543784.17.10.1533 ; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Selivanova G, 2010, SEMIN CANCER BIOL, V20, P46, DOI 10.1016/j.semcancer.2010.02.006; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Smith TAD, 2006, J NUCL MED, V47, P1525; Spinnler C., 2011, CELL DEATH IN PRESS; Stegmaier P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017738; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Williams KJ, 2005, RADIOTHER ONCOL, V75, P89, DOI 10.1016/j.radonc.2005.01.009; Yang J, 2009, MOL CELL BIOL, V29, P2243, DOI 10.1128/MCB.00959-08; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Younes M, 1996, CANCER RES, V56, P1164; Zhao CY, 2010, CANCER RES, V70, P3372, DOI 10.1158/0008-5472.CAN-09-2787; Zhao RB, 2000, GENE DEV, V14, P981; Zhao YH, 2011, FRONT BIOSCI-LANDMRK, V16, P1844, DOI 10.2741/3826; Zhong H, 1999, CANCER RES, V59, P5830	73	88	88	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41600	41615		10.1074/jbc.M111.240812	http://dx.doi.org/10.1074/jbc.M111.240812			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21862591	hybrid, Green Published			2022-12-27	WOS:000298057500045
J	Dash, B; Chang, YC; Lukas, RJ				Dash, Bhagirathi; Chang, Yongchang; Lukas, Ronald J.			Reporter Mutation Studies Show That Nicotinic Acetylcholine Receptor (nAChR) alpha 5 Subunits and/or Variants Modulate Function of alpha 6*-nAChR*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; ION CHANNELS; IN-VIVO; GENE; ALPHA-4-BETA-2; ACTIVATION; EXPRESSION; SUBTYPES; RELEASE; NEURONS	To further the understanding of functional alpha 6 alpha 5*-nicotinic acetylcholine receptors (nAChR; the asterisk (*) indicates known or possible presence of other subunits), we have heterologously expressed in oocytes different, mouse or human, nAChR subunit combinations. Coexpression with wild-type alpha 5 subunits or chimeric alpha 5/beta 3 subunits (in which the human alpha 5 subunit N-terminal, extracellular domain is linked to the remaining domains of the human beta 3 subunit) almost completely abolishes the very small amount of function seen for alpha 6 beta 4*-nAChR and does not induce function of alpha 6 beta 2*-nAChR. Coexpression with human alpha 5(V9)'(S) subunits bearing a valine 290 to serine mutation in the 9' position of the second transmembrane domain does not rescue the function of alpha 6 beta 4*-nAChR or induce function of alpha 6 beta 2*-nAChR. However, coexpression with mutant chimeric alpha 5/beta 3(V9)'(S) subunits has a gain-of-function effect (higher functional expression and agonist sensitivity and spontaneous opening inhibited by mecamylamine) on alpha 6 beta 4*-nAChR. Moreover, N143D + M145V mutations in the alpha 6 subunit N-terminal domain enable alpha 5/beta 3(V9)'(S) subunits to have a gain-of-function effect on alpha 6 beta 2*-nAChR. nAChR containing chimeric alpha 6/alpha 3 subunits plus either beta 2 or beta 4 subunits have some function that is modulated in the presence of alpha 5 or alpha 5/beta 3 subunits. Coexpression with alpha 5/beta 3(V9)'(S) subunits has a gain-of-function effect more pronounced than that in the presence of alpha 5(V9)'(S) subunits. Gain-of-function effects are dependent, sometimes subtly, on the nature and apparently the extracellular, cytoplasmic, and/or transmembrane domain topology of partner subunits. These studies yield insight into assembly of functional alpha 6 alpha 5*-nAChR and provide tools for development of alpha 6*-nAChR-selective ligands that could be important in the treatment of nicotine dependence, and perhaps other neurological diseases.	[Dash, Bhagirathi; Chang, Yongchang; Lukas, Ronald J.] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA	Barrow Neurological Institute	Lukas, RJ (corresponding author), 350 W Thomas Rd, Phoenix, AZ 85013 USA.	rlukas@chw.edu		Dash, Bhagirathi/0000-0002-5314-5372	National Institutes of Health [R01 DA015389]; Philip Morris USA Inc.; Philip Morris International; Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris USA Inc.; Philip Morris International; Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA015389 and the External Research Program by Philip Morris USA Inc. and Philip Morris International, and endowment and capitalization funds from the Men's and Women's Boards of the Barrow Neurological Foundation. Portions of this work have been presented in abstract form (Dash, B., Bhakta, M., Chang, Y., and Lukas, R.J. (2010) Soc. Neurosci. Abst. 36, 39.19).	BOULTER J, 1990, J BIOL CHEM, V265, P4472; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Brown RWB, 2007, J NEUROCHEM, V103, P204, DOI 10.1111/j.1471-4159.2007.04700.x; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; COUTURIER S, 1990, J BIOL CHEM, V265, P17560; Cui CH, 2003, J NEUROSCI, V23, P11045; Dash B, 2011, J BIOL CHEM, V286, P37976, DOI 10.1074/jbc.M111.263673; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Flora A, 2000, J NEUROCHEM, V75, P18, DOI 10.1046/j.1471-4159.2000.0750018.x; Fucile S, 1998, EUR J NEUROSCI, V10, P172, DOI 10.1046/j.1460-9568.1998.00001.x; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lester HA, 2000, ANNU REV NEUROSCI, V23, P89, DOI 10.1146/annurev.neuro.23.1.89; Lukas RJ, 2001, EUR J NEUROSCI, V13, P1849, DOI 10.1046/j.0953-816x.2001.01560.x; Lukas RJ, 1999, PHARMACOL REV, V51, P397; McClure-Begley TD, 2009, MOL PHARMACOL, V75, P918, DOI 10.1124/mol.108.052274; Miko A, 2004, J BIOL CHEM, V279, P22833, DOI 10.1074/jbc.M402577200; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Orr-Urtreger A, 2000, J NEUROCHEM, V74, P2154, DOI 10.1046/j.1471-4159.2000.0742154.x; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; TREININ M, 1995, NEURON, V14, P871, DOI 10.1016/0896-6273(95)90231-7; WADA E, 1990, BRAIN RES, V526, P45, DOI 10.1016/0006-8993(90)90248-A; Wang N, 2002, J PHYSIOL-LONDON, V542, P347, DOI 10.1113/jphysiol.2001.013456; Wang NS, 2004, J NEUROL SCI, V222, P87, DOI 10.1016/j.jns.2004.04.009; Winzer-Serhan UH, 2005, J COMP NEUROL, V481, P19, DOI 10.1002/cne.20357; Yu CR, 1998, J PHYSIOL-LONDON, V509, P667, DOI 10.1111/j.1469-7793.1998.667bm.x	30	14	14	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37905	37918		10.1074/jbc.M111.264044	http://dx.doi.org/10.1074/jbc.M111.264044			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21873428	hybrid, Green Published			2022-12-27	WOS:000296594200004
J	Fasken, MB; Leung, SW; Banerjee, A; Kodani, MO; Chavez, R; Bowman, EA; Purohit, MK; Rubinson, ME; Rubinson, EH; Corbett, AH				Fasken, Milo B.; Leung, Sara W.; Banerjee, Ayan; Kodani, Maja O.; Chavez, Ramiro; Bowman, Elizabeth A.; Purohit, Meghan K.; Rubinson, Max E.; Rubinson, Emily H.; Corbett, Anita H.			Air1 Zinc Knuckles 4 and 5 and a Conserved IWRXY Motif Are Critical for the Function and Integrity of the Trf4/5-Air1/2-Mtr4 Polyadenylation (TRAMP) RNA Quality Control Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; NUCLEAR EXOSOME; YEAST EXOSOME; RIBOSOMAL-RNA; BIDIRECTIONAL PROMOTERS; POLY(A) POLYMERASE; DEGRADATION; PROTEIN; SURVEILLANCE	In Saccharomyces cerevisiae, non-coding RNAs, including cryptic unstable transcripts (CUTs), are subject to degradation by the exosome. The Trf4/5-Air1/2-Mtr4 polyadenylation (TRAMP) complex in S. cerevisiae is a nuclear exosome cofactor that recruits the exosome to degrade RNAs. Trf4/5 are poly(A) polymerases, Mtr4 is an RNA helicase, and Air1/2 are putative RNA-binding proteins that contain five CCHC zinc knuckles (ZnKs). One central question is how the TRAMP complex, especially the Air1/2 protein, recognizes its RNA substrates. To characterize the function of the Air1/2 protein, we used random mutagenesis of the AIR1/2 gene to identify residues critical for Air protein function. We identified air1-C178R and air2-C167R alleles encoding air1/2 mutant proteins with a substitution in the second cysteine of ZnK5. Mutagenesis of the second cysteine in AIR1/2 ZnK1-5 reveals that Air1/2 ZnK4 and -5 are critical for Air protein function in vivo. In addition, we find that the level of CUT, NEL025c, in air1 ZnK1-5 mutants is stabilized, particularly in air1 ZnK4, suggesting a role for Air1 ZnK4 in the degradation of CUTs. We also find that Air1/2 ZnK4 and -5 are critical for Trf4 interaction and that the Air1-Trf4 interaction and Air1 level are critical for TRAMP complex integrity. We identify a conserved IWRXY motif in the Air1 ZnK4-5 linker that is important for Trf4 interaction. We also find that hZC-CHC7, a putative human orthologue of Air1 that contains the IWRXY motif, localizes to the nucleolus in human cells and interacts with both mammalian Trf4 orthologues, PAPD5 and PAPD7 (PAP-associated domain containing 5 and 7), suggesting that hZCCHC7 is the Air component of a human TRAMP complex.	[Fasken, Milo B.; Leung, Sara W.; Banerjee, Ayan; Kodani, Maja O.; Chavez, Ramiro; Purohit, Meghan K.; Rubinson, Max E.; Rubinson, Emily H.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Bowman, Elizabeth A.] Emory Univ, Sch Med, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Fasken, MB (corresponding author), 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	mfasken@emory.edu	Fasken, Milo/K-2177-2019; Corbett, Anita/AAH-6106-2021	Fasken, Milo/0000-0003-4317-7909; Corbett, Anita/0000-0002-0461-6895	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health grant (to A. H. C.).	Adams A, 1997, METHODS YEAST GENETI; Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; An Q, 2009, HAEMATOL-HEMATOL J, V94, P1164, DOI 10.3324/haematol.2008.002808; Anderson JT, 2009, CRIT REV BIOCHEM MOL, V44, P16, DOI [10.1080/10409230802640218 , 10.1080/10409230802640218]; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bernstein J, 2008, J BIOL CHEM, V283, P4930, DOI 10.1074/jbc.M706677200; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; D'Souza V, 2004, NATURE, V431, P586, DOI 10.1038/nature02944; Das B, 2003, MOL CELL BIOL, V23, P5502, DOI 10.1128/MCB.23.16.5502-5515.2003; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hamill S, 2010, P NATL ACAD SCI USA, V107, P15045, DOI 10.1073/pnas.1003505107; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Inoue K, 2000, J BIOL CHEM, V275, P32793, DOI 10.1074/jbc.M004560200; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Keller C, 2010, RNA, V16, P1124, DOI 10.1261/rna.2053710; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Liang S, 1996, MOL CELL BIOL, V16, P5139; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Nakamura R, 2008, MOL CELL BIOL, V28, P6620, DOI 10.1128/MCB.00448-08; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Reis CC, 2007, GENETICS, V175, P993, DOI 10.1534/genetics.106.065987; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; SADOFF BU, 1995, GENETICS, V141, P465; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanudo M, 2011, BIOMOL NMR ASSIGN, V5, P19, DOI 10.1007/s12104-010-9257-2; Shcherbik N, 2010, EMBO REP, V11, P106, DOI 10.1038/embor.2009.271; SIKORSKI RS, 1989, GENETICS, V122, P19; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Walowsky C, 1999, J BIOL CHEM, V274, P7302, DOI 10.1074/jbc.274.11.7302; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; Wang ZH, 2000, SCIENCE, V289, P774, DOI 10.1126/science.289.5480.774; Wang ZH, 2002, GENETICS, V160, P381; Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zhou AD, 2008, J GENET GENOMICS, V35, P467, DOI 10.1016/S1673-8527(08)60064-8	66	49	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37429	37445		10.1074/jbc.M111.271494	http://dx.doi.org/10.1074/jbc.M111.271494			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878619	Green Published, hybrid			2022-12-27	WOS:000296542400043
J	Lin, L; Bankaitis, E; Heimbach, L; Li, N; Abrink, M; Pejler, G; An, LJ; Diaz, LA; Werb, Z; Liu, Z				Lin, Lan; Bankaitis, Eric; Heimbach, Lisa; Li, Ning; Abrink, Magnus; Pejler, Gunnar; An, Lijia; Diaz, Luis A.; Werb, Zena; Liu, Zhi			Dual Targets for Mouse Mast Cell Protease-4 in Mediating Tissue Damage in Experimental Bullous Pemphigoid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGELATINASE-B; IV COLLAGENASE; DEFICIENT MICE; ANTIGEN BPAG2; KEY ROLE; ACTIVATION; CHYMASE; INFLAMMATION; CLONING; PROTEIN	Mouse mast cell protease-4 (mMCP-4) has been linked to autoimmune and inflammatory diseases, although the exact mechanisms underlying its role in these pathological conditions remain unclear. Here, we have found that mMCP-4 is critical in a mouse model of the autoimmune skin blistering disease bullous pemphigoid (BP). Mice lacking mMCP-4 were resistant to experimental BP. Complement activation, mast cell (MC) degranulation, and the early phase of neutrophil (PMN) recruitment occurred comparably in mMCP-4(-/-) and WT mice. However, without mMCP-4, activation of matrix metalloproteinase (MMP)-9 was impaired in cultured mMCP-4(-/-) MCs and in the skin of pathogenic IgG-injected mMCP-4(-/-) mice. MMP-9 activation was not fully restored by local reconstitution with WT or mMCP-4(-/-) PMNs. Local reconstitution with mMCP-4(-/-) MCs, but not with mMCP-4(-/-) MCs, restored blistering, MMP-9 activation, and PMN recruitment in mMCP-4(-/-) mice. mMCP-4 also degraded the hemidesmosomal transmembrane protein BP180 both in the skin and in vitro. These results demonstrate that mMCP-4 plays two different roles in the pathogenesis of experimental BP, by both activating MMP-9 and by cleaving BP180, leading to injury of the hemidesmosomes and extracellular matrix of the basement membrane zone.	[Lin, Lan; Bankaitis, Eric; Heimbach, Lisa; Li, Ning; Diaz, Luis A.; Liu, Zhi] Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27599 USA; [Lin, Lan; An, Lijia] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian 116024, Liaoning, Peoples R China; [Heimbach, Lisa; Liu, Zhi] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Abrink, Magnus] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, S-75123 Uppsala, Sweden; [Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden; [Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of North Carolina; University of North Carolina Chapel Hill; Dalian University of Technology; University of North Carolina; University of North Carolina Chapel Hill; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; University of California System; University of California San Francisco	Liu, Z (corresponding author), Univ N Carolina, Dept Dermatol, 116 Manning Dr,Rm 422, Chapel Hill, NC 27599 USA.	zhiliu@med.unc.edu	Åbrink, Magnus/AAK-8346-2020	Diaz, Luis/0000-0002-7079-8914; Abrink, Magnus/0000-0002-1335-3927	National Institutes of Health, USPHS [AI40768, AI61430, AR052109, AR053313, AR32599, AR32081, CA057621]; Swedish Medical Research Council; China Scholarship Council; National Institutes of Health [AI007273]; NATIONAL CANCER INSTITUTE [R01CA057621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040768, R01AI040768, R01AI061430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR053313, R37AR032081, R01AR032081, R01AR032599, K01AR052109] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); China Scholarship Council(China Scholarship Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI40768 and AI61430 (to Z. L.), AR052109 and AR053313 (to N. L.), AR32599 and AR32081 (to L. A. D.), and CA057621 (to Z. W.) from the USPHS. This work was also supported by grants from the Swedish Medical Research Council (to M. A. and G. P).; Supported in part by a predoctoral fellowship from the China Scholarship Council.; Supported in part by National Institutes of Health Predoctoral Fellowship AI007273.	Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Chen RY, 2001, J CLIN INVEST, V108, P1151, DOI 10.1172/jci11494; Clark Robert A, 2001, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0723s19; Davis GE, 2001, J CELL SCI, V114, P917; DESRIVIERES S, 1993, J CELL PHYSIOL, V157, P587, DOI 10.1002/jcp.1041570319; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; Fang KC, 1997, J BIOL CHEM, V272, P25628, DOI 10.1074/jbc.272.41.25628; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; FRIDMAN R, 1995, CANCER RES, V55, P2548; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; Gurish MF, 2001, J EXP MED, V194, pF1, DOI 10.1084/jem.194.1.F1; Heimbach L, 2011, J BIOL CHEM, V286, P15003, DOI 10.1074/jbc.M111.221036; HOPKINSON SB, 1992, J INVEST DERMATOL, V99, P264, DOI 10.1111/1523-1747.ep12616615; IMAI K, 1995, J BIOL CHEM, V270, P6691, DOI 10.1074/jbc.270.12.6691; Jiang HB, 1997, J BIOL CHEM, V272, P1082, DOI 10.1074/jbc.272.2.1082; Jippo T, 1997, AM J PATHOL, V150, P1373; JORDON RE, 1967, J AMER MED ASSOC, V200, P751, DOI 10.1001/jama.200.9.751; Knauper V, 1997, EUR J BIOCHEM, V248, P369, DOI 10.1111/j.1432-1033.1997.00369.x; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LEVER WF, 1953, MEDICINE, V32, P1; LI KH, 1993, J BIOL CHEM, V268, P8825; LI KH, 1992, J INVEST DERMATOL, V99, P258, DOI 10.1111/1523-1747.ep12616611; Lijnen HR, 1998, ARTERIOSCL THROM VAS, V18, P1035, DOI 10.1161/01.ATV.18.7.1035; Liu Z, 2005, J CLIN INVEST, V115, P879, DOI 10.1172/JCI200523977; Liu Z, 1997, J CLIN INVEST, V100, P1256, DOI 10.1172/JCI119639; LIU Z, 1995, J CLIN INVEST, V95, P1539, DOI 10.1172/JCI117826; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Liu Z, 1998, J EXP MED, V188, P475, DOI 10.1084/jem.188.3.475; Liu Z, 2000, J CLIN INVEST, V105, P113, DOI 10.1172/JCI3693; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; LIU Z, 1992, J BIOL CHEM, V267, P15829; Magnusson SE, 2009, FASEB J, V23, P875, DOI 10.1096/fj.08-120394; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; Metcalf J. A., 1985, LAB MANUAL NEUTROPHI, P2; Miller HRP, 2002, IMMUNOLOGY, V105, P375, DOI 10.1046/j.1365-2567.2002.01375.x; MURPHY G, 1992, ANN NY ACAD SCI, V667, P1, DOI 10.1111/j.1749-6632.1992.tb51590.x; PEJLER G, 1993, J BIOL CHEM, V268, P11817; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; Ryan JJ, 1998, J IMMUNOL, V161, P6915; Scandiuzzi L, 2010, J IMMUNOL, V185, P624, DOI 10.4049/jimmunol.0902129; SCHWARTZ LB, 1987, J IMMUNOL, V138, P2611; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; STANLEY JR, 1981, CELL, V24, P897, DOI 10.1016/0092-8674(81)90115-X; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Twining SS, 1996, INVEST OPHTH VIS SCI, V37, P511; von Bredow DC, 1998, BIOCHEM J, V331, P965, DOI 10.1042/bj3310965; Waern I, 2009, J IMMUNOL, V183, P6369, DOI 10.4049/jimmunol.0900180; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WERSHIL BK, 1987, J IMMUNOL, V139, P2605; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; Woessner J.F., 2000, PROTEIN PROFILE SER; Younan G, 2010, J IMMUNOL, V185, P7681, DOI 10.4049/jimmunol.1002803	59	42	45	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37358	37367		10.1074/jbc.M111.272401	http://dx.doi.org/10.1074/jbc.M111.272401			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880713	Green Published, hybrid			2022-12-27	WOS:000296542400036
J	Uren, PJ; Burns, SC; Ruan, JH; Singh, KK; Smith, AD; Penalva, LOF				Uren, Philip J.; Burns, Suzanne C.; Ruan, Jianhua; Singh, Kusum K.; Smith, Andrew D.; Penalva, Luiz O. F.			Genomic Analyses of the RNA-binding Protein Hu Antigen R (HuR) Identify a Complex Network of Target Genes and Novel Characteristics of Its Binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; EXPRESSION; STABILITY; MICROARRAYS; PROMOTERS; MICRORNAS; SOFTWARE; CELLS; ELAV	The ubiquitously expressed RNA-binding protein Hu antigen R (HuR) or ELAVL1 is implicated in a variety of biological processes as well as being linked with a number of diseases, including cancer. Despite a great deal of prior investigation into HuR, there is still much to learn about its function. We take an important step in this direction by conducting cross-linking and immunoprecipitation and RNA sequencing experiments followed by an extensive computational analysis to determine the characteristics of the HuR binding site and impact on the transcriptome. We reveal that HuR targets predominantly uracil-rich single-stranded stretches of varying size, with a strong conservation of structure and sequence composition. Despite the fact that HuR sites are observed in intronic regions, our data do not support a role for HuR in regulating splicing. HuR sites in 3'-UTRs overlap extensively with predicted microRNA target sites, suggesting interplay between the functions of HuR and microRNAs. Network analysis showed that identified targets containing HuR binding sites in the 3' UTR are highly interconnected.	[Uren, Philip J.; Smith, Andrew D.] Univ So Calif, Los Angeles, CA 90089 USA; [Burns, Suzanne C.; Singh, Kusum K.; Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Ruan, Jianhua] Univ Texas San Antonio, Dept Comp Sci, San Antonio, TX 78701 USA	University of Southern California; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA)	Smith, AD (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	andrewds@usc.edu; penalva@uthscsa.edu	Ruan, Jianhua/I-2529-2012; Smith, Andrew D./G-4104-2013; Uren, Philip J./H-5275-2019	Smith, Andrew D./0000-0002-3337-1970; Penalva, Luiz/0000-0003-4491-6769; Ruan, Jianhua/0000-0002-5622-3137	National Institutes of Health [5R21HG004664-02]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM086305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R21HG004664-02 (to L. O. F. P.).	Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Calaluce R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-126; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghosh M, 2009, J CLIN INVEST, V119, P3530, DOI 10.1172/JCI38263; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Koushika SP, 1996, CURR BIOL, V6, P1634, DOI 10.1016/S0960-9822(02)70787-2; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lisbin MJ, 2001, GENE DEV, V15, P2546, DOI 10.1101/gad.903101; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mazan-Mamczarz K, 2008, ONCOGENE, V27, P6151, DOI 10.1038/onc.2008.215; Mittal N, 2009, P NATL ACAD SCI USA, V106, P20300, DOI 10.1073/pnas.0906940106; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Nohata N, 2011, ONCOTARGET, V2, P29; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Srikantan S., 2011, FRONT BIOME IN PRESS; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yi J, 2010, NUCLEIC ACIDS RES, V38, P1547, DOI 10.1093/nar/gkp1114; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160	40	56	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37063	37066		10.1074/jbc.C111.266882	http://dx.doi.org/10.1074/jbc.C111.266882			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21890634	hybrid, Green Published			2022-12-27	WOS:000296542400006
J	Uittenbogaard, JP; Zomer, B; Hoogerhout, P; Metz, B				Uittenbogaard, Joost P.; Zomer, Bert; Hoogerhout, Peter; Metz, Bernard			Reactions of beta-Propiolactone with Nucleobase Analogues, Nucleosides, and Peptides IMPLICATIONS FOR THE INACTIVATION OF VIRUSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMALDEHYDE-INDUCED MODIFICATIONS; SELECTIVE INACTIVATION; GAMMA-BUTYROLACTONE; MOLECULAR-MECHANISM; ONCOGENE ACTIVATION; VIRAL GENOME; HEPATITIS-A; VACCINES; DNA; DERIVATIVES	beta-Propiolactone is often applied for inactivation of viruses and preparation of viral vaccines. However, the exact nature of the reactions of beta-propiolactone with viral components is largely unknown. The purpose of the current study was to elucidate the chemical modifications occurring on nucleotides and amino acid residues caused by beta-propiolactone. Therefore, a set of nucleobase analogues was treated with beta-propiolactone, and reaction products were identified and quantified. NMR revealed at least one modification in either deoxyguanosine, deoxyadenosine, or cytidine after treatment with beta-propiolactone. However, no reaction products were found from thymidine and uracil. The most reactive sides of the nucleobase analogues and nucleosides were identified by NMR. Furthermore, a series of synthetic peptides was used to determine the conversion of reactive amino acid residues by liquid chromatography-mass spectrometry. beta-Propiolactone was shown to react with nine different amino acid residues. The most reactive residues are cysteine, methionine, and histidine and, to a lesser degree, aspartic acid, glutamic acid, tyrosine, lysine, serine, and threonine. Remarkably, cystine residues (disulfide groups) do not react with beta-propiolactone. In addition, no reaction was observed for beta-propiolactone with asparagine, glutamine, and tryptophan residues. beta-Propiolactone modifies proteins to a larger extent than expected from current literature. In conclusion, the study determined the reactivity of beta-propiolactone with nucleobase analogues, nucleosides, and amino acid residues and elucidated the chemical structures of the reaction products. The study provides detailed knowledge on the chemistry of beta-propiolactone inactivation of viruses.	[Uittenbogaard, Joost P.; Zomer, Bert; Hoogerhout, Peter; Metz, Bernard] Natl Inst Publ Hlth & Environm, Unit Vaccinol, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Metz, B (corresponding author), Natl Inst Publ Hlth & Environm, Unit Vaccinol, POB 1, NL-3720 BA Bilthoven, Netherlands.	bernard.metz@rivm.nl			World Health Organization; Bill and Melinda Gates Foundation	World Health Organization(World Health Organization); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the World Health Organization using a grant from the Bill and Melinda Gates Foundation.	Ada G., 1997, NEW GENERATION VACCI, V2, P13; ANDRE FE, 1995, J INFECT DIS, V171, pS33, DOI 10.1093/infdis/171.Supplement_1.S33; ATASSI MZ, 1969, IMMUNOCHEMISTRY, V6, P801, DOI 10.1016/0019-2791(69)90286-9; BARTLETT PD, 1951, J AM CHEM SOC, V73, P4273, DOI 10.1021/ja01153a072; BARTLETT PD, 1950, J AM CHEM SOC, V72, P4867, DOI 10.1021/ja01167a006; BAUGH CM, 1966, BIOCHIM BIOPHYS ACTA, V114, P213, DOI 10.1016/0005-2787(66)90029-3; BLACKBURN GM, 1977, J CHEM SOC PERK T 2, P1492, DOI 10.1039/p29770001492; BROWN A, 1974, J VIROL, V14, P840, DOI 10.1128/JVI.14.4.840-845.1974; BRUSICK DJ, 1977, MUTAT RES, V39, P241, DOI 10.1016/0165-1110(77)90007-0; BUDOWSKY EI, 1991, VACCINE, V9, P319, DOI 10.1016/0264-410X(91)90057-D; BUDOWSKY EI, 1991, VACCINE, V9, P398, DOI 10.1016/0264-410X(91)90125-P; CAMPBELL TM, 1982, VET MICROBIOL, V7, P535, DOI 10.1016/0378-1135(82)90047-5; CARLSON RM, 1990, ENVIRON HEALTH PERSP, V87, P227, DOI 10.2307/3431029; CHEN R, 1981, CARCINOGENESIS, V2, P73, DOI 10.1093/carcin/2.2.73; COLBURN NH, 1969, VOX SANG, V17, P64; COLBURN NH, 1965, BIOCHEM PHARMACOL, V14, P1113, DOI 10.1016/0006-2952(65)90040-7; DAVIS RE, 1969, J AM CHEM SOC, V91, P91, DOI 10.1021/ja01029a020; Delrue I, 2009, VET RES, V40, DOI 10.1051/vetres/2009047; DETERMANN H, 1971, Z KLIN CHEM KLIN BIO, V9, P398; DIJKSTRA J, 1975, CHEM-BIOL INTERACT, V10, P115, DOI 10.1016/0009-2797(75)90105-2; FROSNER GG, 1983, EUR J CLIN MICROBIOL, V2, P355, DOI 10.1007/BF02019469; Fu Z. F., 1997, NEW GENERATION VACCI, P607; GARTE SJ, 1989, ENVIRON HEALTH PERSP, V81, P29, DOI 10.2307/3430800; GRESHAM TL, 1948, J AM CHEM SOC, V70, P999, DOI 10.1021/ja01183a031; GRESHAM TL, 1951, J AM CHEM SOC, V73, P3168, DOI 10.1021/ja01151a050; GRESHAM TL, 1948, J AM CHEM SOC, V70, P1004, DOI 10.1021/ja01183a034; GRESHAM TL, 1948, J AM CHEM SOC, V70, P1003, DOI 10.1021/ja01183a033; GRESHAM TL, 1949, J AM CHEM SOC, V71, P661, DOI 10.1021/ja01170a078; HEMMINKI K, 1981, CHEM-BIOL INTERACT, V34, P323, DOI 10.1016/0009-2797(81)90104-6; HO TL, 1975, CHEM REV, V75, P1, DOI 10.1021/cr60293a001; HOCHWALT AE, 1988, MOL CARCINOGEN, V1, P4, DOI 10.1002/mc.2940010104; HOCHWALT AE, 1988, CANCER RES, V48, P556; HOFFMAN RK, 1966, APPL MICROBIOL, V14, P989, DOI 10.1128/AEM.14.6.989-992.1966; Horowitz B, 1991, Biotechnology, V19, P417; IARC, 1999, IARC MON EV CARC RIS, V71, P1103; JONES JB, 1971, CAN J CHEMISTRY, V49, P3012, DOI 10.1139/v71-502; Jones RL, 2001, VACCINE, V19, P4635, DOI 10.1016/S0264-410X(01)00238-9; Kalbfuss B, 2007, BIOTECHNOL BIOENG, V97, P73, DOI 10.1002/bit.21139; Katritzky A.R., 2010, HDB HETEROCYCLIC CHE; LOGRIPPO GA, 1960, ANN NY ACAD SCI, V83, P578, DOI 10.1111/j.1749-6632.1960.tb40931.x; LONG FA, 1950, J AM CHEM SOC, V72, P3267, DOI 10.1021/ja01163a133; LoPachin RM, 2005, TOXICOL SCI, V86, P214, DOI 10.1093/toxsci/kfi197; LYLE TA, 1980, CHEM-BIOL INTERACT, V29, P197, DOI 10.1016/0009-2797(80)90033-2; Manso JA, 2005, CHEM RES TOXICOL, V18, P1161, DOI 10.1021/tx050031d; MATE U, 1977, CHEM-BIOL INTERACT, V18, P327, DOI 10.1016/0009-2797(77)90018-7; Meiring HD, 2002, J SEP SCI, V25, P557, DOI 10.1002/1615-9314(20020601)25:9<557::AID-JSSC557>3.0.CO;2-F; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Metz B, 2003, VACCINE, V22, P156, DOI 10.1016/j.vaccine.2003.08.003; Metz B, 2006, BIOCONJUGATE CHEM, V17, P815, DOI 10.1021/bc050340f; PERRIN P, 1995, BIOLOGICALS, V23, P207, DOI 10.1006/biol.1995.0034; POLLEY JR, 1957, CAN J MICROBIOL, V3, P863, DOI 10.1139/m57-095; POLLEY JR, 1957, CAN J MICROBIOL, V3, P871, DOI 10.1139/m57-096; RACE E, 1995, VACCINE, V13, P1567, DOI 10.1016/0264-410X(95)00086-G; RANDERATH K, 1981, P NATL ACAD SCI-BIOL, V78, P6126, DOI 10.1073/pnas.78.10.6126; Rappuoli R., 1997, NEW GENERATION VACCI, P417; ROBERTS JJ, 1963, BIOCHEM PHARMACOL, V12, P1441, DOI 10.1016/0006-2952(63)90216-8; Roos G, 2006, CHEMBIOCHEM, V7, P981, DOI 10.1002/cbic.200500507; SACK GH, 1978, J ORG CHEM, V43, P3932, DOI 10.1021/jo00414a028; SALK JE, 1954, AM J PUBLIC HEALTH, V44, P563; Scheidler A, 1998, BIOLOGICALS, V26, P135, DOI 10.1006/biol.1998.0125; SEARLE CE, 1961, BRIT J CANCER, V15, P804, DOI 10.1038/bjc.1961.91; SEARLE CE, 1961, BIOCHIM BIOPHYS ACTA, V52, P579, DOI 10.1016/0006-3002(61)90419-X; SEGAL A, 1976, CHEM-BIOL INTERACT, V15, P319, DOI 10.1016/0009-2797(76)90137-X; SWAIN CG, 1953, J AM CHEM SOC, V75, P141, DOI 10.1021/ja01097a041; TAUBMAN MA, 1968, BIOCHEM J, V106, P829, DOI 10.1042/bj1060829; TIDKE R, 1987, VACCINE, V5, P229, DOI 10.1016/0264-410X(87)90106-X; WATTENBERG LW, 1987, CANCER RES, V47, P4351; WOODWORTH BA, 1986, CANCER LETT, V31, P293, DOI 10.1016/0304-3835(86)90150-3; Zhang YL, 2000, J MOL STRUC-THEOCHEM, V496, P139, DOI 10.1016/S0166-1280(99)00186-4	69	36	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36198	36214		10.1074/jbc.M111.279232	http://dx.doi.org/10.1074/jbc.M111.279232			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21868382	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000296538300005
J	Zhang, WJ; Chen, HY; Wang, Y; Yong, WD; Zhu, WQ; Liu, YL; Wagner, GR; Payne, RM; Field, LJ; Xin, HB; Cai, CL; Shou, WN				Zhang, Wenjun; Chen, Hanying; Wang, Yong; Yong, Weidong; Zhu, Wuqiang; Liu, Yunlong; Wagner, Gregory R.; Payne, R. Mark; Field, Loren J.; Xin, Hongbo; Cai, Chen-Leng; Shou, Weinian			Tbx20 Transcription Factor Is a Downstream Mediator for Bone Morphogenetic Protein-10 in Regulating Cardiac Ventricular Wall Development and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-BOX GENES; HEART DEVELOPMENT; CHROMATIN IMMUNOPRECIPITATION; P19 CELLS; EXPRESSION; DIFFERENTIATION; INDUCTION; PATHWAY; CARDIOGENESIS; MYOCARDIUM	Bone morphogenetic protein 10 (BMP10) belongs to the TGF beta-superfamily. Previously, we had demonstrated that BMP10 is a key regulator for ventricular chamber formation, growth, and maturation. Ablation of BMP10 leads to hypoplastic ventricular wall formation, and elevated levels of BMP10 are associated with abnormal ventricular trabeculation/compaction and wall maturation. However, the molecular mechanism(s) by which BMP10 regulates ventricle wall growth and maturation is still largely unknown. In this study, we sought to identify the specific transcriptional network that is potentially mediated by BMP10. We analyzed and compared the gene expression profiles between alpha-myosin heavy chain (alpha MHC)-BMP10 transgenic hearts and nontransgenic littermate controls using Affymetrix mouse exon arrays. T-box 20 (Tbx20), a cardiac transcription factor, was significantly up-regulated in alpha MHC-BMP10 transgenic hearts, which was validated by quantitative RT-PCR and in situ hybridization. Ablation of BMP10 reduced Tbx20 expression specifically in the BMP10-expressing region of the developing ventricle. In vitro promoter analysis demonstrated that BMP10 was able to induce Tbx20 promoter activity through a conserved Smad binding site in the Tbx20 promoter proximal region. Furthermore, overexpression of Tbx20 in myocardium led to dilated cardiomyopathy that exhibited ventricular hypertrabeculation and an abnormal muscular septum, which phenocopied genetically modified mice with elevated BMP10 levels. Taken together, our findings demonstrate that the BMP10-Tbx20 signaling cascade is important for ventricular wall development and maturation.	[Zhang, Wenjun; Chen, Hanying; Wang, Yong; Yong, Weidong; Zhu, Wuqiang; Wagner, Gregory R.; Payne, R. Mark; Field, Loren J.; Shou, Weinian] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Riley Heart Res Ctr,Dept Pediat, Indianapolis, IN 46202 USA; [Zhang, Wenjun; Chen, Hanying; Wang, Yong; Yong, Weidong; Zhu, Wuqiang; Wagner, Gregory R.; Payne, R. Mark; Field, Loren J.; Shou, Weinian] Indiana Univ, Sch Med, Dept Bioinformat, Indianapolis, IN 46202 USA; [Xin, Hongbo] Nanchang Univ, Sch Med, Ctr Translat Res, Nanchang 330031, Jiangxi, Peoples R China; [Cai, Chen-Leng] Mt Sinai Med Ctr, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Cai, Chen-Leng] Mt Sinai Med Ctr, Child Hlth & Dev Inst, Black Family Stem Cell Inst, Ctr Mol Cardiol, New York, NY 10029 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Nanchang University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Shou, WN (corresponding author), Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Riley Heart Res Ctr,Dept Pediat, 1044 W Walnut St,R4-302D, Indianapolis, IN 46202 USA.	wshou@iupui.edu		Wang, Yong/0000-0001-6602-0491	National Institutes of Health [HL81092, HL70259, HL85098]; Riley Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081092, P01HL085098, R01HL070259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL81092 (to W. S.), HL70259 (to W. S.), and HL85098 (to L. J. F., R. M. P, and W. S.). This work was also supported by the Riley Children's Foundation (to W. S., R. M. P., and L. J. F.) and a postdoctoral fellowship supported by Riley Children's Foundation (to W. Z.).	Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Angello JC, 2006, DEV DYNAM, V235, P2122, DOI 10.1002/dvdy.20863; Brown DD, 2005, DEVELOPMENT, V132, P553, DOI 10.1242/dev.01596; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Carson CT, 2000, MECH DEVELOP, V96, P137, DOI 10.1016/S0925-4773(00)00376-2; Chen H, 2006, J BIOL CHEM, V281, P27481, DOI 10.1074/jbc.M604818200; Chen HY, 2009, PEDIATR CARDIOL, V30, P626, DOI 10.1007/s00246-009-9406-5; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Christoffels VM, 2004, DEV DYNAM, V229, P763, DOI 10.1002/dvdy.10487; Evans SM, 2010, CIRC RES, V107, P1428, DOI 10.1161/CIRCRESAHA.110.227405; Finsterer J, 2009, PEDIATR CARDIOL, V30, P659, DOI 10.1007/s00246-008-9359-0; Franco D, 2001, EUR J MORPHOL, V39, P3, DOI 10.1076/ejom.39.1.3.7982; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; Harada K, 2008, J BIOL CHEM, V283, P26705, DOI 10.1074/jbc.M801485200; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; Kraus F, 2001, MECH DEVELOP, V100, P87, DOI 10.1016/S0925-4773(00)00499-8; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; Mandel EM, 2010, DEVELOPMENT, V137, P1919, DOI 10.1242/dev.043588; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Neuhaus H, 1999, MECH DEVELOP, V80, P181, DOI 10.1016/S0925-4773(98)00221-4; Packham EA, 2003, HUM MOL GENET, V12, pR37, DOI 10.1093/hmg/ddg077; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Plageman TF, 2004, J BIOL CHEM, V279, P19026, DOI 10.1074/jbc.M314041200; Shelton EL, 2007, DEV BIOL, V302, P376, DOI 10.1016/j.ydbio.2006.09.047; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Simon HG, 1999, CELL TISSUE RES, V296, P57, DOI 10.1007/s004410051266; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Singh R, 2009, CIRC RES, V105, P442, DOI 10.1161/CIRCRESAHA.109.196063; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Teichmann U, 2004, DEV GENES EVOL, V214, P96, DOI 10.1007/s00427-003-0380-2; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Yamada M, 2000, DEV BIOL, V228, P95, DOI 10.1006/dbio.2000.9927; Yamagishi T, 2004, DEV DYNAM, V230, P576, DOI 10.1002/dvdy.20076; Zhang WJ, 2002, J BIOL CHEM, V277, P45435, DOI 10.1074/jbc.M208056200; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	40	36	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36820	36829		10.1074/jbc.M111.279679	http://dx.doi.org/10.1074/jbc.M111.279679			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21890625	hybrid, Green Published			2022-12-27	WOS:000296538300062
J	Naumann, TA; Wicklow, DT; Price, NPJ				Naumann, Todd A.; Wicklow, Donald T.; Price, Neil P. J.			Identification of a Chitinase-modifying Protein from Fusarium verticillioides TRUNCATION OF A HOST RESISTANCE PROTEIN BY A FUNGALYSIN METALLOPROTEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-IV CHITINASE; INTRAMOLECULAR CHAPERONES; ASPERGILLUS-FUMIGATUS; ARABIDOPSIS-THALIANA; CLADOSPORIUM-FULVUM; MOLECULAR-CLONING; MAIZE SEED; GENE; BINDING; EXPRESSION	Chitinase-modifying proteins (cmps) are proteases secreted by fungal pathogens that truncate the plant class IV chitinases ChitA and ChitB during maize ear rot. cmp activity has been characterized for Bipolaris zeicola and Stenocarpella maydis, but the identities of the proteases are not known. Here, we report that cmps are secreted by multiple species from the genus Fusarium, that cmp from Fusarium verticillioides (Fv-cmp) is a fungalysin metalloprotease, and that it cleaves within a sequence that is conserved in class IV chitinases. Protein extracts from Fusarium cultures were found to truncate ChitA and ChitB in vitro. Based on this activity, Fv-cmp was purified from F. verticillioides. N-terminal sequencing of truncated ChitA and MALDI-TOF-MS analysis of reaction products showed that Fv-cmp is an endoprotease that cleaves a peptide bond on the C-terminal side of the lectin domain. The N-terminal sequence of purified Fv-cmp was determined and compared with a set of predicted proteins, resulting in its identification as a zinc metalloprotease of the fungalysin family. Recombinant Fv-cmp also truncated ChitA, confirming its identity, but had reduced activity, suggesting that the recombinant protease did not mature efficiently from its propeptide-containing precursor. This is the first report of a fungalysin that targets a nonstructural host protein and the first to implicate this class of virulence-related proteases in plant disease.	[Naumann, Todd A.] NCAUR, Bacterial Foodborne Pathogens & Mycol Res Unit, Peoria, IL 61604 USA; [Price, Neil P. J.] NCAUR, Renewable Prod Technol Res Unit, Peoria, IL 61604 USA		Naumann, TA (corresponding author), NCAUR, Bacterial Foodborne Pathogens & Mycol Res Unit, 1815 N Univ St, Peoria, IL 61604 USA.	todd.naumann@ars.usda.gov						Aboitiz N, 2004, CHEMBIOCHEM, V5, P1245, DOI 10.1002/cbic.200400025; Agrios G. N., 2005, PLANT PATHOL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brouta F, 2002, INFECT IMMUN, V70, P5676, DOI 10.1128/IAI.70.10.5676-5683.2002; Brown DW, 2005, FUNGAL GENET BIOL, V42, P848, DOI 10.1016/j.fgb.2005.06.001; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; DEJONG AJ, 1992, PLANT CELL, V4, P425, DOI 10.2307/3869444; Desai K, 2002, BBA-MOL CELL BIOL L, V1585, P188, DOI 10.1016/S1388-1981(02)00340-2; DESJARDINS AE, 2006, FUSARIUM MYCOTOXINS; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; Gao XA, 2010, P NATL ACAD SCI USA, V107, P17569, DOI 10.1073/pnas.1005681107; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; GELDERBLOM WCA, 1988, APPL ENVIRON MICROB, V54, P1806, DOI 10.1128/AEM.54.7.1806-1811.1988; Gerhardt LBD, 1997, FEBS LETT, V419, P69, DOI 10.1016/S0014-5793(97)01332-X; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; HUYNH QK, 1992, J BIOL CHEM, V267, P6635; JOHAL GS, 1992, SCIENCE, V258, P985, DOI 10.1126/science.1359642; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Lange J, 1996, PLANT PHYSIOL, V111, P1135, DOI 10.1104/pp.111.4.1135; Lilly WW, 2008, MYCOL RES, V112, P389, DOI 10.1016/j.mycres.2007.11.013; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; MARKARYAN A, 1994, INFECT IMMUN, V62, P2149, DOI 10.1128/IAI.62.6.2149-2157.1994; Markaryan A, 1996, J BACTERIOL, V178, P2211, DOI 10.1128/jb.178.8.2211-2215.1996; Naumann TA, 2011, MOL PLANT PATHOL, V12, P365, DOI 10.1111/j.1364-3703.2010.00677.x; Naumann TA, 2010, PHYTOPATHOLOGY, V100, P645, DOI 10.1094/PHYTO-100-7-0645; Naumann TA, 2009, PHYSIOL MOL PLANT P, V74, P134, DOI 10.1016/j.pmpp.2009.10.004; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; Rosenblum EB, 2008, P NATL ACAD SCI USA, V105, P17034, DOI 10.1073/pnas.0804173105; Shinde U, 1999, J BIOL CHEM, V274, P15615, DOI 10.1074/jbc.274.22.15615; SHINDE U, 1993, TRENDS BIOCHEM SCI, V18, P442, DOI 10.1016/0968-0004(93)90146-E; Shinde UP, 1997, NATURE, V389, P520, DOI 10.1038/39097; Shinya T, 2007, BIOCHEM BIOPH RES CO, V353, P311, DOI 10.1016/j.bbrc.2006.12.009; SIRAKOVA TD, 1994, INFECT IMMUN, V62, P4208, DOI 10.1128/IAI.62.10.4208-4218.1994; Soanes DM, 2007, PLANT CELL, V19, P3318, DOI 10.1105/tpc.107.056663; Stepien L, 2010, WORLD MYCOTOXIN J, V3, P107, DOI 10.3920/WMJ2009.1193; Takken F, 2010, MOL PLANT PATHOL, V11, P309, DOI 10.1111/j.1364-3703.2009.00605.x; van den Burg HA, 2004, J BIOL CHEM, V279, P16786, DOI 10.1074/jbc.M312594200; van den Burg HA, 2003, J BIOL CHEM, V278, P27340, DOI 10.1074/jbc.M212196200; Wiweger M, 2003, J EXP BOT, V54, P2691, DOI 10.1093/jxb/erg299; Xu J, 2006, CAN J MICROBIOL, V52, P550, DOI 10.1139/W06-004	43	54	56	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35358	35366		10.1074/jbc.M111.279646	http://dx.doi.org/10.1074/jbc.M111.279646			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21878653	hybrid, Green Published			2022-12-27	WOS:000295927100007
J	Takahashi, K; Sugi, Y; Nakano, K; Tsuda, M; Kurihara, K; Hosono, A; Kaminogawa, S				Takahashi, Kyoko; Sugi, Yutaka; Nakano, Kou; Tsuda, Masato; Kurihara, Kenta; Hosono, Akira; Kaminogawa, Shuichi			Epigenetic Control of the Host Gene by Commensal Bacteria in Large Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; SEGMENTED FILAMENTOUS BACTERIA; GUT MICROBIOTA; IMMUNE-SYSTEM; EXPRESSION; DISEASE; LIPOPOLYSACCHARIDE; RECOGNITION; RESPONSES; ALLERGY	Intestinal epithelial cells (IECs) are continuously exposed to large numbers of commensal bacteria but are relatively insensitive to them, thereby averting an excessive inflammatory reaction. We have previously reported that the hyporesponsiveness of a human IEC line to LPS was primarily the result of a down-regulation of TLR4 gene transcription through epigenetic mechanisms. In the present study we show that DNA methylation in the 5' region of the TLR4 gene is significantly higher in IECs than in splenic cells in vivo. The methylation was shown to be dependent on the differentiation state of the IECs, as the differentiated IEC population that expressed higher levels of intestinal alkaline phosphatase (IAP) also displayed greater methylation and lower expression of the TLR4 gene than the undifferentiated population. The IAP(high), differentiated population also showed less abundant expression of CDX2, the transcription factor required for the development of the intestine, than the IAP(low), undifferentiated population. Overexpression of CDX2 in an IEC line decreased the methylation level of the TLR4 gene, increased transcriptional promoter activity of the gene, and increased responsiveness to the TLR4 ligand. Furthermore, the methylation level of the TLR4 gene was significantly lower in IECs of the large intestine of germ-free mice than in those of conventional mice, whereas the level in IECs of the small intestine was almost equal between these mice, indicating that commensal bacteria contribute to the maintenance of intestinal symbiosis by controlling epigenetic modification of the host gene in the large intestine.	[Takahashi, Kyoko; Sugi, Yutaka; Nakano, Kou; Tsuda, Masato; Kurihara, Kenta; Hosono, Akira; Kaminogawa, Shuichi] Nihon Univ, Food & Physiol Funct Lab, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan	Nihon University	Takahashi, K (corresponding author), Nihon Univ, Food & Physiol Funct Lab, Coll Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	ktaka@brs.nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [21580158, 23380073] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a grant-in-aid for Scientific Research from Japan Society for the Promotion of Science.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Abreu MT, 2003, J ENDOTOXIN RES, V9, P322, DOI 10.1179/096805103225002593; Bogunovic M, 2007, AM J PHYSIOL-GASTR L, V292, pG1770, DOI 10.1152/ajpgi.00249.2006; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cebra J J, 1998, Dev Immunol, V6, P13, DOI 10.1155/1998/68382; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Furrie E, 2005, IMMUNOLOGY, V115, P565, DOI 10.1111/j.1365-2567.2005.02200.x; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; McCall CE, 2010, J INNATE IMMUN, V2, P395, DOI 10.1159/000314077; McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Roger T, 2005, BIOCHEM J, V387, P355, DOI 10.1042/BJ20041243; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; Talham GL, 1999, INFECT IMMUN, V67, P1992; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Vamadevan AS, 2010, INNATE IMMUN-LONDON, V16, P93, DOI 10.1177/1753425909339231; Vucetic Z, 2011, NEUROPSYCHOPHARMACOL, V36, P1199, DOI 10.1038/npp.2011.4; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Wolfs TGAM, 2010, INFLAMM BOWEL DIS, V16, P68, DOI 10.1002/ibd.20995; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Zeng H, 2006, AM J PHYSIOL-GASTR L, V290, pG96, DOI 10.1152/ajpgi.00273.2005; Zeuthen LH, 2008, IMMUNOLOGY, V123, P197, DOI 10.1111/j.1365-2567.2007.02687.x	33	115	117	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35755	35762		10.1074/jbc.M111.271007	http://dx.doi.org/10.1074/jbc.M111.271007			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862578	Green Published, hybrid			2022-12-27	WOS:000295927100048
J	Trikha, S; Jeremic, AM				Trikha, Saurabh; Jeremic, Aleksandar M.			Clustering and Internalization of Toxic Amylin Oligomers in Pancreatic Cells Require Plasma Membrane Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET AMYLOID POLYPEPTIDE; II DIABETES-MELLITUS; BETA-CELLS; ALZHEIMERS-DISEASE; LIPID RAFTS; NMR-SPECTROSCOPY; APOLIPOPROTEIN-E; TRANSGENIC MICE; MOUSE MODEL; TYPE-2	Self-assembly of the human pancreatic hormone amylin into toxic oligomers and aggregates is linked to dysfunction of islet beta-cells and pathogenesis of type 2 diabetes mellitus. Recent evidence suggests that cholesterol, an essential component of eukaryotic cells membranes, controls amylin aggregation on model membranes. However, the pathophysiological consequence of cholesterol-regulated amylin polymerization on membranes and biochemical mechanisms that protect beta-cells from amylin toxicity are poorly understood. Here, we report that plasma membrane (PM) cholesterol plays a key role in molecular recognition, sorting, and internalization of toxic amylin oligomers but not monomers in pancreatic rat insulinoma and human islet cells. Depletion of PM cholesterol or the disruption of the cytoskeleton network inhibits internalization of amylin oligomers, which in turn enhances extracellular oligomer accumulation and potentiates amylin toxicity. Confocal microscopy reveals an increased nucleation of amylin oligomers across the plasma membrane in cholesterol-depleted cells, with a 2-fold increase in cell surface coverage and a 3-fold increase in their number on the PM. Biochemical studies confirm accumulation of amylin oligomers in the medium after depletion of PM cholesterol. Replenishment of PM cholesterol from intracellular cholesterol stores or by the addition of water-soluble cholesterol restores amylin oligomer clustering at the PM and internalization, which consequently diminishes cell surface coverage and toxicity of amylin oligomers. In contrast to oligomers, amylin monomers followed clathrin-dependent endocytosis, which is not sensitive to cholesterol depletion. Our studies identify an actin-mediated and cholesterol-dependent mechanism for selective uptake and clearance of amylin oligomers, impairment of which greatly potentiates amylin toxicity.	[Trikha, Saurabh; Jeremic, Aleksandar M.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	George Washington University	Jeremic, AM (corresponding author), George Washington Univ, Dept Biol Sci, 2023 G St NW, Washington, DC 20052 USA.	jerema@gwu.edu			George Washington University Columbian College; Islet Cell Resource Center	George Washington University Columbian College; Islet Cell Resource Center	This work was supported by a George Washington University Columbian College Facilitating Fund grant and the Islet Cell Resource Center Basic Science Islet Distribution Program (to A. J.).	Aitken JF, 2003, BIOCHEM J, V374, P779, DOI 10.1042/BJ20030422; Arispe N, 2002, FASEB J, V16, P1526, DOI 10.1096/fj.02-0829com; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; Brender JR, 2007, BBA-BIOMEMBRANES, V1768, P2026, DOI 10.1016/j.bbamem.2007.07.001; Brender JR, 2008, BIOCHEMISTRY-US, V47, P12680, DOI 10.1021/bi801427c; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; Casas S, 2008, DIABETOLOGIA, V51, P2252, DOI 10.1007/s00125-008-1111-z; Chen Z, 1997, BIOPHYS J, V73, P267, DOI 10.1016/S0006-3495(97)78067-6; Cho WJ, 2009, J MOL BIOL, V393, P765, DOI 10.1016/j.jmb.2009.08.055; Cho WJ, 2008, METHOD CELL BIOL, V90, P267, DOI 10.1016/S0091-679X(08)00813-3; Cizas P, 2010, ARCH BIOCHEM BIOPHYS, V496, P84, DOI 10.1016/j.abb.2010.02.001; Clark A, 2004, DIABETOLOGIA, V47, P157, DOI 10.1007/s00125-003-1304-4; CLARK A, 1987, LANCET, V2, P231; DEKONING EJP, 1994, DIABETES, V43, P640, DOI 10.2337/diabetes.43.5.640; Domanov YA, 2008, J MOL BIOL, V376, P42, DOI 10.1016/j.jmb.2007.11.077; Durrbach A, 1996, J CELL SCI, V109, P457; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Engel MFM, 2006, J MOL BIOL, V356, P783, DOI 10.1016/j.jmb.2005.12.020; Goldsbury CS, 1997, J STRUCT BIOL, V119, P17, DOI 10.1006/jsbi.1997.3858; Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hailstones D, 1998, J LIPID RES, V39, P369; Hansen GH, 2005, BIOCHEMISTRY-US, V44, P873, DOI 10.1021/bi047959+; Hoppener JWM, 1999, DIABETOLOGIA, V42, P427, DOI 10.1007/s001250051175; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Janciauskiene S, 2000, BIOCHEM BIOPH RES CO, V267, P619, DOI 10.1006/bbrc.1999.1989; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jha S, 2009, J MOL BIOL, V389, P907, DOI 10.1016/j.jmb.2009.04.077; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Kawahara M, 2001, CELL MOL NEUROBIOL, V21, P1, DOI 10.1023/A:1007168910582; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Konarkowska B, 2006, FEBS J, V273, P3614, DOI 10.1111/j.1742-4658.2006.05367.x; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Marchetti P, 2009, DIABETES CARE, V32, pS178, DOI 10.2337/dc09-S306; Marek P, 2007, BIOCHEMISTRY-US, V46, P3255, DOI 10.1021/bi0621967; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Nanga RPR, 2009, J AM CHEM SOC, V131, P8252, DOI 10.1021/ja9010095; NARITA R, 1992, DIABETES RES CLIN PR, V15, P3, DOI 10.1016/0168-8227(92)90060-5; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; Ooi EMM, 2009, DIABETES RES CLIN PR, V85, P310, DOI 10.1016/j.diabres.2009.06.003; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pensalfini A, 2011, NEUROBIOL AGING, V32, P210, DOI 10.1016/j.neurobiolaging.2009.02.010; Potter KJ, 2009, BBA-GEN SUBJECTS, V1790, P566, DOI 10.1016/j.bbagen.2009.02.013; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Radovan D, 2009, FEBS LETT, V583, P1439, DOI 10.1016/j.febslet.2009.03.059; Ritzel RA, 2007, DIABETES, V56, P65, DOI 10.2337/db06-0734; Rivera JF, 2011, CELL DEATH DIFFER, V18, P415, DOI 10.1038/cdd.2010.111; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smith PES, 2009, J AM CHEM SOC, V131, P4470, DOI 10.1021/ja809002a; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Sponne I, 2004, FASEB J, V18, P836, DOI 10.1096/fj.03-0372fje; Stirling L, 2009, MOL BIOL CELL, V20, P2991, DOI 10.1091/mbc.E08-10-1074; WAGONER PK, 1993, P NATL ACAD SCI USA, V90, P9145, DOI 10.1073/pnas.90.19.9145; Wakabayashi M, 2007, J MOL BIOL, V371, P924, DOI 10.1016/j.jmb.2007.06.008; Wakabayashi M, 2009, FEBS LETT, V583, P2854, DOI 10.1016/j.febslet.2009.07.044; Weise K, 2010, CHEMBIOCHEM, V11, P1280, DOI 10.1002/cbic.201000039; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Zhang SP, 2003, J BIOL CHEM, V278, P52810, DOI 10.1074/jbc.M308244200; Zhang SP, 2002, J MOL BIOL, V324, P271, DOI 10.1016/S0022-2836(02)01044-6; Zhao HL, 2003, DIABETES, V52, P2759, DOI 10.2337/diabetes.52.11.2759; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x; Zraika S, 2007, DIABETES, V56, P304, DOI 10.2337/db06-0430	74	66	67	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36086	36097		10.1074/jbc.M111.240762	http://dx.doi.org/10.1074/jbc.M111.240762			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865171	Green Published, hybrid			2022-12-27	WOS:000295927100081
J	Hao, H; Tummala, P; Guzman, E; Mali, RS; Gregorski, J; Swaroop, A; Mitton, KP				Hao, Hong; Tummala, Padmaja; Guzman, Eduardo; Mali, Raghuveer S.; Gregorski, Janina; Swaroop, Anand; Mitton, Kenneth P.			The Transcription Factor Neural Retina Leucine Zipper (NRL) Controls Photoreceptor-specific Expression of Myocyte Enhancer Factor Mef2c from an Alternative Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR NR2E3; SEVERE MENTAL-RETARDATION; IN-VIVO; GENE-EXPRESSION; ROD PHOTORECEPTORS; DIFFERENTIATION FACTOR; CONE PHOTORECEPTORS; HISTONE ACETYLATION; HORMONE-RECEPTOR; RHODOPSIN GENE	Neural retina leucine zipper (NRL) is an essential transcription factor for cell fate specification and functional maintenance of rod photoreceptors in the mammalian retina. In the Nrl(-/-) mouse retina, photoreceptor precursors fail to produce rods and generate functional cone photoreceptors that predominantly express S-opsin. Previous global expression analysis using microarrays revealed dramatically reduced expression of myocyte enhancer factor Mef2c in the adult Nrl(-/-) retina. We undertook this study to examine the biological relevance of Mef2c expression in retinal rod photoreceptors. Bioinformatics analysis, rapid analysis of cDNA ends (5'-RACE), and reverse transcription coupled with qPCR using splice site-specific oligonucleotides suggested that Mef2c is expressed in the mature retina from an alternative promoter. Chromatin immunoprecipitation (ChIP) studies showed the association of active RNA polymerase II and acetylated histone H3 just upstream of Mef2c exon 4, providing additional evidence for the utilization of an alternative promoter in the retina. In concordance, we observed the binding of NRL to a putative NRL-response element (NRE) at this location by ChIP-seq and electrophoretic mobility shift assays. NRL also activated the Mef2c alternative promoter in vitro and in vivo. Notably, MEF2C could support Rhodopsin promoter activity in rod photoreceptors. We conclude that Mef2c expression from an alternative promoter in the retina is regulated by NRL. Our studies also implicate MEF2C as a transcriptional regulator of homeostasis in rod photoreceptor cells.	[Tummala, Padmaja; Guzman, Eduardo; Mali, Raghuveer S.; Mitton, Kenneth P.] Oakland Univ, Eye Res Inst, Control Gene Express Lab, Rochester, MI 48309 USA; [Hao, Hong; Gregorski, Janina; Swaroop, Anand] NIH, Neurobiol Neurodegenerat & Repair Lab, NEI, Bethesda, MD 20892 USA	Oakland University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Mitton, KP (corresponding author), Oakland Univ, Eye Res Inst, Control Gene Express Lab, Rm 412,Dodge Hall, Rochester, MI 48309 USA.	mitton@oakland.edu	mitton, kenneth/Y-1974-2019; Tummala, Padmaja/AAT-5157-2021	mitton, kenneth/0000-0002-4751-7440; Swaroop, Anand/0000-0002-1975-1141; TUMMALA, PADMAJA/0000-0003-4841-8599	National Institutes of Health [EY14626, EY14803]; NEI, National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000450, ZIAEY000451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY14626 (to K. P. M.), EY14803 (Oakland University Eye Research Institute), and the intramural program of the NEI, National Institutes of Health.	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cheng H, 2006, HUM MOL GENET, V15, P2588, DOI 10.1093/hmg/ddl185; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; DeAngelis MM, 2002, ARCH OPHTHALMOL-CHIC, V120, P369; Feng J., 2011, CURR PROTOC BIOINFOR, V34, P2141; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Kanda A, 2007, HUM MUTAT, V28, P589, DOI 10.1002/humu.20488; Kautzmann MAI, 2011, J BIOL CHEM, V286, P28247, DOI 10.1074/jbc.M111.257246; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Labhart P, 2005, P NATL ACAD SCI USA, V102, P1339, DOI 10.1073/pnas.0409578102; Le Meur N, 2010, J MED GENET, V47, P22, DOI 10.1136/jmg.2009.069732; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Mali RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-87; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; MARUYAMA K, 1994, GENE, V138, P171; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; Mitton KP, 2003, HUM MOL GENET, V12, P365, DOI 10.1093/hmg/ddg035; Mustafi D, 2011, FASEB J, V25, P3157, DOI 10.1096/fj.11-186767; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Nowakowska BA, 2010, AM J MED GENET B, V153B, P1042, DOI 10.1002/ajmg.b.31071; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Onishi A, 2010, P NATL ACAD SCI USA, V107, P11579, DOI 10.1073/pnas.1000102107; Ooi L, 2008, BIOCHEM J, V414, P327, DOI 10.1042/BJ20080963; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Peng GH, 2007, HUM MOL GENET, V16, P2433, DOI 10.1093/hmg/ddm200; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Tummala P, 2010, MOL VIS, V16, P252; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160	67	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34893	34902		10.1074/jbc.M111.271072	http://dx.doi.org/10.1074/jbc.M111.271072			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21849497	Green Published, hybrid			2022-12-27	WOS:000295406300043
J	Mahali, S; Raviprakash, N; Raghavendra, PB; Manna, SK				Mahali, Sidharth; Raviprakash, Nune; Raghavendra, Pongali B.; Manna, Sunil K.			Advanced Glycation End Products (AGEs) Induce Apoptosis via a Novel Pathway INVOLVEMENT OF CA(2+) MEDIATED BY INTERLEUKIN-8 PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; CELL-CYCLE ARREST; AUTOPHAGIC VACUOLES; ENDOTHELIAL-CELLS; DIABETIC-PATIENTS; NUCLEAR-FACTOR; ACTIVATION; TRANSCRIPTION; CALCINEURIN; DEATH	Advanced glycation end products (AGEs) accumulate in diabetic patients due to high blood glucose levels and cause multiple deleterious effects. In this study, we provide evidence that the AGE increased cell death, one such deleterious effect. Methyl glyoxal-coupled human serum albumin (AGE-HSA) induced transcription factors such as NF-kappa B, NF-AT, and AP-1. AGE acts through its cell surface receptor, RAGE, and degranulates vesicular contents including interleukin-8 (IL-8). The number of RAGEs, as well as the amount of NF-kappa B activation, is low, but the cell death is higher in neuronal cells upon AGE treatment. Degranulated IL-8 acts through its receptors, IL-8Rs, and induces sequential events in cells: increase in intracellular Ca2+, activation of calcineurin, dephosphorylation of cytoplasmic NF-AT, nuclear translocation of NF-AT, and expression of FasL. Expressed FasL increases activity of caspases and induces cell death. Although AGE increases the amount of reactive oxygen intermediate, accompanying cell death is not dependent upon reactive oxygen intermediate. AGE induces autophagy, which partially protects cells from cell death. A novel mechanism of AGE-mediated cell death in different cell types, especially in neuronal cells where it is an early event, is provided here. Thus, this study may be important in several age-related neuronal diseases where AGE-induced apoptosis is observed because of high amounts of AGE.	[Mahali, Sidharth; Raviprakash, Nune; Raghavendra, Pongali B.; Manna, Sunil K.] Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Manna, SK (corresponding author), Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India.	manna@cdfd.org.in	Mahali, Sidhartha/GLT-8791-2022; Mahali, Sidhartha/AAD-8309-2021	Mahali, Sidhartha/0000-0001-5750-7118; 	Defense Research and Development Organization (DRDO), Government of India; Centre for DNA Fingerprinting and Diagnostics (CDFD); Indian Council for Medical Research (ICMR), Government of India; Council for Scientific and Industrial Research (CSIR), Government of India	Defense Research and Development Organization (DRDO), Government of India(Defence Research & Development Organisation (DRDO)); Centre for DNA Fingerprinting and Diagnostics (CDFD); Indian Council for Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR)); Council for Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Defense Research and Development Organization (DRDO), Government of India and a core grant from the Centre for DNA Fingerprinting and Diagnostics (CDFD), a fellowship from the Indian Council for Medical Research (ICMR), Government of India (to N. R.), and a fellowship from the Council for Scientific and Industrial Research (CSIR), Government of India (to S. M).	Abbasi S, 2005, J BIOL CHEM, V280, P36737, DOI 10.1074/jbc.M506493200; Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Bose JS, 2009, J MED CHEM, V52, P3184, DOI 10.1021/jm8015766; Bose JS, 2009, J CELL PHYSIOL, V218, P653, DOI 10.1002/jcp.21640; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Clarke DL, 2008, J IMMUNOL, V181, P3503, DOI 10.4049/jimmunol.181.5.3503; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gangadharan C, 2010, BREAST CANCER RES TR, V120, P671, DOI 10.1007/s10549-009-0493-z; Jeitner TM, 2005, BIOCHEM PHARMACOL, V69, P961, DOI 10.1016/j.bcp.2004.12.011; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Khuhawar MY, 2006, ANAL LETT, V39, P2205, DOI 10.1080/00032710600754093; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Komatsu M, 2007, CELL DEATH DIFFER, V14, P887, DOI 10.1038/sj.cdd.4402120; Lapolla A, 2003, CLIN CHEM LAB MED, V41, P1166, DOI 10.1515/CCLM.2003.180; Lesort M, 2003, J BIOL CHEM, V278, P3825, DOI 10.1074/jbc.M205812200; Liu SF, 1997, EMBO J, V16, P143, DOI 10.1093/emboj/16.1.143; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Manna SK, 2007, CELL DEATH DIFFER, V14, P158, DOI 10.1038/sj.cdd.4401929; Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200; Manna SK, 1999, J IMMUNOL, V162, P1510; Manna SK, 2010, J BIOL CHEM, V285, P22318, DOI 10.1074/jbc.M110.131797; Manna SX, 2006, EUR J IMMUNOL, V36, P754, DOI 10.1002/eji.200535209; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Odani H, 1999, BIOCHEM BIOPH RES CO, V256, P89, DOI 10.1006/bbrc.1999.0221; Patschan S, 2008, AUTOPHAGY, V4, P521, DOI 10.4161/auto.5904; Raghavendra PB, 2007, APOPTOSIS, V12, P307, DOI 10.1007/s10495-006-0626-3; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sarkar A, 2004, J BIOL CHEM, V279, P33768, DOI 10.1074/jbc.M403424200; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Sreenivasan Y, 2003, ONCOGENE, V22, P4356, DOI 10.1038/sj.onc.1206486; Srivastava RK, 1999, J EXP MED, V190, P253, DOI 10.1084/jem.190.2.253; Wang EX, 2001, J CELL SCI, V114, P3309; Yamagishi Sho-ichi, 2006, Curr Drug Discov Technol, V3, P83, DOI 10.2174/157016306776637555; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yeh YC, 2007, BIOCHEM PHARMACOL, V74, P969, DOI 10.1016/j.bcp.2007.06.031; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	43	46	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34903	34913		10.1074/jbc.M111.279190	http://dx.doi.org/10.1074/jbc.M111.279190			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21862577	Green Published, hybrid			2022-12-27	WOS:000295406300044
J	Zhou, G; Marathe, GK; Willard, B; McIntyre, TM				Zhou, Gang; Marathe, Gopal K.; Willard, Belinda; McIntyre, Thomas M.			Intracellular Erythrocyte Platelet-activating Factor Acetylhydrolase I Inactivates Aspirin in Blood	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE A(2); PAF-AH; PROSTAGLANDIN SYNTHESIS; ACETYLSALICYLIC-ACID; ESTERASE-ACTIVITY; HYDROLYSIS; CYCLOOXYGENASE; PURIFICATION; INHIBITION; BIOLOGY	Aspirin (acetylsalicylic acid) prophylaxis suppresses major adverse cardiovascular events, but its rapid turnover limits inhibition of platelet cyclooxygenase activity and thrombosis. Despite its importance, the identity of the enzyme(s) that hydrolyzes the acetyl residue of circulating aspirin, which must be an existing enzyme, remains unknown. We find that circulating aspirin was extensively hydrolyzed within erythrocytes, and chromatography indicated these cells contained a single hydrolytic activity. Purification by over 1400-fold and sequencing identified the PAFAH1B2 and PAFAH1B3 subunits of type I platelet-activating factor (PAF) acetylhydrolase, a phospholipase A(2) with selectivity for acetyl residues of PAF, as a candidate for aspirin acetylhydrolase. Western blotting showed that catalytic PAFAH1B2 and PAFAH1B3 subunits of the type I enzyme co-migrated with purified erythrocyte aspirin hydrolytic activity. Recombinant PAFAH1B2, but not its family member plasma PAF acetylhydrolase, hydrolyzed aspirin, and PAF competitively inhibited aspirin hydrolysis by purified or recombinant erythrocyte enzymes. Aspirin was hydrolyzed by HEK cells transfected with PAFAH1B2 or PAFAH1B3, and the competitive type I PAF acetylhydrolase inhibitor NaF reduced erythrocyte hydrolysis of aspirin. Exposing aspirin to erythrocytes blocked its ability to inhibit thromboxane A2 synthesis and platelet aggregation. Not all individuals or populations are equally protected by aspirin prophylaxis, the phenomenon of aspirin resistance, and erythrocyte hydrolysis of aspirin varied 3-fold among individuals, which correlated with PAFAH1B2 and not PAFAH1B3. We conclude that intracellular type I PAF acetylhydrolase is the major aspirin hydrolase of human blood.	[Zhou, Gang; Marathe, Gopal K.; Willard, Belinda; McIntyre, Thomas M.] Cleveland Clin, Lerner Res Inst, Lerner Coll Med, Dept Cell Biol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	McIntyre, TM (corresponding author), Cleveland Clin, Lerner Res Inst, Lerner Coll Med, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	mcintyt@ccf.org		Marathe, Gopal/0000-0002-0025-6677	National Institutes of Health [P50 HL081011]; NIH/National Center for Research Resources [RR024989]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL081011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 HL081011, and service support from the Case Western Reserve University/Cleveland Clinic CTSA UL1 Grant RR024989 from the NIH/National Center for Research Resources.	Adebayo GI, 2007, EUR J INTERN MED, V18, P299, DOI 10.1016/j.ejim.2006.12.004; AKOPOV SS, 1992, J CLIN PHARMACOL, V32, P133, DOI 10.1002/j.1552-4604.1992.tb03817.x; ALI B, 1983, J PHARMACOL EXP THER, V226, P589; Arai H, 2002, J BIOCHEM, V131, P635, DOI 10.1093/oxfordjournals.jbchem.a003145; Bigler J, 2001, CANCER RES, V61, P3566; Chan AT, 2005, JNCI-J NATL CANCER I, V97, P457, DOI 10.1093/jnci/dji066; Chen JW, 2007, J LIPID RES, V48, P2365, DOI 10.1194/jlr.M700325-JLR200; COSTELLO PB, 1982, ARTHRITIS RHEUM, V25, P550, DOI 10.1002/art.1780250509; COSTELLO PB, 1984, ARTHRITIS RHEUM, V27, P422, DOI 10.1002/art.1780270409; COSTELLO PB, 1983, ARTHRITIS RHEUM, V26, P541, DOI 10.1002/art.1780260414; Fitzgerald Desmond J, 2007, Hematology Am Soc Hematol Educ Program, P114; FITZGERALD GA, 1991, AM J CARDIOL, V68, pB11, DOI 10.1016/0002-9149(91)90379-Y; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; Foulks JM, 2008, FREE RADICAL BIO MED, V45, P434, DOI 10.1016/j.freeradbiomed.2008.04.034; Gresner P, 2006, BBA-GEN SUBJECTS, V1760, P207, DOI 10.1016/j.bbagen.2005.11.018; HATTORI M, 1993, J BIOL CHEM, V268, P18748; HATTORI M, 1994, J BIOL CHEM, V269, P23150; HIGGS GA, 1987, P NATL ACAD SCI USA, V84, P1417, DOI 10.1073/pnas.84.5.1417; Ho YS, 1999, PROTEIN ENG, V12, P693, DOI 10.1093/protein/12.8.693; Ho YS, 1997, NATURE, V385, P89, DOI 10.1038/385089a0; Karasawa K, 2005, J BIOCHEM, V138, P509, DOI 10.1093/jb/mvi144; Koizumi H, 2003, J BIOL CHEM, V278, P12489, DOI 10.1074/jbc.M211836200; Kotani K, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-50; LEVY G, 1965, ANESTH ANAL CURR RES, V44, P837; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; Manya H, 1999, J BIOL CHEM, V274, P31827, DOI 10.1074/jbc.274.45.31827; Maree A. O., 2007, NAT CLIN PRACT CARD, V4, pE2; Maree Andrew O, 2007, Nat Clin Pract Cardiovasc Med, V4, pE2, DOI 10.1038/ncpcardio0834; Masson P, 1998, BBA-PROTEIN STRUCT M, V1387, P41, DOI 10.1016/S0167-4838(98)00104-6; McIntyre TM, 2009, J LIPID RES, V50, pS255, DOI 10.1194/jlr.R800024-JLR200; MENTLEIN R, 1984, BIOCHEM PHARMACOL, V33, P1243, DOI 10.1016/0006-2952(84)90176-X; NEEDS CJ, 1985, CLIN PHARMACOKINET, V10, P164, DOI 10.2165/00003088-198510020-00004; OBRIEN JR, 1968, LANCET, V1, P779; OHSAKO M, 1993, BIOL PHARM BULL, V16, P154; Patrono C, 2003, J THROMB HAEMOST, V1, P1710, DOI 10.1046/j.1538-7836.2003.00284.x; Patrono C, 2007, NAT CLIN PRACT CARD, V4, P42, DOI 10.1038/ncpcardio0728; PEDERSEN AK, 1984, NEW ENGL J MED, V311, P1206, DOI 10.1056/NEJM198411083111902; PUCHE E, 1993, ACTA ANAESTH SCAND, V37, P20, DOI 10.1111/j.1399-6576.1993.tb03590.x; REILLY IAG, 1988, DRUGS, V35, P154, DOI 10.2165/00003495-198835020-00005; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; ROWLAND M, 1972, J PHARM SCI-US, V61, P379, DOI 10.1002/jps.2600610312; Samanta U, 2008, J BIOL CHEM, V283, P31617, DOI 10.1074/jbc.M804750200; Santanam N, 2007, ATHEROSCLEROSIS, V191, P272, DOI 10.1016/j.atherosclerosis.2006.05.027; SEYMOUR RA, 1984, BRIT J CLIN PHARMACO, V17, P697, DOI 10.1111/j.1365-2125.1984.tb02406.x; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; SMITH WL, 1990, ADV PROSTAG THROMB L, V20, P14; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stafforini DM, 2009, CARDIOVASC DRUG THER, V23, P73, DOI 10.1007/s10557-008-6133-8; STAFFORINI DM, 1993, J BIOL CHEM, V268, P3857; STAFFORINI DM, 1991, METHOD ENZYMOL, V197, P411; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4223; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Warner TD, 2002, P NATL ACAD SCI USA, V99, P13371, DOI 10.1073/pnas.222543099; WILLIAMS FM, 1987, EUR J CLIN PHARMACOL, V33, P387, DOI 10.1007/BF00637635; Yamaori S, 2006, DRUG METAB PHARMACOK, V21, P147, DOI 10.2133/dmpk.21.147; Yoshida H, 1996, AM J HEMATOL, V53, P158, DOI 10.1002/(SICI)1096-8652(199611)53:3<158::AID-AJH2>3.3.CO;2-8; Yu Y, 2007, J BIOL CHEM, V282, P1498, DOI 10.1074/jbc.M609930200	58	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34820	34829		10.1074/jbc.M111.267161	http://dx.doi.org/10.1074/jbc.M111.267161			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844189	Green Published, hybrid			2022-12-27	WOS:000295406300036
J	Fedeles, BI; Zhu, AY; Young, KS; Hillier, SM; Proffitt, KD; Essigmann, JM; Croy, RG				Fedeles, Bogdan I.; Zhu, Angela Y.; Young, Kellie S.; Hillier, Shawn M.; Proffitt, Kyle D.; Essigmann, John M.; Croy, Robert G.			Chemical Genetics Analysis of an Aniline Mustard Anticancer Agent Reveals Complex I of the Electron Transport Chain as a Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; CANCER CELLS; MITOCHONDRIAL DYSFUNCTION; APOPTOSIS; CYTOTOXICITY; DECREASES; THERAPY; VIVO	The antitumor agent 11 beta (CAS 865070-37-7), consisting of a DNA-damaging aniline mustard linked to an androgen receptor (AR) ligand, is known to form covalent DNA adducts and to induce apoptosis potently in AR-positive prostate cancer cells in vitro; it also strongly prevents growth of LNCaP xenografts in mice. The present study describes the unexpectedly strong activity of 11 beta against the AR-negative HeLa cells, both in cell culture and tumor xenografts, and uncovers a new mechanism of action that likely explains this activity. Cellular fractionation experiments indicated that mitochondria are the major intracellular sink for 11 beta; flow cytometry studies showed that 11 beta exposure rapidly induced oxidative stress, mitochondria being an important source of reactive oxygen species (ROS). Additionally, 11 beta inhibited oxygen consumption both in intact HeLa cells and in isolated mitochondria. Specifically, 11 beta blocked uncoupled oxygen consumption when mitochondria were incubated with complex I substrates, but it had no effect on oxygen consumption driven by substrates acting downstream of complex I in the mitochondrial electron transport chain. Moreover, 11 beta enhanced ROS generation in isolated mitochondria, suggesting that complex I inhibition is responsible for ROS production. At the cellular level, the presence of antioxidants (N-acetylcysteine or vitamin E) significantly reduced the toxicity of 11 beta, implicating ROS production as an important contributor to cytotoxicity. Collectively, our findings establish complex I inhibition and ROS generation as a new mechanism of action for 11 beta, which supplements conventional DNA adduct formation to promote cancer cell death.	[Essigmann, John M.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Essigmann, JM (corresponding author), MIT, Dept Biol Engn, Bldg 56,Rm 669,77 Massachusetts Ave, Cambridge, MA 02139 USA.	jessig@mit.edu; rgcroy@mit.edu		Fedeles, Bogdan/0000-0001-5252-826X; Zhu, Angela/0000-0002-3010-8464	National Institutes of Health [R01 CA077743]; Department of Defense [DAMD17-98-1-8520]; NATIONAL CANCER INSTITUTE [R01CA077743, R01CA086061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported, in whole or in part, by National Institutes of Health Grant R01 CA077743. This work was also supported by Department of Defense Prostate Cancer Research Program Award DAMD17-98-1-8520.	COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Das GC, 2006, MOL CARCINOGEN, V45, P635, DOI 10.1002/mc.20184; ESTORNELL E, 1993, FEBS LETT, V332, P127, DOI 10.1016/0014-5793(93)80498-J; Fang J, 2008, INT J CANCER, V122, P1135, DOI 10.1002/ijc.22982; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hillier SM, 2006, MOL CANCER THER, V5, P977, DOI 10.1158/1535-7163.MCT-05-0464; Jakubowski W, 2000, CELL BIOL INT, V24, P757, DOI 10.1006/cbir.2000.0556; Kapiszewska M, 2007, TOXICOL IN VITRO, V21, P1020, DOI 10.1016/j.tiv.2007.03.005; Laurent A, 2005, CANCER RES, V65, P948; Le SB, 2007, J BIOL CHEM, V282, P8860, DOI 10.1074/jbc.M611777200; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Marquis JC, 2005, CHEM BIOL, V12, P779, DOI 10.1016/j.chembiol.2005.05.009; Mates JM, 2000, INT J BIOCHEM CELL B, V32, P157, DOI 10.1016/S1357-2725(99)00088-6; Murphy MP, 2008, BBA-BIOENERGETICS, V1777, P1028, DOI 10.1016/j.bbabio.2008.03.029; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NELSONREES WA, 1980, CYTOGENET CELL GENET, V27, P216, DOI 10.1159/000131490; Nicco C, 2005, BIOMED PHARMACOTHER, V59, P169, DOI 10.1016/j.biopha.2005.03.009; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; PETRONILLI V, 1986, EUR J BIOCHEM, V155, P423, DOI 10.1111/j.1432-1033.1986.tb09508.x; Poppe M, 2001, J NEUROSCI, V21, P4551, DOI 10.1523/JNEUROSCI.21-13-04551.2001; POWIS G, 1989, FREE RADICAL BIO MED, V6, P63, DOI 10.1016/0891-5849(89)90162-7; Ravid A, 1999, CANCER RES, V59, P862; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wallach-Dayan SB, 2006, AM J PHYSIOL-LUNG C, V290, pL790, DOI 10.1152/ajplung.00300.2004; WEISS MJ, 1987, P NATL ACAD SCI USA, V84, P5444, DOI 10.1073/pnas.84.15.5444	31	17	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33910	33920		10.1074/jbc.M111.278390	http://dx.doi.org/10.1074/jbc.M111.278390			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832047	Green Published, hybrid			2022-12-27	WOS:000295159200023
J	Thorp, E; Vaisar, T; Subramanian, M; Mautner, L; Blobel, C; Tabas, I				Thorp, Edward; Vaisar, Tomas; Subramanian, Manikandan; Mautner, Lauren; Blobel, Carl; Tabas, Ira			Shedding of the Mer Tyrosine Kinase Receptor Is Mediated by ADAM17 Protein through a Pathway Involving Reactive Oxygen Species, Protein Kinase C delta, and p38 Mitogen-activated Protein Kinase (MAPK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ALPHA-CONVERTING-ENZYME; ARREST-SPECIFIC GENE; NF-KAPPA-B; APOPTOTIC CELLS; TNF-ALPHA; EXPRESSION ANALYSIS; POTENTIAL ROLE; CUTTING EDGE; SOLUBLE FORM	Mer tyrosine kinase (MerTK) is an integral membrane protein that is preferentially expressed by phagocytic cells, where it promotes efferocytosis and inhibits inflammatory signaling. Proteolytic cleavage of MerTK at an unidentified site leads to shedding of its soluble ectodomain (soluble MER; sMER), which can inhibit thrombosis in mice and efferocytosis in vitro. Herein, we show that MerTK is cleaved at proline 485 in murine macrophages. Site-directed deletion of 6 amino acids spanning proline 485 rendered MerTK resistant to proteolysis and suppression of efferocytosis by cleavage-inducing stimuli. LPS is a known inducer of MerTK cleavage, and the intracellular signaling pathways required for this action are unknown. LPS/TLR4-mediated generation of sMER required disintegrin and metalloproteinase ADAM17 and was independent of Myd88, instead requiring TRIF adaptor signaling. LPS-induced cleavage was suppressed by deficiency of NADPH oxidase 2 (Nox2) and PKC delta. The addition of the antioxidant N-acetyl cysteine inhibited PKC delta, and silencing of PKC delta inhibited MAPK p38, which was also required. In a mouse model of endotoxemia, we discovered that LPS induced plasma sMER, and this was suppressed by Adam17 deficiency. Thus, a TRIF-mediated pattern recognition receptor signaling cascade requires NADPH oxidase to activate PKC delta and then p38, culminating in ADAM17-mediated proteolysis of MerTK. These findings link innate pattern recognition receptor signaling to proteolytic inactivation of MerTK and generation of sMER and uncover targets to test how MerTK cleavage affects efferocytosis efficiency and inflammation resolution in vivo.	[Thorp, Edward; Subramanian, Manikandan; Mautner, Lauren; Tabas, Ira] Columbia Univ, Dept Med Pathol & Cell Biol & Physiol, New York, NY 10032 USA; [Thorp, Edward; Subramanian, Manikandan; Mautner, Lauren; Tabas, Ira] Columbia Univ, Dept Cellular Biophys, New York, NY 10032 USA; [Vaisar, Tomas] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Blobel, Carl] Hosp Special Surg, New York, NY 10021 USA	Columbia University; Columbia University; University of Washington; University of Washington Seattle	Thorp, E (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, 303 E Chicago Ave,Tarry Bldg 3-705, Chicago, IL 60611 USA.	ebthorp@northwestern.edu; iat1@columbia.edu		Thorp, Edward/0000-0003-1387-7058; Vaisar, Tomas/0000-0002-7406-6606; Subramanian, Manikandan/0000-0002-2608-3890	National Institutes of Health (NIH); NHLBI; Program of Excellence in Nanotechnology (PEN) [HHSN268201000045C]; NIH [HL54591, HL75662, 1K99HL097021]; National Center for Research Resources (NCRR) [UL1 RR 024156];  [GM64750]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075662, P01HL054591, K99HL097021, T35HL007616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Program of Excellence in Nanotechnology (PEN); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NHLBI, Program of Excellence in Nanotechnology (PEN) Award Contract HHSN268201000045C and NIH Grants HL54591 and HL75662 (to I. T.), GM64750 (to C. B.), and UL1 RR 024156 from the National Center for Research Resources (NCRR), a component of the NIH, and 1K99HL097021 (to E. T.).	ADERKA D, 1992, J EXP MED, V175, P323, DOI 10.1084/jem.175.2.323; Althoff K, 2000, EUR J BIOCHEM, V267, P2624, DOI 10.1046/j.1432-1327.2000.01278.x; Anwar A, 2009, J LEUKOCYTE BIOL, V86, P73, DOI [10.1189/jlb.0608334, 10.1189/JLB.0608334]; Becherer JD, 2003, CURR TOP DEV BIOL, V54, P101, DOI 10.1016/S0070-2153(03)54006-6; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bostanci N, 2009, ORAL MICROBIOL IMMUN, V24, P146, DOI 10.1111/j.1399-302X.2008.00488.x; Brandl K, 2010, P NATL ACAD SCI USA, V107, P19967, DOI 10.1073/pnas.1014669107; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Chen CL, 2010, J CELL SCI, V123, P2901, DOI 10.1242/jcs.069765; Chen CL, 2004, ARTERIOSCL THROM VAS, V24, P1118, DOI 10.1161/01.ATV.0000130662.30537.08; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Costa M, 1996, J CELL PHYSIOL, V168, P737, DOI 10.1002/(SICI)1097-4652(199609)168:3<737::AID-JCP27>3.0.CO;2-U; CROWE PD, 1995, J EXP MED, V181, P1205, DOI 10.1084/jem.181.3.1205; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Feng XY, 2011, IMMUNOLOGY, V132, P287, DOI 10.1111/j.1365-2567.2010.03364.x; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Glenn G, 2008, FEBS LETT, V582, P911, DOI 10.1016/j.febslet.2008.02.029; Gomez MI, 2005, J IMMUNOL, V175, P1930, DOI 10.4049/jimmunol.175.3.1930; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; GRAHAM DK, 1995, ONCOGENE, V10, P2349; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Hurtado B, 2011, THROMB HAEMOSTASIS, V105, P873, DOI 10.1160/TH10-10-0630; Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411, DOI 10.1093/oxfordjournals.jbchem.a022622; Kanthasamy AG, 2003, ANTIOXID REDOX SIGN, V5, P609, DOI 10.1089/152308603770310275; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Kubo-Murai M, 2007, MOL IMMUNOL, V44, P2257, DOI 10.1016/j.molimm.2006.11.005; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lee MC, 2008, J LEUKOCYTE BIOL, V84, P835, DOI 10.1189/jlb.1007691; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Li Y., 2006, J LEUKOCYTE BIOL, V81, P483; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mullberg J, 1997, FEBS LETT, V401, P235, DOI 10.1016/S0014-5793(96)01480-9; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; OBRYAN JP, 1995, J BIOL CHEM, V270, P551, DOI 10.1074/jbc.270.2.551; PABST MJ, 1980, J EXP MED, V151, P101, DOI 10.1084/jem.151.1.101; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Shao MXG, 2005, P NATL ACAD SCI USA, V102, P767, DOI 10.1073/pnas.0408932102; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thorp E., 2010, ART THROMB VASC BIOL, V15; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Tibrewal N, 2008, J BIOL CHEM, V283, P3618, DOI 10.1074/jbc.M706906200; Uehara H, 2008, J IMMUNOL, V180, P2522, DOI 10.4049/jimmunol.180.4.2522; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Young LH, 2005, CARDIOVASC DRUG REV, V23, P255; Zhang ZL, 2001, FASEB J, V15, P303; Ziegler K, 2009, CELL HOST MICROBE, V5, P341, DOI 10.1016/j.chom.2009.03.006	65	181	189	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33335	33344		10.1074/jbc.M111.263020	http://dx.doi.org/10.1074/jbc.M111.263020			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828049	Green Published, hybrid			2022-12-27	WOS:000294968800052
J	Las, G; Serada, SB; Wikstrom, JD; Twig, G; Shirihai, OS				Las, Guy; Serada, Sam B.; Wikstrom, Jakob D.; Twig, Gilad; Shirihai, Orian S.			Fatty Acids Suppress Autophagic Turnover in beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; LIVING MAMMALIAN-CELLS; PANCREATIC-ISLETS; OXIDATIVE STRESS; MONITORING AUTOPHAGY; PUNCTA-FORMATION; PROTON PUMP; FUSION; EXPOSURE; GLUCOSE	Recent studies have shown that autophagy is essential for proper beta-cell function and survival. However, it is yet unclear under what pathogenic conditions autophagy is inhibited in beta-cells. Here, we report that long term exposure to fatty acids and glucose block autophagic flux in beta-cells, contributing to their toxic effect. INS1 cells expressing GFP-LC3 (an autophagosome marker) were treated with 0.4 mM palmitate, 0.4 mM oleate, and various concentrations of glucose for 22 h. Kinetics of the effect of fatty acids on autophagy showed a biphasic response. During the second phase of autophagy, the size of autophagosomes and the content of autophagosome substrates (GFP-LC3, p62) and endogenous LC3 was increased. During the same phase, fatty acids suppressed autophagic degradation of long lived protein in both INS1 cells and islets. In INS1 cells, palmitate induced a 3-fold decrease in the number and the acidity of Acidic Vesicular Organelles. This decrease was associated with a suppression of hydrolase activity, suppression of endocytosis, and suppression of oxidative phosphorylation. The combination of fatty acids with glucose synergistically suppressed autophagic turnover, concomitantly suppressing insulin secretion. Rapamycin treatment resulted in partial reversal of the inhibition of autophagic flux, the inhibition of insulin secretion, and the increase in cell death. Our results indicate that excess nutrient could impair autophagy in the long term, hence contributing to nutrient-induced beta-cell dysfunction. This may provide a novel mechanism that connects diet-induced obesity and diabetes.	[Las, Guy; Serada, Sam B.; Wikstrom, Jakob D.; Twig, Gilad; Shirihai, Orian S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University	Shirihai, OS (corresponding author), EBRC 650 Albany St,Rm 804, Boston, MA 02118 USA.	Shirihai@bu.edu	Twig, Gilad/C-4373-2018	Twig, Gilad/0000-0003-2829-3645; Shirihai, Orian/0000-0002-9502-2661; Wikstrom, Jakob/0000-0002-4287-1774	Evans Center; Mitochondria-Affinity Research Collaborative (mtARC); National Institutes of Health [R01 HL071629-03, R01 DK074778, DK035914]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035914, R56DK035914, R01DK074778, R37DK035914] Funding Source: NIH RePORTER	Evans Center; Mitochondria-Affinity Research Collaborative (mtARC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Evans Center and the Mitochondria-Affinity Research Collaborative (mtARC) and by National Institutes of Health Grants R01 HL071629-03 and R01 DK074778 and DK035914 (to O. S. S. and B. C. Corkey).	Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; Bauvy C, 2009, METHOD ENZYMOL, V452, P47, DOI 10.1016/S0076-6879(08)03604-5; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Fujimoto K, 2009, J BIOL CHEM, V284, P27664, DOI 10.1074/jbc.M109.041616; Grishko V, 2005, FREE RADICAL BIO MED, V38, P755, DOI 10.1016/j.freeradbiomed.2004.11.023; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Komiya K, 2010, BIOCHEM BIOPH RES CO, V401, P561, DOI 10.1016/j.bbrc.2010.09.101; Koshkin V, 2003, J BIOL CHEM, V278, P19709, DOI 10.1074/jbc.M209709200; Koshkin V, 2008, J BIOL CHEM, V283, P7936, DOI 10.1074/jbc.M705652200; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Marino ML, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.67; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Proikas-Cezanne T, 2009, METHOD ENZYMOL, V452, P247, DOI 10.1016/S0076-6879(08)03616-1; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Shvets E, 2009, METHOD ENZYMOL, V452, P131, DOI 10.1016/S0076-6879(08)03609-4; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; YAMASHIRO DJ, 1983, J CELL BIOL, V97, P929, DOI 10.1083/jcb.97.3.929; Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	40	149	154	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42534	42544		10.1074/jbc.M111.242412	http://dx.doi.org/10.1074/jbc.M111.242412			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21859708	Green Published, hybrid			2022-12-27	WOS:000298180900061
J	Abdulkhalek, S; Amith, SR; Franchuk, SL; Jayanth, P; Guo, M; Finlay, T; Gilmour, A; Guzzo, C; Gee, K; Beyaert, R; Szewczuk, MR				Abdulkhalek, Samar; Amith, Schammim Ray; Franchuk, Susan L.; Jayanth, Preethi; Guo, Merry; Finlay, Trisha; Gilmour, Alanna; Guzzo, Christina; Gee, Katrina; Beyaert, Rudi; Szewczuk, Myron R.			Neu1 Sialidase and Matrix Metalloproteinase-9 Cross-talk Is Essential for Toll-like Receptor Activation and Cellular Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-ASSOCIATED SIALIDASE; GROWTH-FACTOR RECEPTOR; PLASMA-MEMBRANE; MATRIX METALLOPROTEINASES; LYSOSOMAL SIALIDASE; EXOGENOUS ANTIGENS; GENE-EXPRESSION; DENDRITIC CELLS; T-LYMPHOCYTES; CLASS-I	The signaling pathways of mammalian Toll-like receptors (TLRs) are well characterized, but the precise mechanism(s) by which TLRs are activated upon ligand binding remains poorly defined. Recently, we reported a novel membrane sialidase-controlling mechanism that depends on ligand binding to its TLR to induce mammalian neuraminidase-1 (Neu1) activity, to influence receptor desialylation, and subsequently to induce TLR receptor activation and the production of nitric oxide and pro-inflammatory cytokines in dendritic and macrophage cells. The alpha-2,3-sialyl residue of TLR was identified as the specific target for hydrolysis by Neu1. Here, we report a membrane signaling paradigm initiated by endotoxin lipopolysaccharide (LPS) binding to TLR4 to potentiate G protein-coupled receptor (GPCR) signaling via membrane G alpha(i) subunit proteins and matrix metalloproteinase-9 (MMP9) activation to induce Neu1. Central to this process is that a Neu1-MMP9 complex is bound to TLR4 on the cell surface of naive macrophage cells. Specific inhibition of MMP9 and GPCR G alpha(i)-signaling proteins blocks LPS-induced Neu1 activity and NF kappa B activation. Silencing MMP9 mRNA using lentivirus MMP9 shRNA transduction or siRNA transfection of macrophage cells and MMP9 knock-out primary macrophage cells significantly reduced Neu1 activity and NF kappa B activation associated with LPS-treated cells. These findings uncover a molecular organizational signaling platform of a novel Neu1 and MMP9 cross-talk in alliance with TLR4 on the cell surface that is essential for ligand activation of TLRs and subsequent cellular signaling.	[Abdulkhalek, Samar; Amith, Schammim Ray; Franchuk, Susan L.; Jayanth, Preethi; Guo, Merry; Finlay, Trisha; Gilmour, Alanna; Guzzo, Christina; Gee, Katrina; Szewczuk, Myron R.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Beyaert, Rudi] Univ Ghent, Dept Mol Biol, B-9052 Zwijnaarde, Belgium; [Beyaert, Rudi] Univ Ghent VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, B-9052 Ghent, Belgium	Queens University - Canada; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Szewczuk, MR (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	szewczuk@queensu.ca	Beyaert, Rudi/B-2589-2009; Abdulkhalek, Samar/GWC-6242-2022; Gee, Katrina/H-3093-2016	Gee, Katrina/0000-0002-7535-2882; Beyaert, Rudi/0000-0002-5704-582X; Guzzo, Christina/0000-0002-3042-0976	Natural Sciences and Engineering Research Council of Canada (NSERC); Ghent University [IAP6/18, 3G010505, 01G06B6]; R.S. McLaughlin Scholarship; Ontario Graduate Scholarship; Queen's University Research Award; Robert J. Wilson Fellowship; Ontario Graduate Scholarship in Science and Technology; Queen's Graduate Award; Franklin Bracken Scholarship; Ontario HIV Treatment Network Studentship; Canadian Institutes of Health	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ghent University(Ghent University); R.S. McLaughlin Scholarship; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Queen's University Research Award; Robert J. Wilson Fellowship; Ontario Graduate Scholarship in Science and Technology; Queen's Graduate Award; Franklin Bracken Scholarship; Ontario HIV Treatment Network Studentship; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a grant (to M.R.S.) from the Natural Sciences and Engineering Research Council of Canada (NSERC). Research work on the TLR transfected cell lines was supported by "Interuniversitaire Attractiepolen" Grant IAP6/18, "Fonds voor Wetenschappelijk Onderzoek-Vlaanderen" Grant 3G010505, and "Geconcerteerde Onderzoeksacties" of Ghent University Grant 01G06B6 (to R.B.).; Recipient of the R.S. McLaughlin Scholarship and the Ontario Graduate Scholarship.; Recipient of the Queen's University Research Award, the Robert J. Wilson Fellowship, and the Ontario Graduate Scholarship.; Recipient of the Ontario Graduate Scholarship in Science and Technology.; Recipient of the Queen's Graduate Award and the Robert J. Wilson Fellowship. Present address: Dept. of Pathology and Molecular Medicine MDCL 4077, McMaster University, MDCL 2319, 1200 Main St. W., Hamilton, Ontario L8N 3Z5, Canada.; Recipient of the NSERC Undergraduate Student Research Award.; Recipient of the Franklin Bracken Scholarship.; Recipient of the Ontario HIV Treatment Network Studentship and the Canadian Institutes of Health Vanier Scholarship.	Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; Amith SR, 2009, GLYCOCONJUGATE J, V26, P1197, DOI 10.1007/s10719-009-9239-8; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Chen XP, 1997, J IMMUNOL, V158, P3070; Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200; Eskan MA, 2008, EUR J IMMUNOL, V38, P1138, DOI 10.1002/eji.200737898; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Finlay TM, 2010, GLYCOCONJUGATE J, V27, P329, DOI 10.1007/s10719-010-9281-6; Fischer Oliver M., 2006, V327, P85; Gebbia JA, 2004, J INFECT DIS, V189, P113, DOI 10.1086/380414; Gooz M, 2006, J BIOL CHEM, V281, P21004, DOI 10.1074/jbc.M512096200; Gouwy M, 2009, J LEUKOCYTE BIOL, V86, P671, DOI 10.1189/jlb.1008638; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; HINEK A, 1995, EXP CELL RES, V220, P312, DOI 10.1006/excr.1995.1321; Hinek A, 2006, J BIOL CHEM, V281, P3698, DOI 10.1074/jbc.M508736200; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Izumi H, 2000, FEBS LETT, V481, P31, DOI 10.1016/S0014-5793(00)01902-5; Jayanth P, 2010, CELL SIGNAL, V22, P1193, DOI 10.1016/j.cellsig.2010.03.011; Kai HST, 2002, J BIOL CHEM, V277, P48696, DOI 10.1074/jbc.M209177200; Kato K, 2006, BIOCHEM J, V394, P647, DOI 10.1042/BJ20050737; Kim SH, 2011, J BIOL CHEM, V286, P8875, DOI 10.1074/jbc.M110.187815; KOVACSOVICSBANKOWSKI M, 1994, EUR J IMMUNOL, V24, P2421; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Lattin JE, 2009, MOL IMMUNOL, V47, P340, DOI 10.1016/j.molimm.2009.09.012; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Le Gall SM, 2003, J BIOL CHEM, V278, P45255, DOI 10.1074/jbc.M307745200; Lee MH, 2004, J CELL SCI, V117, P4015, DOI 10.1242/jcs.01223; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; Loniewski K, 2008, MOL IMMUNOL, V45, P2312, DOI 10.1016/j.molimm.2007.11.012; Lukong KE, 2000, HUM MOL GENET, V9, P1075, DOI 10.1093/hmg/9.7.1075; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Mott JD, 2000, J BIOL CHEM, V275, P1384, DOI 10.1074/jbc.275.2.1384; Murasawa S, 1998, CIRC RES, V82, P1338, DOI 10.1161/01.RES.82.12.1338; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Rallabhandi P, 2008, J BIOL CHEM, V283, P24314, DOI 10.1074/jbc.M804800200; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; Seyrantepe V, 2004, J BIOL CHEM, V279, P37021, DOI 10.1074/jbc.M404531200; Seyrantepe V, 2010, J BIOL CHEM, V285, P206, DOI 10.1074/jbc.M109.055475; Shen ZH, 1997, J IMMUNOL, V158, P2723; Shi GX, 2004, J IMMUNOL, V172, P5175, DOI 10.4049/jimmunol.172.9.5175; Simizu S, 2005, CANCER RES, V65, P7455, DOI 10.1158/0008-5472.CAN-04-4446; Solomon KR, 1998, J CLIN INVEST, V102, P2019, DOI 10.1172/JCI4317; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Takahashi M, 2003, GLYCOCONJUGATE J, V20, P207, DOI 10.1023/B:GLYC.0000024252.63695.5c; Valaperta R, 2006, FASEB J, V20, P1227, DOI 10.1096/fj.05-5077fje; Woronowicz A, 2004, GLYCOBIOLOGY, V14, P987, DOI 10.1093/glycob/cwh123; Woronowicz A, 2007, GLYCOBIOLOGY, V17, P10, DOI 10.1093/glycob/cwl049; Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055; Yogalingam G, 2008, DEV CELL, V15, P74, DOI 10.1016/j.devcel.2008.05.005	58	61	66	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36532	36549		10.1074/jbc.M111.237578	http://dx.doi.org/10.1074/jbc.M111.237578			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21873432	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000296538300038
J	Fu, LC; Balasubramanian, M; Shan, JX; Dudenhausen, EE; Kilberg, MS				Fu, Lingchen; Balasubramanian, Mukundh; Shan, Jixiu; Dudenhausen, Elizabeth E.; Kilberg, Michael S.			Auto-activation of c-JUN Gene by Amino Acid Deprivation of Hepatocellular Carcinoma Cells Reveals a Novel c-JUN-mediated Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE SYNTHETASE GENE; HUMAN HEPATOMA-CELLS; DIETARY-PROTEIN RESTRICTION; TRANSCRIPTION FACTORS; NUTRITIONAL CONTROL; RESPONSE ELEMENTS; HISTONE ACETYLATION; POSITIVE REGULATOR; MAMMALIAN-CELLS; ATF4 EXPRESSION	Mammalian cells respond to protein or amino acid (AA) limitation by activating a number of signaling pathways, collectively referred to as the AA response (AAR), that modulate a range of cellular functions, including transcriptional induction of target genes. This study demonstrates that in hepatocellular carcinoma cells, expression of c-JUN, JUN-B, c-FOS, and FOS-B was induced by the AAR, whereas JUN-D, FRA-1, and FRA-2 were not. Of the four activated FOS/JUN members, c-JUN made the largest contribution to the induction of several known AAR target genes. For several human liver, prostate, and ovarian cell lines, the AAR-induced increase in c-JUN expression was greater in transformed cells compared with nontransformed counterparts, an effect independent of cell growth rate. Thus far, the best characterized AA-responsive genes are all transcriptionally activated by ATF4, but the AAR-dependent induction of c-JUN transcription was ATF4-independent. The increased expression of c-JUN was dependent on ATF2 and on activation of the MEK-ERK and JNK arms of the MAPK signaling pathways. Formation of c-JUN-ATF2-activated heterodimers was increased after AA limitation, and c-JUN or ATF2 knockdown suppressed the induction of c-JUN and other AAR target genes. AA deprivation triggers a feed-forward process that involves phosphorylation of existing c-JUN protein by JNK and subsequent auto-activation of the c-JUN gene by recruitment of c-JUN and ATF2 to two AP-1 sites within the proximal promoter. The results document the novel observation that AP-1 sequences within the c-JUN gene can function as transcriptional amino acid-response elements.	[Kilberg, Michael S.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Ctr Nutr Sci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kilberg, MS (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr, Box 100245, Gainesville, FL 32610 USA.	mkilberg@ufl.edu			National Institutes of Health [DK-092062]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092062, R01DK094729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-092062 (to M. S. K.).	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Aslanian AM, 2001, BIOCHEM J, V357, P321, DOI 10.1042/0264-6021:3570321; Aubel C, 2001, CELL SIGNAL, V13, P417, DOI 10.1016/S0898-6568(01)00159-0; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bruhat A, 2007, NUCLEIC ACIDS RES, V35, P1312, DOI 10.1093/nar/gkm038; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09; Chen C, 2005, BIOCHEM J, V391, P649, DOI 10.1042/BJ20050882; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Franchi-Gazzola R, 1999, J BIOL CHEM, V274, P28922, DOI 10.1074/jbc.274.41.28922; Gietzen DW, 2004, J NUTR, V134, P717, DOI 10.1093/jn/134.4.717; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Hutson RG, 1996, CLIN NUTR, V15, P327, DOI 10.1016/S0261-5614(96)80009-4; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; Li J, 2011, AM J PHYSIOL-CELL PH, V301, pC213, DOI 10.1152/ajpcell.00067.2011; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lim PLK, 2007, TOXICOL IN VITRO, V21, P1390, DOI 10.1016/j.tiv.2007.05.003; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; MORGANE PJ, 1993, NEUROSCI BIOBEHAV R, V17, P91, DOI 10.1016/S0149-7634(05)80234-9; Morley JE, 2009, CURR OPIN CLIN NUTR, V12, P607, DOI 10.1097/MCO.0b013e328331e9ce; MOROOKA H, 1995, J BIOL CHEM, V270, P30084; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Pedrini MT, 1996, ANN INTERN MED, V124, P627, DOI 10.7326/0003-4819-124-7-199604010-00002; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; POHJANPELTO P, 1990, MOL CELL BIOL, V10, P5814, DOI 10.1128/MCB.10.11.5814; Sabapathy K, 2004, CELL CYCLE, V3, P1520, DOI 10.4161/cc.3.12.1315; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Shan JX, 2010, PHYSIOL GENOMICS, V41, P315, DOI 10.1152/physiolgenomics.00217.2009; Shan JX, 2009, J BIOL CHEM, V284, P21241, DOI 10.1074/jbc.M109.011338; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Shimizu M, 1998, EXP CELL RES, V239, P93, DOI 10.1006/excr.1997.3884; Singh J, 2002, ONCOGENE, V21, P1812, DOI 10.1038/sj.onc.1205252; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Su N, 2009, HEPATOLOGY, V50, P282, DOI 10.1002/hep.22971; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051; Thiaville MM, 2008, J BIOL CHEM, V283, P10848, DOI 10.1074/jbc.M708320200; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wei P, 1998, MOL ENDOCRINOL, V12, P1322, DOI 10.1210/me.12.9.1322; Wolter S, 2008, MOL CELL BIOL, V28, P4407, DOI 10.1128/MCB.00535-07; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Yogev O, 2010, CANCER RES, V70, P2318, DOI 10.1158/0008-5472.CAN-09-3408; Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3	68	26	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36724	36738		10.1074/jbc.M111.277673	http://dx.doi.org/10.1074/jbc.M111.277673			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21862593	hybrid, Green Published			2022-12-27	WOS:000296538300055
J	Pagac, M; de la Mora, HV; Duperrex, C; Roubaty, C; Vionnet, C; Conzelmann, A				Pagac, Martin; de la Mora, Hector Vazquez; Duperrex, Cecile; Roubaty, Carole; Vionnet, Christine; Conzelmann, Andreas			Topology of 1-Acyl-sn-glycerol-3-phosphate Acyltransferases SLC1 and ALE1 and Related Membrane-bound O-Acyltransferases (MBOATs) of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEIN TOPOLOGY; ENDOPLASMIC-RETICULUM; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASES; STEROL ESTERIFICATION; PHOSPHATIDIC-ACID; YEAST; IDENTIFICATION; ENCODES; PHOSPHATIDYLCHOLINE; ACCESSIBILITY	In yeast, phosphatidic acid, the biosynthetic precursor for all glycerophospholipids and triacylglycerols, is made de novo by the 1-acyl-sn-glycerol-3-phosphate acyltransferases Ale1p and Slc1p. Ale1p belongs to the membrane-bound O-acyl-transferase (MBOAT) family, which contains many enzymes acylating lipids but also others that acylate secretory proteins residing in the lumen of the ER. A histidine present in a very short loop between two predicted transmembrane domains is the only residue that is conserved throughout the MBOAT gene family. The yeast MBOAT proteins of known function comprise Ale1p, the ergosterol acyltransferases Are1p and Are2p, and Gup1p, the last of which acylates lysophosphatidylinositol moieties of GPI anchors on ER lumenal GPI proteins. C-terminal topology reporters added to truncated versions of Gup1p yield a topology predicting a lumenal location of its uniquely conserved histidine 447 residue. The same approach shows that Ale1p and Are2p also have the uniquely conserved histidine residing in the ER lumen. Because these data raised the possibility that phosphatidic acid could be made in the lumen of the ER, we further investigated the topology of the second yeast 1-acyl-sn-glycerol-3-phosphate acyltransferase, Slc1p. The location of C-terminal topology reporters, microsomal assays probing the protease sensitivity of inserted tags, and the accessibility of natural or artificially inserted cysteines to membrane-impermeant alkylating agents all indicate that the most conserved motif containing the presumed active site histidine of Slc1p is oriented toward the ER lumen, whereas other conserved motifs are cytosolic. The implications of these findings are discussed.	[Pagac, Martin; de la Mora, Hector Vazquez; Duperrex, Cecile; Roubaty, Carole; Vionnet, Christine; Conzelmann, Andreas] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland	University of Fribourg	Conzelmann, A (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	andreas.conzelmann@unifr.ch			Swiss National Science Foundation [31-67188.01, CRSI33_125232/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 31-67188.01 and CRSI33_125232/1.	Agarwal AK, 2010, J LIPID RES, V51, P2143, DOI 10.1194/jlr.M004762; Alberts B., 2008, MOL BIOL CELL, P743; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; BELL RM, 1981, J LIPID RES, V22, P391; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bleve G, 2005, BIOCHEM J, V390, P145, DOI 10.1042/BJ20042045; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; Bratschi MW, 2009, EUKARYOT CELL, V8, P1184, DOI 10.1128/EC.00085-09; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Cassel M, 2008, J MOL BIOL, V381, P860, DOI 10.1016/j.jmb.2008.06.039; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chen QL, 2007, FEBS LETT, V581, P5511, DOI 10.1016/j.febslet.2007.10.061; COLEMAN R, 1978, J CELL BIOL, V76, P245, DOI 10.1083/jcb.76.1.245; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; Guo T, 2007, J CELL BIOL, V177, P289, DOI 10.1083/jcb.200609072; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; Jensen-Pergakes K, 2001, J BACTERIOL, V183, P4950, DOI 10.1128/JB.183.17.4950-4957.2001; Kihara A, 2003, GENES CELLS, V8, P525, DOI 10.1046/j.1365-2443.2003.00653.x; Kim H, 2003, P NATL ACAD SCI USA, V100, P7460, DOI 10.1073/pnas.1332735100; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; Liu Q, 2011, J BIOL CHEM, V286, P13115, DOI 10.1074/jbc.M110.204412; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Schmidt JA, 2010, BIOCHEM BIOPH RES CO, V397, P661, DOI 10.1016/j.bbrc.2010.05.149; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Shui G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011956; Slabas AR, 2002, J BIOL CHEM, V277, P43918, DOI 10.1074/jbc.M206429200; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tamada T, 2004, ACTA CRYSTALLOGR D, V60, P13, DOI 10.1107/S0907444903020778; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Yamashita A, 2007, BBA-MOL CELL BIOL L, V1771, P1202, DOI 10.1016/j.bbalip.2007.07.002; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200	61	37	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36438	36447		10.1074/jbc.M111.256511	http://dx.doi.org/10.1074/jbc.M111.256511			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21849510	Green Published, hybrid			2022-12-27	WOS:000296538300029
J	Schnepple, DJ; Shepard, B; Bren, GD; Cummins, NW; Natesampillai, S; Trushin, S; Algeciras-Schimnich, A; Meng, XW; Sainski, AM; Rizza, SA; Kaufmann, SH; Badley, AD				Schnepple, David J.; Shepard, Brett; Bren, Gary D.; Cummins, Nathan W.; Natesampillai, Sekar; Trushin, Sergey; Algeciras-Schimnich, Alicia; Meng, Xue W.; Sainski, Amy M.; Rizza, Stacey A.; Kaufmann, Scott H.; Badley, Andrew D.			Isolation of a TRAIL Antagonist from the Serum of HIV-infected Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING LIGAND; CD4(+) T-CELLS; NF-KAPPA-B; ANTIRETROVIRAL THERAPY; MEDIATED APOPTOSIS; HUMAN-MELANOMA; UP-REGULATION; TUMOR-GROWTH; FAS LIGAND; VIRUS	Virus-host interactions are characterized by the selection of adaptive mechanisms by which to evade pathogenic and defense mechanisms, respectively. In primary T cells infected with HIV, HIV infection up-regulates TNF-related apoptosis inducing ligand (TRAIL) and death-inducing TRAIL receptors, but blockade of TRAIL: TRAIL receptor interaction does not alter HIV-induced cell death. Instead, HIV infection results in a novel splice variant that we call TRAIL-short (TRAIL-s), which antagonizes TRAIL-R2. In HIV patients, plasma TRAIL-s concentration increases with increasing viral load and renders cells resistant to TRAIL-induced death. Knockdown of TRAIL-s abrogates this resistance. We propose that TRAIL-s is a novel adaptive mechanism of apoptosis resistance acquired by HIV-infected cells to avoid their elimination by TRAIL-dependent effector mechanism.	[Schnepple, David J.; Shepard, Brett; Bren, Gary D.; Cummins, Nathan W.; Natesampillai, Sekar; Trushin, Sergey; Algeciras-Schimnich, Alicia; Sainski, Amy M.; Rizza, Stacey A.; Badley, Andrew D.] Mayo Clin, Coll Med, Div Infect Dis, Rochester, MN 55905 USA; [Schnepple, David J.] Mayo Clin, Coll Med, Program Mol Neurosci, Rochester, MN 55905 USA; [Meng, Xue W.; Kaufmann, Scott H.] Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN 55905 USA; [Sainski, Amy M.; Kaufmann, Scott H.] Mayo Clin, Coll Med, Dept Mol Pharmacol, Rochester, MN 55905 USA; [Cummins, Nathan W.; Badley, Andrew D.] Mayo Clin, Coll Med, Program Translat Immunovirol & Biodef, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Badley, AD (corresponding author), Mayo Clin, Coll Med, Div Infect Dis, 200 1st St SW, Rochester, MN 55905 USA.	badley.andrew@mayo.edu	Serei, Virian D/B-4616-2015; badley, andrew d/O-9022-2014	Kaufmann, Scott/0000-0002-4900-7145; Badley, Andrew/0000-0001-7796-7680	National Institutes of Health [R01 AI62261]; NATIONAL CANCER INSTITUTE [R01CA069008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI62261 (to A. D. B.).	Badley AD, 1998, J CLIN INVEST, V102, P79, DOI 10.1172/JCI2691; BADLEY AD, 2006, CELL DEATH HIV INFEC; Baetu TM, 2002, CYTOKINE GROWTH F R, V13, P199, DOI 10.1016/S1359-6101(02)00006-0; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Bren GD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002112; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; Dockrell DH, 1998, J CLIN INVEST, V101, P2394, DOI 10.1172/JCI1171; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Fryer HR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001196; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Gibellini D, 2005, J CELL PHYSIOL, V203, P547, DOI 10.1002/jcp.20252; Giri MS, 2009, J IMMUNOL, V182, P4459, DOI 10.4049/jimmunol.0801450; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Griffith TS, 1998, J IMMUNOL, V161, P2833; Haas DW, 2006, J INFECT DIS, V194, P1098, DOI 10.1086/507313; HAMILTON TC, 1984, SEMIN ONCOL, V11, P285; Hansjee N, 2004, JAIDS-J ACQ IMM DEF, V36, P671, DOI 10.1097/00126334-200406010-00003; Held J, 2001, DRUG RESIST UPDATE, V4, P243, DOI 10.1054/drup.2001.0208; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Herbeuval JP, 2005, BLOOD, V105, P2458, DOI 10.1182/blood-2004-08-3058; Herbeuval JP, 2005, P NATL ACAD SCI USA, V102, P13974, DOI 10.1073/pnas.0505251102; Holen I, 2002, CANCER RES, V62, P1619; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Johansson P, 2009, J VIROL, V83, P1393, DOI 10.1128/JVI.01637-08; KANZLER S, 2005, EUR J CANCER, V3, P17; Lassen KG, 2010, J BIOL CHEM, V285, P29326, DOI 10.1074/jbc.M110.154054; Lichtner M, 2004, AIDS RES HUM RETROV, V20, P175, DOI 10.1089/088922204773004897; Lum JJ, 2005, AIDS, V19, P1125, DOI 10.1097/01.aids.0000176212.16205.23; Lum JJ, 2004, J VIROL, V78, P6033, DOI 10.1128/JVI.78.11.6033-6042.2004; Lum JJ, 2001, J VIROL, V75, P11128, DOI 10.1128/JVI.75.22.11128-11136.2001; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Miura Y, 2001, J EXP MED, V193, P651, DOI 10.1084/jem.193.5.651; Munshi A, 2001, ONCOGENE, V20, P3757, DOI 10.1038/sj.onc.1204504; Nie Z, 2007, J VIROL, V81, P6947, DOI 10.1128/JVI.02798-06; Richard J, 2010, CELL HOST MICROBE, V8, P389, DOI 10.1016/j.chom.2010.11.001; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Shankar S, 2004, INT J ONCOL, V24, P1133; Shepard BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003096; Shiozaki T, 2011, J GEN VIROL, V92, P315, DOI 10.1099/vir.0.028316-0; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134; TANAKA M, 1995, EMBO J, V14, P1129, DOI 10.1002/j.1460-2075.1995.tb07096.x; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Tazi J, 2010, FEBS J, V277, P867, DOI 10.1111/j.1742-4658.2009.07522.x; Wang SL, 2003, P NATL ACAD SCI USA, V100, P15095, DOI 10.1073/pnas.2435285100; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wu XF, 2001, MOL THER, V3, P368, DOI 10.1006/mthe.2001.0280; Yang YD, 2003, J VIROL, V77, P6700, DOI 10.1128/JVI.77.12.6700-6708.2003; Yoo J, 2006, J GENE MED, V8, P163, DOI 10.1002/jgm.832; Zhang MJ, 2001, J BIOMED SCI, V8, P290, DOI 10.1159/000054045; Zhang XD, 2001, CANCER RES, V61, P7339	58	11	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35742	35754		10.1074/jbc.M111.274639	http://dx.doi.org/10.1074/jbc.M111.274639			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21859711	Green Published, hybrid			2022-12-27	WOS:000295927100047
J	Aggarwal, S; Dewhurst, S; Takimoto, T; Kim, B				Aggarwal, Shilpa; Dewhurst, Stephen; Takimoto, Toru; Kim, Baek			Biochemical Impact of the Host Adaptation-associated PB2 E627K Mutation on the Temperature-dependent RNA Synthesis Kinetics of Influenza A Virus Polymerase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; SINGLE AMINO-ACID; RECEPTOR SPECIFICITY; HIGH VIRULENCE; HUMAN-CELLS; RANGE; NUCLEOPROTEIN; REPLICATION; DETERMINANT; RESIDUES	Most avian influenza A viruses, which preferentially replicate at the high temperatures found in the digestive tract of birds, have a glutamic acid at residue 627 of the viral RNA polymerase PB2 subunit (Glu-627), whereas the human viruses, which optimally replicate at the low temperatures observed in the human respiratory tract, have a lysine (Lys-627). The mechanism of action for this mutation is still not understood, although interaction with host factors has been proposed to play a major role. In this study, we explored an alternative, yet related, hypothesis that this PB2 mutation may alter the temperature-dependent enzymatic polymerase activity of the viral polymerase. First, the avian polymerase protein, which was purified from baculovirus expression system, indeed remained significantly active at higher temperatures (i.e. 37 and 42 degrees C), whereas the human E627K mutant drastically lost activity at these high temperatures. Second, our steady-state kinetics data revealed that the human E627K mutant polymerase is catalytically more active than the avian Glu-627 polymerase at 34 C. Importantly, the E627K mutation elevates apparent K-cat at low temperatures with little effect on K-m, suggesting that the E627K mutation alters the biochemical steps involved in enzyme catalysis rather than the interaction with the incoming NTP. Third, this temperature-dependent kinetic impact of the human E627K mutation was also observed with different RNA templates, with different primers and also in the presence of nucleoprotein. In conclusion, our study suggests that the amino acid sequence variations at residue 627 of PB2 subunit can directly alter the enzyme kinetics of influenza polymerase.	[Aggarwal, Shilpa; Dewhurst, Stephen; Takimoto, Toru; Kim, Baek] Univ Rochester, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14642 USA	University of Rochester	Kim, B (corresponding author), Univ Rochester, Dept Microbiol & Immunol, Med Ctr, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu		Dewhurst, Stephen/0000-0001-7729-7920	National Institutes of Health [HHSN266200700008C]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Contract HHSN266200700008C granted to the New York Influenza Center of Excellence.	Aggarwal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010372; ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; Boyer PL, 2002, J VIROL, V76, P9143, DOI 10.1128/JVI.76.18.9143-9151.2002; Bradel-Tretheway BG, 2008, J GEN VIROL, V89, P2923, DOI 10.1099/vir.0.2008/006254-0; Bussey KA, 2011, J VIROL, V85, P7020, DOI 10.1128/JVI.00522-11; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; DESSELBERGER U, 1978, P NATL ACAD SCI USA, V75, P3341, DOI 10.1073/pnas.75.7.3341; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Ito T, 2000, J VIROL, V74, P9300, DOI 10.1128/JVI.74.19.9300-9305.2000; Kobasa D, 1999, J VIROL, V73, P6743, DOI 10.1128/JVI.73.8.6743-6751.1999; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Liu M, 2003, VIROLOGY, V305, P267, DOI 10.1006/viro.2002.1762; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Mena I, 1999, J VIROL, V73, P1186, DOI 10.1128/JVI.73.2.1186-1194.1999; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; MURPHY BR, 1982, INFECT IMMUN, V37, P1119, DOI 10.1128/IAI.37.3.1119-1126.1982; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Ng AKL, 2009, SCI CHINA SER C, V52, P439, DOI 10.1007/s11427-009-0064-x; Parker WB, 2005, VIRUS RES, V107, P165, DOI 10.1016/j.virusres.2004.11.006; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Shinya K, 2007, J GEN VIROL, V88, P547, DOI 10.1099/vir.0.82411-0; SNYDER MH, 1987, J VIROL, V61, P2857, DOI 10.1128/JVI.61.9.2857-2863.1987; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sun YJ, 2007, ANTIMICROB AGENTS CH, V51, P84, DOI 10.1128/AAC.00790-06; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; TREANOR J, 1994, J VIROL, V68, P7684, DOI 10.1128/JVI.68.12.7684-7688.1994; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yamada S., PLOS PATHOG, V6; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034; Zhang SJ, 2010, BIOCHEM BIOPH RES CO, V391, P570, DOI 10.1016/j.bbrc.2009.11.100	42	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34504	34513		10.1074/jbc.M111.262048	http://dx.doi.org/10.1074/jbc.M111.262048			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21816827	Green Published, hybrid			2022-12-27	WOS:000295406300004
J	Huang, Z; Hoffmann, FW; Norton, RL; Hashimoto, AC; Hoffmann, PR				Huang, Zhi; Hoffmann, Fukun W.; Norton, Robert L.; Hashimoto, Ann C.; Hoffmann, Peter R.			Selenoprotein K Is a Novel Target of m-Calpain, and Cleavage Is Regulated by Toll-like Receptor-induced Calpastatin in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; ACTIVATION; MEMBRANE; COMPLEXES; CALCIUM; PROTEIN; SITE	Calpains are proteolytic enzymes that modulate cellular function through cleavage of targets, thereby modifying their actions. An important role is emerging for calpains in regulating inflammation and immune responses, although specific mechanisms by which this occurs have not been clearly defined. In this study, we identify a novel target of calpain, selenoprotein K (SelK), which is an endoplasmic reticulum transmembrane protein important for Ca2+ flux in immune cells. Calpain-mediated cleavage of SelK was detected in myeloid cells (macrophages, neutrophils, and dendritic cells) but not in lymphoid cells (B and T cells). Both m- and mu-calpain were capable of cleaving immunoprecipitated SelK, but m-calpain was the predominant isoform expressed in mouse immune cells. Consistent with these results, specific inhibitors were used to show that only m-calpain cleaved SelK in macrophages. The cleavage site in SelK was identified between Arg(81) and Gly(82) and the resulting truncated SelK was shown to lack selenocysteine, the amino acid that defines selenoproteins. Resting macrophages predominantly expressed cleaved SelK and, when activated through different Toll-like receptors (TLRs), SelK cleavage was inhibited. We found that decreased calpain cleavage was due to TLR-induced up-regulation of the endogenous inhibitor, calpastatin. TLR-induced calpastatin expression not only inhibited SelK cleavage, but cleavage of another calpain target, talin. Moreover, the expression of the calpain isoforms and calpastatin in macrophages were different from T and B cells. Overall, our findings identify SelK as a novel calpain target and reveal dynamic changes in the calpain/calpastatin system during TLR-induced activation of macrophages.	[Huang, Zhi; Hoffmann, Fukun W.; Norton, Robert L.; Hashimoto, Ann C.; Hoffmann, Peter R.] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA; [Huang, Zhi] Jinan Univ, Dept Biotechnol, Coll Life Sci & Technol, Guangzhou 510632, Guangdong, Peoples R China	University of Hawaii System; Jinan University	Hoffmann, PR (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, 651 Ilalo St, Honolulu, HI 96813 USA.	peterh@pbrc.hawaii.edu			National Institutes of Health [R21AT004844, R01AI089999]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported, in whole or in part, by National Institutes of Health Grants R21AT004844 and R01AI089999.	BROWN N, 1993, FEBS LETT, V322, P65, DOI 10.1016/0014-5793(93)81112-D; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Chen CL, 2006, BIOCHEM BIOPH RES CO, V348, P1296, DOI 10.1016/j.bbrc.2006.07.203; Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294; DESHPANDE RV, 1995, J BIOL CHEM, V270, P2497, DOI 10.1074/jbc.270.6.2497; Du SQ, 2010, ARCH BIOCHEM BIOPHYS, V502, P137, DOI 10.1016/j.abb.2010.08.001; duVerle David, 2010, V22, P202; Fettucciari K, 2011, CELL MICROBIOL, V13, P859, DOI 10.1111/j.1462-5822.2011.01584.x; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hendry L, 2004, EUR J BIOCHEM, V271, P4613, DOI 10.1111/j.1432-1033.2004.04424.x; Hood JL, 2004, J BIOL CHEM, V279, P43126, DOI 10.1074/jbc.M408100200; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lee FYI, 2005, J BIOL CHEM, V280, P29929, DOI 10.1074/jbc.M414600200; Letavernier E, 2011, EUR J IMMUNOL, V41, P473, DOI 10.1002/eji.201040437; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Pietsch M, 2010, CURR TOP MED CHEM, V10, P270, DOI 10.2174/156802610790725489; PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662; Reeves MA, 2009, CELL MOL LIFE SCI, V66, P2457, DOI 10.1007/s00018-009-0032-4; Reeves MA, 2010, ANTIOXID REDOX SIGN, V12, P809, DOI 10.1089/ars.2009.2883; SAIDO TC, 1992, J BIOL CHEM, V267, P24585; Samanta K, 2007, BBA-GEN SUBJECTS, V1770, P1297, DOI 10.1016/j.bbagen.2007.06.010; Samanta K, 2010, J BIOCHEM, V147, P765, DOI 10.1093/jb/mvq009; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Svensson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015090; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Ueda Y, 2002, MOL CELL PROTEOMICS, V1, P357, DOI 10.1074/mcp.M200007-MCP200; Verma S, 2011, J IMMUNOL, V186, P2127, DOI 10.4049/jimmunol.1002878; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Zhang GQ, 2011, LAB INVEST, V91, P106, DOI 10.1038/labinvest.2010.135	36	44	49	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34830	34838		10.1074/jbc.M111.265520	http://dx.doi.org/10.1074/jbc.M111.265520			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21849499	hybrid, Green Published			2022-12-27	WOS:000295406300037
J	Lusher, SJ; Raaijmakers, HCA; Vu-Pham, D; Dechering, K; Lam, TW; Brown, AR; Hamilton, NM; Nimz, O; Bosch, R; McGuire, R; Oubrie, A; de Vlieg, J				Lusher, Scott J.; Raaijmakers, Hans C. A.; Vu-Pham, Diep; Dechering, Koen; Lam, Tsang Wai; Brown, Angus R.; Hamilton, Niall M.; Nimz, Olaf; Bosch, Rolien; McGuire, Ross; Oubrie, Arthur; de Vlieg, Jacob			Structural Basis for Agonism and Antagonism for a Set of Chemically Related Progesterone Receptor Modulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAINS; MINERALOCORTICOID RECEPTOR; B ISOFORMS; CHO-CELLS; IN-VITRO; (ANTI)PROGESTAGENS; TRANSACTIVATION; HYPERTENSION; PROGESTINS; ASOPRISNIL	The progesterone receptor is able to bind to a large number and variety of ligands that elicit a broad range of transcriptional responses ranging from full agonism to full antagonism and numerous mixed profiles inbetween. We describe here two new progesterone receptor ligand binding domain x-ray structures bound to compounds from a structurally related but functionally divergent series, which show different binding modes corresponding to their agonistic or antagonistic nature. In addition, we present a third progesterone receptor ligand binding domain dimer bound to an agonist in monomer A and an antagonist in monomer B, which display binding modes in agreement with the earlier observation that agonists and antagonists from this series adopt different binding modes.	[Lusher, Scott J.; Raaijmakers, Hans C. A.; Bosch, Rolien; McGuire, Ross; Oubrie, Arthur; de Vlieg, Jacob] MSD, DMPK, Dept Mol Design & Informat, NL-5340 BH Oss, Netherlands; [Vu-Pham, Diep; Dechering, Koen; Lam, Tsang Wai] MSD, DMPK, Dept Mol Pharmacol, NL-5340 BH Oss, Netherlands; [Brown, Angus R.; Hamilton, Niall M.; Nimz, Olaf] MSD, Dept Chem, Newhouse ML1 5SH, Lancs, England; [de Vlieg, Jacob] Radboud Univ Nijmegen, Computat Drug Discovery Grp, NL-6525 HP Nijmegen, Netherlands	Merck & Company; Merck & Company; Merck & Company; Radboud University Nijmegen	Lusher, SJ (corresponding author), MSD, DMPK, Dept Mol Design & Informat, NL-5340 BH Oss, Netherlands.	scott.lusher@merck.com	McGuire, Ross/P-8855-2015	McGuire, Ross/0000-0003-3404-6456; Oubrie, Arthur/0000-0001-6765-9246; raaijmakers, hans/0000-0002-2567-7363				Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Benagiano G, 2008, EXPERT OPIN PHARMACO, V9, P2473, DOI [10.1517/14656566.9.14.2473, 10.1517/14656566.9.14.2473 ]; Benagiano G, 2008, EXPERT OPIN PHARMACO, V9, P2459, DOI [10.1517/14656566.9.14.2459, 10.1517/14656566.9.14.2459 ]; Benagiano G, 2008, EXPERT OPIN PHARMACO, V9, P2487, DOI [10.1517/14656566.9.14.2487, 10.1517/14656566.9.14.2487 ]; Bledsoe RK, 2004, VITAM HORM, V68, P49; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Brown AR, 2011, BIOORG MED CHEM LETT, V21, P137, DOI 10.1016/j.bmcl.2010.11.054; Chabbert-Buffet N, 2005, HUM REPROD UPDATE, V11, P293, DOI 10.1093/humupd/dmi002; DeManno D, 2003, STEROIDS, V68, P1019, DOI 10.1016/j.steroids.2003.09.008; Dijkema R, 1998, J STEROID BIOCHEM, V64, P147, DOI 10.1016/S0960-0760(97)00160-X; Egea PF, 2000, FEBS LETT, V476, P62, DOI 10.1016/S0014-5793(00)01672-0; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; Huyet J, 2007, MOL PHARMACOL, V72, P563, DOI 10.1124/mol.107.036459; Jones DG, 2005, BIOORG MED CHEM LETT, V15, P3203, DOI 10.1016/j.bmcl.2005.05.001; Kallander LS, 2010, BIOORG MED CHEM LETT, V20, P371, DOI 10.1016/j.bmcl.2009.10.092; KEIGHTLEY DD, 1979, EUR J CANCER, V15, P785, DOI 10.1016/0014-2964(79)90154-3; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; Madauss KP, 2007, MED RES REV, V27, P374, DOI 10.1002/med.20083; Madauss KP, 2004, J MED CHEM, V47, P3381, DOI 10.1021/jm030640n; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Petit-Topin I, 2009, MOL PHARMACOL, V75, P1317, DOI 10.1124/mol.108.054312; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Raaijmakers HCA, 2009, J BIOL CHEM, V284, P19572, DOI 10.1074/jbc.M109.007872; Schoonen WGEJ, 1998, J STEROID BIOCHEM, V64, P157, DOI 10.1016/S0960-0760(97)00161-1; Schoonen WGEJ, 2000, J STEROID BIOCHEM, V74, P109, DOI 10.1016/S0960-0760(00)00094-7; Spitz IM, 2003, STEROIDS, V68, P981, DOI 10.1016/j.steroids.2003.08.007; Spitz IM, 2000, STEROIDS, V65, P807, DOI 10.1016/S0039-128X(00)00194-X; Thompson SK, 2009, BIOORG MED CHEM LETT, V19, P4777, DOI 10.1016/j.bmcl.2009.06.055; Washburn DG, 2009, BIOORG MED CHEM LETT, V19, P4664, DOI 10.1016/j.bmcl.2009.06.081; Weatherman RV, 1999, ANNU REV BIOCHEM, V68, P559, DOI 10.1146/annurev.biochem.68.1.559; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Winneker RC, 2008, STEROIDS, V73, P689, DOI 10.1016/j.steroids.2008.03.005; Zhang ZM, 2005, J BIOL CHEM, V280, P28468, DOI 10.1074/jbc.M504144200	39	25	28	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35079	35086		10.1074/jbc.M111.273029	http://dx.doi.org/10.1074/jbc.M111.273029			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21849509	hybrid, Green Published			2022-12-27	WOS:000295406300061
J	Tomikawa, J; Shimokawa, H; Uesaka, M; Yamamoto, N; Mori, Y; Tsukamura, H; Maeda, K; Imamura, T				Tomikawa, Junko; Shimokawa, Hiroko; Uesaka, Masahiro; Yamamoto, Naoki; Mori, Yuji; Tsukamura, Hiroko; Maeda, Kei-ichiro; Imamura, Takuya			Single-stranded Noncoding RNAs Mediate Local Epigenetic Alterations at Gene Promoters in Rat Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; DNA METHYLATION; GROWTH-FACTOR; INTERMEDIATE-FILAMENTS; HISTONE MODIFICATION; PC12 CELLS; CPG ISLAND; EXPRESSION; DEMETHYLATION; CHROMATIN	Agrowing number of noncoding RNAs (ncRNAs) are thought to be involved in sequence-specific alterations of epigenetic processes, mostly causing gene repression. In this study, promoterassociated ncRNAs (pancRNAs > 200 nucleotides in size) that were endogenously generated from the sense strand at Map2b, antisense strand at Nefl, and both strands at Vim were investigated regarding their epigenetic potential as positive or negative regulators in rat pheochromocytoma (PC12) and fibroblast (normal rat kidney) cell lines. The respective antisense pancRNAs were associated with several active chromatin marks at the Nefl and Vim promoters. Forced expression of fragments expressing the antisense pancRNAs caused sequence-specific DNA demethylation, whereas a decrease of expression induced methylation of the same sequences. In contrast, perturbing the expression of the two sense pancRNAs did not change the DNA methylation status. These results suggest that a fraction of naturally occurring ncRNAs acts in cis as a single-stranded form and that the transcriptional orientation of pancRNA is important for the establishment of sequence-specific epigenetic modifications consistent with open chromatin structure.	[Tomikawa, Junko; Shimokawa, Hiroko; Mori, Yuji; Tsukamura, Hiroko; Imamura, Takuya] Natl Inst Basic Biol, Div Behav Biol, Okazaki, Aichi 4448585, Japan; [Tomikawa, Junko; Shimokawa, Hiroko; Tsukamura, Hiroko; Maeda, Kei-ichiro] Nagoya Univ, Grad Sch Bioagr Sci, Lab Reprod Sci, Nagoya, Aichi 4648601, Japan; [Uesaka, Masahiro; Yamamoto, Naoki; Imamura, Takuya] Kyoto Univ, Lab Biodivers, Global COE Program, Div Biol Sci,Grad Sch Sci,Sakyo Ku, Kyoto 6068502, Japan; [Mori, Yuji] Univ Tokyo, Lab Vet Ethol, Bunkyo Ku, Tokyo 1138657, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Nagoya University; Kyoto University; University of Tokyo	Imamura, T (corresponding author), Natl Inst Basic Biol, Div Behav Biol, Nishigonaka 38, Okazaki, Aichi 4448585, Japan.	imamura@gcoe.biol.sci.kyoto-u.ac.jp	Tsukamura, Hiroko/AAC-5632-2022	IMAMURA, TAKUYA/0000-0002-1825-2084; Uesaka, Masahiro/0000-0002-2927-4860; Tomikawa, Junko/0000-0002-6149-1400	Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [17052028];  [18770008];  [A06]; Grants-in-Aid for Scientific Research [21688021] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid 17052028, 18770008, if double-stranded structures were formed between RNA/DNA 19040029, and 21688021 (to T.I.) and by Global COE program A06 to Kyoto University from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chan Y, 2004, J BIOL CHEM, V279, P35087, DOI 10.1074/jbc.M405063200; CHING GY, 1993, J CELL BIOL, V122, P1323, DOI 10.1083/jcb.122.6.1323; Deng J, 1999, MOL BRAIN RES, V71, P23, DOI 10.1016/S0169-328X(99)00147-3; FRANKE WW, 1979, EXP CELL RES, V123, P25, DOI 10.1016/0014-4827(79)90418-X; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159; Imamura T, 2001, GENOMICS, V76, P117, DOI 10.1006/geno.2001.6607; Imamura T, 2011, HORM BEHAV, V59, P345, DOI 10.1016/j.yhbeh.2010.05.018; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; KIMELMAN D, 1989, CELL, V59, P687, DOI 10.1016/0092-8674(89)90015-9; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; LEE VMY, 1984, J NEUROSCI, V4, P1705; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Macleod D, 1998, MOL CELL BIOL, V18, P4433, DOI 10.1128/MCB.18.8.4433; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; MUNROE SH, 1991, J BIOL CHEM, V266, P22083; Nishino K, 2004, J BIOL CHEM, V279, P22306, DOI 10.1074/jbc.M309513200; OSBORN M, 1982, CELL, V31, P303, DOI 10.1016/0092-8674(82)90122-2; Persengiev SP, 2001, ONCOGENE, V20, P5124, DOI 10.1038/sj.onc.1204663; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; RITTLING SR, 1987, MOL CELL BIOL, V7, P3908, DOI 10.1128/MCB.7.11.3908; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; TENG KK, 1993, J NEUROSCI, V13, P3124; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107	50	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34788	34799		10.1074/jbc.M111.275750	http://dx.doi.org/10.1074/jbc.M111.275750			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844201	Green Published, hybrid			2022-12-27	WOS:000295406300033
J	Bercovich, Z; Snapir, Z; Keren-Paz, A; Kahana, C				Bercovich, Zippi; Snapir, Zohar; Keren-Paz, Alona; Kahana, Chaim			Antizyme Affects Cell Proliferation and Viability Solely through Regulating Cellular Polyamines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE ANTIZYME; PROTEASOMAL DEGRADATION; REQUIRES INTERACTION; IN-VITRO; GROWTH; EXPRESSION; PROTEIN; DNA; ACCUMULATION; MUTAGENESIS	Antizymes are key regulators of cellular polyamine metabolism that negatively regulate cell proliferation and are therefore regarded as tumor suppressors. Although the regulation of antizyme (Az) synthesis by polyamines and the ability of Az to regulate cellular polyamine levels suggest the centrality of polyamine metabolism to its antiproliferative function, recent studies have suggested that antizymes might also regulate cell proliferation by targeting to degradation proteins that do not belong to the cellular polyamine metabolic pathway. Using a co-degradation assay, we show here that, although they efficiently stimulated the degradation of ornithine decarboxylase (ODC), Az1 and Az2 did not affect or had a negligible effect on the degradation of cyclin D1, Aurora-A, and a p73 variant lacking the N-terminal transactivation domain whose degradation was reported recently to be stimulated by Az1. Furthermore, we demonstrate that, although Az1 and Az2 could not be constitutively expressed in transfected cells, they could be stably expressed in cells that express trypanosome ODC, a form of ODC that does not bind Az and therefore maintains a constant level of cellular polyamines. Taken together, our results clearly demonstrate that Az1 and Az2 affect cell proliferation and viability solely by modulating cellular polyamine metabolism.	[Bercovich, Zippi; Snapir, Zohar; Keren-Paz, Alona; Kahana, Chaim] Weizmann Inst Sci, Dept Mol Genet, IL-76199 Rehovot, Israel	Weizmann Institute of Science	Kahana, C (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76199 Rehovot, Israel.	chaim.kahana@weizmann.ac.il			Israel Academy of Science and Humanities	Israel Academy of Science and Humanities	This work was supported by grants from the Israel Academy of Science and Humanities.	Chen H, 2002, J BIOL CHEM, V277, P45957, DOI 10.1074/jbc.M206799200; Dulloo I, 2010, P NATL ACAD SCI USA, V107, P4902, DOI 10.1073/pnas.0906782107; Fong LYY, 2003, CANCER RES, V63, P3945; GHODA L, 1990, J BIOL CHEM, V265, P11823; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; Gruendler C, 2001, J BIOL CHEM, V276, P46533, DOI 10.1074/jbc.M105500200; HE Y, 1994, BIOCHEM BIOPH RES CO, V203, P608, DOI 10.1006/bbrc.1994.2226; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Ivanov IP, 1998, GENOMICS, V52, P119, DOI 10.1006/geno.1998.5434; Ivanov IP, 2000, NUCLEIC ACIDS RES, V28, P3185, DOI 10.1093/nar/28.17.3185; Ivanov IP, 2007, NUCLEIC ACIDS RES, V35, P1842, DOI 10.1093/nar/gkm035; Iwata S, 1999, ONCOGENE, V18, P165, DOI 10.1038/sj.onc.1202275; Kahana C, 2009, ESSAYS BIOCHEM, V46, P47, DOI [10.1042/BSE0460004, 10.1042/bse0460004]; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Koike C, 1999, CANCER RES, V59, P6109; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Lim SK, 2007, ONCOGENE, V26, P6593, DOI 10.1038/sj.onc.1210482; Lin Y, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-15; MAMROUDKIDRON E, 1994, EUR J BIOCHEM, V226, P547, DOI 10.1111/j.1432-1033.1994.tb20079.x; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Meyskens FL, 1999, CLIN CANCER RES, V5, P945; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; Murai N, 2009, J CELL BIOCHEM, V108, P1012, DOI 10.1002/jcb.22334; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murakami Y, 2000, BIOCHEM BIOPH RES CO, V267, P1, DOI 10.1006/bbrc.1999.1706; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Snapir Z, 2009, BIOCHEM J, V419, P99, DOI 10.1042/BJ20081874; SUZUKI T, 1994, P NATL ACAD SCI USA, V91, P8930, DOI 10.1073/pnas.91.19.8930; TOBIAS KE, 1995, CELL GROWTH DIFFER, V6, P1279; Tosaka Y, 2000, GENES CELLS, V5, P265, DOI 10.1046/j.1365-2443.2000.00324.x; Tsuji T, 2001, ONCOGENE, V20, P24, DOI 10.1038/sj.onc.1204051; Wang TW, 2003, FRONT BIOSCI, V8, pD1109, DOI 10.2741/1057	38	18	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33778	33783		10.1074/jbc.M111.270637	http://dx.doi.org/10.1074/jbc.M111.270637			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832059	Green Published, hybrid			2022-12-27	WOS:000295159200008
J	Borah, S; Shivarathri, R; Kaur, R				Borah, Sapan; Shivarathri, Raju; Kaur, Rupinder			The Rho1 GTPase-activating Protein CgBem2 Is Required for Survival of Azole Stress in Candida glabrata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE PATHWAY; ENDOPLASMIC-RETICULUM STRESS; CELL-CYCLE REGULATOR; SACCHAROMYCES-CEREVISIAE; BIOSYNTHESIS INHIBITORS; MULTIDRUG-RESISTANCE; TRANSPORTER GENE; DRUG-RESISTANCE; BINDING PROTEIN; DISK DIFFUSION	Invasive fungal infections are common clinical complications of neonates, critically ill, and immunocompromised patients worldwide. Candida species are the leading cause of disseminated fungal infections, with Candida albicans being the most prevalent species. Candida glabrata, the second/third most common cause of candidemia, shows reduced susceptibility to a widely used antifungal drug fluconazole. Here, we present findings from a screen of 9134 C. glabrata Tn7 insertion mutants for altered survival profiles in the presence of fluconazole. We have identified two components of RNA polymerase II mediator complex, three players of Rho GTPase-mediated signaling cascade, and two proteins implicated in actin cytoskeleton biogenesis and ergosterol biosynthesis that are required to sustain viability during fluconazole stress. We show that exposure to fluconazole leads to activation of the protein kinase C (PKC)-mediated cell wall integrity pathway in C. glabrata. Our data demonstrate that disruption of a RhoGAP (GTPase activating protein) domain-containing protein, CgBem2, results in bud-emergence defects, azole susceptibility, and constitutive activation of CgRho1-regulated CgPkc1 signaling cascade and cell wall-related phenotypes. The viability loss of Cgbem2 Delta mutant upon fluconazole treatment could be partially rescued by the PKC inhibitor staurosporine. Additionally, we present evidence that CgBEM2 is required for the transcriptional activation of genes encoding multidrug efflux pumps in response to fluconazole exposure. Last, we report that Hsp90 inhibitor geldanamycin renders fluconazole a fungicidal drug in C. glabrata.	[Borah, Sapan; Shivarathri, Raju; Kaur, Rupinder] Ctr DNA Fingerprinting & Diagnost, Hyderabad 500001, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Kaur, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Bldg 7,Gruhakalpa,5-4-399-B, Hyderabad 500001, Andhra Pradesh, India.	rkaur@cdfd.org.in	Shivrathri, Raju/AHC-0076-2022; Borah, Sapan/AAT-1105-2021	Borah, Sapan/0000-0002-9383-9854	Department of Biotechnology, Government of India [BT/BI/12/040/2005]; Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India	This work was supported in part by Innovative Young Biotechnologist Award BT/BI/12/040/2005 from the Department of Biotechnology, Government of India and by core funds of Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India. \ Recipient of a Senior Research Fellowship from Department of Biotechnology, Government of India.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Baetz K, 2001, MOL CELL BIOL, V21, P6515, DOI 10.1128/MCB.21.19.6515-6528.2001; Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Bairwa G, 2011, MOL MICROBIOL, V79, P900, DOI 10.1111/j.1365-2958.2010.07496.x; Berila N, 2009, INT J ANTIMICROB AG, V33, P574, DOI 10.1016/j.ijantimicag.2008.11.011; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Castano I, 2003, GENOME RES, V13, P905, DOI 10.1101/gr.848203; Cid VJ, 1998, MICROBIOL-SGM, V144, P25, DOI 10.1099/00221287-144-1-25; Cota JM, 2008, ANTIMICROB AGENTS CH, V52, P1144, DOI 10.1128/AAC.01542-07; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Emter R, 2002, FEBS LETT, V521, P57, DOI 10.1016/S0014-5793(02)02818-1; GEBER A, 1995, ANTIMICROB AGENTS CH, V39, P2708, DOI 10.1128/AAC.39.12.2708; GRANT SM, 1990, DRUGS, V39, P877, DOI 10.2165/00003495-199039060-00006; Gray JV, 1997, EMBO J, V16, P4924, DOI 10.1093/emboj/16.16.4924; Hazen KC, 2003, J CLIN MICROBIOL, V41, P5623, DOI 10.1128/JCM.41.12.5623-5632.2003; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Izumikawa K, 2003, YEAST, V20, P249, DOI 10.1002/yea.962; Jain P, 2003, ANTIMICROB AGENTS CH, V47, P3195, DOI 10.1128/AAC.47.10.3195-3201.2003; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; Kaur R, 2004, ANTIMICROB AGENTS CH, V48, P1600, DOI 10.1128/AAC.48.5.1600-1613.2004; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; Marquitz AR, 2002, EMBO J, V21, P4012, DOI 10.1093/emboj/cdf416; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Messer SA, 2006, J CLIN MICROBIOL, V44, P1782, DOI 10.1128/JCM.44.5.1782-1787.2006; Miyazaki T, 2010, FEMS YEAST RES, V10, P343, DOI 10.1111/j.1567-1364.2010.00611.x; Myers LC, 1999, P NATL ACAD SCI USA, V96, P67, DOI 10.1073/pnas.96.1.67; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x; Onyewu C, 2003, ANTIMICROB AGENTS CH, V47, P956, DOI 10.1128/AAC.47.3.956-964.2003; PAINTING K, 1990, WORLD J MICROB BIOT, V6, P346, DOI 10.1007/BF01201311; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; PETERSON J, 1994, J CELL BIOL, V127, P1395, DOI 10.1083/jcb.127.5.1395; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Sabatinos Sarah A., 2009, V521, P449, DOI [10.1007/978-1-60327-815-7_25, 10.1007/978-1-60327-817-5_25]; SACHS AB, 1992, CELL, V70, P961, DOI 10.1016/0092-8674(92)90246-9; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Torelli R, 2008, MOL MICROBIOL, V68, P186, DOI 10.1111/j.1365-2958.2008.06143.x; Tsai HF, 2006, ANTIMICROB AGENTS CH, V50, P1384, DOI 10.1128/AAC.50.4.1384-1392.2006; van den Hazel HB, 1999, J BIOL CHEM, V274, P1934, DOI 10.1074/jbc.274.4.1934; Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x; Wada S, 2005, J BIOL CHEM, V280, P94, DOI 10.1074/jbc.M408252200; WANG TT, 1995, MOL BIOL CELL, V6, P1011, DOI 10.1091/mbc.6.8.1011; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71	54	35	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34311	34324		10.1074/jbc.M111.264671	http://dx.doi.org/10.1074/jbc.M111.264671			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832071	Green Published, hybrid			2022-12-27	WOS:000295159200060
J	Su, LH; Pan, YJ; Huang, YC; Cho, CC; Chen, CW; Huang, SW; Chuang, SF; Sun, CH				Su, Li-Hsin; Pan, Yu-Jiao; Huang, Yu-Chang; Cho, Chao-Cheng; Chen, Chia-Wei; Huang, Shao-Wei; Chuang, Sheng-Fung; Sun, Chin-Hung			A Novel E2F-like Protein Involved in Transcriptional Activation of Cyst Wall Protein Genes in Giardia lamblia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA-BINDING PROTEIN; MESSENGER-RNA DECAY; CELL-CYCLE; E2F FAMILY; PRIMITIVE EUKARYOTE; POLYMERASE-II; EXPRESSION; DNA; ENCYSTATION; PROMOTER	Giardia lamblia differentiates into resistant walled cysts for survival outside the host and transmission. During encystation, synthesis of cyst wall proteins is coordinately induced. The E2F family of transcription factors in higher eukaryotes is involved in cell cycle progression and cell differentiation. We asked whether Giardia has E2F-like genes and whether they influence gene expression during Giardia encystation. Blast searches of the Giardia genome database identified one gene (e2f1) encoding a putative E2F protein with two putative DNA-binding domains. We found that the e2f1 gene expression levels increased significantly during encystation. Epitope-tagged E2F1 was found to localize to nuclei. Recombinant E2F1 specifically bound to the thymidine kinase and cwp1-3 gene promoters. E2F1 contains several key residues for DNA binding, and mutation analysis revealed that its binding sequence is similar to those of the known E2F family proteins. The E2F1-binding sequences were positive cis-acting elements of the thymidine kinase and cwp1 promoters. We also found that E2F1 transactivated the thymidine kinase and cwp1 promoters through its binding sequences in vivo. Interestingly, E2F1 overexpression resulted in a significant increase of the levels of CWP1 protein, cwp1-3 gene mRNA, and cyst formation. We also found E2F1 can interact with Myb2, a transcription factor that coordinate up-regulates the cwp1-3 genes during encystation. Our results suggest that E2F family has been conserved during evolution and that E2F1 is an important transcription factor in regulation of the Giardia cwp genes, which are key to Giardia differentiation into cysts.	[Su, Li-Hsin; Pan, Yu-Jiao; Huang, Yu-Chang; Cho, Chao-Cheng; Chen, Chia-Wei; Huang, Shao-Wei; Chuang, Sheng-Fung; Sun, Chin-Hung] Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan	National Taiwan University	Sun, CH (corresponding author), Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan.	chinhsun@ntu.edu.tw	Shin, Jerry/AAO-2515-2021	SUN, CHIN-HUNG/0000-0002-8604-8085	National Science Council (NSC) [98-2320-B-002-018-MY2, 99-2320-B-002-017-MY3, 100-2325-B-002-039]; National Health Research Institutes in Taiwan [NHRI-EX98-9510NC, NHRI-EX99-9510NC]; Department of Medical Research in National Taiwan University Hospital; National Taiwan University	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan); Department of Medical Research in National Taiwan University Hospital; National Taiwan University(National Taiwan University)	This work was supported by the National Science Council Grants NSC 98-2320-B-002-018-MY2, NSC 99-2320-B-002-017-MY3, and NSC 100-2325-B-002-039, National Health Research Institutes Grants NHRI-EX98-9510NC and NHRI-EX99-9510NC in Taiwan, and in part by the Department of Medical Research in National Taiwan University Hospital and the Aim for the Top University Program of National Taiwan University.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; BAGCHI S, 1991, CELL, V65, P1063, DOI 10.1016/0092-8674(91)90558-G; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BANDARA LR, 1993, EMBO J, V12, P4317, DOI 10.1002/j.1460-2075.1993.tb06116.x; BANDARA LR, 1991, NATURE, V351, P494, DOI 10.1038/351494a0; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Black AR, 1999, GENE, V237, P281, DOI 10.1016/S0378-1119(99)00305-4; BUCK V, 1995, ONCOGENE, V11, P31; Cao LH, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-55; Celiksoz A, 2005, PEDIATR INT, V47, P567, DOI 10.1111/j.1442-200x.2005.02110.x; Chaboute ME, 2000, PLANT CELL, V12, P1987, DOI 10.1105/tpc.12.10.1987; Chen YH, 2008, INT J PARASITOL, V38, P1305, DOI 10.1016/j.ijpara.2008.02.006; Chen YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003609; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; COBRINIK D, 1993, GENE DEV, V7, P2392, DOI 10.1101/gad.7.12a.2392; Davis-Hayman SR, 2003, INT J PARASITOL, V33, P1005, DOI 10.1016/S0020-7519(03)00177-2; DeGregori J, 2006, CURR MOL MED, V6, P739; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; DOU QP, 1992, P NATL ACAD SCI USA, V89, P3256, DOI 10.1073/pnas.89.8.3256; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Flygare J, 1996, BBA-MOL CELL RES, V1312, P231, DOI 10.1016/0167-4889(96)00040-7; Frost V, 2008, CRIT REV BIOCHEM MOL, V43, P371, DOI [10.1080/10409230802486208, 10.1080/10409230802486208 ]; Gillin FD, 1996, ANNU REV MICROBIOL, V50, P679, DOI 10.1146/annurev.micro.50.1.679; HASHIMOTO T, 1995, MOL BIOL EVOL, V12, P782; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; HOLBERTON DV, 1995, NUCLEIC ACIDS RES, V23, P2945, DOI 10.1093/nar/23.15.2945; Huang YC, 2008, J BIOL CHEM, V283, P31021, DOI 10.1074/jbc.M805023200; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; Kosugi S, 2002, J BIOL CHEM, V277, P16553, DOI 10.1074/jbc.M200913200; Kundu M, 1997, J BIOL CHEM, V272, P29468, DOI 10.1074/jbc.272.47.29468; Lavia P, 1999, BIOESSAYS, V21, P221; Lee CW, 1998, ONCOGENE, V16, P2695, DOI 10.1038/sj.onc.1201818; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; Logan N, 2004, ONCOGENE, V23, P5138, DOI 10.1038/sj.onc.1207649; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; MacWilliams H, 2006, DEVELOPMENT, V133, P1287, DOI 10.1242/dev.02287; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; McClellan KA, 2007, CELL CYCLE, V6, P2917, DOI 10.4161/cc.6.23.4997; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; Nip J, 2001, ONCOGENE, V20, P910, DOI 10.1038/sj.onc.1204171; Page BD, 2001, MOL CELL, V7, P451, DOI 10.1016/S1097-2765(01)00193-9; Pan YJ, 2009, J BIOL CHEM, V284, P17975, DOI 10.1074/jbc.M109.012047; Ramirez-Parra E, 1999, NUCLEIC ACIDS RES, V27, P3527, DOI 10.1093/nar/27.17.3527; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Schaefer JB, 2004, CELL, V117, P849, DOI 10.1016/j.cell.2004.06.008; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Seshadri V, 2003, J BIOL CHEM, V278, P27804, DOI 10.1074/jbc.M303316200; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; Stevens C, 2003, CELL CYCLE, V2, P435, DOI 10.4161/cc.2.5.462; Stevens R, 2002, J BIOL CHEM, V277, P32978, DOI 10.1074/jbc.M205125200; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2006, MOL BIOCHEM PARASIT, V146, P45, DOI 10.1016/j.molbiopara.2005.10.017; Sun CH, 1999, J BIOL CHEM, V274, P19699, DOI 10.1074/jbc.274.28.19699; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Suzuki M, 1998, ONCOGENE, V17, P853, DOI 10.1038/sj.onc.1202163; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; Vlieghe K, 2003, J CELL SCI, V116, P4249, DOI 10.1242/jcs.00715; Wang CH, 2007, J BIOL CHEM, V282, P8905, DOI 10.1074/jbc.M611170200; Wang HC, 1997, ONCOGENE, V15, P143, DOI 10.1038/sj.onc.1201252; Wang YT, 2010, J BIOL CHEM, V285, P32213, DOI 10.1074/jbc.M110.156620; WOLFE MS, 1992, CLIN MICROBIOL REV, V5, P93, DOI 10.1128/CMR.5.1.93-100.1992; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432; Zalmas LP, 2008, EMBO REP, V9, P252, DOI 10.1038/sj.embor.7401158; ZHANG YH, 1995, ONCOGENE, V10, P2085; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	86	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34101	34120		10.1074/jbc.M111.280206	http://dx.doi.org/10.1074/jbc.M111.280206			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21835923	hybrid, Green Published			2022-12-27	WOS:000295159200042
J	Azarov, I; Liu, C; Reynolds, H; Tsekouras, Z; Lee, JS; Gladwin, MT; Kim-Shapiro, DB				Azarov, Ivan; Liu, Chen; Reynolds, Hannah; Tsekouras, Zaharo; Lee, Janet S.; Gladwin, Mark T.; Kim-Shapiro, Daniel B.			Mechanisms of Slower Nitric Oxide Uptake by Red Blood Cells and Other Hemoglobin-containing Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKED HEMOGLOBIN; PULMONARY-HYPERTENSION; OXYGEN-UPTAKE; ERYTHROCYTE CONSUMPTION; PLASMA HEMOGLOBIN; RELAXING FACTOR; STORAGE LESION; DISEASE; DIFFUSION; NO	Nitric oxide (NO) acts as a smooth muscle relaxation factor and plays a crucial role in maintaining vascular homeostasis. NO is scavenged rapidly by hemoglobin (Hb). However, under normal physiological conditions, the encapsulation of Hb inside red blood cells (RBCs) significantly retards NO scavenging, permitting NO to reach the smooth muscle. The rate-limiting factors (diffusion of NO to the RBC surface, through the RBC membrane or inside of the RBC) responsible for this retardation have been the subject of much debate. Knowing the relative contribution of each of these factors is important for several reasons including optimization of the development of blood substitutes where Hb is contained within phospholipid vesicles. We have thus performed experiments of NO uptake by erythrocytes and microparticles derived from erythrocytes and conducted simulations of these data as well as that of others. We have included extracellular diffusion (that is, diffusion of the NO to the membrane) and membrane permeability, in addition to intracellular diffusion of NO, in our computational models. We find that all these mechanisms may modulate NO uptake by membrane-encapsulated Hb and that extracellular diffusion is the main rate-limiting factor for phospholipid vesicles and erythrocytes. In the case of red cell microparticles, we find a major role for membrane permeability. These results are consistent with prior studies indicating that extracellular diffusion of several gas ligands is also rate-limiting for erythrocytes, with some contribution of a low membrane permeability.	[Azarov, Ivan; Liu, Chen; Reynolds, Hannah; Tsekouras, Zaharo; Kim-Shapiro, Daniel B.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [Azarov, Ivan] Wake Forest Univ, Dept Comp Sci, Winston Salem, NC 27109 USA; [Azarov, Ivan; Lee, Janet S.; Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15213 USA; [Lee, Janet S.; Gladwin, Mark T.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Sch Med, Pittsburgh, PA 15213 USA	Wake Forest University; Wake Forest University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim-Shapiro, DB (corresponding author), Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA.	shapiro@wfu.edu	Kim-Shapiro, Daniel/HGA-2682-2022	Lee, Janet/0000-0002-6812-6043; Azarov, Ivan/0000-0002-9886-3298	National Institutes of Health [HL058091, HL098032]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058091, R37HL058091, R01HL098032, R29HL058091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL058091 and HL098032.	Abassi Z, 1997, J LAB CLIN MED, V129, P603, DOI 10.1016/S0022-2143(97)90194-3; Alayash AI, 1999, NAT BIOTECHNOL, V17, P545, DOI 10.1038/9849; Azarov I, 2005, J BIOL CHEM, V280, P39024, DOI 10.1074/jbc.M509045200; Azarov I, 2008, NITRIC OXIDE-BIOL CH, V18, P296, DOI 10.1016/j.niox.2008.02.006; Butler AR, 1998, BBA-GEN SUBJECTS, V1425, P168, DOI 10.1016/S0304-4165(98)00065-8; Chang TMS, 2006, ARTIF CELL BLOOD SUB, V34, P551, DOI 10.1080/10731190600973808; COIN JT, 1979, J BIOL CHEM, V254, P1178; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698; Dou Y, 2002, BIOPHYS CHEM, V98, P127, DOI 10.1016/S0301-4622(02)00090-X; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; El-Farra NH, 2003, ANN BIOMED ENG, V31, P294, DOI 10.1114/1.1553454; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gladwin MT, 2009, CURR OPIN HEMATOL, V16, P515, DOI 10.1097/MOH.0b013e32833157f4; Gladwin MT, 2005, BLOOD, V106, P2925, DOI 10.1182/blood-2005-08-3285; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gulati A, 1999, J LAB CLIN MED, V133, P112, DOI 10.1016/S0022-2143(99)90003-3; Han TH, 2005, BBA-GEN SUBJECTS, V1723, P135, DOI 10.1016/j.bbagen.2005.01.013; Han TH, 2003, P NATL ACAD SCI USA, V100, P12504, DOI 10.1073/pnas.2133409100; HESS JR, 1993, J APPL PHYSIOL, V74, P1769, DOI 10.1152/jappl.1993.74.4.1769; Huang KT, 2007, NITRIC OXIDE-BIOL CH, V16, P209, DOI 10.1016/j.niox.2006.11.002; Huang KT, 2001, P NATL ACAD SCI USA, V98, P11771, DOI 10.1073/pnas.201276698; Huang Z, 2001, BBA-GEN SUBJECTS, V1568, P252, DOI 10.1016/S0304-4165(01)00227-6; HUXLEY VH, 1981, J PHYSIOL-LONDON, V316, P75, DOI 10.1113/jphysiol.1981.sp013773; IGNARRO LJ, 1987, CIRC RES, V61, P866, DOI 10.1161/01.RES.61.6.866; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; Jeffers A, 2006, FREE RADICAL BIO MED, V41, P1557, DOI 10.1016/j.freeradbiomed.2006.08.017; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; KATSUKI S, 1977, J CYCLIC NUCL PROT, V3, P23; Kim HW, 2004, ARTIF ORGANS, V28, P813, DOI 10.1111/j.1525-1594.2004.07345.x; Kim-Shapiro DB, 2004, FREE RADICAL BIO MED, V36, P402, DOI 10.1016/j.freeradbiomed.2003.10.030; Kriebardis AG, 2008, TRANSFUSION, V48, P1943, DOI 10.1111/j.1537-2995.2008.01794.x; LANCASTER JR, 1994, P NATL ACAD SCI USA, V91, P8137, DOI 10.1073/pnas.91.17.8137; LEE R, 1995, J APPL PHYSIOL, V79, P236, DOI 10.1152/jappl.1995.79.1.236; Liao JC, 1999, P NATL ACAD SCI USA, V96, P8757, DOI 10.1073/pnas.96.15.8757; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; Liu XP, 1998, P NATL ACAD SCI USA, V95, P2175, DOI 10.1073/pnas.95.5.2175; Liu XP, 2002, J BIOL CHEM, V277, P26194, DOI 10.1074/jbc.M201939200; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; MURRAY JA, 1995, GASTROENTEROLOGY, V109, P1241, DOI 10.1016/0016-5085(95)90584-7; Nolan VG, 2005, BLOOD, V106, P3264, DOI 10.1182/blood-2005-04-1594; Olson JS, 2004, FREE RADICAL BIO MED, V36, P685, DOI 10.1016/j.freeradbiomed.2003.11.030; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Patel RP, 2000, FREE RADICAL BIO MED, V28, P1518, DOI 10.1016/S0891-5849(00)00259-8; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Reiter CD, 2003, CURR OPIN HEMATOL, V10, P99, DOI 10.1097/00062752-200303000-00001; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Rudolph AS, 1997, J APPL PHYSIOL, V82, P1826, DOI 10.1152/jappl.1997.82.6.1826; Sakai H, 2008, J BIOL CHEM, V283, P1508, DOI 10.1074/jbc.M707660200; Sampei K, 2005, AM J PHYSIOL-HEART C, V289, pH1191, DOI 10.1152/ajpheart.00251.2005; SHARMA AC, 1995, AM J PHYSIOL-HEART C, V269, pH1379, DOI 10.1152/ajpheart.1995.269.4.H1379; Sloan EP, 1999, JAMA-J AM MED ASSOC, V282, P1857, DOI 10.1001/jama.282.19.1857; Sou K, 2005, J PHARMACOL EXP THER, V312, P702, DOI 10.1124/jpet.104.074534; THOMPSON A, 1994, J APPL PHYSIOL, V77, P2348, DOI 10.1152/jappl.1994.77.5.2348; Ulatowski JA, 1996, CRIT CARE MED, V24, P558, DOI 10.1097/00003246-199604000-00003; VANDEGRIFF KD, 1984, BIOPHYS J, V45, P825, DOI 10.1016/S0006-3495(84)84226-5; VANDEGRIFF KD, 1984, J BIOL CHEM, V259, P2609; Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH1705, DOI 10.1152/ajpheart.1998.274.5.H1705; Vaughn MW, 2000, J BIOL CHEM, V275, P2342, DOI 10.1074/jbc.275.4.2342; Vaughn MW, 2001, NITRIC OXIDE-BIOL CH, V5, P18, DOI 10.1006/niox.2000.0328; VOGEL WM, 1986, AM J PHYSIOL, V251, pH413, DOI 10.1152/ajpheart.1986.251.2.H413; Xiong ZY, 2011, TRANSFUSION, V51, P610, DOI 10.1111/j.1537-2995.2010.02861.x	63	45	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33567	33579		10.1074/jbc.M111.228650	http://dx.doi.org/10.1074/jbc.M111.228650			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808057	Green Published, hybrid			2022-12-27	WOS:000294968800073
J	Gangopahyay, A; Oran, M; Bauer, EM; Wertz, JW; Comhair, SA; Erzurum, SC; Bauer, PM				Gangopahyay, Archana; Oran, Max; Bauer, Eileen M.; Wertz, Jeffrey W.; Comhair, Suzy A.; Erzurum, Serpil C.; Bauer, Philip M.			Bone Morphogenetic Protein Receptor II Is a Novel Mediator of Endothelial Nitric-oxide Synthase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY PULMONARY-HYPERTENSION; GERMLINE MUTATIONS; BMPR2; GENE; PHOSPHORYLATION; CAVEOLIN-1; SURVIVAL; EXPRESSION; HSP90; AXIS	Activation of bone morphogenetic protein (BMP) receptor II (BMPRII) promotes pulmonary artery endothelial cell (PAEC) survival, proliferation, and migration. Mutations to BMPRII are associated with the development of pulmonary arterial hypertension (PAH). Endothelial dysfunction, including decreased endothelial nitric-oxide synthase (eNOS) activity and loss of bioactive nitric oxide (NO), plays a prominent role in the development of PAH. We hypothesized that stimulation of BMPRII promotes normal PAEC function by activating eNOS. We report that BMPRII ligands, BMP2 and BMP4, (i) stimulate eNOS phosphorylation at a critical regulatory site, (ii) increase eNOS activity, and (iii) result in canonical changes in eNOS protein-protein interactions. The stimulation of eNOS activity by BMPRII ligands was largely dependent on protein kinase A (PKA) activation, as demonstrated using the PKA inhibitors H89 and myristoylated PKI(6-22) amide. PAEC migration stimulated by BMP2 and BMP4 was inhibited by the NOS inhibitor L-nitroarginine methyl ester, providing functional evidence of eNOS activation. Furthermore, BMP2 and BMP4 failed to stimulate eNOS phosphorylation when BMPRII was knocked down by siRNA. Most important to the pathophysiology of the disease, BMP2 and BMP4 failed to stimulate eNOS phosphorylation in PAECs isolated from patients with mutations in the BMPR2 gene. These data demonstrate a new action of BMPs/BMPRII in the pulmonary endothelium and provide novel mechanistic insight into the pathogenesis of PAH.	[Gangopahyay, Archana; Oran, Max; Bauer, Eileen M.; Wertz, Jeffrey W.; Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15261 USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA 15261 USA; [Comhair, Suzy A.; Erzurum, Serpil C.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Comhair, Suzy A.; Erzurum, Serpil C.] Cleveland Clin, Resp Inst, Cleveland, OH 44195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Bauer, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, 200 Lothrop St,Starzl Biomed Sci Tower W1147, Pittsburgh, PA 15261 USA.	bauerpm@upmc.edu			National Institutes of Health [HL085134, HL60917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL060917, R01HL060917, P01HL103453, R01HL085134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085134 (to P. M. B.) and HL60917 (to S. C. E.).	Aldred MA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9398; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Cogan JD, 2005, GENET MED, V7, P169, DOI 10.1097/01.GIM.0000156525.09595.E9; Cogan JD, 2006, AM J RESP CRIT CARE, V174, P590, DOI 10.1164/rccm.200602-165OC; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; HIRSCH EZ, 1983, ATHEROSCLEROSIS, V46, P287, DOI 10.1016/0021-9150(83)90179-X; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lee YS, 1997, J CELL PHYSIOL, V170, P153, DOI 10.1002/(SICI)1097-4652(199702)170:2<153::AID-JCP7>3.0.CO;2-N; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; Nohe A, 2005, J CELL SCI, V118, P643, DOI 10.1242/jcs.01402; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Ramos M, 2006, VASC PHARMACOL, V44, P50, DOI 10.1016/j.vph.2005.09.007; SANDOVAL J, 1994, CIRCULATION, V89, P1733, DOI 10.1161/01.CIR.89.4.1733; Santos A, 2010, BIOCHEM BIOPH RES CO, V391, P364, DOI 10.1016/j.bbrc.2009.11.064; Schleicher M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000343; Takahashi S, 2003, J BIOL CHEM, V278, P30821, DOI 10.1074/jbc.M304471200; Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Wertz JW, 2008, BIOCHEM BIOPH RES CO, V375, P557, DOI 10.1016/j.bbrc.2008.08.066; Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68	31	65	69	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33134	33140		10.1074/jbc.M111.274100	http://dx.doi.org/10.1074/jbc.M111.274100			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808054	Green Published, hybrid			2022-12-27	WOS:000294968800032
J	Hashimoto, H; Takeuchi, T; Komatsu, K; Miyazaki, K; Sato, M; Higashi, S				Hashimoto, Hiroshi; Takeuchi, Tomoka; Komatsu, Kyoko; Miyazaki, Kaoru; Sato, Mamoru; Higashi, Shouichi			Structural Basis for Matrix Metalloproteinase-2 (MMP-2)-selective Inhibitory Action of beta-Amyloid Precursor Protein-derived Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1.8-ANGSTROM CRYSTAL-STRUCTURE; AMINO-ACID-RESIDUES; ALZHEIMERS-DISEASE; CATALYTIC DOMAIN; TISSUE INHIBITOR; EXTRACELLULAR-MATRIX; COMPLEX; BINDING; CANCER; IDENTIFICATION	Unlike other synthetic or physiological inhibitors for matrix metalloproteinases (MMPs), the beta-amyloid precursor protein-derived inhibitory peptide (APP-IP) having an ISYGNDALMP sequence has a high selectivity toward MMP-2. Our previous study identified amino acid residues of MMP-2 essential for its selective inhibition by APP-IP and demonstrated that the N to C direction of the decapeptide inhibitor relative to the substrate-binding cleft of MMP-2 is opposite that of substrate. However, detailed interactions between the two molecules remained to be clarified. Here, we determined the crystal structure of the catalytic domain of MMP-2 in complex with APP-IP. We found that APP-IP in the complex is indeed embedded into the substrate-binding cleft of the catalytic domain in the N to C direction opposite that of substrate. With the crystal structure, it was first clarified that the aromatic side chain of Tyr(3) of the inhibitor is accommodated into the S1' pocket of the protease, and the carboxylate group of Asp(6) of APP-IP coordinates bidentately to the catalytic zinc of the enzyme. The Ala(7) to Pro(10) and Tyr(3) to Ile(1) strands of the inhibitor extend into the nonprime and the prime sides of the cleft, respectively. Therefore, the decapeptide inhibitor has long range contact with the substrate-binding cleft of the protease. This mode of interaction is probably essential for the high MMP-2 selectivity of the inhibitor because MMPs share a common architecture in the vicinity of the catalytic center, but whole structures of their substrate-binding clefts have sufficient variety for the inhibitor to distinguish MMP-2 from other MMPs.	[Takeuchi, Tomoka; Komatsu, Kyoko; Miyazaki, Kaoru; Higashi, Shouichi] Yokohama City Univ, Grad Sch Nanobiosci, Dept Genome Syst Sci, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; [Hashimoto, Hiroshi; Sato, Mamoru] Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Yokohama City University; Yokohama City University	Higashi, S (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Dept Genome Syst Sci, Totsuka Ku, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan.	shigashi@yokohama-cu.ac.jp		Hashimoto, Hiroshi/0000-0003-1503-6789	Yokohama City University, Japan [T2201]; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [17014077, 21570118]; MEXT	Yokohama City University, Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by 2010 Grant T2201 for Strategic Research Promotion of Yokohama City University, Japan (to S. H.) and Grants-in-aid for Scientific Research on Priority Areas 17014077 (to K. M.) and Research (C) 21570118 (to S. H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) and the Targeted Proteins Research Program (TPRP) (to H. H. and M. S.) from MEXT.	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613; Betz M, 1997, EUR J BIOCHEM, V247, P356, DOI 10.1111/j.1432-1033.1997.00356.x; BODE W, 1994, EMBO J, V13, P1263, DOI 10.1002/j.1460-2075.1994.tb06378.x; Brandstetter H, 2001, J BIOL CHEM, V276, P17405, DOI 10.1074/jbc.M007475200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caceres J, 1997, J CELL BIOCHEM, V65, P145, DOI 10.1002/(SICI)1097-4644(199705)65:2<145::AID-JCB2>3.0.CO;2-U; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Dhanaraj V, 1999, CROAT CHEM ACTA, V72, P575; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Finzel BC, 1998, PROTEIN SCI, V7, P2118, DOI 10.1002/pro.5560071008; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Higashi S, 2003, J BIOL CHEM, V278, P14020, DOI 10.1074/jbc.M212264200; Higashi S, 2008, J BIOL CHEM, V283, P10068, DOI 10.1074/jbc.M709509200; Higashi S, 2008, J BIOL CHEM, V283, P35735, DOI 10.1074/jbc.M806285200; Jia MC, 2000, ADV EXP MED BIOL, V476, P181; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150; MIYAZAKI K, 1993, NATURE, V362, P839, DOI 10.1038/362839a0; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Ohsawa I, 2001, J NEUROCHEM, V76, P1411, DOI 10.1046/j.1471-4159.2001.00144.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Park HI, 2002, J BIOL CHEM, V277, P35168, DOI 10.1074/jbc.M205071200; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SMALL DH, 1992, J NEUROSCI, V12, P4143; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; Tochowicz A, 2007, J MOL BIOL, V371, P989, DOI 10.1016/j.jmb.2007.05.068; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088	38	37	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33236	33243		10.1074/jbc.M111.264176	http://dx.doi.org/10.1074/jbc.M111.264176			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813640	Green Published, hybrid			2022-12-27	WOS:000294968800042
J	Fye, JM; Orebaugh, CD; Coffin, SR; Hollis, T; Perrino, FW				Fye, Jason M.; Orebaugh, Clinton D.; Coffin, Stephanie R.; Hollis, Thomas; Perrino, Fred W.			Dominant Mutations of the TREX1 Exonuclease Gene in Lupus and Aicardi-Goutieres Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL CHILBLAIN LUPUS; MEDIATED CELL-DEATH; AUTOIMMUNE-DISEASE; DNA FRAGMENTATION; PROTEIN; ERYTHEMATOSUS; APOPTOSIS; EXPRESSION; NM23-H1; FORM	TREX1 is a potent 3'-->35' exonuclease that degrades single- and double-stranded DNA (ssDNA and dsDNA). TREX1 mutations at amino acid positions Asp-18 and Asp-200 in familial chilblain lupus and Aicardi-Goutieres syndrome elicit dominant immune dysfunction phenotypes. Failure to appropriately disassemble genomic DNA during normal cell death processes could lead to persistent DNA signals that trigger the innate immune response and autoimmunity. We tested this concept using dsDNA plasmid and chromatin and show that the TREX1 exonuclease locates 3' termini generated by endonucleases and degrades the nicked DNA polynucleotide. A competition assay was designed using TREX1 dominant mutants and variants to demonstrate that an intact DNA binding process, coupled with dysfunctional chemistry in the active sites, explains the dominant phenotypes in TREX1 D18N, D200N, and D200H alleles. The TREX1 residues Arg-174 and Lys-175 positioned adjacent to the active sites act with the Arg-128 residues positioned in the catalytic cores to facilitate melting of dsDNA and generate ssDNA for entry into the active sites. Metal-dependent ssDNA binding in the active sites of the catalytically inactive dominant TREX1 mutants contributes to DNA retention and precludes access to DNA 3' termini by active TREX1 enzyme. Thus, the dominant disease genetics exhibited by the TREX1 D18N, D200N, and D200H alleles parallel precisely the biochemical properties of these TREX1 dimers during dsDNA degradation of plasmid and chromatin DNA in vitro. These results support the concept that failure to degrade genomic dsDNA is a principal pathway of immune activation in TREX1-mediated autoimmune disease.	[Fye, Jason M.; Orebaugh, Clinton D.; Coffin, Stephanie R.; Hollis, Thomas; Perrino, Fred W.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University	Perrino, FW (corresponding author), Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wfubmc.edu			National Institutes of Health [GM069962]; Alliance for Lupus Research [179222]; American Heart Association [10GRNT3650033];  [F32GM095290]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962, F32GM095290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; American Heart Association(American Heart Association); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069962 (to F.W.P.). This work was also supported by Alliance for Lupus Research Grant 179222 (to F.W.P.), American Heart Association Grant 10GRNT3650033 (to T.H.), and postdoctoral fellowship award F32GM095290 (to S.R.C.).	Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Haaxma CA, 2010, AM J MED GENET A, V152A, P2612, DOI 10.1002/ajmg.a.33620; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Kavanagh D, 2008, CELL CYCLE, V7, P1718, DOI 10.4161/cc.7.12.6162; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lee-Kirsch MA, 2006, AM J HUM GENET, V79, P731, DOI 10.1086/507848; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Perrino FW, 2008, J BIOL CHEM, V283, P21441, DOI 10.1074/jbc.M803629200; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yoshida A, 2003, J BIOL CHEM, V278, P37768, DOI 10.1074/jbc.M304914200	29	51	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32373	32382		10.1074/jbc.M111.276287	http://dx.doi.org/10.1074/jbc.M111.276287			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21808053	Green Published, hybrid			2022-12-27	WOS:000294726800047
J	Mittal, Y; Pavlova, Y; Garcia-Marcos, M; Ghosh, P				Mittal, Yash; Pavlova, Yelena; Garcia-Marcos, Mikel; Ghosh, Pradipta			Src Homology Domain 2-containing Protein-tyrosine Phosphatase-1 (SHP-1) Binds and Dephosphorylates G alpha-interacting, Vesicle-associated Protein (GIV)/Girdin and Attenuates the GIV-Phosphatidylinositol 3-Kinase (PI3K)-Akt Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; MOTH-EATEN MICE; CELL-MIGRATION; LEUKOCYTE PROTEIN; PROSTATE-CANCER; LIPID RAFTS; B-CELLS; ACTIVATION; AKT; PHOSPHORYLATION	GIV (G alpha-interacting vesicle-associated protein, also known as Girdin) is a bona fide enhancer of PI3K-Akt signals during a diverse set of biological processes, e. g. wound healing, macrophage chemotaxis, tumor angiogenesis, and cancer invasion/metastasis. We recently demonstrated that tyrosine phosphorylation of GIV by receptor and non-receptor-tyrosine kinases is a key step that is required for GIV to directly bind and enhance PI3K activity. Here we report the discovery that Src homology 2-containing phosphatase-1 (SHP-1) is the major protein-tyrosine phosphatase that targets two critical phosphotyrosines within GIV and antagonizes phospho-GIV-dependent PI3K enhancement in mammalian cells. Using phosphorylation-dephosphorylation assays, we demonstrate that SHP-1 is the major and specific protein-tyrosine phosphatase that catalyzes the dephosphorylation of tyrosine-phosphorylated GIV in vitro and inhibits ligand-dependent tyrosine phosphorylation of GIV downstream of both growth factor receptors and GPCRs in cells. In vitro binding and co-immunoprecipitation assays demonstrate that SHP-1 and GIV interact directly and constitutively and that this interaction occurs between the SH2 domain of SHP-1 and the C terminus of GIV. Overexpression of SHP-1 inhibits tyrosine phosphorylation of GIV and formation of phospho-GIV-PI3K complexes, and specifically suppresses GIV-dependent activation of Akt. Consistently, depletion of SHP-1 enhances peak tyrosine phosphorylation of GIV, which coincides with an increase in peak Akt activity. We conclude that SHP-1 antagonizes the action of receptor and non-receptor-tyrosine kinases on GIV and down-regulates the phospho-GIV-PI3K-Akt axis of signaling.	[Ghosh, Pradipta] Univ Calif San Diego, Dept Med, George Palade Labs Cellular & Mol Med, La Jolla, CA 92093 USA; [Garcia-Marcos, Mikel; Ghosh, Pradipta] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Ghosh, P (corresponding author), Univ Calif San Diego, Dept Med, George Palade Labs Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	prghosh@ucsd.edu		Garcia-Marcos, Mikel/0000-0001-9513-4826	Burroughs Wellcome Fund; American Gastroenterology Association; Doris Duke Charitable Foundation; University of California, San Diego; Susan G. Komen Postdoctoral Fellowship [KG080079]	Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Gastroenterology Association; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); University of California, San Diego(University of California System); Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation)	This work was funded by the Burroughs Wellcome Fund, Research Scholar Award (American Gastroenterology Association), and a Clinical Scientist Development Award (Doris Duke Charitable Foundation) (to P.G.).; Supported by the Sarah Rogers Fellowship (University of California, San Diego).; Supported by Susan G. Komen Postdoctoral Fellowship KG080079.	Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Bairstow SF, 2005, J BIOL CHEM, V280, P23884, DOI 10.1074/jbc.M500576200; BANVILLE D, 1995, GENOMICS, V27, P165, DOI 10.1006/geno.1995.1020; Bard-Chapeau EA, 2006, MOL CELL BIOL, V26, P4664, DOI 10.1128/MCB.02253-05; Benali N, 2000, P NATL ACAD SCI USA, V97, P9180, DOI 10.1073/pnas.130196697; Berg KL, 1999, J BIOL CHEM, V274, P35855, DOI 10.1074/jbc.274.50.35855; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Bradshaw N. J., 2011, NEUROPHARMA IN PRESS; Burks J, 2006, ONCOGENE, V25, P7166, DOI 10.1038/sj.onc.1209728; Burshtyn DN, 1999, J IMMUNOL, V162, P897; Christophi GP, 2009, VIRAL IMMUNOL, V22, P371, DOI 10.1089/vim.2009.0052; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; Cote JF, 1998, BIOCHEMISTRY-US, V37, P13128, DOI 10.1021/bi981259l; Cuevas B, 1999, J BIOL CHEM, V274, P27583, DOI 10.1074/jbc.274.39.27583; Cui TX, 2002, MOL ENDOCRINOL, V16, P2113, DOI 10.1210/me.2001-0284; Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Enomoto A, 2006, ANN NY ACAD SCI, V1086, P169, DOI 10.1196/annals.1377.016; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Fawcett VCJ, 2005, J IMMUNOL, V174, P2849, DOI 10.4049/jimmunol.174.5.2849; Feng YH, 2002, P NATL ACAD SCI USA, V99, P12049, DOI 10.1073/pnas.192404199; Fortin CF, 2006, J LEUKOCYTE BIOL, V79, P1061, DOI 10.1189/jlb.0805481; Frank C, 2004, J BIOL CHEM, V279, P11375, DOI 10.1074/jbc.M309096200; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2011, CELL ADHES MIGR, V5, P237, DOI 10.4161/cam.5.3.15909; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; Hakak Y, 2000, ONCOGENE, V19, P3164, DOI 10.1038/sj.onc.1203655; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Jiao HY, 1996, MOL CELL BIOL, V16, P6985; Jones ML, 2004, J BIOL CHEM, V279, P40475, DOI 10.1074/jbc.M402970200; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; Kharbanda S, 1996, P NATL ACAD SCI USA, V93, P6898, DOI 10.1073/pnas.93.14.6898; Kim CH, 1999, J EXP MED, V190, P681, DOI 10.1084/jem.190.5.681; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Koyama M, 2003, LAB INVEST, V83, P1849, DOI 10.1097/01.LAB.0000106503.65258.2B; Krotz F, 2005, J AM COLL CARDIOL, V45, P1700, DOI 10.1016/j.jacc.2005.02.039; Kruger J, 2000, J IMMUNOL, V165, P5847, DOI 10.4049/jimmunol.165.10.5847; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lin C., 2011, SCI STKE IN PRESS; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; Miyake H, 2011, CIRC RES, V108, P1170, DOI 10.1161/CIRCRESAHA.110.236174; Mizuno K, 1996, J EXP MED, V184, P457, DOI 10.1084/jem.184.2.457; Mizuno K, 2000, J IMMUNOL, V165, P1344, DOI 10.4049/jimmunol.165.3.1344; Ngai J, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-27; Pei DH, 1996, P NATL ACAD SCI USA, V93, P1141, DOI 10.1073/pnas.93.3.1141; PEI DH, 1994, BIOCHEMISTRY-US, V33, P15483, DOI 10.1021/bi00255a030; Porteous D, 2009, NEURON, V63, P711, DOI 10.1016/j.neuron.2009.09.017; Seo DW, 2006, J BIOL CHEM, V281, P3711, DOI 10.1074/jbc.M509932200; Sugano M, 2005, FASEB J, V19, P2054, DOI 10.1096/fj.05-4020fje; Tassidis H, 2010, PROSTATE, V70, P1491, DOI 10.1002/pros.21184; Tassidis H, 2010, INT J CANCER, V126, P2296, DOI 10.1002/ijc.24917; Tenev T, 1997, J BIOL CHEM, V272, P5966, DOI 10.1074/jbc.272.9.5966; Wadley GD, 2007, J APPL PHYSIOL, V102, P1624, DOI 10.1152/japplphysiol.00821.2006; Witkiewicz A, 2007, HUM PATHOL, V38, P462, DOI 10.1016/j.humpath.2006.09.012; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; Yoshida K, 1999, J BIOL CHEM, V274, P34663, DOI 10.1074/jbc.274.49.34663; Yu ZB, 1998, J BIOL CHEM, V273, P3687, DOI 10.1074/jbc.273.6.3687; Zito CI, 2004, J CELL PHYSIOL, V199, P227, DOI 10.1002/jcp.10446	65	29	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32404	32415		10.1074/jbc.M111.275685	http://dx.doi.org/10.1074/jbc.M111.275685			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21799016	Green Published, hybrid			2022-12-27	WOS:000294726800050
J	Sideri, TC; Koloteva-Levine, N; Tuite, MF; Grant, CM				Sideri, Theodora C.; Koloteva-Levine, Nadejda; Tuite, Mick F.; Grant, Chris M.			Methionine Oxidation of Sup35 Protein Induces Formation of the [PSI+] Prion in a Yeast Peroxiredoxin Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO FORMATION; SACCHAROMYCES-CEREVISIAE; GUANIDINE-HYDROCHLORIDE; ALZHEIMERS-DISEASE; HUMAN BRAIN; AGGREGATION; STRESS; SYSTEM; PROPAGATION; ELIMINATION	The frequency with which the yeast [PSI+] prion form of Sup35 arises de novo is controlled by a number of genetic and environmental factors. We have previously shown that in cells lacking the antioxidant peroxiredoxin proteins Tsa1 and Tsa2, the frequency of de novo formation of [PSI+] is greatly elevated. We show here that Tsa1/Tsa2 also function to suppress the formation of the [PIN+] prion form of Rnq1. However, although oxidative stress increases the de novo formation of both [PIN+] and [PSI+], it does not overcome the requirement of cells being [PIN+] to form the [PSI+] prion. We use an anti-methionine sulfoxide antibody to show that methionine oxidation is elevated in Sup35 during oxidative stress conditions. Abrogating Sup35 methionine oxidation by overexpressing methionine sulfoxide reductase (MSRA) prevents [PSI+] formation, indicating that Sup35 oxidation may underlie the switch from a soluble to an aggregated form of Sup35. In contrast, we were unable to detect methionine oxidation of Rnq1, and MSRA overexpression did not affect [PIN+] formation in a tsa1 tsa2 mutant. The molecular basis of how yeast and mammalian prions form infectious amyloid-like structures de novo is poorly understood. Our data suggest a causal link between Sup35 protein oxidation and de novo [PSI+] prion formation.	[Sideri, Theodora C.; Grant, Chris M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Koloteva-Levine, Nadejda; Tuite, Mick F.] Univ Kent, Kent Fungal Grp, Sch Biosci, Canterbury CT2 7NJ, Kent, England	University of Manchester; University of Kent	Grant, CM (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	chris.grant@manchester.ac.uk	Tuite, Mick/ABC-7909-2020	Tuite, Mick/0000-0002-5214-540X; Sideri, Theodora/0000-0002-5674-0804; Grant, Chris/0000-0002-0616-6576	Wellcome Trust; Biological Sciences Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by funding from the Wellcome Trust.; Supported by funding from the Biotechnology and Biological Sciences Research Council.	Alberti S, 2010, METHOD ENZYMOL, V470, P709, DOI 10.1016/S0076-6879(10)70030-6; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Boutte AM, 2006, FASEB J, V20, P1473, DOI 10.1096/fj.06-5920com; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Canello T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000977; Dean RT, 1997, BIOCHEM J, V324, P1; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Dixon C, 2005, GENETICS, V170, P47, DOI 10.1534/genetics.104.035493; Du ZQ, 2010, MOL CELL BIOL, V30, P4644, DOI 10.1128/MCB.00225-10; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Garrido EO, 2002, MOL MICROBIOL, V43, P993, DOI 10.1046/j.1365-2958.2002.02795.x; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; Iraqui I, 2008, CANCER RES, V68, P1055, DOI 10.1158/0008-5472.CAN-07-2683; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kopacek J, 2000, J VIROL, V74, P411, DOI 10.1128/JVI.74.1.411-417.2000; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Le DT, 2009, J BIOL CHEM, V284, P4354, DOI 10.1074/jbc.M805891200; Leong SL, 2009, FREE RADICAL BIO MED, V46, P1328, DOI 10.1016/j.freeradbiomed.2009.02.009; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Oien DB, 2009, J MOL NEUROSCI, V39, P323, DOI 10.1007/s12031-009-9274-8; Oien DB, 2009, ARCH BIOCHEM BIOPHYS, V485, P35, DOI 10.1016/j.abb.2009.01.020; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; Resende CG, 2003, MOL MICROBIOL, V49, P1005, DOI 10.1046/j.1365-2958.2003.03608.x; Ripaud L, 2003, EMBO J, V22, P5251, DOI 10.1093/emboj/cdg488; Scheibel T, 2001, NAT STRUCT BIOL, V8, P958, DOI 10.1038/nsb1101-958; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Sideri TC, 2010, P NATL ACAD SCI USA, V107, P6394, DOI 10.1073/pnas.1000347107; Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stadtman ER, 2003, ANTIOXID REDOX SIGN, V5, P577, DOI 10.1089/152308603770310239; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Tuite M, 2008, BIOCHEM SOC T, V36, P1083, DOI 10.1042/BST0361083; Tuite MF, 2007, PRION, V1, P101, DOI 10.4161/pri.1.2.4665; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Tyedmers J, 2010, P NATL ACAD SCI USA, V107, P8633, DOI 10.1073/pnas.1003895107; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wolschner C, 2009, P NATL ACAD SCI USA, V106, P7756, DOI 10.1073/pnas.0902688106; Wong CM, 2004, J BIOL CHEM, V279, P23207, DOI 10.1074/jbc.M402095200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zabel C, 2006, J PROTEOME RES, V5, P1948, DOI 10.1021/pr0601077	53	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38924	38931		10.1074/jbc.M111.272419	http://dx.doi.org/10.1074/jbc.M111.272419			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21832086	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000296759800011
J	Andrikopoulos, P; Baba, A; Matsuda, T; Djamgoz, MBA; Yaqoob, MM; Eccles, SA				Andrikopoulos, Petros; Baba, Akemichi; Matsuda, Toshio; Djamgoz, Mustafa B. A.; Yaqoob, Muhammad M.; Eccles, Suzanne A.			Ca2+ Influx through Reverse Mode Na+/Ca2+ Exchange Is Critical for Vascular Endothelial Growth Factor-mediated Extracellular Signal-regulated Kinase (ERK) 1/2 Activation and Angiogenic Functions of Human Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; NA+-CA2+ EXCHANGE; IN-VITRO; INTRACELLULAR NA+; PHOSPHOLIPASE-C; DNA-SYNTHESIS; ENTRY; INHIBITION; PATHWAY; STOICHIOMETRY	VEGF is a key angiogenic cytokine and a major target in antiangiogenic therapeutic strategies. In endothelial cells (ECs), VEGF binds VEGF receptors and activates ERK1/2 through the phospholipase gamma (PLC gamma)-PKC alpha-B-Raf pathway. Our previous work suggested that influx of extracellular Ca2+ is required for VEGF-induced ERK1/2 activation, and we hypothesized that this could occur through reverse mode (Ca2+ in and Na+ out) Na+-Ca2+ exchange (NCX). However, the role of NCX activity in VEGF signaling and angiogenic functions of ECs had not previously been described. Here, using human umbilical vein ECs (HUVECs), we report that extracellular Ca2+ is required for VEGF-induced ERK1/2 activation and that release of Ca2+ from intracellular stores alone, in the absence of extracellular Ca2+, is not sufficient to activate ERK1/2. Furthermore, inhibitors of reverse mode NCX suppressed the VEGF-induced activation of ERK1/2 in a time-and dose-dependent manner and attenuated VEGF-induced Ca2+ transients. Knockdown of NCX1 (the main NCX isoform in HUVECs) by siRNA confirmed the pharmacological data. A panel of NCX inhibitors also significantly reduced VEGF-induced B-Raf activity and inhibited PKC alpha translocation to the plasma membrane and total PKC activity in situ. Finally, NCX inhibitors reduced VEGF-induced HUVEC proliferation, migration, and tubular differentiation in surrogate angiogenesis functional assays in vitro. We propose that Ca2+ influx through reverse mode NCX is required for the activation and the targeting of PKC alpha to the plasma membrane, an essential step for VEGF-induced ERK1/2 phosphorylation and downstream EC functions in angiogenesis.	[Andrikopoulos, Petros; Eccles, Suzanne A.] Inst Canc Res, Canc Res UK Canc Therapeut Unit, McElwain Labs, Sutton SM2 5NG, Surrey, England; [Andrikopoulos, Petros; Djamgoz, Mustafa B. A.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Neurosci Solut Canc Res Grp, London SW7 2AZ, England; [Andrikopoulos, Petros; Yaqoob, Muhammad M.] Queen Marys Univ London, William Harvey Res Inst, Barts & London Sch Med, London EC1M 6BQ, England; [Baba, Akemichi; Matsuda, Toshio] Osaka Univ, Lab Med Pharmacol, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Cancer Research UK; University of London; Institute of Cancer Research - UK; Imperial College London; University of London; Queen Mary University London; Osaka University	Andrikopoulos, P (corresponding author), Inst Canc Res, Canc Res UK Canc Therapeut Unit, McElwain Labs, Cotswold Rd, Sutton SM2 5NG, Surrey, England.	p.andrikopoulos@qmul.ac.uk; sue.eccles@icr.ac.uk	Andrikopoulos, Petros/N-7724-2019; Andrikopoulos, Petros/G-2519-2011	Andrikopoulos, Petros/0000-0002-1555-3498; 	British Heart Foundation [FS/06/22]; National Health Service; Cancer Research UK [C309/A8274]; Institute of Cancer Research; Cancer Research UK [11566] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Health Service; Cancer Research UK(Cancer Research UK); Institute of Cancer Research; Cancer Research UK(Cancer Research UK)	This work was supported by British Heart Foundation Studentship FS/06/22 (to P. A.) and by National Health Service funding to the National Institute for Health Research Biomedical Research Centre.; Supported by Cancer Research UK Grant C309/A8274 and the Institute of Cancer Research. To whom correspondence may be addressed. Tel.: 44-20-8722-4210; Fax: 44-20-8722-4134; E-mail: sue.eccles@icr.ac.uk.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Andrikopoulos P, 2011, J BIOL CHEM, V286, P16846, DOI 10.1074/jbc.M110.187559; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Cook SJ, 1997, J BIOL CHEM, V272, P13309, DOI 10.1074/jbc.272.20.13309; Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8; CRESPO LM, 1990, NATURE, V345, P618, DOI 10.1038/345618a0; Dawson NS, 2006, FASEB J, V20, P991, DOI 10.1096/fj.05-3923fje; Dmitrieva RI, 2003, J BIOL CHEM, V278, P28160, DOI 10.1074/jbc.M303768200; Doanes AM, 1999, BIOCHEM BIOPH RES CO, V255, P545, DOI 10.1006/bbrc.1999.0227; Eccles Suzanne A., 2009, V467, P159, DOI 10.1007/978-1-59745-241-0_9; Eder P, 2007, CARDIOVASC RES, V73, P111, DOI 10.1016/j.cardiores.2006.10.016; Ferrara N, 2010, NAT MED, V16, P1107, DOI 10.1038/nm1010-1107; FLEMING I, 1995, CIRC RES, V76, P522, DOI 10.1161/01.RES.76.4.522; Fujioka Y, 2000, J PHYSIOL-LONDON, V523, P339, DOI 10.1111/j.1469-7793.2000.t01-2-00339.x; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; HEASLEY LE, 1989, J BIOL CHEM, V264, P8646; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Iwamoto T, 2004, MOL PHARMACOL, V66, P45, DOI 10.1124/mol.66.1.45; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; JUHASZOVA M, 1994, AM J PHYSIOL, V266, pC234, DOI 10.1152/ajpcell.1994.266.1.C234; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; KLEYMAN TR, 1990, METHOD ENZYMOL, V191, P739; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lemos VS, 2007, BIOCHEM BIOPH RES CO, V352, P130, DOI 10.1016/j.bbrc.2006.10.160; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; LI L, 1995, CIRC RES, V76, P396, DOI 10.1161/01.RES.76.3.396; Liang GH, 2008, PFLUG ARCH EUR J PHY, V457, P67, DOI 10.1007/s00424-008-0490-9; Liu J, 2000, J BIOL CHEM, V275, P27838; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; MATSUOKA S, 1992, J GEN PHYSIOL, V100, P963, DOI 10.1085/jgp.100.6.963; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ozdemir S, 2008, CIRC RES, V102, P1398, DOI 10.1161/CIRCRESAHA.108.173922; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Platel JC, 2005, P NATL ACAD SCI USA, V102, P19174, DOI 10.1073/pnas.0504540102; Plourde D, 2006, AM J PHYSIOL-CELL PH, V290, pC702, DOI 10.1152/ajpcell.00213.2005; Poburko D, 2007, CIRC RES, V101, P1030, DOI 10.1161/CIRCRESAHA.107.155531; Putney J W Jr, 2001, Mol Interv, V1, P84; REEVES JP, 1984, J BIOL CHEM, V259, P7733; Reuter H, 2002, CIRC RES, V91, P90, DOI 10.1161/01.RES.0000027529.37429.38; SAGE SO, 1991, J PHYSIOL-LONDON, V440, P569, DOI 10.1113/jphysiol.1991.sp018725; Sedova M, 1999, CELL CALCIUM, V25, P333, DOI 10.1054/ceca.1999.0036; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Soltoff SP, 2008, AM J PHYSIOL-CELL PH, V295, pC590, DOI 10.1152/ajpcell.00140.2008; Szewczyk MM, 2007, J CELL MOL MED, V11, P129, DOI 10.1111/j.1582-4934.2007.00010.x; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Teubl M, 1999, J BIOL CHEM, V274, P29529, DOI 10.1074/jbc.274.41.29529; Wang AH, 2002, CIRC RES, V90, P609, DOI 10.1161/01.RES.0000012503.30315.E8; Watanabe Y, 2006, J PHARMACOL SCI, V102, P7, DOI 10.1254/jphs.FMJ06002X2; Watano T, 1996, BRIT J PHARMACOL, V119, P555, DOI 10.1111/j.1476-5381.1996.tb15708.x; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; Xu H, 2008, CARDIOVASC RES, V78, P349, DOI 10.1093/cvr/cvm085; Zeng HY, 2001, J BIOL CHEM, V276, P32714, DOI 10.1074/jbc.M103130200	63	60	65	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37919	37931		10.1074/jbc.M111.251777	http://dx.doi.org/10.1074/jbc.M111.251777			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21873429	Green Published, hybrid			2022-12-27	WOS:000296594200005
J	Agarwal, AK; Sukumaran, S; Cortes, VA; Tunison, K; Mizrachi, D; Sankella, S; Gerard, RD; Horton, JD; Garg, A				Agarwal, Anil K.; Sukumaran, Suja; Cortes, Victor A.; Tunison, Katie; Mizrachi, Dario; Sankella, Shireesha; Gerard, Robert D.; Horton, Jay D.; Garg, Abhimanyu			Human 1-Acylglycerol-3-phosphate O-Acyltransferase Isoforms 1 and 2 BIOCHEMICAL CHARACTERIZATION AND INABILITY TO RESCUE HEPATIC STEATOSIS IN Agpat2(-/-) GENE LIPODYSTROPHIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE; CONGENITAL GENERALIZED LIPODYSTROPHY; INSULIN-RESISTANCE; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; ENZYMATIC-ACTIVITY; DIABETES-MELLITUS; NUCLEAR SREBP-1C; ADIPOSE-TISSUE; CDNA CLONING	Loss-of-function mutations in 1-acylglycerol-3-phosphate O-acyltransferase (AGPAT) 2 in humans and mice result in loss of both the white and brown adipose tissues from birth. AGPAT2 generates precursors for the synthesis of glycerophospholipids and triacylglycerols. Loss of adipose tissue, or lipodystrophy, results in hyperinsulinemia, diabetes mellitus, and severe hepatic steatosis. Here, we analyzed biochemical properties of human AGPAT2 and its close homolog, AGPAT1, and we studied their role in liver by transducing their expression via recombinant adenoviruses in Agpat2(-/-) mice. The in vitro substrate specificities of AGPAT1 and AGPAT2 are quite similar for lysophosphatidic acid and acyl-CoA. Protein homology modeling of both the AGPATs with glycerol-3-phosphate acyltransferase 1 (GPAT1) revealed that they have similar tertiary protein structure, which is consistent with their similar substrate specificities. When co-expressed, both isoforms co-localize to the endoplasmic reticulum. Despite such similarities, restoring AGPAT activity in liver by overexpression of either AGPAT1 or AGPAT2 in Agpat2(-/-) mice failed to ameliorate the hepatic steatosis. From these studies, we suggest that the role of AGPAT1 or AGPAT2 in liver lipogenesis is minimal and that accumulation of liver fat is primarily a consequence of insulin resistance and loss of adipose tissue in Agpat2(-/-) mice.	[Agarwal, Anil K.] Univ Texas SW Med Ctr Dallas, Div Nutr & Metab Dis, Ctr Human Nutr, Dept Internal Med, Dallas, TX 75390 USA; [Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Div Gastroenterol, Dallas, TX 75390 USA; [Cortes, Victor A.; Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Agarwal, AK (corresponding author), Univ Texas SW Med Ctr Dallas, Div Nutr & Metab Dis, Ctr Human Nutr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Anil.Agarwal@UTSouthwestern.edu		Cortes, Victor/0000-0002-1658-0965	National Institutes of Health [R01-DK54387, DK081182, UL1DE019584]; Southwestern Medical Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [PL1DK081182, R01DK054387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southwestern Medical Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK54387, DK081182, and UL1DE019584. This work was also supported by the Southwestern Medical Foundation.	Agarwal AK, 2006, ANNU REV MED, V57, P297, DOI 10.1146/annurev.med.57.022605.114424; Agarwal AK, 2003, TRENDS ENDOCRIN MET, V14, P214, DOI 10.1016/S1043-2760(03)00078-X; Agarwal AK, 2003, J CLIN ENDOCR METAB, V88, P4840, DOI 10.1210/jc.2003-030855; Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Agarwal AK, 2007, J ENDOCRINOL, V193, P445, DOI 10.1677/JOe-07-0027; Agarwal AK, 2006, ANNU REV GENOM HUM G, V7, P175, DOI 10.1146/annurev.genom.7.080505.115715; Agarwal AK, 2006, ARCH BIOCHEM BIOPHYS, V449, P64, DOI 10.1016/j.abb.2006.03.014; Agarwal AK, 2010, J LIPID RES, V51, P2143, DOI 10.1194/jlr.M004762; Aguado B, 1998, J BIOL CHEM, V273, P4096, DOI 10.1074/jbc.273.7.4096; Arora T, 2011, APPETITE, V56, P511, DOI 10.1016/j.appet.2011.01.016; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Copaci Ionel, 2006, J Gastrointestin Liver Dis, V15, P363; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Eberhardt C, 1999, ADV EXP MED BIOL, V469, P351; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Green M, 1979, Methods Enzymol, V58, P425; Haque W, 2005, BIOCHEM BIOPH RES CO, V327, P446, DOI 10.1016/j.bbrc.2004.12.024; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Leung DW, 2001, FRONT BIOSCI, V6, pD944, DOI 10.2741/Leung; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; McMaster CR, 2004, TOP CURR GENET, V6, P5; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Prasad SS, 2011, J LIPID RES, V52, P451, DOI 10.1194/jlr.M007575; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Sukumaran S, 2009, J MOL ENDOCRINOL, V42, P469, DOI 10.1677/JME-09-0010; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Tamada T, 2004, ACTA CRYSTALLOGR D, V60, P13, DOI 10.1107/S0907444903020778; Turnbull AP, 2001, ACTA CRYSTALLOGR D, V57, P451, DOI 10.1107/S0907444901000257; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; West J, 1997, DNA CELL BIOL, V16, P691, DOI 10.1089/dna.1997.16.691; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yamashita A, 2007, BBA-MOL CELL BIOL L, V1771, P1202, DOI 10.1016/j.bbalip.2007.07.002; Ye GM, 2005, DNA SEQUENCE, V16, P386, DOI 10.1080/10425170500213712	55	56	58	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37676	37691		10.1074/jbc.M111.250449	http://dx.doi.org/10.1074/jbc.M111.250449			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21873652	hybrid, Green Published			2022-12-27	WOS:000296542400064
J	Khurana, A; Shao, ES; Kim, RY; Vilin, YY; Huang, XY; Yang, RY; Kurata, HT				Khurana, Anu; Shao, Evan S.; Kim, Robin Y.; Vilin, Yury Y.; Huang, Xinyang; Yang, Runying; Kurata, Harley T.			Forced Gating Motions by a Substituted Titratable Side Chain at the Bundle Crossing of a Potassium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; CRYSTAL-STRUCTURE; SULFONYLUREA RECEPTOR; SUBUNIT STOICHIOMETRY; FUNCTIONAL EXPRESSION; SELECTIVITY FILTER; MOLECULAR-BASIS; KIR6.2; PORE; BINDING	Voltage-gated sodium channels underlie the upstroke of action potentials and are fundamental to neuronal excitability. Small changes in the behavior of these channels are sufficient to change neuronal firing and trigger seizures. These channels are subject to highly conserved alternative splicing, affecting the short linker between the third transmembrane segment (S3) and the voltage sensor (S4) in their first domain. The biophysical consequences of this alternative splicing are incompletely understood. Here we focus on type 1 sodium channels (Nav1.1) that are implicated in human epilepsy. We show that the functional consequences of alternative splicing are highly sensitive to recording conditions, including the identity of the major intracellular anion and the recording temperature. In particular, the inactivation kinetics of channels containing the alternate exon 5N are more sensitive to intracellular fluoride ions and to changing temperature than channels containing exon 5A. Moreover, Nav1.1 channels containing exon 5N recover from inactivation more rapidly at physiological temperatures. Three amino acids differ between exons 5A and 5N. However, the changes in sensitivity and stability of inactivation were reproduced by a single conserved change from aspartate to asparagine in channels containing exon 5A, which was sufficient to make them behave like channels containing the complete exon 5N sequence. These data suggest that splicing at this site can modify the inactivation of sodium channels and reveal a possible interaction between splicing and anti-epileptic drugs that stabilize sodium channel inactivation.	[Khurana, Anu; Shao, Evan S.; Kim, Robin Y.; Vilin, Yury Y.; Huang, Xinyang; Yang, Runying; Kurata, Harley T.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Kurata, HT (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, 2176 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	harley.kurata@ubc.ca		Kurata, Harley/0000-0003-4357-4189	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by a Canadian Institutes of Health Research operating grant and New Investigator Awards from the Heart and Stroke Foundation of Canada and the Michael Smith Foundation for Health Research (to H. T. K.).	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Berneche S, 2002, BIOPHYS J, V82, P772, DOI 10.1016/S0006-3495(02)75439-8; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Claydon TW, 2003, J BIOL CHEM, V278, P50654, DOI 10.1074/jbc.M308183200; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Craig TJ, 2008, J GEN PHYSIOL, V132, P131, DOI 10.1085/jgp.200709874; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Koster JC, 2005, DIABETES, V54, P2645, DOI 10.2337/diabetes.54.9.2645; Kubo Y, 2005, PHARMACOL REV, V57, P509, DOI 10.1124/pr.57.4.11; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000315; Kurata HT, 2006, J GEN PHYSIOL, V127, P467, DOI 10.1085/jgp.200509467; Kurata HT, 2004, J GEN PHYSIOL, V124, P541, DOI 10.1085/jgp.200409159; Lindman S, 2007, BIOPHYS J, V92, P257, DOI 10.1529/biophysj.106.088682; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lorenz E, 1998, MOL CELL BIOL, V18, P1652, DOI 10.1128/MCB.18.3.1652; Loussouarn G, 2000, J BIOL CHEM, V275, P1137, DOI 10.1074/jbc.275.2.1137; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Phillips LR, 2003, J GEN PHYSIOL, V122, P795, DOI 10.1085/jgp.200308953; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Proks P, 2005, EMBO REP, V6, P470, DOI 10.1038/sj.embor.7400393; Proks P, 2003, EMBO REP, V4, P70, DOI 10.1038/embor708; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Rojas A, 2007, BBA-BIOMEMBRANES, V1768, P39, DOI 10.1016/j.bbamem.2006.06.027; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Wang RP, 2006, J MEMBRANE BIOL, V213, P155, DOI 10.1007/s00232-006-0038-x; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; Xu HX, 2001, J BIOL CHEM, V276, P38690, DOI 10.1074/jbc.M106595200; Yan FF, 2006, J BIOL CHEM, V281, P33403, DOI 10.1074/jbc.M605195200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	44	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36686	36693		10.1074/jbc.M111.249110	http://dx.doi.org/10.1074/jbc.M111.249110			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878633	hybrid, Green Published			2022-12-27	WOS:000296538300051
J	Sipes, NS; Feng, YX; Guo, FK; Lee, HO; Chou, FS; Cheng, J; Mulloy, J; Zheng, Y				Sipes, Nisha S.; Feng, Yuxin; Guo, Fukun; Lee, Hyung-Ok; Chou, Fu-Sheng; Cheng, Jonathan; Mulloy, James; Zheng, Yi			Cdc42 Regulates Extracellular Matrix Remodeling in Three Dimensions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL COLLAGEN MATRICES; GEL CONTRACTION; RHO-GTPASES; IN-VIVO; FIBROBLASTS; CULTURE; KERATINOCYTES; ACTIVATION; EXPRESSION; INDUCTION	Extracellular matrix (ECM) actively participates in normal cell regulation and in the process of tumor progression. The Rho GTPase Cdc42 has been shown to regulate cell-ECM interaction in conventional two-dimensional culture conditions by using dominant mutants of Cdc42 in immortalized cell lines that may introduce nonspecific effects. Here, we employ three-dimensional culture systems for conditional gene targeted primary mouse embryonic fibroblasts that better simulate the reciprocal and adaptive interactions between cells and surrounding matrix to define the role of Cdc42 signaling pathways in ECM organization. Cdc42 deficiency leads to a defect in global cell-matrix interactions reflected by a decrease in collagen gel contraction. The defect is associated with an altered cell-matrix interaction that is evident by morphologic changes and reduced focal adhesion complex formation. The matrix defect is also associated with a reduction in synthesis and activation of matrix metalloproteinase 9 (MMP9) and altered fibronectin deposition patterning. A Cdc42 mutant rescue experiment found that downstream of Cdc42, p21-activated kinase (PAK), but not Par6 or WASP, may be involved in regulating collagen gel contraction and fibronectin organization. Thus, in addition to the previously implicated roles in intracellular regulation of actin organization, proliferation, and vesicle trafficking, Cdc42 is essential in ECM remodeling in three dimensions.	[Sipes, Nisha S.; Feng, Yuxin; Guo, Fukun; Chou, Fu-Sheng; Mulloy, James; Zheng, Yi] Childrens Hosp, Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Sipes, Nisha S.; Chou, Fu-Sheng; Mulloy, James; Zheng, Yi] Univ Cincinnati, Dept Cell & Canc Biol, Cincinnati, OH 45229 USA; [Lee, Hyung-Ok; Cheng, Jonathan] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Fox Chase Cancer Center	Zheng, Y (corresponding author), Childrens Hosp, Med Ctr, Div Expt Hematol & Canc Biol, 333 Burnet Ave, Cincinnati, OH 45229 USA.	yi.zheng@cchmc.org	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074; Chou, Fu-Sheng/0000-0002-5770-0580	National Institutes of Health [T32 HD046387, R01 CA150547, R01 HL085362]; Robert and EmmaLou Cardell Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046387] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA150547, T32CA117846] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert and EmmaLou Cardell Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Training Grant T32 HD046387 (to N.S.S.) and by National Institutes of Health Grants R01 CA150547 and R01 HL085362 (to Y.Z.). This work was also supported by the Robert and EmmaLou Cardell Fellowship (to N.S.S.).	Beacham D. A., 2007, CURR PROTOC CELL BIO, V10, P9; Beacham DA, 2005, SEMIN CANCER BIOL, V15, P329, DOI 10.1016/j.semcancer.2005.05.003; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Chen F, 2000, CURR BIOL, V10, P758, DOI 10.1016/S0960-9822(00)00571-6; Chen L, 2006, P NATL ACAD SCI USA, V103, P16520, DOI 10.1073/pnas.0603533103; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dahlmann-Noor AH, 2007, EXP CELL RES, V313, P4158, DOI 10.1016/j.yexcr.2007.07.040; Daniels JT, 2003, INVEST OPHTH VIS SCI, V44, P1104, DOI 10.1167/iovs.02-0412; Defawe OD, 2005, CARDIOVASC RES, V66, P402, DOI 10.1016/j.cardiores.2004.11.025; Deroanne CF, 2005, J CELL SCI, V118, P1173, DOI 10.1242/jcs.01707; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Grinnell F, 2003, MOL BIOL CELL, V14, P384, DOI 10.1091/mbc.E02-08-0493; Grinnell F, 1999, J BIOL CHEM, V274, P918, DOI 10.1074/jbc.274.2.918; GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Guo FK, 2010, P NATL ACAD SCI USA, V107, P18505, DOI 10.1073/pnas.1010249107; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Harunaga JS, 2011, MATRIX BIOL; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ilina O, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015010; Ishii I, 2001, ATHEROSCLEROSIS, V158, P377, DOI 10.1016/S0021-9150(01)00461-0; Ispanovic E, 2008, AM J PHYSIOL-CELL PH, V295, pC600, DOI 10.1152/ajpcell.00460.2007; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; Lakshman N, 2007, CELL MOTIL CYTOSKEL, V64, P434, DOI 10.1002/cm.20194; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Petroll WM, 2003, CELL MOTIL CYTOSKEL, V55, P254, DOI 10.1002/cm.10126; Phillips JA, 2003, BIOCHEM BIOPH RES CO, V312, P725, DOI 10.1016/j.bbrc.2003.10.179; Quiros RM, 2008, GYNECOL ONCOL, V110, P99, DOI 10.1016/j.ygyno.2008.03.006; Rhee S, 2006, J CELL BIOL, V172, P423, DOI 10.1083/jcb.200505175; Rhee S, 2007, P NATL ACAD SCI USA, V104, P5425, DOI 10.1073/pnas.0608030104; Turchi L, 2003, J INVEST DERMATOL, V121, P1291, DOI 10.1111/j.1523-1747.2003.12627.x; Ueda H, 2001, J BIOL CHEM, V276, P6846, DOI 10.1074/jbc.M007541200; Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Wu XW, 2006, MATRIX BIOL, V25, P466, DOI 10.1016/j.matbio.2006.09.001; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Zhuge Y, 2001, J BIOL CHEM, V276, P16248, DOI 10.1074/jbc.M010190200	44	20	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36469	36477		10.1074/jbc.M111.283176	http://dx.doi.org/10.1074/jbc.M111.283176			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880728	Green Published, hybrid			2022-12-27	WOS:000296538300032
J	Hourcade, DE; Mitchell, LM				Hourcade, Dennis E.; Mitchell, Lynne M.			Access to the Complement Factor B Scissile Bond Is Facilitated by Association of Factor B with C3b Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; ALTERNATIVE PATHWAY CONVERTASE; FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; REGULATORY PROTEIN; PROVIDES INSIGHTS; INNATE IMMUNITY; A-DOMAIN; ACTIVATION; SYSTEM	Factor B is a zymogen that carries the catalytic site of the complement alternative pathway C3 convertase. During convertase assembly, factor B associates with C3b and Mg2+ forming a pro-convertase C3bB(Mg2+) that is cleaved at a single factor B site by factor D. In free factor B, a pair of salt bridges binds the Arg(234) side chain to Glu(446) and to Glu(207), forming a double latch structure that sequesters the scissile bond (between Arg(234) and Lys(235)) and minimizes its unproductive cleavage. It is unknown how the double latch is released in the pro-convertase. Here, we introduce single amino acid substitutions into factor B that preclude one or both of the Arg(234) salt bridges, and we examine their impact on several different pro-convertase complexes. Our results indicate that loss of the Arg(234)-Glu(446) salt bridge partially stabilizes C3bB(Mg2+). Loss of the Arg(234)-Glu(207) salt bridge has lesser effects. We propose that when factor B first associates with C3b, it bears two intact Arg(234) salt bridges. The complex rapidly dissociates unless the Arg(234)-Glu(446) salt bridge is released whereupon conformational changes occur that activate the metal ion-dependent adhesion site and partially stabilize the complex. The remaining salt bridge is then released, exposing the scissile bond and permitting factor D cleavage.	[Hourcade, Dennis E.; Mitchell, Lynne M.] Washington Univ, Dept Med, Div Rheumatol, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Hourcade, DE (corresponding author), 660 S Euclid Ave,Campus Box 8045, St Louis, MO 63110 USA.	dhourcad@dom.wustl.edu			National Institutes of Health [R01 AI051436]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI051436 (to D. E. H.).	Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; DeLano W.L, PYMOL MOL GRAPHICS S; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; FISHELSON Z, 1983, J BIOL CHEM, V258, P7411; Flierl MA, 2006, J INVEST SURG, V19, P255, DOI 10.1080/08941930600778263; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Goodship THJ, 2004, TRENDS MOL MED, V10, P226, DOI 10.1016/j.molmed.2004.03.006; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Harris CL, 2005, J BIOL CHEM, V280, P2569, DOI 10.1074/jbc.M410179200; Hauptmann G, 1988, Immunodefic Rev, V1, P3; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Hourcade DE, 1999, J IMMUNOL, V162, P2906; HOURCADE DE, 1995, J BIOL CHEM, V270, P19716, DOI 10.1074/jbc.270.34.19716; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; Janssen BJC, 2009, EMBO J, V28, P2469, DOI 10.1038/emboj.2009.184; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Kavanagh D, 2006, BRIT MED BULL, V77-78, P5, DOI 10.1093/bmb/ldl004; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Liszewski M.K., 1998, HUMAN COMPLEMENT SYS, P149; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MEDICUS RG, 1976, J EXP MED, V144, P1076, DOI 10.1084/jem.144.4.1076; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; MOLE JE, 1984, J BIOL CHEM, V259, P3407; Pagano MB, 2009, CIRCULATION, V119, P1805, DOI 10.1161/CIRCULATIONAHA.108.832972; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Richards A, 2007, ADV IMMUNOL, V96, P141, DOI 10.1016/S0065-2776(07)96004-6; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Taylor FR, 1999, BIOCHEMISTRY-US, V38, P2849, DOI 10.1021/bi982140f; Torreira E, 2009, J IMMUNOL, V183, P7347, DOI 10.4049/jimmunol.0902310; Torreira E, 2009, P NATL ACAD SCI USA, V106, P882, DOI 10.1073/pnas.0810860106; VOGEL CW, 1982, J BIOL CHEM, V257, P8292; Volanakis JE, 1998, HUMAN COMPLEMENT SYS, V20, P9, DOI DOI 10.1201/B14212-3; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Xu YY, 2001, IMMUNOL REV, V180, P123, DOI 10.1034/j.1600-065X.2001.1800111.x; Zipfel PF, 2001, INT IMMUNOPHARMACOL, V1, P461, DOI 10.1016/S1567-5769(00)00047-3	42	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35725	35732		10.1074/jbc.M111.263418	http://dx.doi.org/10.1074/jbc.M111.263418			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862585	Green Published, hybrid			2022-12-27	WOS:000295927100045
J	Forfar, R; Lu, ZL				Forfar, Rachel; Lu, Zhi-Liang			Role of the Transmembrane Domain 4/Extracellular Loop 2 Junction of the Human Gonadotropin-releasing Hormone Receptor in Ligand Binding and Receptor Conformational Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; 2ND EXTRACELLULAR LOOP; GNRH RECEPTOR; CRYSTAL-STRUCTURE; INTRACELLULAR LOOP; IN-VITRO; ANTAGONIST; ACTIVATION; MUTATIONS; AGONIST	Recent crystal structures of G protein-coupled receptors (GPCRs) show the remarkable structural diversity of extracellular loop 2 (ECL2), implying its potential role in ligand binding and ligand-induced receptor conformational selectivity. Here we have applied molecular modeling and mutagenesis studies to the TM4/ECL2 junction (residues Pro(174(4.59))-Met(180(4.66))) of the human gonadotropin-releasing hormone (GnRH) receptor, which uniquely has one functional type of receptor but two endogenous ligands in humans. We suggest that the above residues assume an alpha-helical extension of TM4 in which the side chains of Gln(174(4.60)) and Phe(178(4.64)) face toward the central ligand binding pocket to make H-bond and aromatic contacts with pGlu(1) and Trp(3) of both GnRH I and GnRH II, respectively.The interaction between the side chains of Phe(178(4.64)) of the receptor and Trp(3) of the GnRHs was supported by reciprocal mutations of the interacting residues. Interestingly, alanine mutations of Leu(175(4.61)), Ile(177(4.63)), and Met(180(4.66)) decreased mutant receptor affinity for GnRH I but, in contrast, increased affinity for GnRH II. This suggests that these residues make intramolecular or intermolecular contacts with residues of transmembrane (TM) domain 3, TM5, or the phospholipid bilayer, which couple the ligand structure to specific receptor conformational switches. The marked decrease in signaling efficacy of I177A and F178A also indicates that IIe(177(4.63)) and Phe(178(4.64)) are important in stabilizing receptor-active conformations. These findings suggest that the TM4/ECL2 junction is crucial for peptide ligand binding and, consequently, for ligand-induced receptor conformational selection.	[Lu, Zhi-Liang] Xian Jiaotong Liverpool Univ, Dept Biol Sci, Xian 215123, Jiangsu Provinc, Peoples R China; [Forfar, Rachel] MRC Technol, London NW7 1AD, England	Xi'an Jiaotong-Liverpool University	Lu, ZL (corresponding author), Xian Jiaotong Liverpool Univ, Dept Biol Sci, 111 Renai Rd, Xian 215123, Jiangsu Provinc, Peoples R China.	zhiliang.lu@xjtlu.edu.cn		Lu, Zhiliang/0000-0002-3442-1415	Medical Research Council, United Kingdom [U1276.00.005.00001.01]; MRC [MC_U127685846] Funding Source: UKRI; Medical Research Council [MC_U127685846] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Programme Grant U1276.00.005.00001.01 from the Medical Research Council, United Kingdom.	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Arora KK, 1997, MOL ENDOCRINOL, V11, P1203, DOI 10.1210/me.11.9.1203; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chauvin S, 2000, MOL PHARMACOL, V57, P625, DOI 10.1124/mol.57.3.625; Chengalvala M, 1999, J BIOCHEM BIOPH METH, V38, P163, DOI 10.1016/S0165-022X(98)00046-3; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Coetsee M., 2006, BIOSCIENCE 2006 GLAS; Coetsee M, 2008, BIOCHEMISTRY-US, V47, P10305, DOI 10.1021/bi800911z; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; DEGHENGHI R, 1993, BIOMED PHARMACOTHER, V47, P107, DOI 10.1016/0753-3322(93)90299-Z; Fantini J, 2009, BBA-BIOMEMBRANES, V1788, P2345, DOI 10.1016/j.bbamem.2009.08.016; Goodwin JA, 2007, MOL PHARMACOL, V72, P1484, DOI 10.1124/mol.107.038265; Grundker C, 2001, ENDOCRINOLOGY, V142, P2369, DOI 10.1210/en.142.6.2369; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Herold CL, 2004, J BIOL CHEM, V279, P11456, DOI 10.1074/jbc.M301734200; Hovelmann S, 2002, BIOCHEMISTRY-US, V41, P1129, DOI 10.1021/bi0113162; IMAI A, 1987, METHOD ENZYMOL, V141, P100; Inagaki Y, 2005, BIOCHEM J, V389, P187, DOI 10.1042/BJ20050046; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Janovick JA, 2007, MOL CELL ENDOCRINOL, V272, P77, DOI 10.1016/j.mce.2007.04.012; Javitch JA, 2000, BIOCHEMISTRY-US, V39, P12190, DOI 10.1021/bi001069m; Kenakin T, 2002, ANNU REV PHARMACOL, V42, P349, DOI 10.1146/annurev.pharmtox.42.091401.113012; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Lu Z. L., 2010, 92 ANN M END SOC SAN, P3; Lu ZL, 2007, J BIOL CHEM, V282, P17921, DOI 10.1074/jbc.M610413200; Lu ZL, 2005, J BIOL CHEM, V280, P29796, DOI 10.1074/jbc.M413520200; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; Lu ZL, 1997, MOL PHARMACOL, V51, P234, DOI 10.1124/mol.51.2.234; Mamputha S, 2007, MOL ENDOCRINOL, V21, P281, DOI 10.1210/me.2006-0150; Millar R, 1995, METH NEUROSCI, P145; Millar RP, 2008, FRONT NEUROENDOCRIN, V29, P17, DOI 10.1016/j.yfrne.2007.06.002; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Ott TR, 2002, MOL ENDOCRINOL, V16, P1079, DOI 10.1210/me.16.5.1079; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; Spassov VZ, 2008, PROTEIN ENG DES SEL, V21, P91, DOI 10.1093/protein/gzm083; Stewart AJ, 2008, MOL PHARMACOL, V73, P75, DOI 10.1124/mol.107.040816; Storjohann L, 2008, BIOCHEMISTRY-US, V47, P9198, DOI 10.1021/bi8005016; Tucci FC, 2005, J MED CHEM, V48, P1169, DOI 10.1021/jm049218c; Ulloa-Aguirre A, 1998, ENDOCRINOLOGY, V139, P2472, DOI 10.1210/en.139.5.2472; Unal H, 2010, J BIOL CHEM, V285, P16341, DOI 10.1074/jbc.M109.094870; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; White CD, 2008, MOL ENDOCRINOL, V22, P2520, DOI 10.1210/me.2008-0122; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	51	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34617	34626		10.1074/jbc.M111.240341	http://dx.doi.org/10.1074/jbc.M111.240341			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832286	Green Published, hybrid			2022-12-27	WOS:000295406300016
J	Srikanth, S; Yee, MKW; Gwack, Y; Ribalet, B				Srikanth, Sonal; Yee, Ma-Khin Win; Gwack, Yousang; Ribalet, Bernard			The Third Transmembrane Segment of Orai1 Protein Modulates Ca2+ Release-activated Ca2+ (CRAC) Channel Gating and Permeation Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CALCIUM-CHANNEL; 2-AMINOETHYLDIPHENYL BORATE; INWARD RECTIFICATION; POTASSIUM CHANNELS; FAST INACTIVATION; ION PERMEATION; PORE; STIM1; LYMPHOCYTES; SELECTIVITY	Orai1, the pore subunit of Ca2+ release-activated Ca2+ channels, has four transmembrane segments (TMs). The first segment, TMI, lines the pore and plays an important role in channel activation and ion permeation. TMIII, on the other hand, does not line the pore but still regulates channel gating and permeation properties. To understand the role of TMIII, we have mutated and characterized several residues in this domain. Mutation of Trp-176 to Cys (W176C) and Gly-183 to Ala (G183A) had dramatic effects. Unlike wild-type channels, which exhibit little outward current and are activated by STIM1, W176C mutant channels exhibited a large outward current at positive potentials and were constitutively active in the absence of STIM1. G183A mutant channels also exhibited substantial outward currents but were active only in the presence of 2-aminoethoxydiphenyl borate (2-APB), irrespective of STIM1. With W176C mutant channels inward, monovalent currents were blocked by Ca2+ with a high affinity similar to the wild type, but the Ca2+-dependent blocking of outward currents differed in the two cases. Although a 50% block of the WT outward current required 250 mu M Ca2+, more than 6 mM was necessary to have the same effect on W176C mutant channels. In the presence of extracellular Ca2+, W176C and G183A outward currents developed slowly in a voltage-dependent manner, whereas they developed almost instantaneously in the absence of Ca2+. These changes in permeation and gating properties mimic the changes induced by mutations of Glu-190 in TMIII and Asp-110/Asp-112 in the TMI/TMII loop. On the basis of these data, we propose that TMIII maintains negatively charged residues at or near the selectivity filter in a conformation that facilitates Ca2+ inward currents and prevents outward currents of monovalent cations. In addition, to controlling selectivity, TMIII may also stabilize channel gating in a closed state in the absence of STIM1 in a Trp-176-dependent manner.	[Gwack, Yousang] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gwack, Y (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, 53-266 CHS,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	ygwack@mednet.ucla.edu; bribalet@mednet.ucla.edu			National Institute of Health [AI-083432, AI-088393]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088393, R01AI083432] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institute of Health Grants AI-083432 and AI-088393 (to Y. G.). This work was also supported by a fellowship from the American Heart Association (to S. S.).	Babich O, 2007, J GEN PHYSIOL, V129, P477, DOI 10.1085/jgp.200709734; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Derler I, 2009, J BIOL CHEM, V284, P15903, DOI 10.1074/jbc.M808312200; Eghbali M, 2002, J MEMBRANE BIOL, V188, P73, DOI 10.1007/s00232-001-0173-3; Gwack Y., 2008, MOL CELL BIOL, V19, P2802; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Haug T, 2004, J GEN PHYSIOL, V124, P173, DOI 10.1085/jgp.200308949; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Lear JD, 1997, J AM CHEM SOC, V119, P3212, DOI 10.1021/ja9629672; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; LOPATIN AN, 1995, J GEN PHYSIOL, V106, P923, DOI 10.1085/jgp.106.5.923; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Prakriya M, 2009, IMMUNOL REV, V231, P88, DOI 10.1111/j.1600-065X.2009.00820.x; Putney JW, 2011, NEUROCHEM RES, V36, P1157, DOI 10.1007/s11064-010-0383-0; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Srikanth S, 2010, NAT CELL BIOL, V12, P436, DOI 10.1038/ncb2045; Srikanth S, 2010, J BIOL CHEM, V285, P5066, DOI 10.1074/jbc.M109.072736; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107	35	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35318	35328		10.1074/jbc.M111.265884	http://dx.doi.org/10.1074/jbc.M111.265884			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21865174	Green Published, hybrid			2022-12-27	WOS:000295406300085
J	Steenblock, ER; Fadel, T; Labowsky, M; Pober, JS; Fahmy, TM				Steenblock, Erin R.; Fadel, Tarek; Labowsky, Michael; Pober, Jordan S.; Fahmy, Tarek M.			An Artificial Antigen-presenting Cell with Paracrine Delivery of IL-2 Impacts the Magnitude and Direction of the T Cell Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOSOMAL INTERLEUKIN-2; SECONDARY EXPANSION; ANTITUMOR-ACTIVITY; MEMORY; DEATH; PROTEINS; INSIGHTS; SIGNALS; MODEL	Artificial antigen-presenting cells (aAPCs) are an emerging technology to induce therapeutic cellular immunity without the need for autologous antigen-presenting cells (APCs). To fully replace natural APCs, an optimized aAPC must present antigen (signal 1), provide costimulation (signal 2), and release cytokine (signal 3). Here we demonstrate that the spatial and temporal characteristics of paracrine release of IL-2 from biodegradable polymer aAPCs (now termed paAPCs) can significantly alter the balance in the activation and proliferation of CD8+ and CD4+ T cells. Paracrine delivery of IL-2 upon T cell contact with paAPCs induces significant IL-2 accumulation in the synaptic contact region. This accumulation increases CD25 (the inducible IL-2 R alpha chain) on responding T cells and increases proliferation of CD8+ T cells in vitro to levels 10 times that observed with equivalent amounts of bulk IL-2. These CD8+ T cell responses critically depend upon close contact of T cells and the paAPCs and require sustained release of low levels of IL-2. The same conditions promote activation-induced cell death in CD4+ T cells. These findings provide insight into the response of T cell subsets to paracrine IL-2.	[Steenblock, Erin R.; Fahmy, Tarek M.] Yale Univ, Dept Biomed Engn, New Haven, CT 06511 USA; [Fadel, Tarek; Fahmy, Tarek M.] Yale Univ, Dept Chem Engn, New Haven, CT 06511 USA; [Labowsky, Michael] Ansama Res LLC, Wayne, NJ USA; [Pober, Jordan S.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06511 USA	Yale University; Yale University; Yale University	Fahmy, TM (corresponding author), 55 Prospect St,MEC 412, New Haven, CT 06511 USA.	Tarek.Fahmy@yale.edu	Fadel, Tarek/GQQ-2682-2022	Fadel, Tarek/0000-0002-8416-5157	National Institutes of Health Autoimmunity Center of Excellence [HL051015]; United States Department of Homeland Security; National Science Foundation [0747577]	National Institutes of Health Autoimmunity Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Homeland Security(United States Department of Homeland Security (DHS)); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by a National Institutes of Health Autoimmunity Center of Excellence pilot award (to T. M. F.) and Grant HL051015 (to J. S. P.). This work was also supported by a United States Department of Homeland Security predoctoral fellowship (to E. S.) and National Science Foundation Career Award 0747577 (to T. M. F.).	Barouch DH, 2000, P NATL ACAD SCI USA, V97, P4192, DOI 10.1073/pnas.050417697; Blachere NE, 2006, J IMMUNOL, V176, P7288, DOI 10.4049/jimmunol.176.12.7288; CARLSSON R, 1985, CELL IMMUNOL, V96, P175, DOI 10.1016/0008-8749(85)90349-1; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; Fahmy TM, 2005, BIOMATERIALS, V26, P5727, DOI 10.1016/j.biomaterials.2005.02.025; Fakhrai H, 1997, J IMMUNOTHER, V20, P437, DOI 10.1097/00002371-199711000-00003; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Ganusov VV, 2007, J IMMUNOL, V179, P950, DOI 10.4049/jimmunol.179.2.950; Gillies SD, 2011, CLIN CANCER RES, V17, P3673, DOI 10.1158/1078-0432.CCR-10-2921; Granucci F, 2002, TRENDS IMMUNOL, V23, P169, DOI 10.1016/S1471-4906(02)02187-7; Granucci F, 2003, J IMMUNOL, V170, P5075, DOI 10.4049/jimmunol.170.10.5075; Hu PS, 2003, BLOOD, V101, P4853, DOI 10.1182/blood-2002-10-3089; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kanaoka E, 2002, J CONTROL RELEASE, V82, P183, DOI 10.1016/S0168-3659(02)00083-4; Kaufman HL, 2002, VACCINE, V20, P1862, DOI 10.1016/S0264-410X(02)00032-4; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Labowsky M, 2000, ANAL CHIM ACTA, V406, P105, DOI 10.1016/S0003-2670(99)00595-4; Labowsky M, 2010, RAPID COMMUN MASS SP, V24, P3079, DOI 10.1002/rcm.4738; Lai YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007766; LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Letourneau S, 2010, P NATL ACAD SCI USA, V107, P2171, DOI 10.1073/pnas.0909384107; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Neville ME, 2001, CYTOKINE, V16, P239, DOI 10.1006/cyto.2001.0963; Neville ME, 2000, CYTOKINE, V12, P1691, DOI 10.1006/cyto.2000.0769; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; Park J., 2011, J CONTROL RELEASE; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Shanafelt AB, 2000, NAT BIOTECHNOL, V18, P1197, DOI 10.1038/81199; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shrikant P, 2002, J IMMUNOL, V169, P1753, DOI 10.4049/jimmunol.169.4.1753; Steenblock ER, 2008, MOL THER, V16, P765, DOI 10.1038/mt.2008.11; Steenblock ER, 2009, EXPERT OPIN BIOL TH, V9, P451, DOI [10.1517/14712590902849216 , 10.1517/14712590902849216]; TEPPLER H, 1993, J EXP MED, V177, P483, DOI 10.1084/jem.177.2.483; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; YAMAGUCHI K, 1993, J CONTROL RELEASE, V24, P81, DOI 10.1016/0168-3659(93)90169-6	42	84	92	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34883	34892		10.1074/jbc.M111.276329	http://dx.doi.org/10.1074/jbc.M111.276329			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21849500	hybrid, Green Published			2022-12-27	WOS:000295406300042
J	Arora, PD; Wang, YQ; Janmey, PA; Bresnick, A; Yin, HL; McCulloch, CA				Arora, Pamma D.; Wang, Yongqiang; Janmey, Paul A.; Bresnick, Anne; Yin, Helen L.; McCulloch, Christopher A.			Gelsolin and Non-muscle Myosin IIA Interact to Mediate Calcium-regulated Collagen Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHORYLATION; GEL-SOL TRANSFORMATION; PLASMA GELSOLIN; TERMINAL HALF; F-ACTIN; MATRIX-METALLOPROTEINASE; GINGIVAL FIBROBLASTS; CELL-ADHESION; FISSION YEAST; NON-MUSCLE	The formation of adhesion complexes is the rate-limiting step for collagen phagocytosis by fibroblasts, but the role of Ca2+ and the potential interactions of actin-binding proteins in regulating collagen phagocytosis are not well defined. We found that the binding of collagen beads to fibroblasts was temporally and spatially associated with actin assembly at nascent phagosomes, which was absent in gelsolin null cells. Analysis of tryptic digests isolated from gelsolin immunoprecipitates indicated that nonmuscle (NM) myosin IIA may bind to gelsolin. Immunostaining and immunoprecipitation showed that gelsolin andNMmyosin IIA associated at collagen adhesion sites. Gelsolin andNMmyosin IIA were both required for collagen binding and internalization. Collagen binding to cells initiated a prolonged increase of [Ca2+](i), which was absent in cells null for gelsolin or NM myosin IIA. Collagen bead-induced increases of [Ca2+](i) were associated with phosphorylation of the myosin light chain, which was dependent on gelsolin. NM myosin IIA filament assembly, which was dependent on myosin light chain phosphorylation and increased [Ca2+](i), also required gelsolin. Ionomycin-induced increases of [Ca2+](i) overcame the block of myosin filament assembly in gelsolin null cells. We conclude that gelsolin andNMmyosin IIA interact at collagen adhesion sites to enable NM myosin IIA filament assembly and localized, Ca2+-dependent remodeling of actin at the nascent phagosome and that these steps are required for collagen phagocytosis.	[Arora, Pamma D.; Wang, Yongqiang; McCulloch, Christopher A.] Univ Toronto, Matrix Dynam Grp, Toronto, ON M5S 3E2, Canada; [Janmey, Paul A.] Univ Penn 19104, Dept Biomed Engn, Philadelphia, PA 19104 USA; [Bresnick, Anne] Albert Einstein Med Sch, Dept Biochem, Bronx, NY 10461 USA; [Yin, Helen L.] Univ SW Texas Med Sch, Dept Physiol, Dallas, TX 75390 USA	University of Toronto; University of Pennsylvania; Yeshiva University	McCulloch, CA (corresponding author), Rm 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mcculloch@utoronto.ca			Canadian Institutes of Health Research [MOP 36332]; Ontario Heart and Stroke Operating Grant [T6022]; Canada Research Chair (Tier 1) in Matrix Dynamics	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Heart and Stroke Operating Grant; Canada Research Chair (Tier 1) in Matrix Dynamics(Canada Research Chairs)	This work was supported by Canadian Institutes of Health Research Operating Grant MOP 36332 (to C. A. M.) and by Ontario Heart and Stroke Operating Grant T6022 (to C. A. M.). C. A. M. is also supported by a Canada Research Chair (Tier 1) in Matrix Dynamics.	Arora PD, 2008, MOL BIOL CELL, V19, P5032, DOI 10.1091/mbc.E08-04-0430; Arora PD, 2005, MOL BIOL CELL, V16, P5175, DOI 10.1091/mbc.E05-07-0648; Arora PD, 2004, MOL BIOL CELL, V15, P588, DOI 10.1091/mbc.E03-07-0468; Arora PD, 2003, EXP CELL RES, V286, P366, DOI 10.1016/S0014-4827(03)00096-X; ARORA PD, 1994, J CELL PHYSIOL, V161, P187, DOI 10.1002/jcp.1041610202; Arora PD, 2000, J BIOL CHEM, V275, P35432, DOI 10.1074/jbc.M003221200; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; CHAPONNIER C, 1986, J CELL BIOL, V103, P1473, DOI 10.1083/jcb.103.4.1473; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; CRAIG R, 1983, NATURE, V302, P436, DOI 10.1038/302436a0; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; Defacque H, 2000, CYTOMETRY, V41, P46, DOI 10.1002/1097-0320(20000901)41:1<46::AID-CYTO7>3.0.CO;2-F; Defacque H, 2002, MOL BIOL CELL, V13, P1190, DOI 10.1091/mbc.01-06-0314; Defacque H, 2000, EMBO J, V19, P199, DOI 10.1093/emboj/19.2.199; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011; Ferrari MB, 2006, CELL BIOCHEM BIOPHYS, V45, P317, DOI 10.1385/CBB:45:3:317; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; HARTWIG JH, 1992, J CELL BIOL, V118, P1421, DOI 10.1083/jcb.118.6.1421; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Huang Y, 2009, J CELL SCI, V122, P1637, DOI 10.1242/jcs.046219; Humphrey D, 2002, NATURE, V416, P413, DOI 10.1038/416413; Humphries MJ, 2003, TRENDS BIOCHEM SCI, V28, P313, DOI 10.1016/S0968-0004(03)00112-9; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ip K, 2007, CELL PHYSIOL BIOCHEM, V20, P649, DOI 10.1159/000107548; Isik N, 2008, DEV CELL, V15, P590, DOI 10.1016/j.devcel.2008.08.006; JACOBSON K, 1984, P NATL ACAD SCI-BIOL, V81, P6747, DOI 10.1073/pnas.81.21.6747; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; JANMEY PA, 1985, BIOCHEMISTRY-US, V24, P3714, DOI 10.1021/bi00335a046; Kiselar JG, 2003, P NATL ACAD SCI USA, V100, P3942, DOI 10.1073/pnas.0736004100; KNOWLES GC, 1991, J CELL SCI, V98, P551; Krause KH, 2000, SCHWEIZ MED WSCHR, V130, P97; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; Lee HJ, 2006, MOL BIOL CELL, V17, P4812, DOI 10.1091/mbc.E06-06-0486; LIND SE, 1988, AM REV RESPIR DIS, V138, P429, DOI 10.1164/ajrccm/138.2.429; MCGAW WT, 1983, J INVEST DERMATOL, V81, P375, DOI 10.1111/1523-1747.ep12519983; MELCHER AH, 1981, J ULTRA MOL STRUCT R, V77, P1, DOI 10.1016/S0022-5320(81)80064-0; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Narayan K, 2003, FEBS LETT, V552, P82, DOI 10.1016/S0014-5793(03)00933-5; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; Nyakern-Meazza M, 2002, J BIOL CHEM, V277, P28774, DOI 10.1074/jbc.M203360200; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; PEREZTAMAYO R, 1978, AM J PATHOL, V92, P509; POPE B, 1991, FEBS LETT, V280, P70, DOI 10.1016/0014-5793(91)80206-I; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; SCHOLEY JM, 1980, NATURE, V287, P233, DOI 10.1038/287233a0; Segal G, 2001, J CELL SCI, V114, P119; Selden LA, 1998, BIOPHYS J, V75, P3092, DOI 10.1016/S0006-3495(98)77750-1; Serrander L, 2000, J IMMUNOL, V165, P2451, DOI 10.4049/jimmunol.165.5.2451; SMITH RC, 1983, PHILOS T ROY SOC B, V302, P73, DOI 10.1098/rstb.1983.0039; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; TANSEY MG, 1994, J BIOL CHEM, V269, P9912; TENCATE AR, 1972, J ANAT, V112, P401; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Wang J, 2001, J BIOL CHEM, V276, P14474, DOI 10.1074/jbc.M007324200; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590; WAY M, 1989, J CELL BIOL, V109, P593, DOI 10.1083/jcb.109.2.593; Weeds A, 1993, CURR OPIN CELL BIOL, V5, P63, DOI 10.1016/S0955-0674(05)80009-2; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; YIN HL, 1981, J CELL BIOL, V91, P901, DOI 10.1083/jcb.91.3.901; Yumura S, 2005, MOL BIOL CELL, V16, P4256, DOI 10.1091/mbc.E05-03-0219	79	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34184	34198		10.1074/jbc.M111.247783	http://dx.doi.org/10.1074/jbc.M111.247783			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828045	Green Published, hybrid			2022-12-27	WOS:000295159200049
J	Nunziante, M; Ackermann, K; Dietrich, K; Wolf, H; Gadtke, L; Gilch, S; Vorberg, I; Groschup, M; Schatzl, HM				Nunziante, Max; Ackermann, Kerstin; Dietrich, Kim; Wolf, Hanna; Gaedtke, Lars; Gilch, Sabine; Vorberg, Ina; Groschup, Martin; Schaetzl, Hermann M.			Proteasomal Dysfunction and Endoplasmic Reticulum Stress Enhance Trafficking of Prion Protein Aggregates through the Secretory Pathway and Increase Accumulation of Pathologic Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFECTED CELLS; NEURODEGENERATIVE DISEASES; QUALITY-CONTROL; CULTURED-CELLS; CELLULAR PRION; RETROGRADE TRANSPORT; TRANSMEMBRANE FORM; MOLECULAR-BASIS; NEURONAL CELLS; SCRAPIE PRIONS	A conformational change of the cellular prion protein (PrPc) underlies formation of PrPSc, which is closely associated with pathogenesis and transmission of prion diseases. The precise conformational prerequisites and the cellular environment necessary for this post-translational process remain to be completely elucidated. At steady state, glycosylated PrPc is found primarily at the cell surface, whereas a minor fraction of the population is disposed of by the ER-associated degradation-proteasome pathway. However, chronic ER stress conditions and proteasomal dysfunctions lead to accumulation of aggregation-prone PrP molecules in the cytosol and to neurodegeneration. In this study, we challenged different cell lines by inducing ER stress or inhibiting proteasomal activity and analyzed the subsequent repercussion on PrP metabolism, focusing on PrP in the secretory pathway. Both events led to enhanced detection of PrP aggregates and a significant increase of PrPSc in persistently prion-infected cells, which could be reversed by overexpression of proteins of the cellular quality control. Remarkably, upon proteasomal impairment, an increased fraction of misfolded, fully glycosylated PrP molecules traveled through the secretory pathway and reached the plasma membrane. These findings suggest a novel pathway that possibly provides additional substrate and template necessary for prion formation when protein clearance by the proteasome is impaired.	[Schaetzl, Hermann M.] Univ Wyoming, Dept Vet Sci, MICRO Mol Biol, UW Shipping, Laramie, WY 82071 USA; [Gilch, Sabine; Schaetzl, Hermann M.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Nunziante, Max; Ackermann, Kerstin; Dietrich, Kim; Wolf, Hanna; Gaedtke, Lars; Gilch, Sabine; Vorberg, Ina; Schaetzl, Hermann M.] Tech Univ Munich, Inst Virol, Prion Res Grp, D-81675 Munich, Germany; [Groschup, Martin] Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, D-17493 Greifswald, Riems, Germany	University of Wyoming; University of Wyoming; Technical University of Munich; Friedrich Loeffler Institute	Schatzl, HM (corresponding author), Univ Wyoming, Dept Vet Sci, MICRO Mol Biol, UW Shipping, 16th & Gibbons St, Laramie, WY 82071 USA.	hschatzl@uwyo.edu	Schatzl, Hermann/G-4958-2011	Schatzl, Hermann/0000-0003-4972-8740	Deutsche Forschungsgemeinschaft [Scha594/7-1, SFB-596, A8]; Alberta Prion Research Institute, Alberta, Canada [20080238, 20090122]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alberta Prion Research Institute, Alberta, Canada	This work was also supported by Deutsche Forschungsgemeinschaft Scha594/7-1, SFB-596 (Project A8), and Alberta Prion Research Institute, Alberta, Canada (Projects 20080238 and 20090122).	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Beranger F, 2002, J BIOL CHEM, V277, P38972, DOI 10.1074/jbc.M205110200; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Campana V, 2006, J CELL SCI, V119, P433, DOI 10.1242/jcs.02768; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Daude N, 1997, J BIOL CHEM, V272, P11604, DOI 10.1074/jbc.272.17.11604; Dron M, 2009, J GEN VIROL, V90, P2050, DOI 10.1099/vir.0.010082-0; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Gu YP, 2003, J NEUROCHEM, V84, P10, DOI 10.1046/j.1471-4159.2003.01255.x; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Jin TC, 2000, J BIOL CHEM, V275, P38699, DOI 10.1074/jbc.M005543200; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Narwa R, 1999, BIOCHEMISTRY-US, V38, P8770, DOI 10.1021/bi990736c; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nunziante M, 2003, J BIOL CHEM, V278, P3726, DOI 10.1074/jbc.M206313200; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Prusiner SB, 1997, ANNU REV GENET, V31, P139, DOI 10.1146/annurev.genet.31.1.139; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saborio GP, 1999, BIOCHEM BIOPH RES CO, V258, P470, DOI 10.1006/bbrc.1999.0660; Schatzl HM, 1997, J VIROL, V71, P8821; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen XH, 2004, J CHEM NEUROANAT, V28, P79, DOI 10.1016/j.jchemneu.2004.02.006; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Tatzelt J, 1996, EMBO J, V15, P6363, DOI 10.1002/j.1460-2075.1996.tb01027.x; Tatzelt J, 2007, FEBS J, V274, P606, DOI 10.1111/j.1742-4658.2007.05633.x; Uelhoff A, 2005, J BIOL CHEM, V280, P5137, DOI 10.1074/jbc.C400560200; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396	76	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33942	33953		10.1074/jbc.M111.272617	http://dx.doi.org/10.1074/jbc.M111.272617			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21835918	hybrid, Green Published			2022-12-27	WOS:000295159200026
J	Nottingham, RM; Ganley, IG; Barr, FA; Lambright, DG; Pfeffer, SR				Nottingham, Ryan M.; Ganley, Ian G.; Barr, Francis A.; Lambright, David G.; Pfeffer, Suzanne R.			RUTBC1 Protein, a Rab9A Effector That Activates GTP Hydrolysis by Rab32 and Rab33B Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; TRANS-GOLGI NETWORK; LATE ENDOSOMES; HUMAN-CELLS; FAMILY; TRAFFICKING; DOMAIN; GTPASES; IDENTIFICATION; RECRUITMENT	Rab GTPases regulate all steps of membrane trafficking. Their interconversion between active, GTP-bound states and inactive, GDP-bound states is regulated by guanine nucleotide exchange factors and GTPase-activating proteins. The substrates for most Rab GTPase-activating proteins (GAPs) are unknown. Rab9A and its effectors regulate transport of mannose 6-phosphate receptors from late endosomes to the trans-Golgi network. We show here that RUTBC1 is a Tre2/Bub2/Cdc16 domain-containing protein that binds to Rab9A-GTP both in vitro and in cultured cells, but is not a GTPase-activating protein for Rab9A. Biochemical screening of RUTBC1 Rab protein substrates revealed highest in vitro GTP hydrolysis-activating activity with Rab32 and Rab33B. Catalysis required Arg-803 of RUTBC1, and RUTBC1 could activate a catalytically inhibited Rab33B mutant (Q92A), in support of a dual finger mechanism for RUTBC1 action. Rab9A binding did not influence GAP activity of bead-bound RUTBC1 protein. In cells and cell extracts, RUTBC1 influenced the ability of Rab32 to bind its effector protein, Varp, consistent with a physiological role for RUTBC1 in regulating Rab32. In contrast, binding of Rab33B to its effector protein, Atg16L1, was not influenced by RUTBC1 in cells or extracts. The identification of a protein that binds Rab9A and inactivates Rab32 supports a model in which Rab9A and Rab32 act in adjacent pathways at the boundary between late endosomes and the biogenesis of lysosome-related organelles.	[Nottingham, Ryan M.; Ganley, Ian G.; Pfeffer, Suzanne R.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Barr, Francis A.] Univ Liverpool, Canc Res Ctr, Liverpool L3 9TA, Merseyside, England; [Lambright, David G.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Stanford University; University of Liverpool; University of Massachusetts System; University of Massachusetts Worcester	Pfeffer, SR (corresponding author), 279 Campus Dr B400, Stanford, CA 94305 USA.	pfeffer@stanford.edu		Barr, Francis/0000-0001-7518-253X; Ganley, Ian/0000-0003-1481-9407	National Institutes of Health [DK37332, GM007276]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK037332, R56DK037332, R01DK037332] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_A500_1019] Funding Source: researchfish; MRC [MC_UP_A500_1019] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported, in whole or in part, by National Institutes of Health Grant DK37332 (to S. R. P.).; Supported by National Institutes of Health Training Grant GM007276.	Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; Albert S, 1999, J BIOL CHEM, V274, P33186, DOI 10.1074/jbc.274.47.33186; Bao XK, 2002, EUR J BIOCHEM, V269, P259, DOI 10.1046/j.0014-2956.2001.02645.x; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Callebaut I, 2001, TRENDS BIOCHEM SCI, V26, P79, DOI 10.1016/S0968-0004(00)01730-8; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Espinosa EJ, 2009, CELL, V137, P938, DOI 10.1016/j.cell.2009.03.043; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hirota Y, 2009, CELL MOL LIFE SCI, V66, P2913, DOI 10.1007/s00018-009-0080-9; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Janoueix-Lerosey I, 1998, EUR J BIOCHEM, V252, P290, DOI 10.1046/j.1432-1327.1998.2520290.x; Jiang S, 2005, MOL BIOL CELL, V16, P2586, DOI 10.1091/mbc.e04-10-0861; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Ma JP, 2004, P NATL ACAD SCI USA, V101, P11652, DOI 10.1073/pnas.0401926101; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P243, DOI 10.1016/S0968-0004(97)01073-6; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Park M, 2007, CURR BIOL, V17, P2030, DOI 10.1016/j.cub.2007.10.051; Peck GR, 2009, J BIOL CHEM, V284, P30016, DOI 10.1074/jbc.M109.035568; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Shutes A, 2005, METHODS, V37, P183, DOI 10.1016/j.ymeth.2005.05.019; Sklan EH, 2007, J BIOL CHEM, V282, P36354, DOI 10.1074/jbc.M705221200; Starr T, 2010, TRAFFIC, V11, P626, DOI 10.1111/j.1600-0854.2010.01051.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Valsdottir R, 2001, FEBS LETT, V508, P201, DOI 10.1016/S0014-5793(01)02993-3; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Will E, 2001, METHOD ENZYMOL, V329, P50; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang H, 2007, GENOMICS, V90, P249, DOI 10.1016/j.ygeno.2007.03.013; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Zheng JY, 1998, J CELL SCI, V111, P1061	55	46	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33213	33222		10.1074/jbc.M111.261115	http://dx.doi.org/10.1074/jbc.M111.261115			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808068	hybrid, Green Published			2022-12-27	WOS:000294968800040
J	Zambon, AC; Wilderman, A; Ho, A; Insel, PA				Zambon, Alexander C.; Wilderman, Andrea; Ho, Angela; Insel, Paul A.			Increased Expression of the Pro-apoptotic Protein BIM, a Mechanism for cAMP/Protein Kinase A (PKA)-induced Apoptosis of Immature T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; GLUCOCORTICOID-INDUCED APOPTOSIS; S49 LYMPHOMA-CELLS; BCL-2 RELATIVE BIM; CYCLIC-AMP; BH3-ONLY PROTEIN; CD4(+)CD8(+) THYMOCYTES; SIGNALING PATHWAY; DNA FRAGMENTATION; DEPENDENT PATHWAY	The second messenger cAMP is proapoptotic for numerous cell types, but the mechanism for this proapoptotic action is not defined. Here, we use murine CD4(+)/CD8(+) S49 lymphoma cells and isolated thymocytes to assess this mechanism. In WT S49 cells, cAMP acts via protein kinase A (PKA) to induce G(1) phase cell cycle arrest and apoptosis. Treatment of WT and cAMP-Deathless (D-) S49 cells, which lack cAMP-promoted apoptosis, with the PKA agonist 8-(4-chlorophenylthio)-cAMP (CPT-cAMP) differentially regulates transcripts for numerous proapoptotic and antiapoptotic proteins. In contrast, kin-S49 cells (which lack PKA) show no cAMP-promoted changes in transcript expression. In this study, we use knockdown and overexpression approaches to define the role in cAMP/PKA-promoted apoptosis of the proapoptotic factor BIM (Bcl-2 interacting mediator of cell death), whose expression prominently increases in response to CPT-cAMP treatment of WT but not D-or kin-S49 cells. Conditional expression of BimL, one of the three major forms of Bim, increases apoptosis of WT, D-, and kin-S49 cells, whereas inhibition of cAMP-mediated induction of Bim isoforms by shRNAi attenuates CPT-cAMP-mediated apoptosis of WT S49 cells. Bim protein levels increase in subpopulations of CPT-cAMP-treated cells that undergo apoptosis. Thymic CD4(+)/CD8(+) cells isolated from Bim(-/-) mice corroborated the requirement of Bim expression for cAMP-promoted apoptosis. Thus, up-regulation of Bim appears to be an important determinant of cAMP/PKA-mediated apoptosis in immature T cells and may be a mechanism for such apoptosis in other cell types as well.	[Zambon, Alexander C.; Wilderman, Andrea; Ho, Angela; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Zambon, Alexander C.; Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Zambon, AC (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	azambon@ucsd.edu		Wilderman, Andrea/0000-0002-4832-9476	IRACDA National Institutes of Health [GM068524]; American Heart Association [10SDG2630130]; Lymphoma and Leukemia Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	IRACDA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Lymphoma and Leukemia Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by IRACDA National Institutes of Health Grant GM068524 and research grants. This work was also supported by American Heart Association Scientist Development Grant 10SDG2630130 and research grants from the Lymphoma and Leukemia Society.	Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chang HS, 2000, CELL IMMUNOL, V203, P29, DOI 10.1006/cimm.2000.1668; Cillessen SAGM, 2010, J PATHOL, V220, P509, DOI 10.1002/path.2670; COFFINO P, 1978, CANCER RES, V38, P4285; COFFINO P, 1975, AM J PATHOL, V81, P199; Danilov AV, 2006, CURR MOL MED, V6, P665, DOI 10.2174/156652406778195008; DRAPPA J, 1993, P NATL ACAD SCI USA, V90, P10340, DOI 10.1073/pnas.90.21.10340; Gillings AS, 2009, FEBS J, V276, P6050, DOI 10.1111/j.1742-4658.2009.07329.x; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GUNJI H, 1992, J CLIN INVEST, V89, P954, DOI 10.1172/JCI115677; Haker G, 2007, ARCH BIOCHEM BIOPHYS, V462, P150, DOI 10.1016/j.abb.2006.12.022; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Heinrichs S, 2003, ONCOGENE, V22, P555, DOI 10.1038/sj.onc.1206138; Insel P. A., 2011, ACTA PHYSL, DOI [10.1111/j.1748-1716.2011.2273.x, DOI 10.1111/J.1748-1716.2011.2273.X]; Ivanov VN, 1997, J BIOL CHEM, V272, P8558; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Ji ZY, 2008, J BIOL CHEM, V283, P21920, DOI 10.1074/jbc.M803193200; Kfir-Erenfeld S, 2010, LEUKEMIA LYMPHOMA, V51, P1968, DOI 10.3109/10428194.2010.506570; Kozuma Y, 2010, J THROMB HAEMOST, V8, P1088, DOI 10.1111/j.1538-7836.2010.03785.x; LEMAIRE I, 1977, CELL, V11, P149, DOI 10.1016/0092-8674(77)90325-7; LEPOSAVIC G, 1992, THYMUS, V19, P77; Lerner A, 2006, BIOCHEM J, V393, P21, DOI 10.1042/BJ20051368; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Magnani E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-46; Manganini M, 2002, HUM GENE THER, V13, P1793, DOI 10.1089/104303402760372909; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Martin MC, 2001, J BIOL CHEM, V276, P45041, DOI 10.1074/jbc.M105197200; Medh RD, 1998, CANCER RES, V58, P3684; Miao J, 2007, APOPTOSIS, V12, P1691, DOI 10.1007/s10495-007-0093-5; Molitoris JK, 2011, MOL ENDOCRINOL, V25, P409, DOI 10.1210/me.2010-0402; Moon EY, 2003, BLOOD, V101, P4122, DOI 10.1182/blood-2002-10-3208; Naviglio S, 2009, EXPERT OPIN THER TAR, V13, P83, DOI [10.1517/14728220802602349, 10.1517/14728220802602349 ]; Nishihara H, 2003, P NATL ACAD SCI USA, V100, P8921, DOI 10.1073/pnas.1533221100; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; Singh K, 2001, J CELL PHYSIOL, V189, P257, DOI 10.1002/jcp.10024; Suter DM, 2006, STEM CELLS, V24, P615, DOI 10.1634/stemcells.2005-0226; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang Y, 2006, APOPTOSIS, V11, P441, DOI 10.1007/s10495-005-4293-6; Wang ZQ, 2003, J BIOL CHEM, V278, P23861, DOI 10.1074/jbc.M301843200; Xing Y, 2008, MOL IMMUNOL, V45, P2028, DOI 10.1016/j.molimm.2007.10.028; Yan LZ, 2000, AM J PHYSIOL-CELL PH, V279, pC1665, DOI 10.1152/ajpcell.2000.279.5.C1665; Zambon AC, 2005, P NATL ACAD SCI USA, V102, P8561, DOI 10.1073/pnas.0503363102; Zhang LZ, 2008, J BIOL CHEM, V283, P4304, DOI 10.1074/jbc.M708673200; Zhang LZ, 2008, P NATL ACAD SCI USA, V105, P19532, DOI 10.1073/pnas.0806152105; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200	50	31	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33260	33267		10.1074/jbc.M111.268979	http://dx.doi.org/10.1074/jbc.M111.268979			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808067	hybrid, Green Published			2022-12-27	WOS:000294968800045
J	Rath, P; Demange, P; Saurel, O; Tropis, M; Daffe, M; Dotsch, V; Ghazi, A; Bernhard, F; Milon, A				Rath, Parthasarathi; Demange, Pascal; Saurel, Olivier; Tropis, Marielle; Daffe, Mamadou; Doetsch, Volker; Ghazi, Alexandre; Bernhard, Frank; Milon, Alain			Functional Expression of the PorAH Channel from Corynebacterium glutamicum in Cell-free Expression Systems IMPLICATIONS FOR THE ROLE OF THE NATURALLY OCCURRING MYCOLIC ACID MODIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE-PROTEINS; OUTER-MEMBRANE; FORMING PROTEIN; WALL; IDENTIFICATION; DETERGENTS; PORINS; MYCOBACTERIA; EXISTENCE; REVEAL	PorA and PorH are two small membrane proteins from the outer membrane of Corynebacterium glutamicum, which have been shown to form heteromeric ion channels and to be post-translationally modified by mycolic acids. Any structural details of the channel could not be analyzed so far due to tremendous difficulties in the production of sufficient amounts of protein samples. Cell-free (CF) expression is a new and remarkably successful strategy for the production of membrane proteins for which toxicity, membrane targeting, and degradation are key issues. In addition, reaction conditions can easily be modified to modulate the quality of synthesized protein samples. We developed an efficient CF expression strategy to produce the channel subunits devoid of post-translational modifications. N-15-labeled PorA and PorH samples were furthermore characterized by NMR and gave well resolved spectra, opening the way for structural studies. The comparison of ion channel activities of CF-expressed proteins with channels isolated from C. glutamicum gave clear insights on the influence of the mycolic acid modification of the two subunits on their functional properties.	[Rath, Parthasarathi; Demange, Pascal; Saurel, Olivier; Tropis, Marielle; Daffe, Mamadou; Milon, Alain] Inst Pharmacol & Biol Struct, CNRS, UMR 5089, F-31077 Toulouse 04, France; [Rath, Parthasarathi; Demange, Pascal; Saurel, Olivier; Tropis, Marielle; Daffe, Mamadou; Milon, Alain] Univ Toulouse UPS, IPBS, F-31062 Toulouse, France; [Ghazi, Alexandre] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulair, UMR8619, F-91405 Orsay, France; [Doetsch, Volker; Bernhard, Frank] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Inst Biophys Chem, D-60438 Mainz, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Goethe University Frankfurt	Demange, P (corresponding author), Inst Pharmacol & Biol Struct, CNRS, UMR 5089, 205 Rte Narbonne, F-31077 Toulouse 04, France.	pascal.demange@ipbs.fr; alain.milon@ipbs.fr	Olivier, Saurel/AAQ-7007-2020; demange, pascal JP/U-3561-2018; MILON, Alain/B-3767-2010	demange, pascal JP/0000-0002-9572-9990; MILON, Alain/0000-0001-5692-8201; Dotsch, Volker/0000-0001-5720-212X; Bernhard, Frank/0000-0002-4860-1783; Saurel, Olivier/0000-0003-1439-4103	European Community [FP7/2007-2013, 211800]; European Drug Initiative on Channels and Transporters [HEALTH-F4-2007-201924];  [SFB 807]	European Community(European Commission); European Drug Initiative on Channels and Transporters; 	This work was supported by the European Community's Seventh Framework Programme FP7/2007-2013 (Grant 211800) and from the European Drug Initiative on Channels and Transporters (Grant HEALTH-F4-2007-201924) and by the SFB 807 "Transport across membranes."	Abdine A, 2010, J MAGN RESON, V204, P155, DOI 10.1016/j.jmr.2010.02.003; Barth E, 2010, J BACTERIOL, V192, P786, DOI 10.1128/JB.01142-09; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; Berrier C, 2004, BIOCHEMISTRY-US, V43, P12585, DOI 10.1021/bi049049y; Berrier C, 1997, J MEMBRANE BIOL, V156, P105, DOI 10.1007/s002329900193; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Costa-Riu N, 2003, MOL MICROBIOL, V50, P1295, DOI 10.1046/j.1365-2958.2003.03754.x; Daffe M., 2005, HDB CORYNEBACTERIUM, P121; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Huc E, 2010, J BIOL CHEM, V285, P21908, DOI 10.1074/jbc.C110.133033; Hunten P, 2005, BBA-BIOMEMBRANES, V1715, P25, DOI 10.1016/j.bbamem.2005.07.011; Kai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012972; Klackta C, 2011, BBA-BIOMEMBRANES, V1808, P1601, DOI 10.1016/j.bbamem.2010.11.011; Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x; Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x; Klammt C, 2006, FEBS J, V273, P4141, DOI 10.1111/j.1742-4658.2006.05432.x; Koglin A, 2006, MAGN RESON CHEM, V44, pS17, DOI 10.1002/mrc.1833; Lichtinger T, 1998, BIOCHEMISTRY-US, V37, P15024, DOI 10.1021/bi980961e; Maslennikov I, 2010, P NATL ACAD SCI USA, V107, P10902, DOI 10.1073/pnas.1001656107; Massari P, 2003, TRENDS MICROBIOL, V11, P87, DOI 10.1016/S0966-842X(02)00037-9; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Reckel S, 2008, P NATL ACAD SCI USA, V105, P8262, DOI 10.1073/pnas.0710843105; Reckel S, 2010, METHODS MOL BIOL, V607, P187, DOI 10.1007/978-1-60327-331-2_16; Renault M, 2009, J MOL BIOL, V385, P117, DOI 10.1016/j.jmb.2008.10.021; SAMBROOK J, 2000, MOL CLONING LAB MANU; Savage DF, 2007, PROTEIN SCI, V16, P966, DOI 10.1110/ps.062696307; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schiffler B, 2007, J BACTERIOL, V189, P7709, DOI 10.1128/JB.00864-07; Schneider B, 2010, METHODS MOL BIOL, V601, P165, DOI 10.1007/978-1-60761-344-2_11; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Shirokov Vladimir A., 2007, V375, P19; Svetlikova Z, 2009, ANTIMICROB AGENTS CH, V53, P4015, DOI 10.1128/AAC.00590-09; Thein M, 2008, J BACTERIOL, V190, P7035, DOI 10.1128/JB.00818-08; Wuu JJ, 2008, BBA-BIOMEMBRANES, V1778, P1237, DOI 10.1016/j.bbamem.2008.01.023; Yeung YG, 2008, ANAL BIOCHEM, V382, P135, DOI 10.1016/j.ab.2008.07.034; Ziegler K, 2008, J MOL BIOL, V379, P482, DOI 10.1016/j.jmb.2008.04.017; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	39	20	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32525	32532		10.1074/jbc.M111.276956	http://dx.doi.org/10.1074/jbc.M111.276956			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21799011	Green Published, hybrid			2022-12-27	WOS:000294726800062
J	Boroughs, LK; Antonyak, MA; Johnson, JL; Cerione, RA				Boroughs, Lindsey K.; Antonyak, Marc A.; Johnson, Jared L.; Cerione, Richard A.			A Unique Role for Heat Shock Protein 70 and Its Binding Partner Tissue Transglutaminase in Cancer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVASION; LOCALIZATION; PROTRUSION; EXPRESSION; PROTEINS; ADHESION; BREAST; ACTIN	Cell migration is essential for several important biological outcomes and is involved in various developmental disorders and disease states including cancer cell invasiveness and metastasis. A fundamental step in cell migration is the development of a leading edge. By using HeLa carcinoma cells as an initial model system, we uncovered a surprising role for the heat shock protein 70 (Hsp70) and its ability to bind the protein cross-linking enzyme, tissue transglutaminase (tTG), in cancer cell migration. Treatment of HeLa cells with EGF results in the activation of a plasma membrane-associated pool of tTG and its redistribution to the leading edges of these cells, which are essential events for EGF-stimulated HeLa cell migration. However, we then found that the ability of tTG to be localized to the leading edge is dependent on Hsp70. Similarly, the localization of tTG to the leading edges of MDAMB231 breast carcinoma cells, where it also plays an essential role in their migration, has a strict requirement for Hsp70. Treatment of these different cell lines with inhibitors against the ATP hydrolytic activity of Hsp70 prevented tTG from localizing to their leading edges and thereby blocked EGF-stimulated HeLa cell migration, as well as the constitutive migration normally exhibited by MDAMB231 cells. These findings highlight a new and unconventional role for the chaperonin activity of Hsp70 in the localization of a key regulatory protein (tTG) at the leading edges of cancer cells and the important consequences that this holds for their ability to migrate.	[Boroughs, Lindsey K.; Antonyak, Marc A.; Johnson, Jared L.; Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu		Johnson, Jared/0000-0003-1802-6527	National Institutes of Health [GM061762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM061762.	Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Arispe N, 2004, FASEB J, V18, P1636, DOI 10.1096/fj.04-2088com; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dafik L, 2011, CHEM BIOL, V18, P58, DOI 10.1016/j.chembiol.2010.11.004; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Datta S, 2007, BIOCHEMISTRY-US, V46, P14819, DOI 10.1021/bi701422h; Datta S, 2006, BIOCHEMISTRY-US, V45, P13163, DOI 10.1021/bi0606795; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gehrmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001925; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Jego G., 2010, CANC LETT IN PRESS; Jiang DF, 2003, PROTEOMICS, V3, P724, DOI 10.1002/pmic.200300411; Johnson JL, 2009, J BIOL CHEM, V284, P23860, DOI 10.1074/jbc.M109.031815; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Raja, 2007, Front Biosci, V12, P2849; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Singer CF, 2006, CLIN EXP METASTAS, V23, P33, DOI 10.1007/s10585-006-9015-0; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Yip SC, 2007, J CELL SCI, V120, P3138, DOI 10.1242/jcs.005298	33	35	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37094	37107		10.1074/jbc.M111.242438	http://dx.doi.org/10.1074/jbc.M111.242438			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896482	Green Published, hybrid			2022-12-27	WOS:000296542400010
J	Huang, YC; Cohen, JC; Hobbs, HH				Huang, Yongcheng; Cohen, Jonathan C.; Hobbs, Helen H.			Expression and Characterization of a PNPLA3 Protein Isoform (I148M) Associated with Nonalcoholic Fatty Liver Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; CHANARIN-DORFMAN-SYNDROME; PATATIN; GENE; SUSCEPTIBILITY; CGI-58; FAMILY; ESTERS	A genetic variant of PNPLA3 (patatin-like phospholipase domain-containing 3; PNPLA3-I148M), a serine protease of unknown function, is associated with accumulation of triacylglycerol (TAG) in the liver. To determine the biological substrates of PNPLA3 and the effect of the I148M substitution on enzymatic activity and substrate specificity, we purified and characterized recombinant human PNPLA3 and PNPLA3-I148M. Maximal hydrolytic activity of PNPLA3 was observed against the three major glycerolipids, TAG, diacylglycerol, and monoacylglycerol, with a strong preference for oleic acid as the acyl moiety. Substitution of methionine for isoleucine at position 148 markedly decreased the V-max of the enzyme for glycerolipids but had only a modest effect on the K-m. Purified PNPLA3 also catalyzed the hydrolysis of oleoyl-CoA, but the V-max was 100-fold lower for oleoyl-CoA than for triolein. The thioesterase activity required the catalytic serine but was only modestly decreased by the I148M substitution. The enzyme had little or no hydrolytic activity against the other lipid substrates tested, including phospholipids, cholesteryl ester, and retinyl esters. Neither the wild-type nor mutant enzyme catalyzed transfer of oleic acid from oleoyl-CoA to glycerophosphate, lysophosphatidic acid, or diacylglycerol, suggesting that the enzyme does not promote de novo TAG synthesis. Taken together, our results are consistent with the notion that PNPLA3 plays a role in the hydrolysis of glycerolipids and that the I148M substitution causes a loss of function, although we cannot exclude the possibility that the enzyme has additional substrates or activities.	[Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Huang, Yongcheng; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Huang, Yongcheng; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cohen, JC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jonathan.cohen@utsouthwestern.edu; helen.hobbs@utsouthwestern.edu			National Institutes of Health from NHLBI [P01HL20948, 1RLHL090550, R01DK090066]; NIDDK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090066] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL20948, 1RLHL090550, and R01DK090066 from NHLBI and NIDDK.	BAGINSKY ML, 1977, J LIPID RES, V18, P423; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Falleti E., 2011, LIVER INT IN PRESS; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Krawczyk M, 2010, BEST PRACT RES CL GA, V24, P695, DOI 10.1016/j.bpg.2010.08.005; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; MORRISON WR, 1964, J LIPID RES, V5, P600; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; PARK WD, 1983, PLANT PHYSIOL, V71, P156, DOI 10.1104/pp.71.1.156; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2010, J HEPATOL, V53, P335, DOI 10.1016/j.jhep.2010.02.034; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	24	205	207	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37085	37093		10.1074/jbc.M111.290114	http://dx.doi.org/10.1074/jbc.M111.290114			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878620	Green Published, hybrid			2022-12-27	WOS:000296542400009
J	Thiele, S; Steen, A; Jensen, PC; Mokrosinski, J; Frimurer, TM; Rosenkilde, MM				Thiele, Stefanie; Steen, Anne; Jensen, Pia C.; Mokrosinski, Jacek; Frimurer, Thomas M.; Rosenkilde, Mette M.			Allosteric and Orthosteric Sites in CC Chemokine Receptor (CCR5), a Chimeric Receptor Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOTACTIC PROTEIN-1; BRADYKININ B2 RECEPTOR; SMALL-MOLECULE; CRYSTAL-STRUCTURE; BINDING-SITE; INTRACELLULAR FACE; COUPLED RECEPTORS; MULTIPLE DOMAINS; LIGAND-BINDING; MCP-1 RECEPTOR	Chemokine receptors play a major role in immune system regulation and have consequently been targets for drug development leading to the discovery of several small molecule antagonists. Given the large size and predominantly extracellular receptor interaction of endogenous chemokines, small molecules often act more deeply in an allosteric mode. However, opposed to the well described molecular interaction of allosteric modulators in class C7-transmembrane helix (7TM) receptors, the interaction in class A, to which the chemokine receptors belong, is more sparsely described. Using the CCR5 chemokine receptor as a model system, we studied the molecular interaction and conformational interchange required for proper action of various orthosteric chemokines and allosteric small molecules, including the well known CCR5 antagonists TAK-779, SCH-C, and aplaviroc, and four novel CCR5 ago-allosteric molecules. A chimera was successfully constructed between CCR5 and the closely related CCR2 by transferring all extracellular regions of CCR2 to CCR5, i.e. a Trojan horse that resembles CCR2 extracellularly but signals through a CCR5 transmembrane unit. The chimera bound CCR2 (CCL2 and CCL7), but not CCR5 chemokines (CCL3 and CCL5), with CCR2-like high affinities and potencies throughout the CCR5 signaling unit. Concomitantly, high affinity binding of small molecule CCR5 agonists and antagonists was retained in the transmembrane region. Importantly, whereas the agonistic and antagonistic properties were preserved, the allosteric enhancement of chemokine binding was disrupted. In summary, the Trojan horse chimera revealed that orthosteric and allosteric sites could be structurally separated and still act together with transmission of agonism and antagonism across the different receptor units.	[Thiele, Stefanie; Steen, Anne; Jensen, Pia C.; Mokrosinski, Jacek; Rosenkilde, Mette M.] Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, Fac Hlth Sci, DK-2200 Copenhagen, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Rosenkilde, MM (corresponding author), Blegdamsvej 3,Bldg 18-5, DK-2200 Copenhagen, Denmark.	rosenkilde@sund.ku.dk	Mokrosinski, Jacek/J-9506-2012; Mokrosinski, Jacek/M-1963-2019	Mokrosinski, Jacek/0000-0003-1710-1679; Mokrosinski, Jacek/0000-0001-5008-0457; Rosenkilde, Mette Marie/0000-0001-9600-3254; Karlshoj, Stefanie/0000-0001-6505-0883; Frimruer, Thomas/0000-0002-9682-8245	Danish Council for Independent Research, Medical Sciences; NovoNordisk Foundation; Lundbeck Foundation; European Community [LSHB-CT-2005-518167]; AP-Moller Foundation; Aase and Einar Danielsen Foundation	Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); NovoNordisk Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); European Community(European Commission); AP-Moller Foundation; Aase and Einar Danielsen Foundation	This work was supported by The Danish Council for Independent Research, Medical Sciences, The NovoNordisk Foundation, The Lundbeck Foundation, European Community's Sixth Framework Program INNOCHEM, LSHB-CT-2005-518167, The AP-Moller Foundation, and The Aase and Einar Danielsen Foundation.	Ai LS, 2004, J BIOMED SCI, V11, P818, DOI 10.1159/000081829; Alkhatib G, 1997, J BIOL CHEM, V272, P20420, DOI 10.1074/jbc.272.33.20420; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Berkhout TA, 2003, J MED CHEM, V46, P4070, DOI 10.1021/jm030862l; Blanpain C, 2001, J LEUKOCYTE BIOL, V69, P977; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Gupte J, 2004, P NATL ACAD SCI USA, V101, P1508, DOI 10.1073/pnas.0308250100; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Holst B, 2000, MOL PHARMACOL, V58, P263, DOI 10.1124/mol.58.2.263; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Jensen PC, 2008, J BIOL CHEM, V283, P23121, DOI 10.1074/jbc.M803458200; Jensen PC, 2007, MOL PHARMACOL, V72, P327, DOI 10.1124/mol.106.035543; Jensen PC, 2009, METHOD ENZYMOL, V461, P171, DOI 10.1016/S0076-6879(09)05408-1; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Kostenis E, 1998, J BIOL CHEM, V273, P17886, DOI 10.1074/jbc.273.28.17886; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Maeda K, 2004, J VIROL, V78, P8654, DOI 10.1128/JVI.78.16.8654-8662.2004; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Mirzadegan T, 2000, J BIOL CHEM, V275, P25562, DOI 10.1074/jbc.M000692200; Monteclaro FS, 1996, J BIOL CHEM, V271, P19084, DOI 10.1074/jbc.271.32.19084; Murphy PM, 2000, PHARMACOL REV, V52, P145; Pal-Ghosh R, 2003, ARCH BIOCHEM BIOPHYS, V415, P54, DOI 10.1016/S0003-9861(03)00217-0; Palani A, 2001, J MED CHEM, V44, P3339, DOI 10.1021/jm015526o; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pease JE, 1998, J BIOL CHEM, V273, P19972, DOI 10.1074/jbc.273.32.19972; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenkilde MM, 2006, CURR TOP MED CHEM, V6, P1319, DOI 10.2174/15680266106061319; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; ROSENKILDE MM, 1994, J BIOL CHEM, V269, P28160; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Saita Y, 2006, J IMMUNOL, V177, P3116, DOI 10.4049/jimmunol.177.5.3116; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Samson M, 1997, J BIOL CHEM, V272, P24934, DOI 10.1074/jbc.272.40.24934; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Schwartz TW, 1996, TRENDS PHARMACOL SCI, V17, P213, DOI 10.1016/0165-6147(96)10017-1; Shields DC, 2000, GENE, V246, P239, DOI 10.1016/S0378-1119(00)00072-X; Shiraishi M, 2000, J MED CHEM, V43, P2049, DOI 10.1021/jm9906264; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urwyler S, 2011, PHARMACOL REV, V63, P59, DOI 10.1124/pr.109.002501; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wise EL, 2007, J BIOL CHEM, V282, P27935, DOI 10.1074/jbc.M703255200; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Yu J, 2002, J CELL BIOCHEM, V85, P809, DOI 10.1002/jcb.10171	56	39	40	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37543	37554		10.1074/jbc.M111.243808	http://dx.doi.org/10.1074/jbc.M111.243808			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878623	Green Published, hybrid			2022-12-27	WOS:000296542400053
J	Antolikova, E; Zakova, L; Turkenburg, JP; Watson, CJ; Hanclova, I; Sanda, M; Cooper, A; Kraus, T; Brzozowski, AM; Jiracek, J				Antolikova, Emilia; Zakova, Lenka; Turkenburg, Johan P.; Watson, Christopher J.; Hanclova, Ivona; Sanda, Miloslav; Cooper, Alan; Kraus, Tomas; Brzozowski, A. Marek; Jiracek, Jiri			Non-equivalent Role of Inter- and Intramolecular Hydrogen Bonds in the Insulin Dimer Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; NEGATIVE COOPERATIVITY; ASSOCIATION PROPERTIES; STRUCTURAL SWITCH; SELF-ASSOCIATION; PEPTIDE-BONDS; HEXAMER; PROTEIN; MUTANT; DISSOCIATION	Apart from its role in insulin receptor (IR) activation, the C terminus of the B-chain of insulin is also responsible for the formation of insulin dimers. The dimerization of insulin plays an important role in the endogenous delivery of the hormone and in the administration of insulin to patients. Here, we investigated insulin analogues with selective N-methylations of peptide bond amides at positions B24, B25, or B26 to delineate their structural and functional contribution to the dimer interface. All N-methylated analogues showed impaired binding affinities to IR, which suggests a direct IR-interacting role for the respective amide hydrogens. The dimerization capabilities of analogues were investigated by isothermal microcalorimetry. Selective N-methylations of B24, B25, or B26 amides resulted in reduced dimerization abilities compared with native insulin (K-d = 8.8 mu M). Interestingly, although the N-methylation in [NMeTyrB26]-insulin or [NMePheB24]-insulin resulted in K-d values of 142 and 587 mu M, respectively, the [NMePheB25]-insulin did not form dimers even at high concentrations. This effect may be attributed to the loss of intramolecular hydrogen bonding between NHB25 and COA19, which connects the B-chain beta-strand to the core of the molecule. The release of the B-chain beta-strand from this hydrogen bond lock may result in its higher mobility, thereby shifting solution equilibrium toward the monomeric state of the hormone. The study was complemented by analyses of two novel analogue crystal structures. All examined analogues crystallized only in the most stable R-6 form of insulin oligomers (even if the dimer interface was totally disrupted), confirming the role of R-6-specific intra/intermolecular interactions for hexamer stability.	[Turkenburg, Johan P.; Watson, Christopher J.; Brzozowski, A. Marek] Univ York, Dept Chem, York Struct Biol Lab, Heslington YO10 5YW, York, England; [Antolikova, Emilia; Zakova, Lenka; Hanclova, Ivona; Sanda, Miloslav; Kraus, Tomas; Jiracek, Jiri] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, Prague 16610 6, Czech Republic; [Cooper, Alan] Univ Glasgow, Sch Chem, Coll Sci & Engn, Glasgow G12 8QQ, Lanark, Scotland	University of York - UK; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of Glasgow	Brzozowski, AM (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, Heslington YO10 5YW, York, England.	marek@ysbl.york.ac.uk; jiracek@uochb.cas.cz	Zakova, Lenka/A-7119-2008; Sanda, Miloslav/P-1631-2017; Cooper, Alan/F-7813-2011; Jiracek, Jiri/A-7124-2008; Kraus, Tomas/I-4687-2012; Jiracek, Jiri/Y-6703-2019; Zakova, Lenka/Y-6234-2019	Sanda, Miloslav/0000-0002-7735-3635; Cooper, Alan/0000-0001-6709-7343; Jiracek, Jiri/0000-0003-3848-2773; Kraus, Tomas/0000-0002-0055-5853; Jiracek, Jiri/0000-0003-3848-2773; Zakova, Lenka/0000-0001-6439-2574; Turkenburg, Johan/0000-0001-6992-6838	Ministry of Education, Youth, and Sports of the Czech Republic (Research Centre for Chemical Genetics) [LC060777]; Academy of Sciences of the Czech Republic [Z40550506]; Diamond Light Source (Didcot, United Kingdom); European Synchrotron Radiation Facility (Grenoble, France)	Ministry of Education, Youth, and Sports of the Czech Republic (Research Centre for Chemical Genetics)(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Diamond Light Source (Didcot, United Kingdom); European Synchrotron Radiation Facility (Grenoble, France)	This work was supported by Ministry of Education, Youth, and Sports of the Czech Republic Grant LC060777 (Research Centre for Chemical Genetics, to J. J.), Research Project of the Academy of Sciences of the Czech Republic Grant Z40550506 (to J. J.). This work was also supported by the Diamond Light Source (Didcot, United Kingdom) and European Synchrotron Radiation Facility (Grenoble, France).	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BLOOM CR, 1995, J MOL BIOL, V245, P324, DOI 10.1006/jmbi.1994.0027; BRADER ML, 1991, BIOCHEMISTRY-US, V30, P6636, DOI 10.1021/bi00241a002; BRANGE J, 1990, DIABETES CARE, V13, P923, DOI 10.2337/diacare.13.9.923; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; BROMER WM, 1967, BIOCHIM BIOPHYS ACTA, V133, P219, DOI 10.1016/0005-2795(67)90061-X; BRZOVIC PS, 1994, BIOCHEMISTRY-US, V33, P13057, DOI 10.1021/bi00248a015; CHOI WE, 1993, BIOCHEMISTRY-US, V32, P11638, DOI 10.1021/bi00094a021; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; DeFelippis MR, 2001, CRIT REV THER DRUG, V18, P201; DEMEYTS P, 1978, NATURE, V273, P504; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; DIMARCHI RD, 1994, HORM RES, V41, P93, DOI 10.1159/000183967; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganim Z, 2010, PHYS CHEM CHEM PHYS, V12, P3579, DOI 10.1039/b923515a; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; GOLDMAN J, 1974, BIOCHEMISTRY-US, V13, P4566, DOI 10.1021/bi00719a015; Hassiepen U, 1999, BIOPHYS J, V77, P1638, DOI 10.1016/S0006-3495(99)77012-8; Hedman CA, 2001, DIABETES CARE, V24, P1120, DOI 10.2337/diacare.24.6.1120; Homko C, 2003, DIABETES CARE, V26, P2027, DOI 10.2337/diacare.26.7.2027; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; Huus K, 2006, BIOCHEMISTRY-US, V45, P4014, DOI 10.1021/bi0524520; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; KAARSHOLM NC, 1995, RECEPTOR, V5, P1; KEEFER LM, 1981, BIOCHEM BIOPH RES CO, V100, P1229, DOI 10.1016/0006-291X(81)91955-0; Keller D, 2001, BIOCHEMISTRY-US, V40, P10732, DOI 10.1021/bi0108150; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Lovatt A, 1996, EUR BIOPHYS J BIOPHY, V24, P354; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; LUDVIGSEN S, 1994, BIOCHEMISTRY-US, V33, P7998, DOI 10.1021/bi00192a003; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; McPhail D, 1997, J CHEM SOC FARADAY T, V93, P2283, DOI 10.1039/a701327b; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAGAWA SH, 1993, INT J PEPT PROT RES, V42, P578; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; PITTMAN I, 1995, BIOCHEMISTRY-US, V34, P10578, DOI 10.1021/bi00033a033; RahuelClermont S, 1997, BIOCHEMISTRY-US, V36, P5837, DOI 10.1021/bi963038q; ROY M, 1989, J BIOL CHEM, V264, P19081; SEYDOUX F, 1974, Critical Reviews in Biochemistry, V2, P227, DOI 10.3109/10409237409105448; Smith GD, 2003, ACTA CRYSTALLOGR D, V59, P474, DOI 10.1107/S0907444902023685; STRAZZA S, 1985, ARCH BIOCHEM BIOPHYS, V238, P30, DOI 10.1016/0003-9861(85)90137-7; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weiss MA, 2009, VITAM HORM, V80, P33, DOI 10.1016/S0083-6729(08)00602-X; Whittingham JL, 1998, BIOCHEMISTRY-US, V37, P11516, DOI 10.1021/bi980807s; WOLLMER A, 1994, BIOL CHEM H-S, V375, P219; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Zakova L, 2004, BIOCHEMISTRY-US, V43, P16293, DOI 10.1021/bi048856u; Zakova L, 2004, BIOCHEMISTRY-US, V43, P2323, DOI 10.1021/bi036001w; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w; Zakova L, 2007, J PEPT SCI, V13, P334, DOI 10.1002/psc.847; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033	60	29	29	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36968	36977		10.1074/jbc.M111.265249	http://dx.doi.org/10.1074/jbc.M111.265249			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880708	Green Published, hybrid			2022-12-27	WOS:000296538300075
J	Perdiguero, EG; Galaup, A; Durand, M; Teillon, J; Philippe, J; Valenzuela, DM; Murphy, AJ; Yancopoulos, GD; Thurston, G; Germain, S				Perdiguero, Elisa Gomez; Galaup, Ariane; Durand, Melanie; Teillon, Jeremie; Philippe, Josette; Valenzuela, David M.; Murphy, Andrew J.; Yancopoulos, George D.; Thurston, Gavin; Germain, Stephane			Alteration of Developmental and Pathological Retinal Angiogenesis in angptl4-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR MORPHOGENESIS; MOLECULAR REGULATION; BLOOD-VESSELS; HYPOXIA; EXPRESSION; ANGIOPOIETIN-LIKE-4; PERMEABILITY; CAVEOLIN-1; MOUSE	Proper vessel maturation, remodeling of endothelial junctions, and recruitment of perivascular cells is crucial for establishing and maintaining vessel functions. In proliferative retinopathies, hypoxia-induced angiogenesis is associated with disruption of the vascular barrier, edema, and vision loss. Therefore, identifying factors that regulate vascular maturation is critical to target pathological angiogenesis. Given the conflicting role of angiopoietin-like-4 (ANGPTL4) reported in the current literature using gain of function systems both in vitro and in vivo, the goal of this study was to characterize angiogenesis, focusing on perinatal retinal vascularization and pathological circumstances in angpl4-deficient mice. We report altered organization of endothelial junctions and pericyte coverage, both leading to impaired angiogenesis and increased vascular leakage that were eventually caught up, suggesting a delay in vessel maturation. In a model of oxygen-induced retinopathy, pathological neovascularization, which results from tissue hypoxia, was also strongly inhibited in angptl4-deficient mice. This study therefore shows that ANGPTL4 tunes endothelial cell junction organization and pericyte coverage and controls vascular permeability and angiogenesis, both during development and in pathological conditions.	[Perdiguero, Elisa Gomez; Galaup, Ariane; Durand, Melanie; Philippe, Josette; Germain, Stephane] Coll France, CIRB, F-75005 Paris, France; [Perdiguero, Elisa Gomez; Galaup, Ariane; Durand, Melanie; Philippe, Josette; Germain, Stephane] CNRS, Unite Mixte Rech 7241, F-75005 Paris, France; [Perdiguero, Elisa Gomez; Galaup, Ariane; Durand, Melanie; Philippe, Josette; Germain, Stephane] Inst Sante & Rech Med, U1050, F-75005 Paris, France; [Perdiguero, Elisa Gomez; Galaup, Ariane; Durand, Melanie; Teillon, Jeremie; Philippe, Josette; Germain, Stephane] MEMOLIFE Lab Excellence, F-75005 Paris, France; [Perdiguero, Elisa Gomez; Galaup, Ariane; Durand, Melanie; Teillon, Jeremie; Philippe, Josette; Germain, Stephane] Paris Sci Lettre Res Univ, F-75005 Paris, France; [Teillon, Jeremie] Coll France, Plate Forme Imagerie Ctr Interdisciplinaire Rech, F-75005 Paris, France; [Valenzuela, David M.; Murphy, Andrew J.; Yancopoulos, George D.; Thurston, Gavin] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Germain, Stephane] Univ Paris 06, Ecole Doctorale Physiol & Physiopathol 394, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Regeneron; UDICE-French Research Universities; Sorbonne Universite	Germain, S (corresponding author), Coll France, CIRB, F-75005 Paris, France.	stephane.germain@college-de-france.fr	Germain, Stephane/E-2301-2016; Perdiguero, Elisa Gomez/U-2120-2018	Germain, Stephane/0000-0001-5992-1275; Perdiguero, Elisa Gomez/0000-0002-7717-7897; Teillon, Jeremie/0000-0002-5335-6153; Murphy, Andrew/0000-0003-4152-4081; Thurston, Gavin/0000-0002-4105-5919	Institut de la Sante et de la Recherche Medicale; Agence Nationale de la Recherche [ANR-06-JCJC-0160]; Ligue Nationale contre le Cancer; Fondation de France [R09045JJ]	Institut de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fondation de France(Fondation de France)	This work was supported in part by Institut de la Sante et de la Recherche Medicale, Agence Nationale de la Recherche Grant ANR-06-JCJC-0160, the Ligue Nationale contre le Cancer, Fondation de France Grant R09045JJ, and an Attache Temporaire d'Enseignement et de Recherche position from the College de France (to E. G. P.).	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Arjamaa O, 2006, EXP EYE RES, V83, P473, DOI 10.1016/j.exer.2006.01.016; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Bressler NM, 2009, OPHTHALMOLOGY, V116, pS15, DOI 10.1016/j.ophtha.2009.06.048; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; DeWever J, 2007, AM J PATHOL, V171, P1619, DOI 10.2353/ajpath.2007.060968; Feng YX, 2009, CELL PHYSIOL BIOCHEM, V23, P277, DOI 10.1159/000218174; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Germain S, 2010, CURR OPIN HEMATOL, V17, P245, DOI 10.1097/MOH.0b013e32833865b9; Greenberg JI, 2009, EXPERT OPIN BIOL TH, V9, P1347, DOI 10.1517/14712590903208883; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Ito Y, 2003, CANCER RES, V63, P6651; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jones EAV, 2008, DEVELOPMENT, V135, P2479, DOI 10.1242/dev.014902; Kubota Y, 2009, TRENDS CARDIOVAS MED, V19, P38, DOI 10.1016/j.tcm.2009.04.004; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Le Jan S, 2006, FEBS LETT, V580, P3395, DOI 10.1016/j.febslet.2006.05.011; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Miki K, 2009, OPHTHALMOLOGY, V116, P1748, DOI 10.1016/j.ophtha.2009.05.020; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Nakajima M, 2001, INVEST OPHTH VIS SCI, V42, P2110; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; PEER J, 1995, LAB INVEST, V72, P638; Pfister F, 2010, ACTA DIABETOL, V47, P59, DOI 10.1007/s00592-009-0099-2; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Razani B, 2001, J BIOL CHEM, V276, P38121; SAGATIES MJ, 1987, INVEST OPHTH VIS SCI, V28, P2000; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Skuli N, 2009, BLOOD, V114, P469, DOI 10.1182/blood-2008-12-193581; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Verine J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010421; Walshe TE, 2008, ANNU REV PATHOL-MECH, V3, P615, DOI 10.1146/annurev.pathmechdis.3.121806.151501; Witt KA, 2003, AM J PHYSIOL-HEART C, V285, pH2820, DOI 10.1152/ajpheart.00589.2003; Xu YL, 2010, J CELL BIOL, V188, P115, DOI 10.1083/jcb.200903137	45	59	62	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36841	36851		10.1074/jbc.M111.220061	http://dx.doi.org/10.1074/jbc.M111.220061			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21832056	hybrid, Green Published			2022-12-27	WOS:000296538300064
J	Rusconi, L; Kilstrup-Nielsen, C; Landsberger, N				Rusconi, Laura; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta			Extrasynaptic N-Methyl-D-aspartate (NMDA) Receptor Stimulation Induces Cytoplasmic Translocation of the CDKL5 Kinase and Its Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETT-SYNDROME; CREB SHUTOFF; CELL-DEATH; GENE; EXPRESSION; DISORDERS; CALCIUM; PATHWAY	Mutations in the X-linked gene cyclin-dependent kinase-like 5 (CDKL5) have been found in patients with epileptic encephalopathy characterized by early onset intractable epilepsy, including infantile spasms and other types of seizures, severe developmental delay, and often the development of Rett syndrome-like features. Despite its clear involvement in proper brain development, CDKL5 functions are still far from being understood. In this study, we analyzed the subcellular localization of the endogenous kinase in primary murine hippocampal neurons. CDKL5 was localized both in nucleus and cytoplasm and, conversely to proliferating cells, did not undergo constitutive shuttling between these compartments. Nevertheless, glutamate stimulation was able to induce the exit of the kinase from the nucleus and its subsequent accumulation in the perinuclear cytoplasm. Moreover, we found that sustained glutamate stimulation promoted CDKL5 proteasomal degradation. Both events were mediated by the specific activation of extrasynaptic pool of N-methyl-D-aspartate receptors. Proteasomal degradation was also induced by withdrawal of neurotrophic factors and hydrogen peroxide treatment, two different paradigms of cell death. Altogether, our results indicate that both subcellular localization and expression of CDKL5 are modulated by the activation of extrasynaptic N-methyl-D-aspartate receptors and suggest regulation of CDKL5 by cell death pathways.	[Rusconi, Laura; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta] Univ Insubria, Dept Biomed Informat & Commun Sci, Lab Genet & Epigenet Control Gene Express, I-21052 Busto Arsizio, Italy; [Landsberger, Nicoletta] Ist Sci San Raffaele, San Raffaele Rett Res Ctr, Div Neurosci, I-20132 Milan, Italy	University of Insubria; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Landsberger, N (corresponding author), Univ Insubria, Dept Biomed Informat & Commun Sci, Lab Genet & Epigenet Control Gene Express, Via Alberto da Giussano 12, I-21052 Busto Arsizio, Italy.	landsben@uninsubria.it	Kilstrup-Nielsen, Charlotte/A-6348-2014	Landsberger, Nicoletta/0000-0003-0820-3155; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077	Fondazione Cariplo [2010-0724]; Telethon [GGP10032]; Le Jeune Foundation;  [FP7-PEOPLE-ITN-2008]	Fondazione Cariplo(Fondazione Cariplo); Telethon(Fondazione Telethon); Le Jeune Foundation; 	This work was supported by Fondazione Cariplo (Grant 2010-0724 to N.L.), Telethon (Grant GGP10032 to N.L.), FP7-PEOPLE-ITN-2008 (to C.K.-N.), and Le Jeune Foundation (to C.K.-N.).	Artuso R, 2010, BRAIN DEV-JPN, V32, P17, DOI 10.1016/j.braindev.2009.02.004; Baptista MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010139; Bertani I, 2006, J BIOL CHEM, V281, P32048, DOI 10.1074/jbc.M606325200; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Chen QA, 2010, J NEUROSCI, V30, P12777, DOI 10.1523/JNEUROSCI.1102-10.2010; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Dick O, 2010, J BIOL CHEM, V285, P19354, DOI 10.1074/jbc.M110.127654; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Frasca A, 2011, NEUROBIOL DIS, V43, P507, DOI 10.1016/j.nbd.2011.04.024; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Kameshita I, 2008, BIOCHEM BIOPH RES CO, V377, P1162, DOI 10.1016/j.bbrc.2008.10.113; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Lin C, 2005, HUM MOL GENET, V14, P3775, DOI 10.1093/hmg/ddi391; Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198; Mei D, 2010, EPILEPSIA, V51, P647, DOI 10.1111/j.1528-1167.2009.02308.x; Montini E, 1998, GENOMICS, V51, P427, DOI 10.1006/geno.1998.5391; Ricciardi S, 2009, HUM MOL GENET, V18, P4590, DOI 10.1093/hmg/ddp426; Rusconi L, 2008, J BIOL CHEM, V283, P30101, DOI 10.1074/jbc.M804613200; Sierra-Paredes German, 2007, CNS & Neurological Disorders-Drug Targets, V6, P288; Tajiri S, 2006, FEBS LETT, V580, P3462, DOI 10.1016/j.febslet.2006.05.021	24	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36550	36558		10.1074/jbc.M111.235630	http://dx.doi.org/10.1074/jbc.M111.235630			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21832092	Green Published, hybrid			2022-12-27	WOS:000296538300039
J	Terragni, J; Nayak, G; Banerjee, S; Medrano, JL; Graham, JR; Brennan, JF; Sepulveda, S; Cooper, GM				Terragni, Jolyon; Nayak, Gauri; Banerjee, Swati; Medrano, Jose-Luis; Graham, Julie R.; Brennan, James F.; Sepulveda, Sean; Cooper, Geoffrey M.			The E-box Binding Factors Max/Mnt, MITF, and USF1 Act Coordinately with FoxO to Regulate Expression of Proapoptotic and Cell Cycle Control Genes by Phosphatidylinositol 3-Kinase/Akt/Glycogen Synthase Kinase 3 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR USF; HELIX-LOOP-HELIX; NF-KAPPA-B; C-MYC; MELANOCYTE DEVELOPMENT; MICROPHTHALMIA LOCUS; 3-KINASE PATHWAY; PROTEIN; PHOSPHORYLATION; FORKHEAD	Phosphatidylinositol (PI) 3-kinase/Akt signaling plays a critical role in cell proliferation and survival, partly by regulation of FoxO transcription factors. Previous work using global expression profiling indicated that inhibition of PI 3-kinase in proliferating cells led to induction of genes that promote cell cycle arrest and apoptosis. The upstream regulatory regions of these genes had binding sites not only for FoxO, but also for Myc/Max transcription factors. In the present study, we have addressed the role of Myc family members and related E-box-binding proteins in the regulation of these genes. Chromatin immunoprecipitations and RNA interference indicated that transcription was repressed by Max-Mnt-Sin3a-histone deacetylase complexes in proliferating cells. Inhibition of PI 3-kinase led to a loss of Max/Mnt binding and transcriptional induction by MITF and USF1, as well as FoxO. Both MITF and USF1 were activated by glycogen synthase kinase (GSK) 3, with GSK3 phosphorylation sites on USF1 identified as the previously described activating site threonine 153 as well as serine 186. siRNA against MITF as well as against FoxO3a protected cells from apoptosis following PI 3-kinase inhibition. These results define a novel E-box-regulated network that functions coordinately with FoxO to regulate transcription of apoptotic and cell cycle regulatory genes downstream of PI 3-kinase/Akt/GSK3 signaling.	[Terragni, Jolyon; Nayak, Gauri; Banerjee, Swati; Medrano, Jose-Luis; Graham, Julie R.; Brennan, James F.; Sepulveda, Sean; Cooper, Geoffrey M.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Cooper, GM (corresponding author), 5 Cummington St, Boston, MA 02215 USA.	gmcooper@bu.edu			National Institutes of Health [RO1 CA18689]; NATIONAL CANCER INSTITUTE [R01CA018689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA18689.	Aperlo C, 1996, EUR J BIOCHEM, V241, P249, DOI 10.1111/j.1432-1033.1996.0249t.x; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Chandramohan V, 2004, J IMMUNOL, V172, P5522, DOI 10.4049/jimmunol.172.9.5522; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davis PL, 1999, ONCOGENE, V18, P6000, DOI 10.1038/sj.onc.1202990; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Fuse N, 1999, J BIOCHEM-TOKYO, V126, P1043, DOI 10.1093/oxfordjournals.jbchem.a022548; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Graham JR, 2010, J BIOL CHEM, V285, P4472, DOI 10.1074/jbc.M109.053785; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; Hatta M, 2007, J BIOL CHEM, V282, P35583, DOI 10.1074/jbc.M704735200; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hershey CL, 2005, GENE, V347, P73, DOI 10.1016/j.gene.2004.12.002; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Hooker CW, 2006, J CELL SCI, V119, P208, DOI 10.1242/jcs.02815; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; Khaled M, 2003, J INVEST DERMATOL, V121, P831, DOI 10.1046/j.1523-1747.2003.12420.x; Khaled M, 2002, J BIOL CHEM, V277, P33690, DOI 10.1074/jbc.M202939200; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; Luo X, 1996, P NATL ACAD SCI USA, V93, P1308, DOI 10.1073/pnas.93.3.1308; Martinez-Gac L, 2004, BIOCHEM SOC T, V32, P360, DOI 10.1042/BST0320360; Nowak M, 2005, MOL CELL BIOL, V25, P1537, DOI 10.1128/MCB.25.4.1537-1548.2005; Popov N, 2005, ONCOGENE, V24, P8326, DOI 10.1038/sj.onc.1208961; Qyang YB, 1999, MOL CELL BIOL, V19, P1508; REISMAN D, 1993, NUCLEIC ACIDS RES, V21, P345, DOI 10.1093/nar/21.2.345; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Scholtz B, 1996, J BIOL CHEM, V271, P32375, DOI 10.1074/jbc.271.50.32375; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Takahashi Y, 2000, GENE DEV, V14, P804; Takeda K, 2000, HUM MOL GENET, V9, P125, DOI 10.1093/hmg/9.1.125; Terragni J, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-6; Viney TJ, 2004, J BIOL CHEM, V279, P49948, DOI 10.1074/jbc.M406659200; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Xie P, 2009, J BIOL CHEM, V284, P5488, DOI 10.1074/jbc.M806487200; Yao R, 1996, ONCOGENE, V13, P343	56	28	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36215	36227		10.1074/jbc.M111.246116	http://dx.doi.org/10.1074/jbc.M111.246116			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21873430	Green Published, hybrid			2022-12-27	WOS:000296538300006
J	Biswas, A; Boutaghou, MN; Alvey, RM; Kronfel, CM; Cole, RB; Bryant, DA; Schluchter, WM				Biswas, Avijit; Boutaghou, M. Nazim; Alvey, Richard M.; Kronfel, Christina M.; Cole, Richard B.; Bryant, Donald A.; Schluchter, Wendy M.			Characterization of the Activities of the CpeY, CpeZ, and CpeS Bilin Lyases in Phycoerythrin Biosynthesis in Fremyella diplosiphon Strain UTEX 481	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCOCCUS SP PCC-7002; PHYCOBILIPROTEIN BETA-SUBUNITS; HOLO-ALPHA SUBUNIT; SP PCC 7002; CHROMOPHORE ATTACHMENT; LINKER POLYPEPTIDES; LINKAGE DIVERSITY; CRYSTAL-STRUCTURE; ENERGY-TRANSFER; CPCS-I	When grown in green light, Fremyella diplosiphon strain UTEX 481 produces the red-colored protein phycoerythrin (PE) to maximize photosynthetic light harvesting. PE is composed of two subunits, CpeA and CpeB, which carry two and three phycoerythrobilin (PEB) chromophores, respectively, that are attached to specific Cys residues via thioether linkages. Specific bilin lyases are hypothesized to catalyze each PEB ligation. Using a heterologous, coexpression system in Escherichia coli, the PEB ligation activities of putative lyase subunits CpeY, CpeZ, and CpeS were tested on the CpeA and CpeB subunits from F. diplosiphon. Purified His(6)-tagged CpeA, obtained by coexpressing cpeA, cpeYZ, and the genes for PEB synthesis, had absorbance and fluorescence emission maxima at 566 and 574 nm, respectively. CpeY alone, but not CpeZ, could ligate PEB to CpeA, but the yield of CpeA-PEB was lower than achieved with CpeY and CpeZ together. Studies with site-specific variants of CpeA(C82S and C139S), together with mass spectrometric analysis of trypsin-digested CpeA-PEB, revealed that CpeY/CpeZ attached PEB at Cys(82) of CpeA. The CpeS bilin lyase ligated PEB at both Cys(82) and Cys(139) of CpeA but very inefficiently; the yield of PEB ligated at Cys(82) was much lower than observed with CpeY or CpeY/CpeZ. However, CpeS efficiently attached PEB to Cys(80) of CpeB but neither CpeY, CpeZ, nor CpeY/CpeZ could ligate PEB to CpeB.	[Biswas, Avijit; Kronfel, Christina M.; Schluchter, Wendy M.] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [Boutaghou, M. Nazim; Cole, Richard B.] Univ New Orleans, Dept Chem, New Orleans, LA 70148 USA; [Alvey, Richard M.; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	University of Louisiana System; University of New Orleans; University of Louisiana System; University of New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Schluchter, WM (corresponding author), 2000 Lakeshore Dr, New Orleans, LA 70148 USA.	wschluch@uno.edu	Schluchter, Wendy/G-9662-2013		National Science Foundation [MCB-0843664, DBI-0619272, CHE-1058764, MCB-0519743, MCB-1021725]; Div Of Molecular and Cellular Bioscience [0843664] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB-0843664 (to W. M. S.), DBI-0619272 and CHE-1058764 (to R. B. C.), and MCB-0519743 and MCB-1021725 (to D. A. B.).	Alvey RM, 2011, BIOCHEMISTRY-US, V50, P4890, DOI 10.1021/bi200307s; Alvey RM, 2011, J BACTERIOL, V193, P1663, DOI 10.1128/JB.01392-10; Anderson LK, 1998, MOL MICROBIOL, V30, P467, DOI 10.1046/j.1365-2958.1998.01081.x; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; [Anonymous], [No title captured]; ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; Baier K, 2004, MICROBIOL-SGM, V150, P2739, DOI 10.1099/mic.0.27153-0; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bienert R, 2006, J BIOL CHEM, V281, P5216, DOI 10.1074/jbc.M507243200; BISHOP JE, 1986, J BIOL CHEM, V261, P6790; BISHOP JE, 1987, J AM CHEM SOC, V109, P875, DOI 10.1021/ja00237a039; Biswas A, 2010, APPL ENVIRON MICROB, V76, P2729, DOI 10.1128/AEM.03100-09; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Bohm S, 2007, J BIOL CHEM, V282, P25357, DOI 10.1074/jbc.M702669200; Boutaghou M. N., 2011, P 59 ASMS C MASS SPE; Boutaghou M. N., 2010, P 58 ASMS C MASS SPE; Bryant D.A., 1988, LIGHT ENERGY TRANSDU, P62; Bryant D. A., 1991, CELL CULTURE SOMATIC, P257; BRYANT DA, 1990, ARCH MICROBIOL, V153, P550, DOI 10.1007/BF00245264; BRYANT DA, 1991, GENE, V107, P91, DOI 10.1016/0378-1119(91)90301-Q; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; DELORIMIER R, 1990, BIOCHIM BIOPHYS ACTA, V1019, P29, DOI 10.1016/0005-2728(90)90121-J; DELORIMIER R, 1984, P NATL ACAD SCI-BIOL, V81, P7946; DEMARSAC NT, 1988, METHOD ENZYMOL, V167, P318; Dines M, 2008, J BIOL CHEM, V283, P30330, DOI 10.1074/jbc.M804241200; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P28988; FEDERSPIEL NA, 1990, J BACTERIOL, V172, P4072, DOI 10.1128/jb.172.7.4072-4081.1990; FICNER R, 1992, J MOL BIOL, V228, P935, DOI 10.1016/0022-2836(92)90876-L; GINDT YM, 1992, J PHOTOCH PHOTOBIO B, V15, P75, DOI 10.1016/1011-1344(92)87007-V; GINDT YM, 1994, BBA-BIOENERGETICS, V1186, P153, DOI 10.1016/0005-2728(94)90174-0; GLAZER AN, 1994, J APPL PHYCOL, V6, P105, DOI 10.1007/BF02186064; GLAZER AN, 1989, J BIOL CHEM, V264, P1; Gomez-Lojero C, 2003, BIOCHEMISTRY-US, V42, P13800, DOI 10.1021/bi0346998; Hess WR, 1996, P NATL ACAD SCI USA, V93, P11126, DOI 10.1073/pnas.93.20.11126; Hirose Y, 2010, P NATL ACAD SCI USA, V107, P8854, DOI 10.1073/pnas.1000177107; Hu IC, 2006, BIOCHEMISTRY-US, V45, P7092, DOI 10.1021/bi052067a; Huang B, 2002, CANCER BIOTHER RADIO, V17, P35, DOI 10.1089/10849780252824055; Isailovic D, 2004, J CHROMATOGR A, V1051, P119, DOI 10.1016/j.chroma.2004.07.038; Isailovic D, 2006, ANAL BIOCHEM, V358, P38, DOI 10.1016/j.ab.2006.08.011; JUNG LJ, 1995, J BIOL CHEM, V270, P12877, DOI 10.1074/jbc.270.21.12877; Kahn K, 1997, J BACTERIOL, V179, P998, DOI 10.1128/jb.179.4.998-1006.1997; Kehoe DM, 2006, ANNU REV PLANT BIOL, V57, P127, DOI 10.1146/annurev.arplant.57.032905.105215; KLOTZ AV, 1986, J BIOL CHEM, V261, P6797; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; MAXSON P, 1989, BIOCHIM BIOPHYS ACTA, V977, P40, DOI 10.1016/S0005-2728(89)80007-6; MAZEL D, 1986, NUCLEIC ACIDS RES, V14, P8279, DOI 10.1093/nar/14.21.8279; Miller CA, 2008, J BIOL CHEM, V283, P19293, DOI 10.1074/jbc.M802734200; NGUYEN DC, 1987, ANAL CHEM, V59, P2158, DOI 10.1021/ac00144a032; ONG LJ, 1991, J BIOL CHEM, V266, P9515; PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587; RAPS S, 1990, PLANT PHYSIOL, V92, P358, DOI 10.1104/pp.92.2.358; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Shen G., 2004, PS 2004 LIGHT HARV S, P14; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; SIDLER W, 1986, BIOL CHEM H-S, V367, P627, DOI 10.1515/bchm3.1986.367.2.627; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; Six C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r259; Steglich C, 2005, ENVIRON MICROBIOL, V7, P1611, DOI 10.1111/j.1462-2920.2005.00855.x; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; Takano H, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-15; Toole CM, 1998, MOL MICROBIOL, V30, P475, DOI 10.1046/j.1365-2958.1998.01082.x; Tooley AJ, 2002, J BACTERIOL, V184, P4666, DOI 10.1128/JB.184.17.4666-4671.2002; Tooley AJ, 2001, P NATL ACAD SCI USA, V98, P10560, DOI 10.1073/pnas.181340998; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ulijasz AT, 2009, J BIOL CHEM, V284, P29757, DOI 10.1074/jbc.M109.038513; Wiethaus J, 2010, J BIOL CHEM, V285, P37561, DOI 10.1074/jbc.M110.172619; WILBANKS SM, 1993, J BIOL CHEM, V268, P1226; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Zhao KH, 2007, J BIOL CHEM, V282, P34093, DOI 10.1074/jbc.M703038200; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2005, BBA-BIOENERGETICS, V1706, P81, DOI 10.1016/j.bbabio.2004.09.008; Zhao KH, 2000, FEBS LETT, V469, P9, DOI 10.1016/S0014-5793(00)01245-X; ZHOU JH, 1992, J BIOL CHEM, V267, P16138	79	30	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35509	35521		10.1074/jbc.M111.284281	http://dx.doi.org/10.1074/jbc.M111.284281			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865169	Green Published, hybrid			2022-12-27	WOS:000295927100023
J	Liu, XS; Song, B; Elzey, BD; Ratliff, TL; Konieczny, SF; Cheng, L; Ahmad, N; Liu, XQ				Liu, X. Shawn; Song, Bing; Elzey, Bennett D.; Ratliff, Timothy L.; Konieczny, Stephen F.; Cheng, Liang; Ahmad, Nihal; Liu, Xiaoqi			Polo-like Kinase 1 Facilitates Loss of Pten Tumor Suppressor-induced Prostate Cancer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; MAMMALIAN-CELLS; NUCLEAR PTEN; BI 2536; INHIBITOR; POLO-LIKE-KINASE-1; PTEN/MMAC1; RECOVERY; SURVIVAL; THERAPY	Background: Loss of Pten is thought to mediate the majority of prostate cancers. Results: Polo-like kinase 1 confers the tumorigenic competence of Pten-deleted prostate cancer cells. Conclusion: Polo-like kinase 1 facilitates loss of Pten-induced prostate cancer formation. Significance: These results provide a mechanism explaining how cancer cells overcome oncogenesis-associated cellular stress.	[Liu, X. Shawn; Liu, Xiaoqi] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Song, Bing; Konieczny, Stephen F.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Liu, X. Shawn; Song, Bing; Elzey, Bennett D.; Ratliff, Timothy L.; Konieczny, Stephen F.; Liu, Xiaoqi] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Elzey, Bennett D.; Ratliff, Timothy L.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Cheng, Liang] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Ahmad, Nihal] Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; University of Wisconsin System; University of Wisconsin Madison	Liu, XQ (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	liu8@purdue.edu	Ahmad, Nihal/AAR-4249-2021	Ahmad, Nihal/0000-0002-4239-9887	NCI, National Institutes of Health [K01 CA114401]; NATIONAL CANCER INSTITUTE [R01CA124586, R01CA157429, K01CA114401] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	A recipient of the Howard Temin Award from the NCI, National Institutes of Health (K01 CA114401). To whom correspondence should be addressed: Dept. of Biochemistry and the Purdue Center for Cancer Research, Purdue University, 175 S. University St., West Lafayette, IN 47907. Tel.: 765-496-3764; Fax: 765-494-7897; E-mail: liu8@purdue.edu.	Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haverkamp JM, 2011, PROSTATE, V71, P1139, DOI 10.1002/pros.21327; Hofheinz RD, 2010, CLIN CANCER RES, V16, P4666, DOI 10.1158/1078-0432.CCR-10-0318; Jimeno A, 2010, MOL CANCER THER, V9, P311, DOI 10.1158/1535-7163.MCT-09-0693; Liu XS, 2010, EMBO REP, V11, P626, DOI 10.1038/embor.2010.90; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schoffski P, 2010, EUR J CANCER, V46, P2206, DOI 10.1016/j.ejca.2010.03.039; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Syljuasen RG, 2006, CANCER RES, V66, P10253, DOI 10.1158/0008-5472.CAN-06-2144; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Weichert W, 2004, PROSTATE, V60, P240, DOI 10.1002/pros.20050	27	48	49	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35795	35800		10.1074/jbc.C111.269050	http://dx.doi.org/10.1074/jbc.C111.269050			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21890624	Green Published, hybrid			2022-12-27	WOS:000295927100052
J	Terme, JM; Sese, B; Millan-Arino, L; Mayor, R; Belmonte, JCI; Barrero, MJ; Jordan, A				Terme, Jean-Michel; Sese, Borja; Millan-Arino, Lluis; Mayor, Regina; Izpisua Belmonte, Juan Carlos; Jose Barrero, Maria; Jordan, Albert			Histone H1 Variants Are Differentially Expressed and Incorporated into Chromatin during Differentiation and Reprogramming to Pluripotency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; LINKER HISTONE; GENE-EXPRESSION; PHOSPHORYLATION; TRANSCRIPTION; DYNAMICS; SUBTYPES; MOUSE; LINES; FIBROBLASTS	There are seven linker histone variants in human somatic cells (H1.0 to H1.5 and H1X), and their prevalence varies as a function of cell type and differentiation stage, suggesting that the different variants may have distinct roles. We have revisited this notion by using new methodologies to study pluripotency and differentiation, including the in vitro differentiation of human embryonic stem (ES) and teratocarcinoma cells and the reprogramming of keratinocytes to induced pluripotent stem cells. Our results show that pluripotent cells (PCs) have decreased levels of H1.0 and increased levels of H1.1, H1.3, and H1.5 compared with differentiated cells. PCs have a more diverse repertoire of H1 variants, whereas in differentiated cells, H1.0 expression represents similar to 80% of the H1 transcripts. In agreement with their prevalent expression in ES cells, the regulatory regions of H1.3 and H1.5 genes were found to be occupied by pluripotency factors. Moreover, the H1.0 gene promoter contains bivalent domains (H3K4me2 and H3K27me3) in PCs, suggesting that this variant is likely to have an important role during differentiation. Indeed, the knockdown of H1.0 in human ES did not affect self-renewal but impaired differentiation. Accordingly, H1.0 was recruited to the regulatory regions of differentiation and pluripotency genes during differentiation, confirming that this histone variant plays a critical role in the regulation of these genes. Thus, histone H1 variant expression is controlled by a variety of mechanisms that produce distinct but consistent H1 repertoires in pluripotent and differentiated cells that appear critical to maintain the functionality of such cells.	[Sese, Borja; Izpisua Belmonte, Juan Carlos; Jose Barrero, Maria] Ctr Regenerat Med Barcelona, E-08003 Barcelona, Spain; [Terme, Jean-Michel; Millan-Arino, Lluis; Mayor, Regina; Jordan, Albert] CSIC, Inst Biol Mol Barcelona, E-08028 Barcelona, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Salk Institute	Barrero, MJ (corresponding author), Ctr Regenerat Med Barcelona, Doctor Aiguader 88, E-08003 Barcelona, Spain.	mjbarrero@cmrb.eu; albert.jordan@ibmb.csic.es	Barrero, Maria J./Q-1785-2017; jordan, albert/ABC-8229-2020; jordan, albert/K-4678-2014	Barrero, Maria J./0000-0002-5990-7040; jordan, albert/0000-0002-3970-8693; jordan, albert/0000-0002-3970-8693; Sese, Borja/0000-0001-8554-897X	Ministerio de Ciencia e Innovacion of Spain (MICINN); Fondo Europeo Desarrollo Regional [200820I090, BFU2008-00359/BMC, RYC-2007-01510, SAF2009-08588]; Generalitat de Catalunya [2009-SGR-1222]; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; Centro Investigacion Biomedica en Red de Bioingenieria; Fundacion Cellex; Fondation pour la Recherche Medicale; Consejo Superior de Investigaciones Cientificas-MICINN; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion of Spain (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo Europeo Desarrollo Regional; Generalitat de Catalunya(Generalitat de Catalunya); G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); Centro Investigacion Biomedica en Red de Bioingenieria; Fundacion Cellex(Foundation CELLEX); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Consejo Superior de Investigaciones Cientificas-MICINN; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Ministerio de Ciencia e Innovacion of Spain (MICINN); Fondo Europeo Desarrollo Regional Grants 200820I090 and BFU2008-00359/BMC (to A. J.) and RYC-2007-01510 and SAF2009-08588 (to M. J. B.); and Generalitat de Catalunya Grant 2009-SGR-1222 (to A. J.). Work at the laboratory of J. C. I. B. is supported by grants from the G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi-Aventis, MICINN, Centro Investigacion Biomedica en Red de Bioingenieria, and Fundacion Cellex.; Recipient of a fellowship from the Fondation pour la Recherche Medicale and a JAE-Doc contract from Consejo Superior de Investigaciones Cientificas-MICINN.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brown DT, 2003, BIOCHEM CELL BIOL, V81, P221, DOI 10.1139/o03-049; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Clausell J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007243; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; Franke K, 1998, BBA-GENE STRUCT EXPR, V1398, P232, DOI 10.1016/S0167-4781(98)00062-1; Fu G, 2003, BIOL REPROD, V68, P1569, DOI 10.1095/biolreprod.102.012336; Garcia BA, 2004, J PROTEOME RES, V3, P1219, DOI 10.1021/pr0498887; Gargiulo G, 2009, DEV CELL, V16, P466, DOI 10.1016/j.devcel.2009.02.002; Happel N, 2005, BIOL CHEM, V386, P541, DOI 10.1515/BC.2005.064; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hellauer K, 2001, J BIOL CHEM, V276, P13587, DOI 10.1074/jbc.M011196200; HELLIGER W, 1992, BIOCHEM J, V288, P747, DOI 10.1042/bj2880747; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Kim K, 2008, J BIOL CHEM, V283, P9113, DOI 10.1074/jbc.M708205200; Kratzmeier M, 1999, BIOCHEM J, V337, P319, DOI 10.1042/0264-6021:3370319; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; LENNOX RW, 1983, J BIOL CHEM, V258, P262; Lin QC, 2004, J BIOL CHEM, V279, P23525, DOI 10.1074/jbc.M400925200; Meergans T, 1997, DNA CELL BIOL, V16, P1041, DOI 10.1089/dna.1997.16.1041; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Parseghian MH, 2001, J CELL BIOCHEM, V83, P643, DOI 10.1002/jcb.1224; PINA B, 1987, EUR J BIOCHEM, V164, P71, DOI 10.1111/j.1432-1033.1987.tb10994.x; Raya A, 2008, COLD SH Q B, V73, P127, DOI 10.1101/sqb.2008.73.038; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Shahhoseini M, 2010, FEBS LETT, V584, P4661, DOI 10.1016/j.febslet.2010.10.041; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Wood C, 2009, FEBS J, V276, P4109, DOI 10.1111/j.1742-4658.2009.07079.x; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Yamamoto T, 1996, GENE, V173, P281, DOI 10.1016/0378-1119(96)00020-0; Yellajoshyula D, 2006, P NATL ACAD SCI USA, V103, P18568, DOI 10.1073/pnas.0606478103	41	73	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35347	35357		10.1074/jbc.M111.281923	http://dx.doi.org/10.1074/jbc.M111.281923			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852237	Green Published, hybrid			2022-12-27	WOS:000295927100006
J	Goyal, R; Salahudeen, AA; Jansen, M				Goyal, Raman; Salahudeen, Ahmed Abdullah; Jansen, Michaela			Engineering a Prokaryotic Cys-loop Receptor with a Third Functional Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; ANESTHETIC BINDING-SITE; LARGE CYTOPLASMIC LOOP; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; GABA(A) RECEPTORS; LIGAND-BINDING; 5-HYDROXYTRYPTAMINE TYPE-3; MAMMALIAN-CELLS	Prokaryotic members of the Cys-loop receptor ligand-gated ion channel superfamily were recently identified. Previously, Cys-loop receptors were only known from multicellular organisms (metazoans). Contrary to the metazoan Cys-loop receptors, the prokaryotic ones consist of an extracellular (ECD) and a transmembrane domain (TMD), lacking the large intracellular domain (ICD) present in metazoa (between transmembrane segments M3 and M4). Using a chimera approach, we added the 115-amino acid ICD from mammalian serotonin type 3A receptors (5-HT3A) to the prokaryotic proton-activated Gloeobacter violaceus ligand-gated ion channel (GLIC). We created 12 GLIC-5-HT3A-ICD chimeras by replacing a variable number of amino acids in the short GLIC M3M4 linker with the entire 5-HT3A-ICD. Two-electrode voltage clamp recordings after expression in Xenopus laevis oocytes showed that only two chimeras were functional and produced currents upon acidification. The pH(50) was comparable with wild-type GLIC. 5-HT3A receptor expression can be inhibited by the chaperone protein RIC-3. We have shown previously that the 5-HT3A-ICD is required for the attenuation of 5-HT-induced currents when RIC-3 is co-expressed with 5-HT3A receptors in X. laevis oocytes. Expression of both functional 5-HT3A chimeras was inhibited by RIC-3 co-expression, indicating appropriate folding of the 5-HT3A-ICD in the chimeras. Our results indicate that the ICD can be considered a separate domain that can be removed from or added to the ECD and TMD while maintaining the overall structure and function of the ECD and TMD.	[Goyal, Raman; Salahudeen, Ahmed Abdullah; Jansen, Michaela] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Salahudeen, Ahmed Abdullah] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Summer Res Program, Lubbock, TX 79430 USA; [Goyal, Raman; Jansen, Michaela] Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Sch Med, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Jansen, M (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, 3601 4th St, Lubbock, TX 79430 USA.	michaela.jansen@ttuhsc.edu	Goyal, Raman/AAG-8507-2019	Jansen, Michaela/0000-0003-1325-9700	National Institutes of Health [NS059841]; South Plains Foundation (SPF); Texas Tech University Health Sciences Center (TTUHSC) School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS059841, K99NS059841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Plains Foundation (SPF); Texas Tech University Health Sciences Center (TTUHSC) School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS059841 (to M. J.). This work was also supported by grants from the South Plains Foundation (SPF) (to M. J.) and the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine Student Summer Research Program (to A. A. S.).	Akk G, 2000, J PHYSIOL-LONDON, V527, P405, DOI 10.1111/j.1469-7793.2000.t01-2-00405.x; Bali M, 2007, J GEN PHYSIOL, V129, P145, DOI 10.1085/jgp.200609639; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Belelli D, 1995, MOL PHARMACOL, V48, P1054; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; Castelan F, 2007, J NEUROCHEM, V100, P406, DOI 10.1111/j.1471-4159.2006.04202.x; Castillo M, 2005, J BIOL CHEM, V280, P27062, DOI 10.1074/jbc.M503746200; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Charych EI, 2004, J NEUROCHEM, V90, P173, DOI 10.1111/j.1471-4159.2004.02481.x; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Gensler S, 2001, EUR J BIOCHEM, V268, P2209, DOI 10.1046/j.1432-1327.2001.02093.x; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; GRENNINGLOH G, 1987, NATURE, V330, P25, DOI 10.1038/330025b0; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Grutter T, 2005, CR BIOL, V328, P223, DOI 10.1016/j.crvi.2004.11.004; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Halevi S, 2003, J BIOL CHEM, V278, P34411, DOI 10.1074/jbc.M300170200; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Ilegems E, 2005, CHEMBIOCHEM, V6, P2180, DOI 10.1002/cbic.200500191; Ilegems E, 2004, J BIOL CHEM, V279, P53346, DOI 10.1074/jbc.M407467200; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Janovjak H, 2010, NAT NEUROSCI, V13, P1027, DOI 10.1038/nn.2589; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Keller SH, 2001, J BIOL CHEM, V276, P18384, DOI 10.1074/jbc.M100691200; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; Kottwitz D, 2004, PROTEIN EXPRES PURIF, V38, P237, DOI 10.1016/j.pep.2004.07.017; Kukhtina V, 2006, J NEUROCHEM, V97, P63, DOI 10.1111/j.1471-4159.2005.03468.x; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Li M, 2002, BIOPHYS J, V83, P206, DOI 10.1016/S0006-3495(02)75162-X; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; MIYAKE A, 1995, MOL PHARMACOL, V48, P407; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; Peters JA, 2004, BIOCHEM SOC T, V32, P547, DOI 10.1042/BST0320547; Ren XQ, 2005, J NEUROSCI, V25, P6676, DOI 10.1523/JNEUROSCI.1079-05.2005; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; Tasneem A, 2005, GENOME BIOL, V6; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Valor LM, 2002, BIOCHEMISTRY-US, V41, P7931, DOI 10.1021/bi025831r; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; YU XM, 1994, NEURON, V13, P247, DOI 10.1016/0896-6273(94)90473-1	68	28	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34635	34642		10.1074/jbc.M111.269647	http://dx.doi.org/10.1074/jbc.M111.269647			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844195	Green Published, hybrid			2022-12-27	WOS:000295406300018
J	Otomo, T; Higaki, K; Nanba, E; Ozono, K; Sakai, N				Otomo, Takanobu; Higaki, Katsumi; Nanba, Eiji; Ozono, Keiichi; Sakai, Norio			Lysosomal Storage Causes Cellular Dysfunction in Mucolipidosis II Skin Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME-REPLACEMENT; ENDOCYTIC PATHWAY; PH; MEMBRANES; THERAPY; SUBUNIT; DISEASE; IV	Mucolipidosis II (ML-II) is a fatal inherited metabolic disease caused by deficiency of GlcNAc-phosphotransferase, which plays a role in generating the mannose 6-phosphate recognition marker on lysosomal enzymes. In ML-II, many lysosomal acid hydrolases are mistargeted out of cells, and lysosomes become filled with undigested substrates, which explains inclusion cell disease as an alternative name for this disease. In this study, we revealed various cellular phenotypes in ML-II skin fibroblasts. We quantitated phospholipid and cholesterol within cells and showed similar to 2-fold accumulation in ML-II as compared with normal cells. Lysosomal pH of ML-II cells was higher than that of normal cells (5.29 +/- 0.08 versus 4.79 +/- 0.10, p < 0.001). The proliferated lysosomes in ML-II cells were accumulated similar to 3-fold in amount as compared with normal cells. Intracellular logistics including endocytosis and mannose 6-phosphate receptor recycling were impaired in ML-II cells. To confirm whether these ML-II cellular phenotypes derive from deficient lysosomal acid hydrolases within lysosomes, we performed supplementation of lysosomal enzymes using a partially purified total enzyme mixture, which was derived from the conditioned culture medium of normal skin fibroblasts after NH4Cl treatment. This supplementation corrected all of the previously described ML-II phenotypes. In addition, the autophagic and mitochondrial impairment that we have previously reported improved, and inclusion bodies disappeared on electron micrography following total lysosomal enzyme supplementation. Our results indicate that various cellular phenotypes in ML-II are caused by the deficiency of many lysosomal enzymes and massive accumulation of undigested substrates.	[Otomo, Takanobu; Ozono, Keiichi; Sakai, Norio] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan; [Higaki, Katsumi; Nanba, Eiji] Tottori Univ, Div Funct Genom, Res Ctr Biosci & Technol, Tottori 6838503, Japan	Osaka University; Tottori University	Otomo, T (corresponding author), 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	otomo@ped.med.osaka-u.ac.jp	Otomo, Takanobu/AAD-3586-2019		Ministry of Education, Culture, Science, Sports and Technology of Japan [20790728, 18390299, 21659257, 21591322]; Ministry of Health, Labour and Welfare of Japan [H20-Kokoro-022]	Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the Ministry of Education, Culture, Science, Sports and Technology of Japan (Grants 20790728, 18390299, 21659257, and 21591322) and the Ministry of Health, Labour and Welfare of Japan (Grant H20-Kokoro-022 and a grant for Research for Intractable Diseases).	Amalfitano A, 2001, GENET MED, V3, P132, DOI 10.1097/00125817-200103000-00008; Bach G, 1999, CLIN CHIM ACTA, V280, P173, DOI 10.1016/S0009-8981(98)00183-1; BARTON NW, 1990, P NATL ACAD SCI USA, V87, P1913, DOI 10.1073/pnas.87.5.1913; Beck M, 2007, HUM GENET, V121, P1, DOI 10.1007/s00439-006-0280-4; Boonen M, 2011, MOL BIOL CELL, V22, P1135, DOI 10.1091/mbc.E10-07-0584; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; BROWN JA, 1985, J CELL BIOL, V100, P1894, DOI 10.1083/jcb.100.6.1894; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Desnick RJ, 2004, J INHERIT METAB DIS, V27, P385, DOI 10.1023/B:BOLI.0000031101.12838.c6; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Kawashima I, 2007, CLIN CHIM ACTA, V378, P142, DOI 10.1016/j.cca.2006.11.019; Kobayashi H, 2011, MOL GENET METAB, V102, P170, DOI 10.1016/j.ymgme.2010.09.014; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kogot-Levin A, 2009, PEDIATR RES, V65, P686, DOI 10.1203/PDR.0b013e3181a1681a; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Kornfeld R, 1999, J BIOL CHEM, V274, P32778, DOI 10.1074/jbc.274.46.32778; Kornfeld S., 2001, METABOLIC MOL BASES, P3421; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Otomo T, 2009, MOL GENET METAB, V98, P393, DOI 10.1016/j.ymgme.2009.07.002; Otomo T, 2009, J HUM GENET, V54, P145, DOI 10.1038/jhg.2009.3; Puri V, 1999, NAT CELL BIOL, V1, P386, DOI 10.1038/14084; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; Schiffmann R, 2010, J INHERIT METAB DIS, V33, P373, DOI 10.1007/s10545-010-9047-0; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Storch Stephan, 2005, P17; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L	33	29	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35283	35290		10.1074/jbc.M111.267930	http://dx.doi.org/10.1074/jbc.M111.267930			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846724	Green Published, hybrid			2022-12-27	WOS:000295406300081
J	Pless, SA; Leung, AWY; Galpin, JD; Ahern, CA				Pless, Stephan A.; Leung, Ada W. Y.; Galpin, Jason D.; Ahern, Christopher A.			Contributions of Conserved Residues at the Gating Interface of Glycine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-PI INTERACTION; TRANSMEMBRANE DOMAIN INTERFACE; CYS-LOOP RECEPTORS; GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; COUPLING AGONIST BINDING; SIGNATURE DISULFIDE LOOP; X-RAY-STRUCTURE; GABA(A) RECEPTOR; CONFORMATIONAL-CHANGES	Glycine receptors (GlyRs) are chloride channels that mediate fast inhibitory neurotransmission and are members of the pentameric ligand-gated ion channel (pLGIC) family. The interface between the ligand binding domain and the transmembrane domain of pLGICs has been proposed to be crucial for channel gating and is lined by a number of charged and aromatic side chains that are highly conserved among different pLGICs. However, little is known about specific interactions between these residues that are likely to be important for gating in alpha 1 GlyRs. Here we use the introduction of cysteine pairs and the in vivo nonsense suppression method to incorporate unnatural amino acids to probe the electrostatic and hydrophobic contributions of five highly conserved side chains near the interface, Glu-53, Phe-145, Asp-148, Phe-187, and Arg-218. Our results suggest a salt bridge between Asp-148 in loop 7 and Arg-218 in the pre-M1 domain that is crucial for channel gating. We further propose that Phe-145 and Phe-187 play important roles in stabilizing this interaction by providing a hydrophobic environment. In contrast to the equivalent residues in loop 2 of other pLGICs, the negative charge at Glu-53 alpha 1 GlyRs is not crucial for normal channel function. These findings help decipher the GlyR gating pathway and show that distinct residue interaction patterns exist in different pLGICs. Furthermore, a salt bridge between Asp-148 and Arg-218 would provide a possible mechanistic explanation for the pathophysiologically relevant hyperekplexia, or startle disease, mutant Arg-2183 -> Gln.	Univ British Columbia, Dept Anesthesiol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Pharmacol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Therapeut, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Pless, SA (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	spless@mail.ubc.ca		Ahern, Christopher/0000-0002-7975-2744; Pless, Stephan/0000-0001-6654-114X; Leung, Ada/0000-0002-8018-1248; Galpin, Jason/0000-0003-1923-5312	Canadian Institutes of Health Research [56858]; Heart and Stroke Foundation of Canada; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by Canadian Institutes of Health Research Grant 56858, the Heart and Stroke Foundation of Canada, the Michael Smith Foundation for Health Research (to C. A. A.), and a postdoctoral fellowship by the Heart and Stroke Foundation of Canada (to S. A. P.).	Absalom NL, 2003, J BIOL CHEM, V278, P50151, DOI 10.1074/jbc.M305357200; Ahern CA, 2008, CIRC RES, V102, P86, DOI 10.1161/CIRCRESAHA.107.160663; Ahern CA, 2006, J GEN PHYSIOL, V128, P649, DOI 10.1085/jgp.200609654; Aldea M, 2010, J NEUROCHEM, V113, P1036, DOI 10.1111/j.1471-4159.2010.06665.x; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Cashin AL, 2007, BIOCHEMISTRY-US, V46, P630, DOI 10.1021/bi061638b; Castaldo P, 2004, J BIOL CHEM, V279, P25598, DOI 10.1074/jbc.M311021200; Cederholm JME, 2010, J NEUROCHEM, V115, P1245, DOI 10.1111/j.1471-4159.2010.07021.x; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Crawford DK, 2008, J BIOL CHEM, V283, P27698, DOI 10.1074/jbc.M802384200; Crawford DK, 2007, J NEUROCHEM, V102, P2097, DOI 10.1111/j.1471-4159.2007.04680.x; De Saint Jan D, 2001, J PHYSL, V535, P741; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; Elmslie FV, 1996, J MED GENET, V33, P435, DOI 10.1136/jmg.33.5.435; Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kearney PC, 1996, MOL PHARMACOL, V50, P1401; Keramidas A, 2006, J PHYSIOL-LONDON, V575, P11, DOI 10.1113/jphysiol.2005.102756; Lee WY, 2008, J GEN PHYSIOL, V132, P265, DOI 10.1085/jgp.200810014; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Limapichat W, 2010, J BIOL CHEM, V285, P8976, DOI 10.1074/jbc.M109.060939; Lummis SCR, 2005, CHEM BIOL, V12, P993, DOI 10.1016/j.chembiol.2005.06.012; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; McLaughlin JT, 2007, MOL PHARMACOL, V71, P1312, DOI 10.1124/mol.106.033092; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Padgett CL, 2007, J NEUROSCI, V27, P886, DOI 10.1523/JNEUROSCI.4791-06.2007; Pless SA, 2008, J NEUROSCI, V28, P10937, DOI 10.1523/JNEUROSCI.2540-08.2008; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Pless SA, 2011, NAT CHEM BIOL, V7, P617, DOI [10.1038/nchembio.622, 10.1038/NCHEMBIO.622]; Pless SA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1351; Pless SA, 2011, MOL PHARMACOL, V79, P742, DOI 10.1124/mol.110.069583; Pless SA, 2009, J BIOL CHEM, V284, P27370, DOI 10.1074/jbc.M109.048405; Pless SA, 2009, J BIOL CHEM, V284, P15847, DOI 10.1074/jbc.M809343200; Plested AJR, 2007, J PHYSIOL-LONDON, V581, P51, DOI 10.1113/jphysiol.2006.126920; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Purohit P, 2007, J GEN PHYSIOL, V130, P559, DOI 10.1085/jgp.200709857; RAJENDRA S, 1994, J BIOL CHEM, V269, P18739; RYAN SG, 1992, ANN NEUROL, V31, P663, DOI 10.1002/ana.410310615; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; Santarelli VP, 2007, J BIOL CHEM, V282, P8044, DOI 10.1074/jbc.M611334200; Schofield CM, 2004, BIOCHEMISTRY-US, V43, P10058, DOI 10.1021/bi036159g; Schofield CM, 2003, J BIOL CHEM, V278, P34079, DOI 10.1074/jbc.M302416200; TALEB O, 1994, EMBO J, V13, P1318, DOI 10.1002/j.1460-2075.1994.tb06384.x; Vicente-Agullo F, 2001, BIOCHEMISTRY-US, V40, P8300, DOI 10.1021/bi010087g; Wang J, 2007, J BIOL CHEM, V282, P26210, DOI 10.1074/jbc.M702314200; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	63	22	22	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35129	35136		10.1074/jbc.M111.269027	http://dx.doi.org/10.1074/jbc.M111.269027			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21835920	Green Published, hybrid			2022-12-27	WOS:000295406300066
J	Medler, S; Al Husini, N; Raghunayakula, S; Mukundan, B; Aldea, A; Ansari, A				Medler, Scott; Al Husini, Nadra; Raghunayakula, Sarita; Mukundan, Banupriya; Aldea, Ashley; Ansari, Athar			Evidence for a Complex of Transcription Factor IIB (TFIIB) with Poly(A) Polymerase and Cleavage Factor 1 Subunits Required for Gene Looping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							START SITE SELECTION; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL DOMAINS; PROTEIN COMPLEXES; BINDING PROTEIN; YEAST TFIIB; IN-VIVO; RNA; INITIATION; TERMINATION	Gene looping, defined as the interaction of the promoter and the terminator regions of a gene during transcription, requires transcription factor IIB (TFIIB). We have earlier demonstrated association of TFIIB with the distal ends of a gene in an activator-dependent manner (El Kaderi, B., Medler, S., Raghunayakula, S., and Ansari, A. (2009) J. Biol. Chem. 284, 25015-25025). The presence of TFIIB at the 3' end of a gene required its interaction with cleavage factor 1 (CF1) 3' end processing complex subunit Rna15. Here, employing affinity chromatography and glycerol gradient centrifugation, we show that TFIIB associates with poly(A) polymerase and the entire CF1 complex in yeast cells. The factors required for general transcription such as TATA-binding protein, RNA polymerase II, and TFIIH are not a component of the TFIIB complex. This holo-TFIIB complex was resistant to MNase digestion. The complex was observed only in the looping-competent strains, but not in the looping-defective sua7-1 strain. The requirement of Rna15 in gene looping has been demonstrated earlier. Here we provide evidence that poly(A) polymerase (Pap1) as well as CF1 subunits Rna14 and Pcf11 are also required for loop formation of MET16 and INO1 genes. Accordingly, cross-linking of TFIIB to the 3' end of genes was abolished in the mutants of Pap1, Rna14, and Pcf11. We further show that in sua7-1 cells, where holo-TFIIB complex is not formed, the kinetics of activated transcription is altered. These results suggest that a complex of TFIIB, CF1 subunits, and Pap1 exists in yeast cells. Furthermore, TFIIB interaction with the CF1 complex and Pap1 is crucial for gene looping and transcriptional regulation.	[Medler, Scott; Al Husini, Nadra; Raghunayakula, Sarita; Mukundan, Banupriya; Aldea, Ashley; Ansari, Athar] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Ansari, A (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	bb2749@wayne.edu	Ansari, Athar/AEK-0223-2022	Ansari, Athar/0000-0003-2806-421X	National Science Foundation (NSF) [MCB1020911]; Dept. of Biological Sciences (Wayne State University)	National Science Foundation (NSF)(National Science Foundation (NSF)); Dept. of Biological Sciences (Wayne State University)	This work was supported by National Science Foundation (NSF) Grant MCB1020911.; Supported by an enhancement graduate research assistantship from the Dept. of Biological Sciences (Wayne State University).	Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; ANSARI A, 1995, EMBO J, V14, P4001, DOI 10.1002/j.1460-2075.1995.tb00071.x; Auty R, 2004, J BIOL CHEM, V279, P49973, DOI 10.1074/jbc.M409849200; BAGBY S, 1995, CELL, V82, P857, DOI 10.1016/0092-8674(95)90483-2; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; BURATOWSKI S, 1993, P NATL ACAD SCI USA, V90, P5633, DOI 10.1073/pnas.90.12.5633; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Chew BS, 2007, BIOCHEM J, V406, P265, DOI 10.1042/BJ20070441; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; Dichtl B, 2002, EMBO J, V21, P4125, DOI 10.1093/emboj/cdf390; Dieci G, 1996, CELL, V84, P245, DOI 10.1016/S0092-8674(00)80979-4; Dieci G, 2003, TRENDS BIOCHEM SCI, V28, P202, DOI 10.1016/S0968-0004(03)00054-9; El Kaderi B, 2009, J BIOL CHEM, V284, P25015, DOI 10.1074/jbc.M109.007948; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Kessler MM, 1997, GENE DEV, V11, P2545, DOI 10.1101/gad.11.19.2545; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; MALIK S, 1991, P NATL ACAD SCI USA, V88, P9553, DOI 10.1073/pnas.88.21.9553; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; O'Reilly D, 2007, GENOMICS, V90, P407, DOI 10.1016/j.ygeno.2007.04.010; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Papantonis A, 2010, CURR OPIN CELL BIOL, V22, P271, DOI 10.1016/j.ceb.2010.03.004; Pardee TS, 1998, J BIOL CHEM, V273, P17859, DOI 10.1074/jbc.273.28.17859; Perkins KJ, 2008, MOL CELL, V29, P56, DOI 10.1016/j.molcel.2007.11.030; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Singh BN, 2009, METHODS, V48, P361, DOI 10.1016/j.ymeth.2009.02.018; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Takagi Y, 2003, J BIOL CHEM, V278, P43897, DOI 10.1074/jbc.C300417200; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; TSCHOCHNER H, 1992, P NATL ACAD SCI USA, V89, P11292, DOI 10.1073/pnas.89.23.11292; Vilar JMG, 2005, CURR OPIN GENET DEV, V15, P136, DOI 10.1016/j.gde.2005.02.005; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; Wu WH, 1999, P NATL ACAD SCI USA, V96, P2764, DOI 10.1073/pnas.96.6.2764; Zhang DY, 2000, NUCLEIC ACIDS RES, V28, P1913, DOI 10.1093/nar/28.9.1913	43	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33709	33718		10.1074/jbc.M110.193870	http://dx.doi.org/10.1074/jbc.M110.193870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21835917	hybrid, Green Published			2022-12-27	WOS:000295159200001
J	Torres-Bacete, J; Sinha, PK; Matsuno-Yagi, A; Yagi, T				Torres-Bacete, Jesus; Sinha, Prem Kumar; Matsuno-Yagi, Akemi; Yagi, Takao			Structural Contribution of C-terminal Segments of NuoL (ND5) and NuoM (ND4) Subunits of Complex I from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; IRON-SULFUR CLUSTERS; CONSERVED CHARGED RESIDUES; DNA-ENCODED SUBUNITS; PARACOCCUS-DENITRIFICANS; MEMBRANE DOMAIN; UBIQUINONE OXIDOREDUCTASE; 3-DIMENSIONAL STRUCTURE; PERIPHERAL SUBUNITS; RESPIRATORY-CHAIN	The proton-translocating NADH-quinone oxidoreductase (complex I/NDH-1) is a multisubunit enzymatic complex. It has a characteristic L-shaped form with two domains, a hydrophilic peripheral domain and a hydrophobic membrane domain. The membrane domain contains three antiporter-like subunits (NuoL, NuoM, and NuoN, Escherichia coli naming) that are considered to be involved in the proton translocation. Deletion of either NuoL or NuoM resulted in an incomplete assembly of NDH-1 and a total loss of the NADH-quinone oxidoreductase activity. We have truncated the C terminus segments of NuoM and NuoL by introducing STOP codons at different locations using site-directed mutagenesis of chromosomal DNA. Our results suggest an important structural role for the C-terminal segments of both subunits. The data further advocate that the elimination of the last transmembrane helix (TM14) of NuoM and the TM16 (at least C-terminal seven residues) or together with the HL helix and the TM15 of the NuoL subunit lead to reduced stability of the membrane arm and therefore of the whole NDH-1 complex. A region of NuoL critical for stability of NDH-1 architecture has been discussed.	[Torres-Bacete, Jesus; Sinha, Prem Kumar; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Yagi, T (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd,MEM256, La Jolla, CA 92037 USA.	yagi@scripps.edu		Torres, Jesus/0000-0003-3410-6930	National Institutes of Health, USPHS [R01GM033712]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM033712 from USPHS (to T. Y. and A. M.-Y.).	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Castro-Guerrero N, 2010, BIOCHEMISTRY-US, V49, P10072, DOI 10.1021/bi100885v; Dupuis A, 1997, FEMS MICROBIOL LETT, V148, P107, DOI 10.1016/S0378-1097(97)00023-2; Dupuis A, 1998, MOL MICROBIOL, V28, P531, DOI 10.1046/j.1365-2958.1998.00814.x; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Ghelli A, 1997, J BIOCHEM, V121, P746; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; Hinchliffe P, 2006, BIOCHEMISTRY-US, V45, P4413, DOI 10.1021/bi0600998; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; HOFHAUS G, 1995, MOL CELL BIOL, V15, P964; HOFHAUS G, 1993, EMBO J, V12, P3043, DOI 10.1002/j.1460-2075.1993.tb05973.x; Holt PJ, 2003, J BIOL CHEM, V278, P43114, DOI 10.1074/jbc.M308247200; Hossain MD, 2008, BIOPHYS J, V95, P4837, DOI 10.1529/biophysj.108.140061; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Ito M, 2000, J BACTERIOL, V182, P5663, DOI 10.1128/JB.182.20.5663-5670.2000; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; LEONARD K, 1987, J MOL BIOL, V194, P277, DOI 10.1016/0022-2836(87)90375-5; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Moparthi VK, 2011, BBA-BIOENERGETICS, V1807, P427, DOI 10.1016/j.bbabio.2011.01.005; Morgan DJ, 2008, BBA-BIOENERGETICS, V1777, P711, DOI 10.1016/j.bbabio.2008.03.023; Morino M, 2008, J BACTERIOL, V190, P4162, DOI 10.1128/JB.00294-08; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; Nakamaru-Ogiso E, 2003, FEBS LETT, V549, P43, DOI 10.1016/S0014-5793(03)00766-X; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Ohnishi T, 2008, BBA-BIOENERGETICS, V1777, P703, DOI 10.1016/j.bbabio.2008.04.032; Peng GH, 2003, BIOCHEMISTRY-US, V42, P3032, DOI 10.1021/bi026876v; Radermacher M, 2006, J STRUCT BIOL, V154, P269, DOI 10.1016/j.jsb.2006.02.011; Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578; Sinha P.K, 2009, CURR TOP BIOCH RES, V11, P79; Sinha PK, 2009, J BIOL CHEM, V284, P9814, DOI 10.1074/jbc.M809468200; Steimle S, 2011, BIOCHEMISTRY-US, V50, P3386, DOI 10.1021/bi200264q; Takano S, 1996, BIOCHEMISTRY-US, V35, P9120, DOI 10.1021/bi9605853; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; YAGI T, 1990, BIOCHEMISTRY-US, V29, P5515, DOI 10.1021/bi00475a015; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Yakovlev G, 2007, P NATL ACAD SCI USA, V104, P12720, DOI 10.1073/pnas.0705593104; Yano T, 1996, J BIOL CHEM, V271, P5907, DOI 10.1074/jbc.271.10.5907; Yano T, 1999, J BIOL CHEM, V274, P28606, DOI 10.1074/jbc.274.40.28606	53	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34007	34014		10.1074/jbc.M111.260968	http://dx.doi.org/10.1074/jbc.M111.260968			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21835926	Green Published, hybrid			2022-12-27	WOS:000295159200033
J	Alvarez-Fernandez, M; Halim, VA; Aprelia, M; Mohammed, S; Medema, RH				Alvarez-Fernandez, Monica; Halim, Vincentius A.; Aprelia, Melinda; Mohammed, Shabaz; Medema, Rene H.			Protein Phosphatase 2A (B55 alpha) Prevents Premature Activation of Forkhead Transcription Factor FoxM1 by Antagonizing Cyclin A/Cyclin-dependent Kinase-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; MITOTIC EXIT; IDENTIFICATION; COMPLEXES; PROGRAM; BINDING; DOMAIN	The forkhead transcription factor FoxM1 controls expression of a large number of genes that are specifically expressed during the G(2) phase of the cell cycle. Throughout most of the cell cycle, FoxM1 activity is restrained by an autoinhibitory mechanism, involving a repressor domain present in the N-terminal part of the protein. Activation of FoxM1 in G(2) is achieved by Cyclin A/Cyclin-dependent kinase (Cdk)-mediated phosphorylation, which alleviates autoinhibition by the N-terminal repressor domain. Here, we show that FoxM1 interacts with B55 alpha, a regulatory subunit of protein phosphatase 2A (PP2A). B55 alpha binds the catalytic subunit of PP2A, and this promotes dephosphorylation and inactivation of FoxM1. Indeed, we find that overexpression of B55 alpha results in decreased FoxM1 activity. Inversely, depletion of B55 alpha results in premature activation of FoxM1. The activation of FoxM1 that is observed upon depletion of B55 alpha is fully dependent on Cyclin A/Cdk-mediated phosphorylation of FoxM1. Taken together, these data demonstrate that B55 alpha acts to antagonize Cyclin A/Cdk-dependent activation of FoxM1, to ensure that FoxM1 activity is restricted to the G(2) phase of the cell cycle.	[Alvarez-Fernandez, Monica; Halim, Vincentius A.; Aprelia, Melinda; Medema, Rene H.] UMC Utrecht, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands; [Alvarez-Fernandez, Monica; Halim, Vincentius A.; Aprelia, Melinda; Medema, Rene H.] UMC Utrecht, Canc Genom Ctr, NL-3584 CG Utrecht, Netherlands; [Halim, Vincentius A.; Mohammed, Shabaz] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Halim, Vincentius A.; Mohammed, Shabaz] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University	Medema, RH (corresponding author), UMC Utrecht, Dept Med Oncol, Univ Weg 100,Stratenum 2-118, NL-3584 CG Utrecht, Netherlands.	r.h.medema@umcutrecht.nl	Fernández, Mónica Alvarez/C-5972-2009; Medema, Rene H/E-2981-2013; Mohammed, Shabaz/D-1042-2010; Mohammed, Shabaz/AAY-6313-2020	Fernández, Mónica Alvarez/0000-0002-6454-5128; Mohammed, Shabaz/0000-0003-2640-9560; Mohammed, Shabaz/0000-0003-2640-9560; Medema, Rene/0000-0002-6754-0381	Dutch Cancer Society [UU-2007-3826]; Netherlands Genomic Initiative of Netherlands Organization for Scientific Research	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Genomic Initiative of Netherlands Organization for Scientific Research	This work was supported by Dutch Cancer Society Grant UU-2007-3826) and The Netherlands Genomic Initiative of Netherlands Organization for Scientific Research.	Alvarez-Fernandez M, 2010, EMBO REP, V11, P452, DOI 10.1038/embor.2010.46; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Chae HD, 2004, ONCOGENE, V23, P4084, DOI 10.1038/sj.onc.1207482; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Futcher B, 2002, CURR OPIN CELL BIOL, V14, P676, DOI 10.1016/S0955-0674(02)00391-5; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; Park HJ, 2008, ONCOGENE, V27, P1696, DOI 10.1038/sj.onc.1210814; Pinkse MWH, 2008, J PROTEOME RES, V7, P687, DOI 10.1021/pr700605z; Saville MK, 1998, ONCOGENE, V17, P2679, DOI 10.1038/sj.onc.1202503; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2	22	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33029	33036		10.1074/jbc.M111.253724	http://dx.doi.org/10.1074/jbc.M111.253724			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813648	Green Published, hybrid			2022-12-27	WOS:000294968800021
J	Lalevee, S; Anno, YN; Chatagnon, A; Samarut, E; Poch, O; Laudet, V; Benoit, G; Lecompte, O; Rochette-Egly, C				Lalevee, Sebastien; Anno, Yannick N.; Chatagnon, Amandine; Samarut, Eric; Poch, Olivier; Laudet, Vincent; Benoit, Gerard; Lecompte, Odile; Rochette-Egly, Cecile			Genome-wide in Silico Identification of New Conserved and Functional Retinoic Acid Receptor Response Elements (Direct Repeats Separated by 5 bp)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; GENE-EXPRESSION; RAR-GAMMA; INDUCED DIFFERENTIATION; BINDING-SITE; VINEXIN-BETA; F9 CELLS; ALPHA; PHOSPHORYLATION; TRANSCRIPTION	The nuclear retinoic acid receptors interact with specific retinoic acid (RA) response elements (RAREs) located in the promoters of target genes to orchestrate transcriptional networks involved in cell growth and differentiation. Here we describe a genome-wide in silico analysis of consensus DR5 RAREs based on the recurrent RGKTSA motifs. More than 15,000 DR5 RAREs were identified and analyzed for their localization and conservation in vertebrates. We selected 138 elements located +/- 10 kb from transcription start sites and gene ends and conserved across more than 6 species. We also validated the functionality of these RAREs by analyzing their ability to bind retinoic acid receptors (ChIP sequencing experiments) as well as the RA regulation of the corresponding genes (RNA sequencing and quantitative real time PCR experiments). Such a strategy provided a global set of high confidence RAREs expanding the known experimentally validated RAREs repertoire associated to a series of new genes involved in cell signaling, development, and tumor suppression. Finally, the present work provides a valuable knowledge base for the analysis of a wider range of RA-target genes in different species.	[Lalevee, Sebastien; Samarut, Eric; Rochette-Egly, Cecile] Univ Strasbourg, Dept Funct Genom & Canc, Inst Genet & Biol Mol & Cellulaire, INSERM,U596, F-67404 Illkirch Graffenstaden, France; [Anno, Yannick N.; Poch, Olivier; Lecompte, Odile] Univ Strasbourg, Dept Integrated Struct Biol, Inst Genet & Biol Mol & Cellulaire, INSERM,U596, F-67404 Illkirch Graffenstaden, France; [Anno, Yannick N.; Poch, Olivier; Lecompte, Odile] Univ Strasbourg, CNRS, UMR7104, F-67404 Illkirch Graffenstaden, France; [Lalevee, Sebastien; Chatagnon, Amandine; Benoit, Gerard] CNRS, UMR5534, F-69622 Villeurbanne, France; [Chatagnon, Amandine; Benoit, Gerard] Univ Lyon 1, UMR5534, F-69622 Villeurbanne, France; [Laudet, Vincent] Univ Lyon, Inst Genom Fonct Lyon, UMR 5242, Inst Natl Rech Agron,Ecole Normale Super Lyon, F-69364 Lyon 07, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON)	Rochette-Egly, C (corresponding author), 1 Rue Laurent Fries,BP 10142, F-67404 Illkirch Graffenstaden, France.	cegly@igbmc.fr	Lecompte, Odile/N-7992-2019; Lecompte, Odile/F-4741-2011	Lecompte, Odile/0000-0002-2005-460X; Lecompte, Odile/0000-0002-2005-460X; SAMARUT, ERIC/0000-0001-7818-2009; BENOIT, Gerard/0000-0001-9462-6570	CNRS; INSERM; Association pour la Recherche sur le Cancer (ARC) [3169]; Agence Nationale pour la Recherche [ANR-05-BLAN-0390-02, ANR-09-BLAN-0127-01]; Fondation pour la Recherche Medicale [DEQ20090515423]; Institut National du Cancer [INCa-PLO7-96099, PL09-194]; Association pour la Recherche sur le Cancer (ARC); Ministere de l'Enseignement Superieur et de la Recherche	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported by funds from CNRS, INSERM, the Association pour la Recherche sur le Cancer (ARC 3169), the Agence Nationale pour la Recherche (ANR-05-BLAN-0390-02 and ANR-09-BLAN-0127-01), the Fondation pour la Recherche Medicale (DEQ20090515423), and the Institut National du Cancer (INCa-PLO7-96099 and PL09-194).; Supported by the Association pour la Recherche sur le Cancer (ARC).; Supported by the Ministere de l'Enseignement Superieur et de la Recherche.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anno YN, 2011, NUCLEIC ACIDS RES, V39, P3116, DOI 10.1093/nar/gkq1301; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bollig F, 2009, DEVELOPMENT, V136, P2883, DOI 10.1242/dev.031773; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; BOUILLET P, 1995, DEV DYNAM, V204, P372, DOI 10.1002/aja.1002040404; Bour G, 2005, J BIOL CHEM, V280, P17027, DOI 10.1074/jbc.M501344200; Bour G, 2006, AD DEV BIOL, V16, P211, DOI 10.1016/S1574-3349(06)16007-X; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Bruck N, 2009, EMBO J, V28, P34, DOI 10.1038/emboj.2008.256; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Cotnoir-White D, 2011, MOL CELL ENDOCRINOL, V334, P76, DOI 10.1016/j.mce.2010.10.021; Coulombe Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010600; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Doerksen LF, 1996, NUCLEIC ACIDS RES, V24, P2849, DOI 10.1093/nar/24.14.2849; Duong V, 2011, BBA-MOL BASIS DIS, V1812, P1023, DOI 10.1016/j.bbadis.2010.10.007; Eifert C, 2006, MOL REPROD DEV, V73, P796, DOI 10.1002/mrd.20444; Faralli H, 2011, J BIOL CHEM, V286, P23498, DOI 10.1074/jbc.M110.206003; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Garitaonandia I, 2009, J RECEPT SIG TRANSD, V29, P67, DOI 10.1080/10799890902729456; Gillespie RF, 2007, J BIOL CHEM, V282, P33421, DOI 10.1074/jbc.M704845200; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Harris Thomas M, 2002, Funct Integr Genomics, V2, P105, DOI 10.1007/s10142-002-0062-6; Hoffman BG, 2009, J ENDOCRINOL, V201, P1, DOI 10.1677/JOE-08-0526; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Huang D, 1998, DEVELOPMENT, V125, P3235; Jing Y, 2011, CELL MOL NEUROBIOL, V31, P715, DOI 10.1007/s10571-011-9669-2; Lalevee S, 2010, FASEB J, V24, P4523, DOI 10.1096/fj.10-160572; LANGSTON AW, 1992, MECH DEVELOP, V38, P217, DOI 10.1016/0925-4773(92)90055-O; LEHMANN JM, 1992, MOL CELL BIOL, V12, P2976, DOI 10.1128/MCB.12.7.2976; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LEROY P, 1991, P NATL ACAD SCI USA, V88, P10138, DOI 10.1073/pnas.88.22.10138; Lickert H, 2002, DEV DYNAM, V225, P216, DOI 10.1002/dvdy.10149; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Mead AN, 2003, J NEUROSCI, V23, P9500; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mercader N, 2000, DEVELOPMENT, V127, P3961; Milinkovitch MC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r16; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; OuladAbdelghani M, 1997, DEV DYNAM, V210, P173, DOI 10.1002/(SICI)1097-0177(199710)210:2<173::AID-AJA9>3.0.CO;2-D; OuladAbdelghani M, 1996, EXP CELL RES, V225, P338, DOI 10.1006/excr.1996.0184; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; ROCHETTEEGLY C, 1992, MOL ENDOCRINOL, V6, P2197, DOI 10.1210/me.6.12.2197; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Samarut E., 2011, MOL CELL EN IN PRESS; Samarut E, 2011, MOL BIOL EVOL, V28, P2125, DOI 10.1093/molbev/msr035; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Su D, 2008, BIOCHEM PHARMACOL, V75, P1129, DOI 10.1016/j.bcp.2007.11.006; Tabaries S, 2005, MOL CELL BIOL, V25, P1389, DOI 10.1128/MCB.25.4.1389-1401.2005; Taneja R, 1997, EMBO J, V16, P6452, DOI 10.1093/emboj/16.21.6452; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Xing Y, 2009, MOL CELL ENDOCRINOL, V300, P43, DOI 10.1016/j.mce.2008.10.036	62	62	63	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33322	33334		10.1074/jbc.M111.263681	http://dx.doi.org/10.1074/jbc.M111.263681			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21803772	Green Published, hybrid			2022-12-27	WOS:000294968800051
J	Thangasamy, A; Rogge, J; Krishnegowda, NK; Freeman, JW; Ammanamanchi, S				Thangasamy, Amalraj; Rogge, Jessica; Krishnegowda, Naveen K.; Freeman, James W.; Ammanamanchi, Sudhakar			Novel Function of Transcription Factor Nrf2 as an Inhibitor of RON Tyrosine Kinase Receptor-mediated Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; OXIDATIVE STRESS; ACTIVATION; SENSITIVITY; PREVENTION; MUTATIONS; MICE	Recepteur d' origine nantais (RON), a tyrosine kinase receptor, is aberrantly expressed in human tumors and promotes cancer cell invasion. RON receptor activation is also associated with resistance to tamoxifen treatment in breast cancer cells. Nrf2 is a positive regulator of cytoprotective genes. Using chromatin immunoprecipitation (ChIP) and site-directed mutagenesis studies of the RON promoter, we identified Nrf2 as a negative regulator of RON gene expression. High Nrf2 and low RON expression was observed in normal mammary tissue whereas high RON and low or undetectable expression of Nrf2 was observed in breast tumors. The Nrf2 inducer sulforaphane (SFN) as well as ectopic Nrf2 expression or knock-down of the Nrf2 negative regulator keap1, which stabilizes Nrf2, inhibited RON expression and invasion of carcinoma cells. Consequently, our studies identified a novel functional role for Nrf2 as a "repressor" and RON kinase as a molecular target of SFN, which mediates the anti-tumor effects of SFN. These results are not limited to breast cancer cells since the Nrf2 inducer SFN stabilized Nrf2 and inhibited RON expression in carcinoma cells from various tumor types.	[Thangasamy, Amalraj; Rogge, Jessica; Krishnegowda, Naveen K.; Freeman, James W.; Ammanamanchi, Sudhakar] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol Med Oncol, San Antonio, TX 78229 USA; [Freeman, James W.] Audie L Murphy Mem Vet Adm Med Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Ammanamanchi, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol Med Oncol, San Antonio, TX 78229 USA.	sammanamanchi@hotmail.com			Veterans Administration; NATIONAL CANCER INSTITUTE [R01CA069122] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Veterans Administration Merit Award (to J. W. F.).	Aoki Y, 2007, CANCER RES, V67, P5643, DOI 10.1158/0008-5472.CAN-06-3355; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Keller UAD, 2006, MOL CELL BIOL, V26, P3773, DOI 10.1128/MCB.26.10.3773-3784.2006; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee WY, 2005, CLIN CANCER RES, V11, P2222, DOI 10.1158/1078-0432.CCR-04-1761; Leonis Mike A, 2007, Future Oncol, V3, P441, DOI 10.2217/14796694.3.4.441; Loignon M, 2009, MOL CANCER THER, V8, P2432, DOI 10.1158/1535-7163.MCT-08-1186; McClaine RJ, 2010, NEOPLASIA, V12, P650, DOI 10.1593/neo.10476; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Thangasamy A, 2008, J BIOL CHEM, V283, P5335, DOI 10.1074/jbc.M706957200; Thangasamy A, 2009, J BIOL CHEM, V284, P14001, DOI 10.1074/jbc.M809320200; Wang MH, 2007, J PATHOL, V213, P402, DOI 10.1002/path.2245; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Zinser GM, 2006, CANCER RES, V66, P11967, DOI 10.1158/0008-5472.CAN-06-2473	20	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32115	32122		10.1074/jbc.M111.245746	http://dx.doi.org/10.1074/jbc.M111.245746			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21799005	hybrid, Green Published			2022-12-27	WOS:000294726800021
J	Saito, M; Kurokawa, M; Oda, M; Oshima, M; Tsutsui, K; Kosaka, K; Nakao, K; Ogawa, M; Manabe, R; Suda, N; Ganjargal, G; Hada, Y; Noguchi, T; Teranaka, T; Sekiguchi, K; Yoneda, T; Tsuji, T				Saito, Masahiro; Kurokawa, Misaki; Oda, Masahito; Oshima, Masamitsu; Tsutsui, Ko; Kosaka, Kazutaka; Nakao, Kazuhisa; Ogawa, Miho; Manabe, Ri-ichiroh; Suda, Naoto; Ganjargal, Ganburged; Hada, Yasunobu; Noguchi, Toshihide; Teranaka, Toshio; Sekiguchi, Kiyotoshi; Yoneda, Toshiyuki; Tsuji, Takashi			ADAMTSL6 beta Protein Rescues Fibrillin-1 Microfibril Disorder in a Marfan Syndrome Mouse Model through the Promotion of Fibrillin-1 Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTAL FOLLICLE CELLS; EXTRACELLULAR-MATRIX; PERIODONTAL-LIGAMENT; MUSCLE REGENERATION; IN-VIVO; PATHOGENESIS; EXPRESSION; DISEASE; MUTATIONS; PHENOTYPE	Marfan syndrome (MFS) is a systemic disorder of the connective tissues caused by insufficient fibrillin-1 microfibril formation and can cause cardiac complications, emphysema, ocular lens dislocation, and severe periodontal disease. ADAMTSL6 beta (A disintegrin-like metalloprotease domain with thrombospondin type I motifs-like 6 beta) is a microfibril-associated extracellular matrix protein expressed in various connective tissues that has been implicated in fibrillin-1 microfibril assembly. We here report that ADAMTSL6 beta plays an essential role in the development and regeneration of connective tissues. ADAMTSL6 beta expression rescues microfibril disorder after periodontal ligament injury in an MFS mouse model through the promotion of fibrillin-1 microfibril assembly. In addition, improved fibrillin-1 assembly in MFS mice following the administration of ADAMTSL6 beta attenuates the overactivation of TGF-beta signals associated with the increased release of active TGF-beta from disrupted fibrillin-1 microfibrils within periodontal ligaments. Our current data thus demonstrate the essential contribution of ADAMTSL6 beta to fibrillin-1 microfibril formation. These findings also suggest a new therapeutic strategy for the treatment of MFS through ADAMTSL6 beta-mediated fibrillin-1 microfibril assembly.	[Saito, Masahiro] Tokyo Univ Sci, Fac Ind Sci & Technol, Res Inst Sci & Technol, Chiba 2788510, Japan; [Saito, Masahiro; Kurokawa, Misaki; Oda, Masahito; Hada, Yasunobu; Tsuji, Takashi] Tokyo Univ Sci, Fac Ind Sci, Dept Biol Sci & Technol, Chiba 2788510, Japan; [Ogawa, Miho; Tsuji, Takashi] Organ Technol Inc, Tokyo, Japan; [Yoneda, Toshiyuki] Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, Suita, Osaka 5650871, Japan; [Tsutsui, Ko; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Kosaka, Kazutaka; Teranaka, Toshio] Kanagawa Dent Coll, Dept Oral Med, Div Restorat Dent, Yokosuka Kanagawa 2388580, Japan; [Noguchi, Toshihide] Aichi Gakuin Univ, Sch Dent, Dept Periodontol, Nisshin 4700195, Japan; [Suda, Naoto; Ganjargal, Ganburged; Hada, Yasunobu] Tokyo Med & Dent Univ, Grad Sch, Tokyo 1130034, Japan; [Manabe, Ri-ichiroh] RIKEN Yokohama Inst, RIKEN Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan	Tokyo University of Science; Tokyo University of Science; Osaka University; Osaka University; Kanagawa Dental College; Aichi Gakuin University; Tokyo Medical & Dental University (TMDU); RIKEN	Saito, M (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Res Inst Sci & Technol, Chiba 2788510, Japan.	mssaito@rs.noda.tus.ac.jp	Tsuji, Takashi/N-6086-2015		Ministry of Health, Labour, and Welfare [23164001]; MEXT;  [23659980]; Grants-in-Aid for Scientific Research [21390509] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Health and Labour Sciences Research Grants from the Ministry of Health, Labour, and Welfare (No. 23164001) (to M. S.), a Grant-in-aid for Scientific Research (B) (No. 23659980) (to M. S.), and Program for Development of Strategic Research Center in Private Universities supported by MEXT(2010) (to M. S.).	Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; Baldock C, 2006, P NATL ACAD SCI USA, V103, P11922, DOI 10.1073/pnas.0601609103; Brooke BS, 2003, TRENDS CELL BIOL, V13, P51, DOI 10.1016/S0962-8924(02)00007-7; Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Cheng JF, 2002, EXP BIOL MED, V227, P943, DOI 10.1177/153537020222701102; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Dietz HC, 2005, AM J MED GENET C, V139C, P4, DOI 10.1002/ajmg.c.30068; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Handa K, 2002, BONE, V31, P606, DOI 10.1016/S8756-3282(02)00868-2; Hasegawa T, 2007, CELL TISSUE RES, V329, P259, DOI 10.1007/s00441-007-0424-4; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Hubmacher D, 2008, P NATL ACAD SCI USA, V105, P6548, DOI 10.1073/pnas.0706335105; Hutchinson S, 2003, HUM MOL GENET, V12, P2269, DOI 10.1093/hmg/ddg241; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Judge DP, 2008, ANNU REV MED, V59, P43, DOI 10.1146/annurev.med.59.103106.103801; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; KAWAMOTO T, 1990, J HISTOCHEM CYTOCHEM, V38, P1805, DOI 10.1177/38.12.2254645; Kinsey R, 2008, J CELL SCI, V121, P2696, DOI 10.1242/jcs.029819; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; Massague J, 2008, MOL CELL, V29, P149, DOI 10.1016/j.molcel.2008.01.006; Nakajima M, 2007, J BIOL CHEM, V282, P32185, DOI 10.1074/jbc.M700522200; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Nanci A, 2006, PERIODONTOL 2000, V40, P11, DOI 10.1111/j.1600-0757.2005.00141.x; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Nishida E, 2007, GENE, V404, P70, DOI 10.1016/j.gene.2007.09.009; Nishimura R, 2002, BONE, V31, P303, DOI 10.1016/S8756-3282(02)00826-8; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Ramirez F, 2007, J CELL PHYSIOL, V213, P326, DOI 10.1002/jcp.21189; Ramirez F, 2007, CURR OPIN GENET DEV, V17, P252, DOI 10.1016/j.gde.2007.04.006; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sawada T, 2006, J HISTOCHEM CYTOCHEM, V54, P1095, DOI 10.1369/jhc.5A6905.2006; Shiga M, 2008, CELL TISSUE RES, V331, P461, DOI 10.1007/s00441-007-0528-x; Staszyk C, 2004, ANAT HISTOL EMBRYOL, V33, P17, DOI 10.1111/j.1439-0264.2004.00503.x; Straub AM, 2002, J PERIODONTOL, V73, P823, DOI 10.1902/jop.2002.73.7.823; Tsuruga E, 2002, J DENT RES, V81, P771, DOI 10.1177/154405910208101110; Tsutsui K, 2010, J BIOL CHEM, V285, P4870, DOI 10.1074/jbc.M109.076919; Vollbrandt T, 2004, J BIOL CHEM, V279, P32924, DOI 10.1074/jbc.M405239200; Yamamoto T, 2006, BLOOD, V108, P3305, DOI 10.1182/blood-2006-04-014829; Yokoi T, 2007, CELL TISSUE RES, V327, P301, DOI 10.1007/s00441-006-0257-6	51	32	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38602	38613		10.1074/jbc.M111.243451	http://dx.doi.org/10.1074/jbc.M111.243451			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21880733	Green Published, hybrid			2022-12-27	WOS:000296594200073
J	Ghosh, A; Sakaguchi, R; Liu, CP; Vishveshwara, S; Hou, YM				Ghosh, Amit; Sakaguchi, Reiko; Liu, Cuiping; Vishveshwara, Saraswathi; Hou, Ya-Ming			Allosteric Communication in Cysteinyl tRNA Synthetase A NETWORK OF DIRECT AND INDIRECT READOUT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID DISCRIMINATION; PROTEIN STRUCTURES; ESSENTIAL DYNAMICS; RECOGNITION; PATHWAYS; TRANSITIONS; DOMAIN; GROEL	Protein structure networks are constructed for the identification of long-range signaling pathways in cysteinyl tRNA synthetase (CysRS). Molecular dynamics simulation trajectory of CysRS-ligand complexes were used to determine conformational ensembles in order to gain insight into the allosteric signaling paths. Communication paths between the anticodon binding region and the aminoacylation region have been identified. Extensive interaction between the helix bundle domain and the anticodon binding domain, resulting in structural rigidity in the presence of tRNA, has been detected. Based on the predicted model, six residues along the communication paths have been examined by mutations (single and double) and shown to mediate a coordinated coupling between anticodon recognition and activation of amino acid at the active site. This study on CysRS clearly shows that specific key residues, which are involved in communication between distal sites in allosteric proteins but may be elusive in direct structure analysis, can be identified from dynamics of protein structure networks.	[Ghosh, Amit; Vishveshwara, Saraswathi] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Sakaguchi, Reiko; Liu, Cuiping; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA USA; [Ghosh, Amit] Univ Illinois, Dept Chem & Biomol Engn, Inst Genom Biol, Urbana, IL 61801 USA	Indian Institute of Science (IISC) - Bangalore; Jefferson University; University of Illinois System; University of Illinois Urbana-Champaign	Vishveshwara, S (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	sv@mbu.iisc.ernet.in; Ya-Ming.Hou@jefferson.edu	Ghosh, Amit/AAB-3140-2019; Ghosh, Amit/AAA-3490-2021	Ghosh, Amit/0000-0003-3514-885X; Hou, Ya-Ming/0000-0001-6546-2597	National Institutes of Health [GM56662]; Department of Science and Technology (DST), Government of India [DSTO773]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56662 (to Y.-M. H.).; We acknowledge the Computational grants for the Indian Institute of Science from the Department of Science and Technology (DST) ( support for Mathematical Biology, DSTO773), Government of India, and the computational facilities at the Supercomputer Education and Research Centre, Indian Institute of Science, Bangalore. We thank Moitrayee Bhattacharyya for readings of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Alexander RW, 1999, BIOCHEMISTRY-US, V38, P16359, DOI 10.1021/bi991948c; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Atilgan C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000544; Bhattacharyya M, 2010, PROTEINS, V78, P506, DOI 10.1002/prot.22573; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Case D, 2006, AMBER 9; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Christian T, 2000, J MOL BIOL, V303, P503, DOI 10.1006/jmbi.2000.4169; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Crepin T, 2003, J MOL BIOL, V332, P59, DOI 10.1016/S0022-2836(03)00917-3; del Sol A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r92; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Ghosh A, 2008, BIOCHEMISTRY-US, V47, P11398, DOI 10.1021/bi8007559; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P15711, DOI 10.1073/pnas.0704459104; Ghosh A, 2007, BIOPHYS J, V92, P2523, DOI 10.1529/biophysj.106.099903; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Hansia P, 2009, MOL BIOSYST, V5, P1860, DOI 10.1039/b903807h; Hauenstein S, 2004, NAT STRUCT MOL BIOL, V11, P1134, DOI 10.1038/nsmb849; HOU YM, 1991, P NATL ACAD SCI USA, V88, P976, DOI 10.1073/pnas.88.3.976; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanna N, 1999, J MOL BIOL, V292, P441, DOI 10.1006/jmbi.1999.3058; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; KOMATSOULIS GA, 1993, BIOCHEMISTRY-US, V32, P7435, DOI 10.1021/bi00080a014; Kong YF, 2009, PROTEINS, V74, P145, DOI 10.1002/prot.22139; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Liu CP, 2007, J MOL BIOL, V367, P1063, DOI 10.1016/j.jmb.2007.01.050; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Newberry KJ, 2002, EMBO J, V21, P2778, DOI 10.1093/emboj/21.11.2778; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; ROULD MA, 1991, NATURE, V352, P213, DOI 10.1038/352213a0; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Tang S, 2007, J MOL BIOL, V373, P1361, DOI 10.1016/j.jmb.2007.08.059; WEBSTER T, 1984, SCIENCE, V226, P1315, DOI 10.1126/science.6390679; Zhang CM, 2008, NAT STRUCT MOL BIOL, V15, P507, DOI 10.1038/nsmb.1423; Zhang CM, 2003, BIOCHEMISTRY-US, V42, P10931, DOI 10.1021/bi034812u; Zhang CM, 2003, J MOL BIOL, V327, P911, DOI 10.1016/S0022-2836(03)00241-9; Zheng W, 2007, BIOPHYS J, V93, P2289, DOI 10.1529/biophysj.107.105270	44	61	62	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37721	37731		10.1074/jbc.M111.246702	http://dx.doi.org/10.1074/jbc.M111.246702			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21890630	Green Published, hybrid			2022-12-27	WOS:000296542400068
J	Jansen, C; Hofheinz, K; Vogel, R; Roffeis, J; Anton, M; Reddanna, P; Kuhn, H; Walther, M				Jansen, Christian; Hofheinz, Katharina; Vogel, Robert; Roffeis, Jana; Anton, Monika; Reddanna, Pallu; Kuhn, Hartmut; Walther, Matthias			Stereocontrol of Arachidonic Acid Oxygenation by Vertebrate Lipoxygenases NEWLY CLONED ZEBRAFISH LIPOXYGENASE 1 DOES NOT FOLLOW THE ALA-VERSUS-GLY CONCEPT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; POSITIONAL SPECIFICITY; ACTIVE-SITE; PRODUCT STEREOCHEMISTRY; SEQUENCE DETERMINANTS; PEROXYL RADICALS; STRUCTURAL BASIS; SP PCC-7120; 15-LIPOXYGENASE; MODEL	Background: R-LOX carries a Gly at a critical position, but S-LOX contains an Ala there. Results: Zebrafish LOX1 carries a Gly at this position but catalyzed 12S-lipoxygenation. Conclusion: The Ala-versus-Gly concept is not applicable to zebrafish LOX1. Significance: Prediction of LOX specificity on the basis of primary structure is not always accurate; functional studies are always required.	[Jansen, Christian; Hofheinz, Katharina; Vogel, Robert; Roffeis, Jana; Anton, Monika; Kuhn, Hartmut; Walther, Matthias] Charite, Inst Biochem, D-10117 Berlin, Germany; [Reddanna, Pallu] Univ Hyderabad, Sch Life Sci, Hyderabad 500046, Andhra Pradesh, India	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hyderabad	Kuhn, H (corresponding author), Charite, Inst Biochem, Oudenarderstr 16, D-13347 Berlin, Germany.	hartmut.kuehn@charite.de			European Commission [LSHM-CT-2004-0050333]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by European Commission FP6 Grant LSHM-CT-2004-0050333 (to H. K.).	Andreou AZ, 2008, PHYTOCHEMISTRY, V69, P1832, DOI 10.1016/j.phytochem.2008.03.002; Bannenberg G, 2009, LIPIDS, V44, P85, DOI 10.1007/s11745-008-3245-7; Bhattacharya S, 2009, TUMOR BIOL, V30, P185, DOI 10.1159/000236864; Boeglin WE, 2008, LIPIDS, V43, P979, DOI 10.1007/s11745-008-3230-1; Borngraber S, 1999, J BIOL CHEM, V274, P37345, DOI 10.1074/jbc.274.52.37345; BRYANT RW, 1982, J BIOL CHEM, V257, P6050; Burger F, 2000, BIOCHEM J, V348, P329, DOI 10.1042/bj3480329; CHEN XS, 1994, J BIOL CHEM, V269, P13979; Coffa G, 2005, J BIOL CHEM, V280, P38756, DOI 10.1074/jbc.M504870200; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; FEUSSNER I, 1995, P NATL ACAD SCI USA, V92, P11849, DOI 10.1073/pnas.92.25.11849; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Hersberger M, 2010, CLIN CHEM LAB MED, V48, P1063, DOI 10.1515/CCLM.2010.212; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Johannesson M, 2010, PROSTAG LEUKOTR ESS, V82, P121, DOI 10.1016/j.plefa.2009.11.006; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kitaguchi H, 2005, J AM CHEM SOC, V127, P6605, DOI 10.1021/ja044345j; Koeduka T, 2007, CURR MICROBIOL, V54, P315, DOI 10.1007/s00284-006-0512-9; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1169, P80, DOI 10.1016/0005-2760(93)90085-N; Meruvu S, 2005, J BIOL CHEM, V280, P36633, DOI 10.1074/jbc.M508260200; Moreno JJ, 2009, BIOCHEM PHARMACOL, V77, P1, DOI 10.1016/j.bcp.2008.07.033; NELSON MJ, 1994, BIOCHEMISTRY-US, V33, P4966, DOI 10.1021/bi00182a027; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Saam J, 2007, P NATL ACAD SCI USA, V104, P13319, DOI 10.1073/pnas.0702401104; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schwarz K, 2001, J BIOL CHEM, V276, P773, DOI 10.1074/jbc.M005114200; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Stables MJ, 2011, PROG LIPID RES, V50, P35, DOI 10.1016/j.plipres.2010.07.005; SUZUKI H, 1994, BBA-LIPID LIPID MET, V1210, P308, DOI 10.1016/0005-2760(94)90234-8; Vance RE, 2004, P NATL ACAD SCI USA, V101, P2135, DOI 10.1073/pnas.0307308101; Vascotto SG, 1997, BIOCHEM CELL BIOL, V75, P479, DOI 10.1139/bcb-75-5-479; Vogel R, 2010, J BIOL CHEM, V285, P5369, DOI 10.1074/jbc.M109.057802; Wasternack C, 2010, ACS CHEM BIOL, V5, P63, DOI 10.1021/cb900269u; WATANABE T, 1993, BIOCHEM BIOPH RES CO, V192, P1023, DOI 10.1006/bbrc.1993.1519; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200; Zheng YX, 2010, J BIOL CHEM, V285, P39866, DOI 10.1074/jbc.M110.155374	43	30	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37804	37812		10.1074/jbc.M111.259242	http://dx.doi.org/10.1074/jbc.M111.259242			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880725	hybrid, Green Published			2022-12-27	WOS:000296542400075
J	Lam, KKW; Chiu, PCN; Lee, CL; Pang, RTK; Leung, CON; Koistinen, H; Seppala, M; Ho, PC; Yeung, WSB				Lam, Kevin K. W.; Chiu, Philip C. N.; Lee, Cheuk-Lun; Pang, Ronald T. K.; Leung, Carmen O. N.; Koistinen, Hannu; Seppala, Markku; Ho, Pak-Chung; Yeung, William S. B.			Glycodelin-A Protein Interacts with Siglec-6 Protein to Suppress Trophoblast Invasiveness by Down-regulating Extracellular Signal-regulated Kinase (ERK)/c-Jun Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATERNAL-FETAL INTERFACE; C-JUN; MATRIX METALLOPROTEINASE-2; INFLAMMATORY CYTOKINES; NEGATIVE REGULATION; IMMUNE-SYSTEM; MAP KINASES; IN-VITRO; ACTIVATION; EXPRESSION	During placentation, the cytotrophoblast differentiates into the villous cytotrophoblast and the extravillous cytotrophoblast. The latter invades the decidualized endometrium. Glycodelin-A (GdA) is abundantly synthesized by the decidua but not the trophoblast. Previous data indicate that GdA suppresses the invasion of trophoblast cell lines by down-regulating proteinase expression and activities. This study addresses the signaling pathway involved in the above phenomenon. GdA was found to suppress phosphorylation of ERKs and expression of their downstream effector c-Jun, a component of the transcription factor activator protein-1 (AP-1). The involvement of ERKs and c-Jun in suppressing trophoblast invasion and biosynthesis of proteinases was confirmed by using siRNA knockdown and pharmacological inhibitors. Desialylation reduced binding affinity of GdA toward and invasion suppressive activities on the trophoblast. Co-immunoprecipitation showed that Siglec-6 on the trophoblast was the binding protein of GdA. The binding of GdA to Siglec-6 was sialic acid-dependent. Treatment with anti-Siglec-6 antibody abolished the invasion suppressive activities of GdA. These results show that GdA interacts with Siglec-6 to suppress trophoblast invasiveness by down-regulating the ERK/c-Jun signaling pathway.	[Lam, Kevin K. W.; Chiu, Philip C. N.; Lee, Cheuk-Lun; Pang, Ronald T. K.; Leung, Carmen O. N.; Ho, Pak-Chung; Yeung, William S. B.] Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Chiu, Philip C. N.; Lee, Cheuk-Lun; Pang, Ronald T. K.; Ho, Pak-Chung; Yeung, William S. B.] Univ Hong Kong, Queen Mary Hosp, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Koistinen, Hannu; Seppala, Markku] Univ Helsinki, Dept Clin Chem, Helsinki 00029, Finland; [Koistinen, Hannu; Seppala, Markku] Univ Helsinki, Cent Hosp, Helsinki 00029, Finland	University of Hong Kong; University of Hong Kong; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Yeung, WSB (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	wsbyeung@hkucc.hku.hk	Koistinen, Hannu/AGU-1279-2022; Chiu, Chi Ngong/C-4245-2009; Seppala, Markku/AAT-6618-2021; Lee, Cheuk Lun/AGX-5720-2022; /B-8039-2013	Koistinen, Hannu/0000-0003-0926-3109; Chiu, Chi Ngong/0000-0001-6217-1970; Lee, Cheuk Lun/0000-0003-1553-3478; /0000-0001-5464-4125	Research Grant Council of Hong Kong [HKU7635/08M]; Academy of Finland; Helsinki University Central Hospital	Research Grant Council of Hong Kong(Hong Kong Research Grants Council); Academy of Finland(Academy of Finland); Helsinki University Central Hospital	This work was supported in part by the Research Grant Council of Hong Kong (Grant HKU7635/08M) and by the Academy of Finland and Helsinki University Central Hospital Research Funds.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Assi K, 2006, IMMUNOLOGY, V118, P112, DOI 10.1111/j.1365-2567.2006.02349.x; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Bischof P, 2000, PLACENTA, V21, pS55, DOI 10.1053/plac.2000.0521; Byrne B, 2007, DRUG DISCOV TODAY, V12, P319, DOI 10.1016/j.drudis.2007.02.010; Chez R A, 1976, Perspect Nephrol Hypertens, V5, P421; Chiu PCN, 2003, BIOL REPROD, V69, P365, DOI 10.1095/biolreprod.102.012658; Chiu PCN, 2007, J CELL SCI, V120, P33, DOI 10.1242/jcs.03258; Chiu PCN, 2010, HUM REPROD, V25, P2721, DOI 10.1093/humrep/deq243; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; CROCKER PR, 1986, J EXP MED, V164, P1862, DOI 10.1084/jem.164.6.1862; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; DECESARE D, 1995, ONCOGENE, V11, P365; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Feng Hui Chen, 2005, J Soc Gynecol Investig, V12, pe21, DOI 10.1016/j.jsgi.2005.02.008; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Ganesan LP, 2006, BLOOD, V108, P718, DOI 10.1182/blood-2005-09-3889; Guccione M, 2002, AM J PHYSIOL-RENAL, V282, pF164, DOI 10.1152/ajprenal.0318.2000; HOWELL RJS, 1989, ACTA OBSTET GYN SCAN, V68, P237, DOI 10.3109/00016348909020995; Irwin JC, 2001, J CLIN ENDOCR METAB, V86, P2060, DOI 10.1210/jc.86.5.2060; Ito H, 2004, CANCER RES, V64, P7439, DOI 10.1158/0008-5472.CAN-04-1177; Jeschke U, 2005, VIRCHOWS ARCH, V446, P360, DOI 10.1007/s00428-004-1201-3; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kingdom J, 2000, EUR J OBSTET GYN R B, V92, P35, DOI 10.1016/S0301-2115(00)00423-1; Kita N, 2003, PLACENTA, V24, P164, DOI 10.1053/plac.2002.0880; Lam KKW, 2009, HUM REPROD, V24, P2093, DOI 10.1093/humrep/dep205; Lee CL, 2011, J REPROD IMMUNOL, V90, P29, DOI 10.1016/j.jri.2011.04.007; Lee CL, 2011, HUM REPROD, V26, P517, DOI 10.1093/humrep/deq381; Lee CL, 2010, FERTIL STERIL, V94, P769, DOI 10.1016/j.fertnstert.2009.10.009; Lee CL, 2009, J BIOL CHEM, V284, P15084, DOI 10.1074/jbc.M807960200; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Linden ECMBVD, 2007, GLYCOBIOLOGY, V17, P922, DOI 10.1093/glyco/cwm065; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Malliri A, 1998, J CELL BIOL, V143, P1087, DOI 10.1083/jcb.143.4.1087; Milstone DS, 2000, DEV DYNAM, V219, P63, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1035>3.0.CO;2-D; Moon KC, 2008, PLACENTA, V29, P391, DOI 10.1016/j.placenta.2008.02.001; Morris HR, 1996, J BIOL CHEM, V271, P32159, DOI 10.1074/jbc.271.50.32159; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nagamine Y, 2005, THROMB HAEMOSTASIS, V93, P661, DOI 10.1160/TH04-12-0814; Patel N, 1999, J BIOL CHEM, V274, P22729, DOI 10.1074/jbc.274.32.22729; Pollheimer J, 2005, PLACENTA, V26, pS21, DOI 10.1016/j.placenta.2004.11.013; Poornima BL, 2007, FEBS LETT, V581, P4366, DOI 10.1016/j.febslet.2007.07.078; Qiu Q, 2004, MOL HUM REPROD, V10, P677, DOI 10.1093/molehr/gah088; Rachmilewitz J, 2003, J BIOL CHEM, V278, P14059, DOI 10.1074/jbc.M211716200; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Rohrschneider LR, 2000, GENE DEV, V14, P505; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Seppala M, 2002, ENDOCR REV, V23, P401, DOI 10.1210/er.2001-0026; Shiverick KT, 2001, PLACENTA, V22, pS104, DOI 10.1053/plac.2001.0647; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Takai N, 2006, GYNECOL OBSTET INVES, V61, P15, DOI 10.1159/000087855; Takino T, 2004, CANCER RES, V64, P1044, DOI 10.1158/0008-5472.CAN-03-1843; Tamir I, 2000, CURR OPIN IMMUNOL, V12, P307, DOI 10.1016/S0952-7915(00)00092-3; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Varki A., 2009, ESSENTIALS GLYCOBIOL; VERDE P, 1988, NUCLEIC ACIDS RES, V16, P10699, DOI 10.1093/nar/16.22.10699; von Gunten S, 2006, FASEB J, V20, P601, DOI 10.1096/fj.05-5401hyp; Winn VD, 2009, ENDOCRINOLOGY, V150, P452, DOI 10.1210/en.2008-0990; Yeung WSB, 2006, MOL CELL ENDOCRINOL, V250, P149, DOI 10.1016/j.mce.2005.12.038; Yeung WSB, 2009, J REPROD IMMUNOL, V83, P26, DOI 10.1016/j.jri.2009.04.012	65	36	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37118	37127		10.1074/jbc.M111.233841	http://dx.doi.org/10.1074/jbc.M111.233841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880722	hybrid, Green Published			2022-12-27	WOS:000296542400012
J	Dames, SA; Junemann, A; Sass, HJ; Schonichen, A; Stopschinski, BE; Grzesiek, S; Faix, J; Geyer, M				Dames, Sonja A.; Junemann, Alexander; Sass, Hans J.; Schoenichen, Andre; Stopschinski, Barbara E.; Grzesiek, Stephan; Faix, Jan; Geyer, Matthias			Structure, Dynamics, Lipid Binding, and Physiological Relevance of the Putative GTPase-binding Domain of Dictyostelium Formin C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; 3-DIMENSIONAL STRUCTURE; PROTEIN STRUCTURES; DIPOLAR COUPLINGS; CLEAVAGE FURROW; RAS-BINDING; FH1 DOMAIN; NMR; PHAGOCYTOSIS; ACTIVATION	Dictyostelium Formin C (ForC) is involved in the regulation of local actin cytoskeleton reorganization (e.g. during cellular adhesion or migration). ForC contains formin homology 2 and 3 (FH2 and -3) domains and an N-terminal putative GTPase-binding domain (GBD) but lacks a canonical FH1 region. To better understand the role of the GBD, its structure, dynamics, lipid-binding properties, and cellular functions were analyzed by NMR and CD spectroscopy and by in vivo fluorescence microscopy. Moreover, the program CS-Rosetta was tested for the structure prediction based on chemical shift data only. The ForC GBD adopts an ubiquitin-like alpha/beta-roll fold with an unusually long loop between beta-strands 1 and 2. Based on the lipid-binding data, the presence of DPC micelles induces the formation of alpha-helical secondary structure and a rearrangement of the tertiary structure. Lipid-binding studies with a mutant protein and a peptide suggest that the beta 1-beta 2 loop is not relevant for these conformational changes. Whereas small amounts of negatively charged phosphoinositides (1,2-dioctanoyl-sn-glycero-3(phosphoinositol 4,5-bisphosphate) and 1,2-dihexanoyl-sn-glycero-3-(phosphoinositol 3,4,5-trisphosphate)) lower the micelle concentration necessary to induce the observed spectral changes, other negatively charged phospholipids (1,2-dihexanoyl-sn-glycero-3-(phospho-L-serine) and 1,2-dihexanoyl-snglycero-3-phospho-(1'-rac-glycerol)) had no such effect. Interestingly, bicelles and micelles composed of diacylphospho-cholines had no effect on the GBD structure. Our data suggest a model in which part of the large positively charged surface area of the GBD mediates localization to specific membrane patches, thereby regulating interactions with signaling proteins. Our cellular localization studies show that both the GBD and the FH3 domain are required for ForC targeting to cell-cell contacts and early phagocytic cups and macropinosomes.	[Dames, Sonja A.] Tech Univ Munich, Dept Chem, Chair Biomol NMR Spect, D-85747 Garching, Germany; [Junemann, Alexander; Faix, Jan] Hannover Med Sch, Inst Biophys Chem, D-30623 Hannover, Germany; [Sass, Hans J.; Grzesiek, Stephan] Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland; [Schoenichen, Andre; Stopschinski, Barbara E.; Geyer, Matthias] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany	Technical University of Munich; Hannover Medical School; University of Basel; Max Planck Society	Dames, SA (corresponding author), Tech Univ Munich, Dept Chem, Chair Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany.	sonja.dames@tum.de		Geyer, Matthias/0000-0002-7718-5002; Dames, Sonja/0000-0001-7495-6943; Grzesiek, Stephan/0000-0003-1998-4225; Junemann, Alexander/0000-0002-0048-5410	German Research Foundation [DA 1195/3-1, FA 330-6-1, GE 976/4-2]; Swiss National Science Foundation [31-109712]	German Research Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by German Research Foundation Grants DA 1195/3-1 (to S. A. D.), FA 330-6-1 (to J. F.), and GE 976/4-2 (to M. G.) and Swiss National Science Foundation Grant 31-109712 (to S. G.).	Ahn HC, 2006, J AM CHEM SOC, V128, P4398, DOI 10.1021/ja057773d; Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; Bogner C, 2010, CURR OPIN CELL BIOL, V22, P845, DOI 10.1016/j.ceb.2010.08.002; BRUNE D, 1993, P NATL ACAD SCI USA, V90, P3835, DOI 10.1073/pnas.90.9.3835; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Clarke M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-154; Dames SA, 2011, BIOMOL NMR ASSIGN, V5, P47, DOI 10.1007/s12104-010-9264-3; Dames SA, 2010, J BIOL CHEM, V285, P7766, DOI 10.1074/jbc.M109.058404; Dames Sonja A, 2008, J Biol Chem, V283, P23485, DOI 10.1074/jbc.M708335200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579; Dumontier M, 2000, J CELL SCI, V113, P2253; Faix J, 2001, EMBO J, V20, P3705, DOI 10.1093/emboj/20.14.3705; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fuller N, 2001, BIOPHYS J, V81, P243, DOI 10.1016/S0006-3495(01)75695-0; Geyer M, 1997, NAT STRUCT BIOL, V4, P694, DOI 10.1038/nsb0997-694; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gorelik R, 2011, MOL BIOL CELL, V22, P189, DOI 10.1091/mbc.E10-03-0256; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Han YY, 2009, J BIOL CHEM, V284, P33409, DOI 10.1074/jbc.M109.060699; Harris E, 2002, J CELL SCI, V115, P3703, DOI 10.1242/jcs.00050; Hauser H, 2000, BBA-BIOMEMBRANES, V1508, P164, DOI 10.1016/S0304-4157(00)00008-3; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Huang L, 1997, NAT STRUCT BIOL, V4, P609, DOI 10.1038/nsb0897-609; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; Kessin RH, 2000, NATURE, V408, P917, DOI 10.1038/35050184; Kitayama C, 2003, J CELL SCI, V116, P711, DOI 10.1242/jcs.00265; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kumar N, 2004, J BIOL CHEM, V279, P3096, DOI 10.1074/jbc.M308878200; Kutateladze TG, 2004, J BIOL CHEM, V279, P3050, DOI 10.1074/jbc.M309007200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lazaridis T, 2005, J PHYS CHEM B, V109, P15098, DOI 10.1021/jp0516801; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Losonczi JA, 2000, BIOCHEMISTRY-US, V39, P11024, DOI 10.1021/bi000919v; Lucas LH, 2004, CONCEPT MAGN RESON A, V20A, P24, DOI 10.1002/cmr.a.10094; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Morris Andrew J., 1999, Trends in Pharmacological Sciences, V20, P393, DOI 10.1016/S0165-6147(99)01390-5; Nabuurs SB, 2004, PROTEINS, V55, P483, DOI 10.1002/prot.20118; Oldfield E, 2002, ANNU REV PHYS CHEM, V53, P349, DOI 10.1146/annurev.physchem.53.082201.124235; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; RAGHUNATHAN V, 1992, FEBS LETT, V297, P46, DOI 10.1016/0014-5793(92)80324-A; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Rivero F, 1999, MOL BIOL CELL, V10, P1205, DOI 10.1091/mbc.10.4.1205; Rivero F, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-28; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Rupper A, 2001, J CELL SCI, V114, P2449; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Schonichen A, 2006, J BIOL CHEM, V281, P5084, DOI 10.1074/jbc.M509226200; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SERTH J, 1991, EMBO J, V10, P1325, DOI 10.1002/j.1460-2075.1991.tb07651.x; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; Somesh BP, 2006, EUKARYOT CELL, V5, P1648, DOI 10.1128/EC.00221-06; TAUSK RJM, 1974, BIOPHYS CHEM, V2, P175, DOI 10.1016/0301-4622(74)80004-9; Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Weber I, 1999, EMBO J, V18, P586, DOI 10.1093/emboj/18.3.586; Whiles JA, 2002, BIOORG CHEM, V30, P431, DOI 10.1016/S0045-2068(02)00527-8; Xian WJ, 2002, J MOL BIOL, V322, P755, DOI 10.1016/S0022-2836(02)00841-0; Yeung T, 2006, CURR OPIN CELL BIOL, V18, P429, DOI 10.1016/j.ceb.2006.06.006	72	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36907	36920		10.1074/jbc.M111.225052	http://dx.doi.org/10.1074/jbc.M111.225052			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21846933	hybrid, Green Published			2022-12-27	WOS:000296538300070
J	MacKellar, AL; Greenleaf, AL				MacKellar, April L.; Greenleaf, Arno L.			Cotranscriptional Association of mRNA Export Factor Yra1 with C-terminal Domain of RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HNRNP-LIKE PROTEINS; SACCHAROMYCES-CEREVISIAE; KINASE-I; NUCLEAR EXPORT; REPEAT DOMAIN; TRANSCRIPTION ELONGATION; PROCESSING FACTORS; LARGE SUBUNIT; CTD CODE; PHOSPHORYLATION	The unique C-terminal domain (CTD) of RNA polymerase II, composed of tandem heptad repeats of the consensus sequence YSPTSPS, is subject to differential phosphorylation throughout the transcription cycle. Several RNA processing factors have been shown to bind the phosphorylated CTD and use it to localize to nascent pre-mRNA during transcription. In Saccharomyces cerevisiae, the mRNA export protein Yra1 (ALY/RNA export factor in metazoa) cotranscriptionally associates with mRNA and delivers it to the nuclear pore complex for export to the cytoplasm. Here we report that Yra1 directly binds in vitro the hyperphosphorylated form of theCTDcharacteristic of elongating RNA polymerase II and contains a phospho-CTD-interacting domain within amino acids 18-184, which also include an "RNA recognition motif" (RRM) (residues 77-184). Using UV cross-linking, we showed that the RRM alone binds RNA, although a larger segment extending to the C terminus (amino acids 77-226) displayed stronger RNA binding activity. Although the RRM is implicated in both RNA and CTD binding, RRM point mutations separated these two functions. Both functions are important in vivo as RNA binding-defective or CTD binding-defective versions of Yra1 engendered growth and mRNA export defects. We also report the construction and characterization of a useful new temperature-sensitive YRA1 allele (R107A/F126A). Using ChIP, we demonstrated that removing the N-terminal 76 amino acids of Yra1 (all of the phospho-CTD-interacting domain up to the RRM) results in a 10-fold decrease in Yra1 recruitment to genes during elongation. These results indicate that the phospho-CTD is likely involved directly in the cotranscriptional recruitment of Yra1.	[Greenleaf, Arno L.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr RNA Biol, Durham, NC 27710 USA	Duke University; Duke University	Greenleaf, AL (corresponding author), Duke Univ, Med Ctr, Dept Biochem, 0034 CARL Bldg, Durham, NC 27710 USA.	arno@duke.edu		MacKellar, April/0000-0001-9535-2719	National Institutes of Health [R01 GM040505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM040505.	Abruzzi KC, 2004, EMBO J, V23, P2620, DOI 10.1038/sj.emboj.7600261; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; David CJ, 2011, GENE DEV, V25, P972, DOI 10.1101/gad.2038011; de Almeida SF, 2008, FEBS LETT, V582, P1971, DOI 10.1016/j.febslet.2008.04.019; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Golovanov AP, 2006, RNA, V12, P1933, DOI 10.1261/rna.212106; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Hung ML, 2010, NUCLEIC ACIDS RES, V38, P3351, DOI 10.1093/nar/gkq033; Johnson SA, 2009, MOL CELL, V33, P215, DOI 10.1016/j.molcel.2008.12.007; Jona G, 2001, GENE, V267, P31, DOI 10.1016/S0378-1119(01)00389-4; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; LEE JM, 1991, GENE EXPRESSION, V1, P149; Lee JM, 1997, J BIOL CHEM, V272, P10990; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Lindstrom DL, 2001, GENETICS, V159, P487; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Moore David, 2002, Curr Protoc Mol Biol, VChapter 2, DOI 10.1002/0471142727.mb0201as59; Morris DP, 1997, METHODS, V12, P264, DOI 10.1006/meth.1997.0478; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Phatnani Hemali P, 2004, Methods Mol Biol, V257, P17, DOI 10.1385/1-59259-750-5:017; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Rollenhagen C, 2007, EUKARYOT CELL, V6, P505, DOI 10.1128/EC.00317-06; Rondon AG, 2003, J BIOL CHEM, V278, P39037, DOI 10.1074/jbc.M305718200; Rusche LN, 2001, GENE DEV, V15, P955; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Tokunaga K., 2008, CURR PROTOC CELL BIO; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; ZEHRING WA, 1988, P NATL ACAD SCI USA, V85, P3698, DOI 10.1073/pnas.85.11.3698; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002; Zenklusen D, 2001, MOL CELL BIOL, V21, P4219, DOI 10.1128/MCB.21.13.4219-4232.2001	50	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36385	36395		10.1074/jbc.M111.268144	http://dx.doi.org/10.1074/jbc.M111.268144			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21856751	hybrid, Green Published			2022-12-27	WOS:000296538300024
J	Osabe, M; Negishi, M				Osabe, Makoto; Negishi, Masahiko			Active ERK1/2 Protein Interacts with the Phosphorylated Nuclear Constitutive Active/Androstane Receptor (CAR; NR1I3), Repressing Dephosphorylation and Sequestering CAR in the Cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE-LIVER; CYP2B GENE; INDUCTION; KINASE; TRANSLOCATION; ACTIVATION; ENZYMES; PXR	The nuclear constitutive active/androstane receptor (CAR) is inactivated and sequestered in the cytoplasm when Thr-38 is phosphorylated. Here, we have demonstrated that activated ERK1/2 interacts with phosphorylated CAR to repress dephosphorylation of Thr-38. The phosphorylation-dependent interaction between CAR and ERK1/2 was examined by co-immunoprecipitation experiments of ectopically expressed FLAG-tagged CAR T38A and CAR T38D mutants with endogenous phospho-ERK1/2 in Huh-7 cells. Phospho-ERK1/2 coprecipitated only the phosphorylation-mimicking CAR T38D mutant; this coprecipitation was mediated by the interaction with the xenochemical response signal peptide near the C terminus of CAR. This interaction increased after EGF treatment and decreased after treatment with the MEK inhibitor U0126 as well as after knockdown of MEK1/2 by shRNA in Huh-7 cells. The phosphorylation levels of Thr-38 of CAR decreased in U0126-treated Huh-7 cells. Thus, activated ERK1/2 interacts with CAR and represses dephosphorylation of Thr-38, providing a cell signal-regulated mechanism for CAR activation.	[Osabe, Makoto; Negishi, Masahiko] NIEHS, Pharmacogenet Sect, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), NIEHS, Pharmacogenet Sect, Lab Reprod & Dev Toxicol, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928	National Institutes of Health; National Institutes of Health, NIEHS [Z01ES1005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program and National Institutes of Health Grant Z01ES1005-01 from NIEHS.	Bauer D, 2004, MOL PHARMACOL, V65, P172, DOI 10.1124/mol.65.1.172; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Kamino H, 2012, MOL CARCINOGEN, V51, P206, DOI 10.1002/mc.20783; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Koike C, 2007, MOL PHARMACOL, V71, P1217, DOI 10.1124/mol.107.034538; Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8; Mutoh S, 2009, J BIOL CHEM, V284, P34785, DOI 10.1074/jbc.M109.048108; Osabe M, 2008, BIOCHEM BIOPH RES CO, V369, P1027, DOI 10.1016/j.bbrc.2008.02.140; Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421; Shindo S, 2007, BIOCHEM J, V401, P735, DOI 10.1042/BJ20061238; Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Ueda A, 2002, MOL PHARMACOL, V61, P1284, DOI 10.1124/mol.61.6.1284; Wada T, 2009, TRENDS ENDOCRIN MET, V20, P273, DOI 10.1016/j.tem.2009.03.003; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yamamoto Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010121; Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001	19	40	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35763	35769		10.1074/jbc.M111.284596	http://dx.doi.org/10.1074/jbc.M111.284596			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21873423	hybrid, Green Published			2022-12-27	WOS:000295927100049
J	Park, H; Lee, JH; Gouin, E; Cossart, P; Izard, T				Park, HaJeung; Lee, Jun Hyuck; Gouin, Edith; Cossart, Pascale; Izard, Tina			The Rickettsia Surface Cell Antigen 4 Applies Mimicry to Bind to and Activate Vinculin.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BASED MOTILITY; MOUNTAIN-SPOTTED-FEVER; TALIN ROD; ARP2/3 COMPLEX; MICROFILAMENT BUNDLES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DIFFRACTION DATA; MAMMALIAN-CELLS; CHICKEN GIZZARD	Pathogenic Rickettsia species cause high morbidity and mortality, especially R. prowazekii, the causative agent of typhus. Like many intracellular pathogens, Rickettsia exploit the cytoskeleton to enter and spread within the host cell. Here we report that the cell surface antigen sca4 of Rickettsia co-localizes with vinculin in cells at sites of focal adhesions in sca4-transfected cells and that sca4 binds to and activates vinculin through two vinculin binding sites (VBSs) that are conserved across all Rickettsia. Remarkably, this occurs through molecular mimicry of the vinculin-talin interaction that is also seen with the IpaA invasin of the intracellular pathogen Shigella, where binding of these VBSs to the vinculin seven-helix bundle head domain (Vh1) displaces intramolecular interactions with the vinculin tail domain that normally clamp vinculin in an inactive state. Finally, the vinculin.sca4-VBS crystal structures reveal that vinculin adopts a new conformation when bound to the C-terminal VBS of sca4. Collectively, our data define the mechanism by which sca4 activates vinculin and interacts with the actin cytoskeleton, and they suggest important roles for vinculin in Rickettsia pathogenesis.	[Park, HaJeung; Lee, Jun Hyuck; Izard, Tina] Scripps Res Inst, Cell Adhes Lab, Dept Canc Biol, Jupiter, FL 33458 USA; [Gouin, Edith; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Gouin, Edith; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Gouin, Edith; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France	Scripps Research Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE	Izard, T (corresponding author), Scripps Res Inst, Cell Adhes Lab, Dept Canc Biol, Jupiter, FL 33458 USA.	mkernick@scripps.edu			National Institutes of Health; state of Florida; Stanford Synchrotron Radiation Laboratory for synchrotron	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); state of Florida; Stanford Synchrotron Radiation Laboratory for synchrotron	Supported by grants from the National Institutes of Health and by startup funds to Scripps Florida from the state of Florida. To whom correspondence should be addressed. Tel.: 561-228-3220; Fax: 561-228-3068; E-mail: mkernick@scripps.edu.; We are indebted to our colleagues at Scripps Florida, John L. Cleveland for discussions and critical review of the manuscript, Erumbi S. Rangarajan for fruitful discussions, and Philippe R. Bois and Zhen Wu for sequencing. We are grateful to the staff at Stanford Synchrotron Radiation Laboratory for synchrotron support.	Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Blanc G, 2005, MOL BIOL EVOL, V22, P2073, DOI 10.1093/molbev/msi199; Bois PRJ, 2005, MOL CELL BIOL, V25, P6112, DOI 10.1128/MCB.25.14.6112-6122.2005; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cossart P, 2000, CELL MICROBIOL, V2, P195, DOI 10.1046/j.1462-5822.2000.00053.x; Critchley DR, 1999, BIOCHEM SOC SYMP, V65, P79; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Dantas-Torres F, 2007, LANCET INFECT DIS, V7, P724, DOI 10.1016/S1473-3099(07)70261-X; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; GEIGER B, 1980, P NATL ACAD SCI-BIOL, V77, P4127, DOI 10.1073/pnas.77.7.4127; GEIGER B, 1979, CELL, V18, P193, DOI 10.1016/0092-8674(79)90368-4; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Gingras AR, 2009, J BIOL CHEM, V284, P8857, DOI 10.1074/jbc.M805937200; Gingras AR, 2006, BIOCHEMISTRY-US, V45, P1805, DOI 10.1021/bi052136l; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Hackstadt T, 1996, INFECT AGENT DIS, V5, P127; Haglund CM, 2010, NAT CELL BIOL, V12, P1057, DOI 10.1038/ncb2109; HAND WL, 1970, ARCH INTERN MED, V125, P879, DOI 10.1001/archinte.125.5.879; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; Johnson RP, 1998, BIOCHEMISTRY-US, V37, P10211, DOI 10.1021/bi9727242; Johnson RP, 2000, J BIOL CHEM, V275, P95, DOI 10.1074/jbc.275.1.95; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Martinez JJ, 2005, CELL, V123, P1013, DOI 10.1016/j.cell.2005.08.046; Martinez JJ, 2004, J CELL SCI, V117, P5097, DOI 10.1242/jcs.01382; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Park H, 2011, J BIOL CHEM, V286, P23214, DOI 10.1074/jbc.M110.184283; Ramarao N, 2007, FEBS LETT, V581, P853, DOI 10.1016/j.febslet.2007.01.057; Rangarajan ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010679; Riley SP, 2010, INFECT IMMUN, V78, P1895, DOI 10.1128/IAI.01165-09; SMART OS, 2008, ANN M AM CRYST ASS K; Tran Van Nhieu G., 1997, EMBO J, V16, P2717; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Nhieu GT, 2007, EMBO J, V26, P4588; VANNHIEU GT, 2000, CELL MICROBIOL, V2, P187, DOI DOI 10.1046/J.1462-5822.2000.00046.X; Vonrhein C, 2008, ACTA CRYSTALLOGR A, V64, pC78, DOI 10.1107/S010876730809750X; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; WALKER DH, 1988, HUM PATHOL, V19, P1449, DOI 10.1016/S0046-8177(88)80238-7; Winkler J, 1996, J STRUCT BIOL, V116, P270, DOI 10.1006/jsbi.1996.0042	52	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35096	35103		10.1074/jbc.M111.263855	http://dx.doi.org/10.1074/jbc.M111.263855			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21841197	hybrid, Green Published			2022-12-27	WOS:000295406300063
J	Roze, LV; Chanda, A; Wee, J; Awad, D; Linz, JE				Roze, Ludmila V.; Chanda, Anindya; Wee, Josephine; Awad, Deena; Linz, John E.			Stress-related Transcription Factor AtfB Integrates Secondary Metabolism with Oxidative Stress Response in Aspergilli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFLATOXIN BIOSYNTHESIS; ACTIVATION; EXPRESSION; NRF2; PARASITICUS; ELEMENT; SPORULATION; PATHWAYS; REVEALS; PROTEIN	In filamentous fungi, several lines of experimental evidence indicate that secondary metabolism is triggered by oxidative stress; however, the functional and molecular mechanisms that mediate this association are unclear. The basic leucine zipper (bZIP) transcription factor AtfB, a member of the bZIP/CREB family, helps regulate conidial tolerance to oxidative stress. In this work, we investigated the role of AtfB in the connection between oxidative stress response and secondary metabolism in the filamentous fungus Aspergillus parasiticus. This well characterized model organism synthesizes the secondary metabolite and carcinogen aflatoxin. Chromatin immunoprecipitation with specific anti-AtfB demonstrated AtfB binding at promoters of seven genes in the aflatoxin gene cluster that carry CREs. Promoters lacking CREs did not show AtfB binding. The binding of AtfB to the promoters occurred under aflatoxin-inducing but not under aflatoxin-noninducing conditions and correlated with activation of transcription of the aflatoxin genes. Deletion of veA, a global regulator of secondary metabolism and development, nearly eliminated this binding. Electrophoretic mobility shift analysis demonstrated that AtfB binds to the nor-1 (an early aflatoxin gene) promoter at a composite regulatory element that consists of highly similar, adjacent CRE1 and AP-1-like binding sites. The five nucleotides immediately upstream from CRE1, AGCC(G/C), are highly conserved in five aflatoxin promoters that demonstrate AtfB binding. We propose that AtfB is a key player in the regulatory circuit that integrates secondary metabolism and cellular response to oxidative stress.	[Roze, Ludmila V.; Chanda, Anindya; Wee, Josephine; Awad, Deena; Linz, John E.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Linz, John E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Linz, John E.] Michigan State Univ, Food Safety & Toxicol Ctr, E Lansing, MI 48824 USA; [Linz, John E.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Linz, JE (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, 234B GM Trout Bldg, E Lansing, MI 48824 USA.	jlinz@msu.edu	Chanda, A/G-1436-2015; Linz, John/AAF-1682-2020; Chanda, Anindya/I-1014-2014	Chanda, A/0000-0003-4184-1909; 	National Institutes of Health from NCI [RO1 52003-19]; Michigan Agricultural Experiment Station; NATIONAL CANCER INSTITUTE [R01CA052003] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Michigan Agricultural Experiment Station; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 52003-19 from NCI. This work was also supported by the Michigan Agricultural Experiment Station.	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Balazs A, 2010, MOL GENET GENOMICS, V283, P289, DOI 10.1007/s00438-010-0513-z; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Chanda A, 2010, EUKARYOT CELL, V9, P1724, DOI 10.1128/EC.00118-10; Chanda A, 2009, P NATL ACAD SCI USA, V106, P19533, DOI 10.1073/pnas.0907416106; Chang PK, 2011, TOXINS, V3, P82, DOI 10.3390/toxins3010082; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Coisne C, 2011, ANTIOXID REDOX SIGN, V15, P1285, DOI 10.1089/ars.2011.3929; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; DeWeese TL, 1998, P NATL ACAD SCI USA, V95, P11915, DOI 10.1073/pnas.95.20.11915; Gessler NN, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1091, DOI 10.1134/S0006297907100070; GuzmandePena D, 1997, FUNGAL GENET BIOL, V21, P198, DOI 10.1006/fgbi.1996.0945; Hagiwara D, 2008, BIOSCI BIOTECH BIOCH, V72, P2756, DOI 10.1271/bbb.80001; Hicks JK, 1997, EMBO J, V16, P4916, DOI 10.1093/emboj/16.16.4916; Hu DY, 2007, NEUROBIOL LEARN MEM, V87, P372, DOI 10.1016/j.nlm.2006.10.003; Huang JQ, 2009, INT J FOOD MICROBIOL, V130, P17, DOI 10.1016/j.ijfoodmicro.2008.12.027; Hur W, 2011, CURR OPIN CHEM BIOL, V15, P162, DOI 10.1016/j.cbpa.2010.12.009; Jayashree T, 2000, FREE RADICAL BIO MED, V29, P981, DOI 10.1016/S0891-5849(00)00398-1; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kim JH, 2008, INT J FOOD MICROBIOL, V122, P49, DOI 10.1016/j.ijfoodmicro.2007.11.058; Lara-Rojas F, 2011, MOL MICROBIOL, V80, P436, DOI 10.1111/j.1365-2958.2011.07581.x; Lee JS, 2005, CANCER LETT, V224, P171, DOI 10.1016/j.canlet.2004.09.042; Lee LW, 2002, APPL ENVIRON MICROB, V68, P5718, DOI 10.1128/AEM.68.11.5718-5727.2002; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Meyer TE, 1998, INT J CANCER, V77, P55, DOI 10.1002/(SICI)1097-0215(19980703)77:1<55::AID-IJC10>3.0.CO;2-8; Miskei M, 2009, FUNGAL GENET BIOL, V46, pS105, DOI 10.1016/j.fgb.2008.07.013; Narasaiah KV, 2006, MYCOPATHOLOGIA, V162, P179, DOI 10.1007/s11046-006-0052-7; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Proft M, 2005, EUKARYOT CELL, V4, P1343, DOI 10.1128/EC.4.8.1343-1352.2005; Radunovic A, 1997, NEUROSCI LETT, V239, P105, DOI 10.1016/S0304-3940(97)00905-1; Reverberi M, 2007, FOOD ADDIT CONTAM A, V24, P1070, DOI 10.1080/02652030701553244; Reverberi M, 2008, EUKARYOT CELL, V7, P988, DOI 10.1128/EC.00228-07; Roze LV, 2007, MOL MICROBIOL, V66, P713, DOI 10.1111/j.1365-2958.2007.05952.x; Roze LV, 2011, FUNGAL GENET BIOL, V48, P35, DOI 10.1016/j.fgb.2010.05.006; Roze LV, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-33; Roze LV, 2004, J BIOL CHEM, V279, P27428, DOI 10.1074/jbc.M400075200; Sakamoto K, 2008, FUNGAL GENET BIOL, V45, P922, DOI 10.1016/j.fgb.2008.03.009; Sakamoto K, 2009, FUNGAL GENET BIOL, V46, P887, DOI 10.1016/j.fgb.2009.09.004; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Scott B, 2008, CURR OPIN MICROBIOL, V11, P488, DOI 10.1016/j.mib.2008.10.008; Shen GX, 2010, CAN J PHYSIOL PHARM, V88, P241, DOI 10.1139/Y10-018; SKORY CD, 1993, APPL ENVIRON MICROB, V59, P1642, DOI 10.1128/AEM.59.5.1642-1646.1993; Spooner R, 2011, INT J MOL SCI, V12, P334, DOI 10.3390/ijms12010334; Weseler AR, 2010, CURR HYPERTENS REP, V12, P154, DOI 10.1007/s11906-010-0103-9; Wingler K., 2011, BR J PHARM IN PRESS	51	80	86	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35137	35148		10.1074/jbc.M111.253468	http://dx.doi.org/10.1074/jbc.M111.253468			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21808056	Green Published, hybrid			2022-12-27	WOS:000295406300067
J	Aittaleb, M; Nishimura, A; Linder, ME; Tesmer, JJG				Aittaleb, Mohamed; Nishimura, Akiyuki; Linder, Maurine E.; Tesmer, John J. G.			Plasma Membrane Association of p63 Rho Guanine Nucleotide Exchange Factor (p63RhoGEF) Is Mediated by Palmitoylation and Is Required for Basal Activity in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; PDZ-RHOGEF; G-PROTEINS; P115 RHOGEF; PH DOMAINS; G-ALPHA(13); RECEPTORS; MOTIF; LARG; TRIO	Activation of G protein-coupled receptors at the cell surface leads to the activation or inhibition of intracellular effector enzymes, which include various Rho guanine nucleotide exchange factors (RhoGEFs). RhoGEFs activate small molecular weight GTPases at the plasma membrane (PM). Many of the known G protein-coupled receptor-regulated RhoGEFs are found in the cytoplasm of unstimulated cells, and PM recruitment is a critical aspect of their regulation. In contrast, p63RhoGEF, a G alpha(q)-regulated RhoGEF, appears to be constitutively localized to the PM. The objective of this study was to determine the molecular basis for the localization of p63RhoGEF and the impact of its subcellular localization on its regulation by G alpha(q). Herein, we show that the pleckstrin homology domain of p63RhoGEF is not involved in its PM targeting. Instead, a conserved string of cysteines (Cys-23/25/26) at the N terminus of the enzyme is palmitoylated and required for membrane localization and full basal activity in cells. Conversion of these residues to serine relocates p63RhoGEF from the PM to the cytoplasm, diminishes its basal activity, and eliminates palmitoylation. The activity of palmitoylation-deficient p63RhoGEF can be rescued by targeting to the PM by fusion with tandem phospholipase C-delta 1 pleckstrin homology domains or by co-expression with wild-type G alpha(q) but not with palmitoylation-deficient G alpha(q). Our data suggest that p63RhoGEF is regulated chiefly through allosteric control by G alpha(q), as opposed to other known G alpha-regulated RhoGEFs, which are instead sequestered in the cytoplasm, perhaps because of their high basal activity.	[Aittaleb, Mohamed; Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Nishimura, Akiyuki; Linder, Maurine E.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Tesmer, John J. G.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Cornell University; University of Michigan System; University of Michigan	Tesmer, JJG (corresponding author), 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	johntesmer@umich.edu	Linder, Maurine/AAU-9999-2021	Linder, Maurine/0000-0003-2202-9712; Tesmer, John/0000-0003-1125-3727	National Institutes of Health [HL071818, HL086865, GM051466, DK20572, GM078850-S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086865, R01HL071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL071818 and HL086865 (to J. J. G. T.) and GM051466 (to M. E. L.). This research used the DNA Sequencing Core of the Michigan Diabetes Research and Training Center supported by National Institutes of Health Grant DK20572.; Supported in part by National Institutes of Health Grant GM078850-S1.	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Aittaleb M, 2009, CELL SIGNAL, V21, P1569, DOI 10.1016/j.cellsig.2009.06.003; Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Bellanger JM, 2003, BIOL CELL, V95, P625, DOI 10.1016/j.biolcel.2003.10.002; Bhattacharyya R, 2000, J BIOL CHEM, V275, P14992, DOI 10.1074/jbc.M000415200; Bhattacharyya R, 2009, CELL SIGNAL, V21, P996, DOI 10.1016/j.cellsig.2009.02.010; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Chen Z, 2010, J BIOL CHEM, V285, P21070, DOI 10.1074/jbc.M110.122549; Chisari M, 2007, J BIOL CHEM, V282, P24092, DOI 10.1074/jbc.M704246200; Crouthamel M, 2010, MOL PHARMACOL, V78, P767, DOI 10.1124/mol.110.066340; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Hajicek N, 2011, J BIOL CHEM, V286, P20625, DOI 10.1074/jbc.M110.201392; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hepler JR, 1996, J BIOL CHEM, V271, P496, DOI 10.1074/jbc.271.1.496; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Meyer BH, 2008, J CELL BIOCHEM, V104, P1660, DOI 10.1002/jcb.21732; Pedone KH, 2007, J BIOL CHEM, V282, P25199, DOI 10.1074/jbc.M610297200; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Shankaranarayanan A, 2010, CELL SIGNAL, V22, P1114, DOI 10.1016/j.cellsig.2010.03.006; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; Steenhuis P, 2010, TRAFFIC, V11, P987, DOI 10.1111/j.1600-0854.2010.01073.x; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Sun YJ, 2006, MOL CELL BIOL, V26, P6923, DOI 10.1128/MCB.02474-05; Suzuki N, 2009, NEUROSIGNALS, V17, P55, DOI 10.1159/000186690; Suzuki N, 2009, J BIOL CHEM, V284, P5000, DOI 10.1074/jbc.M804073200; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001	51	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34448	34456		10.1074/jbc.M111.273342	http://dx.doi.org/10.1074/jbc.M111.273342			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832057	Green Published, hybrid			2022-12-27	WOS:000295159200072
J	Finkel, T				Finkel, Toren			Signal Transduction by Mitochondrial Oxidants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HEMATOPOIETIC STEM-CELLS; HYPOXIA-INDUCIBLE FACTOR; OXIDATIVE STRESS; INFLAMMASOME ACTIVATION; RESPIRATORY-CHAIN; ROS PRODUCTION; DJ-1; METABOLISM; AUTOPHAGY; KINASE	The production of mitochondrial reactive oxygen species occurs as a consequence of aerobic metabolism. Mitochondrial oxidants are increasingly viewed less as byproducts of metabolism and more as important signaling molecules. Here, I review several notable examples, including the cellular response to hypoxia, aspects of innate immunity, the regulation of autophagy, and stem cell self-renewal capacity, where evidence suggests an important regulatory role for mitochondrial oxidants.	NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Finkel, T (corresponding author), NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA.	finkelt@nih.gov			National Institutes of Health; Ellison Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health intramural funds. This work was also supported by the Ellison Medical Foundation. This is the sixth article in the Thematic Minireview Series on Redox Sensing and Regulation.	Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Perez-Matute P, 2009, CURR OPIN PHARMACOL, V9, P771, DOI 10.1016/j.coph.2009.08.005; Perry JJP, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001961; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Srinivas V, 2001, J BIOL CHEM, V276, P21995, DOI 10.1074/jbc.C100177200; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Vaux EC, 2001, BLOOD, V98, P296, DOI 10.1182/blood.V98.2.296; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	55	266	272	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4434	4440		10.1074/jbc.R111.271999	http://dx.doi.org/10.1074/jbc.R111.271999			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	21832045	Green Published, hybrid			2022-12-27	WOS:000300608500007
J	Shen, BY; Fang, Y; Wu, N; Gould, SJ				Shen, Beiyi; Fang, Yi; Wu, Ning; Gould, Stephen J.			Biogenesis of the Posterior Pole Is Mediated by the Exosome/Microvesicle Protein-sorting Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LEADING-EDGE; SIGNALING PATHWAYS; PROTEOMIC ANALYSIS; DICTYOSTELIUM-DISCOIDEUM; EUKARYOTIC CHEMOTAXIS; CELL-MIGRATION; ERM PROTEINS; MYOSIN-II; EXOSOMES	Biogenesis of the posterior pole is critical to directed cell migration and other polarity-dependent processes. We show here that proteins are targeted to the posterior pole on the basis of higher order oligomerization and plasma membrane binding, the same elements that target proteins to exosomes/microvesicles (EMVs), HIV, and other retrovirus particles. We also demonstrate that the polarization of the EMV protein-sorting pathway can occur in morphologically non-polarized cells, defines the site of uropod formation, is induced by increased expression of EMV cargo proteins, and is evolutionarily conserved between humans and the protozoan Dictyostelium discoideum. Based on these results, we propose a mechanism of posterior pole biogenesis in which elevated levels of EMV cargoes (i) polarize the EMV protein-sorting pathway, (ii) generate a nascent posterior pole, and (iii) prime cells for signal-induced biogenesis of a uropod. This model also offers a mechanistic explanation for the polarized budding of EMVs and retroviruses, including HIV.	[Shen, Beiyi; Fang, Yi; Wu, Ning; Gould, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Gould, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	sgould@jhmi.edu			National Institutes of Health [DK45787]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK45787.	Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; BOURGUIGNON LYW, 1983, BIOCHIM BIOPHYS ACTA, V728, P186, DOI 10.1016/0005-2736(83)90470-4; BOURGUIGNON LYW, 1981, J CELL BIOL, V91, P889, DOI 10.1083/jcb.91.3.889; Burniston MT, 1999, J VIROL, V73, P8527, DOI 10.1128/JVI.73.10.8527-8540.1999; Cai HQ, 2010, J CELL BIOL, V190, P233, DOI 10.1083/jcb.201001129; Charest PG, 2010, DEV CELL, V18, P737, DOI 10.1016/j.devcel.2010.03.017; Choi DS, 2007, J PROTEOME RES, V6, P4646, DOI 10.1021/pr070192y; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; del Pozo MA, 1998, CELL ADHES COMMUN, V6, P125, DOI 10.3109/15419069809004468; ERRABOLU R, 1994, J CELL SCI, V107, P9; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fonseca AV, 2010, J BIOL CHEM, V285, P31661, DOI 10.1074/jbc.M110.145037; Franca-Koh J, 2007, NAT CELL BIOL, V9, P15, DOI 10.1038/ncb0107-15; Gan X, 2011, MOL BIOL CELL, V22, P817, DOI 10.1091/mbc.E10-07-0625; Gatti JL, 2005, BIOL REPROD, V72, P1452, DOI 10.1095/biolreprod.104.036426; Gaudet P, 2007, NAT PROTOC, V2, P1317, DOI 10.1038/nprot.2007.179; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; Harada A, 2010, J BIOCHEM, V147, P619, DOI 10.1093/jb/mvq027; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; KELLER HU, 1984, BLOOD CELLS, V10, P505; King JS, 2009, TRENDS CELL BIOL, V19, P523, DOI 10.1016/j.tcb.2009.07.004; KOK JW, 1990, EUR J CELL BIOL, V53, P173; Krishnamoorthy L, 2009, NAT CHEM BIOL, V5, P244, DOI 10.1038/nchembio.151; Llewellyn GN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001167; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; Manahan CL, 2004, ANNU REV CELL DEV BI, V20, P223, DOI 10.1146/annurev.cellbio.20.011303.132633; Marsh M, 2009, BIOCHEM SOC T, V37, P185, DOI 10.1042/BST0370185; Mathivanan S, 2010, MOL CELL PROTEOMICS, V9, P197, DOI 10.1074/mcp.M900152-MCP200; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; MCCAFFERY JM, 1995, METHOD ENZYMOL, V257, P259; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Meili R, 2003, CELL, V114, P153, DOI 10.1016/S0092-8674(03)00553-1; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Niggli V, 2003, J CELL SCI, V116, P813, DOI 10.1242/jcs.00306; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Ratner S, 1997, J IMMUNOL, V159, P1063; Rericha EC, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122pe26; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Schreiner G F, 1976, Adv Immunol, V24, P37, DOI 10.1016/S0065-2776(08)60329-6; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Skoglund P, 2010, CURR OPIN CELL BIOL, V22, P589, DOI 10.1016/j.ceb.2010.07.012; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Haastert PJM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001708; Wu Y, 2004, BIOCHEM BIOPH RES CO, V316, P666, DOI 10.1016/j.bbrc.2004.02.107; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	75	60	65	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44162	44176		10.1074/jbc.M111.274803	http://dx.doi.org/10.1074/jbc.M111.274803			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21865156	Green Published, hybrid			2022-12-27	WOS:000298402300057
J	Huang, T; Xie, ZH; Wang, JY; Li, M; Jing, NH; Li, L				Huang, Tao; Xie, Zhihui; Wang, Jiyong; Li, Meng; Jing, Naihe; Li, Lin			Nuclear Factor of Activated T Cells (NFAT) Proteins Repress Canonical Wnt Signaling via Its Interaction with Dishevelled (Dvl) Protein and Participate in Regulating Neural Progenitor Cell Proliferation and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; TRANSCRIPTION FACTORS; CANCER CELLS; C-JUN; PATHWAY; CALCINEURIN; CALCIUM; DISEASE; FAMILY; SUMOYLATION	The Ca2+ signaling pathway appears to regulate the processes of the early development through its antagonism of canonical Wnt/beta-catenin signaling pathway. However, the underlying mechanism is still poorly understood. Here, we show that nuclear factor of activated T cells (NFAT), a component of Ca2+ signaling, interacts directly with Dishevelled (Dvl) in a Ca2+-dependent manner. A dominant negative form of NFAT rescued the inhibition of the Wnt/beta-catenin pathway triggered by the Ca2+ signal. NFAT functioned downstream of beta-catenin without interfering with its stability, but influencing the interaction of beta-catenin with Dvl by its competitively binding to Dvl. Furthermore, we demonstrate that NFAT is a regulator in the proliferation and differentiation of neural progenitor cells by modulating canonical Wnt/beta-catenin signaling pathway in the neural tube of chick embryo. Our findings suggest that NFAT negatively regulates canonical Wnt/beta-catenin signaling by binding to Dvl, thereby participating in vertebrate neurogenesis.	[Huang, Tao; Wang, Jiyong; Li, Meng; Li, Lin] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Xie, Zhihui; Jing, Naihe] Chinese Acad Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	lli@sibs.ac.cn	LI, LI/GVS-5344-2022; li, li/HII-4157-2022; Li, Li/AEM-3636-2022		Ministry of Science and Technology of China [2010CB912100, 2007CB914500]; National Natural Science Foundation of China [30821065, 30930052, 90813024]; Science and Technology Commission of Shanghai Municipality	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work is supported by Ministry of Science and Technology of China Grants 2010CB912100 and 2007CB914500, National Natural Science Foundation of China Grants 30821065, 30930052, and 90813024, and the Science and Technology Commission of Shanghai Municipality.	Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Chow CW, 1999, MOL CELL BIOL, V19, P2300; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Gregory MA, 2010, CANCER CELL, V18, P74, DOI 10.1016/j.ccr.2010.04.025; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ille F, 2007, DEV BIOL, V304, P394, DOI 10.1016/j.ydbio.2006.12.045; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JAIN JN, 1995, J BIOL CHEM, V270, P4138, DOI 10.1074/jbc.270.8.4138; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Lai SL, 2009, CELL RES, V19, P532, DOI 10.1038/cr.2009.41; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Li M, 2010, J BIOL CHEM, V285, P13397, DOI 10.1074/jbc.M109.083246; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo C, 1996, J EXP MED, V184, P141, DOI 10.1084/jem.184.1.141; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Megason SG, 2002, DEVELOPMENT, V129, P2087; Nayak A, 2009, J BIOL CHEM, V284, P10935, DOI 10.1074/jbc.M900465200; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Santoro IM, 1997, CANCER RES, V57, P488; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Terui Y, 2004, J BIOL CHEM, V279, P28257, DOI 10.1074/jbc.M403153200; Torres MA, 2000, J CELL BIOL, V149, P1433, DOI 10.1083/jcb.149.7.1433; Wan YY, 2009, J MOL CELL BIOL, V1, P20, DOI 10.1093/jmcb/mjp001; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Yan Y, 2004, DEV DYNAM, V231, P248, DOI 10.1002/dvdy.20126; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102	44	34	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37399	37405		10.1074/jbc.M111.251165	http://dx.doi.org/10.1074/jbc.M111.251165			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880741	Green Published, hybrid			2022-12-27	WOS:000296542400040
J	Fletcher, EV; Kullmann, DM; Schorge, S				Fletcher, Emily V.; Kullmann, Dimitri M.; Schorge, Stephanie			Alternative Splicing Modulates Inactivation of Type 1 Voltage-gated Sodium Channels by Toggling an Amino Acid in the First S3-S4 Linker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; ANTIEPILEPTIC DRUGS; FEBRILE SEIZURES; MESSENGER-RNAS; STATUS-EPILEPTICUS; RAT HIPPOCAMPUS; NA+ CHANNELS; MOUSE MODEL; HUMAN BRAIN; SCN1A GENE	Voltage-gated sodium channels underlie the upstroke of action potentials and are fundamental to neuronal excitability. Small changes in the behavior of these channels are sufficient to change neuronal firing and trigger seizures. These channels are subject to highly conserved alternative splicing, affecting the short linker between the third transmembrane segment (S3) and the voltage sensor (S4) in their first domain. The biophysical consequences of this alternative splicing are incompletely understood. Here we focus on type 1 sodium channels (Nav1.1) that are implicated in human epilepsy. We show that the functional consequences of alternative splicing are highly sensitive to recording conditions, including the identity of the major intracellular anion and the recording temperature. In particular, the inactivation kinetics of channels containing the alternate exon 5N are more sensitive to intracellular fluoride ions and to changing temperature than channels containing exon 5A. Moreover, Nav1.1 channels containing exon 5N recover from inactivation more rapidly at physiological temperatures. Three amino acids differ between exons 5A and 5N. However, the changes in sensitivity and stability of inactivation were reproduced by a single conserved change from aspartate to asparagine in channels containing exon 5A, which was sufficient to make them behave like channels containing the complete exon 5N sequence. These data suggest that splicing at this site can modify the inactivation of sodium channels and reveal a possible interaction between splicing and anti-epileptic drugs that stabilize sodium channel inactivation.	[Fletcher, Emily V.; Kullmann, Dimitri M.; Schorge, Stephanie] UCL Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England	University of London; University College London	Schorge, S (corresponding author), UCL Inst Neurol Queen Sq, DCEE 8th Floor QSH, London WC1N 3BG, England.	s.schorge@ion.ucl.ac.uk	Schorge, Stephanie/C-8515-2009; Kullmann, Dimitri M/A-3162-2009; Fletcher, Emily V/AAN-9916-2020	Schorge, Stephanie/0000-0003-1541-5148; Kullmann, Dimitri M/0000-0001-6696-3545; Fletcher, Emily V/0000-0002-9786-4221	Medical Research Council [G0601440]; European Union (Epicure) [LSH 037315]; Brain Research Trust; Worshipful Company of Pewterers; Medical Research Council [G0601943, G0802158, G0801316] Funding Source: researchfish; Action Medical Research [1725] Funding Source: researchfish; MRC [G116/147, G0400136, G0400627, G0801316, G0900613, G0802158, G0600368, G9805989, G0200373, G0601440, G0601943] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union (Epicure)(European Commission); Brain Research Trust; Worshipful Company of Pewterers; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0601440 and by the European Union (Epicure, Grant LSH 037315).; Supported by a Brain Research Trust studentship.; Funded by a fellowship by the Worshipful Company of Pewterers. To whom correspondence should be addressed: DCEE 8th floor QSH, UCL-Institute of Neurology Queen Square, London WC1N 3BG. E-mail: s.schorge@ion.ucl. ac.uk.	Abe T, 2008, BRIT J CLIN PHARMACO, V66, P304, DOI 10.1111/j.1365-2125.2008.03203.x; Aman TK, 2009, J NEUROSCI, V29, P2027, DOI 10.1523/JNEUROSCI.4531-08.2009; Aronica E, 2001, EUR J NEUROSCI, V13, P1261, DOI 10.1046/j.0953-816x.2001.01502.x; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BIGAY J, 1985, FEBS LETT, V191, P181, DOI 10.1016/0014-5793(85)80004-1; Burbidge SA, 2002, MOL BRAIN RES, V103, P80, DOI 10.1016/S0169-328X(02)00188-2; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chatelier A, 2008, J NEUROPHYSIOL, V99, P2241, DOI 10.1152/jn.01350.2007; Chioni AM, 2005, J NEUROSCI METH, V147, P88, DOI 10.1016/j.jneumeth.2005.03.010; Choi JS, 2010, BRAIN, V133, P1823, DOI 10.1093/brain/awq114; Copley RR, 2004, TRENDS GENET, V20, P171, DOI 10.1016/j.tig.2004.02.001; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Czapinski P, 2005, CURR TOP MED CHEM, V5, P3, DOI 10.2174/1568026053386962; DibHajj SD, 1997, FEBS LETT, V416, P11, DOI 10.1016/S0014-5793(97)01154-X; Ellerkmann RK, 2003, NEUROSCIENCE, V119, P323, DOI 10.1016/S0306-4522(03)00168-4; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Gastaldi M, 1997, MOL BRAIN RES, V44, P179, DOI 10.1016/S0169-328X(96)00199-4; Gazina EV, 2010, NEUROSCIENCE, V166, P195, DOI 10.1016/j.neuroscience.2009.12.011; Heinzen EL, 2007, AM J HUM GENET, V80, P876, DOI 10.1086/516650; ISOM LL, 1995, J BIOL CHEM, V270, P3306, DOI 10.1074/jbc.270.7.3306; Jarecki BW, 2009, CHANNELS, V3, P259; Liao YX, 2010, BRAIN, V133, P1403, DOI 10.1093/brain/awq057; Lin WH, 2009, J NEUROPHYSIOL, V102, P1994, DOI 10.1152/jn.00613.2009; Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011; Ma JY, 1997, NEURON, V19, P443, DOI 10.1016/S0896-6273(00)80952-6; Mantegazza M, 2005, J NEUROSCI, V25, P3341, DOI 10.1523/JNEUROSCI.0104-05.2005; Mantegazza M, 2010, EPILEPSY RES, V92, P1, DOI 10.1016/j.eplepsyres.2010.08.003; Martin MS, 2010, J BIOL CHEM, V285, P9823, DOI 10.1074/jbc.M109.078568; Meadows LS, 2002, NEUROSCIENCE, V114, P745, DOI 10.1016/S0306-4522(02)00242-7; Onkal R, 2008, J CELL PHYSIOL, V216, P716, DOI 10.1002/jcp.21451; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Petrovski S, 2009, NEUROLOGY, V73, P1928, DOI 10.1212/WNL.0b013e3181c3fd6f; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; SCHALLER KL, 1992, J NEUROSCI, V12, P1370; SCHEINMAN RI, 1989, J BIOL CHEM, V264, P10660; Schlachter K, 2009, NEUROLOGY, V72, P974, DOI 10.1212/01.wnl.0000344401.02915.00; Schorge S, 2006, NEUROLOGY, V67, P1538, DOI 10.1212/01.wnl.0000242618.60344.8c; Strunecka A, 2002, PHYSIOL RES, V51, P557; Tang B, 2009, NEUROBIOL DIS, V35, P91, DOI 10.1016/j.nbd.2009.04.007; Tate SK, 2006, PHARMACOGENET GENOM, V16, P721, DOI 10.1097/01.fpc.0000230114.41828.73; Tate SK, 2005, P NATL ACAD SCI USA, V102, P5507, DOI 10.1073/pnas.0407346102; The YK, 2006, BIOPHYS J, V90, P3511, DOI 10.1529/biophysj.105.073072; Xu R, 2007, MOL CELL NEUROSCI, V35, P292, DOI 10.1016/j.mcn.2007.03.003; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zimprich F, 2008, EPILEPSIA, V49, P1108, DOI 10.1111/j.1528-1167.2008.01549_4.x	47	31	31	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36700	36708		10.1074/jbc.M111.250225	http://dx.doi.org/10.1074/jbc.M111.250225			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21890636	hybrid, Green Published			2022-12-27	WOS:000296538300053
J	Zhang, R; Pan, YT; He, SM; Lam, M; Brayer, GD; Elbein, AD; Withers, SG				Zhang, Ran; Pan, Yuan T.; He, Shouming; Lam, Michael; Brayer, Gary D.; Elbein, Alan D.; Withers, Stephen G.			Mechanistic Analysis of Trehalose Synthase from Mycobacterium smegmatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIMELOBACTER SP R48; SACCHAROMYCES-CEREVISIAE; GLYCOSYL FLUORIDES; ALPHA-GLYCOSIDASES; ESCHERICHIA-COLI; CORD FACTOR; ENZYME; CLONING; TUBERCULOSIS; PURIFICATION	Trehalose synthase (TreS) catalyzes the reversible interconversion of maltose and trehalose and has been shown recently to function primarily in the mobilization of trehalose as a glycogen precursor. Consequently, the mechanism of this intriguing isomerase is of both academic and potential pharmacological interest. TreS catalyzes the hydrolytic cleavage of alpha-aryl glucosides as well as alpha-glucosyl fluoride, thereby allowing facile, continuous assays. Reaction of TreS with 5-fluoroglycosyl fluorides results in the trapping of a covalent glycosyl-enzyme intermediate consistent with TreS being a member of the retaining glycoside hydrolase family 13 enzyme family, thus likely following a two-step, double displacement mechanism. This trapped intermediate was subjected to protease digestion followed by LC-MS/MS analysis, and Asp(230) was thereby identified as the catalytic nucleophile. The isomerization reaction was shown to be an intramolecular process by demonstration of the inability of TreS to incorporate isotope-labeled exogenous glucose into maltose or trehalose consistent with previous studies on other TreS enzymes. The absence of a secondary deuterium kinetic isotope effect and the general independence of k(cat) upon leaving group ability both point to a rate-determining conformational change, likely the opening and closing of the enzyme active site.	[Zhang, Ran; He, Shouming; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Lam, Michael; Brayer, Gary D.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z1, Canada; [Pan, Yuan T.; Elbein, Alan D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of British Columbia; University of British Columbia; University of Arkansas System; University of Arkansas Medical Sciences	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research.	Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; BERVEN LA, 1986, CARBOHYD RES, V156, P282, DOI 10.1016/S0008-6215(00)90123-X; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHEETHAM PSJ, 1984, BIOCHEM J, V220, P213, DOI 10.1042/bj2200213; Chen HM, 2007, CHEMBIOCHEM, V8, P719, DOI 10.1002/cbic.200700021; Chen YS, 2006, J AGR FOOD CHEM, V54, P7098, DOI 10.1021/jf060828q; Cielo CBC, 2010, ACTA CRYSTALLOGR F, V66, P397, DOI 10.1107/S1744309110006354; CLEGG JS, 1961, NATURE, V192, P1077, DOI 10.1038/1921077b0; Edavana VK, 2004, ARCH BIOCHEM BIOPHYS, V426, P250, DOI 10.1016/j.abb.2004.02.014; ELBEIN AD, 2003, GLYCOBIOLOGY, V13, P27; GARCES E, 1969, BIOCHEMISTRY-US, V8, P633, DOI 10.1021/bi00830a026; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Higashiyama T, 2002, PURE APPL CHEM, V74, P1263, DOI 10.1351/pac200274071263; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; Hunter RL, 2009, TUBERCULOSIS, V89, pS18, DOI 10.1016/S1472-9792(09)70007-1; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; Kandror O, 2002, P NATL ACAD SCI USA, V99, P9727, DOI 10.1073/pnas.142314099; Kato M, 2000, BIOSCI BIOTECH BIOCH, V64, P319, DOI 10.1271/bbb.64.319; KEMPTON JB, 1992, BIOCHEMISTRY-US, V31, P9961, DOI 10.1021/bi00156a015; Kobayashi M., 2003, Journal of Applied Glycoscience, V50, P1; Koh S, 1998, BIOTECHNOL LETT, V20, P757, DOI 10.1023/A:1005342921339; Koh S, 2003, CARBOHYD RES, V338, P1339, DOI 10.1016/S0008-6215(03)00172-1; Lee SS, 2003, BIOCHEMISTRY-US, V42, P13081, DOI 10.1021/bi035189g; Lillelund VH, 2002, CHEM REV, V102, P515, DOI 10.1021/cr000433k; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; MARUTA K, 1995, BIOSCI BIOTECH BIOCH, V59, P1829, DOI 10.1271/bbb.59.1829; McCarter JD, 1996, J AM CHEM SOC, V118, P241, DOI 10.1021/ja952732a; McCarter JD, 1996, J BIOL CHEM, V271, P6889, DOI 10.1074/jbc.271.12.6889; Nakada T, 1995, BIOSCI BIOTECH BIOCH, V59, P2215, DOI 10.1271/bbb.59.2215; Nakada T, 1995, BIOSCI BIOTECH BIOCH, V59, P2210, DOI 10.1271/bbb.59.2210; Nishimoto T, 1996, BIOSCI BIOTECH BIOCH, V60, P640, DOI 10.1271/bbb.60.640; NISHIMOTO T, 1995, BIOSCI BIOTECH BIOCH, V59, P2189, DOI 10.1271/bbb.59.2189; Numao S, 2003, J BIOL CHEM, V278, P48074, DOI 10.1074/jbc.M309249200; Pan YT, 2004, EUR J BIOCHEM, V271, P4259, DOI 10.1111/j.1432-1033.2004.04365.x; Pan YT, 2008, FEBS J, V275, P3408, DOI 10.1111/j.1742-4658.2008.06491.x; Ravaud S, 2007, J BIOL CHEM, V282, P28126, DOI 10.1074/jbc.M704515200; Rempel BP, 2008, GLYCOBIOLOGY, V18, P570, DOI 10.1093/glycob/cwn041; Rhimi M, 2008, BIOLOGIA, V63, P1020, DOI 10.2478/s11756-008-0166-0; Schiraldi C, 2002, TRENDS BIOTECHNOL, V20, P420, DOI 10.1016/S0167-7799(02)02041-3; Singer MA, 1998, TRENDS BIOTECHNOL, V16, P460, DOI 10.1016/S0167-7799(98)01251-7; TEWARI YB, 1991, BIOPHYS CHEM, V40, P59, DOI 10.1016/0301-4622(91)85029-P; THEVELEIN JM, 1984, MICROBIOL REV, V48, P42, DOI 10.1128/MMBR.48.1.42-59.1984; Titgemeyer F, 2007, J BACTERIOL, V189, P5903, DOI 10.1128/JB.00257-07; Tsusaki K, 1996, BBA-GEN SUBJECTS, V1290, P1, DOI 10.1016/0304-4165(96)00023-2; Tsusaki K, 1997, BBA-GEN SUBJECTS, V1334, P28, DOI 10.1016/S0304-4165(96)00103-1; Vocadlo DJ, 2002, BIOCHEMISTRY-US, V41, P9727, DOI 10.1021/bi020077v; Wang JH, 2007, J AGR FOOD CHEM, V55, P1256, DOI 10.1021/jf062355t; Williams SJ, 2000, CARBOHYD RES, V327, P27, DOI 10.1016/S0008-6215(00)00041-0; WITHERS SG, 1995, PROTEIN SCI, V4, P361; Yue M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-34; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zechel DL, 2003, BIOCHEMISTRY-US, V42, P7195, DOI 10.1021/bi034329j; Zhang DH, 2003, J BIOL CHEM, V278, P35428, DOI 10.1074/jbc.M302616200; Zhang R, 2008, J ORG CHEM, V73, P3070, DOI 10.1021/jo702565q; Zhang R, 2009, BIOCHEMISTRY-US, V48, P10752, DOI 10.1021/bi901400p; Zhu YM, 2010, EXTREMOPHILES, V14, P1, DOI 10.1007/s00792-009-0281-z	57	30	36	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35601	35609		10.1074/jbc.M111.280362	http://dx.doi.org/10.1074/jbc.M111.280362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21840994	Green Published, hybrid			2022-12-27	WOS:000295927100032
J	Banci, L; Bertini, I; Cefaro, C; Ciofi-Baffoni, S; Gallo, A				Banci, Lucia; Bertini, Ivano; Cefaro, Chiara; Ciofi-Baffoni, Simone; Gallo, Angelo			Functional Role of Two Interhelical Disulfide Bonds in Human Cox17 Protein from a Structural Perspective	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR CHEMICAL-SHIFTS; COPPER METALLOCHAPERONE COX17; CYTOCHROME-C-OXIDASE; INTERMEMBRANE SPACE; ELECTRON-TRANSFER; RELAY SYSTEM; MITOCHONDRIA; CHAPERONE; MIA40; SCO1	Human Cox17 is the mitochondrial copper chaperone responsible for supplying copper ions, through the assistance of Sco1, Sco2, and Cox11, to cytochrome c oxidase, the terminal enzyme of the mitochondrial energy-transducing respiratory chain. It consists of a coiled coil-helix-coiled coil-helix domain stabilized by two disulfide bonds and binds one copper(I) ion through a Cys-Cys motif. Here, the structures and the backbone mobilities of two Cox17 mutated forms with only one interhelical disulfide bond have been analyzed. It appears that the inner disulfide bond (formed by Cys-36 and Cys-45) stabilizes interhelical hydrophobic interactions, providing a structure with essentially the same structural dynamic properties of the mature Cox17 state. On the contrary, the external disulfide bond (formed by Cys-26 and Cys-55) generates a conformationally flexible alpha-helical protein, indicating that it is not able to stabilize interhelical packing contacts, but is important for structurally organizing the copper-binding site region.	[Bertini, Ivano] Univ Florence, Magnet Resonance Ctr, I-50019 Florence, Italy; Univ Florence, Dept Chem, I-50019 Florence, Italy	University of Florence; University of Florence	Bertini, I (corresponding author), Univ Florence, Magnet Resonance Ctr, Via Luigi Sacconi 6, I-50019 Florence, Italy.	ivanobertini@cerm.unifi.it	Gallo, Angelo/N-3781-2017; Ciofi-Baffoni, Simone/AAH-9778-2021	Gallo, Angelo/0000-0001-9778-4822; Ciofi Baffoni, Simone/0000-0002-2376-3321; BANCI, LUCIA/0000-0003-0562-5774	WeNMR Project [261572]; national GRID initiative of Belgium; national GRID initiative of Italy; national GRID initiative of Germany; national GRID initiative of The Netherlands; national GRID initiative of Portugal; national GRID initiative of United Kingdom; national GRID initiative of South Africa; Latin America GRID infrastructure via the Gisela; MIUR [RBRN07BMCT]; United States National Institutes of Health [P41 RR-01081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	WeNMR Project; national GRID initiative of Belgium; national GRID initiative of Italy; national GRID initiative of Germany; national GRID initiative of The Netherlands; national GRID initiative of Portugal; national GRID initiative of United Kingdom; national GRID initiative of South Africa; Latin America GRID infrastructure via the Gisela; MIUR(Ministry of Education, Universities and Research (MIUR)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by WeNMR Project (European FP7 e-Infrastructure grant, Contract 261572), supported by the national GRID initiatives of Belgium, Italy, Germany, The Netherlands (via the Dutch BiG Grid project), Portugal, the United Kingdom, South Africa, and the Latin America GRID infrastructure via the Gisela and by the Italian FIRB PROTEOMICA MIUR Contract RBRN07BMCT. Molecular graphics images were produced using the UCSF Chimera (39) package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, supported by United States National Institutes of Health Grant P41 RR-01081.	Arnesano F, 2005, STRUCTURE, V13, P713, DOI 10.1016/j.str.2005.02.015; Banci L, 2008, P NATL ACAD SCI USA, V105, P6803, DOI 10.1073/pnas.0800019105; Banci L, 2008, J BIOL CHEM, V283, P7912, DOI 10.1074/jbc.M708016200; Banci L, 2007, P NATL ACAD SCI USA, V104, P15, DOI 10.1073/pnas.0606189103; Banci L, 2010, P NATL ACAD SCI USA, V107, P20190, DOI 10.1073/pnas.1010095107; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; CASE DA, 2008, AMBER 10 8 0; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; Heaton D, 2000, J BIOL CHEM, V275, P37582, DOI 10.1074/jbc.M006639200; Heaton DN, 2001, BIOCHEMISTRY-US, V40, P743, DOI 10.1021/bi002315x; Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Keller R., 2004, COMPUTER AIDED RESON, V1; Maxfield AB, 2004, J BIOL CHEM, V279, P5072, DOI 10.1074/jbc.M311772200; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; OTTING G, 1993, BIOCHEMISTRY-US, V32, P3571, DOI 10.1021/bi00065a008; Palumaa P, 2004, BIOCHEM J, V382, P307, DOI 10.1042/BJ20040360; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punter FA, 2000, HUM GENET, V107, P69, DOI 10.1007/s004390050013; Punter FA, 2003, J BIOL CHEM, V278, P30875, DOI 10.1074/jbc.M302358200; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sideris DP, 2010, ANTIOXID REDOX SIGN, V13, P1189, DOI 10.1089/ars.2010.3157; Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134; Siluvai GS, 2011, J BIOL INORG CHEM, V16, P285, DOI 10.1007/s00775-010-0725-z; Terziyska N, 2009, J BIOL CHEM, V284, P1353, DOI 10.1074/jbc.M805035200; Voronova A, 2007, BIOCHEM J, V408, P139, DOI 10.1042/BJ20070804; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Zhou L, 2008, BIOCHEM J, V413, P459, DOI 10.1042/BJ20080467	39	18	21	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34382	34390		10.1074/jbc.M111.246223	http://dx.doi.org/10.1074/jbc.M111.246223			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21816817	hybrid, Green Published			2022-12-27	WOS:000295159200066
J	Samal, AB; Ghanam, RH; Fernandez, TF; Monroe, EB; Saad, JS				Samal, Alexandra B.; Ghanam, Ruba H.; Fernandez, Timothy F.; Monroe, Eric B.; Saad, Jamil S.			NMR, Biophysical, and Biochemical Studies Reveal the Minimal Calmodulin Binding Domain of the HIV-1 Matrix Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 MATRIX; PLASMA-MEMBRANE; TARGET RECOGNITION; GAG PROTEIN; INTRACELLULAR TRAFFICKING; MYRISTATE EXPOSURE; STRUCTURAL BIOLOGY; ENV INCORPORATION; IN-VITRO; PEPTIDE	Subcellular distribution of Calmodulin (CaM) in human immunodeficiency virus type-1 (HIV-1)-infected cells is distinct from that observed in uninfected cells. CaM has been shown to interact and co-localize with the HIV-1 Gag protein in infected cells. However, the precise molecular mechanism of this interaction is not known. Binding of Gag to CaM is dependent on calcium and is mediated by the N-terminal-myristoylated matrix (myr(+) MA) domain. We have recently shown that CaM binding induces a conformational change in the MA protein, triggering exposure of the myristate group. To unravel the molecular mechanism of CaM-MA interaction and to identify the minimal CaM binding domain of MA, we devised multiple approaches utilizing NMR, biochemical, and biophysical methods. Short peptides derived from the MA protein have been examined. Our data revealed that whereas peptides spanning residues 11-28 (MA-(11-28)) and 31-46 (MA-(31-46)) appear to bind preferentially to the C-terminal lobe of CaM, a peptide comprising residues 11-46 (MA-(11-46)) appears to engage both domains of CaM. Limited proteolysis data conducted on the MA-CaM complex yielded a MA peptide (residues 8-43) that is protected by CaM and resistant to proteolysis. MA-(8-43) binds to CaM with a very high affinity (dissociation constant = 25 nM) and in a manner that is similar to that observed for the full-length MA protein. The present findings provide new insights on how MA interacts with CaM that may ultimately help in identification of the functional role of CaM-Gag interactions in the HIV replication cycle.	[Samal, Alexandra B.; Ghanam, Ruba H.; Fernandez, Timothy F.; Monroe, Eric B.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Saad, JS (corresponding author), 845 19th St S, Birmingham, AL 35294 USA.	saad@uab.edu		Monroe, Eric/0000-0002-6404-5801; Saad, Jamil/0000-0001-9503-6484	National Institutes of Health [1R01AI087101, CA13148-35, P30CA13148, 1S10RR026478]; NCI; University of Alabama at Birmingham Comprehensive Cancer Center; Center for AIDS Research at the University of Alabama at Birmingham; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Alabama at Birmingham Comprehensive Cancer Center; Center for AIDS Research at the University of Alabama at Birmingham; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01AI087101 (to J. S. S.), CA13148-35 (NCI; University of Alabama at Birmingham Comprehensive Cancer Center Junior Faculty Development Grant Program, to J. S. S.), and by intramural funding from the Center for AIDS Research at the University of Alabama at Birmingham.; We thank to Madeline Shea (University of Iowa) for providing the CaM molecular clone, Jin-Biao Ma for providing SUMO and SUMO protease plasmids, and Peter Prevelige (University of Alabama at Birmingham) and David King (Howard Hughes Medical Institute, University of California Berkeley) for helping with the mass spectrometry data. We thank the University of Alabama at Birmingham Comprehensive Cancer Center x-ray core facility, funded by NCI, National Institutes of Health Grant P30CA13148, which houses the Auto-ITC<INF>200</INF>, acquired through NIH Grant 1S10RR026478.	Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; Campbell S, 1999, J VIROL, V73, P2270, DOI 10.1128/JVI.73.3.2270-2279.1999; Campbell S, 2001, P NATL ACAD SCI USA, V98, P10875, DOI 10.1073/pnas.191224698; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chow JYH, 2010, J MOL BIOL, V400, P702, DOI 10.1016/j.jmb.2010.05.022; Chu H, 2009, CURR TOP MICROBIOL, V339, P67, DOI 10.1007/978-3-642-02175-6_4; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; DORFMAN T, 1994, J VIROL, V68, P8180, DOI 10.1128/JVI.68.12.8180-8187.1994; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Fledderman EL, 2010, BIOCHEMISTRY-US, V49, P9551, DOI 10.1021/bi101245j; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ghanam RH, 2010, J BIOL CHEM, V285, P41911, DOI 10.1074/jbc.M110.179093; GIETZEN K, 1982, BIOCHEM J, V207, P541, DOI 10.1042/bj2070541; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Han Z, 2007, VIRUS GENES, V35, P511, DOI 10.1007/s11262-007-0125-9; Hayashi N, 2002, PROTEIN SCI, V11, P529, DOI 10.1110/ps.23702; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Izumi Y, 2008, BIOCHEMISTRY-US, V47, P7158, DOI 10.1021/bi702416b; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Matsubara M, 2005, PROTEIN SCI, V14, P494, DOI 10.1110/ps.04969605; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Matsubara M, 2003, J BIOL CHEM, V278, P48898, DOI 10.1074/jbc.M305488200; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MILLER MA, 1993, AIDS RES HUM RETROV, V9, P1057, DOI 10.1089/aid.1993.9.1057; Nishi M, 2009, FEBS LETT, V583, P1243, DOI 10.1016/j.febslet.2009.03.041; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 1997, J VIROL, V71, P4409, DOI 10.1128/JVI.71.6.4409-4418.1997; Ono A, 2010, VACCINE, V28, pB55, DOI 10.1016/j.vaccine.2009.10.021; Ono A, 2010, BIOL CELL, V102, P335, DOI 10.1042/BC20090165; Ono A, 2009, FUTURE VIROL, V4, P241, DOI 10.2217/FVL.09.4; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Osawa M, 1998, J MOL BIOL, V276, P165, DOI 10.1006/jmbi.1997.1524; Paillart JC, 1999, J VIROL, V73, P2604, DOI 10.1128/JVI.73.4.2604-2612.1999; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; Radding W, 2000, AIDS RES HUM RETROV, V16, P1519, DOI 10.1089/088922200750006047; Radding W, 1996, BIOCHEM BIOPH RES CO, V218, P192, DOI 10.1006/bbrc.1996.0034; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; SIIVARI K, 1995, FEBS LETT, V366, P104, DOI 10.1016/0014-5793(95)00504-3; Sorensen BR, 1998, BIOCHEMISTRY-US, V37, P4244, DOI 10.1021/bi9718200; SRINIVAS SK, 1993, J BIOL CHEM, V268, P22895; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; TOWLER DA, 1988, J BIOL CHEM, V263, P1784; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; VOGEL HJ, 1994, BIOCHEM CELL BIOL, V72, P357, DOI 10.1139/o94-049; Waheed AA, 2009, VIRUS RES, V143, P162, DOI 10.1016/j.virusres.2009.04.007; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994	81	19	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33533	33543		10.1074/jbc.M111.273623	http://dx.doi.org/10.1074/jbc.M111.273623			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799007	Green Published, hybrid			2022-12-27	WOS:000294968800070
J	Inoue, T; Kobayashi, K; Inoguchi, T; Sonoda, N; Fujii, M; Maeda, Y; Fujimura, Y; Miura, D; Hirano, K; Takayanagi, R				Inoue, Tomoaki; Kobayashi, Kunihisa; Inoguchi, Toyoshi; Sonoda, Noriyuki; Fujii, Masakazu; Maeda, Yasutaka; Fujimura, Yoshinori; Miura, Daisuke; Hirano, Ken-ichi; Takayanagi, Ryoichi			Reduced Expression of Adipose Triglyceride Lipase Enhances Tumor Necrosis Factor alpha-induced Intercellular Adhesion Molecule-1 Expression in Human Aortic Endothelial Cells via Protein Kinase C-dependent Activation of Nuclear Factor-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETES-MELLITUS; OXIDATIVE STRESS; DIACYLGLYCEROL SYNTHESIS; TRANSCRIPTION FACTOR; GLUCOSE; DISEASE; ACID; ACCUMULATION; MECHANISMS; STEATOSIS	We examined the effects of adipose triglyceride lipase (ATGL) on the initiation of atherosclerosis. ATGL was recently identified as a rate-limiting triglyceride (TG) lipase. Mutations in the human ATGL gene are associated with neutral lipid storage disease with myopathy, a rare genetic disease characterized by excessive accumulation of TG in multiple tissues. The cardiac phenotype, known as triglyceride deposit cardiomyovasculopathy, shows massive TG accumulation in both coronary atherosclerotic lesions and the myocardium. Recent reports show that myocardial triglyceride content is significantly higher in patients with prediabetes or diabetes and that ATGL expression is decreased in the obese insulin-resistant state. Therefore, we investigated the effect of decreased ATGL activity on the development of atherosclerosis using human aortic endothelial cells. We found that ATGL knockdown enhanced monocyte adhesion via increased expression of TNF alpha-induced intercellular adhesion molecule-1 (ICAM-1). Next, we determined the pathways (MAPK, PKC, or NF kappa B) involved in ICAM-1 up-regulation induced by ATGL knockdown. Both phosphorylation of PKC and degradation of I kappa B alpha were increased in ATGL knockdown human aortic endothelial cells. In addition, intracellular diacylglycerol levels and free fatty acid uptake via CD36 were significantly increased in these cells. Inhibition of the PKC pathway using calphostin C and GF109203X suppressed TNF alpha-induced ICAM-1 expression. In conclusion, we showed that ATGL knockdown increased monocyte adhesion to the endothelium through enhanced TNF alpha-induced ICAM-1 expression via activation of NF kappa B and PKC. These results suggest that reduced ATGL expression may influence the atherogenic process in neutral lipid storage diseases and in the insulin-resistant state.	[Inoue, Tomoaki; Kobayashi, Kunihisa; Inoguchi, Toyoshi; Sonoda, Noriyuki; Fujii, Masakazu; Maeda, Yasutaka; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Fukuoka 8128582, Japan; [Kobayashi, Kunihisa] Fukuoka Univ, Chikushi Hosp, Dept Endocrinol & Diabet Mellitus, Fukuoka 8188502, Japan; [Inoguchi, Toyoshi; Sonoda, Noriyuki; Fujimura, Yoshinori; Miura, Daisuke] Kyushu Univ, Innovat Ctr Med Redox Nav, Higashi Ku, Fukuoka 8128582, Japan; [Hirano, Ken-ichi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan	Kyushu University; Fukuoka University; Kyushu University; Osaka University	Kobayashi, K (corresponding author), 1-1-1 Zokumyoin, Fukuoka 8188502, Japan.	nihisak@fukuoka-u.ac.jp	Kobayashi, Kunihisa/V-9554-2019; Fujimura, Yoshinori/AAG-4403-2019; fujimura, yoshinori/E-4684-2012; Miura, Daisuke/H-1517-2019	Kobayashi, Kunihisa/0000-0002-7741-846X; Fujimura, Yoshinori/0000-0003-0798-0649; Inoguchi, Toyoshi/0000-0002-7344-6199	Ministry of Health, Labor, and Welfare of the Japanese Government	Ministry of Health, Labor, and Welfare of the Japanese Government(Ministry of Health, Labour and Welfare, Japan)	This work was supported by research grants-in-aid for rare and intractable diseases from the Ministry of Health, Labor, and Welfare of the Japanese Government (to K. H. and K. K.).	BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Belfrage P, 1978, Adv Exp Med Biol, V101, P113; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Casasnovas JM, 1998, J VIROL, V72, P6244, DOI 10.1128/JVI.72.7.6244-6246.1998; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Febbraio M, 2007, INT J BIOCHEM CELL B, V39, P2012, DOI 10.1016/j.biocel.2007.03.012; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; FOLCH J, 1957, J BIOL CHEM, V226, P497; GERRITY RG, 1981, AM J PATHOL, V103, P181; HA HJ, 1994, FREE RADICAL BIO MED, V16, P271, DOI 10.1016/0891-5849(94)90152-X; Hirano K, 2008, NEW ENGL J MED, V359, P2396, DOI 10.1056/NEJMc0805305; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; INOGUCHI T, 1994, AM J PHYSIOL, V267, pE369, DOI 10.1152/ajpendo.1994.267.3.E369; Jocken JWE, 2007, J CLIN ENDOCR METAB, V92, P2292, DOI 10.1210/jc.2006-1318; Kakimoto M, 2002, DIABETES, V51, P1588, DOI 10.2337/diabetes.51.5.1588; Kevil CG, 2001, AM J PHYSIOL-CELL PH, V281, pC1442, DOI 10.1152/ajpcell.2001.281.5.C1442; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Kobayashi K, 2008, J CLIN ENDOCR METAB, V93, P2877, DOI 10.1210/jc.2007-2247; Kuroki T, 1998, BIOCHEM BIOPH RES CO, V247, P473, DOI 10.1006/bbrc.1998.8814; Lingvay I, 2009, NAT REV CARDIOL, V6, P268, DOI 10.1038/nrcardio.2009.30; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Muller M, 2002, MOL CELL BIOL, V22, P1060, DOI 10.1128/MCB.22.4.1060-1072.2002; OBERLEY LW, 1988, FREE RADICAL BIO MED, V5, P113, DOI 10.1016/0891-5849(88)90036-6; Ozes ON, 1999, NATURE, V401, P82; Ragheb R, 2008, BIOCHEM BIOPH RES CO, V370, P134, DOI 10.1016/j.bbrc.2008.03.044; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schmitz ML, 2003, FASEB J, V17, P2187, DOI 10.1096/fj.02-1100rev; Seckin D, 2006, DIABETES RES CLIN PR, V73, P191, DOI 10.1016/j.diabres.2006.01.001; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; Steinberg GR, 2007, AM J PHYSIOL-ENDOC M, V293, pE958, DOI 10.1152/ajpendo.00235.2007; Tsubouchi H, 2005, FREE RADICAL BIO MED, V39, P444, DOI 10.1016/j.freeradbiomed.2005.03.031; WOLF BA, 1989, BIOCHEMISTRY-US, V28, P4291, DOI 10.1021/bi00436a026; WOLFF SP, 1991, FREE RADICAL BIO MED, V10, P339, DOI 10.1016/0891-5849(91)90040-A; Yu HY, 2001, DIABETOLOGIA, V44, P614, DOI 10.1007/s001250051668; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	39	24	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32045	32053		10.1074/jbc.M111.285650	http://dx.doi.org/10.1074/jbc.M111.285650			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21828047	hybrid, Green Published			2022-12-27	WOS:000294726800014
J	Logue, JS; Whiting, JL; Tunquist, B; Sacks, DB; Langeberg, LK; Wordeman, L; Scott, JD				Logue, Jeremy S.; Whiting, Jennifer L.; Tunquist, Brian; Sacks, David B.; Langeberg, Lorene K.; Wordeman, Linda; Scott, John D.			AKAP220 Protein Organizes Signaling Elements That Impact Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE ANCHORING PROTEIN; DYNAMIC INSTABILITY; EPITHELIAL-CELLS; IN-VIVO; MICROTUBULE; IQGAP1; ASSOCIATION; ADHESION; GROWTH; PHOSPHORYLATION	Cell movement requires the coordinated reception, integration, and processing of intracellular signals. We have discovered that the protein kinase A anchoring protein AKAP220 interacts with the cytoskeletal scaffolding protein IQGAP1 to influence cell motility. AKAP220/IQGAP1 networks receive and integrate calcium and cAMP second messenger signals and position signaling enzymes near their intended substrates at leading edges of migrating cells. IQGAP1 supports calcium/calmodulin-dependent association of factors that modulate microtubule dynamics. AKAP220 suppresses GSK-3 beta and positions this kinase to allow recruitment of the plus-end microtubule tracking protein CLASP2. Gene silencing of AKAP220 alters the rate of microtubule polymerization and the lateral tracking of growing microtubules and retards cell migration in metastatic human cancer cells. This reveals an unappreciated role for this anchored kinase/microtubule effector protein network in the propagation of cell motility.	[Logue, Jeremy S.; Whiting, Jennifer L.; Tunquist, Brian; Langeberg, Lorene K.; Scott, John D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Whiting, Jennifer L.; Langeberg, Lorene K.; Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Logue, Jeremy S.] Univ Washington, Sch Med, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Wordeman, Linda] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA	Scott, JD (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, 1959 Pacific Ave NE,Box 357750, Seattle, WA 98195 USA.	scottjdw@u.washington.edu		Sacks, David/0000-0003-3100-0735; Wordeman, Linda/0000-0002-9444-0650	National Institutes of Health [DK54441, GM69429, CA93645]; NATIONAL CANCER INSTITUTE [R01CA093645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069429] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CLINICAL CENTER	This work was supported, in whole or in part, by National Institutes of Health Grants DK54441 (to J. D. S.), GM69429 (to L. W.), and CA93645 (to D. B. S.).	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Al-Bassam J, 2010, DEV CELL, V19, P245, DOI 10.1016/j.devcel.2010.07.016; Barth AIM, 2008, SEMIN CELL DEV BIOL, V19, P245, DOI 10.1016/j.semcdb.2008.02.003; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; CARR DW, 1991, J BIOL CHEM, V266, P14188; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Graves LM, 1996, J BIOL CHEM, V271, P505, DOI 10.1074/jbc.271.1.505; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lester LB, 1996, J BIOL CHEM, V271, P9460, DOI 10.1074/jbc.271.16.9460; Logue JS, 2011, J BIOL CHEM, V286, P22113, DOI 10.1074/jbc.M111.232660; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Suter DM, 1998, CURR OPIN NEUROBIOL, V8, P106, DOI 10.1016/S0959-4388(98)80014-7; Tanji C, 2002, J BIOL CHEM, V277, P36955, DOI 10.1074/jbc.M206210200; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; Wong W, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000026; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107	42	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39269	39281		10.1074/jbc.M111.277756	http://dx.doi.org/10.1074/jbc.M111.277756			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21890631	Green Published, hybrid			2022-12-27	WOS:000296759800045
J	Kalita, MK; Sargsyan, K; Tian, B; Paulucci-Holthauzen, A; Najm, HN; Debusschere, BJ; Brasier, AR				Kalita, Mridul K.; Sargsyan, Khachik; Tian, Bing; Paulucci-Holthauzen, Adriana; Najm, Habib N.; Debusschere, Bert J.; Brasier, Allan R.			Sources of Cell-to-cell Variability in Canonical Nuclear Factor-kappa B (NF-kappa B) Signaling Pathway Inferred from Single Cell Dynamic Images	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; ALPHA; OSCILLATIONS; ACTIVATION; MODEL; IKK; UBIQUITINATION; IDENTIFICATION; PROTEINS; KINASES	The canonical nuclear factor-kappa B (NF-kappa B) signaling pathway controls a gene network important in the cellular inflammatory response. Upon activation, NF-kappa B/RelA is released from cytoplasmic inhibitors, from where it translocates into the nucleus, subsequently activating negative feedback loops producing either monophasic or damped oscillatory nucleo-cytoplasmic dynamics. Although the population behavior of the NF-kappa B pathway has been extensively modeled, the sources of cell-to-cell variability are not well understood. We describe an integrated experimental-computational analysis of NF-kappa B/RelA translocation in a validated cell model exhibiting monophasic dynamics. Quantitative measures of cellular geometry and total cytoplasmic concentration and translocated RelA amounts were used as priors in Bayesian inference to estimate biophysically realistic parameter values based on dynamic live cell imaging studies of enhanced GFP-tagged RelA in stable transfectants. Bayesian inference was performed on multiple cells simultaneously, assuming identical reaction rate parameters, whereas cellular geometry and initial and total NF-kappa B concentration-related parameters were cell-specific. A subpopulation of cells exhibiting distinct kinetic profiles was identified that corresponded to differences in the I kappa B alpha translation rate. We conclude that cellular geometry, initial and total NF-kappa B concentration, I kappa B alpha translation, and I kappa B alpha degradation rates account for distinct cell-to-cell differences in canonical NF-kappa B translocation dynamics.	[Kalita, Mridul K.; Tian, Bing; Brasier, Allan R.] Univ Texas Med Branch, Dept Med, Galveston, TX 77555 USA; [Paulucci-Holthauzen, Adriana] Univ Texas Med Branch, Opt Imaging Lab, Galveston, TX 77555 USA; [Brasier, Allan R.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Sargsyan, Khachik; Najm, Habib N.; Debusschere, Bert J.] Sandia Natl Labs, Livermore, CA 94551 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; United States Department of Energy (DOE); Sandia National Laboratories	Brasier, AR (corresponding author), Univ Texas Med Branch, Dept Med, MRB 8-138,301 Univ Blvd, Galveston, TX 77555 USA.	arbrasie@utmb.edu		Brasier, Allan/0000-0002-5012-4090; Debusschere, Bert/0000-0001-7253-7059	National Institutes of Health (NIH) [AI062885]; NIH, NHLBI [BAA-HL-02-04]; NIH [RO1 GM086885]; University of Texas-Sandia National Laboratories; Sandia Laboratory; United States Department of Energy Office of Science through Office of Advanced Scientific Computing Research [07-012783]; Sandia Corp. [DE-AC04-94AL85000]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086885] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas-Sandia National Laboratories; Sandia Laboratory(United States Department of Energy (DOE)); United States Department of Energy Office of Science through Office of Advanced Scientific Computing Research; Sandia Corp.(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant AI062885 (to A. R. B.), NIH, NHLBI, Contract BAA-HL-02-04 (to A. R. B.) and NIH Grant RO1 GM086885 (to M. Kimmel, Rice University). This work was supported in part by a University of Texas-Sandia National Laboratories joint postdoctoral program (to M. K. K.).; Supported by the Sandia Laboratory Directed Research and Development program as well as the United States Department of Energy Office of Science through the Applied Mathematics program in the Office of Advanced Scientific Computing Research under Contract 07-012783 with Sandia National Laboratories. Sandia National Laboratories is a multiprogram laboratory managed and operated by Sandia Corp., a wholly owned subsidiary of Lockheed Martin Corporation, for the United States Department of Energy National Nuclear Security Administration under Contract DE-AC04-94AL85000.	BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Brasier AR, 2009, CELLULAR SIGNALING AND INNATE IMMUNE RESPONSES TO RNA VIRUS INFECTIONS, P1; Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Forbus J, 2006, PROTEOMICS, V6, P2656, DOI 10.1002/pmic.200500652; Gelman A., 1996, BAYESIAN STAT, V5, P599; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Han YQ, 1997, J BIOL CHEM, V272, P9825; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Jamaluddin M, 1998, J VIROL, V72, P4849, DOI 10.1128/JVI.72.6.4849-4857.1998; Jamaluddin M, 2010, J VIROL, V84, P9533, DOI 10.1128/JVI.01005-10; Joo J, 2007, ANN NY ACAD SCI, V1115, P221, DOI 10.1196/annals.1407.014; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Lipniacki T, 2006, BIOPHYS J, V90, P725, DOI 10.1529/biophysj.104.056754; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Liu P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008079; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Reagan MT, 2003, COMBUST FLAME, V132, P545, DOI 10.1016/S0010-2180(02)00503-5; Shen H, 2006, J R SOC INTERFACE, V3, P787, DOI 10.1098/rsif.2006.0137; Sivia D, 1996, BAYESIAN ANAL TUTORI; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tian B, 2003, RECENT PROG HORM RES, V58, P95, DOI 10.1210/rp.58.1.95; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; Wang YJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-23; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zhao YX, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008771	40	35	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37741	37757		10.1074/jbc.M111.280925	http://dx.doi.org/10.1074/jbc.M111.280925			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21868381	hybrid, Green Published			2022-12-27	WOS:000296542400070
J	Saeed, M; Suzuki, R; Watanabe, N; Masaki, T; Tomonaga, M; Muhammad, A; Kato, T; Matsuura, Y; Watanabe, H; Wakita, T; Suzuki, T				Saeed, Mohsan; Suzuki, Ryosuke; Watanabe, Noriyuki; Masaki, Takahiro; Tomonaga, Mitsunori; Muhammad, Amir; Kato, Takanobu; Matsuura, Yoshiharu; Watanabe, Haruo; Wakita, Takaji; Suzuki, Tetsuro			Role of the Endoplasmic Reticulum-associated Degradation (ERAD) Pathway in Degradation of Hepatitis C Virus Envelope Proteins and Production of Virus Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JAPANESE-ENCEPHALITIS-VIRUS; INFECTION; STRESS; INDUCTION; GENOME; REPLICATION; INVOLVEMENT; APOPTOSIS; HOMOLOG; CHOP	Viral infections frequently cause endoplasmic reticulum (ER) stress in host cells leading to stimulation of the ER-associated degradation (ERAD) pathway, which subsequently targets unassembled glycoproteins for ubiquitylation and proteasomal degradation. However, the role of the ERAD pathway in the viral life cycle is poorly defined. In this paper, we demonstrate that hepatitis C virus (HCV) infection activates the ERAD pathway, which in turn controls the fate of viral glycoproteins and modulates virus production. ERAD proteins, such as EDEM1 and EDEM3, were found to increase ubiquitylation of HCV envelope proteins via direct physical interaction. Knocking down of EDEM1 and EDEM3 increased the half-life of HCV E2, as well as virus production, whereas exogenous expression of these proteins reduced the production of infectious virus particles. Further investigation revealed that only EDEM1 and EDEM3 bind with SEL1L, an ER membrane adaptor protein involved in translocation of ERAD substrates from the ER to the cytoplasm. When HCV-infected cells were treated with kifunensine, a potent inhibitor of the ERAD pathway, the half-life of HCV E2 increased and so did virus production. Kifunensine inhibited the binding of EDEM1 and EDEM3 with SEL1L, thus blocking the ubiquitylation of HCV E2 protein. Chemical inhibition of the ERAD pathway neither affected production of the Japanese encephalitis virus (JEV) nor stability of the JEV envelope protein. A co-immunoprecipitation assay showed that EDEM orthologs do not bind with JEV envelope protein. These findings highlight the crucial role of the ERAD pathway in the life cycle of specific viruses.	[Suzuki, Tetsuro] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4313192, Japan; [Suzuki, Ryosuke; Watanabe, Noriyuki; Masaki, Takahiro; Tomonaga, Mitsunori; Kato, Takanobu; Wakita, Takaji; Suzuki, Tetsuro] Natl Inst Infect Dis, Dept Virol 2, Tokyo 1628640, Japan; [Saeed, Mohsan; Watanabe, Haruo] Univ Tokyo, Dept Infect & Pathol, Grad Sch Med, Tokyo 1130033, Japan; [Muhammad, Amir] Khyber Girls Med Coll, Dept Pathol, Peshawar 25000, Pakistan; [Matsuura, Yoshiharu] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Hamamatsu University School of Medicine; National Institute of Infectious Diseases (NIID); University of Tokyo; Osaka University	Suzuki, T (corresponding author), Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4313192, Japan.	tesuzuki@hama-med.ac.jp	Saeed, Mohsan/AAM-8375-2021		Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid from the Ministry of Health, Labor and Welfare, and from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Eriksson KK, 2004, J BIOL CHEM, V279, P44600, DOI 10.1074/jbc.M407972200; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005; Lim CK, 2008, VIROLOGY, V374, P60, DOI 10.1016/j.virol.2007.12.021; Masaki T, 2010, J VIROL, V84, P5824, DOI 10.1128/JVI.02397-09; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Murakami K, 2008, J GEN VIROL, V89, P1587, DOI 10.1099/vir.0.83618-0; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Reggiori F, 2010, CELL HOST MICROBE, V7, P500, DOI 10.1016/j.chom.2010.05.013; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Tani H, 2010, J VIROL, V84, P2798, DOI 10.1128/JVI.02499-09; Tardif KD, 2004, J BIOL CHEM, V279, P17158, DOI 10.1074/jbc.M312144200; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06; Zhao ZJ, 2005, J GEN VIROL, V86, P2209, DOI 10.1099/vir.0.80638-0; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	29	67	69	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37264	37273		10.1074/jbc.M111.259085	http://dx.doi.org/10.1074/jbc.M111.259085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878646	Green Published, hybrid			2022-12-27	WOS:000296542400026
J	Amosova, O; Kumar, V; Deutsch, A; Fresco, JR				Amosova, Olga; Kumar, Veena; Deutsch, Aaron; Fresco, Jacques R.			Self-catalyzed Site-specific Depurination of G Residues Mediated by Cruciform Extrusion in Closed Circular DNA Plasmids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; STRUCTURAL TRANSITION; SECONDARY STRUCTURES; BINDING PROTEIN; ABASIC SITES; STRANDED-DNA; IN-VIVO; CELLS; GENE; REPAIR	A major variety of "spontaneous" genomic damage is endogenous generation of apurinic sites. Depurination rates vary widely across genomes, occurring with higher frequency at "depurination hot spots." Recently, we discovered a site-specific self-catalyzed depurinating activity in short (14-18 nucleotides) DNA stem-loop-forming sequences with a 5'-G(T/A)GG-3' loop and T.A or G.C as the first base pair at the base of the loop; the 5'-G residue of the loop self-depurinates at least 10(5)-fold faster than random "spontaneous" depurination at pH 5. Formation of the catalytic intermediate for self-depurination in double-stranded DNA requires a stem-loop to extrude as part of a cruciform. In this study, evidence is presented for self-catalyzed depurination mediated by cruciform formation in plasmid DNA in vitro. Cruciform extrusion was confirmed, and its extent was quantitated by digestion of the plasmid with single strand-specific mung bean endonuclease, followed by restriction digestion and sequencing of resulting mung bean-generated fragments. Appearance of the apurinic site in the self-depurinating stem-loop was confirmed by digestion of plasmid DNA with apurinic endonuclease IV, followed by primer extension and/or PCR amplification to detect the endonuclease-generated strand break and identify its location. Self-catalyzed depurination was contingent on the plasmid being supercoiled and was not observed in linearized plasmids, consistent with the presence of the extruded cruciform in the supercoiled plasmid and not in the linear one. These results indicate that self-catalyzed depurination is not unique to single-stranded DNA; rather, it can occur in stem-loop structures extruding from double-stranded DNA and therefore could, in principle, occur in vivo.	[Amosova, Olga; Kumar, Veena; Deutsch, Aaron; Fresco, Jacques R.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Fresco, JR (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	jrfresco@princeton.edu		Deutsch, Aaron/0000-0001-6750-5335; Kumar, Veena/0000-0002-7001-0277	United States Army Research Office [W911NF-07-1-0152]; Higgins Trust	United States Army Research Office; Higgins Trust	This work was supported by United States Army Research Office Grant W911NF-07-1-0152 and the Higgins Trust. The previous paper in this series is Ref. 10.	Alvarez D, 2002, J CELL BIOCHEM, V87, P194, DOI 10.1002/jcb.10294; Amosova O, 2006, P NATL ACAD SCI USA, V103, P4392, DOI 10.1073/pnas.0508499103; Amosova O, 2011, J BIOL CHEM, V286, P36316, DOI 10.1074/jbc.M111.272047; ASAKURA Y, 1985, J BIOCHEM-TOKYO, V98, P41, DOI 10.1093/oxfordjournals.jbchem.a135270; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Chakravarti D, 2000, MUTAT RES-FUND MOL M, V456, P17, DOI 10.1016/S0027-5107(00)00102-0; Chen ZD, 1996, BIOTECHNIQUES, V21, P820; Cunningham LA, 2003, MOL CELL BIOL, V23, P8740, DOI 10.1128/MCB.23.23.8740-8750.2003; Dai X, 1998, J MOL BIOL, V283, P43, DOI 10.1006/jmbi.1998.2096; Dai X, 1997, P NATL ACAD SCI USA, V94, P2174, DOI 10.1073/pnas.94.6.2174; DAYN A, 1991, J BACTERIOL, V173, P2658, DOI 10.1128/jb.173.8.2658-2664.1991; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Fresco JR, 2011, EVOLUTIONARY BIOLOGY: CONCEPTS, BIODIVERSITY, MACROEVOLUTION AND GENOME EVOLUTION, P3, DOI 10.1007/978-3-642-20763-1_1; Guillet M, 2002, EMBO J, V21, P2833, DOI 10.1093/emboj/21.11.2833; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Inagaki H, 2005, HUM MUTAT, V26, P332, DOI 10.1002/humu.20228; Inagaki H, 2009, GENOME RES, V19, P191, DOI 10.1101/gr.079244.108; Kato T, 2006, SCIENCE, V311, P971, DOI 10.1126/science.1121452; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Kolb J, 2009, CHROMOSOME RES, V17, P469, DOI 10.1007/s10577-009-9039-9; Krasilnikov AS, 1999, J MOL BIOL, V292, P1149, DOI 10.1006/jmbi.1999.3117; Kurahashi H, 2004, J BIOL CHEM, V279, P35377, DOI 10.1074/jbc.M400354200; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; PANYUTIN I, 1985, J BIOMOL STRUCT DYN, V2, P1221, DOI 10.1080/07391102.1985.10507634; PEARSON CE, 1994, BIOCHEMISTRY-US, V33, P14185, DOI 10.1021/bi00251a030; Pierce KE, 2005, P NATL ACAD SCI USA, V102, P8609, DOI 10.1073/pnas.0501946102; Potaman VN, 2005, J MOL BIOL, V348, P609, DOI 10.1016/j.jmb.2005.03.010; Sambrook J., 1989, MOL CLONING, pA1; SHEFLIN LG, 1985, NUCLEIC ACIDS RES, V13, P6137, DOI 10.1093/nar/13.17.6137; Shlyakhtenko LS, 2000, J MOL BIOL, V296, P1169, DOI 10.1006/jmbi.2000.3542; Simonelli V, 2005, NUCLEIC ACIDS RES, V33, P4404, DOI 10.1093/nar/gki749; Svoboda P., 2009, COLD SPRING HARB PRO, ptop56; Tornaletti S, 2006, CHEM RES TOXICOL, V19, P1215, DOI 10.1021/tx060103g; Viswanathan VK, 1999, BIOTECHNIQUES, V27, P508, DOI 10.2144/99273st04; Wright B. E., 2011, CARCINOGENE IN PRESS; Wright BE, 2008, MOL IMMUNOL, V45, P3589, DOI 10.1016/j.molimm.2008.02.030; Wright BE, 2003, MOL MICROBIOL, V48, P429, DOI 10.1046/j.1365-2958.2003.t01-1-03436.x; Wright BE, 2002, CANCER RES, V62, P5641; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2; Zheng KW, 2010, NUCLEIC ACIDS RES, V38, P327, DOI 10.1093/nar/gkp898	43	8	9	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36322	36330		10.1074/jbc.M111.272112	http://dx.doi.org/10.1074/jbc.M111.272112			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21868375	Green Published, hybrid			2022-12-27	WOS:000296538300017
J	Huang, GZ; Fang, JM; Sant'Anna, C; Li, ZH; Wellems, DL; Rohloff, P; Docampo, R				Huang, Guozhong; Fang, Jianmin; Sant'Anna, Celso; Li, Zhu-Hong; Wellems, Dianne L.; Rohloff, Peter; Docampo, Roberto			Adaptor Protein-3 (AP-3) Complex Mediates the Biogenesis of Acidocalcisomes and Is Essential for Growth and Virulence of Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL MEMBRANE-PROTEINS; YEAST SACCHAROMYCES-CEREVISIAE; UNICELLULAR EUKARYOTES; POLYPHOSPHATE STORAGE; H+-PYROPHOSPHATASE; VACUOLE FUSION; CLATHRIN; TRAFFICKING; TRANSPORT; LEISHMANIA	Acidocalcisomes are acidic calcium and polyphosphate storage organelles found in a diverse range of organisms. Here we present evidence that the biogenesis of acidocalcisomes in Trypanosoma brucei is linked to the expression of adaptor protein-3 (AP-3) complex. Localization studies in cell lines expressing beta 3 and delta subunits of AP-3 fused to epitope tags revealed their partial co-localization with the vacuolar proton pyrophosphatase, a marker of acidocalcisomes, with the Golgi marker Golgi reassembly and stacking protein, and with antibodies against the small GTPase Rab11. Ablation of the beta 3 subunit by RNA interference (RNAi) resulted in disappearance of acidocalcisomes from both procyclic and bloodstream form trypanosomes, as revealed by immmunofluorescence and electron microscopy assays, with no alterations in trafficking of different markers to lysosomes. Knockdown of the beta 3 subunit resulted in lower acidic calcium, pyrophosphate, and polyphosphate content as well as defects in growth in culture, resistance to osmotic stress, and virulence in mice. Similar results were obtained by knocking down the expression of the delta subunit of AP-3. These results indicate that AP-3 is essential for the biogenesis of acidocalcisomes and for growth and virulence of T. brucei.	[Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Docampo, R (corresponding author), Univ Georgia, Dept Cellular Biol, 350B Paul D Coverdell Ctr, Athens, GA 30602 USA.	rdocampo@uga.edu	Rohloff, Peter/P-8722-2017	Rohloff, Peter/0000-0001-7274-8315	National Institutes of Health [AI-077538]; Ellison Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-077538 (to R.D.).; Supported by a training grant from the Ellison Medical Foundation to the Center for Tropical and Emerging Global Diseases. Present address: Diretoria de Programas, Instituto Nacional de Metrologia, Normalizacao e Qualidade Industrial-INMETRO. Av. Nossa Senhora das Gracas, 50, Xerem, Duque de Caxias-Rio de Janeiro 25250-020, Brazil.	Alexander DL, 2002, J CELL SCI, V115, P3253; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Allen CL, 2007, MOL BIOCHEM PARASIT, V156, P175, DOI 10.1016/j.molbiopara.2007.07.020; Anand VC, 2009, MOL BIOL CELL, V20, P1592, DOI 10.1091/mbc.E08-08-0819; Anitei M, 2010, MOL MEMBR BIOL, V27, P443, DOI 10.3109/09687688.2010.522601; Ault-Riche D, 1999, Prog Mol Subcell Biol, V23, P241; Babes V., 1895, Z HYG INFEKTIONSKR, V20, P412, DOI DOI 10.1007/BF02216664; Baust T, 2008, MOL BIOL CELL, V19, P1942, DOI 10.1091/mbc.E08-02-0110; BENAIM G, 1993, BIOCHEM J, V296, P759, DOI 10.1042/bj2960759; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Besteiro S, 2008, J CELL SCI, V121, P561, DOI 10.1242/jcs.022574; Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; COPPENS I, 1993, MOL BIOCHEM PARASIT, V58, P223, DOI 10.1016/0166-6851(93)90044-X; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; Cutler DF, 2002, SEMIN CELL DEV BIOL, V13, P261, DOI 10.1016/S108495210200054X; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; DOCAMPO R, 1995, BIOCHEM J, V310, P1005, DOI 10.1042/bj3101005; Docampo R, 2001, MOL BIOCHEM PARASIT, V114, P151, DOI 10.1016/S0166-6851(01)00246-8; Docampo R, 2010, PHILOS T R SOC B, V365, P775, DOI 10.1098/rstb.2009.0179; Fang JM, 2007, BIOCHEM J, V407, P161, DOI 10.1042/BJ20070612; Grimme A., 1902, ZENTRALBL BAKTERIO 1, V32, P161; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Ihrke G, 2004, TRAFFIC, V5, P946, DOI 10.1111/j.1600-0854.2004.00236.x; Jeffries TR, 2001, J CELL SCI, V114, P2617; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; Lemercier G, 2004, J BIOL CHEM, V279, P3420, DOI 10.1074/jbc.M309974200; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Lu S, 2007, PARASITOLOGY, V134, P1639, DOI 10.1017/S0031182007003046; Luo SH, 2005, MOL MICROBIOL, V55, P1034, DOI 10.1111/j.1365-2958.2004.04464.x; Meyer A., 1904, BOT Z, V62, P113; Morgan GW, 2001, J CELL SCI, V114, P2605; Mullin KA, 2001, MOL BIOL CELL, V12, P2364, DOI 10.1091/mbc.12.8.2364; Mullins C, 2001, BIOESSAYS, V23, P333, DOI 10.1002/bies.1048; Nakamura N, 1997, J BIOL CHEM, V272, P11344; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Ohno H, 2006, J BIOCHEM, V139, P943, DOI 10.1093/jb/mvj120; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Ramos IB, 2010, BIOL CELL, V102, P421, DOI 10.1042/BC20100011; Rios E, 2010, J PHYSIOL SCI, V60, P81, DOI 10.1007/s12576-009-0069-z; Rodrigues CO, 1999, MOL CELL BIOL, V19, P7712; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Scott DA, 1997, J BIOL CHEM, V272, P28020, DOI 10.1074/jbc.272.44.28020; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Seufferheld M, 2004, J BIOL CHEM, V279, P51193, DOI 10.1074/jbc.M406099200; Seufferheld M, 2003, J BIOL CHEM, V278, P29971, DOI 10.1074/jbc.M304548200; SHATTON JB, 1983, ANAL BIOCHEM, V130, P114, DOI 10.1016/0003-2697(83)90657-7; Tazeh NN, 2009, EUKARYOT CELL, V8, P1352, DOI 10.1128/EC.00156-09; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Vannier-Santos MA, 1999, MICROBIOL-UK, V145, P3213, DOI 10.1099/00221287-145-11-3213; VERCESI AE, 1994, BIOCHEM J, V304, P227, DOI 10.1042/bj3040227; Vowels JJ, 1998, EMBO J, V17, P2482, DOI 10.1093/emboj/17.9.2482; WIAME JM, 1947, BIOCHIM BIOPHYS ACTA, V1, P234, DOI 10.1016/0006-3002(47)90137-6; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Yang W, 2000, J CELL SCI, V113, P4077; Zhang K, 2005, MOL MICROBIOL, V55, P1566, DOI 10.1111/j.1365-2958.2005.04493.x	70	37	37	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36619	36630		10.1074/jbc.M111.284661	http://dx.doi.org/10.1074/jbc.M111.284661			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880705	hybrid, Green Published			2022-12-27	WOS:000296538300045
J	Huang, HQ; Huang, SF; Yu, YC; Yuan, SC; Li, R; Wang, X; Zhao, HC; Yu, YH; Li, J; Yang, MY; Xu, LQ; Chen, SW; Xu, AL				Huang, Huiqing; Huang, Shengfeng; Yu, Yingcai; Yuan, Shaochun; Li, Rui; Wang, Xin; Zhao, Hongchen; Yu, Yanhong; Li, Jun; Yang, Manyi; Xu, Liqun; Chen, Shangwu; Xu, Anlong			Functional Characterization of a Ficolin-mediated Complement Pathway in Amphioxus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE-BINDING LECTIN; IMMUNE GENE REPERTOIRE; BRANCHIOSTOMA-BELCHERI; FIBRINOGEN-LIKE; PROTEIN; ORIGIN; SYSTEM; INSIGHTS; CLONING; C1Q	The ficolin-mediated complement pathway plays an important role in vertebrate immunity, but it is not clear whether this pathway exists in invertebrates. Here we identified homologs of ficolin pathway components from the cephalochordate amphioxus and investigated whether they had been co-opted into a functional ficolin pathway. Four of these homologs, ficolin FCN1, serine protease MASP1 and MASP3, and complement component C3, were highly expressed in mucosal tissues and gonads, and were significantly up-regulated following bacterial infection. Recombinant FCN1 could induce hemagglutination, discriminate among sugar components, and specifically recognize and aggregate several bacteria (especially Gram-positive strains) without showing bactericidal activity. This suggested that FCN1 is a dedicated pattern-recognition receptor. Recombinant serine protease MASP1/3 formed complexes with recombinant FCN1 and facilitated the activation of native C3 protein in amphioxus humoral fluid, in which C3 acted as an immune effector. We conclude that amphioxus have developed a functional ficolin-complement pathway. Because ficolin pathway components have not been reported in non-chordate species, our findings supported the idea that this pathway may represent a chordate-specific innovation in the evolution of the complement system.	[Huang, Huiqing; Huang, Shengfeng; Yu, Yingcai; Yuan, Shaochun; Li, Rui; Wang, Xin; Zhao, Hongchen; Li, Jun; Yang, Manyi; Xu, Liqun; Chen, Shangwu; Xu, Anlong] Sun Yat Sen Univ, Coll Life Sci, State Key Lab Biocontrol, Dept Biochem,Natl Engn Res Ctr S China Sea Marine, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Yanhong] Jinan Univ, Inst Reprod Immunol, Guangzhou 510632, Guangdong, Peoples R China	Sun Yat Sen University; Jinan University	Xu, AL (corresponding author), Sun Yat Sen Univ, Coll Life Sci, State Key Lab Biocontrol, Dept Biochem,Natl Engn Res Ctr S China Sea Marine, Guangzhou 510275, Guangdong, Peoples R China.	lssxal@mail.sysu.edu.cn	Yuan, Shaochun/GQB-5134-2022	Yu, Yanhong/0000-0002-1652-201X; Huang, Shengfeng/0000-0002-0968-1370	National Basic Research Program (973) [2007CB815800, 2011CB946101]; State High-Tech Development Project (863) [2008AA092603]; Ministry of Science and Technology of China [2007DFA30840]; Ministry of Education [0107]; National Natural Science Foundation of China [30901103, 30730089]; Commission of Science and Technology of Guangdong Province and Guangzhou City; Sun Yet-sen University Science Foundation	National Basic Research Program (973)(National Basic Research Program of China); State High-Tech Development Project (863)(National High Technology Research and Development Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Commission of Science and Technology of Guangdong Province and Guangzhou City; Sun Yet-sen University Science Foundation	This work was supported by Projects 2007CB815800 and 2011CB946101 of the National Basic Research Program (973), Project 2008AA092603 of the State High-Tech Development Project (863), and 2007DFA30840 (International S&T Cooperation Program) from the Ministry of Science and Technology of China; Key Project (0107) from the Ministry of Education; Key Project (30901103) and Project (30730089) from the National Natural Science Foundation of China; and projects from the Commission of Science and Technology of Guangdong Province and Guangzhou City and from Sun Yet-sen University Science Foundation.	Aoyagi Y, 2005, J IMMUNOL, V174, P418, DOI 10.4049/jimmunol.174.1.418; Arlaud GJ, 2002, BIOCHEM SOC T, V30, P1001, DOI 10.1042/bst0301001; Cruyssen BV, 2007, RHEUMATOLOGY, V46, P1792, DOI 10.1093/rheumatology/kem266; Cseh S, 2002, J IMMUNOL, V169, P5735, DOI 10.4049/jimmunol.169.10.5735; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; Endo Y, 2003, J IMMUNOL, V170, P4701, DOI 10.4049/jimmunol.170.9.4701; Epstein J, 1996, CURR OPIN IMMUNOL, V8, P29, DOI 10.1016/S0952-7915(96)80101-4; Fan CX, 2008, MOL IMMUNOL, V45, P3338, DOI 10.1016/j.molimm.2008.04.019; Fan CX, 2007, INT J BIOCHEM CELL B, V39, P450, DOI 10.1016/j.biocel.2006.09.013; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Huang SF, 2011, J IMMUNOL, V186, P2042, DOI 10.4049/jimmunol.1001824; ICHIJO H, 1993, J BIOL CHEM, V268, P14505; ICHIJO H, 1991, J BIOL CHEM, V266, P22459; Kadirvelraj R, 2006, P NATL ACAD SCI USA, V103, P8149, DOI 10.1073/pnas.0602815103; Kenjo A, 2001, J BIOL CHEM, V276, P19959, DOI 10.1074/jbc.M011723200; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kohl J, 2006, ADV EXP MED BIOL, V586, P71; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Liang YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004234; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Lu JH, 1998, IMMUNOBIOLOGY, V199, P190, DOI 10.1016/S0171-2985(98)80026-0; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; Matsushita M, 2004, P NATL ACAD SCI USA, V101, P10127, DOI 10.1073/pnas.0402180101; Matsushita M, 2002, J IMMUNOL, V168, P3502, DOI 10.4049/jimmunol.168.7.3502; Messias-Reason IJ, 2009, CLIN EXP IMMUNOL, V157, P395, DOI 10.1111/j.1365-2249.2009.03975.x; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Schlapbach LJ, 2009, CLIN EXP IMMUNOL, V157, P83, DOI 10.1111/j.1365-2249.2009.03957.x; Sekine H, 2001, J IMMUNOL, V167, P4504, DOI 10.4049/jimmunol.167.8.4504; Smith LC, 1998, J IMMUNOL, V161, P6784; Sunyer JO, 1998, IMMUNOL REV, V166, P39, DOI 10.1111/j.1600-065X.1998.tb01251.x; Takahashi M, 2006, J IMMUNOL, V176, P4861, DOI 10.4049/jimmunol.176.8.4861; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yu YH, 2008, J IMMUNOL, V181, P7024, DOI 10.4049/jimmunol.181.10.7024; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zhang SC, 2003, ZOOL SCI, V20, P1207, DOI 10.2108/zsj.20.1207; Zhang XL, 2008, ADV EXP MED BIOL, V632, P105, DOI 10.1007/978-0-387-78952-1_9; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	51	28	34	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36739	36748		10.1074/jbc.M111.245944	http://dx.doi.org/10.1074/jbc.M111.245944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21832079	Green Published, hybrid			2022-12-27	WOS:000296538300056
J	Joshi, A; Nyakeriga, AM; Ravi, R; Garg, H				Joshi, Anjali; Nyakeriga, Alice M.; Ravi, Revathi; Garg, Himanshu			HIV ENV Glycoprotein-mediated Bystander Apoptosis Depends on Expression of the CCR5 Co-receptor at the Cell Surface and ENV Fusogenic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4 T-CELLS; HUMAN LYMPHOID-TISSUE; AIDS-LIKE DISEASE; SCID-HU MICE; TYPE-1 INFECTION; CHEMOKINE RECEPTORS; CLINICAL-COURSE; IN-VITRO; PROMOTER POLYMORPHISM	HIV-1 infections lead to a progressive depletion of CD4 cells culminating in AIDS. The coreceptor usage by HIV varies from CCR5(R5) tropic early in infection to CXCR4(X4) tropic in later infections. Although the coreceptor switch from R5 to X4 tropic HIV is well associated with progression to AIDS, the role of CCR5 in disease progression especially in patients infected exclusively with R5 isolates throughout the disease remains enigmatic. To better understand the role of CCR5 and R5 tropic HIV envelope in AIDS pathogenesis, we asked whether the levels of CCR5 and/or HIV Env-mediated fusion determine apoptosis of bystander cells. We generated CD4(+) T cell lines expressing varying levels of CCR5 on the cell surface to show that CCR5 expression levels correlate with bystander apoptosis induction. The mechanism of apoptosis involved caspase-3 activation and mitochondrial depolarization and was dependent on gp41 fusion activity as confirmed by fusion-restricted gp41 point mutants and use of the fusion inhibitor T20. Interestingly, lower levels of CCR5 were able to support virus replication in the absence of bystander apoptosis. Our findings suggest that R5 HIV-1-mediated bystander apoptosis is dependent on both CCR5 expression levels as well as fusogenic activity of the Env glycoprotein.	[Joshi, Anjali; Garg, Himanshu] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Ctr Excellence Infect Dis, El Paso, TX 79905 USA; [Joshi, Anjali; Garg, Himanshu] Texas Tech Univ, Hlth Sci Ctr, Dept Pediat, El Paso, TX 79905 USA; [Ravi, Revathi] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Garg, H (corresponding author), 5001 El Paso Dr,MSB-1 Annex, El Paso, TX 79905 USA.	himanshu.garg@ttuhsc.edu			Texas Tech University Health Sciences Center	Texas Tech University Health Sciences Center	This work was supported in part by a Seed Grant from Texas Tech University Health Sciences Center (to H.G.).	Ahr Barbara, 2004, Retrovirology, V1, P12, DOI 10.1186/1742-4690-1-12; Albright AV, 1999, J VIROL, V73, P205, DOI 10.1128/JVI.73.1.205-213.1999; Bazan HA, 1998, J VIROL, V72, P4485, DOI 10.1128/JVI.72.5.4485-4491.1998; Blanco J, 1999, AIDS, V13, P909, DOI 10.1097/00002030-199905280-00006; Blanco J, 2003, VIROLOGY, V305, P318, DOI 10.1006/viro.2002.1764; Blanco J, 2004, J LEUKOCYTE BIOL, V76, P804, DOI 10.1189/jlb.0204100; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Camerini D, 2000, J VIROL, V74, P3196, DOI 10.1128/JVI.74.7.3196-3204.2000; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Edo-Matas D, 2011, VIROLOGY, V412, P269, DOI 10.1016/j.virol.2011.01.010; Espert L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005787; Etemad-Moghadam B, 2001, J VIROL, V75, P5646, DOI 10.1128/JVI.75.12.5646-5655.2001; FREED EO, 1992, P NATL ACAD SCI USA, V89, P70, DOI 10.1073/pnas.89.1.70; Gallo SA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-90; Garg H, 2008, CELL MOL LIFE SCI, V65, P3134, DOI 10.1007/s00018-008-8147-6; Garg H, 2007, J BIOL CHEM, V282, P16899, DOI 10.1074/jbc.M701701200; Garg H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-34; Garg H, 2009, AIDS RES HUM RETROV, V25, P811, DOI 10.1089/aid.2009.0010; Garg H, 2006, J LEUKOCYTE BIOL, V79, P351, DOI 10.1189/jlb.0805430; GOUGEON ML, 1993, SCIENCE, V260, P1269, DOI 10.1126/science.8098552; Holm GH, 2004, J VIROL, V78, P4541, DOI 10.1128/JVI.78.9.4541-4551.2004; Hunt PW, 2008, CURR OPIN HIV AIDS, V3, P342, DOI 10.1097/COH.0b013e3282fbaa92; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Jekle A, 2003, J VIROL, V77, P5846, DOI 10.1128/JVI.77.10.5846-5854.2003; Jian H, 2003, J BIOL CHEM, V278, P44326, DOI 10.1074/jbc.C300378200; Joshi A, 2006, J VIROL, V80, P7939, DOI 10.1128/JVI.00355-06; Karlsson GB, 1998, J EXP MED, V188, P1159, DOI 10.1084/jem.188.6.1159; Karlsson I, 2005, J VIROL, V79, P11151, DOI 10.1128/JVI.79.17.11151-11160.2005; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kitchen SG, 1999, AIDS RES HUM RETROV, V15, P143, DOI 10.1089/088922299311565; Koot M, 1996, J INFECT DIS, V173, P349, DOI 10.1093/infdis/173.2.349; Kwa D, 2003, AIDS, V17, P759, DOI 10.1097/00002030-200303280-00017; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Michael NL, 1997, NAT MED, V3, P338, DOI 10.1038/nm0397-338; Muthumani K, 2003, BIOCHEM BIOPH RES CO, V304, P583, DOI 10.1016/S0006-291X(03)00631-4; Olivieri K, 2007, VIROLOGY, V358, P23, DOI 10.1016/j.virol.2006.08.027; Ostrowski MA, 1998, J IMMUNOL, V161, P3195; Pastore C, 2004, J VIROL, V78, P7565, DOI 10.1128/JVI.78.14.7565-7574.2004; Penn ML, 1999, P NATL ACAD SCI USA, V96, P663, DOI 10.1073/pnas.96.2.663; Perfettini JL, 2005, CELL DEATH DIFFER, V12, P916, DOI 10.1038/sj.cdd.4401584; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Priceputu E, 2005, J VIROL, V79, P6377, DOI 10.1128/JVI.79.10.6377-6391.2005; PURVIS SF, 1995, AIDS RES HUM RETROV, V11, P443, DOI 10.1089/aid.1995.11.443; Reiche EMV, 2007, CURR MED CHEM, V14, P1325; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Reynes J, 2000, J INFECT DIS, V181, P927, DOI 10.1086/315315; Rucker J, 1997, J VIROL, V71, P8999, DOI 10.1128/JVI.71.12.8999-9007.1997; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salkowitz JR, 2003, CLIN IMMUNOL, V108, P234, DOI 10.1016/S1521-6616(03)00147-5; Scheller C, 2001, VIROLOGY, V282, P48, DOI 10.1006/viro.2000.0811; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Schuitemaker H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S5; Scoggins RM, 2000, J VIROL, V74, P3205, DOI 10.1128/JVI.74.7.3205-3216.2000; Shieh B, 2000, INT IMMUNOL, V12, P1311, DOI 10.1093/intimm/12.9.1311; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034; Spijkerman I, 1998, J INFECT DIS, V178, P397, DOI 10.1086/515627; van Rij RP, 2003, VIROLOGY, V314, P451, DOI 10.1016/S0042-6822(03)00454-9; van't Wout AB, 1998, J VIROL, V72, P5099; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Zauli G, 1999, BLOOD, V93, P1000, DOI 10.1182/blood.V93.3.1000.403a12_1000_1010	69	23	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36404	36413		10.1074/jbc.M111.281659	http://dx.doi.org/10.1074/jbc.M111.281659			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21859712	Green Published, hybrid			2022-12-27	WOS:000296538300026
J	Wurie, HR; Buckett, L; Zammit, VA				Wurie, Haja R.; Buckett, Linda; Zammit, Victor A.			Evidence That Diacylglycerol Acyltransferase 1 (DGAT1) Has Dual Membrane Topology in the Endoplasmic Reticulum of HepG2 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR ACCESSORY PROTEIN; RAT-LIVER MICROSOMES; TRIACYLGLYCEROL SYNTHESIS; CARNITINE ACYLTRANSFERASES; INSULIN-RESISTANCE; APOLIPOPROTEIN-B; ACYL-COA; SECRETION; OVERT; IDENTIFICATION	Triacylglycerol (TAG) synthesis and secretion are important functions of the liver that have major impacts on health, as over-accumulation of TAG within the liver (steatosis) or hypersecretion of TAG within very low density lipoproteins (VLDL) both have deleterious metabolic consequences. Two diacylglycerol acyltransferases (DGATs 1 and 2) can catalyze the final step in the synthesis of TAG from diacylglycerol, which has been suggested to play an important role in the transfer of the glyceride moiety across the endoplasmic reticular membrane for (re)synthesis of TAG on the lumenal aspect of the endoplasmic reticular (ER) membrane (Owen, M., Corstorphine, C. C., and Zammit, V. A. (1997) Biochem. J. 323, 17-21). Recent topographical studies suggested that the oligomeric enzyme DGAT1 is exclusively lumen facing (latent) in the ER membrane. By contrast, in the present study, using two specific inhibitors of human DGAT1, we present evidence that DGAT1 has a dual topology within the ER of HepG2 cells, with approximately equal DGAT1 activities exposed on the cytosolic and lumenal aspects of the ER membrane. This was confirmed by the observation of the loss of both overt (partial) and latent (total) DGAT activity in microsomes prepared from livers of Dgat1(-/-) mice. Conformational differences between DGAT1 molecules having the different topologies were indicated by the markedly disparate sensitivities of the overt DGAT1 to one of the inhibitors. These data suggest that DGAT1 belongs to the family of oligomeric membrane proteins that adopt a dual membrane topology.	[Wurie, Haja R.; Zammit, Victor A.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Buckett, Linda] Astra Zeneca Pharmaceut, Macclesfield SK10 4TF, Cheshire, England	University of Warwick; AstraZeneca	Zammit, VA (corresponding author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	v.a.zammit@warwick.ac.uk		Wurie, Haja Ramatulai/0000-0002-2500-3393	UK Biotechnology and Biological Sciences Research Council-Collaborative Award in Science and Engineering; Astra Zeneca Ltd.	UK Biotechnology and Biological Sciences Research Council-Collaborative Award in Science and Engineering; Astra Zeneca Ltd.(AstraZeneca)	Supported by a UK Biotechnology and Biological Sciences Research Council-Collaborative Award in Science and Engineering studentship in association with Astra Zeneca Ltd.	Abo-Hashema KAH, 1999, J BIOL CHEM, V274, P35577, DOI 10.1074/jbc.274.50.35577; ADELI K, 1994, J BIOL CHEM, V269, P9166; BELL RM, 1981, J LIPID RES, V22, P391; BOON MR, 1988, BIOCHEM J, V249, P645, DOI 10.1042/bj2490645; Broadway NM, 1999, ADV EXP MED BIOL, V466, P59; BROADWAY NM, 1995, BIOCHEM J, V310, P989, DOI 10.1042/bj3100989; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Gotto Jr. A. M., 1998, Am J Cardiol, V82, p22Q; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Hinkle PM, 2009, MOL CELL ENDOCRINOL, V300, P25, DOI 10.1016/j.mce.2008.10.041; Kolbusz MA, 2010, J MOL BIOL, V402, P127, DOI 10.1016/j.jmb.2010.07.019; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lankester DL, 1998, J LIPID RES, V39, P1889; Levy D, 1996, Essays Biochem, V31, P49; Lolkema JS, 2008, J MOL BIOL, V378, P596, DOI 10.1016/j.jmb.2008.03.005; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Olofsson SO, 1999, CURR OPIN LIPIDOL, V10, P341, DOI 10.1097/00041433-199908000-00008; Owen Mark, 1997, Biochemical Society Transactions, V25, p21S; Owen MR, 1997, BIOCHEM J, V323, P17, DOI 10.1042/bj3230017; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Sebag JA, 2009, J BIOL CHEM, V284, P610, DOI 10.1074/jbc.M804413200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Waterman IJ, 2002, DIABETES, V51, P1708, DOI 10.2337/diabetes.51.6.1708; Waterman IJ, 2002, J LIPID RES, V43, P1555, DOI 10.1194/jlr.M200051-JLR200; Yamazaki T, 2005, J BIOL CHEM, V280, P21506, DOI 10.1074/jbc.M412989200; YANG LY, 1995, J LIPID RES, V36, P125; Zammit VA, 2001, J NUTR, V131, P2074, DOI 10.1093/jn/131.8.2074; Zammit VA, 2008, PHARMACOL THERAPEUT, V118, P295, DOI 10.1016/j.pharmthera.2008.03.010	33	50	50	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36238	36247		10.1074/jbc.M111.251900	http://dx.doi.org/10.1074/jbc.M111.251900			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21846726	Green Published, hybrid			2022-12-27	WOS:000296538300008
J	Bae, B; Cobb, RE; DeSieno, MA; Zhao, HM; Nair, SK				Bae, Brian; Cobb, Ryan E.; DeSieno, Matthew A.; Zhao, Huimin; Nair, Satish K.			New N-Acetyltransferase Fold in the Structure and Mechanism of the Phosphonate Biosynthetic Enzyme FrbF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE; VIVO ANTIMALARIAL ACTIVITY; MACROMOLECULAR STRUCTURES; NONMEVALONATE PATHWAY; MAXIMUM-LIKELIHOOD; ESTER PRODRUGS; FOSMIDOMYCIN; FR900098; REFINEMENT; MALARIA	The enzyme FrbF from Streptomyces rubellomurinus has attracted significant attention due to its role in the biosynthesis of the antimalarial phosphonate FR-900098. The enzyme catalyzes acetyl transfer onto the hydroxamate of the FR-900098 precursors cytidine 5'-monophosphate-3-aminopropylphosphonate and cytidine 5'-monophosphate-N-hydroxy-3-aminopropylphosphonate. Despite the established function as a bona fide N-acetyltransferase, FrbF shows no sequence similarity to any member of the GCN5-like N-acetyltransferase (GNAT) superfamily. Here, we present the 2.0 angstrom resolution crystal structure of FrbF in complex with acetyl-CoA, which demonstrates a unique architecture that is distinct from those of canonical GNAT-like acetyltransferases. We also utilized the co-crystal structure to guide structure-function studies that identified the roles of putative active site residues in the acetyltransferase mechanism. The combined biochemical and structural analyses of FrbF provide insights into this previously uncharacterized family of N-acetyltransferases and also provide a molecular framework toward the production of novel N-acyl derivatives of FR-900098.	[Bae, Brian; Zhao, Huimin; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Cobb, Ryan E.; DeSieno, Matthew A.; Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Cobb, Ryan E.; DeSieno, Matthew A.; Zhao, Huimin; Nair, Satish K.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Zhao, HM (corresponding author), Univ Illinois, Dept Biochem, 600 S Mathews Ave, Urbana, IL 61801 USA.	zhao5@illinois.edu; snair@illinois.edu	Nair, Satish/AAY-2510-2021		National Institutes of Health [P01 GM077596]; NIGMS, National Institutes of Health [5 T32 GM070421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421, P01GM077596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant P01 GM077596 (to H. Z. and S. K. N.) and National Institutes of Health Ruth L. Kirschstein National Research Award 5 T32 GM070421 from NIGMS (to R. E. C. and M. A. D.).	Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Burrows JN, 2011, CURR TOP MED CHEM, V11, P1226; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Eliot AC, 2008, CHEM BIOL, V15, P765, DOI 10.1016/j.chembiol.2008.07.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Griffith KS, 2007, JAMA-J AM MED ASSOC, V297, P2264, DOI 10.1001/jama.297.20.2264; Hastings I, 2011, TRENDS PARASITOL, V27, P67, DOI 10.1016/j.pt.2010.09.005; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Johannes TW, 2010, CHEM BIOL, V17, P57, DOI 10.1016/j.chembiol.2009.12.009; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Kurz T, 2006, BIOORGAN MED CHEM, V14, P5121, DOI 10.1016/j.bmc.2006.04.018; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P7913, DOI 10.1016/S0040-4039(98)01755-9; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OKUHARA M, 1980, J ANTIBIOT, V33, P13, DOI 10.7164/antibiotics.33.13; Ortmann R, 2005, ARCH PHARM, V338, P305, DOI 10.1002/ardp.200500976; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Proteau PJ, 2004, BIOORG CHEM, V32, P483, DOI 10.1016/j.bioorg.2004.08.004; Reichenberg A, 2001, BIOORG MED CHEM LETT, V11, P833, DOI 10.1016/S0960-894X(01)00075-0; Schluter K, 2006, EUR J MED CHEM, V41, P1385, DOI 10.1016/j.ejmech.2006.06.015; Sim E, 2008, CURR DRUG METAB, V9, P510, DOI 10.2174/138920008784892100; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wiesner J, 2003, PARASITOL RES, V90, pS71, DOI 10.1007/s00436-002-0770-9; Wiesner J, 2002, ANTIMICROB AGENTS CH, V46, P2889, DOI 10.1128/AAC.46.9.2889-2894.2002; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	34	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36132	36141		10.1074/jbc.M111.263533	http://dx.doi.org/10.1074/jbc.M111.263533			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865168	Green Published, hybrid			2022-12-27	WOS:000295927100085
J	Gizard, F; Zhao, Y; Findeisen, HM; Qing, H; Cohn, D; Heywood, EB; Jones, KL; Nomiyama, T; Bruemmer, D				Gizard, Florence; Zhao, Yue; Findeisen, Hannes M.; Qing, Hua; Cohn, Dianne; Heywood, Elizabeth B.; Jones, Karrie L.; Nomiyama, Takashi; Bruemmer, Dennis			Transcriptional Regulation of S Phase Kinase-associated Protein 2 by NR4A Orphan Nuclear Receptor NOR1 in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEOINTIMA FORMATION; PROLIFERATION; ATHEROSCLEROSIS; P27(KIP1); SKP2; DEGRADATION; PROGRESSION; INHIBITORS; CYCLE; DEFICIENCY	Members of the NR4A subgroup of the nuclear hormone receptor superfamily have emerged as key transcriptional regulators of proliferation and inflammation. NOR1 constitutes a ligand-independent transcription factor of this subgroup and induces cell proliferation; however, the transcriptional mechanisms underlying this mitogenic role remain to be defined. Here, we demonstrate that the F-box protein SKP2 (S phase kinase-associated protein 2), the substrate-specific receptor of the ubiquitin ligase responsible for the degradation of p27(KIP1) through the proteasome pathway, constitutes a direct transcriptional target for NOR1. Mitogen-induced Skp2 expression is silenced in vascular smooth muscle cells (VSMC) isolated from Nor1-deficient mice or transfected with Nor1 siRNA. Conversely, adenovirus-mediated overexpression of NOR1 induces Skp2 expression in VSMC and decreases protein abundance of its target p27. Transient transfection experiments establish that NOR1 transactivates the Skp2 promoter through a nerve growth factor-induced clone B response element (NBRE). Electrophoretic mobility shift and chromatin immunoprecipitation assays further revealed that NOR1 is recruited to this NBRE site in the Skp2 promoter in response to mitogenic stimulation. In vivo Skp2 expression is increased during the proliferative response underlying neointima formation, and this transcriptional induction depends on the expression of NOR1. Finally, we demonstrate that overexpression of Skp2 rescues the proliferative arrest of Nor1-deficient VSMC. Collectively, these results characterize Skp2 as a novel NOR1-regulated target gene and detail a previously unrecognized transcriptional cascade regulating mitogen-induced VSMC proliferation.	[Gizard, Florence; Zhao, Yue; Findeisen, Hannes M.; Qing, Hua; Cohn, Dianne; Heywood, Elizabeth B.; Jones, Karrie L.; Bruemmer, Dennis] Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Zhao, Yue; Bruemmer, Dennis] Univ Kentucky, Coll Med, Grad Ctr Nutr Sci, Lexington, KY 40536 USA; [Nomiyama, Takashi] Fukuoka Univ, Sch Med, Dept Endocrinol & Diabet Mellitus, Fukuoka 8140180, Japan	University of Kentucky; University of Kentucky; Fukuoka University	Bruemmer, D (corresponding author), Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Wethington Hlth Sci Bldg,Room 575,900 S Limestone, Lexington, KY 40536 USA.	Dennis.Bruemmer@uky.edu			National Institutes of Health [R01HL084611]; American Recovery and Reinvestment Act [R01HL084611-04S1]; American Heart Association [0815514D]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL084611 and the American Recovery and Reinvestment Act of 2009 Grant R01HL084611-04S1 (to D. B.).; Supported by Fellowship Grant 0815514D from the American Heart Association.	Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; Bond M, 2004, J BIOL CHEM, V279, P37304, DOI 10.1074/jbc.M404307200; Bonta PI, 2007, TRENDS CARDIOVAS MED, V17, P105, DOI 10.1016/j.tcm.2007.02.001; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Diez-Juan A, 2004, BLOOD, V103, P158, DOI 10.1182/blood-2003-07-2319; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Gallo R, 1999, CIRCULATION, V99, P2164, DOI 10.1161/01.CIR.99.16.2164; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Imaki H, 2003, CANCER RES, V63, P4607; Laufs U, 1999, J BIOL CHEM, V274, P21926, DOI 10.1074/jbc.274.31.21926; Majesky Mark W, 2003, Curr Atheroscler Rep, V5, P208, DOI 10.1007/s11883-003-0026-x; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Martinez-Gonzalez J, 2003, CIRC RES, V92, P96, DOI 10.1161/01.ES.0000050921.53008.47; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nomiyama T, 2006, J BIOL CHEM, V281, P33467, DOI 10.1074/jbc.M603436200; Nomiyama T, 2009, CIRCULATION, V119, P577, DOI 10.1161/CIRCULATIONAHA.108.822056; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tanner FC, 2000, CIRCULATION, V101, P2022, DOI 10.1161/01.CIR.101.17.2022; Wakino S, 2000, J BIOL CHEM, V275, P22435, DOI 10.1074/jbc.M910452199; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Wu YJ, 2006, CIRC RES, V98, P1141, DOI 10.1161/01.RES.0000219905.16312.28; Wu YJ, 2009, J VASC SURG, V50, P1135, DOI 10.1016/j.jvs.2009.07.066; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286; Zhao Y, 2010, CIRC RES, V107, P501, DOI 10.1161/CIRCRESAHA.110.222083; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	31	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35485	35493		10.1074/jbc.M111.295840	http://dx.doi.org/10.1074/jbc.M111.295840			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21868379	Green Published, hybrid			2022-12-27	WOS:000295927100020
J	Ilias, A; Liliom, K; Greiderer-Kleinlercher, B; Reitinger, S; Lepperdinger, G				Ilias, Attila; Liliom, Karoly; Greiderer-Kleinlercher, Brigitte; Reitinger, Stephan; Lepperdinger, Guenter			Unbinding of Hyaluronan Accelerates the Enzymatic Activity of Bee Hyaluronidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE TESTICULAR HYALURONIDASE; BINDING DOMAIN; LINK MODULE; PROTEIN; EXPRESSION; ACID; RECEPTOR; SURFACE; GROWTH; VENOM	Hyaluronan (HA), a polymeric glycosaminoglycan ubiquitously present in higher animals, is hydrolyzed by hyaluronidases (HAases). Here, we used bee HAase as a model enzyme to study the HA-HAase interaction. Located in close proximity to the active center, a bulky surface loop, which appears to obstruct one end of the substrate binding groove, was found to be functionally involved in HA turnover. To better understand kinetic changes in substrate interaction, binding of high molecular weight HA to catalytically inactive HAase was monitored by means of quartz crystal microbalance technology. Replacement of the delimiting loop by a tetrapeptide interconnection increased the affinity for HA up to 100-fold, with a K-D below 1 nM being the highest affinity among HA-binding proteins surveyed so far. The experimental data of HA-HAase interaction were further validated showing best fit to the theoretically proposed sequential two-site model. Besides the one, which had been shown previously in course of x-ray structure determination, a previously unrecognized binding site works in conjunction with an unbinding loop that facilitates liberation of hydrolyzed HA.	[Ilias, Attila; Greiderer-Kleinlercher, Brigitte; Reitinger, Stephan; Lepperdinger, Guenter] Austrian Acad Sci, Inst Biomed Aging Res, A-6020 Innsbruck, Austria; [Liliom, Karoly] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, H-1518 Budapest, Hungary	Austrian Academy of Sciences; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Lepperdinger, G (corresponding author), Austrian Acad Sci, Inst Biomed Aging Res, Rennweg 10, A-6020 Innsbruck, Austria.	guenter.lepperdinger@oeaw.ac.at	Liliom, Karoly/A-6563-2011; Iliás, Attila/I-7072-2017	Liliom, Karoly/0000-0002-7177-6872; Iliás, Attila/0000-0003-3196-0795; Lepperdinger, Gunter/0000-0002-4265-4489	Marie-Curie International Reintegration; Austrian Research Agency; Tyrolean Future Fund; European Commission	Marie-Curie International Reintegration(European Commission); Austrian Research Agency; Tyrolean Future Fund; European Commission(European CommissionEuropean Commission Joint Research Centre)	Recipient of a Marie-Curie International Reintegration grant.; Supported by research funds from by the Austrian Research Agency, the Tyrolean Future Fund, and the European Commission 7th framework program. To whom correspondence should be addressed: Extracellular Matrix Research, Institute for Biomedical Aging Research, Austrian Academy of Sciences, Rennweg 10, Innsbruck A-6020, Austria. Tel.: 43-512-583919-40; Fax: 43-512-583919-8; E-mail: guenter.lepperdinger@oeaw.ac.at.	Arming S, 1997, EUR J BIOCHEM, V247, P810, DOI 10.1111/j.1432-1033.1997.t01-1-00810.x; BANERJI S, 2005, STRUCTURE CD44 HYALU, V2, P625; Banerji S, 2010, J BIOL CHEM, V285, P10724, DOI 10.1074/jbc.M109.047647; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BRUCKENSTEIN S, 1985, ELECTROCHIM ACTA, V30, P1295, DOI 10.1016/0013-4686(85)85005-2; Chao KL, 2007, BIOCHEMISTRY-US, V46, P6911, DOI 10.1021/bi700382g; CRAMER JA, 1994, BBA-GEN SUBJECTS, V1200, P315, DOI 10.1016/0304-4165(94)90173-2; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; De Crescenzo G, 2000, BIOCHEMISTRY-US, V39, P9466, DOI 10.1021/bi992987r; DELMAGE JM, 1986, ANN CLIN LAB SCI, V16, P303; Deschrevel B, 2008, MATRIX BIOL, V27, P475, DOI 10.1016/j.matbio.2008.01.007; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; GMACHL M, 1993, P NATL ACAD SCI USA, V90, P3569, DOI 10.1073/pnas.90.8.3569; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Harris EN, 2010, GLYCOBIOLOGY, V20, P991, DOI 10.1093/glycob/cwq057; Hascall V, 2009, ESSENTIALS GLYCOBIOL, P219; Hess R, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000194; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jumel K, 2002, CARBOHYD POLYM, V48, P241, DOI 10.1016/S0144-8617(01)00242-9; Kahmann JD, 2000, STRUCTURE, V8, P763, DOI 10.1016/S0969-2126(00)00163-5; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; MARKOVICHOUSLEY Z, 2002, STRUCTURAL EVIDENCE, P19; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; OGSTON AG, 1966, J BIOL CHEM, V241, P17; Rees SG, 2002, BIOCHEM BIOPH RES CO, V292, P727, DOI 10.1006/bbrc.2002.6699; REISSIG JL, 1955, J BIOL CHEM, V217, P959; Reitinger S, 2008, PROTEIN EXPRES PURIF, V57, P226, DOI 10.1016/j.pep.2007.10.001; Reitinger S, 2009, J BIOL CHEM, V284, P19173, DOI 10.1074/jbc.C109.004358; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; SHAW M, 1977, BIOPHYS J, V17, P47, DOI 10.1016/S0006-3495(77)85626-9; Shen BJ, 2003, J PHARMACEUT BIOMED, V31, P83, DOI 10.1016/S0731-7085(02)00606-4; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; Skov LK, 2006, ACTA CRYSTALLOGR D, V62, P595, DOI 10.1107/S0907444906010687; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; Vincent J.-C., 2003, Journal of Biological Physics and Chemistry, V3, P35; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Watanabe H, 1997, J BIOL CHEM, V272, P28057, DOI 10.1074/jbc.272.44.28057; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Xu HP, 2002, J BIOL CHEM, V277, P17308, DOI 10.1074/jbc.M112371200; Zhang L, 2009, J BIOL CHEM, V284, P9433, DOI 10.1074/jbc.M900210200	49	3	3	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35699	35707		10.1074/jbc.M111.263731	http://dx.doi.org/10.1074/jbc.M111.263731			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21840987	hybrid, Green Published			2022-12-27	WOS:000295927100042
J	Jilkova, A; Rezacova, P; Lepsik, M; Horn, M; Vachova, J; Fanfrlik, J; Brynda, J; McKerrow, JH; Caffrey, CR; Mares, M				Jilkova, Adela; Rezacova, Pavlina; Lepsik, Martin; Horn, Martin; Vachova, Jana; Fanfrlik, Jindrich; Brynda, Jiri; McKerrow, James H.; Caffrey, Conor R.; Mares, Michael			Structural Basis for Inhibition of Cathepsin B Drug Target from the Human Blood Fluke, Schistosoma mansoni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE INHIBITORS; RAY CRYSTAL-STRUCTURE; H-BONDING CORRECTION; OCCLUDING LOOP; SUBSTRATE-SPECIFICITY; SELECTIVE INHIBITORS; RNA INTERFERENCE; VINYL SULFONES; POTENT; IDENTIFICATION	Schistosomiasis caused by a parasitic blood fluke of the genus Schistosoma afflicts over 200 million people worldwide. Schistosoma mansoni cathepsin B1 (SmCB1) is a gut-associated peptidase that digests host blood proteins as a source of nutrients. It is under investigation as a drug target. To further this goal, we report three crystal structures of SmCB1 complexed with peptidomimetic inhibitors as follows: the epoxide CA074 at 1.3 angstrom resolution and the vinyl sulfones K11017 and K11777 at 1.8 and 2.5 angstrom resolutions, respectively. Interactions of the inhibitors with the subsites of the active-site cleft were evaluated by quantum chemical calculations. These data and inhibition profiling with a panel of vinyl sulfone derivatives identify key binding interactions and provide insight into the specificity of SmCB1 inhibition. Furthermore, hydrolysis profiling of SmCB1 using synthetic peptides and the natural substrate hemoglobin revealed that carboxydipeptidase activity predominates over endopeptidolysis, thereby demonstrating the contribution of the occluding loop that restricts access to the active-site cleft. Critically, the severity of phenotypes induced in the parasite by vinyl sulfone inhibitors correlated with enzyme inhibition, providing support that SmCB1 is a valuable drug target. The present structure and inhibitor interaction data provide a footing for the rational design of anti-schistosomal inhibitors.	[Jilkova, Adela; Rezacova, Pavlina; Lepsik, Martin; Horn, Martin; Vachova, Jana; Fanfrlik, Jindrich; Brynda, Jiri; Mares, Michael] Acad Sci Czech Republ, Inst Organ Chem & Biochem, CR-16610 Prague, Czech Republic; [Jilkova, Adela] Charles Univ Prague, Dept Biochem, Fac Sci, Prague 12843, Czech Republic; [Rezacova, Pavlina; Brynda, Jiri] Acad Sci Czech Republ, Inst Mol Genet, Dept Biol Struct, Prague 16610, Czech Republic; [McKerrow, James H.; Caffrey, Conor R.] Univ Calif San Francisco, Sandler Ctr Drug Discovery, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [McKerrow, James H.; Caffrey, Conor R.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mares, M (corresponding author), Flemingovo 2, Prague 16610, Czech Republic.	mares@uochb.cas.cz	Lepšík, Martin/X-8603-2019; Rezacova, Pavlina/G-3600-2014; Brynda, Jiri/G-2760-2014; Lepsik, Martin/C-6614-2012; Mares, Michael/B-2413-2009; Jilkova, Adela/G-5809-2014; Horn, Martin/A-8701-2008	Lepšík, Martin/0000-0003-2607-8132; Rezacova, Pavlina/0000-0001-9626-346X; Brynda, Jiri/0000-0003-3675-6769; Lepsik, Martin/0000-0003-2607-8132; Mares, Michael/0000-0002-0847-5022; Jilkova, Adela/0000-0002-3158-9626; Horn, Martin/0000-0001-9110-2018; Fanfrlik, Jindrich/0000-0002-1257-1201	Grant Agency of the Czech Republic [203/09/1585, P208/11/0295]; Academy of Sciences of the Czech Republic; Sandler Center for Drug Discovery; Ministry of Education, Youth and Sports of the Czech Repulic [OC09007]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357];  [Z40550506];  [Z50520514]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Sandler Center for Drug Discovery; Ministry of Education, Youth and Sports of the Czech Repulic; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); ; 	This work was supported, in whole or in part, by Grant 203/09/1585 from the Grant Agency of the Czech Republic, Institutional Research Projects Z40550506 and Z50520514, the Academy of Sciences of the Czech Republic, and by the Sandler Center for Drug Discovery. Additional support was by Grant P208/11/0295 (to M. L. and J. F.) from the Grant Agency of the Czech Republic and by Grant OC09007 (to M. M.) from the Ministry of Education, Youth and Sports of the Czech Repulic. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.	Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Abdulla MH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000478; [Anonymous], 2008, AMBER 10; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASCH PF, 1981, J PARASITOL, V67, P179, DOI 10.2307/3280632; Betts MJ, 1999, PROTEIN ENG, V12, P271, DOI 10.1093/protein/12.4.271; Brady CP, 1999, INFECT IMMUN, V67, P368, DOI 10.1128/IAI.67.1.368-374.1999; Brindley PJ, 1997, MOL BIOCHEM PARASIT, V89, P1, DOI 10.1016/S0166-6851(97)00098-4; Brinen LS, 2000, STRUCT FOLD DES, V8, P831, DOI 10.1016/S0969-2126(00)00173-8; Bromme D, 1996, BIOCHEM J, V315, P85; Caffrey CR, 2007, CURR OPIN CHEM BIOL, V11, P433, DOI 10.1016/j.cbpa.2007.05.031; Caffrey CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004413; Caffrey CR, 1997, PARASITOL RES, V83, P37, DOI 10.1007/s004360050204; Caffrey CR, 2002, MOL BIOCHEM PARASIT, V121, P49, DOI 10.1016/S0166-6851(02)00022-1; Caffrey CR, 2004, TRENDS PARASITOL, V20, P241, DOI 10.1016/j.pt.2004.03.004; Caffrey CR, 1997, PARASITOL RES, V83, P632, DOI 10.1007/s004360050310; Caffrey CR, 2000, FEBS LETT, V466, P244, DOI 10.1016/S0014-5793(99)01798-6; Cezari MHS, 2002, BIOCHEM J, V368, P365, DOI 10.1042/BJ20020840; Chen YT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000825; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Correnti JA, 2005, MOL BIOCHEM PARASIT, V143, P209, DOI 10.1016/j.molbiopara.2005.06.007; DeLano W.L, PYMOL MOL GRAPHICS S; Delcroix M, 2006, J BIOL CHEM, V281, P39316, DOI 10.1074/jbc.M607128200; Dvorak J, 2005, INT J PARASITOL, V35, P895, DOI 10.1016/j.ijpara.2005.02.018; Dvorak J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000449; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Greenspan PD, 2001, J MED CHEM, V44, P4524, DOI 10.1021/jm010206q; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; HASNAIN S, 1993, J BIOL CHEM, V268, P235; Horn M, 2011, ACS CHEM BIOL, V6, P609, DOI 10.1021/cb100411v; Horn M, 2009, CHEM BIOL, V16, P1053, DOI 10.1016/j.chembiol.2009.09.009; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Jaishankar P, 2008, BIOORG MED CHEM LETT, V18, P624, DOI 10.1016/j.bmcl.2007.11.070; JIA ZC, 1995, J BIOL CHEM, V270, P5527, DOI 10.1074/jbc.270.10.5527; Kerr ID, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000701; Kerr ID, 2009, J BIOL CHEM, V284, P25697, DOI 10.1074/jbc.M109.014340; Korth M, 2010, J CHEM THEORY COMPUT, V6, P344, DOI 10.1021/ct900541n; Krissinel E., 2005, DETECTION PROTEIN AS, P163; Krupa JC, 2002, BIOCHEM J, V361, P613, DOI 10.1042/0264-6021:3610613; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lowther J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000369; Masa M, 2006, BIOCHEMISTRY-US, V45, P15474, DOI 10.1021/bi0614986; McCarthy E, 2004, INT J PARASITOL, V34, P703, DOI 10.1016/j.ijpara.2004.01.008; McKerrow JH, 2009, MEM I OSWALDO CRUZ, V104, P263, DOI 10.1590/S0074-02762009000900034; McKerrow JH, 2008, CURR OPIN INFECT DIS, V21, P668, DOI 10.1097/QCO.0b013e328315cca9; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MURATA M, 1991, FEBS LETT, V280, P307, DOI 10.1016/0014-5793(91)80318-W; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; Nagler DK, 1997, BIOCHEMISTRY-US, V36, P12608, DOI 10.1021/bi971264+; Olson JE, 1999, BIOORGAN MED CHEM, V7, P633, DOI 10.1016/S0968-0896(99)00004-8; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; Quraishi O, 1999, BIOCHEMISTRY-US, V38, P5017, DOI 10.1021/bi981950o; Rai G, 2009, J MED CHEM, V52, P6474, DOI 10.1021/jm901021k; Ranjit N, 2008, MOL BIOCHEM PARASIT, V160, P90, DOI 10.1016/j.molbiopara.2008.04.008; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; Rezac J, 2009, J CHEM THEORY COMPUT, V5, P1749, DOI 10.1021/ct9000922; Roush WR, 2001, BIOORG MED CHEM LETT, V11, P2759, DOI 10.1016/S0960-894X(01)00566-2; Roush WR, 1998, J AM CHEM SOC, V120, P10994, DOI 10.1021/ja981792o; Sajid M, 2003, MOL BIOCHEM PARASIT, V131, P65, DOI 10.1016/S0166-6851(03)00194-4; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Scheidt KA, 1998, BIOORGAN MED CHEM, V6, P2477, DOI 10.1016/S0968-0896(98)80022-9; Somoza JR, 2000, BIOCHEMISTRY-US, V39, P12543, DOI 10.1021/bi000951p; Sorgine MHF, 2000, J BIOL CHEM, V275, P28659, DOI 10.1074/jbc.M005675200; Sripa J, 2010, CELL MICROBIOL, V12, P781, DOI 10.1111/j.1462-5822.2010.01433.x; Stefanic S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000850; Steverding D, 2006, MINI-REV MED CHEM, V6, P1025, DOI 10.2174/138955706778195207; TURK D, 1995, BIOCHEMISTRY-US, V34, P4791, DOI 10.1021/bi00014a037; UTZINGER J, 2011, ACTA TROP IN PRESS; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Watanabe D, 2006, J MOL BIOL, V362, P979, DOI 10.1016/j.jmb.2006.07.070; Williamson AL, 2004, J BIOL CHEM, V279, P35950, DOI 10.1074/jbc.M405842200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamamoto A, 2000, J BIOCHEM-TOKYO, V127, P635, DOI 10.1093/oxfordjournals.jbchem.a022651	75	57	57	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35770	35781		10.1074/jbc.M111.271304	http://dx.doi.org/10.1074/jbc.M111.271304			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21832058	Green Published, hybrid			2022-12-27	WOS:000295927100050
J	Qi, XM; Hou, SW; Lepp, A; Li, RS; Basir, Z; Lou, ZK; Chen, G				Qi, Xiaomei; Hou, Songwang; Lepp, Adrienne; Li, Rongshan; Basir, Zainab; Lou, Zhenkun; Chen, Guan			Phosphorylation and Stabilization of Topoisomerase II alpha Protein by p38 gamma Mitogen-activated Protein Kinase Sensitize Breast Cancer Cells to Its Poisons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECATENATION CHECKPOINT; RAS TRANSFORMATION; CYCLE ARREST; MAP KINASES; DNA-DAMAGE; APOPTOSIS; EXPRESSION; PATHWAY; DRUG; CHEMOTHERAPY	Cancer drugs suppress tumor cell growth by inhibiting specific cellular targets. However, most drugs also activate several cellular nonspecific stress pathways, and the implications of these off-target effects are mostly unknown. Here, we report that p38 gamma, but not p38 alpha, MAPK is specifically activated by treatment of breast cancer cells with topoisomerase II (Topo II) drugs, whereas paclitaxel (Taxol) does not have this effect. The activated p38 gamma in turn phosphorylates and stabilizes Topo II alpha protein, and this enhances the growth inhibition by Topo II drugs. Moreover, p38 gamma activity was shown to be necessary and sufficient for Topo II alpha expression, the drug-p38 gamma-Topo II alpha axis is only detected in intrinsically sensitive but not resistant cells, and p38 gamma is co-overexpressed with Topo II alpha protein in primary breast cancers. These results reveal a new paradigm in which p38 gamma actively regulates the drug-Topo II alpha signal transduction, and this may be exploited to increase the therapeutic activity of Topo II drugs.	[Qi, Xiaomei; Hou, Songwang; Lepp, Adrienne; Chen, Guan] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Li, Rongshan; Basir, Zainab] Med Coll Wisconsin, Dept Pathol, Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Chen, Guan] Med Coll Wisconsin, Dept Res Serv, Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Lou, Zhenkun] Mayo Clin & Mayo Fdn, Dept Oncol, Rochester, MN 55905 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Mayo Clinic	Chen, G (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	gchen@mcw.edu			National Institutes of Health [2R01 91576]; Veterans Affairs Merit Review, a Cancer Center Breast Cancer Show-House; Medical College of Wisconsin; NATIONAL CANCER INSTITUTE [R01CA129344, R01CA130996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review, a Cancer Center Breast Cancer Show-House(US Department of Veterans Affairs); Medical College of Wisconsin(General Electric); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01 91576. This work was also supported by a Veterans Affairs Merit Review, a Cancer Center Breast Cancer Show-House, and the Medical College of Wisconsin.	Antony S, 2005, MOL PHARMACOL, V67, P523, DOI 10.1124/mol.104.003889; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Bandele OJ, 2008, BIOCHEMISTRY-US, V47, P11900, DOI 10.1021/bi800981j; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chen G, 1997, ONCOGENE, V15, P1643, DOI 10.1038/sj.onc.1201347; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; Chen G, 1999, ONCOGENE, V18, P7149, DOI 10.1038/sj.onc.1203149; CHEN GA, 1995, BIOCHEM PHARMACOL, V49, P1691, DOI 10.1016/0006-2952(95)00079-F; Chen L, 2009, CANCER RES, V69, P8853, DOI 10.1158/0008-5472.CAN-09-1636; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200; Gross EA, 2002, J BIOL CHEM, V277, P13873, DOI 10.1074/jbc.M111994200; HELLEMANS P, 1995, J CLIN PATHOL, V48, P147, DOI 10.1136/jcp.48.2.147; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Juo P, 1997, MOL CELL BIOL, V17, P24, DOI 10.1128/MCB.17.1.24; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Li H, 2008, J BIOL CHEM, V283, P6209, DOI 10.1074/jbc.M709007200; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; LIPPMAN ME, 1978, NEW ENGL J MED, V298, P1223, DOI 10.1056/NEJM197806012982203; Loesch M, 2008, FRONT BIOSCI-LANDMRK, V13, P3581, DOI 10.2741/2951; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; MacGrogan G, 2003, BRIT J CANCER, V89, P666, DOI 10.1038/sj.bjc.6601185; McPherson JP, 1998, CANCER RES, V58, P4519; Mensah-Osman EJ, 2002, MOL CANCER THER, V1, P1321; MIRSKI SEL, 1993, CANCER RES, V53, P4866; Munro AF, 2010, ONCOGENE, V29, P5231, DOI 10.1038/onc.2010.286; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Pillaire MJ, 2000, BIOCHEM BIOPH RES CO, V278, P724, DOI 10.1006/bbrc.2000.3877; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Qi XM, 2007, J BIOL CHEM, V282, P31398, DOI 10.1074/jbc.M703857200; Qi XM, 2006, CANCER RES, V66, P7540, DOI 10.1158/0008-5472.CAN-05-4639; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Stacey DW, 2000, MOL CELL BIOL, V20, P9127, DOI 10.1128/MCB.20.24.9127-9137.2000; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; WELLS NJ, 1994, J BIOL CHEM, V269, P29746; WOESSNER RD, 1990, CANCER RES, V50, P2901; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	49	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35883	35890		10.1074/jbc.M111.229260	http://dx.doi.org/10.1074/jbc.M111.229260			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21878638	Green Published, hybrid			2022-12-27	WOS:000295927100061
J	Saletta, F; Rahmanto, YS; Siafakas, AR; Richardson, DR				Saletta, Federica; Rahmanto, Yohan Suryo; Siafakas, Aritee R.; Richardson, Des R.			Cellular Iron Depletion and the Mechanisms Involved in the Iron-dependent Regulation of the Growth Arrest and DNA Damage Family of Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EFFECTIVE ANTIPROLIFERATIVE AGENTS; PYRIDOXAL ISONICOTINOYL HYDRAZONE; MESSENGER-RNA; NF-Y; ANTITUMOR-ACTIVITY; MOLECULAR TARGETS; GADD45 PROMOTER; CYCLE ARREST; EXPRESSION; CHELATORS	Iron plays a crucial part in proliferation while iron deficiency results in G(1)/S arrest, DNA damage, and apoptosis. However, the precise role of iron in cell cycle control remains unclear. We showed that iron depletion using the iron chelators, desferrioxamine (DFO), or 2-hydroxy-1-napthylaldehyde isonicotinoyl hydrazone (311), increased the mRNA levels of the growth arrest and DNA damage 45 alpha gene, GADD45 alpha (Darnell, G. and Richardson, D. R. (1999) Blood 94, 781-792). In this study, we examined the effect of iron depletion on up-regulating GADD family members involved in growth control, including cell cycle arrest, apoptosis, and DNA repair, making them therapeutic targets for tumor suppression. We showed the GADD family members were up-regulated by cellular iron depletion. Further, upregulation of GADD45 alpha after iron deprivation was independent of hypoxia-inducible factor-1 alpha (HIF-1 alpha), octamer-1 (Oct-1), p53 and early growth response 1 (Egr1). We then analyzed the regulatory elements responsible for iron depletion-mediated regulation of GADD45 alpha and identified the specific transcription factor/s involved. This region was within -117 bp and -81 bp relative to the start codon where the consensus sequences of three transcription factors are located: the CCAAT-binding factor/nuclear factor-Y (NF-Y), the stabilizing molecule v-MYB and the enhancer, CCAAT enhancer-binding protein (CEBP alpha). Mutation analysis, shRNA studies, Western blotting, and electrophoretic mobility shift assays led to the identification of NF-Y in the transcriptional up-regulation of GADD45 alpha after iron depletion. Furthermore, like GADD45 alpha, NF-YA was upregulated after iron chelation and down-regulated by iron supplementation. These results are important for understanding the mechanisms of iron depletion-mediated cell cycle arrest, DNA damage repair, and apoptosis.	[Richardson, Des R.] Univ Sydney, Dept Pathol, Iron Metab & Chelat Program, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Iron Metab & Chelat Program, Blackburn Bldg D06, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au	Suryo Rahmanto, Yohan/K-8043-2018	Suryo Rahmanto, Yohan/0000-0003-1453-7872; Richardson, Des/0000-0003-0960-6415; Espedido, Aritee Rosemary/0000-0002-8059-1757; Richardson, Des/0000-0002-5506-3274; Saletta, Federica/0000-0003-0598-3504	Cancer Institute NSW (CINSW) [07/RSA/1-22, 08/ECF/1-36]; University of Sydney; National Health and Medical Research Council of Australia	Cancer Institute NSW (CINSW); University of Sydney(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a Cancer Institute NSW (CINSW) Research Scholar Award (07/RSA/1-22) and University of Sydney PhD Scholarship and University Post-Graduate Award (to F. S.), a CINSW Early Career Fellowship (08/ECF/1-36) (to Y. S. R.), and a National Health and Medical Research Council of Australia Senior Principal Research Fellowship and Project Grants (to D. R. R.).	Abcouwer SF, 1999, J BIOL CHEM, V274, P28645, DOI 10.1074/jbc.274.40.28645; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Bulavin DV, 2003, MOL CELL BIOL, V23, P3859, DOI 10.1128/MCB.23.11.3859-3871.2003; Campanero MR, 2008, ONCOGENE, V27, P1263, DOI 10.1038/sj.onc.1210735; CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736; Darnell G, 1999, BLOOD, V94, P781, DOI 10.1182/blood.V94.2.781.414k32_781_792; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; Fanzo JC, 2001, AM J PHYSIOL-CELL PH, V281, pC751, DOI 10.1152/ajpcell.2001.281.3.C751; Fu D, 2007, BLOOD, V110, P752, DOI 10.1182/blood-2007-03-076737; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Greene BT, 2002, J BIOL CHEM, V277, P25568, DOI 10.1074/jbc.M110345200; Hollander MC, 2001, INT J CANCER, V96, P22, DOI 10.1002/1097-0215(20010220)96:1<22::AID-IJC3>3.0.CO;2-K; Kahle J, 2005, MOL CELL BIOL, V25, P5339, DOI 10.1128/MCB.25.13.5339-5354.2005; KEARSEY JM, 1995, ONCOGENE, V11, P1675; Khan QA, 1997, CARCINOGENESIS, V18, P2313, DOI 10.1093/carcin/18.12.2313; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Liang SX, 2003, CARCINOGENESIS, V24, P1601, DOI 10.1093/carcin/bgg116; Martinez E, 2010, CELL CYCLE, V9, P642, DOI 10.4161/cc.9.4.10828; Maytin EV, 2001, EXP CELL RES, V267, P193, DOI 10.1006/excr.2001.5248; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; Oh-Hashi K, 2001, FREE RADICAL BIO MED, V30, P213, DOI 10.1016/S0891-5849(00)00461-5; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; PRICE BD, 1992, CANCER RES, V52, P3814; Radomska HS, 1999, BLOOD, V94, P3772, DOI 10.1182/blood.V94.11.3772.423k19_3772_3780; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Richardson DR, 1999, J BIOL INORG CHEM, V4, P266, DOI 10.1007/s007750050312; Richardson DR, 1997, BLOOD, V89, P3025, DOI 10.1182/blood.V89.8.3025; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Sanchez M, 2006, J BIOL CHEM, V281, P22865, DOI 10.1074/jbc.M603876200; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Takahashi S, 2001, CANCER RES, V61, P1187; Tardito S, 2009, CURR MED CHEM, V16, P1325, DOI 10.2174/092986709787846532; Turner J, 2005, BLOOD, V106, P3191, DOI 10.1182/blood-2005-03-1263; Ubeda M, 2000, NUCLEIC ACIDS RES, V28, P4987, DOI 10.1093/nar/28.24.4987; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; WAITEREES PA, 1991, J BACTERIOL, V173, P5207, DOI 10.1128/jb.173.16.5207-5219.1991; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Yu Y, 2011, J BIOL CHEM, V286, P15413, DOI 10.1074/jbc.M111.225946; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zerbini LF, 2005, CLIN CANCER RES, V11, P6409, DOI 10.1158/1078-0432.CCR-05-1475; Zhan QM, 1998, MOL CELL BIOL, V18, P2768, DOI 10.1128/MCB.18.5.2768; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361; Zhang YD, 2009, MOL CARCINOGEN, V48, P454, DOI 10.1002/mc.20483	46	31	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35396	35406		10.1074/jbc.M111.273060	http://dx.doi.org/10.1074/jbc.M111.273060			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852233	hybrid, Green Published			2022-12-27	WOS:000295927100011
J	Soong, G; Martin, FJ; Chun, JR; Cohen, TS; Ahn, DS; Prince, A				Soong, Grace; Martin, Francis J.; Chun, Jarin; Cohen, Taylor S.; Ahn, Danielle S.; Prince, Alice			Staphylococcus aureus Protein A Mediates Invasion across Airway Epithelial Cells through Activation of RhoA GTPase Signaling and Proteolytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANTON-VALENTINE LEUKOCIDIN; ENDOTHELIAL-CELLS; BARRIER FUNCTION; ALPHA-HEMOLYSIN; TNF-ALPHA; IN-VIVO; BINDING-PROTEIN; PNEUMONIA; RECEPTOR; KINASE	Background: S. aureus is an important cause of severe pneumonia acquired following upper airway colonization. Results: S. aureus-expressing SpA induces RhoA, EGFR, and calpain activity resulting in disruption of tight junctions. Conclusion: SpA is necessary but not sufficient to mediate invasive infection across the airway epithelium. Significance: S. aureus activates multiple epithelial signaling cascades to initiate invasive pulmonary infection.	[Martin, Francis J.; Chun, Jarin; Prince, Alice] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Soong, Grace; Cohen, Taylor S.; Ahn, Danielle S.; Prince, Alice] Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA	Columbia University; Columbia University	Prince, A (corresponding author), 650 W 168th St,BB 416, New York, NY 10032 USA.	asp7@columbia.edu	Cohen, Taylor/C-9927-2016	Cohen, Taylor/0000-0001-9368-0903	National Institutes of Health [R01 HL079395]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL079395 (to A. P.).	Bekeredjian-Ding I, 2007, J IMMUNOL, V178, P2803, DOI 10.4049/jimmunol.178.5.2803; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Cheung AL, 1997, INFECT IMMUN, V65, P2243, DOI 10.1128/IAI.65.6.2243-2249.1997; Chun J, 2009, CELL HOST MICROBE, V5, P47, DOI 10.1016/j.chom.2008.11.009; Clarke SR, 2010, CELL HOST MICROBE, V7, P423, DOI 10.1016/j.chom.2010.05.015; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Finlay BB, 2005, CURR TOP MICROBIOL, V291, P1; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Gomez MI, 2006, J BIOL CHEM, V281, P20190, DOI 10.1074/jbc.M601956200; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Goodyear CS, 2003, J EXP MED, V197, P1125, DOI 10.1084/jem.20020552; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Harari PM, 2007, J CLIN ONCOL, V25, P4057, DOI 10.1200/JCO.2007.11.8984; Hartleib J, 2000, BLOOD, V96, P2149; Jarry TM, 2008, CELL MICROBIOL, V10, P1801, DOI 10.1111/j.1462-5822.2008.01166.x; Kakiashvili E, 2011, J BIOL CHEM, V286, P9268, DOI 10.1074/jbc.M110.179903; Kedinger V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003518; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Liao DK, 2007, J CARDIOVASC PHARM, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Martin FJ, 2009, J CLIN INVEST, V119, P1931, DOI 10.1172/JCI35879; Mateus AR, 2007, HUM MOL GENET, V16, P1639, DOI 10.1093/hmg/ddm113; Mathew SJ, 2009, J CELL SCI, V122, P1939, DOI 10.1242/jcs.044487; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Mong PY, 2008, J IMMUNOL, V180, P550, DOI 10.4049/jimmunol.180.1.550; Otto M, 2011, NAT MED, V17, P169, DOI 10.1038/nm0211-169; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Sax JK, 2003, J BIOL CHEM, V278, P36435, DOI 10.1074/jbc.M303191200; Schmidt KA, 2001, INFECT IMMUN, V69, P4749, DOI 10.1128/IAI.69.8.4749-4758.2001; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Soong G, 2008, J BACTERIOL, V190, P2814, DOI 10.1128/JB.01567-07; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; Usatyuk PV, 2004, J BIOL CHEM, V279, P11789, DOI 10.1074/jbc.M311184200; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B	43	47	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35891	35898		10.1074/jbc.M111.295386	http://dx.doi.org/10.1074/jbc.M111.295386			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21878647	hybrid, Green Published			2022-12-27	WOS:000295927100062
J	Suzuki, T; Miyauchi, K; Suzuki, T; Yokobori, S; Shigi, N; Kondow, A; Takeuchi, N; Yamagishi, A; Watanabe, K				Suzuki, Takeo; Miyauchi, Kenjyo; Suzuki, Tsutomu; Yokobori, Shin-ichi; Shigi, Naoki; Kondow, Akiko; Takeuchi, Nono; Yamagishi, Akihiko; Watanabe, Kimitsuna			Taurine-containing Uridine Modifications in tRNA Anticodons Are Required to Decipher Non-universal Genetic Codes in Ascidian Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1ST POSITION; NUCLEOTIDE-SEQUENCE; MODIFYING ENZYMES; BOVINE LIVER; CODONS AGA; GENOME; ORGANIZATION; TRNA(MET); DISEASES; DNA	Variations in the genetic code are found frequently in mitochondrial decoding systems. Four non-universal genetic codes are employed in ascidian mitochondria: AUA for Met, UGA for Trp, and AGA/AGG(AGR) for Gly. To clarify the decoding mechanism for the non-universal genetic codes, we isolated and analyzed mitochondrial tRNAs for Trp, Met, and Gly from an ascidian, Halocynthia roretzi. Mass spectrometric analysis identified 5-taurinomethyluridine (tau m(5)U) at the anticodon wobble positions of tRNA(Met)(AUR), tRNA(Trp)(UGR), and tRNA(Gly)(AGR), suggesting that tau m(5)U plays a critical role in the accurate deciphering of all four non-universal codes by preventing the misreading of pyrimidine-ending near-cognate codons (NNY) in their respective family boxes. Acquisition of the wobble modification appears to be a prerequisite for the genetic code alteration.	[Suzuki, Takeo; Miyauchi, Kenjyo; Suzuki, Tsutomu] Univ Tokyo, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Yokobori, Shin-ichi; Yamagishi, Akihiko; Watanabe, Kimitsuna] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Dept Mol Biol, Tokyo 1920392, Japan; [Shigi, Naoki] Natl Inst Adv Ind Sci & Technol, Biomed Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Kondow, Akiko] Fujita Hlth Univ, Inst Comprehens Med Sci, Aichi 4701192, Japan; [Takeuchi, Nono] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome, Chiba 2778652, Japan; [Watanabe, Kimitsuna] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; Tokyo University of Pharmacy & Life Sciences; National Institute of Advanced Industrial Science & Technology (AIST); Fujita Health University; University of Tokyo; University of Tokyo	Suzuki, T (corresponding author), Univ Tokyo, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ts@chembio.t.u-tokyo.ac.jp; kim-wata@toyaku.ac.jp	Yokobori, Shin-ichi/K-9537-2017; Suzuki, Tsutomu/J-1776-2015; Shigi, Naoki/L-7135-2018	Yokobori, Shin-ichi/0000-0002-7356-3299; Suzuki, Tsutomu/0000-0002-9731-1731; Shigi, Naoki/0000-0003-4452-8264; Yamagishi, Akihiko/0000-0001-5162-3927	Japan Society for the Promotion of Science; Ministry of Education, Science, Sports, and Culture of Japan; Grants-in-Aid for Scientific Research [21570242, 21570101, 23770202] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research (C) from The Japan Society for the Promotion of Science (to K. W.) and by grants-in-aid for scientific research on priority areas from the Ministry of Education, Science, Sports, and Culture of Japan (to Takeo Suzuki and Tsutomu Suzuki).	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BARRELL BG, 1979, NATURE, V282, P189, DOI 10.1038/282189a0; BESSHO Y, 1992, J MOL EVOL, V34, P331, DOI 10.1007/BF00160240; Bilbille Y, 2011, J MOL BIOL, V406, P257, DOI 10.1016/j.jmb.2010.11.042; CANTATORE P, 1989, J BIOL CHEM, V264, P10965; GAREY JR, 1989, J MOL EVOL, V28, P374, DOI 10.1007/BF02603072; HIMENO H, 1987, GENE, V56, P219; HOFFMANN RJ, 1992, GENETICS, V131, P397; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Kiryu H, 2011, BIOINFORMATICS, V27, P1788, DOI 10.1093/bioinformatics/btr276; Kondow A, 1999, NUCLEIC ACIDS RES, V27, P2554, DOI 10.1093/nar/27.12.2554; Kondow A, 1998, NUCLEOS NUCLEOT NUCL, V17, P531, DOI 10.1080/07328319808005196; KONDOW A, 1998, THESIS U TOKYO; KUCHINO Y, 1987, METHOD ENZYMOL, V155, P379; Kurata S, 2008, J BIOL CHEM, V283, P18801, DOI 10.1074/jbc.M800233200; Lavrov DV, 2005, MOL BIOL EVOL, V22, P1231, DOI 10.1093/molbev/msi108; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; LIAO HX, 1991, J BIOL CHEM, V266, P20714; Lusic H, 2008, NUCLEIC ACIDS RES, V36, P6548, DOI 10.1093/nar/gkn703; MARTIN RP, 1990, BIOCHEMISTRY-US, V29, P956, DOI 10.1021/bi00456a016; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P60, DOI 10.1016/1044-0305(92)85019-G; Miyauchi K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1129; MORIYA J, 1994, BIOCHEMISTRY-US, V33, P2234, DOI 10.1021/bi00174a033; Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; RAJBHANDARY UL, 1994, J BACTERIOL, V176, P547, DOI 10.1128/jb.176.3.547-552.1994; Sakurai M, 2005, FEBS LETT, V579, P2767, DOI 10.1016/j.febslet.2005.04.009; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; SUZUKI T, 2011, ANN REV GEN IN PRESS; SUZUKI T, 2005, FINE TUNING RNA FUNC, P23; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65; Takemoto C, 2009, NUCLEIC ACIDS RES, V37, P1616, DOI 10.1093/nar/gkp001; Takeuchi N, 2001, J BIOL CHEM, V276, P20064, DOI 10.1074/jbc.M101007200; Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085; UEDA T, 1985, J BIOCHEM-TOKYO, V98, P1275, DOI 10.1093/oxfordjournals.jbchem.a135394; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; WATANABE K, 1995, TRNA STRUCTURE SBIOS; WATANABE K, 2011, J NUCL ACID IN PRESS; Watanabe K, 2010, P JPN ACAD B-PHYS, V86, P11, DOI 10.2183/pjab.86.11; Yassin AS, 2011, P NATL ACAD SCI USA, V108, P3918, DOI 10.1073/pnas.1017425108; YOKOBORI S, 1993, J MOL EVOL, V36, P1, DOI 10.1007/BF02407301; Yokobori S, 2001, J MOL EVOL, V53, P314, DOI 10.1007/s002390010221; Yokobori S, 1999, GENETICS, V153, P1851; YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905	47	15	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35494	35498		10.1074/jbc.M111.279810	http://dx.doi.org/10.1074/jbc.M111.279810			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21873425	hybrid, Green Published			2022-12-27	WOS:000295927100021
J	Benbow, JH; DeGray, B; Ehrlich, BE				Benbow, Jennifer H.; DeGray, Brenda; Ehrlich, Barbara E.			Protection of Neuronal Calcium Sensor 1 Protein in Cells Treated with Paclitaxel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CALPAIN; FREQUENIN; BINDING; OSCILLATIONS; DEGRADATION; NEUROPATHY; REGULATOR; SYSTEM; FAMILY	Paclitaxel (Taxol) is one of the most effective treatment options for patients suffering from a variety of cancers. A major side effect seen in a high percentage of patients treated with paclitaxel is irreversible peripheral neuropathy. We previously reported that prolonged treatment with paclitaxel activates a calcium-dependent enzyme, calpain, which degrades neuronal calcium sensor 1 (NCS-1) and subsequent loss of intracellular calcium signaling. Because it appears that activation of calpain is an early step in this destructive cascade, we proposed that inhibition of calpain will protect against the unwanted side effects of paclitaxel treatment. First, NCS-1 levels and intracellular calcium signaling were found to be protected by the presence of lactacystin, a protesome inhibitor. To reinforce the role of calpain in this process, we showed that increased concentrations of calpastatin, a naturally occurring calpain inhibitor, were protective. Next, we tested two mutated versions of NCS-1 developed with point mutations at the P2 position of the calpain cleavage site of NCS-1 to decrease the likelihood of NCS-1 degradation. One mutant was cleaved more favorably by calpain compared with NCS-1 WT, whereas the other mutant was less favorably cleaved. Expression of either mutated version of NCS-1 in neuroblastoma cells protected intracellular calcium signals from paclitaxel-induced changes. These results support our hypothesis that it is possible to protect cells from paclitaxel-induced degradation of NCS-1 by inhibiting calpain activity.	[Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University	Ehrlich, BE (corresponding author), Yale Univ, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	barbara.ehrlich@yale.edu	/AAX-8408-2021	/0000-0001-9657-9704	National Institutes of Health [DK57751, DK61747, 5T32DK007356-32]; Department of Defense for Breast Cancer Research [DOD J00181]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007356, R01DK061747, P01DK057751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense for Breast Cancer Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57751 and DK61747. This work was also supported by National Institutes of Health Training Grant 5T32DK007356-32 administered by the Department of Digestive Diseases at Yale University and by Department of Defense for Breast Cancer Research Grant DOD J00181.	Aravind P, 2008, J MOL BIOL, V376, P1100, DOI 10.1016/j.jmb.2007.12.033; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Blachford C, 2009, CELL CALCIUM, V46, P257, DOI 10.1016/j.ceca.2009.08.002; Boehmerle W, 2007, P NATL ACAD SCI USA, V104, P11103, DOI 10.1073/pnas.0701546104; Boehmerle W, 2006, P NATL ACAD SCI USA, V103, P18356, DOI 10.1073/pnas.0607240103; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Estrada M, 2006, J CELL SCI, V119, P733, DOI 10.1242/jcs.02775; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Fisher JR, 2000, PROTEIN EXPRES PURIF, V20, P66, DOI 10.1006/prep.2000.1298; Florea AM, 2009, NEUROTOXICOLOGY, V30, P803, DOI 10.1016/j.neuro.2009.04.014; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hilfiker S, 2003, BIOCHEM SOC T, V31, P828, DOI 10.1042/BST0310828; Hilkens P H, 1997, J Peripher Nerv Syst, V2, P350; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; Mielke S, 2006, EUR J CANCER, V42, P24, DOI 10.1016/j.ejca.2005.06.030; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Petko JA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-27; Preston N J, 1996, Eur J Cancer Care (Engl), V5, P147, DOI 10.1111/j.1365-2354.1996.tb00226.x; Ramos-Franco J, 1998, BIOPHYS J, V75, P2783, DOI 10.1016/S0006-3495(98)77721-5; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Schlecker C, 2006, J CLIN INVEST, V116, P1668, DOI 10.1172/JCI22466; SPENCER CM, 1994, DRUGS, V48, P794, DOI 10.2165/00003495-199448050-00009; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Wang MS, 2004, BRAIN, V127, P671, DOI 10.1093/brain/awh078	27	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34575	34582		10.1074/jbc.M111.265751	http://dx.doi.org/10.1074/jbc.M111.265751			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21808066	Green Published, hybrid			2022-12-27	WOS:000295406300012
J	Dunschede, B; Bals, T; Funke, S; Schunemann, D				Duenschede, Beatrix; Bals, Thomas; Funke, Silke; Schuenemann, Danja			Interaction Studies between the Chloroplast Signal Recognition Particle Subunit cpSRP43 and the Full-length Translocase Alb3 Reveal a Membrane-embedded Binding Region in Alb3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYLAKOID MEMBRANES; FUNCTIONAL INTERACTION; YIDC; INSERTION; HOMOLOG; COMPLEX; INTEGRATION; SUBSTRATE; COMPONENT; SECA	Posttranslational targeting of the light-harvesting chlorophyll a, b-binding proteins depends on the function of the chloroplast signal recognition particle, its receptor cpFtsY, and the translocase Alb3. The thylakoid membrane protein Alb3 of Arabidopsis chloroplasts belongs to the evolutionarily conserved YidC/Oxa1/Alb3 protein family; the members of this family facilitate the insertion, folding, and assembly of membrane proteins in bacteria, mitochondria, and chloroplasts. Here, we analyzed the interaction sites of full-length Alb3 with the cpSRP pathway component cpSRP43 by using in vitro and in vivo studies. Bimolecular fluorescence complementation and Alb3 proteoliposome studies showed that the interaction of cpSRP43 is dependent on a binding domain in the C terminus of Alb3 as well as an additional membrane-embedded binding site in the fifth transmembrane domain (TMD5) of Alb3. The C-terminal binding domain was mapped to residues 374-388, and the binding domain within TMD5 was mapped to residues 314-318 located close to the luminal end of TMD5. A direct binding between cpSRP43 and these binding motifs was shown by pepspot analysis. Further studies using blue-native gel electrophoresis revealed that full-length Alb3 is able to form dimers. This finding and the identification of a membrane-embedded cpSRP43 binding site in Alb3 support a model in which cpSRP43 inserts into a dimeric Alb3 translocation pore during cpSRP-dependent delivery of light-harvesting chlorophyll a, b-binding proteins.	[Duenschede, Beatrix; Bals, Thomas; Funke, Silke; Schuenemann, Danja] Ruhr Univ Bochum, D-44780 Bochum, Germany	Ruhr University Bochum	Schunemann, D (corresponding author), Univ Str 150, D-44780 Bochum, Germany.	Danja.Schuenemann@rub.de		Schuenemann, Danja/0000-0001-8894-7685	Deutsche Forschungsgemeinschaft [SCHU 1163/5-1]; Ruhr-University Research School; Germany Excellence Initiative [DFG GSC 98/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruhr-University Research School; Germany Excellence Initiative	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHU 1163/5-1 and by the Ruhr-University Research School funded by Germany Excellence Initiative Grant DFG GSC 98/1.	Bals T, 2010, FEBS LETT, V584, P4138, DOI 10.1016/j.febslet.2010.08.053; Benz M, 2009, MOL PLANT, V2, P1410, DOI 10.1093/mp/ssp095; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; FRANKLIN AE, 1993, J BIOL CHEM, V268, P22175; Gerdes L, 2006, J BIOL CHEM, V281, P16632, DOI 10.1074/jbc.M513623200; Glick BS, 1996, PROTEIN SCI, V5, P2651, DOI 10.1002/pro.5560051229; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; Hermkes R, 2006, FEBS LETT, V580, P3107, DOI 10.1016/j.febslet.2006.04.055; HOFFMAN NE, 1994, PLANT PHYSIOL, V105, P295, DOI 10.1104/pp.105.1.295; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Jonas-Straube E, 2001, J BIOL CHEM, V276, P24654, DOI 10.1074/jbc.M100153200; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kol S, 2008, J BIOL CHEM, V283, P31269, DOI 10.1074/jbc.R800029200; Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005; Lewis NE, 2010, J BIOL CHEM, V285, P34220, DOI 10.1074/jbc.M110.160093; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moore M, 2003, J CELL BIOL, V162, P1245, DOI 10.1083/jcb.200307067; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Randelj Olga, 2007, V390, P417; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Richter CV, 2010, EUR J CELL BIOL, V89, P965, DOI 10.1016/j.ejcb.2010.06.020; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; van der Slurs EO, 2006, J MOL BIOL, V361, P839, DOI 10.1016/j.jmb.2006.07.017; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang P, 2011, BBA-BIOMEMBRANES, V1808, P866, DOI 10.1016/j.bbamem.2010.08.014; YANG C, 2005, CELL BIOL TECHNIQUES, P300; Yuan J, 2002, J BIOL CHEM, V277, P32400, DOI 10.1074/jbc.M206192200; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	44	37	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35187	35195		10.1074/jbc.M111.250746	http://dx.doi.org/10.1074/jbc.M111.250746			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832051	Green Published, hybrid			2022-12-27	WOS:000295406300071
J	Emmer, KL; Waxman, EA; Covy, JP; Giasson, BI				Emmer, Kristel L.; Waxman, Elisa A.; Covy, Jason P.; Giasson, Benoit I.			E46K Human alpha-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORADIC PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; NONMOTOR SYMPTOMS; PRECURSOR PROTEIN; SUBSTANTIA-NIGRA; ANIMAL-MODELS; MOUSE MODELS; MUTATION; AGGREGATION; GENE	Synucleinopathies are a group of neurodegenerative disorders associated with the formation of aberrant amyloid inclusions composed of the normally soluble presynaptic protein alpha-synuclein (alpha-syn). Parkinson disease is the most well known of these disorders because it bears alpha-syn pathological inclusions known as Lewy bodies (LBs). Mutations in the gene for alpha-syn, including the E46K missense mutation, are sufficient to cause Parkinson disease as well as other synucleinopathies like dementia with LBs. Herein, we describe transgenic mice expressing E46K human alpha-syn in CNS neurons that develop detrimental age-dependent motor impairments. These animals accumulate age-dependent intracytoplasmic neuronal alpha-syn inclusions that parallel disease and recapitulate the biochemical, histological, and morphological properties of LBs. Surprisingly, the morphology of alpha-syn inclusions in E46K human alpha-syn transgenic mice more closely resemble LBs than the previously described transgenic mice (line M83) that express neuronal A53T human alpha-syn. E46K human alpha-syn mice also develop abundant neuronal tau inclusions that resemble neurofibrillary tangles. Subsequent studies on the ability of E46K alpha-syn to induce tau inclusions in cellular models suggest that both direct and indirect mechanisms of protein aggregation are probably involved in the formation of the tau inclusions observed here in vivo. Re-evaluation of presymptomatic transgenic mice expressing A53T human alpha-syn reveals that the formation of alpha-syn inclusions in mice must be synchronized; however, inclusion formation is diffuse within affected areas of the neuroaxis such that there was no clustering of inclusions. Collectively, these findings provide insights in the mechanisms of formation of these aberrant proteinaceous inclusions and support the notion that alpha-syn aggregates are involved in the pathogenesis of human diseases.	[Giasson, Benoit I.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Giasson, BI (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk,125 John Morgan Bldg, Philadelphia, PA 19104 USA.	giassonb@mail.med.upenn.edu		Emmer, Kristel/0000-0002-9353-1622; Waxman, Elisa/0000-0003-4562-7969	National Institutes of Health (NIH), NIA [AG09215, T32 AG00255]; NIH, NINDS [NS053488]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000255, P01AG009215] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NIA, Grant AG09215 and NIH, NINDS, Grant NS053488.; Supported by NIH, NIA, Training Grant T32 AG00255. Present address: Neurobiology Division, Medical Diagnostic Laboratories, Hamilton, NJ 08690.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ahn KJ, 2006, J NEUROCHEM, V97, P265, DOI 10.1111/j.1471-4159.2006.03731.x; Athanassiadou A, 1999, AM J HUM GENET, V65, P555, DOI 10.1086/302486; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Baba M, 1998, AM J PATHOL, V152, P879; Bjorklund A, 2010, PROG BRAIN RES, V184, P53, DOI 10.1016/S0079-6123(10)84004-X; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; CORNFORD ME, 1995, BRAIN COGNITION, V28, P321, DOI 10.1006/brcg.1995.1261; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dickson DW, 1999, AM J PATHOL, V155, P1241, DOI 10.1016/S0002-9440(10)65226-1; Duda JE, 2000, J NEUROPATH EXP NEUR, V59, P830, DOI 10.1093/jnen/59.9.830; Duda JE, 2002, ANN NEUROL, V52, P205, DOI 10.1002/ana.10279; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Forman MS, 2005, NEURON, V47, P479, DOI 10.1016/j.neuron.2005.07.021; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Galvin JE, 2000, AM J PATHOL, V157, P361, DOI 10.1016/S0002-9440(10)64548-8; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 2003, ACTA NEUROPATHOL, V106, P243, DOI 10.1007/s00401-003-0726-x; Giasson BI, 2001, EXP NEUROL, V172, P354, DOI 10.1006/exnr.2001.7805; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Gotz J, 2007, BRAIN PATHOL, V17, P91, DOI 10.1111/j.1750-3639.2007.00051.x; Gotz J, 2004, MOL PSYCHIATR, V9, P664, DOI 10.1038/sj.mp.4001508; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Heck DH, 2008, HUM MOL GENET, V17, P2181, DOI 10.1093/hmg/ddn117; Hutton M, 2001, TRENDS MOL MED, V7, P467, DOI 10.1016/S1471-4914(01)02123-2; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Janus C, 2000, BBA-MOL BASIS DIS, V1502, P63, DOI 10.1016/S0925-4439(00)00033-8; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Markopoulou K, 1999, ANN NEUROL, V46, P374, DOI 10.1002/1531-8249(199909)46:3<374::AID-ANA13>3.0.CO;2-9; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; PAKKENBERG B, 1991, J NEUROL NEUROSUR PS, V54, P30, DOI 10.1136/jnnp.54.1.30; Papadimitriou A, 1999, NEUROLOGY, V52, P651, DOI 10.1212/WNL.52.3.651; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Poewe W, 2008, EUR J NEUROL, V15, P14, DOI 10.1111/j.1468-1331.2008.02056.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Richfield EK, 2002, EXP NEUROL, V175, P35, DOI 10.1006/exnr.2002.7882; RODRIGUEZ EM, 1984, HISTOCHEMISTRY, V81, P253, DOI 10.1007/BF00495636; Ruiperez V, 2010, PROG LIPID RES, V49, P420, DOI 10.1016/j.plipres.2010.05.004; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; SIMUNI T, 2000, NEURODEGENERATIVE DE, P193; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spira PJ, 2001, ANN NEUROL, V49, P313, DOI 10.1002/ana.67; TeclemariamMesbah R, 1997, J HISTOCHEM CYTOCHEM, V45, P619, DOI 10.1177/002215549704500414; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Waxman EA, 2008, ACTA NEUROPATHOL, V116, P37, DOI 10.1007/s00401-008-0375-1; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Waxman EA, 2010, J NEUROCHEM, V113, P374, DOI 10.1111/j.1471-4159.2010.06592.x; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Withers GS, 1997, DEV BRAIN RES, V99, P87, DOI 10.1016/S0165-3806(96)00210-6; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	91	87	89	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35104	35118		10.1074/jbc.M111.247965	http://dx.doi.org/10.1074/jbc.M111.247965			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846727	Green Published, hybrid			2022-12-27	WOS:000295406300064
J	Jiang, R; Zhang, B; Kurokawa, K; So, YI; Kim, EH; Hwang, HO; Lee, JH; Shiratsuchi, A; Zhang, JH; Nakanishi, Y; Lee, HS; Lee, BL				Jiang, Rui; Zhang, Bing; Kurokawa, Kenji; So, Young-In; Kim, Eun-Hye; Hwang, Hyun Ok; Lee, Joon-Hee; Shiratsuchi, Akiko; Zhang, Jinghai; Nakanishi, Yoshinobu; Lee, Hee-Seung; Lee, Bok Luel			93-kDa Twin-domain Serine Protease Inhibitor (Serpin) Has a Regulatory Function on the Beetle Toll Proteolytic Signaling Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGAL-INFECTIONS; CRYSTAL-STRUCTURE; DROSOPHILA; ACTIVATION; INSECT; PEPTIDOGLYCAN; MELANIZATION; RECOGNITION; PATHWAY; MECHANISM	Serpins are protease inhibitors that play essential roles in the down-regulation of extracellular proteolytic cascades. The core serpin domain is highly conserved, and typical serpins are encoded with a molecular size of 35-50 kDa. Here, we describe a novel 93-kDa protein that contains two complete, tandemly arrayed serpin domains. This twin serpin, SPN93, was isolated from the larval hemolymph of the large beetle Tenebrio molitor. The N-terminal serpin domain of SPN93 forms a covalent complex with the Spatzle-processing enzyme, a terminal serine protease of the Toll signaling cascade, whereas the C-terminal serpin domain of SPN93 forms complexes with a modular serine protease and the Spatzle-processing enzyme-activating enzyme, which are two different enzymes of the cascade. Consequently, SPN93 inhibited beta-1,3-glucan-mediated Toll proteolytic cascade activation in an in vitro system. Site-specific proteolysis of SPN93 at the N-terminal serpin domain was observed after activation of the Toll proteolytic cascade in vivo, and down-regulation of SPN93 by RNAi sensitized beta-1,3-glucan-mediated larval death. Therefore, SPN93 is the first serpin that contains twin tandemly arrayed and functionally active serpin domains that have a regulatory role in the larval Toll proteolytic signaling cascade.	[Lee, Hee-Seung] Korea Adv Inst Sci & Technol, Dept Chem, Mol Level Interface Res Ctr, Taejon 305701, South Korea; [Jiang, Rui; Zhang, Bing; Kurokawa, Kenji; So, Young-In; Kim, Eun-Hye; Hwang, Hyun Ok; Lee, Joon-Hee; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Global Res Lab Insect Symbiosis, Pusan 609735, South Korea; [Jiang, Rui; Zhang, Jinghai] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 110016, Peoples R China; [Shiratsuchi, Akiko; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan	Korea Advanced Institute of Science & Technology (KAIST); Pusan National University; Shenyang Pharmaceutical University; Kanazawa University	Lee, HS (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Mol Level Interface Res Ctr, Taejon 305701, South Korea.	hee-seung_lee@kaist.ac.kr; brlee@pusan.ac.kr	Nakanishi, Yoshinobu/D-4602-2014; Shiratsuchi, Akiko/D-8391-2015; Lee, Hee-Seung/C-1627-2011; Jiang, Rui/F-9248-2011	Nakanishi, Yoshinobu/0000-0002-8767-3587; Shiratsuchi, Akiko/0000-0002-7811-4409; Jiang, Rui/0000-0002-5580-9822; Lee, Yongseok/0000-0002-8687-589X	Rural Development Administration, Republic of Korea [PJ008186022011]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by Grant PJ008186022011 from the Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea.	BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; Chen VC, 2000, J BIOL CHEM, V275, P38457, DOI 10.1074/jbc.M005605200; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Fullaondo A, 2011, MOL CELL BIOL, V31, P2960, DOI 10.1128/MCB.01397-10; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Hashimoto C, 2003, DEV CELL, V5, P945, DOI 10.1016/S1534-5807(03)00338-1; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2003, CURR BIOL, V13, P2097, DOI 10.1016/j.cub.2003.10.062; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Park SH, 2011, J BIOL CHEM, V286, P1567, DOI 10.1074/jbc.M110.144006; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Reichhart JM, 2005, TRENDS CELL BIOL, V15, P659, DOI 10.1016/j.tcb.2005.10.001; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roberts RM, 1995, CRIT REV EUKAR GENE, V5, P385, DOI 10.1615/CritRevEukarGeneExpr.v5.i3-4.80; Roh KB, 2009, J BIOL CHEM, V284, P19474, DOI 10.1074/jbc.M109.007419; Scherfer C, 2008, DEV BIOL, V323, P189, DOI 10.1016/j.ydbio.2008.08.030; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yu Y, 2010, J BIOL CHEM, V285, P32937, DOI 10.1074/jbc.M110.144014	27	22	24	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35087	35095		10.1074/jbc.M111.277343	http://dx.doi.org/10.1074/jbc.M111.277343			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21862574	hybrid, Green Published			2022-12-27	WOS:000295406300062
J	Lai, SJ; O'Callaghan, B; Zoghbi, HY; Orr, HT				Lai, Shaojuan; O'Callaghan, Brennon; Zoghbi, Huda Y.; Orr, Harry T.			14-3-3 Binding to Ataxin-1(ATXN1) Regulates Its Dephosphorylation at Ser-776 and Transport to the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYGLUTAMINE-INDUCED DISEASE; MEDIATES NEURODEGENERATION; PROTEIN PHOSPHATASES; PHOSPHORYLATION; LOCALIZATION; RECOGNITION; INHIBITORS; EXPANSION; REPEAT; DOMAIN	Spinocerebellar ataxia type 1 (SCA1) is a lethal neurodegenerative disorder caused by expansion of a polyglutamine tract in ATXN1. A prominent site of pathology in SCA1 is cerebellar Purkinje neurons where mutant ATXN1 must enter the nucleus to cause disease. In SCA1, phosphorylation of ATXN1 at Ser-776 modulates disease. Interestingly, Ser-776 is located within a region of ATXN1 that harbors several functional motifs including binding sites for 14-3-3, and splicing factors RBM17 and U2AF65. The interaction of ATXN1 with these proteins is thought to be regulated by the phosphorylation status of Ser-776. In addition, Ser-776 is adjacent to the NLS in ATXN1. Although pS776-ATXN1 is enriched in nuclear extracts of cerebellar cells, the vast majority of 14-3-3 is in the cytoplasmic fraction. We found that dephosphorylation of cytoplasmic pS776-ATXN1 is blocked by virtue of it being in a complex with 14-3-3. In addition, data suggest that binding of 14-3-3 to cytoplasmic ATXN1 impeded its transport to the nucleus, suggesting that 14-3-3 must disassociate from ATXN1 for transport of ATXN1 to the nucleus. Consistent with this hypothesis is the observation that once in the nucleus pS776 is able to be dephosphorylated. Evidence is presented that PP2A is the pS776-ATXN1 phosphatase in the mammalian cerebellum. In the nucleus, we propose that dephosphorylation of pS776-ATXN1 by PP2A regulates the interaction of ATXN1 with the splicing factors RBM17 and U2AF65.	[Lai, Shaojuan; O'Callaghan, Brennon; Orr, Harry T.] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA; [Lai, Shaojuan; Orr, Harry T.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [O'Callaghan, Brennon; Orr, Harry T.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Human Genet, Houston, TX 77030 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Orr, HT (corresponding author), Univ Minnesota, Inst Translat Neurosci, 2101 6th St SE, Minneapolis, MN 55455 USA.	orrxx002@umn.edu	Lai, Shaojuan/O-5477-2014	Lai, Shaojuan/0000-0002-7721-1266; Zoghbi, Huda/0000-0002-0700-3349; O'Callaghan, Brennon L/0000-0002-0800-5856; Orr, Harry/0000-0001-6118-741X	National Institutes of Health/NINDS [NS045667]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045667] Funding Source: NIH RePORTER	National Institutes of Health/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported, in whole or in part, by National Institutes of Health/NINDS Grant NS045667.	Carlson KM, 2009, J NEUROGENET, V23, P313, DOI 10.1080/01677060802399976; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; de Chiara C, 2003, FEBS LETT, V551, P107, DOI 10.1016/S0014-5793(03)00818-4; de Chiara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008372; Duvick L, 2010, NEURON, V67, P929, DOI 10.1016/j.neuron.2010.08.022; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; HASHIKAWA T, 1995, NEUROSCI RES, V22, P133, DOI 10.1016/0168-0102(95)00886-X; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jorgensen ND, 2009, J NEUROCHEM, V110, P675, DOI 10.1111/j.1471-4159.2009.06164.x; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; ROBITAILLE Y, 1995, ACTA NEUROPATHOL, V90, P572; Rossie S, 2006, BRAIN RES, V1111, P1, DOI 10.1016/j.brainres.2006.06.106; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Shi YS, 2006, MOL CELL, V23, P819, DOI 10.1016/j.molcel.2006.07.022; Strack S, 1998, J COMP NEUROL, V392, P515; Swingle Mark, 2007, V365, P23; Tanimukai H, 2004, MOL BRAIN RES, V126, P146, DOI 10.1016/j.molbrainres.2004.04.003; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Tzivion G., 2011, BIOCH BIOPH IN PRESS; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25	36	41	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34606	34616		10.1074/jbc.M111.238527	http://dx.doi.org/10.1074/jbc.M111.238527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21835928	hybrid, Green Published			2022-12-27	WOS:000295406300015
J	Pemberton, S; Madiona, K; Pieri, L; Kabani, M; Bousset, L; Melki, R				Pemberton, Samantha; Madiona, Karine; Pieri, Laura; Kabani, Mehdi; Bousset, Luc; Melki, Ronald			Hsc70 Protein Interaction with Soluble and Fibrillar alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; MOLECULAR CHAPERONES; HSP70; AGGREGATION; TOXICITY; TRANSMISSION; COMPLEX; BRAIN; DEATH	The aggregation of alpha-synuclein (alpha-Syn), the primary component of Lewy bodies, into high molecular weight assemblies is strongly associated with Parkinson disease. This event is believed to result from a conformational change within native alpha-Syn. Molecular chaperones exert critical housekeeping functions in vivo including refolding, maintaining in a soluble state, and/or pacifying protein aggregates. The influence of the stress-induced heat shock protein 70 (Hsp70) on alpha-Syn aggregation has been notably investigated. The constitutively expressed chaperone Hsc70 acts as an antiaggregation barrier before cellsare overwhelmed with alpha-Syn aggregates and Hsp70 expression induced. Here, we investigate the interaction between Hsc70 and alpha-Syn, the consequences of this interaction, and the role of nucleotides and co-chaperones Hdj1 and Hdj2 as modulators. We show that Hsc70 sequesters soluble alpha-Syn in an assembly incompetent complex in the absence of ATP. The affinity of Hsc70 for soluble alpha-Syn diminishes upon addition of ATP alone or together with its co-chaperones Hdj1 or Hdj2 allowing faster binding and release of client proteins thus abolishing alpha-Syn assembly inhibition by Hsc70. We show that Hsc70 binds alpha-Syn fibrils with a 5-fold tighter affinity compared with soluble alpha-Syn. This suggests that Hsc70 preferentially interacts with high molecular weight alpha-Syn assemblies in vivo. Hsc70 binding certainly has an impact on the physicochemical properties of alpha-Syn assemblies. We show a reduced cellular toxicity of alpha-Syn fibrils coated with Hsc70 compared with "naked" fibrils. Hsc70 may therefore significantly affect the cellular propagation of alpha-Syn aggregates and their spread throughout the central nervous system in Parkinson disease.	[Pemberton, Samantha; Madiona, Karine; Pieri, Laura; Kabani, Mehdi; Bousset, Luc; Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Melki, R (corresponding author), CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France.	melki@lebs.cnrs-gif.fr	Kabani, Mehdi/G-7456-2012	Kabani, Mehdi/0000-0001-7440-6394; bousset, luc/0000-0002-0433-4337	French Ministry of Education, Research and Technology; Centre National de la Recherche Scientifique (CNRS); Agence Nationale pour la Recherche [ANR-08-NEUR-001-01]; Human Frontier Science Program; Era-Net Neuron	French Ministry of Education, Research and Technology; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Human Frontier Science Program(Human Frontier Science Program); Era-Net Neuron	This work was supported by the French Ministry of Education, Research and Technology, the Centre National de la Recherche Scientifique (CNRS), the Era-Net Neuron, Agence Nationale pour la Recherche Grant ANR-08-NEUR-001-01, and the Human Frontier Science Program.	BENAROUDJ N, 1995, BIOCHEMISTRY-US, V34, P15282, DOI 10.1021/bi00046a037; Borges JC, 2006, ARCH BIOCHEM BIOPHYS, V452, P46, DOI 10.1016/j.abb.2006.05.006; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chirico WJ, 1998, BIOCHEMISTRY-US, V37, P13862, DOI 10.1021/bi980597j; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Davies P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015814; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Falsone SF, 2009, J BIOL CHEM, V284, P31190, DOI 10.1074/jbc.M109.057240; Ghee M, 2005, FEBS J, V272, P4023, DOI 10.1111/j.1742-4658.2005.04776.x; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; HALFMANN R, 2008, J VIS EXP, V17; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luk KC, 2008, BIOCHEMISTRY-US, V47, P12614, DOI 10.1021/bi801475r; MELKI R, 1990, BIOCHEMISTRY-US, V29, P8921, DOI 10.1021/bi00490a007; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; Ohtsuka K, 2000, BRAIN RES BULL, V53, P141, DOI 10.1016/S0361-9230(00)00325-7; Opazo F, 2008, J NEUROCHEM, V106, P529, DOI 10.1111/j.1471-4159.2008.05407.x; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Pieri L, 2006, J BIOL CHEM, V281, P15337, DOI 10.1074/jbc.M511647200; Pieri L, 2009, BIOPHYS J, V96, P3319, DOI 10.1016/j.bpj.2008.12.3958; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Ross CA, 2007, PARKINSONISM RELAT D, V13, pS309, DOI 10.1016/S1353-8020(08)70022-1; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shimshek DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010014; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Witt SN, 2010, BIOPOLYMERS, V93, P218, DOI 10.1002/bip.21302; Wolfe LS, 2010, P NATL ACAD SCI USA, V107, P16863, DOI 10.1073/pnas.1002867107	41	84	87	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34690	34699		10.1074/jbc.M111.261321	http://dx.doi.org/10.1074/jbc.M111.261321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832061	Green Published, hybrid			2022-12-27	WOS:000295406300023
J	Saeed, M; Sheff, D; Kohen, A				Saeed, Muhammad; Sheff, David; Kohen, Amnon			Novel Positron Emission Tomography Tracer Distinguishes Normal from Cancerous Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR IMAGING TECHNOLOGIES; THYMIDYLATE SYNTHASE; ESOPHAGEAL CANCER; ESCHERICHIA-COLI; F-18-FLT PET; LUNG-CANCER; PROLIFERATION; EXPRESSION; TUMOR; 3'-DEOXY-3'-F-18-FLUOROTHYMIDINE	Development of tumor-specific probes for imaging by positron emission tomography has broad implications in clinical oncology, such as diagnosis, staging, and monitoring therapeutic responses in patients, as well as in biomedical research. Thymidylate synthase (TSase)-based de novo biosynthesis of DNA is an important target for drug development. Increased DNA replication in proliferating cancerous cells requires TSase activity, which catalyzes the reductive methylation of dUMP to dTMP using (R)-N-5,N-10-methylene-5,6,7,8-tetrahydrofolate (MTHF) as a cofactor. In principle, radiolabeled MTHF can be used as a substrate for this reaction to identify rapidly dividing cells. In this proof-of-principle study, actively growing (log phase) breast cancer (MCF7, MDA-MB-231, and hTERT-HME1), normal breast (human mammary epithelial and MCF10A), colon cancer (HT-29), and normal colon (FHC) cells were incubated with [C-14]MTHF in culture medium from 30 min to 2 h, and uptake of radiotracer was measured. Cancerous cell lines incorporated significantly more radioactivity than their normal counterparts. The uptake of radioactively labeled MTHF depended upon a combination of cell doubling time, folate receptor status, S phase percentage, and TSase expression in the cells. These findings suggest that the recently synthesized [C-11]MTHF may serve as a new positron emission tomography tracer for cancer imaging.	[Saeed, Muhammad; Kohen, Amnon] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA; [Sheff, David] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Kohen, A (corresponding author), Univ Iowa, Dept Chem, Iowa City, IA 52242 USA.	amnon-kohen@uiowa.edu			Institute of Clinical and Translational Science; University of Iowa	Institute of Clinical and Translational Science; University of Iowa	This work was supported by a pilot grant from the Institute of Clinical and Translational Science and a Biological Science Funding Program grant from the University of Iowa.	Agrawal N, 2004, ANAL BIOCHEM, V328, P44, DOI 10.1016/j.ab.2004.01.029; Agrawal N, 2004, BIOCHEMISTRY-US, V43, P1998, DOI 10.1021/bi036124g; Bading JR, 2008, J NUCL MED, V49, p64S, DOI 10.2967/jnumed.107.046391; Been LB, 2004, EUR J NUCL MED MOL I, V31, P1659, DOI 10.1007/s00259-004-1687-6; Bouchelouche K, 2009, CURR OPIN ONCOL, V21, P469, DOI 10.1097/CCO.0b013e32832d56e4; Bradbury MS, 2008, J NUCL MED, V49, P422, DOI 10.2967/jnumed.107.047092; Buck AK, 2005, EUR J NUCL MED MOL I, V32, P525, DOI 10.1007/s00259-004-1706-7; Changchien LM, 2000, PROTEIN EXPRES PURIF, V19, P265, DOI 10.1006/prep.2000.1245; Chao KSC, 2006, SEMIN ONCOL, V33, pS59, DOI 10.1053/j.seminoncol.2006.10.011; Drzezga A, 2009, BEHAV NEUROL, V21, P101, DOI [10.3233/BEN-2009-0228, 10.1155/2009/276026]; Hayat M. A., 2008, CANC IMAGING, V1; Hayat MA, 2008, CANC IMAGING, V2; Honer M, 2010, TRANSL ONCOL, V3, P264, DOI 10.1593/tlo.10127; Hong BY, 2007, BIOCHEMISTRY-US, V46, P14188, DOI 10.1021/bi701363s; Hooker JM, 2008, ANGEW CHEM INT EDIT, V47, P5989, DOI 10.1002/anie.200800991; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; Kiss-Laszlo Zsuzsanna, 2006, Magy Onkol, V50, P33; Lindebjerg J, 2006, APPL IMMUNOHISTO M M, V14, P37, DOI 10.1097/01.pai.0000154057.41274.6b; Lodge MA, 2008, J NUCL MED, V49, P1620, DOI 10.2967/jnumed.108.052076; McEwan AJ, 2008, J NUCL MED, V49, p37N; Miele E, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-52; MURPHY M, 1976, BIOCHEM BIOPH RES CO, V71, P1017, DOI 10.1016/0006-291X(76)90756-7; Nair VS, 2009, J THORAC ONCOL, V4, P1473, DOI 10.1097/JTO.0b013e3181bccbc6; Pelosi E, 2007, EJSO-EUR J SURG ONC, V33, P1, DOI 10.1016/j.ejso.2006.10.020; Perrone A, 2008, J NUCL MED, V49, p25N; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Phelps ME, 2000, J NUCL MED, V41, P661; Saga T, 2006, CLIN NUCL MED, V31, P774, DOI 10.1097/01.rlu.0000246820.14892.d2; Sajjad M, 2002, APPL RADIAT ISOTOPES, V57, P607, DOI 10.1016/S0969-8043(02)00175-6; Shields AF, 2005, EUR J NUCL MED MOL I, V32, P1269, DOI 10.1007/s00259-005-1813-0; Shimoda M, 2009, PATHOBIOLOGY, V76, P193, DOI 10.1159/000218335; Song WS, 2009, NUCL MED COMMUN, V30, P462, DOI 10.1097/MNM.0b013e32832aa7ce; Timmers HJLM, 2009, J CLIN ENDOCR METAB, V94, P4757, DOI 10.1210/jc.2009-1248; Troost EGC, 2007, J NUCL MED, V48, P726, DOI 10.2967/jnumed.106.037473; Ullrich RT, 2009, J NUCL MED, V50, P1962, DOI 10.2967/jnumed.109.065904; van der Meel R, 2010, DRUG DISCOV TODAY, V15, P102, DOI 10.1016/j.drudis.2009.12.003; van Waarde A, 2008, CURR PHARM DESIGN, V14, P3326; van Westreenen HL, 2005, J NUCL MED, V46, P400; Verlinde PHCJ, 2009, J AGR FOOD CHEM, V57, P6803, DOI 10.1021/jf900832g; Wang WG, 2004, CANCER RES, V64, P8167, DOI 10.1158/0008-5472.CAN-04-0970; Yap CS, 2006, CHEST, V129, P393, DOI 10.1378/chest.129.2.393; Yasumatsu R, 2009, CHEMOTHERAPY, V55, P36, DOI 10.1159/000175465; Yoshida Y, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-7; Yu Z, 2005, HISTOL HISTOPATHOL, V20, P871, DOI 10.14670/HH-20.871; Zhang XS, 2008, NUCL MED COMMUN, V29, P1052, DOI 10.1097/MNM.0b013e328310af34	45	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33872	33878		10.1074/jbc.M111.275446	http://dx.doi.org/10.1074/jbc.M111.275446			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832075	Green Published, hybrid			2022-12-27	WOS:000295159200019
J	Ferraris, DM; Sbardella, D; Petrera, A; Marini, S; Amstutz, B; Coletta, M; Sander, P; Rizzi, M				Ferraris, Davide M.; Sbardella, Diego; Petrera, Agnese; Marini, Stefano; Amstutz, Beat; Coletta, Massimo; Sander, Peter; Rizzi, Menico			Crystal Structure of Mycobacterium tuberculosis Zinc-dependent Metalloprotease-1 (Zmp1), a Metalloprotease Involved in Pathogenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIN-CONVERTING ENZYME-1; BENZOFUSED MACROCYCLIC LACTAMS; MEMBRANE-BOUND METALLOPROTEASE; NEUTRAL ENDOPEPTIDASE; ACTIVE-SITE; INFLAMMASOME; POTENT; NEPRILYSIN; INHIBITOR	Mycobacterium tuberculosis, the causative agent of tuberculosis, parasitizes host macrophages. The resistance of the tubercle bacilli to the macrophage hostile environment relates to their ability to impair phagosome maturation and its fusion with the lysosome, thus preventing the formation of the phago-lysosome and eventually arresting the process of phagocytosis. The M. tuberculosis zinc-dependent metalloproteaseZmp1has been proposed to play a key role in the process of phagosome maturation inhibition and emerged as an important player in pathogenesis. Here, we report the crystal structure of wild-type Zmp1 at 2.6A resolution in complex with the generic zinc metalloprotease inhibitor phosphoramidon, which we demonstrated to inhibit the enzyme potently. Our data represent the first structural characterization of a bacterial member of the zinc-dependent M13 endopeptidase family and revealed a significant degree of conservation with eukaryotic enzymes. However, structural comparison of the Zmp1-phosphoramidon complex with homologous human proteins neprilysin and endothelinconverting enzyme-1 revealed unique features of the Zmp1 active site to be exploited for the rational design of specific inhibitors that may prove useful as a pharmacological tool for better understanding Zmp1 biological function.	[Rizzi, Menico] Univ Piemonte Orientale Amedeo Avogadro, DiSCAFF, DISCAFF Dept Chem Food Pharmaceut & Pharmacol Sci, I-28100 Novara, Italy; [Sbardella, Diego; Marini, Stefano; Coletta, Massimo] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Sbardella, Diego] Interuniv Consortium Res Chem Met Biol Syst, I-70126 Bari, Italy; [Petrera, Agnese; Amstutz, Beat; Sander, Peter] Univ Zurich, Inst Med Microbiol, CH-8006 Zurich, Switzerland	University of Eastern Piedmont Amedeo Avogadro; University of Rome Tor Vergata; University of Zurich	Rizzi, M (corresponding author), Univ Piemonte Orientale Amedeo Avogadro, DiSCAFF, DISCAFF Dept Chem Food Pharmaceut & Pharmacol Sci, Via Bovio 6, I-28100 Novara, Italy.	menico.rizzi@pharm.unipmn.it	Marini, Stefano/B-1161-2012; Coletta, Massimiliano/GSN-5927-2022; Sbardella, Diego/K-7519-2016; Sander, Peter/D-2548-2009; Ferraris, Davide Maria/AAP-7110-2020; Coletta, Massimo/N-9049-2015; Ferraris, Davide Maria/AAO-9743-2020; Sbardella, Diego/N-9187-2015	Marini, Stefano/0000-0003-1299-6696; Sbardella, Diego/0000-0002-9924-7761; Sander, Peter/0000-0003-1581-0682; Ferraris, Davide Maria/0000-0001-5112-9910; COLETTA, Massimiliano/0000-0002-5489-9467	European Union [SysteMTb HEALTH-F4-2010-241587, New TBvac 241745]; Swiss National Science Foundation [31003A_135705]	European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the European Union FP7 program SysteMTb HEALTH-F4-2010-241587 and New TBvac 241745 projects and by Swiss National Science Foundation Grant 31003A_135705.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bianchetti L, 2002, PROTEINS, V47, P481, DOI 10.1002/prot.10075; Chan J, 2004, CLIN IMMUNOL, V110, P2, DOI 10.1016/S1521-6616(03)00210-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; De Lombaert S, 2000, J MED CHEM, V43, P488, DOI 10.1021/jm990507o; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DELOMBAERT S, 1994, BIOCHEM BIOPH RES CO, V204, P407, DOI 10.1006/bbrc.1994.2473; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Gaucher JF, 1999, BIOCHEMISTRY-US, V38, P12569, DOI 10.1021/bi991043z; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guarda G, 2010, IMMUNOLOGY, V130, P329, DOI 10.1111/j.1365-2567.2010.03283.x; Ikeda K, 1999, J BIOL CHEM, V274, P32469, DOI 10.1074/jbc.274.45.32469; Johnson GD, 2002, ARCH BIOCHEM BIOPHYS, V398, P240, DOI 10.1006/abbi.2001.2708; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Ksander GM, 1997, J MED CHEM, V40, P506, DOI 10.1021/jm960583g; Ksander GM, 1997, J MED CHEM, V40, P495, DOI 10.1021/jm960582o; KUKKOLA PJ, 1995, J CARDIOVASC PHARM, V26, pS65; LEE S, 1991, P NATL ACAD SCI USA, V88, P6353, DOI 10.1073/pnas.88.14.6353; Lorand L, 1976, Methods Enzymol, V45, P31; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muttucumaru DGN, 2011, TUBERCULOSIS, V91, P111, DOI 10.1016/j.tube.2010.11.010; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; Oefner C, 2004, ACTA CRYSTALLOGR D, V60, P392, DOI 10.1107/S0907444903027410; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Ramachandra L, 2005, INFECT IMMUN, V73, P1097, DOI 10.1128/IAI.73.2.1097-1105.2005; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schulz H, 2009, J MOL BIOL, V385, P178, DOI 10.1016/j.jmb.2008.10.052; Shetty SS, 1998, J CARDIOVASC PHARM, V31, pS68, DOI 10.1097/00005344-199800001-00022; Shimada K, 1996, BIOCHEM J, V315, P863, DOI 10.1042/bj3150863; SUDA H, 1973, J ANTIBIOT, V26, P621, DOI 10.7164/antibiotics.26.621; Sutterwala FS, 2007, J LEUKOCYTE BIOL, V82, P259, DOI 10.1189/jlb.1206755; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Torres M, 2006, INFECT IMMUN, V74, P1621, DOI 10.1128/IAI.74.3.1621-1630.2006; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1	48	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32475	32482		10.1074/jbc.M111.271809	http://dx.doi.org/10.1074/jbc.M111.271809			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21813647	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000294726800057
J	Kresge, N; Simoni, RD; Hill, RL				Kresge, Nicole; Simoni, Robert D.; Hill, Robert L.			The Molecular Genetics of Bacteriophage: The Work of Norton Zinder	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Reprint														Kresge, Nicole/0000-0003-1551-6627				LEDERBERG J, 1948, J AM CHEM SOC, V70, P4267, DOI 10.1021/ja01192a521; LODISH HF, 1966, SCIENCE, V152, P372, DOI 10.1126/science.152.3720.372; ZINDER ND, 1952, J BACTERIOL, V64, P679, DOI 10.1002/path.1700640402	3	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25							e4	10.1074/jbc.O111.000244	http://dx.doi.org/10.1074/jbc.O111.000244			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21830328	Green Published, hybrid			2022-12-27	WOS:000291719900001
J	VanSchouwen, B; Selvaratnam, R; Fogolari, F; Melacini, G				VanSchouwen, Bryan; Selvaratnam, Rajeevan; Fogolari, Federico; Melacini, Giuseppe			Role of Dynamics in the Autoinhibition and Activation of the Exchange Protein Directly Activated by Cyclic AMP (EPAC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL SELECTION; MOLECULAR-DYNAMICS; NMR-SPECTROSCOPY; BINDING DOMAINS; CELL-ADHESION; INDUCED FIT; KINASE-A; CAMP; MECHANISM; RECEPTOR	The exchange protein directly activated by cAMP (EPAC) is a key receptor of cAMP in eukaryotes and controls critical signaling pathways. Currently, no residue resolution information is available on the full-length EPAC dynamics, which are known to be pivotal determinants of allostery. In addition, no information is presently available on the intermediates for the classical induced fit and conformational selection activation pathways. Here these questions are addressed through molecular dynamics simulations on five key states along the thermodynamic cycle for the cAMP-dependent activation of a fully functional construct of EPAC2, which includes the cAMP-binding domain and the integral catalytic region. The simulations are not only validated by the agreement with the experimental trends in cAMP-binding domain dynamics determined by NMR, but they also reveal unanticipated dynamic attributes, rationalizing previously unexplained aspects of EPAC activation and autoinhibition. Specifically, the simulations show that cAMP binding causes an extensive perturbation of dynamics in the distal catalytic region, assisting the recognition of the Rap1b substrate. In addition, analysis of the activation intermediates points to a possible hybrid mechanism of EPAC allostery incorporating elements of both the induced fit and conformational selection models. In this mechanism an entropy compensation strategy results in a low free-energy pathway of activation. Furthermore, the simulations indicate that the autoinhibitory interactions of EPAC are more dynamic than previously anticipated, leading to a revised model of autoinhibition in which dynamics fine tune the stability of the autoinhibited state, optimally sensitizing it to cAMP while avoiding constitutive activation.	[VanSchouwen, Bryan; Selvaratnam, Rajeevan; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada; [Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada; [Fogolari, Federico] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy	McMaster University; McMaster University; University of Udine	Melacini, G (corresponding author), McMaster Univ, Dept Chem & Chem Biol, 1280 Main St W, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca		Fogolari, Federico/0000-0001-9862-250X; Selvaratnam, Rajeevan/0000-0003-4457-616X	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada (NSERC); Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by grants from the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada (NSERC) (to G. M.), and a Heart and Stroke Foundation of Canada M. Andrew New Investigator Award (to G. M.).	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171; Cho JH, 2011, NAT STRUCT MOL BIOL, V18, P550, DOI 10.1038/nsmb.2039; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Deindl S, 2009, P NATL ACAD SCI USA, V106, P20699, DOI 10.1073/pnas.0911512106; Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200; Grant BJ, 2010, CURR OPIN STRUC BIOL, V20, P142, DOI 10.1016/j.sbi.2009.12.004; Grunberg R, 2004, STRUCTURE, V12, P2125, DOI 10.1016/j.str.2004.09.014; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Harper SM, 2008, J BIOL CHEM, V283, P6501, DOI 10.1074/jbc.M707849200; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Jayaraman B, 2007, BIOCHEMISTRY-US, V46, P12174, DOI 10.1021/bi701281e; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Li S, 2011, J BIOL CHEM, V286, P17889, DOI 10.1074/jbc.M111.224535; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Mazhab-Jafari MT, 2007, J AM CHEM SOC, V129, P14482, DOI 10.1021/ja0753703; McCammon MG, 2004, CURR OPIN CHEM BIOL, V8, P60, DOI 10.1016/j.cbpa.2003.11.005; Nicholson LK, 2002, BIOPHYS J, V82, p3A; Patel N, 2011, J PHYS CHEM B, V115, P4856, DOI 10.1021/jp2012792; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Robert S, 2005, FEBS LETT, V579, P1136, DOI 10.1016/j.febslet.2005.01.010; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Schmidt M, 2007, CURR OPIN PHARMACOL, V7, P193, DOI 10.1016/j.coph.2006.10.004; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Tsalkova T, 2009, J BIOL CHEM, V284, P23644, DOI 10.1074/jbc.M109.024950; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Wong CF, 2003, ANNU REV PHARMACOL, V43, P31, DOI 10.1146/annurev.pharmtox.43.100901.140216	42	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42655	42669		10.1074/jbc.M111.277723	http://dx.doi.org/10.1074/jbc.M111.277723			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21873431	hybrid, Green Published			2022-12-27	WOS:000298180900073
J	Kilger, E; Buehler, A; Woelfing, H; Kumar, S; Kaeser, SA; Nagarathinam, A; Walter, J; Jucker, M; Coomaraswamy, J				Kilger, Ellen; Buehler, Anika; Woelfing, Heidrun; Kumar, Sathish; Kaeser, Stephan A.; Nagarathinam, Amudha; Walter, Jochen; Jucker, Mathias; Coomaraswamy, Janaky			BRI2 Protein Regulates beta-Amyloid Degradation by Increasing Levels of Secreted Insulin-degrading Enzyme (IDE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL BRITISH DEMENTIA; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; A-BETA; INTRACELLULAR DOMAIN; IN-VIVO; EXTRACELLULAR LEVELS; MEMORY DEFICITS; DANISH DEMENTIA; RECEPTOR	The amyloid precursor protein (APP) is one of the major proteins involved in Alzheimer disease (AD). Proteolytic cleavage of APP gives rise to amyloid-beta (A beta) peptides that aggregate and deposit extensively in the brain of AD patients. Although the increase in levels of aberrantly folded A beta peptide is considered to be important to disease pathogenesis, the regulation of APP processing and A beta metabolism is not fully understood. Recently, the British precursor protein (BRI2, ITM2B) has been implicated in influencing APP processing in cells and A beta deposition in vivo. Here, we show that the wild type BRI2 protein reduces plaque load in an AD mouse model, similar to its disease-associated mutant form, ADan precursor protein (ADanPP), and analyze in more detail the mechanism of how BRI2 and ADanPP influence APP processing and A beta metabolism. We find that overexpression of either BRI2 or ADanPP reduces extracellular A beta by increasing levels of secreted insulin-degrading enzyme (IDE), a major A beta-degrading protease. This effect is also observed with BRI2 lacking its C-terminal 23-amino acid peptide sequence. Our results suggest that BRI2 might act as a receptor protein that regulates IDE levels that in turn influences APP metabolism in a previously unrecognized way. Targeting the regulation of IDE may be a promising therapeutic approach to sporadic AD.	[Kilger, Ellen; Buehler, Anika; Woelfing, Heidrun; Kaeser, Stephan A.; Nagarathinam, Amudha; Jucker, Mathias; Coomaraswamy, Janaky] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany; [Kilger, Ellen; Buehler, Anika; Woelfing, Heidrun; Kaeser, Stephan A.; Nagarathinam, Amudha; Jucker, Mathias; Coomaraswamy, Janaky] German Ctr Neurodegenerat Dis, DZNE, D-72076 Tubingen, Germany; [Nagarathinam, Amudha] Grad Sch Cellular & Mol Neurosci, D-72074 Tubingen, Germany; [Kumar, Sathish; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn	Kilger, E (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Otfried Muller Str 27, D-72076 Tubingen, Germany.	ellen.kilger@uni-tuebingen.de; janaky.coomaraswamy@uni-tuebingen.de	Wang, Caihong/T-5837-2019; Kumar, Sathish/L-1367-2019; Walter, Jochen/B-3677-2014	Wang, Caihong/0000-0002-6808-3709; Kumar, Sathish/0000-0002-2792-7047; Walter, Jochen/0000-0002-4678-2912	German Research Foundation [Ju 655/3-1]; Carl-Zeiss Foundation	German Research Foundation(German Research Foundation (DFG)); Carl-Zeiss Foundation	This work was supported in part by German Research Foundation Grant Ju 655/3-1 and a stipend from the Carl-Zeiss Foundation.	Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Coomaraswamy J, 2010, P NATL ACAD SCI USA, V107, P7969, DOI 10.1073/pnas.1001056107; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; Du J, 2010, PHARMAZIE, V65, P231, DOI 10.1691/ph.2010.9607; Du J, 2009, BIOCHEM BIOPH RES CO, V383, P485, DOI 10.1016/j.bbrc.2009.04.047; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Eisele YS, 2007, MOL BIOL CELL, V18, P3591, DOI 10.1091/mbc.E07-01-0035; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Espuny-Camacho I, 2010, J ALZHEIMERS DIS, V20, P1119, DOI 10.3233/JAD-2010-091633; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fotinopoulou A, 2005, J BIOL CHEM, V280, P30768, DOI 10.1074/jbc.C500231200; Franklin K, 2004, MOUSE BRAIN STEREOTA; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Mathews PM, 2000, MOL MED, V6, P878, DOI 10.1007/BF03401825; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Matsuda S, 2011, NEUROBIOL AGING, V32, P1400, DOI 10.1016/j.neurobiolaging.2009.08.005; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Morelli L, 2005, BIOCHEM BIOPH RES CO, V332, P808, DOI 10.1016/j.bbrc.2005.05.020; Peng SW, 2010, BIOCHEM BIOPH RES CO, V393, P356, DOI 10.1016/j.bbrc.2009.12.122; Pittois K, 1998, GENE, V217, P141, DOI 10.1016/S0378-1119(98)00354-0; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Tamayev R, 2010, J NEUROSCI, V30, P14915, DOI 10.1523/JNEUROSCI.3917-10.2010; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Tsachaki M, 2010, NEUROBIOL AGING, V31, P88, DOI 10.1016/j.neurobiolaging.2008.03.004; Turner AJ, 2004, ANN NY ACAD SCI, V1035, P1, DOI 10.1196/annals.1332.001; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Weggen S, 2003, J BIOL CHEM, V278, P30748, DOI 10.1074/jbc.M304824200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4; Zhao LQ, 2011, NEUROBIOL AGING, V32, P1949, DOI 10.1016/j.neurobiolaging.2009.12.010; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004	51	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37446	37457		10.1074/jbc.M111.288373	http://dx.doi.org/10.1074/jbc.M111.288373			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21873424	Green Published, hybrid			2022-12-27	WOS:000296542400044
J	Veillard, F; Saidi, A; Burden, RE; Scott, CJ; Gillet, L; Lecaille, F; Lalmanach, G				Veillard, Florian; Saidi, Ahlame; Burden, Roberta E.; Scott, Christopher J.; Gillet, Ludovic; Lecaille, Fabien; Lalmanach, Gilles			Cysteine Cathepsins S and L Modulate Anti-angiogenic Activities of Human Endostatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; TUMOR-GROWTH; AMINOPEPTIDASE-N; COLLAGEN-XVIII; EMERGING ROLES; INHIBITORS; DEGRADATION; GENERATION; FRAGMENTS	Human endostatin, a potent anti-angiogenic protein, is generated by release of the C terminus of collagen XVIII. Here, we propose that cysteine cathepsins are involved in both the liberation and activation of bioactive endostatin fragments, thus regulating their anti-angiogenic properties. Cathepsins B, S, and L efficiently cleaved in vitro FRET peptides that encompass the hinge region corresponding to the N terminus of endostatin. However, in human umbilical vein endothelial cell-based assays, silencing of cathepsins S and L, but not cathepsin B, impaired the generation of the similar to 22-kDa endostatin species. Moreover, cathepsins L and S released two peptides from endostatin with increased angiostatic properties and both encompassing the NGR sequence, a vasculature homing motif. The G10T peptide (residues 1455-1464: collagen XVIII numbering) displayed compelling anti-proliferative (EC50 = 0.23 nM) and proapoptotic properties. G10T inhibited aminopeptidase N (APN/CD13) and reduced tube formation of endothelial cells in a manner similar to bestatin. Combination of G10T with bestatin resulted in no further increase in anti-angiogenic activity. Taken together, these data suggest that endostatin-derived peptides may represent novel molecular links between cathepsins and APN/CD13 in the regulation of angiogenesis.	[Lalmanach, Gilles] Univ Tours, Fac Med, Equipe Proteases & Pathol Pulm, INSERM,U618 Proteases & Vectorisat Pulm, F-37032 Tours, France; [Burden, Roberta E.; Scott, Christopher J.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland; [Gillet, Ludovic] Univ Tours, INSERM, Nutr Croissance & Canc U921, F-37000 Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Queens University Belfast; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Lalmanach, G (corresponding author), Univ Tours, Fac Med, Equipe Proteases & Pathol Pulm, INSERM,U618 Proteases & Vectorisat Pulm, 10 Blvd Tonnelle, F-37032 Tours, France.	gilles.lalmanach@univ-tours.fr	Lecaille, Fabien/GRY-5313-2022	Lalmanach, Gilles/0000-0001-8562-4821; Gillet, Ludovic/0000-0002-4990-6212; Veillard, Florian/0000-0003-1248-2396; Saidi, Ahlame/0000-0002-0282-2476; Lecaille, Fabien/0000-0003-1060-4222	Institut National de la Sante et de la Recherche Medicale (INSERM); l'Institut Federatif de Recherche "Imagerie Fonctionnelle", Tours, France [IFR 135]; Ministere de l'Education Nationale, de la Recherche et de la Technologie (France)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); l'Institut Federatif de Recherche "Imagerie Fonctionnelle", Tours, France; Ministere de l'Education Nationale, de la Recherche et de la Technologie (France)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM) and a grant from l'Institut Federatif de Recherche "Imagerie Fonctionnelle" (IFR 135, Tours, France).; Recipient of a doctoral fellowship from Ministere de l'Education Nationale, de la Recherche et de la Technologie (France).	Arap Wadih, 1998, Current Opinion in Oncology, V10, P560, DOI 10.1097/00001622-199811000-00014; Bauvois B, 2006, MED RES REV, V26, P88, DOI 10.1002/med.20044; Burden RE, 2009, CLIN CANCER RES, V15, P6042, DOI 10.1158/1078-0432.CCR-09-1262; Chang SH, 2009, CANCER RES, V69, P4537, DOI 10.1158/0008-5472.CAN-08-4539; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; Dennemarker J, 2010, ONCOGENE, V29, P1611, DOI 10.1038/onc.2009.466; Dhanabal M, 1999, BIOCHEM BIOPH RES CO, V258, P345, DOI 10.1006/bbrc.1999.0595; Dixelius J, 2002, CANCER RES, V62, P1944; Farias SL, 2006, BIOL CHEM, V387, P611, DOI 10.1515/BC.2006.078; Faye C, 2010, BIOCHEM J, V427, P467, DOI 10.1042/BJ20091594; Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187; Ferreras M, 2000, FEBS LETT, V486, P247, DOI 10.1016/S0014-5793(00)02249-3; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; Fukasawa K, 2006, CANCER LETT, V243, P135, DOI 10.1016/j.canlet.2005.11.051; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Godat E, 2004, BIOCHEM J, V383, P501, DOI 10.1042/BJ20040864; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; John H, 1999, BIOCHEMISTRY-US, V38, P10217, DOI 10.1021/bi990787+; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Ling Y, 2007, BIOCHEM BIOPH RES CO, V361, P79, DOI 10.1016/j.bbrc.2007.06.155; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Ma DHK, 2007, INVEST OPHTH VIS SCI, V48, P644, DOI 10.1167/iovs.06-0884; Marneros AG, 2001, MATRIX BIOL, V20, P337, DOI 10.1016/S0945-053X(01)00151-2; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Mucha A, 2010, BIOCHIMIE, V92, P1509, DOI 10.1016/j.biochi.2010.04.026; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Pasqualini R, 2000, CANCER RES, V60, P722; Reinheckel T, 2005, J CELL SCI, V118, P3387, DOI 10.1242/jcs.02469; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Serveau C, 1996, BIOCHEM J, V313, P951, DOI 10.1042/bj3130951; Serveau-Avesque C, 2006, BIOL CELL, V98, P15, DOI 10.1042/BC20040512; Standker L, 1997, FEBS LETT, V420, P129, DOI 10.1016/S0014-5793(97)01503-2; Suhr F, 2009, CURR PHARM DESIGN, V15, P389, DOI 10.2174/138161209787315756; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Veillard F, 2009, THESIS U FRANCOIS RA; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Wen W, 1999, CANCER RES, V59, P6052; Xu HL, 2008, CURR PROTEIN PEPT SC, V9, P275, DOI 10.2174/138920308784534050; Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414; Yokoyama Y, 2004, BRIT J CANCER, V90, P1627, DOI 10.1038/sj.bjc.6601745; YONEDA J, 1992, CLIN EXP METASTAS, V10, P49, DOI 10.1007/BF00163576	44	48	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37158	37167		10.1074/jbc.M111.284869	http://dx.doi.org/10.1074/jbc.M111.284869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896479	Green Published, hybrid			2022-12-27	WOS:000296542400016
J	Espinosa, A; Hennig, J; Ambrosi, A; Anandapadmanaban, M; Abelius, MS; Sheng, Y; Nyberg, F; Arrowsmith, CH; Sunnerhagen, M; Wahren-Herlenius, M				Espinosa, Alexander; Hennig, Janosch; Ambrosi, Aurelie; Anandapadmanaban, Madhanagopal; Abelius, Martina Sandberg; Sheng, Yi; Nyberg, Filippa; Arrowsmith, Cheryl H.; Sunnerhagen, Maria; Wahren-Herlenius, Marie			Anti-Ro52 Autoantibodies from Patients with Sjogren's Syndrome Inhibit the Ro52 E3 Ligase Activity by Blocking the E3/E2 Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; UBIQUITIN-CONJUGATING ENZYMES; CONGENITAL HEART-BLOCK; AUTOANTIGEN RO52; CYTOKINE EXPRESSION; FINGER PROTEIN; RING DOMAIN; RO/SS-A; COMPLEX; UBIQUITYLATION	Ro52 (TRIM21) is an E3 ligase of the tripartite motif family that negatively regulates proinflammatory cytokine production by ubiquitinating transcription factors of the interferon regulatory factor family. Autoantibodies to Ro52 are present in patients with lupus and Sjogren's syndrome, but it is not known if these autoantibodies affect the function of Ro52. To address this question, the requirements for Ro52 E3 ligase activity were first analyzed in detail. Scanning a panel of E2 ubiquitin-conjugating enzymes, we found that UBE2D1-4 and UBE2E1-2 supported the E3 ligase activity of Ro52 and that the E3 ligase activity of Ro52 was dependent on its RING domain. We also found that the N-terminal extensions in the class III E2 enzymes affected their interaction with Ro52. Although the N-terminal extension in UBE2E3 made this E2 enzyme unable to function together with Ro52, the N-terminal extensions in UBE2E1 and UBE2E2 allowed for a functional interaction with Ro52. Anti-Ro52-positive patient sera and affinity-purified anti-RING domain autoantibodies inhibited the E3 activity of Ro52 in ubiquitination assays. Using NMR, limited proteolysis, ELISA, and Ro52 mutants, we mapped the interactions between Ro52, UBE2E1, and anti-Ro52 autoantibodies. We found that anti-Ro52 autoantibodies inhibited the E3 ligase activity of Ro52 by sterically blocking the E2/E3 interaction between Ro52 and UBE2E1. Our data suggest that anti-Ro52 autoantibodies binding the RING domain of Ro52 may be actively involved in the pathogenesis of rheumatic autoimmune disease by inhibiting Ro52-mediated ubiquitination.	[Sunnerhagen, Maria] Linkoping Univ, Div Mol Biotechnol, IFM, SE-58183 Linkoping, Sweden; [Espinosa, Alexander; Ambrosi, Aurelie; Wahren-Herlenius, Marie] Karolinska Inst, Rheumatol Unit, Ctr Mol Med, Dept Med, SE-17176 Stockholm, Sweden; [Sheng, Yi; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Nyberg, Filippa] Karolinska Inst, Dept Clin Sci, Danderyd Hosp, SE-18288 Stockholm, Sweden; [Sheng, Yi] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada	Linkoping University; Karolinska Institutet; University of Toronto; Danderyds Hospital; Karolinska Institutet; York University - Canada	Sunnerhagen, M (corresponding author), Linkoping Univ, Div Mol Biotechnol, IFM, SE-58183 Linkoping, Sweden.	marsu@ifm.liu.se; marie.wahren@ki.se	Anandapadamanaban, Madhanagopal/F-3702-2014; Wahren-Herlenius, Marie/AAN-6942-2021	Wahren-Herlenius, Marie/0000-0002-0915-7245; Hennig, Janosch/0000-0001-5214-7002; Arrowsmith, Cheryl/0000-0002-4971-3250; Anandapadamanaban, Madhanagopal/0000-0002-4237-0048	Swedish Research Council; Swedish Foundation for Strategic Research; VINNOVA; CeNano; Swedish Cancer Society; Karolinska Institutet; Linkoping University; King Gustaf V's 80-Year Foundation; Heart-Lung Foundation; Stockholm County Council; Gustafsson Foundation; Soderberg Foundation; National Cancer Institute of Canada; Swedish Rheumatism Association; Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); VINNOVA(Vinnova); CeNano; Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet(Karolinska Institutet); Linkoping University; King Gustaf V's 80-Year Foundation; Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council); Gustafsson Foundation; Soderberg Foundation; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Swedish Rheumatism Association; Wallenberg Foundation(European Commission)	This work was supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, VINNOVA, CeNano, Swedish Cancer Society, Karolinska Institutet, Linkoping University, King Gustaf V's 80-Year Foundation, the Heart-Lung Foundation, the Stockholm County Council, The Gustafsson Foundation, The Soderberg Foundation, the National Cancer Institute of Canada, the Swedish Rheumatism Association, and The Wallenberg Foundation.	Arnett F C, 1990, Orthop Nurs, V9, P58, DOI 10.1097/00006416-199003000-00011; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; BORDEN KLB, 1993, FEBS LETT, V335, P255, DOI 10.1016/0014-5793(93)80741-C; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Ciechanover A, 2000, J CELL BIOCHEM, P40; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Espinosa A, 2006, J IMMUNOL, V176, P6277, DOI 10.4049/jimmunol.176.10.6277; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Espinosa A, 2008, EXP CELL RES, V314, P3605, DOI 10.1016/j.yexcr.2008.09.011; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hennig J, 2005, J BIOL CHEM, V280, P33250, DOI 10.1074/jbc.M503066200; Hennig J, 2008, BIOINFORMATICS, V24, P1310, DOI 10.1093/bioinformatics/btn116; Hennig J, 2008, J MOL BIOL, V377, P431, DOI 10.1016/j.jmb.2008.01.005; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Huang A, 2009, J MOL BIOL, V385, P507, DOI 10.1016/j.jmb.2008.10.044; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; JULKUNEN H, 1995, BRIT J RHEUMATOL, V34, P901; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Mercier P, 2007, PROTEIN SCI, V16, P602, DOI 10.1110/ps.062358007; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Ottosson L, 2005, SCAND J IMMUNOL, V61, P109, DOI 10.1111/j.0300-9475.2005.01542.x; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Sabile A, 2006, MOL CELL BIOL, V26, P5994, DOI 10.1128/MCB.01630-05; Salomonsson S, 2002, ARTHRITIS RHEUM-US, V46, P1233, DOI 10.1002/art.10232; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Shloush J, 2011, J BIOL CHEM, V286, P4796, DOI 10.1074/jbc.M110.157669; Strandberg L, 2008, J CLIN IMMUNOL, V28, P220, DOI 10.1007/s10875-007-9157-0; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wada K, 2006, BIOCHEM BIOPH RES CO, V339, P415, DOI 10.1016/j.bbrc.2005.11.029; Wahren M, 1998, J AUTOIMMUN, V11, P29, DOI 10.1006/jaut.1997.0173; Wahren-Herlenius M, 1999, IMMUNOL TODAY, V20, P234, DOI 10.1016/S0167-5699(99)01458-9; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yoshimi R, 2009, J IMMUNOL, V182, P7527, DOI 10.4049/jimmunol.0804121; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	50	46	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36478	36491		10.1074/jbc.M111.241786	http://dx.doi.org/10.1074/jbc.M111.241786			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21862588	Green Published, hybrid			2022-12-27	WOS:000296538300033
J	Liu, T; Deng, M; Li, JH; Tong, XM; Wei, Q; Ye, X				Liu, Ting; Deng, Min; Li, Junhui; Tong, Xiaomei; Wei, Qian; Ye, Xin			Phosphorylation of Right Open Reading Frame 2 (Rio2) Protein Kinase by Polo-like Kinase 1 Regulates Mitotic Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE PROGRESSION; SCF-BETA-TRCP; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ORGANIZATION; CYTOPLASMIC MATURATION; DNA-DAMAGE; YEAST; SUBUNIT; SPINDLE	Polo-like kinase 1 (Plk1) plays essential roles during multiple stages of mitosis by phosphorylating a number of substrates. Here, we report that the atypical protein kinase Rio2 is a novel substrate of Plk1 and can be phosphorylated by Plk1 at Ser-335, Ser-380, and Ser-548. Overexpression of Rio2 causes a prolonged mitotic exit whereas knockdown of Rio2 accelerates mitotic progression, suggesting that Rio2 is required for the proper mitotic progression. Overexpression of phospho-mimicking mutant Rio2 S3D but not the nonphosphorylatable mutant Rio2 S3A displays a profile similar to that of wild-type Rio2. These results indicate that the phosphorylation status of Rio2 correlates with its function in mitosis. Furthermore, time-lapse imaging data show that overexpression of Rio2 but not Rio2 S3A results in a slowed metaphase-anaphase transition. Collectively, these findings strongly indicate that the Plk1-mediated phosphorylation of Rio2 regulates metaphase-anaphase transition during mitotic progression.	[Liu, Ting; Deng, Min; Li, Junhui; Tong, Xiaomei; Wei, Qian; Ye, Xin] Chinese Acad Sci, Ctr Mol Immunol, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing 100101, Peoples R China; [Liu, Ting; Deng, Min; Li, Junhui; Wei, Qian] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, X (corresponding author), Chinese Acad Sci, Ctr Mol Immunol, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, 1 Beichen W Rd, Beijing 100101, Peoples R China.	yex@im.ac.cn			National Natural Science Foundation of China [30871238]; Ministry of Science and Technology of China [2009ZX10004-101, 2008ZX10002-009, 2011CB504705, 2012CB519003]; Chinese Academy of Sciences [KSCX2-YW-R-198, KSCX2-EW-J-6];  [81021003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); 	This work was supported by National Natural Science Foundation of China Grant 30871238, Ministry of Science and Technology of China Grants 2009ZX10004-101, 2008ZX10002-009, 2011CB504705, and 2012CB519003, and Chinese Academy of Sciences Innovation Projects KSCX2-YW-R-198 and KSCX2-EW-J-6.; Principal investigator of the Innovative Research Group of the National Natural Science Foundation of China and recipient of Foundation Grant 81021003. To whom correspondence should be addressed: Center for Molecular Immunology, CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 1 Beichen West Rd., Chaoyang District, Beijing 100101, China. Tel.: 86-1064807508; Fax: 86-10-64807513; E-mail: yex@im.ac.cn.	Angermayr M, 2002, MOL MICROBIOL, V44, P309, DOI 10.1046/j.1365-2958.2002.02881.x; Angermayr M, 2007, FEBS J, V274, P4654, DOI 10.1111/j.1742-4658.2007.05993.x; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Deng M, 2009, J BIOL CHEM, V284, P7875, DOI 10.1074/jbc.M807827200; Dez C, 2004, CURR OPIN MICROBIOL, V7, P631, DOI 10.1016/j.mib.2004.10.007; Eckerdt F, 2006, CANCER RES, V66, P6895, DOI 10.1158/0008-5472.CAN-06-0358; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Fry AM, 2006, DEV CELL, V11, P431, DOI 10.1016/j.devcel.2006.09.012; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geerlings TH, 2003, J BIOL CHEM, V278, P22537, DOI 10.1074/jbc.M300759200; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; LaRonde-LeBlanc N, 2005, J BIOL CHEM, V280, P37297, DOI 10.1074/jbc.R500013200; LaRonde-LeBlanc N, 2005, BBA-PROTEINS PROTEOM, V1754, P14, DOI 10.1016/j.bbapap.2005.07.037; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Oeffinger M, 2007, NUCLEIC ACIDS RES, V35, P1354, DOI 10.1093/nar/gkl824; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Yuan K, 2007, J BIOL CHEM, V282, P27414, DOI 10.1074/jbc.M703555200; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048	36	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36352	36360		10.1074/jbc.M111.250175	http://dx.doi.org/10.1074/jbc.M111.250175			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880710	hybrid, Green Published			2022-12-27	WOS:000296538300020
J	Luo, YH; Liu, Y; Sun, D; Ojcius, DM; Zhao, JF; Lin, XA; Wu, D; Zhang, RG; Chen, M; Li, LJ; Yan, J				Luo, Yihui; Liu, Yan; Sun, Dexter; Ojcius, David M.; Zhao, Jinfang; Lin, Xuai; Wu, Dong; Zhang, Rongguang; Chen, Ming; Li, Lanjuan; Yan, Jie			InvA Protein Is a Nudix Hydrolase Required for Infection by Pathogenic Leptospira in Cell Lines and Animals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE HOMOLOG INVA; BARTONELLA-BACILLIFORMIS; ADP-RIBOSE; POLYPHOSPHATES; EXPRESSION; ENCODES; STRESS; FAMILY; YGDP; PCR	Leptospirosis caused by pathogenic species of the genus Leptospira is a re-emerging zoonotic disease, which affects a wide variety of host species and is transmitted by contaminated water. The genomes of several pathogenic Leptospira species contain a gene named invA, which contains a Nudix domain. However, the function of this gene has never been characterized. Here, we demonstrated that the invA gene was highly conserved in protein sequence and present in all tested pathogenic Leptospira species. The recombinant InvA protein of pathogenic L. interrogans strain Lai hydrolyzed several specific dinucleoside oligophosphate substrates, reflecting the enzymatic activity of Nudix in Leptospira species. Pathogenic leptospires did not express this protein in media but temporarily expressed it at early stages (within 60 min) of infection of macrophages and nephric epithelial cells. Comparing with the wild type, the invA-deficient mutant displayed much lower infectivity and a significantly reduced survival rate in macrophages and nephric epithelial cells. Moreover, the invA-deficient leptospires presented an attenuated virulence in hamsters, caused mild histopathological damage, and were transmitted in lower numbers in the urine, compared with the wild-type strain. The invA revertant, made by complementing the invA-deficient mutant with the invA gene, reacquired virulence similar to the wild type in vitro and in vivo. The LD50 in hamsters was 1000-fold higher for the invA-deficient mutant than for the invA revertant and wild type. These results demonstrate that the InvA protein is a Nudix hydrolase, and the invA gene is essential for virulence in pathogenic Leptospira species.	[Luo, Yihui; Zhao, Jinfang; Lin, Xuai; Li, Lanjuan; Yan, Jie] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Div Bas, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Ming] Zhejiang Univ, Coll Life Sci, Dept Bioinformat, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Yan; Wu, Dong; Zhang, Rongguang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Sun, Dexter] Cornell Univ SinoUnited Hlth, New York Presbyterian Hosp, New York, NY 10021 USA; [Sun, Dexter] Cornell Univ SinoUnited Hlth, Hosp Special Surg, Weill Med Coll, New York, NY 10021 USA; [Ojcius, David M.] Univ Calif, Hlth Sci Res Inst, Merced, CA 95343 USA; [Ojcius, David M.] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA; [Luo, Yihui; Zhao, Jinfang; Lin, Xuai; Yan, Jie] Zhejiang Univ, Coll Med, Dept Med Microbiol & Parasitol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Institute of Biophysics, CAS; NewYork-Presbyterian Hospital; Cornell University; University of California System; University of California Merced; University of California System; University of California Merced; Zhejiang University	Li, LJ (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Div Bas, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn; med_bp@zju.edu.cn	Ojcius, David/ABE-6557-2020; Chen, Ming/AAV-3682-2020	Chen, Ming/0000-0002-9677-1699	National Natural Science Foundation of China [30970112, 31000334]; National Key Lab for Diagnosis and Treatment of Infectious Diseases of China [2010ZZ09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Lab for Diagnosis and Treatment of Infectious Diseases of China	This work was supported by the National Natural Science Foundation of China (Grants 30970112 and 31000334) and the National Key Lab for Diagnosis and Treatment of Infectious Diseases of China (Grant 2010ZZ09).	AMES BN, 1960, J BIOL CHEM, V235, P769; Bauby H, 2003, MICROBIOL-SGM, V149, P689, DOI 10.1099/mic.0.26065-0; BAXI MD, 1995, J PHARMACOL TOX MET, V33, P121, DOI 10.1016/1056-8719(94)00127-P; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bessman MJ, 2001, J BIOL CHEM, V276, P37834; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Carrillo-Casas EM, 2008, CURR MICROBIOL, V56, P539, DOI 10.1007/s00284-008-9096-x; Cartwright JL, 1999, BIOCHEM BIOPH RES CO, V256, P474, DOI 10.1006/bbrc.1999.0354; Carvalho E, 2010, CURR MICROBIOL, V60, P134, DOI 10.1007/s00284-009-9519-3; Chidambaram N, 2007, J Commun Dis, V39, P105; Cholujova D, 2008, IMMUNOBIOLOGY, V213, P629, DOI 10.1016/j.imbio.2008.02.006; Conyers GB, 1999, J BIOL CHEM, V274, P1203, DOI 10.1074/jbc.274.3.1203; DeCoursey TE, 1996, J MEMBRANE BIOL, V152, P141, DOI 10.1007/s002329900093; DESOUZA L, 1992, CAN J MICROBIOL, V38, P284, DOI 10.1139/m92-047; Djadid ND, 2009, DIAGN MICR INFEC DIS, V63, P251, DOI 10.1016/j.diagmicrobio.2008.10.017; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Fowler JD, 2006, CHEM REV, V106, P2092, DOI 10.1021/cr040445w; Gaywee J, 2002, MOL CELL PROTEOMICS, V1, P179, DOI 10.1074/mcp.M100030-MCP200; Gaywee J, 2002, INFECT IMMUN, V70, P6346, DOI 10.1128/IAI.70.11.6346-6354.2002; Ismail TM, 2003, J BIOL CHEM, V278, P32602, DOI 10.1074/jbc.M305994200; Jamur MC, 2010, METHODS MOL BIOL, V588, P63, DOI 10.1007/978-1-59745-324-0_9; Jin DD, 2009, INFECT IMMUN, V77, P799, DOI 10.1128/IAI.00914-08; Kisselev LL, 1998, FEBS LETT, V427, P157, DOI 10.1016/S0014-5793(98)00420-7; Krishnamurthy H, 2005, PROTEINS, V58, P88, DOI 10.1002/prot.20301; LEE PC, 1983, P NATL ACAD SCI-BIOL, V80, P7496, DOI 10.1073/pnas.80.24.7496; Lee SH, 2002, INFECT IMMUN, V70, P315, DOI 10.1128/IAI.70.1.315-322.2002; Li SJ, 2010, INNATE IMMUN-LONDON, V16, P80, DOI 10.1177/1753425909105580; Louis Petra, 2010, Science Progress, V93, P7, DOI 10.3184/003685009X12605525292307; Lundin A, 2003, J BIOL CHEM, V278, P12574, DOI 10.1074/jbc.M212542200; Luo DJ, 2009, VACCINE, V28, P243, DOI 10.1016/j.vaccine.2009.09.089; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; McLennan AG, 2001, DRUG DEVELOP RES, V52, P249, DOI 10.1002/ddr.1122; McLennan AG, 2000, PHARMACOL THERAPEUT, V87, P73, DOI 10.1016/S0163-7258(00)00041-3; Monahan AM, 2008, INFECT IMMUN, V76, P4952, DOI 10.1128/IAI.00511-08; Murphy GA, 2000, CANCER RES, V60, P2342; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Nishimura A, 1998, TRENDS BIOCHEM SCI, V23, P157, DOI 10.1016/S0968-0004(98)01197-9; O'Handley SF, 1998, J BIOL CHEM, V273, P3192, DOI 10.1074/jbc.273.6.3192; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x; PRESCOTT M, 1989, BIOCHEM J, V259, P831, DOI 10.1042/bj2590831; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Saint Girons I, 2000, J BACTERIOL, V182, P5700, DOI 10.1128/JB.182.20.5700-5705.2000; Schreier S, 2009, BIOL RES, V42, P5, DOI [10.4067/S0716-97602009000100001, /S0716-97602009000100001]; Vijayachari P, 2008, J BIOSCIENCES, V33, P557, DOI 10.1007/s12038-008-0074-z; WANG B, 1984, INFECT IMMUN, V46, P809, DOI 10.1128/IAI.46.3.809-813.1984; Warren R, 2011, MICROB PATHOGENESIS, V50, P12, DOI 10.1016/j.micpath.2010.10.002; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Zhang J., 2010, PLOS ONE, V5	50	10	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36852	36863		10.1074/jbc.M111.219931	http://dx.doi.org/10.1074/jbc.M111.219931			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21862592	hybrid, Green Published			2022-12-27	WOS:000296538300065
J	Cohen, CJ; Rebollo, R; Babovic, S; Dai, EL; Robinson, WP; Mager, DL				Cohen, Carla J.; Rebollo, Rita; Babovic, Sonja; Dai, Elizabeth L.; Robinson, Wendy P.; Mager, Dixie L.			Placenta-specific Expression of the Interleukin-2 (IL-2) Receptor beta Subunit from an Endogenous Retroviral Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIN-B RECEPTOR; NATURAL-KILLER-CELLS; LONG TERMINAL REPEAT; ALTERNATIVE PROMOTERS; MAMMALIAN GENOMES; IN-VITRO; METHYLATION; GENES; CHAIN; IDENTIFICATION	The long terminal repeat (LTR) sequences of endogenous retroviruses and retroelements contain promoter elements and are known to form chimeric transcripts with nearby cellular genes. Here we show that an LTR of the THE1D retroelement family has been domesticated as an alternative promoter of human IL2RB, the gene encoding the beta subunit of the IL-2 receptor. The LTR promoter confers expression specifically in the placental trophoblast as opposed to its native transcription in the hematopoietic system. Rather than sequence-specific determinants, DNA methylation was found to regulate transcription initiation and splicing efficiency in a tissue-specific manner. Furthermore, we detected the cytoplasmic signaling domain of the IL-2R beta protein in the placenta, suggesting that IL-2R beta undergoes preferential proteolytic cleavage in this tissue. These findings implicate novel functions for this cytokine receptor subunit in the villous trophoblast and reveal an intriguing example of ancient LTR exaptation to drive tissue-specific gene expression.	[Cohen, Carla J.; Rebollo, Rita; Babovic, Sonja; Dai, Elizabeth L.; Mager, Dixie L.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Robinson, Wendy P.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; [Robinson, Wendy P.] Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada	British Columbia Cancer Agency; University of British Columbia; Child & Family Research Institute	Mager, DL (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	dmager@bccrc.ca	Robinson, Wendy/AAB-6420-2020; Robinson, Wendy P/I-9590-2014	Robinson, Wendy/0000-0002-2010-6174; Robinson, Wendy P/0000-0002-2010-6174; Cohen, Carla/0000-0002-8398-0010; Rebollo, Rita/0000-0002-8138-5082	Canadian Institute for Health Research	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institute for Health Research (to D. L. M.) with core support provided by the BC Cancer Agency.	Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Amash A, 2007, EUR CYTOKINE NETW, V18, P188, DOI 10.1684/ecn.2007.0102; Avila L, 2010, PLACENTA, V31, P1070, DOI 10.1016/j.placenta.2010.09.011; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Belshaw R, 2007, J VIROL, V81, P9437, DOI 10.1128/JVI.02216-06; Blikstad V, 2008, CELL MOL LIFE SCI, V65, P3348, DOI 10.1007/s00018-008-8495-2; BOEHM KD, 1989, P NATL ACAD SCI USA, V86, P656, DOI 10.1073/pnas.86.2.656; Bulmer JN, 2010, INT J DEV BIOL, V54, P281, DOI 10.1387/ijdb.082763jb; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; Conley AB, 2008, BIOINFORMATICS, V24, P1563, DOI 10.1093/bioinformatics/btn243; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Dunn CA, 2003, P NATL ACAD SCI USA, V100, P12841, DOI 10.1073/pnas.2134464100; Fernandez-Botran R, 1999, CRIT REV CL LAB SCI, V36, P165, DOI 10.1080/10408369991239196; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Hamai Y, 1999, AM J REPROD IMMUNOL, V41, P153; Henderson KG, 1996, HUM GENET, V97, P650; HONDA M, 1990, J IMMUNOL, V145, P4131; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Kilic M, 1999, AM J REPROD IMMUNOL, V41, P61; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lan RY, 2008, J AUTOIMMUN, V31, P7, DOI 10.1016/j.jaut.2008.03.002; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Landry JR, 2003, J VIROL, V77, P7459, DOI 10.1128/JVI.77.13.7459-7466.2003; Landry JR, 2002, MOL BIOL EVOL, V19, P1934, DOI 10.1093/oxfordjournals.molbev.a004017; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; MAJORS J, 1990, CURR TOP MICROBIOL, V157, P49; Matouskova M, 2006, EXP CELL RES, V312, P1011, DOI 10.1016/j.yexcr.2005.12.010; Medstrand P, 2001, J BIOL CHEM, V276, P1896, DOI 10.1074/jbc.M006557200; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; de Oca PM, 2010, J BIOL CHEM, V285, P22050, DOI 10.1074/jbc.M109.093088; Murakami S, 2004, FRONT BIOSCI-LANDMRK, V9, P3085, DOI 10.2741/1461; MURANYI W, 1991, J VIROL, V65, P727, DOI 10.1128/JVI.65.2.727-735.1991; Okahara G, 2004, GENOMICS, V84, P982, DOI 10.1016/j.ygeno.2004.09.004; Prudhomme S, 2004, J VIROL, V78, P12157, DOI 10.1128/JVI.78.22.12157-12168.2004; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Rein DT, 2003, CYTOKINE, V23, P119, DOI 10.1016/S1043-4666(03)00220-5; Reiss D, 2007, NUCLEIC ACIDS RES, V35, P4743, DOI 10.1093/nar/gkm455; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; Sugimoto J, 2009, REPROD SCI, V16, P1023, DOI 10.1177/1933719109336620; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szpakowski S, 2009, GENE, V448, P151, DOI 10.1016/j.gene.2009.08.006; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; Varela M, 2009, ANN NY ACAD SCI, V1178, P157, DOI 10.1111/j.1749-6632.2009.05002.x; Verma S, 2000, BIOL REPROD, V62, P959, DOI 10.1095/biolreprod62.4.959; Walser JC, 2008, GENOME RES, V18, P1403, DOI 10.1101/gr.076455.108; Witkowska AM, 2005, MEDIAT INFLAMM, P121, DOI 10.1155/MI.2005.121; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Yoshida M, 1999, ANN NY ACAD SCI, V886, P23, DOI 10.1111/j.1749-6632.1999.tb09397.x; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Zygmunt M, 1998, AM J REPROD IMMUNOL, V40, P326	57	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35543	35552		10.1074/jbc.M111.227637	http://dx.doi.org/10.1074/jbc.M111.227637			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865161	hybrid, Green Published			2022-12-27	WOS:000295927100026
J	Torrelles, JB; Sieling, PA; Arcos, J; Knaup, R; Bartling, C; Rajaram, MVS; Stenger, S; Modlin, RL; Schlesinger, LS				Torrelles, Jordi B.; Sieling, Peter A.; Arcos, Jesus; Knaup, Rose; Bartling, Craig; Rajaram, Murugesan V. S.; Stenger, Steffen; Modlin, Robert L.; Schlesinger, Larry S.			Structural Differences in Lipomannans from Pathogenic and Nonpathogenic Mycobacteria That Impact CD1b-restricted T Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROCOCCUS-LYSODEIKTICUS; ANTIGEN PRESENTATION; LIPOGLYCAN ANTIGENS; HUMAN MACROPHAGES; HOST-DEFENSE; BOVIS BCG; LIPOARABINOMANNAN; TUBERCULOSIS; RECOGNITION; CD1B	Mannosylated molecules on the Mycobacterium tuberculosis surface are important determinants in the immunopathogenesis of tuberculosis. To date, much attention has been paid to mannose-capped lipoarabinomannan, which mediates phagocytosis and intracellular trafficking of M. tuberculosis by engaging the macrophage mannose receptor and subsequently binds to intracellular CD1b molecules for presentation to T cells. Another important mannosylated lipoglycan on the M. tuberculosis surface is lipomannan (LM). Comparative structural detail of the LMs from virulent and avirulent strains is limited as is knowledge regarding their differential capacity to be recognized by the adaptive immune response. Here, we purified LM from the avirulent M. smegmatis and the virulent M. tuberculosis H37Rv, performed a comparative structural biochemical analysis, and addressed their ability to stimulate CD1b-restricted T cell clones. We found that M. tuberculosis H37Rv produces a large neutral LM (TB-LM); in contrast, M. smegmatis produces a smaller linear acidic LM (SmegLM) with a high succinate content. Correspondingly, TB-LM was not as efficiently presented to CD1b-restricted T cells as SmegLM. Thus, here we correlate the structure-function relationships for LMs with CD1b-restricted T cell responses and provide evidence that the structural features of TB-LM contribute to its diminished T cell responsiveness.	[Torrelles, Jordi B.; Arcos, Jesus; Knaup, Rose; Bartling, Craig; Rajaram, Murugesan V. S.; Schlesinger, Larry S.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Torrelles, Jordi B.; Arcos, Jesus; Knaup, Rose; Bartling, Craig; Rajaram, Murugesan V. S.; Schlesinger, Larry S.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Torrelles, Jordi B.; Arcos, Jesus; Knaup, Rose; Bartling, Craig; Rajaram, Murugesan V. S.; Schlesinger, Larry S.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Sieling, Peter A.; Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Stenger, Steffen] Univ Hosp Ulm, Inst Med Microbiol & Hyg, D-89081 Ulm, Germany	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ulm University	Schlesinger, LS (corresponding author), Ohio State Univ, Ctr Microbial Interface Biol, 460 W 12th Ave,Rm 1004, Columbus, OH 43210 USA.	larry.schlesinger@osumc.edu	Modlin, Robert L/M-7941-2014; Torrelles, Jordi/E-4204-2011; Rajaram, Murugesan/E-5203-2013	Modlin, Robert L/0000-0003-4720-031X; Rajaram, Murugesan/0000-0002-1515-1122	National Institutes of Health [AI052458, AI33004, AR040312, AI073856]; Parker B. Francis Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI033004, R21AI052458, R01AI033004, K99AI073856, R01AI052458, R00AI073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI052458 and AI33004 (to L. S. S.), AR040312 (to R. L. M. and P. A. S.), and AI073856. This work was also supported by a Parker B. Francis Fellowship (to J. B. T.).	Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Behar SM, 2007, CURR TOP MICROBIOL, V314, P215; BEHAR SM, 1995, J EXP MED, V182, P2007, DOI 10.1084/jem.182.6.2007; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cheng TY, 2006, EMBO J, V25, P2989, DOI 10.1038/SJ.EMBOJ.7601185; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; DELL A, 1994, METHOD ENZYMOL, V230, P108; Delmas C, 1997, GLYCOBIOLOGY, V7, P811, DOI 10.1093/glycob/7.6.811; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Gilleron M, 1999, J MOL BIOL, V285, P2147, DOI 10.1006/jmbi.1998.2438; Guerardel Y, 2003, J BIOL CHEM, V278, P36637, DOI 10.1074/jbc.M305427200; Guerardel Y, 2002, J BIOL CHEM, V277, P30635, DOI 10.1074/jbc.M204398200; KASINRERK W, 1993, J IMMUNOL, V150, P579; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; LIM SH, 1981, BIOCHIM BIOPHYS ACTA, V638, P275, DOI 10.1016/0005-2728(81)90237-1; MEHRA V, 1992, J EXP MED, V175, P275, DOI 10.1084/jem.175.1.275; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Moody DB, 2005, NAT REV IMMUNOL, V5, P387, DOI 10.1038/nri1605; Moody DB, 1999, IMMUNOL REV, V172, P285, DOI 10.1111/j.1600-065X.1999.tb01373.x; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; OWEN P, 1975, BIOCHEM BIOPH RES CO, V63, P875, DOI 10.1016/0006-291X(75)90649-X; PANCHOLI P, 1993, SCIENCE, V260, P984, DOI 10.1126/science.8098550; PLESS DD, 1975, J BIOL CHEM, V250, P1319; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Relloso M, 2008, IMMUNITY, V28, P774, DOI 10.1016/j.immuni.2008.04.017; Schlesinger LS, 2008, HDB TUBERCULOSIS IMM, P1; Sieling PA, 2005, J IMMUNOL, V174, P2637, DOI 10.4049/jimmunol.174.5.2637; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Torrelles JB, 2004, J BIOL CHEM, V279, P41227, DOI 10.1074/jbc.M405180200; Torrelles JB, 2008, J BIOL CHEM, V283, P31417, DOI 10.1074/jbc.M806350200; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Torrelles JB, 2010, TUBERCULOSIS, V90, P84, DOI 10.1016/j.tube.2010.02.003; Vercellone A, 1998, FRONT BIOSCI-LANDMRK, V3, pE149; Zajonc DM, 2007, CURR OPIN STRUC BIOL, V17, P521, DOI 10.1016/j.sbi.2007.09.010	39	27	28	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35438	35446		10.1074/jbc.M111.232587	http://dx.doi.org/10.1074/jbc.M111.232587			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21859718	Green Published, hybrid			2022-12-27	WOS:000295927100015
J	Chen, GB; Tan, CS; Teh, BK; Lu, JH				Chen, Guobao; Tan, Carol Shurong; Teh, Boon King; Lu, Jinhua			Molecular Mechanisms for Synchronized Transcription of Three Complement C1q Subunit Genes in Dendritic Cells and Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MULTIPOTENT HEMATOPOIETIC PROGENITORS; APOPTOTIC CELLS; CYTOKINE PRODUCTION; INTERFERON-GAMMA; 1ST COMPONENT; IN-VIVO; DEFICIENCY; ACTIVATION; EXPRESSION	Hereditary homozygous C1q deficiency is rare, but it almost certainly causes systemic lupus erythematosus. On the other hand, C1q levels can decline in systemic lupus erythematosus patients without apparent C1q gene defects and the versatility in C1q production is a likely cause. As an 18-subunit protein, C1q is assembled in a 1:1:1 ratio from three different subunits. The three human C1q genes are closely bundled on chromosome 1 (C1qA-C1qC-C1qB) and their basal and IFN gamma-stimulated expression, largely restricted to macrophages and dendritic cells, is apparently synchronized. We cloned the three gene promoters and observed that although the C1qB promoter exhibited basal and IFN gamma-stimulated activities consistent with the endogenous C1qB gene, the activities of the cloned C1qA and C1qC promoters were suppressed by IFN gamma. To certain extents, these were corrected when the C1qB promoter was cloned at the 3' end across the luciferase reporter gene. A 53-bp element is essential to the activities of the C1qB promoter and the transcription factors PU.1 and IRF8 bound to this region. By chromatin immunoprecipitation, the C1qB promoter was co-precipitated with PU.1 and IRF8. shRNA knockdown of PU.1 and IRF8 diminished C1qB promoter response to IFN gamma. STAT1 instead regulated C1qB promoter through IRF8 induction. Collectively, our results reveal a novel transcriptional mechanism by which the expression of the three C1q genes is synchronized.	[Lu, Jinhua] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore; Natl Univ Singapore, Immunol Programme, Singapore 117597, Singapore	National University of Singapore; National University of Singapore	Lu, JH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Blk MD4,5 Sci Dr 2, Singapore 117597, Singapore.	miclujh@nus.edu.sg	Chen, Guobao/D-1198-2017	Chen, Guobao/0000-0001-5853-5962; Lu, Jinhua/0000-0002-3699-9894	National Medical Research Council (Singapore) [NMRC/0950/2005, NMRC/1144/200]	National Medical Research Council (Singapore)(National Medical Research Council, Singapore)	This work was supported by National Medical Research Council (Singapore) Grants NMRC/0950/2005 and NMRC/1144/200.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Agostinis C, 2010, J IMMUNOL, V185, P4420, DOI 10.4049/jimmunol.0903215; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Baruah P, 2009, BLOOD, V113, P3485, DOI 10.1182/blood-2008-06-164392; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Cao WP, 2003, CARDIOVASC RES, V60, P175, DOI 10.1016/S0008-6363(03)00345-6; Castellano G, 2004, BLOOD, V103, P3813, DOI 10.1182/blood-2003-09-3046; Castellano G, 2007, EUR J IMMUNOL, V37, P2803, DOI 10.1002/eji.200636845; COLTEN HR, 1986, CIBA F SYMP, V118, P141, DOI 10.1002/9780470720998.ch10; Contursi C, 2000, P NATL ACAD SCI USA, V97, P91, DOI 10.1073/pnas.97.1.91; Edelbauer M, 2011, PEDIATR NEPHROL, V26, P401, DOI 10.1007/s00467-010-1720-x; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Gordon MM, 2000, LUPUS, V9, P68, DOI 10.1177/096120330000900113; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; GREISMAN SG, 1987, J IMMUNOL, V138, P739; Hu YL, 2010, J BIOL CHEM, V285, P28777, DOI 10.1074/jbc.M110.131318; Kaneko T, 2006, EXP DERMATOL, V15, P308, DOI 10.1111/j.0906-6705.2006.00408.x; Kanno Y, 2005, J INTERF CYTOK RES, V25, P770, DOI 10.1089/jir.2005.25.770; Korb LC, 1997, J IMMUNOL, V158, P4525; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Lood C, 2009, ARTHRITIS RHEUM-US, V60, P3081, DOI 10.1002/art.24852; LOOS M, 1980, J IMMUNOL, V124, P59; Lu JH, 2002, BBA-GEN SUBJECTS, V1572, P387, DOI 10.1016/S0304-4165(02)00320-3; Lu J, 2008, CELL MOL IMMUNOL, V5, P9, DOI 10.1038/cmi.2008.2; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Marecki S, 2001, J IMMUNOL, V166, P6829, DOI 10.4049/jimmunol.166.11.6829; Marecki S, 2000, CELL BIOCHEM BIOPHYS, V33, P127, DOI 10.1385/CBB:33:2:127; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; MIRKOVITCH J, 1992, MOL CELL BIOL, V12, P1; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; MULLER W, 1978, J IMMUNOL, V121, P1578; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Ogden CA, 2005, AUTOIMMUNITY, V38, P259, DOI 10.1080/08916930500124452; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Petry F, 2005, IMMUNOGENETICS, V57, P566, DOI 10.1007/s00251-005-0023-z; Pickering M C, 2000, Adv Immunol, V76, P227; Qi CF, 2009, IMMUNOL RES, V45, P62, DOI 10.1007/s12026-008-8032-2; Radjainia M, 2008, J MOL BIOL, V381, P419, DOI 10.1016/j.jmb.2008.06.015; REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019; REID KBM, 1986, ESSAYS BIOCHEM, V22, P27; SCHWAEBLE W, 1995, J IMMUNOL, V155, P4971; SELLAR GC, 1991, BIOCHEM J, V274, P481, DOI 10.1042/bj2740481; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Teh BK, 2011, MOL IMMUNOL, V48, P1128, DOI 10.1016/j.molimm.2011.02.006; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wu FQ, 2011, RHEUMATOL INT, V31, P501, DOI 10.1007/s00296-009-1257-0; Yamada M, 2004, EUR J IMMUNOL, V34, P221, DOI 10.1002/eji.200324026; Yuzaki M, 2011, CURR OPIN NEUROBIOL, V21, P215, DOI 10.1016/j.conb.2011.01.010	49	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34941	34950		10.1074/jbc.M111.286427	http://dx.doi.org/10.1074/jbc.M111.286427			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21862594	hybrid, Green Published			2022-12-27	WOS:000295406300048
J	Farzan, SF; Palermo, LM; Yokoyama, CC; Orefice, G; Fornabaio, M; Sarkar, A; Kellogg, GE; Greengard, O; Porotto, M; Moscona, A				Farzan, Shohreh F.; Palermo, Laura M.; Yokoyama, Christine C.; Orefice, Gianmarco; Fornabaio, Micaela; Sarkar, Aurijit; Kellogg, Glen E.; Greengard, Olga; Porotto, Matteo; Moscona, Anne			Premature Activation of the Paramyxovirus Fusion Protein before Target Cell Attachment with Corruption of the Viral Fusion Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PARAINFLUENZA VIRUS; HEMAGGLUTININ-NEURAMINIDASE PROTEIN; HN-RECEPTOR INTERACTION; MEMBRANE-FUSION; BINDING-SITE; INFLUENZA HEMAGGLUTININ; CONFORMATIONAL-CHANGE; 4-GU-DANA ZANAMIVIR; RESPIRATORY-DISEASE; AIRWAY EPITHELIUM	Paramyxoviruses, including the childhood pathogen human parainfluenza virus type 3, enter host cells by fusion of the viral and target cell membranes. This fusion results from the concerted action of its two envelope glycoproteins, the hemagglutinin-neuraminidase (HN) and the fusion protein (F). The receptor-bound HN triggers F to undergo conformational changes that render it competent to mediate fusion of the viral and cellular membranes. We proposed that, if the fusion process could be activated prematurely before the virion reaches the target host cell, infection could be prevented. We identified a small molecule that inhibits paramyxovirus entry into target cells and prevents infection. We show here that this compound works by an interaction with HN that results in F-activation prior to receptor binding. The fusion process is thereby prematurely activated, preventing fusion of the viral membrane with target cells and precluding viral entry. This first evidence that activation of a paramyxovirus F can be specifically induced before the virus contacts its target cell suggests a new strategy with broad implications for the design of antiviral agents.	[Farzan, Shohreh F.; Palermo, Laura M.; Yokoyama, Christine C.; Orefice, Gianmarco; Greengard, Olga; Porotto, Matteo; Moscona, Anne] Cornell Univ, Dept Pediat, Weill Med Coll, New York, NY 10021 USA; [Farzan, Shohreh F.; Palermo, Laura M.; Yokoyama, Christine C.; Orefice, Gianmarco; Greengard, Olga; Porotto, Matteo; Moscona, Anne] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; [Fornabaio, Micaela; Sarkar, Aurijit; Kellogg, Glen E.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Fornabaio, Micaela; Sarkar, Aurijit; Kellogg, Glen E.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA; [Greengard, Olga] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA	Cornell University; Cornell University; Virginia Commonwealth University; Virginia Commonwealth University; Icahn School of Medicine at Mount Sinai	Moscona, A (corresponding author), Cornell Univ, Dept Pediat, Weill Med Coll, 515 E 71st St,Box 309, New York, NY 10021 USA.	anm2047@med.cornell.edu	Sarkar, Aurijit/AAW-3417-2020; Sarkar, Aurijit/I-5175-2012	Sarkar, Aurijit/0000-0003-3735-6345; Kellogg, Glen/0000-0002-6282-6794; POROTTO, Matteo/0000-0003-3866-9220	National Institutes of Health [U54AI057158, R01AI31971, 3R01AI031971-19S1, R21EBO11707, R01GM017894]; Parker B. Francis Fellowship in Pulmonary Research; Bill and Melinda Gates Grand Challenges Exploration grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R01AI031971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB011707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship in Pulmonary Research; Bill and Melinda Gates Grand Challenges Exploration grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants U54AI057158 (to M. P. and A. M., from the Northeast Center of Excellence for Bio-defense and Emerging Infectious Disease Research R01AI31971 (to A. M.), 3R01AI031971-19S1 (Research Supplement to Promote Diversity in Health-related Research Program, to A. M.), R21EBO11707 (to M. P.), and R01GM017894 (to G. E. K.). This work was also supported by a Parker B. Francis Fellowship in Pulmonary Research (to L. M. P.) and by a Bill and Melinda Gates Grand Challenges Exploration grant (to A. M.).	Calvo C., 2011, PEDIAT INFECT DIS J; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Collins P. L., 1996, FIELDS VIROLOGY, P1205; Connolly SA, 2009, J VIROL, V83, P10857, DOI 10.1128/JVI.01191-09; Cozzini P, 2002, J MED CHEM, V45, P2469, DOI 10.1021/jm0200299; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; Cunha BA, 2011, HEART LUNG, V40, P76, DOI 10.1016/j.hrtlng.2010.05.060; Damico R, 2000, J VIROL, V74, P6469, DOI 10.1128/JVI.74.14.6469-6475.2000; Damico R, 1999, J VIROL, V73, P3087, DOI 10.1128/JVI.73.4.3087-3094.1999; Deng R, 1997, ARCH VIROL, P115; DENG RT, 1995, VIROLOGY, V209, P457, DOI 10.1006/viro.1995.1278; Greengard O, 2000, J VIROL, V74, P11108, DOI 10.1128/JVI.74.23.11108-11114.2000; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Hodson A., 2011, BONE MARROW TRANSPLA; Hoffman LR, 1997, J VIROL, V71, P8808, DOI 10.1128/JVI.71.11.8808-8820.1997; HOMMA M, 1973, J VIROL, V12, P1457, DOI 10.1128/JVI.12.6.1457-1465.1973; HURST T, 1994, J CHEM INF COMP SCI, V34, P190, DOI 10.1021/ci00017a025; Irwin JJ, 2005, BIOCHEMISTRY-US, V44, P12316, DOI 10.1021/bi050801k; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; LAMB RA, 1993, VIROLOGY, V197, P1, DOI 10.1006/viro.1993.1561; Lawrence MC, 2004, J MOL BIOL, V335, P1343, DOI 10.1016/j.jmb.2003.11.032; Lee A. V., 2011, TRANSPL INFECT DIS; Madhi SA, 2006, VACCINE, V24, P2432, DOI 10.1016/j.vaccine.2005.12.002; Marcolini JA, 2003, EUR J CLIN MICROBIOL, V22, P79, DOI 10.1007/s10096-002-0864-4; Mirza AM, 2011, J BIOL CHEM, V286, P17851, DOI 10.1074/jbc.M111.233965; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P1171, DOI 10.1093/nar/24.6.1171; Moscona A, 2005, J CLIN INVEST, V115, P1688, DOI 10.1172/JCI25669; MOSCONA A, 1992, J VIROL, V66, P6280, DOI 10.1128/JVI.66.11.6280-6287.1992; Moscona A, 2010, J INFECT DIS, V202, P234, DOI 10.1086/653621; Murrell M, 2003, J VIROL, V77, P309, DOI 10.1128/JVI.77.1.309-317.2003; Neurath AR, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-6; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Palermo LM, 2007, J VIROL, V81, P9152, DOI 10.1128/JVI.00888-07; Palermo LM, 2009, J VIROL, V83, P6900, DOI 10.1128/JVI.00475-09; Perlman SL, 1999, VIROLOGY, V265, P57, DOI 10.1006/viro.1999.0024; Plemper RK, 2003, BIOCHEMISTRY-US, V42, P6645, DOI 10.1021/bi034385k; Porotto M, 2007, J VIROL, V81, P10567, DOI 10.1128/JVI.01181-07; Porotto M, 2006, J VIROL, V80, P9837, DOI 10.1128/JVI.00736-06; Porotto M, 2006, J VIROL, V80, P1204, DOI 10.1128/JVI.80.3.1204-1213.2006; Porotto M, 2005, J VIROL, V79, P2383, DOI 10.1128/JVI.79.4.2383-2392.2005; Porotto M, 2004, J VIROL, V78, P13911, DOI 10.1128/JVI.78.24.13911-13919.2004; Porotto M, 2003, J VIROL, V77, P3647, DOI 10.1128/JVI.77.6.3647-3654.2003; Porotto M, 2001, J VIROL, V75, P7481, DOI 10.1128/JVI.75.16.7481-7488.2001; Porotto M, 2007, J VIROL, V81, P3216, DOI 10.1128/JVI.02617-06; Porotto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016874; Porotto M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001168; Porotto M, 2010, J VIROL, V84, P6760, DOI 10.1128/JVI.00135-10; Porotto M, 2009, J VIROL, V83, P6947, DOI 10.1128/JVI.00416-09; Romero-Gomez MP, 2011, J CLIN MICROBIOL, V49, P2072, DOI 10.1128/JCM.02638-10; Russell CJ, 2003, J CELL BIOL, V163, P363, DOI 10.1083/jcb.200305130; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; Sarkar A, 2010, CURR TOP MED CHEM, V10, P67, DOI 10.2174/156802610790232233; SCHEID A, 1974, VIROLOGY, V57, P475, DOI 10.1016/0042-6822(74)90187-1; Srinivasan A., 2011, BIOL BLOOD MARROW TR; Toupin M., 2011, BONE MARROW TRANSPLA; Wharton SA, 2000, VIROLOGY, V271, P71, DOI 10.1006/viro.2000.0280; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Yang HT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-58; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	65	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37945	37954		10.1074/jbc.M111.256248	http://dx.doi.org/10.1074/jbc.M111.256248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21799008	hybrid, Green Published			2022-12-27	WOS:000296594200007
J	Sarkany, Z; Ikonen, TP; Ferreira-da-Silva, F; Saraiva, MJ; Svergun, D; Damas, AM				Sarkany, Zsuzsa; Ikonen, Teemu P.; Ferreira-da-Silva, Frederico; Saraiva, Maria Joao; Svergun, Dmitri; Damas, Ana Margarida			Solution Structure of the Soluble Receptor for Advanced Glycation End Products (sRAGE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGLE SCATTERING DATA; CELL-SURFACE RECEPTOR; X-RAY-SCATTERING; RAGE; PROTEINS; BLOCKADE; RECOGNITION; ENDPRODUCTS; ACTIVATION; EXPRESSION	The receptor for advanced glycation end products (RAGE) is a multiligand cell surface receptor involved in various human diseases, as it binds to numerous molecules and proteins that modulate the activity of other proteins. Elucidating the three-dimensional structure of this receptor is therefore most important for understanding its function during activation and cellular signaling. The major alternative splice product of RAGE comprises its extracellular region that occurs as a soluble protein (sRAGE). Although the structures of sRAGE domains were available, their assembly into the functional full-length protein remained unknown. We observed that the protein has concentration-dependent oligomerization behavior, and this is also mediated by the presence of Ca2+ ions. Moreover, using synchrotron small angle x-ray scattering, the solution structure of human sRAGE was determined in the monomeric and dimeric forms. The model for the monomer displays a J-like shape, whereas the dimer is formed through the association of the two N-terminal domains and has an elongated structure. These results provide insights into the assembly of the RAGE homodimer, which is essential for signal transduction, and the sRAGE:RAGE heterodimer that leads to blockage of the receptor signaling, paving the way for the design of therapeutic strategies for a large number of different pathologies.	[Svergun, Dmitri] EMBL Hamburg, DESY, Hamburg Outstn, D-22603 Hamburg, Germany; [Sarkany, Zsuzsa; Ferreira-da-Silva, Frederico; Saraiva, Maria Joao; Damas, Ana Margarida] Univ Porto, Inst Mol & Cell Biol, P-4150180 Oporto, Portugal; [Saraiva, Maria Joao; Damas, Ana Margarida] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4099003 Oporto, Portugal	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Universidade do Porto; Universidade do Porto	Svergun, D (corresponding author), EMBL Hamburg, DESY, Hamburg Outstn, Bldg 25A,Notkestr 85, D-22603 Hamburg, Germany.	svergun@embl-hamburg.de; amdamas@ibmc.up.pt	Silva, Frederico F/K-3820-2013; Sarkany, Zsuzsa/K-1298-2013; Saraiva, Maria João/K-3907-2013	Silva, Frederico F/0000-0002-8890-4228; Sarkany, Zsuzsa/0000-0001-9185-8210; Saraiva, Maria João/0000-0002-3360-6899; Svergun, Dmitri/0000-0003-0830-5696	Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/SAU-NEU/69123/2006, SFRH/BPD/63465/2009]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Grants PTDC/SAU-NEU/69123/2006 and SFRH/BPD/63465/2009 (to Z.S.) from Fundacao para a Ciencia e Tecnologia, Portugal.	[Anonymous], 2004, ZETASIZER NANOSERIES; Berne B. J, 2000, DYNAMIC LIGHT SCATTE, P10; Chaney MO, 2005, BBA-MOL BASIS DIS, V1741, P199, DOI 10.1016/j.bbadis.2005.03.014; Cohn E. J., 1943, PROTEINS AMINOACIDS, P153; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; Ding QX, 2005, NEUROSCI LETT, V373, P67, DOI 10.1016/j.neulet.2004.09.059; Galichet A, 2008, BIOCHEM BIOPH RES CO, V370, P1, DOI 10.1016/j.bbrc.2008.02.163; Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Monteiro FA, 2006, FEBS LETT, V580, P3451, DOI 10.1016/j.febslet.2006.05.020; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Rong LL, 2004, FASEB J, V18, P1812, DOI 10.1096/fj.04-1899com; SCHMIDT AM, 1994, ARTERIOSCLER THROMB, V14, P1521, DOI 10.1161/01.ATV.14.10.1521; Sevillano N, 2009, J BIOCHEM, V145, P21, DOI 10.1093/jb/mvn137; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sousa MM, 2000, LAB INVEST, V80, P1101, DOI 10.1038/labinvest.3780116; Sturchler E, 2008, J NEUROSCI, V28, P5149, DOI 10.1523/JNEUROSCI.4878-07.2008; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296; Zhou L., 2010, MRK70401 MALV INSTR; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827	35	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37525	37534		10.1074/jbc.M111.223438	http://dx.doi.org/10.1074/jbc.M111.223438			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21865159	Green Published, hybrid			2022-12-27	WOS:000296542400051
J	Boutemy, LS; King, SRF; Win, J; Hughes, RK; Clarke, TA; Blumenschein, TMA; Kamoun, S; Banfield, MJ				Boutemy, Laurence S.; King, Stuart R. F.; Win, Joe; Hughes, Richard K.; Clarke, Thomas A.; Blumenschein, Tharin M. A.; Kamoun, Sophien; Banfield, Mark J.			Structures of Phytophthora RXLR Effector Proteins A CONSERVED BUT ADAPTABLE FOLD UNDERPINS FUNCTIONAL DIVERSITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE RESISTANCE; PLANT IMMUNITY; CELL-DEATH; AVIRULENCE; AVR3A; HYPERSENSITIVITY; SUPPRESSION; ACTIVATION; VIRULENCE; EVOLUTION	Phytopathogens deliver effector proteins inside host plant cells to promote infection. These proteins can also be sensed by the plant immune system, leading to restriction of pathogen growth. Effector genes can display signatures of positive selection and rapid evolution, presumably a consequence of their co-evolutionary arms race with plants. The molecular mechanisms underlying how effectors evolve to gain new virulence functions and/or evade the plant immune system are poorly understood. Here, we report the crystal structures of the effector domains from two oomycete RXLR proteins, Phytophthora capsici AVR3a11 and Phytophthora infestans PexRD2. Despite sharing <20% sequence identity in their effector domains, they display a conserved core alpha-helical fold. Bioinformatic analyses suggest that the core fold occurs in similar to 44% of annotated Phytophthora RXLR effectors, both as a single domain and in tandem repeats of up to 11 units. Functionally important and polymorphic residues map to the surface of the structures, and PexRD2, but not AVR3a11, oligomerizes in planta. We conclude that the core alpha-helical fold enables functional adaptation of these fast evolving effectors through (i) insertion/deletions in loop regions between alpha-helices, (ii) extensions to the N and C termini, (iii) amino acid replacements in surface residues, (iv) tandem domain duplications, and (v) oligomerization. We hypothesize that the molecular stability provided by this core fold, combined with considerable potential for plasticity, underlies the evolution of effectors that maintain their virulence activities while evading recognition by the plant immune system.	[Win, Joe; Kamoun, Sophien] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Boutemy, Laurence S.; King, Stuart R. F.; Hughes, Richard K.; Banfield, Mark J.] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Clarke, Thomas A.; Blumenschein, Tharin M. A.] Univ E Anglia, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Kamoun, S (corresponding author), Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	sophien.kamoun@tsl.ac.uk; mark.banfield@jic.ac.uk	Kamoun, Sophien/B-3529-2009; Blumenschein, Tharin/C-5984-2009; Hughes, Richard K./E-9642-2015; Banfield, Mark/C-7453-2013; Win, Joe/H-2557-2014; clarke, tom/D-1837-2009	Kamoun, Sophien/0000-0002-0290-0315; Blumenschein, Tharin/0000-0002-4932-5178; Hughes, Richard K./0000-0001-9910-6566; Banfield, Mark/0000-0001-8921-3835; Win, Joe/0000-0002-9851-2404; clarke, tom/0000-0002-6234-1914; King, Stuart/0000-0003-4374-3587	Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council; Royal Society; BBSRC [BBS/E/J/000C0624] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0624] Funding Source: researchfish	Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Gatsby Charitable Foundation, the Biotechnology and Biological Sciences Research Council (studentship to S. R. F. K. and core funding to M. J. B.), and the Royal Society (through a University Research Fellowship to M. J. B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Aminetzach YT, 2009, CURR BIOL, V19, P1925, DOI 10.1016/j.cub.2009.09.022; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; BOS JIB, 2007, THESIS OHIO STATE U; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bos JIB, 2009, MOL PLANT MICROBE IN, V22, P269, DOI 10.1094/MPMI-22-3-0269; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lindbo JA, 2007, PLANT PHYSIOL, V145, P1232, DOI 10.1104/pp.107.106377; Liu ZY, 2005, MOL BIOL EVOL, V22, P659, DOI 10.1093/molbev/msi049; Markson JS, 2009, FEBS LETT, V583, P3938, DOI 10.1016/j.febslet.2009.11.021; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nomura K, 2006, SCIENCE, V313, P220, DOI 10.1126/science.1129523; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Samanta U, 1999, ACTA CRYSTALLOGR D, V55, P1421, DOI 10.1107/S090744499900726X; Schmidt SM, 2011, CURR OPIN PLANT BIOL, V14, P392, DOI 10.1016/j.pbi.2011.03.006; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534	51	128	132	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35834	35842		10.1074/jbc.M111.262303	http://dx.doi.org/10.1074/jbc.M111.262303			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21813644	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000295927100056
J	Stieren, ES; El Ayadi, A; Xiao, Y; Siller, E; Landsverk, ML; Oberhauser, AF; Barral, JM; Boehning, D				Stieren, Emily S.; El Ayadi, Amina; Xiao, Yao; Siller, Efrain; Landsverk, Megan L.; Oberhauser, Andres F.; Barral, Jose M.; Boehning, Darren			Ubiquilin-1 Is a Molecular Chaperone for the Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; IN-VIVO; A-BETA; ENDOPLASMIC-RETICULUM; NUTRIENT STARVATION; UBQLN1 POLYMORPHISM; GENETIC ASSOCIATION; AGGRESOME FORMATION; CITRATE SYNTHASE; GAMMA-SECRETASE	Alzheimer disease (AD) is associated with extracellular deposition of proteolytic fragments of amyloid precursor protein (APP). Although mutations in APP and proteases that mediate its processing are known to result in familial, early onset forms of AD, the mechanisms underlying the more common sporadic, yet genetically complex forms of the disease are still unclear. Four single-nucleotide polymorphisms within the ubiquilin-1 gene have been shown to be genetically associated with AD, implicating its gene product in the pathogenesis of late onset AD. However, genetic linkage between ubiquilin-1 and AD has not been confirmed in studies examining different populations. Here we show that regardless of genotype, ubiquilin-1 protein levels are significantly decreased in late onset AD patient brains, suggesting that diminished ubiquilin function may be a common denominator in AD progression. Our interrogation of putative ubiquilin-1 activities based on sequence similarities to proteins involved in cellular quality control showed that ubiquilin-1 can be biochemically defined as a bona fide molecular chaperone and that this activity is capable of preventing the aggregation of amyloid precursor protein both in vitro and in live neurons. Furthermore, we show that reduced activity of ubiquilin-1 results in augmented production of pathogenic amyloid precursor protein fragments as well as increased neuronal death. Our results support the notion that ubiquilin-1 chaperone activity is necessary to regulate the production of APP and its fragments and that diminished ubiquilin-1 levels may contribute to AD pathogenesis.	[Stieren, Emily S.; El Ayadi, Amina; Xiao, Yao; Siller, Efrain; Oberhauser, Andres F.; Barral, Jose M.; Boehning, Darren] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Oberhauser, Andres F.; Barral, Jose M.; Boehning, Darren] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Barral, Jose M.; Boehning, Darren] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Landsverk, Megan L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine	Barral, JM (corresponding author), Dept Neurosci & Cell Biol, 301 Univ Blvd, Galveston, TX 77550 USA.	jmbarral@utmb.edu; dfboehni@utmb.edu	Boehning, Darren/I-8539-2015	Boehning, Darren/0000-0001-7920-6922; El Ayadi, Amina/0000-0002-3657-0633	National Institutes of Health [R21AG031948, F30AG030878, UL1RR029876, P30-AG-024832, P50AG05128]; Jean C. and William D. Willis Neuroscience Research Endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832, F30AG030878, P50AG005128, R21AG031948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jean C. and William D. Willis Neuroscience Research Endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AG031948 (to J. M. B. and D. B.) and F30AG030878 (to E. S. S.). J. M. B. is a scholar in the Translational Research Scholar Program and a member of the University of Texas Medical Branch Claude E. Pepper Older Americans Independence Center (supported by NIH Grants UL1RR029876 and P30-AG-024832, respectively). This work was also supported by funds from the Jean C. and William D. Willis Neuroscience Research Endowment (to E. S. S.). Cortical tissue samples were obtained from the Joseph and Kathleen Bryan Alzheimer's Disease Research Center (Duke University Medical Center), which is funded by National Institutes of Health Grant P50AG05128.	Arias-Vasquez A, 2007, NEUROSCI LETT, V424, P1, DOI 10.1016/j.neulet.2007.07.015; Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Bensemain F, 2006, NEUROBIOL DIS, V22, P691, DOI 10.1016/j.nbd.2006.01.007; Bergemalm D, 2006, J NEUROSCI, V26, P4147, DOI 10.1523/JNEUROSCI.5461-05.2006; Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brouwers N, 2006, NEUROSCI LETT, V392, P72, DOI 10.1016/j.neulet.2005.08.064; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; Cao F, 2001, BBA-MOL BASIS DIS, V1537, P158, DOI 10.1016/S0925-4439(01)00068-0; Chuo LJ, 2010, NEUROSCI LETT, V475, P108, DOI 10.1016/j.neulet.2010.03.061; Ciuculescu ED, 2005, CHEM-EUR J, V11, P903, DOI 10.1002/chem.200400786; De Strooper B, 2000, J CELL SCI, V113, P1857; Feng PH, 2004, MOL CELL BIOL, V24, P3938, DOI 10.1128/MCB.24.9.3938-3948.2004; Findeis MA, 2007, PHARMACOL THERAPEUT, V116, P266, DOI 10.1016/j.pharmthera.2007.06.006; Golan MP, 2008, DEMENT GERIATR COGN, V25, P366, DOI 10.1159/000121006; Gosal WS, 2006, PROTEIN PEPTIDE LETT, V13, P261, DOI 10.2174/092986606775338498; Haapasalo A, 2010, BIOCHEM SOC T, V38, P150, DOI 10.1042/BST0380150; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; Heir R, 2006, EMBO REP, V7, P1252, DOI 10.1038/sj.embor.7400823; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Hulette CM, 1997, ARCH PATHOL LAB MED, V121, P615; Hwang GW, 2005, MOL PHARMACOL, V68, P1074, DOI 10.1124/mol.105.013516; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Jankowsky JL, 2007, J BIOL CHEM, V282, P22707, DOI 10.1074/jbc.M611050200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kamboh MI, 2006, MOL PSYCHIATR, V11, P273, DOI 10.1038/sj.mp.4001775; Kamionka M, 2004, PROTEIN SCI, V13, P2370, DOI 10.1110/ps.04824304; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Lee MH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.83; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Massey LK, 2005, BIOCHEM J, V391, P513, DOI 10.1042/BJ20050491; Massey LK, 2004, J ALZHEIMERS DIS, V6, P79; N'Diaye EN, 2009, AUTOPHAGY, V5, P573, DOI 10.4161/auto.5.4.8312; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Regan-Klapisz E, 2005, J CELL SCI, V118, P4437, DOI 10.1242/jcs.02571; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Slifer MA, 2006, AM J MED GENET B, V141B, P208, DOI 10.1002/ajmg.b.30298; Slifer MA, 2005, NEW ENGL J MED, V352, P2752; Smemo S, 2006, ANN NEUROL, V59, P21, DOI 10.1002/ana.20673; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tonoki A, 2011, GENES CELLS, V16, P557, DOI 10.1111/j.1365-2443.2011.01505.x; Volz J, 1998, J CHROMATOGR A, V800, P29, DOI 10.1016/S0021-9673(97)00877-7; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wang H, 2006, HUM MOL GENET, V15, P1025, DOI 10.1093/hmg/ddl017; Wang HM, 2007, BIOCHEM BIOPH RES CO, V360, P423, DOI 10.1016/j.bbrc.2007.06.097; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wozniak AL, 2006, J CELL BIOL, V175, P709, DOI 10.1083/jcb.200608035; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029; Zhao G, 2006, J BIOL CHEM, V281, P13751, DOI 10.1074/jbc.M600137200	64	75	77	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35689	35698		10.1074/jbc.M111.243147	http://dx.doi.org/10.1074/jbc.M111.243147			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852239	Green Published, hybrid			2022-12-27	WOS:000295927100041
J	Zheng, Y; Anderson, S; Zhang, YF; Garavito, RM				Zheng, Yi; Anderson, Spencer; Zhang, Yanfeng; Garavito, R. Michael			The Structure of Sucrose Synthase-1 from Arabidopsis thaliana and Its Functional Implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO PHOSPHORYLATION; SOLANUM-TUBEROSUM L.; ESCHERICHIA-COLI; CELL-WALL; MEMBRANE ASSOCIATION; CRYSTAL-STRUCTURE; METABOLISM; LOCALIZATION; ENZYMES; GLYCOSYLTRANSFERASES	Sucrose transport is the central system for the allocation of carbon resources in vascular plants. During growth and development, plants control carbon distribution by coordinating sites of sucrose synthesis and cleavage in different plant organs and different cellular locations. Sucrose synthase, which reversibly catalyzes sucrose synthesis and cleavage, provides a direct and reversible means to regulate sucrose flux. Depending on the metabolic environment, sucrose synthase alters its cellular location to participate in cellulose, callose, and starch biosynthesis through its interactions with membranes, organelles, and cytoskeletal actin. The x-ray crystal structure of sucrose synthase isoform 1 from Arabidopsis thaliana (AtSus1) has been determined as a complex with UDP-glucose and as a complex with UDP and fructose, at 2.8- and 2.85-angstrom resolutions, respectively. The AtSus1 structure provides insights into sucrose catalysis and cleavage, as well as the regulation of sucrose synthase and its interactions with cellular targets.	[Zheng, Yi; Zhang, Yanfeng; Garavito, R. Michael] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Anderson, Spencer] Northwestern Univ, Life Sci Collaborat Access Team, Argonne, IL 60439 USA	Michigan State University; Northwestern University	Garavito, RM (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	garavito@msu.edu	zheng, yi/G-1917-2016	zheng, yi/0000-0002-4871-0779	National Institutes of Health [GM65501]; Michigan State University [REF03-016]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM65501 and Michigan State University Grant REF03-016 (to R. M. G.).; We thank Dexin Sui for assistance and suggestions on DNA cloning and Drs. C. Benning and Y. Shachar-Hill for helpful comments on the manuscript. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract number DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the research program of the Michigan Technology Tri-Corridor under Grant 085P1000817.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht G, 2003, PLANTA, V217, P252, DOI 10.1007/s00425-003-0995-6; Baier MC, 2007, PLANT PHYSIOL, V145, P1600, DOI 10.1104/pp.107.106955; Baier MC, 2010, PLANT PHYSIOL, V152, P1000, DOI 10.1104/pp.109.149898; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; Barrero-Sicilia C, 2011, PLANTA, V234, P391, DOI 10.1007/s00425-011-1408-x; Batut J, 2011, CURR OPIN MICROBIOL, V14, P181, DOI 10.1016/j.mib.2010.12.010; Bieniawska Z, 2007, PLANT J, V49, P810, DOI 10.1111/j.1365-313X.2006.03011.x; Bologa KL, 2003, PLANT PHYSIOL, V132, P2058, DOI 10.1104/pp.103.022236; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Cai G, 2011, PLANT PHYSIOL, V155, P1169, DOI 10.1104/pp.110.171371; Chua TK, 2008, PLANT CELL, V20, P1059, DOI 10.1105/tpc.107.051193; Coleman HD, 2010, TRANSGENIC RES, V19, P269, DOI 10.1007/s11248-009-9309-5; Coleman HD, 2009, P NATL ACAD SCI USA, V106, P13118, DOI 10.1073/pnas.0900188106; Duncan KA, 2007, PLANT CELL PHYSIOL, V48, P1612, DOI 10.1093/pcp/pcm133; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Etxeberria E, 2003, J EXP BOT, V54, P1407, DOI 10.1093/jxb/erg148; FRENCH AD, 1990, BIOPOLYMERS, V29, P1599, DOI 10.1002/bip.360291210; Fujii S, 2010, PLANT CELL PHYSIOL, V51, P294, DOI 10.1093/pcp/pcp190; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; Haigler CH, 2001, PLANT MOL BIOL, V47, P29, DOI 10.1023/A:1010615027986; Hardin SC, 2004, PLANT PHYSIOL BIOCH, V42, P197, DOI 10.1016/j.plaphy.2003.12.004; Hardin SC, 2004, PLANT PHYSIOL, V134, P1427, DOI 10.1104/pp.103.036780; Hardin SC, 2003, PLANT J, V35, P588, DOI 10.1046/j.1365-313X.2003.01831.x; Hardin SC, 2006, PLANT PHYSIOL, V141, P1106, DOI 10.1104/pp.106.078006; Hennen-Bierwagen TA, 2009, PLANT PHYSIOL, V149, P1541, DOI 10.1104/pp.109.135293; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huber C, 1996, PLANT PHYSIOL, V112, P793, DOI 10.1104/pp.112.2.793; Jiang QY, 2011, FUNCT INTEGR GENOMIC, V11, P49, DOI 10.1007/s10142-010-0188-x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleczkowski LA, 2010, CRIT REV PLANT SCI, V29, P191, DOI 10.1080/07352689.2010.483578; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Komina O, 2002, PLANT PHYSIOL, V129, P1664, DOI 10.1104/pp.002360; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Mulichak AM, 2004, BIOCHEMISTRY-US, V43, P5170, DOI 10.1021/bi036130c; Mulichak AM, 2003, P NATL ACAD SCI USA, V100, P9238, DOI 10.1073/pnas.1233577100; Nakai T, 1998, PLANT CELL PHYSIOL, V39, P1337, DOI 10.1093/oxfordjournals.pcp.a029339; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Persia D, 2008, PLANT PHYSIOL, V147, P1603, DOI 10.1104/pp.108.115956; Rohrig H, 2004, BIOCHEM BIOPH RES CO, V325, P864, DOI 10.1016/j.bbrc.2004.10.100; Rohrig H, 2002, P NATL ACAD SCI USA, V99, P1915, DOI 10.1073/pnas.022664799; Romer U, 2004, J BIOTECHNOL, V107, P135, DOI 10.1016/j.jbiotec.2003.10.017; Salerno GL, 2003, TRENDS PLANT SCI, V8, P63, DOI 10.1016/S1360-1385(02)00029-8; Sauerzapfe B, 2008, ENZYME MICROB TECH, V43, P289, DOI 10.1016/j.enzmictec.2008.04.001; Schubert M, 2011, PLANTA, V233, P139, DOI 10.1007/s00425-010-1285-8; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; Subbaiah CC, 2006, J BIOL CHEM, V281, P15625, DOI 10.1074/jbc.M600355200; Tang T, 2009, J EXP BOT, V60, P2641, DOI 10.1093/jxb/erp114; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Wachter R, 2003, PLANT PHYSIOL, V133, P1024, DOI 10.1104/pp.103.028142; Winter H, 1998, FEBS LETT, V430, P205, DOI 10.1016/S0014-5793(98)00659-0; Winter H, 2000, CRIT REV BIOCHEM MOL, V35, P253, DOI 10.1080/10409230008984165; Yang JC, 2004, PLANT PHYSIOL, V135, P1621, DOI 10.1104/pp.104.041038; Yep A, 2004, BIOCHEM BIOPH RES CO, V316, P960, DOI 10.1016/j.bbrc.2004.02.136; Yu SK, 2008, IUBMB LIFE, V60, P798, DOI 10.1002/iub.125	58	65	87	5	68	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36108	36118		10.1074/jbc.M111.275974	http://dx.doi.org/10.1074/jbc.M111.275974			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865170	Green Published, hybrid			2022-12-27	WOS:000295927100083
J	Awai, T; Ochi, A; Ihsanawati; Sengoku, T; Hirata, A; Bessho, Y; Yokoyama, S; Hori, H				Awai, Takako; Ochi, Anna; Ihsanawati; Sengoku, Toru; Hirata, Akira; Bessho, Yoshitaka; Yokoyama, Shigeyuki; Hori, Hiroyuki			Substrate tRNA Recognition Mechanism of a Multisite-specific tRNA Methyltransferase, Aquifex aeolicus Trm1, Based on the X-ray Crystal Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PYROCOCCUS-FURIOSUS; BINDING; ACID; GENE; TRNA(M(2)(2)G(26))DIMETHYLTRANSFERASE; IDENTIFICATION; GUANOSINE-26; BIOSYNTHESIS; PURIFICATION	Archaeal and eukaryotic tRNA (N-2,N-2-guanine)-dimethyltransferase (Trm1) produces N-2,N-2-dimethylguanine at position 26 in tRNA. In contrast, Trm1 from Aquifex aeolicus, a hyper-thermophilic eubacterium, modifies G27 as well as G26. Here, a gel mobility shift assay revealed that the T-arm in tRNA is the binding site of A. aeolicus Trm1. To address the multisite specificity, we performed an x-ray crystal structure study. The overall structure of A. aeolicus Trm1 is similar to that of archaeal Trm1, although there is a zinc-cysteine cluster in the C-terminal domain of A. aeolicus Trm1. The N-terminal domain is a typical catalytic domain of S-adenosyl-L-methionine-dependent methyltransferases. On the basis of the crystal structure and amino acid sequence alignment, we prepared 30 mutant Trm1 proteins. These mutant proteins clarified residues important for S-adenosyl-L-methionine binding and enabled us to propose a hypothetical reaction mechanism. Furthermore, the tRNA-binding site was also elucidated by methyl transfer assay and gel mobility shift assay. The electrostatic potential surface models of A. aeolicus and archaeal Trm1 proteins demonstrated that the distribution of positive charges differs between the two proteins. We constructed a tRNA-docking model, in which the T-arm structure was placed onto the large area of positive charge, which is the expected tRNA-binding site, of A. aeolicus Trm1. In this model, the target G26 base can be placed near the catalytic pocket; however, the nucleotide at position 27 gains closer access to the pocket. Thus, this docking model introduces a rational explanation of the multisite specificity of A. aeolicus Trm1.	[Awai, Takako; Ochi, Anna; Hirata, Akira; Hori, Hiroyuki] Ehime Univ, Dept Mat Sci & Biotechnol, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Ihsanawati; Sengoku, Toru; Bessho, Yoshitaka; Yokoyama, Shigeyuki; Hori, Hiroyuki] RIKEN, Syst & Struct Biol Ctr, Yokohama Inst, Tsurumi Ku, Kanagawa 2300045, Japan; [Bessho, Yoshitaka; Yokoyama, Shigeyuki] RIKEN SPring 8 Ctr, Harima Inst, Sayo, Hyogo 6795148, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Hori, Hiroyuki] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan	Ehime University; RIKEN; RIKEN; University of Tokyo; Ehime University	Hori, H (corresponding author), Ehime Univ, Dept Mat Sci & Biotechnol, Grad Sch Sci & Engn, Bunkyo 3, Matsuyama, Ehime 7908577, Japan.	hori@eng.ehime-u.ac.jp	Bessho, Yoshitaka/K-7702-2012; Hori, Hiroyuki/AAB-3911-2021; Yokoyama, Shigeyuki/N-6911-2015; Sengoku, Toru/E-4304-2013	Bessho, Yoshitaka/0000-0001-9297-7473; Yokoyama, Shigeyuki/0000-0003-3133-7338; Sengoku, Toru/0000-0001-9461-8714	Ministry of Education, Science, Sports, and Culture of Japan [20034041, 19350087, 2350081, 21603018]; Grants-in-Aid for Scientific Research [23350081] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Science Research on Priority Areas 20034041 (to H. H.), Grants-in-aid for Science Research 19350087 and 2350081 (to H. H.) and 21603018 (to Y. B.), and the National Project on Targeted Proteins Research Program for Science Research from the Ministry of Education, Science, Sports, and Culture of Japan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson J, 2000, P NATL ACAD SCI USA, V97, P5173, DOI 10.1073/pnas.090102597; Anderson J, 1998, GENE DEV, V12, P3650, DOI 10.1101/gad.12.23.3650; ARENA F, 1978, NUCLEIC ACIDS RES, V5, P4523, DOI 10.1093/nar/5.12.4523; Auxilien S, 2007, J BIOL CHEM, V282, P18711, DOI 10.1074/jbc.M607459200; Awai T, 2009, J BIOL CHEM, V284, P20467, DOI 10.1074/jbc.M109.020024; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barraud P, 2008, J MOL BIOL, V377, P535, DOI 10.1016/j.jmb.2008.01.041; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bujnicki JM, 2002, J MOL MICROB BIOTECH, V4, P405; Constantinesco F, 1999, NUCLEIC ACIDS RES, V27, P1308, DOI 10.1093/nar/27.5.1308; Constantinesco F, 1999, J MOL BIOL, V291, P375, DOI 10.1006/jmbi.1999.2976; Constantinesco F, 1998, NUCLEIC ACIDS RES, V26, P3753, DOI 10.1093/nar/26.16.3753; CORTESE R, 1974, J BIOL CHEM, V249, P1103; Doi Y, 2007, J AM CHEM SOC, V129, P14458, DOI 10.1021/ja075557u; Droogmans L, 2003, NUCLEIC ACIDS RES, V31, P2148, DOI 10.1093/nar/gkg314; Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084; EDQVIST J, 1992, NUCLEIC ACIDS RES, V20, P6575, DOI 10.1093/nar/20.24.6575; EDQVIST J, 1994, BIOCHEMISTRY-US, V33, P9546, DOI 10.1021/bi00198a021; ELLIS SR, 1986, J BIOL CHEM, V261, P9703; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GARCIA GA, 1998, MODIFICATION EDITING, P135; GARCIA GR, 1998, MODIFICATION EDITING, P555; GLICK JM, 1978, BIOCHIM BIOPHYS ACTA, V518, P158, DOI 10.1016/0005-2787(78)90125-9; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grosjean H, 1996, J MOL BIOL, V255, P67, DOI 10.1006/jmbi.1996.0007; Grosjean H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-470; Guelorget A, 2010, NUCLEIC ACIDS RES, V38, P6206, DOI 10.1093/nar/gkq381; Hur S, 2007, MOL CELL, V26, P189, DOI 10.1016/j.molcel.2007.02.027; Ihsanawati, 2008, J MOL BIOL, V383, P871, DOI 10.1016/j.jmb.2008.08.068; KEITH G, 1995, BIOCHIMIE, V77, P142, DOI 10.1016/0300-9084(96)88118-1; KIM SH, 1974, P NATL ACAD SCI USA, V71, P4970, DOI 10.1073/pnas.71.12.4970; KUCHINO Y, 1970, BIOCHEM BIOPH RES CO, V40, P306, DOI 10.1016/0006-291X(70)91010-7; Liu JM, 1998, NUCLEIC ACIDS RES, V26, P5102, DOI 10.1093/nar/26.22.5102; Liu JM, 1999, GENE, V226, P73, DOI 10.1016/S0378-1119(98)00550-2; Liu JM, 2000, NUCLEIC ACIDS RES, V28, P3445, DOI 10.1093/nar/28.18.3445; Michel SLJ, 2002, CHEM BIOL, V9, P667, DOI 10.1016/S1074-5521(02)00160-6; Motorin Y, 1999, RNA, V5, P1105, DOI 10.1017/S1355838299982201; Niederberger C, 1999, FEBS LETT, V464, P67, DOI 10.1016/S0014-5793(99)01679-8; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; Ochi A, 2010, J BIOL CHEM, V285, P9018, DOI 10.1074/jbc.M109.065698; Ohtsuki T, 2002, NUCLEIC ACIDS RES, V30, P5444, DOI 10.1093/nar/gkf679; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHILLIPS JH, 1967, J MOL BIOL, V26, P509, DOI 10.1016/0022-2836(67)90318-X; Pintard L, 2002, EMBO J, V21, P1811, DOI 10.1093/emboj/21.7.1811; PUGH CSG, 1978, J BIOL CHEM, V253, P4075; REINHART MP, 1986, NUCLEIC ACIDS RES, V14, P1131, DOI 10.1093/nar/14.3.1131; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Roovers M, 2004, NUCLEIC ACIDS RES, V32, P465, DOI 10.1093/nar/gkh191; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Sharpe BK, 2002, STRUCTURE, V10, P639, DOI 10.1016/S0969-2126(02)00757-8; STANGE N, 1987, EMBO J, V6, P2811, DOI 10.1002/j.1460-2075.1987.tb02577.x; Takeda H, 2006, GENES CELLS, V11, P1353, DOI 10.1111/j.1365-2443.2006.01022.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VEDEL M, 1981, FEBS LETT, V128, P87, DOI 10.1016/0014-5793(81)81086-1; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Watanabe K, 2006, J BIOL CHEM, V281, P34630, DOI 10.1074/jbc.M606141200	60	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35236	35246		10.1074/jbc.M111.253641	http://dx.doi.org/10.1074/jbc.M111.253641			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844194	Green Published, hybrid			2022-12-27	WOS:000295406300076
J	Deikus, G; Bechhofer, DH				Deikus, Gintaras; Bechhofer, David H.			5 ' End-independent RNase J1 Endonuclease Cleavage of Bacillus subtilis Model RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRP LEADER RNA; MESSENGER-RNA; ESCHERICHIA-COLI; TRANSCRIPTION ATTENUATION; RIBOSOMAL-RNA; DECAY; TURNOVER; DEGRADATION; MATURATION; INITIATION	Bacillus subtilis trp leader RNA is a small (140-nucleotide) RNA that results from attenuation of trp operon transcription upon binding of the regulatory TRAP complex. Previously, endonucleolytic cleavage by ribonuclease RNase J1 in a 3'-proximal, single-stranded region was shown to be critical for initiation of trp leader RNA decay. RNase J1 is a dual-specificity enzyme, with both 5' exonucleolytic and endonucleolytic activities. Here, we provide in vivo and in vitro evidence that RNase J1 accesses its internal target site on trp leader RNA in a 5' end-independent manner. This has important implications for the role of RNase J1 in RNA decay. We also tested the involvement in trp leader RNA decay of the more recently discovered endonuclease RNase Y. Half-lives of several trp leader RNA constructs, which were designed to probe pathways of endonucleolytic versus exonucleolytic decay, were measured in an RNase Y-deficient mutant. Remarkably, the half-lives of these constructs were indistinguishable from their half-lives in an RNase J1-deficient mutant. These results suggest that lowering RNase Y concentration may affect RNA decay indirectly via an effect on RNase J1, which is thought to exist with RNase Y in a degradosome complex. To generalize our findings with trp leader RNA to other RNAs, we show that the mechanism of trp leader RNA decay is not dependent on TRAP binding.	[Deikus, Gintaras; Bechhofer, David H.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Bechhofer, DH (corresponding author), Box 1603,1 Gustave L Levy Pl, New York, NY 10029 USA.	david.bechhofer@mssm.edu			National Institutes of Health [GM48804]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by United States Public Health Service Grant GM48804 (to D. H. B.) from the National Institutes of Health.	[Anonymous], 2011, OCTOBER; Babitzke P, 1997, MOL MICROBIOL, V26, P1, DOI 10.1046/j.1365-2958.1997.5541915.x; Baker KE, 2003, MOL MICROBIOL, V47, P75, DOI 10.1046/j.1365-2958.2003.03292.x; Bechhofer DH, 2009, PROG MOL BIOL TRANSL, V85, P231, DOI 10.1016/S0079-6603(08)00806-4; Bechhofer DH, 1998, J BACTERIOL, V180, P3470, DOI 10.1128/JB.180.13.3470-3473.1998; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Condon C, 2010, RNA BIOL, V7, P316, DOI 10.4161/rna.7.3.11913; Condon C, 2008, METHOD ENZYMOL, V447, P277, DOI 10.1016/S0076-6879(08)02215-5; Daou-Chabo R, 2009, MOL MICROBIOL, V71, P1538, DOI 10.1111/j.1365-2958.2009.06620.x; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Deikus G, 2004, P NATL ACAD SCI USA, V101, P2747, DOI 10.1073/pnas.0307343101; Deikus G, 2008, J BIOL CHEM, V283, P17158, DOI 10.1074/jbc.M801461200; Deikus G, 2007, J BIOL CHEM, V282, P20238, DOI 10.1074/jbc.M702747200; Deikus G, 2009, J BIOL CHEM, V284, P26394, DOI 10.1074/jbc.M109.015875; Du H, 2000, J BACTERIOL, V182, P1819, DOI 10.1128/JB.182.7.1819-1827.2000; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Garrey SM, 2011, MOL MICROBIOL, V80, P1613, DOI 10.1111/j.1365-2958.2011.07670.x; Garrey SM, 2009, J BIOL CHEM, V284, P31843, DOI 10.1074/jbc.M109.063263; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Kime L, 2010, MOL MICROBIOL, V76, P590, DOI 10.1111/j.1365-2958.2009.06935.x; Lehnik-Habrink M, 2010, MOL MICROBIOL, V77, P958, DOI 10.1111/j.1365-2958.2010.07264.x; Mader U, 2008, MOL MICROBIOL, V70, P183, DOI 10.1111/j.1365-2958.2008.06400.x; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Mathy N, 2010, MOL MICROBIOL, V75, P489, DOI 10.1111/j.1365-2958.2009.07004.x; Oussenko IA, 2005, J BACTERIOL, V187, P2758, DOI 10.1128/JB.187.8.2758-2767.2005; Petit MA, 1998, MOL MICROBIOL, V29, P261, DOI 10.1046/j.1365-2958.1998.00927.x; Richards J., 2011, MOL CELL IN PRESS; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Sharp JS, 2003, J BACTERIOL, V185, P5372, DOI 10.1128/JB.185.18.5372-5379.2003; Wang W, 1996, J BACTERIOL, V178, P2375, DOI 10.1128/jb.178.8.2375-2382.1996; Yakhnin AV, 2000, J BIOL CHEM, V275, P4519, DOI 10.1074/jbc.275.6.4519	35	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34932	34940		10.1074/jbc.M111.287409	http://dx.doi.org/10.1074/jbc.M111.287409			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21862575	hybrid, Green Published			2022-12-27	WOS:000295406300047
J	Osawa, Y; Kanamori, H; Seki, E; Hoshi, M; Ohtaki, H; Yasuda, Y; Ito, H; Suetsugu, A; Nagaki, M; Moriwaki, H; Saito, K; Seishima, M				Osawa, Yosuke; Kanamori, Hiromitsu; Seki, Ekihiro; Hoshi, Masato; Ohtaki, Hirofumi; Yasuda, Yoichi; Ito, Hiroyasu; Suetsugu, Atsushi; Nagaki, Masahito; Moriwaki, Hisataka; Saito, Kuniaki; Seishima, Mitsuru			L-Tryptophan-mediated Enhancement of Susceptibility to Nonalcoholic Fatty Liver Disease Is Dependent on the Mammalian Target of Rapamycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; PROTEIN-SYNTHESIS; OXIDATIVE STRESS; RAT-LIVER; LIPID-METABOLISM; AMINO-ACID; SEROTONIN; MICE; LEUCINE; MTOR	Nonalcoholic fatty liver disease is one of the most common liver diseases. L-Tryptophan and its metabolite serotonin are involved in hepatic lipid metabolism and inflammation. However, it is unclear whether L-tryptophan promotes hepatic steatosis. To explore this issue, we examined the role of L-tryptophan in mouse hepatic steatosis by using a high fat and high fructose diet (HFHFD) model. L-Tryptophan treatment in combination with an HFHFD exacerbated hepatic steatosis, expression of HNE-modified proteins, hydroxyproline content, and serum alanine aminotransaminase levels, whereas L-tryptophan alone did not result in these effects. We also found that L-tryptophan treatment increases serum serotonin levels. The introduction of adenoviral aromatic amino acid decarboxylase, which stimulates the serotonin synthesis from L-tryptophan, aggravated hepatic steatosis induced by the HFHFD. The fatty acid-induced accumulation of lipid was further increased by serotonin treatment in cultured hepatocytes. These results suggest that L-tryptophan increases the sensitivity to hepatic steatosis through serotonin production. Furthermore, L-tryptophan treatment, adenoviral AADC introduction, and serotonin treatment induced phosphorylation of the mammalian target of rapamycin (mTOR), and a potent mTOR inhibitor rapamycin attenuated hepatocyte lipid accumulation induced by fatty acid with serotonin. These results suggest the importance of mTOR activation for the exacerbation of hepatic steatosis. In conclusion, L-tryptophan exacerbates hepatic steatosis induced by HFHFD through serotonin-mediated activation of mTOR.	[Osawa, Yosuke; Kanamori, Hiromitsu; Hoshi, Masato; Ohtaki, Hirofumi; Ito, Hiroyasu; Seishima, Mitsuru] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu 5011194, Japan; [Osawa, Yosuke; Yasuda, Yoichi; Suetsugu, Atsushi; Nagaki, Masahito; Moriwaki, Hisataka] Gifu Univ, Grad Sch Med, Dept Gastroenterol, Gifu 5011194, Japan; [Seki, Ekihiro] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Saito, Kuniaki] Kyoto Univ, Dept Human Hlth Sci, Grad Sch Med, Kyoto 6068507, Japan; [Saito, Kuniaki] Kyoto Univ, Fac Med, Kyoto 6068507, Japan	Gifu University; Gifu University; University of California System; University of California San Diego; Kyoto University; Kyoto University	Osawa, Y (corresponding author), 1-1 Yanagido, Gifu 5011194, Japan.	osawa-gif@umin.ac.jp	Seki, Ekihiro/K-2481-2016	Seki, Ekihiro/0000-0002-9472-6085	Takeda Science Foundation; Mitsubishi Pharma Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [21790657, 23790787]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020172] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20390167] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants from the Takeda Science Foundation, Mitsubishi Pharma Research Foundation and by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants 21790657 and 23790787.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Chang GR, 2009, J PHARMACOL SCI, V109, P496, DOI 10.1254/jphs.08215FP; Czaja MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC973, DOI 10.1152/ajpcell.00527.2009; Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0; Drakos Elias, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000586; FACER P, 1979, HISTOCHEM J, V11, P117, DOI 10.1007/BF01041271; FEARS R, 1980, BRIT J NUTR, V43, P349, DOI 10.1079/BJN19800097; Feksa LR, 2006, NEUROCHEM INT, V49, P87, DOI 10.1016/j.neuint.2006.01.001; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Forrest CM, 2004, FREE RADICAL RES, V38, P1167, DOI 10.1080/10715760400011437; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; HIRATA Y, 1967, BIOCHIM BIOPHYS ACTA, V144, P233; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kubovcakova L, 2004, NEUROSCIENCE, V126, P375, DOI 10.1016/j.neuroscience.2004.04.005; Lang PA, 2008, NAT MED, V14, P756, DOI 10.1038/nm1780; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Lesurtel M, 2008, CELL MOL LIFE SCI, V65, P940, DOI 10.1007/s00018-007-7377-3; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE824, DOI 10.1152/ajpendo.00085.2002; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; MATTHIES DL, 1993, J NUTR, V123, P852, DOI 10.1093/jn/123.5.852; Nocito A, 2007, GASTROENTEROLOGY, V133, P608, DOI 10.1053/j.gastro.2007.05.019; Osawa Y, 2005, HEPATOLOGY, V42, P1320, DOI 10.1002/hep.20967; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Osawa Y, 2011, FASEB J, V25, P1133, DOI 10.1096/fj.10-168351; Osawa Y, 2010, HEPATOLOGY, V51, P237, DOI 10.1002/hep.23262; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Reiter AK, 2004, INT J BIOCHEM CELL B, V36, P2169, DOI 10.1016/j.biocel.2004.04.004; Richard DM, 2009, INT J TRYPTOPHAN RES, V2, P45; Sainio EL, 1996, AMINO ACIDS, V10, P21, DOI 10.1007/BF00806091; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Soll C, 2010, HEPATOLOGY, V51, P1244, DOI 10.1002/hep.23441; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Toye AA, 2007, DIABETOLOGIA, V50, P1867, DOI 10.1007/s00125-007-0738-5; TRULSON ME, 1986, J NUTR, V116, P1109, DOI 10.1093/jn/116.6.1109; Wilson FA, 2011, AMINO ACIDS, V40, P157, DOI 10.1007/s00726-010-0629-9; Yu PL, 1999, J COMP NEUROL, V411, P654, DOI 10.1002/(SICI)1096-9861(19990906)411:4<654::AID-CNE9>3.0.CO;2-H; Zelber-Sagil S, 2007, J HEPATOL, V47, P711, DOI 10.1016/j.jhep.2007.06.020	42	53	55	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34800	34808		10.1074/jbc.M111.235473	http://dx.doi.org/10.1074/jbc.M111.235473			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21841000	hybrid, Green Published			2022-12-27	WOS:000295406300034
J	Witkowski, A; Thweatt, J; Smith, S				Witkowski, Andrzej; Thweatt, Jennifer; Smith, Stuart			Mammalian ACSF3 Protein Is a Malonyl-CoA Synthetase That Supplies the Chain Extender Units for Mitochondrial Fatty Acid Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A-SYNTHETASE; MOLECULAR-CLONING; CARRIER PROTEIN; RAT-BRAIN; CARBOXYLASE; BIOSYNTHESIS; METABOLISM; EXPRESSION; SEQUENCE; SYNTHASE	The objective of this study was to identify a source of intramitochondrial malonyl-CoA that could be used for de novo fatty acid synthesis in mammalian mitochondria. Because mammalian mitochondria lack an acetyl-CoA carboxylase capable of generating malonyl-CoA inside mitochondria, the possibility that malonate could act as a precursor was investigated. Although malonyl-CoA synthetases have not been identified previously in animals, interrogation of animal protein sequence databases identified candidates that exhibited sequence similarity to known prokaryotic forms. The human candidate protein ACSF3, which has a predicted N-terminal mitochondrial targeting sequence, was cloned, expressed, and characterized as a 65-kDa acyl-CoA synthetase with extremely high specificity for malonate and methylmalonate. An arginine residue implicated in malonate binding by prokaryotic malonyl-CoA synthetases was found to be positionally conserved in animal ACSF3 enzymes and essential for activity. Subcellular fractionation experiments with HEK293T cells confirmed that human ACSF3 is located exclusively in mitochondria, and RNA interference experiments verified that this enzyme is responsible for most, if not all, of the malonyl-CoA synthetase activity in the mitochondria of these cells. In conclusion, unlike fungi, which have an intramitochondrial acetyl-CoA carboxylase, animals require an alternative source of mitochondrial malonyl-CoA; the mitochondrial ACSF3 enzyme is capable of filling this role by utilizing free malonic acid as substrate.	[Witkowski, Andrzej; Thweatt, Jennifer; Smith, Stuart] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Smith, S (corresponding author), Childrens Hosp Oakland, Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	ssmith@chori.org		Witkowski, Andrzej/0000-0002-0442-4586	National Institutes of Health [GM069717]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM069717.	ABUELHEIGA L, 1995, P NATL ACAD SCI USA, V92, P4011, DOI 10.1073/pnas.92.9.4011; An JH, 1998, EUR J BIOCHEM, V257, P395, DOI 10.1046/j.1432-1327.1998.2570395.x; Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Bunkoczi G, 2009, CHEM BIOL, V16, P667, DOI 10.1016/j.chembiol.2009.04.011; Chen ZJ, 2009, FASEB J, V23, P3682, DOI 10.1096/fj.09-133587; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; Fernandez-Gomez FJ, 2005, BRIT J PHARMACOL, V144, P528, DOI 10.1038/sj.bjp.0706069; Gueguen V, 2000, J BIOL CHEM, V275, P5016, DOI 10.1074/jbc.275.7.5016; Hiltunen JK, 2010, PROG LIPID RES, V49, P27, DOI 10.1016/j.plipres.2009.08.001; Hoja U, 2004, J BIOL CHEM, V279, P21779, DOI 10.1074/jbc.M401071200; Hughes AJ, 2011, CHEM BIOL, V18, P165, DOI 10.1016/j.chembiol.2010.12.014; JANG SH, 1989, J BIOL CHEM, V264, P3500; Jung JW, 2000, PROTEIN SCI, V9, P1294, DOI 10.1110/ps.9.7.1294; KIM YS, 1991, BIOCHEM J, V273, P511, DOI 10.1042/bj2730511; KIM YS, 1985, J BIOL CHEM, V260, P5098; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; KOEPPEN AH, 1974, BIOCHEMISTRY-US, V13, P3589, DOI 10.1021/bi00714a029; LOPEZCASILLAS F, 1988, P NATL ACAD SCI USA, V85, P5784, DOI 10.1073/pnas.85.16.5784; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; MENON GKK, 1960, J BIOL CHEM, V235, P3393; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; MITZEN EJ, 1984, J NEUROCHEM, V43, P499, DOI 10.1111/j.1471-4159.1984.tb00927.x; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; PATTEE HE, 1965, BOT GAZ, V126, P179, DOI 10.1086/336316; SAINTMACARY M, 1980, BIOCHEM BIOPH RES CO, V96, P457, DOI 10.1016/0006-291X(80)91236-X; SCHOOLWERTH AC, 1985, ANNU REV PHYSIOL, V47, P143; SINGH I, 1983, J LIPID RES, V24, P662; Stokes AH, 2001, J NEUROSCI RES, V64, P43, DOI 10.1002/jnr.1052; SUZUKI H, 1989, BIOCHIM BIOPHYS ACTA, V990, P25, DOI 10.1016/S0304-4165(89)80007-8; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Widmer J, 1996, BIOCHEM J, V316, P915, DOI 10.1042/bj3160915; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; Wojtovich AP, 2008, BBA-BIOENERGETICS, V1777, P882, DOI 10.1016/j.bbabio.2008.03.025; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200	39	43	44	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33729	33736		10.1074/jbc.M111.291591	http://dx.doi.org/10.1074/jbc.M111.291591			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21846720	Green Published, hybrid			2022-12-27	WOS:000295159200003
J	Wu, JJ; Zhang, YS; Frilot, N; Kim, JI; Kim, WJ; Daaka, Y				Wu, Juanjuan; Zhang, Yushan; Frilot, Nicole; Kim, Jae I.; Kim, Wan-Ju; Daaka, Yehia			Prostaglandin E-2 Regulates Renal Cell Carcinoma Invasion through the EP4 Receptor-Rap GTPase Signal Transduction Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; PROMOTES INVASION; PROTEIN-KINASE; KIDNEY CANCER; TUMOR-GROWTH; RAP1GAP; EXPRESSION; CYCLOOXYGENASE-2; BREAST; PHOSPHORYLATION	Prognosis for patients with early stage kidney cancer has improved, but the treatment options for patients with locally advanced disease and metastasis remain few. Understanding the molecular mechanisms that regulate invasion and metastasis is critical for developing successful therapies to treat these patients. Proinflammatory prostaglandin E-2 plays an important role in cancer initiation and progression via activation of cognate EP receptors that belong to the superfamily of G protein-coupled receptors. Here we report that prostaglandin E-2 promotes renal cancer cell invasion through a signal transduction pathway that encompasses EP4 and small GTPase Rap. Inactivation of Rap signaling with Rap1GAP, like inhibition of EP4 signaling with ligand antagonist or knockdown with shRNA, reduces the kidney cancer cell invasion. Human kidney cells evidence increased EP4 and decreased Rap1GAP expression levels in the malignant compared with benign samples. These results support the idea that targeted inhibition of EP4 signaling and restoration of Rap1GAP expression constitute a new strategy to control kidney cancer progression.	[Wu, Juanjuan; Frilot, Nicole; Daaka, Yehia] Georgia Hlth Sci Univ, Dept Pathol, Augusta, GA 30912 USA; [Zhang, Yushan; Kim, Jae I.; Kim, Wan-Ju; Daaka, Yehia] Univ Florida, Coll Med, Dept Urol, Gainesville, FL 32610 USA; [Zhang, Yushan; Kim, Jae I.; Kim, Wan-Ju; Daaka, Yehia] Univ Florida, Coll Med, Prostate Dis Ctr, Gainesville, FL 32610 USA	University System of Georgia; Augusta University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Daaka, Y (corresponding author), CGRC, Rm 462,2033 Mowry Rd, Gainesville, FL 32610 USA.	ydaaka@ufl.edu		Kim, Jae/0000-0003-1668-3910	National Institutes of Health Public Health Service, NCI [CA129155]; NATIONAL CANCER INSTITUTE [R01CA129155] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant CA129155 from the NCI.	An ZL, 1999, CLIN EXP METASTAS, V17, P265, DOI 10.1023/A:1006654600095; Asano T, 2002, CLIN CANCER RES, V8, P1157; Atkins MB, 2004, CLIN CANCER RES, V10, p6342S, DOI 10.1158/1078-0432.CCR-040029; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; BASTIEN L, 1994, J BIOL CHEM, V269, P11873; Belldegrun AS, 2008, CANCER-AM CANCER SOC, V113, P2457, DOI 10.1002/cncr.23851; Bisignani GJ, 1999, J UROLOGY, V162, P2186, DOI 10.1016/S0022-5347(05)68157-8; Biswas S, 2009, NAT REV CLIN ONCOL, V6, P478, DOI 10.1038/nrclinonc.2009.91; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Brinkmann T, 2002, J BIOL CHEM, V277, P12525, DOI 10.1074/jbc.M109176200; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen QZ, 2004, J UROLOGY, V172, P2153, DOI 10.1097/01.ju.0000143440.08760.3a; Cheng HF, 2005, CURR PHARM DESIGN, V11, P1795, DOI 10.2174/1381612053764922; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Fragoso MCBV, 1998, J CLIN ENDOCR METAB, V83, P2074, DOI 10.1210/jc.83.6.2074; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; FUNK CD, 1993, J BIOL CHEM, V268, P26767; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kadhim SA, 1997, CANCER RES, V57, P4803; Kalfa N, 2006, J UROLOGY, V176, P891, DOI 10.1016/j.juro.2006.04.023; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Lanas A, 2006, ANN MED, V38, P415, DOI 10.1080/07853890600925843; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; Meng JW, 1999, J BIOL CHEM, V274, P36663, DOI 10.1074/jbc.274.51.36663; Mitra RS, 2008, CANCER RES, V68, P3959, DOI 10.1158/0008-5472.CAN-07-2755; Muller M, 2006, ENDOCRINOLOGY, V147, P3356, DOI 10.1210/en.2005-1429; Mungan MU, 2006, EUR UROL, V50, P92, DOI 10.1016/j.eururo.2005.12.039; Murai M, 2004, CURR OPIN UROL, V14, P229, DOI 10.1097/01.mou.0000135078.04721.f5; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; Nellore A, 2009, J CLIN ENDOCR METAB, V94, P1026, DOI 10.1210/jc.2008-1042; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nomura T, 2007, J UROLOGY, V178, P292, DOI 10.1016/j.juro.2007.03.007; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; POLAKIS P, 1992, J BIOL CHEM, V267, P10780; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; PUGH S, 1994, GUT, V35, P675, DOI 10.1136/gut.35.5.675; REGAN JW, 1994, MOL PHARMACOL, V46, P213; Schlesinger-Raab A, 2008, EUR J CANCER, V44, P2485, DOI 10.1016/j.ejca.2008.07.039; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; SONNENBURG WK, 1990, J BIOL CHEM, V265, P8479; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tawfik OW, 2007, ARCH PATHOL LAB MED, V131, P261; Tsygankova OM, 2010, MOL CELL BIOL, V30, P3262, DOI 10.1128/MCB.01345-09; VALLAR L, 1987, NATURE, V330, P566, DOI 10.1038/330566a0; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Young AN, 2006, UROLOGY, V67, P873, DOI 10.1016/j.urology.2005.11.042; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhang LZ, 2006, CANCER RES, V66, P898, DOI 10.1158/0008-5472.CAN-05-3025; Zhang ZC, 2006, AM J PATHOL, V168, P585, DOI 10.2353/ajpath.2006.050132; Zheng H, 2009, CANCER RES, V69, P449, DOI 10.1158/0008-5472.CAN-08-2399; Zuo H, 2010, CANCER RES, V70, P1389, DOI 10.1158/0008-5472.CAN-09-2812	64	40	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33954	33962		10.1074/jbc.M110.187344	http://dx.doi.org/10.1074/jbc.M110.187344			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832044	Green Published, hybrid			2022-12-27	WOS:000295159200027
J	Nohara, A; Okada, S; Ohshima, K; Pessin, JE; Mori, M				Nohara, Atsushi; Okada, Shuichi; Ohshima, Kihachi; Pessin, Jeffrey E.; Mori, Masatomo			Cyclin-dependent Kinase-5 Is a Key Molecule in Tumor Necrosis Factor-alpha-induced Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUT4 TRANSLOCATION; 3T3-L1 ADIPOCYTES; TNF-ALPHA; TRANSCRIPTIONAL REPRESSION; OBESITY; PHOSPHORYLATION; GENES; COMPARTMENTALIZATION; ACTIVATION; EXPRESSION	The mechanism of TNF-alpha-induced insulin resistance has remained unresolved with evidence for down-regulation of insulin effector targets effects or blockade of proximal as well as distal insulin signaling events depending upon the dose, time, and cell type examined. To address this issue we examined the acute actions of TNF-alpha in differentiated 3T3L1 adipocytes. Acute (5-15 min) treatment with 20 ng/ml (similar to 0.8 nM) TNF-alpha had no significant effect on IRS1-associated phosphatidylinositol 3-kinase. In contrast, TNF-alpha increased insulin-stimulated cyclin-dependent kinase-5 (CDK5) phosphorylation on tyrosine residue 15 through an Erk-dependent pathway and up-regulated the expression of the CDK5 regulator protein p35. In parallel, TNF-alpha stimulation also resulted in the phosphorylation and GTP loading of the Rho family GTP-binding protein, TC10 alpha. TNF-alpha enhanced the depolymerization of cortical F-actin and inhibited insulin-stimulated glucose transporter-4 (GLUT4) translocation. Treatment with the MEK inhibitor, PD98059, blocked the TNF-alpha-induced increase in CDK5 phosphorylation and the depolymerization of cortical F-actin. Conversely, siRNA-mediated knockdown of CDK5 or treatment with the MEK inhibitor restored the impaired insulin-stimulated GLUT4 translocation induced by TNF-alpha. Furthermore, siRNA-mediated knockdown of p44/42 Erk also rescued the TNF-alpha inhibition of insulin-stimulated GLUT4 translocation. Together, these data demonstrate that TNF-alpha-mediated insulin resistance of glucose uptake can occur through a MEK/Erk-dependent activation of CDK5.	[Nohara, Atsushi; Okada, Shuichi; Mori, Masatomo] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan; [Ohshima, Kihachi] Gunma Univ, Hlth & Med Ctr, Maebashi, Gunma 3718511, Japan; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med & Mol Pharmacol, Bronx, NY 10461 USA	Gunma University; Gunma University; Yeshiva University; Albert Einstein College of Medicine	Mori, M (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, 3-39-15 Showa Machi, Maebashi, Gunma 371, Japan.	okadash@showa.gunma-u.ac.jp			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541] Funding Source: NIH RePORTER; NIDDK NIH HHS [P60 DK020541] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Eyster CA, 2009, VITAM HORM, V80, P193, DOI 10.1016/S0083-6729(08)00608-0; Guo DQ, 1996, J BIOL CHEM, V271, P615, DOI 10.1074/jbc.271.2.615; Hisanaga S., 2008, KINASE ACTIVITY CDK5, P1; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Kanzaki M, 2002, J BIOL CHEM, V277, P25867, DOI 10.1074/jbc.C200292200; Kanzaki M, 2003, CURR BIOL, V13, pR574, DOI 10.1016/S0960-9822(03)00478-0; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Mao DQ, 2010, J BIOL CHEM, V285, P14671, DOI 10.1074/jbc.M109.066118; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Nolte LA, 1998, DIABETES, V47, P721, DOI 10.2337/diabetes.47.5.721; Okada S, 2008, J BIOL CHEM, V283, P35455, DOI 10.1074/jbc.M806531200; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Sato K, 2007, J NEUROSCI RES, V85, P3071, DOI 10.1002/jnr.21438; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; STEPHENS JM, 1992, J BIOL CHEM, V267, P13580; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Valverde AM, 1998, ENDOCRINOLOGY, V139, P1229, DOI 10.1210/en.139.3.1229; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078; WEINER FR, 1991, J BIOL CHEM, V266, P23525; Yamada E, 2005, J CELL BIOL, V168, P921, DOI 10.1083/jcb.200408182; Yamaguchi K, 2003, HYPERTENS RES, V26, P389, DOI 10.1291/hypres.26.389; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723	33	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33457	33465		10.1074/jbc.M111.231431	http://dx.doi.org/10.1074/jbc.M111.231431			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813649	hybrid, Green Published			2022-12-27	WOS:000294968800063
J	Sears, N; Sen, GC; Stark, GR; Chattopadhyay, S				Sears, Nathaniel; Sen, Ganes C.; Stark, George R.; Chattopadhyay, Saurabh			Caspase-8-mediated Cleavage Inhibits IRF-3 Protein by Facilitating Its Proteasome-mediated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERFERON REGULATORY FACTOR-3; INNATE ANTIVIRAL RESPONSE; SENDAI-VIRUS INFECTION; SVM-BASED PREDICTION; DOUBLE-STRANDED-RNA; CELL LINE; TRANSCRIPTION FACTOR; NEGATIVE REGULATION; IMMUNE-RESPONSES	Interferon regulatory factor 3 (IRF-3) plays a central role in inducing the expression of cellular antiviral genes, including the interferon-beta gene, in response to Pattern Recognition Receptors. IRF-3 is targeted for proteasome-mediated degradation, which modulates the strength and duration of the innate immune responses that depend on it. We have found that caspase-8, which is activated by cytosolic RIG-I-dependent signaling, catalyzes an essential intermediate step in the ubiquitination and proteasome-mediated degradation of IRF-3. Mutation of a consensus cleavage site within IRF-3 generates a form that is not cleaved by caspase-8 and that is protected from ubiquitination and degradation. An in vitro assay confirms the direct action of caspase-8 cleavage on IRF-3. We also show that caspase-8-mediated cleavage of IRF-3 helps to modulate dsRNA-dependent gene induction.	[Sears, Nathaniel; Sen, Ganes C.; Stark, George R.; Chattopadhyay, Saurabh] Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Chattopadhyay, S (corresponding author), Cleveland Clin, Dept Mol Genet, Lerner Res Inst, 9500 Euclid Ave,NE20, Cleveland, OH 44195 USA.	chattos@ccf.org	Chattopadhyay, Saurabh/I-4091-2019	Chattopadhyay, Saurabh/0000-0002-2930-1523; Sears, Nathaniel/0000-0002-6879-9782	National Institutes of Health [R01 AI 073303, P01 CA062220]; NATIONAL CANCER INSTITUTE [P01CA062220, R01CA095851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI 073303 (to G. C. S.) and P01CA062220 (to G. C. S. and G. R. S.).	Areste C, 2009, J BIOL CHEM, V284, P23272, DOI 10.1074/jbc.M109.033290; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Chattopadhyay S, 2011, J VIROL, V85, P3708, DOI 10.1128/JVI.02133-10; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chen ZH, 2007, VIROLOGY, V366, P277, DOI 10.1016/j.virol.2007.04.023; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Elco CP, 2005, J VIROL, V79, P3920, DOI 10.1128/JVI.79.7.3920-3929.2005; Genin P, 2009, CYTOKINE GROWTH F R, V20, P283, DOI 10.1016/j.cytogfr.2009.07.005; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Leaman DW, 1998, P NATL ACAD SCI USA, V95, P9442, DOI 10.1073/pnas.95.16.9442; Lee HR, 2009, J INTERF CYTOK RES, V29, P621, DOI 10.1089/jir.2009.0067; Li HM, 2009, CELL DEATH DIFFER, V16, P1615, DOI 10.1038/cdd.2009.97; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lu G, 2006, CELL MOL BIOL, V52, P29, DOI 10.1170/T695; Meylan E, 2002, EMBO REP, V3, P1201, DOI 10.1093/embo-reports/kvf236; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Prinarakis E, 2008, EMBO J, V27, P865, DOI 10.1038/emboj.2008.28; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Rebsamen M, 2008, CELL DEATH DIFFER, V15, P1804, DOI 10.1038/cdd.2008.119; Saira K, 2007, J VIROL, V81, P3077, DOI 10.1128/JVI.02064-06; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Wee LJK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S14; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334; White CL, 2011, J VIROL, V85, P5224, DOI 10.1128/JVI.00053-11; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yang P, 2007, INVEST OPHTH VIS SCI, V48, P3341, DOI 10.1167/iovs.06-1340; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277	40	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33037	33044		10.1074/jbc.M111.257022	http://dx.doi.org/10.1074/jbc.M111.257022			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21816816	Green Published, hybrid			2022-12-27	WOS:000294968800022
J	Kuzhikandathil, EV; Clark, L; Li, Y				Kuzhikandathil, Eldo V.; Clark, Leslie; Li, Ying			The Extracellular cAMP-Adenosine Pathway Regulates Expression of Renal D1 Dopamine Receptors in Diabetic Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR-FILTRATION RATE; CENTRAL-NERVOUS-SYSTEM; OBESE ZUCKER RATS; CYCLIC-AMP; GLUCAGON; RELEASE; PLASMA; CELLS; HYPERTENSION; 3',5'-MONOPHOSPHATE	Activation of D1 dopamine receptors expressed in the kidneys promotes the excretion of sodium and regulates sodium levels during increases in dietary sodium intake. A decrease in the expression or function of D1 receptors results in increased sodium retention which can potentially lead to the development of hypertension. Studies have shown that in the absence of functional D1 receptors, in null mice, the systolic, diastolic, and mean arterial pressures are higher. Previous studies have shown that the expression and function of D1 receptors in the kidneys are decreased in animal models of diabetes. The mechanisms that down-regulate the expression of renal D1 receptor gene in diabetes are not well understood. Using primary renal cells and acutely isolated kidneys from the streptozotocin-induced rat diabetic model, we demonstrate that the renal D1 receptor expression is down-regulated by the extracellular cAMP-adenosine pathway in vitro and in vivo. In cultures of primary renal cells, a 3 mM, 60-h cAMP treatment down-regulated the expression of D1 receptors. In vivo, we determined that the plasma and urine cAMP levels as well as the expression of 5'-ectonucleotidase, tissue-nonspecific alkaline phosphatase, and adenosine A2a receptors are significantly increased in diabetic rats. Inhibitors of 5'-ectonucleotidase and tissue-nonspecific alkaline phosphatase, alpha,beta-methyleneadenosine 5'-diphosphate, and levamisole, respectively, blocked the down-regulation of D1 receptors in the primary renal cells and in the kidney of diabetic animals. The results suggest that inhibitors of the extracellular cAMP-adenosine pathway reverse the down-regulation of renal D1 receptor in diabetes.	[Kuzhikandathil, Eldo V.; Clark, Leslie; Li, Ying] Univ Med & Dent New Jersey, Dept Physiol & Pharmacol, New Jersey Med Sch, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kuzhikandathil, EV (corresponding author), MSB, 185 S Orange Ave,I-647, Newark, NJ 07103 USA.	kuzhikev@umdnj.edu			American Heart Association Heritage Affiliate [0755940T]	American Heart Association Heritage Affiliate(American Heart Association)	The work was supported by Grant-in-aid 0755940T from the American Heart Association Heritage Affiliate (to E. V. K.).	Albrecht FE, 1996, J CLIN INVEST, V97, P2283, DOI 10.1172/JCI118670; Angielski S, 1989, Contrib Nephrol, V73, P52; Aperia AC, 2000, ANNU REV PHYSIOL, V62, P621, DOI 10.1146/annurev.physiol.62.1.621; Banday AA, 2004, AM J PHYSIOL-RENAL, V287, pF109, DOI 10.1152/ajprenal.00396.2003; BROADUS AE, 1970, J CLIN INVEST, V49, P2237, DOI 10.1172/JCI106442; Cometti B, 2003, BIOL REPROD, V69, P868, DOI 10.1095/biolreprod.103.017962; DAVOREN PR, 1963, J BIOL CHEM, V238, P3009; Do T, 2007, J NEUROCHEM, V101, P619, DOI 10.1111/j.1471-4159.2006.04388.x; Dubey RK, 2000, HYPERTENSION, V36, P337, DOI 10.1161/01.HYP.36.3.337; EXTON JH, 1971, J BIOL CHEM, V246, P6166; HENDY GN, 1977, EUR J CLIN INVEST, V7, P155, DOI 10.1111/j.1365-2362.1977.tb01591.x; Hoshi K, 1997, HISTOCHEM CELL BIOL, V107, P183, DOI 10.1007/s004180050103; Hussain T, 1999, HYPERTENSION, V34, P1091, DOI 10.1161/01.HYP.34.5.1091; Hussain T, 2003, EXP BIOL MED, V228, P134, DOI 10.1177/153537020322800202; Iannello S, 1998, MOL GENET METAB, V63, P214, DOI 10.1006/mgme.1997.2670; Jackson EK, 2006, J PHARMACOL EXP THER, V317, P1219, DOI 10.1124/jpet.106.101360; Jackson EK, 2001, AM J PHYSIOL-RENAL, V281, pF597, DOI 10.1152/ajprenal.2001.281.4.F597; Jackson EK, 2003, J PHARMACOL EXP THER, V307, P888, DOI 10.1124/jpet.103.057166; Jackson EK, 2004, ANNU REV PHYSIOL, V66, P571, DOI 10.1146/annurev.physiol.66.032102.111604; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; JAMAL Z, 1987, BIOCHEM J, V245, P881, DOI 10.1042/bj2450881; KUSTER J, 1973, FEBS LETT, V32, P73, DOI 10.1016/0014-5793(73)80740-9; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; LEVY M, 1972, KIDNEY INT, V2, P76, DOI 10.1038/ki.1972.74; Lunkes GI, 2003, THROMB RES, V109, P189, DOI 10.1016/S0049-3848(03)00178-6; Lunkes GIL, 2004, DIABETES RES CLIN PR, V65, P1, DOI 10.1016/j.diabres.2003.11.016; Marwaha A, 2004, AM J PHYSIOL-RENAL, V286, pF451, DOI 10.1152/ajprenal.00227.2003; Matsuoka I, 2004, J PHARMACOL SCI, V94, P95, DOI 10.1254/jphs.94.95; MCCOY DE, 1993, SEMIN NEPHROL, V13, P31; MCDONALD RH, 1964, J CLIN INVEST, V43, P1116, DOI 10.1172/JCI104996; Mishra SK, 2006, DEVELOPMENT, V133, P675, DOI 10.1242/dev.02233; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Muruganandan S, 2005, TOXICOLOGY, V215, P57, DOI 10.1016/j.tox.2005.06.008; NOUWEN EJ, 1994, KIDNEY INT, pS43; Ohkubo S, 2000, JPN J PHARMACOL, V84, P325, DOI 10.1254/jjp.84.325; Pasuit JB, 2004, J NEUROCHEM, V89, P1508, DOI 10.1111/j.1471-4159.2004.02450.x; Pawelczyk T, 2005, AM J PATHOL, V167, P315, DOI 10.1016/S0002-9440(10)62977-X; Pawelczyk T, 2000, ARCH BIOCHEM BIOPHYS, V375, P1, DOI 10.1006/abbi.1999.1548; SABRA R, 1991, ANTIMICROB AGENTS CH, V35, P2509, DOI 10.1128/AAC.35.12.2509; Song ZL, 2005, BRAIN RES, V1047, P105, DOI 10.1016/j.brainres.2005.04.025; STONE EA, 1990, J NEUROCHEM, V55, P1942, DOI 10.1111/j.1471-4159.1990.tb05780.x; Vekaria RM, 2006, AM J PHYSIOL-RENAL, V290, pF550, DOI 10.1152/ajprenal.00151.2005; Velliquette RA, 2002, EXP BIOL MED, V227, P164, DOI 10.1177/153537020222700303; Yaar R, 2005, J CELL PHYSIOL, V202, P9, DOI 10.1002/jcp.20138; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	45	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32454	32463		10.1074/jbc.M111.268136	http://dx.doi.org/10.1074/jbc.M111.268136			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21803776	hybrid, Green Published			2022-12-27	WOS:000294726800055
J	Delgado-Martin, C; Escribano, C; Pablos, JL; Riol-Blanco, L; Rodriguez-Fernandez, JL				Delgado-Martin, Cristina; Escribano, Cristina; Luis Pablos, Jose; Riol-Blanco, Lorena; Luis Rodriguez-Fernandez, Jose			Chemokine CXCL12 Uses CXCR4 and a Signaling Core Formed by Bifunctional Akt, Extracellular Signal-regulated Kinase (ERK) 1/2, and Mammalian Target of Rapamycin Complex 1 (mTORC1) Proteins to Control Chemotaxis and Survival Simultaneously in Mature Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN RECEPTOR RDC1; T-LYMPHOCYTES; PHOSPHOINOSITIDE 3-KINASE; RHEUMATOID-ARTHRITIS; MIGRATION; ACTIVATION; CCR7; TRANSDUCTION; MATURATION; APOPTOSIS	Chemokines control several cell functions in addition to chemotaxis. Although much information is available on the involvement of specific signaling molecules in the control of single functions controlled by chemokines, especially chemotaxis, the mechanisms used by these ligands to regulate several cell functions simultaneously are completely unknown. Mature dendritic cells (maDCs) migrate through the afferent lymphatic vessels to the lymph nodes, where they regulate the initiation of the immune response. As maDCs are exposed to chemokine CXCL12 ( receptors CXCR4 and CXCR7) during their migration, its functions are amenable to be regulated by this ligand. We have used maDCs as a model system to analyze the mechanisms whereby CXCL12 simultaneously controls chemotaxis and survival in maDCs. We show that CXCL12 uses CXCR4, but not CXCR7, and the components of a signaling core that includes Gi/G beta gamma, PI3K-alpha/-beta/-gamma, Akt, ERK1/2 and mammalian target of rapamycin complex 1 (mTORC1), which organize hierarchically to control both functions. Downstream of Akt, Fork-head box class O (FOXO) regulates CXCL12-dependent survival, but not chemotaxis, suggesting that downstream of the aforementioned signaling core, additional signaling molecules may control more selectively CXCL12-dependent chemotaxis or survival. Finally, the data obtained also show that CXCR4 uses a signaling signature that is different from that used by CCR7 to control similar functions.	[Delgado-Martin, Cristina; Escribano, Cristina; Riol-Blanco, Lorena; Luis Rodriguez-Fernandez, Jose] Consejo Super Invest Cient, Ctr Invest Biol, Madrid 28040, Spain; [Luis Pablos, Jose] Inst Invest Hosp, Serv Reumatol, Madrid 28041, Spain; [Luis Pablos, Jose] Inst Invest Hosp, Unidad Invest, Madrid 28041, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Rodriguez-Fernandez, JL (corresponding author), Consejo Super Invest Cient, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	rodrifer@cib.csic.es	Rodriguez-Fernandez, Jose Luis/Q-5021-2019	Rodriguez-Fernandez, Jose Luis/0000-0001-8874-1425	Redes Tematicas de Investigacion Cooperativas (RETICS) Program/Instituto de Salud Carlos III [RD08/0075]; Ministerio de Educacion y Ciencia [SAF2005-00801]; Proyectos Intramurales de Incorporacion, Consejo Superior de Investigaciones Cientificas [200620I167]; Genoma Espana; Formacion de Personal Investigador (FPI); RETICS Program/Instituto de Salud Carlos III [RD08/0075]; I3P scholarship from the Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo; Ministerio de Sanidad (Spain) [PI021058]	Redes Tematicas de Investigacion Cooperativas (RETICS) Program/Instituto de Salud Carlos III(Instituto de Salud Carlos III); Ministerio de Educacion y Ciencia(Spanish Government); Proyectos Intramurales de Incorporacion, Consejo Superior de Investigaciones Cientificas; Genoma Espana; Formacion de Personal Investigador (FPI)(Spanish Government); RETICS Program/Instituto de Salud Carlos III(Instituto de Salud Carlos III); I3P scholarship from the Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo; Ministerio de Sanidad (Spain)(Spanish Government)	This work was supported by Redes Tematicas de Investigacion Cooperativas (RETICS) Program/Instituto de Salud Carlos III Grant RD08/0075 (to J. L. R.-F. and J. L. P.), Ministerio de Educacion y Ciencia Grant SAF2005-00801 (to J. L. R.-F.), Proyectos Intramurales de Incorporacion, Consejo Superior de Investigaciones Cientificas Grant 200620I167, and by Genoma Espana.; Supported by fellowship Formacion de Personal Investigador (FPI), conferred by the Ministerio de Educacion y Ciencia (Spain) and by a contract associated with RETICS Program/Instituto de Salud Carlos III Grant RD08/0075.; Recipient of an I3P scholarship from the Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo.; Supported by a scholarship associated with Grant PI021058 awarded by the Ministerio de Sanidad (Spain).	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Berahovich RD, 2010, J IMMUNOL, V185, P5130, DOI 10.4049/jimmunol.1001660; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Chen M, 2007, MOL IMMUNOL, V44, P2558, DOI 10.1016/j.molimm.2006.12.020; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Del Prete A, 2004, EMBO J, V23, P3505, DOI 10.1038/sj.emboj.7600361; Delgado E, 1998, IMMUNOBIOLOGY, V198, P490, DOI 10.1016/S0171-2985(98)80073-9; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Escribano C, 2009, J IMMUNOL, V183, P6282, DOI 10.4049/jimmunol.0804093; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Gonzalez N, 2010, J VIROL, V84, P4341, DOI 10.1128/JVI.02449-09; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hernandez-Lopez C, 2008, IMMUNOL LETT, V120, P72, DOI 10.1016/j.imlet.2008.07.006; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Huttenlocher A, 2008, TRENDS CELL BIOL, V18, P298, DOI 10.1016/j.tcb.2008.04.001; Infantino S, 2006, J IMMUNOL, V176, P2197, DOI 10.4049/jimmunol.176.4.2197; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kabashima K, 2007, BIOCHEM BIOPH RES CO, V361, P1012, DOI 10.1016/j.bbrc.2007.07.128; Kim S, 2007, BLOOD, V110, P4206, DOI 10.1182/blood-2007-03-080804; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Lin CL, 1998, EUR J IMMUNOL, V28, P4114, DOI 10.1002/(SICI)1521-4141(199812)28:12<4114::AID-IMMU4114>3.0.CO;2-C; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Ouwehand K, 2008, EUR J IMMUNOL, V38, P3050, DOI 10.1002/eji.200838384; Pablos JL, 1999, AM J PATHOL, V155, P1577, DOI 10.1016/S0002-9440(10)65474-0; Procko E, 2005, BIOESSAYS, V27, P153, DOI 10.1002/bies.20157; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Riol-Blanco L, 2004, EUR J IMMUNOL, V34, P108, DOI 10.1002/eji.200324640; Riol-Blanco L, 2009, NAT IMMUNOL, V10, P753, DOI 10.1038/ni.1750; Rodriguez-Fernandez JL, 1999, MOL BIOL CELL, V10, P1891, DOI 10.1091/mbc.10.6.1891; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sanchez-Sanchez N, 2004, BLOOD, V104, P619, DOI 10.1182/blood-2003-11-3943; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Scandella E, 2004, BLOOD, V103, P1595, DOI 10.1182/blood-2003-05-1643; Sozzani S, 1998, J IMMUNOL, V161, P1083; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Timmer TCG, 2007, ARTHRITIS RHEUM-US, V56, P2492, DOI 10.1002/art.22748; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vecchi A, 1999, J LEUKOCYTE BIOL, V66, P489, DOI 10.1002/jlb.66.3.489; Vlahakis SR, 2002, J IMMUNOL, V169, P5546, DOI 10.4049/jimmunol.169.10.5546; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Yanagawa Y, 2003, BLOOD, V101, P4923, DOI 10.1182/blood-2002-11-3474; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	59	63	66	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37222	37236		10.1074/jbc.M111.294116	http://dx.doi.org/10.1074/jbc.M111.294116			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878648	Green Published, hybrid			2022-12-27	WOS:000296542400023
J	Hsu, YL; Huang, MS; Yang, CJ; Hung, JY; Wu, LY; Kuo, PL				Hsu, Ya-Ling; Huang, Ming-Shyan; Yang, Chih-Jen; Hung, Jen-Yu; Wu, Ling-Yu; Kuo, Po-Lin			Lung Tumor-associated Osteoblast-derived Bone Morphogenetic Protein-2 Increased Epithelial-to-Mesenchymal Transition of Cancer by Runx2/Snail Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVATION; TGF-BETA; RUNX2; CELLS; METASTASIS; EXPRESSION; KINASE; ACETYLATION; GROWTH	Bone is a frequent target of lung cancer metastasis and is associated with significant morbidity and a dismal prognosis. Interaction between cancer cells and the bone microenvironment causes a vicious cycle of tumor progression and bone destruction. This study analyzed the soluble factors secreted by lung tumor-associated osteoblast (TAOB), which are responsible for increasing cancer progression. The addition of bone morphogenetic protein-2 (BMP-2), present in large amounts in TAOB conditioned medium (TAOB-CM) and lung cancer patient sera, mimicked the inductive effect of TAOB-CM on lung cancer migration, invasion, and epithelial-to-mesenchymal transition. In contrast, inhibition of BMP by noggin decreases the inductive properties of TAOB-CM and lung cancer patient sera on cancer progression. Induction of lung cancer migration by BMP-2 is associated with increased ERK and p38 activation and the up-regulation of Runx2 and Snail. Blocking ERK and p38 by a specific inhibitor significantly decreases cancer cell migration by inhibiting Runx2 up-regulation and subsequently attenuating the expression of Snail. Enhancement of Runx2 facilitates Rux2 to recruit p300, which in turn enhances histone acetylation, increases Snail expression, and decreases E-cadherin. Furthermore, inhibiting Runx2 by siRNA also suppresses BMP-2-induced Snail up-regulation and cell migration. Our findings provide novel evidence that inhibition of BMP-2 or BMP-2-mediated MAPK/Runx2/Snail signaling is an attractive therapeutic target for osteolytic bone metastases in lung cancer patients.	[Kuo, Po-Lin] Kaohsiung Med Univ, Inst Clin Med, Coll Med, Kaohsiung 807, Taiwan; [Hsu, Ya-Ling; Yang, Chih-Jen; Hung, Jen-Yu; Wu, Ling-Yu] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung 807, Taiwan; [Huang, Ming-Shyan; Yang, Chih-Jen; Hung, Jen-Yu] Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Huang, Ming-Shyan; Yang, Chih-Jen; Hung, Jen-Yu; Kuo, Po-Lin] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung 807, Taiwan; [Kuo, Po-Lin] Kaohsiung Med Univ Kaohsiung, Ctr Excellence Environm Med, Kaohsiung 807, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Kuo, PL (corresponding author), Kaohsiung Med Univ, Inst Clin Med, Coll Med, 100,Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.	kuopolin@seed.net.tw			National Science Council of Taiwan [NSC 98-2320-B-037-007-MY3]; Department of Health, Executive Yuan, Taipei, Taiwan [DOH100-TD-C-111-002]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taipei, Taiwan	This work is supported by National Science Council of Taiwan Grant NSC 98-2320-B-037-007-MY3) and Excellence for Cancer Research Center Grant DOH100-TD-C-111-002 from the Department of Health, Executive Yuan, Taipei, Taiwan.	Akech J, 2010, ONCOGENE, V29, P811, DOI 10.1038/onc.2009.389; Baniwal SK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-258; Boumah CE, 2009, MOL ENDOCRINOL, V23, P1255, DOI 10.1210/me.2008-0217; Bunyaratavej P, 2000, EXP CELL RES, V260, P324, DOI 10.1006/excr.2000.5019; Chen HW, 2008, CANCER RES, V68, P7428, DOI 10.1158/0008-5472.CAN-07-6734; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Clezardin P, 2007, CLIN EXP METASTAS, V24, P599, DOI 10.1007/s10585-007-9112-8; Coleman RE, 2010, CANCER TREAT REV, V36, P615, DOI 10.1016/j.ctrv.2010.04.003; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Galvan JA, 2010, LUNG CANCER, V69, P289, DOI 10.1016/j.lungcan.2009.12.010; Gamell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016477; Georges S, 2009, CYTOKINE GROWTH F R, V20, P29, DOI 10.1016/j.cytogfr.2008.11.005; Gordon KJ, 2009, CARCINOGENESIS, V30, P238, DOI 10.1093/carcin/bgn274; Graham TR, 2009, PROSTATE, V69, P168, DOI 10.1002/pros.20870; Graves EE, 2010, SEMIN RADIAT ONCOL, V20, P156, DOI 10.1016/j.semradonc.2010.01.003; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Juarez P, 2011, BONE, V48, P23, DOI 10.1016/j.bone.2010.08.004; Jun JH, 2010, J BIOL CHEM, V285, P36410, DOI 10.1074/jbc.M110.142307; Knerr K, 2004, INT J CANCER, V111, P152, DOI 10.1002/ijc.20223; Kuo PL, 2005, J PHARMACOL EXP THER, V314, P1290, DOI 10.1124/jpet.105.085092; Kuo PL, 2011, J CELL PHYSIOL, V226, P1224, DOI 10.1002/jcp.22445; Kvale PA, 2003, CHEST, V123, p284S, DOI 10.1378/chest.123.1_suppl.284S; Lai TH, 2008, PROSTATE, V68, P1341, DOI 10.1002/pros.20799; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Lee M, 2010, J BIOL CHEM, V285, P38014, DOI 10.1074/jbc.M110.142141; Lin QA, 2010, JPN J CLIN ONCOL, V40, P670, DOI 10.1093/jjco/hyq041; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Nannuru Kalyan C, 2010, Curr Osteoporos Rep, V8, P105, DOI 10.1007/s11914-010-0011-6; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Onishi T, 2010, NAT REV CLIN ONCOL, V7, P641, DOI 10.1038/nrclinonc.2010.134; Onodera Y, 2010, CANCER SCI, V101, P2670, DOI 10.1111/j.1349-7006.2010.01742.x; Ooi LL, 2011, BONE, V48, P66, DOI 10.1016/j.bone.2010.05.007; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; Paredes R, 2004, J STEROID BIOCHEM, V89-90, P269, DOI 10.1016/j.jsbmb.2004.03.076; Park OJ, 2010, J BIOL CHEM, V285, P3568, DOI 10.1074/jbc.M109.055053; Park Y, 2010, MED ONCOL, V27, P1192, DOI 10.1007/s12032-009-9358-x; Pratap J, 2008, CANCER RES, V68, P7795, DOI 10.1158/0008-5472.CAN-08-1078; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Rosen LS, 2003, J CLIN ONCOL, V21, P3150, DOI 10.1200/JCO.2003.04.105; Scherberich A, 2005, ONCOGENE, V24, P1525, DOI 10.1038/sj.onc.1208342; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Yanagawa J, 2009, CLIN CANCER RES, V15, P6820, DOI 10.1158/1078-0432.CCR-09-1558	44	58	61	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37335	37346		10.1074/jbc.M111.256156	http://dx.doi.org/10.1074/jbc.M111.256156			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21885439	Green Published, hybrid			2022-12-27	WOS:000296542400034
J	Lee, SYC; De la Mota-Peynado, A; Roelofs, J				Lee, Stella Yu-Chien; De la Mota-Peynado, Alina; Roelofs, Jeroen			Loss of Rpt5 Protein Interactions with the Core Particle and Nas2 Protein Causes the Formation of Faulty Proteasomes That Are Inhibited by Ecm29 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							26 S-PROTEASOME; REGULATORY PARTICLE; C-TERMINI; ASSEMBLY PATHWAY; 20S PROTEASOME; ATPASES; COMPLEX; ROLES; YEAST; ACTIVATION	The proteasome is a large and complex protease formed by 66 polypeptides. The assembly of the proteasome is assisted by at least nine chaperones. One of these chaperones, Nas2/p27, binds to the C-terminal region of the AAA-ATPase Rpt5. We report here that the tail of Rpt5 provides two functions. First, it facilitates the previously reported interaction with the proteasome core particle (CP). Second, it is essential for the interaction with Nas2. Deletion of the C-terminal amino acid of Rpt5 disrupts the CP interaction, but not the binding to Nas2. The latter is surprising considering Nas2 contains a PDZ domain, which is often involved in binding to C termini. Interestingly, deletion of the last three amino acids interferes with both functions. The disruption of the Rpt5-CP interactions gave distinct phenotypes different from disruption of the Nas2-Rpt5 interaction. Additionally, proteasomes purified from a Saccharomyces cerevisiae rpt5-Delta 3 strain show a strong enrichment of Ecm29. The function of Ecm29, a proteasome-associated protein, is not well understood. Our data show that Ecm29 can inhibit proteasomes, because our Ecm29-containing proteasomes have reduced suc-LLVY-AMC hydrolytic activity. Consistent with this apparent role as negative regulator, the deletion of ECM29 rescues the phenotypes of rpt5-Delta 3 and nas2 Delta in an hsm3 Delta background. In sum, the interactions facilitated by the tail of Rpt5 act synergistically to minimize the formation of faulty proteasomes, thereby preventing recognition and inhibition by Ecm29.	[Lee, Stella Yu-Chien; De la Mota-Peynado, Alina; Roelofs, Jeroen] Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA	Kansas State University	Roelofs, J (corresponding author), Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, 338 Ackert Hall, Manhattan, KS 66506 USA.	jroelofs@ksu.edu	Roelofs, Jeroen/AAC-5119-2021	Roelofs, Jeroen/0000-0003-0944-2465	National Institutes of Health [P20 RR017708, P20 RR016475]; Terry Johnson Center for basic cancer research at Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475, P20RR017708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry Johnson Center for basic cancer research at Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR017708 and P20 RR016475. This work was also supported by a grant from the Terry Johnson Center for basic cancer research at Kansas State University.	Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Fehlker M, 2003, EMBO REP, V4, P959, DOI 10.1038/sj.embor.embor938; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster F, 2009, BIOCHEM BIOPH RES CO, V388, P228, DOI 10.1016/j.bbrc.2009.07.145; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gallastegui N, 2010, TRENDS BIOCHEM SCI, V35, P634, DOI 10.1016/j.tibs.2010.05.005; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Gorbea C, 2004, J BIOL CHEM, V279, P54849, DOI 10.1074/jbc.M410444200; Gorbea C, 2010, J BIOL CHEM, V285, P31616, DOI 10.1074/jbc.M110.154120; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Iwanczyk J, 2006, J MOL BIOL, V363, P648, DOI 10.1016/j.jmb.2006.08.010; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Leggett David S., 2005, V301, P57; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehmann A, 2010, MOL CELL, V38, P879, DOI 10.1016/j.molcel.2010.06.016; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Lopez AD, 2011, MOL BIOL CELL, V22, P528, DOI 10.1091/mbc.E10-04-0352; Marques AJ, 2007, J BIOL CHEM, V282, P34869, DOI 10.1074/jbc.M705836200; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Ortega J, 2005, J MOL BIOL, V346, P1221, DOI 10.1016/j.jmb.2004.12.049; Panasenko OO, 2011, MOL CELL BIOL, V31, P1610, DOI 10.1128/MCB.01210-10; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Park S, 2010, BIOCHEM SOC T, V38, P6, DOI 10.1042/BST0380006; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Sakata E, 2011, MOL CELL, V42, P637, DOI 10.1016/j.molcel.2011.04.021; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smulski PA, 2009, STRUCTURE, V17, P1137, DOI 10.1016/j.str.2009.06.011; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021	47	45	46	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36641	36651		10.1074/jbc.M111.280875	http://dx.doi.org/10.1074/jbc.M111.280875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878651	Green Published, hybrid			2022-12-27	WOS:000296538300047
J	Tang, FQ; Zou, FY; Peng, ZK; Huang, DM; Wu, Y; Chen, Y; Duan, CJ; Cao, Y; Mei, WH; Tang, XW; Dong, ZG				Tang, Faqing; Zou, Feiyan; Peng, Zhengke; Huang, Damao; Wu, Yuan; Chen, Yu; Duan, Chaojun; Cao, Ya; Mei, Wenhua; Tang, Xiaowei; Dong, Zigang			N,N '-Dinitrosopiperazine-mediated Ezrin Protein Phosphorylation via Activation of Rho Kinase and Protein Kinase C Is Involved in Metastasis of Nasopharyngeal Carcinoma 6-10B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHINESE SALTED FISH; NITROSO-COMPOUNDS; ORGANIZER EZRIN; LINKER EZRIN; ERM PROTEINS; HUMAN CANCER; CYTOSKELETON; MECHANISMS; INDUCTION; FILOPODIA	N,N'-Dinitrosopiperazine (DNP) is a carcinogen for nasopharyngeal carcinoma (NPC), which shows organ specificity to nasopharyngeal epithelium. Herein, we demonstrate that DNP induces fiber formation of NPC cells (6-10B) and also increases invasion and motility of 6-10B cells. DNP-mediated NPC metastasis also was confirmed in nude mice. Importantly, DNP induced the expression of phosphorylated ezrin (phos-ezrin) at threonine 567 (Thr-567) dose-and time-dependently but had no effect on the total ezrin expression at these concentrations. Furthermore, DNP-induced phos-ezrin expression was dependent on increased Rho kinase and protein kinase C (PKC) activity. DNP may activate Rho kinase through binding to its pleckstrin homology and may activate PKC through promoting its translocation to the plasma membrane in vivo. DNP-induced phos-ezrin was associated with induction of fiber growth in 6-10B cells. However, DNP could not induce motility and invasion of NPC cells containing ezrin mutated at Thr-567. Similarly, DNP could not induce motility and invasion of the cells containing siRNAs against Rho or PKC. These results indicate that DNP induces ezrin phosphorylation at Thr-567, increases motility and invasion of cells, and promotes tumor metastasis. DNP may be involved in NPC metastasis through regulation of ezrin phosphorylation at Thr-567.	[Tang, Faqing; Mei, Wenhua] Jinan Univ, Med Res Ctr, Zhuhai Hosp, Guangzhou 510000, Guangdong, Peoples R China; [Zou, Feiyan] Jinan Univ, Coll Life Sci, Guangzhou 510000, Guangdong, Peoples R China; [Peng, Zhengke; Huang, Damao; Wu, Yuan; Chen, Yu; Duan, Chaojun; Tang, Xiaowei] Cent S Univ, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Cao, Ya] Cent S Univ, Canc Res Inst, Changsha 410008, Hunan, Peoples R China; [Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	Jinan University; Jinan University; Central South University; Central South University; University of Minnesota System	Tang, FQ (corresponding author), Jinan Univ, Zhuhai Hosp, Zhuhai 519000, Guangdong, Peoples R China.	tangfaqing33@hotmail.com			National Natural Science Foundation of China [81071718, 81000881, 30973400, 30572455]; Program for New Century Excellent Talents in University [NCET-06-0685]; Technology Foundation of Hunan [08FJ3176]; Science Foundation of Central South University [08SDF07]; Department of Pathology of Xiangya Hospital, Central South University; Youping Sun of BEST Inc.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Technology Foundation of Hunan; Science Foundation of Central South University; Department of Pathology of Xiangya Hospital, Central South University; Youping Sun of BEST Inc.	This work was supported in part by National Natural Science Foundation of China Grants 81071718, 81000881, 30973400, and 30572455; Program for New Century Excellent Talents in University Grant NCET-06-0685; Technology Foundation of Hunan Grant 08FJ3176; and Science Foundation of Central South University Grant 08SDF07.; We thank Director Tieyong Li at the Cancer Research Institute of Central South University for providing DNP and Prof. Haiying Jian and Deyun Feng at the Department of Pathology of Xiangya Hospital, Central South University and Youping Sun of BEST Inc. for support.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Armstrong RW, 1998, INT J CANCER, V77, P228, DOI 10.1002/(SICI)1097-0215(19980717)77:2&lt;228::AID-IJC11&gt;3.0.CO;2-7; Attiga FA, 2000, CANCER RES, V60, P4629; BARTSCH H, 1992, PHARMACOGENETICS, V2, P272, DOI 10.1097/00008571-199212000-00005; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chang TC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009187; CHEN J, 1995, P NATL ACAD SCI USA, V92, P7495, DOI 10.1073/pnas.92.16.7495; Chen Z C, 1991, IARC Sci Publ, P434; Chua DTT, 1998, INT J RADIAT ONCOL, V41, P379, DOI 10.1016/S0360-3016(98)00063-7; Chuan YC, 2006, J BIOL CHEM, V281, P29938, DOI 10.1074/jbc.M602237200; Deng XY, 2007, CLIN EXP METASTAS, V24, P107, DOI 10.1007/s10585-007-9059-9; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Gallicchio L, 2006, INT J CANCER, V119, P1125, DOI 10.1002/ijc.21946; Gallo G, 2008, DEV NEUROBIOL, V68, P926, DOI 10.1002/dneu.20631; Henderson B E, 1978, IARC Sci Publ, P251; Howlett AC, 2000, J NEUROCHEM, V74, P2174, DOI 10.1046/j.1471-4159.2000.0742174.x; Huang D P, 1978, IARC Sci Publ, P315; HUANG SC, 1985, INT J RADIAT ONCOL, V11, P1789, DOI 10.1016/0360-3016(85)90033-1; Jakszyn P, 2006, WORLD J GASTROENTERO, V12, P4296, DOI 10.3748/wjg.v12.i27.4296; Jimenez-Sainz MC, 2006, MOL BIOL CELL, V17, P25, DOI 10.1091/mbc.e05-05-0399; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Leung TW, 2005, HEAD NECK-J SCI SPEC, V27, P555, DOI 10.1002/hed.20189; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Merajver SD, 2005, J MAMMARY GLAND BIOL, V10, P291, DOI 10.1007/s10911-006-9002-8; Meschler JP, 1999, PHARMACOL BIOCHEM BE, V62, P473, DOI 10.1016/S0091-3057(98)00195-6; Mitani N, 2001, CANCER LETT, V165, P35, DOI 10.1016/S0304-3835(00)00710-2; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Poirier S, 1987, IARC Sci Publ, P415; PRESTONMARTIN S, 1989, CANCER SURV, V8, P459; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Schafer C, 2009, EXP CELL RES, V315, P1212, DOI 10.1016/j.yexcr.2008.11.008; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Tang FQ, 2009, CANCER SCI, V100, P216, DOI 10.1111/j.1349-7006.2008.01028.x; Tang FQ, 2009, J BIOL CHEM, V284, P27456, DOI 10.1074/jbc.M109.033795; Yang XY, 2005, CELL ONCOL, V27, P215; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249; Yonemura S, 2002, J CELL SCI, V115, P2569; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; YU MC, 1989, INT J CANCER, V43, P1077, DOI 10.1002/ijc.2910430621; YU MC, 1989, BRIT J CANCER, V60, P198, DOI 10.1038/bjc.1989.250; YU MC, 1986, CANCER RES, V46, P956; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; Zh LX, 2007, AM J PHYSIOL-CELL PH, V293, pC874, DOI 10.1152/ajpcell.00111.2007; Zhang Y, 2006, J CANCER RES CLIN, V132, P685, DOI 10.1007/s00432-006-0117-5; ZHENG X, 1994, ACTA OTO-LARYNGOL, V114, P98, DOI 10.3109/00016489409126024; Zou J, 2000, J Radiat Res, V41 Suppl, P53; ZOU XN, 1994, INT J CANCER, V59, P155, DOI 10.1002/ijc.2910590202; 1987, IARC SCI PUBL, V88, P1	55	24	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36956	36967		10.1074/jbc.M111.259234	http://dx.doi.org/10.1074/jbc.M111.259234			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878630	Green Published, hybrid			2022-12-27	WOS:000296538300074
J	Adwan, TS; Ohm, AM; Jones, DNM; Humphries, MJ; Reyland, ME				Adwan, Tariq S.; Ohm, Angela M.; Jones, David N. M.; Humphries, Michael J.; Reyland, Mary E.			Regulated Binding of Importin-alpha to Protein Kinase C delta in Response to Apoptotic Signals Facilitates Nuclear Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLAND ACINAR-CELLS; SALIVARY EPITHELIAL-CELLS; ABL TYROSINE KINASE; PKC-DELTA; LOCALIZATION SIGNALS; DNA-DAMAGE; PHOSPHORYLATION; ACTIVATION; HSP90; TRANSLOCATION	PKC delta translocates into the nucleus in response to apoptotic agents and functions as a potent cell death signal. Cytoplasmic retention of PKC delta and its transport into the nucleus are essential for cell homeostasis, but how these processes are regulated is poorly understood. We show that PKC delta resides in the cytoplasm in a conformation that precludes binding of importin-alpha. A structural model of PKC delta in the inactive state suggests that the nuclear localization sequence (NLS) is prevented from binding to importin-alpha through intramolecular contacts between the C2 and catalytic domains. We have previously shown that PKC delta is phosphorylated on specific tyrosine residues in response to apoptotic agents. Here, we show that phosphorylation of PKC delta at Tyr-64 and Tyr-155 results in a conformational change that allows exposure of the NLS and binding of importin-alpha. In addition, Hsp90 binds to PKC delta with similar kinetics as importin-alpha and is required for the interaction of importin-alpha with the NLS. Finally, we elucidate a role for a conserved PPxxP motif, which overlaps the NLS, in nuclear exclusion of PKC delta. Mutagenesis of the conserved prolines to alanines enhanced importin-alpha binding to PKC delta and induced its nuclear import in resting cells. Thus, the PPxxP motif is important for maintaining a conformation that facilitates cytosplasmic retention of PKC delta. Taken together, this study establishes a novel mechanism that retains PKC delta in the cytoplasm of resting cells and regulates its nuclear import in response to apoptotic stimuli.	[Adwan, Tariq S.; Humphries, Michael J.; Reyland, Mary E.] Univ Colorado, Program Cell Biol Stem Cells & Dev, Aurora, CO 80045 USA; [Jones, David N. M.] Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA; [Ohm, Angela M.; Reyland, Mary E.] Univ Colorado, Dept Craniofacial Biol, Sch Dent Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Reyland, ME (corresponding author), Univ Colorado, Program Cell Biol Stem Cells & Dev, Mail Stop 8120,POB 6511,Anschutz Med Campus, Aurora, CO 80045 USA.	Mary.Reyland@UCDenver.edu	Jones, David N/C-5764-2013		NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA046934] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acs P, 2000, CARCINOGENESIS, V21, P887, DOI 10.1093/carcin/21.5.887; An WG, 2000, CELL GROWTH DIFFER, V11, P355; Anderson SM, 1999, CELL DEATH DIFFER, V6, P454, DOI 10.1038/sj.cdd.4400507; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Damelin M, 2002, METHOD ENZYMOL, V351, P587; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Feldherr C, 2002, J CELL SCI, V115, P2997; Gallegos LL, 2008, IUBMB LIFE, V60, P782, DOI 10.1002/iub.122; Giannini A, 2004, MOL CELL BIOL, V24, P5667, DOI 10.1128/MCB.24.13.5667-5676.2004; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Humphries MJ, 2008, ONCOGENE, V27, P3045, DOI 10.1038/sj.onc.1210967; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Jackson D, 2005, ONCOGENE, V24, P3067, DOI 10.1038/sj.onc.1208465; Jackson DN, 2004, FASEB J, V18, P627, DOI 10.1096/fj.03-0979rev; Kajimoto T, 2004, J BIOL CHEM, V279, P12668, DOI 10.1074/jbc.M312350200; Kakuk A, 2008, EXP CELL RES, V314, P2376, DOI 10.1016/j.yexcr.2008.05.006; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Kazlauskas A, 2001, MOL CELL BIOL, V21, P2594, DOI 10.1128/MCB.21.7.2594-2607.2001; Kheifets V, 2007, PHARMACOL RES, V55, P467, DOI 10.1016/j.phrs.2007.04.014; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Kronfeld I, 2000, J BIOL CHEM, V275, P35491, DOI 10.1074/jbc.M005991200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leitges M, 2001, J CLIN INVEST, V108, P1505; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Leung SW, 2003, J BIOL CHEM, V278, P41947, DOI 10.1074/jbc.M307162200; Li WQ, 1998, MOL CELL BIOL, V18, P5888, DOI 10.1128/MCB.18.10.5888; Li WQ, 1996, J BIOL CHEM, V271, P26404, DOI 10.1074/jbc.271.42.26404; Liu J, 2010, J TISSUE ENG REGEN M, V4, P329, DOI 10.1002/term.242; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Matassa A, 2003, CELL DEATH DIFFER, V10, P269, DOI 10.1038/sj.cdd.4401149; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Mecklenbrauker I, 2004, NATURE, V431, P456, DOI 10.1038/nature02955; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Okhrimenko H, 2005, J BIOL CHEM, V280, P23643, DOI 10.1074/jbc.M501374200; Reno EM, 2008, HUM PATHOL, V39, P21, DOI 10.1016/j.humpath.2007.05.023; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Reyland ME, 2000, CELL DEATH DIFFER, V7, P1200, DOI 10.1038/sj.cdd.4400744; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Solodukhin AS, 2007, CELL SIGNAL, V19, P2035, DOI 10.1016/j.cellsig.2007.05.010; Symonds JM, 2011, CANCER RES, V71, P2087, DOI 10.1158/0008-5472.CAN-10-1511; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Tapia JA, 2003, J BIOL CHEM, V278, P35220, DOI 10.1074/jbc.M303119200; Violin JD, 2003, IUBMB LIFE, V55, P653, DOI 10.1080/152165401310001642216; Voss OH, 2005, J BIOL CHEM, V280, P17371, DOI 10.1074/jbc.M412449200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yoshida K, 2005, CELL CYCLE, V4, P777, DOI 10.4161/cc.4.6.1746; Yoshida K, 2007, CELL SIGNAL, V19, P892, DOI 10.1016/j.cellsig.2007.01.027; Yuan ZM, 1998, ONCOGENE, V16, P1643, DOI 10.1038/sj.onc.1201698	56	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35716	35724		10.1074/jbc.M111.255950	http://dx.doi.org/10.1074/jbc.M111.255950			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865164	Green Published, hybrid			2022-12-27	WOS:000295927100044
J	Bueter, CL; Lee, CK; Rathinam, VAK; Healy, GJ; Taron, CH; Specht, CA; Levitz, SM				Bueter, Chelsea L.; Lee, Chrono K.; Rathinam, Vijay A. K.; Healy, Gloria J.; Taron, Christopher H.; Specht, Charles A.; Levitz, Stuart M.			Chitosan but Not Chitin Activates the Inflammasome by a Mechanism Dependent upon Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGEN CANDIDA-ALBICANS; NALP3 INFLAMMASOME; IMMUNE-RESPONSES; NLRP3 INFLAMMASOME; DENDRITIC CELLS; BRUGIA-MALAYI; CUTTING EDGE; HOST-DEFENSE; INNATE; MACROPHAGES	Chitin is an abundant polysaccharide found in fungal cell walls, crustacean shells, and insect exoskeletons. The immunological properties of both chitin and its deacetylated derivative chitosan are of relevance because of frequent natural exposure and their use in medical applications. Depending on the preparation studied and the end point measured, these compounds have been reported to induce allergic responses, inflammatory responses, or no response at all. We prepared highly purified chitosan and chitin and examined the capacity of these glycans to stimulate murine macrophages to release the inflammasome-associated cytokine IL-1 beta. We found that although chitosan was a potent NLRP3 inflammasome activator, acetylation of the chitosan to chitin resulted in a near total loss of activity. The size of the chitosan particles played an important role, with small particles eliciting the greatest activity. An inverse relationship between size and stimulatory activity was demonstrated using chitosan passed through size exclusion filters as well as with chitosan-coated beads of defined size. Partial digestion of chitosan with pepsin resulted in a larger fraction of small phagocytosable particles and more potent inflammasome activity. Inhibition of phagocytosis with cytochalasin D abolished the IL-1 beta stimulatory activity of chitosan, offering an explanation for why the largest particles were nearly devoid of activity. Thus, the deacetylated polysaccharide chitosan potently activates the NLRP3 inflammasome in a phagocytosis-dependent manner. In contrast, chitin is relatively inert.	[Levitz, Stuart M.] Univ Massachusetts, Med Ctr, Dept Med, Sch Med, Worcester, MA 01605 USA; [Rathinam, Vijay A. K.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Healy, Gloria J.; Taron, Christopher H.] New England Biolabs Inc, Ipswich, MA 01938 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; New England Biolabs	Levitz, SM (corresponding author), Univ Massachusetts, Med Ctr, Dept Med, Sch Med, 346 Plantat St,LRB317, Worcester, MA 01605 USA.	stuart.levitz@umassmed.edu	Rathinam, Vijay/ABE-7544-2020	Rathinam, Vijay/0000-0002-8009-3977; Taron, Christopher/0000-0001-8149-4556	National Institutes of Health [RO1 AI025780, R21 AI093302-01, RO1 AI066087]; University of Massachusetts Medical School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025780, R01AI066087, T32AI095213, R21AI093302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts Medical School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI025780, R21 AI093302-01, and RO1 AI066087. This work was also supported by the University of Massachusetts Medical School.	Aranaz I., 2009, CURR CHEM BIOL, V3, P203, DOI [DOI 10.2174/2212796810903020203, DOI 10.2174/187231309788166415]; ARAUJO ACG, 1993, J HISTOCHEM CYTOCHEM, V41, P571, DOI 10.1177/41.4.8450196; Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3; Da Silva CA, 2009, J IMMUNOL, V182, P3573, DOI 10.4049/jimmunol.0802113; DEBONO M, 1994, ANNU REV MICROBIOL, V48, P471, DOI 10.1146/annurev.mi.48.100194.002351; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; ESCOTT GM, 1995, INFECT IMMUN, V63, P4770, DOI 10.1128/IAI.63.12.4770-4773.1995; Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; FUHRMAN JA, 1985, MOL BIOCHEM PARASIT, V17, P93, DOI 10.1016/0166-6851(85)90130-6; GAL AE, 1968, ANAL BIOCHEM, V24, P452, DOI 10.1016/0003-2697(68)90152-8; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gorzelanny C, 2010, BIOMATERIALS, V31, P8556, DOI 10.1016/j.biomaterials.2010.07.100; GOW NAR, 1980, CURR MICROBIOL, V4, P357, DOI 10.1007/BF02605377; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; HUNSLEY D, 1968, NATURE, V218, P462, DOI 10.1038/218462a0; Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001; JOHNSON CR, 1983, J IMMUNOL METHODS, V65, P319, DOI 10.1016/0022-1759(83)90127-8; Kang ML, 2006, EUR J PHARM BIOPHARM, V63, P215, DOI 10.1016/j.ejpb.2006.01.010; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Lee CG, 2009, YONSEI MED J, V50, P22, DOI 10.3349/ymj.2009.50.1.22; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Lenardon MD, 2007, MOL MICROBIOL, V66, P1164, DOI 10.1111/j.1365-2958.2007.05990.x; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McNeela EA, 2004, VACCINE, V22, P909, DOI 10.1016/j.vaccine.2003.09.012; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mora-Montes HM, 2011, INFECT IMMUN, V79, P1961, DOI 10.1128/IAI.01282-10; Morganti P, 2008, CLIN DERMATOL, V26, P334, DOI 10.1016/j.clindermatol.2008.01.003; Nakagawa Y, 2003, J BIOMED MATER RES B, V66B, P347, DOI 10.1002/jbm.b.10020; Netea MG, 2004, MICROBES INFECT, V6, P985, DOI 10.1016/j.micinf.2004.05.013; NEVILLE AC, 1976, J CELL SCI, V21, P73; PERREGAUX D, 1992, J IMMUNOL, V149, P1294; Read RC, 2005, VACCINE, V23, P4367, DOI 10.1016/j.vaccine.2005.04.021; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Roncal T, 2007, CARBOHYD RES, V342, P2750, DOI 10.1016/j.carres.2007.08.023; SHAHABUDDIN M, 1994, EXP PARASITOL, V79, P85, DOI 10.1006/expr.1994.1066; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shibata Y, 1997, INFECT IMMUN, V65, P1734, DOI 10.1128/IAI.65.5.1734-1741.1997; SOMLYO B, 1992, INT J IMMUNOPHARMACO, V14, P131, DOI 10.1016/0192-0561(92)90023-E; van de Veerdonk FL, 2009, J INFECT DIS, V199, P1087, DOI 10.1086/597274; van der Lubben IM, 2003, VACCINE, V21, P1400, DOI 10.1016/S0264-410X(02)00686-2; van der Lubben IM, 2001, ADV DRUG DELIVER REV, V52, P139, DOI 10.1016/S0169-409X(01)00197-1; Wagner CJ, 2010, EUR J IMMUNOL, V40, P2882, DOI 10.1002/eji.201040422	59	127	133	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35447	35455		10.1074/jbc.M111.274936	http://dx.doi.org/10.1074/jbc.M111.274936			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862582	Green Published, hybrid			2022-12-27	WOS:000295927100016
J	Clemencon, B; Rey, M; Trezeguet, V; Forest, E; Pelosi, L				Clemencon, Benjamin; Rey, Martial; Trezeguet, Veronique; Forest, Eric; Pelosi, Ludovic			Yeast ADP/ATP Carrier Isoform 2 CONFORMATIONAL DYNAMICS AND ROLE OF THE RRRMMM SIGNATURE SEQUENCE METHIONINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP ATP TRANSLOCATOR; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; HYDROGEN/DEUTERIUM EXCHANGE; TERMINAL REGION; MATRIX LOOP; WILD-TYPE; PROTEIN; PURIFICATION; MITOCHONDRIA	The mitochondrial ADP/ATPcarrier, or Ancp, is a member of the mitochondrial carrier family responsible for exchanging ADP and ATP across the mitochondrial inner membrane. ADP/ATP transport involves Ancp switching between two conformational states. These can be analyzed using specific inhibitors, carboxyatractyloside (CATR) and bongkrekic acid (BA). The high resolution three-dimensional structure of bovine Anc1p (bAnc1p), as a CATR-carrier complex, has been solved. However, because the structure of the BA-carrier complex has not yet been determined, the detailed mechanism of transport remains unknown. Recently, sample processing for hydrogen/deuterium exchange experiments coupled to mass spectrometry was improved, providing novel insights into bAnc1p conformational transitions due to inhibitor binding. In this work we performed both hydrogen/deuterium exchange-mass spectrometry experiments and genetic manipulations. Because these are very difficult to apply with bovine Anc1p, we used Saccharomyces cerevisiae Anc isoform 2 (ScAnc2p). Significant differences in solvent accessibility were observed throughout the amino acid sequence for ScAnc2p complexed to either CATR or BA. Interestingly, in detergent solution, the conformational dynamics of ScAnc2p were dissimilar to those of bAnc1p, in particular for the upper half of the cavity, toward the intermembrane space, and the m2 loop, which is thought to be easily accessible to the solvent from the matrix in bAnc1p. Our study then focused on the methionyl residues of the Ancp signature sequence, RRRMMM. All our results indicate that the methionine cluster is involved in the ADP/ATP transport mechanism and confirm that the Ancp cavity is a highly dynamic structure.	[Forest, Eric] UJF, CEA, CNRS UMR 5075, Inst Biol Struct,Lab Spectrometrie Masse Prot, F-38027 Grenoble, France; [Clemencon, Benjamin; Rey, Martial; Pelosi, Ludovic] CEA, DSV, Inst Rech Technol & Sci Vivant, Lab Biol Grande Echelle, F-38054 Grenoble, France; [Clemencon, Benjamin; Rey, Martial; Forest, Eric; Pelosi, Ludovic] Univ Grenoble 1, F-38000 Grenoble, France; [Clemencon, Benjamin; Rey, Martial] INSERM, U1038, F-38054 Grenoble, France; [Trezeguet, Veronique] CNRS, Inst Biochim & Genet Cellulaires, Lab Physiol Mol & Cellulaire, UMR 5095, F-33077 Bordeaux, France; [Trezeguet, Veronique] Univ Victor Segalen, F-33076 Bordeaux, France; [Forest, Eric] CEA, DSV, Inst Biol Struct, F-38054 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Forest, E (corresponding author), UJF, CEA, CNRS UMR 5075, Inst Biol Struct,Lab Spectrometrie Masse Prot, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	eric.forest@ibs.fr; ludovic.pelosi@cea.fr	Forest, Eric/E-9042-2012; Pelosi, Ludovic/AAB-9832-2020; Pelosi, Ludovic/M-6406-2014	Pelosi, Ludovic/0000-0002-4198-5681; Rey, Martial/0000-0002-7378-1106; Trezeguet, Veronique/0000-0003-2487-7571	Universite Joseph Fourier; French CNRS; Commissariat a l'Energie Atomique; Region Rhone-Alpes	Universite Joseph Fourier; French CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by grants from the Universite Joseph Fourier, the French CNRS, and the Commissariat a l'Energie Atomique.; Supported by a fellowship from the Region Rhone-Alpes.	BOULAY F, 1984, BIOCHEMISTRY-US, V23, P4807, DOI 10.1021/bi00315a042; BRANDOLIN G, 1974, FEBS LETT, V46, P149, DOI 10.1016/0014-5793(74)80356-X; BRANDOLIN G, 1989, BIOCHEMISTRY-US, V28, P1093, DOI 10.1021/bi00429a025; BRANDOLIN G, 1993, BIOCHEM BIOPH RES CO, V192, P143, DOI 10.1006/bbrc.1993.1393; BRANDOLIN G, 1993, J BIOENERG BIOMEMBR, V25, P459, DOI 10.1007/BF01108403; Clemencon B, 2008, J BIOL CHEM, V283, P11218, DOI 10.1074/jbc.M709565200; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006; Dahout-Gonzalez C, 2005, BIOCHEMISTRY-US, V44, P16310, DOI 10.1021/bi0514820; Dassa EP, 2005, PROTEIN EXPRES PURIF, V40, P358, DOI 10.1016/j.pep.2004.12.019; Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004; Dianoux AC, 2000, BIOCHEMISTRY-US, V39, P11477, DOI 10.1021/bi000618l; DRGON T, 1991, FEBS LETT, V289, P159, DOI 10.1016/0014-5793(91)81059-H; Fiore C, 2000, PROTEIN EXPRES PURIF, V19, P57, DOI 10.1006/prep.2000.1213; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Iwahashi A, 2006, MITOCHONDRION, V6, P245, DOI 10.1016/j.mito.2006.07.007; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kihira Y, 2005, BIOCHEMISTRY-US, V44, P184, DOI 10.1021/bi0488653; Kihira Y, 2007, BIOL PHARM BULL, V30, P885, DOI 10.1248/bpb.30.885; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; KNIRSCH M, 1989, FEBS LETT, V244, P427, DOI 10.1016/0014-5793(89)80577-0; LAUQUIN GJM, 1976, BIOCHEMISTRY-US, V15, P2316, DOI 10.1021/bi00656a011; LeSaux A, 1996, BIOCHEMISTRY-US, V35, P16116, DOI 10.1021/bi961714i; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; MARTY I, 1992, BIOCHEMISTRY-US, V31, P4058, DOI 10.1021/bi00131a023; NELSON DR, 1993, J MOL BIOL, V230, P1171, DOI 10.1006/jmbi.1993.1234; NELSON DR, 1993, J MOL BIOL, V230, P1159, DOI 10.1006/jmbi.1993.1233; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Rey M, 2010, J BIOL CHEM, V285, P34981, DOI 10.1074/jbc.M110.146209; Rey M, 2010, ANAL CHEM, V82, P5107, DOI 10.1021/ac100171m; Rey M, 2009, RAPID COMMUN MASS SP, V23, P3431, DOI 10.1002/rcm.4260; Thomas A, 2011, BIOCHIMIE, V93, P1415, DOI 10.1016/j.biochi.2011.04.015; Trezeguet V, 2008, J BIOENERG BIOMEMBR, V40, P435, DOI 10.1007/s10863-008-9178-2; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	36	14	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36119	36131		10.1074/jbc.M111.277376	http://dx.doi.org/10.1074/jbc.M111.277376			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21868387	Green Published, hybrid			2022-12-27	WOS:000295927100084
J	Brigotti, M; Carnicelli, D; Arfilli, V; Rocchi, L; Ricci, F; Pagliaro, P; Tazzari, PL; Vara, AG; Amelia, M; Manoli, F; Monti, S				Brigotti, Maurizio; Carnicelli, Domenica; Arfilli, Valentina; Rocchi, Laura; Ricci, Francesca; Pagliaro, Pasqualepaolo; Tazzari, Pier Luigi; Vara, Antonio Gonzalez; Amelia, Matteo; Manoli, Francesco; Monti, Sandra			Change in Conformation with Reduction of alpha-Helix Content Causes Loss of Neutrophil Binding Activity in Fully Cytotoxic Shiga Toxin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; ESCHERICHIA-COLI O157-H7; RICIN A-CHAIN; HUMAN ENDOTHELIAL-CELLS; SHIGELLA-DYSENTERIAE; PROTEINS; SITE; CHILDREN; RECEPTOR	Shiga toxins (Stx) play an important role in the pathogenesis of hemolytic uremic syndrome, a life-threatening renal sequela of human intestinal infection caused by specific Escherichia coli strains. Stx target a restricted subset of human endothelial cells that possess the globotriaosylceramide receptor, like that in renal glomeruli. The toxins, composed of five B chains and a single enzymatic A chain, by removing adenines from ribosomes and DNA, trigger apoptosis and the production of pro-inflammatory cytokines in target cells. Because bacteria are confined to the gut, the toxins move to the kidney through the circulation. Polymorphonuclear leukocytes (PMN) have been indicated as the carriers that "piggyback" shuttle toxins to the kidney. However, there is no consensus on this topic, because not all laboratories have been able to reproduce the Stx/PMN interaction. Here, we demonstrate that conformational changes of Shiga toxin 1, with reduction of alpha-helix content and exposition to solvent of hydrophobic tryptophan residues, cause a loss of PMN binding activity. The partially unfolded toxin was found to express both enzymatic and globotriaosylceramide binding activities being fully active in intoxicating human endothelial cells; this suggests the presence of a distinct PMN-binding domain. By reviewing functional and structural data, we suggest that A chain moieties close to Trp-203 are recognized by PMN. Our findings could help explain the conflicting results regarding Stx/PMN interactions, especially as the groups reporting positive results obtained Stx by single-step affinity chromatography, which could have preserved the correct folding of Stx with respect to more complicated multi-step purification methods.	[Brigotti, Maurizio; Carnicelli, Domenica; Arfilli, Valentina; Rocchi, Laura] Univ Bologna, Dipartimento Patol Sperimentale, I-40126 Bologna, Italy; [Ricci, Francesca; Pagliaro, Pasqualepaolo; Tazzari, Pier Luigi] Osped S Orsola Malpighi, Serv Immunoematol & Trasfus, Bologna, Italy; [Vara, Antonio Gonzalez] Univ Bologna, Dipartimento Chim Ind & Mat, I-40136 Bologna, Italy; [Amelia, Matteo] Univ Bologna, Dipartimento Chim G Ciamician, I-40126 Bologna, Italy; [Manoli, Francesco; Monti, Sandra] CNR, Ist Sintesi Organ & Fotoreattivita, Bologna, Italy	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR)	Brigotti, M (corresponding author), Via San Giacomo 14, I-40126 Bologna, Italy.	maurizio.brigotti@unibo.it	Monti, Sandra/B-9272-2009; Brigotti, Maurizio/AAB-9007-2022; TAZZARI, PIER LUIGI/HGC-8394-2022; Manoli, Francesco/E-5981-2014	Brigotti, Maurizio/0000-0001-7429-744X; TAZZARI, PIER LUIGI/0000-0002-8789-657X; Manoli, Francesco/0000-0003-2734-1625; Ricci, Francesca/0000-0003-4387-1415	University of Bologna; Centro per la Cura e lo Studio della Sindrome Emolitico Uremica	University of Bologna; Centro per la Cura e lo Studio della Sindrome Emolitico Uremica	This work is supported by the University of Bologna (RFO funds to M. B.) and Centro per la Cura e lo Studio della Sindrome Emolitico Uremica.	Arfilli V, 2010, BIOCHEM J, V432, P173, DOI 10.1042/BJ20100455; Barbieri L, 1998, MOL MICROBIOL, V29, P661, DOI 10.1046/j.1365-2958.1998.00911.x; Beechem J. M., 1988, FLUORESCENCE SPECTRO; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; Brigotti M, 1998, NUCLEIC ACIDS RES, V26, P4306, DOI 10.1093/nar/26.18.4306; Brigotti M, 2006, J CLIN MICROBIOL, V44, P313, DOI 10.1128/JCM.44.2.313-317.2006; Brigotti M, 2002, FASEB J, V16, DOI 10.1096/fj.01-0521com; Brigotti M, 2008, J LEUKOCYTE BIOL, V84, P1019, DOI 10.1189/jlb.0308157; Brigotti M, 2007, INFECT IMMUN, V75, P2201, DOI 10.1128/IAI.01707-06; Brigotti M, 2011, PEDIATR INFECT DIS J, V30, P486, DOI 10.1097/INF.0b013e3182074d22; Brigotti M, 2010, J LEUKOCYTE BIOL, V88, P201, DOI 10.1189/jlb.0709475; Bulheller BM, 2007, PHYS CHEM CHEM PHYS, V9, P2020, DOI 10.1039/b615870f; CAPRIOLI A, 1992, J INFECT DIS, V166, P154, DOI 10.1093/infdis/166.1.154; CASSATELLA MA, 1988, IMMUNOLOGY, V63, P499; Chang BS, 1996, J PHARM SCI, V85, P1325, DOI 10.1021/js960080y; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Fernandez GC, 2005, PEDIATR NEPHROL, V20, P1306, DOI 10.1007/s00467-005-1906-9; Flagler MJ, 2007, INFECT IMMUN, V75, P760, DOI 10.1128/IAI.01594-06; Fraser ME, 2006, ACTA CRYSTALLOGR F, V62, P627, DOI 10.1107/S1744309106021968; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; GARRED O, 1995, J BIOL CHEM, V270, P10817; Geelen JM, 2007, NEPHROL DIAL TRANSPL, V22, P749, DOI 10.1093/ndt/gfl688; Griener TP, 2007, J MED MICROBIOL, V56, P1423, DOI 10.1099/jmm.0.47282-0; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; Hoffmann P, 2010, RAPID COMMUN MASS SP, V24, P2295, DOI 10.1002/rcm.4636; JEMAL C, 1995, J BACTERIOL, V177, P3128, DOI 10.1128/jb.177.11.3128-3132.1995; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; KATZIN BJ, 1991, PROTEINS, V10, P251, DOI 10.1002/prot.340100309; Lakowicz, 2006, PRINCIPLES FLUORESCE; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; MONZINGO AF, 1992, J MOL BIOL, V227, P1136, DOI 10.1016/0022-2836(92)90526-P; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; PETRONINI PG, 1987, EXP CELL RES, V172, P450, DOI 10.1016/0014-4827(87)90403-4; RYD M, 1989, FEBS LETT, V258, P320, DOI 10.1016/0014-5793(89)81684-9; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; STROCKBINE NA, 1988, J BACTERIOL, V170, P1116, DOI 10.1128/jb.170.3.1116-1122.1988; SWANK RT, 1971, ANAL BIOCHEM, V39, P462, DOI 10.1016/0003-2697(71)90436-2; Tazzari PL, 2004, CYTOM PART B-CLIN CY, V61B, P40, DOI 10.1002/cyto.b.20022; te Loo DMWM, 2000, BLOOD, V95, P3396, DOI 10.1182/blood.V95.11.3396.011k19_3396_3402; TROMPETER RS, 1983, ARCH DIS CHILD, V58, P101, DOI 10.1136/adc.58.2.101; vanSetten PA, 1996, BLOOD, V88, P174, DOI 10.1182/blood.V88.1.174.bloodjournal881174; Yan XJ, 1998, PROTEINS, V31, P33, DOI 10.1002/(SICI)1097-0134(19980401)31:1<33::AID-PROT4>3.0.CO;2-I	44	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34514	34521		10.1074/jbc.M111.255414	http://dx.doi.org/10.1074/jbc.M111.255414			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832076	Green Published, hybrid			2022-12-27	WOS:000295406300005
J	Chi, SS; Cao, H; Wang, Y; McNiven, MA				Chi, Susan; Cao, Hong; Wang, Yu; McNiven, Mark A.			Recycling of the Epidermal Growth Factor Receptor Is Mediated by a Novel Form of the Clathrin Adaptor Protein Eps15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE SUBSTRATE; COATED PITS; ENDOCYTIC PATHWAY; PLASMA-MEMBRANE; MYOSIN VB; EARLY ENDOSOMES; INTERNALIZATION; TRAFFICKING; TRANSPORT; TRANSFERRIN	Levels of the epidermal growth factor receptor (EGFR) at the cell surface are tightly regulated by a complex endocytic machinery. Following internalization, EGFR is either recycled back to the cell surface or transported to the late endosome/lysosome for degradation. Currently, the molecular machinery that regulates this sorting pathway is only partially defined. Eps15 (EGFR pathway substrate 15) is an endocytic adaptor protein that is well known to support clathrin-mediated internalization of EGFR at the plasma membrane. Using RT-PCR, we have identified a novel short form of Eps15 (Eps15S) from rat liver that lacks the 111 C-terminal amino acids present in the traditional Eps15 form. The goal of this study was to define the functional role of the novel Eps15S form in EGFR trafficking. Overexpression of a mutant form of Eps15S (Eps15S Delta EH2/EH3) did not block EGFR internalization but reduced its recycling to the cell surface. After knockdown of all Eps15 forms, re-expression of Eps15S significantly reduced EGFR degradation while promoting recycling back to the cell surface. In contrast, re-expression of Eps15 did not potentiate receptor recycling. Furthermore, overexpression of the mutant Eps15S substantially reduced cell proliferation, linking EGFR recycling to downstream mitogenic effects. Finally, we found that Eps15S is localized to the Rab11-positive recycling endosome that is disrupted in cells expressing the Eps15S mutant, leading to an accumulation of the EGFR in early endosomes. These findings suggest that distinct forms of Eps15 direct EGFR to either the late endosome/lysosome for degradation (Eps15) or to the recycling endosome for transit back to the cell surface (Eps15S).	[McNiven, Mark A.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	McNiven, MA (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Guggenheim 1637,200 1st St SW, Rochester, MN 55905 USA.	mcniven.mark@mayo.edu			Optical Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology [R01 DK44650, P30DK84567]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044650, P30DK084567] Funding Source: NIH RePORTER	Optical Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Grants R01 DK44650 (to M. A. M.) and P30DK84567 from the Optical Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Carbone R, 1997, CANCER RES, V57, P5498; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chi S, 2008, MOL BIOL CELL, V19, P3564, DOI 10.1091/mbc.E07-10-0997; Coda L, 1998, J BIOL CHEM, V273, P3003, DOI 10.1074/jbc.273.5.3003; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; de Melker AA, 2004, J BIOL CHEM, V279, P55465, DOI 10.1074/jbc.M409765200; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Haffner C, 1997, FEBS LETT, V419, P175, DOI 10.1016/S0014-5793(97)01451-8; Henegouwen PMPVE, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-24; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Iannolo G, 1997, CANCER RES, V57, P240; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Poupon V, 2002, J BIOL CHEM, V277, P8941, DOI 10.1074/jbc.M108385200; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Roxrud I, 2008, J CELL BIOL, V180, P1205, DOI 10.1083/jcb.200708115; Schlierf B, 2000, EXP CELL RES, V259, P257, DOI 10.1006/excr.2000.4947; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; Torrisi MR, 1999, MOL BIOL CELL, V10, P417, DOI 10.1091/mbc.10.2.417; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Woodman PG, 2008, CURR OPIN CELL BIOL, V20, P408, DOI 10.1016/j.ceb.2008.04.001	51	33	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35196	35208		10.1074/jbc.M111.247577	http://dx.doi.org/10.1074/jbc.M111.247577			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832070	Green Published, hybrid			2022-12-27	WOS:000295406300072
J	Fulkerson, Z; Wu, T; Sunkara, M; Vander Kooi, C; Morris, AJ; Smyth, SS				Fulkerson, Zachary; Wu, Tao; Sunkara, Manjula; Vander Kooi, Craig; Morris, Andrew J.; Smyth, Susan S.			Binding of Autotaxin to Integrins Localizes Lysophosphatidic Acid Production to Platelets and Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHOLIPASE-D; ACTIVATION; RECEPTORS; LPA; LIPOPROTEIN; INHIBITOR; PROMOTES; PLASMA; ENZYME; ROLES	Autotaxin (ATX) is a secreted lysophospholipase D that generates the bioactive lipid mediator lysophosphatidic acid (LPA). We and others have reported that ATX binds to integrins, but the function of ATX-integrin interactions is unknown. The recently reported crystal structure of ATX suggests a role for the solvent-exposed surface of the N-terminal tandem somatomedin B-like domains in binding to platelet integrin alpha IIb beta(3). The opposite face of the somatomedin B-like domain interacts with the catalytic phosphodiesterase (PDE) domain to form a hydrophobic channel through which lysophospholipid substrates enter and leave the active site. Based on this structure, we hypothesize that integrin-bound ATX can access cell surface substrates and deliver LPA to cell surface receptors. To test this hypothesis, we investigated the integrin selectivity and signaling pathways that promote ATX binding to platelets. We report that both platelet beta 1 and beta 3 integrins interact in an activation-dependent manner with ATX via the SMB2 domain. ATX increases thrombin-stimulated LPA production by washed platelets similar to 10-fold. When incubated under conditions to promote integrin activation, ATX generates LPA from CHO cellsprimed with bee venom phospholipase A(2), and ATX-mediated LPA production is enhanced more than 2-fold by CHO cell overexpression of integrin beta(3). The effects of ATX on platelet and cell-associated LPA production, but not hydrolysis of small molecule or detergent-solubilized substrates, are attenuated by point mutations in the SMB2 that impair integrin binding. Integrin binding therefore localizes ATX activity to the cell surface, providing a mechanism to generate LPA in the vicinity of its receptors.	[Fulkerson, Zachary; Wu, Tao; Sunkara, Manjula; Morris, Andrew J.; Smyth, Susan S.] Univ Kentucky, Div Cardiovasc Med, Gill Heart Inst, Lexington, KY 40536 USA; [Vander Kooi, Craig] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Smyth, Susan S.] Dept Vet Affairs Med Ctr, Lexington, KY 40511 USA	University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Smyth, SS (corresponding author), Univ Kentucky, Div Cardiovasc Med, Gill Heart Inst, 900 S Limestone St,326 CTW Bldg, Lexington, KY 40536 USA.	SusanSmyth@uky.edu	sunkara, Manjula/H-7944-2016	sunkara, Manjula/0000-0001-6151-1929	National Institutes of Health [GM050388, RR026884, HL078663, GM094155, P20RR021954, F30 HL099272]; Lexington Veterans Affairs Medical Center; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026884, P20RR021954, S10RR024598] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078663, F30HL099272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050388, R01GM094155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lexington Veterans Affairs Medical Center; American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM050388 and RR026884 (to A. J. M.), HL078663 (to S. S. S.), GM094155 (to C. V. K.), and P20RR021954 and F30 HL099272 (to Z. F.). This work was also supported by the resources and use of the facilities at the Lexington Veterans Affairs Medical Center.; Supported by an American Heart Association postdoctoral fellowship.	Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Bolen AL, 2011, J LIPID RES, V52, P958, DOI 10.1194/jlr.M013326; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; COLLER BS, 1993, J CLIN INVEST, V92, P2796, DOI 10.1172/JCI116899; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Federico L, 2008, CURR DRUG TARGETS, V9, P698, DOI 10.2174/138945008785132439; Fox MA, 2003, MOL CELL NEUROSCI, V23, P507, DOI 10.1016/S1044-7431(03)00073-3; Gierse J, 2010, J PHARMACOL EXP THER, V334, P310, DOI 10.1124/jpet.110.165845; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Hayashi K, 2001, CIRC RES, V89, P251, DOI 10.1161/hh1501.094265; Jirouskova M, 2007, BLOOD, V109, P5260, DOI 10.1182/blood-2006-10-054015; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Nakamura K, 2008, CLIN CHIM ACTA, V388, P51, DOI 10.1016/j.cca.2007.10.005; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Pamuklar Z, 2008, ARTERIOSCL THROM VAS, V28, P555, DOI 10.1161/ATVBAHA.107.151837; Pamuklar Z, 2009, J BIOL CHEM, V284, P7385, DOI 10.1074/jbc.M807820200; Panchatcharam M, 2008, CIRC RES, V103, P662, DOI 10.1161/CIRCRESAHA.108.180778; Panetti TS, 2004, J THROMB HAEMOST, V2, P1645, DOI 10.1111/j.1538-7836.2004.00902.x; Perrin-Cocon L, 2004, EUR J IMMUNOL, V34, P2293, DOI 10.1002/eji.200324797; Rizza C, 1999, LAB INVEST, V79, P1227; Sano T, 2002, J BIOL CHEM, V277, P21197, DOI 10.1074/jbc.M201289200; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Smyth SS, 2003, J BIOL CHEM, V278, P43214, DOI 10.1074/jbc.M306709200; Smyth SS, 2008, BBA-MOL CELL BIOL L, V1781, P563, DOI 10.1016/j.bbalip.2008.05.008; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Subramanian P, 2010, CIRC RES, V107, P96, DOI 10.1161/CIRCRESAHA.109.212647; Tabchy A, 2011, NAT STRUCT MOL BIOL, V18, P117, DOI 10.1038/nsmb0211-117; TIGYI G, 1992, J BIOL CHEM, V267, P21360; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Tomsig JL, 2009, BIOCHEM J, V419, P611, DOI 10.1042/BJ20081888; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016	35	103	105	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34654	34663		10.1074/jbc.M111.276725	http://dx.doi.org/10.1074/jbc.M111.276725			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832043	Green Published, hybrid			2022-12-27	WOS:000295406300020
J	Redelinghuys, P; Antonopoulos, A; Liu, Y; Campanero-Rhodes, MA; McKenzie, E; Haslam, SM; Dell, A; Feizi, T; Crocker, PR				Redelinghuys, Pierre; Antonopoulos, Aristotelis; Liu, Yan; Campanero-Rhodes, Maria A.; McKenzie, Emma; Haslam, Stuart M.; Dell, Anne; Feizi, Ten; Crocker, Paul R.			Early Murine T-lymphocyte Activation Is Accompanied by a Switch from N-Glycolyl- to N-Acetyl-neuraminic Acid and Generation of Ligands for Siglec-E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHATASES SHP-1; O-GLYCAN BIOSYNTHESIS; SURFACE SIALIC ACIDS; IMMUNE-SYSTEM; DIFFERENTIAL GLYCOSYLATION; NEOGLYCOLIPID TECHNOLOGY; GLYCOLYLNEURAMINIC ACID; LINKED OLIGOSACCHARIDES; HUMAN-EVOLUTION; CELL-DEATH	It is well established that murine T-lymphocyte activation is accompanied by major changes in cell-surface sialylation, potentially influencing interactions with sialic acid-binding immunoglobulin-like lectins (siglecs). In the present study, we analyzed early activation of murine CD4+ and CD8+ T-lymphocytes at 24 h. We observed a striking and selective up-regulation in the binding of a recombinant soluble form of siglec-E, an inhibitory siglec, which is expressed on several myeloid cell types including antigen-presenting dendritic cells. In contrast, much lower levels of T cell binding were observed with other siglecs, including sialoadhesin, CD22, and siglec-F and the plant lectins Maackia amurensis leukoagglutinin and Sambucus nigra agglutinin. By mass spectrometry, the sialic acid content of 24-h-activated CD4+ and CD8+ T-lymphocytes exhibited an increased proportion of N-acetyl-neuraminic acid (NeuAc) to N-glycolyl-neuraminic acid (NeuGc) in N-glycans. Reduced levels of NeuGc on the surface of activated T cells were demonstrated using an antibody specific for NeuGc and the expression levels of the gene encoding NeuAc-to NeuGc-converting enzyme, CMP-NeuAc hydroxylase, were also reduced. Siglec-E bound a wide range of sialylated structures in glycan arrays, had a preference for NeuAc versus NeuGc-terminated sequences and could recognize a set of sialoglycoproteins that included CD45, in lysates from activated T-lymphocytes. Collectively, these results show that early in T cell activation, glycan remodelling involves a switch from NeuGc- to NeuAc-terminating oligosaccharides on cell surface glycoproteins. This is associated with a strong up-regulation of siglec-E ligands, which may be important in promoting cellular interactions between early activated T-lymphocytes and myeloid cells expressing this inhibitory receptor.	[Crocker, Paul R.] Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; [Antonopoulos, Aristotelis; Haslam, Stuart M.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Liu, Yan; Campanero-Rhodes, Maria A.; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, Harrow HA1 3UJ, Middx, England	University of Dundee; Imperial College London; Imperial College London	Crocker, PR (corresponding author), Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Wellcome Trust Bioctr, Wellcome Trust Bldg,Dow St, Dundee DD1 5EH, Scotland.	p.r.crocker@dundee.ac.uk	Liu, Yan/D-9117-2013; RASOR, Scotland/A-3274-2011; Campanero-Rhodes, María Asunción/M-3158-2014	Campanero-Rhodes, María Asunción/0000-0002-3373-0064; Liu, Yan/0000-0002-2566-6867; Feizi, Ten/0000-0001-6495-0329; Crocker, Paul/0000-0001-6230-0293; Dell, Anne/0000-0003-1380-2347; McKenzie, Emma/0000-0002-4355-317X	Biotechnology and Biological Sciences Research Council [BBF0083091]; Engineering and Physical Sciences Research Council [BB/C511572/1, EP/G037604/1]; Wellcome Trust [WT081882MA]; Analytical Glycotechnology Core (Core C) of the Consortium for Functional Glycomics [GM 62116]; MRC; RCUK Basic Technology Initiative Glycoarrays [GRS/79268]; Biotechnology and Biological Sciences Research Council [BB/C511572/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/S79268/02] Funding Source: researchfish; EPSRC [EP/G037604/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Analytical Glycotechnology Core (Core C) of the Consortium for Functional Glycomics; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RCUK Basic Technology Initiative Glycoarrays; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Biotechnology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council through the Radical Solutions for Researching the Proteome (RASOR) Project BB/C511572/1, and the Wellcome Trust (WT081882MA). This work was also supported in part by funding from the Analytical Glycotechnology Core (Core C) of the Consortium for Functional Glycomics (GM 62116) and the Biotechnology and Biological Sciences Research Council (BBSRC) Grant number BBF0083091 (to A. D. and S. M. H.), the MRC and the RCUK Basic Technology Initiative Glycoarrays (GRS/79268) and EPSRC Translational Grant (EP/G037604/1) (EP/G037604/1) (to T. F.).	Ando M, 2008, BIOCHEM BIOPH RES CO, V369, P878, DOI 10.1016/j.bbrc.2008.02.111; Attrill H, 2006, J BIOL CHEM, V281, P32774, DOI 10.1074/jbc.M601714200; Avril T, 2006, INFECT IMMUN, V74, P4133, DOI 10.1128/IAI.02094-05; Bi SG, 2009, BBA-GEN SUBJECTS, V1790, P1599, DOI 10.1016/j.bbagen.2009.07.027; Bochner BS, 2009, CLIN EXP ALLERGY, V39, P317, DOI 10.1111/j.1365-2222.2008.03173.x; Boyd CR, 2009, J IMMUNOL, V183, P7703, DOI 10.4049/jimmunol.0902780; Brinkman-Van der Linden ECM, 2000, J BIOL CHEM, V275, P8633, DOI 10.1074/jbc.275.12.8633; Campanero-Rhodes MA, 2006, BIOCHEM BIOPH RES CO, V344, P1141, DOI 10.1016/j.bbrc.2006.03.223; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chai WG, 2003, METHOD ENZYMOL, V362, P160; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; Earl LA, 2008, IMMUNOL CELL BIOL, V86, P608, DOI 10.1038/icb.2008.46; Earl LA, 2010, J BIOL CHEM, V285, P2242, DOI 10.1074/jbc.M109.066191; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Galustian C, 1997, BIOCHEM BIOPH RES CO, V240, P748, DOI 10.1006/bbrc.1997.7737; Guo JP, 2011, AM J RESP CELL MOL, V44, P238, DOI 10.1165/rcmb.2010-0007OC; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; Haslam SM, 2008, IMMUNOL CELL BIOL, V86, P564, DOI 10.1038/icb.2008.54; Hernandez JD, 2007, INT IMMUNOL, V19, P847, DOI 10.1093/intimm/dxm053; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; KELM S, 1994, GLYCOCONJUGATE J, V11, P576, DOI 10.1007/BF00731309; Khatua B, 2010, FEBS LETT, V584, P555, DOI 10.1016/j.febslet.2009.11.087; Liu Y, 2007, CHEM BIOL, V14, P847, DOI 10.1016/j.chembiol.2007.06.009; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; PILLER F, 1988, J BIOL CHEM, V263, P15146; POWELL LD, 1993, J BIOL CHEM, V268, P7019; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Rabinovich GA, 2009, IMMUNOL REV, V230, P144, DOI 10.1111/j.1600-065X.2009.00787.x; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Ramya TNC, 2010, MOL CELL PROTEOMICS, V9, P1339, DOI 10.1074/mcp.M900461-MCP200; Song DJ, 2009, J IMMUNOL, V183, P5333, DOI 10.4049/jimmunol.0801421; Sonnenburg JL, 2004, GLYCOBIOLOGY, V14, P339, DOI 10.1093/glycob/cwh039; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; STAMENKOVIC I, 1991, CELL, V66, P1133, DOI 10.1016/0092-8674(91)90036-X; Stoll MS, 2009, P BEILST S GLYC BIOI, P123; Tateno H, 2005, GLYCOBIOLOGY, V15, P1125, DOI 10.1093/glycob/cwi097; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Ulyanova T, 2001, J BIOL CHEM, V276, P14451, DOI 10.1074/jbc.M011650200; van den Berg TK, 2001, J IMMUNOL, V166, P3637, DOI 10.4049/jimmunol.166.6.3637; Van Dyken SJ, 2007, MOL CELL BIOL, V27, P1096, DOI 10.1128/MCB.01750-06; Varki A, 2001, YEARB PHYS ANTHROPOL, V44, P54, DOI 10.1002/ajpa.10018; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Yamaji T, 2002, J BIOL CHEM, V277, P6324, DOI 10.1074/jbc.M110146200; Yu ZB, 2001, BIOCHEM J, V353, P483, DOI 10.1042/0264-6021:3530483; YUEN CT, 1992, BIOCHEMISTRY-US, V31, P9126, DOI 10.1021/bi00153a003; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zhang M, 2004, GLYCOBIOLOGY, V14, P939, DOI 10.1093/glycob/cwh126; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255; Zimmermann N, 2008, ALLERGY, V63, P1156, DOI 10.1111/j.1398-9995.2008.01709.x	57	35	35	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34522	34532		10.1074/jbc.M111.243410	http://dx.doi.org/10.1074/jbc.M111.243410			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21835922	Green Published, hybrid			2022-12-27	WOS:000295406300006
J	Chai, XY; Wu, S; Murray, TK; Kinley, R; Cella, CV; Sims, H; Buckner, N; Hanmer, J; Davies, P; O'Neill, MJ; Hutton, ML; Citron, M				Chai, Xiyun; Wu, Su; Murray, Tracey K.; Kinley, Robert; Cella, Claire V.; Sims, Helen; Buckner, Nicola; Hanmer, Jenna; Davies, Peter; O'Neill, Michael J.; Hutton, Michael L.; Citron, Martin			Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models REDUCTION OF TAU PATHOLOGY AND DELAY OF DISEASE PROGRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANGLE MOUSE MODEL; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; CEREBROSPINAL-FLUID; P301L TAU; PROTEIN; MICE; IMMUNOTHERAPY; TAUOPATHY; FILAMENTS	The microtubule-associated protein Tau plays a critical role in the pathogenesis of Alzheimer disease and several related disorders (tauopathies). In the disease Tau aggregates and becomes hyperphosphorylated forming paired helical and straight filaments, which can further condense into higher order neurofibrillary tangles in neurons. The development of this pathology is consistently associated with progressive neuronal loss and cognitive decline. The identification of tractable therapeutic targets in this pathway has been challenging, and consequently very few clinical studies addressing Tau pathology are underway. Recent active immunization studies have raised the possibility of modulating Tau pathology by activating the immune system. Here we report for the first time on passive immunotherapy for Tau in two well established transgenic models of Tau pathogenesis. We show that peripheral administration of two antibodies against pathological Tau forms significantly reduces biochemical Tau pathology in the JNPL3 mouse model. We further demonstrate that peripheral administration of the same antibodies in the more rapidly progressive P301S tauopathy model not only reduces Tau pathology quantitated by biochemical assays and immunohistochemistry, but also significantly delays the onset of motor function decline and weight loss. This is accompanied by a reduction in neurospheroids, providing direct evidence of reduced neurodegeneration. Thus, passive immunotherapy is effective at preventing the buildup of intracellular Tau pathology, neurospheroids, and associated symptoms, although the exact mechanism remains uncertain. Tau immunotherapy should therefore be considered as a therapeutic approach for the treatment of Alzheimer disease and other tauopathies.	[Citron, Martin] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Murray, Tracey K.; Kinley, Robert; Cella, Claire V.; Sims, Helen; Buckner, Nicola; Hanmer, Jenna; O'Neill, Michael J.; Hutton, Michael L.] Eli Lilly & Co, Lilly Erl Wood Manor, Windlesham GU20 6PH, Surrey, England; [Davies, Peter] Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY 10461 USA; [Davies, Peter] Feinstein Inst, Litwin Zucker Ctr Res Alzheimers Dis, Manhasset, NY 11030 USA	Eli Lilly; Eli Lilly; Yeshiva University; Albert Einstein College of Medicine; Northwell Health	Citron, M (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA.	citronma@lilly.com	Hanmer, Jenna Mary/ABB-4884-2021	Hanmer, Jenna Mary/0000-0002-7652-6098; Buckner, Nikki/0000-0003-2842-9928; Davies, Peter/0000-0002-8015-1997	NATIONAL INSTITUTE ON AGING [R37AG022102] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG022102, R37 AG022102] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allen B, 2002, J NEUROSCI, V22, P9340; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Goedert M, 2006, J ALZHEIMERS DIS, V9, P195; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Le Corre S, 2006, P NATL ACAD SCI USA, V103, P9673, DOI 10.1073/pnas.0602913103; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Reynolds MR, 2006, J NEUROSCI, V26, P10636, DOI 10.1523/JNEUROSCI.2143-06.2006; Rosenmann H, 2006, ARCH NEUROL-CHICAGO, V63, P1459, DOI 10.1001/archneur.63.10.1459; Sahara N, 2002, J NEUROCHEM, V83, P1498, DOI 10.1046/j.1471-4159.2002.01241.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Thal DR, 2000, EXP NEUROL, V163, P98, DOI 10.1006/exnr.2000.7380; THOMPSON EJ, 1990, ANN CLIN BIOCHEM, V27, P425, DOI 10.1177/000456329002700503; Tremblay MA, 2010, J ALZHEIMERS DIS, V19, P721, DOI 10.3233/JAD-2010-1271; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Yamamori H, 2007, NEUROSCI LETT, V418, P186, DOI 10.1016/j.neulet.2007.03.022	26	261	285	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34457	34467		10.1074/jbc.M111.229633	http://dx.doi.org/10.1074/jbc.M111.229633			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21841002	Green Published, hybrid			2022-12-27	WOS:000295159200073
J	Choi, YH; Lee, SN; Aoyagi, H; Yamasaki, Y; Yoo, JY; Park, B; Shin, DM; Yoon, HG; Yoon, JH				Choi, Yeon Ho; Lee, Sang-Nam; Aoyagi, Hiroki; Yamasaki, Yasundo; Yoo, Jung-Yoon; Park, Boryung; Shin, Dong Min; Yoon, Ho-Geun; Yoon, Joo-Heon			The Extracellular Signal-regulated Kinase Mitogen-activated Protein Kinase/Ribosomal S6 Protein Kinase 1 Cascade Phosphorylates cAMP Response Element-binding Protein to Induce MUC5B Gene Expression via D-Prostanoid Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN D-2 RECEPTOR; 11P15 MUCIN GENES; MOLECULAR-CLONING; ALLERGIC INFLAMMATION; RETINOIC-ACID; MAST-CELLS; D SYNTHASE; CREB; TRANSCRIPTION; MECHANISM	Mucus hypersecretion is a prominent feature of respiratory diseases, and MUC5B is a major airway mucin. Mucin gene expression can be affected by inflammatory mediators, including prostaglandin (PG) D-2, an inflammatory mediator synthesized by hematopoietic PGD synthase (H-PGDS). PGD(2) binds to either D-prostanoid receptor (DP1) or chemoattractant receptor homologous molecule expressed on T-helper type 2 cells (CRTH2). We investigated the mechanisms by which PGD(2) induces MUC5B gene expression in airway epithelial cells. Western blot analysis showed that H-PGDS was highly expressed in nasal polyps. Similar results were obtained for PGD2 expression. In addition, we could clearly detect the expressions of both H-PGDS and DP1 in nasal epithelial cells but not CRTH2. We demonstrated that PGD(2) increased MUC5B gene expression in normal human nasal epithelial cells as well as in NCI-H292 cells in vitro. S5751, a DP1 antagonist, inhibited PGD(2)-induced MUC5B expression, whereas a CRTH2 antagonist (OC0459) did not. These data suggest that PGD(2) induced MUC5B expression via DP1. Pretreatment with extracellular signal-regulated kinase (ERK) inhibitor (PD98059) blocked both PGD(2)-induced ERK mitogen-activated protein kinase (MAPK) activation and MUC5B expression. Proximity ligation assays showed direct interaction between RSK1 and cAMP response element-binding protein (CREB). Stimulation with PGD2 caused an increase in intracellular cAMP levels, whereas intracellular Ca2+ did not have such an effect. PGD2-induced MUC5B mRNA levels were regulated by CREB via direct interaction with two cAMP-response element sites (-921/-914 and -900/-893). Finally, we demonstrated that PGD(2) can induce MUC5B overproduction via ERK MAPK/RSK1/CREB signaling and that DP1 receptor may have suppressive effects in controlling MUC5B overproduction in the airway.	[Yoon, Joo-Heon] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul 120752, South Korea; [Choi, Yeon Ho; Lee, Sang-Nam; Yoon, Joo-Heon] Yonsei Univ, Coll Med, Airway Mucus Inst, Seoul 120752, South Korea; [Choi, Yeon Ho; Yoo, Jung-Yoon; Yoon, Ho-Geun; Yoon, Joo-Heon] Yonsei Univ, Coll Med, Project Med Sci BK21, Seoul 120752, South Korea; [Choi, Yeon Ho; Lee, Sang-Nam; Yoon, Joo-Heon] Yonsei Univ, Coll Med, Res Ctr Human Nat Def Syst, Seoul 120752, South Korea; [Park, Boryung; Shin, Dong Min] Yonsei Univ, Coll Dent, Dept Oral Biol, Seoul 120752, South Korea; [Yoo, Jung-Yoon; Yoon, Ho-Geun] Yonsei Univ, Coll Med, Ctr Chron Metab Dis Res, Dept Biochem & Mol Biol, Seoul 120752, South Korea; [Aoyagi, Hiroki; Yamasaki, Yasundo] TAIHO Pharmaceut Co Ltd, Drug Discovery & Dev, Saitama 3578527, Japan	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Taiho Pharmaceutical	Yoon, JH (corresponding author), Yonsei Univ, Coll Med, Dept Otorhinolaryngol, 134 Shinchon Dong, Seoul 120752, South Korea.	jhyoon@yuhs.ac	rchnds, rchnds/D-7595-2016; Yoon, Joo-Heon/E-5781-2016	Shin, Dong Min/0000-0001-6042-0435; Yoon, Joo-Heon/0000-0003-2404-7156; Yoo, Jung-Yoon/0000-0001-9366-3863; Yoon, Ho-Geun Yoon/0000-0003-2718-3372	National Research Foundation of Korea; Ministry of Education, Science, and Technology [2011-0001168]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2011-0001168).	Ali MS, 2007, LARYNGOSCOPE, V117, P932, DOI 10.1097/MLG.0b013e3180383651; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Arimura A, 2001, J PHARMACOL EXP THER, V298, P411; Armer RE, 2005, J MED CHEM, V48, P6174, DOI 10.1021/jm050519b; Binker MG, 2009, BIOCHEM BIOPH RES CO, V386, P124, DOI 10.1016/j.bbrc.2009.05.136; Blodorn B, 1996, NEUROSCI LETT, V209, P117, DOI 10.1016/0304-3940(96)12614-8; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Borchers MT, 1999, AM J PHYSIOL-LUNG C, V276, pL549, DOI 10.1152/ajplung.1999.276.4.L549; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chen Y, 2004, AM J RESP CELL MOL, V30, P155, DOI 10.1165/rcmb.2003-0103OC; Chen Y, 2001, AM J RESP CELL MOL, V25, P409, DOI 10.1165/ajrcmb.25.4.4413; Chen YY, 2007, J IMMUNOL, V179, P2766, DOI 10.4049/jimmunol.179.5.2766; Choi HJ, 2009, AM J RESP CELL MOL, V40, P168, DOI 10.1165/rcmb.2007-0377OC; Choi KC, 2008, BIOCHEM J, V411, P19, DOI 10.1042/BJ20071393; Chokki M, 2005, FEBS J, V272, P6387, DOI 10.1111/j.1742-4658.2005.05035.x; Chung WC, 2009, J IMMUNOL, V182, P2349, DOI 10.4049/jimmunol.0713637; Enss ML, 1997, PROSTAG LEUKOTR ESS, V56, P93, DOI 10.1016/S0952-3278(97)90503-2; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hatoum OA, 2005, ARTERIOSCL THROM VAS, V25, P2355, DOI 10.1161/01.ATV.0000184757.50141.8d; HIRATA M, 1994, P NATL ACAD SCI USA, V91, P11192, DOI 10.1073/pnas.91.23.11192; HO SB, 1995, GASTROENTEROLOGY, V109, P735, DOI 10.1016/0016-5085(95)90380-1; Isakson BE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-105; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Keates AC, 1997, BIOCHEM J, V324, P295, DOI 10.1042/bj3240295; Kim HJ, 2010, AM J RESP CELL MOL, V43, P349, DOI 10.1165/rcmb.2009-0205OC; Kim JH, 2010, AM J OPHTHALMOL, V149, P45, DOI 10.1016/j.ajo.2009.07.030; Lam BYH, 2010, J NEUROCHEM, V112, P1065, DOI 10.1111/j.1471-4159.2009.06521.x; LEWIS RA, 1982, J IMMUNOL, V129, P1627; MAROM Z, 1984, PROSTAGLANDINS, V28, P79, DOI 10.1016/0090-6980(84)90115-1; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; McNamara N, 2004, FASEB J, V18, P1770, DOI 10.1096/fj.04-1964fje; Mellstrom B, 2008, PHYSIOL REV, V88, P421, DOI 10.1152/physrev.00041.2005; Murray PD, 2009, GLIA, V57, P828, DOI 10.1002/glia.20809; NACLERIO RM, 1983, AM REV RESPIR DIS, V128, P597; Nantel F, 2004, PROSTAG OTH LIPID M, V73, P87, DOI 10.1016/j.prostaglandins.2003.12.002; Pena J, 2009, INFECT IMMUN, V77, P2857, DOI 10.1128/IAI.01355-08; ROGERS DF, 1994, EUR RESPIR J, V7, P1690; Sawyer N, 2002, BRIT J PHARMACOL, V137, P1163, DOI 10.1038/sj.bjp.0704973; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Song KS, 2003, J BIOL CHEM, V278, P23243, DOI 10.1074/jbc.M300096200; Spik I, 2005, J IMMUNOL, V174, P3703, DOI 10.4049/jimmunol.174.6.3703; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; URADE Y, 1989, J IMMUNOL, V143, P2982; URADE Y, 1990, J BIOL CHEM, V265, P371; van de Bovenkamp JHB, 1998, BIOCHEM BIOPH RES CO, V245, P853, DOI 10.1006/bbrc.1998.8535; Van Hecken A, 2007, EUR J CLIN PHARMACOL, V63, P135, DOI 10.1007/s00228-006-0211-2; Van Seuningen I, 2001, FRONT BIOSCI-LANDMRK, V6, pD1216; Vincent A, 2007, ONCOGENE, V26, P6566, DOI 10.1038/sj.onc.1210479; Voynow JA, 2006, AM J RESP CELL MOL, V34, P661, DOI 10.1165/rcmb.2006-0035SF; Voynow Judith A, 2002, Paediatr Respir Rev, V3, P98, DOI 10.1016/S1526-0550(02)00007-0; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wu DYC, 2007, AM J PATHOL, V170, P20, DOI 10.2353/ajpath.2007.060452; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yasui K, 2008, EUR J PHARMACOL, V578, P286, DOI 10.1016/j.ejphar.2007.09.014; Yoon JH, 1997, AM J RESP CELL MOL, V16, P724, DOI 10.1165/ajrcmb.16.6.9191474; Yoon JH, 2002, DIFFERENTIATION, V70, P77, DOI 10.1046/j.1432-0436.2002.700202.x; Yuta A, 1997, AM J PHYSIOL-LUNG C, V273, pL1203, DOI 10.1152/ajplung.1997.273.6.L1203	62	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34199	34214		10.1074/jbc.M111.247684	http://dx.doi.org/10.1074/jbc.M111.247684			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832046	Green Published, hybrid			2022-12-27	WOS:000295159200050
J	Hattori, N; Carrino, DA; Lauer, ME; Vasanji, A; Wylie, JD; Nelson, CM; Apte, SS				Hattori, Noriko; Carrino, David A.; Lauer, Mark E.; Vasanji, Amit; Wylie, James D.; Nelson, Courtney M.; Apte, Suneel S.			Pericellular Versican Regulates the Fibroblast-Myofibroblast Transition A ROLE FOR ADAMTS5 PROTEASE-MEDIATED PROTEOLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; ADAMTS METALLOPROTEASES; MOLECULAR-MECHANISMS; HYALURONAN; MATRIX; CLEAVAGE; PROTEOGLYCANS; AGGRECAN; MICROENVIRONMENT; DIFFERENTIATION	The cell and its glycosaminoglycan-rich pericellular matrix (PCM) comprise a functional unit. Because modification of PCM influences cell behavior, we investigated molecular mechanisms that regulate PCM volume and composition. In fibroblasts and other cells, aggregates of hyaluronan and versican are found in the PCM. Dermal fibroblasts from Adamts5(-/-) mice, which lack a versican-degrading protease, ADAMTS5, had reduced versican proteolysis, increased PCM, altered cell shape, enhanced alpha-smooth muscle actin (SMA) expression and increased contractility within three-dimensional collagen gels. The myofibroblast-like phenotype was associated with activation of TGF beta signaling. We tested the hypothesis that fibroblast-myofibroblast transition in Adamts5(-/-) cells resulted from versican accumulation in PCM. First, we noted that versican overexpression inhumandermal fibroblasts led to increased SMA expression, enhanced contractility, and increased Smad2 phosphorylation. In contrast, dermal fibroblasts from Vcan haploinsufficient (Vcan(hdf/+)) mice had reduced contractility relative to wild type fibroblasts. Using a genetic approach to directly test if myofibroblast transition in Adamts5(-/-) cells resulted from increased PCM versican content, we generated Adamts5(-/-); Vcan(hdf/+) mice and isolated their dermal fibroblasts for comparison with dermal fibroblasts from Adamts5(-/-) mice. In Adamts5(-/-) fibroblasts, Vcan haploinsufficiency or exogenous ADAMTS5 restored normal fibroblast contractility. These findings demonstrate that altering PCM versican content through proteolytic activity of ADAMTS5 profoundly influenced the dermal fibroblast phenotype and may regulate a phenotypic continuum between the fibroblast and its alter ego, the myofibroblast. We propose that a physiological function of ADAMTS5 in dermal fibroblasts is to maintain optimal versican content and PCM volume by continually trimming versican in hyaluronan-versican aggregates.	[Apte, Suneel S.] Case Western Reserve Univ, Dept Biomed Engn, Lerner Res Inst, Cleveland Clin, Cleveland, OH 44195 USA; [Carrino, David A.] Case Western Reserve Univ, Skeletal Res Ctr, Dept Biol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Apte, SS (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Lerner Res Inst, Cleveland Clin, ND20,9500 Euclid Ave, Cleveland, OH 44195 USA.	aptes@ccf.org		Wylie, James/0000-0003-2657-0311; Apte, Suneel/0000-0001-8441-1226	National Institutes of Health [AR53890, HL 107147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR53890 and HL 107147.	Abraham DJ, 2005, TRENDS IMMUNOL, V26, P587, DOI 10.1016/j.it.2005.09.004; Aspberg A, 1999, J BIOL CHEM, V274, P20444, DOI 10.1074/jbc.274.29.20444; ASPBERG A, 1995, P NATL ACAD SCI USA, V92, P10590, DOI 10.1073/pnas.92.23.10590; BENNETT HS, 1963, J HISTOCHEM CYTOCHEM, V11, P14, DOI 10.1177/11.1.14; Brown HM, 2010, BIOL REPROD, V83, P549, DOI 10.1095/biolreprod.110.084434; Camaioni A, 1996, ARCH BIOCHEM BIOPHYS, V325, P190, DOI 10.1006/abbi.1996.0024; CARRINO DA, 1991, BIOCHEM INT, V24, P485; Carrino DA, 2000, ARCH BIOCHEM BIOPHYS, V373, P91, DOI 10.1006/abbi.1999.1545; Carrino DA, 2011, GLYCOBIOLOGY, V21, P257, DOI 10.1093/glycob/cwq162; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; Choocheep K, 2010, J BIOL CHEM, V285, P21114, DOI 10.1074/jbc.M109.096479; CLARRIS BJ, 1967, NATURE, V214, P1159, DOI 10.1038/2141159a0; CLARRIS BJ, 1968, EXP CELL RES, V49, P181, DOI 10.1016/0014-4827(68)90530-2; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Enomoto H, 2010, DEVELOPMENT, V137, P4029, DOI 10.1242/dev.050591; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; KNUDSON W, 1991, J CELL SCI, V99, P227; Koo BH, 2010, AM J PATHOL, V176, P1494, DOI 10.2353/ajpath.2010.090655; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Kuno K, 1999, J BIOL CHEM, V274, P18821, DOI 10.1074/jbc.274.26.18821; Kuznetsova SA, 2006, J CELL SCI, V119, P4499, DOI 10.1242/jcs.03171; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Maleski M, 1997, GLIA, V20, P193, DOI 10.1002/(SICI)1098-1136(199707)20:3<193::AID-GLIA3>3.0.CO;2-9; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; OIKE Y, 1980, BIOCHEM J, V191, P193, DOI 10.1042/bj1910193; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; POOLE CA, 1987, J ORTHOP RES, V5, P509, DOI 10.1002/jor.1100050406; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Silver DL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000003; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Thompson WR, 2011, J BONE MINER RES, V26, P618, DOI 10.1002/jbmr.236; VanTeeffelen JW, 2007, TRENDS CARDIOVAS MED, V17, P101, DOI 10.1016/j.tcm.2007.02.002; Velasco J, 2011, J BIOL CHEM, V286, P26016, DOI 10.1074/jbc.M110.208694; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	49	71	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34298	34310		10.1074/jbc.M111.254938	http://dx.doi.org/10.1074/jbc.M111.254938			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828051	Green Published, hybrid			2022-12-27	WOS:000295159200059
J	Karolczak-Bayatti, M; Sweeney, M; Cheng, JAN; Edey, L; Robson, SC; Ulrich, SM; Treumann, A; Taggart, MJ; Europe-Finner, GN				Karolczak-Bayatti, Magdalena; Sweeney, Michele; Cheng, Joanna; Edey, Lydia; Robson, Stephen C.; Ulrich, Scott M.; Treumann, Achim; Taggart, Michael J.; Europe-Finner, G. Nicholas			Acetylation of Heat Shock Protein 20 (Hsp20) Regulates Human Myometrial Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I HISTONE DEACETYLASE; SMOOTH-MUSCLE; KINASE-A; ACTIN DYNAMICS; EXPRESSION; COFILIN; PARTURITION; RELAXATION; PREGNANCY; SUBSTRATE	Phosphorylation of heat shock protein 20 (Hsp20) by protein kinase A (PKA) is now recognized as an important regulatory mechanism modulating contractile activity in the human myometrium. Thus agonists that stimulate cyclic AMP production may cause relaxation with resultant beneficial effects on pathologies that affect this tissue such as the onset of premature contractions prior to term. Here we describe for the first time that acetylation of Hsp20 is also a potent post-translational modification that can affect human myometrial activity. We show that histone deacetylase 8 (HDAC8) is a non-nuclear lysine deacetylase (KDAC) that can interact with Hsp20 to affect its acetylation. Importantly, use of a selective linkerless hydroxamic acid HDAC8 inhibitor increases Hsp20 acetylation with no elevation of nuclear-resident histone acetylation nor marked global gene expression changes. These effects are associated with significant inhibition of spontaneous and oxytocin-augmented contractions of ex vivo human myometrial tissue strips. A potential molecular mechanism by which Hsp20 acetylation can affect myometrial activity by liberating cofilin is described and further high-lights the use of specific effectors of KDACs as therapeutic agents in regulating contractility in this smooth muscle.	[Karolczak-Bayatti, Magdalena; Sweeney, Michele; Cheng, Joanna; Edey, Lydia; Robson, Stephen C.; Taggart, Michael J.; Europe-Finner, G. Nicholas] Newcastle Univ, Inst Cellular Med, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Ulrich, Scott M.] Ithaca Coll, Dept Chem, Ithaca, NY 14850 USA; [Treumann, Achim] NEPAF, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Karolczak-Bayatti, M (corresponding author), Newcastle Univ, Inst Cellular Med, Fac Med Sci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	magda.karolczak@ncl.ac.uk; g.n.europe-finner@ncl.ac.uk	europe-finner, Nicholas/F-2569-2010; Treumann, Achim/H-1295-2013	Taggart, Michael/0000-0002-9981-2783; Treumann, Achim/0000-0002-9417-3505	Medical Research Council, UK [G00800202]; MRC [G0800202] Funding Source: UKRI; Medical Research Council [G0800202] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Grant G00800202 from the Medical Research Council, UK.	Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Birkenfeld J, 2003, BIOCHEM J, V369, P45, DOI 10.1042/BJ20021152; Brophy CM, 1999, J BIOL CHEM, V274, P6324, DOI 10.1074/jbc.274.10.6324; Bugg GJ, 2006, EUR J CLIN INVEST, V36, P133, DOI 10.1111/j.1365-2362.2006.01600.x; Buggy JJ, 2000, BIOCHEM J, V350, P199, DOI 10.1042/0264-6021:3500199; Chapman NR, 2004, J CLIN ENDOCR METAB, V89, P5683, DOI 10.1210/jc.2004-0873; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Chernik IS, 2007, MOL CELL BIOCHEM, V295, P9, DOI 10.1007/s11010-006-9266-8; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dreiza CM, 2004, FASEB J, V18, P261, DOI 10.1096/fj.04-2911fje; Estiu G, 2010, BIOORGAN MED CHEM, V18, P4103, DOI 10.1016/j.bmc.2010.03.080; EUROPEFINNER GN, 1993, ENDOCRINOLOGY, V132, P2484, DOI 10.1210/en.132.6.2484; EUROPEFINNER GN, 1994, J CLIN ENDOCR METAB, V79, P1835, DOI 10.1210/jc.79.6.1835; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gupta MP, 2008, J BIOL CHEM, V283, P10135, DOI 10.1074/jbc.M710277200; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Karolczak-Bayatti M., 2009, J CELL MOL MED, V15, P94; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007; KrennHrubec K, 2007, BIOORG MED CHEM LETT, V17, P2874, DOI 10.1016/j.bmcl.2007.02.064; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; MacDougall MWJ, 2003, J CLIN ENDOCR METAB, V88, P2194, DOI 10.1210/jc.2002-021862; MacIntyre DA, 2008, ENDOCRINOLOGY, V149, P245, DOI 10.1210/en.2007-0662; Moynihan AT, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.01.002; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; PHANEUF S, 1993, J ENDOCRINOL, V136, P497, DOI 10.1677/joe.0.1360497; Salinthone S, 2008, PHARMACOL THERAPEUT, V119, P44, DOI 10.1016/j.pharmthera.2008.04.005; San Martin A, 2008, CIRC RES, V102, P432, DOI 10.1161/CIRCRESAHA.107.158923; Thangapandian S, 2010, EUR J MED CHEM, V45, P4409, DOI 10.1016/j.ejmech.2010.06.024; Tyson EK, 2008, ENDOCRINOLOGY, V149, P6157, DOI 10.1210/en.2008-0593; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Waltregny D, 2004, AM J PATHOL, V165, P553, DOI 10.1016/S0002-9440(10)63320-2; Yoshino Y, 2005, JPN J PHYSIOL, V55, P373, DOI 10.2170/jjphysiol.RP002605	36	47	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34346	34355		10.1074/jbc.M111.278549	http://dx.doi.org/10.1074/jbc.M111.278549			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21803775	Green Published, hybrid			2022-12-27	WOS:000295159200063
J	Ma, BY; Nussinov, R				Ma, Buyong; Nussinov, Ruth			Polymorphic Triple beta-Sheet Structures Contribute to Amide Hydrogen/Deuterium (H/D) Exchange Protection in the Alzheimer Amyloid beta 42 Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; A-BETA; MOLECULAR-DYNAMICS; FIBRIL FORMATION; EXPERIMENTAL CONSTRAINTS; SECONDARY STRUCTURE; SOLVENT PROTECTION; PRION PROTEIN; WILD-TYPE; OLIGOMERS	Characterization of the polymorphic structural range of A beta oligomers is important to the understanding of the mechanisms of toxicity. Yet for highly polymorphic ensembles, experimental structural elucidation is difficult. Here, we use a combination of NMR solvent protection experiments and computational structural screening to identify major species in the amyloid conformational ensemble. We examined the polymorphic pentamer and fibril seeds of A beta 42 and its mutants and compared the theoretical backbone amide protection obtained from simulations with experimental hydrogen/deuterium (H/D) exchange protection ratio. Weobserved that highly flexible pentamers do not share structural similarities with fibril seed oligomers, except the turn regions. We found that a novel amyloid structural motif of a triple beta-sheet, with the N-terminal residues interacting with the core (Lys(17)-Glu(22)) beta-sheet region, correlates with H/D exchange protection. The triple beta-sheet A beta 42 oligomer has a minimal exposure of hydrophobic residues and is further stabilized by the E22Q (Dutch) mutation in Alzheimer disease. The experimental H/D exchange solvent protection ratio implies that triple beta-sheet fibrils and globulomers could coexist in the A beta 42 ensemble, pointing to a broad heterogeneous aggregate population. Our results suggest that an approach that combines computational modeling with NMR protection data can be a useful strategy for obtaining clues to the preferred conformational species of the assemblies in solution and help in alleviating experimental difficulties and consequently possible errors in the exchange data for A beta 42 fibrils.	[Ma, Buyong; Nussinov, Ruth] NCI, Basic Sci Program, SAIC Frederick Inc, Ctr Canc Res Nanobiol Program,NIH, Frederick, MD 21702 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Sch Med, Sackler Inst Mol Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tel Aviv University; Sackler Faculty of Medicine	Ma, BY (corresponding author), NCI, Basic Sci Program, SAIC Frederick Inc, Ctr Canc Res Nanobiol Program,NIH, Bldg 469,Rm 151, Frederick, MD 21702 USA.	mabuyong@mail.nih.gov	Ma, Buyong/F-9491-2011	Ma, Buyong/0000-0002-7383-719X; Nussinov, Ruth/0000-0002-8115-6415	National Institutes of Health, NCI [HHSN261200800001E]; NCI, CCR; NATIONAL CANCER INSTITUTE [ZIABC010440, ZIABC010441] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI, CCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant HHSN261200800001E from the NCI and by the Intramural Research Program NCI, CCR.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Blinov N, 2010, BIOPHYS J, V98, P282, DOI 10.1016/j.bpj.2009.09.062; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Demeester N, 2001, EUR J NEUROSCI, V13, P2015, DOI 10.1046/j.0953-816x.2001.01579.x; Ding H, 2009, BIOPHYS J, V97, P912, DOI 10.1016/j.bpj.2009.05.035; Frydman-Marom A, 2009, ANGEW CHEM INT EDIT, V48, P1981, DOI 10.1002/anie.200802123; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Hoshino M, 2007, BBA-BIOMEMBRANES, V1768, P1886, DOI 10.1016/j.bbamem.2007.03.001; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Konuma T, 2011, J MOL BIOL, V405, P851, DOI 10.1016/j.jmb.2010.11.029; Kuwata K, 2003, P NATL ACAD SCI USA, V100, P14790, DOI 10.1073/pnas.2433563100; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Lin NS, 2010, CHEM-EUR J, V16, P5492, DOI 10.1002/chem.200903290; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2006, CURR OPIN CHEM BIOL, V10, P445, DOI 10.1016/j.cbpa.2006.08.018; Ma BY, 2010, J BIOL CHEM, V285, P37102, DOI 10.1074/jbc.M110.133488; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Massi F, 2002, PROTEIN SCI, V11, P1639, DOI 10.1110/ps.3150102; Miller Y, 2010, P NATL ACAD SCI USA, V107, P14128, DOI 10.1073/pnas.1004704107; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Morelli L, 2003, J BIOL CHEM, V278, P23221, DOI 10.1074/jbc.M300276200; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Olofsson A, 2009, ANAL BIOCHEM, V385, P374, DOI 10.1016/j.ab.2008.10.034; Paparcone R, 2010, BIOCHEMISTRY-US, V49, P8967, DOI 10.1021/bi100953t; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sabate R, 2010, J MOL BIOL, V404, P337, DOI 10.1016/j.jmb.2010.09.052; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Shen Y, 2010, PROTEIN SCI, V19, P349, DOI 10.1002/pro.303; Tsubuki S, 2003, LANCET, V361, P1957, DOI 10.1016/S0140-6736(03)13555-6; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; Whittemore NA, 2005, BIOCHEMISTRY-US, V44, P4434, DOI 10.1021/bi048292u; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yan LM, 2007, ANGEW CHEM INT EDIT, V46, P1246, DOI 10.1002/anie.200604056; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Yun SJ, 2007, BIOPHYS J, V92, P4064, DOI 10.1529/biophysj.106.097766; Zhang R, 2009, P NATL ACAD SCI USA, V106, P4653, DOI 10.1073/pnas.0901085106	45	35	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34244	34253		10.1074/jbc.M111.241141	http://dx.doi.org/10.1074/jbc.M111.241141			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832091	hybrid, Green Published			2022-12-27	WOS:000295159200054
J	Robinson, JW; Potter, LR				Robinson, Jerid W.; Potter, Lincoln R.			ATP Potentiates Competitive Inhibition of Guanylyl Cyclase A and B by the Staurosporine Analog, Go6976 RECIPROCAL REGULATION OF ATP AND GTP BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRIURETIC-PEPTIDE RECEPTOR; PROTEIN-KINASE-C; NPR-B/GC-B; ADENINE-NUCLEOTIDES; DOMAIN; DESENSITIZATION; ACTIVATION; CALCIUM	Natriuretic peptides and ATP activate and Go6976 inhibits guanylyl cyclase (GC)-A and GC-B. Here, the mechanism of inhibition was determined. Go6976 progressively increased the Michaelis-Menten constant and decreased the Hill coefficient without reducing the maximal velocity of GC-A and GC-B. In the presence of 1 mM ATP, the K-i was 1 mu M for both enzymes. Inhibition of GC-B was minimal in the absence of ATP, and 1 mM ATP increased the inhibition 4-fold. In a reciprocal manner, 10 mu M Go6976 increased the potency of ATP for GC-B 4-fold. In contrast to a recent study (Duda, T., Yadav, P., and Sharma, R. K. (2010) FEBS J. 277, 2550-2553), neither staurosporine nor Go6976 activated GC-A or GC-B. This is the first study to show that Go6976 reduces GTP binding and the first demonstration of a competitive inhibitor of a receptor guanylyl cyclase. We conclude that Go6976 reduces GTP binding to the catalytic site of GC-A and GC-B and that ATP increases the magnitude of the inhibition.	[Potter, Lincoln R.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Potter, Lincoln R.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Potter, LR (corresponding author), Univ Minnesota, Dept Pharmacol, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	potter@umn.edu			University of Minnesota Graduate School [21,922]; National Institutes of Health from the NIAMS [T32AR050938]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050938] Funding Source: NIH RePORTER	University of Minnesota Graduate School(University of Minnesota System); National Institutes of Health from the NIAMS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Grant-in Aid 21,922 from the University of Minnesota Graduate School (to L. R. P.) and National Institutes of Health Training Grant T32AR050938 (to J. W. R.) from the NIAMS.	Abbey SE, 2002, J BIOL CHEM, V277, P42423, DOI 10.1074/jbc.M206686200; Abbey-Hosch SE, 2005, BIOCHEM PHARMACOL, V70, P686, DOI 10.1016/j.bcp.2005.04.034; Antos LK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1756, DOI 10.1152/ajpendo.00321.2007; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; Dickey DM, 2010, MOL PHARMACOL, V78, P431, DOI 10.1124/mol.110.066084; Duda T, 2011, BIOCHEMISTRY-US, V50, P1213, DOI 10.1021/bi1018978; Duda T, 2010, FEBS J, V277, P2550, DOI 10.1111/j.1742-4658.2010.07670.x; Fan DH, 2005, MOL PHARMACOL, V67, P174, DOI 10.1124/mol.104.002436; Flora DR, 2010, ENDOCRINOLOGY, V151, P2769, DOI 10.1210/en.2009-1239; Foster DC, 1998, J BIOL CHEM, V273, P16311, DOI 10.1074/jbc.273.26.16311; He XL, 2006, J MOL BIOL, V361, P698, DOI 10.1016/j.jmb.2006.06.060; Joubert S, 2001, BIOCHEMISTRY-US, V40, P11096, DOI 10.1021/bi010580s; KOLLER KJ, 1992, MOL CELL BIOL, V12, P2581, DOI 10.1128/MCB.12.6.2581; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Potter LR, 2011, PHARMACOL THERAPEUT, V130, P71, DOI 10.1016/j.pharmthera.2010.12.005; ROBINSON JW, 2011, BR J PHARM      0303, DOI DOI 10.1111/J.1476-5381.2011.01291.X; RONDEAU JJ, 1995, BIOCHEMISTRY-US, V34, P2130, DOI 10.1021/bi00007a005; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; Yoder AR, 2008, PEPTIDES, V29, P1575, DOI 10.1016/j.peptides.2008.04.020; Yoder AR, 2010, BIOCHEMISTRY-US, V49, P10137, DOI 10.1021/bi101700e	21	9	9	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33841	33844		10.1074/jbc.M111.273565	http://dx.doi.org/10.1074/jbc.M111.273565			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828054	Green Published, hybrid			2022-12-27	WOS:000295159200015
J	Fronz, K; Guttinger, S; Burkert, K; Kuhn, U; Stohr, N; Schierhorn, A; Wahle, E				Fronz, Katharina; Guettinger, Stefan; Burkert, Kerstin; Kuehn, Uwe; Stoehr, Nadine; Schierhorn, Angelika; Wahle, Elmar			Arginine Methylation of the Nuclear Poly(A) Binding Protein Weakens the Interaction with Its Nuclear Import Receptor, Transportin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; POLY(A)-BINDING PROTEIN; N-METHYLTRANSFERASE; IN-VIVO; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-SPECIFICITY; EXPORT; LOCALIZATION; PRMT1; SIGNAL	The nuclear poly(A) binding protein, PABPN1, promotes mRNA polyadenylation in the cell nucleus by increasing the processivity of poly(A) polymerase and contributing to poly(A) tail length control. In its C-terminal domain, the protein carries 13 arginine residues that are all asymmetrically dimethylated. The function of this modification in PABPN1 has been unknown. Part of the methylated domain serves as nuclear localization signal, binding the import receptor transportin. Here we report that arginine methylation weakens the affinity of PABPN1 for transportin. Recombinant, unmethylated PABPN1 binds more strongly to transportin than its methylated counterpart from mammalian tissue, and in vitro methylation reduces the affinity. Transportin and RNA compete for binding to PABPN1. Methylation favors RNA binding. Transportin also inhibits in vitro methylation of the protein. Finally, a peptide corresponding to the nuclear localization signal of PABPN1 competes with transportin-dependent nuclear import of the protein in a permeabilized cell assay and does so less efficiently when it is methylated. We hypothesize that transportin binding might delay methylation of PABPN1 until after nuclear import. In the nucleus, arginine methylation may favor the transition of PABPN1 to the competing ligand RNA and serve to reduce the risk of the protein being reexported to the cytoplasm by transportin.	[Fronz, Katharina; Burkert, Kerstin; Kuehn, Uwe; Schierhorn, Angelika; Wahle, Elmar] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06099 Halle, Germany; [Guettinger, Stefan] Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland; [Stoehr, Nadine] Univ Halle Wittenberg, Sect Mol Cell Biol, Dept Med, D-06097 Halle, Germany	Martin Luther University Halle Wittenberg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Martin Luther University Halle Wittenberg	Wahle, E (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06099 Halle, Germany.	ewahle@biochemtech.uni-halle.de		Guttinger, Stephan/0000-0001-9448-973X; Wahle, Elmar/0000-0003-2504-0677	Deutsche Forschungsgemeinschaft [SFB 610]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 610 (to E. W.).	Aoki K, 2002, NUCLEIC ACIDS RES, V30, P5182, DOI 10.1093/nar/gkf638; Araya N, 2005, BIOCHEM BIOPH RES CO, V329, P653, DOI 10.1016/j.bbrc.2005.02.018; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Becskei A, 2003, P NATL ACAD SCI USA, V100, P1717, DOI 10.1073/pnas.252766999; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Belyanskaya LL, 2001, J BIOL CHEM, V276, P18681, DOI 10.1074/jbc.M011446200; Benoit B, 2005, DEV CELL, V9, P511, DOI 10.1016/j.devcel.2005.09.002; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Calado A, 2000, RNA, V6, P245, DOI 10.1017/S1355838200991908; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Fronz K, 2008, J BIOL CHEM, V283, P20408, DOI 10.1074/jbc.M802329200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Guttinger S, 2004, P NATL ACAD SCI USA, V101, P2918, DOI 10.1073/pnas.0400342101; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Iijima M, 2006, FEBS LETT, V580, P1365, DOI 10.1016/j.febslet.2006.01.058; Imasaki T, 2007, MOL CELL, V28, P57, DOI 10.1016/j.molcel.2007.08.006; Ishidate T, 1997, FEBS LETT, V409, P237, DOI 10.1016/S0014-5793(97)00455-9; Jobert L, 2009, EXP CELL RES, V315, P1273, DOI 10.1016/j.yexcr.2008.12.008; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Kolbel K, 2009, J BIOL CHEM, V284, P8274, DOI 10.1074/jbc.M809547200; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lacovides DC, 2007, J VIROL, V81, P13209, DOI 10.1128/JVI.01415-06; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; McBride AE, 2005, J BIOL CHEM, V280, P30888, DOI 10.1074/jbc.M505831200; McBride AE, 2007, EUKARYOT CELL, V6, P1119, DOI 10.1128/EC.00074-07; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Nichols RC, 2000, EXP CELL RES, V256, P522, DOI 10.1006/excr.2000.4827; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Passos DO, 2006, BIOCHEM BIOPH RES CO, V346, P517, DOI 10.1016/j.bbrc.2006.05.152; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Perreault A, 2007, J BIOL CHEM, V282, P7552, DOI 10.1074/jbc.M610512200; Pintucci G, 1996, MOL BIOL CELL, V7, P1249, DOI 10.1091/mbc.7.8.1249; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; Smith WA, 2004, J BIOL CHEM, V279, P22795, DOI 10.1074/jbc.C300512200; Souki SK, 2009, J VIROL, V83, P5309, DOI 10.1128/JVI.00238-09; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Suzuki M, 2005, FEBS J, V272, P3975, DOI 10.1111/j.1742-4658.2005.04820.x; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tavanez JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006418; Temme C, 2009, J BIOL CHEM, V284, P8337, DOI 10.1074/jbc.M808319200; Verheesen P, 2006, HUM MOL GENET, V15, P105, DOI 10.1093/hmg/ddi432; Verheesen P, 2006, BBA-PROTEINS PROTEOM, V1764, P1307, DOI 10.1016/j.bbapap.2006.05.011; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; Xu C, 2004, MOL CELL BIOL, V24, P10742, DOI 10.1128/MCB.24.24.10742-10756.2004; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707; Zakaryan RP, 2006, J MOL BIOL, V363, P27, DOI 10.1016/j.jmb.2006.08.018	74	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32986	32994		10.1074/jbc.M111.273912	http://dx.doi.org/10.1074/jbc.M111.273912			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808065	Green Published, hybrid			2022-12-27	WOS:000294968800016
J	Llarrull, LI; Toth, M; Champion, MM; Mobashery, S				Llarrull, Leticia I.; Toth, Marta; Champion, Matthew M.; Mobashery, Shahriar			Activation of BlaR1 Protein of Methicillin-resistant Staphylococcus aureus, Its Proteolytic Processing, and Recovery from Induction of Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LACTAM ANTIBIOTICS; N-ZETA-DECARBOXYLATION; SIGNALING PATHWAY; ESCHERICHIA-COLI; SENSOR DOMAIN; MEMBRANE; BINDING; TRANSDUCER; OPERON	The fates of BlaI, the gene repressor protein for the bla operon, BlaR1, the beta-lactam sensor/signal transducer, and PC1 beta-lactamase in four strains of Staphylococcus aureus upon exposure to four different beta-lactam antibiotics were investigated as a function of time. The genes for the three proteins are encoded by the bla operon, the functions of which afford inducible resistance to beta-lactam antibiotics in S. aureus. BlaR1 protein is expressed at low copy number. Acylation of the sensor domain of BlaR1 by beta-lactam antibiotics initiates signal transduction to the cytoplasmic domain, a zinc protease, which is activated and degrades BlaI. This proteolytic degradation derepresses transcription of all three genes, resulting in inducible resistance. These processes take place within minutes of exposure to the antibiotics. The BlaR1 protein was shown to undergo fragmentation in three S. aureus strains within the time frame relevant for manifestation of resistance and was below the detection threshold in the fourth. Two specific sites of fragmentation were identified, one cytoplasmic and the other in the sensor domain. This is proposed as a means for turnover, a process required for recovery from induction of resistance in S. aureus in the absence of the antibiotic challenge. In S. aureus not exposed to beta-lactam antibiotics (i.e. not acylated by antibiotic) the same fragmentation of BlaR1 is still observed, including the shedding of the sensor domain, an observation that leads to the conclusion that the sites of proteolysis might have evolved to predispose the protein to degradation within a set period of time.	[Llarrull, Leticia I.; Toth, Marta; Champion, Matthew M.; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Mobashery, S (corresponding author), 423 Nieuwland Sci Ctr, Notre Dame, IN 46556 USA.	mobashery@nd.edu		Champion, Matthew M./0000-0001-5927-5277; Llarrull, Leticia/0000-0002-5679-4343	National Institutes of Health [AI 33170]; Pew Charitable Trusts; NIAID, National Institutes of Health [HHSN272200700055C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 33170.; A Pew Latin American Fellow in the Biomedical Sciences, supported by The Pew Charitable Trusts.; S. aureus isolates NRS128, NRS123, NRS70, and NRS144 were obtained through the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) program, supported under NIAID, National Institutes of Health, Contract HHSN272200700055C. We acknowledge Dr. Maxim Suvorov for construction of the vector pET-24a(+)_BlaRHis<INF>6</INF>.	Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Antunes NT, 2011, BIOCHEMISTRY-US, V50, P6387, DOI 10.1021/bi200403e; Bernsel A, 2009, TRENDS MICROBIOL, V17, P444, DOI 10.1016/j.tim.2009.07.005; Borbulevych O, 2011, J BIOL CHEM, V286, P31466, DOI 10.1074/jbc.M111.252189; Carrasco-Lopez C, 2011, J BIOL CHEM, V286, P31714, DOI 10.1074/jbc.M111.264366; Cha J, 2007, J AM CHEM SOC, V129, P3834, DOI 10.1021/ja070472e; Champion PAD, 2009, MOL MICROBIOL, V73, P950, DOI 10.1111/j.1365-2958.2009.06821.x; CHRISTENSEN H, 1990, BIOCHEM J, V266, P853; Clarke SR, 2001, J ANTIMICROB CHEMOTH, V47, P377, DOI 10.1093/jac/47.4.377; Collins J. F., 1979, BETA LACTAMASES, P351; Golemi-Kotra D, 2003, J BIOL CHEM, V278, P18419, DOI 10.1074/jbc.M300611200; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guo FS, 1999, BBA-PROTEIN STRUCT M, V1431, P132, DOI 10.1016/S0167-4838(99)00048-5; Hanique S, 2004, J BIOL CHEM, V279, P14264, DOI 10.1074/jbc.M313488200; Hardt K, 1997, MOL MICROBIOL, V23, P935, DOI 10.1046/j.1365-2958.1997.2761642.x; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Jones AR, 2008, MOL CELL PROTEOMICS, V7, P2067, DOI 10.1074/mcp.H800010-MCP200; Jones JD, 2011, PROTEOMICS, V11, P3012, DOI 10.1002/pmic.201000812; KOZAK M, 1983, MICROBIOL REV, V47, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Llarrull LI, 2010, BIOCHEMISTRY-US, V49, P7975, DOI 10.1021/bi101177a; Powers ME, 2011, J BACTERIOL, V193, P340, DOI 10.1128/JB.01052-10; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; SUGINO Y, 1980, J BIOCHEM-TOKYO, V87, P351, DOI 10.1093/oxfordjournals.jbchem.a132746; Tang JZ, 2004, PROTEIN EXPRES PURIF, V36, P100, DOI 10.1016/j.pep.2004.03.007; Thumanu K, 2006, P NATL ACAD SCI USA, V103, P10630, DOI 10.1073/pnas.0601971103; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Weiner JH, 2008, BBA-BIOMEMBRANES, V1778, P1698, DOI 10.1016/j.bbamem.2007.07.020; Wikler M., 2006, METHODS DILUTION ANT; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144; ZHU YF, 1992, J BACTERIOL, V174, P6171, DOI 10.1128/JB.174.19.6171-6178.1992	34	47	47	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38148	38158		10.1074/jbc.M111.288985	http://dx.doi.org/10.1074/jbc.M111.288985			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21896485	Green Published, hybrid			2022-12-27	WOS:000296594200028
J	Garcia-Saez, AJ; Buschhorn, SB; Keller, H; Anderluh, G; Simons, K; Schwille, P				Garcia-Saez, Ana J.; Buschhorn, Sabine B.; Keller, Heiko; Anderluh, Gregor; Simons, Kai; Schwille, Petra			Oligomerization and Pore Formation by Equinatoxin II Inhibit Endocytosis and Lead to Plasma Membrane Reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; SEA-ANEMONE; FORMING TOXIN; LIPID RAFTS; PHASE COEXISTENCE; STICHOLYSIN-II; RECEPTOR; PROTEINS; SPHINGOMYELIN; ORGANIZATION	Pore-forming toxins have evolved to induce membrane injury by formation of pores in the target cell that alter ion homeostasis and lead to cell death. Many pore-forming toxins use cholesterol, sphingolipids, or other raft components as receptors. However, the role of plasma membrane organization for toxin action is not well understood. In this study, we have investigated cellular dynamics during the attack of equinatoxin II, a pore-forming toxin from the sea anemone Actinia equina, by combining time lapse three-dimensional live cell imaging, fluorescence recovery after photobleaching, FRET, and fluorescence cross-correlation spectroscopy. Our results show that membrane binding by equinatoxin II is accompanied by extensive plasma membrane reorganization into microscopic domains that resemble coalesced lipid rafts. Pore formation by the toxin induces Ca2+ entry into the cytosol, which is accompanied by hydrolysis of phosphatidylinositol 4,5-bisphosphate, plasma membrane blebbing, actin cytoskeleton reorganization, and inhibition of endocytosis. We propose that plasma membrane reorganization into stabilized raft domains is part of the killing strategy of equinatoxin II.	[Garcia-Saez, Ana J.; Keller, Heiko; Schwille, Petra] Tech Univ Dresden, BIOTEC, D-01307 Dresden, Germany; [Garcia-Saez, Ana J.] Max Planck Inst Intelligent Syst, D-69120 Heidelberg, Germany; [Garcia-Saez, Ana J.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Buschhorn, Sabine B.; Simons, Kai] Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; [Anderluh, Gregor] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana 1000, Slovenia	Technische Universitat Dresden; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; University of Ljubljana	Garcia-Saez, AJ (corresponding author), Neuenheimer Feld 267, D-69120 Heidelberg, Germany.	ana.garcia@mf.mpg.de; petra.schwille@biotec.tu-dresden.de	Schwille, Petra/A-4983-2010; Anderluh, Gregor/C-6905-2014; Saez, Ana J. Garcia/U-1611-2019	Anderluh, Gregor/0000-0002-9916-8465; Simons, Kai/0000-0002-9231-9996	German Cancer Research Center; Max Planck Society	German Cancer Research Center(Helmholtz Association); Max Planck Society(Max Planck Society)	This work was supported by funds from the German Cancer Research Center (to A. J. G.-S.) and the Max Planck Society.	Abe Y, 2008, J BIOCHEM, V143, P269, DOI 10.1093/jb/mvm220; Alegre-Cebollada J, 2006, FEBS J, V273, P863, DOI 10.1111/j.1742-4658.2006.05122.x; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderluh G, 2000, J MEMBRANE BIOL, V173, P47, DOI 10.1007/s002320001006; Anderluh G, 2008, TRENDS BIOCHEM SCI, V33, P482, DOI 10.1016/j.tibs.2008.07.004; Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Bakrac B, 2010, J BIOL CHEM, V285, P22186, DOI 10.1074/jbc.M110.105122; Bakrac B, 2010, ADV EXP MED BIOL, V677, P106; Barlic A, 2004, J BIOL CHEM, V279, P34209, DOI 10.1074/jbc.M313817200; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Bischofberger M, 2009, CURR OPIN CELL BIOL, V21, P589, DOI 10.1016/j.ceb.2009.04.003; Charrier C, 2010, NAT NEUROSCI, V13, P1388, DOI 10.1038/nn.2645; Garcia-Saez AJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706162200; Garcia-Saez AJ, 2010, METHODS MOL BIOL, V606, P493, DOI 10.1007/978-1-60761-447-0_33; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Garcia-Saez AJ, 2008, METHODS, V46, P116, DOI 10.1016/j.ymeth.2008.06.011; Gekara NO, 2004, BIOCHEM SOC T, V32, P712, DOI 10.1042/BST0320712; Goehring NW, 2010, BIOPHYS J, V99, P2443, DOI 10.1016/j.bpj.2010.08.033; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Gonzalez MR, 2011, CELL MICROBIOL, V13, P1026, DOI 10.1111/j.1462-5822.2011.01600.x; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Keller H, 2009, CHEMPHYSCHEM, V10, P2805, DOI 10.1002/cphc.200900598; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kitada S, 2009, TOXICOLOGY, V264, P80, DOI 10.1016/j.tox.2009.07.016; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kristan K, 2004, J BIOL CHEM, V279, P46509, DOI 10.1074/jbc.M406193200; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Malovrh P, 2003, J BIOL CHEM, V278, P22678, DOI 10.1074/jbc.M300622200; Mancheno JA, 2006, BIOPHYS CHEM, V119, P219, DOI 10.1016/j.bpc.2005.09.021; Martin-Benito J, 2000, BIOPHYS J, V78, P3186, DOI 10.1016/S0006-3495(00)76855-X; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; Meder D, 2006, P NATL ACAD SCI USA, V103, P329, DOI 10.1073/pnas.0509885103; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Nelson KL, 1997, J BIOL CHEM, V272, P12170, DOI 10.1074/jbc.272.18.12170; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Ries J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113009; Saxena R, 2011, J NEUROCHEM, V116, P726, DOI 10.1111/j.1471-4159.2010.07037.x; Schon P, 2008, BIOPHYS J, V95, P691, DOI 10.1529/biophysj.108.129981; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Tejuca M, 2001, J MEMBRANE BIOL, V183, P125, DOI 10.1007/s00232-001-0060-y; Torgersen ML, 2001, J CELL SCI, V114, P3737; Tweten RK, 2001, CURR TOP MICROBIOL, V257, P15; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; ZOREC R, 1990, J MEMBRANE BIOL, V118, P243, DOI 10.1007/BF01868608	54	44	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37768	37777		10.1074/jbc.M111.281592	http://dx.doi.org/10.1074/jbc.M111.281592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21885440	hybrid, Green Published			2022-12-27	WOS:000296542400072
J	Karasawa, A; Erkens, GB; Berntsson, RPA; Otten, R; Schuurman-Wolters, GK; Mulder, FAA; Poolman, B				Karasawa, Akira; Erkens, Guus B.; Berntsson, Ronnie P. -A.; Otten, Renee; Schuurman-Wolters, Gea K.; Mulder, Frans A. A.; Poolman, Bert			Cystathionine beta-Synthase (CBS) Domains 1 and 2 Fulfill Different Roles in Ionic Strength Sensing of the ATP-binding Cassette (ABC) Transporter OpuA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CHLORIDE CHANNELS; CARRIER BETP; CORYNEBACTERIUM-GLUTAMICUM; LACTOCOCCUS-LACTIS; OSMOTIC ACTIVATION; COILED-COIL; PROTEIN	The cystathionine beta-synthase module of OpuA in conjunction with an anionic membrane surface acts as a sensor of internal ionic strength, which allows the protein to respond to osmotic stress. We now show by chemical modification and cross-linking studies that CBS2-CBS2 interface residues are critical for transport activity and/or ionic regulation of transport, whereas CBS1 serves no functional role. We establish that Cys residues in CBS1, CBS2, and the nucleotide-binding domain are more accessible for cross-linking at high than low ionic strength, indicating that these domains undergo conformational changes when transiting between the active and inactive state. Structural analyses suggest that the cystathionine beta-synthase module is largely unstructured. Moreover, we could substitute CBS1 by a linker and preserve ionic regulation of transport. These data suggest that CBS1 serves as a linker and the structured CBS2-CBS2 interface forms a hinge point for ionic strength-dependent rearrangements that are transmitted to the nucleotide-binding domain and thereby affect translocation activity.	Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Poolman, B (corresponding author), Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.poolman@rug.nl	Karasawa, Akira/ABC-9782-2021; Berntsson, Ronnie/J-3535-2019; Mulder, Frans AA/C-7158-2017; Institute, Zernike/W-7033-2019; Karasawa, Akira/ABF-4128-2021; Poolman, Bert/D-1882-2012	Berntsson, Ronnie/0000-0001-6848-322X; Mulder, Frans AA/0000-0001-9427-8406; Otten, Renee/0000-0001-7342-6131	Netherlands Organization for Scientific Research Top Subsidy [700.56.302]; European Union	Netherlands Organization for Scientific Research Top Subsidy; European Union(European Commission)	This work was supported by Netherlands Organization for Scientific Research Top Subsidy Grant 700.56.302 (to B.P.) and the European Union EDICT Program.	Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Biemans-Oldehinkel E, 2003, EMBO J, V22, P5983, DOI 10.1093/emboj/cdg581; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; Bolen D W, 2001, Methods Mol Biol, V168, P17; Checroun C, 2004, FEMS MICROBIOL LETT, V236, P221, DOI 10.1016/j.femsle.2004.05.046; Chen CL, 2007, J BACTERIOL, V189, P6901, DOI 10.1128/JB.00763-07; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Colby TD, 1999, P NATL ACAD SCI USA, V96, P3531, DOI 10.1073/pnas.96.7.3531; Culham DE, 2003, BIOCHEMISTRY-US, V42, P410, DOI 10.1021/bi0264364; Culham DE, 2008, BIOCHEMISTRY-US, V47, P8176, DOI 10.1021/bi800794z; Culham DE, 2008, BIOCHEMISTRY-US, V47, P13584, DOI 10.1021/bi801576x; DeLano WL., 2020, PYMOL MOL GRAPHICS S; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Garcia-Olivares J, 2008, J PHYSIOL-LONDON, V586, P5325, DOI 10.1113/jphysiol.2008.158097; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Gomez-Garcia I, 2010, J MOL BIOL, V399, P53, DOI 10.1016/j.jmb.2010.03.045; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Hillar A, 2005, BIOCHEMISTRY-US, V44, P10170, DOI 10.1021/bi050774y; Horn C, 2003, J MOL BIOL, V334, P403, DOI 10.1016/j.jmb.2003.09.079; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Ishitani R, 2008, P NATL ACAD SCI USA, V105, P15393, DOI 10.1073/pnas.0802991105; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Keates RAB, 2010, BIOCHEMISTRY-US, V49, P8847, DOI 10.1021/bi101281f; LANDFALD B, 1986, J BACTERIOL, V165, P849, DOI 10.1128/jb.165.3.849-855.1986; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Lucas M, 2010, J MOL BIOL, V396, P800, DOI 10.1016/j.jmb.2009.12.012; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; Mahmood NABN, 2006, J BIOL CHEM, V281, P29830, DOI 10.1074/jbc.M604907200; Mahmood NABN, 2009, J BIOL CHEM, V284, P14368, DOI 10.1074/jbc.M901238200; Meinema AC, 2011, SCIENCE, V333, P90, DOI 10.1126/science.1205741; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Miller MD, 2004, PROTEINS, V57, P213, DOI 10.1002/prot.20024; Mulder F. A., 2010, NUCL MAGNETIC RESONA, P59; Ozcan N, 2007, J BACTERIOL, V189, P7485, DOI 10.1128/JB.00986-07; Ott V, 2008, BIOCHEMISTRY-US, V47, P12208, DOI 10.1021/bi801325r; Poolman B, 2005, METHOD ENZYMOL, V400, P429, DOI 10.1016/S0076-6879(05)00025-X; Proudfoot M, 2008, J MOL BIOL, V375, P301, DOI 10.1016/j.jmb.2007.10.060; Racher KI, 2001, BIOCHEMISTRY-US, V40, P7324, DOI 10.1021/bi002331u; Ragunathan P, 2008, BIOCHEM BIOPH RES CO, V375, P124, DOI 10.1016/j.bbrc.2008.07.140; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schiller D, 2004, BIOCHEMISTRY-US, V43, P5583, DOI 10.1021/bi0359628; Schiller D, 2004, FEBS LETT, V563, P108, DOI 10.1016/S0014-5793(04)00279-0; SchmidtRose T, 1997, J BIOL CHEM, V272, P20515, DOI 10.1074/jbc.272.33.20515; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Sharpe ML, 2008, J MOL BIOL, V383, P822, DOI 10.1016/j.jmb.2008.07.001; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Tan L, 2006, MOL MICROBIOL, V61, P861, DOI 10.1111/j.1365-2958.2006.05265.x; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Tsatskis Y, 2005, J BIOL CHEM, V280, P41387, DOI 10.1074/jbc.M508362200; Tuominen H, 2010, J MOL BIOL, V398, P400, DOI 10.1016/j.jmb.2010.03.019; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; van der Heide T, 2001, EMBO J, V20, P7022, DOI 10.1093/emboj/20.24.7022; Viana R, 2007, J BIOL CHEM, V282, P16117, DOI 10.1074/jbc.M611804200; Wolters JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010361; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou RB, 2009, P NATL ACAD SCI USA, V106, P16174, DOI 10.1073/pnas.0901455106; Ziegler C, 2010, MOL MICROBIOL, V78, P13, DOI 10.1111/j.1365-2958.2010.07332.x	70	11	13	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37280	37291		10.1074/jbc.M111.284059	http://dx.doi.org/10.1074/jbc.M111.284059			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878634	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000296542400028
J	Robichaud, TK; Steffensen, B; Fields, GB				Robichaud, Trista K.; Steffensen, Bjorn; Fields, Gregg B.			Exosite Interactions Impact Matrix Metalloproteinase Collagen Specificities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; SUBSTRATE-SPECIFICITY; I COLLAGEN; FLUOROGENIC SUBSTRATE; TISSUE INHIBITOR; PEPTIDE MODELS; GELATINASE-A; DESIGN; CANCER; ACTIVATION	Members of the matrix metalloproteinase (MMP) family selectively cleave collagens in vivo. However, the substrate structural determinants that facilitate interaction with specific MMPs are not well defined. We hypothesized that type I-III collagen sequences located N- or C-terminal to the physiological cleavage site mediate substrate selectivity among MMP-1, MMP-2, MMP-8, MMP-13, and MMP-14/membrane-type 1 (MT1)-MMP. The enzyme kinetics for hydrolysis of three fluorogenic triple-helical peptides (fTHPs) was evaluated herein. The first fTHP contained consensus residues 769-783 from type I-III collagens, the second inserted alpha 1(II) collagen residues 763-768 N-terminal to the consensus sequence, and the third inserted alpha 1(II) collagen residues 784-792 C-terminal to the consensus sequence. Our analyses showed that insertion of the C-terminal residues significantly increased k(cat)/K-m and k(cat) for MMP-1. MMP-13 showed the opposite behavior with a decreased k(cat)/K-m and k(cat) and a greatly improved K-m in response to the C-terminal residues. Insertion of the N-terminal residues enhanced k(cat)/K-m and k(cat) for MMP-8 and MT1-MMP. For MMP-2, the C-terminal residues enhanced K-m and dramatically decreased k(cat), resulting in a decrease in the overall activity. These changes in activities and kinetic parameters represented the collagen preferences of MMP-8, MMP-13, and MT1-MMP well. Thus, interactions with secondary binding sites (exosites) helped direct the specificity of these enzymes. However, MMP-1 collagen preferences were not recapitulated by the fTHP studies. The preference of MMP-1 for type III collagen appears to be primarily based on the flexibility of the hydrolysis site of type III collagen compared with types I and II. Further characterization of exosite determinants that govern interactions of MMPs with collagenous substrates should aid the development of pharmacotherapeutics that target individual MMPs.	[Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA; [Robichaud, Trista K.; Steffensen, Bjorn] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA; [Robichaud, Trista K.; Steffensen, Bjorn; Fields, Gregg B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	Torrey Pines Institute for Molecular Studies, Florida; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Fields, GB (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	gfields@tpims.org			National Institutes of Health [HL07446, DE017139, CA098799]; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants HL07446 (T32 training grant to T.K.R.), DE017139 (to B.S.), and CA098799 (to G.B.F.).	AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; AMES RT, 1994, BIOCHEM J, V300, P729, DOI 10.1042/bj3000729; Bhaskaran R, 2008, J BIOL CHEM, V283, P21779, DOI 10.1074/jbc.M709966200; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Fisher JF, 2006, CANCER METAST REV, V25, P115, DOI 10.1007/s10555-006-7894-9; Gioia M, 2007, J MOL BIOL, V368, P1101, DOI 10.1016/j.jmb.2007.02.076; Gordon MK, 2010, CELL TISSUE RES, V339, P247, DOI 10.1007/s00441-009-0844-4; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; HASTY KA, 1987, J BIOL CHEM, V262, P10048; Ingvarsen S, 2008, BIOL CHEM, V389, P943, DOI 10.1515/BC.2008.097; ITOH Y, 1995, BIOCHEM J, V308, P645, DOI 10.1042/bj3080645; Jacobsen JA, 2010, BBA-MOL CELL RES, V1803, P72, DOI 10.1016/j.bbamcr.2009.08.006; KNAUPER V, 1993, BIOCHEM J, V291, P847; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Lauer-Fields J, 2007, J AM CHEM SOC, V129, P10408, DOI 10.1021/ja0715849; Lauer-Fields JL, 2008, J BIOL CHEM, V283, P20087, DOI 10.1074/jbc.M801438200; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Lauer-Fields JL, 2001, BIOCHEMISTRY-US, V40, P5795, DOI 10.1021/bi0101190; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Muller JCD, 2000, BIOCHEMISTRY-US, V39, P5111, DOI 10.1021/bi992724x; MURPHY G, 1992, J BIOL CHEM, V267, P9612; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Neumann U, 2004, ANAL BIOCHEM, V328, P166, DOI 10.1016/j.ab.2003.12.035; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Ottl J, 1996, FEBS LETT, V398, P31, DOI 10.1016/S0014-5793(96)01212-4; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Palmier MO, 2007, ANAL BIOCHEM, V371, P43, DOI 10.1016/j.ab.2007.07.008; Palmier MO, 2010, J BIOL CHEM, V285, P30918, DOI 10.1074/jbc.M110.136903; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; Piez K.A., 1984, EXTRACELLULAR MATRIX; Rao BG, 2005, CURR PHARM DESIGN, V11, P295, DOI 10.2174/1381612053382115; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Sang QXA, 2006, CURR TOP MED CHEM, V6, P289, DOI 10.2174/156802606776287045; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; Song FY, 2006, FRONT BIOSCI-LANDMRK, V11, P3100, DOI 10.2741/2036; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Tochowicz A, 2011, J BIOL CHEM, V286, P7587, DOI 10.1074/jbc.M110.178434; Uttamchandani M, 2007, J AM CHEM SOC, V129, P7848, DOI 10.1021/ja070870h; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; WELGUS HG, 1985, J BIOL CHEM, V260, P1052; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543; Williams KE, 2009, MATRIX BIOL, V28, P373, DOI 10.1016/j.matbio.2009.04.009; Woessner J.F., 2000, PROTEIN PROFILE SER	57	31	31	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37535	37542		10.1074/jbc.M111.273391	http://dx.doi.org/10.1074/jbc.M111.273391			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896477	Green Published, hybrid			2022-12-27	WOS:000296542400052
J	Mizutani, K; Kawano, S; Minami, A; Waseda, M; Ikeda, W; Takai, Y				Mizutani, Kiyohito; Kawano, Satoshi; Minami, Akihiro; Waseda, Masazumi; Ikeda, Wataru; Takai, Yoshimi			Interaction of Nectin-like Molecule 2 with Integrin alpha(6)beta(4) and Inhibition of Disassembly of Integrin alpha(6)beta(4) from Hemidesmosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; CELL-CELL ADHESION; TUMOR-SUPPRESSOR TSLC1; MOVING NIH3T3 CELLS; IMMUNOGLOBULIN SUPERFAMILY; NECL-5/POLIOVIRUS RECEPTOR; ALPHA-6-BETA-4 INTEGRIN; LUNG-CANCER; MDCK CELLS; GENE	In normal epithelial cells, integrin alpha(6)beta(4) is abundantly expressed and forms hemidesmosomes, which is a cellular structure that mediates cell-extracellular matrix binding. In many types of cancer cells, integrin alpha(6)beta(4) is up-regulated, laminin is cleaved, and hemidesmosomes are disrupted, eventually causing an enhancement of cancer cell movement and facilitation of their invasion. We previously showed that the immunoglobulin-like cell adhesion molecule Necl-2 (Nectin-like molecule 2), known as a tumor suppressor, inhibits cancer cell movement by suppressing the ErbB3/ErbB2 signaling. We show here that Necl-2 interacts in cis with integrin alpha(6)beta(4). The binding of Necl-2 with integrin beta(4) was mediated by its extracellular region. In human colorectal adenocarcinoma Caco-2 cells, integrin alpha(6)beta(4) was localized at hemidesmosomes. Small interfering RNA-mediated suppression of Necl-2 expression enhanced the phorbol ester-induced disruption of the integrin alpha(6)beta(4) complex at hemidesmosomes, whereas expression of Necl-2 suppressed the disruption of this structure. These results indicate that tumor-suppressive functions of Necl-2 are mediated by the stabilization of the hemidesmosome structure in addition to the inhibition of the ErbB3/ErbB2 signaling.	[Mizutani, Kiyohito; Kawano, Satoshi; Minami, Akihiro; Waseda, Masazumi; Ikeda, Wataru; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan	Kobe University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Ikeda, Wataru/V-8531-2019; Mizutani, Kiyohito/L-8474-2019	Ikeda, Wataru/0000-0002-6907-9058; Waseda, Masazumi/0000-0001-7179-5945	Ministry of Education, Culture, Sports, Science, and Technology in Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Global COE Program "Global Center for Education and Research in Integrative Membrane Biology" and the Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology in Japan and by grants-in-aid from the Japan Society for the Promotion of Science.	Amano H, 2008, GENES CELLS, V13, P269, DOI 10.1111/j.1365-2443.2008.01167.x; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Fukami T, 2002, GENE, V295, P7, DOI 10.1016/S0378-1119(02)00835-1; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; Giangreco A, 2009, DEVELOPMENT, V136, P3505, DOI 10.1242/dev.038232; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; Gromeier M, 2000, P NATL ACAD SCI USA, V97, P6803, DOI 10.1073/pnas.97.12.6803; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Honore S, 2000, HISTOCHEM CELL BIOL, V114, P323; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Kawano S, 2010, GENES CELLS, V15, P995, DOI 10.1111/j.1365-2443.2010.01438.x; Kawano S, 2009, J BIOL CHEM, V284, P23793, DOI 10.1074/jbc.M109.025155; Kim DY, 2002, J BIOL CHEM, V277, P49976, DOI 10.1074/jbc.M210179200; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Lussier C, 2000, MICROSC RES TECHNIQ, V51, P169; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; Minami A, 2010, GENES CELLS, V15, P1123, DOI 10.1111/j.1365-2443.2010.01450.x; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; Nagamatsu Y, 2008, J BIOL CHEM, V283, P14532, DOI 10.1074/jbc.M801647200; Pal-Ghosh S, 2011, J CELL SCI, V124, P2666, DOI 10.1242/jcs.085480; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; SCHOENENBERGER CA, 1994, J CELL SCI, V107, P527; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tanabe Y, 2008, NEUROSCI LETT, V444, P16, DOI 10.1016/j.neulet.2008.08.023; Tanaka Y, 2002, BIOCHEM BIOPH RES CO, V299, P472, DOI 10.1016/S0006-291X(02)02681-5; Underwood RA, 2009, J HISTOCHEM CYTOCHEM, V57, P123, DOI 10.1369/jhc.2008.952176; Urase K, 2001, NEUROREPORT, V12, P3217, DOI 10.1097/00001756-200110290-00015; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wakayama T, 2001, MOL REPROD DEV, V60, P158, DOI 10.1002/mrd.1072; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Yageta M, 2002, CANCER RES, V62, P5129	46	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36667	36676		10.1074/jbc.M110.200535	http://dx.doi.org/10.1074/jbc.M110.200535			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880726	Green Published, hybrid			2022-12-27	WOS:000296538300049
J	Kjaersgaard, T; Jensen, MK; Christiansen, MW; Gregersen, P; Kragelund, BB; Skriver, K				Kjaersgaard, Trine; Jensen, Michael K.; Christiansen, Michael W.; Gregersen, Per; Kragelund, Birthe B.; Skriver, Karen			Senescence-associated Barley NAC (NAM, ATAF1,2, CUC) Transcription Factor Interacts with Radical-induced Cell Death 1 through a Disordered Regulatory Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; LEAF SENESCENCE; BINDING-SPECIFICITY; STRUCTURAL DISORDER; ACTIVATION DOMAINS; PROTEIN INTERACTS; FACTOR FAMILY; IDENTIFICATION; CONSERVATION; RCD1	Senescence in plants involves massive nutrient relocation and age-related cell death. Characterization of the molecular components, such as transcription factors (TFs), involved in these processes is required to understand senescence. We found that HvNAC005 and HvNAC013 of the plant-specific NAC (NAM, ATAF1,2, CUC) TF family are up-regulated during senescence in barley (Hordeum vulgare). Both HvNAC005 and HvNAC013 bound the conserved NAC DNA target sequence. Computational and biophysical analyses showed that both proteins are intrinsically disordered in their large C-terminal domains, which are transcription regulatory domains (TRDs) in many NAC TFs. Using motif searches and interaction studies in yeast we identified an evolutionarily conserved sequence, the LP motif, in the TRD of HvNAC013. This motif was sufficient for transcriptional activity. In contrast, HvNAC005 did not function as a transcriptional activator suggesting that an involvement of HvNAC013 and HvNAC005 in senescence will be different. HvNAC013 interacted with barley radical-induced cell death 1 (RCD1) via the very C-terminal part of its TRD, outside of the region containing the LP motif. No significant secondary structure was induced in the HvNAC013 TRD upon interaction with RCD1. RCD1 also interacted with regions dominated by intrinsic disorder in TFs of the MYB and basic helix-loop-helix families. We propose that RCD1 is a regulatory protein capable of interacting with many different TFs by exploiting their intrinsic disorder. In addition, we present the first structural characterization of NAC C-terminal domains and relate intrinsic disorder and sequence motifs to activity and protein-protein interactions.	[Kjaersgaard, Trine; Jensen, Michael K.; Kragelund, Birthe B.; Skriver, Karen] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Christiansen, Michael W.; Gregersen, Per] Univ Aarhus, Res Ctr Flakkebjerg, Dept Genet & Biotechnol, DK-4200 Slagelse, Denmark	University of Copenhagen; Aarhus University	Skriver, K (corresponding author), Univ Copenhagen, Dept Biol, Ole Maaloesvej 5, DK-2200 Copenhagen, Denmark.	KSkriver@bio.ku.dk	Gregersen, Per/P-8896-2019; Skriver, Karen/K-9860-2014; Kragelund, Birthe/M-3927-2014; Gregersen, Per L/R-1950-2018	Gregersen, Per/0000-0001-8243-0976; Skriver, Karen/0000-0003-2225-4012; Kragelund, Birthe/0000-0002-7454-1761; Gregersen, Per L/0000-0001-8243-0976; Jensen, Michael Krogh/0000-0001-7574-4707	Danish Agency for Science [274-07-0173]; Villum Kann Rasmussen Foundation	Danish Agency for Science; Villum Kann Rasmussen Foundation(Villum Fonden)	This work was supported by Danish Agency for Science Grant 274-07-0173 (to K. S. and P. G.) and the Villum Kann Rasmussen Foundation (to M. K. J.).	Balazadeh S, 2011, MOL PLANT, V4, P346, DOI 10.1093/mp/ssq080; Choi Y, 2000, J BIOL CHEM, V275, P15912, DOI 10.1074/jbc.275.21.15912; Christiansen Michael W, 2011, BMC Res Notes, V4, P302, DOI 10.1186/1756-0500-4-302; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ernst HA, 2004, EMBO REP, V5, P297, DOI 10.1038/sj.embor.7400093; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Garza AS, 2009, LIFE SCI, V84, P189, DOI 10.1016/j.lfs.2008.12.002; Gregersen PL, 2008, PLANT BIOLOGY, V10, P37, DOI 10.1111/j.1438-8677.2008.00114.x; Greve K, 2003, BIOCHEM J, V371, P97, DOI 10.1042/BJ20021123; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Jaspers P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-170; Jaspers P, 2009, PLANT J, V60, P268, DOI 10.1111/j.1365-313X.2009.03951.x; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18816, DOI 10.1073/pnas.0604711103; Kim HS, 2007, J BIOL CHEM, V282, P36292, DOI 10.1074/jbc.M705217200; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Ko JH, 2007, PLANT J, V50, P1035, DOI 10.1111/j.1365-313X.2007.03109.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEHRMAN SR, 1990, BIOCHEMISTRY-US, V29, P5590, DOI 10.1021/bi00475a025; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; Lin B, 2001, J GEN VIROL, V82, P1245, DOI 10.1099/0022-1317-82-5-1245; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; MORRISET.JD, 1973, BIOCHEMISTRY-US, V12, P1290, DOI 10.1021/bi00731a008; Nestoras K, 2010, GENE DEV, V24, P1145, DOI 10.1101/gad.561910; Oh SA, 1997, PLANT J, V12, P527, DOI 10.1046/j.1365-313X.1997.00527.x; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Olsen AN, 2005, PLANT SCI, V169, P785, DOI 10.1016/j.plantsci.2005.05.035; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Overmyer K, 2000, PLANT CELL, V12, P1849, DOI 10.1105/tpc.12.10.1849; Radivojac Predrag, 2003, Pac Symp Biocomput, P216; Selth LA, 2005, PLANT CELL, V17, P311, DOI 10.1105/tpc.104.027235; Seo PJ, 2010, PLANT J, V61, P661, DOI 10.1111/j.1365-313X.2009.04091.x; Sigalov AB, 2007, BIOCHIMIE, V89, P419, DOI 10.1016/j.biochi.2006.11.003; Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281; Smyczynski C, 2006, J BIOL CHEM, V281, P25475, DOI 10.1074/jbc.M601815200; Sperotto RA, 2009, PLANTA, V230, P985, DOI 10.1007/s00425-009-1000-9; Teotia S, 2011, J EXP BOT, V62, P1271, DOI 10.1093/jxb/erq363; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yamaguchi M, 2010, PLANT CELL, V22, P1249, DOI 10.1105/tpc.108.064048; Yoon HK, 2008, MOL CELLS, V25, P438; Zhong RQ, 2010, TRENDS PLANT SCI, V15, P625, DOI 10.1016/j.tplants.2010.08.007	53	65	77	3	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35418	35429		10.1074/jbc.M111.247221	http://dx.doi.org/10.1074/jbc.M111.247221			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21856750	Green Published, hybrid			2022-12-27	WOS:000295927100013
J	Seok, HY; Tatsuguchi, M; Callis, TE; He, AB; Pu, WT; Wang, DZ				Seok, Hee Young; Tatsuguchi, Mariko; Callis, Thomas E.; He, Aibin; Pu, William T.; Wang, Da-Zhi			miR-155 Inhibits Expression of the MEF2A Protein to Repress Skeletal Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; REGULATORY NETWORKS; GENE-EXPRESSION; MICE LACKING; MICRORNAS; MYOD; CELLS; HEART; PROLIFERATION; DEACETYLASES	microRNAs (miRNAs) are 21-23-nucleotide non-coding RNAs. It has become more and more evident that this class of small RNAs plays critical roles in the regulation of gene expression at the post-transcriptional level. MEF2A is a member of the MEF2 (myogenic enhancer factor 2) family of transcription factors. Prior report showed that the 3'-untranslated region (3'-UTR) of the Mef2A gene mediated its repression; however, the molecular mechanism underlying this intriguing observation was unknown. Here, we report that MEF2A is repressed by miRNAs. We identify miR-155 as one of the primary miRNAs that significantly represses the expression of MEF2A. We show that knockdown of the Mef2A gene by siRNA impairs myoblast differentiation. Similarly, overexpression of miR-155 leads to the repression of endogenous MEF2A expression and the inhibition of myoblast differentiation. Most importantly, reintroduction of MEF2A in miR-155 overexpressed myoblasts was able to partially rescue the miR-155-induced myoblast differentiation defect. Our data therefore establish miR-155 as an important regulator of MEF2A expression and uncover its function in muscle gene expression and myogenic differentiation.	[Seok, Hee Young; Tatsuguchi, Mariko; He, Aibin; Pu, William T.; Wang, Da-Zhi] Harvard Univ, Sch Med, Dept Cardiol, Childrens Hosp Boston, Boston, MA 02115 USA; [Seok, Hee Young; Callis, Thomas E.; Wang, Da-Zhi] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill	Wang, DZ (corresponding author), Harvard Univ, Sch Med, Dept Cardiol, Childrens Hosp Boston, Boston, MA 02115 USA.	dwang@enders.tch.harvard.edu	seok, heeyoung/ABC-3957-2020; He, Aibin/AAI-1639-2019; Pu, William/AAJ-8301-2020	He, Aibin/0000-0002-3489-2305; Pu, William/0000-0002-4551-8079	National Institutes of Health; March of Dimes Foundation; Muscular Dystrophy Association; Wang laboratory	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); Muscular Dystrophy Association(Muscular Dystrophy Association); Wang laboratory	This work was supported, in whole or in part, by National Institutes of Health. This work was also supported by the March of Dimes Foundation and Muscular Dystrophy Association.; We thank members of the Wang laboratory for discussion and support. We are grateful to Dr. John McDermott (York University) for generous gift of anti-MEF2A antibody and to Dr. Isidore Rigoutsos (Thomas Jefferson University) for the initial analyses of miRNAs that target MEF2A. We thank Dr. Francisco Naya (Boston University) for sharing unpublished results and reagents.	Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Black BL, 1997, MOL CELL BIOL, V17, P2756, DOI 10.1128/MCB.17.5.2756; Callis TE, 2008, EXP BIOL MED, V233, P131, DOI 10.3181/0709-MR-237; Callis TE, 2008, TRENDS MOL MED, V14, P254, DOI 10.1016/j.molmed.2008.03.006; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Chen JF, 2009, J CELL SCI, V122, P13, DOI 10.1242/jcs.041723; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	39	73	86	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35339	35346		10.1074/jbc.M111.273276	http://dx.doi.org/10.1074/jbc.M111.273276			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21868385	Green Published, hybrid			2022-12-27	WOS:000295927100005
J	Chrzanowska-Lightowlers, ZMA; Pajak, A; Lightowlers, RN				Chrzanowska-Lightowlers, Zofia M. A.; Pajak, Aleksandra; Lightowlers, Robert N.			Termination of Protein Synthesis in Mammalian Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							STOP CODON RECOGNITION; RIBOSOMAL-RNA IMPORT; RELEASE FACTORS RF1; TRANSLATION TERMINATION; CRYSTAL-STRUCTURE; GENETIC-CODE; FACTOR ERF1; MESSENGER-RNA; MECHANISM; SEQUENCE	All mechanisms of protein synthesis can be considered in four stages: initiation, elongation, termination, and ribosome recycling. Remarkable progress has been made in understanding how these processes are mediated in the cytosol of many species; however, details of organellar protein synthesis remain sketchy. This is an important omission, as defects in human mitochondrial translation are known to cause disease and may contribute to the aging process itself. In this minireview, we focus on the recent advances that have been made in understanding how one of these processes, translation termination, occurs in the human mitochondrion.	[Chrzanowska-Lightowlers, Zofia M. A.; Pajak, Aleksandra; Lightowlers, Robert N.] Newcastle Univ, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Chrzanowska-Lightowlers, ZMA (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Inst Ageing & Hlth, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	z.chrzanowska-lightowlers@ncl.ac.uk		Pajak, Aleksandra/0000-0001-8294-9620; Chrzanowska-Lightowlers, Zofia/0000-0002-0045-3152	Biotechnology and Biological Sciences Research Council [BB/F011520/1] Funding Source: Medline; BBSRC [BB/F011520/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004; Askarian-Amiri ME, 2000, J BIOL CHEM, V275, P17241, DOI 10.1074/jbc.M910448199; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Bongiorni L, 2005, PROTIST, V156, P303, DOI 10.1016/j.protis.2005.05.001; BOORE JL, 1995, GENETICS, V141, P305; Bulygin KN, 2002, FEBS LETT, V514, P96, DOI 10.1016/S0014-5793(02)02304-9; Chavatte L, 2002, EMBO J, V21, P5302, DOI 10.1093/emboj/cdf484; CHI JCH, 1970, J MOL BIOL, V53, P531, DOI 10.1016/0022-2836(70)90082-3; Coucheron DH, 2011, CURR GENET, V57, P213, DOI 10.1007/s00294-011-0338-2; DELACRUZ VF, 1984, J BIOL CHEM, V259, P5136; Dontsova M, 2000, FEBS LETT, V472, P213, DOI 10.1016/S0014-5793(00)01466-6; Frolova L, 2002, RNA, V8, P129, DOI 10.1017/S1355838202013262; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; HayashiIshimaru Y, 1996, CURR GENET, V30, P29, DOI 10.1007/s002940050096; Ito K, 2002, P NATL ACAD SCI USA, V99, P8494, DOI 10.1073/pnas.142690099; Ivanov V, 2001, RNA, V7, P1683; Jacob Joachim E M, 2009, BMC Res Notes, V2, P192, DOI 10.1186/1756-0500-2-192; JOHANSEN S, 1990, NUCLEIC ACIDS RES, V18, P411, DOI 10.1093/nar/18.3.411; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Knight RD, 2001, J MOL EVOL, V53, P299, DOI 10.1007/s002390010220; Koc EC, 2010, ISR J CHEM, V50, P45, DOI 10.1002/ijch.201000002; Kolosov P, 2005, NUCLEIC ACIDS RES, V33, P6418, DOI 10.1093/nar/gki927; Korostelev A, 2008, CURR OPIN CHEM BIOL, V12, P674, DOI 10.1016/j.cbpa.2008.08.037; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Korostelev AA, 2011, RNA, V17, P1409, DOI 10.1261/rna.2733411; KUNTZEL H, 1967, NATURE, V215, P1340, DOI 10.1038/2151340a0; Laforest MJ, 1997, NUCLEIC ACIDS RES, V25, P626, DOI 10.1093/nar/25.3.626; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Massey SE, 2007, J MOL EVOL, V64, P399, DOI 10.1007/s00239-005-0260-7; Nakamura Y, 1996, CELL, V87, P147, DOI 10.1016/S0092-8674(00)81331-8; Nakao M, 2000, MOL BIOCHEM PARASIT, V111, P415, DOI 10.1016/S0166-6851(00)00334-0; Nedelcu AM, 2000, GENOME RES, V10, P819, DOI 10.1101/gr.10.6.819; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Nozaki Y, 2008, GENES CELLS, V13, P429, DOI 10.1111/j.1365-2443.2008.01181.x; OBRIEN TW, 1971, J BIOL CHEM, V246, P3409; OBRIEN TW, 1967, J BIOL CHEM, V242, P2180; Oparina NJ, 2005, NUCLEIC ACIDS RES, V33, P5226, DOI 10.1093/nar/gki841; OSAWA S, 1989, J MOL EVOL, V29, P202, DOI 10.1007/BF02100203; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Richter R, 2010, EMBO J, V29, P1116, DOI 10.1038/emboj.2010.14; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Scarlett DJG, 2003, J BIOL CHEM, V278, P15095, DOI 10.1074/jbc.M211024200; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Seit-Nebi A, 2002, EMBO REP, V3, P881, DOI 10.1093/embo-reports/kvf178; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711; Smirnov A, 2010, J BIOL CHEM, V285, P30792, DOI 10.1074/jbc.M110.151183; Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; SWANSON RF, 1970, P NATL ACAD SCI USA, V66, P117, DOI 10.1073/pnas.66.1.117; Tate WP, 1996, PROG NUCLEIC ACID RE, V52, P293, DOI 10.1016/S0079-6603(08)60970-8; Telford MJ, 2000, P NATL ACAD SCI USA, V97, P11359, DOI 10.1073/pnas.97.21.11359; Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674; VIGNAIS PV, 1972, J CELL BIOL, V54, P468, DOI 10.1083/jcb.54.3.468; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Young DJ, 2010, RNA, V16, P1146, DOI 10.1261/rna.1970310; Zhang YL, 1998, BBA-GENE STRUCT EXPR, V1443, P245, DOI 10.1016/S0167-4781(98)00223-1	59	29	31	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34479	34485		10.1074/jbc.R111.290585	http://dx.doi.org/10.1074/jbc.R111.290585			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21873426	Green Published, hybrid			2022-12-27	WOS:000295406300001
J	Ren, HG; Fu, K; Wang, D; Mu, CC; Wang, GH				Ren, Haigang; Fu, Kai; Wang, Dan; Mu, Chenchen; Wang, Guanghui			Oxidized DJ-1 Interacts with the Mitochondrial Protein BCL-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED PROTEIN; CYSTEINE-SULFINIC ACID; NEURONAL CELL-DEATH; PARKINSONS-DISEASE; OXIDATIVE STRESS; CANCER-CELLS; APOPTOSIS; BAX; LOCALIZATION; INHIBITION	Parkinson disease (PD)- and cancer-associated protein, DJ-1, mediates cellular protection via many signaling pathways. Deletions or mutations in the DJ-1 gene are directly linked to autosomal recessive early-onset PD. DJ-1 has potential roles in mitochondria. Here, we show that DJ-1 increases its mitochondrial distribution in response to ultraviolet B (UVB) irradiation and binds to Bcl-X-L. The interactions between DJ-1 and Bcl-X-L are oxidation-dependent. DJ-1(C106A), a mutant form of DJ-1 that is unable to be oxidized, binds Bcl-X-L much less than DJ-1 does. Moreover, DJ-1 stabilizes Bcl-X-L protein level by inhibiting its ubiquitination and degradation through ubiquitin proteasome system (UPS) in response to UVB irradiation. Furthermore, under UVB irradiation, knockdown of DJ-1 leads to increases of Bcl-X-L ubiquitination and degradation upon UVB irradiation, thereby increasing mitochondrial Bax, caspase-3 activation and PARP cleavage. These data suggest that DJ-1 protects cells against UVB-induced cell death dependent on its oxidation and its association with mitochondrial Bcl-X-L.	[Fu, Kai; Mu, Chenchen; Wang, Guanghui] Univ Sci & Technol China, Lab Mol Neuropathol, Sch Life Sci,Chinese Acad Sci, Key Lab Brain Funct & Dis, Hefei 230027, Anhui, Peoples R China; [Ren, Haigang; Wang, Dan] SW Univ Sci & Technol, Sch Life Sci & Engn, Mianyang 621010, Sichuan, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Southwest University of Science & Technology - China	Wang, GH (corresponding author), Univ Sci & Technol China, Lab Mol Neuropathol, Sch Life Sci,Chinese Acad Sci, Key Lab Brain Funct & Dis, 443 Huangshan Rd, Hefei 230027, Anhui, Peoples R China.	wghui@ustc.edu.cn	Ren, Haigang/U-6034-2017; Wang, Guanghui/U-3979-2017	Ren, Haigang/0000-0001-8844-4754; Wang, Guanghui/0000-0001-8551-6468	National Natural Sciences Foundation of China [30970921]; National High-tech Research and Development program of China [2011CB5004102]; Chinese Academy of Sciences [KSCX2-YW-R138]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech Research and Development program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by the National Natural Sciences Foundation of China (No. 30970921), the National High-tech Research and Development program of China 973-Projects (2011CB5004102) and the Chinese Academy of Sciences Knowledge Innovation Project (KSCX2-YW-R138).	Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Blackinton J, 2005, MOL BRAIN RES, V134, P76, DOI 10.1016/j.molbrainres.2004.09.004; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Burlacu A, 2003, J CELL MOL MED, V7, P249, DOI 10.1111/j.1582-4934.2003.tb00225.x; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2010, MOVEMENT DISORD, V25, pS44, DOI 10.1002/mds.22713; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; da Costa CA, 2007, CURR MOL MED, V7, P650, DOI 10.2174/156652407782564426; Davidson B, 2008, HUM PATHOL, V39, P87, DOI 10.1016/j.humpath.2007.05.014; Dietz G. P., 2008, J NEUROCHEM, V104, P757; Ethell DW, 2009, ANTIOXID REDOX SIGN, V11, P529, DOI [10.1089/ars.2008.2228, 10.1089/ARS.2008.2228]; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Feng Y, 2009, ARCH BIOCHEM BIOPHYS, V484, P46, DOI 10.1016/j.abb.2009.01.003; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Hedrich K, 2004, NEUROLOGY, V62, P389, DOI 10.1212/01.WNL.0000113022.51739.88; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Hod Y, 2004, J CELL BIOCHEM, V92, P1221, DOI 10.1002/jcb.20159; Hong Z, 2006, INT J ONCOL, V28, P661; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kanli A., 2007, Experimental Oncology, V29, P314; Lev N, 2006, J MOL NEUROSCI, V29, P215, DOI 10.1385/JMN:29:3:215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacKeigan JP, 2003, CANCER RES, V63, P6928; Mccoy MK, 2011, AUTOPHAGY, V7, P531, DOI 10.4161/auto.7.5.14684; Mo JS, 2008, CELL DEATH DIFFER, V15, P1030, DOI 10.1038/cdd.2008.26; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Park K, 2009, ONCOL REP, V21, P689, DOI 10.3892/or_00000272; Ren HG, 2010, CANCER LETT, V297, P101, DOI 10.1016/j.canlet.2010.05.001; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Savitt JM, 2005, J NEUROSCI, V25, P6721, DOI 10.1523/JNEUROSCI.0760-05.2005; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Vila M, 2001, P NATL ACAD SCI USA, V98, P2837, DOI 10.1073/pnas.051633998; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Ziv I, 1997, APOPTOSIS, V2, P149, DOI 10.1023/A:1026408313758	56	62	65	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35308	35317		10.1074/jbc.M110.207134	http://dx.doi.org/10.1074/jbc.M110.207134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21852238	Green Published, hybrid			2022-12-27	WOS:000295406300084
J	Gulshan, K; Lee, SS; Moye-Rowley, WS				Gulshan, Kailash; Lee, Stella S.; Moye-Rowley, W. Scott			Differential Oxidant Tolerance Determined by the Key Transcription Factor Yap1 Is Controlled by Levels of the Yap1-binding Protein, Ybp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-STRESS; SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT; CANDIDA-GLABRATA; DRUG-RESISTANCE; YEAST-CELLS; H2O2; ACTIVATION; LOCALIZATION; EXPRESSION	The Saccharomyces cerevisiae transcription factor Yap1 is a central determinant of oxidative stress tolerance. This protein is found primarily in the cytoplasm in the absence of oxidative stress but, upon exposure to oxidants, rapidly translocates to the nucleus and activates expression of target genes. Although both diamide and H2O2 have been used to impose oxidative stress on cells, these different oxidants trigger Yap1 nuclear localization in distinctly different ways. Diamide appears to oxidize particular cysteine residues on Yap1, leading to inhibition of association of Yap1 with the nuclear exportin Crm1. Crm1 would normally transport Yap1 out of the nucleus. H2O2 activation of Yap1 nuclear localization requires the participation of the glutathione peroxidase Gpx3 and the Yap1-binding protein Ybp1. H2O2 exposure triggers formation of a dual disulfide bonded Yap1 that is catalyzed by the presence of Gpx3 and Ybp1. In the current study, we have determined that two distinct pools of Yap1 exist in the cell. These pools are designated by the level of Ybp1. Ybp1 interacts directly with Yap1 and these proteins form a stable complex in vivo. Genetic and biochemical experiments indicate that Ybp1 is rate-limiting for Yap1 oxidative folding during H2O2 stress. The fungal pathogen Candida glabrata expresses a protein homologous to Ybp1 called CgYbp1. Overproduction of CgYbp1 elevated H2O2 tolerance in this pathogen indicating that the determinative role of Ybp1 in setting the level of H2O2 resistance has been evolutionarily conserved.	[Gulshan, Kailash; Moye-Rowley, W. Scott] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA; [Lee, Stella S.] Univ Iowa, Program Mol Biol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Moye-Rowley, WS (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, 6-530 Bowen Sci Bldg, Iowa City, IA 52242 USA.	scott-moye-rowley@uiowa.edu	Moye-Rowley, Scott/AFL-7135-2022	Moye-Rowley, Scott/0000-0002-7163-1120; Lee, Stella/0000-0002-2629-2422	National Institutes of Health [GM49825]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM49825.	BOSSIER P, 1993, J BIOL CHEM, V268, P23640; Chen KH, 2007, GENE, V386, P63, DOI 10.1016/j.gene.2006.08.010; Coleman ST, 1999, MOL CELL BIOL, V19, P8302; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Gulshan K, 2005, J BIOL CHEM, V280, P40524, DOI 10.1074/jbc.M504716200; Gulshan K, 2004, EUKARYOT CELL, V3, P318, DOI 10.1128/EC.3.2.318-330.2004; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Iles KE, 2002, IMMUNOL RES, V26, P95, DOI 10.1385/IR:26:1-3:095; Isoyama T, 2001, J BIOL CHEM, V276, P21863, DOI 10.1074/jbc.M009258200; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kuge S, 1998, GENES CELLS, V3, P521, DOI 10.1046/j.1365-2443.1998.00209.x; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; LEPPERT G, 1990, GENETICS, V125, P13; Moye-Rowley WS, 2003, EUKARYOT CELL, V2, P381, DOI 10.1128/EC.2.3.381-389.2003; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Ohkuni K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001617; Okazaki S, 2007, MOL CELL, V27, P675, DOI 10.1016/j.molcel.2007.06.035; Rodrigues-Pousada C, 2010, YEAST, V27, P245, DOI 10.1002/yea.1752; Takeuchi T, 1997, FEBS LETT, V416, P339, DOI 10.1016/S0014-5793(97)01233-7; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Ueno K, 2007, EUKARYOT CELL, V6, P1239, DOI 10.1128/EC.00414-06; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; Wemmie JA, 1997, J BIOL CHEM, V272, P7908, DOI 10.1074/jbc.272.12.7908; Wood MJ, 2004, NATURE, V430, P917, DOI 10.1038/nature02790; WU AL, 1993, J BIOL CHEM, V268, P18850; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416	32	33	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34071	34081		10.1074/jbc.M111.251298	http://dx.doi.org/10.1074/jbc.M111.251298			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21844193	Green Published, hybrid			2022-12-27	WOS:000295159200039
J	Tong, M; Arora, K; White, MM; Nichols, RA				Tong, Mei; Arora, Komal; White, Michael M.; Nichols, Robert A.			Role of Key Aromatic Residues in the Ligand-binding Domain of alpha 7 Nicotinic Receptors in the Agonist Action of beta-Amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIOMA HYBRID-CELLS; ALZHEIMERS-DISEASE; ACETYLCHOLINE-RECEPTOR; NEUROBLASTOMA-CELLS; SYNAPTIC PLASTICITY; IN-VIVO; EXTRACELLULAR DOMAIN; HIPPOCAMPAL SLICE; CRYSTAL-STRUCTURE; ENDOGENOUS TAU	Soluble beta-amyloid (A beta) resides in certain regions of the brain at or near picomolar concentration, rising in level during the prodromic stage of Alzheimer disease. Recently, we identified the homomeric alpha 7 nicotinic acetylcholine receptor (alpha 7-nAChR) as one possible functional target for picomolar A beta. This study was aimed at addressing which residues in alpha 7-nAChRs potentially interact with A beta to regulate the presynaptic function of this receptor. Site-directed mutagenesis was carried out to study the key aromatic residues in the mouse alpha 7-nAChR agonist-binding pocket. Mutations of tyrosine188 resulted in a decrease in activation of presynaptic alpha 7-nAChRs by ACh and A beta but with no change in response to nicotine, indicating the critical role of Tyr-188 in presynaptic regulation by A beta. Coimmunoprecipitation additionally revealed direct binding of A beta to alpha 7-nAChRs and to the Tyr-188 mutant receptor. In contrast, mutations of Tyr-195 in alpha 7-nAChR led to decreased activation by nicotine without apparent effects on ACh- or A beta-induced responses. Agonist-induced responses of Tyr-93 mutant alpha 7-nAChRs indicated possible interactions of nicotine and A beta with its hydroxyl group, but there was no change in presynaptic responses after mutation of Trp-149. All of the mutants were shown to be expressed on the plasma membrane using cell surface labeling. Together, these results directly demonstrate an essential role for the aromatic residue Tyr-188 as a key component in the agonist binding domain for the activation of alpha 7-nAChRs by A beta	[Tong, Mei; Arora, Komal; Nichols, Robert A.] Univ Hawaii Manoa, Dept Cell & Mol Biol, Honolulu, HI 96813 USA; [Tong, Mei] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA; [White, Michael M.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA	University of Hawaii System; University of Hawaii Manoa; Drexel University; Drexel University	Nichols, RA (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, 651 Ilalo St, Honolulu, HI 96813 USA.	robert.nichols@hawaii.edu			American Health Assistance Foundation; The Hawaii Community Foundation; National Institute on Aging [AG21586]; National Center for Research Resources of the National Institutes of Health via Research Centers in Minority Institutions [G12 RR003061]; Centers of Biomedical Research Excellence [P20 RR016453]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR016453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021586] Funding Source: NIH RePORTER	American Health Assistance Foundation(BrightFocus Foundation); The Hawaii Community Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources of the National Institutes of Health via Research Centers in Minority Institutions; Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by grants from the American Health Assistance Foundation, The Hawaii Community Foundation, and the National Institute on Aging Grant AG21586. Support for the confocal microscopy core at the University of Hawaii was provided by the National Center for Research Resources of the National Institutes of Health via Research Centers in Minority Institutions Grant G12 RR003061 and Centers of Biomedical Research Excellence Grant P20 RR016453.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; AYLWIN ML, 1994, FEBS LETT, V349, P99, DOI 10.1016/0014-5793(94)00649-0; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Bell KA, 2004, J NEUROCHEM, V91, P349, DOI 10.1111/j.1471-4159.2004.02722.x; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Dougherty DA, 2001, NATURE, V411, P252, DOI 10.1038/35077192; Dougherty JJ, 2003, J NEUROSCI, V23, P6740; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; Gay EA, 2007, J PHYSIOL-LONDON, V584, P727, DOI 10.1113/jphysiol.2007.142554; Gee VJ, 2007, BRIT J PHARMACOL, V152, P501, DOI 10.1038/sj.bjp.0707429; Grandori R, 1997, PROTEIN ENG, V10, P1099, DOI 10.1093/protein/10.9.1099; HAN HQ, 1991, NATURE, V349, P697, DOI 10.1038/349697a0; Kenney JW, 2008, MOL NEUROBIOL, V38, P101, DOI 10.1007/s12035-008-8037-9; Khan GM, 2010, EUR J NEUROSCI, V31, P788, DOI 10.1111/j.1460-9568.2010.07116.x; Lazarov O, 2002, J NEUROSCI, V22, P9785; Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598; MCGEE R, 1978, P NATL ACAD SCI USA, V75, P1314, DOI 10.1073/pnas.75.3.1314; Mehta TK, 2009, J NEUROCHEM, V109, P1452, DOI 10.1111/j.1471-4159.2009.06070.x; NELSON P, 1976, P NATL ACAD SCI USA, V73, P123, DOI 10.1073/pnas.73.1.123; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; Pettit DL, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-01-j0003.2001; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Ronde P, 2001, NEUROSCIENCE, V102, P979, DOI 10.1016/S0306-4522(00)00512-1; Ronde P, 2000, J PHYSIOL-LONDON, V529, P307, DOI 10.1111/j.1469-7793.2000.00307.x; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Sheng JG, 2002, J NEUROSCI, V22, P9794; Small DH, 2007, J NEUROCHEM, V101, P1527, DOI 10.1111/j.1471-4159.2006.04444.x; Spier AD, 1999, MOL BRAIN RES, V67, P221; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HY, 2009, J NEUROSCI, V29, P10961, DOI 10.1523/JNEUROSCI.6088-08.2009; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x; Wu G, 1998, J NEUROCYTOL, V27, P1, DOI 10.1023/A:1006910001869; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	45	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34373	34381		10.1074/jbc.M111.241299	http://dx.doi.org/10.1074/jbc.M111.241299			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828053	Green Published, hybrid			2022-12-27	WOS:000295159200065
J	Hwang, HI; Ji, JH; Jang, YJ				Hwang, Hyo-In; Ji, Jae-Hoon; Jang, Young-Joo			Phosphorylation of Ran-binding Protein-1 by Polo-like Kinase-1 Is Required for Interaction with Ran and Early Mitotic Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; MAMMALIAN-CELLS; SPINDLE; MITOSIS; GTPASE; PLK1; AMPLIFICATION; CHROMOSOMES; CENTROSOME; DOMAIN	Polo-like kinase-1 (Plk1) is essential for progression of mitosis and localizes to centrosomes, central spindles, midbody, and kinetochore. Ran, a small GTPase of the Ras superfamily, plays a role in microtubule dynamics and chromosome segregation during mitosis. Although Ran-binding protein-1 (RanBP1) has been reported as a regulator of RanGTPase for its mitotic functions, the action mechanism between Ran and RanBP1 during mitosis is still unknown. Here, we demonstrated in vitro and in vivo phosphorylation of RanBP1 by Plk1 as well as the importance of phosphorylation of RanBP1 in the interaction between Plk1 and Ran during early mitosis. Both phosphorylation-defective and N-terminal deletion mutant constructs of RanBP1 disrupted the interaction with Ran, and depletion of Plk1 also disrupted the formation of a complex between Ran and RanBP1. In addition, the results from both ectopic expression of phosphorylation-defective mutant construct and a functional complementation on RanBP1 deficiency with this mutant indicated that phosphorylation of RanBP1 by Plk1 might be crucial to microtubule nucleation and spindle assembly during mitosis.	[Jang, Young-Joo] Dankook Univ, Lab Cell Cycle & Signal Transduct, World Class Univ Res Dept Nanobiomed Sci, Cheonan 330714, South Korea; Dankook Univ, Inst Tissue Regenerat Engn, Cheonan 330714, South Korea	Dankook University; Dankook University	Jang, YJ (corresponding author), Dankook Univ, Lab Cell Cycle & Signal Transduct, World Class Univ Res Dept Nanobiomed Sci, 29 Anseo Dong, Cheonan 330714, South Korea.	jameschi@paran.com; yjjang@dankook.ac.kr			National Research Foundation of Korea [R31-10069]; Ministry of Education, Science, and Technology [2009-0093829]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea Grant R31-10069 (World Class University program) and Grant 2009-0093829 (Priority Research Centers Program) funded by the Ministry of Education, Science, and Technology.	Abrieu A, 1998, J CELL SCI, V111, P1751; Arnaoutov A, 2005, CELL CYCLE, V4, P1161, DOI 10.4161/cc.4.9.1979; Arnaoutov A, 2003, DEV CELL, V5, P99, DOI 10.1016/S1534-5807(03)00194-1; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bin OY, 1997, J BIOL CHEM, V272, P28646, DOI 10.1074/jbc.272.45.28646; BISCHOFF FR, 1995, P NATL ACAD SCI USA, V92, P1749, DOI 10.1073/pnas.92.5.1749; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Dasso M, 2002, CURR BIOL, V12, pR502, DOI 10.1016/S0960-9822(02)00970-3; Di Fiore B, 2003, J CELL SCI, V116, P3399, DOI 10.1242/jcs.00624; DIMATTEO G, 1995, CELL GROWTH DIFFER, V6, P1213; Donaldson MM, 2001, J CELL SCI, V114, P2357; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Guarguaglini G, 2000, CELL GROWTH DIFFER, V11, P455; Hutchins JRA, 2004, CURR BIOL, V14, P1099, DOI 10.1016/j.cub.2004.05.021; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Ji JH, 2006, J BIOCHEM MOL BIOL, V39, P709; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Karaiskou A, 1999, J CELL SCI, V112, P3747; Keryer G, 2003, MOL BIOL CELL, V14, P4260, DOI 10.1091/mbc.E02-11-0773; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lane HA, 1997, TRENDS CELL BIOL, V7, P63, DOI 10.1016/S0962-8924(96)10051-9; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Li HY, 2007, CELL CYCLE, V6, P1886, DOI 10.4161/cc.6.15.4487; Li HY, 2004, GENE DEV, V18, P512, DOI 10.1101/gad.1177304; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Moore WJ, 2002, CURR BIOL, V12, P1442, DOI 10.1016/S0960-9822(02)01076-X; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Peloponese JM, 2005, P NATL ACAD SCI USA, V102, P18974, DOI 10.1073/pnas.0506659103; Qian YW, 1998, MOL CELL BIOL, V18, P4262, DOI 10.1128/MCB.18.7.4262; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; SUNKEL CE, 1988, J CELL SCI, V89, P25; Swaminathan S, 2004, J CELL BIOL, V164, P965, DOI 10.1083/jcb.200309126; Tedeschi A, 2007, J CELL SCI, V120, P3748, DOI 10.1242/jcs.009308; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; Uchiumi T, 1997, J BIOL CHEM, V272, P9166; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024	44	6	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33012	33020		10.1074/jbc.M111.255620	http://dx.doi.org/10.1074/jbc.M111.255620			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813642	Green Published, hybrid			2022-12-27	WOS:000294968800019
J	Shibayama, N; Sugiyama, K; Park, SY				Shibayama, Naoya; Sugiyama, Kanako; Park, Sam-Yong			Structures and Oxygen Affinities of Crystalline Human Hemoglobin C (beta 6 Glu -> Lys) in the R and R2 Quaternary Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CARBONMONOXY-HEMOGLOBIN; ALLOSTERIC REGULATION; X-RAY; BINDING; STATE; DEOXYHEMOGLOBIN; METHEMOGLOBIN; CONSTANTS; SUBUNITS; MUTATION	Recent crystallographic studies suggested that fully liganded human hemoglobin can adopt multiple quaternary conformations that include the two previously solved relaxed conformations, R and R2, whereas fully unliganded deoxyhemoglobin may adopt only one T (tense) quaternary conformation. An important unanswered question is whether R, R2, and other relaxed quaternary conformations represent different physiological states with different oxygen affinities. Here, we answer this question by showing the oxygen equilibrium curves of single crystals of human hemoglobin in the R and R2 state. In this study, we have used a naturally occurring mutant hemoglobin C (beta 6 Glu -> Lys) to stabilize the R and R2 crystals. Additionally, we have refined the x-ray crystal structure of carbonmonoxyhemoglobin C, in the R and R2 state, to 1.4 and 1.8 angstrom resolution, respectively, to compare precisely the structures of both types of relaxed states. Despite the large quaternary structural difference between the R and R2 state, both crystals exhibit similar noncooperative oxygen equilibrium curves with a very high affinity for oxygen, comparable with the fourth oxygen equilibrium constant (K-4) of human hemoglobin in solution. One small difference is that the R2 crystals have an oxygen affinity that is 2-3 times higher than that of the R crystals. These results demonstrate that the functional difference between the two typical relaxed quaternary conformations is small and physiologically less important, indicating that these relaxed conformations simply reflect a structural polymorphism of a high affinity relaxed state.	[Shibayama, Naoya] Jichi Med Univ, Dept Physiol, Div Biophys, Shimotsuke, Tochigi 3290498, Japan; [Sugiyama, Kanako; Park, Sam-Yong] Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 2300045, Japan	Jichi Medical University; Yokohama City University	Shibayama, N (corresponding author), Jichi Med Univ, Dept Physiol, Div Biophys, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	shibayam@jichi.ac.jp		Shibayama, Naoya/0000-0002-2208-1126	Japan Society for the Promotion of Science [23570197]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was in part supported by Grant-in-aid for Scientific Research 23570197 from the Japan Society for the Promotion of Science (to N. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BALDWIN JM, 1980, J MOL BIOL, V136, P103, DOI 10.1016/0022-2836(80)90308-3; Birukou I, 2011, J BIOL CHEM, V286, P10515, DOI 10.1074/jbc.M110.176271; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Biswal BK, 2001, CURR SCI INDIA, V81, P1100; COLOMBO MF, 1992, SCIENCE, V256, P655, DOI 10.1126/science.1585178; Dewan JC, 2002, ACTA CRYSTALLOGR D, V58, P2038, DOI 10.1107/S0907444902016426; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERMI G, 1984, J MOL BIOL, V175, P159, DOI 10.1016/0022-2836(84)90472-8; FITZGERALD PMD, 1979, J MOL BIOL, V132, P603; Harrington DJ, 1997, J MOL BIOL, V272, P398, DOI 10.1006/jmbi.1997.1253; IMAI K, 1975, J BIOL CHEM, V250, P2227; Imai K., 1982, ALLOSTRIC EFFECTS HA; Jenkins JD, 2009, ACTA CRYSTALLOGR D, V65, P41, DOI 10.1107/S0907444908037256; KAVANAUGH JS, 1992, BIOCHEMISTRY-US, V31, P4111, DOI 10.1021/bi00131a030; LADNER RC, 1977, J MOL BIOL, V114, P385, DOI 10.1016/0022-2836(77)90256-X; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lukin JA, 2003, P NATL ACAD SCI USA, V100, P517, DOI 10.1073/pnas.232715799; MIMS MP, 1983, J BIOL CHEM, V258, P4219; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MOZZARELLI A, 1991, NATURE, V351, P416, DOI 10.1038/351416a0; Mueser TC, 2000, BIOCHEMISTRY-US, V39, P15353, DOI 10.1021/bi0012944; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Park SY, 2004, BIOCHEMISTRY-US, V43, P8711, DOI 10.1021/bi049932w; Patskovska LN, 2005, ACTA CRYSTALLOGR D, V61, P566, DOI 10.1107/S0907444905004622; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; RIVETTI C, 1993, BIOCHEMISTRY-US, V32, P2888, DOI 10.1021/bi00062a021; Safo MK, 2011, BBA-PROTEINS PROTEOM, V1814, P797, DOI 10.1016/j.bbapap.2011.02.013; Safo MK, 2005, BIOCHEMISTRY-US, V44, P8347, DOI 10.1021/bi050412q; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; Shibayama N., 2011, HEMOGLOBIN RECENT DE, P138; SILVA MM, 1992, J BIOL CHEM, V267, P17248; SMITH FR, 1991, PROTEINS, V10, P81, DOI 10.1002/prot.340100202; SRINIVASAN R, 1994, P NATL ACAD SCI USA, V91, P11113, DOI 10.1073/pnas.91.23.11113; Unzai S, 1996, J BIOL CHEM, V271, P12451, DOI 10.1074/jbc.271.21.12451; Unzai S, 1998, J BIOL CHEM, V273, P23150, DOI 10.1074/jbc.273.36.23150; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409	39	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33661	33668		10.1074/jbc.M111.266056	http://dx.doi.org/10.1074/jbc.M111.266056			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21816820	Green Published, hybrid			2022-12-27	WOS:000294968800082
J	Tang, WJ; Li, Y; Osimiri, L; Zhang, C				Tang, Wanjin; Li, Yang; Osimiri, Lindsey; Zhang, Chi			Osteoblast-specific Transcription Factor Osterix (Osx) Is an Upstream Regulator of Satb2 during Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED TRANSCRIPTION; DIFFERENTIATION; EXPRESSION; PROTEIN; GENE; GROWTH; CANCER; OSTEOPOROSIS; TARGET	Osterix (Osx) is an osteoblast-specific transcription factor essential for osteoblast differentiation and bone formation. Osx knock-out mice lack bone completely. Satb2 is critical for osteoblast differentiation as a special AT-rich binding transcription factor. It is not known how Satb2 is transcriptionally regulated during bone formation. In this study, quantitative real-time RTPCR results demonstrated that Satb2 was down-regulated in Osx-null calvaria. In stable C2C12 mesenchymal cells using the tetracycline (Tet)-Off system, overexpression of Osx stimulated Satb2 expression. Moreover, inhibition of Osx by siRNA led to repression of Satb2 expression in osteoblasts. These results suggest that Osx controls Satb2 expression. Transient transfection assay showed that Osx activated 1kb Satb2 promoter reporter activity in a dose-dependent manner. To define the region of Satb2 promoter responsive to Osx activation, a series of deletion mutants of Satb2 constructs were made, and the minimal region was narrowed down to the proximal 130 bp of the Satb2 promoter. Further point mutation studies found that two GC-rich region mutations disrupted the Satb2 130bp promoter activation by Osx, suggesting that these GC-rich binding sites were responsible for Satb2 activation by Osx. Gel shift assay showed that Osx bound to the Satb2 promoter sequence directly. ChIP assays indicated that endogenous Osx associated with the native Satb2 promoter in osteoblasts. Importantly, Satb2 siRNA significantly inhibited Osx-induced osteoblast marker gene expressions. Taken together, our findings indicate that Osx is an upstream regulator of Satb2 during bone formation. This reveals a new additional link of the transcriptional regulation mechanism that Osx controls bone formation.	[Tang, Wanjin; Li, Yang; Osimiri, Lindsey; Zhang, Chi] Univ Texas SW Med Ctr Dallas, Bone Res Lab, Texas Scottish Rite Hosp Children, Dallas, TX 75390 USA; [Zhang, Chi] Univ Texas SW Med Ctr Dallas, Dept Orthoped Surg, Dallas, TX 75390 USA; [Zhang, Chi] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, C (corresponding author), Univ Texas SW Med Ctr Dallas, Bone Res Lab, Texas Scottish Rite Hosp Children, 2222 Welborn St, Dallas, TX 75219 USA.	Chi5.Zhang@utsouthwestern.edu	Zhang, Chi/K-4467-2012		Arthritis Foundation; Texas Scottish Rite Hospital for Children [RAP01]	Arthritis Foundation; Texas Scottish Rite Hospital for Children	This work was supported by a research grant from the Arthritis Foundation (to C. Z.) and a RAP01 grant from the Texas Scottish Rite Hospital for Children (to C. Z.).	Aprelikova O, 2010, CELL CYCLE, V9, P4387, DOI 10.4161/cc.9.21.13674; Britanova O, 2006, AM J HUM GENET, V79, P668, DOI 10.1086/508214; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Gyorgy AB, 2008, EUR J NEUROSCI, V27, P865, DOI 10.1111/j.1460-9568.2008.06061.x; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; KIM RH, 1994, MATRIX BIOL, V14, P31, DOI 10.1016/0945-053X(94)90027-2; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leoyklang P, 2007, HUM MUTAT, V28, P732, DOI 10.1002/humu.20515; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Patani N, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-18; Rosen CJ, 2000, BEST PRACT RES CL EN, V14, P181, DOI 10.1053/beem.2000.0068; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; Wang S, 2009, J PATHOL, V219, P114, DOI 10.1002/path.2575; Yang F, 2010, BIOCHEM BIOPH RES CO, V400, P684, DOI 10.1016/j.bbrc.2010.08.128; Zhang C, 2001, J BIOL CHEM, V276, P40614, DOI 10.1074/jbc.M106263200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	26	63	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32995	33002		10.1074/jbc.M111.244236	http://dx.doi.org/10.1074/jbc.M111.244236			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828043	Green Published, hybrid			2022-12-27	WOS:000294968800017
J	Thylur, RP; Senthivinayagam, S; Campbell, EM; Rangasamy, V; Thorenoor, N; Sondarva, G; Mehrotra, S; Mishra, P; Zook, E; Le, PT; Rana, A; Rana, B				Thylur, Ramesh P.; Senthivinayagam, Subramanian; Campbell, Edward M.; Rangasamy, Velusamy; Thorenoor, Nithyananda; Sondarva, Gautam; Mehrotra, Suneet; Mishra, Prajna; Zook, Erin; Le, Phong T.; Rana, Ajay; Rana, Basabi			Mixed Lineage Kinase 3 Modulates beta-Catenin Signaling in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE GROWTH; ACTIVATION; WNT; APOPTOSIS; POLYPOSIS; APC; PHOSPHORYLATION; TRANSCRIPTION; DEGRADATION; REQUIREMENT	Expression of beta-catenin is strictly regulated in normal cells via the glycogen synthase kinase 3 beta (GSK3 beta)-adenomatous polyposis coli-axin-mediated degradation pathway. Mechanisms leading to inactivation of this pathway (example: activation of Wnt/beta-catenin signaling or mutations of members of the degradation complex) can result in beta-catenin stabilization and activation of beta-catenin/T-cell factor (TCF) signaling. beta-Catenin-mediated cellular events are diverse and complex. A better understanding of the cellular signaling networks that control beta-catenin pathway is important for designing effective therapeutic strategies targeting this axis. To gain more insight, we focused on determining any possible cross-talk between beta-catenin and mixed lineage kinase 3 (MLK3), a MAPK kinase kinase member. Our studies indicated that MLK3 can induce beta-catenin expression via post-translational stabilization in various cancer cells, including prostate cancer. This function of MLK3 was dependent on its kinase activity. MLK3 can interact with beta-catenin and phosphorylate it in vitro. Overexpression of GSK3 beta-WT or the S9A mutant was unable to antagonize MLK3-induced stabilization, suggesting this to be independent of GSK3 beta pathway. Surprisingly, despite stabilizing beta-catenin, MLK3 inhibited TCF transcriptional activity in the presence of both WT and S37A beta-catenin. These resulted in reduced expression of beta-catenin/TCF downstream targets Survivin and myc. Immunoprecipitation studies indicated that MLK3 did not decrease beta-catenin/TCF interaction but promoted interaction between beta-catenin and KLF4, a known repressor of beta-catenin/TCF transcriptional activity. In addition, co-expression of MLK3 and beta-catenin resulted in significant G(2)/M arrest. These studies provide a novel insight toward the regulation of beta-catenin pathway, which can be targeted to control cancer cell proliferation, particularly those with aberrant activation of beta-catenin signaling.	[Thylur, Ramesh P.; Senthivinayagam, Subramanian; Thorenoor, Nithyananda; Mishra, Prajna; Rana, Basabi] Loyola Univ Chicago, Dept Med, Div Gastroenterol Hepatol & Nutr, Maywood, IL 60153 USA; [Rangasamy, Velusamy; Sondarva, Gautam; Mehrotra, Suneet; Rana, Ajay] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Campbell, Edward M.; Zook, Erin; Le, Phong T.] Loyola Univ Chicago, Dept Microbiol & Immunol, Maywood, IL 60153 USA; [Rana, Basabi] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Rana, Ajay; Rana, Basabi] Hines Vet Affairs Med Ctr, Hines, IL 60141 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Rana, B (corresponding author), Loyola Univ Chicago, Dept Med, Div Gastroenterol Hepatol & Nutr, Bldg 101,Rm 2729,2160 S 1st Ave, Maywood, IL 60153 USA.	brana@lumc.edu	MEHROTRA, SUNEET/A-5673-2012; Thorenoor, Nithyananda/X-5746-2019; Rana, Ajay/ABE-3739-2020; Senthivinayagam, Subramanian/E-3141-2012; Puttalingaiah, Ramesh Thylur/AAH-9087-2020	Rana, Ajay/0000-0003-0951-2566; Senthivinayagam, Subramanian/0000-0001-8796-3640; Thorenoor, Nithyananda/0000-0003-2958-4065; Mishra, Prajna/0000-0002-1906-0244	National Institutes of Health [CA121221, K22 AI078757, RO1 AI093258, GM55835]; Veterans Affairs Merit awards [BX000571-01, BX000312-01]; NATIONAL CANCER INSTITUTE [R21CA121221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093258, K22AI078757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055835] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000571, I01BX000312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit awards(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants CA121221 (to B. R.), K22 AI078757 and RO1 AI093258 (to E. M. C.), and GM55835 (to A. R.). This work was also supported by Veterans Affairs Merit awards BX000571-01 (to B. R.) and BX000312-01 (to A. R.).	Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bierie B, 2003, ONCOGENE, V22, P3875, DOI 10.1038/sj.onc.1206426; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cadoret A, 2001, CANCER RES, V61, P3245; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Chesire DR, 2000, PROSTATE, V45, P323, DOI 10.1002/1097-0045(20001201)45:4<323::AID-PROS7>3.0.CO;2-W; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Evans PM, 2010, MOL CELL BIOL, V30, P372, DOI 10.1128/MCB.00063-09; GALLO KA, 1994, J BIOL CHEM, V269, P15092; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gounari F, 2002, ONCOGENE, V21, P4099, DOI 10.1038/sj.onc.1205562; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Koh SS, 2002, J BIOL CHEM, V277, P26031, DOI 10.1074/jbc.M110865200; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Mishra Prajna, 2010, J Mol Signal, V5, P9, DOI 10.1186/1750-2187-5-9; Mishra P, 2010, MOL ENDOCRINOL, V24, P598, DOI 10.1210/me.2009-0387; Mishra R, 2007, J BIOL CHEM, V282, P30393, DOI 10.1074/jbc.M705895200; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pradeep A, 2004, ONCOGENE, V23, P3689, DOI 10.1038/sj.onc.1207454; Prieve MG, 1999, MOL CELL BIOL, V19, P4503; Rana A, 1996, J BIOL CHEM, V271, P19025, DOI 10.1074/jbc.271.32.19025; Rangasamy V, 2010, CANCER RES, V70, P1731, DOI 10.1158/0008-5472.CAN-09-3492; Senthivinayagam S, 2009, J BIOL CHEM, V284, P13577, DOI 10.1074/jbc.M900248200; Sharma C, 2004, J BIOL CHEM, V279, P35583, DOI 10.1074/jbc.M403143200; Smit L, 2004, J BIOL CHEM, V279, P17232, DOI 10.1074/jbc.M307801200; Sondarva G, 2010, CELL RES, V20, P89, DOI 10.1038/cr.2009.125; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Truica CI, 2000, CANCER RES, V60, P4709; Voeller HJ, 1998, CANCER RES, V58, P2520; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Yu XP, 2009, PROSTATE, V69, P249, DOI 10.1002/pros.20877; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006	50	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37470	37482		10.1074/jbc.M111.298943	http://dx.doi.org/10.1074/jbc.M111.298943			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880738	Green Published, hybrid			2022-12-27	WOS:000296542400046
J	Yadav, S; Pandey, A; Shukla, A; Talwelkar, SS; Kumar, A; Pant, AB; Parmar, D				Yadav, Sanjay; Pandey, Ankita; Shukla, Aruna; Talwelkar, Sarang S.; Kumar, Ashutosh; Pant, Aditya B.; Parmar, Devendra			miR-497 and miR-302b Regulate Ethanol-induced Neuronal Cell Death through BCL2 Protein and Cyclin D2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; ADULT NEUROGENESIS; POSTTRANSCRIPTIONAL REGULATION; MOUSE-BRAIN; RAT-BRAIN; EXPRESSION; APOPTOSIS; ROLES; NEURODEGENERATION; MICRORNAS	In chronic alcoholism, brain shrinkage and cognitive defects because of neuronal death are well established, although the sequence of molecular events has not been fully explored yet. We explored the role of microRNAs (miRNAs) in ethanol-induced apoptosis of neuronal cells. Ethanol-sensitive miRNAs in SH-SY5Y, a human neuroblastoma cell line, were identified using real-time PCR-based TaqMan low-density arrays. Longterm exposure to ethanol (0.5% v/v for 72 h) produced a maximum increase in expression of miR-497 (474-fold) and miR-302b (322-fold). Similar to SH-SY5Y, long-term exposure to ethanol induced miR-497 and miR-302b in IMR-32, another human neuroblastoma cell line. Using in silico approaches, BCL2 and cyclin D2 (CCND2) were identified as probable target genes of these miRNAs. Cotransfection studies with 3'-UTR of these genes and miRNA mimics have demonstrated that BCL2 is a direct target of miR-497 and that CCND2 is regulated negatively by either miR-302b or miR-497. Overexpression of either miR-497 or miR-302b reduced expression of their identified target genes and increased caspase 3-mediated apoptosis of SH-SY5Y cells. However, overexpression of only miR-497 increased reactive oxygen species formation, disrupted mitochondrial membrane potential, and induced cytochrome c release (mitochondria-related events of apoptosis). Moreover, ethanol induced changes in miRNAs, and their target genes were substantially prevented by pre-exposure to GSK-3B inhibitors. In conclusion, our studies have shown that ethanol-induced neuronal apoptosis follows both the mitochondria-mediated (miR-497- and BCL2-mediated) and non-mitochondria-mediated (miR-302b- and CCND2-mediated) pathway.	[Yadav, Sanjay; Pandey, Ankita; Shukla, Aruna; Talwelkar, Sarang S.; Kumar, Ashutosh; Pant, Aditya B.; Parmar, Devendra] Indian Inst Toxicol Res, Div Dev Toxicol, CSIR, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Yadav, S (corresponding author), Indian Inst Toxicol Res, Div Dev Toxicol, CSIR, MG Marg 80, Lucknow 226001, Uttar Pradesh, India.	sanjay@iitr.res.in	Yadav, Sanjay/E-2902-2010; Kumar, Ashutosh/V-8563-2019; Talwelkar, Sarang/C-8925-2015	Kumar, Ashutosh/0000-0002-6856-3980; 	CSIR, New Delhi [SIP08, NWP34]; ICMR, New Delhi	CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); ICMR, New Delhi(Indian Council of Medical Research (ICMR))	This work was supported by the SIP08 and NWP34 projects of CSIR, New Delhi.; Recipient of a Senior Research Fellowship from ICMR, New Delhi.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Baroukh NN, 2009, FEBS J, V276, P6509, DOI 10.1111/j.1742-4658.2009.07353.x; Brust JCM, 2010, INT J ENV RES PUB HE, V7, P1540, DOI 10.3390/ijerph7041540; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Chen G, 2009, NEUROTOX RES, V15, P321, DOI 10.1007/s12640-009-9036-y; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chin VS, 2010, ALCOHOL, V44, P3, DOI 10.1016/j.alcohol.2009.10.015; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Elibol-Can B., 2011, ALCOHOL CLIN EXP RES; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Heaton MB, 1999, BRAIN RES, V817, P13, DOI 10.1016/S0006-8993(98)01173-1; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Huang W, 2007, ONCOGENE, V26, P2471, DOI 10.1038/sj.onc.1210033; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Ji JF, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-4; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Liu CM, 2009, NEUROMOL MED, V11, P141, DOI 10.1007/s12017-009-8077-y; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Luo J, 2009, MOL NEUROBIOL, V40, P108, DOI 10.1007/s12035-009-8075-y; Mitchell JJ, 1998, ALCOHOL, V15, P137, DOI 10.1016/S0741-8329(97)00124-9; Nixon K, 2006, HIPPOCAMPUS, V16, P287, DOI 10.1002/hipo.20162; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Shen Q, 2009, NAT NEUROSCI, V12, P369, DOI 10.1038/nn0409-369; Siddiqui MA, 2008, TOXICOL IN VITRO, V22, P1681, DOI 10.1016/j.tiv.2008.07.001; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Subramanian S, 2010, J CELL PHYSIOL, V223, P289, DOI 10.1002/jcp.22066; Susaki E, 2007, MOL CELL BIOL, V27, P4626, DOI 10.1128/MCB.00862-06; Wada A, 2009, J PHARMACOL SCI, V110, P14, DOI 10.1254/jphs.09R02CR; Wang XY, 2009, BRAIN RES BULL, V80, P268, DOI 10.1016/j.brainresbull.2009.08.006; Yadav S, 2006, TOXICOL APPL PHARM, V217, P15, DOI 10.1016/j.taap.2006.07.008; Yadav S, 2006, MOL CELL BIOCHEM, V286, P171, DOI 10.1007/s11010-005-9109-z; Yin KJ, 2010, NEUROBIOL DIS, V38, P17, DOI 10.1016/j.nbd.2009.12.021; Young C, 2003, CELL DEATH DIFFER, V10, P1148, DOI 10.1038/sj.cdd.4401277; Zhang BH, 2009, ENVIRON HEALTH PERSP, V117, P231, DOI 10.1289/ehp.11841; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131	43	114	129	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37347	37357		10.1074/jbc.M111.235531	http://dx.doi.org/10.1074/jbc.M111.235531			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878650	Green Published, hybrid			2022-12-27	WOS:000296542400035
J	Yuen, S; Ogut, O; Brozovich, FV				Yuen, Samantha; Ogut, Ozgur; Brozovich, Frank V.			MYPT1 Protein Isoforms Are Differentially Phosphorylated by Protein Kinase G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHATASE; MUSCLE MYOSIN PHOSPHATASE; SMOOTH-MUSCLE; LEUCINE-ZIPPER; INCREASED SENSITIVITY; TARGETING SUBUNIT; BINDING SUBUNIT; NITRIC-OXIDE; I-ALPHA; RELAXATION	Smooth muscle relaxation in response to NO signaling is due, in part, to a Ca2+-independent activation of myosin light chain (MLC) phosphatase by protein kinase GI alpha (PKGI alpha). MLC phosphatase is a trimeric complex of a 20-kDa subunit, a 38-kDa catalytic subunit, and a 110-133-kDa myosin-targeting subunit (MYPT1). Alternative mRNA splicing produces four MYPT1 isoforms, differing by the presence or absence of a central insert and leucine zipper (LZ). The LZ domain of MYPT1 has been shown to be important for PKGI alpha-mediated activation of MLC phosphatase activity, and changes in LZ+ MYPT1 isoform expression result in changes in the sensitivity of smooth muscle to NO-mediated relaxation. Furthermore, PKGI alpha has been demonstrated to phosphorylate Ser-694 of MYPT1, but phosphorylation at this site does not always accompany cGMP-mediated smooth muscle relaxation. This study was designed to determine whether MYPT1 isoforms are differentially phosphorylated by PKGI alpha. The results demonstrate that purified LZ+ MYPT1 fragments are rapidly phosphorylated by PKGI alpha at Ser-667 and Ser-694, whereas fragments lacking the LZ domain are poor PKGI alpha substrates. Mutation of Ser-667 and Ser-694 to Ala and/or Asp showed that Ser-667 phosphorylation is more rapid than Ser-694 phosphorylation, suggesting that Ser-667 may play an important role in the activation of MLC phosphatase. These results demonstrate that MYPT1 isoform expression is important for determining the heterogeneous response of vascular beds to NO and NO-based vasodilators, thereby playing a central role in the regulation of vascular tone in health and disease.	[Yuen, Samantha; Ogut, Ozgur; Brozovich, Frank V.] Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Brozovich, FV (corresponding author), Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	brozovich.frank@mayo.edu			Mayo Clinic	Mayo Clinic	This work was supported by the Mayo Clinic.	Alioua A, 1998, J BIOL CHEM, V273, P32950, DOI 10.1074/jbc.273.49.32950; Chen FC, 2006, J MOL CELL CARDIOL, V41, P488, DOI 10.1016/j.yjmcc.2006.05.018; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Choudhury N, 2004, J MUSCLE RES CELL M, V25, P657, DOI 10.1007/s10974-004-7807-x; Dirksen WP, 2000, AM J PHYSIOL-CELL PH, V278, pC589, DOI 10.1152/ajpcell.2000.278.3.C589; El-Toukhy A, 2006, FEBS LETT, V580, P5779, DOI 10.1016/j.febslet.2006.09.035; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; Furchgott RF, 1999, BIOSCIENCE REP, V19, P235, DOI 10.1023/A:1020537506008; Given AM, 2007, AM J PHYSIOL-CELL PH, V292, pC432, DOI 10.1152/ajpcell.00175.2006; GONG MC, 1992, J BIOL CHEM, V267, P14662; Hartshorne D. J, 1987, PHYSL GASTROINTESTIN; Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064; Huang QQ, 2004, J BIOL CHEM, V279, P597, DOI 10.1074/jbc.M308496200; Karim SM, 2004, CIRC RES, V95, P612, DOI 10.1161/01.RES.0000142736.39359.58; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Khromov AS, 2006, P NATL ACAD SCI USA, V103, P2440, DOI 10.1073/pnas.0508566103; Lee E, 2007, J MOL BIOL, V373, P1198, DOI 10.1016/j.jmb.2007.08.049; Lu Y, 2008, AM J PHYSIOL-CELL PH, V294, pC564, DOI 10.1152/ajpcell.00285.2007; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Ogut O, 2000, AM J PHYSIOL-CELL PH, V279, pC1722, DOI 10.1152/ajpcell.2000.279.6.C1722; Payne MC, 2004, AM J PHYSIOL-HEART C, V286, pH1801, DOI 10.1152/ajpheart.00696.2003; SCHMIDT HHHW, 1993, BIOCHIM BIOPHYS ACTA, V1178, P153, DOI 10.1016/0167-4889(93)90006-B; Sharma AK, 2008, J BIOL CHEM, V283, P32860, DOI 10.1074/jbc.M804916200; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Surks HK, 2003, CELL SIGNAL, V15, P937, DOI 10.1016/S0898-6568(03)00057-3; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Zhang HY, 2007, CIRC RES, V100, P730, DOI 10.1161/01.RES.0000260189.38975.35	30	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37274	37279		10.1074/jbc.M111.282905	http://dx.doi.org/10.1074/jbc.M111.282905			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21890627	Green Published, hybrid			2022-12-27	WOS:000296542400027
J	Montana, CL; Lawrence, KA; Williams, NL; Tran, NM; Peng, GH; Chen, SM; Corbo, JC				Montana, Cynthia L.; Lawrence, Karen A.; Williams, Natecia L.; Tran, Nicholas M.; Peng, Guang-Hua; Chen, Shiming; Corbo, Joseph C.			Transcriptional Regulation of Neural Retina Leucine Zipper (Nrl), a Photoreceptor Cell Fate Determinant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR NR2E3; IN-VIVO; DIFFERENTIATION FACTOR; ROD PHOTORECEPTORS; GENE-EXPRESSION; HOMEOBOX GENE; MOUSE RETINA; PINEAL-GLAND; CRX; OTX2	The transcription factor neural retina leucine zipper (Nrl) is a critical determinant of rod photoreceptor cell fate and a key regulator of rod differentiation. Nrl(-/-) rod precursors fail to turn on rod genes and instead differentiate as cones. Furthermore, NRL mutations in humans cause retinitis pigmentosa. Despite the developmental and clinical significance of this gene, little is known about the transcriptional regulation of Nrl itself. In this study, we sought to define the cis- and trans-acting factors responsible for initiation and maintenance of Nrl transcription in the mouse retina. Utilizing a quantitative mouse retinal explant electroporation assay, we discovered a phylogenetically conserved, 30-base pair region immediately upstream of the transcription start site that is required for Nrl promoter activity. This region contains binding sites for the retinal transcription factors CRX, OTX2, and ROR beta, and point mutations in these sites completely abolish promoter activity in living retinas. Gelshift experiments show that CRX, OTX2, and ROR beta can bind to the critical region in vitro, whereas ChIP experiments demonstrate binding of CRX and OTX2 to the critical region in vivo. Thus, our results indicate that CRX, OTX2, and ROR beta directly regulate Nrl transcription by binding to critical sites within the Nrl promoter. We propose a model in which Nrl expression is primarily initiated by OTX2 and ROR beta and later maintained at high levels by CRX and ROR beta	[Montana, Cynthia L.; Lawrence, Karen A.; Williams, Natecia L.; Corbo, Joseph C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Tran, Nicholas M.; Peng, Guang-Hua; Chen, Shiming] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Chen, Shiming] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Corbo, Joseph C.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbo, JC (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave,Campus Box 8118, St Louis, MO 63110 USA.	jcorbo@pathology.wustl.edu	Huang, Yifei/ABE-7566-2020; Lawrence, Karen/AFQ-3557-2022	Corbo, Joseph/0000-0002-9323-7140; Lawrence, Karen/0000-0002-7235-5594; Tran, Nicholas/0000-0002-4213-3499	National Institutes of Health, NEI [EY018826, 5-T32-EY13360-08]; Hope Center for Neurologic Diseases; Children's Discovery Institute; NATIONAL EYE INSTITUTE [R01EY012543, R01EY018826, T32EY013360] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Hope Center for Neurologic Diseases; Children's Discovery Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health, NEI Grant EY018826 (to J. C. C.) and Institutional Vision Science Training Grant 5-T32-EY13360-08 (to C. L. M. and N. M. T.). This work was also supported by The Hope Center for Neurologic Diseases (to J. C. C.) and The Children's Discovery Institute (to J. C. C.).	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Alvarez-Delfin K, 2009, P NATL ACAD SCI USA, V106, P2023, DOI 10.1073/pnas.0809439106; Andre E, 1998, GENE, V216, P277, DOI 10.1016/S0378-1119(98)00348-5; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chatelain G, 2006, J MOL MED, V84, P604, DOI 10.1007/s00109-006-0048-2; Chen CMA, 2000, MECH DEVELOP, V90, P293; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Corbo JC, 2007, P NATL ACAD SCI USA, V104, P12069, DOI 10.1073/pnas.0705465104; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Hyatt GA, 1996, P NATL ACAD SCI USA, V93, P13298, DOI 10.1073/pnas.93.23.13298; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Kautzmann MAI, 2011, J BIOL CHEM, V286, P28247, DOI 10.1074/jbc.M111.257246; KELLEY MW, 1994, DEVELOPMENT, V120, P2091; Khanna H, 2006, J BIOL CHEM, V281, P27327, DOI 10.1074/jbc.M605500200; Koike C, 2007, MOL CELL BIOL, V27, P8318, DOI 10.1128/MCB.01209-07; Kumar R, 1996, J BIOL CHEM, V271, P29612, DOI 10.1074/jbc.271.47.29612; Lee J, 2010, GENE THER, V17, P1390, DOI 10.1038/gt.2010.77; Liu H, 2008, J NEUROSCI, V28, P749, DOI 10.1523/JNEUROSCI.4832-07.2008; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Peng GH, 2005, VISUAL NEUROSCI, V22, P575, DOI 10.1017/S0952523805225063; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; Tian E, 2002, DEV BIOL, V242, P204, DOI 10.1006/dbio.2001.0531; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	41	35	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36921	36931		10.1074/jbc.M111.279026	http://dx.doi.org/10.1074/jbc.M111.279026			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21865162	hybrid, Green Published			2022-12-27	WOS:000296538300071
J	Ho, TC; Chen, SL; Shih, SC; Chang, SJ; Yang, SL; Hsieh, JW; Cheng, HC; Chen, LJ; Tsao, YP				Ho, Tsung-Chuan; Chen, Show-Li; Shih, Shou-Chuan; Chang, Shing-Jyh; Yang, Su-Lin; Hsieh, Jui-Wen; Cheng, Huey-Chuan; Chen, Lee-Jen; Tsao, Yeou-Ping			Pigment Epithelium-derived Factor (PEDF) Promotes Tumor Cell Death by Inducing Macrophage Membrane Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; HUMAN DENDRITIC CELLS; NF-KAPPA-B; PPAR-GAMMA; CANCER; MICE; EXPRESSION; INHIBITION; CARCINOMA; BINDING	Pigment epithelium-derived factor (PEDF) is an intrinsic anti-angiogenic factor and a potential anti-tumor agent. The tumoricidal mechanism of PEDF, however, has not been fully elucidated. Here we report that PEDF induces the apoptosis of TC-1 and SK-Hep-1 tumor cells when they are cocultured with bone marrow-derived macrophages (BMDMs). This macrophage-mediated tumor killing is prevented by blockage of TNF-related apoptosis-inducing ligand (TRAIL) following treatment with the soluble TRAIL receptor. PEDF also increases the amount of membrane-bound TRAIL on cultured mouse BMDMs and on macrophages surrounding subcutaneous tumors. PEDF-induced tumor killing and TRAIL induction are abrogated by peroxisome proliferator-activated receptor gamma (PPAR gamma) antagonists or small interfering RNAs targeting PPAR gamma. PEDF also induces PPAR gamma in BMDMs. Furthermore, the activity of the TRAIL promoter in human macrophages is increased by PEDF stimulation. Chromatin immunoprecipitation and DNA pull-down assays confirmed that endogenous PPAR gamma binds to a functional PPAR-response element (PPRE) in the TRAIL promoter, and mutation of this PPRE abolishes the binding of the PPAR gamma-RXR alpha heterodimer. Also, PPAR gamma-dependent transactivation and PPAR gamma-RXR alpha binding to this PPRE are prevented by PPAR gamma antagonists. Our results provide a novel mechanism for the tumoricidal activity of PEDF, which involves tumor cell killing via PPAR gamma-mediated TRAIL induction in macrophages.	[Ho, Tsung-Chuan; Tsao, Yeou-Ping] Mackay Mem Hosp, Dept Med Res, Taipei 104, Taiwan; [Shih, Shou-Chuan] Mackay Mem Hosp, Dept Gastroenterol, Taipei 104, Taiwan; [Chang, Shing-Jyh] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei 104, Taiwan; [Hsieh, Jui-Wen; Cheng, Huey-Chuan; Chen, Lee-Jen; Tsao, Yeou-Ping] Mackay Mem Hosp, Dept Ophthalmol, Taipei 104, Taiwan; [Chen, Show-Li] Natl Taiwan Univ, Sch Med, Dept Microbiol, Taipei 100, Taiwan; [Shih, Shou-Chuan; Hsieh, Jui-Wen; Chen, Lee-Jen] Mackay Med Nursing & Management Coll, Taipei 112, Taiwan; [Chang, Shing-Jyh] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu 30013, Taiwan; [Yang, Su-Lin] Ctr Dis Control, Taipei 115, Taiwan; [Yang, Su-Lin; Tsao, Yeou-Ping] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei 114, Taiwan	Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; National Taiwan University; Mackay Junior College of Medicine, Nursing & Management; National Tsing Hua University; Centers For Disease Control - Taiwan; National Defense Medical Center	Tsao, YP (corresponding author), Mackay Mem Hosp, Dept Med Res, 92 Sec 2,Chung Shan N Rd, Taipei 104, Taiwan.	yptsao@yahoo.com			National Science Council, Taiwan [NSC 97-2314-B-195-014-MY3]; Mackay Memorial Hospital [MMH-E-100-006]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This study was supported by National Science Council, Taiwan, Grant NSC 97-2314-B-195-014-MY3 and Mackay Memorial Hospital Grant MMH-E-100-006.	Baetu TM, 2001, J IMMUNOL, V167, P3164, DOI 10.4049/jimmunol.167.6.3164; Bellail AC, 2009, REV RECENT CLIN TRIA, V4, P34, DOI 10.2174/157488709787047530; Cai J, 2006, CLIN CANCER RES, V12, P3510, DOI 10.1158/1078-0432.CCR-06-0094; Chen PL, 2010, BIOCHEM BIOPH RES CO, V391, P936, DOI 10.1016/j.bbrc.2009.11.168; Cheung LWT, 2006, ENDOCRINOLOGY, V147, P4179, DOI 10.1210/en.2006-0168; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Dong ZY, 1997, CELL, V88, P801, DOI 10.1016/S0092-8674(00)81926-1; Evans NP, 2010, J NUTR, V140, P515, DOI 10.3945/jn.109.115642; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Finnberg N, 2005, MOL CELL BIOL, V25, P2000, DOI 10.1128/MCB.25.5.2000-2013.2005; Galmbacher K, 2010, PLOS ONE, V5, pA93, DOI 10.1371/journal.pone.0009572; Gerard CM, 2001, CLIN CANCER RES, V7, p838S; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Guan M, 2004, CANCER GENE THER, V11, P325, DOI 10.1038/sj.cgt.7700675; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Halin S, 2010, NEOPLASIA, V12, P336, DOI 10.1593/neo.92046; Hase R, 2005, CLIN CANCER RES, V11, P8737, DOI 10.1158/1078-0432.CCR-05-1323; Hihi AK, 2002, CELL MOL LIFE SCI, V59, P790, DOI 10.1007/s00018-002-8467-x; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Ho TC, 2008, MOL IMMUNOL, V45, P898, DOI 10.1016/j.molimm.2007.08.004; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kayagaki N, 1999, J IMMUNOL, V162, P2639; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; Majdalawieh Amin, 2010, Nucl Recept Signal, V8, pe004, DOI 10.1621/nrs.08004; Matsumoto K, 2004, HEPATOLOGY, V40, P252, DOI 10.1002/hep.20259; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Orgaz JL, 2009, ONCOGENE, V28, P4147, DOI 10.1038/onc.2009.284; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Petersen SV, 2003, BIOCHEM J, V374, P199, DOI 10.1042/BJ20030313; Sakoe Y, 2010, BLOOD, V115, P3787, DOI 10.1182/blood-2009-05-222976; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Siveen KS, 2009, IMMUNOL LETT, V123, P97, DOI 10.1016/j.imlet.2009.02.011; Solis M, 2006, BIOCHEM PHARMACOL, V72, P1469, DOI 10.1016/j.bcp.2006.06.002; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Szatmari I, 2006, J BIOL CHEM, V281, P23812, DOI 10.1074/jbc.M604890200; Takenaka K, 2005, LIFE SCI, V77, P3231, DOI 10.1016/j.lfs.2005.05.048; Taniguchi H, 2010, ANTICANCER RES, V30, P3159; Thompson PW, 2007, CYTOKINE, V39, P184, DOI 10.1016/j.cyto.2007.07.191; Tombran-Tink J, 1996, Mol Vis, V2, P11; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Van Ginderachter JA, 2006, BLOOD, V108, P525, DOI 10.1182/blood-2005-09-3777; Vishvakarma NK, 2010, IMMUNOL LETT, V134, P83, DOI 10.1016/j.imlet.2010.09.002; Watkins SK, 2009, EUR J IMMUNOL, V39, P2126, DOI 10.1002/eji.200839010; Yang SL, 2010, LIFE SCI, V87, P26, DOI 10.1016/j.lfs.2010.05.007; Yang XY, 2000, J BIOL CHEM, V275, P4541, DOI 10.1074/jbc.275.7.4541; Yang YC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-216; Yu J, 2010, HEPATOLOGY, V51, P2008, DOI 10.1002/hep.23550; Zhang LJ, 2006, INT J MOL MED, V17, P937; Zhang SX, 2006, FASEB J, V20, P323, DOI 10.1096/fj.05-4313fje; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904	56	30	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35943	35954		10.1074/jbc.M111.266064	http://dx.doi.org/10.1074/jbc.M111.266064			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21846721	Green Published, hybrid			2022-12-27	WOS:000295927100068
J	Scott, AJ; O'Dea, KP; O'Callaghan, D; Williams, L; Dokpesi, JO; Tatton, L; Handy, JM; Hogg, PJ; Takata, M				Scott, Alasdair J.; O'Dea, Kieran P.; O'Callaghan, David; Williams, Lynn; Dokpesi, Justina O.; Tatton, Louise; Handy, Jonathan M.; Hogg, Philip J.; Takata, Masao			Reactive Oxygen Species and p38 Mitogen-activated Protein Kinase Mediate Tumor Necrosis Factor alpha-Converting Enzyme (TACE/ADAM-17) Activation in Primary Human Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC DISULFIDE BONDS; THIOL ISOMERASE ACTIVITY; NF-KAPPA-B; L-SELECTIN; TNF-ALPHA; NITRIC-OXIDE; INTRACELLULAR MATURATION; CELLS; RECEPTOR; ADAM17	Tumor necrosis factor alpha-converting enzyme (TACE) is responsible for the shedding of cell surface TNF. Studies suggest that reactive oxygen species (ROS) mediate up-regulation of TACE activity by direct oxidization or modification of the protein. However, these investigations have been largely based upon nonphysiological stimulation of promonocytic cell lines which may respond and process TACE differently from primary cells. Furthermore, investigators have relied upon TACE substrate shedding as a surrogate for activity quantification. We addressed these concerns, employing a direct, cell-based fluorometric assay to investigate the regulation of TACE catalytic activity on freshly isolated primary human monocytes during LPS stimulation. We hypothesized that ROS mediate up-regulation of TACE activity indirectly, by activation of intracellular signaling pathways. LPS up-regulated TACE activity rapidly (within 30 min) without changing cell surface TACE expression. Scavenging of ROS or inhibiting their production by flavoprotein oxidoreductases significantly attenuated LPS-induced TACE activity up-regulation. Exogenous ROS (H2O2) also up-regulated TACE activity with similar kinetics and magnitude as LPS. H2O2- and LPS-induced TACE activity up-regulation were effectively abolished by a variety of selective p38 MAPK inhibitors. Activation of p38 was redox-sensitive as H2O2 caused p38 phosphorylation, and ROS scavenging significantly reduced LPS-induced phospho-p38 expression. Inhibition of the p38 substrate, MAPK-activated protein kinase 2, completely attenuated TACE activity up-regulation, whereas inhibition of ERK had little effect. Lastly, inhibition of cell surface oxidoreductases prevented TACE activity up-regulation distal to p38 activation. In conclusion, our data indicate that in primary human monocytes, ROS mediate LPS-induced up-regulation of TACE activity indirectly through activation of the p38 signaling pathway.	[Scott, Alasdair J.; O'Dea, Kieran P.; O'Callaghan, David; Dokpesi, Justina O.; Tatton, Louise; Handy, Jonathan M.; Takata, Masao] Chelsea & Westminster Hosp, Sect Anaesthet Pain Med & Intens Care, Fac Med, London SW10 9NH, England; [Williams, Lynn] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, London SW7 2AZ, England; [Hogg, Philip J.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia	Imperial College London; Imperial College London; University of Oxford; University of New South Wales Sydney	Takata, M (corresponding author), Chelsea & Westminster Hosp, Sect Anaesthet Pain Med & Intens Care, Fac Med, 369 Fulham Rd, London SW10 9NH, England.	m.takata@imperial.ac.uk	Scott, Alasdair/AAE-8715-2020	Scott, Alasdair/0000-0003-4621-9756; Hogg, Philip/0000-0001-6486-2863	Westminster Medical School Research Trust; Medical Research Council [G0700128] Funding Source: researchfish; MRC [G0700128] Funding Source: UKRI	Westminster Medical School Research Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Westminster Medical School Research Trust.	AFFRES H, 1991, KIDNEY INT, V39, P822, DOI 10.1038/ki.1991.103; Alvarez-Iglesias M, 2005, LAB INVEST, V85, P1440, DOI 10.1038/labinvest.3700340; Anderson DR, 2007, J MED CHEM, V50, P2647, DOI 10.1021/jm0611004; Armstrong L, 2006, AM J RESP CELL MOL, V34, P219, DOI 10.1165/rcmb.2005-0087OC; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blouin E, 1999, EUR J IMMUNOL, V29, P3419, DOI 10.1002/(SICI)1521-4141(199911)29:11<3419::AID-IMMU3419>3.3.CO;2-T; Brennan FM, 2008, EUR J IMMUNOL, V38, P1106, DOI 10.1002/eji.200737821; Brill A, 2009, CARDIOVASC RES, V84, P137, DOI 10.1093/cvr/cvp176; Bzowska M, 2009, ACTA BIOCHIM POL, V56, P325; CHEN AJ, 1995, J EXP MED, V182, P519, DOI 10.1084/jem.182.2.519; Condon TP, 2001, ANTISENSE NUCLEIC A, V11, P107, DOI 10.1089/108729001750171353; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Donoghue N, 2000, PROTEIN SCI, V9, P2436, DOI 10.1110/ps.9.12.2436; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Fan HZ, 2003, J BIOL CHEM, V278, P18617, DOI 10.1074/jbc.M300331200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Foxwell B, 1998, P NATL ACAD SCI USA, V95, P8211, DOI 10.1073/pnas.95.14.8211; Ganesan Srinivasan, 2002, Curr Opin Investig Drugs, V3, P1301; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; Griffith CE, 1998, J BIOL CHEM, V273, P10771, DOI 10.1074/jbc.273.17.10771; Hino T, 1999, AM J RESP CELL MOL, V20, P122, DOI 10.1165/ajrcmb.20.1.3217; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; MIGAKI GI, 1995, J EXP MED, V182, P549, DOI 10.1084/jem.182.2.549; Milla ME, 1999, J BIOL CHEM, V274, P30563, DOI 10.1074/jbc.274.43.30563; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; O'Neill S, 2000, J BIOL CHEM, V275, P36984, DOI 10.1074/jbc.M003279200; Ottosen ER, 2003, J MED CHEM, V46, P5651, DOI 10.1021/jm030851s; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Pedron T, 2003, J BIOL CHEM, V278, P20555, DOI 10.1074/jbc.M203551200; Peiretti F, 2003, EXP CELL RES, V285, P278, DOI 10.1016/S0014-4827(03)00052-1; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; PHILIPPE C, 1992, CLIN EXP IMMUNOL, V87, P499; Pietri M, 2005, FASEB J, V19, P1078, DOI 10.1096/fj.04-3631com; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Riche FC, 2000, CRIT CARE MED, V28, P433, DOI 10.1097/00003246-200002000-00024; Rizoli SB, 1999, J BIOL CHEM, V274, P22072, DOI 10.1074/jbc.274.31.22072; Rozenova KA, 2010, J BIOL CHEM, V285, P21103, DOI 10.1074/jbc.M109.080671; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schmidt B, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-49; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Shurety W, 2001, LAB INVEST, V81, P107, DOI 10.1038/labinvest.3780216; SPERTINI O, 1991, J IMMUNOL, V147, P2565; Srour N, 2003, FEBS LETT, V554, P275, DOI 10.1016/S0014-5793(03)01159-1; STUEHR DJ, 1991, FASEB J, V5, P98, DOI 10.1096/fasebj.5.1.1703974; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Walsh GM, 2004, BIOCHEMISTRY-US, V43, P473, DOI 10.1021/bi0354536; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Woo CH, 2004, J IMMUNOL, V173, P6973, DOI 10.4049/jimmunol.173.11.6973; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Zhang ZL, 2000, J BIOL CHEM, V275, P15839, DOI 10.1074/jbc.M000604200; Zhang ZL, 2001, FASEB J, V15, P303	64	77	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35466	35476		10.1074/jbc.M111.277434	http://dx.doi.org/10.1074/jbc.M111.277434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865167	Green Published, hybrid			2022-12-27	WOS:000295927100018
J	Tulloch, LB; Howie, J; Wypijewski, KJ; Wilson, CR; Bernard, WG; Shattock, MJ; Fuller, W				Tulloch, Lindsay B.; Howie, Jacqueline; Wypijewski, Krzysztof J.; Wilson, Catherine R.; Bernard, William G.; Shattock, Michael J.; Fuller, William			The Inhibitory Effect of Phospholemman on the Sodium Pump Requires Its Palmitoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CARDIAC NA/K ATPASE; NA+-K+-ATPASE; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; POTASSIUM PUMP; FXYD PROTEINS; PHOSPHORYLATION; MYOCYTES; SITES	Background: Phospholemman regulates the plasmalemmal sodium pump in excitable tissues such as the heart. Results: Phospholemman is palmitoylated at two intracellular cysteines, and this reduces ion transport by the sodium pump. Conclusion: Phospholemman must be palmitoylated to inhibit the sodium pump. Significance: This is a potentially new way to regulate the sodium pump, an enzyme expressed in most eukaryotic cells.	[Tulloch, Lindsay B.; Howie, Jacqueline; Wypijewski, Krzysztof J.; Wilson, Catherine R.; Bernard, William G.; Fuller, William] Univ Dundee, Ctr Cardiovasc & Lung Biol, Div Med Sci, Coll Med Dent & Nursing, Dundee DD1 9SY, Scotland; [Shattock, Michael J.] Kings Coll London, St Thomas Hosp, Div Cardiovasc, Rayne Inst, London SE1 7EH, England	University of Dundee; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Fuller, W (corresponding author), Ninewells Hosp, Ctr Cardiovasc & Lung Biol, Mailbox 1, Dundee DD1 9SY, Scotland.	w.fuller@dundee.ac.uk		Shattock, Michael/0000-0001-6242-7585; Fuller, William/0000-0002-5883-4433; Tulloch, Lindsay/0000-0001-7223-5106; Bernard, William/0000-0002-2622-5115	British Heart Foundation [RG/07/001]; Medical Research Council [G0700903]; Tenovus Scotland [T07/26]; British Heart Foundation [RG/07/001/22628, PG/10/93/28650] Funding Source: researchfish; MRC [G0700903] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tenovus Scotland; British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the British Heart Foundation (RG/07/001 to W. F. and M. J. S.), the Medical Research Council (G0700903 to W. F.), and Tenovus Scotland (T07/26 to W. F.).	Bibert S, 2011, J BIOL CHEM, V286, P18562, DOI 10.1074/jbc.M110.184101; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Cirri E, 2011, BIOCHEMISTRY-US, V50, P3736, DOI 10.1021/bi2001714; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Despa S, 2008, CIRCULATION, V117, P1849, DOI 10.1161/CIRCULATIONAHA.107.754051; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Franzin CM, 2007, J BIOENERG BIOMEMBR, V39, P379, DOI 10.1007/s10863-007-9105-y; Fuller W, 2004, FASEB J, V18, P197, DOI 10.1096/fj.03-0213fje; Fuller W, 2006, CIRC RES, V99, P1290, DOI 10.1161/01.RES.0000253090.54488.81; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; Han F, 2009, AM J PHYSIOL-CELL PH, V297, pC699, DOI 10.1152/ajpcell.00063.2009; Huang CF, 1999, P NATL ACAD SCI USA, V96, P412, DOI 10.1073/pnas.96.2.412; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kostiuk MA, 2008, FASEB J, V22, P721, DOI 10.1096/fj.07-9199com; Lansbery KL, 2006, AM J PHYSIOL-CELL PH, V290, pC1275, DOI 10.1152/ajpcell.00110.2005; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; Pavlovic D, 2007, FASEB J, V21, P1539, DOI 10.1096/fj.06-7269com; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Singaraja RR, 2009, CIRC RES, V105, P138, DOI 10.1161/CIRCRESAHA.108.193011; Song JL, 2008, AM J PHYSIOL-HEART C, V295, pH1615, DOI 10.1152/ajpheart.00287.2008; Song QJ, 2011, J BIOL CHEM, V286, P9120, DOI 10.1074/jbc.M110.198036; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Teriete P, 2007, BIOCHEMISTRY-US, V46, P6774, DOI 10.1021/bi700391b; Teriete P, 2009, BBA-BIOMEMBRANES, V1788, P2462, DOI 10.1016/j.bbamem.2009.09.001; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; WALAAS SI, 1994, BIOCHEM J, V304, P635, DOI 10.1042/bj3040635; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Zhang XQ, 2006, J BIOL CHEM, V281, P7784, DOI 10.1074/jbc.M512092200	48	53	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36020	36031		10.1074/jbc.M111.282145	http://dx.doi.org/10.1074/jbc.M111.282145			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21868384	Green Published, hybrid			2022-12-27	WOS:000295927100075
J	Visanji, NP; Wislet-Gendebien, S; Oschipok, LW; Zhang, G; Aubert, I; Fraser, PE; Tandon, A				Visanji, Naomi P.; Wislet-Gendebien, Sabine; Oschipok, Loren W.; Zhang, Gang; Aubert, Isabelle; Fraser, Paul E.; Tandon, Anurag			RETRACTED: Effect of Ser-129 Phosphorylation on Interaction of alpha-Synuclein with Synaptic and Cellular Membranes (Retracted article. See vol. 295, pg. 13695, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							PARKINSONS-DISEASE; DIFFERENTIAL REGULATION; STEM-CELLS; RAT MODEL; BRAIN; FIBRILLATION; AGGREGATION; TOXICITY; BINDING	Background: The majority of alpha-synuclein is phosphorylated at serine 129 in Lewy bodies. Results: The membrane association of PD-linked mutant alpha-synuclein, but not wild-type alpha-synuclein, was increased by serine 129 phosphorylation. Conclusion: Pathological serine 129 phosphorylation regulates membrane accumulation of mutant alpha-synuclein. Significance: The relationship of serine 129 phosphorylation to pathogenic aggregation of normal and mutant alpha-synuclein may be governed by distinct effects on phosphoprotein membrane accumulation.	[Visanji, Naomi P.; Zhang, Gang; Fraser, Paul E.; Tandon, Anurag] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Wislet-Gendebien, Sabine] Univ Liege, GIGA Neurosci, B-4000 Liege, Belgium; [Oschipok, Loren W.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Aubert, Isabelle] Univ Toronto, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Aubert, Isabelle] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M4N 3M5, Canada; [Fraser, Paul E.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Tandon, Anurag] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Liege; University of British Columbia; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto	Tandon, A (corresponding author), Univ Toronto, Ctr Res Neurodegenerat Dis, 6 Queens Pk Crescent W, Toronto, ON M5S 3H2, Canada.	a.tandon@utoronto.ca	Aubert, Isabelle/AAG-4001-2019; Visanji, Naomi P/AAW-4618-2021	Aubert, Isabelle/0000-0001-5163-9961; Visanji, Naomi/0000-0001-5968-7845; wislet, sabine/0000-0003-4279-9669	Canadian Institutes of Health Research [MOP 84501, FRN 93603, MOP 84527]; Alzheimer Association; Parkinson Society of Canada; Medical Research Council [MC_G1000734] Funding Source: researchfish; MRC [MC_G1000734] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Parkinson Society of Canada; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Canadian Institutes of Health Research Operating Grants MOP 84501 (to A. T.), FRN 93603 (to I. A.), and MOP 84527 (to P. E. F.) and an Alzheimer Association grant (to I. A.).; Supported by a fellowship from the Parkinson Society of Canada.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Burns TF, 2003, MOL CELL BIOL, V23, P5556, DOI 10.1128/MCB.23.16.5556-5571.2003; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cenciarelli C, 2006, NEUROL RES, V28, P505, DOI 10.1179/016164106X115161; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Cookson MR, 2008, EXP NEUROL, V209, P5, DOI 10.1016/j.expneurol.2007.05.022; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dyllick-Brenzinger M, 2010, NEUROTOX RES, V17, P215, DOI 10.1007/s12640-009-9094-1; El-Agnaf OMA, 1998, FEBS LETT, V440, P67, DOI 10.1016/S0014-5793(98)01419-7; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; MAROTEAUX L, 1991, MOL BRAIN RES, V11, P335, DOI 10.1016/0169-328X(91)90043-W; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; McFarland NR, 2009, J NEUROPATH EXP NEUR, V68, P515, DOI 10.1097/NEN.0b013e3181a24b53; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Takahashi M, 2003, NEUROSCI LETT, V336, P155, DOI 10.1016/S0304-3940(02)01258-2; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; Tiscornia G, 2006, NAT PROTOC, V1, P234, DOI 10.1038/nprot.2006.36; Venda LL, 2010, TRENDS NEUROSCI, V33, P559, DOI 10.1016/j.tins.2010.09.004; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Waxman EA, 2011, J NEUROSCI RES, V89, P231, DOI 10.1002/jnr.22537; Wislet-Gendebien S, 2006, J BIOL CHEM, V281, P32148, DOI 10.1074/jbc.M605965200; Wislet-Gendebien S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-92; Zabrocki P, 2005, FEBS J, V272, P1386, DOI 10.1111/j.1742-4658.2005.04571.x; Zabrocki P, 2008, BBA-MOL CELL RES, V1783, P1767, DOI 10.1016/j.bbamcr.2008.06.010	47	43	43	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35863	35873		10.1074/jbc.M111.253450	http://dx.doi.org/10.1074/jbc.M111.253450			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21849493	Green Published, hybrid			2022-12-27	WOS:000295927100059
J	Chertov, AO; Holzhausen, L; Kuok, IT; Couron, D; Parker, E; Linton, JD; Sadilek, M; Sweet, IR; Hurley, JB				Chertov, Andrei O.; Holzhausen, Lars; Kuok, Iok Teng; Couron, Drew; Parker, Ed; Linton, Jonathan D.; Sadilek, Martin; Sweet, Ian R.; Hurley, James B.			Roles of Glucose in Photoreceptor Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; RAT RETINA; PANCREATIC-ISLETS; OXIDATIVE STRESS; RABBIT RETINA; RD MOUSE; METABOLISM; APOPTOSIS; GLYCOSYLATION; AUTOPHAGY	Vertebrate photoreceptor neurons have a high demand for metabolic energy, and their viability is very sensitive to genetic and environmental perturbations. We investigated the relationship between energy metabolism and cell death by evaluating the metabolic effects of glucose deprivation on mouse photoreceptors. Oxygen consumption, lactate production, ATP, NADH/NAD(+), TCA cycle intermediates, morphological changes, autophagy, and viability were evaluated. We compared retinas incubated with glucose to retinas deprived of glucose or retinas treated with a mixture of mitochondrion-specific fuels. Rapid and slow phases of cell death were identified. The rapid phase is linked to reduced mitochondrial activity, and the slower phase reflects a need for substrates for cell maintenance and repair.	[Hurley, James B.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Kuok, Iok Teng; Couron, Drew; Sweet, Ian R.] Univ Washington, Dept Med, Obes Ctr Excellence, Seattle, WA 98195 USA; [Parker, Ed] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Sadilek, Martin] Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hurley, JB (corresponding author), Univ Washington, Dept Biochem, POB 357350, Seattle, WA 98195 USA.	jbhhh@uw.edu			National Institutes of Health [RO1 EY017863, RO1 EY06641]; Diabetes Endocrine Research Center Islet Core [P30EY1730, DK17047]; NATIONAL EYE INSTITUTE [P30EY001730, R01EY017863, R01EY006641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrine Research Center Islet Core; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 EY017863 (to J. B. H.) and RO1 EY06641 (to J. B. H.), Core Grant for Vision Research P30EY1730, and Grant DK17047 from Diabetes Endocrine Research Center Islet Core (to I. R. S.).	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; ASANO T, 1991, J BIOL CHEM, V266, P24632; Coffe V, 2004, J NEUROCHEM, V88, P885, DOI 10.1046/j.1471-4159.2003.02207.x; COHEN LH, 1960, J NEUROCHEM, V5, P253, DOI 10.1111/j.1471-4159.1960.tb13363.x; Doonan F, 2005, INVEST OPHTH VIS SCI, V46, P3530, DOI 10.1167/iovs.05-0248; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; FLIESLER SJ, 1984, NATURE, V311, P575, DOI 10.1038/311575a0; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; FUTTERMAN S, 1970, J NEUROCHEM, V17, P149, DOI 10.1111/j.1471-4159.1970.tb02195.x; Garcia-Arencibia M, 2010, SEMIN CELL DEV BIOL, V21, P691, DOI 10.1016/j.semcdb.2010.02.008; GIBLIN FJ, 1980, EXP EYE RES, V31, P601, DOI 10.1016/S0014-4835(80)80019-4; Goebel DJ, 2006, J NEUROCHEM, V98, P1732, DOI 10.1111/j.1471-4159.2006.04065.x; Gospe SM, 2010, J CELL SCI, V123, P3639, DOI 10.1242/jcs.072389; Groeger G, 2009, J NEUROCHEM, V109, P1544, DOI 10.1111/j.1471-4159.2009.06081.x; Guimaraes CA, 2003, J BIOL CHEM, V278, P41938, DOI 10.1074/jbc.M306547200; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Kunchithapautham K, 2011, INVEST OPHTH VIS SCI, V52, P2967, DOI 10.1167/iovs.10-6278; LINSENMEIER RA, 1986, J GEN PHYSIOL, V88, P521, DOI 10.1085/jgp.88.4.521; LINSENMEIER RA, 1990, GRAEF ARCH CLIN EXP, V228, P143, DOI 10.1007/BF02764309; Murray AR, 2009, OPHTHALMIC GENET, V30, P109, DOI 10.1080/13816810902962405; Mylvaganam GH, 2006, MOL VIS, V12, P1496; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Ramamurthy V, 2003, P NATL ACAD SCI USA, V100, P12630, DOI 10.1073/pnas.2134194100; Reidel B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002469; Rohrer B, 2004, J BIOL CHEM, V279, P41903, DOI 10.1074/jbc.M405085200; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Sharma AK, 2004, J BIOL CHEM, V279, P35564, DOI 10.1074/jbc.M401037200; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P661, DOI 10.1089/152091502320798303; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P67, DOI 10.1089/15209150252924111; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wang L, 1997, INVEST OPHTH VIS SCI, V38, P48; Wang T, 2009, J CELL BIOL, V186, P703, DOI 10.1083/jcb.200904090; Wang XD, 2001, GENE DEV, V15, P2922; Ward MW, 2007, J NEUROSCI, V27, P8238, DOI 10.1523/JNEUROSCI.1984-07.2007; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; WICK AN, 1957, J BIOL CHEM, V224, P963; Winkler BS, 2008, INVEST OPHTH VIS SCI, V49, P4613, DOI 10.1167/iovs.08-2004; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; WINKLER BS, 1972, VISION RES, V12, P1183, DOI 10.1016/0042-6989(72)90106-X; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Yang CS, 2010, EMBO J, V29, P3196, DOI 10.1038/emboj.2010.191; Yang S, 2010, J CHROMATOGR A, V1217, P7401, DOI 10.1016/j.chroma.2010.09.055; Ying H S, 2001, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0718s13; Young JE, 2009, J BIOL CHEM, V284, P2363, DOI 10.1074/jbc.M806088200; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200	58	59	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34700	34711		10.1074/jbc.M111.279752	http://dx.doi.org/10.1074/jbc.M111.279752			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21840997	Green Published, hybrid			2022-12-27	WOS:000295406300024
J	Schwarz, F; Fan, YY; Schubert, M; Aebi, M				Schwarz, Flavio; Fan, Yao-Yun; Schubert, Mario; Aebi, Markus			Cytoplasmic N-Glycosyltransferase of Actinobacillus pleuropneumoniae Is an Inverting Enzyme and Recognizes the NX(S/T) Consensus Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZAE HMW1 ADHESIN; O-GLCNAC TRANSFERASE; IN-VIVO; BACTERIAL OLIGOSACCHARYLTRANSFERASE; GLYCOSYLATION; PROTEIN; NMR; GLYCOPROTEINS; SPECIFICITY; GLYCANS	N-Linked glycosylation is a frequent protein modification that occurs in all three domains of life. This process involves the transfer of a preassembled oligosaccharide from a lipid donor to asparagine side chains of polypeptides and is catalyzed by the membrane-bound oligosaccharyltransferase (OST). We characterized an alternative bacterial pathway wherein a cytoplasmic N-glycosyltransferase uses nucleotide-activated monosaccharides as donors to modify asparagine residues of peptides and proteins. N-Glycosyltransferase is an inverting glycosyltransferase and recognizes the NX(S/T) consensus sequence. It therefore exhibits similar acceptor site specificity as eukaryotic OST, despite the unrelated predicted structural architecture and the apparently different catalytic mechanism. The identification of an enzyme that integrates some of the features of OST in a cytoplasmic pathway defines a novel class of N-linked protein glycosylation found in pathogenic bacteria.	[Schubert, Mario] ETH, Inst Mol Biol & Biophys, Dept Biol, CH-8093 Zurich, Switzerland; [Schwarz, Flavio; Fan, Yao-Yun; Aebi, Markus] ETH, Inst Microbiol, Dept Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schubert, M (corresponding author), ETH, Inst Mol Biol & Biophys, Dept Biol, Schafmattstr 20, CH-8093 Zurich, Switzerland.	schubert@mol.biol.ethz.ch; aebi@micro.biol.ethz.ch	Schubert, Mario/B-3972-2008; Fan, YaoYun/AAS-5920-2020	Schubert, Mario/0000-0003-0278-4091; Schwarz, Flavio/0000-0002-1060-1585	Swiss National Science Foundation [3100AQ-105541]; Sinergia [CRSII3_127333]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sinergia; ETH Zurich(ETH Zurich)	This work was supported by Swiss National Science Foundation Grant 3100AQ-105541 (to M. A.), Sinergia Grant CRSII3_127333, and ETH Zurich.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Antoine T, 2003, CHEMBIOCHEM, V4, P406, DOI 10.1002/cbic.200200540; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Choi KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015888; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; CLORE GM, 1988, FEBS LETT, V238, P17, DOI 10.1016/0014-5793(88)80216-3; Goddard TD, 2008, SPARKY VERSION 3; Grass S, 2003, MOL MICROBIOL, V48, P737, DOI 10.1046/j.1365-2958.2003.03450.x; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hansen PI, 2008, BIOPOLYMERS, V89, P1179, DOI 10.1002/bip.21075; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kohda D, 2007, GLYCOBIOLOGY, V17, P1175, DOI 10.1093/glycob/cwm087; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; Marshall R D, 1974, Biochem Soc Symp, P17; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; OGAWA T, 1983, AGR BIOL CHEM TOKYO, V47, P1213, DOI 10.1080/00021369.1983.10863384; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schwarz F, 2011, GLYCOBIOLOGY, V21, P45, DOI 10.1093/glycob/cwq130; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; Simon B, 2000, THESIS FREE U BERLIN; Slynko V, 2009, J AM CHEM SOC, V131, P1274, DOI 10.1021/ja808682v; TAKEDA T, 1980, CAN J CHEM, V58, P2600, DOI 10.1139/v80-415; Thijssen-van Zuylen CWEM, 1998, BIOCHEMISTRY-US, V37, P1933, DOI 10.1021/bi9718548; Valliere-Douglass JF, 2009, J BIOL CHEM, V284, P32493, DOI 10.1074/jbc.M109.014803; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Wang LX, 2008, CARBOHYD RES, V343, P1509, DOI 10.1016/j.carres.2008.03.025; WILLIAMSON MP, 1995, CARBOHYD RES, V266, P229, DOI 10.1016/0008-6215(94)00273-I; Wood MJ, 2000, NAT STRUCT BIOL, V7, P200; Yamaguchi Y, 2000, J BIOMOL NMR, V18, P357, DOI 10.1023/A:1026776721348; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	39	61	65	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35267	35274		10.1074/jbc.M111.277160	http://dx.doi.org/10.1074/jbc.M111.277160			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21852240	hybrid, Green Published			2022-12-27	WOS:000295406300079
J	Zhou, BO; Zhou, JQ				Zhou, Bo O.; Zhou, Jin-Qiu			Recent Transcription-induced Histone H3 Lysine 4 (H3K4) Methylation Inhibits Gene Reactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CHROMATIN MODIFICATIONS; S. CEREVISIAE; YEAST; MEMORY; UBIQUITINATION; COMPLEX; SET1; ACTIVATION; EXPRESSION	Recent transcription of GAL genes transiently leaves an H3K4 methylation mark at their promoters, providing an epigenetic memory for the recent transcriptional activity. However, the physiological significance of this mark is enigmatic. In our study, we show that the transient H3K4di- and trimethylation at recently transcribed GAL1 inhibited the reinduction of GAL1. The H3K4 methylation functioned by recruiting the Isw1 ATPase onto GAL1 and thereby limiting the action of RNA polymerase II during GAL1 reactivation. Strikingly, the H3K4 methylation was also observed at the promoters of inositol- and fatty acid-responsive genes after recent transcription and played a negative role in their reinduction. Taken together, our data present a new mechanism by which H3K4 methylation regulates gene transcription.	[Zhou, Bo O.; Zhou, Jin-Qiu] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci,Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhou, JQ (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci,Grad Sch, Shanghai 200031, Peoples R China.	jqzhou@sibs.ac.cn			National Natural Science Foundation of China [90919027]; Ministry of Science and Technology [2007CB914502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by National Natural Science Foundation of China Grant 90919027 and Ministry of Science and Technology Grant 2007CB914502.	Berretta J, 2008, GENE DEV, V22, P615, DOI 10.1101/gad.458008; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Camblong J, 2009, GENE DEV, V23, P1534, DOI 10.1101/gad.522509; Carvin CD, 2004, J BIOL CHEM, V279, P33057, DOI 10.1074/jbc.M405033200; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kundu S, 2007, GENE DEV, V21, P997, DOI 10.1101/gad.1506607; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Ng HH, 2000, MOL CELL BIOL, V20, P1394, DOI 10.1128/MCB.20.4.1394-1406.2000; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Wang SS, 2011, MOL CELL BIOL, V31, P3171, DOI 10.1128/MCB.05017-11; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zacharioudakis L, 2007, CURR BIOL, V17, P2041, DOI 10.1016/j.cub.2007.10.044; Zhou BO, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001272; Zhou BO, 2010, MOL CELL BIOL, V30, P2391, DOI 10.1128/MCB.01106-09	34	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34770	34776		10.1074/jbc.M111.273128	http://dx.doi.org/10.1074/jbc.M111.273128			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21849496	Green Published, hybrid			2022-12-27	WOS:000295406300031
J	Takahata, Y; Takarada, T; Hinoi, E; Nakamura, Y; Fujita, H; Yoneda, Y				Takahata, Yoshifumi; Takarada, Takeshi; Hinoi, Eiichi; Nakamura, Yukari; Fujita, Hiroyuki; Yoneda, Yukio			Osteoblastic gamma-Aminobutyric Acid, Type B Receptors Negatively Regulate Osteoblastogenesis toward Disturbance of Osteoclastogenesis Mediated by Receptor Activator of Nuclear Factor kappa B Ligand in Mouse Bone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION IN-VITRO; GABA(B) RECEPTOR; GENE-EXPRESSION; CHONDROGENIC DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; TRANSCRIPTION FACTOR-4; GLUTAMATE RECEPTORS; OSTERIX; RUNX2; BRAIN	The prevailing view is that signaling machineries for the neurotransmitter GABA are also expressed by cells outside the CNS. In cultured murine calvarial osteoblasts, mRNA was constitutively expressed for both subunits 1 and 2 of metabotropic GABA(B) receptor (GABA(B)R), along with inhibition by the GABA(B)R agonist baclofen of cAMP formation, alkaline phosphatase (ALP) activity, and Ca2+ accumulation. Moreover, baclofen significantly inhibited the transactivation of receptor activator of nuclear factor-kappa B ligand (RANKL) gene in a manner sensitive to a GABA(B)R antagonist, in addition to decreasing mRNA expression of bone morphogenetic protein-2 (BMP2), osteocalcin, and osterix. In osteoblastic MC3T3-E1 cells stably transfected with GABA(B)R1 subunit, significant reductions were seen in ALP activity and Ca2+ accumulation, as well as mRNA expression of osteocalcin, osteopontin, and osterix. In cultured calvarial osteoblasts from GABA(B)R1-null mice exhibiting low bone mineral density in tibia and femur, by contrast, both ALP activity and Ca2+ accumulation were significantly increased together with promoted expression of both mRNA and proteins for BMP2 and osterix. No significant change was seen in the number of multinucleated cells stained for tartrate-resistant acid phosphatase during the culture of osteoclasts prepared from GABA(B)R1-null mice, whereas a significant increase was seen in the number of tartrate-resistant acid phosphatase-positive multinucleated cells in co-culture of osteoclasts with osteoblasts isolated from GABA(B)R1-null mice. These results suggest that GABA(B)R is predominantly expressed by osteoblasts to negatively regulate osteoblastogenesis through down-regulation of BMP2 expression toward disturbance of osteoclastogenesis after down-regulation of RANKL expression in mouse bone.	[Takahata, Yoshifumi; Takarada, Takeshi; Hinoi, Eiichi; Nakamura, Yukari; Fujita, Hiroyuki; Yoneda, Yukio] Kanazawa Univ, Grad Sch Nat Sci & Technol, Mol Pharmacol Lab, Div Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Yoneda, Y (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Mol Pharmacol Lab, Div Pharmaceut Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	yyoneda@p.kanazawa-u.ac.jp	Yoneda, Yukio/ABI-1864-2020; Takahata, Yoshifumi/AAZ-6869-2021	Yoneda, Yukio/0000-0002-4624-177X; Takarada, Takeshi/0000-0002-2363-7704	Ministry of Education, Culture, Sports, Science and Technology, Japan [22500330, 21659018]; Grants-in-Aid for Scientific Research [09J03309] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aids for Scientific Research 22500330 (to T. T.) and 21659018 (to Y. Y.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Castelli MP, 1999, LIFE SCI, V64, P1321, DOI 10.1016/S0024-3205(99)00067-3; Chien KR, 2005, CELL, V120, P533, DOI 10.1016/j.cell.2005.02.006; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; ERDO SL, 1982, J NEUROCHEM, V38, P1174, DOI 10.1111/j.1471-4159.1982.tb05368.x; Fu HH, 2007, J BIOMED MATER RES A, V83A, P770, DOI 10.1002/jbm.a.31356; Fujimori S, 2002, BIOCHEM BIOPH RES CO, V293, P1445, DOI 10.1016/S0006-291X(02)00405-9; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hinoi E, 2002, BIOCHEM BIOPH RES CO, V297, P452, DOI 10.1016/S0006-291X(02)02223-4; Hinoi E, 2006, J BIOL CHEM, V281, P18015, DOI 10.1074/jbc.M600603200; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kobayashi H, 2000, BIOCHEM BIOPH RES CO, V273, P630, DOI 10.1006/bbrc.2000.2981; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Mori K, 2006, J CELL BIOCHEM, V98, P1629, DOI 10.1002/jcb.20891; Nakamura Y, 2009, J PHARMACOL SCI, V109, P413, DOI 10.1254/jphs.08315FP; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nehring RB, 2000, J BIOL CHEM, V275, P35185, DOI 10.1074/jbc.M002727200; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; OKADA Y, 1976, SCIENCE, V194, P620, DOI 10.1126/science.185693; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Takahata Y, 2009, J CELL PHYSIOL, V218, P268, DOI 10.1002/jcp.21594; Takarada T, 2008, J CELL PHYSIOL, V215, P320, DOI 10.1002/jcp.21310; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; White JH, 2000, P NATL ACAD SCI USA, V97, P13967, DOI 10.1073/pnas.240452197; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Zambotti A, 2002, J BIOL CHEM, V277, P41497, DOI 10.1074/jbc.M204271200	36	25	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32906	32917		10.1074/jbc.M111.253526	http://dx.doi.org/10.1074/jbc.M111.253526			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828041	hybrid, Green Published			2022-12-27	WOS:000294968800009
J	Liu, Z; Turan, S; Wehbi, VL; Vilardaga, JP; Bastepe, M				Liu, Zun; Turan, Serap; Wehbi, Vanessa L.; Vilardaga, Jean-Pierre; Bastepe, Murat			Extra-long G alpha s Variant XL alpha s Protein Escapes Activation-induced Subcellular Redistribution and Is Able to Provide Sustained Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATORY G-PROTEIN; MCCUNE-ALBRIGHT-SYNDROME; GNAS1 T393C POLYMORPHISM; PARATHYROID-HORMONE RECEPTOR; COUPLED RECEPTORS; ADENYLYL-CYCLASE; CELL CARCINOMA; FREE SURVIVAL; GENE VARIANT; SUBUNIT	Murine models indicate that G alpha s and its extra-long variant XL alpha s, both of which are derived from GNAS, markedly differ regarding their cellular actions, but these differences are unknown. Here we investigated activation-induced trafficking of G alpha s and XL alpha s, using immunofluorescence microscopy, cell fractionation, and total internal reflection fluorescence microscopy. In transfected cells, XL alpha s remained localized to the plasma membrane, whereas G alpha s redistributed to the cytosol after activation by GTPase-inhibiting mutations, cholera toxin treatment, or G protein-coupled receptor agonists (isoproterenol or parathyroid hormone (PTH)(1-34)). Cholera toxin treatment or agonist (isoproterenol or pituitary adenylate cyclase activating peptide-27) stimulation of PC12 cells expressing G alpha s and XL alpha s endogenously led to an increased abundance of G alpha s, but not XL alpha s, in the soluble fraction. Mutational analyses revealed two conserved cysteines and the highly charged domain as being critically involved in the plasma membrane anchoring of XL alpha s. The cAMP response induced by M-PTH(1-14), a parathyroid hormone analog, terminated quickly in HEK293 cells stably expressing the type 1 PTH/PTH-related peptide receptor, whereas the response remained maximal for at least 6 min in cells that co-expressed the PTH receptor and XL alpha s. Although isoproterenol-induced cAMP response was not prolonged by XL alpha s expression, a GTPase-deficient XL alpha s mutant found in certain tumors and patients with fibrous dysplasia of bone and McCune-Albright syndrome generated more basal cAMP accumulation in HEK293 cells and caused more severe impairment of osteoblastic differentiation of MC3T3-E1 cells than the cognate G alpha s mutant (gsp oncogene). Thus, activated XL alpha s and G alpha s traffic differently, and this may form the basis for the differences in their cellular actions.	[Liu, Zun; Turan, Serap; Vilardaga, Jean-Pierre; Bastepe, Murat] Massachusetts Gen Hosp, Endocrine Unit, Dept Med, Boston, MA 02114 USA; [Liu, Zun; Turan, Serap; Vilardaga, Jean-Pierre; Bastepe, Murat] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Turan, Serap] Marmara Univ, Sch Med Hosp, TR-34662 Istanbul, Turkey; [Wehbi, Vanessa L.; Vilardaga, Jean-Pierre] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab Protein Coupled Receptor Biol G, Pittsburgh, PA 15213 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Marmara University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bastepe, M (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Dept Med, 50 Blossom St Thier 10, Boston, MA 02114 USA.	bastepe@helix.mgh.harvard.edu	Turan, Serap/U-7195-2018; Bastepe, Murat/GQQ-3389-2022	Turan, Serap/0000-0002-5172-5402; Vilardaga, Jean-Pierre/0000-0002-1217-1435; Bastepe, Murat/0000-0002-2643-3504	National Institutes of Health from NIDDK [R01DK073911, R01DK087688]; March of Dimes Foundation [6-FY10-336]; European Society for Paediatric Endocrinology through Lilly, LLC.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087688, R01DK073911] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; March of Dimes Foundation(March of Dimes); European Society for Paediatric Endocrinology through Lilly, LLC.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK073911 (to M. B.) and R01DK087688 (to J.-P. V.) from NIDDK. This work was also supported in part by March of Dimes Foundation Research Grant 6-FY10-336 (to M. B.).; Supported by a grant of the Sabbatical Leave Programme from the European Society for Paediatric Endocrinology through an educational grant from Lilly, LLC.	Abramowitz J, 2004, P NATL ACAD SCI USA, V101, P8366, DOI 10.1073/pnas.0308758101; Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Allen JA, 2009, MOL PHARMACOL, V76, P1082, DOI 10.1124/mol.109.060160; Aydin C, 2009, ENDOCRINOLOGY, V150, P3567, DOI 10.1210/en.2009-0318; Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; Bastepe M, 2002, MOL ENDOCRINOL, V16, P1912, DOI 10.1210/me.2002-0054; Bunemann M, 1999, ANNU REV PHYSIOL, V61, P169, DOI 10.1146/annurev.physiol.61.1.169; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Chen YS, 2003, HYPERTENS RES, V26, P439, DOI 10.1291/hypres.26.439; Crouthamel M, 2008, CELL SIGNAL, V20, P1900, DOI 10.1016/j.cellsig.2008.06.019; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Frey UH, 2006, CLIN CANCER RES, V12, P759, DOI 10.1158/1078-0432.CCR-05-1722; Frey UH, 2005, CLIN CANCER RES, V11, P5071, DOI 10.1158/1078-0432.CCR-05-0472; Frey UH, 2005, CANCER EPIDEM BIOMAR, V14, P871, DOI 10.1158/1055-9965.EPI-04-0720; Germain-Lee EL, 2005, ENDOCRINOLOGY, V146, P4697, DOI 10.1210/en.2005-0681; Hahn S, 2006, EUR J ENDOCRINOL, V155, P763, DOI 10.1530/eje.1.02275; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kaya AI, 2009, J PHARMACOL EXP THER, V329, P350, DOI 10.1124/jpet.108.149989; KEHLENBACH RH, 1994, NATURE, V372, P804; Klemke M, 2000, J BIOL CHEM, V275, P33633, DOI 10.1074/jbc.M006594200; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; KOZASA T, 1988, P NATL ACAD SCI USA, V85, P2081, DOI 10.1073/pnas.85.7.2081; Lehnerdt GF, 2008, CLIN CANCER RES, V14, P1753, DOI 10.1158/1078-0432.CCR-07-1605; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Linglart AS, 2006, ENDOCRINOLOGY, V147, P2253, DOI 10.1210/en.2005-1487; Liu Z, 2011, ENDOCRINOLOGY, V152, P1222, DOI 10.1210/en.2010-1034; Makita N, 2007, P NATL ACAD SCI USA, V104, P17424, DOI 10.1073/pnas.0708561104; Mantovani G, 2004, J CLIN ENDOCR METAB, V89, P3007, DOI 10.1210/jc.2004-0194; Mariot V, 2011, BONE, V48, P312, DOI 10.1016/j.bone.2010.09.032; Michienzi S, 2007, HUM MOL GENET, V16, P1921, DOI 10.1093/hmg/ddm139; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Okazaki M, 2008, P NATL ACAD SCI USA, V105, P16525, DOI 10.1073/pnas.0808750105; Otterbach F, 2007, BREAST CANCER RES TR, V105, P311, DOI 10.1007/s10549-006-9462-y; PARENTI M, 1993, BIOCHEM J, V291, P349, DOI 10.1042/bj2910349; Pasolli HA, 2000, J BIOL CHEM, V275, P33622, DOI 10.1074/jbc.M001335200; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Peters J, 2008, ADV EXP MED BIOL, V626, P16; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Plagge A, 2008, J ENDOCRINOL, V196, P193, DOI 10.1677/JOE-07-0544; Reik W, 2000, INT J DEV BIOL, V44, P145; Sandgren J, 2010, EXP MOL MED, V42, P484, DOI 10.3858/emm.2010.42.7.050; Schmitz KJ, 2007, NEOPLASIA, V9, P159, DOI 10.1593/neo.06796; SCHWINDINGER WF, 1992, P NATL ACAD SCI USA, V89, P5152, DOI 10.1073/pnas.89.11.5152; Shimizu N, 2005, J BIOL CHEM, V280, P1797, DOI 10.1074/jbc.M408270200; Skinner JA, 2002, GENOMICS, V80, P373, DOI 10.1006/geno.2002.6842; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Thiyagarajan MM, 2002, BIOCHEMISTRY-US, V41, P9470, DOI 10.1021/bi025533u; Tintut Y, 1999, J BIOL CHEM, V274, P28875, DOI 10.1074/jbc.274.41.28875; Tominaga E, 2010, GYNECOL ONCOL, V118, P160, DOI 10.1016/j.ygyno.2010.03.010; Ugur O, 2000, MOL BIOL CELL, V11, P1421, DOI 10.1091/mbc.11.4.1421; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; Wedegaertner PB, 1996, MOL BIOL CELL, V7, P1225, DOI 10.1091/mbc.7.8.1225; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Xie T, 2006, J BIOL CHEM, V281, P18989, DOI 10.1074/jbc.M511752200; Yamamoto M, 2004, HYPERTENS RES, V27, P919, DOI 10.1291/hypres.27.919; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200; Yu SH, 2000, J CLIN INVEST, V105, P615, DOI 10.1172/JCI8437; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757	69	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38558	38569		10.1074/jbc.M111.240150	http://dx.doi.org/10.1074/jbc.M111.240150			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21890629	Green Published, hybrid			2022-12-27	WOS:000296594200069
J	Brittain, JM; Chen, L; Wilson, SM; Brustovetsky, T; Gao, X; Ashpole, NM; Molosh, AI; You, HT; Hudmon, A; Shekhar, A; White, FA; Zamponi, GW; Brustovetsky, N; Chen, JH; Khanna, R				Brittain, Joel M.; Chen, Liang; Wilson, Sarah M.; Brustovetsky, Tatiana; Gao, Xiang; Ashpole, Nicole M.; Molosh, Andrei I.; You, Haitao; Hudmon, Andy; Shekhar, Anantha; White, Fletcher A.; Zamponi, Gerald W.; Brustovetsky, Nickolay; Chen, Jinhui; Khanna, Rajesh			Neuroprotection against Traumatic Brain Injury by a Peptide Derived from the Collapsin Response Mediator Protein 2 (CRMP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTATE RECEPTORS; CONTROLLED CORTICAL IMPACT; NEURONAL DEATH; MITOCHONDRIAL DYSFUNCTION; POSTSYNAPTIC DENSITY-95; CALPAIN CLEAVAGE; CLINICAL-TRIALS; NMDA-RECEPTORS; NR2B SUBUNIT; IN-VITRO	Background: CRMP2 is an axonal guidance protein that has been linked to NMDA receptor-mediated excitotoxicity. Results: A CRMP2 peptide protects against NMDA receptor-mediated excitotoxicity in vitro and in vivo following a traumatic brain injury. Conclusion: CRMP2 is a novel target for neuroprotection. Significance: Targeting CRMP2 could lead to development of neurotherapeutics against traumatic brain injury as well as other neuronal insults.	[Brittain, Joel M.; Wilson, Sarah M.; Ashpole, Nicole M.; Hudmon, Andy; White, Fletcher A.; Brustovetsky, Nickolay; Chen, Jinhui; Khanna, Rajesh] Indiana Univ, Sch Med, Program Med Neurosci, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Chen, Liang; Gao, Xiang; Chen, Jinhui] Indiana Univ, Sch Med, Dept Neurol Surg, Indianapolis, IN 46202 USA; [Brustovetsky, Tatiana; Brustovetsky, Nickolay] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Ashpole, Nicole M.; Hudmon, Andy] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Molosh, Andrei I.; Shekhar, Anantha] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [White, Fletcher A.] Indiana Univ, Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA; [Shekhar, Anantha] Indiana Univ, Sch Med, Indiana Clin & Translat Sci Inst, Indianapolis, IN 46202 USA; [White, Fletcher A.; Chen, Jinhui; Khanna, Rajesh] Indiana Univ, Sch Med, Indiana Spinal Cord & Brain Injury Grp, Indianapolis, IN 46202 USA; [You, Haitao; Zamponi, Gerald W.] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Calgary	Khanna, R (corresponding author), 950 W Walnut St,R2 Rm 478, Indianapolis, IN 46202 USA.	khanna5@iupui.edu	White, Fletcher/F-3203-2015; White, Fletcher A/F-2895-2012	White, Fletcher/0000-0002-8408-9262; Khanna, Rajesh/0000-0002-9066-2969; Zamponi, Gerald W./0000-0002-0644-9066; Molosh, Andrei/0000-0001-6451-7912	National Institutes of Health [R01 NS050131]; Alberta Heritage Foundation for Medical Research (AHFMR); American Heart Association [SDG5280023]; Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Research Resources [RR025761]; Ralph W. and Grace M. Showalter foundation [A70-0-079212, A70-9-079138]; Elwert Award in Medicine; Larry Kays Medical Neuroscience Fellowship; Canadian Institutes of Health Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072631, R01NS050131, R21NS075733, R01NS049136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); American Heart Association(American Heart Association); Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ralph W. and Grace M. Showalter foundation; Elwert Award in Medicine; Larry Kays Medical Neuroscience Fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS050131 (to N. B.). This work was also supported by a fellowship from the Alberta Heritage Foundation for Medical Research (AHFMR) (to H. Y.), American Heart Association National Scientist Development Grant SDG5280023 (to R. K.), a grant from the Indiana Clinical and Translational Sciences Institute funded, in part by a Project Development Team Grant Number RR025761 from the National Institutes of Health, National Center for Research Resources, Clinical and Translational Sciences Award (Indiana State Department of Health, Indiana Spinal Cord and Brain Injury Research Fund, Grants A70-0-079212 (to N. B.) and A70-9-079138 (to R. K.)), grants from the Ralph W. and Grace M. Showalter foundation (to A. H., N. B., and R. K.), and the Elwert Award in Medicine (to R. K.).; Recipient of a Larry Kays Medical Neuroscience Fellowship.; An AHFMR Scientist and a Canada Research Chair, supported by the Canadian Institutes of Health Research.	Adamec E, 1998, MOL BRAIN RES, V54, P35, DOI 10.1016/S0169-328X(97)00304-5; Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; [Anonymous], 2003, COCHRANE DATABASE SY; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Chen A, 2007, NEUROCHEM INT, V50, P1078, DOI 10.1016/j.neuint.2006.11.008; Chi XX, 2009, J CELL SCI, V122, P4351, DOI 10.1242/jcs.053280; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Chung MA, 2005, NEUROREPORT, V16, P1647, DOI 10.1097/01.wnr.0000176520.49841.e6; Clapp P, 2010, J PHARMACOL EXP THER, V332, P720, DOI 10.1124/jpet.109.158741; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; CRUNELLI V, 1983, J PHYSIOL-LONDON, V341, P627, DOI 10.1113/jphysiol.1983.sp014829; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Dong YN, 2004, J NEUROSCI, V24, P11035, DOI 10.1523/JNEUROSCI.3722-04.2004; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2009, J NEUROTRAUM, V26, P1325, DOI [10.1089/neu.2008.0744, 10.1089/neu.2008-0744]; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Hou ST, 2009, J NEUROCHEM, V111, P870, DOI 10.1111/j.1471-4159.2009.06375.x; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Jain KK, 2000, EXPERT OPIN INV DRUG, V9, P1397, DOI 10.1517/13543784.9.6.1397; Jiang SX, 2007, EUR J NEUROSCI, V26, P801, DOI 10.1111/j.1460-9568.2007.05715.x; Kennett SB, 2004, J BIOL CHEM, V279, P3300, DOI 10.1074/jbc.M305734200; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kowara R, 2005, J NEUROCHEM, V95, P466, DOI 10.1111/j.1471-4159.2005.03383.x; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Liu W, 2009, PROTEOMICS, V9, P3712, DOI 10.1002/pmic.200800979; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Molosh AI, 2010, NEUROPSYCHOPHARMACOL, V35, P1333, DOI 10.1038/npp.2010.2; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Nicholls DG, 2004, CURR MOL MED, V4, P149, DOI 10.2174/1566524043479239; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; PARK CK, 1988, ANN NEUROL, V24, P543, DOI 10.1002/ana.410240411; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Pickel VM, 2006, NEUROSCIENCE, V142, P671, DOI 10.1016/j.neuroscience.2006.06.059; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Sonkusare SK, 2005, PHARMACOL RES, V51, P1, DOI 10.1016/j.phrs.2004.05.005; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Touma E, 2007, EUR J NEUROSCI, V26, P3368, DOI 10.1111/j.1460-9568.2007.05943.x; Villmann C, 2007, NEUROSCIENTIST, V13, P594, DOI 10.1177/1073858406296259; Volbracht C, 2006, EUR J NEUROSCI, V23, P2611, DOI 10.1111/j.1460-9568.2006.04787.x; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang Yuying, 2010, Commun Integr Biol, V3, P172; Wilson S. M., 2011, CHANNELS AU IN PRESS; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Yuen EY, 2008, MOL PHARMACOL, V74, P360, DOI 10.1124/mol.108.046813; Zhang S, 2008, J NEUROSCI, V28, P415, DOI 10.1523/JNEUROSCI.1900-07.2008; Zhang Z, 2009, CELL MOL LIFE SCI, V66, P526, DOI 10.1007/s00018-008-8362-1; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078	72	75	80	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37778	37792		10.1074/jbc.M111.255455	http://dx.doi.org/10.1074/jbc.M111.255455			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21832084	Green Published, hybrid			2022-12-27	WOS:000296542400073
J	Dun, MD; Smith, ND; Baker, MA; Lin, MJ; Aitken, RJ; Nixon, B				Dun, Matthew D.; Smith, Nathan D.; Baker, Mark A.; Lin, Minjie; Aitken, R. John; Nixon, Brett			The Chaperonin Containing TCP1 Complex (CCT/TRiC) Is Involved in Mediating Sperm-Oocyte Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZONA-PELLUCIDA BINDING; BLUE-NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; O-LINKED OLIGOSACCHARIDES; MOUSE SPERM; TYROSINE PHOSPHORYLATION; CYTOPLASMIC CHAPERONIN; T-COMPLEX; MOLECULAR CHAPERONE; RECEPTOR-ACTIVITY	Sperm-oocyte interactions are among the most remarkable processes in cell biology. These cellular recognition events are initiated by an exquisitely specific adhesion of free-swimming spermatozoa to the zona pellucida, an acellular matrix that surrounds the ovulated oocyte. Decades of research focusing on this interaction have led to the establishment of a widely held paradigm that the zona pellucida receptor is a single molecular entity that is constitutively expressed on the sperm cell surface. In contrast, we have employed the techniques of blue native-polyacrylamide gel electrophoresis, far Western blotting, and proximity ligation to secure the first direct evidence in support of a novel hypothesis that zona binding is mediated by multimeric sperm receptor complex(es). Furthermore, we show that one such multimeric association, comprising the chaperonin-containing TCP1 complex (CCT/TRiC) and a zona-binding protein, zona pellucida-binding protein 2, is present on the surface of capacitated spermatozoa and could account for the zona binding activity of these cells. Collectively, these data provide an important biochemical insight into the molecular basis of sperm-zona pellucida interaction and a plausible explanation for how spermatozoa gain their ability to fertilize.	[Dun, Matthew D.; Smith, Nathan D.; Baker, Mark A.; Lin, Minjie; Aitken, R. John; Nixon, Brett] Univ Newcastle, Reprod Sci Grp, Sch Environm & Life Sci, Discipline Biol Sci, Callaghan, NSW 2308, Australia; [Dun, Matthew D.; Baker, Mark A.; Aitken, R. John] Univ Newcastle, ARC Ctr Excellence Biotechnol & Dev, Sch Environm & Life Sci, Discipline Biol Sci, Callaghan, NSW 2308, Australia	University of Newcastle; University of Newcastle	Nixon, B (corresponding author), Univ Newcastle, Reprod Sci Grp, Sch Environm & Life Sci, Discipline Biol Sci, Callaghan, NSW 2308, Australia.	Brett.Nixon@newcastle.edu.au	Aitken, Robert John/AAY-8238-2020; Dun, Matthew D./I-3399-2012; Nixon, Brett/B-5121-2012	Aitken, Robert John/0000-0002-9152-156X; Nixon, Brett/0000-0003-2745-8188; Dun, Matthew/0000-0002-9063-5370				Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Adham IM, 1997, MOL REPROD DEV, V46, P370, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;370::AID-MRD16&gt;3.0.CO;2-2; Aitken RJ, 2008, J CLIN INVEST, V118, P1330, DOI 10.1172/JCI33873; Aivaliotis M, 2006, PHOTOSYNTH RES, V88, P143, DOI 10.1007/s11120-006-9046-z; ARTZT K, 1979, GENET RES, V33, P279, DOI 10.1017/S0016672300018425; Asquith KL, 2004, J CELL SCI, V117, P3645, DOI 10.1242/jcs.01214; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Baker MA, 2010, J PROTEOME RES, V9, P718, DOI 10.1021/pr900513d; BENNETT D, 1975, NATURE, V257, P236, DOI 10.1038/257236a0; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; BLEIL JD, 1980, DEV BIOL, V76, P185, DOI 10.1016/0012-1606(80)90371-1; BLEIL JD, 1981, DEV BIOL, V86, P189, DOI 10.1016/0012-1606(81)90329-8; BLEIL JD, 1988, P NATL ACAD SCI USA, V85, P6778, DOI 10.1073/pnas.85.18.6778; BLEIL JD, 1983, DEV BIOL, V95, P317, DOI 10.1016/0012-1606(83)90032-5; Buffone MG, 2008, J BIOL CHEM, V283, P12438, DOI 10.1074/jbc.M706421200; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; CHENG CC, 1980, CELL, V19, P537, DOI 10.1016/0092-8674(80)90528-0; Clark GF, 2006, J BIOL CHEM, V281, P13853, DOI 10.1074/jbc.R600001200; Cooper T., 1998, ENCY REPROD, V2, P1; Couldrey C, 1999, HUM MOL GENET, V8, P2489, DOI 10.1093/hmg/8.13.2489; Dean J, 2004, BIOESSAYS, V26, P29, DOI 10.1002/bies.10412; Dean J, 2005, ANDROLOGIA, V37, P198, DOI 10.1111/j.1439-0272.2005.00686.x; Dekker C, 2008, EMBO J, V27, P1827, DOI 10.1038/emboj.2008.108; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; FRANKEN DR, 1989, J IN VITRO FERTIL EM, V6, P44, DOI 10.1007/BF01134581; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; GINSBERG L, 1975, J EMBRYOL EXP MORPH, V33, P715; Harrison RAP, 2005, THERIOGENOLOGY, V63, P342, DOI 10.1016/j.theriogenology.2004.09.016; Hoodbhoy T, 2004, REPRODUCTION, V127, P417, DOI 10.1530/rep.1.00181; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Khalil MB, 2006, DEV BIOL, V290, P220, DOI 10.1016/j.ydbio.2005.11.030; Krause F, 2006, ELECTROPHORESIS, V27, P2759, DOI 10.1002/elps.200600049; KUBOTA H, 1994, CURR BIOL, V4, P89, DOI 10.1016/S0960-9822(94)00024-2; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; LITSCHER ES, 1995, BIOCHEMISTRY-US, V34, P4662, DOI 10.1021/bi00014a020; Lu QX, 1997, DEVELOPMENT, V124, P4121; Luong MX, 2002, MOL CELL BIOL, V22, P1424, DOI 10.1128/MCB.22.5.1424-1437.2002; Lyng R, 2009, J CELL SCI, V122, P3894, DOI 10.1242/jcs.058776; MARCO S, 1994, BIOPHYS J, V67, P364, DOI 10.1016/S0006-3495(94)80489-8; Mbikay M, 1997, P NATL ACAD SCI USA, V94, P6842, DOI 10.1073/pnas.94.13.6842; MORI E, 1993, BIOCHEM BIOPH RES CO, V196, P196, DOI 10.1006/bbrc.1993.2234; Neff D, 1999, BIOCHEM BIOPH RES CO, V259, P569, DOI 10.1006/bbrc.1999.0820; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; Nixon B, 2007, CELL MOL LIFE SCI, V64, P1805, DOI 10.1007/s00018-007-6552-x; Nixon B, 2006, BIOL REPROD, V74, P275, DOI 10.1095/biolreprod.105.044644; Nixon B, 2009, J CELL PHYSIOL, V218, P122, DOI 10.1002/jcp.21575; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Pappenberger G, 2006, J MOL BIOL, V360, P484, DOI 10.1016/j.jmb.2006.05.003; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rivenzon-Segal D, 2005, NAT STRUCT MOL BIOL, V12, P233, DOI 10.1038/nsmb901; Rodeheffer C, 2004, DEVELOPMENT, V131, P503, DOI 10.1242/dev.00937; Rossato Marco, 2005, Purinergic Signal, V1, P369, DOI 10.1007/s11302-005-1172-0; Salicioni Ana M, 2007, Soc Reprod Fertil Suppl, V65, P245; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SHUR BD, 1981, GENET RES, V38, P225, DOI 10.1017/S0016672300020577; SILVER LM, 1985, ANNU REV GENET, V19, P179, DOI 10.1146/annurev.ge.19.120185.001143; SILVER LM, 1979, CELL, V17, P275, DOI 10.1016/0092-8674(79)90153-3; Soues S, 2003, EXP CELL RES, V288, P363, DOI 10.1016/S0014-4827(03)00248-9; THALL AD, 1995, J BIOL CHEM, V270, P21437, DOI 10.1074/jbc.270.37.21437; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Walsh A, 2008, BIOL REPROD, V78, P983, DOI 10.1095/biolreprod.107.066860; Wassarman PM, 2009, BIOESSAYS, V31, P153, DOI 10.1002/bies.200800152; Wassarman PM, 2004, CYTOGENET GENOME RES, V105, P228, DOI 10.1159/000078193; WUDL LR, 1978, J EMBRYOL EXP MORPH, V48, P127; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977; Yu Y, 2006, DEV BIOL, V290, P32, DOI 10.1016/j.ydbio.2005.11.003; Yu Y, 2009, MICROSC RES TECHNIQ, V72, P558, DOI 10.1002/jemt.20696	76	81	88	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36875	36887		10.1074/jbc.M110.188888	http://dx.doi.org/10.1074/jbc.M110.188888			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880732	Green Published, hybrid			2022-12-27	WOS:000296538300067
J	Shen, WW; Frieden, M; Demaurex, N				Shen, Wei-Wei; Frieden, Maud; Demaurex, Nicolas			Local Cytosolic Ca2+ Elevations Are Required for Stromal Interaction Molecule 1 (STIM1) De-oligomerization and Termination of Store-operated Ca2+ Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES CRAC CHANNELS; INITIATION MECHANISM; ORAI1; DEPLETION; PROTEIN; DOMAIN; SENSOR; DEFICIENCY; REVEALS; BINDING	The Ca2+ depletion of the endoplasmic reticulum (ER) activates the ubiquitous store-operated Ca2+ entry (SOCE) pathway that sustains long-term Ca2+ signals critical for cellular functions. ER Ca2+ depletion initiates the oligomerization of stromal interaction molecules (STIM) that control SOCE activation, but whether ER Ca2+ refilling controls STIM de-oligomerization and SOCE termination is not known. Here, we correlate the changes in free luminal ER Ca2+ concentrations ([Ca2+](ER)) and in STIM1 oligomerization, using fluorescence resonance energy transfer (FRET) between CFP-STIM1 and YFP-STIM1. We observed that STIM1 de-oligomerized at much lower [Ca2+](ER) levels during store refilling than it oligomerized during store depletion. We then refilled ER stores without adding exogenous Ca2+ using a membrane-permeable Ca2+ chelator to provide a large reservoir of buffered Ca2+. This procedure rapidly restored pre-stimulatory [Ca2+](ER) levels but did not trigger STIM1 de-oligomerization, the FRET signals remaining elevated as long as the external [Ca2+] remained low. STIM1 dissociation evoked by Ca2+ readmission was prevented by SOC channel inhibition and was associated with cytosolic Ca2+ elevations restricted to STIM1 puncta, indicating that Ca2+ acts on a cytosolic target close to STIM1 clusters. These data indicate that the refilling of ER Ca2+ stores is not sufficient to induce STIM1 de-oligomerization and that localized Ca2+ elevations in the vicinity of assembled SOCE complexes are required for the termination of SOCE.	[Shen, Wei-Wei; Frieden, Maud; Demaurex, Nicolas] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Geneva	Demaurex, N (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.	Nicolas.Demaurex@unige.ch		Demaurex, Nicolas/0000-0002-9933-6772; Frieden, Maud/0000-0001-7135-0874	Swiss National Foundation [310030B-133126]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Foundation Grant 310030B-133126 (to N.D.).	Bauer MC, 2008, BIOCHEMISTRY-US, V47, P6089, DOI 10.1021/bi800496a; Calloway N, 2010, BIOCHEMISTRY-US, V49, P1067, DOI 10.1021/bi901936q; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Collins SR, 2011, TRENDS CELL BIOL, V21, P202, DOI 10.1016/j.tcb.2011.01.002; Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200; Demaurex N, 2003, CELL CALCIUM, V34, P109, DOI 10.1016/S0143-4160(03)00081-2; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Larson L, 2005, P NATL ACAD SCI USA, V102, P1921, DOI 10.1073/pnas.0409062102; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Malli R, 2008, J CELL SCI, V121, P3133, DOI 10.1242/jcs.034496; Manjarres IM, 2010, CELL CALCIUM, V47, P412, DOI 10.1016/j.ceca.2010.03.001; Mogami H, 1997, CELL, V88, P49, DOI 10.1016/S0092-8674(00)81857-7; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sampieri A, 2009, CELL CALCIUM, V45, P439, DOI 10.1016/j.ceca.2009.02.010; Srikanth S, 2010, NAT CELL BIOL, V12, P436, DOI 10.1038/ncb2045; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stathopulos PB, 2010, BIOCHEM CELL BIOL, V88, P175, DOI [10.1139/o09-125, 10.1139/O09-125]; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wang YJ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3148pe42; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	44	34	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36448	36459		10.1074/jbc.M111.269415	http://dx.doi.org/10.1074/jbc.M111.269415			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880734	Green Published, hybrid			2022-12-27	WOS:000296538300030
J	Chu, CS; Hsu, PH; Lo, PW; Scheer, E; Tora, L; Tsai, HJ; Tsai, MD; Juan, LJ				Chu, Chi-Shuen; Hsu, Pang-Hung; Lo, Pei-Wen; Scheer, Elisabeth; Tora, Laszlo; Tsai, Hang-Jen; Tsai, Ming-Daw; Juan, Li-Jung			Protein Kinase A-mediated Serine 35 Phosphorylation Dissociates Histone H1.4 from Mitotic Chromosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; COMPLEX; BINDING; MITOSIS; PKA; TRANSCRIPTION; CENTROSOMES; SIGNALS	Global histone H1 phosphorylation correlates with cell cycle progression. However, the function of site-specific H1 variant phosphorylation remains unclear. Our mass spectrometry analysis revealed a novel N-terminal phosphorylation of the major H1 variant H1.4 at serine 35 (H1.4S35ph), which accumulates at mitosis immediately after H3 phosphorylation at serine 10. Protein kinase A (PKA) was found to be a kinase for H1.4S35. Importantly, Ser-35-phosphorylated H1.4 dissociates from mitotic chromatin. Moreover, H1.4S35A substitution mutant cannot efficiently rescue the mitotic defect following H1.4 depletion, and inhibition of PKA activity increases the mitotic chromatin compaction depending on H1.4. Our results not only indicate that PKA-mediated H1.4S35 phosphorylation dissociates H1.4 from mitotic chromatin but also suggest that this phosphorylation is necessary for specific mitotic functions.	[Chu, Chi-Shuen; Hsu, Pang-Hung; Lo, Pei-Wen; Tsai, Hang-Jen; Tsai, Ming-Daw; Juan, Li-Jung] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chu, Chi-Shuen; Juan, Li-Jung] Natl Taiwan Univ, Inst Mol Med, Taipei 100, Taiwan; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Dept Life Sci, Keelung 20224, Taiwan; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung 20224, Taiwan; [Scheer, Elisabeth; Tora, Laszlo] Univ Strasbourg, Program Funct Genom & Canc, Inst Genet & Biol Mol & Cellulaire, CNRS UMR 7104,INSERM U964, F-67404 Illkirch Graffenstaden, France; [Tsai, Ming-Daw] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan Ocean University; National Taiwan Ocean University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Academia Sinica - Taiwan	Juan, LJ (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	ljjuan@gate.sinica.edu.tw	Tora, Laszlo/E-9999-2018; Juan, Li-Jung/H-6631-2015; Tsai, Ming-Daw/G-4689-2019; Hsu, Pang-Hung/C-5587-2018	Tora, Laszlo/0000-0001-7398-2250; Tsai, Ming-Daw/0000-0003-1374-0414; Hsu, Pang-Hung/0000-0001-6873-6434	National Science Council; Academia Sinica [NSC-96-2311-B-001-029, NSC-99-2320-B-001-017]; Agence Nationale de la Recherche [ANR-09-BLAN-0266]	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by National Science Council and Academia Sinica Grants NSC-96-2311-B-001-029 and NSC-99-2320-B-001-017 (to L.-J. J.) and Agence Nationale de la Recherche Grant ANR-09-BLAN-0266 (to L. T.).	Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Freedman BS, 2010, CURR BIOL, V20, P1048, DOI 10.1016/j.cub.2010.04.025; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; Gutierrez JL, 2007, EMBO J, V26, P730, DOI 10.1038/sj.emboj.7601524; Hale TK, 2006, MOL CELL, V22, P693, DOI 10.1016/j.molcel.2006.04.016; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; Happel N, 2009, J MOL BIOL, V386, P339, DOI 10.1016/j.jmb.2008.12.047; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hashimoto H, 2010, NUCLEIC ACIDS RES, V38, P3533, DOI 10.1093/nar/gkq076; Hergeth SP, 2011, J CELL SCI, V124, P1623, DOI 10.1242/jcs.084947; HILL CS, 1991, EMBO J, V10, P1939, DOI 10.1002/j.1460-2075.1991.tb07720.x; Horn PJ, 2002, NAT STRUCT BIOL, V9, P263, DOI 10.1038/nsb776; Hsu CH, 2004, EMBO J, V23, P2269, DOI 10.1038/sj.emboj.7600239; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; JUAN LJ, 1994, EMBO J, V13, P6031, DOI 10.1002/j.1460-2075.1994.tb06949.x; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Lee CF, 2010, J CLIN INVEST, V120, P2920, DOI 10.1172/JCI42275; Lee HL, 1998, EMBO J, V17, P1454, DOI 10.1093/emboj/17.5.1454; Lee JH, 2002, J BIOL CHEM, V277, P42259, DOI 10.1074/jbc.M205054200; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; OTAEGUI PJ, 1994, MOL REPROD DEV, V39, P147, DOI 10.1002/mrd.1080390205; Padilla-Nash HM, 2007, EXP DERMATOL, V16, P98, DOI 10.1111/j.1600-0625.2006.00507.x; POCHRON SF, 1979, J BIOL CHEM, V254, P6352; ROTH SY, 1992, TRENDS BIOCHEM SCI, V17, P93, DOI 10.1016/0968-0004(92)90243-3; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; Wood C, 2009, FEBS J, V276, P4109, DOI 10.1111/j.1742-4658.2009.07079.x; Zheng YP, 2010, J CELL BIOL, V189, P407, DOI 10.1083/jcb.201001148	33	32	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35843	35851		10.1074/jbc.M111.228064	http://dx.doi.org/10.1074/jbc.M111.228064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852232	Green Published, hybrid			2022-12-27	WOS:000295927100057
J	Asakuma, S; Hatakeyama, E; Urashima, T; Yoshida, E; Katayama, T; Yamamoto, K; Kumagai, H; Ashida, H; Hirose, J; Kitaoka, M				Asakuma, Sadaki; Hatakeyama, Emi; Urashima, Tadasu; Yoshida, Erina; Katayama, Takane; Yamamoto, Kenji; Kumagai, Hidehiko; Ashida, Hisashi; Hirose, Junko; Kitaoka, Motomitsu			Physiology of Consumption of Human Milk Oligosaccharides by Infant Gut-associated Bifidobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-BIOSE-I; LONGUM SUBSP INFANTIS; GENOME SEQUENCE; BINDING PROTEIN; BIFIDUM; DERIVATIZATION; DEGRADATION; MICROBIOTA; DIGESTION; CLONING	The bifidogenic effect of human milk oligosaccharides (HMOs) has long been known, yet the precise mechanism underlying it remains unresolved. Recent studies show that some species/subspecies of Bifidobacterium are equipped with genetic and enzymatic sets dedicated to the utilization of HMOs, and consequently they can grow on HMOs; however, the ability to metabolize HMOs has not been directly linked to the actual metabolic behavior of the bacteria. In this report, we clarify the fate of each HMO during cultivation of infant gut-associated bifidobacteria. Bifidobacterium bifidum JCM1254, Bifidobacterium longum subsp. infantis JCM1222, Bifidobacterium longum subsp. longum JCM1217, and Bifidobacterium breve JCM1192 were selected for this purpose and were grown on HMO media containing a main neutral oligosaccharide fraction. The mono-and oligosaccharides in the spent media were labeled with 2-anthranilic acid, and their concentrations were determined at various incubation times using normal phase high performance liquid chromatography. The results reflect the metabolic abilities of the respective bifidobacteria. B. bifidum used secretory glycosidases to degrade HMOs, whereas B. longum subsp. infantis assimilated all HMOs by incorporating them in their intact forms. B. longum subsp. longum and B. breve consumed lacto-N-tetraose only. Interestingly, B. bifidum left degraded HMO metabolites outside of the cell even when the cells initiate vegetative growth, which indicates that the different species/subspecies can share the produced sugars. The predominance of type 1 chains in HMOs and the preferential use of type 1 HMO by infant gut-associated bifidobacteria suggest the coevolution of the bacteria with humans.	[Yoshida, Erina; Katayama, Takane; Yamamoto, Kenji; Kumagai, Hidehiko] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Asakuma, Sadaki] Natl Agr Res Ctr Hokkaido Reg, Intens Grazing Res Team, Sapporo, Hokkaido 0628555, Japan; [Hatakeyama, Emi; Urashima, Tadasu] Obihiro Univ Agr & Vet Med, Obihiro, Hokkaido 0808555, Japan; [Ashida, Hisashi] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Hirose, Junko] Univ Shiga Prefecture, Dept Life Style Studies, Shiga 5228533, Japan; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Ishikawa Prefecture University; National Agriculture & Food Research Organization - Japan; Obihiro University of Agriculture & Veterinary Medicine; Kyoto University; University Shiga Prefecture; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Katayama, T (corresponding author), Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan.	takane@ishikawa-pu.ac.jp	Ashida, Hisashi/HCI-0293-2022; Kitaoka, Motomitsu/R-1536-2019	Kitaoka, Motomitsu/0000-0002-0083-1838; Ashida, Hisashi/0000-0001-5844-4075; Katayama, Takane/0000-0003-4009-7874	Ministry of Education, Culture, Sports, Science and Technology, Japan [22780072]; Urakami Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Urakami Foundation(Urakami Foundation)	This work was supported in part by a Grant-in-aid for Scientific Research by Young Scientists (B) 22780072 from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and grant-in-aid from The Urakami Foundation.	Amano J, 2009, GLYCOBIOLOGY, V19, P601, DOI 10.1093/glycob/cwp026; Anumula KR, 2006, ANAL BIOCHEM, V350, P1, DOI 10.1016/j.ab.2005.09.037; Asakuma S, 2008, EUR J CLIN NUTR, V62, P488, DOI 10.1038/sj.ejcn.1602738; Asakuma S, 2007, BIOSCI BIOTECH BIOCH, V71, P1447, DOI 10.1271/bbb.60529; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Bode L, 2006, J NUTR, V136, P2127, DOI 10.1093/jn/136.8.2127; Brand-Miller JC, 1998, J PEDIATR-US, V133, P95, DOI 10.1016/S0022-3476(98)70185-4; Chaturvedi P, 2001, GLYCOBIOLOGY, V11, P365, DOI 10.1093/glycob/11.5.365; Coppa GV, 1999, ACTA PAEDIATR, V88, P89, DOI 10.1080/080352599750029808; Gnoth MJ, 2000, J NUTR, V130, P3014, DOI 10.1093/jn/130.12.3014; JOURDIAN GW, 1971, J BIOL CHEM, V246, P430; Katayama T, 2000, APPL ENVIRON MICROB, V66, P4764, DOI 10.1128/AEM.66.11.4764-4771.2000; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kiyohara M, 2011, GLYCOBIOLOGY, V21, P437, DOI 10.1093/glycob/cwq175; Kiyohara M, 2009, BIOSCI BIOTECH BIOCH, V73, P1175, DOI 10.1271/bbb.80697; Klaassens ES, 2009, APPL ENVIRON MICROB, V75, P2668, DOI 10.1128/AEM.02492-08; Kobata A, 2010, P JPN ACAD B-PHYS, V86, P731, DOI 10.2183/pjab.86.731; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Lee JH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-247; Leo F, 2009, J CHROMATOGR A, V1216, P1520, DOI 10.1016/j.chroma.2009.01.015; Leo F, 2010, BIOSCI BIOTECH BIOCH, V74, P298, DOI 10.1271/bbb.90614; Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480; LoCascio RG, 2010, APPL ENVIRON MICROB, V76, P7373, DOI 10.1128/AEM.00675-10; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Newburg D, 1995, HDB MILK COMPOSITION, P273; Ninonuevo MR, 2006, J AGR FOOD CHEM, V54, P7471, DOI 10.1021/jf0615810; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Sakata S, 2005, FEMS MICROBIOL LETT, V243, P417, DOI 10.1016/j.femsle.2005.01.002; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sela DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193359; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Thurl S, 1996, ANAL BIOCHEM, V235, P202, DOI 10.1006/abio.1996.0113; Thurl S, 2010, BRIT J NUTR, V104, P1261, DOI 10.1017/S0007114510002072; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Urashima T, 2011, OLIGOSACCHARIDES SOU, P1; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Wada J, 2007, ACTA CRYSTALLOGR F, V63, P751, DOI 10.1107/S1744309107036263; Ward RE, 2007, MOL NUTR FOOD RES, V51, P1398, DOI 10.1002/mnfr.200700150; Xiao JZ, 2010, APPL ENVIRON MICROB, V76, P54, DOI 10.1128/AEM.01683-09; Zhurina D, 2011, J BACTERIOL, V193, P301, DOI 10.1128/JB.01180-10	48	276	292	6	88	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34583	34592		10.1074/jbc.M111.248138	http://dx.doi.org/10.1074/jbc.M111.248138			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832085	Green Published, hybrid			2022-12-27	WOS:000295406300013
J	Morishima, N; Nakanishi, K; Nakano, A				Morishima, Nobuhiro; Nakanishi, Keiko; Nakano, Akihiko			Activating Transcription Factor-6 (ATF6) Mediates Apoptosis with Reduction of Myeloid Cell Leukemia Sequence 1 (Mcl-1) Protein via Induction of WW Domain Binding Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL OUTER-MEMBRANE; NF-Y CBF; TRANSMEMBRANE PROTEIN; ER STRESS; DIABETES-MELLITUS; MAMMALIAN GENOME; OPTIC ATROPHY; BCL-2 FAMILY; DEATH	Endoplasmic reticulum (ER) stress is involved in both physiological and pathological apoptosis. ER stress triggers the unfolded protein response (UPR), which can then initiate apoptosis, when the cell fails to restore ER homeostasis. However, the mechanism employed by the UPR to lead cells into apoptosis is unknown. Among the three proximal sensors of ER stress, activating transcription factor-6 (ATF6) is specifically activated in apoptotic myoblasts during myoblast differentiation. This implies that active ATF6 has the ability to mediate apoptosis. Here, we demonstrate that overexpression of active ATF6 induced apoptosis in myoblast cells. Moreover, coexpression of a dominant negative form of ATF6 suppressed apoptosis. This suggested that apoptosis-related pathways depended on ATF6-mediated transcription activation. ATF6 caused up-regulation of the WBP1 (WW domain binding protein 1), probably via an indirect mechanism. Furthermore, WBP1 was also found to be proapoptotic. The silencing of WBP1 with small hairpin RNAs caused partial, but significant suppression of ATF6-induced apoptosis. Overexpression of active ATF6 or WBP1 caused a specific reduction in an anti-apoptotic protein, Mcl-1 (myeloid cell leukemia sequence 1). This suggested a molecular link between the UPR and an apoptosis regulator. Neither Bcl-2 nor Bcl-xL were reduced upon apoptosis induction in C2C12 cells that overexpressed ATF6 or WBP1. Cells treated with ER stressors underwent apoptosis concomitant with an up-regulation of WBP1 and suppression of Mcl-1. These results suggested that Mcl-1 is a determinant of cell fate, and ATF6 mediates apoptosis via specific suppression of Mcl-1 through up-regulation of WBP1.	[Morishima, Nobuhiro; Nakanishi, Keiko; Nakano, Akihiko] RIKEN, Adv Sci Inst, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan; [Nakano, Akihiko] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; University of Tokyo	Morishima, N (corresponding author), 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	morishim@riken.jp	Morishima, Nobuhiro/D-3946-2017; Nakanishi, Keiko/B-9963-2013; Nakano, Akihiko/A-6420-2016; Nakano, Akihiko/G-4942-2014	Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X	Unit for Biomaterial Analysis, RIKEN BSI Research Resources Center; Grants-in-Aid for Scientific Research [20001009] Funding Source: KAKEN	Unit for Biomaterial Analysis, RIKEN BSI Research Resources Center; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the RIKEN Bioarchitect Research Project and by the Japan Society for the Promotion of Science (to N. M).; We thank Ron Prywes for providing human ATF6 cDNA, and Junying Yuan for providing the anti-caspase-12 monoclonal antibody. We also thank Rie Nakazawa and Yasue Ichikawa for DNA sequencing and Keisuke Fukumoto (the Support Unit for Biomaterial Analysis, RIKEN BSI Research Resources Center) for assistance with GeneChip and real-time PCR analyses.	Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Dominov JA, 2001, DEV DYNAM, V220, P18, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1088>3.0.CO;2-#; FIDZIANSKA A, 1991, ACTA NEUROPATHOL, V81, P572, DOI 10.1007/BF00310140; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Kaba SA, 2002, PARASITOLOGY, V125, P497, DOI 10.1017/S003118200200241X; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Morishima N, 2004, J BIOL CHEM, V279, P50375, DOI 10.1074/jbc.M408493200; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; NEGRINI M, 1987, CELL, V49, P455, DOI 10.1016/0092-8674(87)90448-X; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Thuerauf DJ, 2002, J BIOL CHEM, V277, P20734, DOI 10.1074/jbc.M201749200; Tsujii H, 2010, J BIOCHEM, V148, P157, DOI 10.1093/jb/mvq042; Wang Y, 2000, J BIOL CHEM, V275, P27013; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	44	74	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35227	35235		10.1074/jbc.M111.233502	http://dx.doi.org/10.1074/jbc.M111.233502			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21841196	Green Published, hybrid			2022-12-27	WOS:000295406300075
J	Barnes, PJ				Barnes, Peter J.			Biochemical Basis of Asthma Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; RECEPTOR NUCLEAR TRANSLOCATION; LONG-ACTING BETA(2)-AGONISTS; HISTONE DEACETYLASE ACTIVITY; INHALED COMBINATION THERAPY; G-BETA-GAMMA; GLUCOCORTICOID-RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; KAPPA-B; CORTICOSTEROID INSENSITIVITY	Current therapy for asthma is highly effective. beta(2)-Adrenergic receptor (beta(2)AR) agonists are the most effective bronchodilators and relax airway smooth muscle cells through increased cAMP concentrations and directly opening large conductance Ca2+ channels. beta(2)AR may also activate alternative signaling pathways that may have detrimental effects in asthma. Glucocorticoids are the most effective anti-inflammatory treatments and switch off multiple activated inflammatory genes through recruitment of histone deacetylase-2, activating anti-inflammatory genes, and through increasing mRNA stability of inflammatory genes. There are beneficial molecular interactions between beta(2)AR and glucocorticoid-activated pathways. Understanding these signaling pathways may lead to even more effective therapies in the future.	Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England	Imperial College London	Barnes, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England.	p.j.barnes@imperial.ac.uk		Barnes, Peter/0000-0002-5122-4018				Baraniuk JN, 1997, AM J RESP CRIT CARE, V155, P704, DOI 10.1164/ajrccm.155.2.9032216; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; Barnes PJ, 2010, TRENDS PHARMACOL SCI, V31, P335, DOI 10.1016/j.tips.2010.04.009; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barnes PJ, 2009, ANNU REV PHYSIOL, V71, P451, DOI 10.1146/annurev.physiol.010908.163257; Barnes PJ, 2003, AM J RESP CRIT CARE, V167, P813, DOI 10.1164/rccm.200210-1142PP; Barnes PJ, 2002, EUR RESPIR J, V19, P182, DOI 10.1183/09031936.02.00283202; Barnes PJ, 2003, ANN INTERN MED, V139, P359, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00012; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bateman ED, 2009, PULM PHARMACOL THER, V22, P533, DOI 10.1016/j.pupt.2009.06.002; Bergmann MW, 2004, AM J RESP CELL MOL, V30, P555, DOI 10.1165/rcmb.2003-0295OC; Bleecker ER, 2007, LANCET, V370, P2118, DOI 10.1016/S0140-6736(07)61906-0; Bos IST, 2007, EUR RESPIR J, V30, P653, DOI 10.1183/09031936.00004907; Cazzola M, 2009, EUR RESPIR J, V34, P757, DOI 10.1183/09031936.00013109; Charron CE, 2009, J BIOL CHEM, V284, P36047, DOI 10.1074/jbc.M109.025387; Chung IY, 2000, CELL IMMUNOL, V203, P95, DOI 10.1006/cimm.2000.1678; Clark AR, 2003, J ENDOCRINOL, V178, P5, DOI 10.1677/joe.0.1780005; Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416; Cruse G, 2010, J ALLERGY CLIN IMMUN, V125, P257, DOI 10.1016/j.jaci.2009.08.020; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dostert A, 2004, CURR PHARM DESIGN, V10, P2807; Duffy SM, 2005, FASEB J, V19, P1006, DOI 10.1096/fj.04-3439fje; Fryer AD, 2006, J CLIN INVEST, V116, P228, DOI 10.1172/JCI25423; Garcia-Garcia HM, 2009, CURR OPIN LIPIDOL, V20, P327, DOI 10.1097/MOL.0b013e32832dd4c7; Gibson PG, 2007, J ALLERGY CLIN IMMUN, V119, P344, DOI 10.1016/j.jaci.2006.10.043; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gong KZ, 2008, J BIOL CHEM, V283, P29028, DOI 10.1074/jbc.M801313200; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Hanania NA, 2008, PULM PHARMACOL THER, V21, P134, DOI 10.1016/j.pupt.2007.07.002; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; Hawkins GA, 2008, PHARMACOGENOMICS, V9, P349, DOI 10.2217/14622416.9.3.349; Hew M, 2006, AM J RESP CRIT CARE, V174, P134, DOI 10.1164/rccm.200512-1930OC; Hollingsworth JW, 2010, AM J RESP CELL MOL, V43, P269, DOI 10.1165/rcmb.2009-0198OC; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Howarth PH, 2000, RESP MED, V94, pS22, DOI 10.1016/S0954-6111(00)90129-X; Ichiyama T, 2001, N-S ARCH PHARMACOL, V364, P558, DOI 10.1007/s00210-001-0494-x; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Kassel KM, 2008, AM J PHYSIOL-LUNG C, V294, pL131, DOI 10.1152/ajplung.00381.2007; Kummer W, 2008, HISTOCHEM CELL BIOL, V130, P219, DOI 10.1007/s00418-008-0455-2; Lai Y, 2010, J BIOL CHEM, V285, P41491, DOI 10.1074/jbc.M110.153338; Lewis-Tuffin LJ, 2007, MOL CELL BIOL, V27, P2266, DOI 10.1128/MCB.01439-06; Lewis-Tuffin LJ, 2006, ANN NY ACAD SCI, V1069, P1, DOI 10.1196/annals.1351.001; MAK JCW, 1995, J CLIN INVEST, V96, P99, DOI 10.1172/JCI118084; Mak JCW, 2002, EUR J PHARMACOL, V436, P165, DOI 10.1016/S0014-2999(01)01625-9; Mak JCW, 2002, BRIT J PHARMACOL, V135, P987, DOI 10.1038/sj.bjp.0704545; MAK JCW, 1995, AM J PHYSIOL-LUNG C, V268, pL41, DOI 10.1152/ajplung.1995.268.1.L41; Maneechotesuwan K, 2008, J ALLERGY CLIN IMMUN, V121, P43, DOI 10.1016/j.jaci.2007.10.011; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Maneechotesuwan K, 2010, J ALLERGY CLIN IMMUN, V126, P754, DOI 10.1016/j.jaci.2010.08.005; Maneechotesuwan K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000076; Marwick JA, 2009, AM J RESP CRIT CARE, V179, P542, DOI 10.1164/rccm.200810-1570OC; Matthews JG, 2004, J ALLERGY CLIN IMMUN, V113, P1100, DOI 10.1016/j.jaci.2004.03.018; McGraw DW, 2003, J CLIN INVEST, V112, P619, DOI 10.1172/JCI200318193; McGraw DW, 1997, J BIOL CHEM, V272, P7338, DOI 10.1074/jbc.272.11.7338; MINETTE PAH, 1989, J APPL PHYSIOL, V67, P2461, DOI 10.1152/jappl.1989.67.6.2461; Nelson HS, 2006, ANN INTERN MED, V145, P706, DOI 10.7326/0003-4819-145-9-200611070-00017; Newcomer ME, 2010, J BIOL CHEM, V285, P25109, DOI 10.1074/jbc.R110.125880; Newton R, 2010, PHARMACOL THERAPEUT, V125, P286, DOI 10.1016/j.pharmthera.2009.11.003; Nguyen LP, 2009, P NATL ACAD SCI USA, V106, P2435, DOI 10.1073/pnas.0810902106; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Osoata GO, 2009, BIOCHEM BIOPH RES CO, V384, P366, DOI 10.1016/j.bbrc.2009.04.128; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Pujols L, 2007, CURR ALLERGY ASTHM R, V7, P93, DOI 10.1007/s11882-007-0005-3; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Roth M, 2002, LANCET, V360, P1293, DOI 10.1016/S0140-6736(02)11319-5; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; Schmid CL, 2009, PHARMACOL THERAPEUT, V121, P285, DOI 10.1016/j.pharmthera.2008.11.005; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Smoak K, 2006, MOL CELL BIOL, V26, P9126, DOI 10.1128/MCB.00679-06; Tao T, 2006, AM J RESP CELL MOL, V35, P668, DOI 10.1165/rcmb.2006-0073OC; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Usmani OS, 2005, AM J RESP CRIT CARE, V172, P704, DOI 10.1164/rccm.200408-1041OC; van Noord JA, 2010, THORAX, V65, P1086, DOI 10.1136/thx.2010.139113; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Wilson CN, 2008, BRIT J PHARMACOL, V155, P475, DOI 10.1038/bjp.2008.361; Yasui K, 2000, J LEUKOCYTE BIOL, V67, P529, DOI 10.1002/jlb.67.4.529; Zhou XB, 2008, J BIOL CHEM, V283, P21036, DOI 10.1074/jbc.M800447200; Zhou YX, 2008, BIOCHEMISTRY-US, V47, P4410, DOI 10.1021/bi800044n	90	81	82	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32899	32905		10.1074/jbc.R110.206466	http://dx.doi.org/10.1074/jbc.R110.206466			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799015	hybrid, Green Published			2022-12-27	WOS:000294968800008
J	Taniguchi, N; Carames, B; Hsu, E; Cherqui, S; Kawakami, Y; Lotz, M				Taniguchi, Noboru; Carames, Beatriz; Hsu, Emily; Cherqui, Stephanie; Kawakami, Yasuhiko; Lotz, Martin			Expression Patterns and Function of Chromatin Protein HMGB2 during Mesenchymal Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTICULAR-CARTILAGE; TRANSCRIPTION FACTOR-2; PROGENITOR CELLS; GENE-REGULATION; DNA-BINDING; IN-VITRO; IDENTIFICATION; CHONDROGENESIS; PROMOTER; SURFACE	The superficial zone (SZ) of articular cartilage is critical in maintaining tissue function and homeostasis and represents the site of the earliest changes in osteoarthritis (OA). The expression of chromatin protein HMGB2 is restricted to the SZ, which contains cells expressing mesenchymal stein cell (MSC) markers. Age-related loss of HMGB2 and gene deletion are associated with reduced SL cellularity and early onset OA. This study addressed HMGB2 expression patterns in MSC and its role during differentiation. HMGB2 was detected at higher levels in human MSC as compared with human articular chondrocytes, and its expression declined during chondrogenic differentiation of MSC. Lentiviral HMGB2 transduction of MSC suppressed chondrogenesis as reflected by an inhibition of Col2a1 and Col10al expression. Conversely, in bone marrow MSC from Hmgb2(-/-) mice, Col10a1 was more strongly expressed than in wild-type MSC. This is consistent with in vivo results from mouse growth plates showing that Hmgb2 is expressed in proliferating and prehypertrophic zones but not in hypertrophic cartilage where Col10a1 is strongly expressed. Osteogenesis was also accelerated in Hmgb2(-/-) MSC. The expression of Runx2, which plays a major role in late stage chondrocyte differentiation, was enhanced in Hmgb2(-/-) MSC, and HMGB2 negatively regulated the stimulatory effect of Wnt/beta-catenin signaling on the Runx2 proximal promoter. These results demonstrate that HMGB2 expression is inversely correlated with the differentiation status of MSC and that HMGB2 suppresses chondrogenic differentiation. The age-related loss of HMGB2 in articular cartilage may represent a mechanism responsible for the decline in adult cartilage stem cell populations.	[Taniguchi, Noboru; Carames, Beatriz; Hsu, Emily; Cherqui, Stephanie; Lotz, Martin] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Kawakami, Yasuhiko] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Kawakami, Yasuhiko] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA	Scripps Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lotz, M (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mlotz@scripps.edu		Cherqui, Stephanie/0000-0003-1240-5219; Carames, Beatriz/0000-0002-8353-6526; Kawakami, Yasuhiko/0000-0002-0043-9705	National Institutes of Health [AR056026, AG007996, RR027557]; Consortium for Functional Glycomics [GM62116]; Sam and Rose Stein Endowment Fund; Arthritis National Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG007996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Functional Glycomics; Sam and Rose Stein Endowment Fund; Arthritis National Research Foundation(National Research Foundation of Korea); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AR056026, AG007996, RR027557 and the Consortium for Functional Glycomics GM62116. This work was also supported by the Sam and Rose Stein Endowment Fund (to M. L) and the Arthritis National Research Foundation (to N. T.).	Akiyama H, 1999, J CELL PHYSIOL, V181, P169, DOI 10.1002/(SICI)1097-4652(199910)181:1<169::AID-JCP18>3.0.CO;2-5; Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Collas P, 2007, J CELL MOL MED, V11, P602, DOI 10.1111/j.1582-4934.2007.00079.x; Daumer KM, 2004, J CELL BIOCHEM, V93, P526, DOI 10.1002/jcb.20190; Dong YF, 2006, J CELL PHYSIOL, V208, P77, DOI 10.1002/jcp.20656; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Drissi H, 2002, J CELL BIOCHEM, V86, P403, DOI 10.1002/jcb.10238; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Drissi H, 2002, EXP CELL RES, V274, P323, DOI 10.1006/excr.2002.5474; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Grogan SP, 2008, ARTHRITIS RHEUM-US, V58, P2754, DOI 10.1002/art.23730; Grogan SP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2719; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hashimoto S, 1998, P NATL ACAD SCI USA, V95, P3094, DOI 10.1073/pnas.95.6.3094; Higashikawa A, 2009, ARTHRITIS RHEUM-US, V60, P166, DOI 10.1002/art.24243; Hiraoka K, 2006, BIORHEOLOGY, V43, P447; Husa M, 2010, NAT MED, V16, P641, DOI 10.1038/nm0610-641; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Itou J, 2011, DEV DYNAM, V240, P1151, DOI 10.1002/dvdy.22598; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kim CG, 2006, MOL CELLS, V21, P343; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Lee HJ, 2009, ARTHRITIS RHEUM-US, V60, P2325, DOI 10.1002/art.24786; Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200; Nadri S, 2007, INT J DEV BIOL, V51, P723, DOI 10.1387/ijdb.072352ns; Nakade K, 2009, J BIOL CHEM, V284, P10808, DOI 10.1074/jbc.M808333200; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Ronfani L, 2001, DEVELOPMENT, V128, P1265; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Stiehler M, 2009, J BIOMED MATER RES A, V89A, P96, DOI 10.1002/jbm.a.31967; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Stros M, 2002, J BIOL CHEM, V277, P7157, DOI 10.1074/jbc.M110233200; Syres K, 2009, BLOOD, V114, P2542, DOI 10.1182/blood-2009-03-213934; Tamiya H, 2008, GENE, V416, P53, DOI 10.1016/j.gene.2008.03.003; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Taniguchi N, 2007, MOL CELL BIOL, V27, P5650, DOI 10.1128/MCB.00130-07; Taniguchi N, 2009, P NATL ACAD SCI USA, V106, P16817, DOI 10.1073/pnas.0904414106; Taniguchi N, 2009, P NATL ACAD SCI USA, V106, P1181, DOI 10.1073/pnas.0806062106; Tetsunaga T, 2011, OSTEOARTHR CARTILAGE, V19, P222, DOI 10.1016/j.joca.2010.11.004; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Xiao ZS, 2001, J CELL BIOCHEM, V82, P647, DOI 10.1002/jcb.1192; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	52	41	43	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41489	41498		10.1074/jbc.M111.236984	http://dx.doi.org/10.1074/jbc.M111.236984			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21890638	Green Published, hybrid			2022-12-27	WOS:000298057500035
J	Bae, JY; Park, HH				Bae, Ju Young; Park, Hyun Ho			Crystal Structure of NALP3 Protein Pyrin Domain (PYD) and Its Implications in Inflammasome Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; RECRUITMENT DOMAIN; EFFECTOR-DOMAIN; INNATE-IMMUNITY; NMR STRUCTURE; DEATH; ACTIVATION; APOPTOSIS; ASC; MECHANISM	NALP3 inflammasome, composed of the three proteins NALP3, ASC, and Caspase-1, is a macromolecular complex responsible for the innate immune response against infection with bacterial and viral pathogens. Formation of the inflammasome can lead to the activation of inflammatory caspases, such as Caspase-1, which then activate pro-inflammatory cytokines by proteolytic cleavage. The assembly of the NALP3 inflammasome depends on the protein-interacting domain known as the death domain superfamily. NALP3 inflammasome is assembled via a pyrin domain (PYD)/PYD interaction between ASC and NALP3 and a caspase recruitment domain/caspase recruitment domain interaction between ASC and Caspase-1. As a first step toward elucidating the molecular mechanisms of inflammatory caspase activation by formation of inflammasome, we report the crystal structure of the PYD from NALP3 at 1.7-angstrom resolution. Although NALP3 PYD has the canonical six-helical bundle structural fold similar to other PYDs, the high resolution structure reveals the possible biologically important homodimeric interface and the dynamic properties of the fold. Comparison with other PYD structures shows both similarities and differences that may be functionally relevant. Structural and sequence analyses further implicate conserved surface residues in NALP3 PYD for ASC interaction and inflammasome assembly. The most interesting aspect of the structure was the unexpected disulfide bond between Cys-8 and Cys-108, which might be important for regulation of the activity of NALP3 by redox potential.	[Park, Hyun Ho] Yeungnam Univ, Grad Sch Biochem, Sch Biotechnol, Gyongsan, South Korea; Yeungnam Univ, Res Inst Prot Sensor, Gyongsan, South Korea	Yeungnam University; Yeungnam University	Park, HH (corresponding author), Yeungnam Univ, Grad Sch Biochem, Sch Biotechnol, Gyongsan, South Korea.	hyunho@ynu.ac.kr		park, hyun ho/0000-0001-9928-0847	National Research Foundation of Korea, Ministry of Education, Science, and Technology [2011-0003406, 2011-0025697]	National Research Foundation of Korea, Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by Grants 2011-0003406 and 2011-0025697 from the Basic Science Research Program through the National Research Foundation of Korea, Ministry of Education, Science, and Technology.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; Damiano JS, 2004, CURR DRUG TARGETS, V5, P367, DOI 10.2174/1389450043345470; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; DeLano W.L, PYMOL MOL GRAPHICS S; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Eisenbarth SC, 2009, EMBO MOL MED, V1, P92, DOI 10.1002/emmm.200900014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jang TH, 2011, J BIOTECHNOL, V151, P335, DOI 10.1016/j.jbiotec.2011.01.003; Kolly L, 2010, IMMUNOLOGY, V129, P178, DOI 10.1111/j.1365-2567.2009.03174.x; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Liu-Bryan R, 2010, IMMUNOL CELL BIOL, V88, P20, DOI 10.1038/icb.2009.93; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2008, J LEUKOCYTE BIOL, V83, P507, DOI 10.1189/jlb.0607362; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; Otwinowski Z., 1990, DENZO DATA PROCESSIN; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park HH, 2011, APOPTOSIS, V16, P209, DOI 10.1007/s10495-010-0571-z; Pinheiro AS, 2010, J BIOL CHEM, V285, P27402, DOI 10.1074/jbc.M110.113191; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shiohara M, 2002, BIOCHEM BIOPH RES CO, V293, P1314, DOI 10.1016/S0006-291X(02)00384-4; Srimathi T, 2008, J BIOL CHEM, V283, P15390, DOI 10.1074/jbc.M801589200; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023	45	142	146	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39528	39536		10.1074/jbc.M111.278812	http://dx.doi.org/10.1074/jbc.M111.278812			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21880711	hybrid, Green Published			2022-12-27	WOS:000296759800070
J	Yim, SH; Kim, YJ; Oh, SY; Fujii, J; Zhang, Y; Gladyshev, VN; Rhee, SG				Yim, Sun Hee; Kim, Yoo-Jin; Oh, Sue Young; Fujii, Junichi; Zhang, Yan; Gladyshev, Vadim N.; Rhee, Sue Goo			Identification and Characterization of Alternatively Transcribed Form of Peroxiredoxin IV Gene That Is Specifically Expressed in Spermatids of Postpubertal Mouse Testis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; THIOL-DISULFIDE STATUS; NF-KAPPA-B; OXIDATIVE STRESS; MAMMALIAN SPERM; MATURATION; PROTEIN; GLUTATHIONE; ACTIVATION; REDUCTION	2-Cysteine (Cys) peroxiredoxins (Prxs), which include mammalian Prxs I-IV, possess two conserved Cys residues that are readily oxidized by H2O2 to form a disulfide. In the case of Prx I-III, the disulfide is reduced by thioredoxin, thus enabling these proteins to function as peroxidases. Prx IV was shown previously to be synthesized as a 31-kDa polypeptide with an NH2-terminal signal peptide that is subsequently cleaved to generate a 27-kDa form of the protein that is localized to the endoplasmic reticulum. A form of Prx IV, larger than 27 kDa revealed by immunoblot analysis was suggested to represent the unprocessed, 31-kDa form, but this larger form was detected only in spermatids of the postpubertal testis. We now show that the larger form of Prx IV (here designated Prx IV-L) detected in the testis is actually a product of alternative transcription of the Prx IV gene that is encoded by newly identified exon 1A together with exons 2-7 that are shared with the 27-kDa form (designated Prx IV-S). Prx IV-L was detected in spermatids but not in mature sperm, it could form disulfide-linked dimers but not higher order oligomers via oxidation, and it was resistant to hyperoxidation unless additional reductant was added, suggesting that its peroxidase activity is limited in vivo. Phylogenetic analysis showed that the Prx IV-S gene is present in all vertebrates examined, whereas the Prx IV-L gene was detected only in placental mammals. We suggest that Prx IV-L functions as an H2O2 sensor that mediates protein thiol oxidation required for the maturation of spermatozoa in placental mammals.	[Yim, Sun Hee; Kim, Yoo-Jin; Oh, Sue Young; Rhee, Sue Goo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Gladyshev, Vadim N.; Rhee, Sue Goo] Ewha Womans Univ, Dept Bioinspired Sci, Seoul 120750, South Korea; [Fujii, Junichi] Yamagata Univ, Sch Med, Dept Biochem, Yamagata 9909585, Japan; [Zhang, Yan; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA 02115 USA; [Zhang, Yan] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Ewha Womans University; Ewha Womans University; Yamagata University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yim, SH (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, 11-1 Daehyun Dong, Seoul 120750, South Korea.	shyim@rics.bwh.harvard.edu; rheesg@ewha.ac.kr	Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Gladyshev, Vadim/0000-0002-0372-7016; Fujii, Junichi/0000-0003-2267-7357	National Research Foundation of Korea [2009-0052293, M10642040001-07N4204-00110]; World Class University [R31-2008-000-10010-0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); World Class University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Research Foundation of Korea (National Honor Scientist Program Grant 2009-0052293 and Bio Research and Development Program Grant M10642040001-07N4204-00110 to S. G. R.) and World Class University Program Grant R31-2008-000-10010-0.	Bae SH, 2011, HEPATOLOGY, V53, P945, DOI 10.1002/hep.24104; BALHORN R, 1982, J CELL BIOL, V93, P298, DOI 10.1083/jcb.93.2.298; BEDFORD JM, 1974, J EXP ZOOL, V187, P181, DOI 10.1002/jez.1401870202; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; de Lamirande E, 1998, FREE RADICAL BIO MED, V25, P803, DOI 10.1016/S0891-5849(98)00156-7; Fisher AB, 2011, ANTIOXID REDOX SIGN, V15, P831, DOI 10.1089/ars.2010.3412; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Gerashchenko MV, 2010, J BIOL CHEM, V285, P4595, DOI 10.1074/jbc.M109.070532; Griveau JF, 1997, INT J ANDROL, V20, P61, DOI 10.1046/j.1365-2605.1997.00044.x; GROSSHANS K, 1985, BIOL REPROD, V33, P1197, DOI 10.1095/biolreprod33.5.1197; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Haridas V, 1998, J IMMUNOL, V161, P1; Iuchi Y, 2009, BIOCHEM J, V419, P149, DOI 10.1042/BJ20081526; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Knoops B, 2011, ANTIOXID REDOX SIGN, V15, P817, DOI 10.1089/ars.2010.3584; KOSOWER NS, 1992, J ANDROL, V13, P342; Lolis D, 1996, INT J ANDROL, V19, P23, DOI 10.1111/j.1365-2605.1996.tb00429.x; Maiorino M, 2002, BIOL CHEM, V383, P591, DOI 10.1515/BC.2002.061; Matsumoto A, 1999, FEBS LETT, V443, P246, DOI 10.1016/S0014-5793(98)01736-0; NAGAO Y, 1989, IN VITRO CELL DEV B, V25, P1088, DOI 10.1007/BF02621259; Okado-Matsumoto A, 2000, J BIOCHEM, V127, P493, DOI 10.1093/oxfordjournals.jbchem.a022632; OLIVA R, 1991, PROG NUCLEIC ACID RE, V40, P25; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; RETIEF JD, 1995, P ROY SOC B-BIOL SCI, V259, P7, DOI 10.1098/rspb.1995.0002; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; ROUSSEAUX J, 1995, BIOL REPROD, V52, P1066, DOI 10.1095/biolreprod52.5.1066; RUFAS O, 1991, MOL REPROD DEV, V29, P282, DOI 10.1002/mrd.1080290311; Sasagawa I, 2001, EUR J BIOCHEM, V268, P3053, DOI 10.1046/j.1432-1327.2001.02200.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SELIGMAN J, 1994, J REPROD FERTIL, V101, P435; SHALGI R, 1989, BIOL REPROD, V40, P1037, DOI 10.1095/biolreprod40.5.1037; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Sutovsky P, 1997, BIOL REPROD, V56, P1503, DOI 10.1095/biolreprod56.6.1503; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; Wong CM, 2000, ANTIOXID REDOX SIGN, V2, P507, DOI 10.1089/15230860050192288; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zini A, 2001, UROLOGY, V58, P80, DOI 10.1016/S0090-4295(01)00997-9; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	48	15	18	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39002	39012		10.1074/jbc.M111.257220	http://dx.doi.org/10.1074/jbc.M111.257220			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21835919	Green Published, hybrid			2022-12-27	WOS:000296759800019
J	Rawlings, ND; Barrett, AJ; Bateman, A				Rawlings, Neil David; Barrett, Alan John; Bateman, Alex			Asparagine Peptide Lyases A SEVENTH CATALYTIC TYPE OF PROTEOLYTIC ENZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; AUTOTRANSPORTER; VIRUS; CHYMOTRYPSIN; EXPRESSION; HYDROLASE; MECHANISM; CLEAVAGE; DOMAIN	The terms "proteolytic enzyme" and "peptidase" have been treated as synonymous, and all proteolytic enzymes have been considered to be hydrolases (EC 3.4). However, the recent discovery of proteins that cleave themselves at asparagine residues indicates that not all peptide bond cleavage occurs by hydrolysis. These self-cleaving proteins include the Tsh protein precursor of Escherichia coli, in which the large C-terminal propeptide acts as an autotransporter; certain viral coat proteins; and proteins containing inteins. Proteolysis is the action of an amidine lyase (EC 4.3.2). These proteolytic enzymes are also the first in which the nucleophile is an asparagine, defining the seventh proteolytic catalytic type and the first to be discovered since 2004. We have assembled ten families based on sequence similarity in which cleavage is thought to be catalyzed by an asparagine.	[Rawlings, Neil David; Barrett, Alan John; Bateman, Alex] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England	Wellcome Trust Sanger Institute	Rawlings, ND (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	ndr@sanger.ac.uk	Rawlings, Neil D./I-4867-2012; Rawlings, Neil/M-5566-2013; Bateman, Alex/H-2861-2019; Barrett, Alan J/G-8970-2013	Rawlings, Neil/0000-0001-5557-7665; Bateman, Alex/0000-0002-6982-4660; Barrett, Alan J/0000-0002-6082-4437	Wellcome Trust [WT077044/Z/05/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust Grant Number WT077044/Z/05/Z.	ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amitai G, 2004, J BIOL CHEM, V279, P3121, DOI 10.1074/jbc.M311343200; BARRETT AJ, 1994, METHOD ENZYMOL, V244, P1; Bjornfot AC, 2009, J BACTERIOL, V191, P4259, DOI 10.1128/JB.01730-08; Charbonneau ME, 2009, J BIOL CHEM, V284, P17340, DOI 10.1074/jbc.M109.010108; CHOI HK, 1991, NATURE, V354, P37, DOI 10.1038/354037a0; Chung YC, 2006, WORLD J GASTROENTERO, V12, P921, DOI 10.3748/wjg.v12.i6.921; Curry S, 1997, J VIROL, V71, P9743, DOI 10.1128/JVI.71.12.9743-9752.1997; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; De E, 2008, MOL MEMBR BIOL, V25, P192, DOI 10.1080/09687680701771925; Dehart MP, 2007, J PHARM SCI-US, V96, P2667, DOI 10.1002/jps.20905; Doukov TI, 2007, J BIOL CHEM, V282, P6609, DOI 10.1074/jbc.M609828200; Du XL, 2000, P NATL ACAD SCI USA, V97, P14079, DOI 10.1073/pnas.260503597; Duquerroy S, 2009, EMBO J, V28, P1655, DOI 10.1038/emboj.2009.109; Eckstein M, 2002, BIOTECHNOL LETT, V24, P867, DOI 10.1023/A:1015564608261; Fujinaga M, 2004, P NATL ACAD SCI USA, V101, P3364, DOI 10.1073/pnas.0400246101; Hadfield AT, 1997, STRUCTURE, V5, P427, DOI 10.1016/S0969-2126(97)00199-8; Hakansson K, 2000, P NATL ACAD SCI USA, V97, P14097, DOI 10.1073/pnas.260376797; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; HARTLEY BS, 1960, ANNU REV BIOCHEM, V29, P45, DOI 10.1146/annurev.bi.29.070160.000401; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Jager S, 1999, J MOL BIOL, V291, P997, DOI 10.1006/jmbi.1999.2995; Lackner T, 2006, P NATL ACAD SCI USA, V103, P1510, DOI 10.1073/PNAS.0508247103; Li HM, 2002, J BIOL CHEM, V277, P24522, DOI 10.1074/jbc.M202020200; Mann RK, 2000, BBA-MOL CELL BIOL L, V1529, P188, DOI 10.1016/S1388-1981(00)00148-7; McDonough MA, 1999, PROTEIN SCI, V8, P1971, DOI 10.1110/ps.8.10.1971; Moure CM, 2002, NAT STRUCT BIOL, V9, P764, DOI 10.1038/nsb840; NC-IUBMB (Nomenclature Committee of the International Union of Biochemistry and Molecular Biology), 1992, ENZ NOM 1992 REC NOM; Raghavan R, 2009, J BACTERIOL, V191, P6193, DOI 10.1128/JB.00675-09; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; RICHARDSON JS, 1985, METHOD ENZYMOL, V115, P359; Romano JD, 2001, MOL BIOL CELL, V12, P1957, DOI 10.1091/mbc.12.7.1957; Satani M, 2003, PROTEIN EXPRES PURIF, V28, P293, DOI 10.1016/S1046-5928(02)00684-8; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; Suresh CG, 1999, NAT STRUCT BIOL, V6, P414, DOI 10.1038/8213; Tajima N, 2010, J MOL BIOL, V402, P645, DOI 10.1016/j.jmb.2010.06.068; Turner DPJ, 2002, INFECT IMMUN, V70, P4447, DOI 10.1128/IAI.70.8.4447-4461.2002; van Ulsen P, 2003, MOL MICROBIOL, V50, P1017, DOI 10.1046/j.1365-2958.2003.03773.x; Wei W, 2007, J BIOL CHEM, V282, P21729, DOI 10.1074/jbc.M703218200; WERY JP, 1994, J MOL BIOL, V235, P565, DOI 10.1006/jmbi.1994.1014; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Zhang X, 2005, STRUCTURE, V13, P1545, DOI 10.1016/j.str.2005.07.012; Zhang Y, 2004, J VIROL, V78, P11061, DOI 10.1128/JVI.78.20.11061-11069.2004	48	56	55	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38321	38328		10.1074/jbc.M111.260026	http://dx.doi.org/10.1074/jbc.M111.260026			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21832066	hybrid, Green Published			2022-12-27	WOS:000296594200045
J	Asim, M; Bin Hafeez, B; Siddiqui, IA; Gerlach, C; Patz, M; Mukhtar, H; Baniahmad, A				Asim, Mohammad; Bin Hafeez, Bilal; Siddiqui, Imtiaz Ahmad; Gerlach, Claudia; Patz, Michaela; Mukhtar, Hasan; Baniahmad, Aria			Ligand-dependent Corepressor Acts as a Novel Androgen Receptor Corepressor, Inhibits Prostate Cancer Growth, and Is Functionally Inactivated by the Src Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-GROWTH; C4-2; SMRT; PHOSPHORYLATION; PROMOTES; PATHWAY; AR	The activated androgen receptor (AR) promotes prostate cancer (PCa) growth. AR antagonists repress the AR by recruitment of corepressors. Not much is known about the inactivation of AR by corepressors in the presence of agonists (androgens). Here we show that the corepressor LCoR acts as an androgen-dependent corepressor that represses human PCa growth in vivo. In line with this, progressive decrease of ligand-dependent corepressor expression was observed in the PCa TRAMP mouse model with increasing age. LCoR interacts with AR and is recruited to chromatin in an androgen-induced manner. Unexpectedly, the LXXLL motif of LCoR is dispensable for interaction with the AR. Rather, the data indicate that LCoR interacts with the AR DNA binding domain on DNA. Interestingly, the interaction of LCoR with AR is inhibited by signaling pathways that are associated with androgen-independent PCa. Here we also show that the Src kinase inactivates the corepressive function of LCoR. Interfering with endogenous Src function by a dominant negative Src mutant, the growth inhibitory activity of LCoR is enhanced in vivo in a xenograft mouse model system. Thus, our studies indicate a role of LCoR as an AR corepressor and a tumor suppressor. Further, the decreased expression or in activation of LCoR is as an important step toward PCa carcinogenesis in vivo.	[Asim, Mohammad; Bin Hafeez, Bilal; Siddiqui, Imtiaz Ahmad; Mukhtar, Hasan] Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA; [Gerlach, Claudia; Patz, Michaela; Baniahmad, Aria] Jena Univ Hosp, Inst Human Genet, Jena, Germany	University of Wisconsin System; University of Wisconsin Madison; Friedrich Schiller University of Jena	Mukhtar, H (corresponding author), Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA.	hmukhtar@wisc.edu; aban@mti.uni-jena.de			German Research Foundation [DFG BA 1457/2]; United States Public Health Service [RO1CA78809, RO1CA101039, RO1CA120451]; O'Brian Center [P50DK065303-01]; NATIONAL CANCER INSTITUTE [R01CA101039, R01CA120451, R01CA078809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK065303] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); O'Brian Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by German Research Foundation Grant DFG BA 1457/2 (to A. B.), by United States Public Health Service Grants RO1CA78809, RO1CA101039, and RO1CA120451 (to H. M.), and by O'Brian Center Grant P50DK065303-01 (to H. M.).	Asim M, 2008, ONCOGENE, V27, P3596, DOI 10.1038/sj.onc.1211016; Bakin RE, 2003, CANCER RES, V63, P1975; Barnes CJ, 2003, NAT STRUCT BIOL, V10, P622, DOI 10.1038/nsb957; Berrevoets CA, 2004, BIOCHEM J, V379, P731, DOI 10.1042/BJ20031456; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Dotzlaw H, 2002, MOL ENDOCRINOL, V16, P661, DOI 10.1210/me.16.4.661; Eisold M, 2009, J MOL ENDOCRINOL, V42, P429, DOI 10.1677/JME-08-0084; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Liao GQ, 2003, J BIOL CHEM, V278, P5052, DOI 10.1074/jbc.M206374200; Liu Z, 2002, P NATL ACAD SCI USA, V99, P7940, DOI 10.1073/pnas.122225699; Moehren U, 2007, MOL ENDOCRINOL, V21, P1039, DOI 10.1210/me.2006-0468; Murillo H, 2001, CANCER RES, V61, P7408; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Sun C, 2006, ONCOGENE, V25, P3905, DOI 10.1038/sj.onc.1209424; Taplin ME, 1999, CANCER RES, V59, P2511; Wang L, 2005, PROSTATE, V63, P117, DOI 10.1002/pros.20170	24	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37108	37117		10.1074/jbc.M111.292771	http://dx.doi.org/10.1074/jbc.M111.292771			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21856747	Green Published, hybrid			2022-12-27	WOS:000296542400011
J	Hug, I; Zheng, B; Reiz, B; Whittal, RM; Fentabil, MA; Klassen, JS; Feldman, MF				Hug, Isabelle; Zheng, Blake; Reiz, Bela; Whittal, Randy M.; Fentabil, Messele A.; Klassen, John S.; Feldman, Mario F.			Exploiting Bacterial Glycosylation Machineries for the Synthesis of a Lewis Antigen-containing Glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; PROTEIN GLYCOSYLATION; SUBSTRATE-SPECIFICITY; MASS SPECTROMETRY; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; SEQUENCE	Glycoproteins constitute a class of compounds of increasing importance for pharmaceutical applications. The manipulation of bacterial protein glycosylation systems from Gram-negative bacteria for the synthesis of recombinant glycoproteins is a promising alternative to the current production methods. Proteins carrying Lewis antigens have been shown to have potential applications for the treatment of diverse autoimmune diseases. In this work, we developed a mixed approach consisting of in vivo and in vitro steps for the synthesis of glycoproteins containing the Lewis x antigen. Using glycosyltransferases from Haemophilus influenzae, we engineered Escherichia coli to assemble a tetrasaccharide on the lipid carrier undecaprenylphosphate. This glycan was transferred in vivo from the lipid to a carrier protein by the Campylobacter jejuni oligosaccharyltransferase PglB. The glycoprotein was then fucosylated in vitro by a truncated fucosyltransferase from Helicobacter pylori. Diverse mass spectrometry techniques were used to confirm the structure of the glycan. The strategy presented here could be adapted in the future for the synthesis of diverse glycoproteins. Our experiments demonstrate that bacterial enzymes can be exploited for the production of glycoproteins carrying glycans present in human cells for potential therapeutic applications.	[Hug, Isabelle; Feldman, Mario F.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Zheng, Blake; Reiz, Bela; Whittal, Randy M.; Fentabil, Messele A.; Klassen, John S.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2E9, Canada	University of Alberta; University of Alberta	Feldman, MF (corresponding author), Univ Alberta, Dept Biol Sci, 405 Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	mfeldman@ualberta.ca	Feldman, Mario/A-2637-2014	Feldman, Mario/0000-0003-4497-0976; Hug, Isabelle/0000-0002-4524-9569; Klassen, John/0000-0002-3389-7112; Whittal, Randy/0000-0003-1174-8172	Alberta Innovates Health Solutions; Alberta Innovates Centre for Carbohydrate Science (AICCS)	Alberta Innovates Health Solutions; Alberta Innovates Centre for Carbohydrate Science (AICCS)	This work was supported in part by grants from Alberta Innovates Health Solutions and the Alberta Innovates Centre for Carbohydrate Science (AICCS) (to M. F. F.).	Alley WR, 2010, ANAL CHEM, V82, P5095, DOI 10.1021/ac100131e; Antoine T, 2003, CHEMBIOCHEM, V4, P406, DOI 10.1002/cbic.200200540; Atochina O, 2006, EXP DERMATOL, V15, P461, DOI 10.1111/j.1600-0625.2006.00431.x; CHAN NWC, 1995, GLYCOBIOLOGY, V5, P683, DOI 10.1093/glycob/5.7.683; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Dumon C, 2006, CHEMBIOCHEM, V7, P359, DOI 10.1002/cbic.200500293; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; Faridmoayer A, 2008, J BIOL CHEM, V283, P34596, DOI 10.1074/jbc.M807113200; Feldman MF, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P903; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Harvey DJ, 2002, ANAL CHEM, V74, P734, DOI 10.1021/ac0109321; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hug I, 2011, GLYCOBIOLOGY, V21, P138, DOI 10.1093/glycob/cwq148; Ielmini MV, 2011, GLYCOBIOLOGY, V21, P734, DOI 10.1093/glycob/cwq192; Jones C, 2005, AN ACAD BRAS CIENC, V77, P293, DOI 10.1590/S0001-37652005000200009; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Langdon RH, 2009, FUTURE MICROBIOL, V4, P401, DOI 10.2217/FMB.09.10; Liu X, 2006, ANAL CHEM, V78, P6081, DOI 10.1021/ac060516m; Ma B, 2006, J BIOL CHEM, V281, P6385, DOI 10.1074/jbc.M511320200; Ma B, 2003, J BIOL CHEM, V278, P21893, DOI 10.1074/jbc.M301704200; MEIERDIETER U, 1992, J BIOL CHEM, V267, P746; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; ORIOL R, 1986, VOX SANG, V51, P161, DOI 10.1111/j.1423-0410.1986.tb01946.x; Phillips NJ, 2000, J BIOL CHEM, V275, P4747, DOI 10.1074/jbc.275.7.4747; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rook GAW, 2009, IMMUNOLOGY, V126, P3, DOI 10.1111/j.1365-2567.2008.03007.x; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SRIVATSAN J, 1992, J BIOL CHEM, V267, P20196; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790	34	27	29	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37887	37894		10.1074/jbc.M111.287755	http://dx.doi.org/10.1074/jbc.M111.287755			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878645	hybrid, Green Published			2022-12-27	WOS:000296542400083
J	Seifert, W; Kuhnisch, J; Maritzen, T; Horn, D; Haucke, V; Hennies, HC				Seifert, Wenke; Kuehnisch, Jirko; Maritzen, Tanja; Horn, Denise; Haucke, Volker; Hennies, Hans Christian			Cohen Syndrome-associated Protein, COH1, Is a Novel, Giant Golgi Matrix Protein Required for Golgi Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; ORGANELLE STRUCTURE; MENTAL-RETARDATION; RIBBON FORMATION; GRIP DOMAIN; GENE; LOCALIZATION; EXPRESSION; MUTATIONS; TRANSPORT	Loss-of-function mutations in the gene COH1, also known as VPS13B, lead to autosomal recessive Cohen syndrome. However, the cellular distribution and function of the encoded protein COH1 ( 3997 amino acids), which lacks functional homologies to other mammalian proteins, have remained enigmatic. We show here that COH1 is a peripheral Golgi membrane protein that strongly co-localizes with the cis-Golgi matrix protein GM130. Consistent with its subcellular localization, COH1 depletion using RNAi causes fragmentation of the Golgi ribbon into ministacks. Disruption of Golgi organization observed in fibroblasts from Cohen syndrome patients suggests that Golgi dysfunction contributes to Cohen syndrome pathology. In conclusion, our findings establish COH1 as a Golgi-associated matrix protein required for Golgi integrity.	[Seifert, Wenke] Charite, CCM, Inst Vegetat Anat, D-10115 Berlin, Germany; [Seifert, Wenke; Hennies, Hans Christian] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Seifert, Wenke; Kuehnisch, Jirko; Maritzen, Tanja; Haucke, Volker] Charite, D-14195 Berlin, Germany; [Seifert, Wenke; Kuehnisch, Jirko; Maritzen, Tanja; Haucke, Volker] Free Univ Berlin, Dept Membrane Biochem, Inst Chem & Biochem, D-14195 Berlin, Germany; [Kuehnisch, Jirko; Horn, Denise] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Kuehnisch, Jirko] Max Planck Inst Mol Genet, Res Grp Dev & Dis, D-14195 Berlin, Germany; [Hennies, Hans Christian] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; Univ Cologne, D-50674 Cologne, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; University of Cologne; University of Cologne	Seifert, W (corresponding author), Charite, CCM, Inst Vegetat Anat, Philippstr 12, D-10115 Berlin, Germany.	wenke.seifert@charite.de	Kühnisch, Jirko/M-3744-2019; Hennies, Hans C/G-9424-2014; Kühnisch, Jirko/L-7761-2013; Seifert, Wenke/B-8772-2011	Kühnisch, Jirko/0000-0003-4744-5421; Hennies, Hans C/0000-0001-7210-2389; Maritzen, Tanja/0000-0003-4993-0340; Haucke, Volker/0000-0003-3119-6993; Seifert, Wenke/0000-0003-1432-9862	Deutsche Forschungsgemeinschaft; Charite Universitatsmedizin Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Charite Universitatsmedizin Berlin	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to T. M., V. H., D. H., and H. C. H.) and a studentship from the Charite Universitatsmedizin Berlin (to W. S.).	Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; Brown DL, 2001, TRAFFIC, V2, P336, DOI 10.1034/j.1600-0854.2001.002005336.x; COHEN MM, 1973, J PEDIATR-US, V83, P280; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; de Figueiredo P, 1999, MOL BIOL CELL, V10, P1763, DOI 10.1091/mbc.10.6.1763; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Donaldson JG, 2000, CELL, V101, P693, DOI 10.1016/S0092-8674(00)80881-8; El Chehadeh S, 2010, J MED GENET, V47, P549, DOI 10.1136/jmg.2009.075028; El Chehadeh-Djebbar S., 2011, J MED GENET IN PRESS; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Gillingham AK, 2004, J CELL BIOL, V167, P281, DOI 10.1083/jcb.200407088; Goud B, 2010, TRENDS CELL BIOL, V20, P329, DOI 10.1016/j.tcb.2010.02.006; Hennies HC, 2004, AM J HUM GENET, V75, P138, DOI 10.1086/422219; Horn D, 2000, AM J MED GENET, V92, P285, DOI 10.1002/(SICI)1096-8628(20000605)92:4<285::AID-AJMG13>3.3.CO;2-4; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Kivitie-Kallio S, 1998, NEUROPEDIATRICS, V29, P298, DOI 10.1055/s-2007-973581; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kolehmainen J, 1997, EUR J HUM GENET, V5, P206, DOI 10.1159/000484765; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meriin AB, 2003, MOL CELL BIOL, V23, P7554, DOI 10.1128/MCB.23.21.7554-7565.2003; Mochida GH, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.014779; Munro S, 1999, CURR BIOL, V9, P377, DOI 10.1016/S0960-9822(99)80166-3; Parri V, 2010, EUR J HUM GENET, V18, P1133, DOI 10.1038/ejhg.2010.59; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Redding K, 1996, MOL CELL BIOL, V16, P6208; Rios RM, 2003, CURR OPIN CELL BIOL, V15, P60, DOI 10.1016/S0955-0674(02)00013-3; Seifert W, 2009, HUM MUTAT, V30, pE404, DOI 10.1002/humu.20886; Short B, 2003, CURR BIOL, V13, pR311, DOI 10.1016/S0960-9822(03)00234-3; Valente C, 2010, NAT CELL BIOL, V12, P635, DOI 10.1038/ncb0710-635; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012	36	77	82	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37665	37675		10.1074/jbc.M111.267971	http://dx.doi.org/10.1074/jbc.M111.267971			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21865173	Green Published, hybrid			2022-12-27	WOS:000296542400063
J	Tiwari, A; Jung, JJ; Inamdar, SM; Brown, CO; Goel, A; Choudhury, A				Tiwari, Ajit; Jung, Jae-Joon; Inamdar, Shivangi M.; Brown, Charles O.; Goel, Apollina; Choudhury, Amit			Endothelial Cell Migration on Fibronectin Is Regulated by Syntaxin 6-mediated alpha 5 beta 1 Integrin Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNARE-MEDIATED TRAFFICKING; MEMBRANE-FUSION; TRANS-GOLGI; EXTRACELLULAR-MATRIX; VASCULAR DEVELOPMENT; 3T3-L1 ADIPOCYTES; EARLY ENDOSOMES; CHO-CELLS; ADHESION; RAC	The alpha 5 beta 1 integrin heterodimer regulates many processes that contribute to embryonic development and angiogenesis, in both physiological and pathological contexts. As one of the major adhesion complexes on endothelial cells, it plays a vital role in adhesion and migration along the extracellular matrix. We recently showed that angiogenesis is modulated by syntaxin 6, a Golgi-and endosome-localized t-SNARE, and that it does so by regulating the post-Golgi trafficking of VEGFR2. Here we show that syntaxin 6 is also required for alpha 5 beta 1 integrin-mediated adhesion of endothelial cells to, and migration along, fibronectin. We demonstrate that syntaxin 6 and alpha 5 beta 1 integrin colocalize in EEA1-containing early endosomes, and that functional inhibition of syntaxin 6 leads to misrouting of beta 1 integrin to the degradation pathway (late endosomes and lysosomes) rather transport along recycling pathway from early endosomes; an increase in the pool of ubiquitinylated alpha 5 integrin and its lysosome-dependent degradation; reduced cell spreading on fibronectin; decreased Rac1 activation; and altered Rac1 localization. Collectively, our data show that functional syntaxin 6 is required for the regulation of alpha 5 beta 1-mediated endothelial cell movement on fibronectin. These syntaxin 6-regulated membrane trafficking events control outside-in signaling via haptotactic and chemotactic mechanisms.	[Tiwari, Ajit; Jung, Jae-Joon; Inamdar, Shivangi M.; Choudhury, Amit] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Brown, Charles O.; Goel, Apollina] Univ Iowa, Dept Radiat Oncol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Choudhury, A (corresponding author), 51 Newton Rd, Iowa City, IA 52242 USA.	amit-choudhury@uiowa.edu	Jung, Jae-Joon/I-2186-2014		NHLBI, National Institutes of Health [HL089599]; NCI, National Institutes of Health [CA127958]; NATIONAL CANCER INSTITUTE [R01CA127958] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089599] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL089599 from the NHLBI (to A. C.) and CA127958 from the NCI (to A. G.).	Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Banerjee ER, 2008, EXP HEMATOL, V36, P1004, DOI 10.1016/j.exphem.2008.03.008; Berrier AL, 2002, J CELL SCI, V115, P4285, DOI 10.1242/jcs.00109; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; BRETSCHER MS, 1989, EMBO J, V8, P1341, DOI 10.1002/j.1460-2075.1989.tb03514.x; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Choudhury A, 2004, MOL BIOL CELL, V15, P4500, DOI 10.1091/mbc.E04-05-0432; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Gonon EM, 2005, FEBS LETT, V579, P6169, DOI 10.1016/j.febslet.2005.09.090; Hasan N, 2010, EXP CELL RES, V316, P12, DOI 10.1016/j.yexcr.2009.10.007; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Luftman K, 2009, BIOCHEM BIOPH RES CO, V380, P65, DOI 10.1016/j.bbrc.2009.01.036; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Manickam V, 2011, BLOOD, V117, P1425, DOI 10.1182/blood-2010-06-291690; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Perera HKI, 2003, MOL BIOL CELL, V14, P2946, DOI 10.1091/mbc.E02-11-0722; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Proctor KM, 2006, BIOCHEM BIOPH RES CO, V347, P433, DOI 10.1016/j.bbrc.2006.06.135; Rapaport D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009759; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Skalski M, 2005, BIOCHEM BIOPH RES CO, V335, P1199, DOI 10.1016/j.bbrc.2005.07.195; Skalski M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-62; Tayeb MA, 2005, EXP CELL RES, V305, P63, DOI 10.1016/j.yexcr.2004.12.004; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Teng FYH, 2001, GENOME BIOL, V2; Wang Y, 2005, MOL MEMBR BIOL, V22, P313, DOI 10.1080/09687860500143829; Wendler F, 2001, MOL BIOL CELL, V12, P1699, DOI 10.1091/mbc.12.6.1699; YANG JT, 1993, DEVELOPMENT, V119, P1093; Zhang YH, 2008, J BIOL CHEM, V283, P30689, DOI 10.1074/jbc.M801711200	58	49	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36749	36761		10.1074/jbc.M111.260828	http://dx.doi.org/10.1074/jbc.M111.260828			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880737	Green Published, hybrid			2022-12-27	WOS:000296538300057
J	Jayaraman, S; Abe-Dohmae, S; Yokoyama, S; Cavigiolio, G				Jayaraman, Shobini; Abe-Dohmae, Sumiko; Yokoyama, Shinji; Cavigiolio, Giorgio			Impact of Self-association on Function of Apolipoprotein A-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; ABCA1-DEPENDENT CHOLESTEROL TRANSPORT; N-TERMINAL DOMAIN; LIPID-FREE; APOA-I; HUMAN-PLASMA; PRE-BETA; PROTEIN INTERACTIONS; STRUCTURAL-ANALYSIS; AQUEOUS-SOLUTIONS	Self-association is an inherent property of the lipid-free forms of several exchangeable apolipoproteins, including apolipoprotein A-I (apoA-I), the main protein component of high density lipoproteins (HDL) and an established anti-atherogenic factor. Monomeric lipid-free apoA-I is believed to be the biologically active species, but abnormal conditions, such as specific natural mutations or oxidation, produce an altered state of self-association that may contribute to apoA-I dysfunction. Replacement of the tryptophans of apoA-I with phenylalanines (Delta W-apoA-I) leads to unusually large and stable self-associated species. We took advantage of this unique solution property of Delta W-apoA-I to analyze the role of self-association in determining the structure and lipid-binding properties of apoA-I as well as ATP-binding cassette A1 (ABCA1)-mediated cellular lipid release, a relevant pathway in atherosclerosis. Monomeric Delta W-apoA-I and wild-type apoA-I activated ABCA1-mediated cellular lipid release with similar efficiencies, whereas the efficiency of high order self-associated species was reduced to less than 50%. Analysis of specific self-associated subclasses revealed that different factors influence the rate of HDL formation in vitro and ABCA1-mediated lipid release efficiency. The alpha-helix-forming ability of apoA-I is the main determinant of in vitro lipid solubilization rates, whereas loss of cellular lipid release efficiency is mainly caused by reduced structural flexibility by formation of stable quaternary interactions. Thus, stabilization of self-associated species impairs apoA-I biological activity through an ABCA1-mediated mechanism. These results afford mechanistic insights into the ABCA1 reaction and suggest self-association as a functional feature of apoA-I. Physiologic mechanisms may alter the native self-association state and contribute to apoA-I dysfunction.	[Cavigiolio, Giorgio] Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA; [Abe-Dohmae, Sumiko; Yokoyama, Shinji] Nagoya City Univ, Grad Sch Med Sci, Dept Biochem, Nagoya, Aichi 4678601, Japan; Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Nagoya City University; Boston University	Cavigiolio, G (corresponding author), Childrens Hosp Oakland Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	gcavigiolio@chori.org		/0000-0003-1616-5347; Cavigiolio, Giorgio/0000-0002-1622-0628	Tobacco-Related Disease Research Program of California [18KT-0021]; International Atherosclerosis Society; Ministry of Education, Culture, Sports, Science and Technology [21591164]; National Institutes of Health [GM067260, HL026355]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067260] Funding Source: NIH RePORTER	Tobacco-Related Disease Research Program of California(University of California System); International Atherosclerosis Society; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a new investigator award from the Tobacco-Related Disease Research Program of California (Grant 18KT-0021) and an International Atherosclerosis Society Visiting Fellowship Award. Partial support was also provided by a Grant-in-Aid for Science Research in Japan from the Ministry of Education, Culture, Sports, Science and Technology (Grant 21591164) and by National Institutes of Health Grants GM067260 and HL026355.	Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Abe-Dohmae S, 2000, BIOCHEMISTRY-US, V39, P11092, DOI 10.1021/bi0008175; Arnulphi C, 2004, BIOCHEMISTRY-US, V43, P12258, DOI 10.1021/bi036118k; BARBEAU DL, 1979, BIOCHEMISTRY-US, V18, P362, DOI 10.1021/bi00569a021; Bashtovyy D, 2011, J LIPID RES, V52, P435, DOI 10.1194/jlr.R012658; Benjwal S, 2010, PROTEINS, V78, P1175, DOI 10.1002/prot.22637; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Brouillette CG, 2005, BIOCHEMISTRY-US, V44, P16413, DOI 10.1021/bi051018v; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Garai K, 2011, BIOCHEMISTRY-US, V50, P2550, DOI 10.1021/bi1020106; Garai K, 2010, BIOCHEMISTRY-US, V49, P9533, DOI 10.1021/bi101407m; Gianazza E, 1997, BIOCHEMISTRY-US, V36, P7898, DOI 10.1021/bi962600+; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; GWYNNE J, 1974, J BIOL CHEM, V249, P2411; HARA H, 1992, BIOCHEMISTRY-US, V31, P2040, DOI 10.1021/bi00122a021; Jerlich A, 2000, EUR J BIOCHEM, V267, P4137, DOI 10.1046/j.1432-1327.2000.01449.x; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kono M, 2010, J LIPID RES, V51, P809, DOI 10.1194/jlr.M002113; Koyama M, 2009, BIOCHEMISTRY-US, V48, P2529, DOI 10.1021/bi802317v; Laccotripe M, 1997, J BIOL CHEM, V272, P17511, DOI 10.1074/jbc.272.28.17511; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; MANTULIN WW, 1980, J BIOL CHEM, V255, P8185; MANTULIN WW, 1986, BIOCHEMISTRY-US, V25, P8034, DOI 10.1021/bi00372a036; Marcel YL, 2008, CURR OPIN LIPIDOL, V19, P455, DOI 10.1097/MOL.0b013e32830f4a1d; MASSEY JB, 1981, BIOCHEM BIOPH RES CO, V99, P466, DOI 10.1016/0006-291X(81)91768-X; Mehta R, 2003, J MOL BIOL, V328, P183, DOI 10.1016/S0022-2836(03)00155-4; MONERA OD, 1993, J BIOL CHEM, V268, P19218; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBAHA.107.142455; Nanjee MN, 2000, CLIN CHEM, V46, P207; Narayanaswami V, 2000, BBA-MOL CELL BIOL L, V1483, P15, DOI 10.1016/S1388-1981(99)00176-6; Narayanaswami V, 2010, COMP BIOCHEM PHYS A, V155, P123, DOI 10.1016/j.cbpa.2009.09.009; Oda MN, 2001, BIOCHEMISTRY-US, V40, P1710, DOI 10.1021/bi001922h; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Okuhira K, 2004, J LIPID RES, V45, P645, DOI 10.1194/jlr.M300257-JLR200; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Pyle LE, 1996, BIOCHEMISTRY-US, V35, P12046, DOI 10.1021/bi9609073; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Ren XF, 2005, BIOCHEMISTRY-US, V44, P14907, DOI 10.1021/bi0508385; Roberts LM, 1997, BIOCHEMISTRY-US, V36, P7615, DOI 10.1021/bi962952g; Rogers DP, 1997, BIOCHEMISTRY-US, V36, P288, DOI 10.1021/bi961876e; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Sacks FM, 2009, J LIPID RES, V50, P894, DOI 10.1194/jlr.M800622-JLR200; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Saito H, 2004, J BIOL CHEM, V279, P20974, DOI 10.1074/jbc.M402043200; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Saito H, 2001, J BIOL CHEM, V276, P40949, DOI 10.1074/jbc.M106337200; Sakamoto T, 2008, BIOCHEMISTRY-US, V47, P2968, DOI 10.1021/bi701923h; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; Segrest JP, 2002, CURR TOP MEMBR, V52, P397; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Sigalov AB, 2001, CHEM PHYS LIPIDS, V113, P133, DOI 10.1016/S0009-3084(01)00186-4; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; Sparks DL, 1999, BIOCHEMISTRY-US, V38, P1727, DOI 10.1021/bi981945k; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; Tanaka M, 2011, BBA-MOL CELL BIOL L, V1811, P25, DOI 10.1016/j.bbalip.2010.10.003; Teoh CL, 2011, PROTEIN CELL, V2, P116, DOI 10.1007/s13238-011-1013-6; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; Tricerri MA, 2002, J LIPID RES, V43, P187; Tripet B, 1997, J BIOL CHEM, V272, P8946; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; VITELLO LB, 1976, J BIOL CHEM, V251, P1131; VONECKARDSTEIN A, 1990, J BIOL CHEM, V265, P8610; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Weers PMM, 2011, J LIPID RES, V52, P35, DOI 10.1194/jlr.M007500; WEINBERG RB, 1985, J BIOL CHEM, V260, P4279; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Yokoyama S, 2005, CURR OPIN LIPIDOL, V16, P269, DOI 10.1097/01.mol.0000169346.15450.90; YOKOYAMA S, 1985, J BIOL CHEM, V260, P6375; Zhao YW, 1996, J BIOL CHEM, V271, P25145, DOI 10.1074/jbc.271.41.25145; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	90	29	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35610	35623		10.1074/jbc.M111.262485	http://dx.doi.org/10.1074/jbc.M111.262485			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21835924	hybrid, Green Published			2022-12-27	WOS:000295927100033
J	Rahaman, SO; Zhou, G; Silverstein, RL				Rahaman, S. Ohidar; Zhou, Gang; Silverstein, Roy L.			Vav Protein Guanine Nucleotide Exchange Factor Regulates CD36 Protein-mediated Macrophage Foam Cell Formation via Calcium and Dynamin-dependent Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR CD36; LOW-DENSITY-LIPOPROTEIN; T-CELLS; ACTIN CYTOSKELETON; MEMBRANE FISSION; OXIDATIVE BURST; REQUIRE VAV; ACTIVATION; FAMILY; MICE	Background: The scavenger receptor CD36 is known to activate Vav proteins, which function as GEFs for Rho GTPases and scaffolds for assembly of various signaling proteins. Results: CD36-dependent activation of Vav proteins in macrophages by oxidized phospholipids was shown to trigger lipid uptake and foam cell formation by activating dynamin 2 and generating calcium signals. Conclusion: Vav family GEFs regulate CD36-mediated oxLDL uptake and foam cell formation via calcium and dynamin 2-dependent processes. Significance: Results from these studies will have therapeutic interest because small chemical inhibitors of dynamin GTPase activity or calcium antagonists may be useful as potential anti-atherosclerotic reagents.	[Rahaman, S. Ohidar; Zhou, Gang; Silverstein, Roy L.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Silverstein, Roy L.] Cleveland Clin Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Rahaman, SO (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA.	rahamao@ccf.org; silverr2@ccf.org			National Institutes of Health [HL087018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL087018.	Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Collins RF, 2009, J BIOL CHEM, V284, P30288, DOI 10.1074/jbc.M109.045104; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Etzion Y, 2009, CIRC RES, V105, P148, DOI 10.1161/CIRCRESAHA.109.195818; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Henry P. D., 1990, AM J CARDIOL, V66, p3I; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Kasri NN, 2006, J BIOL CHEM, V281, P8332, DOI 10.1074/jbc.M510971200; Koncz G, 2008, CELL DEATH DIFFER, V15, P494, DOI 10.1038/sj.cdd.4402282; LEW PD, 1980, J BIOL CHEM, V255, P5841; MacDonald PE, 2005, J CELL SCI, V118, P5911, DOI 10.1242/jcs.02685; Malhotra S, 2009, J BIOL CHEM, V284, P24088, DOI 10.1074/jbc.M109.014209; Manetz TS, 2001, MOL CELL BIOL, V21, P3763, DOI 10.1128/MCB.21.11.3763-3774.2001; Miletic AV, 2007, BLOOD, V109, P3360, DOI 10.1182/blood-2006-07-033662; Moller A, 2001, J BIOL CHEM, V276, P20022, DOI 10.1074/jbc.M011139200; Pearce AC, 2004, J BIOL CHEM, V279, P53955, DOI 10.1074/jbc.M410355200; Phillipson M, 2009, J IMMUNOL, V182, P6870, DOI 10.4049/jimmunol.0803414; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rahaman SO, 2011, J BIOL CHEM, V286, P7010, DOI 10.1074/jbc.M110.192450; Riteau B, 2003, J EXP MED, V198, P469, DOI 10.1084/jem.20021995; Spurrell DR, 2009, J IMMUNOL, V183, P310, DOI 10.4049/jimmunol.0802096; Sun B, 2007, J LIPID RES, V48, P2560, DOI 10.1194/jlr.M700163-JLR200; Swat W, 2005, IMMUNOL RES, V32, P259, DOI 10.1385/IR:32:1-3:259; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Tybulewicz VLJ, 2003, IMMUNOL REV, V192, P42, DOI 10.1034/j.1600-065X.2003.00032.x; van Tits LJH, 2000, FREE RADICAL BIO MED, V29, P747, DOI 10.1016/S0891-5849(00)00372-5; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Wells CM, 2005, EXP CELL RES, V310, P303, DOI 10.1016/j.yexcr.2005.07.015; Wilkinson B, 2006, J BIOL CHEM, V281, P20842, DOI 10.1074/jbc.M600627200; Zhao ZZ, 2005, ARTERIOSCL THROM VAS, V25, P168, DOI 10.1161/01.ATV.0000149145.00865.d9; Zhou Z, 2007, J BIOL CHEM, V282, P23737, DOI 10.1074/jbc.M702975200	38	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36011	36019		10.1074/jbc.M111.265082	http://dx.doi.org/10.1074/jbc.M111.265082			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865158	Green Published, hybrid			2022-12-27	WOS:000295927100074
J	Yu, XJ; Liu, M; Matthews, S; Holden, DW				Yu, Xiu-Jun; Liu, Mei; Matthews, Steve; Holden, David W.			Tandem Translation Generates a Chaperone for the Salmonella Type III Secretion System Protein SsaQ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; PATHOGENICITY ISLAND-2; INITIATION SITES; CHROMOSOMAL GENES; C-RING; TYPHIMURIUM; VIRULENCE; CONSTRUCTION; EXPRESSION; LOCUS	Type III secretion systems (T3SSs) of bacterial pathogens involve the assembly of a surface-localized needle complex, through which translocon proteins are secreted to form a pore in the eukaryotic cell membrane. This enables the transfer of effector proteins from the bacterial cytoplasm to the host cell. A structure known as the C-ring is thought to have a crucial role in secretion by acting as a cytoplasmic sorting platform at the base of the T3SS. Here, we studied SsaQ, an FliN-like putative C-ring protein of the Salmonella pathogenicity island 2 (SPI-2)-encoded T3SS. ssaQ produces two proteins by tandem translation: a long form (SsaQ(L)) composed of 322 amino acids and a shorter protein (SsaQ(S)) comprising the C-terminal 106 residues of SsaQ(L). SsaQ(L) is essential for SPI-2 T3SS function. Loss of SsaQ(S) impairs the function of the T3SS both ex vivo and in vivo. SsaQ(S) binds to its corresponding region within SsaQ(L) and stabilizes the larger protein. Therefore, SsaQ(L) function is optimized by a novel chaperone-like protein, produced by tandem translation from its own mRNA species.	[Yu, Xiu-Jun; Liu, Mei; Holden, David W.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Microbiol Sect, London SW7 2AZ, England; [Matthews, Steve] Univ London Imperial Coll Sci Technol & Med, Struct Biol Ctr, Div Mol Biosci, London SW7 2AZ, England	Imperial College London; Imperial College London	Holden, DW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Microbiol Sect, London SW7 2AZ, England.	d.holden@imperial.ac.uk		Liu, Mei/0000-0002-4319-3063; Matthews, Steve/0000-0003-0676-0927	Medical Research Council (United Kingdom); Wellcome Trust; Medical Research Council [G0800148] Funding Source: researchfish; MRC [G0800148] Funding Source: UKRI	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council (United Kingdom) and the Wellcome Trust (to D. W. H.).	Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Beuzon CR, 2001, INFECT IMMUN, V69, P7254, DOI 10.1128/IAI.69.12.7254-7261.2001; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bispham J, 2001, INFECT IMMUN, V69, P367, DOI 10.1128/IAI.69.1.367-377.2001; Brown PN, 2005, J BACTERIOL, V187, P2890, DOI 10.1128/JB.187.8.2890-2902.2005; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Fadouloglou VE, 2004, P NATL ACAD SCI USA, V101, P70, DOI 10.1073/pnas.0304579101; Garmendia J, 2003, MICROBIOL-SGM, V149, P2385, DOI 10.1099/mic.0.26397-0; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Jackson MW, 2000, FEMS MICROBIOL LETT, V186, P85, DOI 10.1111/j.1574-6968.2000.tb09086.x; Jones MA, 2001, INFECT IMMUN, V69, P5471, DOI 10.1128/IAI.69.9.5471-5476.2001; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Mathews MAA, 1998, J BACTERIOL, V180, P5580, DOI 10.1128/JB.180.21.5580-5590.1998; Mazurkiewicz P, 2008, MOL MICROBIOL, V67, P1371, DOI 10.1111/j.1365-2958.2008.06134.x; MCCARTHY JEG, 1994, TRENDS GENET, V10, P402, DOI 10.1016/0168-9525(94)90057-4; McLaughlin LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000671; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; PARK SK, 1993, J BIOL CHEM, V268, P20170; PLUMBRIDGE JA, 1985, EMBO J, V4, P223, DOI 10.1002/j.1460-2075.1985.tb02339.x; Poh J, 2008, CELL MICROBIOL, V10, P20, DOI 10.1111/j.1462-5822.2007.01010.x; ROSS TK, 1989, J BACTERIOL, V171, P1974, DOI 10.1128/jb.171.4.1974-1981.1989; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Sarkar MK, 2010, J BIOL CHEM, V285, P675, DOI 10.1074/jbc.M109.068676; Schoenhals GJ, 1998, J BACTERIOL, V180, P2936, DOI 10.1128/JB.180.11.2936-2942.1998; Schuch R, 2001, INFECT IMMUN, V69, P2180, DOI 10.1128/IAI.69.4.2180-2189.2001; SMITH RA, 1980, P NATL ACAD SCI-BIOL, V77, P5370, DOI 10.1073/pnas.77.9.5370; Tomljenovic-Berube AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000875; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Valdivia RH, 1996, MOL MICROBIOL, V22, P367, DOI 10.1046/j.1365-2958.1996.00120.x; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Worley MJ, 2006, P NATL ACAD SCI USA, V103, P17915, DOI 10.1073/pnas.0604054103; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000; Yu XJ, 2004, MOL MICROBIOL, V54, P604, DOI 10.1111/j.1365-2958.2004.04297.x; Zhao RH, 1996, J MOL BIOL, V261, P195, DOI 10.1006/jmbi.1996.0452	45	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36098	36107		10.1074/jbc.M111.278663	http://dx.doi.org/10.1074/jbc.M111.278663			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21878641	hybrid, Green Published			2022-12-27	WOS:000295927100082
J	Fu, CL; Tong, CF; Wang, ML; Gao, YX; Zhang, Y; Lu, SQ; Liang, SL; Dong, C; Long, MA				Fu, Changliang; Tong, Chunfang; Wang, Manliu; Gao, Yuxin; Zhang, Yan; Lu, Shouqin; Liang, Shile; Dong, Cheng; Long, Mian			Determining beta(2)-Integrin and Intercellular Adhesion Molecule 1 Binding Kinetics in Tumor Cell Adhesion to Leukocytes and Endothelial Cells by a Gas-driven Micropipette Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY ADENOCARCINOMA CELLS; HYDRODYNAMIC SHEAR; MELANOMA ADHESION; 2-DIMENSIONAL KINETICS; HUMAN NEUTROPHILS; P-SELECTIN; METASTASIS DEVELOPMENT; LIGAND INTERACTIONS; CONCURRENT BINDING; CANCER METASTASIS	Interactions between polymorphonuclear neutrophils (PMNs) and tumor cells have been reported to facilitate the adhesion and subsequent extravasation of tumor cells through the endothelium under blood flow, both of which are mediated by binding beta(2)-integrin to intercellular adhesion molecule 1 (ICAM-1). Here the adhesions between humanWM9 metastatic melanoma cells, PMNs, and human pulmonary microvascular endothelial cells (HPMECs) were quantified by a gas-driven micropipette aspiration technique (GDMAT). Our data indicated that the cellular binding affinity of PMN-WM9 pair was 3.9-fold higher than that of the PMN-HPMEC pair. However, the effective binding affinities per molecular pair were comparable between the two cell pairs no matter whether WM9 cells or HPMECs were quiescent or cytokine-activated, indicating that the stronger adhesion between PMN-WM9 pair is mainly attributed to the high expression of ICAM-1 on WM9 cells. These results proposed an alternative mechanism, where WM9 melanoma cells adhere first with PMNs near vessel-wall regions and then bind to endothelial cells via PMNs under blood flow. In contrast, the adhesions between human MDA-MB-231 metastatic breast carcinoma cells and PMNs showed a comparable cellular binding affinity to PMN-HPMEC pair because the ICAM-1 expressions on MDA-MB-231 cells and HPMECs are similar. Furthermore, differences were observed in the intrinsic forward and reverse rates of the beta(2)-integrin-ICAM-1 bond between PMN-TC and PMN-EC pairs. This GDMAT assay enables us to quantify the binding kinetics of cell adhesion molecules physiologically expressed on nucleated cells. The findings also further the understanding of leukocyte-facilitated tumor cell adhesion from the viewpoint of molecular binding kinetics.	[Fu, Changliang; Tong, Chunfang; Wang, Manliu; Gao, Yuxin; Zhang, Yan; Lu, Shouqin; Long, Mian] Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Beijing 100190, Peoples R China; [Fu, Changliang; Tong, Chunfang; Wang, Manliu; Gao, Yuxin; Zhang, Yan; Lu, Shouqin; Long, Mian] Chinese Acad Sci, Natl Micrograv Lab, Beijing 100190, Peoples R China; [Fu, Changliang; Tong, Chunfang; Wang, Manliu; Gao, Yuxin; Zhang, Yan; Lu, Shouqin; Long, Mian] Chinese Acad Sci, Ctr Biomech & Bioengn, Inst Mech, Beijing 100190, Peoples R China; [Liang, Shile; Dong, Cheng] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA	Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Mechanics, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Long, MA (corresponding author), Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Beijing 100190, Peoples R China.	mlong@imech.ac.cn	Fu, Changliang/E-4779-2010		National Institutes of Health [CA-97306, CA-125707, M01-RR-010732, C06-RR-016499]; National Natural Science Foundation of China [30730032, 10702075, 10902117]; National Key Basic Research Foundation of China [2006CB910303, 2011CB710904]; Chinese Academy of Science [XDA01030102, XDA04020219, KJCX2-YW-L08]; National Science Foundation [BES-0138474, CBET-0729091]; NATIONAL CANCER INSTITUTE [R01CA097306, R01CA125707] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016499, M01RR010732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-97306, CA-125707, M01-RR-010732, and C06-RR-016499. This work was also supported by National Natural Science Foundation of China Grants 30730032, 10702075, and 10902117; National Key Basic Research Foundation of China Grants 2006CB910303 and 2011CB710904; Strategic Priority Research Program of Chinese Academy of Science grants XDA01030102 and XDA04020219, Knowledge Innovation Program of Chinese Academy of Science Grant KJCX2-YW-L08 (to M.L.), and National Science Foundation Grants BES-0138474 and CBET-0729091 (to C.D.).	AEED PA, 1988, INT J CANCER, V42, P748, DOI 10.1002/ijc.2910420521; BATEMAN J, 1993, CELL BIOCHEM FUNCT, V11, P87, DOI 10.1002/cbf.290110203; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Dong C, 2009, BIORHEOLOGY, V46, P265, DOI 10.3233/BIR-2009-0545; Fu CL, 2011, CELL MOL BIOENG, V4, P427, DOI 10.1007/s12195-011-0167-x; Fu G, 2006, BIOCHEM BIOPH RES CO, V351, P847, DOI 10.1016/j.bbrc.2006.10.127; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Goetz DJ, 1996, INT J CANCER, V65, P192, DOI 10.1002/(SICI)1097-0215(19960117)65:2<192::AID-IJC11>3.0.CO;2-G; Hentzen ER, 2000, BLOOD, V95, P911, DOI 10.1182/blood.V95.3.911.003k36_911_920; Hoskins Meghan H., 2006, Molecular & Cellular Biomechanics, V3, P79; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Jadhav S, 2002, AM J PHYSIOL-CELL PH, V283, pC1133, DOI 10.1152/ajpcell.00104.2002; Jadhav S, 2001, J IMMUNOL, V167, P5986, DOI 10.4049/jimmunol.167.10.5986; Jun CD, 2001, P NATL ACAD SCI USA, V98, P6830, DOI 10.1073/pnas.121186998; Konstantopoulos K, 2009, ANNU REV BIOMED ENG, V11, P177, DOI 10.1146/annurev-bioeng-061008-124949; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; Levin JD, 2001, BIOPHYS J, V80, P656, DOI 10.1016/S0006-3495(01)76046-8; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liang S, 2005, EXP CELL RES, V310, P282, DOI 10.1016/j.yexcr.2005.07.028; Liang S, 2008, AM J PHYSIOL-CELL PH, V295, pC701, DOI 10.1152/ajpcell.00245.2008; Liang S, 2008, ANN BIOMED ENG, V36, P661, DOI 10.1007/s10439-008-9445-8; Liang SL, 2008, AM J PHYSIOL-CELL PH, V294, pC743, DOI 10.1152/ajpcell.00250.2007; Liang SL, 2007, CANCER RES, V67, P5814, DOI 10.1158/0008-5472.CAN-06-4233; Lomakina EB, 2004, BIOPHYS J, V86, P1223, DOI 10.1016/S0006-3495(04)74196-X; Lomakina EB, 2009, BIOPHYS J, V96, P276, DOI 10.1016/j.bpj.2008.10.001; Long M, 2001, ANN BIOMED ENG, V29, P935, DOI 10.1114/1.1415529; Long M, 2006, CELL MOL IMMUNOL, V3, P79; Ludwig RJ, 2004, CANCER RES, V64, P2743, DOI 10.1158/0008-5472.CAN-03-1054; Ma YQ, 2000, J IMMUNOL, V165, P558, DOI 10.4049/jimmunol.165.1.558; MCCARTHY DA, 1994, CYTOMETRY, V17, P39, DOI 10.1002/cyto.990170106; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Miles FL, 2008, CLIN EXP METASTAS, V25, P305, DOI 10.1007/s10585-007-9098-2; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; MILLER J, 1995, J EXP MED, V182, P1231, DOI 10.1084/jem.182.5.1231; Muller WA, 2002, LAB INVEST, V82, P521, DOI 10.1038/labinvest.3780446; Neelamegham S, 1998, BLOOD, V92, P1626, DOI 10.1182/blood.V92.5.1626.417a02_1626_1638; Parthasarathy K, 2008, PROTEIN SCI, V17, P930, DOI 10.1110/ps.073234208; REILLY PL, 1995, J IMMUNOL, V155, P529; Rinker KD, 2001, BIOPHYS J, V80, P1722, DOI 10.1016/S0006-3495(01)76143-7; Shao JY, 1996, BIOPHYS J, V71, P2892, DOI 10.1016/S0006-3495(96)79486-9; Shao JY, 1998, P NATL ACAD SCI USA, V95, P6797, DOI 10.1073/pnas.95.12.6797; Shao JY, 2002, J BIOMECH ENG-T ASME, V124, P388, DOI 10.1115/1.1486469; Slattery MJ, 2005, AM J PHYSIOL-CELL PH, V288, pC831, DOI 10.1152/ajpcell.00439.2004; Slattery MJ, 2003, INT J CANCER, V106, P713, DOI 10.1002/ijc.11297; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Sun GY, 2009, CELL MOL BIOENG, V2, P495, DOI 10.1007/s12195-009-0079-1; Sun GY, 2009, EUR BIOPHYS J BIOPHY, V38, P701, DOI 10.1007/s00249-009-0428-y; Vitte J, 2004, J LEUKOCYTE BIOL, V76, P594, DOI 10.1189/jlb.0204077; WELCH DR, 1989, P NATL ACAD SCI USA, V86, P5859, DOI 10.1073/pnas.86.15.5859; Williams TE, 2000, BIOPHYS J, V79, P1858, DOI 10.1016/S0006-3495(00)76435-6; Williams TE, 2001, J BIOL CHEM, V276, P13283, DOI 10.1074/jbc.M010427200; Wu L, 2007, J BIOL CHEM, V282, P9846, DOI 10.1074/jbc.M609219200; Wu QD, 2001, AM J PHYSIOL-CELL PH, V280, pC814, DOI 10.1152/ajpcell.2001.280.4.C814; Yang HY, 2007, EXP CELL RES, V313, P3497, DOI 10.1016/j.yexcr.2007.08.001; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8; Zhu C, 2000, BIOPHYS J, V79, P1850, DOI 10.1016/S0006-3495(00)76434-4	62	25	29	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34777	34787		10.1074/jbc.M111.281642	http://dx.doi.org/10.1074/jbc.M111.281642			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21840991	Green Published, hybrid			2022-12-27	WOS:000295406300032
J	Dennis, MD; Schrufer, TL; Bronson, SK; Kimball, SR; Jefferson, LS				Dennis, Michael D.; Schrufer, Tabitha L.; Bronson, Sarah K.; Kimball, Scot R.; Jefferson, Leonard S.			Hyperglycemia-Induced O-GlcNAcylation and Truncation of 4E-BP1 Protein in Liver of a Mouse Model of Type 1 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE LEVELS; INSULIN-RESISTANCE; SKELETAL-MUSCLE; MESSENGER-RNA; 3T3-L1 ADIPOCYTES; AMINO-ACIDS; RAT-LIVER; GLCNAC; PHOSPHORYLATION; GLYCOSYLATION	4E-BP1 is a protein that, in its hypophosphorylated state, binds the mRNA cap-binding protein eIF4E and represses cap-dependent mRNA translation. By doing so, it plays a major role in the regulation of gene expression by controlling the overall rate of mRNA translation as well as the selection of mRNAs for translation. Phosphorylation of 4E-BP1 causes it to release eIF4E to function in mRNA translation. 4E-BP1 is also subject to covalent addition of N-acetylglucosamine to Ser or Thr residues (O-GlcNAcylation) as well as to truncation. In the truncated form, it is both resistant to phosphorylation and able to bind eIF4E with high affinity. In the present study, Ins2(Akita/+) diabetic mice were used to test the hypothesis that hyperglycemia and elevated flux of glucose through the hexosamine biosynthetic pathway lead to increased O-GlcNAcylation and truncation of 4E-BP1 and consequently decreased eIF4E function in the liver. The amounts of both full-length and truncated 4E-BP1 bound to eIF4E were significantly elevated in the liver of diabetic as compared with non-diabetic mice. In addition, O-GlcNAcylation of both the full-length and truncated proteins was elevated by 2.5- and 5-fold, respectively. Phlorizin treatment of diabetic mice lowered blood glucose concentrations and reduced the expression and O-GlcNAcylation of 4E-BP1. Additionally, when livers were perfused in the absence of insulin, 4E-BP1 phosphorylation in the livers of diabetic mice was normalized to the control value, yet O-GlcNAcylation and the association of 4E-BP1 with eIF4E remained elevated in the liver of diabetic mice. These findings provide insight into the pathogenesis of metabolic abnormalities associated with diabetes.	[Dennis, Michael D.; Schrufer, Tabitha L.; Bronson, Sarah K.; Kimball, Scot R.; Jefferson, Leonard S.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kimball, SR (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA.	skimball@psu.edu		Bronson, Sarah/0000-0002-5456-953X; Dennis, Michael/0000-0002-0645-6864	National Institutes of Health [DK13499, DK088416-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499, R37DK013499, F32DK088416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK13499 (to L. S. J.) and DK088416-01A1 (to M. D. D.).	Ball LE, 2006, MOL CELL PROTEOMICS, V5, P313, DOI 10.1074/mcp.M500314-MCP200; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Bosch RR, 2004, ENDOCRINE, V23, P17, DOI 10.1385/ENDO:23:1:17; Buse MG, 2002, AM J PHYSIOL-ENDOC M, V283, pE241, DOI 10.1152/ajpendo.00060.2002; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Constantinou C, 2007, CELL DEATH DIFFER, V14, P576, DOI 10.1038/sj.cdd.4402045; Constantinou C, 2005, ONCOGENE, V24, P4839, DOI 10.1038/sj.onc.1208648; Constantinou C, 2008, BIOL CELL, V100, P279, DOI 10.1042/BC20070121; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Datta R, 2001, BIOCHIMIE, V83, P919, DOI 10.1016/S0300-9084(01)01344-X; Dennis MD, 2011, J BIOL CHEM, V286, P8287, DOI 10.1074/jbc.M110.209171; Du XL, 2003, J CLIN INVEST, V112, P1049, DOI 10.1172/JCI200318127; Elia A, 2008, ONCOGENE, V27, P811, DOI 10.1038/sj.onc.1210678; FLAIM KE, 1982, J BIOL CHEM, V257, P2939; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Griffith LS, 1999, EUR J BIOCHEM, V262, P824, DOI 10.1046/j.1432-1327.1999.00439.x; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hong EG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1687, DOI 10.1152/ajpendo.00256.2007; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; Kimball SR, 1996, AM J PHYSIOL-CELL PH, V270, pC705, DOI 10.1152/ajpcell.1996.270.2.C705; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Klein AL, 2009, MOL CELL PROTEOMICS, V8, P2733, DOI 10.1074/mcp.M900207-MCP200; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Massa ML, 2011, IUBMB LIFE, V63, P1, DOI 10.1002/iub.411; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; McClain DA, 2002, J DIABETES COMPLICAT, V16, P72, DOI 10.1016/S1056-8727(01)00188-X; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Ptushkina M, 1999, EMBO J, V18, P4068, DOI 10.1093/emboj/18.14.4068; Snow DM, 1998, INT REV CYTOL, V181, P43, DOI 10.1016/S0074-7696(08)60416-7; Sun HY, 2008, NAT PROTOC, V3, P1485, DOI 10.1038/nprot.2008.139; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; YkiJarvinen H, 1996, DIABETES, V45, P302, DOI 10.2337/diabetes.45.3.302; Yoshinaga T, 2005, BIOL CHEM, V386, P1077, DOI 10.1515/BC.2005.124; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u; Zachara NE, 2002, CURR PROTOC MOL BIOL; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	50	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34286	34297		10.1074/jbc.M111.259457	http://dx.doi.org/10.1074/jbc.M111.259457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21840999	hybrid, Green Published			2022-12-27	WOS:000295159200058
J	Fyfe, I; Schuh, AL; Edwardson, JM; Audhya, A				Fyfe, Ian; Schuh, Amber L.; Edwardson, J. Michael; Audhya, Anjon			Association of the Endosomal Sorting Complex ESCRT-II with the Vps20 Subunit of ESCRT-III Generates a Curvature-sensitive Complex Capable of Nucleating ESCRT-III Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; MECHANISM; TSG101; MODEL; RECONSTITUTION; SIMULATIONS; MACHINERY; SCISSION	The scission of membranes necessary for vesicle biogenesis and cytokinesis is mediated by cytoplasmic proteins, which include members of the ESCRT (endosomal sorting complex required for transport) machinery. During the formation of intralumenal vesicles that bud into multivesicular endosomes, the ESCRT-II complex initiates polymerization of ESCRT-III subunits essential for membrane fission. However, mechanisms underlying the spatial and temporal regulation of this process remain unclear. Here, we show that purified ESCRT-II binds to the ESCRT-III subunit Vps20 on chemically defined membranes in a curvature-dependent manner. Using a combination of liposome co-flotation assays, fluorescence-based liposome interaction studies, and high-resolution atomic force microscopy, we found that the interaction between ESCRT-II and Vps20 decreases the affinity of ESCRT-II for flat lipid bilayers. We additionally demonstrate that ESCRT-II and Vps20 nucleate flexible filaments of Vps32 that polymerize specifically along highly curved membranes as a single string of monomers. Strikingly, Vps32 filaments are shown to modulate membrane dynamics in vitro, a prerequisite for membrane scission events in cells. We propose that a curvature-dependent assembly pathway provides the spatial regulation of ESCRT-III to fuse juxtaposed bilayers of elevated curvature.	[Schuh, Amber L.; Audhya, Anjon] Univ Wisconsin, Madison Med Sch, Dept Biomol Chem, Madison, WI 53706 USA; [Fyfe, Ian; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Wisconsin System; University of Wisconsin Madison; University of Cambridge	Audhya, A (corresponding author), Univ Wisconsin, Madison Med Sch, Dept Biomol Chem, Madison, WI 53706 USA.	audhya@wisc.edu		Fyfe, Ian/0000-0002-9362-0254	National Institutes of Health [1R01GM088151-01A1]; Greater Milwaukee Foundation; Biotechnology and Biological Sciences Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greater Milwaukee Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM088151-01A1 (to A. A.). This work was also supported by a Shaw Scientist award (Greater Milwaukee Foundation; to A. A.) and a Biotechnology and Biological Sciences Research Council doctoral training award (to I. F.).	Audhya A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000956; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; de Joannis J, 2006, LANGMUIR, V22, P998, DOI 10.1021/la051278d; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Im YJ, 2008, DEV CELL, V14, P902, DOI 10.1016/j.devcel.2008.04.004; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Jackson MB, 2009, J MEMBRANE BIOL, V231, P101, DOI 10.1007/s00232-009-9209-x; Jiang FY, 2004, BIOPHYS J, V87, P182, DOI 10.1529/biophysj.103.031054; Jiang Y, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2430714; Kasson PM, 2004, BIOPHYS J, V86, P3744, DOI 10.1529/biophysj.103.029652; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lee MCS, 2004, SCIENCE, V303, P479, DOI 10.1126/science.1094231; LITSTER JD, 1975, PHYS LETT A, VA 53, P193, DOI 10.1016/0375-9601(75)90402-8; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Liu J, 2010, CURR OPIN CELL BIOL, V22, P36, DOI 10.1016/j.ceb.2009.11.009; Mayers JR, 2011, J BIOL CHEM, V286, P9636, DOI 10.1074/jbc.M110.185363; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Saksena S, 2009, BIOCHEM SOC T, V37, P167, DOI 10.1042/BST0370167; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Teis D, 2010, EMBO J, V29, P871, DOI 10.1038/emboj.2009.408; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Wang H, 2008, BIOPHYS J, V95, P2647, DOI 10.1529/biophysj.108.131409; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xie WQ, 1998, P NATL ACAD SCI USA, V95, P1595, DOI 10.1073/pnas.95.4.1595; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	41	65	67	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34262	34270		10.1074/jbc.M111.266411	http://dx.doi.org/10.1074/jbc.M111.266411			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21835927	hybrid, Green Published			2022-12-27	WOS:000295159200056
J	Dodson, HC; Morris, MT; Morris, JC				Dodson, Heidi C.; Morris, Meredith T.; Morris, James C.			Glycerol 3-Phosphate Alters Trypanosoma brucei Hexokinase Activity in Response to Environmental Change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA INTERFERENCE; GLYCOLYSIS; GLYCOSOMES; PHOSPHOFRUCTOKINASE; PURIFICATION; COMPARTMENTATION; INHIBITION; EXPRESSION; TURNOVER; PH	The African trypanosome, Trypanosoma brucei, compartmentalizes some metabolic enzymes within peroxisome-like organelles called glycosomes. The amounts, activities, and types of glycosomal enzymes are modulated coincident with developmental and environmental changes. Pexophagy (fusion of glycosomes with acidic lysosomes) has been proposed to facilitate this glycosome remodeling. Here, we report that, although glycosome-resident enzyme T. brucei hexokinase 1 (TbHK1) protein levels are maintained during pexophagy, acidification inactivates the activity. Glycerol 3-phosphate, which is produced in vivo by a glycosome-resident glycerol kinase, mitigated acid inactivation of lysate-derived TbHK activity. Using recombinant TbHK1, we found that glycerol 3-P influenced enzyme activity at pH 6.5 by preventing substrate and product inhibition by ATP and ADP, respectively. Additionally, TbHK1 inhibition by the flavonol quercetin (QCN) was partially reversed by glycerol 3-P at pH 7.4, whereas at pH 6.5, enzyme activity in the presence of QCN was completely maintained by glycerol 3-P. However, glycerol 3-P did not alter the interaction of QCN with TbHK1, as the lone Trp residue (Trp-177) was quenched under all conditions tested. These findings suggest potential novel mechanisms for the regulation of TbHK1, particularly given the acidification of glycosomes that can be induced under a variety of parasite growth conditions.	[Dodson, Heidi C.; Morris, Meredith T.; Morris, James C.] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA	Clemson University	Morris, JC (corresponding author), Clemson Univ, Dept Biochem & Genet, 214 BRC,51 New Cherry St, Clemson, SC 29634 USA.	jmorri2@clemson.edu	Morris, James/L-7253-2019	Morris, James/0000-0003-2515-5714	National Institutes of Health [1R15AI075326]; Wade Stackhouse fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI075326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wade Stackhouse fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant 1R15AI075326 (to J. C. M.).; Supported by a Wade Stackhouse fellowship.	Albert MA, 2005, J BIOL CHEM, V280, P28306, DOI 10.1074/jbc.M502403200; Chambers JW, 2008, J BIOL CHEM, V283, P14963, DOI 10.1074/jbc.M802124200; Chambers JW, 2008, MOL BIOCHEM PARASIT, V158, P202, DOI 10.1016/j.molbiopara.2007.12.013; Chudzik DM, 2000, J MOL BIOL, V300, P697, DOI 10.1006/jmbi.2000.3910; CRONIN CN, 1985, BIOCHEM J, V227, P113, DOI 10.1042/bj2270113; CRONIN CN, 1987, BIOCHEM J, V245, P13, DOI 10.1042/bj2450013; Dodson HC, 2011, EXP PARASITOL, V127, P423, DOI 10.1016/j.exppara.2010.10.011; Drew ME, 2003, J BIOL CHEM, V278, P46596, DOI 10.1074/jbc.M309320200; Farre JC, 2004, TRENDS CELL BIOL, V14, P515, DOI 10.1016/j.tcb.2004.07.014; Furuya T, 2002, P NATL ACAD SCI USA, V99, P14177, DOI 10.1073/pnas.222454899; Haanstra JR, 2008, P NATL ACAD SCI USA, V105, P17718, DOI 10.1073/pnas.0806664105; Herman M, 2008, AUTOPHAGY, V4, P294, DOI 10.4161/auto.5443; Kessler PS, 2005, J BIOL CHEM, V280, P9030, DOI 10.1074/jbc.M412033200; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Lorenz P, 1998, EMBO J, V17, P3542, DOI 10.1093/emboj/17.13.3542; MASSON S, 1992, EUR J BIOCHEM, V205, P187, DOI 10.1111/j.1432-1033.1992.tb16767.x; McCann AK, 2008, MOL BIOCHEM PARASIT, V159, P146, DOI 10.1016/j.molbiopara.2008.02.003; Michal G., 1974, METHOD ENZYMAT AN, P1415; MICHELS PAM, 1991, PARASITOL TODAY, V7, P105, DOI 10.1016/0169-4758(91)90167-M; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; MISSET O, 1984, EUR J BIOCHEM, V144, P475, DOI 10.1111/j.1432-1033.1984.tb08490.x; Morris MT, 2006, EUKARYOT CELL, V5, P2014, DOI 10.1128/EC.00146-06; Moyersoen J, 2004, FEMS MICROBIOL REV, V28, P603, DOI 10.1016/j.femsre.2004.06.004; NWAGWU M, 1982, ACTA TROP, V39, P61; OPPERDOES FR, 1984, J CELL BIOL, V98, P1178, DOI 10.1083/jcb.98.4.1178; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; terKuile BH, 1997, J BACTERIOL, V179, P4699, DOI 10.1128/jb.179.15.4699-4705.1997; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	31	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33150	33157		10.1074/jbc.M111.235705	http://dx.doi.org/10.1074/jbc.M111.235705			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813651	Green Published, hybrid			2022-12-27	WOS:000294968800034
J	Hopp, A				Hopp, Angela			Thematic Minireview Series on Molecular Bases of Disease: Asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Amer Soc Biochem & Mol Biol, Rockville, MD 20852 USA		Hopp, A (corresponding author), Amer Soc Biochem & Mol Biol, Rockville, MD 20852 USA.								0	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32875	32876		10.1074/jbc.R111.287284	http://dx.doi.org/10.1074/jbc.R111.287284			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799012	hybrid, Green Published			2022-12-27	WOS:000294968800004
J	Kresge, N; Simoni, RD; Hill, RL				Kresge, Nicole; Simoni, Robert D.; Hill, Robert L.			The Lipid A Assembly Pathway: The Work of Christian Raetz	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Reprint							ESCHERICHIA-COLI; BIOSYNTHESIS	During his career, Christian Raetz has characterized many enzymes responsible for synthesizing or modifying lipid molecules, including the entire nine-enzyme pathway for the biosynthesis of lipid A, an essential part of bacterial outer membranes that plays a role in making many Gram-negative bacteria toxic. The findings from the two Journal of Biological Chemistry (JBC) Classic articles reprinted here were the start of Raetz' elucidation of the enzymology, genetics, and structural biology of lipid A assembly.										KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KENNEDY EP, 1949, J BIOL CHEM, V179, P957; LEHNINGER AL, 1945, J BIOL CHEM, V157, P363; NISHIJIMA M, 1979, J BIOL CHEM, V254, P7837; TABOR CW, 1987, J BIOL CHEM, V262, P16037; TABOR H, 1958, J BIOL CHEM, V233, P907	6	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					E6	E8		10.1074/jbc.O111.000247	http://dx.doi.org/10.1074/jbc.O111.000247			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21887864	Green Published, hybrid			2022-12-27	WOS:000293073000001
J	Kresge, N; Simoni, RD; Hill, RL				Kresge, Nicole; Simoni, Robert D.; Hill, Robert L.			Blood Clotting and Coagulation Factors: The Work of Yale Nemerson	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material														Kresge, Nicole/0000-0003-1551-6627				SILVERBERG SA, 1977, J BIOL CHEM, V252, P8481	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26							e5	10.1074/jbc.O111.000245	http://dx.doi.org/10.1074/jbc.O111.000245			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21842549	Green Published, hybrid			2022-12-27	WOS:000292025000001
J	Kukar, TL; Ladd, TB; Robertson, P; Pintchovski, SA; Moore, B; Bann, MA; Ren, Z; Jansen-West, K; Malphrus, K; Eggert, S; Maruyama, H; Cottrell, BA; Das, P; Basi, GS; Koo, EH; Golde, TE				Kukar, Thomas L.; Ladd, Thomas B.; Robertson, Paul; Pintchovski, Sean A.; Moore, Brenda; Bann, Maralyssa A.; Ren, Zhao; Jansen-West, Karen; Malphrus, Kim; Eggert, Simone; Maruyama, Hiroko; Cottrell, Barbara A.; Das, Pritam; Basi, Guriqbal S.; Koo, Edward H.; Golde, Todd E.			Lysine 624 of the Amyloid Precursor Protein (APP) Is a Critical Determinant of Amyloid beta Peptide Length SUPPORT FOR A SEQUENTIAL MODEL OF gamma-SECRETASE INTRAMEMBRANE PROTEOLYSIS AND REGULATION BY THE AMYLOID beta PRECURSOR PROTEIN (APP) JUXTAMEMBRANE REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL FRAGMENT; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; CLEAVAGE SITE; ZETA-CLEAVAGE; GXXXG MOTIFS; SUBSTRATE; SPECIFICITY; MODULATION	gamma-Secretase is a multiprotein intramembrane cleaving aspartyl protease (I-CLiP) that catalyzes the final cleavage of the amyloid beta precursor protein (APP) to release the amyloid beta peptide (A beta). A beta is the primary component of senile plaques in Alzheimer's disease (AD), and its mechanism of production has been studied intensely. gamma-Secretase executes multiple cleavages within the transmembrane domain of APP, with cleavages producing A beta and the APP intracellular domain (AICD), referred to as gamma and epsilon, respectively. The heterogeneous nature of the gamma cleavage that produces various A beta peptides is highly relevant to AD, as increased production of A beta 1-42 is genetically and biochemically linked to the development of AD. We have identified an amino acid in the juxtamembrane region of APP, lysine 624, on the basis of APP695 numbering (position 28 relative to A beta) that plays a critical role in determining the final length of A beta peptides released by gamma-secretase. Mutation of this lysine to alanine (K28A) shifts the primary site of gamma-secretase cleavage from 1-40 to 1-33 without significant changes to epsilon cleavage. These results further support a model where epsilon cleavage occurs first, followed by sequential proteolysis of the remaining transmembrane fragment, but extend these observations by demonstrating that charged residues at the luminal boundary of the APP transmembrane domain limit processivity of gamma-secretase.	[Kukar, Thomas L.] Emory Univ, Sch Med, Dept Pharmacol, Ctr Neurodegenerat Dis,Dept Neurol, Atlanta, GA 30322 USA; [Ladd, Thomas B.; Moore, Brenda; Golde, Todd E.] Univ Florida, Gainesville, FL 32610 USA; [Robertson, Paul; Jansen-West, Karen; Malphrus, Kim; Das, Pritam] Mayo Clin, Jacksonville, FL 32224 USA; [Pintchovski, Sean A.; Ren, Zhao; Basi, Guriqbal S.] Elan Pharmaceut, San Francisco, CA 94080 USA; [Bann, Maralyssa A.] Univ Washington, Seattle, WA 98195 USA; [Eggert, Simone; Maruyama, Hiroko; Cottrell, Barbara A.; Koo, Edward H.] Univ Calif San Diego, San Diego, CA 92093 USA	Emory University; State University System of Florida; University of Florida; Mayo Clinic; University of Washington; University of Washington Seattle; University of California System; University of California San Diego	Kukar, TL (corresponding author), 1510 Clifton Rd,5123 Rollins Res Ctr, Atlanta, GA 30322 USA.	tkukar@emory.edu	Kukar, Thomas/AAW-2612-2021	Kukar, Thomas/0000-0002-3750-6262; Moore, Brenda/0000-0002-9685-6561; Bann, Maralyssa/0000-0002-5893-950X	National Institutes of Health [AG20206, AG29886, AG032362, NS069289]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG032362, R01AG029886, K99AG032362, P01AG020206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG20206 (to T. E. G.), AG29886 (to E. H. K.), AG032362 (to T. L. K.), and NS069289 (to T. L. K.).	Barten Donna M, 2006, Drugs R D, V7, P87, DOI 10.2165/00126839-200607020-00003; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; De Jonghe C, 2001, HUM MOL GENET, V10, P1665, DOI 10.1093/hmg/10.16.1665; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Dillen K, 2006, INT REV CYTOL, V254, P215, DOI 10.1016/S0074-7696(06)54005-7; Ford MJ, 2008, J NEUROSCI METH, V168, P465, DOI 10.1016/j.jneumeth.2007.11.019; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Golde TE, 2009, SCIENCE, V324, P603, DOI 10.1126/science.1174267; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hecimovic S, 2004, NEUROBIOL DIS, V17, P205, DOI 10.1016/j.nbd.2004.04.018; Holt A, 2010, EUR BIOPHYS J BIOPHY, V39, P609, DOI 10.1007/s00249-009-0567-1; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kawooya JK, 2003, ANAL BIOCHEM, V323, P103, DOI 10.1016/j.ab.2003.08.027; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lichtenthaler SF, 1999, FEBS LETT, V453, P288, DOI 10.1016/S0014-5793(99)00730-9; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Narlawar R, 2007, BIOORG MED CHEM LETT, V17, P5428, DOI 10.1016/j.bmcl.2007.07.044; Ohki Y., 2011, EMBO J IN PRESS; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; OTTER T, 1987, ANAL BIOCHEM, V162, P370, DOI 10.1016/0003-2697(87)90406-4; Page RM, 2010, J BIOL CHEM, V285, P17798, DOI 10.1074/jbc.M110.103283; Ren Z, 2007, J BIOL CHEM, V282, P35350, DOI 10.1074/jbc.M702739200; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Rosen Rebecca F, 2010, J Vis Exp, DOI 10.3791/1916; Sagi SA, 2011, J BIOL CHEM, V286, P39794, DOI 10.1074/jbc.M111.277228; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Strandberg E, 2003, FEBS LETT, V544, P69, DOI 10.1016/S0014-5793(03)00475-7; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; USAMI M, 1993, J NEUROCHEM, V61, P239, DOI 10.1111/j.1471-4159.1993.tb03560.x; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Xu XM, 2009, J ALZHEIMERS DIS, V16, P211, DOI 10.3233/JAD-2009-0957; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200	49	50	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39804	39812		10.1074/jbc.M111.274696	http://dx.doi.org/10.1074/jbc.M111.274696			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21868378	Green Published, hybrid			2022-12-27	WOS:000296925700014
J	Vellano, CP; Maher, EM; Hepler, JR; Blumer, JB				Vellano, Christopher P.; Maher, Ellen M.; Hepler, John R.; Blumer, Joe B.			G Protein-coupled Receptors and Resistance to Inhibitors of Cholinesterase-8A (Ric-8A) Both Regulate the Regulator of G Protein Signaling 14 (RGS14).G alpha(i1) Complex in Live Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; HETEROTRIMERIC G-PROTEINS; GOLOCO MOTIF; BETA(2)-ADRENERGIC RECEPTOR; EXPRESSION ANALYSIS; PLASMA-MEMBRANE; POINT MUTATION; ALPHA; RGS14; ACTIVATION	Regulator of G protein Signaling 14 (RGS14) is a multifunctional scaffolding protein that integrates both conventional and unconventional G protein signaling pathways. Like other RGS (regulator of G protein signaling) proteins, RGS14 acts as a GTPase accelerating protein to terminate conventional G alpha(i/o) signaling. However, unlike other RGS proteins, RGS14 also contains a G protein regulatory/GoLoco motif that specifically binds G alpha(i1/3)-GDP in cells and in vitro. The non-receptor guanine nucleotide exchange factor Ric-8A can bind and act on the RGS14.G alpha(i1)-GDP complex to play a role in unconventional G protein signaling independent of G protein-coupled receptors (GPCRs). Here we demonstrate that RGS14 forms a G alpha(i/o)-dependent complex with a G(i)-linked GPCR and that this complex is regulated by receptor agonist and Ric-8A (resistance to inhibitors of cholinesterase-8A). Using live cell bioluminescence resonance energy transfer, we show that RGS14 functionally associates with the alpha(2A)-adrenergic receptor (alpha(2A)-AR) in a G alpha(i/o)-dependent manner. This interaction is markedly disrupted after receptor stimulation by the specific agonist UK14304, suggesting complex dissociation or rearrangement. Agonist-mediated dissociation of the RGS14.alpha(2A)-AR complex occurs in the presence of G alpha(i/o) but not G alpha(s) or G alpha(q). Unexpectedly, RGS14 does not dissociate from G alpha(i1) in the presence of stimulated alpha(2A)-AR, suggesting preservation of RGS14.G alpha(i1) complexes after receptor activation. However, Ric-8A facilitates dissociation of both the RGS14.G alpha(i1) complex and the G alpha(i1)-dependent RGS14.alpha(2A)-AR complex after receptor activation. Together, these findings indicate that RGS14 can form complexes with GPCRs in cells that are dependent on G alpha(i/o) and that these RGS14.G alpha(i1).GPCR complexes may be substrates for other signaling partners such as Ric-8A.	[Vellano, Christopher P.; Hepler, John R.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Maher, Ellen M.; Blumer, Joe B.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA	Emory University; Medical University of South Carolina	Vellano, CP (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd,Rollins Res Ctr G205, Atlanta, GA 30322 USA.	cvellan@emory.edu; blumerjb@musc.edu		Blumer, Joe/0000-0002-0020-3815	National Institutes of Health [R01NS049195, R01NS037112, R01GM086510]; Pharmacological Sciences Training Grant [T32 GM008602]; PhRMA Foundation; Microscopy Core of the Emory Neuroscience NINDS Core Facilities [P30NS055077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086510, T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037112, R01NS049195, P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacological Sciences Training Grant; PhRMA Foundation; Microscopy Core of the Emory Neuroscience NINDS Core Facilities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS049195 and R01NS037112 (to J. R. H.), R01GM086510 (to J. B. B.), and Pharmacological Sciences Training Grant T32 GM008602 (to C. P. V.). This work was also supported by a PhRMA Foundation Pre-doctoral Pharmacology/Toxicology Fellowship (to C. P. V.). This research was also supported in part by the Microscopy Core of the Emory Neuroscience NINDS Core Facilities Grant P30NS055077.	Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Blumer J. B., 2011, ACTA PHYSL IN PRESS; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; DUZIC E, 1992, J BIOL CHEM, V267, P9844; Fenech C, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.011.2009; Gabay M., 2011, FASEB J, V25, p[804, 805]; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hampoelz B, 2004, CELL, V119, P453, DOI 10.1016/j.cell.2004.10.025; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hepler JR, 2005, BIOCHEMISTRY-US, V44, P5495, DOI 10.1021/bi048359d; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Ingi T, 1998, J NEUROSCI, V18, P7178; Khafizov K, 2009, J MOL MODEL, V15, P1491, DOI 10.1007/s00894-009-0516-z; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Lambert NA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125re5; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mittal V, 2004, J BIOL CHEM, V279, P46772, DOI 10.1074/jbc.M407409200; Natochin M, 2002, BIOCHEMISTRY-US, V41, P258, DOI 10.1021/bi015708k; Neitzel KL, 2006, SEMIN CELL DEV BIOL, V17, P383, DOI 10.1016/j.semcdb.2006.03.002; Nishimura A, 2006, GENES CELLS, V11, P487, DOI 10.1111/j.1365-2443.2006.00959.x; Oner SS, 2010, J BIOL CHEM, V285, P33949, DOI 10.1074/jbc.M110.138073; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schade MA, 2005, GENETICS, V169, P631, DOI 10.1534/genetics.104.032334; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Snow BE, 1997, BIOCHEM BIOPH RES CO, V233, P770, DOI 10.1006/bbrc.1997.6537; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Vellano CP, 2011, BIOCHEMISTRY-US, V50, P752, DOI 10.1021/bi101910n; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Yoshikawa K, 2009, CHEM SENSES, V34, P15, DOI 10.1093/chemse/bjn047	61	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38659	38669		10.1074/jbc.M111.274928	http://dx.doi.org/10.1074/jbc.M111.274928			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21880739	hybrid, Green Published			2022-12-27	WOS:000296594200078
J	Achuthan, S; Santhoshkumar, TR; Prabhakar, J; Nair, SA; Pillai, MR				Achuthan, Santhi; Santhoshkumar, Thankayyan R.; Prabhakar, Jem; Nair, S. Asha; Pillai, M. Radhakrishna			Drug-induced Senescence Generates Chemoresistant Stemlike Cells with Low Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; OXIDATIVE STRESS; CD133 EXPRESSION; SIDE-POPULATION; IDENTIFICATION; RESISTANCE; LINES; DEGRADATION; ASSOCIATION; OCT-4	Tumor recurrence after chemotherapy or radiation remains a major obstacle to successful cancer treatment. A subset of cancer cells, termed cancer stem cells, can elude conventional treatments and eventually regenerate a tumor that is more aggressive. Despite the large number of studies, molecular events that govern the emergence of aggressive therapy-resistant cells with stem cell properties after chemotherapy are poorly defined. The present study provides evidence for the rare escape of tumor cells from drug-induced cell death, after an intermediate stay in a non-cycling senescent stage followed by unstable multiplication characterized by spontaneous cell death. However, some cells appear to escape and generate stable colonies with an aggressive tumor stem cell-like phenotype. These cells displayed higher CD133 and Oct-4 expression. Notably, the drug-selected cells that contained low levels of reactive oxygen species (ROS) also showed an increase in antioxidant enzymes. Consistent with this in vitro experimental data, we observed lower levels of ROSin breast tumors obtained after neoadjuvant chemotherapy compared with samples that did not receive preoperative chemotherapy. These latter tissues also expressed enhanced levels of ROS defenses with enhanced expression of superoxide dismutase. Higher levels of Oct-4 and CD133 were also observed in tumors obtained after neoadjuvant chemotherapy. Further studies provided evidence for the stabilization of Nrf2 due to reduced 26 S proteasome activity and increased p21 association as the driving signaling event that contributes to the transition from a high ROS quiescent state to a low ROS proliferating stage in drug-induced tumor stem cell enrichment.	[Achuthan, Santhi; Santhoshkumar, Thankayyan R.; Nair, S. Asha; Pillai, M. Radhakrishna] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India; [Prabhakar, Jem] Reg Canc Ctr, Div Surg Oncol, Thiruvananthapuram 695011, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Pillai, MR (corresponding author), Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thycaud PO, Thiruvananthapuram 695014, Kerala, India.	mrpillai@rgcb.res.in			Department of Biotechnology, Government of India [BT/PR/7793/MED/14/1112/2006]; Innovative Young Biotechnologist Award [BT/B1/12/040/2005]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Innovative Young Biotechnologist Award	This work was supported by Department of Biotechnology, Government of India, Grant BT/PR/7793/MED/14/1112/2006 (to M. R. P.) and Innovative Young Biotechnologist Award Grant BT/B1/12/040/2005 (to T. R. S. K.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chen MF, 2006, INT J RADIAT ONCOL, V66, P244, DOI 10.1016/j.ijrobp.2006.03.062; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Collins AT, 2006, EUR J CANCER, V42, P1213, DOI 10.1016/j.ejca.2006.01.037; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Goodell Margaret A, 2005, Methods Mol Biol, V290, P343; Guo Y, 2004, STEM CELLS, V22, P259, DOI 10.1634/stemcells.22-3-259; Hancock JT, 2001, BIOCHEM SOC T, V29, P345, DOI 10.1042/BST0290345; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hu L, 2010, BRIT J CANCER, V102, P1276, DOI 10.1038/sj.bjc.6605626; Jiang XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-116; Joseph J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020114; Karakas B, 2007, CANCER BIOL THER, V6, P1025, DOI 10.4161/cbt.6.7.4202; Karimi-Busheri F, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2583; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liang Y, 2010, J BIOL CHEM, V285, P4931, DOI 10.1074/jbc.M109.048397; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Ong CW, 2010, MODERN PATHOL, V23, P450, DOI 10.1038/modpathol.2009.181; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Pan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013298; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Portakal O, 2000, CLIN BIOCHEM, V33, P279, DOI 10.1016/S0009-9120(00)00067-9; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Ramanathan B, 2005, CANCER RES, V65, P8455, DOI 10.1158/0008-5472.CAN-05-1162; Rao AK, 2008, MOL ENDOCRINOL, V22, P1113, DOI 10.1210/me.2007-0381; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sundaram M, 2004, CANCER BIOL THER, V3, P207, DOI 10.4161/cbt.3.2.663; te Poele RH, 2002, CANCER RES, V62, P1876; Vlashi E, 2009, JNCI-J NATL CANCER I, V101, P350, DOI 10.1093/jnci/djn509; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Wang XQ, 2010, HEPATOLOGY, V52, P528, DOI 10.1002/hep.23692; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Zheng X, 2004, CANCER RES, V64, P1773, DOI 10.1158/0008-5472.CAN-03-0820; Zhong WX, 1997, ONCOGENE, V14, P481, DOI 10.1038/sj.onc.1200852	50	145	156	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37813	37829		10.1074/jbc.M110.200675	http://dx.doi.org/10.1074/jbc.M110.200675			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878644	hybrid, Green Published			2022-12-27	WOS:000296542400076
J	Birkenfeld, AL; Lee, HY; Majumdar, S; Jurczak, MJ; Camporez, JP; Jornayvaz, FR; Frederick, DW; Guigni, B; Kahn, M; Zhang, DY; Weismann, D; Arafat, AM; Pfeiffer, AF; Lieske, S; Oyadomari, S; Ron, D; Samuel, VT; Shulman, GI				Birkenfeld, Andreas L.; Lee, Hui-Young; Majumdar, Sachin; Jurczak, Michael J.; Camporez, Joao Paulo; Jornayvaz, Francois R.; Frederick, David W.; Guigni, Blas; Kahn, Mario; Zhang, Dongyang; Weismann, Dirk; Arafat, Ayman M.; Pfeiffer, Andreas F.; Lieske, Stefanie; Oyadomari, Seiichi; Ron, David; Samuel, Varman T.; Shulman, Gerald I.			Influence of the Hepatic Eukaryotic Initiation Factor 2 alpha (eIF2 alpha) Endoplasmic Reticulum (ER) Stress Response Pathway on Insulin-mediated ER Stress and Hepatic and Peripheral Glucose Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; RESISTANCE; DELETION; HOMEOSTASIS; OBESITY; MICE	Recent studies have implicated endoplasmic reticulum (ER) stress in insulin resistance associated with caloric excess. In mice placed on a 3-day high fat diet, we find augmented eIF2 alpha signaling, together with hepatic lipid accumulation and insulin resistance. To clarify the role of the liver ER stress-dependent phospho-eIF2 alpha (eIF2 alpha-P) pathway in response to acute caloric excess on liver and muscle glucose and lipid metabolism, we studied transgenic mice in which the hepatic ER stress-dependent eIF2 alpha-P pathway was inhibited by overexpressing a constitutively active C-terminal fragment of GADD34/PPP1R15a, a regulatory subunit of phosphatase that terminates ER stress signaling by phospho-eIF2 alpha. Inhibition of the eIF2 alpha-P signaling in liver led to a decrease in hepatic glucose production in the basal and clamped state, which could be attributed to reduced gluco-neogenic gene expression, resulting in reduced basal plasma glucose concentrations. Surprisingly, hepatic eIF2 alpha inhibition also impaired insulin-stimulated muscle and adipose tissue insulin sensitivity. This latter effect could be attributed at least in part by an increase in circulating IGFBP-3 levels in the transgenic animals. In addition, infusion of insulin during a hyperinsulinemic-euglycemic clamp induced conspicuous ER stress in the 3-day high fat diet-fed mice, which was aggravated through continuous dephosphorylation of eIF2 alpha. Together, these data imply that the hepatic ER stress eIF2 alpha signaling pathway affects hepatic glucose production without altering hepatic insulin sensitivity. Moreover, hepatic ER stress-dependent eIF2 alpha-P signaling is implicated in an unanticipated cross-talk between the liver and peripheral organs to influence insulin sensitivity, probably via IGFBP-3. Finally, eIF2 alpha is crucial for proper resolution of insulin-induced ER stress.	[Birkenfeld, Andreas L.; Lee, Hui-Young; Majumdar, Sachin; Jurczak, Michael J.; Camporez, Joao Paulo; Jornayvaz, Francois R.; Frederick, David W.; Guigni, Blas; Kahn, Mario; Zhang, Dongyang; Weismann, Dirk; Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Birkenfeld, Andreas L.; Lee, Hui-Young; Majumdar, Sachin; Jurczak, Michael J.; Camporez, Joao Paulo; Jornayvaz, Francois R.; Frederick, David W.; Guigni, Blas; Kahn, Mario; Zhang, Dongyang; Weismann, Dirk; Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Birkenfeld, Andreas L.; Lee, Hui-Young; Majumdar, Sachin; Jurczak, Michael J.; Camporez, Joao Paulo; Jornayvaz, Francois R.; Frederick, David W.; Guigni, Blas; Kahn, Mario; Zhang, Dongyang; Weismann, Dirk; Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Samuel, Varman T.] Vet Affairs Med Ctr, West Haven, CT 06516 USA; [Arafat, Ayman M.; Pfeiffer, Andreas F.; Lieske, Stefanie] Charite Univ Sch Med, D-10117 Berlin, Germany; [Arafat, Ayman M.; Pfeiffer, Andreas F.; Lieske, Stefanie] German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, D-14558 Nuthetal, Germany; [Oyadomari, Seiichi] Univ Tokushima, Inst Genome Res, Tokushima 770, Japan; [Ron, David] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Tokushima University; New York University	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	gerald.shulman@yale.edu	Oyadomari, Seiichi/GZA-7157-2022; Pfeiffer, Andreas F.H./AAJ-2311-2020; Oyadomari, Seiichi/GZA-7072-2022; Shulman, Gerald I./P-7176-2019; Camporez, Joao Paulo G/B-9122-2015; Birkenfeld, Andreas L./U-3954-2019; Jornayvaz, François/AAL-2134-2020	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Shulman, Gerald I./0000-0003-1529-5668; Birkenfeld, Andreas L./0000-0003-1407-9023; Ron, David/0000-0002-3014-5636; Lee, Hui-Young/0000-0002-3464-6382; Guigni, Blas/0000-0002-9667-8195; Arafat, Ayman/0000-0003-3069-8385; /0000-0001-9732-4543; Jornayvaz, Francois/0000-0001-9425-3137; Camporez, Joao Paulo/0000-0003-3486-4301; Jurczak, Michael/0000-0002-6335-6915	United States Public Health Service [R01 DK-40936, U24 DK-059635, P30 DK-45735, P30 DK-034989]; Veterans Affaris Merit Award; American Diabetes Association; Deutsche Forschungsgemeinschaft [BI1292/2-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, P30DK045735, U24DK059635, R01DK040936] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Veterans Affaris Merit Award; American Diabetes Association(American Diabetes Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the United States Public Health Service Grants R01 DK-40936 (to G. I. S.), U24 DK-059635 (to V. T. S. and G. I. S.), P30 DK-45735, and P30 DK-034989, a Veterans Affaris Merit Award (to V. T. S.), and a Mentor-Based Postdoctoral Fellowship Award from the American Diabetes Association (to G. I. S.).; Supported by Scholarship BI1292/2-1 from the Deutsche Forschungsgemeinschaft.	Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Chutkow WA, 2010, DIABETES, V59, P1424, DOI 10.2337/db09-1212; Fanayan S, 2002, J BIOL CHEM, V277, P7255, DOI 10.1074/jbc.M108038200; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Greene MW, 2010, J BIOL CHEM, V285, P42115, DOI 10.1074/jbc.M110.168575; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jurczak MJ, 2011, DIABETES, V60, P890, DOI 10.2337/db10-1328; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; RICCA GA, 1978, J CELL PHYSIOL, V97, P137, DOI 10.1002/jcp.1040970202; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubio-Cabezas O, 2009, J CLIN ENDOCR METAB, V94, P4162, DOI 10.1210/jc.2009-1137; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Silha JV, 2002, AM J PHYSIOL-ENDOC M, V283, pE937, DOI 10.1152/ajpendo.00014.2002; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Wiseman RL, 2010, CELL, V140, P590, DOI 10.1016/j.cell.2010.02.006; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012	30	57	58	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36163	36170		10.1074/jbc.M111.228817	http://dx.doi.org/10.1074/jbc.M111.228817			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21832042	hybrid, Green Published			2022-12-27	WOS:000296538300001
J	Lowery, J; Szul, T; Seetharaman, J; Jian, XY; Su, M; Forouhar, F; Xiao, R; Acton, TB; Montelione, GT; Lin, HL; Wright, JW; Lee, E; Holloway, ZG; Randazzo, PA; Tong, L; Sztul, E				Lowery, Jason; Szul, Tomasz; Seetharaman, Jayaraman; Jian, Xiaoying; Su, Min; Forouhar, Farhad; Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.; Lin, Helen; Wright, John W.; Lee, Eunjoo; Holloway, Zoe G.; Randazzo, Paul A.; Tong, Liang; Sztul, Elizabeth			Novel C-terminal Motif within Sec7 Domain of Guanine Nucleotide Exchange Factors Regulates ADP-ribosylation Factor (ARF) Binding and Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREFELDIN-A; PRODUCTION PLATFORM; STRUCTURAL BASIS; PROTEIN-1 BIG1; FACTOR GBF1; GOLGI; DYNAMICS; INTERFACE; RESIDUES; REVEALS	ADP-ribosylation factors (ARFs) and their activating guanine nucleotide exchange factors (GEFs) play key roles in membrane traffic and signaling. All ARF GEFs share a similar to 200-residue Sec7 domain (Sec7d) that alone catalyzes the GDP to GTP exchange that activates ARF. We determined the crystal structure of human BIG2 Sec7d. A C-terminal loop immediately following helix J (loop>J) was predicted to form contacts with helix H and the switch I region of the cognate ARF, suggesting that loop>J may participate in the catalytic reaction. Indeed, we identified multiple alanine substitutions within loop>J of the full length and/or Sec7d of two large brefeldin A-sensitive GEFs (GBF1 and BIG2) and one small brefeldin A-resistant GEF (ARNO) that abrogated binding of ARF and a single alanine substitution that allowed ARF binding but inhibited GDP to GTP exchange. Loop>J sequences are highly conserved, suggesting that loop>J plays a crucial role in the catalytic activity of all ARF GEFs. Using GEF mutants unable to bind ARF, we showed that GEFs associate with membranes independently of ARF and catalyze ARF activation in vivo only when membrane-associated. Our structural, cell biological, and biochemical findings identify loop>J as a key regulatory motif essential for ARF binding and GDP to GTP exchange by GEFs and provide evidence for the requirement of membrane association during GEF activity.	[Lowery, Jason; Szul, Tomasz; Lin, Helen; Wright, John W.; Lee, Eunjoo; Sztul, Elizabeth] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Seetharaman, Jayaraman; Su, Min; Forouhar, Farhad; Tong, Liang] Columbia Univ, NE Struct Genom Consortium, Dept Biol Sci, New York, NY 10027 USA; [Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] NE Struct Genom Consortium, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Jian, Xiaoying; Randazzo, Paul A.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Holloway, Zoe G.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Alabama System; University of Alabama Birmingham; Columbia University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; Wellcome Centre for Human Genetics	Sztul, E (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA.	esztul@uab.edu		Montelione, Gaetano/0000-0002-9440-3059; Tong, Liang/0000-0002-0563-6468	National Science Foundation [NSF0744471]; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074958, U54GM094597] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Award NSF0744471 (to E. S.).	Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; Amor JC, 2005, J BIOL CHEM, V280, P1392, DOI 10.1074/jbc.M410820200; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bui QT, 2009, MOL GENET GENOMICS, V282, P329, DOI 10.1007/s00438-009-0473-3; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Citterio C, 2006, P NATL ACAD SCI USA, V103, P2683, DOI 10.1073/pnas.0510571103; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Honda A, 2005, J CELL BIOL, V168, P1039, DOI 10.1083/jcb.200409138; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; Kuroda F, 2007, P NATL ACAD SCI USA, V104, P3201, DOI 10.1073/pnas.0611696104; Miyamoto T, 2008, J BIOL CHEM, V283, P4430, DOI 10.1074/jbc.M708296200; Monetta P, 2007, MOL BIOL CELL, V18, P2400, DOI 10.1091/mbc.E06-11-1005; Morohashi Y, 2010, BIOCHEM J, V427, P401, DOI 10.1042/BJ20091681; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; RANDAZZO PA, 1995, METHOD ENZYMOL, V257, P128; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Szul T, 2007, J CELL SCI, V120, P3929, DOI 10.1242/jcs.010769; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Xiao R, 2010, J STRUCT BIOL, V172, P21, DOI 10.1016/j.jsb.2010.07.011; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	38	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36898	36906		10.1074/jbc.M111.230631	http://dx.doi.org/10.1074/jbc.M111.230631			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21828055	Green Published, hybrid			2022-12-27	WOS:000296538300069
J	Degousee, N; Kelvin, DJ; Geisslinger, G; Hwang, DM; Stefanski, E; Wang, XH; Danesh, A; Angioni, C; Schmidt, H; Lindsay, TF; Gelb, MH; Bollinger, J; Payre, C; Lambeau, G; Arm, JP; Keating, A; Rubin, BB				Degousee, Norbert; Kelvin, David J.; Geisslinger, Gerd; Hwang, David M.; Stefanski, Eva; Wang, Xing-Hua; Danesh, Ali; Angioni, Carlo; Schmidt, Helmut; Lindsay, Thomas F.; Gelb, Michael H.; Bollinger, James; Payre, Christine; Lambeau, Gerard; Arm, Jonathan P.; Keating, Armand; Rubin, Barry B.			Group V Phospholipase A(2) in Bone Marrow-derived Myeloid Cells and Bronchial Epithelial Cells Promotes Bacterial Clearance after Escherichia coli Pneumonia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSE; GROUP-X; MAST-CELLS; EICOSANOID GENERATION; LEUKOCYTE RECRUITMENT; HUMAN NEUTROPHILS; IN-VITRO; LUNG; EXPRESSION; MICE	Group V-secreted phospholipase A(2) (GV sPLA(2)) hydrolyzes bacterial phospholipids and initiates eicosanoid biosynthesis. Here, we elucidate the role of GV sPLA(2) in the pathophysiology of Escherichia coli pneumonia. Inflammatory cells and bronchial epithelial cells both express GV sPLA(2) after pulmonary E. coli infection. GV(-/-) mice accumulate fewer polymorphonuclear leukocytes in alveoli, have higher levels of E. coli in bronchoalveolar lavage fluid and lung, and develop respiratory acidosis, more severe hypothermia, and higher IL-6, IL-10, and TNF-alpha levels than GV(+/+) mice after pulmonary E. coli infection. Eicosanoid levels in bronchoalveolar lavage are similar in GV(+/+) and GV(-/-) mice after lung E. coli infection. In contrast, GV(+/+) mice have higher levels of prostaglandin D-2 (PGD(2)), PGF(2 alpha), and 15-keto-PGE(2) in lung and express higher levels of ICAM-1 and PECAM-1 on pulmonary endothelial cells than GV(-/-) mice after lung infection with E. coli. Selective deletion of GV sPLA(2) in non-myeloid cells impairs leukocyte accumulation after pulmonary E. coli infection, and lack of GV sPLA(2) in either bone marrow-derived myeloid cells or non-myeloid cells attenuates E. coli clearance from the alveolar space and the lung parenchyma. These observations show that GV sPLA(2) in bone marrow-derived myeloid cells as well as non-myeloid cells, which are likely bronchial epithelial cells, participate in the regulation of the innate immune response to pulmonary infection with E. coli.	[Degousee, Norbert; Stefanski, Eva; Lindsay, Thomas F.; Rubin, Barry B.] Toronto Gen Hosp, Div Vasc Surg, Peter Munk Cardiac Ctr, Res Inst,Univ Hlth Network, Toronto, ON M5G 2C4, Canada; [Kelvin, David J.; Danesh, Ali] Toronto Gen Hosp, Div Expt Therapeut, Dept Med Oncol & Hematol, Res Inst,Univ Hlth Network, Toronto, ON M5G 2C4, Canada; [Hwang, David M.] Toronto Gen Hosp, Dept Pathol, Res Inst, Univ Hlth Network, Toronto, ON M5G 2C4, Canada; Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5G 2C4, Canada; [Arm, Jonathan P.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Arm, Jonathan P.] Brigham & Womens Hosp, Partners Asthma Ctr, Boston, MA 02115 USA; [Gelb, Michael H.; Bollinger, James] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.; Bollinger, James] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Payre, Christine; Lambeau, Gerard] Univ Nice, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Payre, Christine; Lambeau, Gerard] CNRS, F-06560 Valbonne, France; [Geisslinger, Gerd; Angioni, Carlo; Schmidt, Helmut] Inst Klin Pharmakol, D-60590 Frankfurt, Germany; [Kelvin, David J.] Shantou Univ, Coll Med, Int Inst Infect & Immun, Div Immunol, Shantou 515041, Guangdong, Peoples R China	University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Shantou University	Rubin, BB (corresponding author), Toronto Gen Hosp, Div Vasc Surg, Peter Munk Cardiac Ctr, Res Inst,Univ Hlth Network, 200 Elizabeth St,EN6-222, Toronto, ON M5G 2C4, Canada.	barry.rubin@uhn.on.ca	Lambeau, Gerard/GRJ-5624-2022	Lambeau, Gerard/0000-0002-9239-518X; Payre, Christine/0000-0003-3640-5061; gelb, michael/0000-0001-7000-5219	Canadian Institutes of Health Research [MOP-53297, MOP-97827, FRN-97827]; Physicians' Services Incorporated Foundation [98-049]; American Academy of Allergy Asthma and Immunology; Brigham and Women's Hospital Biomedical Research Institute; Deutsche Forschungsgemeinschaft; Li Ka Sing Foundation of Canada; National Institutes of Health [R01 HL070946, R37 HL36235]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235, R01HL070946] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Physicians' Services Incorporated Foundation; American Academy of Allergy Asthma and Immunology; Brigham and Women's Hospital Biomedical Research Institute; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Li Ka Sing Foundation of Canada; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Canadian Institutes of Health Research Grants MOP-53297, MOP-97827, and FRN-97827 (to B. B. R.), Physicians of Ontario through the Physicians' Services Incorporated Foundation (98-049 to T. L.), bridge grants from the American Academy of Allergy Asthma and Immunology and the Brigham and Women's Hospital Biomedical Research Institute (to J. A.), the Deutsche Forschungsgemeinschaft, Excellence Cluster Cardio Pulmonary System (to G. G.), and the Li Ka Sing Foundation of Canada (to D. J. K.). This work was also supported, in whole or in part, by National Institutes of Health Grants R01 HL070946 (to J. A.) and R37 HL36235 (to M. H. G.).	ANCIAN P, 1995, J BIOL CHEM, V270, P8963, DOI 10.1074/jbc.270.15.8963; Balboa MA, 2003, J BIOL CHEM, V278, P48059, DOI 10.1074/jbc.M305904200; Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; Baughman RP, 1999, RESPIRATION, V66, P95, DOI 10.1159/000029349; Bingham CO, 1999, J BIOL CHEM, V274, P31476, DOI 10.1074/jbc.274.44.31476; Bostrom MA, 2007, ARTERIOSCL THROM VAS, V27, P600, DOI 10.1161/01.ATV.0000257133.60884.44; Boyanovsky B, 2009, ARTERIOSCL THROM VAS, V29, P532, DOI 10.1161/ATVBAHA.108.183038; Bubnic SJ, 2002, BONE MARROW TRANSPL, V30, P867, DOI 10.1038/sj.bmt.1703761; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; de Menezes GB, 2005, INFLAMMATION, V29, P163, DOI 10.1007/s10753-006-9013-z; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Degousee N, 2008, CIRCULATION, V117, P1701, DOI 10.1161/CIRCULATIONAHA.107.749739; Dudek SM, 2011, AM J RESP CELL MOL, V44, P361, DOI 10.1165/rcmb.2009-0446OC; ELSBACH P, 1991, METHOD ENZYMOL, V197, P24; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gao XP, 2005, PHYSIOL GENOMICS, V21, P230, DOI 10.1152/physiolgenomics.00291.2004; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Kim KP, 2001, J BIOL CHEM, V276, P11126, DOI 10.1074/jbc.M004604200; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V52, P1; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; KOZAK W, 1995, AM J PHYSIOL-REG I, V269, pR23, DOI 10.1152/ajpregu.1995.269.1.R23; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lapointe S, 2010, J CELL PHYSIOL, V224, P127, DOI 10.1002/jcp.22106; Leon LR, 1998, AM J PHYSIOL-REG I, V275, pR269, DOI 10.1152/ajpregu.1998.275.1.R269; Leon LR, 2004, FRONT BIOSCI, V9, P1877, DOI 10.2741/1381; Leon LR, 2002, J APPL PHYSIOL, V92, P2648, DOI 10.1152/japplphysiol.01005.2001; Masuda S, 2005, BBA-MOL CELL BIOL L, V1736, P200, DOI 10.1016/j.bbalip.2005.08.014; Masuda S, 2005, BIOCHEM J, V387, P27, DOI 10.1042/BJ20041307; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Munoz NM, 2007, J IMMUNOL, V179, P4800, DOI 10.4049/jimmunol.179.7.4800; Munoz NM, 2006, J IMMUNOL, V177, P574, DOI 10.4049/jimmunol.177.1.574; Munoz NM, 2009, AM J PHYSIOL-LUNG C, V296, pL879, DOI 10.1152/ajplung.90580.2008; Murakami M, 1997, CRIT REV IMMUNOL, V17, P225, DOI 10.1615/CritRevImmunol.v17.i3-4.10; Niederman MS, 1998, CLIN THER, V20, P820, DOI 10.1016/S0149-2918(98)80144-6; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Park GY, 2006, AM J PHYSIOL-LUNG C, V290, pL797, DOI 10.1152/ajplung.00513.2005; Pruzanski W, 1998, BBA-MOL CELL RES, V1403, P47, DOI 10.1016/S0167-4889(98)00029-9; Pryhuber GS, 2008, J IMMUNOL, V181, P1409, DOI 10.4049/jimmunol.181.2.1409; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Reddy ST, 1997, J BIOL CHEM, V272, P13591, DOI 10.1074/jbc.272.21.13591; Rosenson RS, 2009, LANCET, V373, P649, DOI 10.1016/S0140-6736(09)60403-7; Rubin BB, 2005, J BIOL CHEM, V280, P7519, DOI 10.1074/jbc.M407438200; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Seeds MC, 2000, AM J RESP CELL MOL, V23, P37, DOI 10.1165/ajrcmb.23.1.4034; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Suckling KE, 2009, EXPERT OPIN INV DRUG, V18, P1425, DOI 10.1517/13543780903184583; Thommesen L, 1998, J IMMUNOL, V161, P3421; Valentin E, 2000, BBA-MOL CELL BIOL L, V1488, P59, DOI 10.1016/S1388-1981(00)00110-4; Wooton-Kee CR, 2004, ARTERIOSCL THROM VAS, V24, P762, DOI 10.1161/01.ATV.0000122363.02961.c1; WRIGHT GC, 1990, J CLIN INVEST, V85, P1925, DOI 10.1172/JCI114655; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x	53	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35650	35662		10.1074/jbc.M111.262733	http://dx.doi.org/10.1074/jbc.M111.262733			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21849511	Green Published, hybrid			2022-12-27	WOS:000295927100037
J	Lenz, LS; Marx, J; Chamulitrat, W; Kaiser, I; Grone, HJ; Liebisch, G; Schmitz, G; Elsing, C; Straub, BK; Fullekrug, J; Stremmel, W; Herrmann, T				Lenz, Lena-Solveig; Marx, Jana; Chamulitrat, Walee; Kaiser, Iris; Groene, Hermann-Josef; Liebisch, Gerhard; Schmitz, Gerd; Elsing, Christoph; Straub, Beate K.; Fuellekrug, Joachim; Stremmel, Wolfgang; Herrmann, Thomas			Adipocyte-specific Inactivation of Acyl-CoA Synthetase Fatty Acid Transport Protein 4 (Fatp4) in Mice Causes Adipose Hypertrophy and Alterations in Metabolism of Complex Lipids under High Fat Diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; RAT ADIPOCYTES; OBESITY; TISSUE; GENE; DISRUPTION; DISEASE; FAMILY	Fatp4 exhibits acyl-CoA synthetase activity and is thereby able to catalyze the activation of fatty acids for further metabolism. However, its actual function in most tissues remains unresolved, and its role in cellular fatty acid uptake is still controversial. To characterize Fatp4 functions in adipocytes in vivo, we generated a mouse line with adipocyte-specific inactivation of the Fatp4 gene (Fatp4(A-/-)). Under standard conditions mutant mice showed no phenotypical aberrance. Uptake of radiolabeled palmitic and lignoceric acid into adipose tissue of Fatp4(A-/-) mice was unchanged. When exposed to a diet enriched in long chain fatty acids, Fatp4(A-/-) mice gained more body weight compared with control mice, although they were not consuming more food. Pronounced obesity was accompanied by a thicker layer of subcutaneous fat and greater adipocyte circumference, although expression of genes involved in de novo lipogenesis was not changed. However, the increase in total fat mass was contrasted by a significant decrease in various phospholipids, sphingomyelin, and cholesteryl esters in adipocytes. Livers of Fatp4-deficient animals under a high fat diet exhibited a higher degree of fatty degeneration. Nonetheless, no evidence for changes in insulin sensitivity and adipose inflammation was found. In summary, the results of this study confirm that Fatp4 is not crucial for fatty acid uptake into adipocytes. Instead, under the condition of a diet enriched in long chain fatty acids, adipocyte-specific Fatp4 deficiency results in adipose hypertrophy and profound alterations in the metabolism of complex lipids.	[Lenz, Lena-Solveig; Marx, Jana; Chamulitrat, Walee; Kaiser, Iris; Fuellekrug, Joachim; Stremmel, Wolfgang; Herrmann, Thomas] Univ Heidelberg, Dept Internal Med 4, D-69120 Heidelberg, Germany; [Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, D-69120 Heidelberg, Germany; [Liebisch, Gerhard; Schmitz, Gerd] Univ Regensburg, Inst Clin Chem, D-93042 Regensburg, Germany; [Elsing, Christoph] St Elizabeth Hosp, Dept Internal Med, D-46225 Dorsten, Germany; [Straub, Beate K.] Inst Pathol, Dept Gen Pathol, D-69120 Heidelberg, Germany; [Herrmann, Thomas] Klinikum Idar Oberstein, Dept Internal Med 1, D-55743 Idar Oberstein, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Regensburg	Herrmann, T (corresponding author), Univ Heidelberg, Dept Internal Med 4, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.	dr._thomas_herrmann@email.de	Füllekrug, Joachim/A-6581-2008; Liebisch, Gerhard/G-6130-2010	Liebisch, Gerhard/0000-0003-4886-0811; Stremmel, Wolfgang/0000-0002-8545-1753; Schmitz, Gerd/0000-0002-1325-1007; Straub, Beate/0000-0002-4857-1561	Deutsche Forschungsgemeinschaft [HE 5521/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant HE 5521/1-1 (to T. H.).	Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X; Cernkovich ER, 2008, ENDOCRINOLOGY, V149, P1581, DOI 10.1210/en.2007-1148; Chen HC, 2002, DIABETES, V51, P3189, DOI 10.2337/diabetes.51.11.3189; Ehehalt R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-45; Fernandis AZ, 2007, CURR OPIN LIPIDOL, V18, P121, DOI 10.1097/MOL.0b013e328082e4d5; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Gimeno RE, 2003, J BIOL CHEM, V278, P16039, DOI 10.1074/jbc.M211412200; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Havel PJ, 2004, DIABETES, V53, pS143, DOI 10.2337/diabetes.53.2007.S143; Herrmann T, 2005, J INVEST DERMATOL, V125, P1228, DOI 10.1111/j.0022-202X.2005.23972.x; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Jia ZZ, 2007, J MOL NEUROSCI, V33, P25, DOI 10.1007/s12031-007-0038-z; Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200; Kage-Nakadai E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008857; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Muller G, 2010, BRIT J PHARMACOL, V160, P878, DOI 10.1111/j.1476-5381.2010.00724.x; Mueller Guenter, 2010, Archives of Physiology and Biochemistry, V116, P28, DOI 10.3109/13813450903508812; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Shim J, 2009, J LIPID RES, V50, P491, DOI 10.1194/jlr.M800400-JLR200; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang X, 2007, DIABETOLOGIA, V50, P1127, DOI 10.1007/s00125-007-0640-1	31	36	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35578	35587		10.1074/jbc.M111.226530	http://dx.doi.org/10.1074/jbc.M111.226530			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21808061	Green Published, hybrid			2022-12-27	WOS:000295927100030
J	Hast, MA; Nichols, CB; Armstrong, SM; Kelly, SM; Hellinga, HW; Alspaugh, JA; Beese, LS				Hast, Michael A.; Nichols, Connie B.; Armstrong, Stephanie M.; Kelly, Shannon M.; Hellinga, Homme W.; Alspaugh, J. Andrew; Beese, Lorena S.			Structures of Cryptococcus neoformans Protein Farnesyltransferase Reveal Strategies for Developing Inhibitors That Target Fungal Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERASE INHIBITORS; GERANYLGERANYLTRANSFERASE-I; CRYSTALLOGRAPHIC ANALYSIS; ANGSTROM RESOLUTION; MALARIA PARASITES; CRYSTAL-STRUCTURE; DIFFRACTION DATA; N-RAS; FARNESYL; BINDING	Cryptococcus neoformans is a fungal pathogen that causes life-threatening infections in immunocompromised individuals, including AIDS patients and transplant recipients. Few antifungals can treat C. neoformans infections, and drug resistance is increasing. Protein farnesyltransferase (FTase) catalyzes post-translational lipidation of key signal transduction proteins and is essential in C. neoformans. We present a multidisciplinary study validating C. neoformans FTase (CnFTase) as a drug target, showing that several anticancer FTase inhibitors with disparate scaffolds can inhibit C. neoformans and suggesting structure-based strategies for further optimization of these leads. Structural studies are an essential element for species-specific inhibitor development strategies by revealing similarities and differences between pathogen and host orthologs that can be exploited. We, therefore, present eight crystal structures of CnFTase that define the enzymatic reaction cycle, basis of ligand selection, and structurally divergent regions of the active site. Crystal structures of clinically important anticancer FTase inhibitors in complex with CnFTase reveal opportunities for optimization of selectivity for the fungal enzyme by modifying functional groups that interact with structurally diverse regions. A substrate-induced conformational change in CnFTase is observed as part of the reaction cycle, a feature that is mechanistically distinct from human FTase. Our combined structural and functional studies provide a framework for developing FTase inhibitors to treat invasive fungal infections.	[Hast, Michael A.; Armstrong, Stephanie M.; Kelly, Shannon M.; Hellinga, Homme W.; Beese, Lorena S.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Nichols, Connie B.; Alspaugh, J. Andrew] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Beese, LS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, 134 Nanaline Duke Bldg,Box 3711,Res Dr, Durham, NC 27710 USA.	lb12@duke.edu	Alspaugh, Andrew/AAB-1664-2019	Alspaugh, Andrew/0000-0003-3009-627X	National Institutes of Health [GM052382, AI050128]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Department of Energy (DOE) [DE-AC02-05CH11231]; United States Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050128, R21AI050128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052382, R37GM052382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy (DOE)(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM052382 (to L. S. B.) and AI050128 (to J. A. A.).; We thank the laboratory of Professor Andrew D. Hamilton for providing the ethylenediamine inhibitors used in this study. Diffraction data were collected Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source (Argonne National Laboratory) or at SIBYLS beamline 12.3.1 at the Advanced Light Source (Lawrence Berkeley National Laboratory). Use of the Advanced Photon Source was supported in part by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract W-31-109-Eng-38. Use of the SIBYLS beamline at the Advanced Light Source, Lawrence Berkeley National Laboratory, was supported in part by Department of Energy (DOE) program Integrated Diffraction Analysis Technologies and DOE program Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE) under Contract DE-AC02-05CH11231 with the United States Department of Energy.	Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; DeGraw AJ, 2008, CHEM BIOL DRUG DES, V72, P171, DOI 10.1111/j.1747-0285.2008.00698.x; Dursina B, 2006, J AM CHEM SOC, V128, P2822, DOI 10.1021/ja052196e; Eastman RT, 2006, J LIPID RES, V47, P233, DOI 10.1194/jlr.R500016-JLR200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; FURFINE ES, 1995, BIOCHEMISTRY-US, V34, P6857, DOI 10.1021/bi00020a032; Gelb MH, 2003, MOL BIOCHEM PARASIT, V126, P155, DOI 10.1016/S0166-6851(02)00282-7; Glenn MP, 2006, J MED CHEM, V49, P5710, DOI 10.1021/jm060081v; Glenn MR, 2005, ANGEW CHEM INT EDIT, V44, P4903, DOI 10.1002/anie.200500674; HARA M, 1993, P NATL ACAD SCI USA, V90, P2281, DOI 10.1073/pnas.90.6.2281; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Hast MA, 2009, CHEM BIOL, V16, P181, DOI 10.1016/j.chembiol.2009.01.014; HE B, 1991, P NATL ACAD SCI USA, V88, P11373, DOI 10.1073/pnas.88.24.11373; Hougland JL, 2010, J MOL BIOL, V395, P176, DOI 10.1016/j.jmb.2009.10.038; Ito T, 1996, JPN J CANCER RES, V87, P113, DOI 10.1111/j.1349-7006.1996.tb03146.x; Jessup CJ, 1998, J CLIN MICROBIOL, V36, P2874, DOI 10.1128/JCM.36.10.2874-2876.1998; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Long SB, 2000, STRUCTURE, V8, P209, DOI 10.1016/S0969-2126(00)00096-4; Long SB, 1998, BIOCHEMISTRY-US, V37, P9612, DOI 10.1021/bi980708e; Long SB, 2002, NATURE, V419, P645, DOI 10.1038/nature00986; Long SB, 2001, P NATL ACAD SCI USA, V98, P12948, DOI 10.1073/pnas.241407898; Mangues R, 1998, CANCER RES, V58, P1253; Mijimolle N, 2005, CANCER CELL, V7, P313, DOI 10.1016/j.ccr.2005.03.004; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nallan L, 2005, J MED CHEM, V48, P3704, DOI 10.1021/jm0491039; Nichols CB, 2009, EUKARYOT CELL, V8, P181, DOI 10.1128/EC.00351-08; Norman Peter, 2002, Curr Opin Investig Drugs, V3, P313; O'Meara TR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000776; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; PFALLER MA, 1995, J CLIN MICROBIOL, V33, P1104, DOI 10.1128/JCM.33.5.1104-1107.1995; Pickett JS, 2003, J BIOL CHEM, V278, P51243, DOI 10.1074/jbc.M309226200; Pickett JS, 2003, BIOCHEMISTRY-US, V42, P9741, DOI 10.1021/bi0346852; Reid TS, 2004, BIOCHEMISTRY-US, V43, P6877, DOI 10.1021/bi049723b; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Reid TS, 2004, BIOCHEMISTRY-US, V43, P9000, DOI 10.1021/bi049280b; Rex JH, 2001, CLIN MICROBIOL REV, V14, P643, DOI 10.1128/CMR.14.4.643-658.2001; Saderholm MJ, 2000, BIOCHEMISTRY-US, V39, P12398, DOI 10.1021/bi0011781; Singh N, 2000, Transpl Infect Dis, V2, P101, DOI 10.1034/j.1399-3062.2000.020302.x; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strickland CL, 1999, J MED CHEM, V42, P2125, DOI 10.1021/jm990030g; Taylor JS, 2003, EMBO J, V22, P5963, DOI 10.1093/emboj/cdg571; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; TRUEBLOOD CE, 1993, MOL CELL BIOL, V13, P4260, DOI 10.1128/MCB.13.7.4260; Vallim MA, 2004, MICROBIOL-SGM, V150, P1925, DOI 10.1099/mic.0.27030-0; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Yang Y, 2010, BIOCHEMISTRY-US, V49, P9658, DOI 10.1021/bi1008358; Zaragoza O, 2008, CELL MICROBIOL, V10, P2043, DOI 10.1111/j.1462-5822.2008.01186.x	57	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35149	35162		10.1074/jbc.M111.250506	http://dx.doi.org/10.1074/jbc.M111.250506			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21816822	hybrid, Green Published			2022-12-27	WOS:000295406300068
J	Morina, K; Schulte, M; Hubrich, F; Dorner, K; Steimle, S; Stolpe, S; Friedrich, T				Morina, Klaudia; Schulte, Marius; Hubrich, Florian; Doerner, Katerina; Steimle, Stefan; Stolpe, Stefan; Friedrich, Thorsten			Engineering the Respiratory Complex I to Energy-converting NADPH:Ubiquinone Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; BOVINE HEART-MITOCHONDRIA; ESCHERICHIA-COLI NADH; QUINONE OXIDOREDUCTASE; NADHUBIQUINONE OXIDOREDUCTASE; CONFORMATIONAL-CHANGE; COENZYME SPECIFICITY; MODULAR EVOLUTION; PROTON PUMP; BEEF-HEART	The respiratory complex I couples the electron transfer from NADH to ubiquinone with a translocation of protons across the membrane. Its nucleotide-binding site is made up of a unique Rossmann fold to accommodate the binding of the substrate NADH and of the primary electron acceptor flavin mononucleotide. Binding of NADH includes interactions of the hydroxyl groups of the adenosine ribose with a conserved glutamic acid residue. Structural analysis revealed that due to steric hindrance and electrostatic repulsion, this residue most likely prevents the binding of NADPH, which is a poor substrate of the complex. We produced several variants with mutations at this position exhibiting up to 200-fold enhanced catalytic efficiency with NADPH. The reaction of the variants with NAD(P)H is coupled with proton translocation in an inhibitor-sensitive manner. Thus, we have created an energy-converting NADPH: ubiquinone oxidoreductase, an activity so far not found in nature. Remarkably, the oxidation of NAD(P) H by the variants leads to an enhanced production of reactive oxygen species.	[Morina, Klaudia; Schulte, Marius; Hubrich, Florian; Doerner, Katerina; Steimle, Stefan; Stolpe, Stefan; Friedrich, Thorsten] Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	University of Freiburg	Friedrich, T (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, Albertstr 21,Chemiehochhaus, D-79104 Freiburg, Germany.	tfriedri@uni-freiburg.de		Hubrich, Florian/0000-0001-7093-8123	Volkswagen Stiftung; Deutsche Forschungsgemeinschaft	Volkswagen Stiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Volkswagen Stiftung and the Deutsche Forschungsgemeinschaft.	Albracht SPJ, 1997, BBA-BIOENERGETICS, V1318, P92, DOI 10.1016/S0005-2728(96)00153-3; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Brandt U, 2003, FEBS LETT, V545, P9, DOI 10.1016/S0014-5793(03)00387-9; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DJAVADIOHANIANCE L, 1975, J BIOL CHEM, V250, P9397; Dudek HM, 2010, APPL MICROBIOL BIOT, V88, P1135, DOI 10.1007/s00253-010-2769-y; Dupuis A, 2001, J BIOENERG BIOMEMBR, V33, P159, DOI 10.1023/A:1010770600418; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Fendel U, 2008, BBA-BIOENERGETICS, V1777, P660, DOI 10.1016/j.bbabio.2008.04.033; Friedrich T, 1997, J THEOR BIOL, V187, P529, DOI 10.1006/jtbi.1996.0387; Friedrich T, 2004, BBA-BIOENERGETICS, V1608, P1, DOI 10.1016/j.bbabio.2003.10.002; Friedrich T, 1998, BBA-BIOENERGETICS, V1364, P134, DOI 10.1016/S0005-2728(98)00024-3; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Glinn MA, 1997, BBA-BIOENERGETICS, V1318, P246, DOI 10.1016/S0005-2728(96)00142-9; Hanes CS, 1932, BIOCHEM J, V26, P1406, DOI 10.1042/bj0261406; HATEFI Y, 1973, BIOCHEMISTRY-US, V12, P3515, DOI 10.1021/bi00742a026; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; Markham KA, 2004, ANAL BIOCHEM, V325, P62, DOI 10.1016/j.ab.2003.10.027; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; MITTL PRE, 1994, PROTEIN SCI, V3, P1504, DOI 10.1002/pro.5560030916; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1901, DOI 10.1016/j.bbabio.2010.05.012; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIS C, 1995, ACTA CRYSTALLOGR D, V51, P290, DOI 10.1107/S0907444994012229; Pohl T, 2007, BIOCHEMISTRY-US, V46, P10694, DOI 10.1021/bi701057t; Pohl T, 2007, BIOCHEMISTRY-US, V46, P6588, DOI 10.1021/bi700371c; RYDSTROM J, 1978, BIOCHIM BIOPHYS ACTA, V501, P370, DOI 10.1016/0005-2728(78)90105-6; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; Stolpe S, 2004, J BIOL CHEM, V279, P18377, DOI 10.1074/jbc.M311242200; THORN JM, 1995, J MOL BIOL, V249, P785, DOI 10.1006/jmbi.1995.0337; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WEISS H, 1991, EUR J BIOCHEM, V197, P563, DOI 10.1111/j.1432-1033.1991.tb15945.x; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b	49	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34627	34634		10.1074/jbc.M111.274571	http://dx.doi.org/10.1074/jbc.M111.274571			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832062	Green Published, hybrid			2022-12-27	WOS:000295406300017
J	Zhu, WL; Hossain, MS; Guo, DY; Liu, S; Tong, HL; Khakpoor, A; Casey, PJ; Wang, M				Zhu, Wan Long; Hossain, Mohammed S.; Guo, Dian Yan; Liu, Sen; Tong, Honglian; Khakpoor, Atefeh; Casey, Patrick J.; Wang, Mei			A Role for Rac3 GTPase in the Regulation of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; CANCER-CELLS; PROTEIN PRENYLATION; TUMOR-GROWTH; K-RAS; PATHWAY; DEATH; MTOR; RHO; DIFFERENTIATION	The process of autophagy is situated at the intersection of multiple cell signaling pathways, including cell metabolism, growth, and death, and hence is subject to multiple forms of regulation. We previously reported that inhibition of isoprenylcysteine carboxylmethyltransferase (Icmt), which catalyzes the final step in the post-translational prenylation of so-called CAAX proteins, results in the induction of autophagy which enhances cell death in some cancer cells. In this study, using siRNA-mediated knockdown of a group of small GTPases that are predicted Icmt substrates, we identify Rac3 GTPase as a negative regulator of the process of autophagy. Knockdown of Rac3, but not the closely related isoforms Rac1 and Rac2, results in induction of autophagy. Ectopic expression of Rac3, significantly rescues cells from autophagy and cell death induced by Icmt inhibition, strengthening the notion of an isoform-specific autophagy regulatory function of Rac3. This role of Rac3 was observed in multiple cell lines with varying Rac subtype expression profiles, suggesting its broad involvement in the process. The identification of this less-studied Rac member as a novel regulator provides new insight into autophagy and opens opportunities in identifying additional regulatory inputs of the process.	[Casey, Patrick J.; Wang, Mei] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore; [Casey, Patrick J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	National University of Singapore; Duke University	Wang, M (corresponding author), 07-15,8 Coll Rd, Singapore 169857, Singapore.	mei.wang@duke-nus.edu.sg	Hossain, Mohammad Sorowar/AAX-2009-2020; Zhu, Wan Long/GYA-3382-2022	Hossain, Mohammad Sorowar/0000-0001-7143-2909; Casey, Patrick/0000-0002-7366-9309; zhu, Wanlong/0000-0003-0025-6674; Wang, Mei/0000-0001-6887-6840	Singapore National Medical Research Council; Agency for Science, Technology, and Research (A*STAR)	Singapore National Medical Research Council(National Medical Research Council, Singapore); Agency for Science, Technology, and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	This work was supported by awards from the Singapore National Medical Research Council and A*STAR, the Agency for Science, Technology, and Research.	Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bolis A, 2003, EUR J NEUROSCI, V18, P2417, DOI 10.1046/j.1460-9568.2003.02938.x; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Engers R, 2007, ENDOCR-RELAT CANCER, V14, P245, DOI 10.1677/ERC-06-0036; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Haataja L, 1997, J BIOL CHEM, V272, P20384, DOI 10.1074/jbc.272.33.20384; Hajdo-Milasinovic A, 2007, J CELL SCI, V120, P555, DOI 10.1242/jcs.03364; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Joyce PL, 2003, CANCER RES, V63, P7959; Juhasz G, 2003, FEBS LETT, V543, P154, DOI 10.1016/S0014-5793(03)00431-9; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schonteich E, 2008, J CELL SCI, V121, P3824, DOI 10.1242/jcs.032441; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Wahlstrom AM, 2008, BLOOD, V112, P1357, DOI 10.1182/blood-2007-06-094060; Wang M, 2010, ONCOGENE, V29, P4959, DOI 10.1038/onc.2010.247; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Winter-Vann AM, 2005, P NATL ACAD SCI USA, V102, P4336, DOI 10.1073/pnas.0408107102; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P8923, DOI 10.1073/pnas.0903621106	43	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35291	35298		10.1074/jbc.M111.280990	http://dx.doi.org/10.1074/jbc.M111.280990			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21852230	hybrid, Green Published			2022-12-27	WOS:000295406300082
J	Davrazou, F; Dong, E; Murphy, EJ; Johnson, HT; Jones, DNM				Davrazou, Foteini; Dong, Emily; Murphy, Emma J.; Johnson, Hannah T.; Jones, David N. M.			New Insights into the Mechanism of Odorant Detection by the Malaria-transmitting Mosquito Anopheles gambiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHEROMONE-BINDING-PROTEIN; ANTHERAEA-POLYPHEMUS; NMR STRUCTURE; HUMAN SWEAT; STRUCTURAL BASIS; MOTH; PH; IDENTIFICATION; ACTIVATION; RECEPTOR	Anopheles gambiae mosquitoes that transmit Plasmodium falciparum malaria use a series of olfactory cues present in human sweat to locate their hosts for a blood meal. Recognition of these odor cues occurs through the interplay of odorant receptors and odorant-binding proteins (OBPs) that bind to odorant molecules and transport and present them to the receptors. Recent studies have implicated potential heterodimeric interactions between two OBPs, OBP1 and OBP4, as important for perception of indole by the mosquito (Biessmann, H., Andronopoulou, E., Biessmann, M. R., Douris, V., Dimitratos, S. D., Eliopoulos, E., Guerin, P. M., Iatrou, K., Justice, R. W., Krober, T., Marinotti, O., Tsitoura, P., Woods, D. F., and Walter, M. F. (2010) PLoS ONE 5, e9471; Qiao, H., He, X., Schymura, D., Ban, L., Field, L., Dani, F. R., Michelucci, E., Caputo, B., della Torre, A., Iatrou, K., Zhou, J. J., Krieger, J., and Pelosi, P. (2011) Cell. Mol. Life Sci. 68, 1799-1813). Here we present the 2.0 angstrom crystal structure of the OBP4-indole complex, which adopts a classical odorant-binding protein fold, with indole bound at one end of a central hydrophobic cavity. Solution-based NMR studies reveal that OBP4 exists in a molten globule state and binding of indole induces a dramatic conformational shift to a well ordered structure, and this leads to the formation of the binding site for OBP1. Analysis of the OBP4-OBP1 interaction reveals a network of contacts between residues in the OBP1 binding site and the core of the protein and suggests how the interaction of the two proteins can alter the binding affinity for ligands. These studies provide evidence that conformational ordering plays a key role in regulating heteromeric interactions between OBPs.	[Davrazou, Foteini; Dong, Emily; Murphy, Emma J.; Johnson, Hannah T.; Jones, David N. M.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Jones, David N. M.] Univ Colorado, Sch Med, Program Struct Biol & Biophys, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Jones, DNM (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, 12801 E 17th Ave, Aurora, CO 80045 USA.	david.jones@ucdenver.edu	Jones, David N/C-5764-2013	Murphy, Emma/0000-0003-4551-8068	Program in Structural Biology and Biophysics; University of Colorado Cancer Center; National Institutes of Health (NIH) [IH P30-CA046934, P41-GM068928, DC008834]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM068928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008834] Funding Source: NIH RePORTER	Program in Structural Biology and Biophysics; University of Colorado Cancer Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Dr. Jay Nix for assistance in x-ray data collection, Patrick Jones, Jason Pitts, and Dr. Larry Zwiebel for An. gambiae cDNA libraries, and Dr. Geoff Armstrong for assistance with the 900 MHz NMR spectrometers. The x-ray crystallography and NMR facilities at University of Colorado School of Medicine are supported by the Program in Structural Biology and Biophysics and the University of Colorado Cancer Center Support Grant (National Institutes of Health IH P30-CA046934). Operation of the 900 MHz NMR spectrometer was supported by NIH Grant P41-GM068928.; This work was supported, in whole or in part, by National Institutes of Health Grant DC008834 (to D. N. M. J.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andronopoulou E, 2006, INSECT MOL BIOL, V15, P797, DOI 10.1111/j.1365-2583.2006.00685.x; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Bette S, 2002, INSECT BIOCHEM MOLEC, V32, P241, DOI 10.1016/S0965-1748(01)00171-0; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Braks MAH, 1999, PARASITOL TODAY, V15, P409, DOI 10.1016/S0169-4758(99)01514-8; Braks MAH, 1999, J CHEM ECOL, V25, P663, DOI 10.1023/A:1020970307748; Bucci BK, 2006, BIOCHEMISTRY-US, V45, P1693, DOI 10.1021/bi0516576; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Damberger F, 2000, PROTEIN SCI, V9, P1038, DOI 10.1110/ps.9.5.1038; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gillies M.T., 1987, PUBL S AFR I MED RES, V55, P1; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Honson N, 2003, CHEM SENSES, V28, P479, DOI 10.1093/chemse/28.6.479; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Justice RW, 2003, INSECT MOL BIOL, V12, P581, DOI 10.1046/j.1365-2583.2003.00443.x; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lee D, 2002, FEBS LETT, V531, P314, DOI 10.1016/S0014-5793(02)03548-2; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Lescop E, 2009, BIOCHEMISTRY-US, V48, P2431, DOI 10.1021/bi802300k; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meijerink J, 2000, J CHEM ECOL, V26, P1367, DOI 10.1023/A:1005475422978; Mohanty S, 2004, J MOL BIOL, V337, P443, DOI 10.1016/j.jmb.2004.01.009; Mohl Claudia, 2002, Invertebrate Neuroscience, V4, P165, DOI 10.1007/s10158-002-0018-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pesenti ME, 2009, J MOL BIOL, V390, P981, DOI 10.1016/j.jmb.2009.05.067; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Qiao HL, 2011, CELL MOL LIFE SCI, V68, P1799, DOI 10.1007/s00018-010-0539-8; Ronderos DS, 2009, FLY, V3, P290, DOI 10.4161/fly.9801; Ronderos DS, 2010, J NEUROSCI, V30, P2595, DOI 10.1523/JNEUROSCI.4819-09.2010; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shanbhag SR, 2005, ARTHROPOD STRUCT DEV, V34, P153, DOI 10.1016/j.asd.2005.01.003; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Thode AB, 2008, J MOL BIOL, V376, P1360, DOI 10.1016/j.jmb.2007.12.063; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zubkov S, 2005, J MOL BIOL, V354, P1081, DOI 10.1016/j.jmb.2005.10.015	63	24	25	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34175	34183		10.1074/jbc.M111.274712	http://dx.doi.org/10.1074/jbc.M111.274712			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21816826	Green Published, hybrid			2022-12-27	WOS:000295159200048
J	Saxena, R; Rozgaja, T; Grimwade, J; Crooke, E				Saxena, Rahul; Rozgaja, Tania; Grimwade, Julia; Crooke, Elliott			Remodeling of Nucleoprotein Complexes Is Independent of the Nucleotide State of a Mutant AAA plus Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL REPLICATION ORIGIN; ESCHERICHIA-COLI K-12; DNAA PROTEIN; SEQUENTIAL BINDING; INITIATOR PROTEIN; REQUIRES DNAA; ATP; SITES; GENE; OLIGOMERIZATION	DnaA protein, a member of the AAA+ (ATPase associated with various cellular activities) family, initiates DNA synthesis at the chromosomal origin of replication (oriC) and regulates the transcription of several genes, including its own. The assembly of DnaA complexes at chromosomal recognition sequences is affected by the tight binding of ATP or ADP by DnaA. DnaA with a point mutation in its membrane-binding amphipathic helix, DnaA(L366K), previously described for its ability to support growth in cells with altered phospholipid content, has biochemical characteristics similar to those of the wild-type protein. Yet DnaA(L366K) fails to initiate in vitro or in vivo replication from oriC. We found here, through in vitro dimethyl sulfate footprinting and gel mobility shift assays, that DnaA(L366K) in either nucleotide state was unable to assemble into productive prereplication complexes. In contrast, at the dnaA promoter, both the ATP and the ADP form of DnaA(L366K) generated active nucleoprotein complexes that efficiently repressed transcription in a manner similar to wildtype ATP-DnaA. Thus, it appears that unlike wild-type DnaA protein DnaA(L366K) can adopt architectures that are independent of its bound nucleotide, and instead the locus determines the functionality of the higher order DnaA(L366K)-DNA complexes.	[Saxena, Rahul; Crooke, Elliott] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA; [Crooke, Elliott] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Rozgaja, Tania; Grimwade, Julia] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	Georgetown University; Georgetown University; Florida Institute of Technology	Crooke, E (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA.	crooke@georgetown.edu		Grimwade, Julia/0000-0002-8630-2696	National Institutes of Health [GM49700, GM54042]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM049700, R01GM049700, R01GM054042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM49700 and GM54042.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN RE, 1985, CELL, V40, P159, DOI 10.1016/0092-8674(85)90319-8; Carr KM, 2001, J BIOL CHEM, V276, P44919, DOI 10.1074/jbc.M107463200; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CASSLER MR, 1995, EMBO J, V14, P5833, DOI 10.1002/j.1460-2075.1995.tb00271.x; CROOKE E, 1993, J MOL BIOL, V233, P16, DOI 10.1006/jmbi.1993.1481; Crooke E, 1995, METHOD ENZYMOL, V262, P500; CROOKE E, 1992, J BIOL CHEM, V267, P16779; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Duderstadt KE, 2010, J BIOL CHEM, V285, P28229, DOI 10.1074/jbc.M110.147975; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; Garner J, 1996, EMBO J, V15, P3477, DOI 10.1002/j.1460-2075.1996.tb00714.x; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Grimwade JE, 2000, MOL MICROBIOL, V35, P835, DOI 10.1046/j.1365-2958.2000.01755.x; HANSEN EB, 1986, P NATL ACAD SCI USA, V83, P4423, DOI 10.1073/pnas.83.12.4423; HEACOCK PN, 1989, J BIOL CHEM, V264, P14972; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Kawakami H, 2010, BIOCHEM CELL BIOL, V88, P49, DOI [10.1139/o09-154, 10.1139/O09-154]; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Lee YS, 1997, J BIOL CHEM, V272, P83; Li ZY, 2005, J BIOL CHEM, V280, P9796, DOI 10.1074/jbc.M413923200; Li ZY, 1999, PROTEIN EXPRES PURIF, V17, P41, DOI 10.1006/prep.1999.1094; Margulies C, 1996, J BIOL CHEM, V271, P17035, DOI 10.1074/jbc.271.29.17035; MATSUI M, 1985, J MOL BIOL, V184, P529, DOI 10.1016/0022-2836(85)90299-2; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Messer W, 1999, BIOCHIMIE, V81, P819, DOI 10.1016/S0300-9084(00)87165-5; Miller DT, 2009, P NATL ACAD SCI USA, V106, P18479, DOI 10.1073/pnas.0909472106; Miller J. H, 1972, EXPT MOL GENETICS; Neuwald AF, 1999, GENOME RES, V9, P27; Nievera C, 2006, MOL CELL, V24, P581, DOI 10.1016/j.molcel.2006.09.016; Roth A, 1998, MOL MICROBIOL, V28, P395, DOI 10.1046/j.1365-2958.1998.00813.x; Ryan VT, 2004, MOL MICROBIOL, V51, P1347, DOI 10.1046/j.1365-2958.2003.03906.x; SAMITT CE, 1989, EMBO J, V8, P989, DOI 10.1002/j.1460-2075.1989.tb03462.x; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7131; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; WANG QP, 1987, MOL GEN GENET, V209, P518, DOI 10.1007/BF00331158	43	10	10	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33770	33777		10.1074/jbc.M111.223495	http://dx.doi.org/10.1074/jbc.M111.223495			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832063	Green Published, hybrid			2022-12-27	WOS:000295159200007
J	Tang, YY; Wells, JA; Arkin, MR				Tang, Yinyan; Wells, James A.; Arkin, Michelle R.			Structural and Enzymatic Insights into Caspase-2 Protein Substrate Recognition and Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; MECHANISM; SPECIFICITIES; APOPTOSIS; FAMILY; SITE	Caspase-2, the most evolutionarily conserved member in the human caspase family, may play important roles in stress-induced apoptosis, cell cycle regulation, and tumor suppression. In biochemical assays, caspase-2 uniquely prefers a pentapeptide (such as VDVAD) rather than a tetrapeptide, as required for efficient cleavage by other caspases. We investigated the molecular basis for pentapeptide specificity using peptide analog inhibitors and substrates that vary at the P5 position. We determined the crystal structures of apo caspase-2, caspase-2 in complex with peptide inhibitors VDVAD-CHO, ADVAD-CHO, and DVAD-CHO, and a T380A mutant of caspase-2 in complex with VDVAD-CHO. Two residues, Thr-380 and Tyr-420, are identified to be critical for the P5 residue recognition; mutation of the two residues reduces the catalytic efficiency by about 4- and 40-fold, respectively. The structures also provide a series of snapshots of caspase-2 in different catalytic states, shedding light on the mechanism of capase-2 activation, substrate binding, and catalysis. By comparing the apo and inhibited caspase-2 structures, we propose that the disruption of a non-conserved salt bridge between Glu-217 and the invariant Arg-378 is important for the activation of caspase-2. These findings broaden our understanding of caspase-2 substrate specificity and catalysis.	[Tang, Yinyan; Wells, James A.; Arkin, Michelle R.] Univ Calif San Francisco, Dept Pharmaceut Chem, Small Mol Discovery Ctr, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Arkin, MR (corresponding author), 1700 4th St,MC 2552, San Francisco, CA 94158 USA.	michelle.arkin@ucsf.edu	Wells, Jim A/O-9854-2016; arkin, michelle/AAN-4298-2021; Arkin, Michelle/AAO-2009-2021	arkin, michelle/0000-0002-9366-6770; 	CHDI Foundation	CHDI Foundation	This work was supported by a grant from the CHDI Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agniswamy J, 2009, APOPTOSIS, V14, P1135, DOI 10.1007/s10495-009-0388-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baliga BC, 2004, CELL DEATH DIFFER, V11, P1234, DOI 10.1038/sj.cdd.4401492; Benkova B, 2009, ANAL BIOCHEM, V394, P68, DOI 10.1016/j.ab.2009.07.012; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bouchier-Hayes L, 2010, J CELL MOL MED, V14, P1212, DOI 10.1111/j.1582-4934.2010.01037.x; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang B, 2006, J MOL BIOL, V360, P654, DOI 10.1016/j.jmb.2006.05.041; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Krumschnabel G, 2009, CELL DEATH DIFFER, V16, P195, DOI 10.1038/cdd.2008.170; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Romanowski MJ, 2004, STRUCTURE, V12, P1361, DOI 10.1016/j.str.2004.05.010; Schweizer A, 2003, J BIOL CHEM, V278, P42441, DOI 10.1074/jbc.M304895200; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Vakifahmetoglu-Norberg H, 2010, TRENDS CELL BIOL, V20, P150, DOI 10.1016/j.tcb.2009.12.006; Witkowski WA, 2009, PROTEIN SCI, V18, P1459, DOI 10.1002/pro.151; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585	31	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34147	34154		10.1074/jbc.M111.247627	http://dx.doi.org/10.1074/jbc.M111.247627			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828056	Green Published, hybrid			2022-12-27	WOS:000295159200045
J	Zhong, YW; Wang, Y; Yang, H; Ballar, P; Lee, JG; Ye, YH; Monteiro, MJ; Fang, SY				Zhong, Yongwang; Wang, Yang; Yang, Hui; Ballar, Petek; Lee, Jin-gu; Ye, Yihong; Monteiro, Mervyn J.; Fang, Shengyun			Importin beta Interacts with the Endoplasmic Reticulum-associated Degradation Machinery and Promotes Ubiquitination and Degradation of Mutant alpha 1-Antitrypsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; PROTEIN-QUALITY CONTROL; NUCLEAR-PORE COMPLEX; RETRO-TRANSLOCATION; MEMBRANE-PROTEIN; AAA-ATPASE; IN-VITRO; MISFOLDED GLYCOPROTEINS; DEUBIQUITINATING ENZYME; LIGASE	The mechanism by which misfolded proteins in the endoplasmic reticulum (ER) are retrotranslocated to the cytosol for proteasomal degradation is still poorly understood. Here, we show that importin beta, a well established nucleocytoplasmic transport protein, interacts with components of the retrotranslocation complex and promotes ER-associated degradation (ERAD). Knockdown of importin beta specifically inhibited the degradation of misfolded ERAD substrates but did not affect turnover of non-ERAD proteasome substrates. Genetic studies and in vitro reconstitution assays demonstrate that importin beta is critically required for ubiquitination of mutant beta 1-antitrypsin, a luminal ERAD substrate. Furthermore, we show that importin beta cooperates with Ran GTPase to promote ubiquitination and proteasomal degradation of mutant beta 1-antitrypsin. These results establish an unanticipated role for importin beta in ER protein quality control.	[Zhong, Yongwang; Wang, Yang; Fang, Shengyun] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA; [Zhong, Yongwang; Wang, Yang; Yang, Hui; Ballar, Petek; Monteiro, Mervyn J.; Fang, Shengyun] Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Lee, Jin-gu; Ye, Yihong] NIH, Mol Biol Lab, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA	Zhong, YW (corresponding author), 725 W Lombard St,Rm N360, Baltimore, MD 21201 USA.	sfang@umaryland.edu	Fang, Shengyun/H-3802-2011; Monteiro, Mervyn J/H-3813-2011; Zhong, Yongwang/A-2527-2012; Kirmizibayrak, Petek Ballar/Y-6869-2018	Kirmizibayrak, Petek Ballar/0000-0002-6189-1818; Fang, Shengyun/0000-0001-7280-5463; Lee, Jin-Gu/0000-0001-9477-6990	National Institutes of Health [GM06696, GM066287]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM06696 (to S. F.) and GM066287 (to M. J. M.).	Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chi NC, 1997, J BIOL CHEM, V272, P6818, DOI 10.1074/jbc.272.10.6818; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Forwood JK, 2008, J MOL BIOL, V383, P772, DOI 10.1016/j.jmb.2008.07.090; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Lonhienne TG, 2009, J BIOL CHEM, V284, P22549, DOI 10.1074/jbc.M109.019935; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mehnert M, 2010, BIOESSAYS, V32, P905, DOI 10.1002/bies.201000046; MELCHIOR F, 1995, J CELL BIOL, V131, P571, DOI 10.1083/jcb.131.3.571; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nadav E, 2003, BIOCHEM BIOPH RES CO, V303, P91, DOI 10.1016/S0006-291X(03)00279-1; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Plafker K, 2002, J BIOL CHEM, V277, P30121, DOI 10.1074/jbc.M203006200; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wang SY, 2008, NAT CELL BIOL, V10, P251, DOI 10.1038/ncb0308-251; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Yasuda Y, 2006, EXP CELL RES, V312, P512, DOI 10.1016/j.yexcr.2005.11.017; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Zachariae U, 2008, STRUCTURE, V16, P906, DOI 10.1016/j.str.2008.03.007; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	69	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33921	33930		10.1074/jbc.M111.272906	http://dx.doi.org/10.1074/jbc.M111.272906			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832065	Green Published, hybrid			2022-12-27	WOS:000295159200024
J	Dubrovsky, EB; Dubrovskaya, VA; Bernardo, T; Otte, V; DiFilippo, R; Bryan, H				Dubrovsky, Edward B.; Dubrovskaya, Veronica A.; Bernardo, Travis; Otte, Valerie; DiFilippo, Robert; Bryan, Heather			The Drosophila FTZ-F1 Nuclear Receptor Mediates Juvenile Hormone Activation of E75A Gene Expression through an Intracellular Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BEETLE TRIBOLIUM-CASTANEUM; DNA-BINDING PROTEIN; BHLH-PAS FAMILY; METHOPRENE-TOLERANT; ECDYSONE RECEPTOR; INDEPENDENT ACTIVATION; FACTOR BETA-FTZ-F1; MOLECULAR ACTIONS; MANDUCA-SEXTA; KINASE-C	Juvenile hormone (JH) regulates a wide variety of biological activities in holometabolous insects, ranging from vitellogenesis and caste determination in adults to the timing of metamorphosis in larvae. The mechanism of JH signaling in such a diverse array of processes remains either unknown or contentious. We previously found that the nuclear receptor gene E75A is activated in S2 cells as a primary response to JH. Here, by expressing an intracellular form of JH esterase, we demonstrate that JH must enter the cell in order to activate E75A. To find intracellular receptors involved in the JH response, we performed an RNAi screen against nuclear receptor genes expressed in this cell line and identified the orphan receptor FTZ-F1. Removal of FTZ-F1 prevents JH activation of E75A, whereas overexpression enhances activation, implicating FTZ-F1 as a critical component of the JH response. FTZ-F1 is bound in vivo to multiple enhancers upstream of E75A, suggesting that it participates in direct JH-mediated gene activation. To better define the role of FTZ-F1 in JH signaling, we investigated interactions with candidate JH receptors and found that the bHLH-PAS proteins MET and GCE both interact with FTZ-F1 and can activate transcription through the FTZ-F1 response element. Removal of endogenous GCE, but not MET, prevents JH activation of E75A. We propose that FTZ-F1 functions as a competence factor by loading JH signaling components to the promoter, thus facilitating the direct regulation of E75A gene expression by JH.	[Dubrovsky, Edward B.; Dubrovskaya, Veronica A.; Bernardo, Travis; Otte, Valerie; DiFilippo, Robert; Bryan, Heather] Fordham Univ, Dept Biol, Bronx, NY 10458 USA; [Dubrovsky, Edward B.] Fordham Univ, Ctr Canc Genet Dis & Gene Regulat, Bronx, NY 10458 USA	Fordham University; Fordham University	Dubrovsky, EB (corresponding author), Fordham Univ, Dept Biol, 441 E Fordham Rd, Bronx, NY 10458 USA.	dubrovsky@fordham.edu		Bernardo, Travis/0000-0003-4432-9724	National Science Foundation [0653567]; Fordham University	National Science Foundation(National Science Foundation (NSF)); Fordham University	This work was supported by National Science Foundation Grant 0653567 (to E. B. D.).; Supported by the summer research program at Fordham University.	Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Baumann A, 2010, GENETICS, V185, P1327, DOI 10.1534/genetics.110.116962; Belgacem YH, 2002, P NATL ACAD SCI USA, V99, P15154, DOI 10.1073/pnas.232244199; Berger EM, 2005, VITAM HORM, V73, P175, DOI 10.1016/S0083-6729(05)73006-5; Bernardo TJ, 2009, J MOL BIOL, V387, P794, DOI 10.1016/j.jmb.2009.02.013; Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; Bowler T, 2006, DEV BIOL, V299, P78, DOI 10.1016/j.ydbio.2006.07.007; BOWNES M, 1989, J INSECT PHYSIOL, V35, P409, DOI 10.1016/0022-1910(89)90115-7; Broadus J, 1999, MOL CELL, V3, P143, DOI 10.1016/S1097-2765(00)80305-6; Campbell PM, 1998, INSECT BIOCHEM MOLEC, V28, P501, DOI 10.1016/S0965-1748(98)00037-X; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Davey KG, 1996, INVERTEBR REPROD DEV, V30, P249, DOI 10.1080/07924259.1996.9672551; Davey KG, 2000, INSECT BIOCHEM MOLEC, V30, P663, DOI 10.1016/S0965-1748(00)00037-0; Dubrovsky EB, 2004, DEV BIOL, V268, P258, DOI 10.1016/j.ydbio.2004.01.009; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Dubrovsky EB, 2000, DEV BIOL, V224, P486, DOI 10.1006/dbio.2000.9800; Fang F, 2005, FEBS J, V272, P1577, DOI 10.1111/j.1742-4658.2005.04578.x; Farkas R, 2001, BIOCHEM CELL BIOL, V79, P755, DOI 10.1139/bcb-79-6-755; GIORGI F, 1993, DEVELOPMENT, V117, P319; Godlewski J, 2006, BIOCHEM BIOPH RES CO, V342, P1305, DOI 10.1016/j.bbrc.2006.02.097; HAMMOCK BD, 1990, NATURE, V344, P458, DOI 10.1038/344458a0; Hinton AC, 2003, INSECT BIOCHEM MOLEC, V33, P317, DOI 10.1016/S0965-1748(02)00246-1; Hinton AC, 2001, INSECT BIOCHEM MOLEC, V32, P57, DOI 10.1016/S0965-1748(01)00079-0; JONES G, 1995, ANNU REV ENTOMOL, V40, P147, DOI 10.1146/annurev.en.40.010195.001051; Kamita SG, 2010, J PESTIC SCI, V35, P265, DOI 10.1584/jpestics.R10-09; Kawasaki H, 2002, DEV GROWTH DIFFER, V44, P419, DOI 10.1046/j.1440-169X.2002.00655.x; Kethidi DR, 2006, MOL CELL ENDOCRINOL, V247, P127, DOI 10.1016/j.mce.2005.12.016; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; LAVORGNA G, 1993, P NATL ACAD SCI USA, V90, P3004, DOI 10.1073/pnas.90.7.3004; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Mrazek J, 2006, BIOINFORMATICS, V22, P3099, DOI 10.1093/bioinformatics/btl551; Murata T, 1996, MOL CELL BIOL, V16, P6509; Palli SR, 2009, BIORATIONAL CONTROL OF ARTHROPOD PESTS: APPLICATION AND RESISTANCE MANAGEMENT, P111, DOI 10.1007/978-90-481-2316-2_5; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Pick L, 2006, AD DEV BIOL, V16, P255, DOI 10.1016/S1574-3349(06)16008-1; RICHARDS G, 1978, DEV BIOL, V66, P32, DOI 10.1016/0012-1606(78)90271-3; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Riddiford LM, 2010, DEVELOPMENT, V137, P1117, DOI 10.1242/dev.037218; Sablin EP, 2003, MOL CELL, V11, P1575, DOI 10.1016/S1097-2765(03)00236-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Soller M, 1999, DEV BIOL, V208, P337, DOI 10.1006/dbio.1999.9210; SPARKS TC, 1980, PESTIC BIOCHEM PHYS, V14, P290, DOI 10.1016/0048-3575(80)90037-1; Sullivan AA, 2003, MOL ENDOCRINOL, V17, P2125, DOI 10.1210/me.2002-0430; Thomas BA, 1999, PROTEINS, V34, P184, DOI 10.1002/(SICI)1097-0134(19990201)34:2<184::AID-PROT4>3.3.CO;2-#; UEDA H, 1991, NUCLEIC ACIDS RES, V19, P3689, DOI 10.1093/nar/19.13.3689; UEDA H, 1990, GENE DEV, V4, P624, DOI 10.1101/gad.4.4.624; Wang SL, 2007, J INSECT PHYSIOL, V53, P246, DOI 10.1016/j.jinsphys.2006.07.011; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; WARD VK, 1992, INT J BIOCHEM, V24, P1933, DOI 10.1016/0020-711X(92)90289-D; Wheeler DE, 2003, BIOESSAYS, V25, P994, DOI 10.1002/bies.10337; Wogulis M, 2006, BIOCHEMISTRY-US, V45, P4045, DOI 10.1021/bi0521644; Wolfner MF, 1997, J INSECT PHYSL, V43, P1117; WOODARD CT, 1994, CELL, V79, P607, DOI 10.1016/0092-8674(94)90546-0; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Yamada M, 2000, DEVELOPMENT, V127, P5083; YAMAMOTO K, 1988, SCIENCE, V239, P916, DOI 10.1126/science.3124270; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Yavatkar AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-106; Yoo JH, 2008, ACTA CRYSTALLOGR A, V64, pC241, DOI 10.1107/S0108767308092246; Zhou S, 2002, MOL CELL ENDOCRINOL, V190, P177, DOI 10.1016/S0303-7207(01)00602-5; Zhu JS, 2006, MOL CELL BIOL, V26, P9402, DOI 10.1128/MCB.01318-06	68	37	40	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33689	33700		10.1074/jbc.M111.273458	http://dx.doi.org/10.1074/jbc.M111.273458			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21832074	Green Published, hybrid			2022-12-27	WOS:000294968800085
J	Kolandaivelu, S; Chang, B; Ramamurthy, V				Kolandaivelu, Saravanan; Chang, Bo; Ramamurthy, Visvanathan			Rod Phosphodiesterase-6 (PDE6) Catalytic Subunits Restore Cone Function in a Mouse Model Lacking Cone PDE6 Catalytic Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; INHIBITORY GAMMA-SUBUNIT; CGMP-PHOSPHODIESTERASE; PHOTORECEPTOR CELLS; VISUAL TRANSDUCTION; GENE; NRL; PHOTOTRANSDUCTION; DEGENERATION; MUTATIONS	Rod and cone photoreceptor neurons utilize discrete PDE6 enzymes that are crucial for phototransduction. Rod PDE6 is composed of heterodimeric catalytic subunits (alpha beta), while the catalytic core of cone PDE6 (alpha') is a homodimer. It is not known if variations between PDE6 subunits preclude rod PDE6 catalytic subunits from coupling to the cone phototransduction pathway. To study this issue, we generated a cone-dominated mouse model lacking cone PDE6 (Nrl(-/-) cpfl1). In this animal model, using several independent experimental approaches, we demonstrated the expression of rod PDE6 (alpha beta) and the absence of cone PDE6 (alpha') catalytic subunits. The rod PDE6 enzyme expressed in cone cells is active and contributes to the hydrolysis of cGMP in response to light. In addition, rod PDE6 expressed in cone cells couples to the light signaling pathway to produce S-cone responses. However, S-cone responses and light-dependent cGMP hydrolysis were eliminated when the beta-subunit of rod PDE6 was removed (Nrl(-/-) cpfl1 rd). We conclude that either rod or cone PDE6 can effectively couple to the cone phototransduction pathway to mediate visual signaling. Interestingly, we also found that functional PDE6 is required for trafficking of M-opsin to cone outer segments.	[Ramamurthy, Visvanathan] W Virginia Univ, Inst Eye, Ctr Neurosci, Dept Ophthalmol, Morgantown, WV 26506 USA; [Kolandaivelu, Saravanan; Ramamurthy, Visvanathan] W Virginia Univ, Ctr Neurosci, Dept Biochem, Morgantown, WV 26506 USA; [Chang, Bo] Jackson Lab, Bar Harbor, ME 04609 USA	West Virginia University; West Virginia University; Jackson Laboratory	Ramamurthy, V (corresponding author), W Virginia Univ, Inst Eye, Ctr Neurosci, Dept Ophthalmol, 1 Stadium Dr,E-363, Morgantown, WV 26506 USA.	ramamurthyv@wvuhealthcare.com		Ramamurthy, Visvanathan/0000-0003-0289-3685; Chang, Bo/0000-0001-8259-7290	National Institutes of Health [R01EY017035]; WV Lions Eye Bank; Lions Club International Foundation; Research to Prevent Blindness (RPB); NATIONAL EYE INSTITUTE [R01EY019943, R01EY017035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WV Lions Eye Bank; Lions Club International Foundation; Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01EY017035 (to V. R.), WV Lions Eye Bank, Lions Club International Foundation, and Research to Prevent Blindness (RPB) challenge grant to West Virginia University.	ANANT JS, 1992, J BIOL CHEM, V267, P687; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Chen CK, 2010, J PHYSIOL-LONDON, V588, P3231, DOI 10.1113/jphysiol.2010.191221; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Deng WT, 2009, P NATL ACAD SCI USA, V106, P17681, DOI 10.1073/pnas.0901382106; FARBER DB, 1995, INVEST OPHTH VIS SCI, V36, P263; FARBER DB, 1982, METHOD ENZYMOL, V81, P551; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GILLESPIE PG, 1989, P NATL ACAD SCI USA, V86, P4311, DOI 10.1073/pnas.86.11.4311; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; HAMILTON SE, 1990, J BIOL CHEM, V265, P11259; HURWITZ RL, 1984, J BIOL CHEM, V259, P8612; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; Kirschman LT, 2010, HUM MOL GENET, V19, P1076, DOI 10.1093/hmg/ddp571; Kolandaivelu S, 2009, J BIOL CHEM, V284, P30853, DOI 10.1074/jbc.M109.036780; LI T, 1990, P NATL ACAD SCI USA, V87, P293, DOI 10.1073/pnas.87.1.293; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov H, 2004, VISION RES, V44, P2437, DOI 10.1016/j.visres.2004.05.013; Muradov H, 2010, J BIOL CHEM, V285, P39828, DOI 10.1074/jbc.M110.170068; Nikonov SS, 2005, J GEN PHYSIOL, V125, P287, DOI 10.1085/jgp.200409208; PITTLER SJ, 1991, PROG CLIN BIOL RES, V362, P33; Pittler SJ, 2004, J BIOL CHEM, V279, P19800, DOI 10.1074/jbc.M401864200; PUGH EN, 1986, VISION RES, V26, P1613, DOI 10.1016/0042-6989(86)90051-9; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Sakamoto K, 2009, HUM MOL GENET, V18, P178, DOI 10.1093/hmg/ddn327; Trifunovic D, 2010, J COMP NEUROL, V518, P3604, DOI 10.1002/cne.22416; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Zhang XJ, 2008, J BIOL CHEM, V283, P29699, DOI 10.1074/jbc.M803948200; Zhang XJ, 2005, FRONT BIOSCI-LANDMRK, V10, P1191, DOI 10.2741/1612	33	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33252	33259		10.1074/jbc.M111.259101	http://dx.doi.org/10.1074/jbc.M111.259101			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799013	Green Published, hybrid			2022-12-27	WOS:000294968800044
J	Dash, B; Bhakta, M; Chang, YC; Lukas, RJ				Dash, Bhagirathi; Bhakta, Minoti; Chang, Yongchang; Lukas, Ronald J.			Identification of N-terminal Extracellular Domain Determinants in Nicotinic Acetylcholine Receptor (nAChR) alpha 6 Subunits That Influence Effects of Wild-type or Mutant beta 3 Subunits on Function of alpha 6 beta 2*- or alpha 6 beta 4*-nAChR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPORTER MUTATION APPROACH; MIDBRAIN DOPAMINE NEURONS; XENOPUS OOCYTES; GENES; PHARMACOLOGY; DEPENDENCE; CONOTOXIN; RELEASE; ASSOCIATION; EXPRESSION	Despite the apparent function of naturally expressed mammalian alpha 6*-nicotinic acetylcholine receptors (alpha 6*-nAChR; where * indicates the known or possible presence of additional subunits), their functional and heterologous expression has been difficult. Here, we report that coexpression with wild-type beta 3 subunits abolishes the small amount of function typically seen for all-human or all-mouse alpha 6 beta 4*-nAChR expressed in Xenopus oocytes. However, levels of function and agonist potencies are markedly increased, and there is atropine-sensitive blockade of spontaneous channel opening upon coexpression of alpha 6 and beta 4 subunits with mutant beta 3 subunits harboring valine-to-serine mutations at 9'- or 13'-positions. There is no function when alpha 6 and beta 2 subunits are expressed alone or in the presence of wild-type or mutant beta 3 subunits. Interestingly, hybrid nAChR containing mouse alpha 6 and human (h) beta 4 subunits have function potentiated rather than suppressed by coexpression with wild-type h beta 3 subunits and potentiated further upon coexpression with h beta 3(V9)'(S) subunits. Studies using nAChR chimeric mouse/human alpha 6 subunits indicated that residues involved in effects seen with hybrid nAChR are located in the alpha 6 subunit N-terminal domain. More specifically, nAChR h alpha 6 subunit residues Asn-143 and Met-145 are important for dominant-negative effects of nAChR h beta 3 subunits on h alpha 6h beta 4-nAChR function. Asn-143 and additional residues in the N-terminal domain of nAChR h alpha 6 subunits are involved in the gain-of-function effects of nAChR h beta 3(V9)'(S) subunits on alpha 6 beta 2*-nAChR function. These studies illuminate the structural bases for effects of beta 3 subunits on alpha 6*-nAChR function and suggest that unique subunit interfaces involving the complementary rather than the primary face of alpha 6 subunits are involved.	[Dash, Bhagirathi; Bhakta, Minoti; Chang, Yongchang; Lukas, Ronald J.] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA	Barrow Neurological Institute	Lukas, RJ (corresponding author), Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	rlukas@chw.edu		Dash, Bhagirathi/0000-0002-5314-5372	National Institutes of Health [R01 DA015389]; Philip Morris U. S. A. Inc.; Philip Morris International; Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris U. S. A. Inc.; Philip Morris International; Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA015389. This work was also supported by the External Research Program of Philip Morris U. S. A. Inc. and Philip Morris International and by endowment and capitalization funds from the Men's and Women's Boards of the Barrow Neurological Foundation. Portions of this work have been presented in abstract form (Dash, B., Zhang, J., Chang, Y., and Lukas, R. J. (2007) Soc. Neurosci. Abstr. 33, 39.19; Dash, B., Bhakta, M., Whiteaker, P., Stitzel, J. A., Chang, Y., and Lukas, R. J. (2009) Soc. Neurosci. Abstr. 35, 34.7).	Azam L, 2002, J COMP NEUROL, V444, P260, DOI 10.1002/cne.10138; Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Bencherif M, 2002, CNS NEUROL DISORD-DR, V1, P349, DOI 10.2174/1568007023339094; Bierut LJ, 2007, PHARMACOGENOMICS, V8, P881, DOI 10.2217/14622416.8.8.881; Boorman JP, 2003, J BIOL CHEM, V278, P44033, DOI 10.1074/jbc.M211719200; Boorman JPB, 2000, J PHYSIOL-LONDON, V529, P565, DOI 10.1111/j.1469-7793.2000.00565.x; Bordia T, 2007, MOL PHARMACOL, V72, P52, DOI 10.1124/mol.107.035998; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Cui CH, 2003, J NEUROSCI, V23, P11045; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Evans NM, 2003, EUR J PHARMACOL, V466, P31, DOI 10.1016/S0014-2999(03)01540-1; Fucile S, 1998, EUR J NEUROSCI, V10, P172, DOI 10.1046/j.1460-9568.1998.00001.x; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Greenbaum L, 2006, MOL PSYCHIATR, V11, P312, DOI 10.1038/sj.mp.4001774; Groot-Kormelink PJ, 1998, J BIOL CHEM, V273, P15317, DOI 10.1074/jbc.273.25.15317; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Hoft NR, 2009, NEUROPSYCHOPHARMACOL, V34, P698, DOI 10.1038/npp.2008.122; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Kulak JM, 1997, J NEUROSCI, V17, P5263; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Lai A, 2005, MOL PHARMACOL, V67, P1639, DOI 10.1124/mol.104.006429; LeNovere N, 1996, EUR J NEUROSCI, V8, P2428; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Palma E, 1999, J BIOL CHEM, V274, P18335, DOI 10.1074/jbc.274.26.18335; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Zeiger JS, 2008, HUM MOL GENET, V17, P724, DOI 10.1093/hmg/ddm344	30	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37976	37989		10.1074/jbc.M111.263673	http://dx.doi.org/10.1074/jbc.M111.263673			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21832048	Green Published, hybrid			2022-12-27	WOS:000296594200010
J	Norris, NC; Bingham, RJ; Harris, G; Speakman, A; Jones, RPO; Leech, A; Turkenburg, JP; Potts, JR				Norris, Nicole C.; Bingham, Richard J.; Harris, Gemma; Speakman, Adrian; Jones, Richard P. O.; Leech, Andrew; Turkenburg, Johan P.; Potts, Jennifer R.			Structural and Functional Analysis of the Tandem beta-Zipper Interaction of a Streptococcal Protein with Human Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSIC DISORDER; BINDING PROTEIN; BORRELIA-BURGDORFERI; HOT-SPOTS; RECOGNITION; IDENTIFICATION; PYOGENES; HORMONE; ENERGY; SERVER	Bacterial fibronectin-binding proteins (FnBPs) contain a large intrinsically disordered region (IDR) that mediates adhesion of bacteria to host tissues, and invasion of host cells, through binding to fibronectin (Fn). These FnBP IDRs consist of Fn-binding repeats (FnBRs) that form a highly extended tandem beta-zipper interaction on binding to the N-terminal domain of Fn. Several FnBR residues are highly conserved across bacterial species, and here we investigate their contribution to the interaction. Mutation of these residues to alanine in SfbI-5 (a disordered FnBR from the human pathogen Streptococcus pyogenes) reduced binding, but for each residue the change in free energy of binding was <2 kcal/mol. The structure of an SfbI-5 peptide in complex with the second and third F1 modules from Fn confirms that the conserved FnBR residues play equivalent functional roles across bacterial species. Thus, in SfbI-5, the binding energy for the tandem beta-zipper interaction with Fn is distributed across the interface rather than concentrated in a small number of "hot spot" residues that are frequently observed in the interactions of folded proteins. We propose that this might be a common feature of the interactions of IDRs and is likely to pose a challenge for the development of small molecule inhibitors of FnBP-mediated adhesion to and invasion of host cells.	[Norris, Nicole C.; Bingham, Richard J.; Harris, Gemma; Speakman, Adrian; Jones, Richard P. O.; Potts, Jennifer R.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Leech, Andrew] Univ York, Technol Facil, Dept Biol, Area 15, York YO10 5DD, N Yorkshire, England; [Turkenburg, Johan P.; Potts, Jennifer R.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK; University of York - UK	Potts, JR (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	jennifer.potts@york.ac.uk	Bingham, Richard J/H-6169-2019	Bingham, Richard J/0000-0003-3805-0364; Harris, Gemma/0000-0002-4587-4620; Turkenburg, Johan/0000-0001-6992-6838	British Heart Foundation; Overseas Research Students Awards Scheme Scholarship; University of Sydney; University of York; Biotechnology and Biological Sciences Research Council [D010608/1]; BBSRC [BB/D010608/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D010608/1, 1023651] Funding Source: researchfish; British Heart Foundation [FS/07/034/22969, PG/09/079/28008] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Overseas Research Students Awards Scheme Scholarship; University of Sydney(University of Sydney); University of York(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported by a British Heart Foundation Senior Basic Science Fellowship (to J. R. P.), an Overseas Research Students Awards Scheme Scholarship, scholarships from the Universities of Sydney and York (to N. N.), and by Biotechnology and Biological Sciences Research Council Grant D010608/1.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bright Jr, 2000, METH MOL B, V139, P59; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Darnell SJ, 2007, PROTEINS, V68, P813, DOI 10.1002/prot.21474; Deane JE, 2004, EMBO J, V23, P3589, DOI 10.1038/sj.emboj.7600376; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DESIMONE DW, 1992, DEV BIOL, V149, P357, DOI 10.1016/0012-1606(92)90291-N; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dunker AK, 2010, CURR OPIN PHARMACOL, V10, P782, DOI 10.1016/j.coph.2010.09.005; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; HousePompeo K, 1996, J BIOL CHEM, V271, P1379, DOI 10.1074/jbc.271.3.1379; Hutchinson EG, 1998, PROTEIN SCI, V7, P2287, DOI 10.1002/pro.5560071106; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; LESLIE AGW, 1992, JOINT CCP4 ESF EACBM; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; Mosher DF, 2006, ARTERIOSCL THROM VAS, V26, P1193, DOI 10.1161/01.ATV.0000223342.15969.7a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nitsche-Schmitz DP, 2007, THROMB HAEMOSTASIS, V98, P488, DOI 10.1160/TH07-03-0179; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Penkett CJ, 2000, BIOCHEMISTRY-US, V39, P2887, DOI 10.1021/bi992267k; Penkett CJ, 1998, BIOCHEMISTRY-US, V37, P17054, DOI 10.1021/bi9814080; Pope B, 1996, NUCLEIC ACIDS RES, V24, P536, DOI 10.1093/nar/24.3.536; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Rohde M, 2003, CELL MICROBIOL, V5, P323, DOI 10.1046/j.1462-5822.2003.00279.x; Saha RP, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-11; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tucker RP, 2009, INT J BIOCHEM CELL B, V41, P424, DOI 10.1016/j.biocel.2008.08.003; Tuncbag N, 2010, NUCLEIC ACIDS RES, V38, pW402, DOI 10.1093/nar/gkq323; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang YJ, 2002, J AM CHEM SOC, V124, P14075, DOI 10.1021/ja026811f; WATT FM, 1994, CURR BIOL, V4, P270, DOI 10.1016/S0960-9822(00)00063-4; WELLS JA, 1993, ANNU REV BIOPH BIOM, V22, P329, DOI 10.1146/annurev.bb.22.060193.001553	64	31	31	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38311	38320		10.1074/jbc.M111.276592	http://dx.doi.org/10.1074/jbc.M111.276592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21840989	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000296594200044
J	Sinan, S; Yuan, XY; Russell, R				Sinan, Selma; Yuan, Xiaoyan; Russell, Rick			The Azoarcus Group I Intron Ribozyme Misfolds and Is Accelerated for Refolding by ATP-dependent RNA Chaperone Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEAD-BOX PROTEINS; TETRAHYMENA RIBOZYME; FOLDING LANDSCAPE; STRUCTURED RNA; CATALYTIC CORE; UNWINDING RNA; GENERAL RNA; PATHWAYS; BINDING; MECHANISMS	Structured RNAs traverse complex energy landscapes that include valleys representing misfolded intermediates. In Neurospora crassa and Saccharomyces cerevisiae, efficient splicing of mitochondrial group I and II introns requires the DEAD box proteins CYT-19 and Mss116p, respectively, which promote folding transitions and function as general RNA chaperones. To test the generality of RNA misfolding and the activities of DEAD box proteins in vitro, here we measure native folding of a small group I intron ribozyme from the bacterium Azoarcus by monitoring its catalytic activity. To develop this assay, we first measure cleavage of an oligonucleotide substrate by the prefolded ribozyme. Substrate cleavage is rate-limited by binding and is readily reversible, with an internal equilibrium near unity, such that the amount of product observed is less than the amount of native ribozyme. We use this assay to show that approximately half of the ribozyme folds readily to the native state, whereas the other half forms an intermediate that transitions slowly to the native state. This folding transition is accelerated by urea and increased temperature and slowed by increased Mg2+ concentration, suggesting that the intermediate is misfolded and must undergo transient unfolding during refolding to the native state. CYT-19 and Mss116p accelerate refolding in an ATP-dependent manner, presumably by disrupting structure in the intermediate. These results highlight the tendency of RNAs to misfold, underscore the roles of CYT-19 and Mss116p as general RNA chaperones, and identify a refolding transition for further dissection of the roles of DEAD box proteins in RNA folding.	[Sinan, Selma; Yuan, Xiaoyan; Russell, Rick] Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Sinan, Selma] Balikesir Univ, Sci & Art Fac, Dept Biol, TR-10000 Balikesir, Turkey	University of Texas System; University of Texas Austin; Balikesir University	Russell, R (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, 1 Univ Stn,A4800, Austin, TX 78712 USA.	rick_russell@mail.utexas.edu	Russell, Rick/A-9256-2012		National Institutes of Health [GM70456]; Welch Foundation [F-1563]; Scientific and Technological Research Council of Turkey; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM70456 (to R. R.). This work was also supported by Welch Foundation Grant F-1563 (to R. R.).; Supported by a fellowship from the Scientific and Technological Research Council of Turkey.	Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Bhaskaran H, 2007, NATURE, V449, P1014, DOI 10.1038/nature06235; Bifano AL, 2008, J MOL BIOL, V383, P667, DOI 10.1016/j.jmb.2008.08.070; Bifano AL, 2010, J MOL BIOL, V398, P429, DOI 10.1016/j.jmb.2010.03.025; Chauhan S, 2005, J MOL BIOL, V353, P1199, DOI 10.1016/j.jmb.2005.09.015; Chauhan S, 2008, J AM CHEM SOC, V130, P1296, DOI 10.1021/ja076166i; Chauhan S, 2009, J MOL BIOL, V386, P1167, DOI 10.1016/j.jmb.2008.12.075; Del Campo M, 2007, MOL CELL, V28, P159, DOI 10.1016/j.molcel.2007.07.028; Del Campo M, 2009, J MOL BIOL, V389, P674, DOI 10.1016/j.jmb.2009.04.043; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fedorova O, 2010, J MOL BIOL, V397, P799, DOI 10.1016/j.jmb.2010.02.001; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Golden BL, 1996, BIOCHEMISTRY-US, V35, P3754, DOI 10.1021/bi952599z; Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472; Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Jarmoskaite I, 2011, WIRES RNA, V2, P135, DOI 10.1002/wrna.50; Jiang YF, 2006, RNA, V12, P561, DOI 10.1261/rna.2188306; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Johnson TH, 2005, P NATL ACAD SCI USA, V102, P10176, DOI 10.1073/pnas.0501498102; Karbstein K, 2002, BIOCHEMISTRY-US, V41, P11171, DOI 10.1021/bi0202631; Karunatilaka KS, 2010, NATURE, V467, P935, DOI 10.1038/nature09422; Kuo LY, 1999, BBA-GENE STRUCT EXPR, V1489, P281, DOI 10.1016/S0167-4781(99)00200-6; Kwok LW, 2006, J MOL BIOL, V355, P282, DOI 10.1016/j.jmb.2005.10.070; Laederach A, 2007, P NATL ACAD SCI USA, V104, P7045, DOI 10.1073/pnas.0608765104; MCCONNELL TS, 1993, P NATL ACAD SCI USA, V90, P8362, DOI 10.1073/pnas.90.18.8362; Mei R, 1996, BIOCHEMISTRY-US, V35, P5796, DOI 10.1021/bi9527653; Mitra S, 2011, RNA, V17, P1589, DOI 10.1261/rna.2694811; Moghaddam S, 2009, J MOL BIOL, V393, P753, DOI 10.1016/j.jmb.2009.08.044; Mohr S, 2006, P NATL ACAD SCI USA, V103, P3569, DOI 10.1073/pnas.0600332103; Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7; Narlikar GJ, 1996, NAT STRUCT BIOL, V3, P701, DOI 10.1038/nsb0896-701; Pan C, 2010, RNA BIOL, V7, P667, DOI 10.4161/rna.7.6.13571; Pan J, 1998, J MOL BIOL, V280, P597, DOI 10.1006/jmbi.1998.1901; Pan J, 1997, J MOL BIOL, V273, P7, DOI 10.1006/jmbi.1997.1311; Potratz JP, 2011, J MOL BIOL, V411, P661, DOI 10.1016/j.jmb.2011.05.047; Rangan P, 2004, J MOL BIOL, V339, P41, DOI 10.1016/j.jmb.2004.03.059; Rangan P, 2003, P NATL ACAD SCI USA, V100, P1574, DOI 10.1073/pnas.0337743100; Roh JH, 2010, J AM CHEM SOC, V132, P10148, DOI 10.1021/ja103867p; Russell R, 2000, NAT STRUCT BIOL, V7, P367; Russell R, 1999, J MOL BIOL, V291, P1155, DOI 10.1006/jmbi.1999.3026; Russell R, 2002, P NATL ACAD SCI USA, V99, P155, DOI 10.1073/pnas.221593598; Russell R, 2001, J MOL BIOL, V308, P839, DOI 10.1006/jmbi.2001.4751; Russell R, 2008, FRONT BIOSCI-LANDMRK, V13, P1, DOI 10.2741/2557; Russell R, 2006, J MOL BIOL, V363, P531, DOI 10.1016/j.jmb.2006.08.024; Sclavi B, 1998, SCIENCE, V279, P1940, DOI 10.1126/science.279.5358.1940; Serra MJ, 1995, METHOD ENZYMOL, V259, P242; Shcherbakova I, 2008, CURR OPIN CHEM BIOL, V12, P655, DOI 10.1016/j.cbpa.2008.09.017; Shelton VM, 1999, BIOCHEMISTRY-US, V38, P16831, DOI 10.1021/bi991699s; Solem A, 2006, MOL CELL, V24, P611, DOI 10.1016/j.molcel.2006.10.032; Strauss-Soukup JK, 2000, J MOL BIOL, V302, P339, DOI 10.1006/jmbi.2000.4056; Tanner MA, 1996, RNA, V2, P74; Testa SM, 1997, BIOCHEMISTRY-US, V36, P15303, DOI 10.1021/bi9713097; Tijerina P, 2006, P NATL ACAD SCI USA, V103, P16698, DOI 10.1073/pnas.0603127103; Treiber DK, 1999, CURR OPIN STRUC BIOL, V9, P339, DOI 10.1016/S0959-440X(99)80045-1; Wan YQ, 2010, J MOL BIOL, V400, P1067, DOI 10.1016/j.jmb.2010.06.010; Wan YQ, 2009, METHOD ENZYMOL, V468, P195, DOI 10.1016/S0076-6879(09)68010-1; Woodson SA, 2010, ANNU REV BIOPHYS, V39, P61, DOI 10.1146/annurev.biophys.093008.131334; Yang Q, 2007, MOL CELL, V28, P253, DOI 10.1016/j.molcel.2007.08.016; ZAUG AJ, 1988, BIOCHEMISTRY-US, V27, P8924, DOI 10.1021/bi00425a008; Zhang LB, 2005, RNA, V11, P59, DOI 10.1261/rna.7145105; Zingler N, 2010, NUCLEIC ACIDS RES, V38, P6602, DOI 10.1093/nar/gkq530	64	24	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37304	37312		10.1074/jbc.M111.287706	http://dx.doi.org/10.1074/jbc.M111.287706			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878649	hybrid, Green Published			2022-12-27	WOS:000296542400030
J	Dhindwal, S; Patil, DN; Mohammadi, M; Sylvestre, M; Tomar, S; Kumar, P				Dhindwal, Sonali; Patil, Dipak N.; Mohammadi, Mahmood; Sylvestre, Michel; Tomar, Shailly; Kumar, Pravindra			Biochemical Studies and Ligand-bound Structures of Biphenyl Dehydrogenase from Pandoraea pnomenusa Strain B-356 Reveal a Basis for Broad Specificity of the Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMAMONAS-TESTOSTERONI B-356; CIS-2,3-DIHYDRO-2,3-DIHYDROXYBIPHENYL DEHYDROGENASE; D-3-HYDROXYBUTYRATE DEHYDROGENASE; POLYCHLORINATED-BIPHENYLS; CRYSTAL-STRUCTURES; ACTIVE-SITE; DEGRADATION; PURIFICATION; DIOXYGENASE; STRATEGIES	Biphenyl dehydrogenase, a member of short-chain dehydrogenase/reductase enzymes, catalyzes the second step of the biphenyl/polychlorinated biphenyls catabolic pathway in bacteria. To understand the molecular basis for the broad substrate specificity of Pandoraea pnomenusa strain B-356 biphenyl dehydrogenase (BphB(B-356)), the crystal structures of the apoenzyme, the binary complex with NAD(+), and the ternary complexes with NAD(+)-2,3-dihydroxybiphenyl and NAD(+)-4,4'-dihydroxybiphenyl were determined at 2.2-, 2.5-, 2.4-, and 2.1-angstrom resolutions, respectively. A crystal structure representing an intermediate state of the enzyme was also obtained in which the substrate binding loop was ordered as compared with the apo and binary forms but it was displaced significantly with respect to the ternary structures. These five structures reveal that the substrate binding loop is highly mobile and that its conformation changes during ligand binding, starting from a disorganized loop in the apo state to a well organized loop structure in the ligand-bound form. Conformational changes are induced during ligand binding; forming a well defined cavity to accommodate a wide variety of substrates. This explains the biochemical data that shows BphB(B-356) converts the dihydrodiol metabolites of 3,3'-dichlorobiphenyl, 2,4,4'-trichlorobiphenyl, and 2,6-dichlorobiphenyl to their respective dihydroxy metabolites. For the first time, a combination of structural, biochemical, and molecular docking studies of BphB(B-356) elucidate the unique ability of the enzyme to transform the cis-dihydrodiols of double meta-, para-, and ortho-substituted chlorobiphenyls.	[Dhindwal, Sonali; Patil, Dipak N.; Tomar, Shailly; Kumar, Pravindra] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee 247667, Uttarakhand, India; [Mohammadi, Mahmood; Sylvestre, Michel] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ H7V 1B7, Canada	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; University of Quebec; Institut national de la recherche scientifique (INRS)	Kumar, P (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee 247667, Uttarakhand, India.	pravshai@gmail.com	Patil, Dipak N./X-9567-2019; KUMAR, PRAVINDRA/AAF-2859-2020	Patil, Dipak N./0000-0003-1112-5557; KUMAR, PRAVINDRA/0000-0003-2128-7736; Sylvestre, Michel/0000-0002-6942-3373	Council of Scientific and Industrial Research (CSIR), New Delhi, India; Ministry of Human Resource Development, India; Department of Biotechnology (DBT), India	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Human Resource Development, India(Ministry of Higher Education & Scientific Research (MHESR)); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This work was supported by grants from the Council of Scientific and Industrial Research (CSIR), New Delhi, India, and the Ministry of Human Resource Development, India (to S. D. and D. N. P.).; We thank the Macromolecular Crystallographic Facility (MCU) at the Indian Institute of Technology, IIT Roorkee. We also thank the Department of Biotechnology (DBT), India, for providing financial assistance and the allocation and provision of synchrotron beamtime at the BM14, ESRF (Grenoble, France). We thank Hassan Belrhali and Babu Manjasetty for help during data collection at the synchrotron. We are grateful to Dr. David Neau for carefully reading the manuscript and Dr. Ashwani Kumar Sharma for helpful discussions.	Andersson A, 1997, FEBS LETT, V400, P173, DOI 10.1016/S0014-5793(96)01382-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barriault D, 1999, BIOCHEM BIOPH RES CO, V260, P181, DOI 10.1006/bbrc.1999.0706; Barriault D, 2002, J BACTERIOL, V184, P3794, DOI 10.1128/JB.184.14.3794-3800.2002; Benach-Andreu J., 1999, XRAY STRUCTURE ANAL; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Borja J, 2005, PROCESS BIOCHEM, V40, P1999, DOI 10.1016/j.procbio.2004.08.006; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; FUKUDA M, 1994, BIOCHEM BIOPH RES CO, V202, P850, DOI 10.1006/bbrc.1994.2008; Furukawa K, 2003, TRENDS BIOTECHNOL, V21, P187, DOI 10.1016/S0167-7799(03)00054-4; Furukawa K, 2008, J BIOSCI BIOENG, V105, P433, DOI 10.1263/jbb.105.433; Gomez-Gil L, 2007, J BACTERIOL, V189, P5705, DOI 10.1128/JB.01476-06; HADDOCK JD, 1993, J BACTERIOL, V175, P395, DOI 10.1128/JB.175.2.395-400.1993; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hosfield DJ, 2005, J BIOL CHEM, V280, P4639, DOI 10.1074/jbc.M411104200; Hulsmeyer M, 1998, PROTEIN SCI, V7, P1286; HURTUBISE Y, 1995, J BACTERIOL, V177, P6610, DOI 10.1128/jb.177.22.6610-6618.1995; Ito K, 2006, J MOL BIOL, V355, P722, DOI 10.1016/j.jmb.2005.10.072; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Jouanneau Y, 2006, APPL ENVIRON MICROB, V72, P4726, DOI 10.1128/AEM.00395-06; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohtsubo Y, 2004, APPL MICROBIOL BIOT, V65, P250, DOI 10.1007/s00253-004-1654-y; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paithankar KS, 2007, FEBS J, V274, P5767, DOI 10.1111/j.1742-4658.2007.06102.x; Pieper DH, 2005, APPL MICROBIOL BIOT, V67, P170, DOI 10.1007/s00253-004-1810-4; Pieper DH, 2000, CURR OPIN BIOTECH, V11, P262, DOI 10.1016/S0958-1669(00)00094-X; ROSSMANN MG, 1973, J MOL BIOL, V76, P533, DOI 10.1016/0022-2836(73)90491-9; Sakshi, 2010, ACTA CRYSTALLOGR F, V66, P1517, DOI 10.1107/S1744309110036894; Smilda T, 1998, BIOCHEM GENET, V36, P37, DOI 10.1023/A:1018748118901; Strand S. E., 2004, CEWA ESC MICRO, V518, P1; Sylvestre M, 1996, APPL ENVIRON MICROB, V62, P2710, DOI 10.1128/AEM.62.8.2710-2715.1996; TAIRA K, 1992, J BIOL CHEM, V267, P4844; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Tanaka N, 2001, CURR ORG CHEM, V5, P89, DOI 10.2174/1385272013375751; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vedadi M, 2000, BIOCHEMISTRY-US, V39, P5028, DOI 10.1021/bi992232k; Yamazawa R, 2011, J BIOCHEM, V149, P701, DOI 10.1093/jb/mvr024	43	23	23	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					37011	37022		10.1074/jbc.M111.291013	http://dx.doi.org/10.1074/jbc.M111.291013			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880718	Green Published, hybrid			2022-12-27	WOS:000296538300079
J	Melo, SP; Barbour, KW; Berger, FG				Melo, Sandra P.; Barbour, Karen W.; Berger, Franklin G.			Cooperation between an Intrinsically Disordered Region and a Helical Segment Is Required for Ubiquitin-independent Degradation by the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN THYMIDYLATE SYNTHASE; KAPPA-B-ALPHA; ORNITHINE-DECARBOXYLASE; SECONDARY-STRUCTURE; CRYSTAL-STRUCTURE; GAMMA-PROTEASOME; C-FOS; PROTEIN; PATHWAY; SITE	The 26 S proteasomal complex, which is responsible for the bulk of protein degradation within the cell, recognizes its target substrates via covalently linked polyubiquitin moieties. However, a small but growing number of proteasomal substrates are degraded without a requirement for ubiquitinylation. One such substrate is the pyrimidine biosynthetic enzyme thymidylate synthase (EC 2.1.1.45), which catalyzes the synthesis of TMP and is the sole de novo source of TTP for DNA replication and repair. Previous work showed that intracellular proteolysis of human thymidylate synthase is directed by a degron at the polypeptide's N-terminal end, composed of an intrinsically disordered region (IDR) followed by a highly conserved amphipathic alpha-helix (hA). In the present report, we show that the hA helix does not function simply as an extension or scaffold for the IDR; rather, it provides a specific structural component that is necessary for degradation. Furthermore, its helical conformation is required for this function. We demonstrate that small domains from heterologous proteins can substitute for the IDR and the hA helix of human thymidylate synthase, indicating that the degradation-promoting function of these regions is not sequence-specific. The results, in general, indicate that cooperation between intrinsically disordered domains and alpha-helical segments is required for ubiquitin-independent degradation by the proteasome. There appears to be little sequence constraint on the ability of these regions to function as degron constituents. Rather, it is the overall conformation (or lack thereof) that is critical.	[Berger, Franklin G.] Univ S Carolina, Jones Phys Sci Ctr, Ctr Colon Canc Res, Columbia, SC 29208 USA; Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Berger, FG (corresponding author), Univ S Carolina, Jones Phys Sci Ctr, Ctr Colon Canc Res, Rm 614, Columbia, SC 29208 USA.	fgberger@mailbox.sc.edu			National Institutes of Health [CA44013]; NATIONAL CANCER INSTITUTE [R01CA044013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA44013.	Basbous J, 2008, BIOCHIMIE, V90, P296, DOI 10.1016/j.biochi.2007.07.016; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Berger FG, 2006, CANCER BIOL THER, V5, P1238, DOI 10.4161/cbt.5.9.3414; Bossis G, 2003, MOL CELL BIOL, V23, P7425, DOI 10.1128/MCB.23.20.7425-7436.2003; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Burns KE, 2010, SUBCELL BIOCHEM, V54, P149, DOI 10.1007/978-1-4419-6676-6_12; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Chen X, 2009, J MOL BIOL, V392, P208, DOI 10.1016/j.jmb.2009.07.018; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Cheng YF, 2009, CURR OPIN STRUC BIOL, V19, P203, DOI 10.1016/j.sbi.2009.02.004; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forsthoefel AM, 2004, BIOCHEMISTRY-US, V43, P1972, DOI 10.1021/bi035894p; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Godderz D, 2011, J MOL BIOL, V407, P354, DOI 10.1016/j.jmb.2011.01.051; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Kumar S, 1998, PROTEINS, V31, P460, DOI 10.1002/(SICI)1097-0134(19980601)31:4<460::AID-PROT12>3.0.CO;2-D; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Liao SH, 2009, BIOCHEM J, V422, P207, DOI 10.1042/BJ20090738; MAHALINGAM S, 1995, P NATL ACAD SCI USA, V92, P3794, DOI 10.1073/pnas.92.9.3794; Mathes E, 2008, EMBO J, V27, P1357, DOI 10.1038/emboj.2008.73; Melo SP, 2010, BIOCHEM J, V432, P217, DOI 10.1042/BJ20101027; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; NUSSBAUM RL, 1985, AM J HUM GENET, V37, P1192; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Pena MMO, 2009, J BIOL CHEM, V284, P31597, DOI 10.1074/jbc.M109.038455; Pena MMO, 2006, BIOCHEM J, V394, P355, DOI 10.1042/BJ20051479; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Phan J, 2001, J BIOL CHEM, V276, P14170, DOI 10.1074/jbc.M009493200; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Schiffer CA, 1995, BIOCHEMISTRY-US, V34, P16279, DOI 10.1021/bi00050a007; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Slijper M, 1996, J MOL BIOL, V259, P761, DOI 10.1006/jmbi.1996.0356; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Sutter M, 2009, FEBS LETT, V583, P3151, DOI 10.1016/j.febslet.2009.09.020; Takeuchi J, 2008, BIOCHEM J, V410, P401, DOI 10.1042/BJ20071239; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Truhlar SME, 2008, J MOL BIOL, V380, P67, DOI 10.1016/j.jmb.2008.02.053; Tsvetkov P, 2009, J BIOL CHEM, V284, P26234, DOI 10.1074/jbc.M109.040493; Wang T, 2010, NAT STRUCT MOL BIOL, V17, P1352, DOI 10.1038/nsmb.1918; Yang Z, 2001, BIOCHEMISTRY-US, V40, P12515, DOI 10.1021/bi011394p; Yuksek K, 2009, J VIROL, V83, P612, DOI 10.1128/JVI.00832-08; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	53	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36559	36567		10.1074/jbc.M111.274258	http://dx.doi.org/10.1074/jbc.M111.274258			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878626	Green Published, hybrid			2022-12-27	WOS:000296538300040
J	Moffat, LD; Brown, SBA; Grassie, ME; Ulke-Lemee, A; Williamson, LM; Walsh, MP; MacDonald, JA				Moffat, Lori D.; Brown, Shannon B. A.; Grassie, Michael E.; Ulke-Lemee, Annegret; Williamson, Laura M.; Walsh, Michael P.; MacDonald, Justin A.			Chemical Genetics of Zipper-interacting Protein Kinase Reveal Myosin Light Chain as a Bona Fide Substrate in Permeabilized Arterial Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; PHOSPHATASE-ASSOCIATED KINASE; UNNATURAL NUCLEOTIDE SPECIFICITY; CA2+ SENSITIZATION; TARGET SUBUNIT; PSEUDOSUBSTRATE PEPTIDE; PHOSPHORYLATION; IDENTIFICATION; CONTRACTION; CPI-17	Zipper-interacting protein kinase (ZIPK) has been implicated in Ca2+-independent smooth muscle contraction, although its specific role is unknown. The addition of ZIPK to demembranated rat caudal arterial strips induced an increase in force, which correlated with increases in LC20 and MYPT1 phosphorylation. However, because of the number of kinases capable of phosphorylating LC20 and MYPT1, it has proven difficult to identify the mechanism underlying ZIPK action. Therefore, we set out to identify bona fide ZIPK substrates using a chemical genetics method that takes advantage of ATP analogs with bulky substituents at the N-6 position and an engineered ZIPK capable of utilizing such substrates. P-32-Labeled 6-phenyl-ATP and ZIPK-L93G mutant protein were added to permeabilized rat caudal arterial strips, and substrate proteins were detected by autoradiography following SDS-PAGE. Mass spectrometry identified LC20 as a direct target of ZIPK in situ for the first time. Tissues were also exposed to 6-phenyl-ATP and ZIPK-L93G in the absence of endogenous ATP, and putative ZIPK substrates were identified by Western blotting. LC20 was thereby confirmed as a direct target of ZIPK; however, no phosphorylation of MYPT1 was detected. We conclude that ZIPK is involved in the regulation of smooth muscle contraction through direct phosphorylation of LC20.	[MacDonald, Justin A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4Z6, Canada; Univ Calgary, Smooth Muscle Res Grp, Calgary, AB T2N 4Z6, Canada	University of Calgary; University of Calgary	MacDonald, JA (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	jmacdo@ucalgary.ca		MacDonald, Justin/0000-0002-9238-8473	Canadian Institutes of Health Research (CIHR) [MOP-72720, MT-13101]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Research Grants MOP-72720 (to J. A. M.) and MT-13101 (to M. P. W.) from the Canadian Institutes of Health Research (CIHR).	Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Blethrow J., 2004, CURR PROTOC MOL MAY; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Borman MA, 2002, J BIOL CHEM, V277, P23441, DOI 10.1074/jbc.M201597200; Borman MA, 2007, BIOCHEM CELL BIOL, V85, P111, DOI 10.1139/O06-209; Chang AN, 2010, J BIOL CHEM, V285, P5122, DOI 10.1074/jbc.C109.076489; Deng JT, 2002, BIOCHEM J, V367, P517, DOI 10.1042/BJ20020522; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Eblen ST, 2003, J BIOL CHEM, V278, P14926, DOI 10.1074/jbc.M300485200; Endo A, 2004, J BIOL CHEM, V279, P42055, DOI 10.1074/jbc.M403676200; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Habelhah H, 2001, J BIOL CHEM, V276, P18090, DOI 10.1074/jbc.M011396200; Haystead TAJ, 2005, CELL SIGNAL, V17, P1313, DOI 10.1016/j.cellsig.2005.05.008; Hindley AD, 2004, FEBS LETT, V556, P26, DOI 10.1016/S0014-5793(03)01352-8; Ihara E, 2007, AM J PHYSIOL-GASTR L, V293, pG699, DOI 10.1152/ajpgi.00214.2007; Ihara E, 2007, AM J PHYSIOL-CELL PH, V292, pC1951, DOI 10.1152/ajpcell.00434.2006; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; Ihara E, 2009, AM J PHYSIOL-GASTR L, V297, pG361, DOI 10.1152/ajpgi.00112.2009; Ihara E, 2009, MOL PHARMACOL, V75, P1031, DOI 10.1124/mol.108.049858; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kim N, 2004, AM J PHYSIOL-CELL PH, V287, pC384, DOI 10.1152/ajpcell.00390.2003; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Koyama M, 2000, FEBS LETT, V475, P197, DOI 10.1016/S0014-5793(00)01654-9; Liu Y, 1998, CHEM BIOL, V5, P91, DOI 10.1016/S1074-5521(98)90143-0; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; MacDonald JA, 2001, FEBS LETT, V493, P91, DOI 10.1016/S0014-5793(01)02277-3; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; McNamara LK, 2009, ACTA CRYSTALLOGR D, V65, P241, DOI 10.1107/S0907444908043679; Morrison DL, 1996, BIOCHEM CELL BIOL, V74, P549, DOI 10.1139/o96-459; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Murata-Hori M, 1999, FEBS LETT, V451, P81, DOI 10.1016/S0014-5793(99)00550-5; Niiro N, 2001, J BIOL CHEM, V276, P29567, DOI 10.1074/jbc.M102753200; Okuzumi T, 2010, MOL BIOSYST, V6, P1389, DOI 10.1039/c003917a; Patel CA, 2006, AM J PHYSIOL-GASTR L, V291, pG830, DOI 10.1152/ajpgi.00130.2006; Schauble S, 2007, J BIOL CHEM, V282, P14952, DOI 10.1074/jbc.M609221200; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; SHIBATA S, 1982, J PHARMACOL EXP THER, V223, P135; Sliedrecht T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010251; Somlyo A P, 1999, Rev Physiol Biochem Pharmacol, V134, P201; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Surks HK, 2003, J BIOL CHEM, V278, P51484, DOI 10.1074/jbc.M305622200; Takeya K, 2008, AM J PHYSIOL-RENAL, V294, pF1487, DOI 10.1152/ajprenal.00060.2008; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ulke-Lemee A, 2010, PHARMACEUTICALS, V3, P1739, DOI 10.3390/ph3061739; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Vetterkind S, 2010, MOL BIOL CELL, V21, P1214, DOI 10.1091/mbc.E09-08-0711; Vetterkind S, 2009, J CELL MOL MED, V13, P887, DOI 10.1111/j.1582-4934.2008.00374.x; Walsh Michael P., 2007, V365, P209; Weber LP, 1999, J PHYSIOL-LONDON, V516, P805, DOI 10.1111/j.1469-7793.1999.0805u.x; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173	56	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36978	36991		10.1074/jbc.M111.257949	http://dx.doi.org/10.1074/jbc.M111.257949			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880706	Green Published, hybrid			2022-12-27	WOS:000296538300076
J	Afrikanova, I; Yebra, M; Simpkinson, M; Xu, Y; Hayek, A; Montgomery, A				Afrikanova, Ivka; Yebra, Mayra; Simpkinson, Megan; Xu, Yang; Hayek, Alberto; Montgomery, Anthony			Inhibitors of Src and Focal Adhesion Kinase Promote Endocrine Specification IMPACT ON THE DERIVATION OF beta-CELLS FROM HUMAN PLURIPOTENT STEM CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-PRODUCING CELLS; TYROSINE KINASES; IN-VITRO; MESENCHYMAL TRANSITION; FAMILY KINASES; SELF-RENEWAL; CANCER-CELLS; DIFFERENTIATION; EXPRESSION; PANCREAS	Stepwise approaches for the derivation of beta-cells from human embryonic stem cells have been described. However, low levels of endocrine specification limit the final yield of insulin-producing beta-cells. In this study, we show that the pyrrolo-pyrimidine Src family kinase (SFK) inhibitor PP2 effectively promotes the endocrine specification of human embryonic stem cell derivatives based on its capacity to induce the expression of proendocrine transcription factors (NGN3, NEUROD1, NKX2.2, and PAX4) and to significantly increase the final yield of insulin-positive cells. We further demonstrate that PP2 inhibits the activation of focal adhesion kinase (FAK), and selective inhibition of this kinase is also sufficient to induce early endocrine commitment based on increased expression of NGN3, NEUROD1, and NKX2.2. Additional studies using dominant negative constructs and isolated human fetal pancreata suggest that c-Src is at least partially responsible for inhibiting early endocrine specification. Mechanistically, we propose that inhibition of SFK/FAK signaling can promote endocrine specification by limiting activation of the TGF beta R/Smad2/3 pathway. Moreover, we show that inhibition of SFK/FAK signaling suppresses cell growth, increases the expression of the beta-cell-associated cyclin-dependent kinase inhibitor p57kip2, and simultaneously suppresses the expression of Id1 and Id2. This study has important implications for the derivation of beta-cells for the cell-based therapy of diabetes and sheds new light on the signaling events that regulate early endocrine specification.	[Afrikanova, Ivka; Yebra, Mayra; Simpkinson, Megan; Hayek, Alberto; Montgomery, Anthony] Univ Calif San Diego, Pediat Diabet Res Ctr, San Diego, CA 92121 USA; Univ Calif San Diego, Dept Pediat, San Diego, CA 92121 USA; [Xu, Yang] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92121 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Montgomery, A (corresponding author), Univ Calif San Diego, Pediat Diabet Res Ctr, 3525 John Hopkins Ct, San Diego, CA 92121 USA.	ammontgo@ucsd.edu		Xu, Yang/0000-0001-5574-921X	American Diabetes Association; Juvenile Diabetes Research Foundation; California Institute of Regenerative Medicine; Larry L. Hillblom Foundation	American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Larry L. Hillblom Foundation	This work was supported by the American Diabetes Association (Innovation Award), by the Juvenile Diabetes Research Foundation (Regular Research Grant), by the California Institute of Regenerative Medicine (Early Translation Grant), and by the Larry L. Hillblom Foundation (network grant).	Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Avizienyte E, 2005, CELLS TISSUES ORGANS, V179, P73, DOI 10.1159/000084511; Bailey KM, 2008, J BIOL CHEM, V283, P13714, DOI 10.1074/jbc.M709329200; Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; BEATTIE GM, 1994, J CLIN ENDOCR METAB, V78, P1232, DOI 10.1210/jc.78.5.1232; Beattie GM, 1997, J CLIN ENDOCR METAB, V82, P1852, DOI 10.1210/jc.82.6.1852; Boretti MI, 2007, TISSUE ENG, V13, P775, DOI 10.1089/ten.2006.0258; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Broome MA, 1996, J BIOL CHEM, V271, P16798, DOI 10.1074/jbc.271.28.16798; Bryant P, 2006, MOL CELL BIOL, V26, P4201, DOI 10.1128/MCB.01612-05; Bursell L, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2308; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Collombat P, 2009, CELL CYCLE, V8, P3450, DOI 10.4161/cc.8.21.9791; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Daoud G, 2006, J PHYSIOL-LONDON, V571, P537, DOI 10.1113/jphysiol.2005.102285; Fizazi K, 2007, ANN ONCOL, V18, P1765, DOI 10.1093/annonc/mdm086; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Garamszegi N, 2010, ONCOGENE, V29, P2368, DOI 10.1038/onc.2009.514; Gautschi O, 2008, CANCER RES, V68, P2250, DOI 10.1158/0008-5472.CAN-07-6403; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Hakuno D, 2005, J BIOL CHEM, V280, P39534, DOI 10.1074/jbc.M505575200; Hua H, 2006, J BIOL CHEM, V281, P13574, DOI 10.1074/jbc.M600526200; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Kaido TJ, 2010, J CELL PHYSIOL, V224, P101, DOI 10.1002/jcp.22101; Kassem SA, 2001, DIABETES, V50, P2763, DOI 10.2337/diabetes.50.12.2763; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Meyn MA, 2005, MOL PHARMACOL, V68, P1320, DOI 10.1124/mol.104.010231; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Pala D, 2008, J BIOL CHEM, V283, P9239, DOI 10.1074/jbc.M705175200; Park MS, 2010, MATRIX BIOL, V29, P135, DOI 10.1016/j.matbio.2009.10.001; Phillips BW, 2007, STEM CELLS DEV, V16, P561, DOI 10.1089/scd.2007.0029; Potikha T, 2005, LAB INVEST, V85, P364, DOI 10.1038/labinvest.3700229; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sosa-Pineda B, 2004, MOL CELLS, V18, P289; Tatosyan AG, 2000, BIOCHEMISTRY-MOSCOW+, V65, P49; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Theus MH, 2006, EXP CELL RES, V312, P3096, DOI 10.1016/j.yexcr.2006.06.022; Tsaniras SC, 2010, J ENDOCRINOL, V206, P13, DOI 10.1677/JOE-10-0073; Vadali K, 2007, IUBMB LIFE, V59, P709, DOI 10.1080/15216540701694245; VARDIMON L, 1991, MOL CELL BIOL, V11, P5275, DOI 10.1128/MCB.11.10.5275; Walker JL, 2007, INVEST OPHTH VIS SCI, V48, P2214, DOI 10.1167/iovs.06-1059; Wu HW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-125; Xing JP, 2008, AM J PHYSIOL-RENAL, V295, pF145, DOI 10.1152/ajprenal.00092.2008; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28	51	18	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36042	36052		10.1074/jbc.M111.290825	http://dx.doi.org/10.1074/jbc.M111.290825			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21852242	Green Published, hybrid			2022-12-27	WOS:000295927100077
J	Ardura, JA; Wang, B; Watkins, SC; Vilardaga, JP; Friedman, PA				Ardura, Juan A.; Wang, Bin; Watkins, Simon C.; Vilardaga, Jean-Pierre; Friedman, Peter A.			Dynamic Na+-H+ Exchanger Regulatory Factor-1 Association and Dissociation Regulate Parathyroid Hormone Receptor Trafficking at Membrane Microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; PDZ DOMAINS; BETA-ARRESTIN; BRUSH-BORDER; ERM PROTEINS; CELL CORTEX; NHERF1; INTERNALIZATION; ACTIVATION; COMPLEX	Na/H exchanger regulatory factor-1 (NHERF1) is a cytoplasmic PDZ (postsynaptic density 95/disc large/zona occludens) protein that assembles macromolecular complexes and determines the localization, trafficking, and signaling of select G protein-coupled receptors and other membrane-delimited proteins. The parathyroid hormone receptor (PTHR), which regulates mineral ion homeostasis and bone turnover, is a G protein-coupled receptor harboring a PDZ-binding motif that enables association with NHERF1 and tethering to the actin cytoskeleton. NHERF1 interactions with the PTHR modify its trafficking and signaling. Here, we characterized by live cell imaging the mechanism whereby NHERF1 coordinates the interactions of multiple proteins, as well as the fate of NHERF1 itself upon receptor activation. Upon PTHR stimulation, NHERF1 rapidly dissociates from the receptor and induces receptor aggregation in long lasting clusters that are enriched with the actin-binding protein ezrin and with clathrin. After NHERF1 dissociates from the PTHR, ezrin then directly interacts with the PTHR to stabilize the PTHR at the cell membrane. Recruitment of beta-arrestins to the PTHR is delayed until NHERF1 dissociates from the receptor, which is then trafficked to clathrin for internalization. The ability of NHERF to interact dynamically with the PTHR and cognate adapter proteins regulates receptor trafficking and signaling in a spatially and temporally coordinated manner.	[Ardura, Juan A.; Wang, Bin; Vilardaga, Jean-Pierre; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab Prot Coupled Receptor Biol G, Pittsburgh, PA 15261 USA; [Watkins, Simon C.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab Prot Coupled Receptor Biol G, W1340 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	paf10@pitt.edu	Ardura, Juan/L-8139-2014; Watkins, Simon/ABG-2590-2021; Ardura, Juan Antonio/F-3378-2017	Ardura, Juan/0000-0002-8881-4775; Watkins, Simon/0000-0003-4092-1552; Ardura, Juan Antonio/0000-0002-2827-3364; Vilardaga, Jean-Pierre/0000-0002-1217-1435; Wang, Bin/0000-0002-5396-6111	National Institutes of Health [R01DK06998, R01DK054171, U54RR022241, R01DK087688]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054171, R01DK069998, R01DK087688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK06998, R01DK054171 (to P. A. F.), U54RR022241 (to S. C. W.), and R01DK087688 (to J.-P.V.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Amizuka N, 1997, ENDOCRINOLOGY, V138, P469, DOI 10.1210/en.138.1.469; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Capuano P, 2007, AM J PHYSIOL-CELL PH, V292, pC927, DOI 10.1152/ajpcell.00126.2006; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Chorev M, 2002, RECEPTOR CHANNEL, V8, P219, DOI 10.1080/10606820213685; Conway RR, 2001, J CELL PHYSIOL, V189, P341, DOI 10.1002/jcp.10028; Cunningham R, 2006, AM J PHYSIOL-RENAL, V291, pF896, DOI 10.1152/ajprenal.00036.2006; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Ferrari SL, 1999, J BIOL CHEM, V274, P29968, DOI 10.1074/jbc.274.42.29968; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Galperin E, 2003, J CELL SCI, V116, P4799, DOI 10.1242/jcs.00801; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Harris BZ, 2001, J CELL SCI, V114, P3219; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Klenk C, 2010, J BIOL CHEM, V285, P30355, DOI 10.1074/jbc.M110.114900; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Li JQ, 2009, J MOL BIOL, V392, P166, DOI 10.1016/j.jmb.2009.07.005; Mahon MJ, 2009, MOL ENDOCRINOL, V23, P1691, DOI 10.1210/me.2009-0164; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Seidler U, 2009, ANN NY ACAD SCI, V1165, P249, DOI 10.1111/j.1749-6632.2009.04046.x; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; Sneddon WB, 2004, ENDOCRINOLOGY, V145, P2815, DOI 10.1210/en.2003-1185; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vilardaga JP, 2001, J BIOL CHEM, V276, P33435, DOI 10.1074/jbc.M011495200; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2010, J BIOL CHEM, V285, P26976, DOI 10.1074/jbc.M110.147785; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	53	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35020	35029		10.1074/jbc.M111.264978	http://dx.doi.org/10.1074/jbc.M111.264978			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832055	hybrid, Green Published			2022-12-27	WOS:000295406300055
J	Eom, GH; Kim, KB; Kim, JH; Kim, JY; Kim, JR; Kee, HJ; Kim, DW; Choe, N; Park, HJ; Son, HJ; Choi, SY; Kook, H; Seo, SB				Eom, Gwang Hyeon; Kim, Kee-Beom; Kim, Jin Hee; Kim, Ji-Young; Kim, Ju-Ryung; Kee, Hae Jin; Kim, Dong-Wook; Choe, Nakwon; Park, Hye-Jeong; Son, Hye-Ju; Choi, Seok-Yong; Kook, Hyun; Seo, Sang-Beom			Histone Methyltransferase SETD3 Regulates Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; CHROMATIN MODIFICATIONS; LYSINE METHYLATION; GENE-EXPRESSION; TRANSCRIPTION; INHIBITION; MYOGENESIS; ZEBRAFISH; INTERACTS; PROTEIN	Histone lysine methylation, as one of the most important factors in transcriptional regulation, is associated with a various physiological conditions. Using a bioinformatics search, we identified and subsequently cloned mouse SET domain containing 3 (SETD3) with SET (Su(var) 3-9, Enhancer-of-zeste and Trithorax) and Rubis-subs-bind domains. SETD3 is a novel histone H3K4 and H3K36 methyltransferase with transcriptional activation activity. SETD3 is expressed abundantly in muscular tissues and, when overexpressed, activates transcription of muscle- related genes, myogenin, muscle creatine kinase (MCK), and myogenic factor 6 (Myf6), thereby inducing muscle cell differentiation. Conversely, knockdown of SETD3 by shRNA significantly retards muscle cell differentiation. In this study, SETD3 was recruited to the myogenin gene promoter along with MyoD where it activated transcription. Together, these data indicate that SETD3 is a H3K4/K36 methyltransferase and plays an important role in the transcriptional regulation of muscle cell differentiation.	[Eom, Gwang Hyeon; Kim, Ju-Ryung; Kee, Hae Jin; Choe, Nakwon; Seo, Sang-Beom] Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Kwangju 501746, South Korea; [Eom, Gwang Hyeon; Kim, Ju-Ryung; Kee, Hae Jin; Choe, Nakwon; Seo, Sang-Beom] Chonnam Natl Univ, Sch Med, Dept Pharmacol, Kwangju 501746, South Korea; [Kim, Jin Hee; Park, Hye-Jeong] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Kwangju 501746, South Korea; [Kim, Kee-Beom; Kim, Ji-Young; Kim, Dong-Wook] Chung Ang Univ, Dept Life Sci, Coll Nat Sci, Seoul 156756, South Korea; [Park, Hye-Jeong] Chosun Univ, Dept Biol, Kwangju 501759, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chung Ang University; Chosun University	Kook, H (corresponding author), Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Kwangju 501746, South Korea.	kookhyun@chonnam.ac.kr; sangbs@cau.ac.kr	Kim, Kee-Beom/AFL-8804-2022; Kim, Kee-Beom/AAG-9225-2022; Kee, Hae Jin/ABC-9979-2021; Kook, Hyun/AAR-5405-2021	Kim, Kee-Beom/0000-0003-0132-8924; Kim, Kee-Beom/0000-0003-0132-8924; Kook, Hyun/0000-0002-0740-1806; Kee, Hae Jin/0000-0002-9774-4828	National Research Foundation of Korea, Ministry of Education, Science and Technology [R01-2008-000-20358-0, KRF-2007-313-E00126]	National Research Foundation of Korea, Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by the Mid-career Researcher Program, National Research Foundation of Korea, Ministry of Education, Science and Technology Grants R01-2008-000-20358-0 and KRF-2007-313-E00126.	Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Choi J, 2010, BIOCHEM BIOPH RES CO, V401, P327, DOI 10.1016/j.bbrc.2010.09.014; Cirillo L, 2004, SCIENCE, V304, P1607, DOI 10.1126/science.1099577; Eom GH, 2009, BIOCHEM BIOPH RES CO, V388, P131, DOI 10.1016/j.bbrc.2009.07.134; Golob JL, 2008, DEV DYNAM, V237, P1389, DOI 10.1002/dvdy.21545; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Kim JR, 2009, J BIOL CHEM, V284, P16308, DOI 10.1074/jbc.M807725200; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lockman K, 2007, CIRC RES, V101, pE115, DOI 10.1161/CIRCRESAHA.107.164178; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Mal AK, 2006, EMBO J, V25, P3323, DOI 10.1038/sj.emboj.7601229; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; Qiao J, 2010, FERTIL STERIL, V93, P1628, DOI 10.1016/j.fertnstert.2009.03.002; Rai K, 2006, MOL CELL BIOL, V26, P7077, DOI 10.1128/MCB.00312-06; Rai K, 2010, J BIOL CHEM, V285, P4110, DOI 10.1074/jbc.M109.073676; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	28	65	71	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34733	34742		10.1074/jbc.M110.203307	http://dx.doi.org/10.1074/jbc.M110.203307			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832073	hybrid, Green Published			2022-12-27	WOS:000295406300027
J	Shinozaki, S; Choi, CS; Shimizu, N; Yamada, M; Kim, M; Zhang, T; Dong, HH; Kim, YB; Kaneki, M				Shinozaki, Shohei; Choi, Cheol Soo; Shimizu, Nobuyuki; Yamada, Marina; Kim, Minhye; Zhang, Ting; Dong, H. Henry; Kim, Young-Bum; Kaneki, Masao			Liver-specific Inducible Nitric-oxide Synthase Expression Is Sufficient to Cause Hepatic Insulin Resistance and Mild Hyperglycemia in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SKELETAL-MUSCLE CELLS; AKT/PROTEIN KINASE-B; S-NITROSYLATION; FASTING HYPERGLYCEMIA; RECEPTOR SUBSTRATE-1; POSSIBLE INVOLVEMENT; MAMMALIAN TARGET; GENE-EXPRESSION; OB/OB MICE	Inducible nitric-oxide synthase (iNOS), a major mediator of inflammation, plays an important role in obesity-induced insulin resistance. Inhibition of iNOS by gene disruption or pharmacological inhibitors reverses or ameliorates obesity-induced insulin resistance in skeletal muscle and liver in mice. It is unknown, however, whether increased expression of iNOS is sufficient to cause insulin resistance in vivo. To address this issue, we generated liver-specific iNOS transgenic (L-iNOS-Tg) mice, where expression of the transgene, iNOS, is regulated under mouse albumin promoter. L-iNOS-Tg mice exhibited mild hyperglycemia, hyperinsulinemia, insulin resistance, and impaired insulin-induced suppression of hepatic glucose output, as compared with wild type (WT) littermates. Insulin-stimulated phosphorylation of insulin receptor substrate-1 (IRS-1) and -2, and Akt was significantly attenuated in liver, but not in skeletal muscle, of L-iNOS-Tg mice relative to WT mice without changes in insulin receptor phosphorylation. Moreover, liver-specific iNOS expression abrogated insulin-stimulated phosphorylation of glycogen synthase kinase-3 beta, forkhead box O1, and mTOR (mammalian target of rapamycin), endogenous substrates of Akt, along with increased S-nitrosylation of Akt relative to WT mice. However, the expression of insulin receptor, IRS-1, IRS-2, Akt, glycogen synthase kinase-3 beta, forkhead box O1, protein-tyrosine phosphatase-1B, PTEN (phosphatase and tensin homolog), and p85 phosphatidylinositol 3-kinase was not altered by iNOS transgene. Hyperglycemia was associated with elevated glycogen phosphorylase activity and decreased glycogen synthase activity in the liver of L-iNOS-Tg mice, whereas phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, and proliferator-activated receptor gamma coactivator-1 alpha expression were not altered. These results clearly indicate that selective expression of iNOS in liver causes hepatic insulin resistance along with deranged insulin signaling, leading to hyperglycemia and hyperinsulinemia. Our data highlight a critical role for iNOS in the development of hepatic insulin resistance and hyperglycemia.	[Shinozaki, Shohei; Shimizu, Nobuyuki; Yamada, Marina; Kim, Minhye; Kaneki, Masao] Harvard Univ, Sch Med, Dept Anesthesia Crit Care & Pain Med, Massachusetts Gen Hosp,Shriners Hosp Children, Charlestown, MA 02129 USA; [Choi, Cheol Soo] Gachon Univ Med & Sci, Dept Internal Med, Inchon 406840, South Korea; [Choi, Cheol Soo] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea; [Zhang, Ting; Dong, H. Henry] Univ Pittsburgh, Med Ctr, Div Immunogenet, Rangos Res Ctr,Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Kim, Young-Bum] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kim, Young-Bum] Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Gachon University; Gachon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kaneki, M (corresponding author), 149 13th St,Rm 6604, Charlestown, MA 02129 USA.	mkaneki@helix.mgh.harvard.edu	Shinozaki, Shohei/AAT-3018-2021; Zhang, Ting/J-5074-2015	Dong, H. Henry/0000-0003-0279-5241	National Institutes of Health [R01DK05827, R01DK066301]; American Diabetes Association [7-08-RA-77, 109-RA-87]; Korea Healthcare Technology R&D Project, Republic of Korea [A084651]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Korea Healthcare Technology R&D Project, Republic of Korea; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK05827 (to M. K.) and R01DK066301 (to H. H. D.). This work was also supported by American Diabetes Association Grants 7-08-RA-77 (to Y.-B. K.) and 1-09-RA-87 (to H. H. D.), and Korea Healthcare Technology R&D Project, Republic of Korea Grant A084651 (to C. S. C.).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Borgs M, 1996, HEPATOLOGY, V23, P1564, DOI 10.1053/jhep.1996.v23.pm0008675178; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Carvalho MA, 2009, DIABETOLOGIA, V52, P2425, DOI 10.1007/s00125-009-1498-1; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Farghali H, 2008, PHYSIOL RES, V57, P569, DOI 10.33549/physiolres.931232; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Fujita K, 2010, ALCOHOL CLIN EXP RES, V34, pS18, DOI 10.1111/j.1530-0277.2008.00756.x; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Geloneze B, 2009, ARQ BRAS ENDOCRINOL, V53, P281, DOI 10.1590/S0004-27302009000200020; He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hodis J, 2007, PHYSIOL RES, V56, P419, DOI 10.33549/physiolres.931023; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kamagate A, 2010, ENDOCRINOLOGY, V151, P3521, DOI 10.1210/en.2009-1306; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kaneki M, 2007, ANTIOXID REDOX SIGN, V9, P319, DOI 10.1089/ars.2006.1464; Katta A, 2009, EXP DIABETES RES, DOI 10.1155/2009/384683; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kone BC, 1999, AM J PHYSIOL-RENAL, V276, pF614, DOI 10.1152/ajprenal.1999.276.4.F614; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Martyn JAJ, 2008, ANESTHESIOLOGY, V109, P137, DOI 10.1097/ALN.0b013e3181799d45; Miller AM, 2008, AM J PHYSIOL-REG I, V295, pR1431, DOI 10.1152/ajpregu.90428.2008; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Noronha BT, 2005, DIABETES, V54, P1082, DOI 10.2337/diabetes.54.4.1082; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pauli JR, 2008, J PHYSIOL-LONDON, V586, P659, DOI 10.1113/jphysiol.2007.142414; Perdomo G, 2010, J LIPID RES, V51, P1298, DOI 10.1194/jlr.M001206; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Shinozaki S, 2007, HORM METAB RES, V39, P192, DOI 10.1055/s-2007-970417; Sugita H, 2005, J BIOL CHEM, V280, P14203, DOI 10.1074/jbc.M411226200; Sugita H, 2002, AM J PHYSIOL-ENDOC M, V282, pE386, DOI 10.1152/ajpendo.00087.2001; Tajima T, 2009, BIOCHEM BIOPH RES CO, V387, P789, DOI 10.1016/j.bbrc.2009.07.115; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wu MZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006430; Yanagitani A, 2004, HEPATOLOGY, V40, P366, DOI 10.1002/hep.20335; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	50	53	56	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34959	34975		10.1074/jbc.M110.187666	http://dx.doi.org/10.1074/jbc.M110.187666			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846719	Green Published, hybrid			2022-12-27	WOS:000295406300050
J	Horn, DM; Mason, SL; Karbstein, K				Horn, Darryl M.; Mason, Saundra L.; Karbstein, Katrin			Rcl1 Protein, a Novel Nuclease for 18 S Ribosomal RNA Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; 3'-PHOSPHATE CYCLASE; PHOSPHATE CYCLASE; SITE A(2); YEAST; BIOGENESIS; DOMAIN	In all forms of life, rRNAs for the small and large ribosomal subunit are co-transcribed as a single transcript. Although this ensures the equimolar production of rRNAs, it requires the endonucleolytic separation of pre-rRNAs to initiate rRNA production. In yeast, processing of the primary transcript encoding 18 S, 5.8 S, and 25 S rRNAs has been studied extensively. Nevertheless, most nucleases remain to be identified. Here, we show that Rcl1, conserved in all eukaryotes, cleaves pre-rRNA at so-called site A(2), a co-transcriptional cleavage step that separates rRNAs destined for the small and large subunit. Recombinant Rcl1 cleaves pre-rRNA mimics at site A(2) in a reaction that is sensitive to nearby RNA mutations that inhibit cleavage in vivo. Furthermore, mutations in Rcl1 disrupt rRNA processing at site A(2) in vivo and in vitro. Together, these results demonstrate that the role of Rcl1 in eukaryotic pre-rRNA processing is identical to that of RNase III in bacteria: to co-transcriptionally separate the pre-rRNAs destined for the small and large subunit. Furthermore, because Rcl1 has no homology to other known endonucleases, these data also establish a novel class of nucleases.	[Horn, Darryl M.; Karbstein, Katrin] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Mason, Saundra L.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Scripps Research Institute; University of Michigan System; University of Michigan	Karbstein, K (corresponding author), Scripps Res Inst, Dept Canc Biol, 130 Scripps Way 2C1, Jupiter, FL 33458 USA.	kkarbst@scripps.edu		Karbstein, Katrin/0000-0002-4034-1331	National Science Foundation [MCB0845156]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB0845156.	AbouElela S, 1996, CELL, V85, P115, DOI 10.1016/S0092-8674(00)81087-9; Allmang C, 1996, RNA, V2, P51; Billy E, 2000, EMBO J, V19, P2115, DOI 10.1093/emboj/19.9.2115; BIRKTOFT JJ, 1972, J MOL BIOL, V68, P187, DOI 10.1016/0022-2836(72)90210-0; Bleichert F, 2006, P NATL ACAD SCI USA, V103, P9464, DOI 10.1073/pnas.0603673103; DEJONGE P, 1977, EUR J BIOCHEM, V72, P361; Genschik P, 1997, EMBO J, V16, P2955, DOI 10.1093/emboj/16.10.2955; Karbstein K, 2006, J MOL BIOL, V356, P432, DOI 10.1016/j.jmb.2005.11.052; Karbstein K, 2005, MOL CELL, V20, P633, DOI 10.1016/j.molcel.2005.09.017; Karbstein K, 2002, BIOCHEMISTRY-US, V41, P11171, DOI 10.1021/bi0202631; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Lamanna AC, 2011, J MOL BIOL, V405, P3, DOI 10.1016/j.jmb.2010.09.064; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; LINDAHL L, 1994, NUCLEIC ACIDS RES, V22, P5399, DOI 10.1093/nar/22.24.5399; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Palm GJ, 2000, STRUCTURE, V8, P13, DOI 10.1016/S0969-2126(00)00076-9; Pertschy B, 2009, J BIOL CHEM, V284, P35079, DOI 10.1074/jbc.M109.040774; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Tanaka N, 2011, RNA, V17, P595, DOI 10.1261/rna.2571811; Tanaka N, 2010, STRUCTURE, V18, P449, DOI 10.1016/j.str.2010.01.016; Torchet C, 1998, RNA, V4, P1636, DOI 10.1017/S1355838298981511; Venema J, 1996, EMBO J, V15, P5701, DOI 10.1002/j.1460-2075.1996.tb00954.x; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Vos HR, 2004, EUKARYOT CELL, V3, P1504, DOI 10.1128/EC.3.6.1504-1512.2004; Weaver PL, 1997, MOL CELL BIOL, V17, P1354, DOI 10.1128/MCB.17.3.1354; Wegierski T, 2001, RNA, V7, P1254, DOI 10.1017/S1355838201012079; Woolls HA, 2011, J BIOL CHEM, V286, P2578, DOI 10.1074/jbc.M110.191494; Young CL, 2011, RNA, V17, P512, DOI 10.1261/rna.2458811	28	51	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34082	34087		10.1074/jbc.M111.268649	http://dx.doi.org/10.1074/jbc.M111.268649			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21849504	Green Published, hybrid			2022-12-27	WOS:000295159200040
J	Mandal, M; Wei, J; Zhong, P; Cheng, J; Duffney, LJ; Liu, WH; Yuen, EY; Twelvetrees, AE; Li, SH; Li, XJ; Kittler, JT; Yan, Z				Mandal, Madhuchhanda; Wei, Jing; Zhong, Ping; Cheng, Jia; Duffney, Lara J.; Liu, Wenhua; Yuen, Eunice Y.; Twelvetrees, Alison E.; Li, Shihua; Li, Xiao-Jiang; Kittler, Josef T.; Yan, Zhen			Impaired alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Trafficking and Function by Mutant Huntingtin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST AXONAL-TRANSPORT; KINESIN LIGHT-CHAIN; NMDA RECEPTOR; MOUSE MODEL; INTRACELLULAR TRAFFICKING; SYNAPTIC-TRANSMISSION; TRANSGENIC MICE; PROTEIN-1 HAP1; DISEASE; NEURONS	Emerging evidence from studies of Huntington disease (HD) pathophysiology suggests that huntingtin (htt) and its associated protein HAP1 participate in intracellular trafficking and synaptic function. However, it is largely unknown whether AMPA receptor trafficking, which is crucial for controlling the efficacy of synaptic excitation, is affected by the mutant huntingtin with polyglutamine expansion (polyQ-htt). In this study, we found that expressing polyQ-htt in neuronal cultures significantly decreased the amplitude and frequency of AMPAR-mediated miniature excitatory postsynaptic current (mEPSC), while expressing wild-type huntingtin (WT-htt) increased mEPSC. AMPAR-mediated synaptic transmission was also impaired in a transgenic mouse model of HD expressing polyQ-htt. The effect of polyQ-htt on mEPSC was mimicked by knockdown of HAP1 and occluded by the dominant negative HAP1. Moreover, we found that huntingtin affected mESPC via a mechanism depending on the kinesin motor protein, KIF5, which controls the transport of GluR2-containing AMPARs along microtubules in dendrites. The GluR2/KIF5/HAP1 complex was disrupted and dissociated from microtubules in the HD mouse model. Together, these data suggest that AMPAR trafficking and function is impaired by mutant huntingtin, presumably due to the interference of KIF5-mediated microtubule-based transport of AMPA receptors. The diminished strength of glutamatergic transmission could contribute to the deficits in movement control and cognitive processes in HD conditions.	[Mandal, Madhuchhanda; Wei, Jing; Zhong, Ping; Cheng, Jia; Duffney, Lara J.; Liu, Wenhua; Yuen, Eunice Y.; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Twelvetrees, Alison E.; Kittler, Josef T.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Li, Shihua; Li, Xiao-Jiang] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of London; University College London; Emory University	Yan, Z (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, 124 Sherman Hall, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu	Kittler, Josef/N-7589-2019; Kittler, Josef T/E-9113-2010; Twelvetrees, Alison/K-8712-2019	Kittler, Josef/0000-0002-3437-9456; Kittler, Josef T/0000-0002-3437-9456; Twelvetrees, Alison/0000-0002-1796-1508	National Institutes of Health [NS69929]; MRC [G0802377] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH077823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019206] Funding Source: NIH RePORTER; Medical Research Council [G0802377] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant NS69929 (to Z. Y.).	Andre VM, 2011, J NEUROSCI, V31, P1170, DOI 10.1523/JNEUROSCI.3539-10.2011; Andre VM, 2006, J NEUROPHYSIOL, V95, P2108, DOI 10.1152/jn.01118.2005; BlockGalarza J, 1997, NEUROREPORT, V8, P2247, DOI 10.1097/00001756-199707070-00031; Cepeda C, 2003, J NEUROSCI, V23, P961; Cepeda C, 2001, J NEUROSCI RES, V66, P525, DOI 10.1002/jnr.1244; Cummings DM, 2009, J NEUROSCI, V29, P10371, DOI 10.1523/JNEUROSCI.1592-09.2009; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Fan MMY, 2007, J NEUROSCI, V27, P3768, DOI 10.1523/JNEUROSCI.4356-06.2007; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Guillaud L, 2003, J NEUROSCI, V23, P131; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Gyoeva FK, 2004, BIOCHEMISTRY-US, V43, P13525, DOI 10.1021/bi049288l; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Kim CH, 2001, J NEUROSCI, V21, P4188, DOI 10.1523/JNEUROSCI.21-12-04188.2001; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Laforet GA, 2001, J NEUROSCI, V21, P9112, DOI 10.1523/JNEUROSCI.21-23-09112.2001; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Li LJ, 2004, J NEUROPHYSIOL, V92, P2738, DOI 10.1152/jn.00308.2004; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Li YK, 2002, J BIOL CHEM, V277, P28212, DOI 10.1074/jbc.M111612200; Lione LA, 1999, J NEUROSCI, V19, P10428; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Milnerwood AJ, 2007, J PHYSIOL-LONDON, V585, P817, DOI 10.1113/jphysiol.2007.142448; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Page KJ, 1998, EUR J NEUROSCI, V10, P1835, DOI 10.1046/j.1460-9568.1998.00185.x; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Rong J, 2006, J NEUROSCI, V26, P6019, DOI 10.1523/JNEUROSCI.1251-06.2006; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Simmons DA, 2009, P NATL ACAD SCI USA, V106, P4906, DOI 10.1073/pnas.0811228106; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; Smith R, 2005, CELL MOL LIFE SCI, V62, P1901, DOI 10.1007/s00018-005-5084-5; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Twelvetrees AE, 2010, NEURON, V65, P53, DOI 10.1016/j.neuron.2009.12.007; Wei J, 2010, J BIOL CHEM, V285, P26369, DOI 10.1074/jbc.M110.121376; Yuen EY, 2011, J BIOL CHEM, V286, P24957, DOI 10.1074/jbc.M111.221416; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; Yuen EY, 2005, J NEUROSCI, V25, P5488, DOI 10.1523/JNEUROSCI.1187-05.2005; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3	53	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33719	33728		10.1074/jbc.M111.236521	http://dx.doi.org/10.1074/jbc.M111.236521			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832090	hybrid, Green Published			2022-12-27	WOS:000295159200002
J	Singleton, RS; Trudgian, DC; Fischer, R; Kessler, BM; Ratcliffe, PJ; Cockman, ME				Singleton, Rachelle S.; Trudgian, David C.; Fischer, Roman; Kessler, Benedikt M.; Ratcliffe, Peter J.; Cockman, Matthew E.			Quantitative Mass Spectrometry Reveals Dynamics of Factor-inhibiting Hypoxia-inducible Factor-catalyzed Hydroxylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN REPEAT DOMAIN; ASPARAGINYL HYDROXYLASE; FACTOR HIF; BETA-HYDROXYLATION; STATISTICAL-MODEL; FIH; PROTEIN; SUBSTRATE; NOTCH; IDENTIFICATIONS	The asparaginyl hydroxylase, factor-inhibiting hypoxia-inducible factor (HIF), is central to the oxygen-sensing pathway that controls the activity of HIF. Factor-inhibiting HIF (FIH) also catalyzes the hydroxylation of a large set of proteins that share a structural motif termed the ankyrin repeat domain (ARD). In vitro studies have defined kinetic properties of FIH with respect to different substrates and have suggested FIH binds more tightly to certain ARD proteins than HIF and that ARD hydroxylation may have a lower K-m value for oxygen than HIF hydroxylation. However, regulation of asparaginyl hydroxylation on ARD substrates has not been systematically studied in cells. To address these questions, we employed isotopic labeling and mass spectrometry to monitor the accrual, inhibition, and decay of hydroxylation under defined conditions. Under the conditions examined, hydroxylation was not reversed but increased as the protein aged. The extent of hydroxylation on ARD proteins was increased by addition of ascorbate, whereas iron and 2-oxoglutarate supplementation had no significant effect. Despite preferential binding of FIH to ARD substrates in vitro, when expressed as fusion proteins in cells, hydroxylation was found to be more complete on HIF polypeptides compared with sites within the ARD. Furthermore, comparative studies of hydroxylation in graded hypoxia revealed ARD hydroxylation was suppressed in a site-specific manner and was as sensitive as HIF to hypoxic inhibition. These findings suggest that asparaginyl hydroxylation of HIF-1 and ARD proteins is regulated by oxygen over a similar range, potentially tuning the HIF transcriptional response through competition between the two types of substrate.	[Singleton, Rachelle S.; Trudgian, David C.; Fischer, Roman; Kessler, Benedikt M.; Ratcliffe, Peter J.; Cockman, Matthew E.] Univ Oxford, Ctr Cellular & Mol Physiol, Oxford OX3 7BN, England	University of Oxford	Cockman, ME (corresponding author), Univ Oxford, Ctr Cellular & Mol Physiol, Henry Wellcome Bldg Mol Physiol, Oxford OX3 7BN, England.	matthew@well.ox.ac.uk	Trudgian, David/D-4785-2012; Fischer, Roman/N-4408-2017; Cockman, Matthew/V-9619-2019; Kessler, Benedikt/AAY-8614-2021	Trudgian, David/0000-0002-7084-6787; Fischer, Roman/0000-0002-9715-5951; Cockman, Matthew/0000-0002-3310-4821; Kessler, Benedikt/0000-0002-8160-2446; Singleton, Rachelle/0000-0001-7337-5688; Ratcliffe, Peter/0000-0002-2853-806X	Biotechnology and Biological Sciences Research Council; European Union; Wellcome Trust; Action Medical Research Charity [208701, SC039284]; Biomedical Research Centre (National Institute for Health Research), Oxford, UK; Biotechnology and Biological Sciences Research Council [BB/G014124/1] Funding Source: researchfish; British Heart Foundation [RG/11/1/28684] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Action Medical Research Charity; Biomedical Research Centre (National Institute for Health Research), Oxford, UK(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported in part by the Biotechnology and Biological Sciences Research Council, the European Union (7th Framework), and the Wellcome Trust (to P.J.R.).; Supported by Action Medical Research Charity Grants 208701 and SC039284.; Supported by the Biomedical Research Centre (National Institute for Health Research), Oxford, UK.	Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Deutsch EW, 2010, PROTEOMICS, V10, P1190, DOI 10.1002/pmic.200900567; Devries IL, 2010, FEBS LETT, V584, P4725, DOI 10.1016/j.febslet.2010.10.060; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Flashman E, 2010, BIOCHEM J, V427, P135, DOI 10.1042/BJ20091609; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Hardy AP, 2009, J MOL BIOL, V392, P994, DOI 10.1016/j.jmb.2009.07.070; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kelly L, 2009, MOL BIOSYST, V5, P52, DOI 10.1039/b815271c; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lee SH, 2008, J BIOMOL SCREEN, V13, P494, DOI 10.1177/1087057108318800; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pasa-Tolic L, 2004, BIOTECHNIQUES, V37, P621, DOI 10.2144/04374RV01; Robinson N. E, 2004, MOL CLOCKS DEAMIDATI, P1; Schmierer B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-139; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Trudgian DC, 2010, BIOINFORMATICS, V26, P1131, DOI 10.1093/bioinformatics/btq081; Webb JD, 2009, BIOCHEM J, V420, P327, DOI 10.1042/BJ20081905; Wilkins SE, 2009, INT J BIOCHEM CELL B, V41, P1563, DOI 10.1016/j.biocel.2009.01.005; Xu DM, 2008, MOL CELL PROTEOMICS, V7, P2215, DOI 10.1074/mcp.M800095-MCP200; Yang M, 2011, FEBS J, V278, P1086, DOI 10.1111/j.1742-4658.2011.08022.x; Yang M, 2011, J BIOL CHEM, V286, P7648, DOI 10.1074/jbc.M110.193540; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	39	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33784	33794		10.1074/jbc.M111.262808	http://dx.doi.org/10.1074/jbc.M111.262808			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21808058	hybrid, Green Published			2022-12-27	WOS:000295159200009
J	Honsa, ES; Fabian, M; Cardenas, AM; Olson, JS; Maresso, AW				Honsa, Erin Sarah; Fabian, Marian; Cardenas, Ana Maria; Olson, John S.; Maresso, Anthony William			The Five Near-iron Transporter (NEAT) Domain Anthrax Hemophore, IsdX2, Scavenges Heme from Hemoglobin and Transfers Heme to the Surface Protein IsdC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY BINDING; UPTAKE SYSTEM; ACQUISITION; RECEPTOR; STREPTOCOCCUS; ANTIBODY; IDENTIFICATION; SIDEROPHORES; COORDINATION; HAPTOGLOBIN	Pathogenic bacteria require iron to replicate inside mammalian hosts. Recent studies indicate that heme acquisition in Gram-positive bacteria is mediated by proteins containing one or more near-iron transporter (NEAT) domains. Bacillus anthracis is a spore-forming, Gram-positive pathogen and the causative agent of anthrax disease. The rapid, extensive, and efficient replication of B. anthracis in host tissues makes this pathogen an excellent model organism for the study of bacterial heme acquisition. B. anthracis secretes two NEAT hemophores, IsdX1 and IsdX2. IsdX1 contains a single NEAT domain, whereas IsdX2 has five, a novel property among hemophores. To understand the functional significance of harboring multiple, non-identical NEAT domains, we purified each individual NEAT domain of IsdX2 as a GST fusion and analyzed the specific function of each domain as it relates to heme acquisition and transport. NEAT domains 1, 3, 4, and 5 all bind heme, with domain 5 having the highest affinity. All NEATs associate with hemoglobin, but only NEAT1 and -5 can extract heme from hemoglobin, seemingly by a specific and active process. NEAT1, -3, and -4 transfer heme to IsdC, a cell wall-anchored anthrax NEAT protein. These results indicate that IsdX2 has all the features required to acquire heme from the host and transport heme to the bacterial cell wall. Additionally, these results suggest that IsdX2 may accelerate iron import rates by acting as a "heme sponge" that enhances B. anthracis replication in ironstarved environments.	[Honsa, Erin Sarah; Cardenas, Ana Maria; Maresso, Anthony William] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Fabian, Marian; Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77096 USA	Baylor College of Medicine; Rice University	Maresso, AW (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.	maresso@bcm.edu		Olson, John/0000-0002-0760-5403	National Institutes of Health [AI069697, GM035649, HL047020, GM84348]; Robert A. Welch Foundation [C0612]; Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI096314, R21AI088329, K22AI079165, F32AI069697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084348, R01GM035649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI069697 (to A. W. M.), GM035649 and HL047020 (to J. S. O.), and GM84348 (to M. F.).; Supported by Robert A. Welch Foundation Grant C0612.; Supported by seed funds from Baylor College of Medicine. To whom correspondence should be addressed: Dept. of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. Tel.: 713-798-7368; Fax: 713-798-7375; E-mail: maresso@bcm.edu.	Abramova A. A., 1993, Arkhiv Patologii, V55, P18; Andrade MA, 2002, GENOME BIOL, V3; Ascoli F, 1981, Methods Enzymol, V76, P72; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carlson PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006988; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Crosa JH., 2004, IRON TRANSPORT BACTE; Culbertson DS, 2010, BIOCHEMISTRY-US, V49, P6052, DOI 10.1021/bi1006942; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Dementieva IS, 2009, J MOL BIOL, V387, P175, DOI 10.1016/j.jmb.2009.01.030; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Ebert Tim, 2010, Human Antibodies, V19, P113, DOI 10.3233/HAB-2010-0235; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Gao JL, 2010, J BIOL CHEM, V285, P40028, DOI 10.1074/jbc.M110.163535; Gat O, 2008, MOL MICROBIOL, V70, P983, DOI 10.1111/j.1365-2958.2008.06460.x; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Guidi-Rontani C, 1999, MOL MICROBIOL, V31, P9, DOI 10.1046/j.1365-2958.1999.01137.x; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; HILLIER J, 1953, J CELL COMPAR PHYSL, V42, P203, DOI 10.1002/jcp.1030420205; Honsa ES, 2011, BIOMETALS, V24, P533, DOI 10.1007/s10534-011-9413-x; Howell S, 1998, J MOL RECOGNIT, V11, P200, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<200::AID-JMR423>3.0.CO;2-7; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Klichko VI, 2003, BIOCHEM BIOPH RES CO, V303, P855, DOI 10.1016/S0006-291X(03)00440-6; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Letoffe S, 1999, MOL MICROBIOL, V33, P546, DOI 10.1046/j.1365-2958.1999.01499.x; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Meehan M, 2010, MICROBIOL-SGM, V156, P1824, DOI 10.1099/mic.0.036087-0; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Murphy Michael, 2006, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471142301.ps1914s45; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pluym M, 2008, J INORG BIOCHEM, V102, P480, DOI 10.1016/j.jinorgbio.2007.11.011; ROSS JM, 1955, BRIT J EXP PATHOL, V36, P336; Shannon JG, 2003, INFECT IMMUN, V71, P3183, DOI 10.1128/IAI.71.6.3183-3189.2003; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Yukl ET, 2010, BIOCHEMISTRY-US, V49, P6646, DOI 10.1021/bi100692f; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	65	40	41	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33652	33660		10.1074/jbc.M111.241687	http://dx.doi.org/10.1074/jbc.M111.241687			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808055	hybrid, Green Published			2022-12-27	WOS:000294968800081
J	Shinkyo, R; Xu, LB; Tallman, KA; Cheng, Q; Porter, NA; Guengerich, FP				Shinkyo, Raku; Xu, Libin; Tallman, Keri A.; Cheng, Qian; Porter, Ned A.; Guengerich, F. Peter			Conversion of 7-Dehydrocholesterol to 7-Ketocholesterol Is Catalyzed by Human Cytochrome P450 7A1 and Occurs by Direct Oxidation without an Epoxide Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEMLI-OPITZ SYNDROME; CHOLESTEROL AUTOXIDATION; BIOLOGICAL-ACTIVITIES; ESCHERICHIA-COLI; OXYSTEROLS; METABOLISM; PRODUCTS; MIGRATION; PLASMA; 4-BETA-HYDROXYCHOLESTEROL	7-Ketocholesterol is a bioactive sterol, a potent competitive inhibitor of cytochrome P450 7A1, and toxic in liver cells. Multiple origins of this compound have been identified, with cholesterol being the presumed precursor. Although routes for formation of the 7-keto compound from cholesterol have been established, we found that 7-dehydrocholesterol (the immediate precursor of cholesterol) is oxidized by P450 7A1 to 7-ketocholesterol (k(cat)/K-m = 3 x 10(4) M-1 s(-1)). P450 7A1 converted lathosterol (Delta(5)-dihydro-7-dehydrocholesterol) to a mixture of the 7-keto and 7 alpha,8 alpha-epoxide products (similar to 1:2 ratio), with the epoxide not rearranging to the ketone. The oxidation of 7-dehydrocholesterol occured with predominant formation of 7-ketocholesterol and with the 7 alpha,8 alpha-epoxide as only a minor product; the synthesized epoxide was stable in the presence of P450 7A1. The mechanism of 7-dehydrocholesterol oxidation to 7-ketocholesterol is proposed to involve a FeIII-O-C-C+ intermediate and a 7,8-hydride shift or an alternative closing to yield the epoxide (Liebler, D. C., and Guengerich, F. P. (1983) Biochemistry 22, 5482-5489). Accordingly, reaction of P450 7A1 with 7-[H-2(1)]dehydrocholesterol yielded complete migration of deuterium in the product 7-ketocholesterol. The finding that 7-dehydrocholesterol is a precursor of 7-ketocholesterol has relevance to an inborn error of metabolism known as Smith-Lemli-Opitz syndrome (SLOS) caused by defective cholesterol biosynthesis. Mutations within the gene encoding 7-dehydrocholesterol reductase, the last enzyme in the pathway, lead to the accumulation of 7-dehydrocholesterol in tissues and fluids of SLOS patients. Our findings suggest that 7-ketocholesterol levels may also be elevated in SLOS tissue and fluids as a result of P450 7A1 oxidation of 7-dehydrocholesterol.	[Shinkyo, Raku; Cheng, Qian; Porter, Ned A.; Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Xu, Libin; Tallman, Keri A.; Porter, Ned A.] Vanderbilt Univ, Dept Chem, Sch Med, Nashville, TN 37232 USA; [Porter, Ned A.; Guengerich, F. Peter] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Cheng, Q (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Shinkyo, Raku/HIK-2997-2022; Xu, Libin/J-3693-2019	Xu, Libin/0000-0003-1021-5200	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064727] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD064727] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BJORKHEM I, 1986, ANAL BIOCHEM, V154, P497, DOI 10.1016/0003-2697(86)90021-7; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Bodin K, 2001, J BIOL CHEM, V276, P38685, DOI 10.1074/jbc.M105127200; Bodin K, 2002, J BIOL CHEM, V277, P31534, DOI 10.1074/jbc.M201712200; BREUER O, 1990, STEROIDS, V55, P185, DOI 10.1016/0039-128X(90)90109-O; BREUER O, 1993, EUR J BIOCHEM, V215, P705, DOI 10.1111/j.1432-1033.1993.tb18082.x; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Brown AJ, 1997, J LIPID RES, V38, P1730; BROWN MS, 1974, J BIOL CHEM, V249, P7306; Chang YH, 1997, FREE RADICAL BIO MED, V23, P202, DOI 10.1016/S0891-5849(96)00626-0; de Sain-van der Velden MGM, 2008, J INHERIT METAB DIS, V31, pS387, DOI 10.1007/s10545-008-0963-1; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; Gontscharow N. P., 1971, J STEROID BIOCHEM, V2, P389; GONTSCHAROW NP, 1975, ENDOKRINOLOGIE, V64, P213; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich F. P., 2007, PRINCIPLES METHODS T, P1981; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; GUROFF G, 1967, SCIENCE, V157, P1524, DOI 10.1126/science.157.3796.1524; Haas D, 2007, J INHERIT METAB DIS, V30, P375, DOI 10.1007/s10545-007-0537-7; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HOLICK MF, 1977, BIOCHEM BIOPH RES CO, V76, P107, DOI 10.1016/0006-291X(77)91674-6; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; HOWARD JA, 1968, J AM CHEM SOC, V90, P1056, DOI 10.1021/ja01006a037; HUGHES H, 1994, ARTERIOSCLER THROMB, V14, P1177, DOI 10.1161/01.ATV.14.7.1177; Javitt NB, 2008, STEROIDS, V73, P149, DOI 10.1016/j.steroids.2007.10.004; KEENEY DS, 1993, PHARMACOL THERAPEUT, V58, P301, DOI 10.1016/0163-7258(93)90026-A; Kelley RI, 2000, J MED GENET, V37, P321, DOI 10.1136/jmg.37.5.321; KELLEY RI, 1995, CLIN CHIM ACTA, V236, P45, DOI 10.1016/0009-8981(95)06038-4; Korade Z, 2010, J LIPID RES, V51, P3259, DOI 10.1194/jlr.M009365; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LIEBLER DC, 1983, BIOCHEMISTRY-US, V22, P5482, DOI 10.1021/bi00293a005; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; MANSUY D, 1984, BIOCHEM BIOPH RES CO, V119, P319, DOI 10.1016/0006-291X(84)91654-1; Mast N, 2005, J LIPID RES, V46, P1561, DOI 10.1194/jlr.D500008-JLR200; MILLER RE, 1982, BIOCHEMISTRY-US, V21, P1090, DOI 10.1021/bi00534a041; Moreira EF, 2009, INVEST OPHTH VIS SCI, V50, P523, DOI 10.1167/iovs.08-2373; Murphy RC, 2008, J BIOL CHEM, V283, P15521, DOI 10.1074/jbc.R700049200; Parikh A, 1997, NAT BIOTECHNOL, V15, P784, DOI 10.1038/nbt0897-784; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Rodriguez IR, 2009, PHOTOCHEM PHOTOBIOL, V85, P1116, DOI 10.1111/j.1751-1097.2009.00568.x; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Shaw PM, 1997, ARCH BIOCHEM BIOPHYS, V348, P107, DOI 10.1006/abbi.1997.0378; Shinkyo R, 2011, J BIOL CHEM, V286, P18426, DOI 10.1074/jbc.M111.240457; Shinkyo R, 2011, J BIOL CHEM, V286, P4632, DOI 10.1074/jbc.M110.193409; Smith, 1981, CHOLESTEROL AUTOXIDA; SMITH LL, 1989, FREE RADICAL BIO MED, V7, P285, DOI 10.1016/0891-5849(89)90136-6; SMITH LL, 1987, CHEM PHYS LIPIDS, V44, P87, DOI 10.1016/0009-3084(87)90046-6; Song W, 1998, J BIOL CHEM, V273, P16223, DOI 10.1074/jbc.273.26.16223; STRANDVIK B, 1994, SCAND J CLIN LAB INV, V54, P1, DOI 10.3109/00365519409086503; TINT GS, 1995, J LIPID RES, V36, P89; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; Vejux A, 2008, BRAZ J MED BIOL RES, V41, P545, DOI 10.1590/S0100-879X2008000700001; Vejux A, 2009, MOL ASPECTS MED, V30, P153, DOI 10.1016/j.mam.2009.02.006; Xu L., 2011, J LIPID RES IN PRESS; Xu LB, 2011, J LIPID RES, V52, P1222, DOI 10.1194/jlr.M014498; Xu LB, 2010, J AM CHEM SOC, V132, P2222, DOI 10.1021/ja9080265; Xu LB, 2009, J AM CHEM SOC, V131, P13037, DOI 10.1021/ja9029076	59	74	74	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33021	33028		10.1074/jbc.M111.282434	http://dx.doi.org/10.1074/jbc.M111.282434			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813643	Green Published, hybrid			2022-12-27	WOS:000294968800020
J	Diercke, K; Kohl, A; Lux, CJ; Erber, R				Diercke, Katja; Kohl, Annette; Lux, Christopher J.; Erber, Ralf			Strain-dependent Up-regulation of Ephrin-B2 Protein in Periodontal Ligament Fibroblasts Contributes to Osteogenesis during Tooth Movement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPH RECEPTORS; VASCULAR DEVELOPMENT; GENE-EXPRESSION; RHO GTPASES; ACTIVATION; CELLS; STRESS; KINASES; MECHANOTRANSDUCTION; PHOSPHORYLATION	During orthodontic tooth movement, the application of adequate orthodontic forces allows teeth to be moved through the alveolar bone. These forces are transmitted through the periodontal ligaments (PDL) to the supporting alveolar bone and lead to deposition or resorption of bone, depending on whether the tissues are exposed to a tensile or compressive mechanical strain. Fibroblasts within the PDL (PDLF) are considered to be mechanoresponsive. The transduction mechanisms from mechanical loading of the PDLF to the initiation of bone remodeling are not clearly understood. Recently, members of the ephrin/Eph family have been shown to be involved in the regulation of bone homeostasis. For the first time, we demonstrate that PDLF exposed to tensile strain induce the expression of ephrin-B2 via a FAK-, Ras-, ERK1/2-, and SP1-dependent pathway. Osteoblasts of the alveolar bone stimulated with ephrin-B2 increased their osteoblastogenic gene expression and showed functional signs of osteoblastic differentiation. In a physiological setting, ephrin-B2-EphB4 signaling between PDLF and osteoblasts of the alveolar bone might contribute to osteogenesis at tension sites during orthodontic tooth movement.	[Diercke, Katja; Kohl, Annette; Lux, Christopher J.; Erber, Ralf] Univ Heidelberg, Sch Dent, Dept Orthodont & Dentofacial Orthopaed, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Erber, R (corresponding author), Univ Heidelberg, Sch Dent, Dept Orthodont & Dentofacial Orthopaed, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	ralf.erber@med.uni-heidelberg.de	Erber, Ralf/AAF-3002-2020	Lux, Christopher J./0000-0002-6995-5572				Abumiya T, 2002, ARTERIOSCL THROM VAS, V22, P907, DOI 10.1161/01.ATV.0000018300.43492.83; Adams RH, 2000, TRENDS CARDIOVAS MED, V10, P183, DOI 10.1016/S1050-1738(00)00046-3; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; BASDRA EK, 1995, BBA-MOL CELL RES, V1268, P209, DOI 10.1016/0167-4889(95)00090-F; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Dalla Costa AP, 2010, CARDIOVASC RES, V86, P421, DOI 10.1093/cvr/cvp416; de Oliveira MV, 2009, FEBS LETT, V583, P2975, DOI 10.1016/j.febslet.2009.08.022; Diercke K, 2011, J DENT RES, V90, P1108, DOI 10.1177/0022034511413926; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Erber R, 2006, EMBO J, V25, P628, DOI 10.1038/sj.emboj.7600949; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; HASEGAWA S, 1985, CALCIFIED TISSUE INT, V37, P431, DOI 10.1007/BF02553714; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Holder N, 2000, E SCHERING RES FDN W, V29, P123; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kawarizadeh A, 2005, J DENT RES, V84, P902, DOI 10.1177/154405910508401006; Kono SJ, 2007, BONE, V40, P68, DOI 10.1016/j.bone.2006.07.024; Kook SH, 2009, J CELL BIOCHEM, V106, P1060, DOI 10.1002/jcb.22085; Korff T, 2008, BLOOD, V112, P73, DOI 10.1182/blood-2007-12-128835; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Li BS, 1999, EUR J BIOCHEM, V262, P211, DOI 10.1046/j.1432-1327.1999.00372.x; Liedert A, 2006, BIOCHEM BIOPH RES CO, V342, P1070, DOI 10.1016/j.bbrc.2006.02.063; Martin TJ, 2010, ADV EXP MED BIOL, V658, P51, DOI 10.1007/978-1-4419-1050-9_6; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Mundy GR, 2006, CELL, V126, P441, DOI 10.1016/j.cell.2006.07.015; Myshkin E, 2003, J CHEM INF COMP SCI, V43, P1004, DOI 10.1021/ci0256586; Obi S, 2009, J APPL PHYSIOL, V106, P203, DOI 10.1152/japplphysiol.00197.2008; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Sohl M, 2010, BIOCHEM BIOPH RES CO, V391, P24, DOI 10.1016/j.bbrc.2009.10.146; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Urbich C, 2003, FEBS LETT, V535, P87, DOI 10.1016/S0014-5793(02)03879-6; Wescott DC, 2007, J DENT RES, V86, P1212, DOI 10.1177/154405910708601214; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Zhang SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2057, DOI 10.1152/ajpcell.00493.2006; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	42	38	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37651	37664		10.1074/jbc.M110.166900	http://dx.doi.org/10.1074/jbc.M110.166900			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880727	Green Published, hybrid			2022-12-27	WOS:000296542400062
J	Lin, LYC; Rakic, B; Chiu, CPC; Lameignere, E; Wakarchuk, WW; Withers, SG; Strynadka, NCJ				Lin, Leo Y. -C.; Rakic, Bojana; Chiu, Cecilia P. C.; Lameignere, Emilie; Wakarchuk, Warren W.; Withers, Stephen G.; Strynadka, Natalie C. J.			Structure and Mechanism of the Lipooligosaccharide Sialyltransferase from Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PASTEURELLA-MULTOCIDA; CATALYTIC MECHANISM; BIOSYNTHETIC-PATHWAY; MOLECULAR MIMICRY; SERUM RESISTANCE; GLYCOSYLTRANSFERASES; ACCEPTOR; COMPLEX; BINDING	The first x-ray crystallographic structure of a CAZY family-52 glycosyltransferase, that of the membrane associated alpha 2,3/alpha 2,6 lipooligosaccharide sialyltransferase from Neisseria meningitidis serotype L1 (NST), has been solved to 1.95 angstrom resolution. The structure of NST adopts a GT-B-fold common with other glycosyltransferase (GT) families but exhibits a novel domain swap of the N-terminal 130 residues to create a functional homodimeric form not observed in any other class to date. The domain swap is mediated at the structural level by a loop-helix-loop extension between residues Leu-108 and Met-130 (we term the swapping module) and a unique lipid-binding domain. NST catalyzes the creation of alpha 2,3- or 2,6-linked oligosaccharide products from a CMP-sialic acid (Neu5Ac) donor and galactosyl-containing acceptor sugars. Our structures of NST bound to the non-hydrolyzable substrate analog CMP-3F((axial))-Neu5Ac show that the swapping module from one monomer of NST mediates the binding of the donor sugar in a composite active site formed at the dimeric interface. Kinetic analysis of designed point mutations observed in the CMP-3F((axial))-Neu5Ac binding site suggests potential roles of a requisite general base (Asp-258) and general acid (His-280) in the NST catalytic mechanism. A long hydrophobic tunnel adjacent to the dimer interface in each of the two monomers contains electron density for two extended linear molecules that likely belong to either the two fatty acyl chains of a diglyceride lipid or the two polyethylene glycol groups of the detergent Triton X-100. In this work, Triton X-100 maintains the activity and increases the solubility of NST during purification and is critical to the formation of ordered crystals. Together, the mechanistic implications of the NST structure provide insight into lipooligosaccharide sialylation with respect to the association of substrates and the essential membrane-anchored nature of NST on the bacterial surface.	[Lin, Leo Y. -C.; Chiu, Cecilia P. C.; Lameignere, Emilie; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Lin, Leo Y. -C.; Chiu, Cecilia P. C.; Lameignere, Emilie; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Rakic, Bojana; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Wakarchuk, Warren W.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; National Research Council Canada	Strynadka, NCJ (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca	Wakarchuk, Warren/AAO-2774-2020; Wakarchuk, Warren/Q-9514-2017	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Rakic, Bojana/0000-0002-3460-6081	Canadian Institutes of Health Research [MOP84272]; Howard Hughes Medical Institute; Michael Smith Foundation for Health Research; NSERC; Canada Foundation for Innovation; British Columbia Knowledge Development Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund	This work was supported by Canadian Institutes of Health Research Operating Grant MOP84272 (to N. C. J. S., W. W. W., and S. G. W.), the Howard Hughes Medical Institute International Scholar Program (to N. C. J. S.), scholarship funding from the Michael Smith Foundation for Health Research (to L. Y.-C. L. and C. P. C. C.), postdoctoral fellowship from the NSERC (to B. R.), and infrastructure funding from the Canada Foundation for Innovation and the British Columbia Knowledge Development Fund.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bolam DN, 2007, P NATL ACAD SCI USA, V104, P5336, DOI 10.1073/pnas.0607897104; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cebo C, 2001, J BIOL CHEM, V276, P5685, DOI 10.1074/jbc.M008662200; Chen JQ, 2002, J MOL MICROB BIOTECH, V4, P519; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; Fromme R, 2007, BIOCHEMISTRY-US, V46, P9199, DOI 10.1021/bi700666m; Gilbert M, 1997, EUR J BIOCHEM, V249, P187, DOI 10.1111/j.1432-1033.1997.t01-1-00187.x; Gilbert M, 1996, J BIOL CHEM, V271, P28271, DOI 10.1074/jbc.271.45.28271; Gulati S, 2005, INFECT IMMUN, V73, P7390, DOI 10.1128/IAI.73.11.7390-7397.2005; Gunawan J, 2005, J BIOL CHEM, V280, P3555, DOI 10.1074/jbc.M411942200; Hadden JM, 2001, NAT STRUCT BIOL, V8, P62; Hare S, 2006, J MOL BIOL, V360, P56, DOI 10.1016/j.jmb.2006.04.060; Houliston RS, 2007, BIOCHEMISTRY-US, V46, P8164, DOI 10.1021/bi700685s; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Izumi M, 2001, J AM CHEM SOC, V123, P10909, DOI 10.1021/ja011382r; Jennings MP, 1995, MOL MICROBIOL, V18, P729, DOI 10.1111/j.1365-2958.1995.mmi_18040729.x; Kahler CM, 1998, INFECT IMMUN, V66, P5939, DOI 10.1128/IAI.66.12.5939-5947.1998; Kakuta Y, 2008, GLYCOBIOLOGY, V18, P66, DOI 10.1093/glycob/cwm119; Kaniuk NA, 2002, MOL MICROBIOL, V46, P1305, DOI 10.1046/j.1365-2958.2002.03243.x; Kim DU, 2008, BMB REP, V41, P48; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LASKY LA, 1995, ANNU REV BIOCHEM, V64, P113, DOI 10.1146/annurev.bi.64.070195.000553; Lewis RJ, 2000, J MOL BIOL, V297, P757, DOI 10.1006/jmbi.2000.3598; Liaw SH, 2004, J BIOL CHEM, V279, P35479, DOI 10.1074/jbc.M405304200; MANDRELL RE, 1993, MICROB PATHOGENESIS, V14, P307, DOI 10.1006/mpat.1993.1030; MANDRELL RE, 1993, IMMUNOBIOLOGY, V187, P382, DOI 10.1016/S0171-2985(11)80352-9; Mittler M, 2007, J MOL BIOL, V372, P67, DOI 10.1016/j.jmb.2007.06.005; Moran AP, 1996, FEMS IMMUNOL MED MIC, V16, P105, DOI 10.1111/j.1574-695X.1996.tb00127.x; Mulichak AM, 2004, BIOCHEMISTRY-US, V43, P5170, DOI 10.1021/bi036130c; Mulichak AM, 2003, P NATL ACAD SCI USA, V100, P9238, DOI 10.1073/pnas.1233577100; Mulichak AM, 2001, STRUCTURE, V9, P547, DOI 10.1016/S0969-2126(01)00616-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEWCOMER ME, 1981, J BIOL CHEM, V256, P3218; Ni LS, 2007, BIOCHEMISTRY-US, V46, P6288, DOI 10.1021/bi700346w; Ni LS, 2006, BIOCHEMISTRY-US, V45, P2139, DOI 10.1021/bi0524013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Preston A, 1996, CRIT REV MICROBIOL, V22, P139, DOI 10.3109/10408419609106458; Qu CX, 2000, STRUCTURE, V8, P1095, DOI 10.1016/S0969-2126(00)00508-6; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Rest RF, 1995, MICROB PATHOGENESIS, V19, P379, DOI 10.1006/mpat.1995.0073; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Shell DM, 2002, INFECT IMMUN, V70, P3744, DOI 10.1128/IAI.70.7.3744-3751.2002; Sun W, 2006, J BIOL CHEM, V281, P12919, DOI 10.1074/jbc.M511986200; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; WAKARCHUK WW, 1994, PROTEIN SCI, V3, P467; Wakarchuk WW, 1998, EUR J BIOCHEM, V254, P626, DOI 10.1046/j.1432-1327.1998.2540626.x; Wakarchuk WW, 2001, J BIOL CHEM, V276, P12785, DOI 10.1074/jbc.M011293200; Yu H, 2004, BIOORGAN MED CHEM, V12, P6427, DOI 10.1016/j.bmc.2004.09.030; Yuki N, 2000, CELL MOL LIFE SCI, V57, P527, DOI 10.1007/PL00000714	58	31	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37237	37248		10.1074/jbc.M111.249920	http://dx.doi.org/10.1074/jbc.M111.249920			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880735	Green Published, hybrid			2022-12-27	WOS:000296542400024
J	Tiden, AK; Sjogren, T; Svensson, M; Bernlind, A; Senthilmohan, R; Auchere, F; Norman, H; Markgren, PO; Gustavsson, S; Schmidt, S; Lundquist, S; Forbes, LV; Magon, NJ; Paton, LN; Jameson, GNL; Eriksson, H; Kettle, AJ				Tiden, Anna-Karin; Sjogren, Tove; Svensson, Mats; Bernlind, Alexandra; Senthilmohan, Revathy; Auchere, Francoise; Norman, Henrietta; Markgren, Per-Olof; Gustavsson, Susanne; Schmidt, Staffan; Lundquist, Stefan; Forbes, Louisa V.; Magon, Nicholas J.; Paton, Louise N.; Jameson, Guy N. L.; Eriksson, Hakan; Kettle, Anthony J.			2-Thioxanthines Are Mechanism-based Inactivators of Myeloperoxidase That Block Oxidative Stress during Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORSERADISH-PEROXIDASE; HYPOCHLOROUS ACID; REDOX PROPERTIES; SUPEROXIDE; KINETICS; ENZYME; 3-CHLOROTYROSINE; CHLORINATION; INHIBITION; CHLORIDE	Myeloperoxidase (MPO) is a prime candidate for promoting oxidative stress during inflammation. This abundant enzyme of neutrophils uses hydrogen peroxide to oxidize chloride to highly reactive and toxic chlorine bleach. We have identified 2-thioxanthines as potent mechanism-based inactivators of MPO. Mass spectrometry and x-ray crystal structures revealed that these inhibitors become covalently attached to the heme prosthetic groups of the enzyme. We propose a mechanism whereby 2-thioxanthines are oxidized, and their incipient free radicals react with the heme groups of the enzyme before they can exit the active site. 2-Thioxanthines inhibited MPO in plasma and decreased protein chlorination in a mouse model of peritonitis. They slowed but did not prevent neutrophils from killing bacteria and were poor inhibitors of thyroid peroxidase. Our study shows that MPO is susceptible to the free radicals it generates, and this Achilles' heel of the enzyme can be exploited to block oxidative stress during inflammation.	[Senthilmohan, Revathy; Auchere, Francoise; Forbes, Louisa V.; Magon, Nicholas J.; Paton, Louise N.; Kettle, Anthony J.] Univ Otago Christchurch, Free Rad Res Grp, Dept Pathol, Christchurch 8140, New Zealand; [Svensson, Mats; Bernlind, Alexandra; Norman, Henrietta; Markgren, Per-Olof; Gustavsson, Susanne; Schmidt, Staffan; Lundquist, Stefan; Eriksson, Hakan] AstraZeneca R&D, SE-15185 Sodertalje, Sweden; [Sjogren, Tove] AstraZeneca R&D, SE-43183 Molndal, Sweden; [Jameson, Guy N. L.] Univ Otago, Dept Chem, Dunedin 9054, New Zealand; [Tiden, Anna-Karin] AstraZeneca R&D, Leicester LE11, Leics, England	University of Otago; AstraZeneca; AstraZeneca; University of Otago; AstraZeneca	Kettle, AJ (corresponding author), Univ Otago Christchurch, Free Rad Res Grp, Dept Pathol, POB 4345, Christchurch 8140, New Zealand.	tony.kettle@otago.ac.nz	Kettle, Anthony J/A-8520-2008; Jameson, Guy N. L./J-3258-2015; Ashby, Louisa/GRN-9388-2022	Kettle, Anthony J/0000-0002-8218-7766; Jameson, Guy N. L./0000-0001-9416-699X; Ashby, Louisa/0000-0001-8247-096X; Paton, Louise N/0000-0002-7055-5170	AstraZeneca	AstraZeneca(AstraZeneca)	A.-K. T., T. S., M. S., A. B., H. N., P.-O. M., S. G., S. S., S. L., and H. E. were employed by AstraZeneca when involved in this study. The following authors own stocks or stock options of AstraZeneca plc.: H. E., A.-K. T., T. S., P.-O. M., H. N., A. B., M. S., S. S., S. G., and S. L. A. J. K. received financial support from AstraZeneca to conduct this research.	Arnhold J, 2001, EUR J BIOCHEM, V268, P5142, DOI 10.1046/j.0014-2956.2001.02449.x; ATOR MA, 1987, J BIOL CHEM, V262, P14954; ATOR MA, 1989, J BIOL CHEM, V264, P9250; ATOR MA, 1987, J BIOL CHEM, V262, P1542; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Burner U, 1999, J BIOL CHEM, V274, P9494, DOI 10.1074/jbc.274.14.9494; Buss IH, 2003, PEDIATR RES, V53, P455, DOI 10.1203/01.PDR.0000050655.25689.CE; CHESNEY JA, 1991, ANAL BIOCHEM, V196, P262, DOI 10.1016/0003-2697(91)90463-4; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Dypbukt JM, 2005, FREE RADICAL BIO MED, V39, P1468, DOI 10.1016/j.freeradbiomed.2005.07.008; Erve JCL, 2004, CHEM RES TOXICOL, V17, P564, DOI 10.1021/tx034238n; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2003, BIOCHEM BIOPH RES CO, V301, P551, DOI 10.1016/S0006-291X(02)03075-9; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298; Green Jessie N., 2007, V412, P319, DOI 10.1007/978-1-59745-467-4_21; Hampton MB, 1996, INFECT IMMUN, V64, P3512, DOI 10.1128/IAI.64.9.3512-3517.1996; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hope HR, 2000, PROTEIN EXPRES PURIF, V18, P269, DOI 10.1006/prep.1999.1197; Jantschko W, 2005, BIOCHEM PHARMACOL, V69, P1149, DOI 10.1016/j.bcp.2005.02.006; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kettle AJ, 2004, AM J RESP CRIT CARE, V170, P1317, DOI 10.1164/rccm.200311-1516OC; KETTLE AJ, 1995, BIOCHEM J, V308, P559, DOI 10.1042/bj3080559; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; KETTLE AJ, 1991, BIOCHEM PHARMACOL, V41, P1485, DOI 10.1016/0006-2952(91)90565-M; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; KETTLE AJ, 1993, BIOCHEM PHARMACOL, V45, P2003, DOI 10.1016/0006-2952(93)90010-T; Kettle AJ, 2007, BIOCHEMISTRY-US, V46, P4888, DOI 10.1021/bi602587k; Klebanoff S.J., 1999, INFLAMMATION BASIC P, P721; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KLEBANOFF SJ, 1970, SCIENCE, V169, P1095, DOI 10.1126/science.169.3950.1095; Koelsch M, 2010, BIOCHEM PHARMACOL, V79, P1156, DOI 10.1016/j.bcp.2009.11.024; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; MARQUEZ LA, 1994, J BIOL CHEM, V269, P7950; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; Mocatta TJ, 2007, J AM COLL CARDIOL, V49, P1993, DOI 10.1016/j.jacc.2007.02.040; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Nordvall G, 2003, Patent No. [WO/2003/089430, 2003089430, WO 2003089430 A1 20031030]; Pullar JM, 2000, IUBMB LIFE, V50, P259, DOI 10.1080/15216540051080958; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; SUBRAHMANYAM VV, 1987, CHEM-BIOL INTERACT, V61, P45, DOI 10.1016/0009-2797(87)90018-4; TAYLOR KL, 1995, ARCH BIOCHEM BIOPHYS, V316, P635, DOI 10.1006/abbi.1995.1083; vanDalen CJ, 1997, BIOCHEM J, V327, P487; WALEY SG, 1985, BIOCHEM J, V227, P843, DOI 10.1042/bj2270843; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200	53	124	127	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37578	37589		10.1074/jbc.M111.266981	http://dx.doi.org/10.1074/jbc.M111.266981			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880720	Green Published, hybrid			2022-12-27	WOS:000296542400056
J	Amosova, O; Smith, A; Fresco, JR				Amosova, Olga; Smith, Alexander; Fresco, Jacques R.			The Consensus Sequence for Self-catalyzed Site-specific G Residue Depurination in DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGONUCLEOTIDES; CONFORMATION; DEPENDENCE; STABILITY	The sequence variation tolerated within the stem-loop-forming genomic consensus sequence for self-catalyzed site-specific depurination of G residues is explored. The variation in self-depurination kinetics with sequence changes in the loop residues and stem base pairs, as well as with pH, provides insights into the self-catalytic mechanism. The observations suggest that self-catalyzed depurination of the 5' G residue of the loop consensus sequence 5'-G(T/A)GG-3' probably involves formation of some intraloop hydrogen-bonded base pair with the 3'-terminal G residue; although the electronic structure of both these G residues is retained, their 2-amino substituents are not critical for that interaction. The strong dependence of the self-depurination kinetics on stem stability suggests that the lifetime of some strained form of the loop is controlled by the integrity of the stem. In addition to the effects of length and base pair sequence on stem stability, there is a base pair requirement at the base of the loop: self-depurination is suppressed by 5'-C.G-3', 5'-A.T-3', or a mismatch but is most favored by 5'T.A3' and less so by 5'-G.C-3'. The occurrence in T and G of a similarly located carbonyl capable of hydrogen-bonding to the water molecule required for glycosyl bond hydrolysis may explain this sequence requirement. In toto, the more complete definition of the consensus sequence provided by this investigation enables a more accurate estimation of their number in the human genome and their distribution among different genes.	[Amosova, Olga; Smith, Alexander; Fresco, Jacques R.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Fresco, JR (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	jrfresco@princeton.edu			National Institutes of Health [5R01HL63888, 4R33CA88547]; U. S. Army Research Office [W911NF-07-1-0152]; Higgins Trust; NATIONAL CANCER INSTITUTE [R33CA088547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Army Research Office; Higgins Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants 5R01HL63888 and 4R33CA88547, by U. S. Army Research Office Grant W911NF-07-1-0152, and by the Higgins Trust. The previous paper in this series is Ref. 1.	Amosova O, 2006, P NATL ACAD SCI USA, V103, P4392, DOI 10.1073/pnas.0508499103; Amosova O, 2011, J BIOL CHEM, V286, P36322, DOI 10.1074/jbc.M111.272112; BLAKE RD, 1973, BIOPOLYMERS, V12, P775, DOI 10.1002/bip.1973.360120407; BRAHMS J, 1967, J MOL BIOL, V25, P465, DOI 10.1016/0022-2836(67)90199-4; BROWN T, 1990, J MOL BIOL, V212, P437, DOI 10.1016/0022-2836(90)90320-L; Cantor C. R., 1980, BIOPHYSICAL CHEM 3; DAYN A, 1992, NUCLEIC ACIDS RES, V20, P5991, DOI 10.1093/nar/20.22.5991; Dill K. A, 2002, MOL DRIVING FORCES S, V418; Fresco JR, 2011, EVOLUTIONARY BIOLOGY: CONCEPTS, BIODIVERSITY, MACROEVOLUTION AND GENOME EVOLUTION, P3, DOI 10.1007/978-3-642-20763-1_1; FRESCO JR, 1960, NATURE, V188, P98, DOI 10.1038/188098a0; FRESCO JR, 1960, P NATL ACAD SCI USA, V46, P311, DOI 10.1073/pnas.46.3.311; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Kurahashi H, 2004, J BIOL CHEM, V279, P35377, DOI 10.1074/jbc.M400354200; Lhomme J, 1999, BIOPOLYMERS, V52, P65, DOI 10.1002/1097-0282(1999)52:2<65::AID-BIP1>3.0.CO;2-U; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; LIPSETT MN, 1960, BIOCHIM BIOPHYS ACTA, V41, P175, DOI 10.1016/0006-3002(60)90394-2; Lomant A J, 1975, Prog Nucleic Acid Res Mol Biol, V15, P185, DOI 10.1016/S0079-6603(08)60120-8; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; MARMUR J, 1959, NATURE, V183, P1427, DOI 10.1038/1831427a0; Marnett LJ, 2001, TRENDS GENET, V17, P214, DOI 10.1016/S0168-9525(01)02239-9; McEwan NR, 1997, BIOTECHNOL TECH, V11, P727, DOI 10.1023/A:1018436132644; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; ORNSTEIN RL, 1983, BIOPOLYMERS, V22, P1979, DOI 10.1002/bip.360220811; PURRELLO R, 1993, J AM CHEM SOC, V115, P760, DOI 10.1021/ja00055a056; SUGIYAMA H, 1994, CHEM RES TOXICOL, V7, P673, DOI 10.1021/tx00041a013; SUZUKI T, 1994, NUCLEIC ACIDS RES, V22, P4997, DOI 10.1093/nar/22.23.4997; TAMM C, 1952, J BIOL CHEM, V195, P49; TOPAL MD, 1976, NATURE, V263, P289, DOI 10.1038/263289a0	29	8	9	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36316	36321		10.1074/jbc.M111.272047	http://dx.doi.org/10.1074/jbc.M111.272047			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21868376	Green Published, hybrid			2022-12-27	WOS:000296538300016
J	Boll, B; Taubitz, T; Heide, L				Boll, Bjoern; Taubitz, Tatjana; Heide, Lutz			Role of MbtH-like Proteins in the Adenylation of Tyrosine during Aminocoumarin and Vancomycin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-COELICOLOR; PEPTIDE SYNTHETASES; GENE-CLUSTER; NONRIBOSOMAL BIOSYNTHESIS; CRYSTAL-STRUCTURE; ANTIBIOTICS; CLONING; DOMAIN; ACTIVATION; MECHANISM	MbtH-like proteins consist of similar to 70 amino acids and are encoded in the biosynthetic gene clusters of non-ribosomally formed peptides and other secondary metabolites derived from amino acids. Recently, several MbtH-like proteins have been shown to be required for the adenylation of amino acid in non-ribosomal peptide synthesis. We now investigated the role of MbtH-like proteins in the biosynthesis of the aminocoumarin antibiotics novobiocin, clorobiocin, and simocyclinone D8 and of the glycopeptide antibiotic vancomycin. The tyrosine-adenylating enzymes CloH, SimH, and Pcza361.18, involved in the biosynthesis of clorobiocin, simocyclinone D8, and vancomycin, respectively, required the presence of MbtH-like proteins in a 1: 1 molar ratio, forming heterotetrameric complexes. In contrast, NovH, involved in novobiocin biosynthesis, showed activity in the absence of MbtH-like proteins. Comparison of the active centers of CloH and NovH showed only one amino acid to be different, i.e. Leu-383 versus Met-383. Mutation of this amino acid in CloH (L383M) indeed led to MbtH-independent adenylating activity. All investigated tyrosine-adenylating enzymes exhibited remarkable promiscuity for MbtH-like proteins from different pathways and organisms. YbdZ, the MbtH-like protein from the expression host Escherichia coli, was found to bind to adenylating enzymes during expression and to influence their biochemical properties markedly. Therefore, the use of ybdZ-deficient expression hosts is important in biochemical studies of adenylating enzymes.	[Boll, Bjoern; Taubitz, Tatjana; Heide, Lutz] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Heide, L (corresponding author), Univ Tubingen, Inst Pharmazeut, Morgenstelle 8, D-72076 Tubingen, Germany.	heide@uni-tuebingen.de	Taubitz, Tatjana/AAA-2941-2021; Boll, Björn/AAJ-2892-2020	Taubitz, Tatjana/0000-0002-6747-4484; Heide, Lutz/0000-0001-7809-7453	Deutsche Forschungsgemeinschaft [SFB 766]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 766.	Alt S, 2011, CHEM BIOL, V18, P304, DOI 10.1016/j.chembiol.2010.12.016; Baltz RH, 2011, J IND MICROBIOL BIOT, V38, P1747, DOI 10.1007/s10295-011-1022-8; Buchko GW, 2010, TUBERCULOSIS, V90, P245, DOI 10.1016/j.tube.2010.04.002; Chen HW, 2001, CHEM BIOL, V8, P301, DOI 10.1016/S1074-5521(01)00009-6; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Drake EJ, 2007, J BIOL CHEM, V282, P20425, DOI 10.1074/jbc.M611833200; Dybkaer R, 2002, CLIN CHEM, V48, P586; Felnagle EA, 2010, BIOCHEMISTRY-US, V49, P8815, DOI 10.1021/bi1012854; Galm U, 2002, ARCH MICROBIOL, V178, P102, DOI 10.1007/s00203-002-0429-z; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Heide L, 2009, BIOTECHNOL ADV, V27, P1006, DOI 10.1016/j.biotechadv.2009.05.017; Heide L, 2009, NAT PROD REP, V26, P1241, DOI 10.1039/b808333a; Hojati Z, 2002, CHEM BIOL, V9, P1175, DOI 10.1016/S1074-5521(02)00252-1; Imker HJ, 2010, CHEM BIOL, V17, P1077, DOI 10.1016/j.chembiol.2010.08.007; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; Koglin A, 2009, NAT PROD REP, V26, P987, DOI 10.1039/b904543k; Lautru S, 2004, MICROBIOL-SGM, V150, P1629, DOI 10.1099/mic.0.26837-0; Lautru S, 2007, MICROBIOL-SGM, V153, P1405, DOI 10.1099/mic.0.2006/003145-0; Mulyani S, 2010, CHEMBIOCHEM, V11, P266, DOI 10.1002/cbic.200900600; Pojer F, 2002, MICROBIOL-SGM, V148, P3901, DOI 10.1099/00221287-148-12-3901; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Recktenwald J, 2002, MICROBIOL-SGM, V148, P1105, DOI 10.1099/00221287-148-4-1105; Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004; STACHELHAUS T, 1995, J BIOL CHEM, V270, P6163, DOI 10.1074/jbc.270.11.6163; Steffensky M, 2000, J BIOL CHEM, V275, P21754, DOI 10.1074/jbc.M003066200; Steffensky M, 2000, ANTIMICROB AGENTS CH, V44, P1214, DOI 10.1128/AAC.44.5.1214-1222.2000; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Wolpert M, 2007, MICROBIOL-SGM, V153, P1413, DOI 10.1099/mic.0.2006/002998-0; Wu R, 2009, BIOCHEMISTRY-US, V48, P4115, DOI 10.1021/bi9002327; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200; Zhang WJ, 2010, BIOCHEMISTRY-US, V49, P9946, DOI 10.1021/bi101539b	31	55	56	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36281	36290		10.1074/jbc.M111.288092	http://dx.doi.org/10.1074/jbc.M111.288092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21890635	Green Published, hybrid			2022-12-27	WOS:000296538300012
J	Hamdane, D; Argentini, M; Cornu, D; Myllykallio, H; Skouloubris, S; Hui-Bon-Hoa, G; Golinelli-Pimpaneau, B				Hamdane, Djemel; Argentini, Manuela; Cornu, David; Myllykallio, Hannu; Skouloubris, Stephane; Hui-Bon-Hoa, Gaston; Golinelli-Pimpaneau, Beatrice			Insights into Folate/FAD-dependent tRNA Methyltransferase Mechanism ROLE OF TWO HIGHLY CONSERVED CYSTEINES IN CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-PRESSURE CRYSTALLOGRAPHY; HYDROSTATIC-PRESSURE; THYMIDYLATE SYNTHASE; CYSTEINE RESIDUES; BACILLUS-SUBTILIS; NMR-SPECTROSCOPY; PROTEINS MNME; SUBSTRATE; GIDA; IDENTIFICATION	The flavoprotein TrmFO methylates specifically the C5 carbon of the highly conserved uridine 54 in tRNAs. Contrary to most methyltransferases, the 1- carbon unit transferred by TrmFO derives from 5,10-methylenetetrahydrofolate and not from S-adenosyl-L-methionine. The enzyme also employs the FAD hydroquinone as a reducing agent of the C5 methylene U54-tRNA intermediate in vitro. By analogy with the catalytic mechanism of thymidylate synthase ThyA, a conserved cysteine located near the FAD isoalloxazine ring was proposed to act as a nucleophile during catalysis. Here, we mutated this residue(Cys-53 in Bacillus subtilis TrmFO) to alanine and investigated its functional role. Biophysical characterization of this variant demonstrated the major structural role of Cys-53 in maintaining both the integrity and plasticity of the flavin binding site. Unexpectedly, gel mobility shift assays showed that, like the wild-type enzyme, the inactive C53A variant was capable of forming a covalent complex with a 5-fluorouridine-containing mini-RNA. This result confirms the existence of a covalent intermediate during catalysis but rules out a nucleophilic role for Cys-53. To identify the actual nucleophile, two other strictly conserved cysteines (Cys-192 and Cys-226) that are relatively far from the active site were replaced with alanine, and a double mutant C53A/C226A was generated. Interestingly, only mutations that target Cys-226 impeded TrmFO from forming a covalent complex and methylating tRNA. Altogether, we propose a revised mechanism for the m(5)U54 modification catalyzed by TrmFO, where Cys-226 attacks the C6 atom of the uridine, and Cys-53 plays the role of the general base abstracting the C5 proton.	[Golinelli-Pimpaneau, Beatrice] CNRS, Ctr Rech Gif, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Argentini, Manuela; Cornu, David] CNRS, Ctr Rech Gif, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France; [Myllykallio, Hannu; Skouloubris, Stephane] Ecole Polytech, CNRS, INSERM, Lab Opt & Biosci, F-91128 Palaiseau, France; [Hui-Bon-Hoa, Gaston] INSERM, U779, F-94275 Le Kremlin Bicetre, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)		hamdane@lebs.cnrs-gif.fr; beatrice.golinelli@lebs.cnrs-gif.fr	Golinelli, Beatrice/ABB-8347-2021; Myllykallio, Hannu/Y-5462-2019	Golinelli, Beatrice/0000-0001-8248-4704; Skouloubris, Stephane/0000-0001-6660-0023; Myllykallio, Hannu/0000-0002-0541-1197	Agence Nationale de la Recherche [PCV07_189094]; CNRS	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by THYMET Grant PCV07_189094 from the Agence Nationale de la Recherche and by CNRS.	Akasaka K, 2006, CHEM REV, V106, P1814, DOI 10.1021/cr040440z; Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; Chimnaronk S, 2009, BIOCHEMISTRY-US, V48, P5057, DOI 10.1021/bi900337d; Collins MD, 2007, J MOL BIOL, V367, P752, DOI 10.1016/j.jmb.2006.12.021; Collins MD, 2005, P NATL ACAD SCI USA, V102, P16668, DOI 10.1073/pnas.0508224102; Day R, 2008, PROTEINS, V70, P1175, DOI 10.1002/prot.21562; DELK AS, 1980, J BIOL CHEM, V255, P4387; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Finer-Moore JS, 2003, BIOCHEMISTRY-US, V42, P248, DOI 10.1021/bi020599a; Frye KJ, 1998, PROTEIN SCI, V7, P2217, DOI 10.1002/pro.5560071020; Geddes CD, 2001, ANAL BIOCHEM, V293, P60, DOI 10.1006/abio.2001.5103; Girard E, 2010, BIOPHYS J, V98, P2365, DOI 10.1016/j.bpj.2010.01.058; Grosjean H, 2007, METHOD ENZYMOL, V425, P57, DOI 10.1016/S0076-6879(07)25003-7; GU XG, 1992, BIOCHEMISTRY-US, V31, P10295, DOI 10.1021/bi00157a017; Guelorget A, 2011, STRUCTURE, V19, P282, DOI 10.1016/j.str.2011.01.005; Hamdane D, 2005, J BIOL CHEM, V280, P36809, DOI 10.1074/jbc.M506253200; Hamdane D, 2007, J BIOL CHEM, V282, P6398, DOI 10.1074/jbc.M610543200; Hamdane D, 2011, BIOCHEMISTRY-US, V50, P5208, DOI 10.1021/bi1019463; Hamdane D, 2010, PROTEIN EXPRES PURIF, V73, P83, DOI 10.1016/j.pep.2010.04.013; Hummer G, 1998, P NATL ACAD SCI USA, V95, P1552, DOI 10.1073/pnas.95.4.1552; JUNG C, 1995, EUR J BIOCHEM, V233, P600, DOI 10.1111/j.1432-1033.1995.600_2.x; Kamatari YO, 2001, EUR J BIOCHEM, V268, P1782, DOI 10.1046/j.1432-1327.2001.02050.x; KEALEY JT, 1995, BIOCHEMISTRY-US, V34, P2441, DOI 10.1021/bi00008a006; KEALEY JT, 1991, BIOCHEMISTRY-US, V30, P9724, DOI 10.1021/bi00104a022; KEALEY JT, 1994, BIOCHIMIE, V76, P1133, DOI 10.1016/0300-9084(94)90042-6; King MY, 2002, BIOCHEMISTRY-US, V41, P11218, DOI 10.1021/bi026055q; Koehn EM, 2009, NATURE, V458, P919, DOI 10.1038/nature07973; KUNDROT CE, 1988, J MOL BIOL, V200, P401, DOI 10.1016/0022-2836(88)90249-5; Leduc D, 2004, P NATL ACAD SCI USA, V101, P7252, DOI 10.1073/pnas.0401365101; Liu YQ, 2000, P NATL ACAD SCI USA, V97, P8263, DOI 10.1073/pnas.97.15.8263; Meyer S, 2008, J MOL BIOL, V380, P532, DOI 10.1016/j.jmb.2008.04.072; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; Nakanishi K, 2009, NATURE, V461, P1144, DOI 10.1038/nature08474; Nishimasu H, 2009, P NATL ACAD SCI USA, V106, P8180, DOI 10.1073/pnas.0901330106; Osawa T, 2009, STRUCTURE, V17, P713, DOI 10.1016/j.str.2009.03.013; Pan H, 2003, P NATL ACAD SCI USA, V100, P12648, DOI 10.1073/pnas.2135585100; Phannachet K, 2004, NUCLEIC ACIDS RES, V32, P1422, DOI 10.1093/nar/gkh287; Royer CA, 2002, BBA-PROTEIN STRUCT M, V1595, P201, DOI 10.1016/S0167-4838(01)00344-2; Scrima A, 2005, EMBO J, V24, P23, DOI 10.1038/sj.emboj.7600507; Seif E, 2009, J BIOL CHEM, V284, P6600, DOI 10.1074/jbc.C800235200; Shi R, 2009, J BACTERIOL, V191, P7614, DOI 10.1128/JB.00650-09; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Urayama P, 2002, STRUCTURE, V10, P51, DOI 10.1016/S0969-2126(01)00699-2; Urbonavicius J, 2005, NUCLEIC ACIDS RES, V33, P3955, DOI 10.1093/nar/gki703; von Ehrenstein G, 1967, METHOD ENZYMOL, V12, P588; Walbott H, 2007, RNA, V13, P967, DOI 10.1261/rna.515707; Wilton DJ, 2008, PROTEINS, V71, P1432, DOI 10.1002/prot.21832; Wilton DJ, 2009, BIOPHYS J, V97, P1482, DOI 10.1016/j.bpj.2009.06.022; Winter R, 2002, BBA-PROTEIN STRUCT M, V1595, P160, DOI 10.1016/S0167-4838(01)00342-9; Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752; Zhang HM, 2009, J BIOL CHEM, V284, P25678, DOI 10.1074/jbc.M109.032748	54	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36268	36280		10.1074/jbc.M111.256966	http://dx.doi.org/10.1074/jbc.M111.256966			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21846722	Green Published, hybrid			2022-12-27	WOS:000296538300011
J	Jemel, I; Ii, H; Oslund, RC; Payre, C; Dabert-Gay, AS; Douguet, D; Chargui, K; Scarzello, S; Gelb, MH; Lambeau, G				Jemel, Ikram; Ii, Hiromi; Oslund, Rob C.; Payre, Christine; Dabert-Gay, Anne-Sophie; Douguet, Dominique; Chargui, Khaoula; Scarzello, Sabine; Gelb, Michael H.; Lambeau, Gerard			Group X Secreted Phospholipase A(2) Proenzyme Is Matured by a Furin-like Proprotein Convertase and Releases Arachidonic Acid inside of Human HEK293 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-V; MAMMALIAN-CELLS; COMPLETE SET; GROUP-II; EXPRESSION; BINDING; PROTEIN; ENZYMES; MICE; PROPHOSPHOLIPASE	Among mammalian secreted phospholipases A(2) (sPLA(2)s), group X sPLA(2) has the most potent hydrolyzing activity toward phosphatidylcholine and is involved in arachidonic acid (AA) release. Group X sPLA(2) is produced as a proenzyme and contains a short propeptide of 11 amino acids ending with a dibasic motif, suggesting cleavage by proprotein convertases. Although the removal of this propeptide is clearly required for enzymatic activity, the cellular location and the protease(s) involved in proenzyme conversion are unknown. Here we have analyzed the maturation of group X sPLA(2) in HEK293 cells, which have been extensively used to analyze sPLA(2)-induced AA release. Using recombinant mouse (PromGX) and human (ProhGX) proenzymes; HEK293 cells transfected with cDNAs coding for full-length ProhGX, PromGX, and propeptide mutants; and various permeable and non-permeable sPLA(2) inhibitors and protease inhibitors, we demonstrate that group X sPLA(2) is mainly converted intracellularly and releases AA before externalization from the cell. Most strikingly, the exogenous proenzyme does not elicit AA release, whereas the transfected proenzyme does elicit AA release in a way insensitive to non-permeable sPLA(2) inhibitors. In transfected cells, a permeable proprotein convertase inhibitor, but not a non-permeable one, prevents group X sPLA(2) maturation and partially blocks AA release. Mutations at the dibasic motif of the propeptide indicate that the last basic residue is required and sufficient for efficient maturation and AA release. All together, these results argue for the intracellular maturation of group X proenzyme in HEK293 cells by a furin-like proprotein convertase, leading to intracellular release of AA during secretion.	[Jemel, Ikram; Payre, Christine; Dabert-Gay, Anne-Sophie; Douguet, Dominique; Chargui, Khaoula; Scarzello, Sabine; Lambeau, Gerard] CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, F-06560 Valbonne, France; [Jemel, Ikram; Payre, Christine; Dabert-Gay, Anne-Sophie; Douguet, Dominique; Chargui, Khaoula; Scarzello, Sabine; Lambeau, Gerard] Univ Nice Sophia Antipolis, F-06560 Valbonne, France; [Ii, Hiromi; Oslund, Rob C.; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gelb, MH (corresponding author), Univ Washington, Dept Chem, Campus Box 351700,36 Bagley Hall, Seattle, WA 98195 USA.	gelb@chem.washington.edu; lambeau@ipmc.cnrs.fr	douguet, dominique/D-5644-2017; Lambeau, Gerard/GRJ-5624-2022	Lambeau, Gerard/0000-0002-9239-518X; gelb, michael/0000-0001-7000-5219; Payre, Christine/0000-0003-3640-5061	National Institutes of Health [R37HL36235]; CNRS; Association pour la Recherche sur le Cancer; Agence Nationale de la Recherche; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R37HL36235 (to M.H.G.). This work was also supported by CNRS (to G.L.), the Association pour la Recherche sur le Cancer (to G.L.), and the Agence Nationale de la Recherche (to G.L.).	ABITA JP, 1972, EUR J BIOCHEM, V30, P37, DOI 10.1111/j.1432-1033.1972.tb02069.x; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; Bezzine S, 2002, J BIOL CHEM, V277, P48523, DOI 10.1074/jbc.M203137200; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Epstein TM, 2001, BIOCHEMISTRY-US, V40, P11411, DOI 10.1021/bi011228h; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Ghosh M, 2007, J BIOL CHEM, V282, P11676, DOI 10.1074/jbc.M608458200; Gorski JP, 2011, J BIOL CHEM, V286, P1836, DOI 10.1074/jbc.M110.151647; Gracy J, 2005, NUCLEIC ACIDS RES, V33, pW65, DOI 10.1093/nar/gki455; Han WK, 2003, J BIOL CHEM, V278, P24153, DOI 10.1074/jbc.M300424200; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; Izidoro MA, 2009, ARCH BIOCHEM BIOPHYS, V487, P105, DOI 10.1016/j.abb.2009.05.013; Kuwata H, 1998, J BIOL CHEM, V273, P1733, DOI 10.1074/jbc.273.3.1733; Lai Y, 2010, J BIOL CHEM, V285, P41491, DOI 10.1074/jbc.M110.153338; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Masuda S, 2005, J BIOL CHEM, V280, P23203, DOI 10.1074/jbc.M500985200; Masuda S, 2005, BIOCHEM J, V387, P27, DOI 10.1042/BJ20041307; Morioka Y, 2000, ARCH BIOCHEM BIOPHYS, V381, P31, DOI 10.1006/abbi.2000.1977; Mounier CM, 2004, J BIOL CHEM, V279, P25024, DOI 10.1074/jbc.M313019200; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; NAKANO T, 1994, BIOCHEM BIOPH RES CO, V198, P10, DOI 10.1006/bbrc.1994.1002; Nevalainen TJ, 2005, BBA-MOL CELL BIOL L, V1733, P210, DOI 10.1016/j.bbalip.2004.12.012; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Oslund RC, 2008, J MED CHEM, V51, P4708, DOI 10.1021/jm800422v; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; Pan YH, 2002, J BIOL CHEM, V277, P29086, DOI 10.1074/jbc.M202531200; Rae D., 1996, SCAND J GASTROENTE S, V219, P24; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; Rouault M, 2007, BIOCHEMISTRY-US, V46, P1647, DOI 10.1021/bi062119b; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Schadow A, 2001, J INVEST DERMATOL, V116, P31, DOI 10.1046/j.1523-1747.2001.00179.x; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Seeds MC, 2000, AM J RESP CELL MOL, V23, P37, DOI 10.1165/ajrcmb.23.1.4034; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Singh DK, 2007, J LIPID RES, V48, P683, DOI 10.1194/jlr.M600421-JLR200; Surrel F, 2009, MOL PHARMACOL, V76, P778, DOI 10.1124/mol.108.053371; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Valentin E, 1999, J BIOL CHEM, V274, P31195, DOI 10.1074/jbc.274.44.31195; Valentin E, 1999, J BIOL CHEM, V274, P19152, DOI 10.1074/jbc.274.27.19152; VERGER R, 1973, J BIOL CHEM, V248, P4023; VERHEIJ HM, 1981, REV PHYSIOL BIOCH P, V91, P91; Xu W, 2009, J BIOL CHEM, V284, P16659, DOI 10.1074/jbc.M808029200	55	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36509	36521		10.1074/jbc.M111.268540	http://dx.doi.org/10.1074/jbc.M111.268540			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878635	hybrid, Green Published			2022-12-27	WOS:000296538300036
J	Harper, CB; Martin, S; Nguyen, TH; Daniels, SJ; Lavidis, NA; Popoff, MR; Hadzic, G; Mariana, A; Chau, N; McCluskey, A; Robinson, PJ; Meunier, FA				Harper, Callista B.; Martin, Sally; Nguyen, Tam H.; Daniels, Shari J.; Lavidis, Nickolas A.; Popoff, Michel R.; Hadzic, Gordana; Mariana, Anna; Chau, Ngoc; McCluskey, Adam; Robinson, Phillip J.; Meunier, Frederic A.			Dynamin Inhibition Blocks Botulinum Neurotoxin Type A Endocytosis in Neurons and Delays Botulism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILIZED CHROMAFFIN CELLS; SMALL-MOLECULE INHIBITORS; MOTOR-NERVE TERMINALS; TOXIN TYPE-A; SYNAPTIC VESICLES; PROTEIN-RECEPTOR; NEUROTRANSMITTER RELEASE; MULTIVESICULAR BODIES; MEDIATED ENDOCYTOSIS; BIOLOGICAL WEAPON	The botulinum neurotoxins (BoNTs) are di-chain bacterial proteins responsible for the paralytic disease botulism. Following binding to the plasma membrane of cholinergic motor nerve terminals, BoNTs are internalized into an endocytic compartment. Although several endocytic pathways have been characterized in neurons, the molecular mechanism underpinning the uptake of BoNTs at the presynaptic nerve terminal is still unclear. Here, a recombinant BoNT/A heavy chain binding domain (Hc) was used to unravel the internalization pathway by fluorescence and electron microscopy. BoNT/A-Hc initially enters cultured hippocampal neurons in an activity-dependent manner into synaptic vesicles and clathrin-coated vesicles before also entering endosomal structures and multivesicular bodies. We found that inhibiting dynamin with the novel potent Dynasore analog, Dyngo-4a (TM), was sufficient to abolish BoNT/A-Hc internalization and BoNT/A-induced SNAP25 cleavage in hippocampal neurons. Dyngo-4a also interfered with BoNT/A-Hc internalization into motor nerve terminals. Furthermore, Dyngo-4a afforded protection against BoNT/A-induced paralysis at the rat hemidiaphragm. A significant delay of >30% in the onset of botulism was observed in mice injected with Dyngo-4a. Dynamin inhibition therefore provides a therapeutic avenue for the treatment of botulism and other diseases caused by pathogens sharing dynamin-dependent uptake mechanisms.	[Harper, Callista B.; Martin, Sally; Nguyen, Tam H.; Daniels, Shari J.; Meunier, Frederic A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Lavidis, Nickolas A.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, F-75724 Paris, France; [Hadzic, Gordana; McCluskey, Adam] Univ Newcastle, Ctr Chem Biol, Callaghan, NSW 2308, Australia; [Mariana, Anna; Chau, Ngoc; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Sydney, NSW 2145, Australia	University of Queensland; University of Queensland; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Newcastle; Children's Medical Research Institute - Australia; University of Sydney	Meunier, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	f.meunier@uq.edu.au	Robinson, Phillip J/G-4008-2011; McCluskey, Adam/F-1894-2011; Martin, Sally/A-7150-2010; Meunier, Frederic A/C-8161-2009; Nguyen, Tam/H-3423-2011; Popoff, Michel/O-7719-2016	Robinson, Phillip J/0000-0002-7878-0313; McCluskey, Adam/0000-0001-7125-863X; Martin, Sally/0000-0001-9294-5404; Meunier, Frederic A/0000-0001-6400-1107; Popoff, Michel/0000-0001-9305-8989	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian National Health and Medical Research Council. Dyngo-4a (TM) and Dyngo (TM) are trademarks of the authors' institutions and affiliates, the Children's Medical Research Institute and Newcastle Innovation, Ltd. (the commercial arm of the University of Newcastle), which have entered into a commercial license agreement with Ascent Scientific, Ltd. (Bristol, United Kingdom) to market and distribute Dyngo-4a as a research tool globally.	Antonucci F, 2008, J NEUROSCI, V28, P3689, DOI 10.1523/JNEUROSCI.0375-08.2008; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; BLACK JD, 1986, J CELL BIOL, V103, P521, DOI 10.1083/jcb.103.2.521; BLACK JD, 1986, J CELL BIOL, V103, P535, DOI 10.1083/jcb.103.2.535; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Chen S, 2011, J BIOL CHEM, V286, P15067, DOI 10.1074/jbc.M111.224493; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Couesnon A, 2009, CELL MICROBIOL, V11, P289, DOI 10.1111/j.1462-5822.2008.01253.x; Darios F, 2010, P NATL ACAD SCI USA, V107, P18197, DOI 10.1073/pnas.1007125107; de Paiva A, 1999, P NATL ACAD SCI USA, V96, P3200, DOI 10.1073/pnas.96.6.3200; DEHOOP MJ, 1994, NEURON, V13, P11, DOI 10.1016/0896-6273(94)90456-1; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; DOLLY JO, 1984, NATURE, V307, P457, DOI 10.1038/307457a0; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Douthitt HL, 2011, NEUROSCIENCE, V172, P187, DOI 10.1016/j.neuroscience.2010.10.002; Ekong TAN, 1997, MICROBIOL-SGM, V143, P3337, DOI 10.1099/00221287-143-10-3337; Eubanks LM, 2007, P NATL ACAD SCI USA, V104, P2602, DOI 10.1073/pnas.0611213104; Fischer A, 2009, P NATL ACAD SCI USA, V106, P1330, DOI 10.1073/pnas.0812839106; Foran P, 1996, BIOCHEMISTRY-US, V35, P2630, DOI 10.1021/bi9519009; Foran PG, 2003, TRENDS MOL MED, V9, P291, DOI 10.1016/S1471-4914(03)00113-8; Foran PG, 2003, J BIOL CHEM, V278, P1363, DOI 10.1074/jbc.M209821200; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; Gibert M, 2011, CELL MICROBIOL, V13, P154, DOI 10.1111/j.1462-5822.2010.01527.x; Hayashi M, 2008, P NATL ACAD SCI USA, V105, P2175, DOI 10.1073/pnas.0712171105; Hill T, 2005, J MED CHEM, V48, P7781, DOI 10.1021/jm040208l; Hill TA, 2004, BIOORG MED CHEM LETT, V14, P3275, DOI 10.1016/j.bmcl.2004.03.096; Hill TA, 2010, J MED CHEM, V53, P4094, DOI 10.1021/jm100119c; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lalli G, 1999, J CELL SCI, V112, P2715; LAWRENCE GW, 1994, EUR J BIOCHEM, V222, P325, DOI 10.1111/j.1432-1033.1994.tb18871.x; Lawrence GW, 1996, EUR J BIOCHEM, V236, P877, DOI 10.1111/j.1432-1033.1996.00877.x; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Meunier FA, 2000, J CELL SCI, V113, P1119; Meunier FA, 2002, EMBO J, V21, P6733, DOI 10.1093/emboj/cdf677; Meunier FA, 2003, MOL CELL NEUROSCI, V22, P454, DOI 10.1016/S1044-7431(02)00016-7; Meunier FA, 1997, NEUROSCIENCE, V78, P883, DOI 10.1016/S0306-4522(96)00568-4; Meunier FA, 2010, J CELL SCI, V123, P1131, DOI 10.1242/jcs.049296; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; NISHIKI T, 1994, J BIOL CHEM, V269, P10498; Odell LR, 2010, J MED CHEM, V53, P5267, DOI 10.1021/jm100442u; Osborne SL, 2007, J NEUROSCI RES, V85, P1149, DOI 10.1002/jnr.21171; Pang YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010129; Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pust S, 2010, CELL MICROBIOL, V12, P1809, DOI 10.1111/j.1462-5822.2010.01512.x; Raciborska DA, 1999, CAN J PHYSIOL PHARM, V77, P679, DOI 10.1139/cjpp-77-9-679; Roxas-Duncan V, 2009, ANTIMICROB AGENTS CH, V53, P3478, DOI 10.1128/AAC.00141-09; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; Rusnak JM, 2009, HUM VACCINES, V5, P794, DOI 10.4161/hv.9420; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; SIMPSON LL, 1973, NEUROPHARMACOLOGY, V12, P165, DOI 10.1016/0028-3908(73)90085-3; SIMPSON LL, 1971, J NEUROCHEM, V18, P1751, DOI 10.1111/j.1471-4159.1971.tb03750.x; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; SLOT JW, 1981, J CELL BIOL, V90, P533, DOI 10.1083/jcb.90.2.533; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; Wen PJ, 2008, MOL BIOL CELL, V19, P5593, DOI 10.1091/mbc.E08-06-0595; Woodman PG, 2008, CURR OPIN CELL BIOL, V20, P408, DOI 10.1016/j.ceb.2008.04.001; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yeh FL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001207	71	113	119	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35966	35976		10.1074/jbc.M111.283879	http://dx.doi.org/10.1074/jbc.M111.283879			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21832053	Green Published, hybrid			2022-12-27	WOS:000295927100070
J	Lee, HJ; Lairson, LL; Rich, JR; Lameignere, E; Wakarchuk, WW; Withers, SG; Strynadka, NCJ				Lee, Ho Jun; Lairson, Luke L.; Rich, Jamie R.; Lameignere, Emilie; Wakarchuk, Warren W.; Withers, Stephen G.; Strynadka, Natalie C. J.			Structural and Kinetic Analysis of Substrate Binding to the Sialyltransferase Cst-II from Campylobacter jejuni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUILLAIN-BARRE-SYNDROME; SIALIC ACIDS; N-ACETYLGLUCOSAMINE; NEISSERIA-MENINGITIDIS; GANGLIOSIDE MIMICS; MECHANISM; ACCEPTOR; GLYCOSYLTRANSFERASE; BIOSYNTHESIS; SPECIFICITY	Background: The transfer of sialic acids is catalyzed by a set of sialyltransferases with defined specificities. Results: We solved the ternary complex of the sialyltransferase Cst-II and kinetically characterized its mechanism. Conclusion: Our analysis gives insights into the acceptor specificity and proposes the iso-ordered Bi Bi mechanism. Significance: This work improves our understanding of sialyltransferase structure/function.	[Lee, Ho Jun; Lameignere, Emilie; Withers, Stephen G.; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Lairson, Luke L.; Rich, Jamie R.; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Lee, Ho Jun; Lameignere, Emilie; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Strynadka, Natalie C. J.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Withers, Stephen G.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Wakarchuk, Warren W.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; National Research Council Canada	Strynadka, NCJ (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca	Wakarchuk, Warren/Q-9514-2017; Wakarchuk, Warren/AAO-2774-2020	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Lairson, Luke/0000-0001-6701-996X	Canadian Institutes of Health Research; Howard Hughes Medical Institute; Michael Smith Foundation for Health Research; Canada Foundation for Innovation; B.C. Knowledge Development Fund; Kwanjeong Educational Foundation (Republic of Korea); University of British Columbia	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); B.C. Knowledge Development Fund; Kwanjeong Educational Foundation (Republic of Korea); University of British Columbia	This work was supported in part by operating grants from the Canadian Institutes of Health Research (to N. C. J. S., W. W. W., and S. G. W.) and the Howard Hughes Medical Institute International Scholar Program (to N. C. J. S.), with infrastructure funding from the Michael Smith Foundation for Health Research, the Canada Foundation for Innovation, and the B.C. Knowledge Development Fund.; Supported by scholarships from the Kwanjeong Educational Foundation (Republic of Korea) and the University of British Columbia. Present address: Dept. of Molecular and Cell Biology, University of California, 356 Stanley Hall, Berkeley, CA 94720.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BENDIAK B, 1987, J BIOL CHEM, V262, P5784; Bernatchez S, 2007, GLYCOBIOLOGY, V17, P1333, DOI 10.1093/glycob/cwm090; Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chan PHW, 2009, BIOCHEMISTRY-US, V48, P11220, DOI 10.1021/bi901606n; Chen L, 2002, BIOCHEMISTRY-US, V41, P6824, DOI 10.1021/bi0256678; Chiu CPC, 2007, BIOCHEMISTRY-US, V46, P7196, DOI 10.1021/bi602543d; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cornish-Bowden A., 2004, FUNDAMENTALS ENZYME, P99; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endtz HP, 2000, J CLIN MICROBIOL, V38, P2297; Fromm H. G., 1975, INITIAL RATE ENZYME, P121; Gilbert M, 1997, EUR J BIOCHEM, V249, P187, DOI 10.1111/j.1432-1033.1997.t01-1-00187.x; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Gilbert M, 2000, J BIOL CHEM, V275, P3896, DOI 10.1074/jbc.275.6.3896; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; HarduinLepers A, 1995, GLYCOBIOLOGY, V5, P741, DOI 10.1093/glycob/5.8.741; Kamath VP, 1999, GLYCOCONJUGATE J, V16, P599; KEARNS AE, 1991, BIOCHEMISTRY-US, V30, P7477, DOI 10.1021/bi00244a016; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; Ly HD, 2002, BIOCHEMISTRY-US, V41, P5075, DOI 10.1021/bi012031s; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; MORRISON JF, 1971, J BIOL CHEM, V246, P3977; Murray BW, 1996, BIOCHEMISTRY-US, V35, P11183, DOI 10.1021/bi961065a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Ohrui H., 1988, European Patent, Patent No. [EP0281067A3, 0281067]; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Piszkiewicz D., 1977, KINETICS CHEM ENZYME, P131; Preston A, 1996, CRIT REV MICROBIOL, V22, P139, DOI 10.3109/10408419609106458; RUDOLPH FB, 1971, J BIOL CHEM, V246, P6611; Saez-Llorens X, 2003, LANCET, V361, P2139, DOI 10.1016/S0140-6736(03)13693-8; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Segel I. H., 1975, ENZYME KINETICS, P560; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; SIMON ES, 1988, J AM CHEM SOC, V110, P7159, DOI 10.1021/ja00229a033; Traving C, 1998, CELL MOL LIFE SCI, V54, P1330, DOI 10.1007/s000180050258; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Vyas AA, 2001, BIOCHIMIE, V83, P677, DOI 10.1016/S0300-9084(01)01308-6; WRAGG S, 1995, J BIOL CHEM, V270, P16947, DOI 10.1074/jbc.270.28.16947; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101; Zhang YH, 2006, BIOCHEMISTRY-US, V45, P10895, DOI 10.1021/bi060872z	56	25	25	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35922	35932		10.1074/jbc.M111.261172	http://dx.doi.org/10.1074/jbc.M111.261172			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21832050	hybrid, Green Published			2022-12-27	WOS:000295927100066
J	Marfori, M; Kobe, B; Forwood, JK				Marfori, Mary; Kobe, Bostjan; Forwood, Jade K.			Ligand-induced Conformational Changes within a Hexameric Acyl-CoA Thioesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Acyl-coenzyme A (acyl-CoA) thioesterases play a crucial role in the metabolism of activated fatty acids, coenzyme A, and other metabolic precursor molecules including arachidonic acid and palmitic acid. These enzymes hydrolyze coenzyme A from acyl-CoA esters to mediate a range of cellular functions including beta-oxidation, lipid biosynthesis, and signal transduction. Here, we present the crystal structure of a hexameric hot-dog domain-containing acyl-CoA thioesterase from Bacillus halodurans in the apo-form and provide structural and comparative analyses to the coenzyme A-bound form to identify key conformational changes induced upon ligand binding. We observed dramatic ligand-induced changes at both the hot-dog dimer and the trimer-of-dimer interfaces; the dimer interfaces in the apo-structure differ by over 20% and decrease to about half the size in the ligand-bound state. We also assessed the specificity of the enzyme against a range of fatty acyl-CoA substrates and have identified a preference for short-chain fatty acyl-CoAs. Coenzyme A was shown both to negatively regulate enzyme activity, representing a direct inhibitory feedback, and consistent with the structural data, to destabilize the quaternary structure of the enzyme. Coenzyme A-induced conformational changes in the C-terminal helices of enzyme were assessed through mutational analysis and shown to play a role in regulating enzyme activity. The conformational changes are likely to be conserved from bacteria through to humans and provide a greater understanding, particularly at a structural level, of thioesterase function and regulation.	[Marfori, Mary; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Marfori, Mary; Kobe, Bostjan] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia; [Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2650, Australia	University of Queensland; University of Queensland; University of Queensland; Charles Sturt University	Kobe, B (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	b.kobe@uq.edu.au; jforwood@csu.edu.au	Kobe, Bostjan/D-1292-2009; Forwood, Jade K/K-4123-2014	Kobe, Bostjan/0000-0001-9413-9166; Forwood, Jade K/0000-0003-3267-9997; Christie, Mary/0000-0002-0955-665X	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC)	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded in part by the Australian Research Council (ARC) and the National Health and Medical Research Council (NHMRC).	Adams SH, 2001, BIOCHEM J, V360, P135, DOI 10.1042/bj3600135; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Dalby NO, 2001, CURR OPIN NEUROL, V14, P187, DOI 10.1097/00019052-200104000-00009; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forwood JK, 2007, P NATL ACAD SCI USA, V104, P10382, DOI 10.1073/pnas.0700974104; Gribble FM, 1998, J BIOL CHEM, V273, P26383, DOI 10.1074/jbc.273.41.26383; GRUNDY SM, 1990, J LIPID RES, V31, P1149; Kirkby B, 2010, PROG LIPID RES, V49, P366, DOI 10.1016/j.plipres.2010.04.001; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Mandel CR, 2009, BIOCHEM BIOPH RES CO, V385, P630, DOI 10.1016/j.bbrc.2009.05.122; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Serek R, 2006, ACTA CRYSTALLOGR F, V62, P133, DOI 10.1107/S1744309106000030; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; WELSCH CW, 1992, CANCER RES, V52, pS2040; Willis MA, 2008, BIOCHEMISTRY-US, V47, P2797, DOI 10.1021/bi702336d; YAMADA J, 1994, ARCH BIOCHEM BIOPHYS, V308, P118, DOI 10.1006/abbi.1994.1017; Yokoyama T, 2009, BBA-PROTEINS PROTEOM, V1794, P1073, DOI 10.1016/j.bbapap.2009.03.002	19	9	9	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35643	35649		10.1074/jbc.M111.225953	http://dx.doi.org/10.1074/jbc.M111.225953			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21849495	Green Published, hybrid			2022-12-27	WOS:000295927100036
J	Ahmed, AH; Wang, S; Chuang, HH; Oswald, RE				Ahmed, Ahmed H.; Wang, Shu; Chuang, Huai-Hu; Oswald, Robert E.			Mechanism of AMPA Receptor Activation by Partial Agonists DISULFIDE TRAPPING OF CLOSED LOBE CONFORMATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURES; SUBUNIT; CHANNEL; COMPLEX; CORE; S1S2; ANTAGONISTS; DYNAMICS	The mechanism by which agonist binding to an ionotropic glutamate receptor leads to channel opening is a central issue in molecular neurobiology. Partial agonists are useful tools for studying the activation mechanism because they produce full channel activation with lower probability than full agonists. Structural transitions that determine the efficacy of partial agonists can provide information on the trigger that begins the channel-opening process. The ligand-binding domain of AMPA receptors is a bilobed structure, and the closure of the lobes is associated with channel activation. One possibility is that partial agonists sterically block full lobe closure but that partial degrees of closure trigger the channel with a lower probability. Alternatively, full lobe closure may be required for activation, and the stability of the fully closed state could determine efficacy with the fully closed state having a lower stability when bound to partial relative to full agonists. Disulfide-trapping experiments demonstrated that even extremely low efficacy ligands such as 6-cyano-7-nitroquinoxaline-2,3-dione can produce a full lobe closure, presumably with low probability. The results are consistent the hypothesis that the efficacy is determined at least in part by the stability of the state in which the lobes are fully closed.	[Ahmed, Ahmed H.; Oswald, Robert E.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Wang, Shu; Chuang, Huai-Hu] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Oswald, RE (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14850 USA.	reo1@cornell.edu			National Institutes of Health [R01-GM068935]; National Science Foundation [DMR 0225180]; National Institutes of Health through National Center for Research Resources [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health through National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM068935. This work was also supported in part by research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by National Science Foundation Award DMR 0225180, and by using the Macromolecular Diffraction at the CHESS (MacCHESS) facility, which is supported by National Institutes of Health Award RR-01646, through its National Center for Research Resources.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed AH, 2009, BIOCHEMISTRY-US, V48, P3894, DOI 10.1021/bi900107m; Ahmed AH, 2007, J BIOL CHEM, V282, P12773, DOI 10.1074/jbc.M610077200; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanke ML, 2008, J BIOL CHEM, V283, P21519, DOI 10.1074/jbc.M709190200; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Cokic B, 2008, NEUROPHARMACOLOGY, V54, P1062, DOI 10.1016/j.neuropharm.2008.02.012; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dingledine R, 1999, PHARMACOL REV, V51, P7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenwick MK, 2007, BIOMOL NMR ASSIGN, V1, P241, DOI 10.1007/s12104-007-9067-3; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gill A, 2008, BIOCHEMISTRY-US, V47, P13831, DOI 10.1021/bi8013196; Goddard T. D., SPARKY 3; GOLDIN AL, 1992, METHOD ENZYMOL, V207, P266; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2003, BIOCHEMISTRY-US, V42, P5201, DOI 10.1021/bi020632t; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Kussius CL, 2010, J NEUROSCI, V30, P12474, DOI 10.1523/JNEUROSCI.3337-10.2010; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; Lau AY, 2011, NAT STRUCT MOL BIOL, V18, P283, DOI 10.1038/nsmb.2010; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Mankiewicz KA, 2007, BIOCHEMISTRY-US, V46, P1343, DOI 10.1021/bi062270l; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; More JCA, 2003, BRIT J PHARMACOL, V138, P1093, DOI 10.1038/sj.bjp.0705148; Nanao MH, 2005, P NATL ACAD SCI USA, V102, P1708, DOI 10.1073/pnas.0409573102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poon K, 2011, MOL PHARMACOL, V80, P49, DOI 10.1124/mol.111.071688; Poon K, 2010, BIOPHYS J, V99, P1437, DOI 10.1016/j.bpj.2010.06.058; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Taverna F, 2000, J BIOL CHEM, V275, P8475, DOI 10.1074/jbc.275.12.8475; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Zhang W, 2008, J NEUROSCI, V28, P932, DOI 10.1523/JNEUROSCI.3309-07.2008	48	28	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35257	35266		10.1074/jbc.M111.269001	http://dx.doi.org/10.1074/jbc.M111.269001			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21846932	Green Published, hybrid			2022-12-27	WOS:000295406300078
J	Iozzo, RV; Buraschi, S; Genua, M; Xu, SQ; Solomides, CC; Peiper, SC; Gomella, LG; Owens, RC; Morrione, A				Iozzo, Renato V.; Buraschi, Simone; Genua, Marco; Xu, Shi-Qiong; Solomides, Charalambos C.; Peiper, Stephen C.; Gomella, Leonard G.; Owens, Rick C.; Morrione, Andrea			Decorin Antagonizes IGF Receptor I (IGF-IR) Function by Interfering with IGF-IR Activity and Attenuating Downstream Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; LEUCINE-RICH PROTEOGLYCANS; CANCER-CELLS; TUMOR MICROENVIRONMENT; DOWN-REGULATION; INSULIN; BLADDER; PROTEINS; TRANSFORMATION; DEGRADATION	We have recently discovered that the insulin-like growth factor receptor I (IGF-IR) is up-regulated in human invasive bladder cancer and promotes migration and invasion of transformed urothelial cells. The proteoglycan decorin, a key component of the tumor stroma, can positively regulate the IGF-IR system in normal cells. However, there are no available data on the role of decorin in modulating IGF-IR activity in transformed cells or in tumor models. Here we show that the expression of decorin inversely correlated with IGF-IR expression in low and high grade bladder cancers (n = 20 each). Decorin bound with high affinity IGF-IR and IGF-I at distinct sites and negatively regulated IGF-IR activity in urothelial cancer cells. Nanomolar concentrations of decorin promoted down-regulation of IRS-1, one of the critical proteins of the IGF-IR pathway, and attenuated IGF-I-dependent activation of Akt and MAPK. This led to decorin-evoked inhibition of migration and invasion upon IGF-I stimulation. Notably, decorin did not cause down-regulation of the IGF-IR in bladder, breast, and squamous carcinoma cells. This indicates that decorin action on the IGF-IR differs from its known activity on other receptor tyrosine kinases such as the EGF receptor and Met. Our results provide a novel mechanism for decorin in negatively modulating both IGF-I and its receptor. Thus, decorin loss may contribute to increased IGF-IR activity in the progression of bladder cancer and perhaps other forms of cancer where IGF-IR plays a role.	[Iozzo, Renato V.; Buraschi, Simone; Solomides, Charalambos C.; Peiper, Stephen C.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Iozzo, Renato V.; Buraschi, Simone; Solomides, Charalambos C.; Peiper, Stephen C.] Thomas Jefferson Univ, Kimmel Canc Ctr, Canc Cell Biol & Signaling Program, Philadelphia, PA 19107 USA; [Genua, Marco; Xu, Shi-Qiong; Gomella, Leonard G.; Morrione, Andrea] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Urol & Endocrine Mech, Philadelphia, PA 19107 USA; [Genua, Marco; Xu, Shi-Qiong; Gomella, Leonard G.; Morrione, Andrea] Thomas Jefferson Univ, Kimmel Canc Ctr, Hormone Act Program, Philadelphia, PA 19107 USA; [Owens, Rick C.] LifeCell Corp, Branchburg, NJ 08876 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Ste 336 JAH, Philadelphia, PA 19107 USA.	iozzo@kimmelcancercenter.org; andrea.morrione@jefferson.edu	Iozzo, Renato/AAS-1980-2020; Genua, Marco/J-4159-2018	Genua, Marco/0000-0002-0764-8163; Buraschi, Simone/0000-0002-4233-7627; Iozzo, Renato/0000-0002-5908-5112	National Institutes of Health [RO1 DK068419, RO1 CA39481, RO1 CA47282, RO1 CA120975]; Benjamin Perkins Bladder Cancer Fund; Martin Greitzer Fund; NATIONAL CANCER INSTITUTE [R01CA120975, R01CA039481, R01CA047282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Benjamin Perkins Bladder Cancer Fund; Martin Greitzer Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK068419 (to A. M.) and RO1 CA39481, RO1 CA47282, and RO1 CA120975 (to R. V. I.). This work was also supported by the Benjamin Perkins Bladder Cancer Fund and the Martin Greitzer Fund.	Araki K, 2009, ONCOLOGY-BASEL, V77, P92, DOI 10.1159/000228253; BASERGA R, 1995, CANCER RES, V55, P249; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Baserga R, 1999, J CELL BIOCHEM, P68; Baserga R, 2000, ONCOGENE, V19, P5574, DOI 10.1038/sj.onc.1203854; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Biglari A, 2004, CANCER GENE THER, V11, P721, DOI 10.1038/sj.cgt.7700783; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Doerr ME, 1996, J BIOL CHEM, V271, P2443, DOI 10.1074/jbc.271.5.2443; Dugan TA, 2003, J BIOL CHEM, V278, P13655, DOI 10.1074/jbc.M300171200; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Fiedler LR, 2008, J BIOL CHEM, V283, P17406, DOI 10.1074/jbc.M710025200; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goldoni S, 2008, AM J PATHOL, V173, P844, DOI 10.2353/ajpath.2008.080275; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Guvakova MA, 1997, EXP CELL RES, V231, P149, DOI 10.1006/excr.1996.3457; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; Iacob D, 2008, ENDOCRINOLOGY, V149, P6187, DOI 10.1210/en.2008-0780; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Knowles MA, 2008, INT J CLIN ONCOL, V13, P287, DOI 10.1007/s10147-008-0812-0; Le Roith D, 2000, GROWTH HORM IGF RES, V10, pS12, DOI 10.1016/S1096-6374(00)90005-4; Le Roith D, 1999, ISR MED ASSOC J, V1, P25; Lee AV, 2000, MOL CELL BIOL, V20, P1489, DOI 10.1128/MCB.20.5.1489-1496.2000; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Lovat F, 2009, CARCINOGENESIS, V30, P861, DOI 10.1093/carcin/bgp050; Mauro L, 1999, EXP CELL RES, V252, P439, DOI 10.1006/excr.1999.4639; Merline R, 2009, J PHYSIOL PHARMACOL, V60, P5; Metalli D, 2010, AM J PATHOL, V176, P2997, DOI 10.2353/ajpath.2010.090904; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Miura T, 2006, BIOCHEM BIOPH RES CO, V340, P675, DOI 10.1016/j.bbrc.2005.12.060; Miyake H, 2005, BJU INT, V95, P987, DOI 10.1111/j.1464-410X.2005.05453.x; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Monami G, 2009, AM J PATHOL, V174, P1037, DOI 10.2353/ajpath.2009.080735; Morrione A, 1997, J BIOL CHEM, V272, P26382, DOI 10.1074/jbc.272.42.26382; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Nash MA, 1999, CANCER RES, V59, P6192; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; ROSE DW, 1994, P NATL ACAD SCI USA, V91, P797, DOI 10.1073/pnas.91.2.797; Salani B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014157; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; SASAOKA T, 1994, J BIOL CHEM, V269, P13689; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; SCHER CD, 1979, NATURE, V281, P390, DOI 10.1038/281390a0; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Shintani K, 2008, ONCOL REP, V19, P1533; STILES CD, 1979, J CELL PHYSIOL, V99, P395, DOI 10.1002/jcp.1040990314; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Tralhao JG, 2003, FASEB J, V17, P464, DOI 10.1096/fj.02-0534fje; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3; Yang VWC, 1999, J BIOL CHEM, V274, P12454, DOI 10.1074/jbc.274.18.12454; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200	77	117	122	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34712	34721		10.1074/jbc.M111.262766	http://dx.doi.org/10.1074/jbc.M111.262766			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21840990	Green Published, hybrid			2022-12-27	WOS:000295406300025
J	Wilkinson, K; Boyd, JD; Glicksman, M; Moore, KJ; El Khoury, J				Wilkinson, Kim; Boyd, Justin D.; Glicksman, Marcie; Moore, Kathryn J.; El Khoury, Joseph			A High Content Drug Screen Identifies Ursolic Acid as an Inhibitor of Amyloid beta Protein Interactions with Its Receptor CD36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; SCAVENGER RECEPTOR; HUMAN BRAIN; CLASS-B; INFLAMMATION; MICROGLIA; ASTROCYTES; EXPRESSION; MIGRATION; FIBRILS	A pathological hallmark of Alzheimer disease (AD) is deposition of amyloid beta (A beta) in the brain. A beta binds to microglia via a receptor complex that includes CD36 leading to production of proinflammatory cytokines and neurotoxic reactive oxygen species and subsequent neurodegeneration. Interruption of A beta binding to CD36 is a potential therapeutic strategy for AD. To identify pharmacologic inhibitors of A beta binding to CD36, we developed a 384-well plate assay for binding of fluorescently labeled A beta to Chinese hamster ovary cells stably expressing human CD36 (CHO-CD36) and screened an Food and Drug Administration-approved compound library. The assay was optimized based on the cells' tolerance to dimethyl sulfoxide, A beta concentration, time required for A beta binding, reproducibility, and signal-to-background ratio. Using this assay, we identified four compounds as potential inhibitors of A beta binding to CD36. These compounds were ursolic acid, ellipticine, zoxazolamine, and homomoschatoline. Of these compounds, only ursolic acid, a naturally occurring pentacyclic triterpenoid, successfully inhibited binding of A beta to CHO-CD36 cells in a dose-dependent manner. The ursolic acid effect reached a plateau at similar to 20 mu M, with a maximal inhibition of 64%. Ursolic acid also blocked binding of A beta to microglial cells and subsequent ROS production. Our data indicate that cell-based high-content screening of small molecule libraries for their ability to block binding of A beta to its receptors is a useful tool to identify novel inhibitors of receptors involved in AD pathogenesis. Our data also suggest that ursolic acid is a potential therapeutic agent for AD via its ability to block A beta-CD36 interactions.	[Wilkinson, Kim; El Khoury, Joseph] Harvard Univ, Sch Med, Ctr Immunol & Inflammatory Dis, Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Boyd, Justin D.; Glicksman, Marcie] Brigham & Womens Hosp, Lab Drug Discovery Neurodegenerat, Boston, MA 02139 USA; [Moore, Kathryn J.] NYU, Leon H Charney Div Cardiol, Dept Med, Med Ctr, New York, NY 10016 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; New York University	El Khoury, J (corresponding author), Harvard Univ, Sch Med, Ctr Immunol & Inflammatory Dis, Massachusetts Gen Hosp, Charlestown, MA 02129 USA.	jelkhoury@partners.org	Moore, Kathryn/ABE-6416-2020	Moore, Kathryn/0000-0003-2505-2547; Boyd, Justin/0000-0002-5197-4724	National Institutes of Health through NINDS [NS059005]; National Institutes of Health through NIAID [AI U24AI082660]; National Institutes of Health through NIA [AG032349, AG020255]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI082660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020255, R01AG032349] Funding Source: NIH RePORTER	National Institutes of Health through NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health through NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health through NIA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS059005 through the NINDS and AI U24AI082660 through the NIAID (to J. E. K.), AG032349 through the NIA (to J. E. K. and K. J. M.), and AG020255 through the NIA (to K. J. M.).	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Echeverria V, 2010, J BIOMOL SCREEN, V15, P1144, DOI 10.1177/1087057110378890; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; ElKhoury J, 1996, NATURE, V382, P716; Giuliano KA, 2003, ASSAY DRUG DEV TECHN, V1, P565, DOI 10.1089/154065803322302826; Grant WB, 2004, ARCH NEUROL-CHICAGO, V61, P802, DOI 10.1001/archneur.61.5.802-b; Hill JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012958; Huh HY, 1996, BLOOD, V87, P2020; Husemann J, 2001, AM J PATHOL, V158, P825, DOI 10.1016/S0002-9440(10)64030-8; Ikeda Y, 2007, J IMMUNOL, V178, P4854, DOI 10.4049/jimmunol.178.8.4854; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Kang SY, 2008, J PHARM PHARMACOL, V60, P1347, DOI 10.1211/jpp/60.10.0011; Manez S, 1997, EUR J PHARMACOL, V334, P103, DOI 10.1016/S0014-2999(97)01187-4; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Oakley RH, 2002, ASSAY DRUG DEV TECHN, V1, P21, DOI 10.1089/154065802761001275; Ricciarelli R, 2004, FREE RADICAL BIO MED, V36, P1018, DOI 10.1016/j.freeradbiomed.2004.01.007; Selkoe DJ, 2000, JAMA-J AM MED ASSOC, V283, P1615, DOI 10.1001/jama.283.12.1615; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stuart LM, 2007, J BIOL CHEM, V282, P27392, DOI 10.1074/jbc.M702887200; Thomas CA, 2000, J EXP MED, V191, P147, DOI 10.1084/jem.191.1.147; TOKUDA H, 1986, CANCER LETT, V33, P279, DOI 10.1016/0304-3835(86)90067-4	24	68	71	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34914	34922		10.1074/jbc.M111.232116	http://dx.doi.org/10.1074/jbc.M111.232116			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21835916	hybrid, Green Published			2022-12-27	WOS:000295406300045
J	Milcarek, C; Albring, M; Langer, C; Park, KS				Milcarek, Christine; Albring, Michael; Langer, Creityeka; Park, Kyung Soo			The Eleven-Nineteen Lysine-rich Leukemia Gene (ELL2) Influences the Histone H3 Protein Modifications Accompanying the Shift to Secretory Immunoglobulin Heavy Chain mRNA Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II; TRANSCRIPTION ELONGATION; PLASMA-CELLS; TERMINAL DOMAIN; HIV-1 TAT; COMPLEX; ACTIVATION; FUSION; MLL; PHOSPHORYLATION	In plasma cells, immunoglobulin heavy chain (IgH) secretory-specific mRNA is made in high abundance as a result of both increased promoter proximal poly(A) site choice and weak splice-site skipping. Ell2, the eleven-nineteen lysine rich leukemia gene, is a transcription elongation factor that is induced similar to 6-fold in plasma cells and has been shown to drive secretory-specific mRNA production. Reducing ELL2 by siRNA, which reduced processing to the secretion-specific poly(A) site, also influenced the methylations of histone H3K4 and H3K79 on the IgH gene and impacted positive transcription factor b (pTEFb), Ser-2 carboxyl-terminal phosphorylation, and polyadenylation factor additions to RNA polymerase II. The multiple lineage leukemia gene (MLL) and Dot1L associations with the IgH gene were also impaired in the absence of ELL2. To investigate the link between histone modifications, transcription elongation, and alternative RNA processing in IgH mRNA production, we performed chromatin immunoprecipitation on cultured mouse B and plasma cells bearing the identical IgH gamma 2a gene. In the plasma cells, as compared with the B cells, the H3K4 and H3K79 methylations extended farther downstream, past the IgH enhancer to the end of the transcribed region. Thus the downstream H3K4 and H3K79 methylation of the IgH associated chromatin in plasma cells is associated with increased polyadenylation and exon skipping, resulting from the actions of ELL2 transcription elongation factor.	[Milcarek, Christine; Albring, Michael; Langer, Creityeka; Park, Kyung Soo] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Milcarek, C (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA.	milcarek@pitt.edu			National Science Foundation [MCB-0842725]; National Institutes of Health [5T32 CA82084-12]; Summer Undergraduate and Office of Research programs at the University of Pittsburgh, School of Medicine; NATIONAL CANCER INSTITUTE [T32CA082084] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Summer Undergraduate and Office of Research programs at the University of Pittsburgh, School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Science Foundation Grant MCB-0842725 (to C. M.), National Institutes of Health Grant 5T32 CA82084-12 (to K. S. P.), and the Summer Undergraduate and Office of Research programs at the University of Pittsburgh, School of Medicine.	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Nguyen AT, 2011, BLOOD, V117, P6912, DOI 10.1182/blood-2011-02-334359; Benedikt A, 2011, LEUKEMIA, V25, P135, DOI 10.1038/leu.2010.249; Chakraborty T, 2009, J EXP MED, V206, P1019, DOI 10.1084/jem.20081621; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; de la Mata M, 2010, RNA, V16, P904, DOI 10.1261/rna.1993510; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; GROSSCHEDL R, 1988, CELL, V55, P645, DOI 10.1016/0092-8674(88)90223-1; Gutierrez NC, 2007, LEUKEMIA, V21, P541, DOI 10.1038/sj.leu.2404520; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Luco RF, 2011, CURR OPIN GENET DEV, V21, P366, DOI 10.1016/j.gde.2011.03.004; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Luse DS, 2011, J BIOL CHEM, V286, P6040, DOI 10.1074/jbc.M110.174722; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Martincic K, 2009, NAT IMMUNOL, V10, P1102, DOI 10.1038/ni.1786; Milcarek C, 1996, MOL IMMUNOL, V33, P691, DOI 10.1016/0161-5890(96)00009-0; Milcarek C., 2011, RNA PROCESS IN PRESS; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Munoz MJ, 2010, TRENDS BIOCHEM SCI, V35, P497, DOI 10.1016/j.tibs.2010.03.010; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Peterson ML, 2002, MOL CELL BIOL, V22, P5606, DOI 10.1128/MCB.22.15.5606-5615.2002; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Sen R, 2010, GENE DEV, V24, P973, DOI 10.1101/gad.1930610; Shell SA, 2007, J IMMUNOL, V179, P7663, DOI 10.4049/jimmunol.179.11.7663; Shilatifard A, 1997, P NATL ACAD SCI USA, V94, P3639, DOI 10.1073/pnas.94.8.3639; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Sugiura N, 2004, EUR J BIOCHEM, V271, P4629, DOI 10.1111/j.1432-1033.2004.04414.x; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024	36	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33795	33803		10.1074/jbc.M111.272096	http://dx.doi.org/10.1074/jbc.M111.272096			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832080	Green Published, hybrid			2022-12-27	WOS:000295159200010
J	Crona, M; Torrents, E; Rohr, AK; Hofer, A; Furrer, E; Tomter, AB; Andersson, KK; Sahlin, M; Sjoberg, BM				Crona, Mikael; Torrents, Eduard; Rohr, Asmund K.; Hofer, Anders; Furrer, Ernst; Tomter, Ane B.; Andersson, K. Kristoffer; Sahlin, Margareta; Sjoberg, Britt-Marie			NrdH-Redoxin Protein Mediates High Enzyme Activity in Manganese-reconstituted Ribonucleotide Reductase from Bacillus anthracis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CORYNEBACTERIUM-AMMONIAGENES; CRYSTAL-STRUCTURE; COFACTOR; SUBUNIT; REVEALS; SYSTEM; GROWTH; GENES; SITE	Bacillus anthracis is a severe mammalian pathogen encoding a class Ib ribonucleotide reductase (RNR). RNR is a universal enzyme that provides the four essential deoxyribonucleotides needed for DNA replication and repair. Almost all Bacillus spp. encode both class Ib and class III RNR operons, but the B. anthracis class III operon was reported to encode a pseudogene, and conceivably class Ib RNR is necessary for spore germination and proliferation of B. anthracis upon infection. The class Ib RNR operon in B. anthracis encodes genes for the catalytic NrdE protein, the tyrosyl radical metalloprotein NrdF, and the flavodoxin protein NrdI. The tyrosyl radical in NrdF is stabilized by an adjacent Mn-2(III) site (Mn-NrdF) formed by the action of the NrdI protein or by a Fe-2(III) site (Fe-NrdF) formed spontaneously from Fe2+ and O-2. In this study, we show that the properties of B. anthracis Mn-NrdF and Fe-NrdF are in general similar for interaction with NrdE and NrdI. Intriguingly, the enzyme activity of Mn-NrdF was approximately an order of magnitude higher than that of Fe-NrdF in the presence of the class Ib-specific physiological reductant NrdH, strongly suggesting that the Mn-NrdF form is important in the life cycle of B. anthracis. Whether the Fe-NrdF form only exists in vitro or whether the NrdF protein in B. anthracis is a true cambialistic enzyme that can work with either manganese or iron remains to be established.	[Crona, Mikael; Torrents, Eduard; Furrer, Ernst; Sahlin, Margareta; Sjoberg, Britt-Marie] Stockholm Univ, Dept Mol Biol & Funct Genom, Arrhenius Labs Nat Sci, SE-10691 Stockholm, Sweden; [Torrents, Eduard] Inst Bioengn Catalonia, ES-08080 Barcelona, Spain; [Rohr, Asmund K.; Tomter, Ane B.; Andersson, K. Kristoffer] Univ Oslo, Dept Mol Biosci, NO-0316 Oslo, Norway; [Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden	Stockholm University; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Oslo; Umea University	Sjoberg, BM (corresponding author), Stockholm Univ, Dept Mol Biol & Funct Genom, Arrhenius Labs Nat Sci, Svante Arrhenius Vag 20C, SE-10691 Stockholm, Sweden.	britt-marie.sjoberg@molbio.su.se	Torrents, Eduard/C-7184-2008; Johnson, Michael D. L./B-4352-2012; Kjendseth, Åsmund Røhr/O-2543-2016	Torrents, Eduard/0000-0002-3010-1609; Kjendseth, Åsmund Røhr/0000-0002-4956-4865; Crona, Mikael/0000-0002-6420-6097; Hofer, Anders/0000-0003-2890-2957; Sjoberg, Britt-Marie/0000-0001-5953-3360	Swedish Cancer Foundation; Swedish Research Council; Spanish Ministerio de Ciencia e Innovacion [PI081062]; ERA-NET PathoGenoMics; Ramon y Cajal program; EMBIO/MLS at the University of Oslo; Carl Trygger Foundation; Research Council of Norway [177661/V30]; Norwegian Cancer Society	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ERA-NET PathoGenoMics; Ramon y Cajal program(Spanish Government); EMBIO/MLS at the University of Oslo; Carl Trygger Foundation; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from the Swedish Cancer Foundation and the Swedish Research Council (to B.-M. S.), from the Fondo de Investigacion Sanitaria from the Spanish Ministerio de Ciencia e Innovacion (Grant PI081062), the ERA-NET PathoGenoMics, and the Ramon y Cajal program (to E. T.), from the EMBIO/MLS at the University of Oslo to (to angstrom. K. R.), from the Carl Trygger Foundation (to A. H.), and from the Research Council of Norway (Grants 177661/V30) and Norwegian Cancer Society (to K. K. A.).	Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Crona M, 2010, PROTEIN ENG DES SEL, V23, P633, DOI 10.1093/protein/gzq035; Fieschi F, 1998, J BIOL CHEM, V273, P4329, DOI 10.1074/jbc.273.8.4329; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Hartig E, 2006, APPL ENVIRON MICROB, V72, P5260, DOI 10.1128/AEM.00599-06; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Johansson R, 2010, FEBS J, V277, P4265, DOI 10.1111/j.1742-4658.2010.07815.x; Jordan A, 1996, J BIOL CHEM, V271, P8779, DOI 10.1074/jbc.271.15.8779; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; MAGNUSSON KE, 1976, BIOTECHNOL BIOENG, V18, P865, DOI 10.1002/bit.260180608; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Nord D, 2007, J BACTERIOL, V189, P5293, DOI 10.1128/JB.00234-07; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Roca I, 2008, J BACTERIOL, V190, P4849, DOI 10.1128/JB.00185-08; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; Rohr A. K., 2010, THESIS U OSLO OSLO N; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Sjoberg BM, 2010, SCIENCE, V329, P1475, DOI 10.1126/science.1196347; Thelander L, 1978, Methods Enzymol, V51, P227; Tomter A. B., 2010, THESIS U OSLO OSLO N; Tomter AB, 2008, BIOCHEMISTRY-US, V47, P11300, DOI 10.1021/bi801212f; Torrents E, 2005, P NATL ACAD SCI USA, V102, P17946, DOI 10.1073/pnas.0506410102; Torrents E, 2003, MICROBIOL-SGM, V149, P1011, DOI 10.1099/mic.0.26133-0; Torrents E, 2008, RIBONUCLEOTIDE REDUC, P17; Torrents E, 2010, BIOL CHEM, V391, P229, DOI [10.1515/BC.2010.017, 10.1515/bc.2010.017]; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Yang FD, 1997, J BACTERIOL, V179, P6408, DOI 10.1128/jb.179.20.6408-6415.1997; Zhang Y, 2011, BIOCHEMISTRY-US, V50, P5615, DOI 10.1021/bi200348q	41	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33053	33060		10.1074/jbc.M111.278119	http://dx.doi.org/10.1074/jbc.M111.278119			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21832039	Green Published, hybrid			2022-12-27	WOS:000294968800024
J	Nickerson, NN; Tosi, T; Dessen, A; Baron, B; Raynal, B; England, P; Pugsley, AP				Nickerson, Nicholas N.; Tosi, Tommaso; Dessen, Andrea; Baron, Bruno; Raynal, Bertrand; England, Patrick; Pugsley, Anthony P.			Outer Membrane Targeting of Secretin PulD Protein Relies on Disordered Domain Recognition by a Dedicated Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; SECONDARY STRUCTURE ANALYSES; PILUS BIOGENESIS; INNER MEMBRANE; PULLULANASE; MULTIMERIZATION; LIPOPROTEINS; FLAGELLIN; PATHWAY; POLYMERIZATION	Interaction of bacterial outer membrane secretin PulD with its dedicated lipoprotein chaperone PulS relies on a disorder-to-order transition of the chaperone binding (S) domain near the PulD C terminus. PulS interacts with purified S domain to form a 1:1 complex. Circular dichroism, one-dimensional NMR, and hydrodynamic measurements indicate that the S domain is elongated and intrinsically disordered but gains secondary structure upon binding to PulS. Limited proteolysis and mass spectrometry identified the 28 C-terminal residues of the S domain as a minimal binding site with low nanomolar affinity for PulS in vitro that is sufficient for outer membrane targeting of PulD in vivo. The region upstream of this binding site is not required for targeting or multimerization and does not interact with PulS, but it is required for secretin function in type II secretion. Although other secretin chaperones differ substantially from PulS in sequence and secondary structure, they have all adopted at least superficially similar mechanisms of interaction with their cognate secretins, suggesting that intrinsically disordered regions facilitate rapid interaction between secretins and their chaperones.	[Nickerson, Nicholas N.; Pugsley, Anthony P.] Inst Pasteur, Mol Genet Unit, Dept Microbiol, F-75724 Paris 15, France; [Nickerson, Nicholas N.; Pugsley, Anthony P.] CNRS, URA2172, F-75015 Paris, France; [Tosi, Tommaso; Dessen, Andrea] Univ Grenoble 1, Inst Biol Struct, Bacterial Pathogenesis Grp, F-38027 Grenoble, France; [Tosi, Tommaso; Dessen, Andrea] CNRS, UMR 5075, F-38027 Grenoble, France; [Tosi, Tommaso; Dessen, Andrea] Commissariat Energie Atom, F-38027 Grenoble, France; [Baron, Bruno; Raynal, Bertrand; England, Patrick] Inst Pasteur, Proteopole & Struct Biol & Chem Dept, F-75015 Paris, France; [Baron, Bruno; Raynal, Bertrand; England, Patrick] CNRS, URA2185, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Pugsley, AP (corresponding author), Inst Pasteur, Mol Genet Unit, Dept Microbiol, 28 Rue Dr Roux, F-75724 Paris 15, France.	max@pasteur.fr		raynal, Bertrand/0000-0001-5634-0408; ENGLAND, Patrick/0000-0001-6410-5918; Dessen, Andrea/0000-0001-6487-4020	French National Research Agency [ANR-05-0307-01, ANR-09-BLAN-0291]; Canadian Louis Pasteur Foundation	French National Research Agency(French National Research Agency (ANR)); Canadian Louis Pasteur Foundation	This work was supported in part by French National Research Agency Grants ANR-05-0307-01 and ANR-09-BLAN-0291.; Supported by a postdoctoral fellowship from the Canadian Louis Pasteur Foundation during part of this work.	AIZAWA SI, 1990, J MOL BIOL, V211, P673, DOI 10.1016/0022-2836(90)90064-S; Arts J., 2007, THESIS UTRECHT U UTR; Bayan N, 2006, MOL MICROBIOL, V60, P1, DOI 10.1111/j.1365-2958.2006.05084.x; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Buchko GW, 2010, MOL BIOSYST, V6, P2448, DOI 10.1039/c0mb00097c; Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Collin S, 2011, MOL MICROBIOL, V80, P655, DOI 10.1111/j.1365-2958.2011.07596.x; Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; DENFERT C, 1989, J BIOL CHEM, V264, P17462; DENFERT C, 1987, MOL MICROBIOL, V1, P107, DOI 10.1111/j.1365-2958.1987.tb00534.x; DENFERT C, 1989, J BACTERIOL, V171, P3673, DOI 10.1128/jb.171.7.3673-3679.1989; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; England P, 1997, BIOCHEMISTRY-US, V36, P164, DOI 10.1021/bi961419y; Francetic O, 2005, J BACTERIOL, V187, P7045, DOI 10.1128/JB.187.20.7045-7055.2005; Guilvout I, 1999, J BACTERIOL, V181, P7212, DOI 10.1128/JB.181.23.7212-7220.1999; Guilvout I, 2008, J MOL BIOL, V382, P13, DOI 10.1016/j.jmb.2008.06.055; Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402; Guilvout I, 2011, RES MICROBIOL, V162, P180, DOI 10.1016/j.resmic.2011.01.006; Hardie KR, 1996, MOL MICROBIOL, V22, P967, DOI 10.1046/j.1365-2958.1996.01539.x; Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x; HARDING SE, 1995, BIOPHYS CHEM, V55, P69, DOI 10.1016/0301-4622(94)00143-8; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Karst JC, 2010, BIOCHEMISTRY-US, V49, P318, DOI 10.1021/bi9016389; Kim K, 2006, BIOCHEM BIOPH RES CO, V340, P1028, DOI 10.1016/j.bbrc.2005.12.108; Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; KOSTYUKOVA AS, 1988, FEBS LETT, V241, P141, DOI 10.1016/0014-5793(88)81047-0; Lario PI, 2005, EMBO J, V24, P1111, DOI 10.1038/sj.emboj.7600610; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Login FH, 2010, MOL MICROBIOL, V76, P944, DOI 10.1111/j.1365-2958.2010.07149.x; Lu YL, 2006, BIOPHYS J, V91, P1688, DOI 10.1529/biophysj.106.083469; MATSUYAMA S, 1995, EMBO J, V14, P3365, DOI 10.1002/j.1460-2075.1995.tb07342.x; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Okon M, 2008, STRUCTURE, V16, P1544, DOI 10.1016/j.str.2008.08.006; Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Pugsley AP, 2001, J BACTERIOL, V183, P1312, DOI 10.1128/JB.183.4.1312-1319.2001; Qu J, 2007, J MOL BIOL, V374, P91, DOI 10.1016/j.jmb.2007.09.020; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200; Ruiz-Perez F, 2010, GUT MICROBES, V1, P339, DOI 10.4161/gmic.1.5.13436; Ruiz-Perez F, 2009, J BACTERIOL, V191, P6571, DOI 10.1128/JB.00754-09; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schuch R, 2001, J BACTERIOL, V183, P6991, DOI 10.1128/JB.183.24.6991-6998.2001; Shevchik VE, 1998, MICROBIOL-UK, V144, P3219, DOI 10.1099/00221287-144-11-3219; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SWINT L, 1993, PROTEIN SCI, V2, P2037, DOI 10.1002/pro.5560021205; TARTOF KD, 1987, FOCUS, V9, P12; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Trindade MB, 2008, J MOL BIOL, V378, P1031, DOI 10.1016/j.jmb.2008.03.028; Uversky V. N., 2010, INSTRUMENTAL ANAL IN; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; VONDERVISZT F, 1989, J MOL BIOL, V209, P127, DOI 10.1016/0022-2836(89)90176-9; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	67	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38833	38843		10.1074/jbc.M111.279851	http://dx.doi.org/10.1074/jbc.M111.279851			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21878629	Green Published, hybrid			2022-12-27	WOS:000296759800002
J	Stapf, C; Cartwright, E; Bycroft, M; Hofmann, K; Buchberger, A				Stapf, Christopher; Cartwright, Edward; Bycroft, Mark; Hofmann, Kay; Buchberger, Alexander			The General Definition of the p97/Valosin-containing Protein (VCP)-interacting Motif (VIM) Delineates a New Family of p97 Cofactors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; AAA ATPASE P97/VCP; ENDOPLASMIC-RETICULUM; UBIQUITIN LIGASES; FRONTOTEMPORAL DEMENTIA; STRUCTURAL INSIGHTS; PAGET-DISEASE; YEAST GENES; BINDING; COMPLEX	Cellular functions of the essential, ubiquitin-selective AAA ATPase p97/valosin-containing protein (VCP) are controlled by regulatory cofactors determining substrate specificity and fate. Most cofactors bind p97 through a ubiquitin regulatory X (UBX) or UBX-like domain or linear sequence motifs, including the hitherto ill defined p97/VCP-interacting motif (VIM). Here, we present the new, minimal consensus sequence RX(5)AAX(2)R as a general definition of the VIM that unites a novel family of known and putative p97 cofactors, among them UBXD1 and ZNF744/ANKZF1. We demonstrate that this minimal VIM consensus sequence is necessary and sufficient for p97 binding. Using NMR chemical shift mapping, we identified several residues of the p97 N-terminal domain (N domain) that are critical for VIM binding. Importantly, we show that cellular stress resistance conferred by the yeast VIM-containing cofactor Vms1 depends on the physical interaction between its VIM and the critical N domain residues of the yeast p97 homolog, Cdc48. Thus, the VIM-N domain interaction characterized in this study is required for the physiological function of Vms1 and most likely other members of the newly defined VIM family of cofactors.	[Stapf, Christopher; Buchberger, Alexander] Univ Wurzburg, Dept Biochem, Bioctr, D-97074 Wurzburg, Germany; [Cartwright, Edward; Bycroft, Mark] Med Res Council Ctr Prot Engn, Cambridge CB2 2QH, England; [Hofmann, Kay] Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany	University of Wurzburg; University of Cambridge; Miltenyi Biotec	Buchberger, A (corresponding author), Univ Wurzburg, Dept Biochem, Bioctr, D-97074 Wurzburg, Germany.	alexander.buchberger@biozentrum.uni-wuerzburg.de	Buchberger, Alexander/AAF-4728-2019; Buchberger, Alexander/J-4070-2019; Bycroft, Mark/D-9446-2017	Buchberger, Alexander/0000-0002-2836-0820; Buchberger, Alexander/0000-0002-2836-0820; Bycroft, Mark/0000-0002-0673-2216	Deutsche Forschungsgemeinschaft [Bu 951/3-1, Bu 951/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Bu 951/3-1 and Bu 951/4-1 (to A. B.).	Alamgir Md, 2010, BMC Chemical Biology, V10, P6, DOI 10.1186/1472-6769-10-6; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Allen MD, 2006, J BIOL CHEM, V281, P25502, DOI 10.1074/jbc.M601173200; Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Ballar P, 2011, INT J BIOCHEM CELL B, V43, P613, DOI 10.1016/j.biocel.2010.12.021; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Bohm S, 2011, MOL CELL BIOL, V31, P1528, DOI 10.1128/MCB.00962-10; Braun RJ, 2008, BBA-MOL CELL RES, V1783, P1418, DOI 10.1016/j.bbamcr.2008.01.015; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Buchberger A., 2006, PROTEIN DEGRADATION, V3, P194; Buchberger A, 2010, SUBCELL BIOCHEM, V54, P17, DOI 10.1007/978-1-4419-6676-6_2; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hanzelmann P, 2011, J BIOL CHEM, V286, P38679, DOI 10.1074/jbc.M111.274506; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hitt R, 2004, FEMS YEAST RES, V4, P721, DOI 10.1016/j.femsyr.2004.02.003; Isaacson RL, 2007, J BIOL CHEM, V282, P21361, DOI 10.1074/jbc.M610069200; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; James P, 1996, GENETICS, V144, P1425; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kern M, 2009, BIOCHEM BIOPH RES CO, V380, P303, DOI 10.1016/j.bbrc.2009.01.076; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Madsen L, 2008, INT J BIOCHEM CELL B, V40, P2927, DOI 10.1016/j.biocel.2008.06.008; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Meyer H, 2008, BIOCHEM SOC T, V36, P126, DOI 10.1042/BST0360126; Morreale G, 2009, FEBS J, V276, P1208, DOI 10.1111/j.1742-4658.2008.06858.x; Mullen JR, 2010, MOL CELL BIOL, V30, P3737, DOI 10.1128/MCB.01649-09; Nagahama M, 2003, MOL BIOL CELL, V14, P262, DOI 10.1091/mbc.02-07-0115; Nagahama M, 2009, BIOCHEM BIOPH RES CO, V382, P303, DOI 10.1016/j.bbrc.2009.03.012; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tran JR, 2011, J BIOL CHEM, V286, P5744, DOI 10.1074/jbc.M110.179259; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Yu GW, 2006, PROTEIN SCI, V15, P384, DOI 10.1110/ps.051927306; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	56	43	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38670	38678		10.1074/jbc.M111.274472	http://dx.doi.org/10.1074/jbc.M111.274472			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21896481	hybrid, Green Published			2022-12-27	WOS:000296594200079
J	Ebke, A; Luebbers, T; Fukumori, A; Shirotani, K; Haass, C; Baumann, K; Steiner, H				Ebke, Amelie; Luebbers, Thomas; Fukumori, Akio; Shirotani, Keiro; Haass, Christian; Baumann, Karlheinz; Steiner, Harald			Novel gamma-Secretase Enzyme Modulators Directly Target Presenilin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; A-BETA; SULINDAC; PEPTIDE; DISEASE; METABOLITES; GENERATION; A-BETA(42); INHIBITOR; MUTATIONS	gamma-Secretase is essential for the generation of the neurotoxic 42-amino acid amyloid beta-peptide (A beta(42)). The aggregation-prone hydrophobic peptide, which is deposited in Alzheimer disease (AD) patient brain, is generated from a C-terminal fragment of the beta-amyloid precursor protein by an intramembrane cleavage of gamma-secretase. Because A beta(42) is widely believed to trigger AD pathogenesis, gamma-secretase is a key AD drug target. Unlike inhibitors of the enzyme, gamma-secretase modulators (GSMs) selectively lower A beta(42) without interfering with the physiological function of gamma-secretase. The molecular target(s) of GSMs and hence the mechanism of GSM action are not established. Here we demonstrate by using a biotinylated photocross-linkable derivative of highly potent novel second generation GSMs that gamma-secretase is a direct target of GSMs. The GSM photoprobe specifically bound to the N-terminal fragment of presenilin, the catalytic subunit of gamma-secretase, but not to other gamma-secretase subunits. Binding was differentially competed by GSMs of diverse structural classes, indicating the existence of overlapping/multiple GSM binding sites or allosteric alteration of the photoprobe binding site. The beta-amyloid precursor protein C-terminal fragment previously implicated as the GSM binding site was not targeted by the compound. The identification of presenilin as the molecular target of GSMs directly establishes allosteric modulation of enzyme activity as a mechanism of GSM action and may contribute to the development of therapeutically active GSMs for the treatment of AD.	[Luebbers, Thomas; Baumann, Karlheinz] F Hoffmann La Roche Ltd, Div Pharmaceut, Preclin CNS Res, CH-4070 Basel, Switzerland; [Ebke, Amelie; Fukumori, Akio; Haass, Christian; Steiner, Harald] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Ebke, Amelie; Fukumori, Akio; Haass, Christian; Steiner, Harald] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Shirotani, Keiro] Fukushima Med Univ, Sch Med, Dept Biochem, Fukushima 9601295, Japan	Roche Holding; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Fukushima Medical University	Baumann, K (corresponding author), F Hoffmann La Roche Ltd, Div Pharmaceut, Preclin CNS Res, CH-4070 Basel, Switzerland.	karlheinz.baumann@roche.com; harald.steiner@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft [SFB596]; Bundesministerium fur Bildung und Forschung (KNDD); Center for Integrated Protein Science Munich (CIPSM); Elitenetzwerk Bayern; LMU	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (KNDD)(Federal Ministry of Education & Research (BMBF)); Center for Integrated Protein Science Munich (CIPSM); Elitenetzwerk Bayern; LMU	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB596) (to H. S. and C. H.), the Bundesministerium fur Bildung und Forschung (KNDD) (to C. H. and H. S.), and the Center for Integrated Protein Science Munich (CIPSM).; Supported by the Elitenetzwerk Bayern.; Supported by a research professorship from the LMU excellent program.	Baumann K., 2009, PCT Int. Appl., Patent No. [WO 2009103652, 2009103652]; Beel AJ, 2009, BIOCHEMISTRY-US, V48, P11837, DOI 10.1021/bi901839d; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Botev A, 2011, BIOCHEMISTRY-US, V50, P828, DOI 10.1021/bi1014002; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Czech C, 2007, J NEUROCHEM, V101, P929, DOI 10.1111/j.1471-4159.2007.04467.x; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; FAN SS, 1981, J MED CHEM, V24, P1197, DOI 10.1021/jm00142a015; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kretner B, 2011, J BIOL CHEM, V286, P15240, DOI 10.1074/jbc.M110.213587; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Portelius E, 2010, J ALZHEIMERS DIS, V21, P1005, DOI 10.3233/JAD-2010-100573; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Santos F, 2008, FREE RADICAL RES, V42, P639, DOI 10.1080/10715760802270326; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Wang J, 2004, NEUROBIOL DIS, V15, P654, DOI 10.1016/j.nbd.2003.12.008; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011	28	69	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37181	37186		10.1074/jbc.C111.276972	http://dx.doi.org/10.1074/jbc.C111.276972			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896486	Green Published, hybrid			2022-12-27	WOS:000296542400018
J	Bhattacharjee, A; Pal, S; Feldman, GM; Cathcart, MK				Bhattacharjee, Ashish; Pal, Srabani; Feldman, Gerald M.; Cathcart, Martha K.			Hck Is a Key Regulator of Gene Expression in Alternatively Activated Human Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; KINASE-C-DELTA; HUMAN ATHEROSCLEROTIC PLAQUES; CENTRIFUGAL ELUTRIATION CCE; SIGNAL-TRANSDUCTION PATHWAY; PERIPHERAL-BLOOD MONOCYTES; POLAR STEROL ESTERS; SRC-FAMILY KINASES; NF-KAPPA-B; PROTEIN-KINASE	IL-13 is a Th2 cytokine that promotes alternative activation (M2 polarization) in primary human monocytes. Our studies have characterized the functional IL-13 receptor complex and the downstream signaling events in response to IL-13 stimulation in alternatively activated monocytes/macrophages. In this report, we present evidence that IL-13 induces the activation of a Src family tyrosine kinase, which is required for IL-13 induction of M2 gene expression, including 15-lipoxygenase (15-LO). Our data show that Src kinase activity regulates IL-13-induced p38 MAPK tyrosine phosphorylation via the upstream kinases MKK3or MKK6. Our findings also reveal that the IL-13 receptor-associated tyrosine kinase Jak2 is required for the activation of both Src kinase as well as p38 MAPK. Further, we found that Src tyrosine kinase-mediated activation of p38 MAPK is required for Stat1 and Stat3 serine 727 phosphorylation in alternatively activated monocytes/macrophages. Additional studies identify Hck as the specific Src family member, stimulated by IL-13 and involved in regulating both p38 MAPK activation and p38 MAPK-mediated 15-LO expression. Finally we show that the Hck regulates the expression of other alternative state (M2)-specific genes (Mannose receptor, MAO-A, and CD36) and therefore conclude that Hck acts as a key regulator controlling gene expression in alternatively activated monocytes/macrophages.	[Bhattacharjee, Ashish; Pal, Srabani; Cathcart, Martha K.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Bhattacharjee, Ashish; Pal, Srabani; Cathcart, Martha K.] Case Western Reserve Univ, Lerner Coll Med, Dept Mol Med, Cleveland Clin, Cleveland, OH 44195 USA; [Feldman, Gerald M.] US FDA, Div Monoclonal Antibodies, Off Therapeut Res & Review, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; US Food & Drug Administration (FDA)	Bhattacharjee, A (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	bhattaa@ccf.org; cathcam@ccf.org			National Institutes of Health [HL051068, HL087018]; National Center for Research Resources [1UL1RR024989]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018, R01HL051068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL051068 and HL087018 (to M. K. C.). This work was also supported by the National Center for Research Resources (Grant Center for Translational Science Activities 1UL1RR024989).	Abe JI, 2007, J MOL CELL CARDIOL, V43, P404, DOI 10.1016/j.yjmcc.2007.07.002; Alexander M, 2004, J CELL PHYSIOL, V201, P35, DOI 10.1002/jcp.20050; Benes C, 2001, AM J PHYSIOL-CELL PH, V280, pC1498, DOI 10.1152/ajpcell.2001.280.6.C1498; Berry A, 2007, EUR J IMMUNOL, V37, P1642, DOI 10.1002/eji.200636625; Bhattacharjee A, 2006, J IMMUNOL, V177, P3771, DOI 10.4049/jimmunol.177.6.3771; Bhattacharjee A, 2010, J IMMUNOL, V185, P5211, DOI 10.4049/jimmunol.1000514; Bhattacharya S, 2006, BIOCHEM J, V397, P437, DOI 10.1042/BJ20060256; Bosco MC, 2000, J IMMUNOL, V164, P4575, DOI 10.4049/jimmunol.164.9.4575; BOULET I, 1992, ONCOGENE, V7, P703; BROOKS CJW, 1971, ATHEROSCLEROSIS, V13, P223, DOI 10.1016/0021-9150(71)90025-6; Callera GE, 2005, HYPERTENSION, V45, P773, DOI 10.1161/01.HYP.0000154365.30593.d3; Cathcart MK, 2000, FREE RADICAL BIO MED, V28, P1726, DOI 10.1016/S0891-5849(00)00230-6; Chabaud-Riou M, 2004, AM J PATHOL, V164, P177, DOI 10.1016/S0002-9440(10)63108-2; Chaitidis P, 2005, CYTOKINE, V30, P366, DOI 10.1016/j.cyto.2005.02.004; Chaitidis P, 2004, J IMMUNOL, V173, P4821, DOI 10.4049/jimmunol.173.8.4821; Chen XL, 2003, BURNS, V29, P533, DOI 10.1016/S0305-4179(03)00147-5; Cirri P, 1997, BIOCHEM BIOPH RES CO, V239, P493, DOI 10.1006/bbrc.1997.7493; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; ENGLISH BK, 1993, J EXP MED, V178, P1017, DOI 10.1084/jem.178.3.1017; FOLCIK VA, 1995, J CLIN INVEST, V96, P504, DOI 10.1172/JCI118062; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; Gharavi NM, 2007, J BIOL CHEM, V282, P31460, DOI 10.1074/jbc.M704267200; GHAZIZADEH S, 1994, J IMMUNOL, V152, P30; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; GSCHWENDT M, 1994, FEBS LETT, V347, P85, DOI 10.1016/0014-5793(94)00514-1; HARLAND WA, 1971, ATHEROSCLEROSIS, V13, P239, DOI 10.1016/0021-9150(71)90026-8; Ishida M, 1998, CIRC RES, V82, P7; Kayama Y, 2009, J EXP MED, V206, P1565, DOI 10.1084/jem.20082596; Khadaroo RG, 2003, SURGERY, V134, P242, DOI 10.1067/msy.2003.228; Klein RF, 2004, SCIENCE, V303, P229, DOI 10.1126/science.1090985; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Kronfeld I, 2000, J BIOL CHEM, V275, P35491, DOI 10.1074/jbc.M005991200; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Kyaw M, 2004, MOL PHARMACOL, V65, P832, DOI 10.1124/mol.65.4.832; Lim MJ, 2007, ARCH BIOCHEM BIOPHYS, V465, P197, DOI 10.1016/j.abb.2007.06.004; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Maung AA, 2005, J LEUKOCYTE BIOL, V78, P565, DOI 10.1189/jlb.1204698; McCloskey CA, 2004, SHOCK, V22, P380, DOI 10.1097/01.shk.0000140660.78744.bf; McMullen M, 2004, ONCOGENE, V23, P1275, DOI 10.1038/sj.onc.1207243; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Murr MM, 2003, J GASTROINTEST SURG, V7, P20, DOI 10.1016/S1091-255X(02)00053-7; MUSSO T, 1995, J EXP MED, V181, P1425, DOI 10.1084/jem.181.4.1425; NASSAR GM, 1994, J BIOL CHEM, V269, P27631; Norkina O, 2007, J LEUKOCYTE BIOL, V82, P752, DOI 10.1189/jlb.0207099; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Okutani Y, 2001, ONCOGENE, V20, P6643, DOI 10.1038/sj.onc.1204807; Poole DP, 2007, GASTROENTEROLOGY, V133, P1229, DOI 10.1053/j.gastro.2007.07.002; Proietti C, 2005, MOL CELL BIOL, V25, P4826, DOI 10.1128/MCB.25.12.4826-4840.2005; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rane SG, 2002, ONCOGENE, V21, P3334, DOI 10.1038/sj.onc.1205398; Rosen RL, 1996, BLOOD, V88, P1206, DOI 10.1182/blood.V88.4.1206.bloodjournal8841206; Rosenzweig T, 2004, CELL SIGNAL, V16, P1299, DOI 10.1016/j.cellsig.2004.03.015; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Roy B, 1998, J BIOL CHEM, V273, P32023, DOI 10.1074/jbc.273.48.32023; Roy B, 2002, J LEUKOCYTE BIOL, V72, P580; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Thobe BM, 2006, AM J PHYSIOL-CELL PH, V291, pC476, DOI 10.1152/ajpcell.00076.2006; Touyz RM, 2001, HYPERTENSION, V38, P56, DOI 10.1161/01.HYP.38.1.56; WAHL LM, 1984, CELL IMMUNOL, V85, P373, DOI 10.1016/0008-8749(84)90251-X; WAHL SM, 1984, CELL IMMUNOL, V85, P384, DOI 10.1016/0008-8749(84)90252-1; Xu B, 2003, MOL CELL BIOL, V23, P3918, DOI 10.1128/MCB.23.11.3918-3928.2003; Yakubenko VP, 2011, CIRC RES, V108, P544, DOI 10.1161/CIRCRESAHA.110.231803; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200; Yogi A, 2007, ARTERIOSCL THROM VAS, V27, P1960, DOI 10.1161/ATVBAHA.107.146746; ZIEGLER SF, 1988, J EXP MED, V168, P1801, DOI 10.1084/jem.168.5.1801	71	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36709	36723		10.1074/jbc.M111.291492	http://dx.doi.org/10.1074/jbc.M111.291492			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878628	Green Published, hybrid			2022-12-27	WOS:000296538300054
J	De Ceunynck, K; Rocha, S; Feys, HB; De Meyer, SF; Uji-i, H; Deckmyn, H; Hofkens, J; Vanhoorelbeke, K				De Ceunynck, Karen; Rocha, Susana; Feys, Hendrik B.; De Meyer, Simon F.; Uji-i, Hiroshi; Deckmyn, Hans; Hofkens, Johan; Vanhoorelbeke, Karen			Local Elongation of Endothelial Cell-anchored von Willebrand Factor Strings Precedes ADAMTS13 Protein-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOTIC THROMBOCYTOPENIC PURPURA; VONWILLEBRAND-FACTOR MULTIMERS; WEIBEL-PALADE BODIES; FLUID SHEAR-STRESS; SELF-ASSOCIATION; FACTOR-VIII; P-SELECTIN; ULTRALARGE; CLEAVAGE; FLOW	Platelet-decorated von Willebrand factor (VWF) strings anchored to the endothelial surface are rapidly cleaved by ADAMTS13. Individual VWF string characteristics such as number, location, and auxiliary features of the ADAMTS13 cleavage sites were explored here using imaging and computing software. By following changes in VWF string length, we demonstrated that VWF strings are cleaved multiple times, successively shortening string length in the function of time and generating fragments ranging in size from 5 to over 100 mu m. These are larger than generally observed in normal plasma, indicating that further proteolysis takes place in circulation. Interestingly, in 89% of all cleavage events, VWF strings elongate precisely at the cleavage site before ADAMTS13 proteolysis. These local elongations are a general characteristic of VWF strings, independent of the presence of ADAMTS13. Furthermore, large elongations, ranging in size from 1.4 to 40 mu m, occur at different sites in space and time. In conclusion, ADAMTS13-mediated proteolysis of VWF strings under flow is preceded by large elongations of the string at the cleavage site. These elongations may lead to the simultaneous exposure of many exosites, thereby facilitating ADAMTS13-mediated cleavage.	[Rocha, Susana; Uji-i, Hiroshi; Hofkens, Johan] Katholieke Univ Leuven, Div Mol & Nano Mat, Dept Chem, B-3001 Heverlee, Belgium; [De Ceunynck, Karen; Feys, Hendrik B.; De Meyer, Simon F.; Deckmyn, Hans; Vanhoorelbeke, Karen] Katholieke Univ Leuven, Lab Thrombosis Res, B-8500 Kortrijk, Belgium	KU Leuven; KU Leuven	Hofkens, J (corresponding author), Katholieke Univ Leuven, Div Mol & Nano Mat, Dept Chem, Celestijnenlaan 200F, B-3001 Heverlee, Belgium.	johan.hofkens@chem.kuleuven.be; karen.vanhoorelbeke@kuleuven-kortrijk.be	Deckmyn, Hans/L-9434-2015; Rocha, Susana/O-7622-2016; Uji-i, Hiroshi/AAK-5275-2020; Hofkens, Johan/AAP-9255-2020; Hofkens, Johan/AAL-4204-2020; Rocha, Susana/AAH-8343-2020; Deckmyn, Hans/N-8932-2019; Hofkens, Johan/D-4284-2017	Deckmyn, Hans/0000-0003-3952-5501; Rocha, Susana/0000-0003-1258-9396; Uji-i, Hiroshi/0000-0002-0463-9659; Rocha, Susana/0000-0003-1258-9396; Deckmyn, Hans/0000-0003-3952-5501; Vanhoorelbeke, Karen/0000-0003-2288-8277; De Meyer, Simon/0000-0002-1807-5882; Hofkens, Johan/0000-0002-9101-0567; Feys, Hendrik/0000-0003-0052-8852	Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)) [G.0299.06, G.0607.09, G.0402.09, G0603.10]; Katholieke Universiteit Leuven (K.U.Leuven) [GOA/2004/09, GOA/2011/03]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [83328]	Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO))(FWO); Katholieke Universiteit Leuven (K.U.Leuven)(KU Leuven); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by grants from the Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)) (Grants G.0299.06, G.0607.09, G.0402.09, and G0603.10) and the Katholieke Universiteit Leuven (K.U.Leuven) (Grants GOA/2004/09 and GOA/2011/03).; Supported by a Ph. D. grant Agentschap voor Innovatie door Wetenschap en Technologie (IWT number 83328) of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen).; A fellow of the Special Research Fund of the K.U. Leuven.	Anderson PJ, 2006, J BIOL CHEM, V281, P850, DOI 10.1074/jbc.M504540200; Bonnefoy A, 2006, BLOOD, V107, P955, DOI 10.1182/blood-2004-12-4856; Chauhan AK, 2007, J THROMB HAEMOST, V5, P583, DOI 10.1111/j.1538-7836.2007.02361.x; De Meyer SF, 2006, BLOOD, V107, P4728, DOI 10.1182/blood-2005-09-3605; De Meyer SF, 2009, BLOOD, V113, P5049, DOI 10.1182/blood-2008-10-165621; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Feys HB, 2009, J THROMB HAEMOST, V7, P2088, DOI 10.1111/j.1538-7836.2009.03620.x; Feys HB, 2006, J THROMB HAEMOST, V4, P955, DOI 10.1111/j.1538-7836.2006.01833.x; Feys HB, 2010, BLOOD, V116, P2005, DOI 10.1182/blood-2010-04-280479; Feys HB, 2009, BLOOD, V114, P4749, DOI 10.1182/blood-2009-07-230615; FOWLER WE, 1985, J CLIN INVEST, V76, P1491, DOI 10.1172/JCI112129; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Huang J, 2009, BLOOD, V113, P1589, DOI 10.1182/blood-2008-05-158584; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Jin SY, 2009, J THROMB HAEMOST, V7, P1749, DOI 10.1111/j.1538-7836.2009.03570.x; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Li Y, 2008, J THROMB HAEMOST, V6, P1135, DOI 10.1111/j.1538-7836.2008.02991.x; Lin Y, 2002, BLOOD, V99, P457, DOI 10.1182/blood.V99.2.457; Michaux G, 2006, DEV CELL, V10, P223, DOI 10.1016/j.devcel.2005.12.012; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; Motto DG, 2005, J CLIN INVEST, V115, P2752, DOI 10.1172/JCI26007; Padilla A, 2004, BLOOD, V103, P2150, DOI 10.1182/blood-2003-08-2956; Ruggeri ZM, 2003, CURR OPIN HEMATOL, V10, P142, DOI 10.1097/00062752-200303000-00008; Sadler JE, 2005, J THROMB HAEMOST, V3, P1702, DOI 10.1111/j.1538-7836.2005.01369.x; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Savage B, 2002, P NATL ACAD SCI USA, V99, P425, DOI 10.1073/pnas.012459599; Shim K, 2008, BLOOD, V111, P651, DOI 10.1182/blood-2007-05-093021; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; Suzuki M, 2004, BIOCHEM BIOPH RES CO, V313, P212, DOI 10.1016/j.bbrc.2003.11.111; Tsai HM, 2007, HEMATOL ONCOL CLIN N, V21, P609, DOI 10.1016/j.hoc.2007.06.003; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Turner N, 2009, J THROMB HAEMOST, V7, P229, DOI 10.1111/j.1538-7836.2008.03209.x; Turner NA, 2009, BLOOD, V114, P5102, DOI 10.1182/blood-2009-07-231597; Ulrichts H, 2005, J THROMB HAEMOST, V3, P552, DOI 10.1111/j.1538-7836.2005.01209.x; van den Biggelaar M, 2009, HAEMATOL-HEMATOL J, V94, P670, DOI 10.3324/haematol.13427; Wang AY, 2010, THROMB RES, V126, pE260, DOI 10.1016/j.thromres.2010.07.009; Zannettino ACW, 2005, J CELL PHYSIOL, V204, P714, DOI 10.1002/jcp.20354; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905	38	41	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36361	36367		10.1074/jbc.M111.271890	http://dx.doi.org/10.1074/jbc.M111.271890			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21896483	Green Published, hybrid			2022-12-27	WOS:000296538300021
J	Ohashi, K; Fujiwara, S; Watanabe, T; Kondo, H; Kiuchi, T; Sato, M; Mizuno, K				Ohashi, Kazumasa; Fujiwara, Sachiko; Watanabe, Takuya; Kondo, Hiroshi; Kiuchi, Tai; Sato, Masaaki; Mizuno, Kensaku			LIM Kinase Has a Dual Role in Regulating Lamellipodium Extension by Decelerating the Rate of Actin Retrograde Flow and the Rate of Actin Polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COFILIN-PHOSPHATASE SLINGSHOT; DEPOLYMERIZING FACTOR; CYTOSKELETAL DYNAMICS; NONMUSCLE CELLS; PHOSPHORYLATION; ACTIVATION; MOTILITY; ADF/COFILIN; PROTRUSION; RHO	Lamellipodium extension is crucial for cell migration and spreading. The rate of lamellipodium extension is determined by the balance between the rate of actin polymerization and the rate of actin retrograde flow. LIM kinase 1 (LIMK1) regulates actin dynamics by phosphorylating and inactivating cofilin, an actin-depolymerizing protein. We examined the role of LIMK1 in lamellipodium extension by measuring the rates of actin polymerization, actin retrograde flow, and lamellipodium extension using time-lapse imaging of fluorescence recovery after photobleaching. In the non-extending lamellipodia of active Rac-expressing N1E-115 cells, LIMK1 expression decelerated and LIMK1 knockdown accelerated actin retrograde flow. In the extending lamellipodia of neuregulin-stimulated MCF-7 cells, LIMK1 knockdown accelerated both the rate of actin polymerization and the rate of actin retrograde flow, but the accelerating effect on retrograde flow was greater than the effect on polymerization, thus resulting in a decreased rate of lamellipodium extension. These results indicate that LIMK1 has a dual role in regulating lamellipodium extension by decelerating actin retrograde flow and polymerization, and in MCF-7 cells endogenous LIMK1 contributes to lamellipodium extension by decelerating actin retrograde flow more effectively than decelerating actin polymerization.	[Ohashi, Kazumasa; Fujiwara, Sachiko; Watanabe, Takuya; Kondo, Hiroshi; Kiuchi, Tai; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Sato, Masaaki] Tohoku Univ, Dept Biomed Engn, Grad Sch Biomed Engn, Sendai, Miyagi 9808578, Japan	Tohoku University; Tohoku University	Ohashi, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kohashi@biology.tohoku.ac.jp; kmizuno@biology.tohoku.ac.jp	Ohashi, Kazumasa/U-7028-2019; Mizuno, Kensaku/G-8631-2015	Ohashi, Kazumasa/0000-0001-7617-403X; Fujiwara, Sachiko/0000-0002-5620-637X	Ministry of Education, Culture, Science, Sports, and Technology of Japan [20200057, 22616001, 20001007, 20013004, 22121501]; Center for Interdisciplinary Research, Tohoku University; Grants-in-Aid for Scientific Research [22616001] Funding Source: KAKEN	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center for Interdisciplinary Research, Tohoku University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants for Scientific Research from the Ministry of Education, Culture, Science, Sports, and Technology of Japan 20200057 and 22616001 (to K. O.), 20001007 (to M. S.), and 20013004 and 22121501 (to K. M.) and by a grant from the Program Research in Center for Interdisciplinary Research, Tohoku University (to K. O.).	Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Cramer Louise P., 1997, Frontiers in Bioscience (online), V2, pD260; Danuser G, 2005, BIOCHEM SOC T, V33, P1250, DOI 10.1042/BST0331250; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Endo M, 2003, J NEUROSCI, V23, P2527; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kiuchi T, 2011, J CELL BIOL, V193, P365, DOI 10.1083/jcb.201101035; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rosenblatt J, 1997, J CELL BIOL, V136, P1323, DOI 10.1083/jcb.136.6.1323; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	44	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36340	36351		10.1074/jbc.M111.259135	http://dx.doi.org/10.1074/jbc.M111.259135			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21868383	Green Published, hybrid			2022-12-27	WOS:000296538300019
J	Gleason, CE; Ordureau, A; Gourlay, R; Arthur, JSC; Cohen, P				Gleason, Catherine E.; Ordureau, Alban; Gourlay, Robert; Arthur, J. Simon C.; Cohen, Philip			Polyubiquitin Binding to Optineurin Is Required for Optimal Activation of TANK-binding Kinase 1 and Production of Interferon beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIGNALING PATHWAY; UBIQUITIN CHAINS; VIRAL-INFECTION; INNATE IMMUNITY; IFN RESPONSES; CUTTING EDGE; IKK-EPSILON; NEMO; DOMAIN	TANK-binding kinase (TBK1) is essential for transcription of the interferon (IFN) beta gene in response to lipopolysaccharide (LPS) and double-stranded RNA, but the molecular mechanisms that underlie the activation of TBK1 are incompletely understood. Previously, we identified the NF-kappa B essential modulator (NEMO)-related polyubiquitin-binding protein, optineurin (OPTN), as a novel binding partner of TBK1. To determine whether the ubiquitin-binding function of OPTN is involved in regulating TBK1 and IFN beta production, we generated a mouse in which wild-type optineurin was replaced by the polyubiquitin binding-defective mutant, OPTND477N/D477N. In this study, we found that LPS or poly(I:C)-induced TBK1 activity was significantly reduced in bone marrow-derived macrophage (BMDM) from OPTND477N/D477N mice. Consistent with this, the phosphorylation of IFN regulatory factor 3 (IRF3) and the production of IFN beta mRNA and secretion were reduced. Stimulation of BMDMs with LPS triggered the phosphorylation of OPTN, which was reversed by phosphatase treatment and prevented by pharmacological inhibition of both the canonical I kappa B kinases (IKK alpha/beta) and the IKK-related kinases (TBK1/IKK epsilon). In contrast, LPS-stimulated phosphorylation of OPTN(D477N) was markedly reduced in BMDMs from OPTND477N/D477N mice, and inhibition of the canonical IKKs alone prevented phosphorylation, providing further evidence that ubiquitin binding to OPTN contributes to LPS-induced TBK1 activation. TBK1 and IKK beta phosphorylated OPTN preferentially at Ser-177 and Ser-513, respectively, in vitro. In conclusion, our results suggest that OPTN binds to polyubiquity-lated species formed in response to LPS and poly(I:C), enhancing the activation of TBK1 that is required for optimal phosphorylation of IRF3 and production of IFN beta.	[Gleason, Catherine E.; Ordureau, Alban; Gourlay, Robert; Arthur, J. Simon C.; Cohen, Philip] Univ Dundee, Prot Phosphorylat Unit, MRC, Sir James Black Ctr,Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Cohen, P (corresponding author), Univ Dundee, Prot Phosphorylat Unit, MRC, Sir James Black Ctr,Coll Life Sci, Dow St, Dundee DD1 5EH, Scotland.	p.cohen@dundee.ac.uk	Arthur, J. Simon/B-8058-2010; Ordureau, Alban/C-7558-2012	Arthur, J. Simon/0000-0002-8135-1958; Ordureau, Alban/0000-0002-4924-8520	United Kingdom Medical Research Council; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Merck-Serono; Pfizer; Medical Research Council [MC_U127084348, MC_U127081014] Funding Source: researchfish; MRC [MC_U127084348, MC_U127081014] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck-Serono(Merck & Company); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the United Kingdom Medical Research Council, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck-Serono, and Pfizer.	Albagha OME, 2010, NAT GENET, V42, P520, DOI 10.1038/ng.562; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Campbell David G, 2002, J Biomol Tech, V13, P119; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Miyahira AK, 2009, J IMMUNOL, V182, P2248, DOI 10.4049/jimmunol.0802466; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Morton S, 2006, BIOCHEM J, V399, P265, DOI 10.1042/BJ20060681; Nanda SK, 2011, J EXP MED, V208, P1215, DOI 10.1084/jem.20102177; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pietras EM, 2006, J ENDOTOXIN RES, V12, P246, DOI 10.1179/096805106X118799; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Zheng H, 2006, J BIOL CHEM, V281, P15809, DOI 10.1074/jbc.M513225200; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	49	134	137	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35663	35674		10.1074/jbc.M111.267567	http://dx.doi.org/10.1074/jbc.M111.267567			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862579	hybrid, Green Published			2022-12-27	WOS:000295927100038
J	Jian, JL; Yang, Q; Huang, X				Jian, Jinlong; Yang, Qing; Huang, Xi			Src Regulates Tyr(20) Phosphorylation of Transferrin Receptor-1 and Potentiates Breast Cancer Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; INDUCED APOPTOSIS; IRON-DEFICIENCY; TARGETING SRC; GAMBOGIC ACID; YOUNG-WOMEN; P38 MAPK; PROLIFERATION; PROTEIN; INTERNALIZATION	Transferrin receptor 1 (TfR1) is a ubiquitous type II membrane receptor with 61 amino acids in the N-terminal cytoplasmic region. TfR1 is highly expressed in cancer cells, particularly under iron deficient conditions. Overexpression of TfR1 is thought to meet the increased requirement of iron uptake necessary for cell growth. In the present study, we used transferrin (Tf), a known ligand of TfR1, and gambogic acid (GA), an apoptosis-inducing agent and newly identified TfR1 ligand to investigate the signaling role of TfR1 in breast cancer cells. We found that GA but not Tf induced apoptosis in a TfR1-dependent manner in breast cancer MDA-MB-231 cells. Estrogen receptor-positive MCF-7 cells lack caspase-3 and were not responsive to GA treatment. GA activated the three major signaling pathways of the MAPK family, as well as caspase-3,-8, and Poly(ADP-ribose)-polymerase apoptotic pathway. Interestingly, only Src inhibitor PP2 greatly sensitized the cells to GA-mediated apoptosis. Further investigations by confocal fluorescence microscopy and immunoprecipitation revealed that Src and TfR1 are constitutively bound. Using TfR1-deficient CHO TRVB cells, point mutation studies showed that Tyr(20) within the (YTRF23)-Y-20 motif of the cytoplasmic region of TfR1 is the phosphorylation site by Src. TfR1 Tyr(20) phosphomutants were more sensitive to GA-mediated apoptosis. Our results indicate that, albeit its iron uptake function, TfR1 is a signaling molecule and tyrosine phosphorylation at position 20 by Src enhances anti-apoptosis and potentiates breast cancer cell survival.	[Huang, Xi] NYU, Dept Med, Inst Canc, Sch Med, New York, NY 10016 USA; [Huang, Xi] NYU, Dept Environm Med, Inst Canc, Sch Med, New York, NY 10016 USA	New York University; New York University	Huang, X (corresponding author), NYU, Dept Med, Inst Canc, Sch Med, HJD Rm 1600,550 1st Ave, New York, NY 10016 USA.	xi.huang@nyumc.org			National Institutes of Health [ES00260, CA34588, CA16087]; NCI, National Institutes of Health [R21 CA132684]; NATIONAL CANCER INSTITUTE [P30CA016087, R21CA132684, R01CA034588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grants ES00260, CA34588, and CA16087 and by NCI, National Institutes of Health Grant R21 CA132684 (to X. H.).	Aebi S, 2005, BREAST, V14, P594, DOI 10.1016/j.breast.2005.08.011; Aisen P, 2004, INT J BIOCHEM CELL B, V36, P2137, DOI 10.1016/j.biocel.2004.02.007; Asano J, 1996, PHYTOCHEMISTRY, V41, P815, DOI 10.1016/0031-9422(95)00682-6; Bianchi L, 1999, NUCLEIC ACIDS RES, V27, P4223, DOI 10.1093/nar/27.21.4223; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Blanc C, 2000, CANCER RES, V60, P4386; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Carlson H, 2005, BLOOD, V105, P2564, DOI 10.1182/blood-2004-03-1204; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; COLLAWN JF, 1993, J BIOL CHEM, V268, P21686; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Cuadrado A, 2003, J BIOL CHEM, V278, P241, DOI 10.1074/jbc.M201010200; Dai JS, 2008, BREAST, V17, P172, DOI 10.1016/j.breast.2007.08.009; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Eckard J, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-28; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Gabriel CA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2647; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Habashy HO, 2010, BREAST CANCER RES TR, V119, P283, DOI 10.1007/s10549-009-0345-x; Jallal H, 2007, CANCER RES, V67, P1580, DOI 10.1158/0008-5472.CAN-06-2027; Kanzaki M, 2004, J BIOL CHEM, V279, P30622, DOI 10.1074/jbc.M401443200; Kasibhatla S, 2005, P NATL ACAD SCI USA, V102, P12095, DOI 10.1073/pnas.0406731102; Kwok JC, 2002, CRIT REV ONCOL HEMAT, V42, P65, DOI 10.1016/S1040-8428(01)00213-X; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Li L, 2010, P NATL ACAD SCI USA, V107, P3505, DOI 10.1073/pnas.0913192107; Li QL, 2010, BIOL PHARM BULL, V33, P415, DOI 10.1248/bpb.33.415; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; Marcotte R, 2009, MOL CELL BIOL, V29, P5858, DOI 10.1128/MCB.01731-08; Mayer EL, 2010, CLIN CANCER RES, V16, P3526, DOI 10.1158/1078-0432.CCR-09-1834; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; MCGRAW TE, 1990, CELL REGUL, V1, P369, DOI 10.1091/mbc.1.4.369; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; NECKERS LM, 1986, CANCER INVEST, V4, P461, DOI 10.3109/07357908609017524; Pandey MK, 2007, BLOOD, V110, P3517, DOI 10.1182/blood-2007-03-079616; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; Rucci N, 2006, J PHARMACOL EXP THER, V318, P161, DOI 10.1124/jpet.106.102004; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Tacchini L, 2008, J BIOL CHEM, V283, P20674, DOI 10.1074/jbc.M800365200; TONIK SE, 1986, BREAST CANCER RES TR, V7, P71, DOI 10.1007/BF01806791; WALKER RA, 1986, J PATHOL, V148, P217, DOI 10.1002/path.1711480305; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	42	47	49	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35708	35715		10.1074/jbc.M111.271585	http://dx.doi.org/10.1074/jbc.M111.271585			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21859709	Green Published, hybrid			2022-12-27	WOS:000295927100043
J	Staresincic, L; Walker, J; Dirac-Svejstrup, AB; Mitter, R; Svejstrup, JQ				Staresincic, Lidija; Walker, Jane; Dirac-Svejstrup, A. Barbara; Mitter, Richard; Svejstrup, Jesper Q.			GTP-dependent Binding and Nuclear Transport of RNA Polymerase II by Npa3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; TRANSCRIPTION; LOCALIZATION; ELONGATION; IMPORT; YEAST; COMPONENT; CHROMATIN; SUBUNIT	We identified XAB1 in a proteomic screen for factors that interact with human RNA polymerase II (RNAPII). Because XAB1 has a conserved Saccharomyces cerevisiae homologue called Npa3, yeast genetics and biochemical analysis were used to dissect the significance of the interaction. Degron-dependent Npa3 depletion resulted in genome-wide transcription decreases, correlating with a loss of RNAPII from genes as measured by chromatin immunoprecipitation. Surprisingly, however, transcription in vitro was unaffected by Npa3, suggesting that it affects a process that is not required for transcription in yeast extracts. Indeed, Npa3 depletion in vivo affects nuclear localization of RNAPII; the polymerase accumulates in the cytoplasm. Npa3 is a member of the GPN-LOOP family of GTPases. Npa3 mutants that either cannot bind GTP or that bind but cannot hydrolyze it are inviable and unable to support nuclear transport of RNAPII. Surprisingly, we were unable to detect interactions between Npa3 and proteins in the classical importin alpha/beta pathway for nuclear import. Interestingly, Npa3-RNAPII binding is significantly increased by the addition of GTP or its slowly hydrolyzable analogue guanosine 5'-3-O-(thio)triphosphate (GTP gamma S). Moreover, the Npa3 mutant that binds GTP, but cannot hydrolyze it, binds RNAPII even in the absence of added GTP, whereas the mutant that cannot bind GTP is unable to bind the polymerase. Together, our data suggest that Npa3 defines an unconventional pathway for nuclear import of RNAPII, which involves GTP-dependent binding of Npa3 to the polymerase.	[Staresincic, Lidija; Walker, Jane; Dirac-Svejstrup, A. Barbara; Svejstrup, Jesper Q.] Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England; [Mitter, Richard] Canc Res UK London Res Inst, Bioinformat & Biostat Grp, London WC2A 3LY, England	Cancer Research UK; Cancer Research UK	Svejstrup, JQ (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk		Svejstrup, Jesper/0000-0003-4964-6147; Mitter, Richard/0000-0002-1279-3760	European Community [LSHG-CT-2005-512113]; Cancer Research UK; Cancer Research UK [11567] Funding Source: researchfish	European Community(European Commission); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by a grant from the European Community (Integrated Project DNA Repair (LSHG-CT-2005-512113)) and by an in-house grant from Cancer Research UK (to J. Q. S.).	Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; AYSCOUGH KR, 1998, IMMUNOFLUORESCENCE M; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; CARRE C, 2011, MOL CELL BI IN PRESS; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Czeko E, 2011, MOL CELL, V42, P261, DOI 10.1016/j.molcel.2011.02.033; Dez C, 2004, MOL CELL BIOL, V24, P6324, DOI 10.1128/MCB.24.14.6324-6337.2004; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Forget D, 2010, MOL CELL PROTEOMICS, V9, P2827, DOI 10.1074/mcp.M110.003616; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gras S, 2007, EMBO REP, V8, P569, DOI 10.1038/sj.embor.7400958; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; Greenwood C, 2009, J BIOL CHEM, V284, P141, DOI 10.1074/jbc.M805312200; Hanover JA, 2007, J BIOL CHEM, V282, P33743, DOI 10.1074/jbc.M705875200; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Kong SE, 2002, DNA REPAIR, V1, P731, DOI 10.1016/S1568-7864(02)00080-0; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lembo F, 2003, MOL CELL BIOL, V23, P1656, DOI 10.1128/MCB.23.5.1656-1665.2003; Nitta M, 2000, NUCLEIC ACIDS RES, V28, P4212, DOI 10.1093/nar/28.21.4212; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rondon AG, 2003, J BIOL CHEM, V278, P39037, DOI 10.1074/jbc.M305718200; SAYRE MH, 1992, J BIOL CHEM, V267, P23376; Selth L, 2007, J BIOL CHEM, V282, P12358, DOI 10.1074/jbc.C700012200; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Yen YM, 2001, TRAFFIC, V2, P449, DOI 10.1034/j.1600-0854.2001.20703.x	33	33	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35553	35561		10.1074/jbc.M111.286161	http://dx.doi.org/10.1074/jbc.M111.286161			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21844196	Green Published, hybrid			2022-12-27	WOS:000295927100027
J	Eng, ET; Smagghe, BJ; Walz, T; Springer, TA				Eng, Edward T.; Smagghe, Benoit J.; Walz, Thomas; Springer, Timothy A.			Intact alpha(IIb)beta(3) Integrin Is Extended after Activation as Measured by Solution X-ray Scattering and Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB; STRUCTURAL BASIS; CONFORMATIONAL REGULATION; CRYSTAL-STRUCTURE; CELL-ADHESION; BINDING-SITE; OUTSIDE-IN; COMPLEX; LIGAND; DOMAIN	Integrins are bidirectional signaling molecules on the cell surface that have fundamental roles in regulating cell behavior and contribute to cell migration and adhesion. Understanding of the mechanism of integrin signaling and activation has been advanced with truncated ectodomain preparations; however, the nature of conformational change in the full-length intact integrin molecule remains an active area of research. Here we used small angle x-ray scattering and electron microscopy to study detergent-solubilized, intact platelet integrin alpha(IIb)beta(3). In the resting state, the intact alpha(IIb)beta(3) adopted a compact, bent conformation. Upon activation with Mn2+, the average integrin extension increased. Further activation by addition of ligand led to stabilization of the extended state and opening of the headpiece. The observed extension and conformational rearrangement upon activation are consistent with the extension and headpiece opening model of integrin activation.	[Eng, Edward T.; Smagghe, Benoit J.; Springer, Timothy A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Immune Dis Inst,CLSB, Boston, MA 02115 USA; [Eng, Edward T.; Smagghe, Benoit J.; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Immune Dis Inst,CLSB, 3 Blackfan Circle,3rd Floor, Boston, MA 02115 USA.	springer@idi.harvard.edu		Walz, Thomas/0000-0003-2606-2835; Eng, Edward/0000-0002-8014-7269	National Institutes of Health [HL103526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL103526.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; HONDA S, 1995, J BIOL CHEM, V270, P11947, DOI 10.1074/jbc.270.20.11947; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwasaki K, 2005, J STRUCT BIOL, V150, P259, DOI 10.1016/j.jsb.2005.03.005; Jennings LK, 2000, THROMB HAEMOSTASIS, V84, P1095; Kamata T, 2010, J BIOL CHEM, V285, P38428, DOI 10.1074/jbc.M110.139667; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Litvinov RI, 2004, BLOOD, V104, P3979, DOI 10.1182/blood-2004-04-1411; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Mitchell WB, 2007, BLOOD, V109, P3725, DOI 10.1182/blood-2006-11-058420; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Nogales A, 2010, J BIOL CHEM, V285, P1023, DOI 10.1074/jbc.M109.050039; Pelletier AJ, 1996, J BIOL CHEM, V271, P1364, DOI 10.1074/jbc.271.3.1364; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS DR, 1988, BLOOD, V71, P831; Rocco M, 2008, STRUCTURE, V16, P954, DOI 10.1016/j.str.2008.02.019; Scarborough RM, 2000, J MED CHEM, V43, P3453, DOI 10.1021/jm000022w; Shi ML, 2007, J BIOL CHEM, V282, P30198, DOI 10.1074/jbc.M701670200; Smagghe BJ, 2010, J BIOL CHEM, V285, P32954, DOI 10.1074/jbc.M110.145177; Springer TA, 2004, ADV PROTEIN CHEM, V68, P29; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200; Zhu JQ, 2010, BLOOD, V116, P5050, DOI 10.1182/blood-2010-04-281154; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	50	50	50	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35218	35226		10.1074/jbc.M111.275107	http://dx.doi.org/10.1074/jbc.M111.275107			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832081	Green Published, hybrid			2022-12-27	WOS:000295406300074
J	Mierke, CT; Bretz, N; Altevogt, P				Mierke, Claudia Tanja; Bretz, Niko; Altevogt, Peter			Contractile Forces Contribute to Increased Glycosylphosphatidylinositol-anchored Receptor CD24-facilitated Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PROGNOSTIC MARKER; BREAST-CARCINOMA CELLS; CD24 EXPRESSION; TUMOR-CELLS; EXTRACELLULAR-MATRIX; ADHESION; METASTASIS; MIGRATION; BINDING; INTEGRINS	The malignancy of a tumor depends on the capability of cancer cells to metastasize. The process of metastasis involves cell invasion through connective tissue and transmigration through endothelial monolayers. The expression of the glycosylphosphatidylinositol- anchored receptor CD24 is increased in several tumor types and is consistently associated with increased metastasis formation in patients. Furthermore, the localization of beta 1-integrins in lipid rafts depends on CD24. Cell invasion is a fundamental biomechanical process and usually requires cell adhesion to the extracellular matrix (ECM) mainly through beta 1 heterodimeric integrin receptors. Here, we studied the invasion of A125 human lung cancer cells with different CD24 expression levels in three-dimensional ECMs. We hypothesized that CD24 expression increases cancer cell invasion through increased contractile forces. To analyze this, A125 cells (CD24 negative) were stably transfected with CD24 and sorted for high and low CD24 expression. The invasiveness of theCD24(high) andCD24(low) transfectants was determined in three-dimensional ECMs. The percentage of invasive cells and their invasion depth was increased in CD24(high) cells compared with CD24(low) cells. Knockdown of CD24 and of the beta 1-integrin subunit in CD24(high) cells decreased their invasiveness, indicating that the increased invasiveness is CD24 and beta 1-integrin subunit-dependent. Fourier transform traction microscopy revealed that the CD24(high) cells generated 5-fold higher contractile forces compared with CD24(low) cells. To analyze whether contractile forces are essential for CD24-facilitated cell invasion, we performed invasion assays in the presence of myosin light chain kinase inhibitor ML-7 as well as Rho kinase inhibitor Y27632. Cell invasiveness was reduced after addition of ML-7 and Y27632 in CD24(high) cells but not in CD24(neg) cells. Moreover, after addition of lysophosphatidic acid or calyculin A, an increase in pre-stress in CD24(neg) cells was observed, which enhanced cellular invasiveness. In addition, inhibition of the Src kinase or STAT3 strongly reduced the invasiveness of CD24(high) cells, slightly reduced that of CD24(low) cells, and did not alter the invasiveness of CD24(neg) cells. Taken together, these results suggest that CD24 enhances cell invasion through increased generation or transmission of contractile forces.	[Mierke, Claudia Tanja] Univ Leipzig, Fac Phys & Earth Sci, Inst Expt Phys 1, Soft Matter Phys Div, D-04103 Leipzig, Germany; [Bretz, Niko; Altevogt, Peter] German Canc Res Ctr, Tumor Immunol Programm, D-69120 Heidelberg, Germany	Leipzig University; Helmholtz Association; German Cancer Research Center (DKFZ)	Mierke, CT (corresponding author), Univ Leipzig, Fac Phys & Earth Sci, Inst Expt Phys 1, Soft Matter Phys Div, Linnestr 5, D-04103 Leipzig, Germany.	claudia.mierke@t-online.de	Mierke, Claudia Tanja/L-5293-2018	Mierke, Claudia Tanja/0000-0002-6622-335X	Deutsche Krebshilfe [109432]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by Deutsche Krebshilfe Grant 109432.	Agrawal S, 2007, J GASTROINTEST SURG, V11, P445, DOI 10.1007/s11605-007-0091-5; Aigner S, 1998, FASEB J, V12, P1241, DOI 10.1096/fasebj.12.12.1241; Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bauer K, 2007, INT J CANCER, V121, P1910, DOI 10.1002/ijc.22879; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chou YY, 2007, ANN SURG ONCOL, V14, P2748, DOI 10.1245/s10434-007-9501-x; DAMSKY CH, 1985, J CELL BIOL, V100, P1528, DOI 10.1083/jcb.100.5.1528; ELSON EL, 1988, ANNU REV BIOPHYS BIO, V17, P397; Fabry B, 2003, RESP PHYSIOL NEUROBI, V137, P109, DOI 10.1016/S1569-9048(03)00141-1; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fredberg JJ, 1996, J APPL PHYSIOL, V81, P2703, DOI 10.1152/jappl.1996.81.6.2703; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fukushima T, 2007, J BIOL CHEM, V282, P18634, DOI 10.1074/jbc.M609567200; Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Giancotti FG, 2000, NAT CELL BIOL, V2, pE13, DOI 10.1038/71397; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Guan JL, 2004, SCIENCE, V303, P773, DOI 10.1126/science.1094376; HEMLER ME, 1987, J BIOL CHEM, V262, P3300; HILDEBRANDT J, 1969, B MATH BIOPHYS, V31, P651, DOI 10.1007/BF02477779; Horwitz AF, 1997, SCI AM, V276, P68, DOI 10.1038/scientificamerican0597-68; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Inutsuka A, 2009, BIOCHEM BIOPH RES CO, V390, P1160, DOI 10.1016/j.bbrc.2009.10.108; JACKSON D, 1992, CANCER RES, V52, P5264; Jacob J, 2004, PANCREATOLOGY, V4, P454, DOI 10.1159/000079824; Kasza KE, 2009, BIOPHYS J, V96, P4326, DOI 10.1016/j.bpj.2009.02.035; Kollmannsberger P, 2011, SOFT MATTER, V7, P3127, DOI 10.1039/c0sm00833h; Kollmannsberger P, 2009, SOFT MATTER, V5, P1771, DOI 10.1039/b820228a; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Loftus JC, 1997, J CLIN INVEST, V99, P2302, DOI 10.1172/JCI119408; McNulty AL, 2009, CLIN ORTHOP RELAT R, V467, P1557, DOI 10.1007/s11999-008-0596-6; Metzner C, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194105; Mickel W, 2008, BIOPHYS J, V95, P6072, DOI 10.1529/biophysj.108.135939; Mierke CT, 2008, EUR J CELL BIOL, V87, P669, DOI 10.1016/j.ejcb.2008.01.002; Mierke CT, 2008, BIOPHYS J, V94, P2832, DOI 10.1529/biophysj.107.113613; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; Mierke CT, 2008, J BIOPHYS, V2008; Mijailovich SM, 2002, J APPL PHYSIOL, V93, P1429, DOI 10.1152/japplphysiol.00255.2002; NEFF NT, 1982, J CELL BIOL, V95, P654, DOI 10.1083/jcb.95.2.654; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Rosel D, 2008, MOL CANCER RES, V6, P1410, DOI 10.1158/1541-7786.MCR-07-2174; Runz S, 2008, BIOCHEM BIOPH RES CO, V365, P35, DOI 10.1016/j.bbrc.2007.10.139; Sagiv E, 2006, GASTROENTEROLOGY, V131, P630, DOI 10.1053/j.gastro.2006.04.028; Schabath H, 2006, J CELL SCI, V119, P314, DOI 10.1242/jcs.02741; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yang XR, 2009, CLIN CANCER RES, V15, P5518, DOI 10.1158/1078-0432.CCR-09-0151; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	66	55	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34858	34871		10.1074/jbc.M111.245183	http://dx.doi.org/10.1074/jbc.M111.245183			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21828044	hybrid, Green Published			2022-12-27	WOS:000295406300040
J	Preller, M; Bauer, S; Adamek, N; Fujita-Becker, S; Fedorov, R; Geeves, MA; Manstein, DJ				Preller, Matthias; Bauer, Stefanie; Adamek, Nancy; Fujita-Becker, Setsuko; Fedorov, Roman; Geeves, Michael A.; Manstein, Dietmar J.			Structural Basis for the Allosteric Interference of Myosin Function by Reactive Thiol Region Mutations G680A and G680V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; HEAVY-CHAIN; CRYSTAL-STRUCTURE; MOTOR DOMAINS; ACTIVE-SITE; DICTYOSTELIUM; NUCLEOTIDE; MUTANTS; FLUORESCENCE; SUPPRESSORS	The cold-sensitive single-residue mutation of glycine 680 in the reactive thiol region of Dictyostelium discoideum myosin-2 or the corresponding conserved glycine in other myosin isoforms has been reported to interfere with motor function. Here we present the x-ray structures of myosin motor domain mutants G680A in the absence and presence of nucleotide as well as the apo structure of mutant G680V. Our results show that the Gly-680 mutations lead to uncoupling of the reactive thiol region from the surrounding structural elements. Structural and functional data indicate that the mutations induce the preferential population of a state that resembles the ADP-bound state. Moreover, the Gly-680 mutants display greatly reduced dynamic properties, which appear to be related to the recovery of myosin motor function at elevated temperatures.	[Preller, Matthias; Bauer, Stefanie; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Fedorov, Roman; Manstein, Dietmar J.] Hannover Med Sch, Forsch Einrichtung Strukturanal, D-30625 Hannover, Germany; [Adamek, Nancy; Geeves, Michael A.] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England; [Fujita-Becker, Setsuko; Manstein, Dietmar J.] Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Hannover Medical School; Hannover Medical School; University of Kent; Max Planck Society	Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	manstein.dietmar@mh-hannover.de	Manstein, Dietmar J. J/M-1034-2013; Preller, Matthias/P-1176-2016; Manstein, Dietmar J./AAG-2640-2019; Geeves, Michael/F-7583-2011	Manstein, Dietmar J. J/0000-0003-0763-0147; Preller, Matthias/0000-0002-7784-4012; Manstein, Dietmar J./0000-0003-0763-0147; Geeves, Michael/0000-0002-9364-8898; Fedorov, Roman/0000-0002-5240-4205	Wellcome Trust [085309]; Deutsche Forschungsgemeinschaft [Ma 1081/16-1]; Cluster of Excellence "Rebirth"	Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Rebirth"	This work was supported in part by Wellcome Trust Grant 085309 (to M. A. G.) and grants from Deutsche Forschungsgemeinschaft Ma 1081/16-1 and the Cluster of Excellence "Rebirth" (to D. J. M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Batra R, 1999, BIOCHEMISTRY-US, V38, P6126, DOI 10.1021/bi982251e; Bauer CB, 2000, J BIOL CHEM, V275, P38494, DOI 10.1074/jbc.M005585200; Bauer CB, 1997, J MOL BIOL, V274, P394, DOI 10.1006/jmbi.1997.1325; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; DALBEY RE, 1983, BIOCHEMISTRY-US, V22, P4696, DOI 10.1021/bi00289a014; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DELOZANNE A, 1985, P NATL ACAD SCI USA, V82, P6807, DOI 10.1073/pnas.82.20.6807; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Giese KC, 1997, BIOCHEMISTRY-US, V36, P8465, DOI 10.1021/bi963141f; Gulick AM, 1997, BIOCHEMISTRY-US, V36, P11619, DOI 10.1021/bi9712596; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HUSTON EE, 1988, BIOCHEMISTRY-US, V27, P8945, DOI 10.1021/bi00425a011; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kinose F, 1996, J CELL BIOL, V134, P895, DOI 10.1083/jcb.134.4.895; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Liang WC, 1998, P NATL ACAD SCI USA, V95, P12844, DOI 10.1073/pnas.95.22.12844; MANSTEIN DJ, 1995, J MUSCLE RES CELL M, V16, P325, DOI 10.1007/BF00121141; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; PATTERSON B, 1995, GENETICS, V140, P505; Patterson B, 1998, GENETICS, V149, P1799; Patterson B, 1997, J BIOL CHEM, V272, P27612, DOI 10.1074/jbc.272.44.27612; Patterson B, 1996, GENETICS, V143, P801; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; TITUS MA, 1989, J MUSCLE RES CELL M, V10, P25, DOI 10.1007/BF01739854; Uyeda TQP, 2002, BIOCHEMISTRY-US, V41, P9525, DOI 10.1021/bi026177i; WELLS JA, 1979, P NATL ACAD SCI USA, V76, P4966, DOI 10.1073/pnas.76.10.4966; WELLS JA, 1980, J BIOL CHEM, V255, P1598; Wu Y, 1999, GENETICS, V153, P107; Yang YT, 2007, STRUCTURE, V15, P553, DOI 10.1016/j.str.2007.03.010	38	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35051	35060		10.1074/jbc.M111.265298	http://dx.doi.org/10.1074/jbc.M111.265298			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21841195	Green Published, hybrid			2022-12-27	WOS:000295406300058
J	Xiong, F; Leonov, S; Howard, AC; Xiong, S; Zhang, B; Mei, L; McNeil, P; Simon, S; Xiong, WC				Xiong, Fei; Leonov, Sergey; Howard, Amber Cyan; Xiong, Shan; Zhang, Bin; Mei, Lin; McNeil, Paul; Simon, Sylvia; Xiong, Wen-Cheng			Receptor for Advanced Glycation End Products (RAGE) Prevents Endothelial Cell Membrane Resealing and Regulates F-actin Remodeling in a beta-Catenin-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; MULTILIGAND RECEPTOR; PATTERN-RECOGNITION; PROGRESSION FACTOR; REPAIR; ACTIVATION; PERTURBATION; PATHOGENESIS; REQUIREMENT	Receptor for advanced glycation end products (RAGE), an immunoglobin superfamily cell surface receptor, contributes to the vascular pathology associated with multiple disorders, including Alzheimer disease (AD), diabetic complications, and inflammatory conditions. However, the underlying mechanisms remain largely unclear. Here, using the human umbilical vein endothelial cell line (ECV-304) expressing human RAGE, we report that RAGE expression leads to an altered F-actin organization and impaired membrane resealing. To investigate the underlying mechanisms, we showed that RAGE expression increases beta-catenin level, which decreases F-actin stress fibers and attenuates plasma membrane resealing. These results thus suggest a negative function for RAGE in endothelial cell membrane repair and reveal a new mechanism underlying RAGE regulation of F-actin remodeling and membrane resealing.	[Xiong, Fei; Xiong, Shan; Zhang, Bin; Mei, Lin; Xiong, Wen-Cheng] Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Xiong, Fei; Xiong, Shan; Zhang, Bin; Mei, Lin; Xiong, Wen-Cheng] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA 30912 USA; [Howard, Amber Cyan; McNeil, Paul] Georgia Hlth Sci Univ, Dept Cell Biol & Anat, Augusta, GA 30912 USA; [Xiong, Fei] Wuhan Univ, Sch Med, Wuhan 430071, Hubei, Peoples R China; [Leonov, Sergey; Simon, Sylvia] AstraZeneca R&D Sodertalje, Dept Neurosci, S-15185 Sodertalje, Sweden; [Leonov, Sergey; Simon, Sylvia] AstraZeneca R&D Sodertalje, Dept Translat Sci, CNS, S-15185 Sodertalje, Sweden; [Leonov, Sergey; Simon, Sylvia] AstraZeneca R&D Sodertalje, Pain Innovat Med, S-15185 Sodertalje, Sweden	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Wuhan University; AstraZeneca; AstraZeneca; AstraZeneca	Xiong, WC (corresponding author), Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA 30912 USA.	wxiong@georgiahealth.edu	Mei, Lin/G-8755-2012; Leonov, Sergey V/M-5514-2013	Leonov, Sergey V/0000-0002-3425-723X; Zhang, Bin/0000-0003-1323-8678	National Institutes of Health, NIAMS [AR048120]; AstraZeneca, Inc.; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048120] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000838] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); AstraZeneca, Inc.(AstraZeneca); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health, NIAMS, Grant AR048120 (to W.-C.X.). This study was also supported by AstraZeneca, Inc.	Allmen EU, 2008, PROSTATE, V68, P748, DOI 10.1002/pros.20736; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Bucciarelli LG, 2002, CELL MOL LIFE SCI, V59, P1117, DOI 10.1007/s00018-002-8491-x; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chen X, 2007, CURR MOL MED, V7, P735; Cui S, 2011, J BONE MINER RES, V26, P1084, DOI 10.1002/jbmr.299; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Giri R, 2000, AM J PHYSIOL-CELL PH, V279, pC1772, DOI 10.1152/ajpcell.2000.279.6.C1772; Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848; Hirose A, 2010, FEBS LETT, V584, P61, DOI 10.1016/j.febslet.2009.11.082; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hong Z, 2009, CELL RES, V19, P1334, DOI 10.1038/cr.2009.130; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jeynes B, 2008, CURR ALZHEIMER RES, V5, P432, DOI 10.2174/156720508785908937; Kuchler-Bopp S, 1999, NEUROREPORT, V10, P1347, DOI 10.1097/00001756-199904260-00035; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; McNeil P. L., 2001, CURR PROTOC CELL BIO; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; McNeil PL, 2002, J CELL SCI, V115, P873; Miyake K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000687; Miyata T, 1996, J CLIN INVEST, V98, P1088, DOI 10.1172/JCI118889; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Rho JH, 2009, PROTEIN J, V28, P148, DOI 10.1007/s10930-009-9177-0; Schmidt AM, 2000, TRENDS ENDOCRIN MET, V11, P368, DOI 10.1016/S1043-2760(00)00311-8; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI200114002; Schmidt AM, 1996, DIABETES, V45, pS77, DOI 10.2337/diab.45.3.S77; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Weisleder Noah, 2009, Commun Integr Biol, V2, P225; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SD, 1998, RESTOR NEUROL NEUROS, V12, P167; Yan SD, 2009, J ALZHEIMERS DIS, V16, P833, DOI 10.3233/JAD-2009-1030; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007; Zhou Z, 2006, J EXP MED, V203, P1067, DOI 10.1084/jem.20051947; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440	43	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35061	35070		10.1074/jbc.M111.261073	http://dx.doi.org/10.1074/jbc.M111.261073			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21844192	hybrid, Green Published			2022-12-27	WOS:000295406300059
J	Bulat, E; Garrett, TA				Bulat, Evgeny; Garrett, Teresa A.			Putative N-Acylphosphatidylethanolamine Synthase from Arabidopsis thaliana Is a Lysoglycerophospholipid Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; ESCHERICHIA-COLI; ELECTROSPRAY-IONIZATION; SALMONELLA-TYPHIMURIUM; RAT-BRAIN; IDENTIFICATION; BIOSYNTHESIS; MECHANISMS; PRECURSORS; ANANDAMIDE	AT1G78690, a gene found in Arabidopsis thaliana, has been reported to encode a N-acyltransferase that transfers an acyl chain from acyl-CoA to the headgroup of phosphatidylethanolamine (PE) to form N-acylphosphatidylethanolamine (N-acyl-PE). Our investigation suggests that At1g78690p is not a PE-dependent N-acyltransferase but is instead a lysoglycerophospholipid O-acyltransferase. We overexpressed AT1G78690 in Escherichia coli, extracted the cellular lipids, and identified the accumulating glycerophospholipid as acylphosphatidylglycerol (acyl-PG). Electrospray ionization quadrupole time-of-flight mass spectrometry (ESI-MS) analysis yielded [M - H](-) ions, corresponding by exact mass to acyl-PG rather than N-acyl-PE. Collision-induced dissociation mass spectrometry (MS/MS) yielded product ions consistent with acyl-PG. In addition, in vitro enzyme assays using both P-32- and C-14-radiolabeled substrates showed that AT1G78690 acylates 1-acyllysophosphatidylethanolamine (1-acyllyso-PE) and 1-acyllysophosphatidylglycerol (1-acyllyso-PG), but not PE or phosphatidylglycerol (PG), to form a diacylated product that co-migrates with PE and PG, respectively. We analyzed the diacylated product formed by AT1G78690 using a combination of base hydrolysis, phospholipase D treatment, ESI-MS, and MS/MS to show that AT1G78690 acylates the sn-2-position of 1-acyllyso-PE and 1-acyllyso-PG.	[Bulat, Evgeny; Garrett, Teresa A.] Vassar Coll, Dept Chem, Poughkeepsie, NY 12604 USA	Vassar College	Garrett, TA (corresponding author), Box 580,124 Raymond Ave, Poughkeepsie, NY 12604 USA.	tegarrett@vassar.edu		Bulat, Evgeny/0000-0002-8444-0067	National Institutes of Health [GM 069338]; National Science Foundation [1039659]; Research Corporation for Science Advancement Cottrell College [7914]; Direct For Mathematical & Physical Scien [1039659] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Research Corporation for Science Advancement Cottrell College(Research Corporation for Science Advancement); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health LIPID MAPS Large Scale Collaborative Grant GM 069338 (to Christian R.H. Raetz). This work was also supported by National Science Foundation Major Research Instrumentation Award 1039659 and Research Corporation for Science Advancement Cottrell College Science Single Investigator Award 7914.	Astarita G, 2008, J LIPID RES, V49, P48, DOI 10.1194/jlr.M700354-JLR200; Bishop RE, 2005, MOL MICROBIOL, V57, P900, DOI 10.1111/j.1365-2958.2005.04711.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cadas H, 1997, J NEUROSCI, V17, P1226; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Chapman KD, 1997, PLANT CELL PHYSIOL, V38, P1359, DOI 10.1093/oxfordjournals.pcp.a029130; Chapman KD, 2000, CHEM PHYS LIPIDS, V108, P221, DOI 10.1016/S0009-3084(00)00198-5; CHAPMAN KD, 1993, ARCH BIOCHEM BIOPHYS, V301, P21, DOI 10.1006/abbi.1993.1110; CHAPMAN KD, 1993, PLANT PHYSIOL, V102, P761, DOI 10.1104/pp.102.3.761; Coulon D., 2011, J BIOCH IN PRESS; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Faure L, 2009, J BIOL CHEM, V284, P18734, DOI 10.1074/jbc.M109.005744; Garrett T. A., 2011, BIOCH BIOPH IN PRESS; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; Garrett TA, 1998, J BIOL CHEM, V273, P12457, DOI 10.1074/jbc.273.20.12457; Garrett TA, 2009, J LIPID RES, V50, P1589, DOI 10.1194/jlr.M800549-JLR200; Guo LL, 2010, ANAL BIOCHEM, V405, P236, DOI 10.1016/j.ab.2010.06.027; GUPTA SD, 1993, J BIOL CHEM, V268, P16551; Holmback J, 2001, LIPIDS, V36, P153, DOI 10.1007/s11745-001-0702-z; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P892, DOI 10.1016/S1044-0305(00)00159-8; Hsu FF, 2004, J AM SOC MASS SPECTR, V15, P1, DOI 10.1016/j.jasms.2003.08.006; Hsu FF, 2009, J CHROMATOGR B, V877, P2673, DOI 10.1016/j.jchromb.2009.02.033; IMAMURA S, 1978, J BIOCHEM-TOKYO, V83, P677, DOI 10.1093/oxfordjournals.jbchem.a131960; Janssen MJW, 1999, PROTEIN ENG, V12, P497, DOI 10.1093/protein/12.6.497; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Jin XH, 2009, BBA-MOL CELL BIOL L, V1791, P32, DOI 10.1016/j.bbalip.2008.09.006; KARASAWA K, 1985, J BIOCHEM, V98, P1117, DOI 10.1093/oxfordjournals.jbchem.a135360; Kilaru A, 2007, CHEM BIODIVERS, V4, P1933, DOI 10.1002/cbdv.200790161; KOBAYASHI T, 1984, J BIOCHEM, V96, P137, DOI 10.1093/oxfordjournals.jbchem.a134805; KOBAYASHI T, 1985, J BIOCHEM-TOKYO, V98, P1017, DOI 10.1093/oxfordjournals.jbchem.a135347; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Merkel O, 2005, BBA-MOL CELL BIOL L, V1734, P215, DOI 10.1016/j.bbalip.2005.03.004; Metzger LE, 2009, BIOCHEMISTRY-US, V48, P11559, DOI 10.1021/bi901750f; Mileykovskaya E, 2009, J BIOL CHEM, V284, P2990, DOI 10.1074/jbc.M805189200; Miller J.H., 1972, EXPT MOL GENETICS; NAGGERT J, 1991, J BIOL CHEM, V266, P11044; NATARAJAN V, 1982, BIOCHIM BIOPHYS ACTA, V712, P342, DOI 10.1016/0005-2760(82)90352-6; Petersen G, 2006, BBA-MOL CELL BIOL L, V1761, P143, DOI 10.1016/j.bbalip.2005.12.011; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Rawyler AJ, 2001, PLANT PHYSIOL, V127, P240, DOI 10.1104/pp.127.1.240; Schmid HHO, 2000, CHEM PHYS LIPIDS, V108, P71, DOI 10.1016/S0009-3084(00)00188-2; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Stalberg K, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; Ueda N, 2010, BBA-MOL CELL BIOL L, V1801, P1274, DOI 10.1016/j.bbalip.2010.08.010; WANG AY, 1994, MOL MICROBIOL, V11, P1009, DOI 10.1111/j.1365-2958.1994.tb00379.x; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200	48	21	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33819	33831		10.1074/jbc.M111.269779	http://dx.doi.org/10.1074/jbc.M111.269779			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21803774	Green Published, hybrid			2022-12-27	WOS:000295159200013
J	Nagashima, S; Fukuda, T; Kubota, Y; Sugiura, A; Nakao, M; Inatome, R; Yanagi, S				Nagashima, Shun; Fukuda, Toshifumi; Kubota, Yuka; Sugiura, Ayumu; Nakao, Mitsuyoshi; Inatome, Ryoko; Yanagi, Shigeru			CRMP5-associated GTPase (CRAG) Protein Protects Neuronal Cells against Cytotoxicity of Expanded Polyglutamine Protein Partially via c-Fos-dependent Activator Protein-1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMYELOCYTIC LEUKEMIA PROTEIN; HUNTINGTONS-DISEASE; SERUM RESPONSE; SULFINIC ACID; MOUSE MODEL; BINDING; RICH; PML; PHOSPHORYLATION; IDENTIFICATION	We previously demonstrated that CRAM (CRMP5)-associated GTPase (CRAG), a short splicing variant of centaurin-gamma 3/AGAP3, facilitated degradation of expanded polyglutamine protein (polyQ) via the nuclear ubiquitin-proteasome pathway. Taking advantage of this feature, we also showed that lentivirus-mediated CRAG expression in the Purkinje cells of mice expressing polyQ resulted in clearance of the polyQ aggregates and rescue from ataxia. However, the molecular basis of the function of CRAG in cell survival against polyQ remains unclear. Here we report that CRAG, but not centaurin-gamma 3, induces transcriptional activation of c-Fos-dependent activator protein-1 (AP-1) via serum response factor (SRF). Mutation analysis indicated that the nuclear localization signal and both the N- and C-terminal regions of CRAG are critical for SRF-dependent c-Fos activation. CRAG knockdown by siRNA or expression of a dominant negative mutant of CRAG significantly attenuated the c-Fos activation triggered by either polyQ or the proteasome inhibitor MG132. Importantly, c-Fos expression partially rescued the enhanced cytotoxicity of CRAG knockdown in polyQ-expressing or MG132-treated cells. Finally, we suggest the possible involvement of CRAG in the sulfiredoxin-mediated antioxidant pathway via AP-1. Taken together, these results demonstrated that CRAG enhances the cell survival signal against the accumulation of unfolded proteins, including polyQ, through not only proteasome activation, but also the activation of c-Fos-dependent AP-1.	[Nagashima, Shun; Fukuda, Toshifumi; Kubota, Yuka; Sugiura, Ayumu; Inatome, Ryoko; Yanagi, Shigeru] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Mol Biochem, Tokyo 1920392, Japan; [Nakao, Mitsuyoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto 8600811, Japan	Tokyo University of Pharmacy & Life Sciences; Kumamoto University	Yanagi, S (corresponding author), 1432-1 Horinouchi, Tokyo 1920392, Japan.	syanagi@toyaku.ac.jp	Yanagi, Shigeru/AAU-9513-2020; Sugiura, Ayumu/G-3648-2018	Yanagi, Shigeru/0000-0002-1392-8663; Sugiura, Ayumu/0000-0002-4776-1478	Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Naito Foundation; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported in part by Grants-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology and the Japan Society for the Promotion of Science (to T. F., R. I., and S. Y.), the Naito Foundation, the Takeda Science Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Uehara Memorial Foundation.	BARBER JR, 1987, MOL CELL BIOL, V7, P2201, DOI 10.1128/MCB.7.6.2201; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; D'Orso I, 2002, J BIOL CHEM, V277, P50520, DOI 10.1074/jbc.M209092200; Garcia M, 2004, NEUROSCIENCE, V127, P859, DOI 10.1016/j.neuroscience.2004.05.054; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hotta A, 2005, MOL BIOL CELL, V16, P32, DOI 10.1091/mbc.E04-08-0679; Inatome R, 2000, J BIOL CHEM, V275, P27291; Iwatsuki M, 2011, TOXICOL APPL PHARM, V251, P209, DOI 10.1016/j.taap.2010.12.015; Izzo A, 2008, NUCLEIC ACIDS RES, V36, P950, DOI 10.1093/nar/gkm1108; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004; Li F, 2005, MOL CELL BIOL, V25, P8913, DOI 10.1128/MCB.25.20.8913-8924.2005; Matsuzaki K, 2003, GENES CELLS, V8, P275, DOI 10.1046/j.1365-2443.2003.00632.x; Merienne K, 2003, J BIOL CHEM, V278, P16957, DOI 10.1074/jbc.M212049200; Meurer S, 2004, J BIOL CHEM, V279, P49346, DOI 10.1074/jbc.M410565200; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Qin QY, 2006, J CELL BIOL, V172, P497, DOI 10.1083/jcb.200505079; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Rubinsztein David C, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006549; Salomoni P, 2005, BLOOD, V105, P3686, DOI 10.1182/blood-2004-09-3782; Samaj J, 2002, EMBO J, V21, P3296, DOI 10.1093/emboj/cdf349; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Sugiura A, 2011, MITOCHONDRION, V11, P139, DOI 10.1016/j.mito.2010.09.001; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Torashima T, 2008, EMBO REP, V9, P393, DOI 10.1038/embor.2008.31; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Xie YX, 2010, J NEUROSCI, V30, P14708, DOI 10.1523/JNEUROSCI.1637-10.2010; Yuan ZM, 2009, MOL CELL BIOL, V29, P2431, DOI 10.1128/MCB.01344-08; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859	37	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33879	33889		10.1074/jbc.M111.234997	http://dx.doi.org/10.1074/jbc.M111.234997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832068	Green Published, hybrid			2022-12-27	WOS:000295159200020
J	Hwangbo, C; Park, J; Lee, JH				Hwangbo, Cheol; Park, Juhee; Lee, Jeong-Hyung			mda-9/Syntenin Protein Positively Regulates the Activation of Akt Protein by Facilitating Integrin-linked Kinase Adaptor Function during Adhesion to Type I Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-MELANOMA CELLS; CH-ILKBP; FOCAL ADHESIONS; CANCER-CELLS; HUMAN BREAST; PDZ DOMAINS; LOCALIZATION; SYNTENIN; BINDING; PINCH	The integrin-linked kinase (ILK)-PINCH1-alpha-parvin (IPP) complex functions as a signaling platform for integrins that modulates various cellular processes. ILK functions as a central adaptor for the assembly of IPP complex. We report here that mda-9/syntenin, a positive regulator of cancer metastasis, regulates the activation of Akt (also known as protein kinase B) by facilitating ILK adaptor function during adhesion to type I collagen (COL-I) in human breast cancer cells. COL-I stimulation induced the phosphorylation and plasma membrane translocation of Akt. Inhibition of mda-9/syntenin or expression of mutant ILK (E359K) significantly blocked the translocation of both ILK and Akt to the plasma membrane. mda-9/syntenin associated with ILK, and this association was increased at the plasma membrane by COL-I stimulation. Knockdown of mda-9/syntenin impaired COL-I-induced association of ILK with Akt and plasma membrane targeting of ILK-Akt complex. These results demonstrated that mda-9/syntenin regulates the activation of Akt by controlling the plasma membrane targeting of Akt via a mechanism that facilitates the association of Akt with ILK at the plasma membrane during adhesion to COL-I. On a striking note, inhibition of mda-9/syntenin impaired COL-I-induced plasma membrane translocation of the IPP complex and assembly of integrin beta 1-IPP signaling complexes. Thus, our study defines the role of mda-9/syntenin in ILK adaptor function and describes a new mechanism of mda-9/syntenin for regulation of cell migration.	[Lee, Jeong-Hyung] Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea; Kangwon Natl Univ, Med & Biomat Res Ctr, Chunchon 200701, South Korea	Kangwon National University; Kangwon National University	Lee, JH (corresponding author), Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea.	jhlee36@kangwon.ac.kr			National Research Foundation of Korea [2009-0073826, 2010-0007366]; Regional Research Core Research Program/Medical and Biomaterials Research Center; Ministry of Education, Science, and Technology	National Research Foundation of Korea(National Research Foundation of Korea); Regional Research Core Research Program/Medical and Biomaterials Research Center; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Basic Science Research Program Grants 2009-0073826 and 2010-0007366 through the National Research Foundation of Korea and the Regional Research Core Research Program/Medical and Biomaterials Research Center funded by the Ministry of Education, Science, and Technology.	Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Boukerche H, 2007, CANCER RES, V67, P1812, DOI 10.1158/0008-5472.CAN-06-3875; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; Dai DL, 2003, CLIN CANCER RES, V9, P4409; Dash R, 2010, ONCOGENE, V29, P4412, DOI 10.1038/onc.2010.194; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Fukuda K, 2011, J BIOL CHEM, V286, P21886, DOI 10.1074/jbc.M111.240093; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Fukuda T, 2003, J CELL BIOL, V160, P1001, DOI 10.1083/jcb.200212113; Grembecka J, 2006, BIOCHEMISTRY-US, V45, P3674, DOI 10.1021/bi052225y; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Hwangbo C, 2010, CANCER RES, V70, P1645, DOI 10.1158/0008-5472.CAN-09-2447; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Kang BS, 2003, STRUCTURE, V11, P459, DOI 10.1016/S0969-2126(03)00052-2; Kim KK, 2008, CARCINOGENESIS, V29, P704, DOI 10.1093/carcin/bgn031; Koo TH, 2002, ONCOGENE, V21, P4080, DOI 10.1038/sj.onc.1205514; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li FG, 1999, J CELL SCI, V112, P4589; Ling L, 2000, J BIOL CHEM, V275, P23852, DOI 10.1074/jbc.M001095200; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Meerschaert K, 2007, EXP CELL RES, V313, P1790, DOI 10.1016/j.yexcr.2007.03.014; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Papachristou DJ, 2008, EUR J CANCER, V44, P2518, DOI 10.1016/j.ejca.2008.07.021; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Restuccia DF, 2009, SCIENCE, V325, P1083, DOI 10.1126/science.1179972; Sarkar D, 2008, CANCER RES, V68, P3087, DOI 10.1158/0008-5472.CAN-07-6210; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	44	20	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33601	33612		10.1074/jbc.M110.206789	http://dx.doi.org/10.1074/jbc.M110.206789			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828040	hybrid, Green Published			2022-12-27	WOS:000294968800076
J	Dang, HQ; Li, ZY				Dang, Hung Quang; Li, Ziyin			The Cdc45.Mcm2-7.GINS Protein Complex in Trypanosomes Regulates DNA Replication and Interacts with Two Orc1-like Proteins in the Origin Recognition Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; S-PHASE PROGRESSION; CELL-CYCLE; BUDDING YEAST; CHROMOSOMAL DNA; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC DNA; NUCLEAR EXPORT; PROCYCLIC FORM; MULTIPROTEIN COMPLEX	Accurate DNA replication requires a complex interplay of many regulatory proteins at replication origins. The CMG (Cdc45.Mcm2-7.GINS) complex, which is composed of Cdc45, Mcm2-7, and the GINS (Go-Ichi-Ni-San) complex consisting of Sld5 and Psf1 to Psf3, is recruited by Cdc6 and Cdt1 onto origins bound by the heterohexameric origin recognition complex (ORC) and functions as a replicative helicase. Trypanosoma brucei, an early branched microbial eukaryote, appears to express an archaea-like ORC consisting of a single Orc1/Cdc6-like protein. However, unlike archaea, trypanosomes possess components of the eukaryote-like CMG complex, but whether they form an active helicase complex, associate with the ORC, and regulate DNA replication remains unknown. Here, we demonstrated that the CMG complex is formed in vivo in trypanosomes and thatMcm2-7 helicase activity is activated by the association with Cdc45 and the GINS complex in vitro. Mcm2-7 and GINS proteins are confined to the nucleus throughout the cell cycle, whereas Cdc45 is exported out of the nucleus after DNA replication, indicating that nuclear exclusion of Cdc45 constitutes one mechanism for preventing DNA re-replication in trypanosomes. With the exception of Mcm4, Mcm6, and Psf1, knockdown of individual CMG genes inhibits DNA replication and cell proliferation. Finally, we identified a novel Orc1-like protein, Orc1b, as an additional component of the ORC and showed that both Orc1b and Orc1/Cdc6 associate with Mcm2-7 via interactions with Mcm3. All together, we identified the Cdc45.Mcm2-7.GINS complex as the replicative helicase that interacts with two Orc1-like proteins in the unusual origin recognition complex in trypanosomes.	[Dang, Hung Quang; Li, Ziyin] Univ Texas Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Li, ZY (corresponding author), Univ Texas Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu		Li, Ziyin/0000-0002-3960-9716	National Institutes of Health [AI090070]; University of Texas Medical School at Houston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI090070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Medical School at Houston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI090070 (to Z. L.) and by start-up funds from the University of Texas Medical School at Houston (to Z. L.).	Akita M, 2010, GENES CELLS, V15, P537, DOI 10.1111/j.1365-2443.2010.01402.x; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Godoy PDD, 2009, EUKARYOT CELL, V8, P1592, DOI 10.1128/EC.00161-09; Devault A, 2008, MOL BIOL CELL, V19, P2267, DOI 10.1091/mbc.E07-06-0614; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gourguechon S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-68; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2004, J BIOL CHEM, V279, P24757, DOI 10.1074/jbc.M401276200; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Hellman K, 2007, EUKARYOT CELL, V6, P2206, DOI 10.1128/EC.00176-07; Huang HK, 2005, MOL CELL BIOL, V25, P9000, DOI 10.1128/MCB.25.20.9000-9015.2005; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Li Y, 2003, MOL MICROBIOL, V49, P251, DOI 10.1046/j.1365-2958.2003.03575.x; Li ZY, 2008, EUKARYOT CELL, V7, P1941, DOI 10.1128/EC.00249-08; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000575; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003814; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Liku ME, 2005, MOL BIOL CELL, V16, P5026, DOI 10.1091/mbc.E05-05-0412; MacNeill SA, 2010, BIOCHEM J, V425, P489, DOI 10.1042/BJ20091531; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nigg Erich A., 1993, Trends in Cell Biology, V3, P296, DOI 10.1016/0962-8924(93)90011-O; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Ogbadoyi E, 2000, CHROMOSOMA, V108, P501, DOI 10.1007/s004120050402; Sanchez-Pulido L, 2011, BIOINFORMATICS, V27, P1885, DOI 10.1093/bioinformatics/btr332; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	65	38	38	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32424	32435		10.1074/jbc.M111.240143	http://dx.doi.org/10.1074/jbc.M111.240143			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21799014	Green Published, hybrid			2022-12-27	WOS:000294726800052
J	Casutt, MS; Nedielkov, R; Wendelspiess, S; Vossler, S; Gerken, U; Murai, M; Miyoshi, H; Moller, HM; Steuber, J				Casutt, Marco S.; Nedielkov, Ruslan; Wendelspiess, Severin; Vossler, Sara; Gerken, Uwe; Murai, Masatoshi; Miyoshi, Hideto; Moeller, Heiko M.; Steuber, Julia			Localization of Ubiquinone-8 in the Na+-pumping NADH: Quinone Oxidoreductase from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; SECONDARY STRUCTURE ANALYSES; ESCHERICHIA-COLI; NADHQUINONE OXIDOREDUCTASE; PROSTHETIC GROUPS; REDOX PROPERTIES; BINDING-SITE; SPECTROSCOPY; ALGINOLYTICUS; PURIFICATION	Na+ is the second major coupling ion at membranes after protons, and many pathogenic bacteria use the sodium-motive force to their advantage. A prominent example is Vibrio cholerae, which relies on the Na+-pumping NADH: quinone oxidoreductase (Na+-NQR) as the first complex in its respiratory chain. The Na+-NQR is a multisubunit, membrane-embedded NADH dehydrogenase that oxidizes NADH and reduces quinone to quinol. Existing models describing redox-driven Na+ translocation by the Na+-NQR are based on the assumption that the pump contains four flavins and one FeS cluster. Here we show that the large, peripheral NqrA subunit of the Na+-NQR binds one molecule of ubiquinone-8. Investigations of the dynamic interaction of NqrA with quinones by surface plasmon resonance and saturation transfer difference NMR reveal a high affinity, which is determined by the methoxy groups at the C-2 and C-3 positions of the quinone headgroup. Using photoactivatable quinone derivatives, it is demonstrated that ubiquinone-8 bound to NqrA occupies a functional site. A novel scheme of electron transfer in Na+-NQR is proposed that is initiated by NADH oxidation on subunit NqrF and leads to quinol formation on subunit NqrA.	[Nedielkov, Ruslan; Moeller, Heiko M.] Univ Konstanz, Dept Chem, D-78457 Constance, Germany; [Casutt, Marco S.] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany; [Wendelspiess, Severin; Vossler, Sara; Gerken, Uwe; Steuber, Julia] Univ Stuttgart Hohenheim, Inst Microbiol, D-70599 Stuttgart, Germany; [Murai, Masatoshi; Miyoshi, Hideto] Kyoto Univ, Div Appl Life Sci, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan	University of Konstanz; University of Freiburg; University Hohenheim; Kyoto University	Moller, HM (corresponding author), Univ Konstanz, Dept Chem, D-78457 Constance, Germany.	heiko.moeller@uni-konstanz.de; julia.steuber@uni-hohenheim.de	Möller, Heiko/AAX-1075-2020; Möller, Heiko/N-1847-2013	Möller, Heiko/0000-0002-5795-1195; Murai, Masatoshi/0000-0001-6601-2854	Swiss National Science Foundation [PP0033-118994]; Baden-Wurttemberg Stiftung; Forschungsprogramm P-LS-Meth/4; Japan Society for the Promotion of Science [20380068]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Baden-Wurttemberg Stiftung; Forschungsprogramm P-LS-Meth/4; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Swiss National Science Foundation (Grant PP0033-118994) (to J. S.), by contract research of the Baden-Wurttemberg Stiftung, Forschungsprogramm P-LS-Meth/4 (to J. S. and H. M. M.), and by Grant-in-Aid for Scientific Research 20380068 from the Japan Society for the Promotion of Science (to H. M.).	Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Dahinden P, 2005, ARCH MICROBIOL, V183, P121, DOI 10.1007/s00203-004-0754-5; GAGNE SM, 1994, PROTEIN SCI, V3, P1961, DOI 10.1002/pro.5560031108; Grimaldi S, 2003, BIOCHEMISTRY-US, V42, P5632, DOI 10.1021/bi034010z; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hayashi M, 2002, ARCH BIOCHEM BIOPHYS, V401, P173, DOI 10.1016/S0003-9861(02)00007-3; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Johnson A. R, 1971, BIOCH METHODOLOGY LI, P131; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Lin PC, 2007, J BACTERIOL, V189, P3902, DOI 10.1128/JB.01651-06; Matsumoto Y, 2006, J BIOL CHEM, V281, P1905, DOI 10.1074/jbc.M508206200; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Murai M, 2010, BIOCHEMISTRY-US, V49, P2973, DOI 10.1021/bi100005j; Nakayama Y, 1998, FEBS LETT, V422, P240, DOI 10.1016/S0014-5793(98)00016-7; PENZER GR, 1967, Q REV CHEM SOC, V21, P43, DOI 10.1039/qr9672100043; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; Tao ML, 2008, BBA-BIOENERGETICS, V1777, P696, DOI 10.1016/j.bbabio.2008.04.006; Turk K, 2004, J BIOL CHEM, V279, P21349, DOI 10.1074/jbc.M311692200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	27	36	36	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40075	40082		10.1074/jbc.M111.224980	http://dx.doi.org/10.1074/jbc.M111.224980			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21885438	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000296925700040
J	Klemm, EJ; Spooner, E; Ploegh, HL				Klemm, Elizabeth J.; Spooner, Eric; Ploegh, Hidde L.			Dual Role of Ancient Ubiquitous Protein 1 (AUP1) in Lipid Droplet Accumulation and Endoplasmic Reticulum (ER) Protein Quality Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUE DOMAIN; MISFOLDED GLYCOPROTEINS; DEGRADATION; DISLOCATION; MEMBRANE; COMPLEX; GP78; UBIQUITINATION; BINDING; REVEALS	Quality control of endoplasmic reticulum proteins involves the identification and engagement of misfolded proteins, dislocation of the misfolded protein across the endoplasmic reticulum (ER) membrane, and ubiquitin-mediated targeting to the proteasome for degradation. Ancient ubiquitous protein 1 (AUP1) physically associates with the mammalian HRD1-SEL1L complex, and AUP1 depletion impairs degradation of misfolded ER proteins. One of the functions of AUP1 in ER quality control is to recruit the soluble E2 ubiquitin-conjugating enzyme UBE2G2. We further show that the CUE domain of AUP1 regulates polyubiquitylation and facilitates the interaction of AUP1 with the HRD1 complex and with dislocation substrates. AUP1 localizes both to the ER and to lipid droplets. The AUP1 expression level affects the abundance of cellular lipid droplets and as such represents the first protein with lipid droplet regulatory activity to be linked to ER quality control. These findings indicate a possible connection between ER protein quality control and lipid droplets.	[Klemm, Elizabeth J.; Spooner, Eric; Ploegh, Hidde L.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Ploegh, HL (corresponding author), 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu						Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0315S29; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Davies BA, 2003, J BIOL CHEM, V278, P19826, DOI 10.1074/jbc.M301059200; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Edwards TL, 2009, BIOCHEM J, V423, P31, DOI 10.1042/BJ20082398; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Kato A, 2002, J BIOL CHEM, V277, P28934, DOI 10.1074/jbc.M204340200; Kato A, 2009, PLATELETS, V20, P105, DOI 10.1080/09537100802641507; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Kostova Z, 2009, J CELL SCI, V122, P1374, DOI 10.1242/jcs.044255; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Masuda Y, 2006, J LIPID RES, V47, P87, DOI 10.1194/jlr.M500170-JLR200; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Spandl J, 2011, J BIOL CHEM, V286, P5599, DOI 10.1074/jbc.M110.190785; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; TSAO YS, 1992, J CELL BIOL, V116, P57, DOI 10.1083/jcb.116.1.57; Vyas JM, 2007, J IMMUNOL, V178, P7199, DOI 10.4049/jimmunol.178.11.7199; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Xu GH, 2006, BBA-MOL CELL BIOL L, V1761, P83, DOI 10.1016/j.bbalip.2005.12.005; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	61	76	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37602	37614		10.1074/jbc.M111.284794	http://dx.doi.org/10.1074/jbc.M111.284794			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21857022	hybrid, Green Published			2022-12-27	WOS:000296542400058
J	Markovics, JA; Araya, J; Cambier, S; Somanath, S; Gline, S; Jablons, D; Hill, A; Wolters, PJ; Nishimura, SL				Markovics, Jennifer A.; Araya, Jun; Cambier, Stephanie; Somanath, Sangeeta; Gline, Stephanie; Jablons, David; Hill, Arthur; Wolters, Paul J.; Nishimura, Stephen L.			Interleukin-1 beta Induces Increased Transcriptional Activation of the Transforming Growth Factor-beta-activating Integrin Subunit beta 8 through Altering Chromatin Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTEIN-KINASE; PULMONARY INFLAMMATION; HISTONE DEACETYLASE; GENE-EXPRESSION; LUNG; ALPHA-V-BETA-8; CELLS; P38; DIFFERENTIATION	The integrin alpha v beta 8 is a cell surface receptor for the latent domain (LAP) of the multifunctional cytokine TGF-beta. Through its association with LAP, TGF-beta is maintained in a latent form that must be activated to function. Binding to the integrin alpha v beta 8 with subsequent metalloproteolytic cleavage of LAP represents a major mechanism of TGF-beta activation in vivo. Altered expression of the integrin beta 8 subunit (ITGB8) is found in human chronic obstructive pulmonary disease, cancers, and brain vascular malformations. We have previously shown that the proinflammatory cytokine interleukin-1 beta (IL-1 beta) increases ITGB8 expression on lung fibroblasts, which increases alpha v beta 8-mediated TGF-beta activation in fibrosis and pathologic inflammation. Here we report the mechanism of increased ITGB8 expression by IL-1 beta. Our data support a model where the chromatin architecture of the ITGB8 core promoter is altered by nucleosomal repositioning that enhances the interaction of an AP1 complex (containing c-Jun and ATF2). This repositioning is caused by the dissociation of HDAC2 with the ITGB8 core promoter, leading to increased histone H4 acetylation and a loosening of nucleosomal-DNA interactions allowing "opening" of the chromatin structure and increased association of c-Jun and ATF-2. These changes are mediated through NF kappa B- and p38-dependent pathways. Ultimately, these events culminate in increasing ITGB8 transcription, alpha v beta 8 surface expression, and alpha v beta 8-mediated TGF beta activation.	[Markovics, Jennifer A.; Cambier, Stephanie; Somanath, Sangeeta; Nishimura, Stephen L.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94110 USA; [Gline, Stephanie; Jablons, David; Hill, Arthur] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94110 USA; [Wolters, Paul J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA; [Wolters, Paul J.] Univ Calif San Francisco, Sch Med, Div Pulm, Lung Biol Ctr, San Francisco, CA 94110 USA; [Araya, Jun] Jikei Univ, Sch Med, Dept Internal Med, Div Resp Dis, Tokyo 1058461, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Jikei University	Nishimura, SL (corresponding author), UCSF SFGH, Bldg 3,Rm 211,1001 Potrero Ave, San Francisco, CA 94110 USA.	stephen.nishimura@ucsf.edu			National Institutes of Health [HL090662, ARRA HL63993, NS04415]; University of California; San Francisco Resource Allocation Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063993, R01HL090662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); San Francisco Resource Allocation Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL090662, ARRA HL63993, and NS04415 (to S. L. N.).; Supported by the University of California, San Francisco Resource Allocation Program.	Adenuga D, 2009, AM J RESP CELL MOL, V40, P464, DOI 10.1165/rcmb.2008-0255OC; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JCI32526; Araya J, 2010, ANNU REV PATHOL-MECH, V5, P77, DOI 10.1146/annurev.pathol.4.110807.092217; Barnes PJ, 2006, CHEST, V129, P151, DOI 10.1378/chest.129.1.151; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Cambier S, 2000, CANCER RES, V60, P7084; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Churg A, 2009, AM J RESP CELL MOL, V40, P482, DOI 10.1165/rcmb.2008-0038OC; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Ekberg-Jansson A, 2001, RESP MED, V95, P363, DOI 10.1053/rmed.2001.1050; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Hynes RO, 2004, MATRIX BIOL, V23, P333, DOI 10.1016/j.matbio.2004.08.001; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Jarad G, 2002, J BIOL CHEM, V277, P47826, DOI 10.1074/jbc.M204901200; Kim H, 2009, CEREBROVASC DIS, V27, P176, DOI 10.1159/000185609; Kitamura H, 2011, J CLIN INVEST, V121, P2863, DOI 10.1172/JCI45589; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Kotaru C, 2006, AM J RESP CRIT CARE, V173, P1208, DOI 10.1164/rccm.200508-1218OC; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Long DL, 2010, OSTEOARTHR CARTILAGE, V18, P1203, DOI 10.1016/j.joca.2010.05.016; Markovics JA, 2010, J BIOL CHEM, V285, P24695, DOI 10.1074/jbc.M110.113977; Melton AC, 2010, J CLIN INVEST, V120, P4436, DOI 10.1172/JCI43786; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Mu ZY, 2008, MECH DEVELOP, V125, P508, DOI 10.1016/j.mod.2008.01.003; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; NISHIMURA SL, 1994, J BIOL CHEM, V269, P28708; Nishimura SL, 2009, AM J PATHOL, V175, P1362, DOI 10.2353/ajpath.2009.090393; Ridley SH, 1997, J IMMUNOL, V158, P3165; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Singh B, 2010, Monaldi Arch Chest Dis, V73, P86; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Su H, 2010, AM J PATHOL, V176, P1018, DOI 10.2353/ajpath.2010.090453; Tomkinson A, 2001, J IMMUNOL, V166, P5792, DOI 10.4049/jimmunol.166.9.5792; Tomlinson KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013136; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Ulivi V, 2008, J CELL BIOCHEM, V104, P1393, DOI 10.1002/jcb.21717; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Wang X, 2006, CANCER RES, V66, P1089, DOI 10.1158/0008-5472.CAN-05-2698; Wilkinson TS, 2004, AM J RESP CELL MOL, V31, P92, DOI 10.1165/rcmb.2003-0380OC; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Zachlederova M, 2006, PHYSIOL RES, V55, P39, DOI 10.33549/physiolres.930703; Zhu JW, 2002, DEVELOPMENT, V129, P2891	54	28	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36864	36874		10.1074/jbc.M111.276790	http://dx.doi.org/10.1074/jbc.M111.276790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878622	Green Published, hybrid			2022-12-27	WOS:000296538300066
J	Qin, S; Jin, L; Zhang, JH; Liu, L; Ji, P; Wu, MA; Wu, JH; Shi, YY				Qin, Su; Jin, Lei; Zhang, Jiahai; Liu, Lei; Ji, Peng; Wu, Mian; Wu, Jihui; Shi, Yunyu			Recognition of Unmodified Histone H3 by the First PHD Finger of Bromodomain-PHD Finger Protein 2 Provides Insights into the Regulation of Histone Acetyltransferases Monocytic Leukemic Zinc-finger Protein (MOZ) and MOZ-related factor (MORF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOX GENE-EXPRESSION; AUTOIMMUNE REGULATOR; MOLECULAR-BASIS; BINDING; METHYLATION; CHROMATIN; LYSINE-4; COMPLEX; DOMAIN; NMR	MOZ (monocytic leukemic zinc-finger protein) and MORF (MOZ-related factor) are histone acetyltransferases important for HOX gene expression as well as embryo and postnatal development. They form complexes with other regulatory subunits through the scaffold proteins BRPF1/2/3 (bromodomain-PHD (plant homeodomain) finger proteins 1, 2, or 3). BRPF proteins have multiple domains, including two PHD fingers, for potential interactions with histones. Here we show that the first PHD finger of BRPF2 specifically recognizes the N-terminal tail of unmodified histone H3 (unH3) and report the solution structures of this PHD finger both free and in complex with the unH3 peptide. Structural analysis revealed that the unH3 peptide forms a third antiparallel beta-strand that pairs with the PHD1 two-stranded antiparallel beta-sheet. The binding specificity was determined primarily through the recognition of arginine 2 and lysine 4 of the unH3 by conserved aspartic acids of PHD1 and of threonine 6 of the unH3 by a conserved asparagine. Isothermal titration calorimetry and NMR assays showed that post-translational modifications such as H3R2me2as, H3T3ph, H3K4me, H3K4ac, and H3T6ph antagonized the interaction between histone H3 and PHD1. Furthermore, histone binding by PHD1 was important for BRPF2 to localize to the HOXA9 locus in vivo. PHD1 is highly conserved in yeast NuA3 and other histone acetyltransferase complexes, so the results reported here also shed light on the function and regulation of these complexes.	[Wu, Jihui; Shi, Yunyu] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Qin, Su/N-7404-2015; Jin, Lei/J-1896-2019; Shi, Yunyu/B-3240-2009; Qin, Su/Y-3750-2019; QIN, SU/H-8735-2015	Qin, Su/0000-0001-9437-6292; Jin, Lei/0000-0001-7187-9671; Shi, Yunyu/0000-0002-1348-4759; Qin, Su/0000-0001-9437-6292; Wu, Mian/0000-0002-2714-0500	Chinese National Natural Science Foundation [30830031]; National Basic Research Program of China (973 Program) [2011CB966302, 2011CB911104]; Chinese National High Technology RD Program [2006AA02A315]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National High Technology RD Program	This work was supported by Chinese National Natural Science Foundation Grant 30830031, National Basic Research Program of China (973 Program) Grants 2011CB966302 and 2011CB911104, and Chinese National High Technology R&D Program Grant 2006AA02A315.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Champagne KS, 2008, PROTEINS, V72, P1371, DOI 10.1002/prot.22140; Chignola F, 2009, NUCLEIC ACIDS RES, V37, P2951, DOI 10.1093/nar/gkp166; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Musselman CA, 2009, BIOCHEM J, V423, P179, DOI 10.1042/BJ20090870; Nebral K, 2009, LEUKEMIA, V23, P134, DOI 10.1038/leu.2008.306; O'Meara MM, 2010, GENETICS, V186, P1497, DOI 10.1534/genetics.110.123661; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Paggetti J, 2010, ONCOGENE, V29, P5019, DOI 10.1038/onc.2010.254; Perry J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-6; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Severinsen JE, 2006, MOL PSYCHIATR, V11, P1126, DOI 10.1038/sj.mp.4001885; Shen WQ, 2007, BIOCHEMISTRY-US, V46, P2100, DOI 10.1021/bi0611208; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Simonson T, 2002, PROTEINS, V49, P37, DOI 10.1002/prot.10200; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Thomas T, 2004, FRONT BIOSCI, V9, P24, DOI 10.2741/1208; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Voss AK, 2009, DEV CELL, V17, P674, DOI 10.1016/j.devcel.2009.10.006; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Xie W, 2009, J CELL MOL MED, V13, P1719, DOI 10.1111/j.1582-4934.2008.00423.x; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139	53	50	53	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36944	36955		10.1074/jbc.M111.244400	http://dx.doi.org/10.1074/jbc.M111.244400			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880731	hybrid, Green Published			2022-12-27	WOS:000296538300073
J	Leyn, SA; Li, XQ; Zheng, QX; Novichkov, PS; Reed, S; Romine, MF; Fredrickson, JK; Yang, C; Osterman, AL; Rodionov, DA				Leyn, Semen A.; Li, Xiaoqing; Zheng, Qingxiang; Novichkov, Pavel S.; Reed, Samantha; Romine, Margaret F.; Fredrickson, James K.; Yang, Chen; Osterman, Andrei L.; Rodionov, Dmitry A.			Control of Proteobacterial Central Carbon Metabolism by the HexR Transcriptional Regulator A CASE STUDY IN SHEWANELLA ONEIDENSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPARATIVE GENOMIC RECONSTRUCTION; UTILIZATION PATHWAYS; PSEUDOMONAS-PUTIDA; GENE-EXPRESSION; PROTEIN; CATABOLISM; SEQUENCE; DOMAIN; NETWORKS; REGULON	Background: Different regulatory strategies are utilized by bacteria to control central carbohydrate metabolism. Results: Transcriptional factor HexR is a global regulator of the central carbohydrate metabolism genes in various groups of proteobacterial genomes. Conclusion: HexR in Shewanella is a repressor/activator of the glycolytic/gluconeogenic genes. Significance: Integration of the comparative genomics and experimental approaches is efficient for reconstruction of transcriptional regulons in bacteria.	[Osterman, Andrei L.; Rodionov, Dmitry A.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Leyn, Semen A.; Rodionov, Dmitry A.] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow 127994, Russia; [Zheng, Qingxiang; Yang, Chen] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Novichkov, Pavel S.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Reed, Samantha; Romine, Margaret F.; Fredrickson, James K.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	Sanford Burnham Prebys Medical Discovery Institute; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Rodionov, DA (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rodionov@sanfordburnham.org	Leyn, Semen A/J-1069-2019; Rodionov, Dmitry/V-2688-2018	Leyn, Semen A/0000-0002-9886-9120; Romine, Margaret/0000-0002-0968-7641; Rodionov, Dmitry/0000-0002-0939-390X	United States Department of Energy, Office of Science [DE-AC05-76RLO]; Pacific Northwest National Laboratory; Sanford-Burnham Medical Research Institute; Lawrence Berkeley National Laboratory [DE-SC0004999]; National Science Foundation [DBI-0850546]; Russian Foundation for Basic Research [10-04-01768]; Russian Academy of Sciences; National Science Foundation of China [30970035, 31070033]; Chinese Academy of Sciences [KSCX2-EW-G-5]; Direct For Biological Sciences [0850546] Funding Source: National Science Foundation	United States Department of Energy, Office of Science(United States Department of Energy (DOE)); Pacific Northwest National Laboratory(United States Department of Energy (DOE)); Sanford-Burnham Medical Research Institute; Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by the United States Department of Energy, Office of Science, as part of the Genomic Science Program under Contract DE-AC05-76RLO with Pacific Northwest National Laboratory (Genomic Science Program Foundational Scientific Focus Area), Sanford-Burnham Medical Research Institute, Lawrence Berkeley National Laboratory Grant DE-SC0004999, National Science Foundation Grant DBI-0850546, Russian Foundation for Basic Research Grant 10-04-01768, and the Russian Academy of Sciences Program Molecular and Cellular Biology.; Supported by National Science Foundation of China Grants 30970035 and 31070033 and Knowledge Innovation Program of Chinese Academy of Sciences Grant KSCX2-EW-G-5.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 1999, TRENDS BIOCHEM SCI, V24, P94, DOI 10.1016/S0968-0004(99)01357-2; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Collier DN, 1996, RES MICROBIOL, V147, P551, DOI 10.1016/0923-2508(96)84011-3; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daddaoua A, 2009, J BIOL CHEM, V284, P21360, DOI 10.1074/jbc.M109.014555; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; del Castillo T, 2008, J BACTERIOL, V190, P2331, DOI 10.1128/JB.01726-07; Driscoll ME, 2007, GENOME INFORM SER, V18, P287; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jaeger T, 2008, J BACTERIOL, V190, P6598, DOI 10.1128/JB.00642-08; Johnston JW, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-240; Kim J, 2008, MICROBIOL-SGM, V154, P3905, DOI 10.1099/mic.0.2008/020362-0; LESSIE TG, 1984, ANNU REV MICROBIOL, V38, P359, DOI 10.1146/annurev.mi.38.100184.002043; Lin CT, 2006, PROTEIN EXPRES PURIF, V47, P16, DOI 10.1016/j.pep.2005.11.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mironov AA, 1999, NUCLEIC ACIDS RES, V27, P2981, DOI 10.1093/nar/27.14.2981; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; NIERSBACH M, 1992, MOL GEN GENET, V231, P332, DOI 10.1007/BF00279808; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; OSTERMAN AL, 1995, BIOCHEMISTRY-US, V34, P13431, DOI 10.1021/bi00041a021; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Petruschka L, 2002, FEMS MICROBIOL LETT, V215, P89, DOI 10.1016/S0378-1097(02)00923-0; Pinchuk GE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000822; Pinchuk GE, 2009, P NATL ACAD SCI USA, V106, P2874, DOI 10.1073/pnas.0806798106; RAMSEIER TM, 1995, MOL MICROBIOL, V16, P1157, DOI 10.1111/j.1365-2958.1995.tb02339.x; Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+; Rodionov DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S3; Rodionov DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-494; ROWLEY DL, 1991, J BACTERIOL, V173, P968, DOI 10.1128/jb.173.3.968-977.1991; Saier MH, 1998, BIOTECHNOL BIOENG, V58, P170, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<170::AID-BIT9>3.0.CO;2-I; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; Shimada T, 2011, J BACTERIOL, V193, P649, DOI 10.1128/JB.01214-10; Sorensen KI, 1996, J BACTERIOL, V178, P1003, DOI 10.1128/jb.178.4.1003-1011.1996; Titolo S, 2003, J VIROL, V77, P5178, DOI 10.1128/JVI.77.9.5178-5191.2003; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	42	39	41	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35782	35794		10.1074/jbc.M111.267963	http://dx.doi.org/10.1074/jbc.M111.267963			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21849503	hybrid, Green Published			2022-12-27	WOS:000295927100051
J	Majumder, R; Liang, XE; Quinn-Allen, MA; Kane, WH; Lentz, BR				Majumder, Rinku; Liang, Xiaoe; Quinn-Allen, Mary Ann; Kane, William H.; Lentz, Barry R.			Modulation of Prothrombinase Assembly and Activity by Phosphatidylethanolamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE FACTOR-V; PHOSPHATIDYLSERINE BINDING-SITE; COAGULATION FACTOR-V; PHOSPHOLIPID-MEMBRANES; FACTOR-VIII; C2 DOMAIN; FACTOR XA; COMPLEX; ACTIVATION; CURVATURE	Constituents of platelet membranes regulate the activity of the prothrombinase complex. We demonstrate that membranes containing phosphatidylcholine and phosphatidylethanolamine (PE) bind factor Va with high affinity (K-d = similar to 10 nM) in the absence of phosphatidylserine (PS). These membranes support formation of a 60-70% functional prothrombinase complex at saturating factor Va concentrations. Although reduced interfacial packing does contribute to factor Va binding in the absence of PS, it does not correlate with the enhanced activity of the Xa-Va complex assembled on PE-containing membranes. Instead, specific protein-PE interactions appear to contribute to the effects of PE. In support of this, soluble C6PE binds to recombinant factor Va(2) (K-d = similar to 6.5 mu M) and to factor Xa (K-d = similar to 91 mu M). C6PE and C6PS binding sites of factor Xa are specific, distinct, and linked, because binding of one lipid enhances the binding and activity effects of the other. C6PE triggers assembly (K-d(app) = similar to 40 nM) of a partially active prothrombinase complex between factor Xa and factor Va(2), compared with K-d(app) for C6PS similar to 2 nM. These findings provide new insights into the possible synergistic roles of platelet PE and PS in regulating thrombin formation, particularly when exposed membrane PS may be limiting.	[Majumder, Rinku; Lentz, Barry R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Liang, Xiaoe; Quinn-Allen, Mary Ann; Kane, William H.] Duke Univ, Med Ctr, Dept Med, Div Hematol, Durham, NC 27702 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University	Majumder, R (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	rinku-majumder@med.unc.edu; william.kane@duke.edu; uncbrl@med.unc.edu	Majumder, Rinku/J-7512-2019	majumder, Rinku/0000-0002-1727-7220	National Institutes of Health [GM32707, HL 072827, HL43106]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043106, R01HL072827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM32707 and HL 072827 (to B. R. L.) and HL43106 (to W. H. K.).	Banerjee M, 2002, BIOCHEMISTRY-US, V41, P7751, DOI 10.1021/bi020017p; Banerjee M, 2002, BIOCHEMISTRY-US, V41, P950, DOI 10.1021/bi0116902; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BEVERS EM, 1983, BIOCHIM BIOPHYS ACTA, V736, P57, DOI 10.1016/0005-2736(83)90169-4; BILLY D, 1995, J BIOL CHEM, V270, P26883, DOI 10.1074/jbc.270.45.26883; Boskovic DS, 2004, J BIOL CHEM, V279, P20786, DOI 10.1074/jbc.M400469200; CULLIS PR, 1986, CHEM PHYS LIPIDS, V40, P127, DOI 10.1016/0009-3084(86)90067-8; CUTSFORTH GA, 1989, BIOCHEMISTRY-US, V28, P7453, DOI 10.1021/bi00444a045; Cutsforth GA, 1996, BIOPHYS J, V70, P2938, DOI 10.1016/S0006-3495(96)79864-8; GILBERT GE, 1990, J BIOL CHEM, V265, P815; GRUNER SM, 1985, P NATL ACAD SCI USA, V82, P3665, DOI 10.1073/pnas.82.11.3665; Haque ME, 2005, BIOPHYS J, V89, P3183, DOI 10.1529/biophysj.105.063032; Haque ME, 2004, BIOCHEMISTRY-US, V43, P3507, DOI 10.1021/bi035794j; HO C, 1995, BIOCHEMISTRY-US, V34, P6188, DOI 10.1021/bi00018a023; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; JONES ME, 1985, THROMB RES, V39, P711, DOI 10.1016/0049-3848(85)90255-5; Kamath P, 2008, J BIOL CHEM, V283, P30164, DOI 10.1074/jbc.M806158200; KANE WH, 1988, BLOOD, V71, P539; Klein S, 2001, ARTERIOSCL THROM VAS, V21, P1695; Koppaka V, 1996, BIOCHEMISTRY-US, V35, P7482, DOI 10.1021/bi952063d; Koppaka V, 1996, BIOPHYS J, V70, P2930, DOI 10.1016/S0006-3495(96)79863-6; KRISHNASWAMY S, 1993, METHOD ENZYMOL, V222, P260; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KUNG C, 1994, J BIOL CHEM, V269, P25838; Majumder R, 2005, BIOCHEMISTRY-US, V44, P16998, DOI 10.1021/bi051469f; Majumder R, 2005, BIOCHEMISTRY-US, V44, P711, DOI 10.1021/bi047962t; Majumder R, 2004, BIOPHYS J, V86, p92A; Majumder R, 2002, J BIOL CHEM, V277, P29765, DOI 10.1074/jbc.M200893200; Majumder R, 2008, BLOOD, V112, P2795, DOI 10.1182/blood-2008-02-138941; MANN KG, 1990, BLOOD, V76, P1; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; Peng WM, 2004, BIOCHEMISTRY-US, V43, P4385, DOI 10.1021/bi035763o; RAND RP, 1990, BIOCHEMISTRY-US, V29, P76, DOI 10.1021/bi00453a010; Saleh M, 2004, THROMB HAEMOSTASIS, V91, P16, DOI 10.1160/TH03-04-0222; Smeets EF, 1996, THROMB RES, V81, P419, DOI 10.1016/0049-3848(96)00014-X; Smirnov MD, 1999, BIOCHEMISTRY-US, V38, P3591, DOI 10.1021/bi982538b; Smirnov MD, 1999, BLOOD, V94, P3839, DOI 10.1182/blood.V94.11.3839.423k07_3839_3846; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; Srivastava A, 2002, J BIOL CHEM, V277, P1855, DOI 10.1074/jbc.M105697200; Weinreb GE, 2003, J BIOL CHEM, V278, P5679, DOI 10.1074/jbc.M208423200; Wu H, 1996, BIOCHEMISTRY-US, V35, P12602, DOI 10.1021/bi960168q; Zhai X, 2002, BIOCHEMISTRY-US, V41, P5675, DOI 10.1021/bi011844d; Zieseniss S, 2001, J BIOL CHEM, V276, P19828, DOI 10.1074/jbc.M007506200; Zwaal R F, 1983, Subcell Biochem, V9, P299	44	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35535	35542		10.1074/jbc.M111.260141	http://dx.doi.org/10.1074/jbc.M111.260141			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21859710	Green Published, hybrid			2022-12-27	WOS:000295927100025
J	Wakabayashi, Y; Tamiya, T; Takada, I; Fukaya, T; Sugiyama, Y; Inoue, N; Kimura, A; Morita, R; Kashiwagi, I; Takimoto, T; Nomura, M; Yoshimura, A				Wakabayashi, Yu; Tamiya, Taiga; Takada, Ichiro; Fukaya, Tomohiro; Sugiyama, Yuki; Inoue, Naoko; Kimura, Akihiro; Morita, Rimpei; Kashiwagi, Ikko; Takimoto, Tomohito; Nomura, Masatoshi; Yoshimura, Akihiko			Histone 3 Lysine 9 (H3K9) Methyltransferase Recruitment to the Interleukin-2 (IL-2) Promoter Is a Mechanism of Suppression of IL-2 Transcription by the Transforming Growth Factor-beta-Smad Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED DISRUPTION; DIRECT BINDING; T-CELLS; FOXP3; DIFFERENTIATION; PLASTICITY; GENE; INFLAMMATION; ACTIVATION; INDUCTION	Suppression of IL-2 beta production from T cells is an important process for the immune regulation by TGF-beta. However, the mechanism by which this suppression occurs remains to be established. Here, we demonstrate that Smad2 and Smad3, two major TGF-beta-downstream transcription factors, are redundantly essential for TGF-beta-mediated suppression of IL-2 production in CD4(+) T cells using Smad2- and Smad3-deficient T cells. Both Smad2 and Smad3 were recruited into the proximal region of the IL-2 promoter in response to TGF-beta. We then investigated the histone methylation status of the IL-2 promoter. Although both histone H3 lysine 9 (H3K9) and H3K27 trimethylation have been implicated in gene silencing, only H3K9 trimethylation was increased in the proximal region of the IL-2 promoter in a Smad2/3-dependent manner, whereas H3K27 trimethylation was not. The H3K9 methyltransferases Setdb1 and Suv39h1 bound to Smad3 and suppressed IL-2 promoter activity in collaboration with Smad3. Overexpression of Suv39h1 in 68-41 T cells strongly inhibited IL-2 production in response to T cell receptor stimulation irrespective of the presence or absence of TGF-beta, whereas Setdb1 overexpression only slightly suppressed IL-2 production. Silencing of Suv39h1 by shRNA reverted the suppressive effect of TGF-beta on IL-2 production. Furthermore, TGF-beta induced Suv39h1 recruitment to the proximal region of the IL-2 promoter in wild type primary T cells; however, this was not observed in Smad2(-/-) Smad3(+/-) T cells. Thus, we propose that Smads recruit H3K9 methyltransferases Suv39h1 to the IL-2 promoter, thereby inducing suppressive histone methylation and inhibiting T cell receptor-mediated IL-2 transcription.	[Wakabayashi, Yu; Tamiya, Taiga; Takada, Ichiro; Fukaya, Tomohiro; Sugiyama, Yuki; Inoue, Naoko; Kimura, Akihiro; Morita, Rimpei; Kashiwagi, Ikko; Takimoto, Tomohito; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Nomura, Masatoshi] Kyushu Univ, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Wakabayashi, Yu; Tamiya, Taiga; Takada, Ichiro; Fukaya, Tomohiro; Sugiyama, Yuki; Inoue, Naoko; Kimura, Akihiro; Morita, Rimpei; Kashiwagi, Ikko; Takimoto, Tomohito; Yoshimura, Akihiko] CREST, Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan	Keio University; Kyushu University; Japan Science & Technology Agency (JST)	Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013	KASHIWAGI, IKKOH/0000-0001-5386-5719; Kimura, Akihiro/0000-0001-5614-8547; Tamiya, Taiga/0000-0002-8021-4628	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation (NIBIO); Mitsubishi Pharma Research Foundation; Kanae Foundation for the Promotion of Medical Science; Mochida Memorial Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Mitsubishi Pharma Research Foundation; Kanae Foundation for the Promotion of Medical Science; Mochida Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by special grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, grants-in-aid for Basic Research on Priority Areas (Dynamics of Extracellular Environments, Immunological Self), the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO), the Mitsubishi Pharma Research Foundation, the Kanae Foundation for the Promotion of Medical Science, the Mochida Memorial Foundation, and the Takeda Science Foundation.	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; BRABLETZ T, 1993, MOL CELL BIOL, V13, P1155, DOI 10.1128/MCB.13.2.1155; Chinen T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1181; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Ichiyama K, 2011, IMMUNITY, V34, P741, DOI 10.1016/j.immuni.2011.02.021; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Letterio JJ, 1996, J CLIN INVEST, V98, P2109, DOI 10.1172/JCI119017; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lopez-Rovira T, 2000, J BIOL CHEM, V275, P28937, DOI 10.1074/jbc.M909923199; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McKarns SC, 2004, J IMMUNOL, V172, P4275, DOI 10.4049/jimmunol.172.7.4275; Miyazono K, 2004, ONCOGENE, V23, P4232, DOI 10.1038/sj.onc.1207131; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Nonami A, 2005, GENES CELLS, V10, P887, DOI 10.1111/j.1365-2443.2005.00886.x; Rudner LA, 2003, J IMMUNOL, V170, P4785, DOI 10.4049/jimmunol.170.9.4785; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sekiya T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1272; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Takaki H, 2008, J BIOL CHEM, V283, P14955, DOI 10.1074/jbc.M801123200; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Wan YY, 2007, IMMUNOL REV, V220, P199, DOI 10.1111/j.1600-065X.2007.00565.x; Ward SB, 1998, NUCLEIC ACIDS RES, V26, P2923, DOI 10.1093/nar/26.12.2923; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	39	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35456	35465		10.1074/jbc.M111.236794	http://dx.doi.org/10.1074/jbc.M111.236794			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862595	Green Published, hybrid			2022-12-27	WOS:000295927100017
J	Xie, C; Li, N; Chen, ZJ; Li, BL; Song, BL				Xie, Chang; Li, Na; Chen, Zheng-Jun; Li, Bo-Liang; Song, Bao-Liang			The Small GTPase Cdc42 Interacts with Niemann-Pick C1-like 1 (NPC1L1) and Controls Its Movement from Endocytic Recycling Compartment to Plasma Membrane in a Cholesterol-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX; PROTEIN; ABSORPTION; VARIANTS; CELLS; TRAFFICKING; HOMEOSTASIS; ACTIVATION; MORPHOLOGY; INSIG-1	Niemann-Pick C1-like 1 (NPC1L1) is a multi-transmembrane protein that mediates the absorption of dietary and biliary cholesterol through vesicular endocytosis. The subcellular localization of NPC1L1 is regulated by cholesterol. Cholesterol depletion induces the transport of NPC1L1 to plasma membrane (PM) from endocytic recycling compartment that requires MyoVb.Rab11a.Rab11-FIP2 triple complex, and cholesterol-replenishment renders the internalization of NPC1L1 together with cholesterol. Here, we find that GTP-bound Cdc42 interacts with NPC1L1. Cholesterol depletion regulates the activation of Cdc42 and enhances NPC1L1-Cdc42 interaction. Overexpression of constitutive GTP-bound Cdc42 mutant form or knockdown of Cdc42 inhibits the transport of NPC1L1 to the PM and disturbs the cholesterol-regulated binding of NPC1L1 to Rab11a, MyoVb, and actin. Knockdown of Cdc42 downstream effectors N-WASP or Arp3 also leads to the similar results. In liver-specific Cdc42 knock-out (Cdc42 LKO) mice, NPC1L1 fails to localize to bile canaliculi, and the biliary cholesterol cannot be efficiently reabsorbed. These results indicate that Cdc42 controls the cholesterol-regulated transport and localization of NPC1L1, and plays a role in cholesterol absorption.	[Xie, Chang; Li, Na; Chen, Zheng-Jun; Li, Bo-Liang; Song, Bao-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	blsong@sibs.ac.cn	Xie, Chang/V-7099-2019; Chen, Zhengjun/X-7133-2019; Xie, Chang/O-8270-2016	Xie, Chang/0000-0002-7643-5321; Song, Bao-Liang/0000-0002-6397-5935	Ministry of Science and Technology of China [2009CB919000, 2011CB910900]; National Natural Science Foundation of China [30925012]; Shanghai Science and Technology Committee [10QH1402900]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by the grants from the Ministry of Science and Technology of China (2009CB919000 and 2011CB910900), National Natural Science Foundation of China (30925012), and Shanghai Science and Technology Committee (10QH1402900).	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; Chu BB, 2009, J BIOL CHEM, V284, P22481, DOI 10.1074/jbc.M109.034355; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; Fahmi S, 2008, HUM MOL GENET, V17, P2101, DOI 10.1093/hmg/ddn108; Fessler MB, 2004, J BIOL CHEM, V279, P39989, DOI 10.1074/jbc.M401080200; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Jaksits S, 2004, J IMMUNOL, V173, P1628, DOI 10.4049/jimmunol.173.3.1628; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kullak-Ublick GA, 2004, GASTROENTEROLOGY, V126, P322, DOI 10.1053/j.gastro.2003.06.005; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Matas OB, 2004, TRAFFIC, V5, P838, DOI 10.1111/j.1600-0854.2004.00225.x; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; Pan JY, 1998, BIOESSAYS, V20, P516, DOI 10.1002/(SICI)1521-1878(199806)20:6<516::AID-BIES11>3.0.CO;2-3; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Sugii S, 2003, J BIOL CHEM, V278, P27180, DOI 10.1074/jbc.M300542200; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Wang LJ, 2011, J BIOL CHEM, V286, P7397, DOI 10.1074/jbc.M110.178368; Weber M, 2005, FUNGAL GENET BIOL, V42, P624, DOI 10.1016/j.fgb.2005.03.012; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Yamanashi Y, 2009, PHARMACOGENET GENOM, V19, P884, DOI 10.1097/FPC.0b013e3283327925; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yuan HX, 2009, HEPATOLOGY, V49, P240, DOI 10.1002/hep.22610; Zhang JH, 2011, J BIOL CHEM, V286, P25088, DOI 10.1074/jbc.M111.244475	34	23	30	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35933	35942		10.1074/jbc.M111.270199	http://dx.doi.org/10.1074/jbc.M111.270199			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21844200	hybrid, Green Published			2022-12-27	WOS:000295927100067
J	Revert-Ros, F; Lopez-Pascual, E; Granero-Molto, F; Macias, J; Breyer, R; Zent, R; Hudson, BG; Saadeddin, A; Revert, F; Blasco, R; Navarro, C; Burks, D; Saus, J				Revert-Ros, Francisco; Lopez-Pascual, Ernesto; Granero-Molto, Froilan; Macias, Jesus; Breyer, Richard; Zent, Roy; Hudson, Billy G.; Saadeddin, Anas; Revert, Fernando; Blasco, Rauel; Navarro, Carmen; Burks, Deborah; Saus, Juan			Goodpasture Antigen-binding Protein (GPBP) Directs Myofibril Formation IDENTIFICATION OF INTRACELLULAR DOWNSTREAM EFFECTOR 130-kDa GPBP-INTERACTING PROTEIN (GIP130)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CERAMIDE TRANSFER PROTEIN; SKELETAL-MUSCLE DIFFERENTIATION; MYOBLAST DIFFERENTIATION; SARCOPLASMIC-RETICULUM; IV COLLAGEN; ENDOPLASMIC-RETICULUM; CELL-DIFFERENTIATION; C2C12 MYOBLASTS; SPLICED VARIANT; KINASE-ACTIVITY	Goodpasture antigen-binding protein-1 (GPBP-1) is an exportable non-conventional Ser/Thr kinase that regulates glomerular basement membrane collagen organization. Here we provide evidence that GPBP-1 accumulates in the cytoplasm of differentiating mouse myoblasts prior to myosin synthesis. Myoblasts deficient in GPBP-1 display defective myofibril formation, whereas myofibrils assemble with enhanced efficiency in those overexpressing GPBP-1. We also show that GPBP-1 targets the previously unidentified GIP130 (GPBP-interacting protein of 130 kDa), which binds to myosin and promotes its myofibrillar assembly. This report reveals that GPBP-1 directs myofibril formation, an observation that expands its reported role in supramolecular organization of structural proteins to the intracellular compartment.	[Revert-Ros, Francisco; Lopez-Pascual, Ernesto; Granero-Molto, Froilan; Macias, Jesus; Saadeddin, Anas; Revert, Fernando; Blasco, Rauel; Burks, Deborah; Saus, Juan] Ctr Invest Principe Felipe, Valencia 46012, Spain; [Lopez-Pascual, Ernesto; Saus, Juan] Univ Valencia, Dept Bioquim & Biol Mol, Valencia 46010, Spain; [Granero-Molto, Froilan; Breyer, Richard; Zent, Roy; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; [Blasco, Rauel] Parc Cient Univ Valencia, Fibrostatin SL, Comunitat Valenciana, Paterna 46890, Spain; [Navarro, Carmen] Complejo Hosp Vigo, Serv Anat Patol, Vigo 36200, Spain	Prince Felipe Research Center; University of Valencia; Vanderbilt University; Complexo Hospitalario Universitario de Vigo	Saus, J (corresponding author), Ctr Invest Principe Felipe, Avda Autopista Saler 16, Valencia 46012, Spain.	jsaus@cipf.es	Revert-Ros, Francisco/AAB-7055-2019; REVERT, FERNANDO/ABF-8171-2021; Granero-Moltó, Froilán/H-6975-2017; Navarro, Carmen/A-9210-2012	REVERT, FERNANDO/0000-0002-7304-5846; Granero-Moltó, Froilán/0000-0003-4817-5232; Saus, Juan/0000-0003-2082-1597; Hudson, Billy/0000-0002-5420-4100; Revert-Ros, Francisco/0000-0002-6162-3370	Ministerio de Ciencia e Innovacion (MICINN) [SAF2003-09772, SAF2006-12520, SAF2009-10703]; Generalitat Valenciana [GV04B-285, BM-001/2002, ACOMP07-188, Prometeo 2009/065]; MICINN [SAF2008-00011]; Fondo de Investigaciones Sanitarias (FIS) [07/1257, 07/90043]; MICINN (Spain); National Institutes of Health [DK 18381]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK018381, R01DK018381] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Ministerio de Ciencia e Innovacion (MICINN) Grants SAF2003-09772, SAF2006-12520, and SAF2009-10703 and Generalitat Valenciana Grants GV04B-285, BM-001/2002, ACOMP07-188, and Prometeo 2009/065 (to J.S.); MICINN Grant SAF2008-00011 (to D. B.); Fondo de Investigaciones Sanitarias (FIS) Grants 07/1257 and 07/90043 (to C.N.); and the Programa Torres Quevedo of MICINN (to R. B.) (Spain). This work was also supported in part by National Institutes of Health Grant DK 18381 (to B. G. H.). Juan Saus, Francisco Revert-Ros, and Fernando Revert are partners of Fibrostatin SL, a biotech company exploiting patents related to GPBP.	Ackermann MA, 2009, MOL BIOL CELL, V20, P2963, DOI 10.1091/mbc.E08-12-1251; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bagnato P, 2003, J CELL BIOL, V160, P245, DOI 10.1083/jcb.200208109; Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; Calera MR, 1998, BIOCHEM BIOPH RES CO, V251, P835, DOI 10.1006/bbrc.1998.9566; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Diel P, 2008, J MOL ENDOCRINOL, V40, P231, DOI 10.1677/JME-07-0175; Donati C, 2004, FASEB J, V18, P449, DOI 10.1096/fj.04-1780fje; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; Granero-Molto F, 2008, J BIOL CHEM, V283, P20495, DOI 10.1074/jbc.M801806200; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Jo K, 2001, MOL CELL BIOL, V21, P1682, DOI 10.1128/MCB.21.5.1682-1687.2001; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kontrogianni-Konstantopoulos A, 2003, J BIOL CHEM, V278, P3985, DOI 10.1074/jbc.M209012200; Lange S, 2009, J CELL SCI, V122, P2640, DOI 10.1242/jcs.046193; McGrath MJ, 2006, J BIOL CHEM, V281, P7666, DOI 10.1074/jbc.M512552200; Meacci E, 2008, J CELL PHYSIOL, V214, P210, DOI 10.1002/jcp.21187; Miralem T, 2010, J BIOL CHEM, V285, P12551, DOI 10.1074/jbc.M109.032771; MOK SC, 1994, GYNECOL ONCOL, V52, P247, DOI 10.1006/gyno.1994.1040; Moran JL, 2002, PHYSIOL GENOMICS, V10, P103, DOI 10.1152/physiolgenomics.00011.2002; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nagano T, 2002, NAT CELL BIOL, V4, P495, DOI 10.1038/ncb808; NANDAN D, 1990, J CELL BIOL, V110, P1673, DOI 10.1083/jcb.110.5.1673; Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001; PENADES JR, 1995, EUR J BIOCHEM, V229, P754, DOI 10.1111/j.1432-1033.1995.tb20524.x; Pomies P, 2007, MOL BIOL CELL, V18, P1723, DOI 10.1091/mbc.E06-09-0815; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; Revert F, 2008, J BIOL CHEM, V283, P30246, DOI 10.1074/jbc.M805026200; Revert F, 2007, AM J PATHOL, V171, P1419, DOI 10.2353/ajpath.2007.070205; Rotwein P, 2009, J CELL PHYSIOL, V219, P503, DOI 10.1002/jcp.21692; Saito S, 2008, J BIOL CHEM, V283, P6584, DOI 10.1074/jbc.M707691200; SALVIATI G, 1985, MUSCLE NERVE, V8, P299, DOI 10.1002/mus.880080406; SAUS J, 1988, J BIOL CHEM, V263, P13374; Takekura H, 2001, DEV BIOL, V239, P204, DOI 10.1006/dbio.2001.0437; Vandromme M, 2001, J BIOL CHEM, V276, P8173, DOI 10.1074/jbc.M005587200; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; ZESCHNIGK M, 1995, J CELL SCI, V108, P2973	46	7	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35030	35043		10.1074/jbc.M111.249458	http://dx.doi.org/10.1074/jbc.M111.249458			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21832087	Green Published, hybrid			2022-12-27	WOS:000295406300056
J	Datta, M; Bhattacharyya, NP				Datta, Moumita; Bhattacharyya, Nitai P.			Regulation of RE1 Protein Silencing Transcription Factor (REST) Expression by HIP1 Protein Interactor (HIPPI)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE PROMOTER SEQUENCE; HUNTINGTONS-DISEASE; MOLECULAR PARTNER; IN-VIVO; APOPTOSIS; CASPASE-1; REST/NRSF; PATHOGENESIS; AGGREGATION; MECHANISMS	Earlier we have shown that the proapoptotic protein HIPPI (huntingtin interacting protein 1 (HIP1) protein interactor) along with its molecular partner HIP1 could regulate transcription of the caspase-1 gene. Here we report that RE1-silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) is a new transcriptional target of HIPPI. HIPPI could bind to the promoter of REST and increased its expression in neuronal as well as non-neuronal cells. Such activation of REST down-regulated expression of REST target genes, such as brain-derived neurotrophic factor (BDNF) or proenkephalin (PENK). The ability of HIPPI to activate REST gene transcription was dependent on HIP1, the nuclear transporter of HIPPI. Using a Huntington disease cell model, we have demonstrated that feeble interaction of HIP1 with mutant huntingtin protein resulted in increased nuclear accumulation of HIPPI and HIP1, leading to higher occupancy of HIPPI at the REST promoter, triggering its transcriptional activation and consequent repression of REST target genes. This novel transcription regulatory mechanism of REST by HIPPI may contribute to the deregulation of transcription observed in the cell model of Huntington disease.	[Datta, Moumita; Bhattacharyya, Nitai P.] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata 700064, W Bengal, India	Saha Institute of Nuclear Physics	Bhattacharyya, NP (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, 1 AF Bidhan Nagar, Kolkata 700064, W Bengal, India.	nitai_sinp@yahoo.com	Datta, Moumita/AAU-8006-2021		Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	This work was supported by the Department of Atomic Energy, Government of India.	Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Banerjee M, 2010, NUCLEIC ACIDS RES, V38, P878, DOI 10.1093/nar/gkp1011; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Hickey MA, 2003, PROG NEURO-PSYCHOPH, V27, P255, DOI 10.1016/S0278-5846(03)00021-6; Houde C, 2006, DEV BIOL, V300, P523, DOI 10.1016/j.ydbio.2006.09.001; Jiang LC, 2008, J NEUROSCI RES, V86, P1209, DOI 10.1002/jnr.21595; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Majumder P, 2007, FEBS J, V274, P3886, DOI 10.1111/j.1742-4658.2007.05922.x; Majumder P, 2007, BIOCHEM BIOPH RES CO, V353, P80, DOI 10.1016/j.bbrc.2006.11.138; Majumder P, 2006, NEUROBIOL DIS, V22, P242, DOI 10.1016/j.nbd.2005.11.003; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; Nishihara S, 2003, BIOCHEM BIOPH RES CO, V311, P55, DOI 10.1016/j.bbrc.2003.09.158; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Ravache M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014311; Raychaudhuri S, 2008, HUM MOL GENET, V17, P240, DOI 10.1093/hmg/ddm301; Rigamonti D, 2001, J BIOL CHEM, V276, P14545, DOI 10.1074/jbc.C100044200; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Shimojo M, 2008, J BIOL CHEM, V283, P34880, DOI 10.1074/jbc.M804183200; Sinha M, 2010, BIOCHEM BIOPH RES CO, V396, P742, DOI 10.1016/j.bbrc.2010.05.007; Smith R, 2006, HUM MOL GENET, V15, P3119, DOI 10.1093/hmg/ddl252; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	41	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33759	33769		10.1074/jbc.M111.265173	http://dx.doi.org/10.1074/jbc.M111.265173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832040	hybrid, Green Published			2022-12-27	WOS:000295159200006
J	Liao, JM; Lu, H				Liao, Jun-Ming; Lu, Hua			Autoregulatory Suppression of c-Myc by miR-185-3p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-PROTEIN L11; CANCER CELL-LINES; RNA-POLYMERASE-I; TRANSCRIPTIONAL ACTIVATION; CYCLE ARREST; GENES; EXPRESSION; ONCOGENE; BINDING; P53	The expression of the c-myc oncogene at both protein and mRNA levels is transient and begins to be turned off 3-6 h after growth stimulation of cultured cells. The exact mechanism(s) underlying this down-regulation of c-Myc remains incompletely understood. Here we report the identification of miR-185-3p as a novel feedback regulator of c-Myc. This microRNA (miRNA) was initially identified as one of the c-Myc target miRNA transcripts through analysis of RNA samples isolated from cells prior to and after serum stimulation and further verified by real-time PCR, luciferase reporter, and ChIP assays. Interestingly, overexpression of wild type, but not mutant, miR-185-3p decreased the protein, but not mRNA, level of c-Myc in a dose-dependent fashion and also drastically abated the serum induction of c-Myc level in human cancer cells by targeting the coding sequence of c-Myc mRNA, consequently suppressing c-Myc-mediated proliferation. A miR-185-3p inhibitor rescued the inhibition of c-Myc expression by endogenous miR-185-3p. Thus, our results unveil miR-185-3p as the first miRNA that monitors c-Myc levels via an autoregulatory feedback mechanism in response to serum stimulation.	[Lu, Hua] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Simon Canc Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Lu, H (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	hualu@iupui.edu	Liao, Jun-Ming/G-3788-2012		National Institutes of Health, NCI [CA127724, CA095441, CA129828]; NATIONAL CANCER INSTITUTE [R01CA095441, R01CA127724, R01CA129828] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants CA127724, CA095441, and CA129828 (to H. L.).	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dai MS, 2007, CELL CYCLE, V6, P2735, DOI 10.4161/cc.6.22.4895; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2010, J BIOL CHEM, V285, P12587, DOI 10.1074/jbc.M109.056259; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; PULVERER BJ, 1994, ONCOGENE, V9, P59; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; ROY AL, 1993, NATURE, V365, P359, DOI 10.1038/365359a0; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; VENNSTROM B, 1982, J VIROL, V42, P773, DOI 10.1128/JVI.42.3.773-779.1982; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540	50	45	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33901	33909		10.1074/jbc.M111.262030	http://dx.doi.org/10.1074/jbc.M111.262030			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832077	hybrid, Green Published			2022-12-27	WOS:000295159200022
J	Liu, ZM; Kanzawa, N; Ono, S				Liu, Zhongmei; Kanzawa, Nobuyuki; Ono, Shoichiro			Calcium-sensitive Activity and Conformation of Caenorhabditis elegans Gelsolin-like Protein 1 Are Altered by Mutations in the First Gelsolin-like Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN DEPOLYMERIZING FACTOR/COFILIN; C-TERMINAL TAIL; PLASMA GELSOLIN; BINDING DOMAIN; F-ACTIN; FILAMENTS; IDENTIFICATION; ACTIVATION; MECHANISM; COMPLEX	The gelsolin family of actin regulatory proteins is activated by Ca2+ to sever and cap actin filaments. Gelsolin has six homologous gelsolin-like domains (G1-G6), and Ca2+-dependent conformational changes regulate its accessibility to actin. Caenorhabditis elegans gelsolin-like protein-1 (GSNL-1) has only four gelsolin-like domains (G1-G4) and still exhibits Ca2+-dependent actin filament-severing and -capping activities. We found that acidic residues (Asp-83 and Asp-84) in G1 of GSNL-1 are important for its Ca2+ activation. These residues are conserved in GSNL-1 and gelsolin and previously implicated in actin-severing activity of the gelsolin family. We found that alanine mutations at Asp-83 and Asp-84 (D83A/D84A mutation) did not disrupt actin-severing or -capping activity. Instead, the mutants exhibited altered Ca2+ sensitivity when compared with wildtype GSNL-1. The D83A/D84A mutation enhanced Ca2+ sensitivity for actin severing and capping and its susceptibility to proteolytic digestion, suggesting a conformational change. Single mutations caused minimal changes in its activity, whereas Asp-83 and Asp-84 were required to stabilize Ca2+-free and Ca2+-bound conformations, respectively. On the other hand, the D83A/D84A mutation suppressed sensitivity of GSNL-1 to phosphatidylinositol 4,5-bisphosphate inhibition. The structure of an inactive form of gelsolin shows that the equivalent acidic residues are in close contact with G3, which may maintain an inactive conformation of the gelsolin family.	[Liu, Zhongmei; Ono, Shoichiro] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Kanzawa, Nobuyuki] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Tokyo 1028554, Japan; Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA	Emory University; Sophia University; Emory University	Ono, S (corresponding author), Emory Univ, Dept Pathol, 615 Michael St,Whitehead Res Bldg,Rm 105N, Atlanta, GA 30322 USA.	sono@emory.edu	Ono, Shoichiro/A-6475-2015	Ono, Shoichiro/0000-0002-4763-0398; Kanzawa, Nobuyuki/0000-0002-8703-6828	National Institutes of Health [R01 AR48615]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR48615 (to S. O.).	Ashish, 2007, J BIOL CHEM, V282, P25884, DOI 10.1074/jbc.M702446200; BRYAN J, 1986, J CELL BIOL, V102, P1439, DOI 10.1083/jcb.102.4.1439; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; CHAPONNIER C, 1986, J CELL BIOL, V103, P1473, DOI 10.1083/jcb.103.4.1473; Choe H, 2002, J MOL BIOL, V324, P691, DOI 10.1016/S0022-2836(02)01131-2; Klaavuniemi T, 2008, J BIOL CHEM, V283, P26071, DOI 10.1074/jbc.M803618200; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; Lin KM, 2000, J BIOL CHEM, V275, P27746; Liu ZM, 2010, BIOCHEMISTRY-US, V49, P4349, DOI 10.1021/bi100215b; Lueck A, 2000, BIOCHEMISTRY-US, V39, P5274, DOI 10.1021/bi992871v; McGough AM, 2003, FEBS LETT, V552, P75, DOI 10.1016/S0014-5793(03)00932-3; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Ono S, 2001, J BIOL CHEM, V276, P5952, DOI 10.1074/jbc.M007563200; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pope BJ, 1997, BIOCHEMISTRY-US, V36, P15848, DOI 10.1021/bi972192p; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; SAFER D, 1989, ANAL BIOCHEM, V178, P32, DOI 10.1016/0003-2697(89)90351-5; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; SOUTHWICK FS, 1995, J BIOL CHEM, V270, P45, DOI 10.1074/jbc.270.1.45; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; SUN HQ, 1994, J BIOL CHEM, V269, P9473; Zhang Y, 2006, EMBO J, V25, P4458, DOI 10.1038/sj.emboj.7601323	28	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34051	34059		10.1074/jbc.M111.237404	http://dx.doi.org/10.1074/jbc.M111.237404			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21840993	Green Published, hybrid			2022-12-27	WOS:000295159200037
J	Olah, J; Vincze, O; Virok, D; Simon, D; Bozso, Z; Tokesi, N; Horvath, I; Hlavanda, E; Kovacs, J; Magyar, A; Szucs, M; Orosz, F; Penke, B; Ovadi, J				Olah, Judit; Vincze, Orsolya; Virok, Dezso; Simon, Dora; Bozso, Zsolt; Tokesi, Natalia; Horvath, Istvan; Hlavanda, Emma; Kovacs, Janos; Magyar, Anna; Szucs, Maria; Orosz, Ferenc; Penke, Botond; Ovadi, Judit			Interactions of Pathological Hallmark Proteins TUBULIN POLYMERIZATION PROMOTING PROTEIN/p25, beta-AMYLOID, AND alpha-SYNUCLEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERIZATION-PROMOTING PROTEIN; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; A-BETA; PARKINSONS-DISEASES; PEPTIDE-SYNTHESIS; RAT-BRAIN; TUBULIN; TPPP/P25; IDENTIFICATION	The disordered tubulin polymerization promoting protein (TPPP/p25) was found to be co-enriched in neuronal and glial inclusions with alpha-synuclein in Parkinson disease and multiple system atrophy, respectively; however, co-occurrence of alpha-synuclein with beta-amyloid (A beta) in human brain inclusions has been recently reported, suggesting the existence of mixed type pathologies that could result in obstacles in the correct diagnosis and treatment. Here we identified TPPP/p25 as an interacting partner of the soluble A beta oligomers as major risk factors for Alzheimer disease using ProtoArray human protein microarray. The interactions of oligomeric A beta with proteins involved in the etiology of neurological disorders were characterized by ELISA, surface plasmon resonance, pelleting experiments, and tubulin polymerization assay. Weshowed that the A beta(42) tightly bound to TPPP/p25 (K-d = 85 nM) and caused aberrant protein aggregation by inhibiting the physiologically relevant TPPP/p25-derived microtubule assembly. The pair-wise interactions of A beta(42), alpha-synuclein, and tubulin were found to be relatively weak; however, these three components formed soluble ternary complex exclusively in the absence of TPPP/p25. The aggregation-facilitating activity of TPPP/p25 and its interaction with A beta was monitored by electron microscopy with purified proteins by pelleting experiments with cell-free extracts as well as by confocal microscopy with CHO cells expressing TPPP/p25 or amyloid. The finding that the interaction of TPPP/p25 with A beta can produce pathological-like aggregates is tightly coupled with unusual pathology of the Alzheimer disease revealed previously; that is, partial co-localization of A beta and TPPP/p25 in the case of diffuse Lewy body disease with Alzheimer disease.	[Olah, Judit; Vincze, Orsolya; Tokesi, Natalia; Horvath, Istvan; Hlavanda, Emma; Orosz, Ferenc; Ovadi, Judit] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, H-1113 Budapest, Hungary; [Virok, Dezso] Univ Szeged, Inst Clin Microbiol, H-6725 Szeged, Hungary; [Simon, Dora; Bozso, Zsolt; Szucs, Maria; Penke, Botond] Univ Szeged, Dept Med Chem, H-6720 Szeged, Hungary; [Penke, Botond] Hungarian Acad Sci, Supramol & Nanostruct Mat Res Grp, H-6720 Szeged, Hungary; [Kovacs, Janos] Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, Hungarian Acad Sci, H-1117 Budapest, Hungary; [Magyar, Anna] Eotvos Lorand Univ, Res Grp Peptide Chem, Hungarian Acad Sci, H-1117 Budapest, Hungary; [Szucs, Maria] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6726 Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Szeged University; Szeged University; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Ovadi, J (corresponding author), Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, Karolina Ut 29, H-1113 Budapest, Hungary.	ovadi@enzim.hu	Horvath, Istvan/B-1889-2009	Horvath, Istvan/0000-0003-4262-1430; Olah, Judit/0000-0002-2470-8631; Ovadi, Judit/0000-0002-3420-682X	Hungarian National Scientific Research Fund (OTKA) [T-067963, PD 76793]; European Commission [DCI-ALA/19.09.01/10/21526/245-297/ALFA111(2010)29]; Hungarian Academy of Sciences; EC [201159]	Hungarian National Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Commission(European CommissionEuropean Commission Joint Research Centre); Hungarian Academy of Sciences(Hungarian Academy of Sciences); EC(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Hungarian National Scientific Research Fund Grants OTKA T-067963 (to J. Ovadi) and PD 76793 (to J. Olah), the European Commission (DCI-ALA/19.09.01/10/21526/245-297/ALFA111(2010)29; to J. Ovadi), a Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (to J. Olah), and EC-7 Health Grant 201159 ("Memoload").	Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bozso Z, 2010, PEPTIDES, V31, P248, DOI 10.1016/j.peptides.2009.12.001; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Crews L, 2009, NEUROTOX RES, V16, P306, DOI 10.1007/s12640-009-9073-6; Duce JA, 2006, J MOL BIOL, V361, P493, DOI 10.1016/j.jmb.2006.06.038; Fabian G, 2002, J PHARMACOL EXP THER, V302, P774, DOI 10.1124/jpet.102.036152; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; Golabek AA, 1996, J BIOL CHEM, V271, P10602, DOI 10.1074/jbc.271.18.10602; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hiltunen M, 2009, J ALZHEIMERS DIS, V18, P401, DOI 10.3233/JAD-2009-1154; Hlavanda E, 2002, BIOCHEMISTRY-US, V41, P8657, DOI 10.1021/bi020140g; Hlavanda E, 2007, J BIOL CHEM, V282, P29531, DOI 10.1074/jbc.M703466200; Hoftberger R, 2010, GLIA, V58, P1847, DOI 10.1002/glia.21054; Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Jensen PH, 2001, METH MOLEC MED, V62, P61; Kazmierczak A, 2008, NEUROCHEM INT, V53, P263, DOI 10.1016/j.neuint.2008.08.004; Koudinov AR, 1998, CLIN CHIM ACTA, V270, P75, DOI 10.1016/S0009-8981(97)00207-6; Kovacs GG, 2004, NEUROBIOL DIS, V17, P155, DOI 10.1016/j.nbd.2004.06.006; KRCHNAK V, 1988, INT J PEPT PROT RES, V32, P415; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lehotzky A, 2004, J CELL SCI, V117, P6249, DOI 10.1242/jcs.01550; Lehotzky A, 2010, GLIA, V58, P157, DOI 10.1002/glia.20909; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002750; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; NA GC, 1986, BIOCHEMISTRY-US, V25, P6214, DOI 10.1021/bi00368a057; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Orosz F, 2004, BIOL CELL, V96, P701, DOI 10.1016/j.biolcel.2004.08.002; Orosz Ferenc, 2009, V7, P225, DOI 10.1007/978-1-4020-9434-7_10; Ovadi J, 2008, IUBMB LIFE, V60, P637, DOI 10.1002/iub.112; Oyama R, 2000, BBA-PROTEIN STRUCT M, V1479, P91, DOI 10.1016/S0167-4838(00)00057-1; Paik SR, 1997, ARCH BIOCHEM BIOPHYS, V344, P325, DOI 10.1006/abbi.1997.0207; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Shah SB, 2009, NEUROBIOL DIS, V36, P11, DOI 10.1016/j.nbd.2009.05.016; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Tompa P, 2009, STRUCTURE FUNCTION I; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Verdier Y, 2005, J NEUROCHEM, V94, P617, DOI 10.1111/j.1471-4159.2005.03158.x; Verdier Y, 2008, J PEPT SCI, V14, P755, DOI 10.1002/psc.998; Vincze O, 2006, BIOCHEMISTRY-US, V45, P13818, DOI 10.1021/bi061305e; Virok DP, 2011, J PROTEOME RES, V10, P1538, DOI 10.1021/pr1009096; Wilhelmus MMM, 2007, MOL NEUROBIOL, V35, P203, DOI 10.1007/s12035-007-0029-7; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5	61	111	116	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34088	34100		10.1074/jbc.M111.243907	http://dx.doi.org/10.1074/jbc.M111.243907			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21832049	Green Published, hybrid			2022-12-27	WOS:000295159200041
J	Huang, HP; Chen, PH; Yu, CY; Chuang, CY; Stone, L; Hsiao, WC; Li, CL; Tsai, SC; Chen, KY; Chen, HF; Ho, HN; Kuo, HC				Huang, Hsiang-Po; Chen, Pin-Hsun; Yu, Chun-Ying; Chuang, Ching-Yu; Stone, Lee; Hsiao, Wen-Chu; Li, Chung-Leung; Tsai, Shih-Chih; Chen, Kai-Yun; Chen, Hsin-Fu; Ho, Hong-Nerng; Kuo, Hung-Chih			Epithelial Cell Adhesion Molecule (EpCAM) Complex Proteins Promote Transcription Factor-mediated Pluripotency Reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; CD44 VARIANT ISOFORMS; CARCINOMA-CELLS; E-CADHERIN; EP-CAM; DEFINED FACTORS; ANTIGEN EPCAM; SELF-RENEWAL; EXPRESSION; FIBROBLASTS	Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein that is highly expressed in embryonic stem cells (ESCs) and its role in maintenance of pluripotency has been suggested previously. In epithelial cancer cells, activation of the EpCAM surface-to-nucleus signaling transduction pathway involves a number of membrane proteins. However, their role in somatic cell reprogramming is still unknown. Here we demonstrate that EpCAM and its associated protein, Cldn7, play a critical role in reprogramming. Quantitative RT-PCR analysis of Oct4, Sox2, Klf4, and c-Myc (OSKM) infected mouse embryonic fibroblasts (MEFs) indicated that EpCAM and Cldn7 were up-regulated during reprogramming. Analysis of numbers of alkaline phosphatase-and Nanog-positive clones, and the expression level of pluripotency-related genes demonstrated that inhibition of either EpCAM or Cldn7 expression resulted in impairment in reprogramming efficiency, whereas overexpression of EpCAM, EpCAM plus Cldn7, or EpCAM intercellular domain (EpICD) significantly enhanced reprogramming efficiency in MEFs. Furthermore, overexpression of EpCAM or EpICD significantly repressed the expression of p53 and p21 in the reprogramming MEFs, and both EpCAM and EpICD activated the promoter activity of Oct4. These observations suggest that EpCAM signaling may enhance reprogramming through up-regulation of Oct4 and possible suppression of the p53-p21 pathway. In vitro and in vivo characterization indicated that the EpCAM-reprogrammed iPSCs exhibited similar molecular and functional features to the mouse ESCs. In summary, our studies provide additional insight into the molecular mechanisms of reprogramming and suggest a more effective means of induced pluripotent stem cell generation.	[Huang, Hsiang-Po; Chen, Kai-Yun] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 100, Taiwan; [Chen, Hsin-Fu; Ho, Hong-Nerng] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Taipei 100, Taiwan; [Chen, Pin-Hsun; Chuang, Ching-Yu; Li, Chung-Leung; Kuo, Hung-Chih] Acad Sinica, Stem Cell Program, Genom Res Ctr, Taipei 115, Taiwan; [Yu, Chun-Ying; Stone, Lee; Li, Chung-Leung; Tsai, Shih-Chih; Kuo, Hung-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Chen, Pin-Hsun] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; [Hsiao, Wen-Chu] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 106, Taiwan; [Chen, Hsin-Fu; Ho, Hong-Nerng] Natl Taiwan Univ, Grad Inst Clin Genom, Taipei 106, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Defense Medical Center; National Taiwan University; National Taiwan University	Kuo, HC (corresponding author), 128,Sec 2,Acad Rd, Taipei, Taiwan.	kuohuch@gate.sinica.edu.tw	yu, chun ying/ABB-3212-2020; Yu, Chun-ying/AAE-8368-2020; Kuo, Hung-Chih/H-7810-2014; NTU, Ref07/AAX-7890-2021	yu, chun ying/0000-0002-7320-7876; Yu, Chun-ying/0000-0002-7320-7876; Kuo, Hung-Chih/0000-0003-1336-1203; HUANG, HSIANG-PO/0000-0002-3382-305X; Ho, Hong-Nerng/0000-0002-7207-0089; CHEN, HSIN-FU/0000-0002-7748-4440	Academia Sinica, Stem Cell Priority [97-3111-B-001-009, 98-2811-B-001-022]; National Science Council, Taiwan [97-2321-B-002-020-MY3]; National RNAi Core Facility [NSC 97-3112-B-001-016]	Academia Sinica, Stem Cell Priority(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National RNAi Core Facility	This work was supported by an intramural grant from Academia Sinica, Stem Cell Priority Grants 97-3111-B-001-009 and 98-2811-B-001-022, and National Science Council, Taiwan, Grant 97-2321-B-002-020-MY3.; We thank the National RNAi Core Facility supported by Grant NSC 97-3112-B-001-016 for lentiviral shRNA clones and Dr. Wei Cui for providing the human OCT4 promoter-containing plasmid.	Akutsu H, 2009, DIFFERENTIATION, V78, P137, DOI 10.1016/j.diff.2009.08.005; Cerretti DP, 1999, CYTOKINE, V11, P541, DOI 10.1006/cyto.1998.0466; Chen HF, 2009, HUM REPROD, V24, P1114, DOI 10.1093/humrep/dep003; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Claas C, 2005, BIOCHEM J, V389, P99, DOI 10.1042/BJ20041287; Edel MJ, 2010, GENE DEV, V24, P561, DOI 10.1101/gad.1876710; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Gires O, 2009, NAT REV CANCER, V9, P143, DOI 10.1038/nrc2499-c1; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang HP, 2010, J BIOL CHEM, V285, P33510, DOI 10.1074/jbc.M110.122093; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Kolle G, 2009, STEM CELLS, V27, P2446, DOI 10.1002/stem.182; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; Le Naour F, 2006, MOL CELL PROTEOMICS, V5, P845, DOI 10.1074/mcp.M500330-MCP200; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lioni M, 2007, AM J PATHOL, V170, P709, DOI 10.2353/ajpath.2007.060343; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maaser K, 2008, BRIT J CANCER, V99, P1635, DOI 10.1038/sj.bjc.6604725; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; MOMBURG F, 1987, CANCER RES, V47, P2883; MORRISH DW, 1991, IN VITRO CELL DEV B, V27, P303; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Nubel T, 2009, MOL CANCER RES, V7, P285, DOI 10.1158/1541-7786.MCR-08-0200; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sankpal NV, 2009, CANCER RES, V69, P753, DOI 10.1158/0008-5472.CAN-08-2708; Schmidt DS, 2004, EXP CELL RES, V297, P329, DOI 10.1016/j.yexcr.2004.02.023; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Sundberg M, 2009, STEM CELL RES, V2, P113, DOI 10.1016/j.scr.2008.08.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trzpis M, 2008, J PATHOL, V216, P201, DOI 10.1002/path.2396; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Winter MJ, 2003, AM J PATHOL, V163, P2139, DOI 10.1016/S0002-9440(10)63570-5; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001	53	70	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33520	33532		10.1074/jbc.M111.256164	http://dx.doi.org/10.1074/jbc.M111.256164			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799003	Green Published, hybrid			2022-12-27	WOS:000294968800069
J	Lefrancois-Martinez, AM; Blondet-Trichard, A; Binart, N; Val, P; Chambon, C; Sahut-Barnola, I; Pointud, JC; Martinez, A				Lefrancois-Martinez, Anne-Marie; Blondet-Trichard, Antonine; Binart, Nadine; Val, Pierre; Chambon, Celine; Sahut-Barnola, Isabelle; Pointud, Jean-Christophe; Martinez, Antoine			Transcriptional Control of Adrenal Steroidogenesis NOVEL CONNECTION BETWEEN JANUS KINASE (JAK) 2 PROTEIN AND PROTEIN KINASE A (PKA) THROUGH STABILIZATION OF cAMP RESPONSE ELEMENT-BINDING PROTEIN (CREB) TRANSCRIPTION FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE REGULATORY PROTEIN; MULTIPLE SIGNALING PATHWAYS; MAMMARY EPITHELIAL-CELLS; PROLACTIN RECEPTOR; LUTEINIZING-HORMONE; CORTICOSTERONE SECRETION; ADRENOCORTICAL-CELLS; SOMATOSTATIN GENE; PRL RECEPTOR; MALE RATS	In the adrenal gland, adrenocorticotropin (ACTH) acting through the cAMP protein kinase (PKA) transduction pathway is the main regulator of genes involved in glucocorticoid synthesis. The prolactin (PRL) receptor is expressed in the adrenal cortex of most mammals, but experimental proof that PRL ensures direct control on glucocorticoid synthesis in rodents remains elusive. To unravel the physiological importance of PRL in adrenocortical functions, we measured steroidogenic capacity of Prlr-deficient mice (Prlr(-/-)) and explored the influence of JAK/STAT signaling, the major PRL transduction pathway, on the steroidogenic activity of adrenocortical cell cultures. We demonstrate that lack of Prlr does not affect basal (nor stress-induced) corticosterone levels in mice. PRL triggers JAK2/STAT5-dependent transcription in adrenal cells, but this does not influence corticosterone release. In contrast, pharmacological or siRNA-mediated inhibition of JAK2 reveals its essential role in both basal and ACTH/cAMP-induced steroidogenesis. We demonstrate that nuclear JAK2 regulates the amount of active transcription factor CREB (cAMP response element-binding protein) through tyrosine phosphorylation and prevention of proteasomal degradation, which in turn leads to transcriptional activation of the rate-limiting steroidogenic Star gene. Hence, we describe a novel link between PKA and JAK2 by which nuclear JAK2 signaling controls adrenal steroidogenesis by increasing the stability of CREB.	[Lefrancois-Martinez, Anne-Marie; Blondet-Trichard, Antonine; Val, Pierre; Chambon, Celine; Sahut-Barnola, Isabelle; Pointud, Jean-Christophe; Martinez, Antoine] Clermont Univ, CNRS, UMR6247, F-63171 Aubiere, France; [Binart, Nadine] Univ Paris 11, Fac Med Paris Sud, F-94276 Le Kremlin Bicetre, France; [Binart, Nadine] Univ Paris 11, INSERM 693, F-94276 Le Kremlin Bicetre, France	Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Lefrancois-Martinez, AM (corresponding author), Clermont Univ, CNRS, UMR6247, BP80026,24 Ave Landais, F-63171 Aubiere, France.	a-marie.lefrancois-martinez@univ-bpclermont.fr; antoine.martinez@univ-bpclermont.fr	Binart, Nadine/F-2949-2013	Binart, Nadine/0000-0002-5606-3866; Val, Pierre/0000-0001-7648-5567	Centre National de la Recherche Scientifique (CNRS); Universite Blaise Pascal; Universite d'Auvergne and Agence Nationale pour la Recherche [ANR06-MRAR-007, ANR08-GENOPAT-002]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Blaise Pascal; Universite d'Auvergne and Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Centre National de la Recherche Scientifique (CNRS), Universite Blaise Pascal, and Universite d'Auvergne and Agence Nationale pour la Recherche Grants ANR06-MRAR-007 and ANR08-GENOPAT-002, Region Auvergne.	Aigueperse C, 2001, MOL ENDOCRINOL, V15, P93, DOI 10.1210/me.15.1.93; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Binart N, 2000, ENDOCRINOLOGY, V141, P2691, DOI 10.1210/en.141.7.2691; Blume A, 2009, ENDOCRINOLOGY, V150, P1841, DOI 10.1210/en.2008-1023; Boer AK, 2002, BLOOD, V100, P467, DOI 10.1182/blood.V100.2.467; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Boscaro M, 2001, LANCET, V357, P783, DOI 10.1016/S0140-6736(00)04172-6; Carvalho CRO, 2003, ENDOCRINOLOGY, V144, P638, DOI 10.1210/en.2002-220706; Chang LL, 1999, J CELL BIOCHEM, V73, P563; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Clevenger CV, 2009, TRENDS ENDOCRIN MET, V20, P223, DOI 10.1016/j.tem.2009.03.001; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; de Santa Barbara P, 1998, J BIOL CHEM, V273, P29654; Ehrhart-Bornstein M, 1998, ENDOCR REV, V19, P101, DOI 10.1210/er.19.2.101; Glasow A, 1996, J CLIN ENDOCR METAB, V81, P3103, DOI 10.1210/jc.81.8.3103; GOEBEL S, 1992, ENDOCRINOLOGY, V130, P914, DOI 10.1210/en.130.2.914; Goffin V, 1996, J BIOL CHEM, V271, P16573, DOI 10.1074/jbc.271.28.16573; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Imrich R, 2002, INT J TISSUE REACT, V24, P73; Jaroenporn S, 2007, ENDOCR J, V54, P703, DOI 10.1507/endocrj.K07-003; Jaroenporn S, 2009, LIFE SCI, V85, P172, DOI 10.1016/j.lfs.2009.05.011; Kaminska B, 2000, DOMEST ANIM ENDOCRIN, V19, P147, DOI 10.1016/S0739-7240(00)00076-X; Kan SF, 2003, EUR J PHARMACOL, V468, P141, DOI 10.1016/S0014-2999(03)01663-7; Kau MM, 2002, J INVEST MED, V50, P101, DOI 10.2310/6650.2002.31271; Kawamura M, 2007, INTERNAL MED, V46, P1117, DOI 10.2169/internalmedicine.46.6436; Kero J, 2000, J CLIN INVEST, V105, P633, DOI 10.1172/JCI7716; KLEMCKE HG, 1990, P SOC EXP BIOL MED, V195, P100, DOI 10.3181/00379727-195-43125; Li JH, 2003, J BIOL CHEM, V278, P52355, DOI 10.1074/jbc.M305232200; Lobie PE, 1996, ENDOCRINOLOGY, V137, P4037, DOI 10.1210/en.137.9.4037; Manna PR, 2003, STEROIDS, V68, P1125, DOI 10.1016/j.steroids.2003.07.009; Manna PR, 2003, J MOL ENDOCRINOL, V30, P381, DOI 10.1677/jme.0.0300381; Manna PR, 2002, MOL ENDOCRINOL, V16, P184, DOI 10.1210/me.16.1.184; MIMOU N, 1992, ENDOCRINOL JAPON, V39, P185; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MOREL G, 1994, NEUROENDOCRINOLOGY, V59, P78, DOI 10.1159/000126641; Mynard V, 2004, MOL ENDOCRINOL, V18, P2997, DOI 10.1210/me.2003-0417; Nilsson J, 2006, MOL CELL BIOL, V26, P5663, DOI 10.1128/MCB.02095-05; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; OUHTIT A, 1993, ENDOCRINOLOGY, V133, P135, DOI 10.1210/en.133.1.135; Pivonello R, 2004, J CLIN ENDOCR METAB, V89, P4493, DOI 10.1210/jc.2003-031746; Ragazzon B, 2006, ENDOCRINOLOGY, V147, P1805, DOI 10.1210/en.2005-1279; Ragazzon B, 2004, ENDOCR RES, V30, P945, DOI 10.1081/ERC-200044168; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Sakamoto K, 2007, MOL ENDOCRINOL, V21, P1877, DOI 10.1210/me.2006-0316; Sautin YuYu, 1992, Endocr Regul, V26, P35; Shraga-Slutzky Ilana, 2006, Pituitary, V9, P151, DOI 10.1007/s11102-006-9290-4; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532	50	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32976	32985		10.1074/jbc.M111.218016	http://dx.doi.org/10.1074/jbc.M111.218016			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808064	hybrid, Green Published			2022-12-27	WOS:000294968800015
J	Singh, BK; Sattler, JM; Chatterjee, M; Huttu, J; Schuler, H; Kursula, I				Singh, Bishal K.; Sattler, Julia M.; Chatterjee, Moon; Huttu, Jani; Schuler, Herwig; Kursula, Inari			Crystal Structures Explain Functional Differences in the Two Actin Depolymerization Factors of the Malaria Parasite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII; FILAMENT TURNOVER; PROTEIN-STRUCTURE; BINDING PROTEIN; HUMAN COFILIN; ADF/COFILIN; ACTOPHORIN; MODEL; DYNAMICS; PROFILIN	Apicomplexan parasites, such as the malaria-causing Plasmodium, utilize an actin-based motor for motility and host cell invasion. The actin filaments of these parasites are unusually short, and actin polymerization is under strict control of a small set of regulatory proteins, which are poorly conserved with their mammalian orthologs. Actin depolymerization factors (ADFs) are among the most important actin regulators, affecting the rates of filament turnover in a multifaceted manner. Plasmodium has two ADFs that display low sequence homology with each other and with the higher eukaryotic family members. Here, we show that ADF2, like canonical ADF proteins but unlike ADF1, binds to both globular and filamentous actin, severing filaments and inducing nucleotide exchange on the actin monomer. The crystal structure of Plasmodium ADF1 shows major differences from the ADF consensus, explaining the lack of F-actin binding. Plasmodium ADF2 structurally resembles the canonical members of the ADF/cofilin family.	[Singh, Bishal K.; Huttu, Jani; Kursula, Inari] Univ Oulu, Dept Biochem, Oulu 90014, Finland; [Sattler, Julia M.; Schuler, Herwig] Heidelberg Univ, Fac Med, Dept Infect Dis Parasitol, D-69120 Heidelberg, Germany; [Chatterjee, Moon; Huttu, Jani; Kursula, Inari] Helmholtz Ctr Infect Res, Ctr Struct Syst Biol, D-22607 Hamburg, Germany; [Chatterjee, Moon; Huttu, Jani; Kursula, Inari] Univ Hamburg, Deutsch Elektronen Synchrotron, D-22607 Hamburg, Germany	Finland National Institute for Health & Welfare; University of Oulu; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg	Schuler, H (corresponding author), Karolinska Inst, Struct Genom Consortium, Scheeles Vag 2, S-17177 Stockholm, Sweden.	herwig.schuler@ki.se; inari.kursula@helmholtz-hzi.de	Singh, Bishal/GPF-8900-2022; Kursula, Inari/F-7140-2013; Schuler, Herwig/E-5751-2011; Kursula, Inari/AHB-9980-2022	Singh, Bishal/0000-0001-5760-6765; Kursula, Inari/0000-0001-5236-7056; Schuler, Herwig/0000-0003-4059-3501; Kursula, Inari/0000-0001-5236-7056	European Community [FP7/2007-2013, 226716]; Academy of Finland; European Commission; Centre for International Mobility/Sitra; Sigrid Juselius Foundation; German Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft [SCHU1561]; Hoffman-Berling International Graduate School of Molecular and Cellular Biology	European Community(European Commission); Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); Centre for International Mobility/Sitra; Sigrid Juselius Foundation(Sigrid Juselius Foundation); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hoffman-Berling International Graduate School of Molecular and Cellular Biology	Data collection was supported by the European Community (FP7/2007-2013) under Grant Agreement 226716. This work was also supported by the Academy of Finland (to I. K.), the European Commission FP7 Marie Curie European Reintegration program (to I. K.), the Centre for International Mobility/Sitra (to B. K. S.), the Sigrid Juselius Foundation (to I. K.), the German Federal Ministry of Education and Research (to I. K.), Deutsche Forschungsgemeinschaft Grant SCHU1561 (to H. S.), and the Hartmut-Hoffman-Berling International Graduate School of Molecular and Cellular Biology (to J. M. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bernstein BW, 2000, CELL MOTIL CYTOSKEL, V47, P319, DOI 10.1002/1097-0169(200012)47:4<319::AID-CM6>3.0.CO;2-I; Blanchoin L, 2000, J MOL BIOL, V295, P203, DOI 10.1006/jmbi.1999.3336; Bowman GD, 2000, PROTEINS, V41, P374, DOI 10.1002/1097-0134(20001115)41:3<374::AID-PROT90>3.0.CO;2-F; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; COOPER JA, 1986, J BIOL CHEM, V261, P477; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Doi Y, 2010, BIOCHEM BIOPH RES CO, V397, P668, DOI 10.1016/j.bbrc.2010.05.155; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Galkin VE, 2003, J CELL BIOL, V163, P1057, DOI 10.1083/jcb.200308144; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Huttu J, 2010, ACTA CRYSTALLOGR F, V66, P583, DOI 10.1107/S1744309110011589; Kardos R, 2009, BIOPHYS J, V96, P2335, DOI 10.1016/j.bpj.2008.12.3906; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; KORN ED, 1978, P NATL ACAD SCI USA, V75, P588, DOI 10.1073/pnas.75.2.588; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kursula I, 2008, STRUCTURE, V16, P1638, DOI 10.1016/j.str.2008.09.008; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard SA, 1997, NAT STRUCT BIOL, V4, P369, DOI 10.1038/nsb0597-369; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Mehta S, 2010, J BIOL CHEM, V285, P6835, DOI 10.1074/jbc.M109.068155; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pfannstiel J, 2001, J BIOL CHEM, V276, P49476, DOI 10.1074/jbc.M104760200; Pope BJ, 2004, J BIOL CHEM, V279, P4840, DOI 10.1074/jbc.M310148200; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; Sattler J. M., 2011, EUR J CELL IN PRESS; Schatten H, 2003, MICROSC MICROANAL, V9, P330, DOI 10.1017/S143192760030095; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382	55	29	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28256	28264		10.1074/jbc.M111.211730	http://dx.doi.org/10.1074/jbc.M111.211730			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21832095	Green Published, Bronze			2022-12-27	WOS:000293557800043
